Psyllid ID: psy9858

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------
Protein Sequence
MPMPKMESTELPLEKSNCFFGGSNIFASSVWYIRVHSALKKQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWCCFAKDPSSHGNLFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKEMYW
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccHHHHHHHHHHccccccccccccccccccccEEEEEcccccEEEEEEEEcccccEEEEEEEEccccccccccccHHHHHHHHHHHHccccccEEEEEEEEEccEEEEEEEccHHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccEEEcccccccccccccccccccEEEEEcccccccccccccccccHHHHHHHHHHcccccccccccHHHHcccccccHHHHHHHcccccccccccHHHHHccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHEEEcEcccccEEEEEEEcccccccEEEEEEEEccccccHHccccHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEEcccEEHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEcccccEccccccccHHHccHHHHccccEccHHHHHHHHHHHHHHccccccccccHHHHcccccHHHHHHHHHHHcccHHHcccHHHHHccccHcccccccc
Coil and Loop (DISEMBL)
mpmpkmestelpleksncffggsnifaSSVWYIRVHSALKkqyllpdcevknDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIklgthadakdgiNRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDleviikdptivftpsnIKAYAIMTLRGLEylhdhwilhrdlkpnnllinkqgvlkigdfglakffgsptrlythQVVTRWYRLIKCLLYCVQFNVKNVqwccfakdpsshgnlfpgiplneifTAAGDDLLAVISSLlclnptkradctaTLKMDYFSLTKEMYW
Flexible Loop (DISEMBL)
MPMPKMESTELPLEKSNCFFGGSNIFASSVWYIRVHSALKKQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKkiklgthadakdgiNRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIkdptivftpsniKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWCCFAKDPSSHGNLFPGIPLNEIFTAAGDDLLAVISSLLclnptkradctatLKMDYFSLTKEMYW
Low Complexity Region (SEG)
MPMPKMESTELPLEKSNCFFGGSNIFASSVWYIRVHSALKKQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWCCFAKDPSSHGNLFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKEMYW
Disordered region (IsUnstruct)
****************NCFFGGSNIFASSVWYIRVHSALKKQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWCCFAKDPSSHGNLFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK****
Disordered Region (DISOPRED)
********************************************************YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWCCFAKDPSSHGNLFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLT*****
Disordered Region (DISEMBL)
**********LPLEKSNCFFGGSNIFASSVWYIRVHSALKKQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWCCFAKDPSSHGNLFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKEMYW
Disordered Region (DISPRO)
**************************************************KNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWCCFAKDPSSHGNLFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKE***
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MPMPKMESTELPLEKSNCFFGGSNIFASSVWYIRVHSALKKQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWCCFAKDPSSHGNLFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKEMYW
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	307	2.2.26 [Sep-21-2011]
P50613	346	Cyclin-dependent kinase 7	yes	N/A	0.820	0.728	0.525	5e-77
Q03147	346	Cyclin-dependent kinase 7	yes	N/A	0.820	0.728	0.515	8e-76
P51952	329	Cyclin-dependent kinase 7	yes	N/A	0.765	0.714	0.532	4e-74
P51953	344	Cyclin-dependent kinase 7	N/A	N/A	0.820	0.732	0.5	5e-74
P20911	352	Cyclin-dependent kinase 7	N/A	N/A	0.765	0.667	0.521	1e-72
Q9LMT0	391	Cyclin-dependent kinase D	yes	N/A	0.785	0.616	0.385	1e-52
Q9C9M7	348	Cyclin-dependent kinase D	no	N/A	0.785	0.692	0.392	6e-51
A2Y4B6	424	Cyclin-dependent kinase D	N/A	N/A	0.814	0.589	0.387	7e-51
P29620	424	Cyclin-dependent kinase D	yes	N/A	0.814	0.589	0.387	1e-50
Q12126	335	Serine/threonine-protein	yes	N/A	0.801	0.734	0.389	6e-50

>sp|P50613|CDK7_HUMAN Cyclin-dependent kinase 7 OS=Homo sapiens GN=CDK7 PE=1 SV=1

 Score =  288 bits (736), Expect = 5e-77,   Method: Compositional matrix adjust.
 Identities = 154/293 (52%), Positives = 187/293 (63%), Gaps = 41/293 (13%)

Query: 49  EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREI 108
           +VK+    Y +   +  G+FATV+KARD  T+ IVA+KKIKLG  ++AKDGINRTALREI
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63

Query: 109 KLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLR 168
           KLLQEL H N++GL D FG+ SN+SLVF+F++TDLEVIIKD ++V TPS+IKAY +MTL+
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123

Query: 169 GLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKC 228
           GLEYLH HWILHRDLKPNNLL+++ GVLK+ DFGLAK FGSP R YTHQVVTRWYR  + 
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPEL 183

Query: 229 LLYCVQFNVKNVQW---CCFAK-------------------------DPSSHG------- 253
           L     + V    W   C  A+                          P+          
Sbjct: 184 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 243

Query: 254 ------NLFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                   FPGIPL+ IF+AAGDDLL +I  L   NP  R   T  LKM YFS
Sbjct: 244 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 296

Serine/threonine kinase involved in cell cycle control and in RNA polymerase II-mediated RNA transcription. Cyclin-dependent kinases (CDKs) are activated by the binding to a cyclin and mediate the progression through the cell cycle. Each different complex controls a specific transition between 2 subsequent phases in the cell cycle. Required for both activation and complex formation of CDK1/cyclin-B during G2-M transition, and for activation of CDK2/cyclins during G1-S transition (but not complex formation). CDK7 is the catalytic subunit of the CDK-activating kinase (CAK) complex. Phosphorylates SPT5/SUPT5H, SF1/NR5A1, POLR2A, p53/TP53, CDK1, CDK2, CDK4, CDK6 and CDK11B/CDK11. CAK activates the cyclin-associated kinases CDK1, CDK2, CDK4 and CDK6 by threonine phosphorylation, thus regulating cell cycle progression. CAK complexed to the core-TFIIH basal transcription factor activates RNA polymerase II by serine phosphorylation of the repetitive C-terminus domain (CTD) of its large subunit (POLR2A), allowing its escape from the promoter and elongation of the transcripts. Phosphorylation of POLR2A in complex with DNA promotes transcription initiation by triggering dissociation from DNA. Its expression and activity are constant throughout the cell cycle. Upon DNA damage, triggers p53/TP53 activation by phosphorylation, but is inactivated in turn by p53/TP53; this feedback loop may lead to an arrest of the cell cycle and of the transcription, helping in cell recovery, or to apoptosis. Required for DNA-bound peptides-mediated transcription and cellular growth inhibition.
Homo sapiens (taxid: 9606)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 3

>sp|Q03147|CDK7_MOUSE Cyclin-dependent kinase 7 OS=Mus musculus GN=Cdk7 PE=1 SV=2

 Score =  283 bits (725), Expect = 8e-76,   Method: Compositional matrix adjust.
 Identities = 151/293 (51%), Positives = 184/293 (62%), Gaps = 41/293 (13%)

Query: 49  EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREI 108
           +VK+    Y +   +  G+FATV+KARD  T+ IVA+KKIKLG  ++AKDGINRTALREI
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63

Query: 109 KLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLR 168
           KLLQEL H N++GL D FG+ SN+SLVF+F++TDLEVIIKD ++V TPS+IKAY +MTL+
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123

Query: 169 GLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKC 228
           GLEYLH HWILHRDLKPNNLL+++ GVLK+ DFGLAK FGSP R YTHQVVTRWYR  + 
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPEL 183

Query: 229 LLYCVQFNVKNVQW---CCFAK-------------------------DPSSHG------- 253
           L     + V    W   C  A+                          P+          
Sbjct: 184 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 243

Query: 254 ------NLFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                   FPG+PL  IF AAGDDLL +I  L   NP  R   +  LK  YFS
Sbjct: 244 PDYVTFKSFPGVPLQHIFIAAGDDLLELIQGLFLFNPCTRTTASQALKTKYFS 296

Serine/threonine kinase involved in cell cycle control and in RNA polymerase II-mediated RNA transcription. Cyclin-dependent kinases (CDKs) are activated by the binding to a cyclin and mediate the progression through the cell cycle. Each different complex controls a specific transition between 2 subsequent phases in the cell cycle. Required for both activation and complex formation of CDK1/cyclin-B during G2-M transition, and for activation of CDK2/cyclins during G1-S transition (but not complex formation). CDK7 is the catalytic subunit of the CDK-activating kinase (CAK) complex. Phosphorylates SPT5/SUPT5H, SF1/NR5A1, POLR2A, p53/TP53, CDK1, CDK2, CDK4, CDK6 and CDK11B/CDK11. CAK activates the cyclin-associated kinases CDK1, CDK2, CDK4 and CDK6 by threonine phosphorylation, thus regulating cell cycle progression. CAK complexed to the core-TFIIH basal transcription factor activates RNA polymerase II by serine phosphorylation of the repetitive C-terminus domain (CTD) of its large subunit (POLR2A), allowing its escape from the promoter and elongation of the transcripts. Phosphorylation of POLR2A in complex with DNA promotes transcription initiation by triggering dissociation from DNA. Its expression and activity are constant throughout the cell cycle. Upon DNA damage, triggers p53/TP53 activation by phosphorylation, but is inactivated in turn by p53/TP53; this feedback loop may lead to an arrest of the cell cycle and of the transcription, helping in cell recovery, or to apoptosis. Required for DNA-bound peptides-mediated transcription and cellular growth inhibition.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|P51952|CDK7_RAT Cyclin-dependent kinase 7 (Fragment) OS=Rattus norvegicus GN=Cdk7 PE=2 SV=2

 Score =  278 bits (711), Expect = 4e-74,   Method: Compositional matrix adjust.
 Identities = 147/276 (53%), Positives = 176/276 (63%), Gaps = 41/276 (14%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G+FATV+KARD  T+ IVA+KKIKLG  ++AKDGINRTALREIKLLQEL H N++GL D 
Sbjct: 13  GQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDA 72

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
           FG+ SN+SLVF+F++TDLEVIIKD ++V TPS+IKAY +MTL+GLEYLH HWILHRDLKP
Sbjct: 73  FGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKP 132

Query: 186 NNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW--- 242
           NNLL+++ GVLK+ DFGLAK FGSP   YTHQVVTRWYR  + L     + V    W   
Sbjct: 133 NNLLLDENGVLKLADFGLAKSFGSPNWAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVG 192

Query: 243 CCFAK-------------------------DPSSHG-------------NLFPGIPLNEI 264
           C  A+                          P+                  FPGIPL  I
Sbjct: 193 CILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLQHI 252

Query: 265 FTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
           F AAGDDLL +I  L   NP  R   +  L+  YFS
Sbjct: 253 FIAAGDDLLELIQGLFLFNPCTRITASQALRTKYFS 288

Serine/threonine kinase involved in cell cycle control and in RNA polymerase II-mediated RNA transcription. Cyclin-dependent kinases (CDKs) are activated by the binding to a cyclin and mediate the progression through the cell cycle. Each different complex controls a specific transition between 2 subsequent phases in the cell cycle. Required for both activation and complex formation of CDK1/cyclin-B during G2-M transition, and for activation of CDK2/cyclins during G1-S transition (but not complex formation). CDK7 is the catalytic subunit of the CDK-activating kinase (CAK) complex. Phosphorylates SPT5/SUPT5H, SF1/NR5A1, POLR2A, p53/TP53, CDK1, CDK2, CDK4, CDK6 and CDK11B/CDK11. CAK activates the cyclin-associated kinases CDK1, CDK2, CDK4 and CDK6 by threonine phosphorylation, thus regulating cell cycle progression. CAK complexed to the core-TFIIH basal transcription factor activates RNA polymerase II by serine phosphorylation of the repetitive C-terminus domain (CTD) of its large subunit (POLR2A), allowing its escape from the promoter and elongation of the transcripts. Phosphorylation of POLR2A in complex with DNA promotes transcription initiation by triggering dissociation from DNA. Its expression and activity are constant throughout the cell cycle. Upon DNA damage, triggers p53/TP53 activation by phosphorylation, but is inactivated in turn by p53/TP53; this feedback loop may lead to an arrest of the cell cycle and of the transcription, helping in cell recovery, or to apoptosis. Required for DNA-bound peptides-mediated transcription and cellular growth inhibition.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|P51953|CDK7_CARAU Cyclin-dependent kinase 7 OS=Carassius auratus GN=cdk7 PE=2 SV=1

 Score =  278 bits (710), Expect = 5e-74,   Method: Compositional matrix adjust.
 Identities = 147/294 (50%), Positives = 186/294 (63%), Gaps = 42/294 (14%)

Query: 49  EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREI 108
           +VK+   +Y +   +  G+FATV+KARD  T+ IVA+KKIK+G   +AKDGINRTALREI
Sbjct: 4   DVKSRAKLYEKLDFLGEGQFATVYKARDKTTNTIVAIKKIKVGHRTEAKDGINRTALREI 63

Query: 109 KLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLR 168
           KLLQEL H N++GL D FG+ SN+SL+  F++TDLEVIIKD ++V TP+NIKAY +M+L+
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLLC-FMETDLEVIIKDTSLVLTPANIKAYILMSLQ 122

Query: 169 GLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKC 228
           GLEY+H+HWILHRDLKPNNLL+++ GVLK+ DFGLAK FGSP R+YTHQVVTRWYR  + 
Sbjct: 123 GLEYMHNHWILHRDLKPNNLLLDENGVLKLADFGLAKAFGSPNRVYTHQVVTRWYRAPEL 182

Query: 229 LLYCVQFNVKNVQWCC-------------FAKD---------------PSSHG------- 253
           L     + V    W                A D               P+          
Sbjct: 183 LFGARMYGVGVDMWAVGSILAELLLRVPFLAGDSDLDQLTGIFEALGTPTEETWPGMSNL 242

Query: 254 ------NLFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSL 301
                  LFPG PL  IF+AAGDDLL ++  L   NP  R   +  LKM YFS+
Sbjct: 243 PDYVSFKLFPGTPLEHIFSAAGDDLLELLKGLFTFNPCTRTTASQALKMRYFSI 296

Serine/threonine kinase involved in cell cycle control and in RNA polymerase II-mediated RNA transcription. Cyclin-dependent kinases (CDKs) are activated by the binding to a cyclin and mediate the progression through the cell cycle. Each different complex controls a specific transition between 2 subsequent phases in the cell cycle. Required for both activation and complex formation of cdk1/cyclin-B during G2-M transition, and for activation of cdk2/cyclins during G1-S transition (but not complex formation). cdk7 is the catalytic subunit of the CDK-activating kinase (CAK) complex. CAK activates the cyclin-associated kinases cdk1, cdk2, cdk4 and cdk6 by threonine phosphorylation, thus regulating cell cycle progression. CAK complexed to the core-TFIIH basal transcription factor activates RNA polymerase II by serine phosphorylation of the repetitive C-terminus domain (CTD) of its large subunit (polr2a), allowing its escape from the promoter and elongation of the transcripts.

Carassius auratus (taxid: 7957)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|P20911|CDK7_XENLA Cyclin-dependent kinase 7 OS=Xenopus laevis GN=cdk7 PE=1 SV=1

 Score =  273 bits (698), Expect = 1e-72,   Method: Compositional matrix adjust.
 Identities = 144/276 (52%), Positives = 176/276 (63%), Gaps = 41/276 (14%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G+FATV+KARD  TD IVA+KKIKLG  A+A DGINRTALREIKLLQEL H N++GL D 
Sbjct: 27  GQFATVYKARDKNTDRIVAIKKIKLGHRAEANDGINRTALREIKLLQELSHPNIIGLLDA 86

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
           FG+ SN+SLVF+F++TDLEVIIKD ++V TP++IK+Y +MTL+GLEYLH  WILHRDLKP
Sbjct: 87  FGHKSNISLVFDFMETDLEVIIKDTSLVLTPAHIKSYMLMTLQGLEYLHHLWILHRDLKP 146

Query: 186 NNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW--- 242
           NNLL+++ GVLK+ DFGLAK FGSP R+YTHQVVTRWYR  + L     + V    W   
Sbjct: 147 NNLLLDENGVLKLADFGLAKSFGSPNRIYTHQVVTRWYRSPELLFGARMYGVGVDMWAVG 206

Query: 243 CCFAK-------------------------DPSSHG-------------NLFPGIPLNEI 264
           C  A+                          P+                  FPG PL+ I
Sbjct: 207 CILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPGMSSLPDYVAFKSFPGTPLHLI 266

Query: 265 FTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
           F AAGDDLL ++  L   NP  R   +  L+  YFS
Sbjct: 267 FIAAGDDLLELLQGLFTFNPCARCTASQALRKRYFS 302

Serine/threonine kinase involved in cell cycle control and in RNA polymerase II-mediated RNA transcription. Cyclin-dependent kinases (CDKs) are activated by the binding to a cyclin and mediate the progression through the cell cycle. Each different complex controls a specific transition between 2 subsequent phases in the cell cycle. Required for both activation and complex formation of cdk1/cyclin-B during G2-M transition, and for activation of cdk2/cyclins during G1-S transition (but not complex formation). cdk7 is the catalytic subunit of the CDK-activating kinase (CAK) complex. CAK activates the cyclin-associated kinases cdk1, cdk2, cdk4 and cdk6 by threonine phosphorylation, thus regulating cell cycle progression. CAK complexed to the core-TFIIH basal transcription factor activates RNA polymerase II by serine phosphorylation of the repetitive C-terminus domain (CTD) of its large subunit (polr2a), allowing its escape from the promoter and elongation of the transcripts (By similarity). Involved in negative regulation of the meiotic maturation of Xenopus oocytes.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q9LMT0|CDKD3_ARATH Cyclin-dependent kinase D-3 OS=Arabidopsis thaliana GN=CDKD-3 PE=1 SV=1

 Score =  207 bits (526), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 110/285 (38%), Positives = 152/285 (53%), Gaps = 44/285 (15%)

Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y +   +  G +  VFKA D +T+  VA+KKI+LG     ++G+N TALREIK+L+EL H
Sbjct: 12  YLKQEVLGQGTYGVVFKATDTKTEQTVAIKKIRLGKQ---REGVNITALREIKMLKELKH 68

Query: 117 ENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH 176
            +++ L D F +  N+ LVFEF++TDLE +I+D  I  +P++IK+Y +MT +GL Y HD 
Sbjct: 69  PHIILLIDAFPHKENLHLVFEFMETDLEAVIRDSNIFLSPADIKSYLLMTFKGLAYCHDK 128

Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFN 236
           W+LHRD+KPNNLLI   G LK+ DFGLA+ FGSP R +THQV  RWYR  + L    Q+ 
Sbjct: 129 WVLHRDMKPNNLLIGVDGQLKLADFGLARIFGSPNRKFTHQVFARWYRAPELLFGAKQYG 188

Query: 237 VKNVQW---CCFA----KDPSSHGN----------------------------------L 255
                W   C FA    + P   GN                                   
Sbjct: 189 AAVDVWAVACIFAELLLRRPFLQGNSDIDQLSKIFAAFGTPKADQWPDLTKLPDYVEYQF 248

Query: 256 FPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
            P   L  +F A  DD L ++S +   +P  R      L+  YF+
Sbjct: 249 VPAPSLRSLFPAVSDDALDLLSKMFTYDPKARISIKQALEHRYFT 293

May form a stable complex with cyclin CYCH1-1 that phosphorylates human CDK2 and the C-terminal domain (CTD) of the large subunit of RNA polymerase II.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q9C9M7|CDKD2_ARATH Cyclin-dependent kinase D-2 OS=Arabidopsis thaliana GN=CDKD-2 PE=1 SV=1

 Score =  201 bits (510), Expect = 6e-51,   Method: Compositional matrix adjust.
 Identities = 112/285 (39%), Positives = 155/285 (54%), Gaps = 44/285 (15%)

Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y + + +  G +  V+KA D +T   VAVKKI+LG     K+G+N TALREIKLL+EL+H
Sbjct: 13  YLRRQILGEGTYGVVYKATDTKTGKTVAVKKIRLGNQ---KEGVNFTALREIKLLKELNH 69

Query: 117 ENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH 176
            +++ L D F +  ++ LVFE++ TDLE +I+D  I  +P +IK+Y +MTL+GL Y H  
Sbjct: 70  PHIVELIDAFPHDGSLHLVFEYMQTDLEAVIRDRNIFLSPGDIKSYMLMTLKGLAYCHKK 129

Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFN 236
           W+LHRD+KPNNLLI + G+LK+ DFGLA+ FGSP R +THQV   WYR  + L    Q+ 
Sbjct: 130 WVLHRDMKPNNLLIGENGLLKLADFGLARLFGSPNRRFTHQVFATWYRAPELLFGSRQYG 189

Query: 237 VKNVQW---CCFAK-------DPSSH-----GNLF------------------------- 256
                W   C FA+        P S      G +F                         
Sbjct: 190 AGVDVWAAGCIFAELLLRRPFLPGSTEIDQLGKIFQAFGTPVPSQWSDMIYLPDYMEFSY 249

Query: 257 -PGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
            P  PL  IF  A DD L +++ +   +P +R      L   YFS
Sbjct: 250 TPAPPLRTIFPMASDDALDLLAKMFIYDPRQRITIQQALDHRYFS 294

Forms a stable complex with cyclin CYCH1-1 that phosphorylates human CDK2 and the C-terminal domain (CTD) of the large subunit of RNA polymerase II.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|A2Y4B6|CDKD1_ORYSI Cyclin-dependent kinase D-1 OS=Oryza sativa subsp. indica GN=CDKD-1 PE=2 SV=1

 Score =  201 bits (510), Expect = 7e-51,   Method: Compositional matrix adjust.
 Identities = 114/294 (38%), Positives = 152/294 (51%), Gaps = 44/294 (14%)

Query: 47  DCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALR 106
           D  VK     Y +   +  G +  VFKA D +T   VA+KKI+LG +   K+G+N TALR
Sbjct: 9   DAGVKRVADRYLKREVLGEGTYGVVFKADDTKTGNTVAIKKIRLGKY---KEGVNFTALR 65

Query: 107 EIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
           EIKLL+EL   N++ L D F Y  N+ LVFEF++TDLE +I+D  IV +P++ K+Y  M 
Sbjct: 66  EIKLLKELKDSNIIELIDAFPYKGNLHLVFEFMETDLEAVIRDRNIVLSPADTKSYIQMM 125

Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           L+GL + H  W+LHRD+KPNNLLI   G LK+ DFGLA+ FGSP R +THQV  RWYR  
Sbjct: 126 LKGLAFCHKKWVLHRDMKPNNLLIGADGQLKLADFGLARIFGSPERNFTHQVFARWYRAP 185

Query: 227 KCLLYCVQFNVKNVQW---CCFAK------------DPSSHGNLFPGI------------ 259
           + L    Q+      W   C FA+            D    G +F               
Sbjct: 186 ELLFGTKQYGSAVDIWAAGCIFAELLLRRPFLQGSSDIDQLGKIFAAFGTPKSSQWPDMV 245

Query: 260 --------------PLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF 299
                         PL  +F  A DD L ++S +   +P  R      L+  YF
Sbjct: 246 YLPDYVEYQFVSAPPLRSLFPMASDDALDLLSRMFTYDPKARITAQQALEHRYF 299

Oryza sativa subsp. indica (taxid: 39946)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|P29620|CDKD1_ORYSJ Cyclin-dependent kinase D-1 OS=Oryza sativa subsp. japonica GN=CDKD-1 PE=1 SV=1

 Score =  200 bits (508), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 114/294 (38%), Positives = 152/294 (51%), Gaps = 44/294 (14%)

Query: 47  DCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALR 106
           D  VK     Y +   +  G +  VFKA D +T   VA+KKI+LG +   K+G+N TALR
Sbjct: 9   DAGVKRVADRYLKREVLGEGTYGVVFKAVDTKTGNTVAIKKIRLGKY---KEGVNFTALR 65

Query: 107 EIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
           EIKLL+EL   N++ L D F Y  N+ LVFEF++TDLE +I+D  IV +P++ K+Y  M 
Sbjct: 66  EIKLLKELKDSNIIELIDAFPYKGNLHLVFEFMETDLEAVIRDRNIVLSPADTKSYIQMM 125

Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           L+GL + H  W+LHRD+KPNNLLI   G LK+ DFGLA+ FGSP R +THQV  RWYR  
Sbjct: 126 LKGLAFCHKKWVLHRDMKPNNLLIGADGQLKLADFGLARIFGSPERNFTHQVFARWYRAP 185

Query: 227 KCLLYCVQFNVKNVQW---CCFAK------------DPSSHGNLFPGI------------ 259
           + L    Q+      W   C FA+            D    G +F               
Sbjct: 186 ELLFGTKQYGSAVDIWAAGCIFAELLLRRPFLQGSSDIDQLGKIFAAFGTPKSSQWPDMV 245

Query: 260 --------------PLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF 299
                         PL  +F  A DD L ++S +   +P  R      L+  YF
Sbjct: 246 YLPDYVEYQFVSAPPLRSLFPMASDDALDLLSRMFTYDPKARITAQQALEHRYF 299

CDK-activating kinase that may control G1/S phase progression. May control the rate of cell differentiation to accomplish proper development of organs, or in response to a changing environment. Forms a complex with cyclin CYCH1-1 that phosphorylates CDKA-1 and the C-terminal domain (CTD) of the large subunit of RNA polymerase II.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q12126|CRK1_SCHPO Serine/threonine-protein kinase crk1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=crk1 PE=1 SV=1

 Score =  197 bits (502), Expect = 6e-50,   Method: Compositional matrix adjust.
 Identities = 114/293 (38%), Positives = 165/293 (56%), Gaps = 47/293 (16%)

Query: 51  KNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKL 110
           K+D   Y + R V  G +A VF  R  ET+  VA+KKIK+G     KDGI+ +ALREIK 
Sbjct: 5   KSDKWTYVKERKVGEGTYAVVFLGRQKETNRRVAIKKIKVGQF---KDGIDISALREIKF 61

Query: 111 LQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGL 170
           L+E  H+NV+ L DVF   SN++++ EF+D+DLE++IKD  IVF P++IK++ +M LRGL
Sbjct: 62  LRESRHDNVIELVDVFSTKSNLNIILEFLDSDLEMLIKDKFIVFQPAHIKSWMVMLLRGL 121

Query: 171 EYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLL 230
            ++H  +ILHRDLKPNNLLI+  GVLK+ DFGL++ FG+P+ + +HQV+TRWYR  +  +
Sbjct: 122 HHIHSRFILHRDLKPNNLLISSDGVLKLADFGLSRDFGTPSHM-SHQVITRWYRPPELFM 180

Query: 231 YCVQFNVKNVQW---CCFA----KDPSSHGN--------LF------------------- 256
            C  +      W   C FA    + P   G         +F                   
Sbjct: 181 GCRSYGTGVDMWSVGCIFAELMLRTPYLPGESDLDQLNVIFRALGTPEPEVIKSMQQLPN 240

Query: 257 ---------PGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                    P   +  +F+AAG + + ++  +L  NP +R      L+  YFS
Sbjct: 241 YVEMKHIPPPNGGMEALFSAAGHEEIDLLKMMLDYNPYRRPTAQQALEHHYFS 293

Protein kinase essential for cell proliferation, where it is required for completion of cytokinesis. Phosphorylates the C-terminal repeat domain (CTD) of RNA polymerase II.

Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	307
91079764	338	PREDICTED: similar to cak1 [Tribolium ca	0.817	0.742	0.544	2e-78
383860799	338	PREDICTED: cyclin-dependent kinase 7-lik	0.765	0.695	0.572	3e-78
194763785	352	GF20951 [Drosophila ananassae] gi|190618	0.830	0.724	0.530	4e-78
441659468	319	PREDICTED: cyclin-dependent kinase 7 [No	0.820	0.789	0.582	4e-78
332031202	338	Cell division protein kinase 7 [Acromyrm	0.765	0.695	0.565	7e-78
307195280	338	Cell division protein kinase 7 [Harpegna	0.765	0.695	0.568	1e-77
158290711	343	AGAP002646-PA [Anopheles gambiae str. PE	0.820	0.734	0.535	3e-77
350414380	338	PREDICTED: cyclin-dependent kinase 7-lik	0.765	0.695	0.565	3e-77
340715191	338	PREDICTED: cyclin-dependent kinase 7-lik	0.765	0.695	0.565	3e-77
380016700	338	PREDICTED: cyclin-dependent kinase 7-lik	0.765	0.695	0.561	4e-77

>gi|91079764|ref|XP_966717.1| PREDICTED: similar to cak1 [Tribolium castaneum] gi|270004513|gb|EFA00961.1| hypothetical protein TcasGA2_TC003871 [Tribolium castaneum]

 Score =  298 bits (763), Expect = 2e-78,   Method: Compositional matrix adjust.
 Identities = 159/292 (54%), Positives = 189/292 (64%), Gaps = 41/292 (14%)

Query: 50  VKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIK 109
           + N L  Y +   +  G+FATV+KARD+ETD IVAVKKIK+G+  +A+DGINRTALREIK
Sbjct: 1   MSNKLTRYEKIEFLGEGQFATVYKARDVETDNIVAVKKIKMGSRQEAQDGINRTALREIK 60

Query: 110 LLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRG 169
           LLQELHH NV+GL DVFG+MSNVSLVF+F+DTDLEVIIKD TI+ T  NIKAY I TL+G
Sbjct: 61  LLQELHHRNVIGLLDVFGHMSNVSLVFDFMDTDLEVIIKDNTIILTTGNIKAYIIQTLQG 120

Query: 170 LEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCL 229
           L+YLH +W+LHRDLKPNNLL+N  GVLKIGDFGLAK +GSP R+ THQVVTRWYR  + L
Sbjct: 121 LDYLHRNWVLHRDLKPNNLLVNSNGVLKIGDFGLAKLYGSPNRINTHQVVTRWYRCPELL 180

Query: 230 LYCVQFNVKNVQWC--CFAKDPSSHGNLFPG----------------------------- 258
                ++     W   C   +      LFPG                             
Sbjct: 181 FGAKLYSTGVDMWAVGCILAELLLRVPLFPGESDLDQLTKIFAVFGNPTEENWPGLKSLS 240

Query: 259 ----------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                     IPL  IFTAAGDDLL V+  LL LNP KR +C+  L M +FS
Sbjct: 241 DYVEFKPFTPIPLKNIFTAAGDDLLDVLEGLLVLNPLKRFECSKCLAMPFFS 292

Source: Tribolium castaneum

Species: Tribolium castaneum

Genus: Tribolium

Family: Tenebrionidae

Order: Coleoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|383860799|ref|XP_003705876.1| PREDICTED: cyclin-dependent kinase 7-like [Megachile rotundata]

 Score =  298 bits (762), Expect = 3e-78,   Method: Compositional matrix adjust.
 Identities = 158/276 (57%), Positives = 185/276 (67%), Gaps = 41/276 (14%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G+FATV+KA+DIET  IVAVKKIK+G+ A+AKDGINRTALREIKLLQEL H+NV+GL DV
Sbjct: 17  GQFATVYKAKDIETSKIVAVKKIKVGSRAEAKDGINRTALREIKLLQELKHDNVIGLLDV 76

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
           FGY SNVSLVF+F+DTDLE+IIKD  IV T +NIKAY I TL+GL+YLH +WILHRDLKP
Sbjct: 77  FGYKSNVSLVFDFMDTDLEIIIKDSNIVLTAANIKAYMIQTLQGLDYLHYNWILHRDLKP 136

Query: 186 NNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW--- 242
           NNLL+N +GVLKIGDFGLAKFFGSP R+ THQVVTRWYR  + L     +      W   
Sbjct: 137 NNLLVNAEGVLKIGDFGLAKFFGSPNRINTHQVVTRWYRAPELLYGARLYGTGIDMWAVG 196

Query: 243 CCFAK-------------------------DPSSHG-------------NLFPGIPLNEI 264
           C  A+                          P+                  FPG PL  I
Sbjct: 197 CILAELLLRVPFLPGESDLDQLTRIFQTLGTPTEETWPGMTELPDFIQFKPFPGTPLKHI 256

Query: 265 FTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
           FTAAGDDLL +I+SLL +NP +R  C   L+M YFS
Sbjct: 257 FTAAGDDLLDLIASLLNVNPLERCTCDQALQMPYFS 292

Source: Megachile rotundata

Species: Megachile rotundata

Genus: Megachile

Family: Megachilidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|194763785|ref|XP_001964013.1| GF20951 [Drosophila ananassae] gi|190618938|gb|EDV34462.1| GF20951 [Drosophila ananassae]

 Score =  297 bits (761), Expect = 4e-78,   Method: Compositional matrix adjust.
 Identities = 158/298 (53%), Positives = 187/298 (62%), Gaps = 43/298 (14%)

Query: 44  LLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRT 103
           +LP+   K D   Y +   +  G+FA V+KARD  T  IVAVKKIK G+  +A+DGINRT
Sbjct: 1   MLPNANDKKDR--YAKLSFLGEGQFAIVYKARDTVTSQIVAVKKIKKGSREEARDGINRT 58

Query: 104 ALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYA 163
           ALREIK+LQEL HEN++GL DVFG +SNVSLVF+F+DTDLEVIIKD  I+ TP+NIKAYA
Sbjct: 59  ALREIKILQELQHENIIGLVDVFGQLSNVSLVFDFMDTDLEVIIKDTKIILTPANIKAYA 118

Query: 164 IMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWY 223
           IMTLRGLEYLH +WILHRDLKPNNLL+N  GVLKIGDFGLAK FGSP R+YTH VVTRWY
Sbjct: 119 IMTLRGLEYLHLNWILHRDLKPNNLLVNSDGVLKIGDFGLAKSFGSPNRIYTHHVVTRWY 178

Query: 224 RLIKCLLYCVQFNVKNVQW---CCFAK-------------------------DPSSHG-- 253
           R  + L    Q+      W   C  A+                          PS H   
Sbjct: 179 RSPELLFGARQYGTGVDMWAVGCILAELMLRVPFMPGDSDLDQLTRIFATLGTPSEHEWP 238

Query: 254 -----------NLFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                        FPG PL  IFTAAG+DL+ ++  L  +NP +R  C   L M YF 
Sbjct: 239 YISKLHDYLQFRHFPGTPLENIFTAAGNDLIHLMRCLFAMNPLRRVSCQEALSMPYFG 296

Source: Drosophila ananassae

Species: Drosophila ananassae

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|441659468|ref|XP_003266156.2| PREDICTED: cyclin-dependent kinase 7 [Nomascus leucogenys]

 Score =  297 bits (761), Expect = 4e-78,   Method: Compositional matrix adjust.
 Identities = 155/266 (58%), Positives = 188/266 (70%), Gaps = 14/266 (5%)

Query: 49  EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREI 108
           +VK+    Y +   +  G+FATV+KARD  T+ IVA+KKIKLG  ++AKDGINRTALREI
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63

Query: 109 KLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLR 168
           KLLQEL H N++GL D FG+ SN+SLVF+F++TDLEVIIKD ++V TPS+IKAY +MTL+
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123

Query: 169 GLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKC 228
           GLEYLH HWILHRDLKPNNLL+++ GVLK+ DFGLAK FGSP R YTHQVVTRWYR  + 
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPEL 183

Query: 229 LLYCVQFNVKNVQW---CCFAK------DPSSHGNL-----FPGIPLNEIFTAAGDDLLA 274
           L     + V    W   C  A+      D  S  +      FPGIPL+ IF+AAGDDLL 
Sbjct: 184 LFGARMYGVGVDMWAVGCILAELLLRVSDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLD 243

Query: 275 VISSLLCLNPTKRADCTATLKMDYFS 300
           +I  L   NP  R   T  LKM YFS
Sbjct: 244 LIQGLFLFNPCARITATQALKMKYFS 269

Source: Nomascus leucogenys

Species: Nomascus leucogenys

Genus: Nomascus

Family: Hylobatidae

Order: Primates

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|332031202|gb|EGI70758.1| Cell division protein kinase 7 [Acromyrmex echinatior]

 Score =  296 bits (758), Expect = 7e-78,   Method: Compositional matrix adjust.
 Identities = 156/276 (56%), Positives = 186/276 (67%), Gaps = 41/276 (14%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G+FATV+KA+DIET+ IVAVKKIK+G+ A+A+DGINRTALREIKLLQEL H+N++GL DV
Sbjct: 17  GQFATVYKAKDIETNKIVAVKKIKVGSRAEARDGINRTALREIKLLQELKHDNIIGLLDV 76

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
           FGY SNVSLVF+F+DTDLEVIIKD  IV T +NIK Y I TL+GL+YLH +WILHRDLKP
Sbjct: 77  FGYKSNVSLVFDFMDTDLEVIIKDSNIVLTAANIKTYMIQTLQGLDYLHFNWILHRDLKP 136

Query: 186 NNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW--- 242
           NNLL+N +GVLKIGDFGLAKFFGSP R+ THQVVTRWYR  + L     +      W   
Sbjct: 137 NNLLVNSEGVLKIGDFGLAKFFGSPNRINTHQVVTRWYRAPELLYGARLYGTGIDMWAVG 196

Query: 243 CCFAK-------------------------DPSSHG-------------NLFPGIPLNEI 264
           C  A+                          P+                  FPG+PL  I
Sbjct: 197 CILAELLLRVPFLPGESDLDQLTKIFQTLGTPTEETWQGMTELPDFIQFKPFPGMPLKHI 256

Query: 265 FTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
           FTAAGDDLL +I+SLL +NP +R  C   L+M YFS
Sbjct: 257 FTAAGDDLLDLIASLLNVNPLERCTCDQALQMPYFS 292

Source: Acromyrmex echinatior

Species: Acromyrmex echinatior

Genus: Acromyrmex

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|307195280|gb|EFN77236.1| Cell division protein kinase 7 [Harpegnathos saltator]

 Score =  296 bits (757), Expect = 1e-77,   Method: Compositional matrix adjust.
 Identities = 157/276 (56%), Positives = 186/276 (67%), Gaps = 41/276 (14%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G+FATV+KARDIET+ IVAVKKIK+G+ A+A+DGINRTALREIKLLQEL H+N++GL DV
Sbjct: 17  GQFATVYKARDIETNNIVAVKKIKVGSRAEARDGINRTALREIKLLQELKHDNIIGLLDV 76

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
           FGY SNVSLVF+F+DTDLEVIIKD  IV T +NIKAY I TL+GL+YLH +WILHRDLKP
Sbjct: 77  FGYKSNVSLVFDFMDTDLEVIIKDNNIVLTAANIKAYMIQTLQGLDYLHFNWILHRDLKP 136

Query: 186 NNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW--- 242
           NNLL+N +GVLKIGDFGLAKFFGSP R+ THQVVTRWYR  + L     +      W   
Sbjct: 137 NNLLVNSEGVLKIGDFGLAKFFGSPNRINTHQVVTRWYRAPELLYGARLYGTAIDMWAVG 196

Query: 243 CCFAK-------------------------DPSSHG-------------NLFPGIPLNEI 264
           C  A+                          P+                  FPG PL  I
Sbjct: 197 CILAELLLRVPFLPGESDLDQLTRIFQTLGTPTEETWPGMIELPDFIQFKPFPGTPLKHI 256

Query: 265 FTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
           FTAAGDDLL +I+SLL +NP +R  C   L+M YF+
Sbjct: 257 FTAAGDDLLDLIASLLNVNPLERCTCDQALQMPYFN 292

Source: Harpegnathos saltator

Species: Harpegnathos saltator

Genus: Harpegnathos

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|158290711|ref|XP_312281.3| AGAP002646-PA [Anopheles gambiae str. PEST] gi|157018027|gb|EAA07668.3| AGAP002646-PA [Anopheles gambiae str. PEST]

 Score =  294 bits (753), Expect = 3e-77,   Method: Compositional matrix adjust.
 Identities = 157/293 (53%), Positives = 188/293 (64%), Gaps = 41/293 (13%)

Query: 49  EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREI 108
           E+ N L  Y +   +  G+FATV+KARD ET+ IVAVKKIK+G   +A DGINRTALREI
Sbjct: 2   EILNRLNRYEKIDFLGEGQFATVYKARDAETNEIVAVKKIKIGNREEAADGINRTALREI 61

Query: 109 KLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLR 168
           KLL EL HEN++GL DVFG+ SNVSLVF+F+DTDLE+IIKDP I+ TP+NIK+Y I TLR
Sbjct: 62  KLLHELQHENIIGLLDVFGHKSNVSLVFDFMDTDLEIIIKDPKIILTPANIKSYMIQTLR 121

Query: 169 GLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKC 228
           GLEYLH HWILHRDLKPNNLLI+  GVLKIGDFGLAKFFGSP R+ T+QVVTRWYR  + 
Sbjct: 122 GLEYLHQHWILHRDLKPNNLLISGTGVLKIGDFGLAKFFGSPNRINTNQVVTRWYRCPEL 181

Query: 229 LLYCVQFNVKNVQW---CCFAK-------------------------DPSSHG------- 253
           L    Q+ +    W   C  A+                          P+          
Sbjct: 182 LFGARQYGIGVDIWAVGCILAELLLRVPFLPGESDLDQLTRIFQVLGTPNETNWPDVKSL 241

Query: 254 ------NLFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                   +P IPL +IFTAA DDL+ + + +L L P  R  CT  LKM YFS
Sbjct: 242 PDYVQYKFYPPIPLRDIFTAASDDLIELANKMLALYPLHRCSCTEALKMAYFS 294

Source: Anopheles gambiae str. PEST

Species: Anopheles gambiae

Genus: Anopheles

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|350414380|ref|XP_003490299.1| PREDICTED: cyclin-dependent kinase 7-like [Bombus impatiens]

 Score =  294 bits (753), Expect = 3e-77,   Method: Compositional matrix adjust.
 Identities = 156/276 (56%), Positives = 185/276 (67%), Gaps = 41/276 (14%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G+FATV+KA+DIET  IVAVKKIK+G+ A+A+DGINRTALREIKLLQEL H+NV+GL DV
Sbjct: 17  GQFATVYKAKDIETSKIVAVKKIKVGSRAEARDGINRTALREIKLLQELKHDNVIGLLDV 76

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
           FG+ SNVSLVF+F+DTDLE+IIKD  IV T +NIKAY I TL+GL+YLH +WILHRDLKP
Sbjct: 77  FGHKSNVSLVFDFMDTDLEIIIKDSNIVLTAANIKAYMIQTLQGLDYLHYNWILHRDLKP 136

Query: 186 NNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW--- 242
           NNLL+N +GVLKIGDFGLAKFFGSP R+ THQVVTRWYR  + L     +      W   
Sbjct: 137 NNLLVNSEGVLKIGDFGLAKFFGSPNRINTHQVVTRWYRSPELLYGARLYGTGIDMWAVG 196

Query: 243 CCFAK-------------------------DPSSHG-------------NLFPGIPLNEI 264
           C  A+                          P+                  FPG PL  I
Sbjct: 197 CILAELLLRVPFLPGESDLDQLTRIFQTLGTPTEETWPGMTELPDFIQFKPFPGTPLKHI 256

Query: 265 FTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
           FTAAGDDLL +I+SLL +NP +R  C   L+M YFS
Sbjct: 257 FTAAGDDLLDLIASLLNVNPLERCTCDQALQMPYFS 292

Source: Bombus impatiens

Species: Bombus impatiens

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|340715191|ref|XP_003396102.1| PREDICTED: cyclin-dependent kinase 7-like [Bombus terrestris]

 Score =  294 bits (753), Expect = 3e-77,   Method: Compositional matrix adjust.
 Identities = 156/276 (56%), Positives = 185/276 (67%), Gaps = 41/276 (14%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G+FATV+KA+DIET  IVAVKKIK+G+ A+A+DGINRTALREIKLLQEL H+NV+GL DV
Sbjct: 17  GQFATVYKAKDIETSKIVAVKKIKVGSRAEARDGINRTALREIKLLQELKHDNVIGLLDV 76

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
           FG+ SNVSLVF+F+DTDLE+IIKD  IV T +NIKAY I TL+GL+YLH +WILHRDLKP
Sbjct: 77  FGHKSNVSLVFDFMDTDLEIIIKDSNIVLTAANIKAYMIQTLQGLDYLHYNWILHRDLKP 136

Query: 186 NNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW--- 242
           NNLL+N +GVLKIGDFGLAKFFGSP R+ THQVVTRWYR  + L     +      W   
Sbjct: 137 NNLLVNSEGVLKIGDFGLAKFFGSPNRINTHQVVTRWYRSPELLYGARLYGTGIDMWAVG 196

Query: 243 CCFAK-------------------------DPSSHG-------------NLFPGIPLNEI 264
           C  A+                          P+                  FPG PL  I
Sbjct: 197 CILAELLLRVPFLPGESDLDQLTRIFQTLGTPTEETWPGMTELPDFIQFKPFPGTPLKHI 256

Query: 265 FTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
           FTAAGDDLL +I+SLL +NP +R  C   L+M YFS
Sbjct: 257 FTAAGDDLLDLIASLLNVNPLERCTCDQALQMPYFS 292

Source: Bombus terrestris

Species: Bombus terrestris

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|380016700|ref|XP_003692313.1| PREDICTED: cyclin-dependent kinase 7-like [Apis florea]

 Score =  294 bits (752), Expect = 4e-77,   Method: Compositional matrix adjust.
 Identities = 155/276 (56%), Positives = 185/276 (67%), Gaps = 41/276 (14%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G+FATV+KA+D+ET  IVAVKKIK+G+ A+A+DGINRTALREIKLLQEL H+NV+GL DV
Sbjct: 17  GQFATVYKAKDVETSKIVAVKKIKVGSRAEARDGINRTALREIKLLQELKHDNVIGLLDV 76

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
           FG+ SNVSLVF+F+DTDLE+IIKD  IV T +NIKAY I TL+GL+YLH +WILHRDLKP
Sbjct: 77  FGHKSNVSLVFDFMDTDLEIIIKDSNIVLTAANIKAYMIQTLQGLDYLHYNWILHRDLKP 136

Query: 186 NNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW--- 242
           NNLL+N +GVLKIGDFGLAKFFGSP R+ THQVVTRWYR  + L     +      W   
Sbjct: 137 NNLLVNAEGVLKIGDFGLAKFFGSPNRINTHQVVTRWYRAPELLYGARLYGTGIDMWAVG 196

Query: 243 CCFAK-------------------------DPSSHG-------------NLFPGIPLNEI 264
           C  A+                          P+                  FPG PL  I
Sbjct: 197 CILAELLLRVPFLPGESDLDQLTRIFQTLGTPTEETWPGMTELPDFIQFKPFPGTPLKHI 256

Query: 265 FTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
           FTAAGDDLL +I+SLL +NP +R  C   L+M YFS
Sbjct: 257 FTAAGDDLLDLIASLLNVNPLERCTCDQALQMPYFS 292

Source: Apis florea

Species: Apis florea

Genus: Apis

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	307
FB|FBgn0263237	353	Cdk7 "Cyclin-dependent kinase	0.729	0.634	0.586	7.5e-76
UNIPROTKB|P50613	346	CDK7 "Cyclin-dependent kinase	0.631	0.560	0.639	3.2e-75
UNIPROTKB|Q08DX5	346	CDK7 "Cyclin-dependent kinase	0.631	0.560	0.639	2.3e-74
UNIPROTKB|C9K505	346	CDK7 "Uncharacterized protein"	0.631	0.560	0.639	2.9e-74
MGI|MGI:102956	346	Cdk7 "cyclin-dependent kinase	0.631	0.560	0.639	5.9e-74
ZFIN|ZDB-GENE-010320-2	345	cdk7 "cyclin-dependent kinase	0.631	0.562	0.623	2.5e-73
RGD|621124	329	Cdk7 "cyclin-dependent kinase	0.576	0.537	0.677	1.1e-72
UNIPROTKB|P51952	329	Cdk7 "Cyclin-dependent kinase	0.576	0.537	0.677	1.1e-72
UNIPROTKB|E1C8L2	294	CDK7 "Uncharacterized protein"	0.576	0.602	0.672	5.3e-71
UNIPROTKB|E2R8R3	346	CDK7 "Uncharacterized protein"	0.631	0.560	0.608	1.1e-70

FB|FBgn0263237 Cdk7 "Cyclin-dependent kinase 7" [Drosophila melanogaster (taxid:7227)]

 Score = 658 (236.7 bits), Expect = 7.5e-76, Sum P(2) = 7.5e-76
 Identities = 136/232 (58%), Positives = 163/232 (70%)

Query:    44 LLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRT 103
             +LP+   K +   Y +   +  G+FATV+KARD  T+ IVAVKKIK G+  DA+DGINRT
Sbjct:     1 MLPNANDKTER--YAKLSFLGEGQFATVYKARDTVTNQIVAVKKIKKGSREDARDGINRT 58

Query:   104 ALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYA 163
             ALREIK+LQEL HEN++GL DVFG +SNVSLVF+F+DTDLEVIIKD  I+ T +NIKAYA
Sbjct:    59 ALREIKILQELQHENIIGLVDVFGQLSNVSLVFDFMDTDLEVIIKDNKIILTQANIKAYA 118

Query:   164 IMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWY 223
             IMTL+GLEYLH +WILHRDLKPNNLL+N  G+LKIGDFGLAK FGSP R+YTH VVTRWY
Sbjct:   119 IMTLKGLEYLHLNWILHRDLKPNNLLVNSDGILKIGDFGLAKSFGSPNRIYTHHVVTRWY 178

Query:   224 RLIKCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPGIP----LNEIFTAAG 269
             R  + L    Q+      W   C   +        PG      L  IF+  G
Sbjct:   179 RSPELLFGARQYGTGVDMWAVGCILAELMLRVPFMPGDSDLDQLTRIFSTLG 230

GO:0000079 "regulation of cyclin-dependent protein serine/threonine kinase activity" evidence=IDA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISS;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=NAS;IDA

GO:0007067 "mitosis" evidence=IMP

GO:0006468 "protein phosphorylation" evidence=NAS;IDA

GO:0005509 "calcium ion binding" evidence=ISS

GO:0006367 "transcription initiation from RNA polymerase II promoter" evidence=ISS

GO:0005675 "holo TFIIH complex" evidence=ISS;IDA

GO:0008353 "RNA polymerase II carboxy-terminal domain kinase activity" evidence=IDA

GO:0032806 "carboxy-terminal domain protein kinase complex" evidence=IDA

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0001111 "promoter clearance from RNA polymerase II promoter" evidence=IDA

GO:0006366 "transcription from RNA polymerase II promoter" evidence=IDA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|P50613 CDK7 "Cyclin-dependent kinase 7" [Homo sapiens (taxid:9606)]

 Score = 643 (231.4 bits), Expect = 3.2e-75, Sum P(2) = 3.2e-75
 Identities = 124/194 (63%), Positives = 152/194 (78%)

Query:    49 EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREI 108
             +VK+    Y +   +  G+FATV+KARD  T+ IVA+KKIKLG  ++AKDGINRTALREI
Sbjct:     4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63

Query:   109 KLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLR 168
             KLLQEL H N++GL D FG+ SN+SLVF+F++TDLEVIIKD ++V TPS+IKAY +MTL+
Sbjct:    64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123

Query:   169 GLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKC 228
             GLEYLH HWILHRDLKPNNLL+++ GVLK+ DFGLAK FGSP R YTHQVVTRWYR  + 
Sbjct:   124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPEL 183

Query:   229 LLYCVQFNVKNVQW 242
             L     + V    W
Sbjct:   184 LFGARMYGVGVDMW 197

GO:0005524 "ATP binding" evidence=IEA

GO:0051301 "cell division" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IEA

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

GO:0008353 "RNA polymerase II carboxy-terminal domain kinase activity" evidence=IDA

GO:0003713 "transcription coactivator activity" evidence=NAS

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=NAS

GO:0050681 "androgen receptor binding" evidence=NAS

GO:0006366 "transcription from RNA polymerase II promoter" evidence=IDA;TAS

GO:0004672 "protein kinase activity" evidence=IDA

GO:0008022 "protein C-terminus binding" evidence=IPI

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=IDA

GO:0030521 "androgen receptor signaling pathway" evidence=NAS

GO:0005675 "holo TFIIH complex" evidence=IDA

GO:0008094 "DNA-dependent ATPase activity" evidence=IDA

GO:0007050 "cell cycle arrest" evidence=TAS

GO:0000079 "regulation of cyclin-dependent protein serine/threonine kinase activity" evidence=TAS

GO:0008283 "cell proliferation" evidence=TAS

GO:0005634 "nucleus" evidence=IDA

GO:0005654 "nucleoplasm" evidence=TAS

GO:0006281 "DNA repair" evidence=TAS

GO:0006283 "transcription-coupled nucleotide-excision repair" evidence=TAS

GO:0006289 "nucleotide-excision repair" evidence=TAS

GO:0006360 "transcription from RNA polymerase I promoter" evidence=TAS

GO:0006361 "transcription initiation from RNA polymerase I promoter" evidence=TAS

GO:0006362 "transcription elongation from RNA polymerase I promoter" evidence=TAS

GO:0006363 "termination of RNA polymerase I transcription" evidence=TAS

GO:0006367 "transcription initiation from RNA polymerase II promoter" evidence=TAS

GO:0006368 "transcription elongation from RNA polymerase II promoter" evidence=TAS

GO:0006370 "7-methylguanosine mRNA capping" evidence=TAS

GO:0010467 "gene expression" evidence=TAS

GO:0016032 "viral reproduction" evidence=TAS

GO:0050434 "positive regulation of viral transcription" evidence=TAS

GO:0000080 "G1 phase of mitotic cell cycle" evidence=TAS

GO:0000082 "G1/S transition of mitotic cell cycle" evidence=TAS

GO:0000084 "S phase of mitotic cell cycle" evidence=TAS

GO:0000086 "G2/M transition of mitotic cell cycle" evidence=TAS

GO:0000278 "mitotic cell cycle" evidence=TAS

GO:0000718 "nucleotide-excision repair, DNA damage removal" evidence=TAS

GO:0005737 "cytoplasm" evidence=IDA

GO:0005739 "mitochondrion" evidence=IDA

UNIPROTKB|Q08DX5 CDK7 "Cyclin-dependent kinase 7" [Bos taurus (taxid:9913)]

 Score = 644 (231.8 bits), Expect = 2.3e-74, Sum P(2) = 2.3e-74
 Identities = 124/194 (63%), Positives = 153/194 (78%)

Query:    49 EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREI 108
             +VK+    Y +   +  G+FATV+KARD  T+ IVA+KKIKLG  ++AKDGINRTALREI
Sbjct:     4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63

Query:   109 KLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLR 168
             KLLQEL H N++GL D FG+ SN+SLVF+F++TDLEVIIKD ++V TPS+IKAY +MTL+
Sbjct:    64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123

Query:   169 GLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKC 228
             GLEYLH HWILHRDLKPNNLL+++ GVLK+ DFGLAK FGSP+R YTHQVVTRWYR  + 
Sbjct:   124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPSRAYTHQVVTRWYRAPEL 183

Query:   229 LLYCVQFNVKNVQW 242
             L     + V    W
Sbjct:   184 LFGARMYGVGVDMW 197

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=IEA

GO:0008353 "RNA polymerase II carboxy-terminal domain kinase activity" evidence=IEA

GO:0008094 "DNA-dependent ATPase activity" evidence=IEA

GO:0008022 "protein C-terminus binding" evidence=IEA

GO:0006366 "transcription from RNA polymerase II promoter" evidence=IEA

GO:0005739 "mitochondrion" evidence=IEA

GO:0005675 "holo TFIIH complex" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|C9K505 CDK7 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 643 (231.4 bits), Expect = 2.9e-74, Sum P(2) = 2.9e-74
 Identities = 124/194 (63%), Positives = 152/194 (78%)

Query:    49 EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREI 108
             +VK+    Y +   +  G+FATV+KARD  T+ IVA+KKIKLG  ++AKDGINRTALREI
Sbjct:     4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63

Query:   109 KLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLR 168
             KLLQEL H N++GL D FG+ SN+SLVF+F++TDLEVIIKD ++V TPS+IKAY +MTL+
Sbjct:    64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123

Query:   169 GLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKC 228
             GLEYLH HWILHRDLKPNNLL+++ GVLK+ DFGLAK FGSP R YTHQVVTRWYR  + 
Sbjct:   124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPEL 183

Query:   229 LLYCVQFNVKNVQW 242
             L     + V    W
Sbjct:   184 LFGARMYGVGVDMW 197

GO:0005634 "nucleus" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

MGI|MGI:102956 Cdk7 "cyclin-dependent kinase 7" [Mus musculus (taxid:10090)]

 Score = 643 (231.4 bits), Expect = 5.9e-74, Sum P(2) = 5.9e-74
 Identities = 124/194 (63%), Positives = 152/194 (78%)

Query:    49 EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREI 108
             +VK+    Y +   +  G+FATV+KARD  T+ IVA+KKIKLG  ++AKDGINRTALREI
Sbjct:     4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63

Query:   109 KLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLR 168
             KLLQEL H N++GL D FG+ SN+SLVF+F++TDLEVIIKD ++V TPS+IKAY +MTL+
Sbjct:    64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123

Query:   169 GLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKC 228
             GLEYLH HWILHRDLKPNNLL+++ GVLK+ DFGLAK FGSP R YTHQVVTRWYR  + 
Sbjct:   124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPEL 183

Query:   229 LLYCVQFNVKNVQW 242
             L     + V    W
Sbjct:   184 LFGARMYGVGVDMW 197

GO:0000166 "nucleotide binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=ISO;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISO;ISS

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO;IDA

GO:0005675 "holo TFIIH complex" evidence=ISO

GO:0005737 "cytoplasm" evidence=IEA

GO:0005829 "cytosol" evidence=ISO

GO:0005856 "cytoskeleton" evidence=ISO

GO:0006281 "DNA repair" evidence=IEA

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006366 "transcription from RNA polymerase II promoter" evidence=ISO

GO:0006468 "protein phosphorylation" evidence=IEA;ISO;ISS;IDA

GO:0006974 "response to DNA damage stimulus" evidence=IEA

GO:0007049 "cell cycle" evidence=ISS

GO:0008022 "protein C-terminus binding" evidence=ISO

GO:0008094 "DNA-dependent ATPase activity" evidence=ISO

GO:0008353 "RNA polymerase II carboxy-terminal domain kinase activity" evidence=ISO

GO:0016020 "membrane" evidence=ISO

GO:0016301 "kinase activity" evidence=IDA

GO:0016310 "phosphorylation" evidence=IDA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0032403 "protein complex binding" evidence=ISO

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=ISO

GO:0051301 "cell division" evidence=IEA

ZFIN|ZDB-GENE-010320-2 cdk7 "cyclin-dependent kinase 7" [Danio rerio (taxid:7955)]

 Score = 638 (229.6 bits), Expect = 2.5e-73, Sum P(2) = 2.5e-73
 Identities = 121/194 (62%), Positives = 153/194 (78%)

Query:    49 EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREI 108
             +VK+    Y +   +  G+FATV+KARD  T+ IVA+KKIK+G   +AKDGINRTALREI
Sbjct:     4 DVKSRAKRYEKLDFLGEGQFATVYKARDKTTNTIVAIKKIKVGHRTEAKDGINRTALREI 63

Query:   109 KLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLR 168
             KLLQEL H N++GL D FG+ SN+SLVF++++TDLEVIIKD ++V TP+NIKAY +MTL+
Sbjct:    64 KLLQELSHPNIIGLLDAFGHKSNISLVFDYMETDLEVIIKDTSLVLTPANIKAYILMTLQ 123

Query:   169 GLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKC 228
             GLEY+H+HWILHRDLKPNNLL+++ GVLK+ DFGLAK FGSP R+YTHQVVTRWYR  + 
Sbjct:   124 GLEYMHNHWILHRDLKPNNLLLDENGVLKLADFGLAKAFGSPNRVYTHQVVTRWYRAPEL 183

Query:   229 LLYCVQFNVKNVQW 242
             L     + V    W
Sbjct:   184 LFGARMYGVGVDMW 197

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

RGD|621124 Cdk7 "cyclin-dependent kinase 7" [Rattus norvegicus (taxid:10116)]

 Score = 634 (228.2 bits), Expect = 1.1e-72, Sum P(2) = 1.1e-72
 Identities = 120/177 (67%), Positives = 144/177 (81%)

Query:    66 GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
             G+FATV+KARD  T+ IVA+KKIKLG  ++AKDGINRTALREIKLLQEL H N++GL D 
Sbjct:    13 GQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDA 72

Query:   126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
             FG+ SN+SLVF+F++TDLEVIIKD ++V TPS+IKAY +MTL+GLEYLH HWILHRDLKP
Sbjct:    73 FGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKP 132

Query:   186 NNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW 242
             NNLL+++ GVLK+ DFGLAK FGSP   YTHQVVTRWYR  + L     + V    W
Sbjct:   133 NNLLLDENGVLKLADFGLAKSFGSPNWAYTHQVVTRWYRAPELLFGARMYGVGVDMW 189

GO:0000307 "cyclin-dependent protein kinase holoenzyme complex" evidence=TAS

GO:0004672 "protein kinase activity" evidence=ISO;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO;IDA

GO:0005675 "holo TFIIH complex" evidence=ISO;ISS

GO:0005737 "cytoplasm" evidence=ISO

GO:0005739 "mitochondrion" evidence=ISO

GO:0005829 "cytosol" evidence=IDA

GO:0005856 "cytoskeleton" evidence=IDA

GO:0006281 "DNA repair" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006366 "transcription from RNA polymerase II promoter" evidence=ISO;ISS

GO:0006468 "protein phosphorylation" evidence=ISO;IDA

GO:0007049 "cell cycle" evidence=TAS

GO:0007126 "meiosis" evidence=IEA

GO:0008022 "protein C-terminus binding" evidence=ISO

GO:0008094 "DNA-dependent ATPase activity" evidence=ISO;ISS

GO:0008353 "RNA polymerase II carboxy-terminal domain kinase activity" evidence=ISO;ISS

GO:0016020 "membrane" evidence=IDA

GO:0016301 "kinase activity" evidence=ISO

GO:0016310 "phosphorylation" evidence=ISO

GO:0032403 "protein complex binding" evidence=IDA

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=ISO

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

GO:0051301 "cell division" evidence=IEA

UNIPROTKB|P51952 Cdk7 "Cyclin-dependent kinase 7" [Rattus norvegicus (taxid:10116)]

 Score = 634 (228.2 bits), Expect = 1.1e-72, Sum P(2) = 1.1e-72
 Identities = 120/177 (67%), Positives = 144/177 (81%)

Query:    66 GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
             G+FATV+KARD  T+ IVA+KKIKLG  ++AKDGINRTALREIKLLQEL H N++GL D 
Sbjct:    13 GQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDA 72

Query:   126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
             FG+ SN+SLVF+F++TDLEVIIKD ++V TPS+IKAY +MTL+GLEYLH HWILHRDLKP
Sbjct:    73 FGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKP 132

Query:   186 NNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW 242
             NNLL+++ GVLK+ DFGLAK FGSP   YTHQVVTRWYR  + L     + V    W
Sbjct:   133 NNLLLDENGVLKLADFGLAKSFGSPNWAYTHQVVTRWYRAPELLFGARMYGVGVDMW 189

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|E1C8L2 CDK7 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 617 (222.3 bits), Expect = 5.3e-71, Sum P(2) = 5.3e-71
 Identities = 119/177 (67%), Positives = 141/177 (79%)

Query:    66 GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
             G+F TV+KA+D  T  IVA+KKIKLG  ++AKDGINRTALREIKLLQEL H NV+GL D 
Sbjct:    19 GQFDTVYKAKDKNTGQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNVIGLLDA 78

Query:   126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
             FG+ SN+SLVF+F++TDLEVIIKD +IV T S+IKAY +MTL+GLEYLH  WILHRDLKP
Sbjct:    79 FGHKSNISLVFDFMETDLEVIIKDTSIVLTQSHIKAYMLMTLQGLEYLHQQWILHRDLKP 138

Query:   186 NNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW 242
             NNLL++  GVLK+ DFGLAK FGSP R+YTHQVVTRWYR  + L     + V    W
Sbjct:   139 NNLLLDGNGVLKLADFGLAKSFGSPNRVYTHQVVTRWYRSPELLFGARMYGVGVDMW 195

GO:0005524 "ATP binding" evidence=IEA

GO:0005675 "holo TFIIH complex" evidence=IEA

GO:0005739 "mitochondrion" evidence=IEA

GO:0006366 "transcription from RNA polymerase II promoter" evidence=IEA

GO:0008022 "protein C-terminus binding" evidence=IEA

GO:0008094 "DNA-dependent ATPase activity" evidence=IEA

GO:0008353 "RNA polymerase II carboxy-terminal domain kinase activity" evidence=IEA

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=IEA

UNIPROTKB|E2R8R3 CDK7 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 609 (219.4 bits), Expect = 1.1e-70, Sum P(2) = 1.1e-70
 Identities = 118/194 (60%), Positives = 146/194 (75%)

Query:    49 EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREI 108
             +VK+    Y +   +  G+ A V++     T  IVA+KKIKLG  ++AKDGINRTALREI
Sbjct:     4 DVKSRAKRYEKLDFLGEGQIAPVYRPETKNTHQIVAIKKIKLGHRSEAKDGINRTALREI 63

Query:   109 KLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLR 168
             KLLQEL H N++GL D FG+ SN+SLVF+F++TDLEVIIKD ++V TPS+IKAY +MTL+
Sbjct:    64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123

Query:   169 GLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKC 228
             GLEYLH HWILHRDLKPNNLL+++ GVLK+ DFGLAK FGSP R YTHQVVTRWYR  + 
Sbjct:   124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPEL 183

Query:   229 LLYCVQFNVKNVQW 242
             L     + V    W
Sbjct:   184 LFGARMYGVGVDMW 197

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
P50613	CDK7_HUMAN	2, ., 7, ., 1, 1, ., 2, 3	0.5255	0.8208	0.7283	yes	N/A
Q27032	CDC2H_THEPA	2, ., 7, ., 1, 1, ., 2, 3	0.3566	0.7752	0.7986	yes	N/A
Q26671	CDC2H_THEAN	2, ., 7, ., 1, 1, ., 2, 3	0.3566	0.7752	0.7986	yes	N/A
Q9LMT0	CDKD3_ARATH	2, ., 7, ., 1, 1, ., 2, 3	0.3859	0.7850	0.6163	yes	N/A
Q12126	CRK1_SCHPO	2, ., 7, ., 1, 1, ., 2, 3	0.3890	0.8013	0.7343	yes	N/A
P51952	CDK7_RAT	2, ., 7, ., 1, 1, ., 2, 3	0.5326	0.7654	0.7142	yes	N/A
Q03147	CDK7_MOUSE	2, ., 7, ., 1, 1, ., 2, 3	0.5153	0.8208	0.7283	yes	N/A
P54685	CDK7_DICDI	2, ., 7, ., 1, 1, ., 2, 3	0.3682	0.7654	0.6527	yes	N/A
P06242	KIN28_YEAST	2, ., 7, ., 1, 1, ., 2, 3	0.3484	0.7817	0.7843	yes	N/A

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	307
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-116
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-81
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-78
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-61
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	7e-59
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-58
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-57
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-55
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-51
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-51
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-50
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	7e-50
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-49
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	6e-49
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	8e-48
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	9e-48
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-47
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	5e-46
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-45
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-45
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-43
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-42
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	9e-42
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-41
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-40
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-39
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-38
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	6e-38
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	6e-38
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-37
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	6e-37
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	8e-37
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-36
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-36
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-34
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-34
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-33
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-32
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-31
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-30
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-30
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	5e-30
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-29
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	9e-29
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-28
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-28
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-28
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-28
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-27
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-26
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-26
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	6e-26
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-25
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-25
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-25
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-25
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-24
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-24
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	6e-24
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-23
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-23
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-23
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-23
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-22
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-22
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-22
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-21
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-20
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-20
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	7e-20
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-19
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-19
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-19
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-19
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	8e-19
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-18
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-18
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-18
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-18
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-18
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	7e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-17
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-17
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-17
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-17
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	5e-17
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	5e-17
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	8e-17
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-16
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-16
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-16
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	7e-16
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	8e-16
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-15
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-15
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-15
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-15
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-15
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	9e-15
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-14
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-14
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-14
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-14
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-14
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-13
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	5e-13
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-13
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	7e-13
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-12
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-12
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-12
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-12
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	6e-12
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	7e-12
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	8e-12
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-11
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-11
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-11
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-11
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-11
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-11
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-11
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-11
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-11
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-11
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	9e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	9e-11
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-10
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-10
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-10
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-10
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-10
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-10
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-10
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-10
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-10
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-10
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-10
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	5e-10
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	8e-10
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	9e-10
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-09
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-09
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-09
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-09
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-09
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-09
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-09
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-09
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-09
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-09
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-09
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-09
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-09
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-09
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-09
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-09
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-09
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-09
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-09
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	5e-09
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-09
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	6e-09
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-09
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	6e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	6e-09
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	6e-09
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	9e-09
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-08
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-08
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-08
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-08
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-08
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-08
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-08
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-08
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-08
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-08
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-08
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-08
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-08
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	3e-08
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-08
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-08
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-08
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-08
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-08
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	5e-08
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-08
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	6e-08
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	7e-08
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	8e-08
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	9e-08
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	9e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-07
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-07
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-07
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-07
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-07
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-07
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-07
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-07
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-07
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-07
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-07
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-07
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-07
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-07
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-07
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-07
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-07
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	4e-07
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	6e-07
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	6e-07
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	7e-07
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	7e-07
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	8e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	8e-07
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	8e-07
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	9e-07
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	9e-07
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-06
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-06
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-06
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-06
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-06
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-06
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-06
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-06
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-06
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-06
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-06
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	5e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	6e-06
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	7e-06
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	7e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	8e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	8e-06
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-05
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	1e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-05
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-05
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-05
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-05
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-05
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-05
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-05
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-05
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	6e-05
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-05
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	8e-05
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	8e-05
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	9e-05
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	9e-05
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-04
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-04
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-04
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-04
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-04
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-04
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-04
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-04
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	5e-04
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	5e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	6e-04
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	7e-04
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	7e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	8e-04
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	8e-04
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	0.001
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.001
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.001
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	0.002
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	0.002
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	0.002
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	0.002
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	0.003
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	0.004
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	0.004

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  336 bits (863), Expect = e-116
 Identities = 142/276 (51%), Positives = 168/276 (60%), Gaps = 41/276 (14%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +A V+KARD ET  IVA+KKIKLG   +AKDGIN TALREIKLLQEL H N++GL DV
Sbjct: 11  GTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDV 70

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
           FG+ SN++LVFEF++TDLE +IKD +IV TP++IK+Y +MTLRGLEYLH +WILHRDLKP
Sbjct: 71  FGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKP 130

Query: 186 NNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW--- 242
           NNLLI   GVLK+ DFGLA+ FGSP R  THQVVTRWYR  + L     + V    W   
Sbjct: 131 NNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVG 190

Query: 243 CCFA-------------------------------------KDPSSHG-NLFPGIPLNEI 264
           C FA                                       P       FP  PL +I
Sbjct: 191 CIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQI 250

Query: 265 FTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
           F AA DD L ++  LL LNP KR      L+  YFS
Sbjct: 251 FPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  248 bits (634), Expect = 1e-81
 Identities = 112/277 (40%), Positives = 144/277 (51%), Gaps = 46/277 (16%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KARD  T  IVA+KKIKL       +GI +TALREIKLL+EL+H N++ L DV
Sbjct: 10  GTYGVVYKARDKLTGEIVAIKKIKLRFE---SEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
           F +  ++ LVFEF+DTDL  +IKD       S IK+Y    L+GL + H H ILHRDLKP
Sbjct: 67  FRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKP 126

Query: 186 NNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVK------- 238
            NLLIN +GVLK+ DFGLA+ FGSP R YTH VVTRWYR  + LL    ++         
Sbjct: 127 ENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVG 186

Query: 239 ---------------------------------NVQWCCFAKDPSSHGNLFP---GIPLN 262
                                               W  F     ++   FP   G+PL 
Sbjct: 187 CIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLP 246

Query: 263 EIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF 299
           ++F  A    L ++S +L  +P KR      L   YF
Sbjct: 247 KLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  239 bits (612), Expect = 3e-78
 Identities = 103/276 (37%), Positives = 136/276 (49%), Gaps = 45/276 (16%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KARD +T  IVA+KKI+L    + ++GI  TALREI LL+EL H N++ L DV
Sbjct: 10  GTYGVVYKARDKKTGEIVALKKIRLD---NEEEGIPSTALREISLLKELKHPNIVKLLDV 66

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
                 + LVFE+ D DL+  +       +P+ IK+     LRGL Y H H ILHRDLKP
Sbjct: 67  IHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKP 126

Query: 186 NNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYR----LIKCLLY---------- 231
            N+LIN+ GVLK+ DFGLA+ FG P R YTH+VVT WYR    L+    Y          
Sbjct: 127 QNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVG 186

Query: 232 CV------------------Q----FNV----KNVQWCCFAKDPSSHGNL--FPGIPLNE 263
           C+                  Q    F +        W    K P        FP   L +
Sbjct: 187 CIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEK 246

Query: 264 IFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF 299
           +      + + ++S +L  NP KR      LK  YF
Sbjct: 247 VLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  195 bits (499), Expect = 3e-61
 Identities = 105/284 (36%), Positives = 136/284 (47%), Gaps = 59/284 (20%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G    VFKA+D ET   VA+KK+ L      + GI   ALREIK LQ   H  V+ L DV
Sbjct: 11  GAHGIVFKAKDRETGETVALKKVALRR---LEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
           F + S   LV E++ +DL  +++D       + +K+Y  M L+G+ Y+H + I+HRDLKP
Sbjct: 68  FPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKP 127

Query: 186 NNLLINKQGVLKIGDFGLAKFFGSPT-RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQ-W- 242
            NLLI+  GVLKI DFGLA+ F     RLY+HQV TRWYR  + LLY  +     V  W 
Sbjct: 128 ANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE-LLYGARKYDPGVDLWA 186

Query: 243 --CCFA----KDPSSHGNLFPG-------------------------------------- 258
             C FA      P     LFPG                                      
Sbjct: 187 VGCIFAELLNGSP-----LFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPE 241

Query: 259 ---IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF 299
              IPL EIF  A  + L ++  LL  +P+KR      L+  YF
Sbjct: 242 SKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  190 bits (484), Expect = 7e-59
 Identities = 92/284 (32%), Positives = 140/284 (49%), Gaps = 56/284 (19%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KAR+ +T  +VA+KKI++    + K+G   TA+REIKLLQ+L H N++ L ++
Sbjct: 10  GTYGQVYKARNKKTGELVALKKIRM---ENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66

Query: 126 FGYM-----SNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
              +      ++ +VFE++D DL  ++  P + FT S IK Y    L GL+YLH + ILH
Sbjct: 67  ---VTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILH 123

Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFF-GSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKN 239
           RD+K +N+LIN  GVLK+ DFGLA+ +    +  YT++V+T WYR  + LL   ++  + 
Sbjct: 124 RDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEV 183

Query: 240 VQW---C----CFAKDPSSHG-------------------NLFPGI---PLNEIFT---- 266
             W   C     F   P   G                     +PG+   P  E       
Sbjct: 184 DMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKP 243

Query: 267 -----------AAGDDLLAVISSLLCLNPTKRADCTATLKMDYF 299
                            L ++  LL L+P KR      L+ +YF
Sbjct: 244 YKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  188 bits (480), Expect = 2e-58
 Identities = 105/277 (37%), Positives = 146/277 (52%), Gaps = 46/277 (16%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KARD  T  IVA+KKI+L T     +G+  TA+REI LL+EL+H N++ L DV
Sbjct: 10  GTYGVVYKARDKLTGEIVALKKIRLETE---DEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 126 FGYMSNVSLVFEFVDTDLEVII-KDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
               + + LVFEF+D DL+  +   P     P  IK+Y    L+G+ Y H H +LHRDLK
Sbjct: 67  VHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLK 126

Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-- 242
           P NLLI+++G LK+ DFGLA+ FG P R YTH+VVT WYR  + LL   Q++     W  
Sbjct: 127 PQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSI 186

Query: 243 -CCFA----KDPSSHGN-----LF--------------PGI----------------PLN 262
            C FA    + P   G+     LF              PG+                 L+
Sbjct: 187 GCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLS 246

Query: 263 EIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF 299
           ++     +D L ++S +L  +P KR    A L+  YF
Sbjct: 247 KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  187 bits (476), Expect = 1e-57
 Identities = 100/298 (33%), Positives = 147/298 (49%), Gaps = 67/298 (22%)

Query: 58  YQWRS-VHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y+  + +  G +  V++ARD +T  IVA+KK+K+      K+G   T+LREI +L +L H
Sbjct: 7   YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKM---EKEKEGFPITSLREINILLKLQH 63

Query: 117 ENVLGLTD-VFG-YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH 174
            N++ + + V G  +  + +V E+V+ DL+ +++     F  S +K   +  L G+ +LH
Sbjct: 64  PNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH 123

Query: 175 DHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQ 234
           D+WILHRDLK +NLL+N +G+LKI DFGLA+ +GSP + YT  VVT WYR  + LL   +
Sbjct: 124 DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKE 183

Query: 235 FNVKNVQW---CCFA----KDPSSHGNLFPGI----PLNEIF------------------ 265
           ++     W   C FA    K P     LFPG      LN+IF                  
Sbjct: 184 YSTAIDMWSVGCIFAELLTKKP-----LFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238

Query: 266 ------------------------TAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF 299
                                   +  G DLL   + LL  +P KR      LK  YF
Sbjct: 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLL---NRLLTYDPAKRISAEDALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  180 bits (458), Expect = 2e-55
 Identities = 73/257 (28%), Positives = 108/257 (42%), Gaps = 35/257 (13%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V+ ARD +T  +VA+K IK               LREIK+L++L H N++ L DV
Sbjct: 10  GSFGKVYLARDKKTGKLVAIKVIKK----KKIKKDRERILREIKILKKLKHPNIVRLYDV 65

Query: 126 FGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           F     + LV E+ +  DL  ++K      +    + Y    L  LEYLH   I+HRDLK
Sbjct: 66  FEDEDKLYLVMEYCEGGDLFDLLKK-RGRLSEDEARFYLRQILSALEYLHSKGIVHRDLK 124

Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYR---LIK-------------- 227
           P N+L+++ G +K+ DFGLA+      +L T  V T  Y    ++               
Sbjct: 125 PENILLDEDGHVKLADFGLARQLDPGEKLTT-FVGTPEYMAPEVLLGKGYGKAVDIWSLG 183

Query: 228 CLLYCVQ-----FNVKNVQWCCFAKDPSSHGNLFPGIPLNEIFTAAGDDLLAVISSLLCL 282
            +LY +      F   +     F           P  P          +   +I  LL  
Sbjct: 184 VILYELLTGKPPFPGDDQLLELF------KKIGKPKPPFPPPEWDISPEAKDLIRKLLVK 237

Query: 283 NPTKRADCTATLKMDYF 299
           +P KR      L+  +F
Sbjct: 238 DPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  170 bits (433), Expect = 1e-51
 Identities = 80/266 (30%), Positives = 121/266 (45%), Gaps = 47/266 (17%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F TV+KA+   T  IVAVK +K       K   ++TA REI++L+ L H N++ L D 
Sbjct: 10  GSFGTVYKAKHKGTGKIVAVKILKK---RSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66

Query: 126 FGYMSNVSLVFEFVD-TDL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
           F    ++ LV E+ +  DL + + +      +    K  A+  LRGLEYLH + I+HRDL
Sbjct: 67  FEDKDHLYLVMEYCEGGDLFDYLSRG--GPLSEDEAKKIALQILRGLEYLHSNGIIHRDL 124

Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYR---LIK------------- 227
           KP N+L+++ GV+KI DFGLAK     +   T  V T WY    ++              
Sbjct: 125 KPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWS 184

Query: 228 --CLLYCVQFNVKNVQWCCFAKDPSSHGN------LFPGIPL------NEIFTAAGDDLL 273
              +LY +             K P S  N      L   I           +++  ++  
Sbjct: 185 LGVILYEL----------LTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAK 234

Query: 274 AVISSLLCLNPTKRADCTATLKMDYF 299
            +I   L  +P+KR      L+  +F
Sbjct: 235 DLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  171 bits (434), Expect = 3e-51
 Identities = 87/279 (31%), Positives = 140/279 (50%), Gaps = 48/279 (17%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V++ARD  +  IVA+KK+++    + +DGI  ++LREI LL  L H N++ L +V
Sbjct: 18  GTYGIVYRARDTTSGEIVALKKVRM---DNERDGIPISSLREITLLLNLRHPNIVELKEV 74

Query: 126 F--GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
               ++ ++ LV E+ + DL  ++ +    F+ S +K   +  LRGL+YLH+++I+HRDL
Sbjct: 75  VVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDL 134

Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWC 243
           K +NLL+  +G LKI DFGLA+ +G P +  T +VVT WYR  + LL C  +      W 
Sbjct: 135 KVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWA 194

Query: 244 C-------FAKDP-------------------SSHGNLFPGI--------------PLNE 263
                    A  P                   + + +++PG               P N 
Sbjct: 195 VGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNN 254

Query: 264 I---FTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF 299
           +   F    +  L +++ LL  +P KRA     L+  YF
Sbjct: 255 LKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF 293

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  167 bits (426), Expect = 2e-50
 Identities = 84/196 (42%), Positives = 117/196 (59%), Gaps = 6/196 (3%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G + TVFKA++ ET  IVA+K+++L    D  +G+  +ALREI LL+EL H+N++ L DV
Sbjct: 11  GTYGTVFKAKNRETHEIVALKRVRL---DDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
                 ++LVFE+ D DL+           P  +K++    L+GL + H H +LHRDLKP
Sbjct: 68  LHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKP 127

Query: 186 NNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW--- 242
            NLLINK G LK+ DFGLA+ FG P R Y+ +VVT WYR    L     ++     W   
Sbjct: 128 QNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAG 187

Query: 243 CCFAKDPSSHGNLFPG 258
           C FA+  ++   LFPG
Sbjct: 188 CIFAELANAGRPLFPG 203

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  166 bits (422), Expect = 7e-50
 Identities = 87/197 (44%), Positives = 120/197 (60%), Gaps = 8/197 (4%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KAR+  T  +VA+KKI+L T  +   G+  TA+REI LL+EL+H N++ L DV
Sbjct: 11  GTYGVVYKARNKLTGEVVALKKIRLDTETE---GVPSTAIREISLLKELNHPNIVKLLDV 67

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSN-IKAYAIMTLRGLEYLHDHWILHRDLK 184
               + + LVFEF+  DL+  +    +   P   IK+Y    L+GL + H H +LHRDLK
Sbjct: 68  IHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 127

Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-- 242
           P NLLIN +G +K+ DFGLA+ FG P R YTH+VVT WYR  + LL C  ++     W  
Sbjct: 128 PQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSL 187

Query: 243 -CCFAKDPSSHGNLFPG 258
            C FA+  +    LFPG
Sbjct: 188 GCIFAEMVTRRA-LFPG 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  165 bits (421), Expect = 1e-49
 Identities = 82/281 (29%), Positives = 129/281 (45%), Gaps = 51/281 (18%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V K R+  T  IVA+KK K    ++  + + +TALRE+K+L++L HEN++ L + 
Sbjct: 12  GAYGVVLKCRNKATGEIVAIKKFK---ESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68

Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           F     + LVFE+V+ T LE++   P  +  P  +++Y    L+ + Y H H I+HRD+K
Sbjct: 69  FRRKGRLYLVFEYVERTLLELLEASPGGL-PPDAVRSYIWQLLQAIAYCHSHNIIHRDIK 127

Query: 185 PNNLLINKQGVLKIGDFGLAKFF-GSPTRLYTHQVVTRWYR------------------L 225
           P N+L+++ GVLK+ DFG A+     P    T  V TRWYR                   
Sbjct: 128 PENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWA 187

Query: 226 IKCL-------------------LYCVQFNVKNV---QWCCFAKDPSSHGNLFPGI---- 259
           I C+                   LY +Q  +  +       F+ +P   G  FP      
Sbjct: 188 IGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPE 247

Query: 260 PLNEIFTAAGDD-LLAVISSLLCLNPTKRADCTATLKMDYF 299
            L   +        L  + + L ++P +R  C   L+  YF
Sbjct: 248 SLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  164 bits (417), Expect = 6e-49
 Identities = 101/279 (36%), Positives = 140/279 (50%), Gaps = 49/279 (17%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KARD  T+  +A+KKI+L       +G+  TA+REI LL+E+ H N++ L DV
Sbjct: 13  GTYGVVYKARDRVTNETIALKKIRL---EQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKD-PTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
                 + LVFE++D DL+  +   P     P  IK Y    LRG+ Y H H +LHRDLK
Sbjct: 70  VHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLK 129

Query: 185 PNNLLINKQ-GVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW- 242
           P NLLI+++   LK+ DFGLA+ FG P R +TH+VVT WYR  + LL    ++     W 
Sbjct: 130 PQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWS 189

Query: 243 --CCFAKDPSSHGNLFPGIP----LNEIFTAAG-------------------------DD 271
             C FA +  +   LFPG      L +IF   G                          D
Sbjct: 190 VGCIFA-EMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKD 248

Query: 272 LLAVI-----------SSLLCLNPTKRADCTATLKMDYF 299
           L  V+           S +L L+P+KR    A L+ +YF
Sbjct: 249 LATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYF 287

Length = 294

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  162 bits (411), Expect = 8e-48
 Identities = 100/311 (32%), Positives = 142/311 (45%), Gaps = 60/311 (19%)

Query: 46  PDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL 105
            +    +++  Y +   +  G F  VFKAR  +T  IVA+KK+ +    + K+G   TAL
Sbjct: 3   YEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLME---NEKEGFPITAL 59

Query: 106 REIKLLQELHHENVLGLTDVF--------GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPS 157
           REIK+LQ L HENV+ L ++          Y  +  LVFEF + DL  ++ +  + FT S
Sbjct: 60  REIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLS 119

Query: 158 NIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR----L 213
            IK    M L GL Y+H + ILHRD+K  N+LI K G+LK+ DFGLA+ F          
Sbjct: 120 EIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR 179

Query: 214 YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KDPSSHGN------------ 254
           YT++VVT WYR  + LL    +      W   C  A    + P   GN            
Sbjct: 180 YTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQL 239

Query: 255 -------LFPGIPLNEIFTAAG----------DDLLAVISS---------LLCLNPTKRA 288
                  ++PG+   E+F              + L   +           LL L+P KR 
Sbjct: 240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRI 299

Query: 289 DCTATLKMDYF 299
           D    L  D+F
Sbjct: 300 DADTALNHDFF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  161 bits (408), Expect = 9e-48
 Identities = 74/167 (44%), Positives = 110/167 (65%), Gaps = 6/167 (3%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +ATV+K R+  T  IVA+K+I L    DA++G   TA+REI L++EL HEN++ L DV
Sbjct: 11  GTYATVYKGRNRTTGEIVALKEIHL----DAEEGTPSTAIREISLMKELKHENIVRLHDV 66

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTI--VFTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
               + + LVFE++D DL+  +    +     P+ +K++    L+G+ + H++ +LHRDL
Sbjct: 67  IHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDL 126

Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLL 230
           KP NLLINK+G LK+ DFGLA+ FG P   ++++VVT WYR    LL
Sbjct: 127 KPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLL 173

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  160 bits (407), Expect = 2e-47
 Identities = 94/280 (33%), Positives = 140/280 (50%), Gaps = 51/280 (18%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+K R+ +T  IVA+KKI+L +    ++G+  TA+REI LL+EL H N++ L DV
Sbjct: 11  GTYGVVYKGRNKKTGQIVAMKKIRLESE---EEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 126 FGYMSNVSLVFEFVDTDL----EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
               S + L+FEF+  DL    + + K   +      +K+Y    L+G+ + H   +LHR
Sbjct: 68  LMQESRLYLIFEFLSMDLKKYLDSLPKGQYM--DAELVKSYLYQILQGILFCHSRRVLHR 125

Query: 182 DLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQ 241
           DLKP NLLI+ +GV+K+ DFGLA+ FG P R+YTH+VVT WYR  + LL   +++     
Sbjct: 126 DLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDI 185

Query: 242 W---CCFA----KDPSSHGN-----LFP-----GIPLNEIFTAA---------------- 268
           W     FA    K P  HG+     LF      G P  +++                   
Sbjct: 186 WSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKG 245

Query: 269 ---------GDDLLAVISSLLCLNPTKRADCTATLKMDYF 299
                     +D L ++  +L  +P KR      L   YF
Sbjct: 246 SLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  157 bits (399), Expect = 5e-46
 Identities = 97/279 (34%), Positives = 137/279 (49%), Gaps = 52/279 (18%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V+KAR I+T  +VA+KKI      + KDG   TALREIK+L++L H NV+ L D+
Sbjct: 19  GTFGEVYKARQIKTGRVVALKKI---LMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75

Query: 126 F--------GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHW 177
                        +V +V  ++D DL  ++++P++  T S IK Y +  L G+ YLH++ 
Sbjct: 76  AVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH 135

Query: 178 ILHRDLKPNNLLINKQGVLKIGDFGLAK-FFGSP----------TRLYTHQVVTRWYRLI 226
           ILHRD+K  N+LI+ QG+LKI DFGLA+ + G P          TR YT+ VVTRWYR  
Sbjct: 136 ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPP 195

Query: 227 KCLLYCVQFNVKNVQW---CCFAKDPSSHGNLFPGIPLNEIFTAAGD-DLLAVISSLL-- 280
           + LL   ++      W   C FA+       +F   P   I     D D L +I  L   
Sbjct: 196 ELLLGERRYTTAVDIWGIGCVFAE-------MFTRRP---ILQGKSDIDQLHLIFKLCGT 245

Query: 281 --------------CLNPTKRADCTATLKMDYFSLTKEM 305
                         C       +   TL+  +  L  E 
Sbjct: 246 PTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEG 284

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  156 bits (395), Expect = 1e-45
 Identities = 67/159 (42%), Positives = 103/159 (64%), Gaps = 4/159 (2%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +ATV+K R   T  +VA+K+I+L    + ++G   TA+RE  LL++L H N++ L D+
Sbjct: 16  GSYATVYKGRSKLTGQLVALKEIRL----EHEEGAPFTAIREASLLKDLKHANIVTLHDI 71

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
                 ++LVFE++DTDL+  + D     +  N++ +    LRGL Y H   +LHRDLKP
Sbjct: 72  IHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKP 131

Query: 186 NNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYR 224
            NLLI+++G LK+ DFGLA+    P++ Y+++VVT WYR
Sbjct: 132 QNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYR 170

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  156 bits (395), Expect = 2e-45
 Identities = 92/299 (30%), Positives = 137/299 (45%), Gaps = 67/299 (22%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKD---------GINRTALREIKLLQELHH 116
           G +  V KA D  T  IVA+KK+K+   ++            GI+ T LRE+K++ E+ H
Sbjct: 20  GTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKH 79

Query: 117 ENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH 176
           EN++GL DV+     ++LV + + +DL+ ++ D  I  T S +K   +  L GL  LH  
Sbjct: 80  ENIMGLVDVYVEGDFINLVMDIMASDLKKVV-DRKIRLTESQVKCILLQILNGLNVLHKW 138

Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAKFFG--------------SPTRLYTHQVVTRW 222
           + +HRDL P N+ IN +G+ KI DFGLA+ +G                    T +VVT W
Sbjct: 139 YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLW 198

Query: 223 YRLIKCLLYCVQFNVKNVQW---CCFAKDPSSHGNLFPG--------------------- 258
           YR  + L+   +++     W   C FA +  +   LFPG                     
Sbjct: 199 YRAPELLMGAEKYHFAVDMWSVGCIFA-ELLTGKPLFPGENEIDQLGRIFELLGTPNEDN 257

Query: 259 ------IPL------------NEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF 299
                 +PL              IF  A DD + ++ SLL LNP +R      LK +YF
Sbjct: 258 WPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF 316

Length = 335

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  151 bits (384), Expect = 2e-43
 Identities = 91/279 (32%), Positives = 126/279 (45%), Gaps = 66/279 (23%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHA-----DAKDGINRTALREIKLLQELHHENVL 120
           G +  V  A D  T   VA+KKI   ++      DAK    R  LREIKLL+ L HEN++
Sbjct: 11  GAYGVVCSAVDKRTGRKVAIKKI---SNVFDDLIDAK----RI-LREIKLLRHLRHENII 62

Query: 121 GLTDVFGYMSN-----VSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
           GL D+    S      V +V E ++TDL  +IK P    T  +I+ +    LRGL+YLH 
Sbjct: 63  GLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHS 121

Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP---TRLYTHQVVTRWYRLIKCLLYC 232
             ++HRDLKP+N+L+N    LKI DFGLA+            T  VVTRWYR  + LL  
Sbjct: 122 ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSS 181

Query: 233 VQFNVKNVQW---CCFA-----------KD--------------PSSHGNLF-------- 256
            ++      W   C FA           +D              PS     F        
Sbjct: 182 SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARN 241

Query: 257 --------PGIPLNEIFTAAGDDLLAVISSLLCLNPTKR 287
                   P  PL+++F  A  + + ++  +L  +P KR
Sbjct: 242 YLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKR 280

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  147 bits (373), Expect = 2e-42
 Identities = 79/195 (40%), Positives = 121/195 (62%), Gaps = 6/195 (3%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +ATVFK R   T+ +VA+K+I+L    + ++G   TA+RE+ LL++L H N++ L D+
Sbjct: 17  GTYATVFKGRSKLTENLVALKEIRL----EHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
                +++LVFE++D DL+  + D   + +  N+K +    LRGL Y H   +LHRDLKP
Sbjct: 73  VHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKP 132

Query: 186 NNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW--C 243
            NLLIN++G LK+ DFGLA+    PT+ Y+++VVT WYR    LL   +++ +   W   
Sbjct: 133 QNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVG 192

Query: 244 CFAKDPSSHGNLFPG 258
           C   + +S   LFPG
Sbjct: 193 CIFFEMASGRPLFPG 207

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  145 bits (368), Expect = 9e-42
 Identities = 80/200 (40%), Positives = 120/200 (60%), Gaps = 6/200 (3%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +ATV+K R   TD +VA+K+I+L    + ++G   TA+RE+ LL++L H N++ L D+
Sbjct: 17  GTYATVYKGRSKLTDNLVALKEIRL----EHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
                +++LVFE++D DL+  + D        N+K +    LRGL Y H   +LHRDLKP
Sbjct: 73  IHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKP 132

Query: 186 NNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW--C 243
            NLLIN++G LK+ DFGLA+    PT+ Y+++VVT WYR    LL    ++ +   W   
Sbjct: 133 QNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVG 192

Query: 244 CFAKDPSSHGNLFPGIPLNE 263
           C   + S+   LFPG  + E
Sbjct: 193 CIFYEMSTGRPLFPGSTVEE 212

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  144 bits (364), Expect = 3e-41
 Identities = 78/200 (39%), Positives = 121/200 (60%), Gaps = 6/200 (3%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +ATVFK R   T+ +VA+K+I+L    + ++G   TA+RE+ LL+ L H N++ L D+
Sbjct: 16  GTYATVFKGRSKLTENLVALKEIRL----EHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
                 ++LVFE++D+DL+  + +   + +  N+K +    LRGL Y H   ILHRDLKP
Sbjct: 72  IHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKP 131

Query: 186 NNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW--C 243
            NLLIN++G LK+ DFGLA+    PT+ Y+++VVT WYR    LL   +++     W   
Sbjct: 132 QNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVG 191

Query: 244 CFAKDPSSHGNLFPGIPLNE 263
           C   + ++   +FPG  + E
Sbjct: 192 CILYEMATGRPMFPGSTVKE 211

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  142 bits (361), Expect = 1e-40
 Identities = 71/169 (42%), Positives = 100/169 (59%), Gaps = 13/169 (7%)

Query: 65  VGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL---HHENVLG 121
            G + TV+KARD+ T   VA+KK+++     +++GI  + LREI LL++L    H N++ 
Sbjct: 9   EGAYGTVYKARDLNTGRFVALKKVRVPL---SEEGIPLSTLREIALLKQLESFEHPNIVR 65

Query: 122 LTDVF-GYMSN----VSLVFEFVDTDLEVII-KDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
           L DV  G  ++    ++LVFE VD DL   + K P     P  IK      LRG+++LH 
Sbjct: 66  LLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS 125

Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYR 224
           H I+HRDLKP N+L+   G +KI DFGLA+ +     L T  VVT WYR
Sbjct: 126 HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL-TSVVVTLWYR 173

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  137 bits (348), Expect = 1e-39
 Identities = 72/232 (31%), Positives = 115/232 (49%), Gaps = 24/232 (10%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F TV+ ARD +T   VA+K IK    +   + +    LREI++L++L+H N++ L  V
Sbjct: 4   GGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEEL----LREIEILKKLNHPNIVKLYGV 59

Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           F   +++ LV E+ +   L+ ++K+     +   I    +  L GLEYLH + I+HRDLK
Sbjct: 60  FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLK 119

Query: 185 PNNLLINK-QGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWC 243
           P N+L++   G +K+ DFGL+K   S   L    V T  Y   + LL    ++ K+  W 
Sbjct: 120 PENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWS 179

Query: 244 CFAKDPSSHGNLFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLK 295
                         G+ L E+      +L  +I  +L  +P KR      L+
Sbjct: 180 L-------------GVILYEL-----PELKDLIRKMLQKDPEKRPSAKEILE 213

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  136 bits (345), Expect = 3e-38
 Identities = 90/287 (31%), Positives = 130/287 (45%), Gaps = 57/287 (19%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHEN-VLGLTD 124
           G +  V+KARD  T  +VA+KK +L      ++GI  TALREI LLQ L     ++ L D
Sbjct: 12  GTYGKVYKARDKNTGKLVALKKTRLEMD---EEGIPPTALREISLLQMLSESIYIVRLLD 68

Query: 125 VFGYMSN-----VSLVFEFVDTDLEVII----KDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
           V           + LVFE++D+DL+  +    + P        IK++    L+G+ + H 
Sbjct: 69  VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK 128

Query: 176 HWILHRDLKPNNLLINKQ-GVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQ 234
           H ++HRDLKP NLL++KQ G+LKI D GL + F  P + YTH++VT WYR  + LL    
Sbjct: 129 HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTH 188

Query: 235 FNVKNVQW---CCFAKDPSSHGNLFPG--------------------------------- 258
           ++     W   C FA + S    LFPG                                 
Sbjct: 189 YSTPVDIWSVGCIFA-EMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHE 247

Query: 259 ------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF 299
                   L+        + L ++  +L  +P KR    A L   YF
Sbjct: 248 FPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  135 bits (342), Expect = 6e-38
 Identities = 89/280 (31%), Positives = 129/280 (46%), Gaps = 51/280 (18%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  VFK R+ ET  IVA+KK      ++    I + ALREI++L++L H N++ L +V
Sbjct: 12  GSYGVVFKCRNRETGQIVAIKKF---VESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSN-IKAYAIMTLRGLEYLHDHWILHRDL 183
           F     + LVFE+ D T L  + K+P  V  P + IK     TL+ + + H H  +HRD+
Sbjct: 69  FRRKRKLHLVFEYCDHTVLNELEKNPRGV--PEHLIKKIIWQTLQAVNFCHKHNCIHRDV 126

Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW- 242
           KP N+LI KQG +K+ DFG A+    P   YT  V TRWYR  + L+   Q+      W 
Sbjct: 127 KPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWA 186

Query: 243 --CCFAKDPSSH-------------------GNLFP-------------GI--------- 259
             C FA+  +                     G+L P             G+         
Sbjct: 187 IGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETRE 246

Query: 260 PLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF 299
           PL   F       L+ +   L ++PT+R  C   L+  YF
Sbjct: 247 PLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  135 bits (342), Expect = 6e-38
 Identities = 65/160 (40%), Positives = 99/160 (61%), Gaps = 5/160 (3%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V K +  ET  IVA+KK      ++    + + A+REI++L++L HEN++ L +V
Sbjct: 12  GSYGMVMKCKHKETGQIVAIKKF---LESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68

Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           F     + LVFEFVD T L+ + K P  +   S ++ Y    LRG+E+ H H I+HRD+K
Sbjct: 69  FRRKKRLYLVFEFVDHTVLDDLEKYPNGL-DESRVRKYLFQILRGIEFCHSHNIIHRDIK 127

Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYR 224
           P N+L+++ GV+K+ DFG A+   +P  +YT  V TRWYR
Sbjct: 128 PENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYR 167

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  134 bits (339), Expect = 4e-37
 Identities = 69/175 (39%), Positives = 98/175 (56%), Gaps = 19/175 (10%)

Query: 66  GRFATVFKARDIETDM--IVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLT 123
           G +  V+KA+          A+KK K     +   GI+++A REI LL+EL HENV+ L 
Sbjct: 11  GTYGRVYKAKRKNGKDGKEYAIKKFK--GDKEQYTGISQSACREIALLRELKHENVVSLV 68

Query: 124 DVF---GYMSNVSLVFEFVDTDLEVIIKD----PTIVFTPSNIKAYAIMTLRGLEYLHDH 176
           +VF      S V L+F++ + DL  IIK       +   PS +K+     L G+ YLH +
Sbjct: 69  EVFLEHADKS-VYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN 127

Query: 177 WILHRDLKPNNLLI----NKQGVLKIGDFGLAKFFGSPTRLYTHQ---VVTRWYR 224
           W+LHRDLKP N+L+     ++GV+KIGD GLA+ F +P +        VVT WYR
Sbjct: 128 WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYR 182

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  134 bits (339), Expect = 6e-37
 Identities = 82/207 (39%), Positives = 111/207 (53%), Gaps = 25/207 (12%)

Query: 66  GRFATVFKARDIETDMIVAVKKIK--LGTHADAKDGINRTALREIKLLQELHHENVLGLT 123
           G +  V  A++ ET+  VA+KKI        DAK    RT LREIKLL+ L HENV+ + 
Sbjct: 16  GAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAK----RT-LREIKLLRHLDHENVIAIK 70

Query: 124 DVF-----GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
           D+         ++V +V+E +DTDL  II+      +  + + +    LRGL+Y+H   +
Sbjct: 71  DIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIHSANV 129

Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVK 238
           LHRDLKP+NLL+N    LKI DFGLA+         T  VVTRWYR  + LL C ++   
Sbjct: 130 LHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTA 189

Query: 239 NVQW---CCFA----KDPSSHGNLFPG 258
              W   C FA    + P     LFPG
Sbjct: 190 IDVWSVGCIFAELLGRKP-----LFPG 211

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  132 bits (334), Expect = 8e-37
 Identities = 87/287 (30%), Positives = 133/287 (46%), Gaps = 66/287 (22%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTD 124
           G F +V+ AR+ ET  +VA+KK+K       ++ +N   LRE+K L++L  H N++ L +
Sbjct: 10  GTFGSVYLARNKETGELVAIKKMK-KKFYSWEECMN---LREVKSLRKLNEHPNIVKLKE 65

Query: 125 VFGYMSNVSLVFEFVDTDLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
           VF     +  VFE+++ +L  ++KD     F+ S I++     L+GL ++H H   HRDL
Sbjct: 66  VFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDL 125

Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGS-PTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW 242
           KP NLL++   V+KI DFGLA+   S P   YT  V TRWYR  + LL    ++     W
Sbjct: 126 KPENLLVSGPEVVKIADFGLAREIRSRPP--YTDYVSTRWYRAPEILLRSTSYSSPVDIW 183

Query: 243 ---CCFAK----DPSSHGNLFPG------------------------------------- 258
              C  A+     P     LFPG                                     
Sbjct: 184 ALGCIMAELYTLRP-----LFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFP 238

Query: 259 ----IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTAT--LKMDYF 299
                 L+++   A  + + +I  +L  +P KR   TA+  L+  YF
Sbjct: 239 QFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKR--PTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  131 bits (332), Expect = 3e-36
 Identities = 66/176 (37%), Positives = 108/176 (61%), Gaps = 14/176 (7%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KARD +T  +VA+KK++L    + K+G   TA+REIK+L++L+H N++ L ++
Sbjct: 18  GTYGQVYKARDKDTGELVALKKVRL---DNEKEGFPITAIREIKILRQLNHRNIVNLKEI 74

Query: 126 FGYMS----------NVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
                             LVFE++D DL  +++   + F+  +IK++    L GL Y H 
Sbjct: 75  VTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHK 134

Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS-PTRLYTHQVVTRWYRLIKCLL 230
              LHRD+K +N+L+N +G +K+ DFGLA+ + S  +R YT++V+T WYR  + LL
Sbjct: 135 KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLL 190

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  132 bits (333), Expect = 4e-36
 Identities = 81/295 (27%), Positives = 131/295 (44%), Gaps = 62/295 (21%)

Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
            ++  G +  V  A D  +   VA+KKI    HA     + +  LRE+K+L+   H+N++
Sbjct: 11  ENIGSGAYGVVCSAIDTRSGKKVAIKKI---PHAFDVPTLAKRTLRELKILRHFKHDNII 67

Query: 121 GLTDVF----GYMSNVSLVFEFVDTDLEVII--KDPTIVFTPSNIKAYAIMTLRGLEYLH 174
            + D+         +V +V + +++DL  II    P    T  +I+ +    LRGL+Y+H
Sbjct: 68  AIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQP---LTEEHIRYFLYQLLRGLKYIH 124

Query: 175 DHWILHRDLKPNNLLINKQGVLKIGDFGLAK-FFGSPT---RLYTHQVVTRWYRLIKCLL 230
              ++HRDLKP+NLL+N+   L+IGDFG+A+    SPT      T  V TRWYR  + LL
Sbjct: 125 SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLL 184

Query: 231 YCVQFNVKNVQW---CCFAKDPSSHGNLFPG----------------------------- 258
              ++      W   C FA +      LFPG                             
Sbjct: 185 SLPEYTTAIDMWSVGCIFA-EMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR 243

Query: 259 -------------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                        +P ++IF  A  + L ++S +L  +P +R      L+  + +
Sbjct: 244 VRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA 298

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  127 bits (320), Expect = 1e-34
 Identities = 75/195 (38%), Positives = 111/195 (56%), Gaps = 9/195 (4%)

Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y +   +  G +ATV+K +      +VA+K I+L      ++G   TA+RE  LL+ L H
Sbjct: 7   YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRL----QEEEGTPFTAIREASLLKGLKH 62

Query: 117 ENVLGLTDVFGYMSNVSLVFEFVDTDL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
            N++ L D+      ++LVFE+V TDL + + K P  +  P N+K +    LRGL Y+H 
Sbjct: 63  ANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLH-PENVKLFLFQLLRGLSYIHQ 121

Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQF 235
            +ILHRDLKP NLLI+  G LK+ DFGLA+    P+  Y+++VVT WYR    LL   ++
Sbjct: 122 RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEY 181

Query: 236 NVKNVQW---CCFAK 247
           +     W   C F +
Sbjct: 182 STCLDMWGVGCIFVE 196

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  128 bits (322), Expect = 1e-34
 Identities = 89/298 (29%), Positives = 130/298 (43%), Gaps = 75/298 (25%)

Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKI--KLGTHADAKDGINRTALREIKLLQEL 114
           Y   + V +G F  V  ARD  T   VA+KKI     T   AK    RT  RE+KLL+ L
Sbjct: 12  YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAK----RT-YRELKLLKHL 66

Query: 115 HHENVLGLTDVF-GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYL 173
            HEN++ L+D+F   + ++  V E + TDL  ++    +      I+ +    LRGL+Y+
Sbjct: 67  RHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPL--EKQFIQYFLYQILRGLKYV 124

Query: 174 HDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQ----VVTRWYRLIKCL 229
           H   ++HRDLKP+N+LIN+   LKI DFGLA       R+   Q    V TR+YR  + +
Sbjct: 125 HSAGVVHRDLKPSNILINENCDLKICDFGLA-------RIQDPQMTGYVSTRYYRAPEIM 177

Query: 230 LYCVQFNVKNVQW---CCFAK----DPSSHGNLFPG------------------------ 258
           L   +++V+   W   C FA+     P     LFPG                        
Sbjct: 178 LTWQKYDVEVDIWSAGCIFAEMLEGKP-----LFPGKDHVNQFSIITDLLGTPPDDVINT 232

Query: 259 ------------------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDY 298
                             +P +E F  A    + ++  +L  +P KR      L   Y
Sbjct: 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPY 290

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  123 bits (309), Expect = 3e-33
 Identities = 81/231 (35%), Positives = 120/231 (51%), Gaps = 18/231 (7%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +ATV+K        +VA+K I        ++G+  TA+RE  LL+ L H N++ L D+
Sbjct: 16  GSYATVYKGISRINGQLVALKVI----SMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71

Query: 126 FGYMSNVSLVFEFVDTDL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
                 ++ VFE++ TDL + +I+ P  +  P N++ +    LRGL Y+H   ILHRDLK
Sbjct: 72  IHTKETLTFVFEYMHTDLAQYMIQHPGGLH-PYNVRLFMFQLLRGLAYIHGQHILHRDLK 130

Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-- 242
           P NLLI+  G LK+ DFGLA+    P++ Y+ +VVT WYR    LL    ++     W  
Sbjct: 131 PQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGA 190

Query: 243 -CCFAKDPSSHGNLFPGIP-----LNEIFTAAG---DDLLAVISSLLCLNP 284
            C F +        FPG+      L +I+T  G   +D    +S L    P
Sbjct: 191 GCIFIEMLQGQ-PAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP 240

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  121 bits (306), Expect = 4e-32
 Identities = 67/181 (37%), Positives = 92/181 (50%), Gaps = 26/181 (14%)

Query: 56  VYYQWRSVHVGRFATVFKARDIETDMIVAVKKI----KLGTHADAKDGINRTALREIKLL 111
            Y     V  G +  V  A D +T   VA+KK+    +   HA       +   RE++LL
Sbjct: 16  RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHA-------KRTYRELRLL 68

Query: 112 QELHHENVLGLTDVFGYMSN------VSLVFEFVDTDLEVIIKDPTIVFTPSNIK--AYA 163
           + + HENV+GL DVF   S+      V LV   +  DL  I+K      +  +I+   Y 
Sbjct: 69  KHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVK--CQKLSDDHIQFLVYQ 126

Query: 164 IMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWY 223
           I  LRGL+Y+H   I+HRDLKP+N+ +N+   LKI DFGLA+         T  V TRWY
Sbjct: 127 I--LRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR---HTDDEMTGYVATRWY 181

Query: 224 R 224
           R
Sbjct: 182 R 182

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  118 bits (298), Expect = 5e-31
 Identities = 66/176 (37%), Positives = 95/176 (53%), Gaps = 31/176 (17%)

Query: 66  GRFATVFKARDIETDMIVAVKKI--KLGTHADAKDGINRTALREIKLLQEL-HHENVLGL 122
           G +  V+KA D  T  +VA+KKI        DA+    RT  REI  LQEL  H N++ L
Sbjct: 18  GAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQ----RT-FREIMFLQELGDHPNIVKL 72

Query: 123 TDVFGYMSN--VSLVFEFVDTDLEVIIKDPTIVFTPSNI-----KAYAIM--TLRGLEYL 173
            +V    ++  + LVFE+++TDL  +I+        +NI     K Y IM   L+ L+Y+
Sbjct: 73  LNVIKAENDKDIYLVFEYMETDLHAVIR--------ANILEDVHKRY-IMYQLLKALKYI 123

Query: 174 HDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS-----PTRLYTHQVVTRWYR 224
           H   ++HRDLKP+N+L+N    +K+ DFGLA+            + T  V TRWYR
Sbjct: 124 HSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYR 179

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  115 bits (289), Expect = 3e-30
 Identities = 71/199 (35%), Positives = 105/199 (52%), Gaps = 13/199 (6%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTD 124
           G F+ V KA+  +T    A+K +K   H  + + +N   LREI+ L+ L  H N+L L +
Sbjct: 10  GTFSEVLKAQSRKTGKYYAIKCMK--KHFKSLEQVNN--LREIQALRRLSPHPNILRLIE 65

Query: 125 V-FGYMSN-VSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
           V F   +  ++LVFE +D +L  +IK          +K+Y    L+ L+++H + I HRD
Sbjct: 66  VLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRD 125

Query: 183 LKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW 242
           +KP N+LI K  +LK+ DFG  +   S    YT  + TRWYR  +CLL    +  K   W
Sbjct: 126 IKPENILI-KDDILKLADFGSCRGIYS-KPPYTEYISTRWYRAPECLLTDGYYGPKMDIW 183

Query: 243 ---CCFAKDPSSHGNLFPG 258
              C F +  S    LFPG
Sbjct: 184 AVGCVFFEILSLF-PLFPG 201

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  116 bits (292), Expect = 4e-30
 Identities = 67/167 (40%), Positives = 92/167 (55%), Gaps = 14/167 (8%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A    T + VA+KKI    H        RT LREIK+L+   HEN++G+ D+
Sbjct: 16  GAYGMVCSATHKPTGVKVAIKKISPFEHQTF---CQRT-LREIKILRRFKHENIIGILDI 71

Query: 126 -----FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
                F   ++V +V E ++TDL  +IK  T   +  +I+ +    LRGL+Y+H   +LH
Sbjct: 72  IRPPSFESFNDVYIVQELMETDLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSANVLH 129

Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGS---PTRLYTHQVVTRWYR 224
           RDLKP+NLL+N    LKI DFGLA+        T   T  V TRWYR
Sbjct: 130 RDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  116 bits (291), Expect = 5e-30
 Identities = 81/308 (26%), Positives = 129/308 (41%), Gaps = 74/308 (24%)

Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y   R +  G    VF A D + D  VAVKKI L    D +    + ALREIK+++ L H
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVL---TDPQS--VKHALREIKIIRRLDH 61

Query: 117 ENVLGLTDVFG--------------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAY 162
           +N++ + +V G               +++V +V E+++TDL  +++   +  +  + + +
Sbjct: 62  DNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPL--SEEHARLF 119

Query: 163 AIMTLRGLEYLHDHWILHRDLKPNNLLIN-KQGVLKIGDFGLAKFFGSPTRLYTHQ---- 217
               LRGL+Y+H   +LHRDLKP N+ IN +  VLKIGDFGLA+        Y+H+    
Sbjct: 120 MYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPH---YSHKGYLS 176

Query: 218 --VVTRWYR-----------------------------------------LIKCLLYCVQ 234
             +VT+WYR                                          ++ +L  V 
Sbjct: 177 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236

Query: 235 FNVKNVQWCCFAKDPS--SHGNLFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTA 292
              +  +       PS   +    P  PL ++      + L  +  +L  NP  R     
Sbjct: 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEE 296

Query: 293 TLKMDYFS 300
            L   Y S
Sbjct: 297 ALMHPYMS 304

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  113 bits (284), Expect = 2e-29
 Identities = 69/177 (38%), Positives = 100/177 (56%), Gaps = 13/177 (7%)

Query: 63  VHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH---HENV 119
           + VG + TV+KARD  +   VA+K +++ T+   +DG+  + +RE+ LL+ L    H N+
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTN---EDGLPLSTVREVALLKRLEAFDHPNI 64

Query: 120 LGLTDVFGYM-----SNVSLVFEFVDTDLEVII-KDPTIVFTPSNIKAYAIMTLRGLEYL 173
           + L DV         + V+LVFE VD DL   + K P        IK      LRGL++L
Sbjct: 65  VRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFL 124

Query: 174 HDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLL 230
           H + I+HRDLKP N+L+   G +K+ DFGLA+ +     L T  VVT WYR  + LL
Sbjct: 125 HANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMAL-TPVVVTLWYRAPEVLL 180

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  111 bits (278), Expect = 9e-29
 Identities = 72/207 (34%), Positives = 114/207 (55%), Gaps = 12/207 (5%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V K R  ET  IVA+KK K    ++  + +  T LRE+K+L+ L  EN++ L + 
Sbjct: 12  GAYGVVLKCRHKETKEIVAIKKFK---DSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 126 FGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           F     + LVFE+V+ + LE++ + P  V  P  +++Y    ++ + + H + I+HRD+K
Sbjct: 69  FRRRGKLYLVFEYVEKNMLELLEEMPNGV-PPEKVRSYIYQLIKAIHWCHKNDIVHRDIK 127

Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRL-YTHQVVTRWYRLIKCLL---YCVQFNVKNV 240
           P NLLI+   VLK+ DFG A+     +   YT  V TRWYR  + LL   Y    ++ +V
Sbjct: 128 PENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSV 187

Query: 241 QWCCFAKDPSSHGNLFPG-IPLNEIFT 266
              C   + S    LFPG   ++++FT
Sbjct: 188 G--CILGELSDGQPLFPGESEIDQLFT 212

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  110 bits (277), Expect = 1e-28
 Identities = 52/159 (32%), Positives = 80/159 (50%), Gaps = 7/159 (4%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V+KAR   T   VA+K IKL +    +  IN     EI++L++  H N++     
Sbjct: 11  GGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIIN-----EIQILKKCKHPNIVKYYGS 65

Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           +     + +V EF     L+ ++K      T S I       L+GLEYLH + I+HRD+K
Sbjct: 66  YLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIK 125

Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWY 223
             N+L+   G +K+ DFGL+    S T+     V T ++
Sbjct: 126 AANILLTSDGEVKLIDFGLSAQL-SDTKARNTMVGTPYW 163

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  109 bits (276), Expect = 2e-28
 Identities = 51/169 (30%), Positives = 85/169 (50%), Gaps = 13/169 (7%)

Query: 59  QWRSVHV---GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH 115
           +W    +   G F +V+ A D +T  ++AVK ++L    D+++ +     REI++L  L 
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSG--DSEEELEAL-EREIRILSSLQ 57

Query: 116 HENV---LGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLE 171
           H N+    G ++     + +++  E+V    L  ++K          I+ Y    L GL 
Sbjct: 58  HPNIVRYYG-SERDEEKNTLNIFLEYVSGGSLSSLLKKFGK-LPEPVIRKYTRQILEGLA 115

Query: 172 YLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS-PTRLYTHQVV 219
           YLH + I+HRD+K  N+L++  GV+K+ DFG AK  G   T   T  V 
Sbjct: 116 YLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVR 164

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  109 bits (273), Expect = 4e-28
 Identities = 78/278 (28%), Positives = 126/278 (45%), Gaps = 51/278 (18%)

Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           + +  G+F+ V+KA  +    +VA+KK+++    DAK    +  L+EI LL++L H NV+
Sbjct: 8   KKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKA--RQDCLKEIDLLKQLDHPNVI 65

Query: 121 GLTDVFGYMSNVSLVFEFVDT-DLEVIIK----DPTIVFTPSNIKAYAIMTLRGLEYLHD 175
                F   + +++V E  D  DL  +IK       ++   + I  Y +     LE++H 
Sbjct: 66  KYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERT-IWKYFVQLCSALEHMHS 124

Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWY---RLIK----- 227
             I+HRD+KP N+ I   GV+K+GD GL +FF S T      V T +Y     I      
Sbjct: 125 KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN 184

Query: 228 ---------CLLY---CVQFNVKNVQWCCFAKDPSSHGNLFPGI------PL-NEIFTAA 268
                    CLLY    +Q          F  D  +  +L   I      PL  + ++  
Sbjct: 185 FKSDIWSLGCLLYEMAALQ--------SPFYGDKMNLYSLCKKIEKCDYPPLPADHYSE- 235

Query: 269 GDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKEMY 306
             +L  ++S  +  +P KR D +  L      + KEM+
Sbjct: 236 --ELRDLVSRCINPDPEKRPDISYVL-----QVAKEMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  108 bits (273), Expect = 4e-28
 Identities = 66/263 (25%), Positives = 111/263 (42%), Gaps = 44/263 (16%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V+  R      +  +K+I L ++   K+     AL E+K+L++L+H N++   + 
Sbjct: 11  GSFGKVYLVRRKSDGKLYVLKEIDL-SNMSEKE--REDALNEVKILKKLNHPNIIKYYES 67

Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKD---PTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
           F     + +V E+ D  DL   IK        F    I  + +     L+YLH   ILHR
Sbjct: 68  FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHR 127

Query: 182 DLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWY---RLIK----------- 227
           D+KP N+ +   G++K+GDFG++K   S   L    V T +Y    L +           
Sbjct: 128 DIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIW 187

Query: 228 ---CLLYCVQFNVKNVQWCCFAK--DPSSHGNLFPGI------PLNEIFTAAGDDLLAVI 276
              C+LY         + C      +  +   L   I      P+   ++    +L  ++
Sbjct: 188 SLGCVLY---------ELCTLKHPFEGENLLELALKILKGQYPPIPSQYS---SELRNLV 235

Query: 277 SSLLCLNPTKRADCTATLKMDYF 299
           SSLL  +P +R      L+  + 
Sbjct: 236 SSLLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  108 bits (271), Expect = 1e-27
 Identities = 66/175 (37%), Positives = 98/175 (56%), Gaps = 14/175 (8%)

Query: 66  GRFATVFKARDIETD-MIVAVKKIKLGTHADAKDGINRTALREIKLLQELH---HENVLG 121
           G +  VFKARD++     VA+K++++ T    ++G+  + +RE+ +L+ L    H NV+ 
Sbjct: 12  GAYGKVFKARDLKNGGRFVALKRVRVQT---GEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 122 LTDVFGYM-----SNVSLVFEFVDTDLEVII-KDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
           L DV         + ++LVFE VD DL   + K P        IK      LRGL++LH 
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 128

Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLL 230
           H ++HRDLKP N+L+   G +K+ DFGLA+ + S     T  VVT WYR  + LL
Sbjct: 129 HRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMALTSVVVTLWYRAPEVLL 182

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  106 bits (267), Expect = 2e-26
 Identities = 55/154 (35%), Positives = 80/154 (51%), Gaps = 10/154 (6%)

Query: 102 RTALREIKLLQELHHENVLGLTDVF-----GYMSNVSLVFEFVDTDLEVIIKDPTIVFTP 156
           +   RE+K+L    H+NVL   D+           + +V E + +DL  II  P  + + 
Sbjct: 44  KRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPL-SS 102

Query: 157 SNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY-T 215
            ++K +    LRGL+YLH   ILHRD+KP NLL+N   VLKI DFGLA+        + T
Sbjct: 103 DHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMT 162

Query: 216 HQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA 246
            +VVT++YR  + L+    +      W   C FA
Sbjct: 163 QEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFA 196

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  105 bits (264), Expect = 3e-26
 Identities = 67/181 (37%), Positives = 96/181 (53%), Gaps = 14/181 (7%)

Query: 56  VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH 115
            Y   + V  G + TV  A D  T   VA+KK+     ++      + A RE++LL+ + 
Sbjct: 16  RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSEL---FAKRAYRELRLLKHMK 72

Query: 116 HENVLGLTDVFGYMSNVS------LVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRG 169
           HENV+GL DVF    ++       LV  F+ TDL  ++K   +  +   I+      L+G
Sbjct: 73  HENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKL--SEDRIQFLVYQMLKG 130

Query: 170 LEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCL 229
           L+Y+H   I+HRDLKP NL +N+   LKI DFGLA+   S    Y   VVTRWYR  + +
Sbjct: 131 LKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGY---VVTRWYRAPEVI 187

Query: 230 L 230
           L
Sbjct: 188 L 188

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  103 bits (259), Expect = 6e-26
 Identities = 50/142 (35%), Positives = 73/142 (51%), Gaps = 7/142 (4%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G    V+K R   T  I A+KKI    H D  +   +  LRE+K L+      V+     
Sbjct: 12  GSSGVVYKVRHKPTGKIYALKKI----HVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67

Query: 126 FGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH-DHWILHRDL 183
           F     +S+V E++D   L  ++K          +   A   L+GL+YLH    I+HRD+
Sbjct: 68  FYKEGEISIVLEYMDGGSLADLLK-KVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDI 126

Query: 184 KPNNLLINKQGVLKIGDFGLAK 205
           KP+NLLIN +G +KI DFG++K
Sbjct: 127 KPSNLLINSKGEVKIADFGISK 148

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  104 bits (260), Expect = 1e-25
 Identities = 67/170 (39%), Positives = 93/170 (54%), Gaps = 15/170 (8%)

Query: 66  GRFATVFKARDIET--DMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-HENVLGL 122
           G +  V  AR+ ET  +  VA+KKI   T+  +K  + + ALRE+KLL+    H+N+  L
Sbjct: 11  GAYGIVCSARNAETSEEETVAIKKI---TNVFSKKILAKRALRELKLLRHFRGHKNITCL 67

Query: 123 TD---VFGYMSN-VSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
            D   VF    N + L  E ++ DL  II+      T ++ +++    L GL+Y+H   +
Sbjct: 68  YDMDIVFPGNFNELYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANV 126

Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAKFF----GSPTRLYTHQVVTRWYR 224
           LHRDLKP NLL+N    LKI DFGLA+ F    G      T  V TRWYR
Sbjct: 127 LHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYR 176

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  103 bits (258), Expect = 2e-25
 Identities = 78/241 (32%), Positives = 110/241 (45%), Gaps = 31/241 (12%)

Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D      VAVKK+        HA       R   RE++LL+
Sbjct: 17  YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHA-------RRTYRELRLLK 69

Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         + V LV   +  DL  I+K   +  +  +++      
Sbjct: 70  HMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKL--SDEHVQFLIYQL 127

Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+N+ +N+   L+I DFGLA+         T  V TRWYR  
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEMTGYVATRWYRAP 184

Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPGI----PLNEIFTAAG---DDLLAVIS 277
           + +L  + +N     W   C   +      LFPG      L  I    G    ++L  IS
Sbjct: 185 EIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS 244

Query: 278 S 278
           S
Sbjct: 245 S 245

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  103 bits (257), Expect = 2e-25
 Identities = 65/186 (34%), Positives = 95/186 (51%), Gaps = 15/186 (8%)

Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y   + V  G + +V  A D  T   VA+KK+     ++      + A RE+ LL+ + H
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEI---FAKRAYRELTLLKHMQH 73

Query: 117 ENVLGLTDVFGY------MSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGL 170
           ENV+GL DVF          +  LV  ++ TDL+ I+  P    +   ++      L GL
Sbjct: 74  ENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHP---LSEDKVQYLVYQMLCGL 130

Query: 171 EYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLL 230
           +Y+H   I+HRDLKP NL +N+   LKI DFGLA+         T  VVTRWYR  + +L
Sbjct: 131 KYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVVTRWYRAPEVIL 187

Query: 231 YCVQFN 236
             + +N
Sbjct: 188 NWMHYN 193

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  103 bits (257), Expect = 3e-25
 Identities = 74/214 (34%), Positives = 106/214 (49%), Gaps = 24/214 (11%)

Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 19  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 71

Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 72  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 129

Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 130 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAP 186

Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 187 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 98.1 bits (245), Expect = 4e-24
 Identities = 46/140 (32%), Positives = 76/140 (54%), Gaps = 5/140 (3%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V+K  ++ET   VA+K+I L      ++ +  + ++EI LL+ L H N++     
Sbjct: 11  GAFGVVYKGLNLETGDFVAIKQISL--EKIKEEALK-SIMQEIDLLKNLKHPNIVKYIGS 67

Query: 126 FGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
                ++ ++ E+ +   L  IIK     F  S +  Y    L+GL YLH+  ++HRD+K
Sbjct: 68  IETSDSLYIILEYAENGSLRQIIK-KFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIK 126

Query: 185 PNNLLINKQGVLKIGDFGLA 204
             N+L  K GV+K+ DFG+A
Sbjct: 127 AANILTTKDGVVKLADFGVA 146

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 98.4 bits (246), Expect = 5e-24
 Identities = 48/149 (32%), Positives = 79/149 (53%), Gaps = 25/149 (16%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G    V+KA D  T   VA+KK++L      K+ I    + EI ++++  H N++   D 
Sbjct: 30  GASGEVYKATDRATGKEVAIKKMRLR--KQNKELI----INEILIMKDCKHPNIVDYYDS 83

Query: 126 FGYMSNVSLVFEFVD----TDL----EVIIKDPTIVFTPSNIKAYAIM--TLRGLEYLHD 175
           +     + +V E++D    TD+     V + +P I        AY +    L+GLEYLH 
Sbjct: 84  YLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQI--------AY-VCREVLQGLEYLHS 134

Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFGLA 204
             ++HRD+K +N+L++K G +K+ DFG A
Sbjct: 135 QNVIHRDIKSDNILLSKDGSVKLADFGFA 163

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  100 bits (248), Expect = 6e-24
 Identities = 59/175 (33%), Positives = 86/175 (49%), Gaps = 16/175 (9%)

Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENV 119
           R +  G F  V+ ARD +   +VA+K +     + +K       LREI++L  L H  N+
Sbjct: 6   RKLGEGSFGEVYLARDRK---LVALKVLAKKLESKSK--EVERFLREIQILASLNHPPNI 60

Query: 120 LGLTDVFGYMSNVSLVFEFVD-TDLEVIIKDP--TIVFTPSNIKAYAIMTLRGLEYLHDH 176
           + L D F    ++ LV E+VD   LE ++K        + S         L  LEYLH  
Sbjct: 61  VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120

Query: 177 WILHRDLKPNNLLINKQG-VLKIGDFGLAKFFGSPT------RLYTHQVVTRWYR 224
            I+HRD+KP N+L+++ G V+K+ DFGLAK    P        L +  V T  Y 
Sbjct: 121 GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Length = 384

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 96.8 bits (242), Expect = 1e-23
 Identities = 42/149 (28%), Positives = 75/149 (50%), Gaps = 15/149 (10%)

Query: 66  GRFATVFKAR----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F  V+K +      +  + VAVK +K        +      LRE +++++L H NV+ 
Sbjct: 10  GAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEF----LREARIMRKLDHPNVVK 65

Query: 122 LTDVFGYMS---NVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHW 177
           L    G  +    + +V E+++  DL   ++      + S++ ++A+   RG+EYL    
Sbjct: 66  L---LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKN 122

Query: 178 ILHRDLKPNNLLINKQGVLKIGDFGLAKF 206
            +HRDL   N L+ +  V+KI DFGL++ 
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGLSRD 151

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 97.5 bits (243), Expect = 2e-23
 Identities = 63/172 (36%), Positives = 91/172 (52%), Gaps = 22/172 (12%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTA--LREIKLLQELHHENVLGLT 123
           G +  V  A D  T   VA+KKI      D  + ++     LREIKLL+ L H +++ + 
Sbjct: 11  GSYGVVCSAIDTHTGEKVAIKKIN-----DVFEHVSDATRILREIKLLRLLRHPDIVEIK 65

Query: 124 DVFGYMS-----NVSLVFEFVDTDLEVIIK---DPTIVFTPSNIKAYAIMTLRGLEYLHD 175
            +    S     ++ +VFE +++DL  +IK   D     TP + + +    LR L+Y+H 
Sbjct: 66  HIMLPPSRREFKDIYVVFELMESDLHQVIKANDD----LTPEHHQFFLYQLLRALKYIHT 121

Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFGLAK--FFGSPTR-LYTHQVVTRWYR 224
             + HRDLKP N+L N    LKI DFGLA+  F  +PT   +T  V TRWYR
Sbjct: 122 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 95.7 bits (239), Expect = 3e-23
 Identities = 44/170 (25%), Positives = 77/170 (45%), Gaps = 20/170 (11%)

Query: 66  GRFATVFKAR----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F  V+K          ++ VAVK +K        +      LRE +++++L H N++ 
Sbjct: 10  GAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEF----LREARIMRKLDHPNIVK 65

Query: 122 LTDVFGYMSNVS---LVFEFVDT-DLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDH 176
           L    G  +      +V E++   DL   ++       + S++ ++A+   RG+EYL   
Sbjct: 66  L---LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK 122

Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQ---VVTRWY 223
             +HRDL   N L+ +  V+KI DFGL++        Y  +   +  RW 
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYKVKGGKLPIRWM 171

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 96.7 bits (240), Expect = 3e-23
 Identities = 83/248 (33%), Positives = 122/248 (49%), Gaps = 43/248 (17%)

Query: 58  YQWRSVHVGR--FATVFKAR--DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQE 113
           +++    VGR  +  V+KA+  D + +   A+K+I+ GT      GI+ +A REI LL+E
Sbjct: 2   FEYEGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIE-GT------GISMSACREIALLRE 54

Query: 114 LHHENVLGLTDVFGYMSN--VSLVFEFVDTDLEVIIK--------DPTIVFTPSNIKAYA 163
           L H NV+ L  VF   S+  V L+F++ + DL  IIK           +    S +K+  
Sbjct: 55  LKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLL 114

Query: 164 IMTLRGLEYLHDHWILHRDLKPNNLLI----NKQGVLKIGDFGLAKFFGSPTRLYTHQ-- 217
              L G+ YLH +W+LHRDLKP N+L+     ++G +KI D G A+ F SP +       
Sbjct: 115 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174

Query: 218 -VVTRWYRLIKCLLYCVQFNVKNVQW---CCFAK----DPSSH--------GNLFPGIPL 261
            VVT WYR  + LL    +      W   C FA+    +P  H         N F    L
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQL 234

Query: 262 NEIFTAAG 269
           + IF+  G
Sbjct: 235 DRIFSVMG 242

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 93.9 bits (234), Expect = 2e-22
 Identities = 44/142 (30%), Positives = 75/142 (52%), Gaps = 6/142 (4%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G    V K     T  I+AVK I      +  + I +  LRE+ +L + +   ++G    
Sbjct: 12  GNSGVVSKVLHRPTGKIMAVKTI----RLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67

Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH-DHWILHRDL 183
           F    ++S+  E++D   L+ I+K+         +   A+  L+GL YLH  H I+HRD+
Sbjct: 68  FYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDV 127

Query: 184 KPNNLLINKQGVLKIGDFGLAK 205
           KP+N+L+N +G +K+ DFG++ 
Sbjct: 128 KPSNILVNSRGQIKLCDFGVSG 149

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 93.2 bits (232), Expect = 3e-22
 Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 13/154 (8%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V+ A +++T  ++AVK+I++    D      +    E+K+L+ L H N++    V
Sbjct: 11  GTFGKVYTAVNLDTGELMAVKEIRI---QDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67

Query: 126 FGYMSNVSLVFEFVD-TDLEVIIK----DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
             +   V +  E+     LE +++        V     I+ Y +  L GL YLH H I+H
Sbjct: 68  EVHREKVYIFMEYCSGGTLEELLEHGRILDEHV-----IRVYTLQLLEGLAYLHSHGIVH 122

Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY 214
           RD+KP N+ ++  GV+K+GDFG A    + T   
Sbjct: 123 RDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 94.0 bits (233), Expect = 3e-22
 Identities = 74/214 (34%), Positives = 110/214 (51%), Gaps = 31/214 (14%)

Query: 58  YQWRSVHVGR--FATVFKAR--DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQE 113
           +++    VGR  +  V+KA+  D + D   A+K+I+ GT      GI+ +A REI LL+E
Sbjct: 2   FEYEGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIE-GT------GISMSACREIALLRE 54

Query: 114 LHHENVLGLTDVFGYMSN--VSLVFEFVDTDLEVIIK--------DPTIVFTPSNIKAYA 163
           L H NV+ L  VF   ++  V L+F++ + DL  IIK           +      +K+  
Sbjct: 55  LKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL 114

Query: 164 IMTLRGLEYLHDHWILHRDLKPNNLLI----NKQGVLKIGDFGLAKFFGSPTRLYTHQ-- 217
              L G+ YLH +W+LHRDLKP N+L+     ++G +KI D G A+ F SP +       
Sbjct: 115 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174

Query: 218 -VVTRWYRLIKCLLYCVQFNVKNVQW---CCFAK 247
            VVT WYR  + LL    +      W   C FA+
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAE 208

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 91.4 bits (228), Expect = 1e-21
 Identities = 41/145 (28%), Positives = 70/145 (48%), Gaps = 9/145 (6%)

Query: 66  GRFATVFKAR----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F  V+K         T+  VAVK +K G   + ++      L E  ++++L H N++ 
Sbjct: 10  GAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEF----LEEASIMKKLSHPNIVR 65

Query: 122 LTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
           L  V      + +V E++   DL   ++      T  ++   A+   +G+EYL     +H
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNFVH 125

Query: 181 RDLKPNNLLINKQGVLKIGDFGLAK 205
           RDL   N L+ +  V+KI DFGL++
Sbjct: 126 RDLAARNCLVTENLVVKISDFGLSR 150

Length = 258

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 88.3 bits (219), Expect = 2e-20
 Identities = 65/258 (25%), Positives = 110/258 (42%), Gaps = 46/258 (17%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G + +V+K + +  +   A+K++ LG+ +  +      A+ EI++L  ++H N++   + 
Sbjct: 11  GSYGSVYKVKRLSDNQFYALKEVDLGSMSQKE---REDAVNEIRILASVNHPNIISYKEA 67

Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIV---FTPSNIKAYAIMTLRGLEYLHDHWILHR 181
           F   + + +V E+    DL   I              I    I  LRGL+ LH+  ILHR
Sbjct: 68  FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHR 127

Query: 182 DLKPNNLLINKQGVLKIGDFGLAK--------------FFGSP----TRLYTHQVVTRWY 223
           DLK  N+L+    ++KIGD G++K               + +P     R Y+++    W 
Sbjct: 128 DLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDI-WS 186

Query: 224 RLIKCLLY-----CVQFNVKNVQWCCFAKDPSSH--GNLFPGIPLNEIFTAAGDDLLAVI 276
             + CLLY        F  +++Q      D         +P IP          DL   I
Sbjct: 187 --LGCLLYEMATFAPPFEARSMQ------DLRYKVQRGKYPPIPPIY-----SQDLQNFI 233

Query: 277 SSLLCLNPTKRADCTATL 294
            S+L + P  R +C   L
Sbjct: 234 RSMLQVKPKLRPNCDKIL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 87.0 bits (215), Expect = 5e-20
 Identities = 52/162 (32%), Positives = 87/162 (53%), Gaps = 6/162 (3%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G+F+ V++A  +     VA+KK+++    DAK    +  ++EI LL++L+H NV+   D 
Sbjct: 13  GQFSEVYRATCLLDRKPVALKKVQIFEMMDAK--ARQDCVKEIDLLKQLNHPNVIKYLDS 70

Query: 126 FGYMSNVSLVFEFVDT-DLEVII---KDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
           F   + +++V E  D  DL  +I   K    +     +  Y +     +E++H   ++HR
Sbjct: 71  FIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHR 130

Query: 182 DLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWY 223
           D+KP N+ I   GV+K+GD GL +FF S T      V T +Y
Sbjct: 131 DIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYY 172

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 86.6 bits (214), Expect = 7e-20
 Identities = 52/162 (32%), Positives = 86/162 (53%), Gaps = 6/162 (3%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G+F+ V++A  +   + VA+KK+++    DAK       ++EI LL++L+H NV+     
Sbjct: 13  GQFSEVYRATCLLDGVPVALKKVQIFDLMDAK--ARADCIKEIDLLKQLNHPNVIKYYAS 70

Query: 126 FGYMSNVSLVFEFVDT-DLEVII---KDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
           F   + +++V E  D  DL  +I   K    +     +  Y +     LE++H   ++HR
Sbjct: 71  FIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHR 130

Query: 182 DLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWY 223
           D+KP N+ I   GV+K+GD GL +FF S T      V T +Y
Sbjct: 131 DIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYY 172

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 86.1 bits (214), Expect = 1e-19
 Identities = 43/153 (28%), Positives = 73/153 (47%), Gaps = 18/153 (11%)

Query: 66  GRFATVFKAR---DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL 122
           G F  V+K +          VAVK +K     DA +   +  L+E +++++L H NV+ L
Sbjct: 6   GAFGEVYKGKLKGKDGKTTEVAVKTLK----EDASEEERKDFLKEARVMKKLGHPNVVRL 61

Query: 123 ----TD------VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEY 172
               T+      V  YM    L+ +++     V         +  ++ ++AI   +G+EY
Sbjct: 62  LGVCTEEEPLYLVLEYMEGGDLL-DYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 173 LHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           L     +HRDL   N L+ +  V+KI DFGL++
Sbjct: 121 LASKKFVHRDLAARNCLVGEDLVVKISDFGLSR 153

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 87.1 bits (216), Expect = 2e-19
 Identities = 60/179 (33%), Positives = 92/179 (51%), Gaps = 23/179 (12%)

Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKI----KLGTHADAKDGINRTALREIKLLQ 112
           Y   + +  G    V  A D  T   VA+KK+    +  THA       + A RE+ L++
Sbjct: 18  YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHA-------KRAYRELVLMK 70

Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDL-EVIIKDPTIVFTPSNIKAYAIM 165
            ++H+N++GL +VF          +V LV E +D +L +VI  D         +      
Sbjct: 71  LVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD----LDHERMSYLLYQ 126

Query: 166 TLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYR 224
            L G+++LH   I+HRDLKP+N+++     LKI DFGLA+  G+   + T  VVTR+YR
Sbjct: 127 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYR 184

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 85.4 bits (212), Expect = 2e-19
 Identities = 47/142 (33%), Positives = 73/142 (51%), Gaps = 4/142 (2%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  VF A+   T  I A+K IK       K+ +++  L E  +L +     V+ L   
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIK-KADMIRKNQVDQ-VLTERDILSQAQSPYVVKLYYS 61

Query: 126 FGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           F    N+ LV E++   DL  ++++          + Y    +  LEYLH + I+HRDLK
Sbjct: 62  FQGKKNLYLVMEYLPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120

Query: 185 PNNLLINKQGVLKIGDFGLAKF 206
           P+N+LI+  G LK+ DFGL+K 
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKV 142

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 84.8 bits (210), Expect = 4e-19
 Identities = 49/157 (31%), Positives = 80/157 (50%), Gaps = 17/157 (10%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V+KA+  ET +  A K I++ +  + +D      + EI +L E  H N++GL + 
Sbjct: 16  GAFGKVYKAQHKETGLFAAAKIIQIESEEELED-----FMVEIDILSECKHPNIVGLYEA 70

Query: 126 FGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           + Y + + ++ EF D   L+ I+ +     T   I+      L  L +LH H ++HRDLK
Sbjct: 71  YFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLK 130

Query: 185 PNNLLINKQGVLKIGDFGL-AK----------FFGSP 210
             N+L+   G +K+ DFG+ AK          F G+P
Sbjct: 131 AGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTP 167

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 83.9 bits (208), Expect = 8e-19
 Identities = 48/147 (32%), Positives = 75/147 (51%), Gaps = 18/147 (12%)

Query: 65  VGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTD 124
            G +  V+KARDI T  +VA+K IKL    +  D       +EI +L+E  H N++    
Sbjct: 13  SGTYGDVYKARDIATGELVAIKVIKL----EPGDDF-EIIQQEISMLKECRHPNIVAY-- 65

Query: 125 VFG-YMSNVSL--VFEFVD----TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHW 177
            FG Y+    L  V E+       D+  + + P    +   I      TL+GL YLH+  
Sbjct: 66  -FGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP---LSELQIAYVCRETLKGLAYLHETG 121

Query: 178 ILHRDLKPNNLLINKQGVLKIGDFGLA 204
            +HRD+K  N+L+ + G +K+ DFG++
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVS 148

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 82.9 bits (205), Expect = 1e-18
 Identities = 66/261 (25%), Positives = 112/261 (42%), Gaps = 30/261 (11%)

Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y   R +  G F      R  E D +V  K++ L       +   R AL EI +L  L H
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNL---TRLSEKERRDALNEIVILSLLQH 58

Query: 117 ENVLGLTDVFGYMSNVSLVFEFVDTD----LEVIIKDPTIVFTPSNIKAYAIMTLRGLEY 172
            N++   + F  M + +L+ E    +     + I++    +F    +  Y    +  + Y
Sbjct: 59  PNIIAYYNHF--MDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSY 116

Query: 173 LHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYC 232
           +H   ILHRD+K  N+ + K G++K+GDFG++K  GS        VV   Y +   L   
Sbjct: 117 IHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY-SMAETVVGTPYYMSPELCQG 175

Query: 233 VQFNVKNVQW---------CCFAK--DPSSHGNLFPGI------PLNEIFTAAGDDLLAV 275
           V++N K+  W             +  D ++  NL   I      P+  ++++    L+++
Sbjct: 176 VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSE---LISL 232

Query: 276 ISSLLCLNPTKRADCTATLKM 296
           + SLL  +P KR      L  
Sbjct: 233 VHSLLQQDPEKRPTADEVLDQ 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 83.4 bits (206), Expect = 1e-18
 Identities = 42/144 (29%), Positives = 80/144 (55%), Gaps = 4/144 (2%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL----REIKLLQELHHENVLG 121
           G F +V+   +  +  ++AVK+++L + + +     R+ L    REI LL+EL HEN++ 
Sbjct: 11  GSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQ 70

Query: 122 LTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
                    ++++  E+V       + +    F  + ++ +    L+GL YLH+  I+HR
Sbjct: 71  YLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHR 130

Query: 182 DLKPNNLLINKQGVLKIGDFGLAK 205
           D+K  N+L++ +G +KI DFG++K
Sbjct: 131 DIKGANILVDNKGGIKISDFGISK 154

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 81.8 bits (202), Expect = 4e-18
 Identities = 71/255 (27%), Positives = 110/255 (43%), Gaps = 22/255 (8%)

Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y + R V  G F  V   R      +V +K+I        KD     A  E ++L+ L H
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIP--VEQMTKDERL-AAQNECQVLKLLSH 58

Query: 117 ENVLGLTDVFGYMSNVSLVFEFVD--TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH 174
            N++   + F     + +V E+    T  E I K    +     I  + +  L  L ++H
Sbjct: 59  PNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH 118

Query: 175 DHWILHRDLKPNNLLINK-QGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCV 233
              ILHRDLK  N+L++K + V+KIGDFG++K   S ++ YT  VV     +   L    
Sbjct: 119 TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPELCEGK 176

Query: 234 QFNVKNVQWC--CFAKDPSSHGNLFPGIPLNEI--------FTAAGD----DLLAVISSL 279
            +N K+  W   C   + +S    F    L  +        F    D    DL  +I S+
Sbjct: 177 PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSM 236

Query: 280 LCLNPTKRADCTATL 294
           L L+P+KR   +  +
Sbjct: 237 LNLDPSKRPQLSQIM 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 81.5 bits (202), Expect = 4e-18
 Identities = 40/143 (27%), Positives = 75/143 (52%), Gaps = 14/143 (9%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G + +V+KA   ET  +VA+K + +       +   +  ++EI +L++     ++     
Sbjct: 14  GSYGSVYKAIHKETGQVVAIKVVPV-------EEDLQEIIKEISILKQCDSPYIVKYYGS 66

Query: 126 FGYMSNVSLVFEFVD----TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
           +   +++ +V E+      +D   I+K      T   I A    TL+GLEYLH +  +HR
Sbjct: 67  YFKNTDLWIVMEYCGAGSVSD---IMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHR 123

Query: 182 DLKPNNLLINKQGVLKIGDFGLA 204
           D+K  N+L+N++G  K+ DFG++
Sbjct: 124 DIKAGNILLNEEGQAKLADFGVS 146

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 81.8 bits (202), Expect = 5e-18
 Identities = 43/146 (29%), Positives = 75/146 (51%), Gaps = 7/146 (4%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKL-----GTHADAKDGINRTALREIKLLQELHHENVL 120
           G +  V+ A ++ T  ++AVK+++L     G H   +  + +    EI+ L++L H N++
Sbjct: 12  GTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIV 71

Query: 121 GLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWIL 179
                      +S+  E+V    +   ++     F    ++ +    L GL YLH   IL
Sbjct: 72  QYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLHSKGIL 130

Query: 180 HRDLKPNNLLINKQGVLKIGDFGLAK 205
           HRDLK +NLL++  G+ KI DFG++K
Sbjct: 131 HRDLKADNLLVDADGICKISDFGISK 156

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 81.2 bits (201), Expect = 7e-18
 Identities = 42/161 (26%), Positives = 71/161 (44%), Gaps = 25/161 (15%)

Query: 63  VHVGRFATVFKARDIETDMIVAVKKIKLGT-HADAKDGINRTALREIKLLQELHHENVLG 121
           + VG  A V+ A  +  +  VA+K+I L        +       +E++ + + +H NV+ 
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDE-----LRKEVQAMSQCNHPNVVK 63

Query: 122 ----------LTDVFGYMSNVSLVFEFVDTDLEVI-IKDPTIVFTPSNIKAYAIMTLRGL 170
                     L  V  Y+S  SL        L+++    P      + I       L+GL
Sbjct: 64  YYTSFVVGDELWLVMPYLSGGSL--------LDIMKSSYPRGGLDEAIIATVLKEVLKGL 115

Query: 171 EYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT 211
           EYLH +  +HRD+K  N+L+ + G +KI DFG++       
Sbjct: 116 EYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 81.0 bits (200), Expect = 1e-17
 Identities = 42/141 (29%), Positives = 76/141 (53%), Gaps = 7/141 (4%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G   +V K + I T  ++A K +    H  AK  + +  LRE++++ E     ++     
Sbjct: 16  GNGGSVSKVKHIPTGTVMAKKVV----HIGAKSSVRKQILRELQIMHECRSPYIVSFYGA 71

Query: 126 FGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD-HWILHRDL 183
           F   +N+ +  EF+D   L+ I K    +     +   A+  + GL YL++ H I+HRD+
Sbjct: 72  FLNENNICMCMEFMDCGSLDRIYKKGGPI-PVEILGKIAVAVVEGLTYLYNVHRIMHRDI 130

Query: 184 KPNNLLINKQGVLKIGDFGLA 204
           KP+N+L+N +G +K+ DFG++
Sbjct: 131 KPSNILVNSRGQIKLCDFGVS 151

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 80.7 bits (200), Expect = 1e-17
 Identities = 49/156 (31%), Positives = 70/156 (44%), Gaps = 23/156 (14%)

Query: 66  GRFATVFKARDIETDMIVAVK---KIKLGTHADAKDGINRTALREIKLLQEL-HHENVLG 121
           G F+TV  A++ ET+   A+K   K +L      K         E ++L  L  H  ++ 
Sbjct: 12  GSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKY-----VKIEKEVLTRLNGHPGIIK 66

Query: 122 LTDVFGYMSNVSLVFEFV-DTDLEVIIK------DPTIVFTPSNIKAYAIMTLRGLEYLH 174
           L   F    N+  V E+  + +L   I+      +    F       YA   L  LEYLH
Sbjct: 67  LYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF-------YAAEILLALEYLH 119

Query: 175 DHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP 210
              I+HRDLKP N+L++K   +KI DFG AK     
Sbjct: 120 SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 79.9 bits (198), Expect = 2e-17
 Identities = 45/151 (29%), Positives = 68/151 (45%), Gaps = 16/151 (10%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V   R  +T  + A+K +K       +  +  T L E  +L  ++H  ++ L   
Sbjct: 4   GSFGKVLLVRKKDTGKLYAMKVLK-KKKIIKRKEVEHT-LTERNILSRINHPFIVKLHYA 61

Query: 126 FGYMSNVSLVFEFVDT-DL------EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
           F     + LV E+    +L      E    +    F       YA   +  LEYLH   I
Sbjct: 62  FQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF-------YAAEIVLALEYLHSLGI 114

Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAKFFGS 209
           ++RDLKP N+L++  G +K+ DFGLAK   S
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAKELSS 145

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 79.4 bits (196), Expect = 2e-17
 Identities = 48/156 (30%), Positives = 74/156 (47%), Gaps = 12/156 (7%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F +V++  +++     AVK++ L           +   +EI LL +L H N++     
Sbjct: 11  GSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGT 70

Query: 126 FGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
                N+ +  E V    L  ++K     F    I+ Y    L GLEYLHD   +HRD+K
Sbjct: 71  EREEDNLYIFLELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIK 129

Query: 185 PNNLLINKQGVLKIGDFGLAK----------FFGSP 210
             N+L++  GV+K+ DFG+AK          F GSP
Sbjct: 130 GANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSP 165

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 80.1 bits (197), Expect = 5e-17
 Identities = 65/213 (30%), Positives = 106/213 (49%), Gaps = 22/213 (10%)

Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKI----KLGTHADAKDGINRTALREIKLLQ 112
           Y   + +  G    V  A D   +  VA+KK+    +  THA       + A RE+ L++
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA-------KRAYRELVLMK 78

Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            ++H+N++GL +VF          +V +V E +D +L  +I+   +      +       
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQM 135

Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           L G+++LH   I+HRDLKP+N+++     LKI DFGLA+  G+ + + T  VVTR+YR  
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAP 194

Query: 227 KCLL-YCVQFNVKNVQWCCFAKDPSSHGNLFPG 258
           + +L    + NV      C   +    G LFPG
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 79.3 bits (195), Expect = 5e-17
 Identities = 51/161 (31%), Positives = 82/161 (50%), Gaps = 17/161 (10%)

Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKL-GTHADAKDGINRTALREIKLLQELHHENV 119
           R +  G F  V+ ARD+    +VA+KK+   G  ++ K    +  ++E++ LQ+L H N 
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK---WQDIIKEVRFLQKLRHPNT 77

Query: 120 LGLTDVFGYMSNVSLVFEFV---DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH 176
           +     +       LV E+     +DL  + K P        I A     L+GL YLH H
Sbjct: 78  IQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAYLHSH 134

Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLA-------KFFGSP 210
            ++HRD+K  N+L+++ G++K+GDFG A        F G+P
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTP 175

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 79.4 bits (195), Expect = 8e-17
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 22/213 (10%)

Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKI----KLGTHADAKDGINRTALREIKLLQ 112
           Y   + +  G    V  A D   D  VA+KK+    +  THA       + A RE+ L++
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA-------KRAYRELVLMK 71

Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            ++H+N++ L +VF          +V LV E +D +L  +I+   +      +       
Sbjct: 72  CVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQM 128

Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           L G+++LH   I+HRDLKP+N+++     LKI DFGLA+  G+ + + T  VVTR+YR  
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAP 187

Query: 227 KCLL-YCVQFNVKNVQWCCFAKDPSSHGNLFPG 258
           + +L    + NV      C   +   H  LFPG
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 77.5 bits (191), Expect = 1e-16
 Identities = 63/252 (25%), Positives = 109/252 (43%), Gaps = 32/252 (12%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  VFK        + A+K+I L +  + ++     A+ E ++L +L    ++   + 
Sbjct: 11  GSFGVVFKVVRKADKRVYAMKQIDL-SKMNRRE--REEAIDEARVLAKLDSSYIIRYYES 67

Query: 126 FGYMSNVSLVFEFVDT-DLEVIIK----DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
           F     +++V E+ +  DL  ++K     P        +  + I  L GL +LH   ILH
Sbjct: 68  FLDKGKLNIVMEYAENGDLHKLLKMQRGRP---LPEDQVWRFFIQILLGLAHLHSKKILH 124

Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNV 240
           RD+K  NL ++    +KIGD G+AK   S    + + +V   Y L   L     +N K+ 
Sbjct: 125 RDIKSLNLFLDAYDNVKIGDLGVAKLL-SDNTNFANTIVGTPYYLSPELCEDKPYNEKSD 183

Query: 241 QW--------CCFAKDP---SSHGNLFPGI------PLNEIFTAAGDDLLAVISSLLCLN 283
            W        CC  K P   ++ G L   I      P++++++     L  +I   L  +
Sbjct: 184 VWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQ---QLAQLIDQCLTKD 240

Query: 284 PTKRADCTATLK 295
             +R D    L+
Sbjct: 241 YRQRPDTFQLLR 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 77.8 bits (191), Expect = 1e-16
 Identities = 44/140 (31%), Positives = 74/140 (52%), Gaps = 6/140 (4%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V+KA++ ET ++ A K I   +  + +D      + EI +L    H N++ L D 
Sbjct: 16  GAFGKVYKAQNKETGVLAAAKVIDTKSEEELED-----YMVEIDILASCDHPNIVKLLDA 70

Query: 126 FGYMSNVSLVFEF-VDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           F Y +N+ ++ EF     ++ ++ +     T   I+     TL  L YLH++ I+HRDLK
Sbjct: 71  FYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLK 130

Query: 185 PNNLLINKQGVLKIGDFGLA 204
             N+L    G +K+ DFG++
Sbjct: 131 AGNILFTLDGDIKLADFGVS 150

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 77.6 bits (191), Expect = 4e-16
 Identities = 49/146 (33%), Positives = 77/146 (52%), Gaps = 10/146 (6%)

Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
             +  G   TV+K     T  + A+K I  G H D    + R   REI++L++++H NV+
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVI-YGNHEDT---VRRQICREIEILRDVNHPNVV 135

Query: 121 GLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWIL 179
              D+F +   + ++ EF+D   LE      T +     +   A   L G+ YLH   I+
Sbjct: 136 KCHDMFDHNGEIQVLLEFMDGGSLE-----GTHIADEQFLADVARQILSGIAYLHRRHIV 190

Query: 180 HRDLKPNNLLINKQGVLKIGDFGLAK 205
           HRD+KP+NLLIN    +KI DFG+++
Sbjct: 191 HRDIKPSNLLINSAKNVKIADFGVSR 216

Length = 353

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 75.7 bits (186), Expect = 7e-16
 Identities = 43/141 (30%), Positives = 77/141 (54%), Gaps = 2/141 (1%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKL-GTHADAKDGINRTALREIKLLQELHHENVLGLTD 124
           G F++ ++ARD++T  ++AVK++      +  ++ +     +EI+L+  L+H +++ +  
Sbjct: 11  GAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLG 70

Query: 125 VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
                S+ +L  E++       +      F  + I  Y    LRGL YLH++ I+HRD+K
Sbjct: 71  ATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVK 130

Query: 185 PNNLLINKQG-VLKIGDFGLA 204
             NLLI+  G  L+I DFG A
Sbjct: 131 GANLLIDSTGQRLRIADFGAA 151

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 76.6 bits (188), Expect = 8e-16
 Identities = 59/184 (32%), Positives = 92/184 (50%), Gaps = 21/184 (11%)

Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKI----KLGTHADAKDGINRTALREIKLLQ 112
           Y Q + +  G    V  A D    + VAVKK+    +  THA       + A RE+ LL+
Sbjct: 23  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHA-------KRAYRELVLLK 75

Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            ++H+N++ L +VF          +V LV E +D +L  +I    +      +       
Sbjct: 76  CVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIH---MELDHERMSYLLYQM 132

Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           L G+++LH   I+HRDLKP+N+++     LKI DFGLA+       + T  VVTR+YR  
Sbjct: 133 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TACTNFMMTPYVVTRYYRAP 191

Query: 227 KCLL 230
           + +L
Sbjct: 192 EVIL 195

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 75.0 bits (185), Expect = 1e-15
 Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 27/150 (18%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V+KA D  T+ +VA+K I L    D  + I +    EI+ L +     +   T  
Sbjct: 12  GSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQ----EIQFLSQCRSPYI---TKY 64

Query: 126 FG-YMSNVSL--VFEFVD----TDL--EVIIKDPTIVFTPSNIKAYAIM--TLRGLEYLH 174
           +G ++    L  + E+       DL     + +  I F         I+   L GLEYLH
Sbjct: 65  YGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF---------ILREVLLGLEYLH 115

Query: 175 DHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           +   +HRD+K  N+L++++G +K+ DFG++
Sbjct: 116 EEGKIHRDIKAANILLSEEGDVKLADFGVS 145

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 74.9 bits (185), Expect = 2e-15
 Identities = 50/160 (31%), Positives = 70/160 (43%), Gaps = 24/160 (15%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRT-----ALREIKLLQELHHENVL 120
           G F  V   R   +    A+K +        K  I +       L E ++LQ + H  ++
Sbjct: 12  GSFGRVMLVRHKGSGKYYALKILS-------KAKIVKLKQVEHVLNEKRILQSIRHPFLV 64

Query: 121 GLTDVFGYMSNVSLVFEFVD-----TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
            L   F   SN+ LV E+V      + L    +     F     + YA   +  LEYLH 
Sbjct: 65  NLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGR-----FPEPVARFYAAQVVLALEYLHS 119

Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYT 215
             I++RDLKP NLL++  G +KI DFG AK      R YT
Sbjct: 120 LDIVYRDLKPENLLLDSDGYIKITDFGFAKRV--KGRTYT 157

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 75.2 bits (185), Expect = 2e-15
 Identities = 50/166 (30%), Positives = 82/166 (49%), Gaps = 17/166 (10%)

Query: 56  VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKL-GTHADAKDGINRTALREIKLLQEL 114
           ++   R +  G F  V+ ARD+ T+ +VA+KK+   G  ++ K    +  ++E++ LQ+L
Sbjct: 16  LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEK---WQDIIKEVRFLQQL 72

Query: 115 HHENVLGLTDVFGYMSNVSLVFEFV---DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLE 171
            H N +     +       LV E+     +D+  + K P        I A     L+GL 
Sbjct: 73  RHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKP---LQEVEIAAICHGALQGLA 129

Query: 172 YLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK-------FFGSP 210
           YLH H  +HRD+K  N+L+ + G +K+ DFG A        F G+P
Sbjct: 130 YLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTP 175

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 74.2 bits (183), Expect = 2e-15
 Identities = 44/157 (28%), Positives = 73/157 (46%), Gaps = 14/157 (8%)

Query: 65  VGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL-----REIKLLQELHHENV 119
           VG F  V   +    +   A+K +K       K  I  T        E ++L+E +H  +
Sbjct: 3   VGGFGRVELVKVKSKNRTFALKCVK-------KRHIVETGQQEHIFSEKEILEECNHPFI 55

Query: 120 LGLTDVFGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
           + L   F     + ++ E+    +L  I++D  + F     + Y    +   EYLH+  I
Sbjct: 56  VKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGL-FDEYTARFYIACVVLAFEYLHNRGI 114

Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYT 215
           ++RDLKP NLL++  G +K+ DFG AK   S  + +T
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT 151

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 74.4 bits (182), Expect = 3e-15
 Identities = 51/161 (31%), Positives = 80/161 (49%), Gaps = 17/161 (10%)

Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKL-GTHADAKDGINRTALREIKLLQELHHENV 119
           R +  G F  V+ ARD+ T+ +VA+KK+   G  ++ K    +  ++E+K LQ + H N 
Sbjct: 31  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEK---WQDIIKEVKFLQRIKHPNS 87

Query: 120 LGLTDVFGYMSNVSLVFEFV---DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH 176
           +     +       LV E+     +DL  + K P        I A     L+GL YLH H
Sbjct: 88  IEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAITHGALQGLAYLHSH 144

Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLA-------KFFGSP 210
            ++HRD+K  N+L+ + G +K+ DFG A        F G+P
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTP 185

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 72.7 bits (179), Expect = 9e-15
 Identities = 46/154 (29%), Positives = 75/154 (48%), Gaps = 25/154 (16%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTD 124
           G +  V+KAR  +T  +VA+K + +    D ++ I      E  +L++  +H N+     
Sbjct: 17  GTYGKVYKARHKKTGQLVAIKIMDI--IEDEEEEI----KEEYNILRKYSNHPNIATFYG 70

Query: 125 VF------GYMSNVSLVFEFVD----TDL--EVIIKDPTIVFTPSNIKAYAIM--TLRGL 170
            F      G    + LV E       TDL   +  K   +        AY I+  TLRGL
Sbjct: 71  AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRL---KEEWIAY-ILRETLRGL 126

Query: 171 EYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
            YLH++ ++HRD+K  N+L+ K   +K+ DFG++
Sbjct: 127 AYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 71.7 bits (176), Expect = 1e-14
 Identities = 51/154 (33%), Positives = 74/154 (48%), Gaps = 12/154 (7%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F +V+ A+   T    A+K +K           N  A R I ++Q      V  L   
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQG-ESPYVAKLYYS 65

Query: 126 FGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSN-IKAYAIMTLRGLEYLHDHWILHRDL 183
           F     + LV E+++  D   +IK  T+   P +  K Y    + G+E LH   I+HRD+
Sbjct: 66  FQSKDYLYLVMEYLNGGDCASLIK--TLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDI 123

Query: 184 KPNNLLINKQGVLKIGDFGLA-------KFFGSP 210
           KP NLLI++ G LK+ DFGL+       KF G+P
Sbjct: 124 KPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTP 157

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 71.5 bits (176), Expect = 2e-14
 Identities = 69/272 (25%), Positives = 107/272 (39%), Gaps = 57/272 (20%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL-REIKLLQELHHENVLGLTD 124
           G F TV K R      I+  K+I  G   + +    +  L  E+ +L+EL H N++   D
Sbjct: 11  GSFGTVRKVRRKSDGKILVWKEIDYGNMTEKE----KQQLVSEVNILRELKHPNIVRYYD 66

Query: 125 VFGYMSN--VSLVFEFVDT-DLEVIIKDPTIVFT--PSNIKAYAIMT--LRGLEYLH--- 174
                SN  + +V E+ +  DL  +I+               + I+T  L  L   H   
Sbjct: 67  RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEF-IWRILTQLLLALYECHNRS 125

Query: 175 --DHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWY---RLIK-- 227
              + +LHRDLKP N+ ++    +K+GDFGLAK  G  +      V T +Y     +   
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHM 185

Query: 228 ------------CLLY--CV---QFNVKN----VQWCCFAKDPSSHGNLFPGIPLNEIFT 266
                       CL+Y  C     F  +N           K        F  IP    ++
Sbjct: 186 SYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK--------FRRIP--YRYS 235

Query: 267 AAGDDLLAVISSLLCLNPTKRADCTATLKMDY 298
               +L  VI S+L ++P KR      L++  
Sbjct: 236 ---SELNEVIKSMLNVDPDKRPSTEELLQLPL 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 71.2 bits (175), Expect = 2e-14
 Identities = 44/145 (30%), Positives = 74/145 (51%), Gaps = 4/145 (2%)

Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           R +  G F  V   +  +T  + A+K +        K  + R  L E ++LQEL+H  ++
Sbjct: 6   RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKC-VEKGSV-RNVLNERRILQELNHPFLV 63

Query: 121 GLTDVFGYMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWIL 179
            L   F    N+ LV + +   DL   +    + F+   +K +    +  LEYLH   I+
Sbjct: 64  NLWYSFQDEENMYLVVDLLLGGDLRYHL-SQKVKFSEEQVKFWICEIVLALEYLHSKGII 122

Query: 180 HRDLKPNNLLINKQGVLKIGDFGLA 204
           HRD+KP+N+L+++QG + I DF +A
Sbjct: 123 HRDIKPDNILLDEQGHVHITDFNIA 147

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 70.6 bits (173), Expect = 4e-14
 Identities = 50/151 (33%), Positives = 74/151 (49%), Gaps = 23/151 (15%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENV---LGL 122
           G +  V+ ARD+ T + +A+K+I      D++    +    EI L   L H N+   LG 
Sbjct: 19  GTYGIVYAARDLSTQVRIAIKEIPE---RDSRY--VQPLHEEIALHSYLKHRNIVQYLGS 73

Query: 123 TDVFGY----MSNV---SLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
               G+    M  V   SL          +   + TI+F       Y    L GL+YLHD
Sbjct: 74  DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIF-------YTKQILEGLKYLHD 126

Query: 176 HWILHRDLKPNNLLINK-QGVLKIGDFGLAK 205
           + I+HRD+K +N+L+N   GV+KI DFG +K
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 70.8 bits (173), Expect = 5e-14
 Identities = 50/158 (31%), Positives = 76/158 (48%), Gaps = 21/158 (13%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLG---THADAKDGINRTALREIKLLQELHHENVLGL 122
           G F  V+ A +  T+ +VAVKK+      T+   +D      ++E+K LQ+L H N +  
Sbjct: 32  GSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQD-----IIKEVKFLQQLKHPNTIEY 86

Query: 123 TDVFGYMSNVSLVFEFV---DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWIL 179
              +       LV E+     +DL  + K P        I A     L+GL YLH H ++
Sbjct: 87  KGCYLKEHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAITHGALQGLAYLHSHNMI 143

Query: 180 HRDLKPNNLLINKQGVLKIGDFGLA-------KFFGSP 210
           HRD+K  N+L+ + G +K+ DFG A        F G+P
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTP 181

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 71.2 bits (174), Expect = 5e-14
 Identities = 45/142 (31%), Positives = 77/142 (54%), Gaps = 9/142 (6%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G    V K +   + +I+A K I    H + K  I    +RE+++L E +   ++G    
Sbjct: 16  GNGGVVTKVQHKPSGLIMARKLI----HLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71

Query: 126 FGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNI-KAYAIMTLRGLEYLHD-HWILHRD 182
           F     +S+  E +D   L+ ++K+   +  P  I    +I  LRGL YL + H I+HRD
Sbjct: 72  FYSDGEISICMEHMDGGSLDQVLKEAKRI--PEEILGKVSIAVLRGLAYLREKHQIMHRD 129

Query: 183 LKPNNLLINKQGVLKIGDFGLA 204
           +KP+N+L+N +G +K+ DFG++
Sbjct: 130 VKPSNILVNSRGEIKLCDFGVS 151

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 69.8 bits (171), Expect = 1e-13
 Identities = 46/137 (33%), Positives = 75/137 (54%), Gaps = 9/137 (6%)

Query: 71  VFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS 130
           V K     + +I+A K I    H + K  I    +RE+K+L E +   ++G    F    
Sbjct: 17  VTKVLHRPSGLIMARKLI----HLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG 72

Query: 131 NVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKA-YAIMTLRGLEYLHD-HWILHRDLKPNN 187
            +S+  E +D   L+ ++K    +  P NI    +I  LRGL YL + H I+HRD+KP+N
Sbjct: 73  EISICMEHMDGGSLDQVLKKAGRI--PENILGKISIAVLRGLTYLREKHKIMHRDVKPSN 130

Query: 188 LLINKQGVLKIGDFGLA 204
           +L+N +G +K+ DFG++
Sbjct: 131 ILVNSRGEIKLCDFGVS 147

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 67.9 bits (166), Expect = 3e-13
 Identities = 47/153 (30%), Positives = 77/153 (50%), Gaps = 26/153 (16%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLG-THADAKDGINRTALR-EIKLLQELHHENVLGLT 123
           G F  V+   D++T   +AVK++       + K  +N  AL  EI+LL+ L HE ++   
Sbjct: 13  GAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVN--ALECEIQLLKNLQHERIV--- 67

Query: 124 DVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT-----------LRGLEY 172
             +G + +   +  F++      +KD         +KAY  +T           L G+EY
Sbjct: 68  QYYGCLRDDETLSIFMEYMPGGSVKD--------QLKAYGALTETVTRKYTRQILEGVEY 119

Query: 173 LHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           LH + I+HRD+K  N+L +  G +K+GDFG +K
Sbjct: 120 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASK 152

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 68.1 bits (166), Expect = 5e-13
 Identities = 44/142 (30%), Positives = 76/142 (53%), Gaps = 9/142 (6%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G    VFK     + +I+A K I    H + K  I    +RE+++L E +   ++G    
Sbjct: 16  GNGGVVFKVSHKPSGLIMARKLI----HLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71

Query: 126 FGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNI-KAYAIMTLRGLEYLHD-HWILHRD 182
           F     +S+  E +D   L+ ++K    +  P  I    +I  ++GL YL + H I+HRD
Sbjct: 72  FYSDGEISICMEHMDGGSLDQVLKKAGRI--PEQILGKVSIAVIKGLTYLREKHKIMHRD 129

Query: 183 LKPNNLLINKQGVLKIGDFGLA 204
           +KP+N+L+N +G +K+ DFG++
Sbjct: 130 VKPSNILVNSRGEIKLCDFGVS 151

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 67.8 bits (166), Expect = 5e-13
 Identities = 40/141 (28%), Positives = 66/141 (46%), Gaps = 16/141 (11%)

Query: 71  VFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVF--GY 128
           V K R   T MI A+K I      D    + +  LRE+++ +      ++     F    
Sbjct: 17  VTKCRLKNTGMIFALKTIT----TDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDES 72

Query: 129 MSNVSLVFEFVDT-DLEVIIKDPTIVFTPSN------IKAYAIMTLRGLEYLHDHWILHR 181
            S++ +  E+ +   L+ I K    V           +   A   L+GL YLH   I+HR
Sbjct: 73  SSSIGIAMEYCEGGSLDSIYKK---VKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHR 129

Query: 182 DLKPNNLLINKQGVLKIGDFG 202
           D+KP+N+L+ ++G +K+ DFG
Sbjct: 130 DIKPSNILLTRKGQVKLCDFG 150

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 66.8 bits (163), Expect = 7e-13
 Identities = 51/213 (23%), Positives = 93/213 (43%), Gaps = 27/213 (12%)

Query: 104 ALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT-DL-EVIIKDPTIVFTPSNIKA 161
           + +E+ +L  + H N++   + F    N+ +V ++ +  DL + I     ++F    I  
Sbjct: 46  SRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILD 105

Query: 162 YAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTR 221
           + +     L+++HD  ILHRD+K  N+ + K G +K+GDFG+A+   S   L    + T 
Sbjct: 106 WFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTP 165

Query: 222 WYRLIKCLLYCVQFNVKNVQWC--------CFAKDPSSHGNL-----------FPGIPLN 262
           +Y L   +     +N K+  W         C  K     GN+           +P +  +
Sbjct: 166 YY-LSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSH 224

Query: 263 EIFTAAGDDLLAVISSLLCLNPTKRADCTATLK 295
             +     DL  ++S L   NP  R    + L+
Sbjct: 225 YSY-----DLRNLVSQLFKRNPRDRPSVNSILE 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 66.1 bits (161), Expect = 1e-12
 Identities = 65/250 (26%), Positives = 112/250 (44%), Gaps = 27/250 (10%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  ++ A+         +K+I L T    K+     + +E+ LL ++ H N++     
Sbjct: 11  GSFGKIYLAKAKSDSEHCVIKEIDL-TKMPVKE--KEASKKEVILLAKMKHPNIVTFFAS 67

Query: 126 FGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
           F     + +V E+ D    ++ I +   ++F+   I ++ +    GL+++HD  ILHRD+
Sbjct: 68  FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDI 127

Query: 184 KPNNLLINKQG-VLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW 242
           K  N+ ++K G V K+GDFG+A+       L    V T +Y L   +     +N K   W
Sbjct: 128 KSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYY-LSPEICQNRPYNNKTDIW 186

Query: 243 C--------CFAKDPSSHGNLFPGI---------PLNEIFTAAGDDLLAVISSLLCLNPT 285
                    C  K P    NL   +         P++  F+    DL ++IS L  ++P 
Sbjct: 187 SLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSR---DLRSLISQLFKVSPR 243

Query: 286 KRADCTATLK 295
            R   T+ LK
Sbjct: 244 DRPSITSILK 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 66.1 bits (161), Expect = 2e-12
 Identities = 46/141 (32%), Positives = 76/141 (53%), Gaps = 10/141 (7%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G   TV+KA  + T  I+AVK I L    D    + +  + E+++L +     ++G    
Sbjct: 12  GNGGTVYKAYHLLTRRILAVKVIPL----DITVELQKQIMSELEILYKCDSPYIIGFYGA 67

Query: 126 FGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           F   + +S+  EF+D   L+V  K P  V     +   A+  ++GL YL    ILHRD+K
Sbjct: 68  FFVENRISICTEFMDGGSLDVYRKIPEHV-----LGRIAVAVVKGLTYLWSLKILHRDVK 122

Query: 185 PNNLLINKQGVLKIGDFGLAK 205
           P+N+L+N +G +K+ DFG++ 
Sbjct: 123 PSNMLVNTRGQVKLCDFGVST 143

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 65.4 bits (159), Expect = 2e-12
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 6/169 (3%)

Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y   R V  G F      + + +D   A+K+I+L   + A +     + +E  LL ++ H
Sbjct: 2   YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVE----DSRKEAVLLAKMKH 57

Query: 117 ENVLGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLH 174
            N++   + F    ++ +V E+ D  DL   IK     +F    I  + +    G++++H
Sbjct: 58  PNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH 117

Query: 175 DHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWY 223
           +  +LHRD+K  N+ + + G +K+GDFG A+   SP       V T +Y
Sbjct: 118 EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYY 166

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 65.1 bits (158), Expect = 4e-12
 Identities = 42/147 (28%), Positives = 73/147 (49%), Gaps = 20/147 (13%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V+KA++ ET  + A K I+  +  + +D      + EI++L   +H  ++ L   
Sbjct: 23  GAFGKVYKAKNKETGALAAAKVIETKSEEELED-----YMVEIEILATCNHPYIVKLLGA 77

Query: 126 FGYMSNVSLVFEF-----VDT---DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHW 177
           F +   + ++ EF     VD    +L+  + +P        I+      L  L+YLH   
Sbjct: 78  FYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-------QIQVICRQMLEALQYLHSMK 130

Query: 178 ILHRDLKPNNLLINKQGVLKIGDFGLA 204
           I+HRDLK  N+L+   G +K+ DFG++
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVS 157

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 65.1 bits (159), Expect = 5e-12
 Identities = 45/147 (30%), Positives = 71/147 (48%), Gaps = 15/147 (10%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRT-----ALREIKLL-QELHHENV 119
           G F  V  A    TD + AVK +K       KD I +       + E ++L     H  +
Sbjct: 6   GSFGKVLLAELKGTDELYAVKVLK-------KDVILQDDDVECTMTEKRVLALAGKHPFL 58

Query: 120 LGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
             L   F     +  V E+V+  DL   I+  +  F     + YA   + GL++LH+  I
Sbjct: 59  TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHERGI 117

Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAK 205
           ++RDLK +N+L++ +G +KI DFG+ K
Sbjct: 118 IYRDLKLDNVLLDSEGHIKIADFGMCK 144

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 65.3 bits (159), Expect = 6e-12
 Identities = 38/113 (33%), Positives = 53/113 (46%), Gaps = 6/113 (5%)

Query: 97  KDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTP 156
           K G   T L E  LLQ ++H +V+ + D     +   +V     +DL   +   T    P
Sbjct: 97  KIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYL---TKRSRP 153

Query: 157 SNIKAYAIM---TLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF 206
             I    I+    L GL YLH   I+HRD+K  N+ IN    + IGD G A+F
Sbjct: 154 LPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQF 206

Length = 357

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 64.2 bits (156), Expect = 7e-12
 Identities = 41/146 (28%), Positives = 72/146 (49%), Gaps = 12/146 (8%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGT-HADAKDGINRTALREIKLLQELHHENVLGLTD 124
           G + TV+         ++AVK+++L T +  A +        E+ LL+ L H N++    
Sbjct: 11  GAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLG 69

Query: 125 VFGYMSNVSLVFEFV-DTDLEVIIKD----PTIVFTPSNIKAYAIMTLRGLEYLHDHWIL 179
                + +S+  EFV    +  I+      P  VF       Y    L G+ YLH++ ++
Sbjct: 70  TCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVF-----CKYTKQILDGVAYLHNNCVV 124

Query: 180 HRDLKPNNLLINKQGVLKIGDFGLAK 205
           HRD+K NN+++   G++K+ DFG A+
Sbjct: 125 HRDIKGNNVMLMPNGIIKLIDFGCAR 150

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 64.7 bits (158), Expect = 8e-12
 Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 3/91 (3%)

Query: 116 HENVLGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH 174
           H  ++ L   F    +V  V E+    DL + I     VF+      YA   + GL+YLH
Sbjct: 61  HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLH 118

Query: 175 DHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           ++ I++RDLK +NLL++ +G +KI DFGL K
Sbjct: 119 ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK 149

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 64.0 bits (156), Expect = 1e-11
 Identities = 39/146 (26%), Positives = 66/146 (45%), Gaps = 24/146 (16%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G    V  A D  T   VAVKK+ L      K         E+ ++++  H N++ +   
Sbjct: 30  GSTGIVCIATDKSTGRQVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHPNIVEMYSS 84

Query: 126 FGYMSNVSLVFEFVD----TDLEVIIKDPTIVFTPSNIKAYAIMT-----LRGLEYLHDH 176
           +     + +V EF++    TD         IV T + +    I T     L+ L +LH  
Sbjct: 85  YLVGDELWVVMEFLEGGALTD---------IV-THTRMNEEQIATVCLAVLKALSFLHAQ 134

Query: 177 WILHRDLKPNNLLINKQGVLKIGDFG 202
            ++HRD+K +++L+   G +K+ DFG
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFG 160

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 63.6 bits (154), Expect = 1e-11
 Identities = 43/148 (29%), Positives = 76/148 (51%), Gaps = 8/148 (5%)

Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y ++  +  G   TVF A D+ T   VA+K+I L      +  IN     EI +++EL +
Sbjct: 21  YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIIN-----EILVMKELKN 75

Query: 117 ENVLGLTDVFGYMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
            N++   D F     + +V E++    L  ++ +  +    + I A     L+ LE+LH 
Sbjct: 76  PNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCM--DEAQIAAVCRECLQALEFLHA 133

Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFGL 203
           + ++HRD+K +N+L+   G +K+ DFG 
Sbjct: 134 NQVIHRDIKSDNVLLGMDGSVKLTDFGF 161

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 53/182 (29%), Positives = 89/182 (48%), Gaps = 32/182 (17%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V++A  I+T   VA+KK+        +D   +   RE+ +++ L+H N++ L D 
Sbjct: 77  GSFGVVYEAICIDTSEKVAIKKV-------LQDPQYKN--RELLIMKNLNHINIIFLKDY 127

Query: 126 FGYMSNV---------SLVFEFVDTDLEVIIKDPTIVFTPSN-------IKAYAIMTLRG 169
           + Y             ++V EF+   +   +K     +  +N       +K Y+    R 
Sbjct: 128 Y-YTECFKKNEKNIFLNVVMEFIPQTVHKYMKH----YARNNHALPLFLVKLYSYQLCRA 182

Query: 170 LEYLHDHWILHRDLKPNNLLIN-KQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKC 228
           L Y+H  +I HRDLKP NLLI+     LK+ DFG AK   +  R  ++ + +R+YR  + 
Sbjct: 183 LAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY-ICSRFYRAPEL 241

Query: 229 LL 230
           +L
Sbjct: 242 ML 243

Length = 440

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 62.9 bits (153), Expect = 2e-11
 Identities = 42/132 (31%), Positives = 67/132 (50%), Gaps = 12/132 (9%)

Query: 79  TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS---NVSLV 135
           T  +VAVKK++  T    +D       REI++L+ L H+N++    V  Y +   N+ LV
Sbjct: 32  TGEVVAVKKLQHSTAEHLRD-----FEREIEILKSLQHDNIVKYKGV-CYSAGRRNLRLV 85

Query: 136 FEFVDTD--LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ 193
            E++      + + K    +     +  YA    +G+EYL     +HRDL   N+L+  +
Sbjct: 86  MEYLPYGSLRDYLQKHRERLDHRKLLL-YASQICKGMEYLGSKRYVHRDLATRNILVESE 144

Query: 194 GVLKIGDFGLAK 205
             +KIGDFGL K
Sbjct: 145 NRVKIGDFGLTK 156

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 62.6 bits (152), Expect = 3e-11
 Identities = 47/184 (25%), Positives = 84/184 (45%), Gaps = 18/184 (9%)

Query: 61  RSVHVGRFATV----FKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           R +  G F  V    +      T   VAVK +K  +  +    + +    EI++L+ L+H
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKK----EIEILRNLYH 65

Query: 117 ENVLGLTDVF--GYMSNVSLVFEFVDTDL--EVIIKDPTIVFTPSNIKAYAIMTLRGLEY 172
           EN++    +      + + L+ EF+ +    E + ++   +     +K YA+   +G++Y
Sbjct: 66  ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLK-YAVQICKGMDY 124

Query: 173 LHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQ----VVTRWYRLIKC 228
           L     +HRDL   N+L+  +  +KIGDFGL K   +    YT +        WY   +C
Sbjct: 125 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYA-PEC 183

Query: 229 LLYC 232
           L+  
Sbjct: 184 LIQS 187

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 62.1 bits (151), Expect = 4e-11
 Identities = 41/158 (25%), Positives = 72/158 (45%), Gaps = 24/158 (15%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V++ + + T  +VA+K I L T  D    I     RE+ LL +L       +T  
Sbjct: 12  GAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQ----REVALLSQLRQSQPPNITKY 67

Query: 126 FG-YM--SNVSLVFEF-----VDTDLEV-IIKDPTIVFTPSNIKAYAIM--TLRGLEYLH 174
           +G Y+    + ++ E+     V T ++   I +  I           I+   L  L+Y+H
Sbjct: 68  YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV---------IIREVLVALKYIH 118

Query: 175 DHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR 212
              ++HRD+K  N+L+   G +K+ DFG+A      + 
Sbjct: 119 KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 62.1 bits (151), Expect = 4e-11
 Identities = 38/137 (27%), Positives = 63/137 (45%), Gaps = 24/137 (17%)

Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL----TD------VFGYMSNV 132
           VAVK +K GT  D KD      L E +++++L H  ++ L    T       V   M   
Sbjct: 33  VAVKTLKPGT-MDPKD-----FLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYG 86

Query: 133 SLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK 192
           SL+ E++       +K P ++   + + +       G+ YL     +HRDL   N+L+ +
Sbjct: 87  SLL-EYLQGGAGRALKLPQLIDMAAQVAS-------GMAYLEAQNYIHRDLAARNVLVGE 138

Query: 193 QGVLKIGDFGLAKFFGS 209
             + K+ DFGLA+    
Sbjct: 139 NNICKVADFGLARVIKE 155

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 62.0 bits (151), Expect = 4e-11
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 23/154 (14%)

Query: 66  GRFATVFKAR-DIETD---MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL- 120
           G F  V   R D   D     VAVK +        ++       REI++L+ L HEN++ 
Sbjct: 15  GHFGKVELCRYDPLGDNTGEQVAVKSLN----HSGEEQHRSDFEREIEILRTLDHENIVK 70

Query: 121 --GLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKA-----YAIMTLRGLEY 172
             G+ +  G  S + L+ E++ +  L   ++          I       ++    +G++Y
Sbjct: 71  YKGVCEKPGGRS-LRLIMEYLPSGSLRDYLQ-----RHRDQINLKRLLLFSSQICKGMDY 124

Query: 173 LHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF 206
           L     +HRDL   N+L+  + ++KI DFGLAK 
Sbjct: 125 LGSQRYIHRDLAARNILVESEDLVKISDFGLAKV 158

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 61.9 bits (150), Expect = 5e-11
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 5/162 (3%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F TV+  +D +      +K +K     +        A +E +LL +L H  ++     
Sbjct: 11  GSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHAS 70

Query: 126 FGYMSNVSLVFEFV-DTDLEVII---KDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
           F       ++ E+    DL+  +   K      + + +  + I  L G+ Y+H   ILHR
Sbjct: 71  FLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHR 130

Query: 182 DLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWY 223
           DLK  N+ + K  +LKIGDFG+++       L T    T +Y
Sbjct: 131 DLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYY 171

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 61.6 bits (150), Expect = 5e-11
 Identities = 38/154 (24%), Positives = 70/154 (45%), Gaps = 8/154 (5%)

Query: 66  GRFATVFKAR---DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL 122
           G F  V + R     + ++ VA+K +K G+    +       L E  ++ +  H N++ L
Sbjct: 15  GEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDF----LTEASIMGQFDHPNIIRL 70

Query: 123 TDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
             V      V ++ E+++   L+  +++    FT   +         G++YL +   +HR
Sbjct: 71  EGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHR 130

Query: 182 DLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYT 215
           DL   N+L+N   V K+ DFGL++        YT
Sbjct: 131 DLAARNILVNSNLVCKVSDFGLSRRLEDSEATYT 164

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 61.8 bits (150), Expect = 5e-11
 Identities = 41/153 (26%), Positives = 73/153 (47%), Gaps = 18/153 (11%)

Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y ++  +  G   TV+ A D+ T   VA+K++ L      +  IN     EI +++E  H
Sbjct: 21  YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIIN-----EILVMRENKH 75

Query: 117 ENVLGLTDVFGYMSNVSLVFEFV------DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGL 170
            N++   D +     + +V E++      D   E  + +         I A     L+ L
Sbjct: 76  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE-------GQIAAVCRECLQAL 128

Query: 171 EYLHDHWILHRDLKPNNLLINKQGVLKIGDFGL 203
           E+LH + ++HRD+K +N+L+   G +K+ DFG 
Sbjct: 129 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF 161

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 61.5 bits (149), Expect = 5e-11
 Identities = 66/265 (24%), Positives = 116/265 (43%), Gaps = 33/265 (12%)

Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y   R V  G +  V   R         +KK+ L  +A  ++   + A +E +LL +L H
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNL-RNASRRE--RKAAEQEAQLLSQLKH 58

Query: 117 ENVLGLTDVF-GYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSN-IKAYAIMTLRGLEYL 173
            N++   + + G    + +V  F +  DL   +K+      P N +  + +     L+YL
Sbjct: 59  PNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYL 118

Query: 174 HDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCV 233
           H+  ILHRDLK  N+ + +  ++K+GD G+A+   +   + +  + T +Y +   L    
Sbjct: 119 HEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYY-MSPELFSNK 177

Query: 234 QFNVKNVQW---CCF-----------AKDPSS------HGNLFPGIPLNEIFTAAGDDLL 273
            +N K+  W   CC            AKD +S       G L P +P +        +L 
Sbjct: 178 PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL-PPMPKD-----YSPELG 231

Query: 274 AVISSLLCLNPTKRADCTATLKMDY 298
            +I+++L   P KR    + L+  Y
Sbjct: 232 ELIATMLSKRPEKRPSVKSILRQPY 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 61.3 bits (149), Expect = 9e-11
 Identities = 28/61 (45%), Positives = 38/61 (62%), Gaps = 2/61 (3%)

Query: 160 KAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK--FFGSPTRLYTHQ 217
           + Y   T+  LEYLH++ I+HRDLKP+NLLI   G +K+ DFGL+K       T LY   
Sbjct: 104 RMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGH 163

Query: 218 V 218
           +
Sbjct: 164 I 164

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 60.9 bits (148), Expect = 9e-11
 Identities = 41/144 (28%), Positives = 69/144 (47%), Gaps = 2/144 (1%)

Query: 62  SVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           +V  G F  V   RD  ++   A+K + +      K    +    E ++L+E+ H  ++ 
Sbjct: 8   TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQ--EQHVHNEKRVLKEVSHPFIIR 65

Query: 122 LTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
           L         + ++ E+V           +  F+ S    YA   +  LEYLH   I++R
Sbjct: 66  LFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYR 125

Query: 182 DLKPNNLLINKQGVLKIGDFGLAK 205
           DLKP N+L++K+G +K+ DFG AK
Sbjct: 126 DLKPENILLDKEGHIKLTDFGFAK 149

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 34/108 (31%), Positives = 56/108 (51%), Gaps = 4/108 (3%)

Query: 107 EIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNI--KAYAI 164
           EI  L  L+HEN+L + ++    +N  ++ +  D DL   + D    +    +  +  AI
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAI 272

Query: 165 MT--LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP 210
           M   L  +EY+HD  ++HRD+K  N+ +N  G + +GDFG A  F   
Sbjct: 273 MKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKE 320

Length = 501

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 60.7 bits (147), Expect = 1e-10
 Identities = 41/131 (31%), Positives = 63/131 (48%), Gaps = 11/131 (8%)

Query: 79  TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL---GLTDVFGYMSNVSLV 135
           T  +VAVK +K         G      +EI +L+ L+HEN++   G     G    + L+
Sbjct: 32  TGEMVAVKTLKRECGQQNTSG----WKKEINILKTLYHENIVKYKGCCSEQGGKG-LQLI 86

Query: 136 FEFVDTDLEVIIKD-PTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG 194
            E+V   L  +    P      + +  +A     G+ YLH    +HRDL   N+L++   
Sbjct: 87  MEYVP--LGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR 144

Query: 195 VLKIGDFGLAK 205
           ++KIGDFGLAK
Sbjct: 145 LVKIGDFGLAK 155

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 60.6 bits (147), Expect = 1e-10
 Identities = 35/150 (23%), Positives = 70/150 (46%), Gaps = 22/150 (14%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G + +V+K     T + +A+K+I+L    +  +      + E+ +L +     ++     
Sbjct: 12  GNYGSVYKVLHRPTGVTMAMKEIRL----ELDESKFNQIIMELDILHKAVSPYIVDFYGA 67

Query: 126 FGYMSNVSLVFEFVD----------TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYL-H 174
           F     V +  E++D                I +  +         YA+  ++GL++L  
Sbjct: 68  FFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRI-----TYAV--VKGLKFLKE 120

Query: 175 DHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           +H I+HRD+KP N+L+N  G +K+ DFG++
Sbjct: 121 EHNIIHRDVKPTNVLVNGNGQVKLCDFGVS 150

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 60.2 bits (146), Expect = 2e-10
 Identities = 43/159 (27%), Positives = 62/159 (38%), Gaps = 23/159 (14%)

Query: 66  GRFATVFKAR-----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           G F  VF              +VAVK +K     DA+    +   RE +LL    HEN++
Sbjct: 16  GAFGKVFLGECYHLEPENDKELVAVKTLKETASNDAR----KDFEREAELLTNFQHENIV 71

Query: 121 GLTDVFGYMSNVSLVFEFV--------------DTDLEVIIKDPTIVFTPSNIKAYAIMT 166
               V        +VFE++              D         P    T S +   A+  
Sbjct: 72  KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131

Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
             G+ YL     +HRDL   N L+    V+KIGDFG+++
Sbjct: 132 ASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 60.0 bits (145), Expect = 2e-10
 Identities = 45/149 (30%), Positives = 70/149 (46%), Gaps = 26/149 (17%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL----- 120
           G F  V +     T   VAVK IK    A A        L E  ++ +LHH+N++     
Sbjct: 17  GEFGAVLQGE--YTGQKVAVKNIKCDVTAQA-------FLEETAVMTKLHHKNLVRLLGV 67

Query: 121 ----GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH 176
               GL  V   MS  +LV  F+ T    ++    ++        +++    G+EYL   
Sbjct: 68  ILHNGLYIVMELMSKGNLV-NFLRTRGRALVSVIQLL-------QFSLDVAEGMEYLESK 119

Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAK 205
            ++HRDL   N+L+++ GV K+ DFGLA+
Sbjct: 120 KLVHRDLAARNILVSEDGVAKVSDFGLAR 148

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 60.2 bits (146), Expect = 2e-10
 Identities = 46/185 (24%), Positives = 72/185 (38%), Gaps = 35/185 (18%)

Query: 49  EVKNDLLVYYQWRSVHVGRFATVFKARDI-----ETDMIVAVKKIKLGTHADAKDGINRT 103
           E   + + Y   R +  G F  VF+AR       E   +VAVK +K    AD +    R 
Sbjct: 1   EYPRNNIEYV--RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR- 57

Query: 104 ALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFV-----------------------D 140
              E  L+ E  H N++ L  V      + L+FE++                        
Sbjct: 58  ---EAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHST 114

Query: 141 TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGD 200
           +       +P  +     +   A     G+ YL +   +HRDL   N L+ +  V+KI D
Sbjct: 115 SSARKCGLNPLPLSCTEQL-CIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIAD 173

Query: 201 FGLAK 205
           FGL++
Sbjct: 174 FGLSR 178

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 59.7 bits (144), Expect = 2e-10
 Identities = 40/139 (28%), Positives = 67/139 (48%), Gaps = 5/139 (3%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KAR++ T  + A+K IKL    D          +EI ++++  H N++     
Sbjct: 20  GTYGDVYKARNVNTGELAAIKVIKLEPGEDFA-----VVQQEIIMMKDCKHSNIVAYFGS 74

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
           +     + +  EF        I   T   + S I   +  TL+GL YLH    +HRD+K 
Sbjct: 75  YLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKG 134

Query: 186 NNLLINKQGVLKIGDFGLA 204
            N+L+   G +K+ DFG++
Sbjct: 135 ANILLTDNGHVKLADFGVS 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 59.5 bits (144), Expect = 2e-10
 Identities = 35/125 (28%), Positives = 63/125 (50%), Gaps = 7/125 (5%)

Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTD 142
           VA+K IK G+ ++ +       + E K++ +L HE ++ L  V      + +V E++   
Sbjct: 31  VAIKMIKEGSMSEDE------FIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNG 84

Query: 143 -LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDF 201
            L   +++    F PS +         G+ YL     +HRDL   N L++ QG +K+ DF
Sbjct: 85  CLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDF 144

Query: 202 GLAKF 206
           GL+++
Sbjct: 145 GLSRY 149

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 59.7 bits (144), Expect = 3e-10
 Identities = 42/141 (29%), Positives = 70/141 (49%), Gaps = 9/141 (6%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  VFK  D  T  +VA+K I L    D  + I +    EI +L +     V      
Sbjct: 15  GSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ----EITVLSQCDSPYVTKYYGS 70

Query: 126 FGYMSNVSLVFEFVD--TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
           +   + + ++ E++   + L+++   P   F    I       L+GL+YLH    +HRD+
Sbjct: 71  YLKGTKLWIIMEYLGGGSALDLLRAGP---FDEFQIATMLKEILKGLDYLHSEKKIHRDI 127

Query: 184 KPNNLLINKQGVLKIGDFGLA 204
           K  N+L+++QG +K+ DFG+A
Sbjct: 128 KAANVLLSEQGDVKLADFGVA 148

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 60.7 bits (147), Expect = 3e-10
 Identities = 30/77 (38%), Positives = 49/77 (63%), Gaps = 2/77 (2%)

Query: 130 SNVSLVFEF-VDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNL 188
           +NV LV E+ +  D++ ++           +K  + + L  L+YLH H I+HRDLKP+N+
Sbjct: 77  NNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVAL-ALDYLHRHGIIHRDLKPDNM 135

Query: 189 LINKQGVLKIGDFGLAK 205
           LI+ +G +K+ DFGL+K
Sbjct: 136 LISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 59.8 bits (145), Expect = 3e-10
 Identities = 39/116 (33%), Positives = 56/116 (48%), Gaps = 12/116 (10%)

Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVD-----TDLEVIIKDPTIVFTPSNI 159
            +E  +L EL H  ++ +   F   + V  + EFV      T L    + P  V      
Sbjct: 66  AQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDV-----A 120

Query: 160 KAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYT 215
           K Y    +   EYLH   I++RDLKP NLL++ +G +K+ DFG AK    P R +T
Sbjct: 121 KFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK--KVPDRTFT 174

Length = 329

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 59.6 bits (144), Expect = 5e-10
 Identities = 35/114 (30%), Positives = 55/114 (48%), Gaps = 1/114 (0%)

Query: 93  HADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTI 152
           H   K G       E  +L+ ++H +++ L   F Y     L+     TDL   +     
Sbjct: 119 HVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRN 178

Query: 153 VFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF 206
           +    +I A     LR ++YLH++ I+HRD+K  N+ IN  G + +GDFG A F
Sbjct: 179 I-AICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACF 231

Length = 391

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 59.2 bits (143), Expect = 5e-10
 Identities = 42/140 (30%), Positives = 64/140 (45%), Gaps = 2/140 (1%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V   R+  T    A+K ++      AKD +  T + E ++LQ   H  +  L   
Sbjct: 6   GTFGKVILVREKATGRYYAMKILRKEV-IIAKDEVAHT-VTESRVLQNTRHPFLTALKYA 63

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
           F     +  V E+ +            VFT    + Y    +  LEYLH   +++RD+K 
Sbjct: 64  FQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKL 123

Query: 186 NNLLINKQGVLKIGDFGLAK 205
            NL+++K G +KI DFGL K
Sbjct: 124 ENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 58.1 bits (140), Expect = 8e-10
 Identities = 42/142 (29%), Positives = 66/142 (46%), Gaps = 5/142 (3%)

Query: 63  VHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL 122
           V  G +  V+KAR++ T  + AVK IKL    D          +EI +++E  H N++  
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFS-----LIQQEIFMVKECKHCNIVAY 71

Query: 123 TDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
              +     + +  E+        I   T   +   I      TL+GL YLH    +HRD
Sbjct: 72  FGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRD 131

Query: 183 LKPNNLLINKQGVLKIGDFGLA 204
           +K  N+L+   G +K+ DFG+A
Sbjct: 132 IKGANILLTDNGDVKLADFGVA 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 57.8 bits (140), Expect = 9e-10
 Identities = 36/125 (28%), Positives = 61/125 (48%), Gaps = 8/125 (6%)

Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTD 142
           VAVK +K    + A        L E  ++  L H N++ L  V    + + +V E++   
Sbjct: 32  VAVKCLK--DDSTAAQAF----LAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKG 85

Query: 143 --LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGD 200
             ++ +      V T +    +A+    G+EYL +   +HRDL   N+L+++  V K+ D
Sbjct: 86  SLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSD 145

Query: 201 FGLAK 205
           FGLAK
Sbjct: 146 FGLAK 150

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 57.8 bits (139), Expect = 1e-09
 Identities = 42/149 (28%), Positives = 76/149 (51%), Gaps = 16/149 (10%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALR-EIKLLQELHHENVLGLTD 124
           G F  V+   D++T   +A K+++    +  +     +AL  EI+LL+ L HE ++    
Sbjct: 13  GAFGRVYLCYDVDTGRELAAKQVQFDPES-PETSKEVSALECEIQLLKNLQHERIV---Q 68

Query: 125 VFGYMSN-----VSLVFEFVDTDLEVIIKDPTIVF---TPSNIKAYAIMTLRGLEYLHDH 176
            +G + +     +++  E++       +KD    +   T S  + Y    L G+ YLH +
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGG---SVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN 125

Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAK 205
            I+HRD+K  N+L +  G +K+GDFG +K
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 57.9 bits (140), Expect = 1e-09
 Identities = 44/144 (30%), Positives = 76/144 (52%), Gaps = 8/144 (5%)

Query: 66  GRFATVFKARDI---ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL 122
           G F  VF  R I   +   + A+K +K  T    +D +     R+I  L E++H  ++ L
Sbjct: 7   GSFGKVFLVRKITGPDAGQLYAMKVLKKAT-LKVRDRVRTKMERDI--LAEVNHPFIVKL 63

Query: 123 TDVFGYMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
              F     + L+ +F+   DL   +    ++FT  ++K Y       L++LH   I++R
Sbjct: 64  HYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYR 122

Query: 182 DLKPNNLLINKQGVLKIGDFGLAK 205
           DLKP N+L++++G +K+ DFGL+K
Sbjct: 123 DLKPENILLDEEGHIKLTDFGLSK 146

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 57.8 bits (139), Expect = 1e-09
 Identities = 38/148 (25%), Positives = 74/148 (50%), Gaps = 8/148 (5%)

Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y ++  +  G   TV+ A D+ T   VA++++ L      +  IN     EI +++E  +
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-----EILVMRENKN 76

Query: 117 ENVLGLTDVFGYMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
            N++   D +     + +V E++    L  ++ +  +      I A     L+ LE+LH 
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLHS 134

Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFGL 203
           + ++HRD+K +N+L+   G +K+ DFG 
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGF 162

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 57.4 bits (138), Expect = 2e-09
 Identities = 39/148 (26%), Positives = 74/148 (50%), Gaps = 8/148 (5%)

Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y ++  +  G   TV+ A DI T   VA+K++ L      +  IN     EI +++E  +
Sbjct: 21  YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIIN-----EILVMRENKN 75

Query: 117 ENVLGLTDVFGYMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
            N++   D +     + +V E++    L  ++ +  +      I A     L+ L++LH 
Sbjct: 76  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALDFLHS 133

Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFGL 203
           + ++HRD+K +N+L+   G +K+ DFG 
Sbjct: 134 NQVIHRDIKSDNILLGMDGSVKLTDFGF 161

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 46/156 (29%), Positives = 76/156 (48%), Gaps = 33/156 (21%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V K R + T  I+AVK+I+          +N    +  +LL +L   ++   +  
Sbjct: 12  GAYGVVDKMRHVPTGTIMAVKRIRAT--------VNSQEQK--RLLMDL---DISMRSVD 58

Query: 126 FGYM----------SNVSLVFEFVDTDLE-----VIIKDPTIVFTPSNIKA-YAIMTLRG 169
             Y            +V +  E +DT L+     V  K  TI   P +I    A+  ++ 
Sbjct: 59  CPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTI---PEDILGKIAVSIVKA 115

Query: 170 LEYLHDHW-ILHRDLKPNNLLINKQGVLKIGDFGLA 204
           LEYLH    ++HRD+KP+N+LIN+ G +K+ DFG++
Sbjct: 116 LEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 56.8 bits (137), Expect = 2e-09
 Identities = 44/170 (25%), Positives = 77/170 (45%), Gaps = 12/170 (7%)

Query: 61  RSVHVGRFATVFKAR---DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHE 117
           + +  G F  V   R     + ++ VA+K +K G + + +    R  L E  ++ +  H 
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAG-YTEKQ---RRDFLSEASIMGQFDHP 65

Query: 118 NVLGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH 176
           N++ L  V      V +V E+++   L+  ++     FT   +         G++YL D 
Sbjct: 66  NIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM 125

Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAKFF-GSPTRLYTH---QVVTRW 222
             +HRDL   N+L+N   V K+ DFGL++     P   YT    ++  RW
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 175

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 56.7 bits (137), Expect = 2e-09
 Identities = 42/152 (27%), Positives = 72/152 (47%), Gaps = 12/152 (7%)

Query: 66  GRFATVFKARDIETDM-IVAVKKIKLGTHADAKDGINRTA-----LREIKLLQE-LHHEN 118
           G F  V+K R       ++A+K+I +   A  KD   R       + E+ +++E L H N
Sbjct: 11  GAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPN 70

Query: 119 VLGLTDVFGYMSNVSLVFEFVD----TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH 174
           ++     F     + +V + ++     +    +K+    FT   I    +  +  L YLH
Sbjct: 71  IVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH 130

Query: 175 -DHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
            +  I+HRDL PNN+++ +   + I DFGLAK
Sbjct: 131 KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK 162

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 57.0 bits (137), Expect = 3e-09
 Identities = 39/138 (28%), Positives = 66/138 (47%), Gaps = 6/138 (4%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G    V  A +  T   VAVKK+ L      K         E+ ++++ HHENV+ + + 
Sbjct: 33  GSTGIVCIATEKHTGKQVAVKKMDL-----RKQQRRELLFNEVVIMRDYHHENVVDMYNS 87

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
           +     + +V EF++      I   T +     I    +  LR L YLH+  ++HRD+K 
Sbjct: 88  YLVGDELWVVMEFLEGGALTDIVTHTRM-NEEQIATVCLSVLRALSYLHNQGVIHRDIKS 146

Query: 186 NNLLINKQGVLKIGDFGL 203
           +++L+   G +K+ DFG 
Sbjct: 147 DSILLTSDGRIKLSDFGF 164

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 56.6 bits (136), Expect = 3e-09
 Identities = 42/148 (28%), Positives = 71/148 (47%), Gaps = 14/148 (9%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V+   D +T   +AVK+++    +            EI+LL+ L HE ++     
Sbjct: 13  GAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV---QY 69

Query: 126 FGYMSN-----VSLVFEFVDTDLEVIIKDPTIVF---TPSNIKAYAIMTLRGLEYLHDHW 177
           +G + +     +S+  E +       IKD    +   T +  + Y    L G+ YLH + 
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGG---SIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM 126

Query: 178 ILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           I+HRD+K  N+L +  G +K+GDFG +K
Sbjct: 127 IVHRDIKGANILRDSVGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 56.3 bits (136), Expect = 3e-09
 Identities = 33/125 (26%), Positives = 59/125 (47%), Gaps = 7/125 (5%)

Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTD 142
           VA+K I+ G  ++  D I      E K++ +L H N++ L  V      + +V E++   
Sbjct: 31  VAIKMIREGAMSE-DDFIE-----EAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84

Query: 143 -LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDF 201
            L   +++         +          +EYL  +  +HRDL   N L+ +  V+K+ DF
Sbjct: 85  CLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDF 144

Query: 202 GLAKF 206
           GLA++
Sbjct: 145 GLARY 149

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 56.3 bits (136), Expect = 3e-09
 Identities = 40/141 (28%), Positives = 66/141 (46%), Gaps = 6/141 (4%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V+K   ++ +  VAVK  +     D K    R  L+E ++L++  H N++ L  V
Sbjct: 6   GNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLK----RKFLQEAEILKQYDHPNIVKLIGV 60

Query: 126 FGYMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
                 + +V E V    L   ++      T   +   ++    G+EYL     +HRDL 
Sbjct: 61  CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLA 120

Query: 185 PNNLLINKQGVLKIGDFGLAK 205
             N L+ +  VLKI DFG+++
Sbjct: 121 ARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 56.9 bits (138), Expect = 3e-09
 Identities = 42/147 (28%), Positives = 70/147 (47%), Gaps = 16/147 (10%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINR---TALREIK-LLQELHHENVLG 121
           G F  V+  RD +T  + A+K ++        D I R     +R  + +L +     ++ 
Sbjct: 12  GAFGEVWLVRDKDTGQVYAMKVLR------KSDMIKRNQIAHVRAERDILADADSPWIVK 65

Query: 122 LTDVFGYMSNVSLVFEFV---DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
           L   F    ++ LV E++   D    +I KD   VF     + Y    +  L+ +H    
Sbjct: 66  LYYSFQDEEHLYLVMEYMPGGDLMNLLIRKD---VFPEETARFYIAELVLALDSVHKLGF 122

Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAK 205
           +HRD+KP+N+LI+  G +K+ DFGL K
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCK 149

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 56.2 bits (135), Expect = 3e-09
 Identities = 43/142 (30%), Positives = 70/142 (49%), Gaps = 11/142 (7%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  VFK  D  T  +VA+K I L    D  + I +    EI +L +     V   T  
Sbjct: 15  GSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ----EITVLSQCDSPYV---TKY 67

Query: 126 FG-YMSNVSL--VFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
           +G Y+ +  L  + E++     + + +P      + I       L+GL+YLH    +HRD
Sbjct: 68  YGSYLKDTKLWIIMEYLGGGSALDLLEPG-PLDETQIATILREILKGLDYLHSEKKIHRD 126

Query: 183 LKPNNLLINKQGVLKIGDFGLA 204
           +K  N+L+++ G +K+ DFG+A
Sbjct: 127 IKAANVLLSEHGEVKLADFGVA 148

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 56.2 bits (135), Expect = 3e-09
 Identities = 39/141 (27%), Positives = 61/141 (43%), Gaps = 5/141 (3%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  VF  R    +  VAVK  +     D K       L+E ++L++  H N++ L  V
Sbjct: 6   GNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKF----LQEARILKQYSHPNIVRLIGV 61

Query: 126 FGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
                 + +V E V   D    ++          +         G+EYL     +HRDL 
Sbjct: 62  CTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLA 121

Query: 185 PNNLLINKQGVLKIGDFGLAK 205
             N L+ ++ VLKI DFG+++
Sbjct: 122 ARNCLVTEKNVLKISDFGMSR 142

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 56.2 bits (136), Expect = 4e-09
 Identities = 41/145 (28%), Positives = 62/145 (42%), Gaps = 15/145 (10%)

Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENV---LGLTDVFGYMSNVSLVFEFV 139
           VAVK +K    A  K       LRE  ++ +L H  +   +G+      M    LV E  
Sbjct: 26  VAVKTLKQEHIAAGKKEF----LREASVMAQLDHPCIVRLIGVCKGEPLM----LVMELA 77

Query: 140 DTD--LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLK 197
                L+ + K   I    S++K  A     G+ YL     +HRDL   N+L+  +   K
Sbjct: 78  PLGPLLKYLKKRREI--PVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAK 135

Query: 198 IGDFGLAKFFGSPTRLYTHQVVTRW 222
           I DFG+++  G+ +  Y      RW
Sbjct: 136 ISDFGMSRALGAGSDYYRATTAGRW 160

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 56.2 bits (136), Expect = 4e-09
 Identities = 41/153 (26%), Positives = 73/153 (47%), Gaps = 26/153 (16%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F TV K     +  I+AVK+I+     D K+        + +LL +L  + V+  +D 
Sbjct: 15  GAFGTVNKMLHKPSGTIMAVKRIRSTV--DEKE--------QKRLLMDL--DVVMRSSDC 62

Query: 126 FGYMSNVSLVF---------EFVDTDLE---VIIKDPTIVFTPSNIKAY-AIMTLRGLEY 172
              +     +F         E +D  L+     + +      P  I    A+ T++ L Y
Sbjct: 63  PYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNY 122

Query: 173 L-HDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           L  +  I+HRD+KP+N+L+++ G +K+ DFG++
Sbjct: 123 LKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS 155

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 56.6 bits (136), Expect = 4e-09
 Identities = 43/140 (30%), Positives = 65/140 (46%), Gaps = 2/140 (1%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V   R+  +    A+K +K      AKD +  T L E ++L+   H  +  L   
Sbjct: 6   GTFGKVILVREKASGKYYAMKILKKEV-IIAKDEVAHT-LTESRVLKNTRHPFLTSLKYS 63

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
           F     +  V E+V+            VF+    + Y    +  L+YLH   I++RDLK 
Sbjct: 64  FQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKL 123

Query: 186 NNLLINKQGVLKIGDFGLAK 205
            NL+++K G +KI DFGL K
Sbjct: 124 ENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 55.9 bits (135), Expect = 4e-09
 Identities = 38/161 (23%), Positives = 75/161 (46%), Gaps = 11/161 (6%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL-REIKLLQELHHENVLGLTD 124
           G F  V++    +  + VA+K +K      + D + +    +E++ L+ L H++++ L  
Sbjct: 17  GYFGEVWEGL-WKNRVRVAIKILK------SDDLLKQQDFQKEVQALKRLRHKHLISLFA 69

Query: 125 VFGYMSNVSLVFEFVDT-DLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
           V      V ++ E ++   L   ++ P   V   +++   A     G+ YL +   +HRD
Sbjct: 70  VCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRD 129

Query: 183 LKPNNLLINKQGVLKIGDFGLAKFFGSPTRL-YTHQVVTRW 222
           L   N+L+ +  V K+ DFGLA+       L    ++  +W
Sbjct: 130 LAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKW 170

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 55.8 bits (134), Expect = 4e-09
 Identities = 45/151 (29%), Positives = 79/151 (52%), Gaps = 20/151 (13%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKL--GTHADAKDGINRTALR-EIKLLQELHHENVLGL 122
           G F  V+   D +T   +AVK++     +   +K+ +N  AL  EI+LL+ L H+ ++  
Sbjct: 13  GAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKE-VN--ALECEIQLLKNLRHDRIV-- 67

Query: 123 TDVFGYMSN-----VSLVFEFVDTDLEVIIKDPTIVF---TPSNIKAYAIMTLRGLEYLH 174
              +G + +     +S+  E++       IKD    +   T +  + Y    L+G+ YLH
Sbjct: 68  -QYYGCLRDPEEKKLSIFVEYMPGG---SIKDQLKAYGALTENVTRRYTRQILQGVSYLH 123

Query: 175 DHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
            + I+HRD+K  N+L +  G +K+GDFG +K
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 56.0 bits (135), Expect = 5e-09
 Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 22/158 (13%)

Query: 66  GRFATVFK--ARDI----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENV 119
           G F  V++  A DI       + VAVK ++ G    A D   +  L+E  L+   +H N+
Sbjct: 6   GAFGEVYEGTATDILGPGSGPIRVAVKTLRKG----ATDQEKKEFLKEAHLMSNFNHPNI 61

Query: 120 LGLTDVFGYMSNVSLVFEFVDT-DLEVIIKD------PTIVFTPSNIKAYAIMTLRGLEY 172
           + L  V        ++ E ++  DL   ++D         + T   +    +   +G  Y
Sbjct: 62  VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121

Query: 173 LHDHWILHRDLKPNNLLINKQG-----VLKIGDFGLAK 205
           L     +HRDL   N L++++G     V+KIGDFGLA+
Sbjct: 122 LEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 55.8 bits (134), Expect = 5e-09
 Identities = 45/163 (27%), Positives = 72/163 (44%), Gaps = 23/163 (14%)

Query: 61  RSVHVGRFATVFKAR-----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH 115
           R +  G F  VF A        +  ++VAVK +K     DA D   +   RE +LL  L 
Sbjct: 11  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLK-----DASDNARKDFHREAELLTNLQ 65

Query: 116 HENVLGLTDVFGYMSNVSLVFEFVD-TDLEVIIK------------DPTIVFTPSNIKAY 162
           HE+++    V      + +VFE++   DL   ++            +     T S +   
Sbjct: 66  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125

Query: 163 AIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           A     G+ YL     +HRDL   N L+ +  ++KIGDFG+++
Sbjct: 126 AQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 56.4 bits (136), Expect = 5e-09
 Identities = 39/153 (25%), Positives = 75/153 (49%), Gaps = 14/153 (9%)

Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIK----LLQELHH 116
           +++ +G F  V   R ++T+ + A+K ++        D + R     +K    +L E  +
Sbjct: 7   KTIGIGAFGEVCLVRKVDTNALYAMKTLR------KADVLMRNQAAHVKAERDILAEADN 60

Query: 117 ENVLGLTDVFGYMSNVSLVFEFV-DTDL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH 174
           E V+ L   F    N+  V +++   D+  ++I+    +F     + Y       +E +H
Sbjct: 61  EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVH 118

Query: 175 DHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF 207
               +HRD+KP+N+LI++ G +K+ DFGL   F
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 56.0 bits (135), Expect = 6e-09
 Identities = 43/140 (30%), Positives = 63/140 (45%), Gaps = 2/140 (1%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V   R+  T    A+K +K      AKD +  T L E ++LQ   H  +  L   
Sbjct: 6   GTFGKVILVREKATGKYYAMKILKKEVII-AKDEVAHT-LTESRVLQNTRHPFLTALKYS 63

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
           F     +  V E+ +            VF+    + Y    +  L YLH   +++RDLK 
Sbjct: 64  FQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKL 123

Query: 186 NNLLINKQGVLKIGDFGLAK 205
            NL+++K G +KI DFGL K
Sbjct: 124 ENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 55.6 bits (134), Expect = 6e-09
 Identities = 43/141 (30%), Positives = 67/141 (47%), Gaps = 4/141 (2%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V   +   T  + A KK  L      K    + AL E K+L+++    ++ L   
Sbjct: 4   GGFGEVCACQVKATGKMYACKK--LDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYA 61

Query: 126 FGYMSNVSLVFEFVDT-DLEV-IIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
           F    ++ LV   ++  DL+  I       F  +    YA   + GLE+LH   I++RDL
Sbjct: 62  FETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDL 121

Query: 184 KPNNLLINKQGVLKIGDFGLA 204
           KP N+L++  G ++I D GLA
Sbjct: 122 KPENVLLDDHGNVRISDLGLA 142

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 56.7 bits (136), Expect = 6e-09
 Identities = 71/274 (25%), Positives = 112/274 (40%), Gaps = 63/274 (22%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           GRF  VF  +   T      K I   ++   K+      + E+ +++EL H+N++   D 
Sbjct: 24  GRFGEVFLVKHKRTQEFFCWKAI---SYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80

Query: 126 FGYMSNVSL--VFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMT-----LRGLEYLHD-- 175
           F   +N  L  + EF D  DL   I+    +F    I+ +AI+      L  L Y H+  
Sbjct: 81  FLNKANQKLYILMEFCDAGDLSRNIQKCYKMF--GKIEEHAIVDITRQLLHALAYCHNLK 138

Query: 176 -----HWILHRDLKPNNLL-----------------INKQGVLKIGDFGLAKFFGSPTRL 213
                  +LHRDLKP N+                  +N + + KIGDFGL+K  G  +  
Sbjct: 139 DGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES-- 196

Query: 214 YTHQVV-TRWYRLIKCLLYCVQ-FNVKNVQWC--------CFAKDPSSHGNLF------- 256
             H  V T +Y   + LL+  + ++ K+  W         C  K P    N F       
Sbjct: 197 MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISEL 256

Query: 257 ---PGIPLNEIFTAAGDDLLAVISSLLCLNPTKR 287
              P +P+         +L  +I +LL L+  +R
Sbjct: 257 KRGPDLPIK----GKSKELNILIKNLLNLSAKER 286

Length = 1021

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 56.0 bits (135), Expect = 6e-09
 Identities = 48/151 (31%), Positives = 73/151 (48%), Gaps = 20/151 (13%)

Query: 66  GRFATVFKARDI---ETDMIVAVKKIKLGTHA-DAKDGINRTALREIKLLQELHHENVLG 121
           G +  VF+ R +   +T  I A+K +K  T   + KD  +  A R I  L+ + H  ++ 
Sbjct: 7   GGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNI--LEAVKHPFIVD 64

Query: 122 LTDVFGYMSNVSLVFE-------FVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH 174
           L   F     + L+ E       F+  + E I  + T  F  S I          LE+LH
Sbjct: 65  LIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEI-------SLALEHLH 117

Query: 175 DHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
              I++RDLKP N+L++ QG +K+ DFGL K
Sbjct: 118 QQGIIYRDLKPENILLDAQGHVKLTDFGLCK 148

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 55.8 bits (135), Expect = 6e-09
 Identities = 42/152 (27%), Positives = 70/152 (46%), Gaps = 7/152 (4%)

Query: 64  HVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLT 123
            VGR   VF  R   T  + A+K +        ++ + R  L E ++L  L H  +  L 
Sbjct: 13  DVGR---VFLVRLKGTGKLFALKVLDK-KEMIKRNKVKR-VLTEQEILATLDHPFLPTLY 67

Query: 124 DVFGYMSNVSLVFEFVDT-DLEVII-KDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
             F   + + LV ++    +L  ++ + P    +    + YA   L  LEYLH   I++R
Sbjct: 68  ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYR 127

Query: 182 DLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL 213
           DLKP N+L+++ G + + DF L+K        
Sbjct: 128 DLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 54.9 bits (132), Expect = 9e-09
 Identities = 21/52 (40%), Positives = 39/52 (75%)

Query: 153 VFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           VF+ + ++ YA   + GLE++H+ ++++RDLKP N+L+++ G ++I D GLA
Sbjct: 93  VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 144

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 54.3 bits (130), Expect = 1e-08
 Identities = 44/150 (29%), Positives = 72/150 (48%), Gaps = 19/150 (12%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTD 124
           G +  V+K R ++T  + A+K + +    D ++ I +    EI +L++  HH N+     
Sbjct: 17  GTYGQVYKGRHVKTGQLAAIKVMDVT--GDEEEEIKQ----EINMLKKYSHHRNIATYYG 70

Query: 125 VF------GYMSNVSLVFEFVD----TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH 174
            F      G    + LV EF      TDL    K  T+      I       LRGL +LH
Sbjct: 71  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL--KEEWIAYICREILRGLSHLH 128

Query: 175 DHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
            H ++HRD+K  N+L+ +   +K+ DFG++
Sbjct: 129 QHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 54.8 bits (132), Expect = 1e-08
 Identities = 73/271 (26%), Positives = 110/271 (40%), Gaps = 67/271 (24%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTD- 124
           G F  V  A    TD + A+K +K       KD I +    E  ++++     VL L   
Sbjct: 11  GSFGKVMLAERKGTDELYAIKILK-------KDVIIQDDDVECTMVEK----RVLALPGK 59

Query: 125 ---------VFGYMSNVSLVFEFVDT-DLEVII------KDPTIVFTPSNIKAYAIMTLR 168
                     F  M  +  V E+V+  DL   I      K+P  VF       YA     
Sbjct: 60  PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVF-------YAAEIAI 112

Query: 169 GLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK---FFGSPTRLYTHQVVTRWYRL 225
           GL +LH   I++RDLK +N++++ +G +KI DFG+ K   F G  TR +     T  Y  
Sbjct: 113 GLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCG---TPDYIA 169

Query: 226 IKCLLYCVQFNVKNVQWCCF--------AKDPSSHGNLFPGIPLNEIFTAAGD------- 270
            + + Y  Q   K+V W  F        A  P      F G   +E+F +  +       
Sbjct: 170 PEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPP-----FDGEDEDELFQSIMEHNVSYPK 222

Query: 271 ----DLLAVISSLLCLNPTKRADCTATLKMD 297
               + +++   LL  +P KR  C  T + D
Sbjct: 223 SLSKEAVSICKGLLTKHPAKRLGCGPTGERD 253

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 54.6 bits (131), Expect = 1e-08
 Identities = 38/117 (32%), Positives = 63/117 (53%), Gaps = 17/117 (14%)

Query: 106 REIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT-DLE--VIIKDP-TIVFTPSN--- 158
           +E  L+ ELHH N++ L  V      V ++FE+++  DL   +I++ P + V   S+   
Sbjct: 56  QEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDG 115

Query: 159 -IKA---------YAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
            +K+          AI    G+EYL  H+ +H+DL   N+LI +Q  +KI D GL++
Sbjct: 116 TVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 54.2 bits (131), Expect = 1e-08
 Identities = 43/150 (28%), Positives = 70/150 (46%), Gaps = 25/150 (16%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G+F  V+      T   VAVK +K GT +          L+E +++++L H+ ++ L  V
Sbjct: 17  GQFGEVWMGTWNGT-TKVAVKTLKPGTMSPE------AFLQEAQIMKKLRHDKLVQLYAV 69

Query: 126 FG----------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
                       YMS  SL+ +F+ +     ++ P +V   + I         G+ YL  
Sbjct: 70  CSEEEPIYIVTEYMSKGSLL-DFLKSGEGKKLRLPQLVDMAAQIAE-------GMAYLES 121

Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
              +HRDL   N+L+ +  V KI DFGLA+
Sbjct: 122 RNYIHRDLAARNILVGENLVCKIADFGLAR 151

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 37/142 (26%), Positives = 68/142 (47%), Gaps = 8/142 (5%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G+F  V+    +E    VA+K I+ G  ++         + E +++ +L H  ++ L  V
Sbjct: 15  GQFGLVWLGYWLEKRK-VAIKTIREGAMSEED------FIEEAQVMMKLSHPKLVQLYGV 67

Query: 126 FGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
               S + LVFEF++   L   ++     F+   +    +    G+ YL    ++HRDL 
Sbjct: 68  CTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLA 127

Query: 185 PNNLLINKQGVLKIGDFGLAKF 206
             N L+ +  V+K+ DFG+ +F
Sbjct: 128 ARNCLVGENQVVKVSDFGMTRF 149

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 53.9 bits (130), Expect = 2e-08
 Identities = 41/137 (29%), Positives = 62/137 (45%), Gaps = 7/137 (5%)

Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVD-- 140
           VAVK +K    +D  D      L+E  ++  L HEN++ L  V      + +V E     
Sbjct: 26  VAVKCLKSDKLSDIMDDF----LKEAAIMHSLDHENLIRLYGVV-LTHPLMMVTELAPLG 80

Query: 141 TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGD 200
           + L+ + KD    F  S +  YA+    G+ YL     +HRDL   N+L+     +KIGD
Sbjct: 81  SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGD 140

Query: 201 FGLAKFFGSPTRLYTHQ 217
           FGL +        Y  +
Sbjct: 141 FGLMRALPQNEDHYVME 157

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 54.7 bits (131), Expect = 2e-08
 Identities = 39/145 (26%), Positives = 70/145 (48%), Gaps = 1/145 (0%)

Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           R +  G +A V   R  +T+ I A+K +K     D +D I+     +    Q  +H  ++
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDED-IDWVQTEKHVFEQASNHPFLV 59

Query: 121 GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
           GL   F   S +  V E+V+    +            + + Y+      L YLH+  I++
Sbjct: 60  GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIY 119

Query: 181 RDLKPNNLLINKQGVLKIGDFGLAK 205
           RDLK +N+L++ +G +K+ D+G+ K
Sbjct: 120 RDLKLDNVLLDSEGHIKLTDYGMCK 144

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 35/110 (31%), Positives = 53/110 (48%)

Query: 97  KDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTP 156
           K G   +++ E +LL+ L H  VL L DV        LV     +DL   +         
Sbjct: 200 KAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYLGARLRPLGL 259

Query: 157 SNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF 206
           + + A A   L  ++Y+H   I+HRD+K  N+L+N    + +GDFG A F
Sbjct: 260 AQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACF 309

Length = 461

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 54.1 bits (130), Expect = 2e-08
 Identities = 33/112 (29%), Positives = 55/112 (49%), Gaps = 18/112 (16%)

Query: 104 ALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT-DLEVII----------KDPTI 152
           A+ E ++L ++H   ++ L   F   +++ LV   ++  DL   I           +P  
Sbjct: 40  AMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRA 99

Query: 153 VFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
            F       Y    + GLE+LH   I++RDLKP N+L++  G ++I D GLA
Sbjct: 100 CF-------YTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLA 144

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 53.9 bits (129), Expect = 2e-08
 Identities = 39/141 (27%), Positives = 70/141 (49%), Gaps = 9/141 (6%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V+K  D  T  +VA+K I L    D  + I +    EI +L +     +      
Sbjct: 15  GSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQ----EITVLSQCDSPYITRYYGS 70

Query: 126 FGYMSNVSLVFEFVD--TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
           +   + + ++ E++   + L+++   P      + I       L+GL+YLH    +HRD+
Sbjct: 71  YLKGTKLWIIMEYLGGGSALDLLKPGP---LEETYIATILREILKGLDYLHSERKIHRDI 127

Query: 184 KPNNLLINKQGVLKIGDFGLA 204
           K  N+L+++QG +K+ DFG+A
Sbjct: 128 KAANVLLSEQGDVKLADFGVA 148

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 54.0 bits (130), Expect = 2e-08
 Identities = 43/162 (26%), Positives = 70/162 (43%), Gaps = 27/162 (16%)

Query: 66  GRFATVFKAR-----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           G F  V+K       +  +   VA+K +K       +    +    E +L+ +L H N++
Sbjct: 16  GAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQ----EAELMSDLQHPNIV 71

Query: 121 GLTDV----------FGYMSNVSLVFEFV-----DTDLEVIIKDPTI--VFTPSNIKAYA 163
            L  V          F Y+++  L  EF+      +D+     D T+      S+    A
Sbjct: 72  CLLGVCTKEQPTCMLFEYLAHGDL-HEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130

Query: 164 IMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           I    G+EYL  H  +HRDL   N L+ +   +KI DFGL++
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 53.8 bits (129), Expect = 2e-08
 Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 25/160 (15%)

Query: 66  GRFATVFKARDIETD---MIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLG 121
           G F  V KAR I+ D   M  A+K++K   +A   D  +R    E+++L +L HH N++ 
Sbjct: 18  GNFGQVLKAR-IKKDGLRMDAAIKRMK--EYASKDD--HRDFAGELEVLCKLGHHPNIIN 72

Query: 122 LTDVFGYMSNVSLVFEF---------------VDTDLEVIIKDPTI-VFTPSNIKAYAIM 165
           L     +   + L  E+               ++TD    I + T    +   +  +A  
Sbjct: 73  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132

Query: 166 TLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
             RG++YL     +HRDL   N+L+ +  V KI DFGL++
Sbjct: 133 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 172

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 53.9 bits (129), Expect = 3e-08
 Identities = 21/52 (40%), Positives = 38/52 (73%)

Query: 153 VFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           VF+   ++ YA   + GLE++H+ ++++RDLKP N+L+++ G ++I D GLA
Sbjct: 93  VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 144

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 43/159 (27%), Positives = 81/159 (50%), Gaps = 16/159 (10%)

Query: 56  VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIK----LL 111
           ++ + +++ +G F  V  A  ++T  + A+K ++       KD +NR  +  +K    +L
Sbjct: 2   MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLR------KKDVLNRNQVAHVKAERDIL 55

Query: 112 QELHHENVLGLTDVFGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAIMTLR- 168
            E  +E V+ L   F    N+  V +++     + ++I+    VF P  +  + I  L  
Sbjct: 56  AEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR--MEVF-PEVLARFYIAELTL 112

Query: 169 GLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF 207
            +E +H    +HRD+KP+N+LI+  G +K+ DFGL   F
Sbjct: 113 AIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 53.6 bits (129), Expect = 3e-08
 Identities = 39/154 (25%), Positives = 66/154 (42%), Gaps = 27/154 (17%)

Query: 66  GRFATVFKARDIETDMI---VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL 122
           G F  V+    I++D      AVK +   T  +  +      L+E  ++++  H NVL L
Sbjct: 6   GHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQF----LKEGIIMKDFSHPNVLSL 61

Query: 123 TD-----------VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLE 171
                        V  YM +          DL   I+  T   T  ++  + +   +G+E
Sbjct: 62  LGICLPSEGSPLVVLPYMKH---------GDLRNFIRSETHNPTVKDLIGFGLQVAKGME 112

Query: 172 YLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           YL     +HRDL   N ++++   +K+ DFGLA+
Sbjct: 113 YLASKKFVHRDLAARNCMLDESFTVKVADFGLAR 146

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 53.3 bits (128), Expect = 3e-08
 Identities = 39/146 (26%), Positives = 68/146 (46%), Gaps = 8/146 (5%)

Query: 66  GRFATVFKAR---DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL 122
           G F  V + R     + ++ VA+K +K G     +    R  L E  ++ +  H N++ L
Sbjct: 15  GEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR----RDFLSEASIMGQFDHPNIIHL 70

Query: 123 TDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
             V      V ++ EF++   L+  ++     FT   +         G++YL +   +HR
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHR 130

Query: 182 DLKPNNLLINKQGVLKIGDFGLAKFF 207
           DL   N+L+N   V K+ DFGL++F 
Sbjct: 131 DLAARNILVNSNLVCKVSDFGLSRFL 156

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 53.4 bits (128), Expect = 3e-08
 Identities = 42/166 (25%), Positives = 73/166 (43%), Gaps = 14/166 (8%)

Query: 66  GRFATVFKA---RDIETDMIVAVKKIKLG-THADAKDGINRTALREIKLLQELHHENVLG 121
           G F  VF+         ++ VA+K +K G T    +D      L E  ++ +  H N++ 
Sbjct: 16  GEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQD-----FLSEASIMGQFSHHNIIR 70

Query: 122 LTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
           L  V        ++ E+++   L+  ++D    F+   +         G++YL D   +H
Sbjct: 71  LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVH 130

Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFF-GSPTRLYTH---QVVTRW 222
           RDL   N+L+N     K+ DFGL++     P   YT    ++  RW
Sbjct: 131 RDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRW 176

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 53.5 bits (129), Expect = 4e-08
 Identities = 37/149 (24%), Positives = 71/149 (47%), Gaps = 16/149 (10%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIK----LLQELHHENVLG 121
           G F  V   +  +T  I A+KK++        + + +  +  ++    +L E  +  V+ 
Sbjct: 12  GAFGEVRLVQKKDTGHIYAMKKLR------KSEMLEKEQVAHVRAERDILAEADNPWVVK 65

Query: 122 LTDVFGYMSNVSLVFEFV---DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
           L   F   + + L+ E++   D    ++ KD    FT    + Y   T+  ++ +H    
Sbjct: 66  LYYSFQDENYLYLIMEYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKLGY 122

Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAKFF 207
           +HRD+KP+NLL++ +G +K+ DFGL    
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 53.3 bits (128), Expect = 4e-08
 Identities = 22/52 (42%), Positives = 35/52 (67%)

Query: 154 FTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           F  +  + YA   + GL++LH   I++RDLK +N+L++K G +KI DFG+ K
Sbjct: 93  FDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 53.5 bits (128), Expect = 4e-08
 Identities = 42/141 (29%), Positives = 65/141 (46%), Gaps = 3/141 (2%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V   ++  T    A+K +K      AKD +  T L E ++LQ   H  +  L   
Sbjct: 6   GTFGKVILVKEKATGRYYAMKILKKEVIV-AKDEVAHT-LTENRVLQNSRHPFLTALKYS 63

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH-DHWILHRDLK 184
           F     +  V E+ +            VF+    + Y    +  L+YLH +  +++RDLK
Sbjct: 64  FQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLK 123

Query: 185 PNNLLINKQGVLKIGDFGLAK 205
             NL+++K G +KI DFGL K
Sbjct: 124 LENLMLDKDGHIKITDFGLCK 144

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 53.5 bits (128), Expect = 5e-08
 Identities = 40/158 (25%), Positives = 79/158 (50%), Gaps = 14/158 (8%)

Query: 56  VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIK----LL 111
           ++ + +++ +G F  V  AR ++T  + A+K ++       KD + R  +  +K    +L
Sbjct: 2   MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLR------KKDVLLRNQVAHVKAERDIL 55

Query: 112 QELHHENVLGLTDVFGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAIMTLRG 169
            E  +E V+ L   F    N+  V +++     + ++I+    +F     + Y       
Sbjct: 56  AEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR--MGIFPEDLARFYIAELTCA 113

Query: 170 LEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF 207
           +E +H    +HRD+KP+N+LI++ G +K+ DFGL   F
Sbjct: 114 VESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 52.8 bits (127), Expect = 5e-08
 Identities = 42/162 (25%), Positives = 69/162 (42%), Gaps = 26/162 (16%)

Query: 66  GRFATVFKARDIETD-----MIVAVKKIKL-GTHADAKDGINRTALREIKLLQELHHENV 119
           G F  V KA  +  D       VAVK +K   T  D  D +  + +  +K++ +  H+N+
Sbjct: 23  GAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLV--SEMEMMKMIGK--HKNI 78

Query: 120 LGLTDVFGYMSNVSLVFEF---------------VDTDLEVIIKDPTI-VFTPSNIKAYA 163
           + L  V      + +V E+                          P     T  ++ ++A
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 164 IMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
               RG+E+L     +HRDL   N+L+ +  V+KI DFGLA+
Sbjct: 139 YQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR 180

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 52.7 bits (126), Expect = 6e-08
 Identities = 42/150 (28%), Positives = 67/150 (44%), Gaps = 19/150 (12%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTD 124
           G +  V+K R ++T  + A+K +      D  +        EI +L++  HH N+     
Sbjct: 27  GTYGQVYKGRHVKTGQLAAIKVM------DVTEDEEEEIKLEINMLKKYSHHRNIATYYG 80

Query: 125 VF------GYMSNVSLVFEFVD----TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH 174
            F      G+   + LV EF      TDL    K          I       LRGL +LH
Sbjct: 81  AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNA--LKEDWIAYICREILRGLAHLH 138

Query: 175 DHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
            H ++HRD+K  N+L+ +   +K+ DFG++
Sbjct: 139 AHKVIHRDIKGQNVLLTENAEVKLVDFGVS 168

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 52.8 bits (127), Expect = 7e-08
 Identities = 43/155 (27%), Positives = 72/155 (46%), Gaps = 8/155 (5%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  VF A+  +T  IVA+K++K        + +    L E  +L     E ++ L   
Sbjct: 12  GGYGQVFLAKKKDTGEIVALKRMKKSL-LFKLNEVRHV-LTERDILTTTKSEWLVKLLYA 69

Query: 126 FGYMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           F     + L  E+V   D   ++ +   V +  + + Y       ++ LH+   +HRDLK
Sbjct: 70  FQDDEYLYLAMEYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLK 128

Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVV 219
           P N LI+  G +K+ DFGL+K   +    Y + VV
Sbjct: 129 PENFLIDASGHIKLTDFGLSKGIVT----YANSVV 159

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 52.5 bits (126), Expect = 8e-08
 Identities = 53/248 (21%), Positives = 106/248 (42%), Gaps = 38/248 (15%)

Query: 69  ATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFG 127
           AT +     +  M VAVK +K   H+  ++ +    + E+K++  L +HEN++ L     
Sbjct: 54  ATAYGLSKSDAVMKVAVKMLKPTAHSSEREAL----MSELKIMSHLGNHENIVNLLGACT 109

Query: 128 YMSNVSLVFEFV---DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
               + ++ E+    D  L  + +      T  ++ +++    +G+ +L     +HRDL 
Sbjct: 110 IGGPILVITEYCCYGDL-LNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLA 168

Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTR----WY---RLIKCLLYCVQFNV 237
             N+L+    ++KI DFGLA+   + +  Y  +   R    W     +  C +Y  + +V
Sbjct: 169 ARNVLLTHGKIVKICDFGLARDIMNDSN-YVVKGNARLPVKWMAPESIFNC-VYTFESDV 226

Query: 238 KN---VQWCCFAKDPSSHGNLFPGIPLNEIFTA-------------AGDDLLAVISSLLC 281
            +   + W  F    S   N +PG+P++  F               A  ++  ++ +   
Sbjct: 227 WSYGILLWEIF----SLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWD 282

Query: 282 LNPTKRAD 289
            +P KR  
Sbjct: 283 ADPLKRPT 290

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 52.5 bits (126), Expect = 9e-08
 Identities = 40/140 (28%), Positives = 62/140 (44%), Gaps = 1/140 (0%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V  A+        AVK ++       K+  +  A R + LL+ + H  ++GL   
Sbjct: 6   GSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNV-LLKNVKHPFLVGLHYS 64

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
           F     +  V ++V+             F     + YA      L YLH   I++RDLKP
Sbjct: 65  FQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKP 124

Query: 186 NNLLINKQGVLKIGDFGLAK 205
            N+L++ QG + + DFGL K
Sbjct: 125 ENILLDSQGHVVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 52.9 bits (127), Expect = 9e-08
 Identities = 46/170 (27%), Positives = 71/170 (41%), Gaps = 29/170 (17%)

Query: 78  ETDMIVAVKKIKLGTHADAKDGINRTAL--REIKLLQELHHENVLGLTD--------VFG 127
            T   VA+K ++     DA +  ++ A   RE  L   L+H N++ L D        +F 
Sbjct: 1   MTGHEVAIKLLRT----DAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFA 56

Query: 128 YMSNVSLVFEFVD--TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
                  VFE+V   T  EV+  D              +  L  L   H+  I+HRDLKP
Sbjct: 57  -------VFEYVPGRTLREVLAADG--ALPAGETGRLMLQVLDALACAHNQGIVHRDLKP 107

Query: 186 NNLLINKQGV---LKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYC 232
            N+++++ GV    K+ DFG+        R      +TR   ++    YC
Sbjct: 108 QNIMVSQTGVRPHAKVLDFGIGT-LLPGVRDADVATLTRTTEVLGTPTYC 156

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 41/140 (29%), Positives = 63/140 (45%), Gaps = 1/140 (0%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V  A+        AVK ++  T    K+  +  A R + LL+ L H  ++GL   
Sbjct: 6   GSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLVGLHYS 64

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
           F     +  V ++V+             F     + YA      + YLH   I++RDLKP
Sbjct: 65  FQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKP 124

Query: 186 NNLLINKQGVLKIGDFGLAK 205
            N+L++ QG + + DFGL K
Sbjct: 125 ENILLDSQGHVVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 33/125 (26%), Positives = 61/125 (48%), Gaps = 6/125 (4%)

Query: 79  TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEF 138
           +  +VAVKK+ L      K         E+ ++++  HENV+ + + +     + +V EF
Sbjct: 44  SGKLVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98

Query: 139 VDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKI 198
           ++      I   T +     I A  +  L+ L  LH   ++HRD+K +++L+   G +K+
Sbjct: 99  LEGGALTDIVTHTRM-NEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKL 157

Query: 199 GDFGL 203
            DFG 
Sbjct: 158 SDFGF 162

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 51.5 bits (123), Expect = 1e-07
 Identities = 43/152 (28%), Positives = 72/152 (47%), Gaps = 8/152 (5%)

Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           + Q+R +  G F  V   +   T  + A K+++       K      AL E ++L++++ 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKG--ESMALNEKQILEKVNS 59

Query: 117 ENVLGLTDVFGYMSNVSLVFEFVDT-DLEVII---KDPTIVFTPSNIKAYAIMTLRGLEY 172
           + V+ L   +     + LV   ++  DL+  I    +P   F       YA   L GLE 
Sbjct: 60  QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG--FEEERALFYAAEILCGLED 117

Query: 173 LHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           LH    ++RDLKP N+L++  G ++I D GLA
Sbjct: 118 LHRENTVYRDLKPENILLDDYGHIRISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 51.1 bits (122), Expect = 2e-07
 Identities = 50/186 (26%), Positives = 86/186 (46%), Gaps = 18/186 (9%)

Query: 66  GRFATVFKA--RDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENV---L 120
           G F TV K   +  +++  VAVK +K   + +    +    LRE  ++Q+L +  +   +
Sbjct: 6   GNFGTVKKGMYKMKKSEKTVAVKILK---NDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 121 GLTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWIL 179
           G+ +   +M    LV E  +   L   ++    V T  NI         G++YL +   +
Sbjct: 63  GICEAESWM----LVMELAELGPLNKFLQKNKHV-TEKNITELVHQVSMGMKYLEETNFV 117

Query: 180 HRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW---YRLIKCLLYCVQFN 236
           HRDL   N+L+  Q   KI DFGL+K  G+    Y  +   +W   +   +C+ Y  +F+
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY-YKFS 176

Query: 237 VKNVQW 242
            K+  W
Sbjct: 177 SKSDVW 182

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 39/140 (27%), Positives = 63/140 (45%), Gaps = 1/140 (0%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V  AR    +   AVK ++       K+  +  + R + LL+ + H  ++GL   
Sbjct: 6   GSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNV-LLKNVKHPFLVGLHFS 64

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
           F     +  V ++++             F     + YA      L YLH   I++RDLKP
Sbjct: 65  FQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKP 124

Query: 186 NNLLINKQGVLKIGDFGLAK 205
            N+L++ QG + + DFGL K
Sbjct: 125 ENILLDSQGHIVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 38/142 (26%), Positives = 77/142 (54%), Gaps = 16/142 (11%)

Query: 70  TVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM 129
            V+K R  +T  ++AVK+++   + +     N+  L ++ ++ + H  +   +   +GY 
Sbjct: 30  QVYKMRFKKTGHVMAVKQMRRTGNKEE----NKRILMDLDVVLKSH--DCPYIVKCYGYF 83

Query: 130 ---SNVSLVFEFVDTDLEVIIKDPTIVFTPSNI---KAYAIMTLRGLEYLHD-HWILHRD 182
              S+V +  E + T L+ ++K       P +I      AI  ++ L YL + H ++HRD
Sbjct: 84  ITDSDVFICMELMSTCLDKLLKR-IQGPIPEDILGKMTVAI--VKALHYLKEKHGVIHRD 140

Query: 183 LKPNNLLINKQGVLKIGDFGLA 204
           +KP+N+L++  G +K+ DFG++
Sbjct: 141 VKPSNILLDASGNVKLCDFGIS 162

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 41/140 (29%), Positives = 58/140 (41%), Gaps = 40/140 (28%)

Query: 148 KDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK-- 205
           K P    T  ++ + A    RG+EYL     +HRDL   N+L+ +  V+KI DFGLA+  
Sbjct: 125 KLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDV 184

Query: 206 ----FFGSPT----------------RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWCCF 245
               ++   T                R+YTHQ    W            F V  + W  F
Sbjct: 185 HNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV-W-----------SFGV--LLWEIF 230

Query: 246 AKDPSSHGNLFPGIPLNEIF 265
               S     +PGIP+ E+F
Sbjct: 231 TLGGSP----YPGIPVEELF 246

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 39/141 (27%), Positives = 62/141 (43%), Gaps = 6/141 (4%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  VFK   ++    VAVK  K     D    +    L E ++L++  H N++ L  V
Sbjct: 6   GNFGEVFKG-TLKDKTPVAVKTCK----EDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60

Query: 126 FGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
                 + +V E V   D    ++          +  +A+    G+ YL     +HRDL 
Sbjct: 61  CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLA 120

Query: 185 PNNLLINKQGVLKIGDFGLAK 205
             N L+ +  VLKI DFG+++
Sbjct: 121 ARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 51.0 bits (122), Expect = 2e-07
 Identities = 36/154 (23%), Positives = 66/154 (42%), Gaps = 10/154 (6%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G++  V++    +  + VAVK +K  T            L+E  +++E+ H N++ L  V
Sbjct: 17  GQYGEVYEGVWKKYSLTVAVKTLKEDTME------VEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 126 FGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
                   ++ EF+     L+ + +          +   A      +EYL     +HRDL
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 130

Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQ 217
              N L+ +  ++K+ DFGL++     T  YT  
Sbjct: 131 AARNCLVGENHLVKVADFGLSRLMTGDT--YTAH 162

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 50.7 bits (121), Expect = 3e-07
 Identities = 19/44 (43%), Positives = 32/44 (72%)

Query: 162 YAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           YA   + GL++LH   I++RDLK +N+++++ G +KI DFG+ K
Sbjct: 101 YAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 50.6 bits (121), Expect = 3e-07
 Identities = 38/149 (25%), Positives = 70/149 (46%), Gaps = 16/149 (10%)

Query: 59  QWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHEN 118
           Q+  VH+G++    K         VA+K I  G  ++ +D I      E K++ +L H  
Sbjct: 16  QFGVVHLGKWRAQIK---------VAIKAINEGAMSE-EDFI-----EEAKVMMKLSHPK 60

Query: 119 VLGLTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHW 177
           ++ L  V      + +V EF++   L   ++      +   + +       G+EYL  + 
Sbjct: 61  LVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS 120

Query: 178 ILHRDLKPNNLLINKQGVLKIGDFGLAKF 206
            +HRDL   N L++  GV+K+ DFG+ ++
Sbjct: 121 FIHRDLAARNCLVSSTGVVKVSDFGMTRY 149

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 50.8 bits (121), Expect = 3e-07
 Identities = 49/166 (29%), Positives = 74/166 (44%), Gaps = 26/166 (15%)

Query: 61  RSVHVGRFATVFKAR-----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH 115
           R +  G F  VF A        +  M+VAVK +K  T A  KD       RE +LL  L 
Sbjct: 11  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD-----FQREAELLTNLQ 65

Query: 116 HENVLGLTDVFGYMSNVSLVFEFVD-TDLEVIIK----DPTIVFTPSNIKAYAIMTLR-- 168
           HE+++    V G    + +VFE++   DL   ++    D  I+      +A   + L   
Sbjct: 66  HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125

Query: 169 ---------GLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
                    G+ YL     +HRDL   N L+    ++KIGDFG+++
Sbjct: 126 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 50.4 bits (120), Expect = 3e-07
 Identities = 37/133 (27%), Positives = 67/133 (50%), Gaps = 23/133 (17%)

Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG---------YMSNVS 133
           VA+K +K GT +          L+E +++++L HE ++ L  V           YMS  S
Sbjct: 33  VAIKTLKPGTMSP------EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGS 86

Query: 134 LVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ 193
           L+ +F+  ++   ++ P +V   + I +       G+ Y+     +HRDL+  N+L+ + 
Sbjct: 87  LL-DFLKGEMGKYLRLPQLVDMAAQIAS-------GMAYVERMNYVHRDLRAANILVGEN 138

Query: 194 GVLKIGDFGLAKF 206
            V K+ DFGLA+ 
Sbjct: 139 LVCKVADFGLARL 151

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 50.5 bits (121), Expect = 3e-07
 Identities = 40/154 (25%), Positives = 70/154 (45%), Gaps = 10/154 (6%)

Query: 66  GRFATVFKAR---DIETDMI-VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F TV+K     + E   I VA+K ++  T   A    N+  L E  ++  + H +V+ 
Sbjct: 18  GAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKA----NKEILDEAYVMASVDHPHVVR 73

Query: 122 LTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
           L  +    S V L+ + +    L   +++         +  + +   +G+ YL +  ++H
Sbjct: 74  LLGI-CLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVH 132

Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY 214
           RDL   N+L+     +KI DFGLAK      + Y
Sbjct: 133 RDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY 166

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 50.3 bits (120), Expect = 4e-07
 Identities = 41/141 (29%), Positives = 66/141 (46%), Gaps = 2/141 (1%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V + R  +T  I A+K I+   H  ++  +  T L E  +L +++   ++ L   
Sbjct: 4   GSFGKVMQVRKRDTQRIYALKTIR-KAHIVSRSEVTHT-LAERTVLAQVNCPFIVPLKFS 61

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
           F     + LV  F++             F  S  + Y    L  LE LH   +++RDLKP
Sbjct: 62  FQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKP 121

Query: 186 NNLLINKQGVLKIGDFGLAKF 206
            N+L++ QG + + DFGL K 
Sbjct: 122 ENILLDYQGHIALCDFGLCKL 142

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 50.3 bits (120), Expect = 4e-07
 Identities = 70/276 (25%), Positives = 112/276 (40%), Gaps = 54/276 (19%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINR-----TALREIKLLQELH-HENV 119
           G F  V  AR  E+  + AVK +K       KD I +       + E ++L     H  +
Sbjct: 6   GSFGKVMLARLKESGRLYAVKVLK-------KDVILQDDDVECTMTEKRILSLARNHPFL 58

Query: 120 LGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
             L   F     +  V EFV+  DL   I+  +  F  +  + YA      L +LHD  I
Sbjct: 59  TQLYCCFQTPDRLFFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKGI 117

Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAK-----------FFGSPTRL-------YTHQVVT 220
           ++RDLK +N+L++ +G  K+ DFG+ K           F G+P  +         +    
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSV 177

Query: 221 RWYRLIKCLLYCVQFNVKNVQWCCFAK-DPSSHGNLFPGIPLNEIF--TAAGDDLLAVIS 277
            W+ +   LLY           C  A  +  +  +LF  I  +E+   T    D + ++ 
Sbjct: 178 DWWAM-GVLLY--------EMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILK 228

Query: 278 SLLCLNPTKRADCT------ATLKMDYFSLTKEMYW 307
           + +  NPT R          A L+  +F   KE+ W
Sbjct: 229 AFMTKNPTMRLGSLTLGGEEAILRHPFF---KELDW 261

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 50.4 bits (120), Expect = 4e-07
 Identities = 41/140 (29%), Positives = 63/140 (45%), Gaps = 1/140 (0%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V  A+        AVK ++     + K+  +  A R + LL+ + H  ++GL   
Sbjct: 6   GSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV-LLKNVKHPFLVGLHYS 64

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
           F     +  V +FV+             F     + YA      L YLH   I++RDLKP
Sbjct: 65  FQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKP 124

Query: 186 NNLLINKQGVLKIGDFGLAK 205
            N+L++ QG + + DFGL K
Sbjct: 125 ENILLDSQGHVVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 50.4 bits (120), Expect = 4e-07
 Identities = 41/116 (35%), Positives = 54/116 (46%), Gaps = 16/116 (13%)

Query: 107 EIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKA----- 161
           E K+L  ++H   + L   F   S + LV EFV       I      F   N +      
Sbjct: 81  ERKILNYINHPFCVNLYGSFKDESYLYLVLEFV-------IGGEFFTFLRRNKRFPNDVG 133

Query: 162 --YAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYT 215
             YA   +   EYL    I++RDLKP NLL++K G +K+ DFG AK     TR YT
Sbjct: 134 CFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV--DTRTYT 187

Length = 340

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 49.6 bits (119), Expect = 6e-07
 Identities = 36/155 (23%), Positives = 60/155 (38%), Gaps = 19/155 (12%)

Query: 66  GRFATVFK--ARDI---ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           G F  V++  A+ +   E +  VA+K      + +A        L E  +++E +  +V+
Sbjct: 17  GSFGMVYEGLAKGVVKGEPETRVAIKT----VNENASMRERIEFLNEASVMKEFNCHHVV 72

Query: 121 GLTDVFGYMSNVSLVFEFVDT-DL---------EVIIKDPTIVFTPSNIKAYAIMTLRGL 170
            L  V        +V E +   DL         E          T       A     G+
Sbjct: 73  RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132

Query: 171 EYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
            YL     +HRDL   N ++ +   +KIGDFG+ +
Sbjct: 133 AYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 49.9 bits (119), Expect = 6e-07
 Identities = 40/154 (25%), Positives = 69/154 (44%), Gaps = 27/154 (17%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V++ R  +T  I A+K +             +  + + ++   +   N+L  T +
Sbjct: 4   GTFGQVYQVRKKDTRRIYAMKVLS-----------KKEIVAKKEVAHTIGERNILVRTLL 52

Query: 126 FGYMSNVSLVFEF-VDTDLEVII-------------KDPTIVFTPSNIKAYAIMTLRGLE 171
                 V L F F  D+DL ++              K+    F+    K Y    +  LE
Sbjct: 53  DESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGR--FSEDRAKFYIAELVLALE 110

Query: 172 YLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           +LH + I++RDLKP N+L++  G + + DFGL+K
Sbjct: 111 HLHKYDIVYRDLKPENILLDATGHIALCDFGLSK 144

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 49.2 bits (117), Expect = 7e-07
 Identities = 40/153 (26%), Positives = 67/153 (43%), Gaps = 8/153 (5%)

Query: 71  VFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS 130
           V+K R  + D  VA+K +K       +D +    +RE +++ +L +  ++ +  V     
Sbjct: 15  VYKMRKKQID--VAIKVLKNENEKSVRDEM----MREAEIMHQLDNPYIVRMIGVC-EAE 67

Query: 131 NVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLL 189
            + LV E      L   +       T SN+         G++YL     +HRDL   N+L
Sbjct: 68  ALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVL 127

Query: 190 INKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW 222
           +  Q   KI DFGL+K  G+    Y  +   +W
Sbjct: 128 LVNQHYAKISDFGLSKALGADDSYYKARSAGKW 160

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 49.6 bits (118), Expect = 7e-07
 Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 18/157 (11%)

Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           + Q+R +  G F  V   +   T  + A KK++       K      AL E ++L++++ 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG--ESMALNEKQILEKVNS 59

Query: 117 ENVLGLTDVFGYMSNVSLVFEFVDT-DLEVII--------KDPTIVFTPSNIKAYAIMTL 167
             V+ L   +     + LV   ++  DL+  I        ++   VF       YA    
Sbjct: 60  RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF-------YAAEIC 112

Query: 168 RGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
            GLE LH   I++RDLKP N+L++  G ++I D GLA
Sbjct: 113 CGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 49.1 bits (117), Expect = 8e-07
 Identities = 21/43 (48%), Positives = 28/43 (65%)

Query: 162 YAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           YA     GLE LH   I++RDLKP N+L++  G ++I D GLA
Sbjct: 107 YAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 49.5 bits (118), Expect = 8e-07
 Identities = 31/105 (29%), Positives = 49/105 (46%), Gaps = 5/105 (4%)

Query: 102 RTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDL--EVIIKDPTIVFTPSNI 159
           +T  REI +L+ + H  ++ L   + + S V +V      DL   V    P  +     I
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITI 190

Query: 160 KAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           +      L  L YLH   I+HRD+K  N+ +++     +GDFG A
Sbjct: 191 QR---RLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAA 232

Length = 392

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 49.3 bits (117), Expect = 8e-07
 Identities = 37/120 (30%), Positives = 53/120 (44%), Gaps = 40/120 (33%)

Query: 168 RGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK------FFGSPT---------- 211
           RG+EYL     +HRDL   N+L+ +  V+KI DFGLA+      ++   T          
Sbjct: 148 RGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMA 207

Query: 212 ------RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWCCFAKDPSSHGNLFPGIPLNEIF 265
                 R+YTHQ    W            F V  + W  F    +  G+ +PGIP+ E+F
Sbjct: 208 PEALFDRVYTHQSDV-W-----------SFGV--LMWEIF----TLGGSPYPGIPVEELF 249

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 49.1 bits (117), Expect = 9e-07
 Identities = 36/138 (26%), Positives = 61/138 (44%), Gaps = 19/138 (13%)

Query: 81  MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVD 140
           ++VAVK ++     DA        L+EIK++  L   N++ L  V      + ++ E+++
Sbjct: 47  VLVAVKMLR----EDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYME 102

Query: 141 T-DLE------------VIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNN 187
             DL                   TI +  S +   A     G++YL     +HRDL   N
Sbjct: 103 NGDLNQFLSRHEPQEAAEKADVVTISY--STLIFMATQIASGMKYLSSLNFVHRDLATRN 160

Query: 188 LLINKQGVLKIGDFGLAK 205
            L+ K   +KI DFG+++
Sbjct: 161 CLVGKNYTIKIADFGMSR 178

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 48.7 bits (116), Expect = 9e-07
 Identities = 35/132 (26%), Positives = 61/132 (46%), Gaps = 23/132 (17%)

Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG---------YMSNVS 133
           VA+K +K G+ +          L E  L+++L H  ++ L  V           YM N S
Sbjct: 33  VAIKSLKQGSMSPE------AFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYMENGS 86

Query: 134 LVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ 193
           LV +F+ T   + +    ++   + I         G+ ++     +HRDL+  N+L+++ 
Sbjct: 87  LV-DFLKTPEGIKLTINKLIDMAAQIA-------EGMAFIERKNYIHRDLRAANILVSET 138

Query: 194 GVLKIGDFGLAK 205
              KI DFGLA+
Sbjct: 139 LCCKIADFGLAR 150

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 48.8 bits (116), Expect = 1e-06
 Identities = 47/160 (29%), Positives = 73/160 (45%), Gaps = 25/160 (15%)

Query: 66  GRFATVFKAR----DIETD-MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           G F  VF A       E D M+VAVK +K     +A +   +   RE +LL  L H++++
Sbjct: 16  GAFGKVFLAECHNLLPEQDKMLVAVKALK-----EASESARQDFQREAELLTVLQHQHIV 70

Query: 121 GLTDVFGYMSNVSLVFEFV-DTDLEVIIK----DPTIV----------FTPSNIKAYAIM 165
               V      + +VFE++   DL   ++    D  I+           T   + A A  
Sbjct: 71  RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130

Query: 166 TLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
              G+ YL     +HRDL   N L+ +  V+KIGDFG+++
Sbjct: 131 IASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 48.8 bits (116), Expect = 1e-06
 Identities = 42/141 (29%), Positives = 65/141 (46%), Gaps = 3/141 (2%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  VF A    T+   A+K +K        D +  T + +  L     H  +  L   
Sbjct: 6   GSFGKVFLAELKGTNQFFAIKALKKDV-VLMDDDVECTMVEKRVLSLAWEHPFLTHLYCT 64

Query: 126 FGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           F    N+  V E+++  DL   I+     F       YA   + GL++LH   I++RDLK
Sbjct: 65  FQTKENLFFVMEYLNGGDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLK 123

Query: 185 PNNLLINKQGVLKIGDFGLAK 205
            +N+L++  G +KI DFG+ K
Sbjct: 124 LDNILLDTDGHIKIADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 48.8 bits (116), Expect = 1e-06
 Identities = 35/120 (29%), Positives = 53/120 (44%), Gaps = 40/120 (33%)

Query: 168 RGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK------FFGSPT---------- 211
           RG+EYL     +HRDL   N+L+ +  V+KI DFGLA+      ++   +          
Sbjct: 145 RGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMA 204

Query: 212 ------RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWCCFAKDPSSHGNLFPGIPLNEIF 265
                 R+YTHQ    W            F +  + W  F    +  G+ +PGIP+ E+F
Sbjct: 205 PEALFDRVYTHQSDV-W-----------SFGI--LMWEIF----TLGGSPYPGIPVEELF 246

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 48.9 bits (116), Expect = 1e-06
 Identities = 39/145 (26%), Positives = 68/145 (46%), Gaps = 1/145 (0%)

Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           R +  G +A V   R  + D I A+K +K     D +D I+     +    Q   +  ++
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDED-IDWVQTEKHVFEQASSNPFLV 59

Query: 121 GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
           GL   F   S + LV E+V+    +            + + YA      L +LH+  I++
Sbjct: 60  GLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIY 119

Query: 181 RDLKPNNLLINKQGVLKIGDFGLAK 205
           RDLK +N+L++  G +K+ D+G+ K
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCK 144

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 48.3 bits (115), Expect = 2e-06
 Identities = 39/141 (27%), Positives = 67/141 (47%), Gaps = 3/141 (2%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +A V      +T  I A+K IK     D +D I+     +       +H  ++GL   
Sbjct: 6   GSYAKVLLVELKKTRRIYAMKVIKKELVNDDED-IDWVQTEKHVFETASNHPFLVGLHSC 64

Query: 126 FGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           F   S +  V EFV   DL   ++         + + Y+      L +LH+  I++RDLK
Sbjct: 65  FQTESRLFFVIEFVSGGDLMFHMQRQR-KLPEEHARFYSAEISLALNFLHERGIIYRDLK 123

Query: 185 PNNLLINKQGVLKIGDFGLAK 205
            +N+L++ +G +K+ D+G+ K
Sbjct: 124 LDNVLLDAEGHIKLTDYGMCK 144

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 48.1 bits (114), Expect = 2e-06
 Identities = 38/138 (27%), Positives = 59/138 (42%), Gaps = 40/138 (28%)

Query: 150 PTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK---- 205
           P    +  ++ + A    RG+EYL     +HRDL   N+L+ +  V+KI DFGLA+    
Sbjct: 133 PEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 192

Query: 206 --FFGSPT----------------RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWCCFAK 247
             ++   T                R+YTHQ    W            F V  + W  F  
Sbjct: 193 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV-W-----------SFGV--LLWEIF-- 236

Query: 248 DPSSHGNLFPGIPLNEIF 265
             +  G+ +PG+P+ E+F
Sbjct: 237 --TLGGSPYPGVPVEELF 252

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 47.7 bits (113), Expect = 2e-06
 Identities = 39/133 (29%), Positives = 63/133 (47%), Gaps = 23/133 (17%)

Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG---------YMSNVS 133
           VAVK +K GT +        + L E +++++L H+ ++ L  V           YMS  S
Sbjct: 33  VAVKTLKPGTMSP------ESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMSKGS 86

Query: 134 LVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ 193
           L+    D +   + K P +V   + + A       G+ Y+     +HRDL+  N+L+   
Sbjct: 87  LLDFLKDGEGRAL-KLPNLVDMAAQVAA-------GMAYIERMNYIHRDLRSANILVGDG 138

Query: 194 GVLKIGDFGLAKF 206
            V KI DFGLA+ 
Sbjct: 139 LVCKIADFGLARL 151

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 47.7 bits (113), Expect = 3e-06
 Identities = 23/58 (39%), Positives = 35/58 (60%), Gaps = 7/58 (12%)

Query: 148 KDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           K+P  VF       YA     GL +LH   I++RDLK +N++++ +G +KI DFG+ K
Sbjct: 99  KEPQAVF-------YAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCK 149

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 47.3 bits (112), Expect = 4e-06
 Identities = 38/136 (27%), Positives = 65/136 (47%), Gaps = 16/136 (11%)

Query: 82  IVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT 141
           +VAVK ++    AD         L+EIK++  L + N++ L  V      + ++ E+++ 
Sbjct: 46  LVAVKMLR----ADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMEN 101

Query: 142 -DLEVIIKDPTI--VFTPSN-IKAYAIMTL--------RGLEYLHDHWILHRDLKPNNLL 189
            DL   +    I   FT +N I + +I  L         G++YL     +HRDL   N L
Sbjct: 102 GDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161

Query: 190 INKQGVLKIGDFGLAK 205
           +     +KI DFG+++
Sbjct: 162 VGNHYTIKIADFGMSR 177

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 46.9 bits (111), Expect = 4e-06
 Identities = 39/134 (29%), Positives = 58/134 (43%), Gaps = 26/134 (19%)

Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL-----------GLTDVFGYMSN 131
           VAVK IK        D   +  L E  ++ +L H N++           GL  V  YM+ 
Sbjct: 32  VAVKCIK-------NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 84

Query: 132 VSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLIN 191
            SLV         V+  D  + F        ++     +EYL  +  +HRDL   N+L++
Sbjct: 85  GSLVDYLRSRGRSVLGGDCLLKF--------SLDVCEAMEYLEANNFVHRDLAARNVLVS 136

Query: 192 KQGVLKIGDFGLAK 205
           +  V K+ DFGL K
Sbjct: 137 EDNVAKVSDFGLTK 150

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 47.1 bits (112), Expect = 4e-06
 Identities = 41/144 (28%), Positives = 64/144 (44%), Gaps = 9/144 (6%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADA---KDGINRTALREIKLLQELHHENVLGL 122
           G F  V  A    TD + A+K +K     D     D ++ T   +  L     H  +  L
Sbjct: 6   GSFGKVMLAELKGTDEVYAIKVLK----KDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61

Query: 123 TDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
              F     +  V E+V+  DL   I+     F     + YA      L +LH H +++R
Sbjct: 62  HCCFQTKDRLFFVMEYVNGGDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLHRHGVIYR 120

Query: 182 DLKPNNLLINKQGVLKIGDFGLAK 205
           DLK +N+L++ +G  K+ DFG+ K
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 46.9 bits (111), Expect = 5e-06
 Identities = 32/91 (35%), Positives = 47/91 (51%), Gaps = 14/91 (15%)

Query: 122 LTDVFGYMSNVSLVFEFVDT-DLEVII------KDPTIVFTPSNIKAYAIMTLRGLEYLH 174
           L   F  M  +  V E+V+  DL   I      K+P  VF       YA     GL +LH
Sbjct: 66  LHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVF-------YAAEIAIGLFFLH 118

Query: 175 DHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
              I++RDLK +N++++ +G +KI DFG+ K
Sbjct: 119 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK 149

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 46.6 bits (110), Expect = 6e-06
 Identities = 21/66 (31%), Positives = 37/66 (56%), Gaps = 3/66 (4%)

Query: 140 DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIG 199
           + + E + K      T  ++  Y+    +G+E+L     +HRDL   N+L+++  V+KI 
Sbjct: 165 EAEQEDLYKKV---LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKIC 221

Query: 200 DFGLAK 205
           DFGLA+
Sbjct: 222 DFGLAR 227

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 46.2 bits (109), Expect = 7e-06
 Identities = 43/156 (27%), Positives = 70/156 (44%), Gaps = 21/156 (13%)

Query: 66  GRFATVFKARDIETDMI--VAVK--KIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F +V + +  + D I  VAVK  KI + T ++ +D      L E   ++E  H NV+ 
Sbjct: 10  GEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMED-----FLSEAVCMKEFDHPNVMR 64

Query: 122 LTDVF-------GYMSNVSLVFEFVDTDLEVIIK----DPTIVFTPSNIKAYAIMTL-RG 169
           L  V        GY S V ++      DL   +          + P+ +    +  +  G
Sbjct: 65  LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124

Query: 170 LEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           +EYL     +HRDL   N ++N+   + + DFGL+K
Sbjct: 125 MEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 46.3 bits (110), Expect = 7e-06
 Identities = 20/58 (34%), Positives = 36/58 (62%)

Query: 154 FTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT 211
           FT S ++ Y    +  L++LH   I++RD+K  N+L++ +G + + DFGL+K F +  
Sbjct: 102 FTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 46.5 bits (110), Expect = 8e-06
 Identities = 20/52 (38%), Positives = 32/52 (61%)

Query: 154 FTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
            T  ++  Y+    RG+E+L     +HRDL   N+L+++  V+KI DFGLA+
Sbjct: 171 LTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR 222

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 47.1 bits (112), Expect = 8e-06
 Identities = 18/38 (47%), Positives = 26/38 (68%)

Query: 169 GLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF 206
            +EY+H   +LHRDLKP+N+L+   G + I D+G A F
Sbjct: 125 TIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIF 162

Length = 932

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 22/47 (46%), Positives = 35/47 (74%), Gaps = 1/47 (2%)

Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL 213
           L GL++LH++ I+HRD+K NN+L+  +G +K+ DFG++    S TRL
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS-TRL 183

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 46.0 bits (109), Expect = 1e-05
 Identities = 23/66 (34%), Positives = 40/66 (60%), Gaps = 3/66 (4%)

Query: 140 DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIG 199
           D + + + K+P    T  ++ +Y+    RG+E+L     +HRDL   N+L+++  V+KI 
Sbjct: 159 DEEGDELYKEP---LTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKIC 215

Query: 200 DFGLAK 205
           DFGLA+
Sbjct: 216 DFGLAR 221

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 23/46 (50%), Positives = 27/46 (58%)

Query: 159 IKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           IK      L GL  LH   I+HRD+KP NLL+   G +KI DFG A
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 45.8 bits (108), Expect = 1e-05
 Identities = 24/75 (32%), Positives = 45/75 (60%), Gaps = 4/75 (5%)

Query: 131 NVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNL 188
           N+ L+ EF+     + +++K  T+  T    + Y   T+  ++ +H    +HRD+KP+NL
Sbjct: 75  NLYLIMEFLPGGDMMTLLMKKDTL--TEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNL 132

Query: 189 LINKQGVLKIGDFGL 203
           L++ +G +K+ DFGL
Sbjct: 133 LLDSKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 45.0 bits (106), Expect = 2e-05
 Identities = 37/154 (24%), Positives = 69/154 (44%), Gaps = 24/154 (15%)

Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           + +  G+F  V+ A        VAVK +K G+ +          L E  +++ L H+ ++
Sbjct: 12  KKLGAGQFGEVWMA-TYNKHTKVAVKTMKPGSMSVE------AFLAEANVMKTLQHDKLV 64

Query: 121 GLTDVFG---------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLE 171
            L  V           +M+  SL+ +F+ +D       P ++        ++     G+ 
Sbjct: 65  KLHAVVTKEPIYIITEFMAKGSLL-DFLKSDEGSKQPLPKLI-------DFSAQIAEGMA 116

Query: 172 YLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           ++     +HRDL+  N+L++   V KI DFGLA+
Sbjct: 117 FIEQRNYIHRDLRAANILVSASLVCKIADFGLAR 150

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 38/133 (28%), Positives = 56/133 (42%), Gaps = 19/133 (14%)

Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENV---LG--LTD-----VFGYMSNV 132
           VAVK ++     DA D      L+E+K+L  L   N+   LG    D     +  YM N 
Sbjct: 49  VAVKVLR----PDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENG 104

Query: 133 SL---VFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLL 189
            L   + + V     +     ++  + S +   A     G+ YL     +HRDL   N L
Sbjct: 105 DLNQFLQKHVAETSGLACNSKSL--SFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL 162

Query: 190 INKQGVLKIGDFG 202
           + K   +KI DFG
Sbjct: 163 VGKNYTIKIADFG 175

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 45.0 bits (106), Expect = 2e-05
 Identities = 37/133 (27%), Positives = 64/133 (48%), Gaps = 24/133 (18%)

Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG----------YMSNV 132
           VAVK +K GT +       +  L E  L++ L H+ ++ L  V            YM+  
Sbjct: 33  VAVKTLKPGTMS------VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKG 86

Query: 133 SLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK 192
           SL+ +F+ +D    +  P ++   + I         G+ Y+     +HRDL+  N+L+++
Sbjct: 87  SLL-DFLKSDEGGKVLLPKLIDFSAQIA-------EGMAYIERKNYIHRDLRAANVLVSE 138

Query: 193 QGVLKIGDFGLAK 205
             + KI DFGLA+
Sbjct: 139 SLMCKIADFGLAR 151

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 45.0 bits (106), Expect = 2e-05
 Identities = 37/140 (26%), Positives = 70/140 (50%), Gaps = 6/140 (4%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V   +  +T  I A+K ++     + +   +  A R+I  L E     V+ +   
Sbjct: 12  GAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDI--LVEADGAWVVKMFYS 69

Query: 126 FGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
           F    N+ L+ EF+     + +++K  T+  +    + Y   T+  ++ +H    +HRD+
Sbjct: 70  FQDKRNLYLIMEFLPGGDMMTLLMKKDTL--SEEATQFYIAETVLAIDAIHQLGFIHRDI 127

Query: 184 KPNNLLINKQGVLKIGDFGL 203
           KP+NLL++ +G +K+ DFGL
Sbjct: 128 KPDNLLLDAKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 44.6 bits (105), Expect = 3e-05
 Identities = 19/53 (35%), Positives = 31/53 (58%)

Query: 162 YAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY 214
           + +   +G+ YL +  ++HRDL   N+L+     +KI DFGLAK  G+  + Y
Sbjct: 114 WCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEY 166

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 44.6 bits (105), Expect = 3e-05
 Identities = 20/43 (46%), Positives = 28/43 (65%)

Query: 162 YAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           YA     GLE L    I++RDLKP N+L++ +G ++I D GLA
Sbjct: 107 YAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 44.4 bits (105), Expect = 3e-05
 Identities = 37/158 (23%), Positives = 67/158 (42%), Gaps = 26/158 (16%)

Query: 66  GRFATVFKAR-----DIETDMIVAVKKIKLGTHADAKDGINRTAL-REIKLLQELHHENV 119
           G F  VF A+     +   + +V VK ++       KD   ++   RE+ + ++L H+NV
Sbjct: 16  GEFGEVFLAKAKGIEEEGGETLVLVKALQ-----KTKDENLQSEFRRELDMFRKLSHKNV 70

Query: 120 LGLTDVFGYMSNVS---LVFEFVD-TDLE---VIIKDPTIVFTPSNIKAYAIMTL----- 167
           + L    G         ++ E+ D  DL+      K       P  +     + L     
Sbjct: 71  VRL---LGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127

Query: 168 RGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
            G+++L +   +HRDL   N L++ Q  +K+    L+K
Sbjct: 128 LGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 43.9 bits (103), Expect = 5e-05
 Identities = 18/43 (41%), Positives = 29/43 (67%)

Query: 160 KAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG 202
           K Y    +  L+ +H   ++HRD+KP+N+L++K G LK+ DFG
Sbjct: 145 KFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG 187

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 44.1 bits (104), Expect = 5e-05
 Identities = 17/38 (44%), Positives = 28/38 (73%)

Query: 170 LEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF 207
           +E +H    +HRD+KP+N+LI++ G +K+ DFGL+  F
Sbjct: 114 IEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 43.5 bits (102), Expect = 6e-05
 Identities = 34/139 (24%), Positives = 61/139 (43%), Gaps = 8/139 (5%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G    V  AR+  +   VAVK + L      K         E+ ++++  H+NV+ +   
Sbjct: 32  GSTGIVCIAREKHSGRQVAVKMMDL-----RKQQRRELLFNEVVIMRDYQHQNVVEMYKS 86

Query: 126 FGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           +     + ++ EF+    L  I+           I       L+ L YLH   ++HRD+K
Sbjct: 87  YLVGEELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIK 144

Query: 185 PNNLLINKQGVLKIGDFGL 203
            +++L+   G +K+ DFG 
Sbjct: 145 SDSILLTLDGRVKLSDFGF 163

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 43.5 bits (102), Expect = 6e-05
 Identities = 36/133 (27%), Positives = 61/133 (45%), Gaps = 23/133 (17%)

Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG---------YMSNVS 133
           VA+K +K GT            L+E +++++L H+ ++ L  V           +M   S
Sbjct: 33  VAIKTLKPGTMMP------EAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGKGS 86

Query: 134 LVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ 193
           L+ +F+       +K P +V   + I         G+ Y+     +HRDL+  N+L+   
Sbjct: 87  LL-DFLKEGDGKYLKLPQLVDMAAQIA-------DGMAYIERMNYIHRDLRAANILVGDN 138

Query: 194 GVLKIGDFGLAKF 206
            V KI DFGLA+ 
Sbjct: 139 LVCKIADFGLARL 151

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 43.2 bits (102), Expect = 8e-05
 Identities = 16/33 (48%), Positives = 25/33 (75%)

Query: 170 LEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG 202
           L+ +H    +HRD+KP+N+L++K G LK+ DFG
Sbjct: 155 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG 187

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 43.1 bits (101), Expect = 8e-05
 Identities = 44/161 (27%), Positives = 72/161 (44%), Gaps = 27/161 (16%)

Query: 66  GRFATVFKARDIETD---MIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENV-- 119
           G F  V +A  I+ D   M  A+K +K    A   D  +R    E+++L +L HH N+  
Sbjct: 13  GNFGQVIRAM-IKKDGLKMNAAIKMLK--EFASEND--HRDFAGELEVLCKLGHHPNIIN 67

Query: 120 -LGLTDVFGYM------SNVSLVFEFVDTDLEVIIKDPTI--------VFTPSNIKAYAI 164
            LG  +  GY+      +    + +F+     V+  DP            T   +  +A 
Sbjct: 68  LLGACENRGYLYIAIEYAPYGNLLDFLRKS-RVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 165 MTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
               G++YL +   +HRDL   N+L+ +    KI DFGL++
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR 167

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 43.1 bits (102), Expect = 9e-05
 Identities = 35/139 (25%), Positives = 61/139 (43%), Gaps = 13/139 (9%)

Query: 69  ATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL-REIKLLQELHHENVLGLTDVFG 127
             V  A+   T+ +VAVKKI L    D+    +   L +EI   ++L H N+L     F 
Sbjct: 14  MIVHLAKHKPTNTLVAVKKINL----DSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI 69

Query: 128 YMSNVSLVFEFVD----TDLEVIIKDPTIVFTPSNIKAYAIM-TLRGLEYLHDHWILHRD 182
             S + +V   +      DL   +K       P    A+ +   L  L+Y+H    +HR 
Sbjct: 70  VDSELYVVSPLMAYGSCEDL---LKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRS 126

Query: 183 LKPNNLLINKQGVLKIGDF 201
           +K +++L++  G + +   
Sbjct: 127 VKASHILLSGDGKVVLSGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 43.1 bits (101), Expect = 9e-05
 Identities = 21/47 (44%), Positives = 33/47 (70%), Gaps = 1/47 (2%)

Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL 213
           L GL++LH +  +HRD+K NN+L+  +G +K+ DFG++    S TRL
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS-TRL 179

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 42.6 bits (100), Expect = 1e-04
 Identities = 38/169 (22%), Positives = 67/169 (39%), Gaps = 33/169 (19%)

Query: 66  GRFATVFKARDIETD-----MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           G F  V KA             VAVK +K    +       R  L E  LL++++H +V+
Sbjct: 11  GEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSEL----RDLLSEFNLLKQVNHPHVI 66

Query: 121 GLTDVFGYMSNVSLVFEFV------------------------DTDLEVIIKDPTIVFTP 156
            L         + L+ E+                         + +   +        T 
Sbjct: 67  KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126

Query: 157 SNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
            ++ ++A    RG++YL +  ++HRDL   N+L+ +   +KI DFGL++
Sbjct: 127 GDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 42.9 bits (101), Expect = 1e-04
 Identities = 39/163 (23%), Positives = 71/163 (43%), Gaps = 15/163 (9%)

Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y+  R +  G   TV  A+ +      AVK + +   ++A    NR A  E+  L     
Sbjct: 34  YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEAD--KNR-AQAEVCCLLNCDF 90

Query: 117 ENVLGLTDVFGY--------MSNVSLVFEFVDT-DLEVIIKDPTIV---FTPSNIKAYAI 164
            +++   + F          +  ++LV ++ +  DL   IK        F         I
Sbjct: 91  FSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFI 150

Query: 165 MTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF 207
             L  + ++H   ++HRD+K  N+L+   G++K+GDFG +K +
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMY 193

Length = 496

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 42.6 bits (100), Expect = 1e-04
 Identities = 42/162 (25%), Positives = 72/162 (44%), Gaps = 22/162 (13%)

Query: 61  RSVHVGRFATVFKAR---DIETDMIVAVKKIK--LGTHADAKDGINRTALREIKLLQELH 115
           R +  G F +V +A+   +  +   VAVK +K  + + +D ++      LRE   ++E  
Sbjct: 5   RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEE-----FLREAACMKEFD 59

Query: 116 HENVLGLTDVF------GYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKA-----YA 163
           H NV+ L  V       G +    ++  F+   DL   +    I   P  +       + 
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119

Query: 164 IMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           I    G+EYL     +HRDL   N ++N+   + + DFGL+K
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 42.6 bits (100), Expect = 1e-04
 Identities = 19/54 (35%), Positives = 35/54 (64%)

Query: 154 FTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF 207
           F+   ++ Y+   +  LE+LH   I++RD+K  N+L++ +G + + DFGL+K F
Sbjct: 102 FSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 42.2 bits (99), Expect = 1e-04
 Identities = 29/110 (26%), Positives = 56/110 (50%), Gaps = 2/110 (1%)

Query: 97  KDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT-DLEV-IIKDPTIVF 154
           K    + AL E ++L++++   ++ L   F   +++ LV   ++  DL+  I        
Sbjct: 33  KKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGL 92

Query: 155 TPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
               +  Y+     G+ +LH   I++RD+KP N+L++ QG  ++ D GLA
Sbjct: 93  EMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLA 142

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 42.5 bits (100), Expect = 1e-04
 Identities = 37/159 (23%), Positives = 67/159 (42%), Gaps = 26/159 (16%)

Query: 66  GRFATVFKAR---DIETDMIVAVKKIKLGTHADAKDGINRTA----LREIKLLQELHHEN 118
           G F +V + +   D  + + VAVK +KL       D    +     L E   +++  H N
Sbjct: 10  GEFGSVMEGQLSQDDGSQLKVAVKTMKL-------DIHTYSEIEEFLSEAACMKDFDHPN 62

Query: 119 VLGLTDVFGYMSNVS------LVFEFVDT-DLEVIIKDPTIVFTPSNIKA-----YAIMT 166
           V+ L  V    S++       ++  F+   DL   +    +   P  +       + +  
Sbjct: 63  VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDI 122

Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
             G+EYL +   +HRDL   N ++ +   + + DFGL+K
Sbjct: 123 ALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 17/41 (41%), Positives = 27/41 (65%)

Query: 162 YAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG 202
           Y    +  L+ +H    +HRD+KP+N+L++K G LK+ DFG
Sbjct: 147 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG 187

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 19/54 (35%), Positives = 33/54 (61%)

Query: 154 FTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF 207
           F    ++ Y+   +  LE+LH   I++RD+K  N+L++  G + + DFGL+K F
Sbjct: 102 FKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 40.8 bits (95), Expect = 5e-04
 Identities = 29/109 (26%), Positives = 52/109 (47%), Gaps = 8/109 (7%)

Query: 162 YAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTH---QV 218
           + +   +G+ YL +  ++HRDL   N+L+     +KI DFGLA+      + Y     ++
Sbjct: 114 WCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM 173

Query: 219 VTRWYRLIKCLLYCVQFNVKNVQW---CCFAKDPSSHGNLFPGIPLNEI 264
             +W  L +C+ Y  +F  ++  W       +  +  G  + GIP  EI
Sbjct: 174 PIKWMAL-ECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 220

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 40.4 bits (94), Expect = 5e-04
 Identities = 54/198 (27%), Positives = 89/198 (44%), Gaps = 29/198 (14%)

Query: 66  GRFATVFKARDIETD---MIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENV-- 119
           G F  V KAR I+ D   M  A+K++K   +A   D  +R    E+++L +L HH N+  
Sbjct: 6   GNFGQVLKAR-IKKDGLRMDAAIKRMK--EYASKDD--HRDFAGELEVLCKLGHHPNIIN 60

Query: 120 -LGLTDVFGYM------SNVSLVFEFVDTDLEVIIKDPTI--------VFTPSNIKAYAI 164
            LG  +  GY+      +    + +F+     V+  DP            +   +  +A 
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKS-RVLETDPAFAIANSTASTLSSQQLLHFAA 119

Query: 165 MTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYR 224
              RG++YL     +HRDL   N+L+ +  V KI DFGL++      +    ++  RW  
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMA 179

Query: 225 LIKCLLYCVQFNVKNVQW 242
            I+ L Y V +   +  W
Sbjct: 180 -IESLNYSV-YTTNSDVW 195

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 40.2 bits (94), Expect = 6e-04
 Identities = 15/44 (34%), Positives = 27/44 (61%)

Query: 159 IKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG 202
           +K +A   +  L+ LH   I+ RDL PNN+L++ +G +++  F 
Sbjct: 87  VKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFS 130

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 40.4 bits (94), Expect = 7e-04
 Identities = 40/159 (25%), Positives = 66/159 (41%), Gaps = 27/159 (16%)

Query: 67  RFATVFKARDI-----ETDMIVAVKKIKLGTHADAKDGINRTALR-EIKLLQELHHENVL 120
           RF  V+K         E    VA+K +K     D  +G  R   + E  +   L H N++
Sbjct: 17  RFGKVYKGHLFGTAPGEQTQAVAIKTLK-----DKAEGPLREEFKHEAMMRSRLQHPNIV 71

Query: 121 GLTDVFGYMSNVSLVF---------EFV-----DTDLEVIIKDPTI--VFTPSNIKAYAI 164
            L  V      +S++F         EF+      +D+     D T+     P++      
Sbjct: 72  CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131

Query: 165 MTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGL 203
               G+E+L  H ++H+DL   N+L+  +  +KI D GL
Sbjct: 132 QIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGL 170

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 40.8 bits (95), Expect = 7e-04
 Identities = 15/36 (41%), Positives = 25/36 (69%)

Query: 170 LEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           L+ +H   ++HRDLK  N+ +   G++K+GDFG +K
Sbjct: 182 LDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSK 217

Length = 478

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 39.9 bits (93), Expect = 8e-04
 Identities = 19/49 (38%), Positives = 28/49 (57%)

Query: 159 IKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF 207
           IK      L  LEY+H+H I H D+KP N++++      I D+G+A  F
Sbjct: 128 IKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHF 176

Length = 294

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 40.2 bits (94), Expect = 8e-04
 Identities = 37/140 (26%), Positives = 59/140 (42%), Gaps = 3/140 (2%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V   R+  T  I A+K +K       +        R+I  L   +   +  L   
Sbjct: 12  GHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDI--LSISNSPWIPQLQYA 69

Query: 126 FGYMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           F    N+ LV E+    DL  ++      F     + Y    +  +  +H    +HRD+K
Sbjct: 70  FQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIK 129

Query: 185 PNNLLINKQGVLKIGDFGLA 204
           P N+LI++ G +K+ DFG A
Sbjct: 130 PENVLIDRTGHIKLADFGSA 149

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 39.6 bits (92), Expect = 0.001
 Identities = 16/46 (34%), Positives = 27/46 (58%)

Query: 162 YAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF 207
           + +   +G+ YL +  ++HRDL   N+L+     +KI DFGLA+  
Sbjct: 114 WCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 39.9 bits (93), Expect = 0.001
 Identities = 18/69 (26%), Positives = 38/69 (55%), Gaps = 1/69 (1%)

Query: 138 FVDTDLEV-IIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVL 196
           ++D D+   I+++  +     ++ +++    +G+ +L     +HRDL   N+L+    + 
Sbjct: 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRIT 253

Query: 197 KIGDFGLAK 205
           KI DFGLA+
Sbjct: 254 KICDFGLAR 262

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 39.6 bits (92), Expect = 0.001
 Identities = 18/52 (34%), Positives = 31/52 (59%)

Query: 154 FTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
            T  ++ ++     RG+E+L     +HRDL   N+L+ +  ++KI DFGLA+
Sbjct: 234 LTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLAR 285

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 39.1 bits (91), Expect = 0.002
 Identities = 41/155 (26%), Positives = 66/155 (42%), Gaps = 26/155 (16%)

Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL----TDVFGYMSNVSLVFEF 138
           V VK+++      A        L E +  + L H N+L      T+V  Y+    LV EF
Sbjct: 25  VVVKELR----VSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYL----LVMEF 76

Query: 139 -----VDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ 193
                +   L    K   +   P+ ++  A     GL +LH +  +H DL   N L+   
Sbjct: 77  CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTAD 136

Query: 194 GVLKIGDFGLA------KFFGSPTRLYTHQVVTRW 222
             +KIGD+GL+       ++ +P +L+   V  RW
Sbjct: 137 LTVKIGDYGLSHNKYKEDYYVTPDQLW---VPLRW 168

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 39.5 bits (93), Expect = 0.002
 Identities = 18/75 (24%), Positives = 36/75 (48%), Gaps = 11/75 (14%)

Query: 133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLIN 191
           ++V E++   DL+ +++       P  ++    +  +    LH   I+H DL  +N ++ 
Sbjct: 412 TIVMEYIGGKDLKDVLEG-----NPELVRKVGEIVAK----LHKAGIVHGDLTTSNFIVR 462

Query: 192 KQGVLKIGDFGLAKF 206
              +  I DFGL K+
Sbjct: 463 DDRLYLI-DFGLGKY 476

Length = 535

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 38.4 bits (90), Expect = 0.002
 Identities = 27/107 (25%), Positives = 49/107 (45%), Gaps = 13/107 (12%)

Query: 102 RTALREIKLLQELHHE--NVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNI 159
           RT  RE ++L +       V  + DV     N  +V E+++     ++KD      P  +
Sbjct: 45  RT-RREARILAKAREAGVPVPIVYDVDPD--NGLIVMEYIE---GELLKDALEEARPDLL 98

Query: 160 KAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF 206
           +    +  +    LH   I+H DL  +N++++   +  I DFGL +F
Sbjct: 99  REVGRLVGK----LHKAGIVHGDLTTSNIILSGGRIYFI-DFGLGEF 140

Length = 204

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 19/65 (29%), Positives = 36/65 (55%), Gaps = 1/65 (1%)

Query: 141 TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGD 200
           T  + +I + +   +  ++  ++     G+E+L     +HRDL   N+LI +  ++KI D
Sbjct: 224 TRRDTLINE-SPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICD 282

Query: 201 FGLAK 205
           FGLA+
Sbjct: 283 FGLAR 287

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 38.3 bits (89), Expect = 0.003
 Identities = 51/196 (26%), Positives = 80/196 (40%), Gaps = 24/196 (12%)

Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT- 141
           V VK+++     D +       L+E++  +EL+H NVL             LV EF    
Sbjct: 25  VVVKELRASATPDEQL----LFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80

Query: 142 DLEVIIKDPTIVFT----PSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLK 197
           DL+  ++    +         ++  A     GL +LH    +H DL   N  +     +K
Sbjct: 81  DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVK 140

Query: 198 IGDFGLAKFFGSPTRLYT----HQVVTRWYRLIKCLLYCVQFNVKNVQWCCFAKDPSSHG 253
           IGD+GLA     P   Y     H V  RW  L   L+     ++         KD +   
Sbjct: 141 IGDYGLA-LEQYPEDYYITKDCHAVPLRW--LAPELVEIRGQDLL-------PKDQTKKS 190

Query: 254 NLFP-GIPLNEIFTAA 268
           N++  G+ + E+FTAA
Sbjct: 191 NIWSLGVTMWELFTAA 206

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 38.0 bits (88), Expect = 0.004
 Identities = 15/49 (30%), Positives = 30/49 (61%)

Query: 156 PSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           P  +  + +   +G+ YL +H ++HR+L   N+L+    +++I DFG+A
Sbjct: 108 PQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVA 156

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 37.8 bits (88), Expect = 0.004
 Identities = 35/150 (23%), Positives = 67/150 (44%), Gaps = 9/150 (6%)

Query: 61  RSVHVGRFATVFKA--RDIETDMI-VAVKKIKLGTHADAKDGINRTALREIKLLQELHHE 117
           R +  G+F  V++      E + I VAVK  K          +    L+E  ++++  H 
Sbjct: 12  RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCK----NCTSPSVREKFLQEAYIMRQFDHP 67

Query: 118 NVLGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH 176
           +++ L  V      V +V E     +L   ++        +++  Y+      L YL   
Sbjct: 68  HIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK 126

Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAKF 206
             +HRD+   N+L++    +K+GDFGL+++
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRY 156

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	307
KOG0615|consensus	475		100.0
KOG0593|consensus	396		100.0
KOG0659|consensus	318		100.0
KOG0575|consensus	592		100.0
KOG0661|consensus	538		100.0
KOG0581|consensus	364		100.0
KOG0600|consensus	560		100.0
KOG0663|consensus	419		100.0
KOG0598|consensus	357		100.0
KOG0592|consensus	604		100.0
KOG0595|consensus	429		100.0
KOG0583|consensus	370		100.0
KOG0660|consensus	359		100.0
KOG0594|consensus	323		100.0
KOG0588|consensus	786		100.0
KOG0578|consensus	550		100.0
KOG0591|consensus	375		100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0582|consensus	516		100.0
KOG0616|consensus	355		100.0
KOG0033|consensus	355		100.0
KOG0605|consensus	550		100.0
KOG0198|consensus	313		100.0
KOG0585|consensus	576		100.0
KOG0597|consensus	808		100.0
KOG0658|consensus	364		100.0
KOG0662|consensus	292		100.0
KOG0032|consensus	382		100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0611|consensus	668		100.0
KOG0694|consensus	694		100.0
KOG0599|consensus	411		100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0580|consensus	281		100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0610|consensus	459		100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0192|consensus	362		100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0201|consensus	467		100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0667|consensus	586		100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG4717|consensus	864		100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0666|consensus	438		100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0574|consensus	502		100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG0589|consensus	426		100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0197|consensus	468		100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0586|consensus	596		100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG4236|consensus	888		100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0669|consensus	376		100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG0579|consensus	1187		100.0
PTZ00284	467	protein kinase; Provisional	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
KOG0690|consensus	516		100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0604|consensus	400		100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG0596|consensus	677		100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
KOG0577|consensus	948		100.0
KOG0193|consensus	678		100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
KOG1187|consensus	361		100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
KOG0607|consensus	463		100.0
KOG4279|consensus	1226		100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG0986|consensus	591		100.0
KOG0671|consensus	415		100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
KOG2345|consensus	302		100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
KOG0194|consensus	474		100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG1989|consensus	738		100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0603|consensus	612		100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG0983|consensus	391		100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0612|consensus	1317		100.0
KOG1026|consensus	774		100.0
KOG1035|consensus	1351		100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG4721|consensus	904		100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0584|consensus	632		100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
KOG0695|consensus	593		100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
KOG1094|consensus	807		100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
KOG0668|consensus	338		100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0670|consensus	752		100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG1095|consensus	1025		100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG4645|consensus	1509		100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0696|consensus	683		100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
KOG0587|consensus	953		100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG1290|consensus	590		100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG0196|consensus	996		100.0
KOG1006|consensus	361		100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG0614|consensus	732		100.0
KOG1027|consensus	903		100.0
KOG0608|consensus	1034		100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG1151|consensus	775		100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG0665|consensus	369		100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG4257|consensus	974		100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0664|consensus	449		100.0
KOG4250|consensus	732		100.0
KOG4278|consensus	1157		100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG2052|consensus	513		100.0
KOG0199|consensus	1039		100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0576|consensus	829		100.0
KOG1167|consensus	418		100.0
KOG3653|consensus	534		100.0
KOG1152|consensus	772		100.0
KOG0200|consensus	609		100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1025|consensus	1177		100.0
KOG0984|consensus	282		99.98
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
PRK09188	365	serine/threonine protein kinase; Provisional	99.96
KOG1345|consensus	378		99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
KOG1024|consensus	563		99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG0590|consensus	601		99.95
KOG1163|consensus	341		99.95
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.93
KOG1164|consensus	322		99.93
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.93
KOG1165|consensus	449		99.92
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.92
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.89
KOG1240|consensus	1431		99.89
smart00090	237	RIO RIO-like kinase.	99.89
PRK10345	210	hypothetical protein; Provisional	99.88
KOG4158|consensus	598		99.88
KOG0603|consensus	612		99.86
PRK14879	211	serine/threonine protein kinase; Provisional	99.85
PRK12274	218	serine/threonine protein kinase; Provisional	99.85
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.83
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.82
KOG1166|consensus	974		99.82
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.81
KOG1033|consensus	516		99.81
KOG0606|consensus	1205		99.8
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.79
KOG0195|consensus	448		99.78
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.77
KOG0601|consensus	524		99.75
KOG0590|consensus	601		99.74
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.73
KOG1023|consensus	484		99.72
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.62
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.61
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.58
KOG3087|consensus	229		99.54
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.54
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.48
KOG1243|consensus	690		99.41
KOG0601|consensus	524		99.37
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.36
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.33
KOG1266|consensus	458		99.33
KOG0606|consensus	1205		99.29
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.28
KOG3741|consensus	655		99.25
KOG2137|consensus	700		99.23
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.2
PRK09902	216	hypothetical protein; Provisional	99.12
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.12
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.96
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.92
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.86
COG4248	637	Uncharacterized protein with protein kinase and he	98.75
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.7
PF01636	239	APH: Phosphotransferase enzyme family This family	98.59
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.57
KOG0576|consensus	829		98.5
PLN02876	822	acyl-CoA dehydrogenase	98.48
KOG1235|consensus	538		98.47
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.45
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.4
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.28
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.14
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.14
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.03
PRK09550	401	mtnK methylthioribose kinase; Reviewed	98.0
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.99
KOG1035|consensus	1351		97.97
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.95
PRK10593	297	hypothetical protein; Provisional	97.94
KOG2268|consensus	465		97.92
KOG2270|consensus	520		97.89
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.86
PRK05231	319	homoserine kinase; Provisional	97.78
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.77
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.62
PLN02236	344	choline kinase	97.56
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.41
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.41
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.4
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.34
PRK12396	409	5-methylribose kinase; Reviewed	97.32
KOG1826|consensus	2724		97.17
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	97.12
PLN02756	418	S-methyl-5-thioribose kinase	97.12
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.98
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.91
PTZ00384	383	choline kinase; Provisional	96.87
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	96.58
PRK11768	325	serine/threonine protein kinase; Provisional	96.35
KOG1236|consensus	565		96.3
PRK06148	1013	hypothetical protein; Provisional	96.29
PTZ00296	442	choline kinase; Provisional	96.27
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	95.39
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.29
PRK10271	188	thiK thiamine kinase; Provisional	95.25

>KOG0615|consensus

Probab=100.00  E-value=7e-57  Score=378.09  Aligned_cols=250  Identities=24%  Similarity=0.322  Sum_probs=213.4

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhh--hHhHHHHHHHHHhcCCCCccccceeeeec
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGI--NRTALREIKLLQELHHENVLGLTDVFGYM  129 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  129 (307)
                      ...+.|.+.+.||+|+||.|-+|..+.+|+.||||++++..........  .....+|+++|++|+|||||+++++|+..
T Consensus       169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~  248 (475)
T KOG0615|consen  169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP  248 (475)
T ss_pred             hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence            3677899999999999999999999999999999999986654433211  22346999999999999999999999999


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecC---CcEEEEeecCcc
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ---GVLKIGDFGLAK  205 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~a~  205 (307)
                      +..|+||||+ +|+|.+.+..+. .+.+..-+.+++|++.||.|||++||+||||||+|||+..+   -.+||+|||+|+
T Consensus       249 ds~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK  327 (475)
T KOG0615|consen  249 DSSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK  327 (475)
T ss_pred             CceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence            9999999999 789999888765 58888889999999999999999999999999999999877   578999999999


Q ss_pred             ccCCCCcccccceeeceehhhhhhhccc--cccccccee---eeee----cCCCCCCCCCCCCC-----------hhhhc
Q psy9858         206 FFGSPTRLYTHQVVTRWYRLIKCLLYCV--QFNVKNVQW---CCFA----KDPSSHGNLFPGIP-----------LNEIF  265 (307)
Q Consensus       206 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~~Diw---~i~~----~~~~f~~~~~~~~~-----------~~~~~  265 (307)
                      ..+ ....+.+.+||+.|.|||++.+..  .+..++|+|   |+++    |.+||.....+...           ....+
T Consensus       328 ~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w  406 (475)
T KOG0615|consen  328 VSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW  406 (475)
T ss_pred             ccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence            986 445677889999999999997652  345689999   5554    99999984443311           11345


Q ss_pred             cccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         266 TAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       266 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      ..++++..+||.+||..||++|||++++|+||||+.++
T Consensus       407 ~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  407 DRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence            67899999999999999999999999999999999665

>KOG0593|consensus

Probab=100.00  E-value=1.8e-57  Score=368.02  Aligned_cols=244  Identities=32%  Similarity=0.542  Sum_probs=217.4

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ++|+.+.++|+|+||.||+|+++.+|+.||||++.-+   ..+....+-.++|+++|++++|+|+|.++++|.....++|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es---edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhL   78 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES---EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHL   78 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccC---CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEE
Confidence            5789999999999999999999999999999999742   2334455667899999999999999999999999999999


Q ss_pred             EEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCccc
Q psy9858         135 VFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY  214 (307)
Q Consensus       135 v~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  214 (307)
                      |+|||+-+.++.+......++++.++.+++|++.|+.|+|+++++||||||+|||++.+|.+||||||+|+.+..+....
T Consensus        79 VFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y  158 (396)
T KOG0593|consen   79 VFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY  158 (396)
T ss_pred             EeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence            99999999888888776679999999999999999999999999999999999999999999999999999998777888


Q ss_pred             ccceeeceehhhhhhhccccccccccee---eeee----cCCCCCC----------------------------------
Q psy9858         215 THQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KDPSSHG----------------------------------  253 (307)
Q Consensus       215 ~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~~~~f~~----------------------------------  253 (307)
                      +..+.|.||+|||.+.+..+|+..+|||   |+++    |+++|.+                                  
T Consensus       159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv  238 (396)
T KOG0593|consen  159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV  238 (396)
T ss_pred             hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence            8999999999999999988999999999   5555    9998888                                  


Q ss_pred             ---CCCCCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCC
Q psy9858         254 ---NLFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSL  301 (307)
Q Consensus       254 ---~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~  301 (307)
                         ......+++.-+++++..+.+|+++||+.||.+|++.+|+|.||||.+
T Consensus       239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~  289 (396)
T KOG0593|consen  239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG  289 (396)
T ss_pred             ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence               111122333445677888999999999999999999999999999954

>KOG0659|consensus

Probab=100.00  E-value=1.3e-56  Score=356.90  Aligned_cols=246  Identities=56%  Similarity=0.895  Sum_probs=224.7

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      .+|...+.||+|.||.||+|++.++|+.||||.+....   .+++......+|++.|+.++|+||+.++++|.+.+.+.|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~---~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~l   78 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGN---AKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSL   78 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccc---cccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEE
Confidence            47889999999999999999999999999999999753   445556778999999999999999999999999999999


Q ss_pred             EEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCccc
Q psy9858         135 VFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY  214 (307)
Q Consensus       135 v~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  214 (307)
                      |+||++.+|...++.+...++...++.++.+++.||+|||++.|+||||||.|+|++.+|.+||+|||+|+.++++....
T Consensus        79 VfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~  158 (318)
T KOG0659|consen   79 VFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ  158 (318)
T ss_pred             EEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence            99999999999999999899999999999999999999999999999999999999999999999999999998887777


Q ss_pred             ccceeeceehhhhhhhccccccccccee---eeee----cCCCCCC----------------------------------
Q psy9858         215 THQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KDPSSHG----------------------------------  253 (307)
Q Consensus       215 ~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~~~~f~~----------------------------------  253 (307)
                      ...+.|.+|+|||.+.|...|+..+|||   ||++    +.+.|.|                                  
T Consensus       159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~  238 (318)
T KOG0659|consen  159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI  238 (318)
T ss_pred             ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence            7779999999999999999999999999   7777    7788877                                  


Q ss_pred             CCCCCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         254 NLFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      ..++......++...+.++.+|+.+||..||.+|+|+.|+|+|+||++.+
T Consensus       239 ~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P  288 (318)
T KOG0659|consen  239 QQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP  288 (318)
T ss_pred             hcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence            33344444456667889999999999999999999999999999999754

>KOG0575|consensus

Probab=100.00  E-value=6e-56  Score=389.38  Aligned_cols=243  Identities=26%  Similarity=0.352  Sum_probs=216.9

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      .+|...+.||+|||+.+|.+++..+|+.||+|++.+......  .......+|++|.+.|+|||||+++++|++.+++||
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~--~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYi   95 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKP--KQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYI   95 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCc--chHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEE
Confidence            679999999999999999999999999999999987544332  336678899999999999999999999999999999


Q ss_pred             EEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc
Q psy9858         135 VFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL  213 (307)
Q Consensus       135 v~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  213 (307)
                      |+|+| .|+|..+++ +++.++|.+++.+++||+.||.|||+++|+|||||..|+|++++.+|||+|||+|..+..+...
T Consensus        96 vLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er  174 (592)
T KOG0575|consen   96 VLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER  174 (592)
T ss_pred             EEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence            99999 678877777 5567999999999999999999999999999999999999999999999999999999777667


Q ss_pred             cccceeeceehhhhhhhccccccccccee---eeee----cCCCCCCCCCCCC------ChhhhccccCHHHHHHHHHhh
Q psy9858         214 YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KDPSSHGNLFPGI------PLNEIFTAAGDDLLAVISSLL  280 (307)
Q Consensus       214 ~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~~~~f~~~~~~~~------~~~~~~~~~~~~l~~li~~~l  280 (307)
                      ..+.+|||.|.|||++... ..+..+|||   ||+|    |++||+.......      ....++..+|.++++||.+||
T Consensus       175 k~TlCGTPNYIAPEVl~k~-gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL  253 (592)
T KOG0575|consen  175 KKTLCGTPNYIAPEVLNKS-GHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLL  253 (592)
T ss_pred             cceecCCCcccChhHhccC-CCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHh
Confidence            7788999999999999977 899999999   7777    9999998533322      122334578999999999999


Q ss_pred             hcCCCCCCCHHHHhcCcccCC
Q psy9858         281 CLNPTKRADCTATLKMDYFSL  301 (307)
Q Consensus       281 ~~dP~~Rpt~~~il~hp~f~~  301 (307)
                      +.||.+|||+++||.|+||++
T Consensus       254 ~~~P~~Rpsl~~vL~h~Ff~~  274 (592)
T KOG0575|consen  254 RPNPSERPSLDEVLDHPFFKS  274 (592)
T ss_pred             cCCcccCCCHHHHhcCHhhhC
Confidence            999999999999999999954

>KOG0661|consensus

Probab=100.00  E-value=7.3e-56  Score=377.94  Aligned_cols=248  Identities=33%  Similarity=0.533  Sum_probs=218.4

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-CCCccccceeeeec
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-HENVLGLTDVFGYM  129 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~  129 (307)
                      ....++|.++++||.|+||.||+|+.+++|..||||.+++.... ++   +-.-+||++.|++|+ ||||+++.+++.+.
T Consensus         6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~e---e~~nLREvksL~kln~hpniikL~Evi~d~   81 (538)
T KOG0661|consen    6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WE---ECMNLREVKSLRKLNPHPNIIKLKEVIRDN   81 (538)
T ss_pred             hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HH---HHHHHHHHHHHHhcCCCCcchhhHHHhhcc
Confidence            34567899999999999999999999999999999998864322 11   122358999999998 99999999999888


Q ss_pred             C-eEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         130 S-NVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       130 ~-~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                      + .+|+||||++.+|.++++.++..++++.++.|+.||++||+|+|.+|+.|||+||+|||+..+..+||+|||+|+...
T Consensus        82 ~~~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   82 DRILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             CceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc
Confidence            7 999999999999999999999899999999999999999999999999999999999999999999999999999884


Q ss_pred             CCCcccccceeeceehhhhhhhccccccccccee---eeee----cCCCCCC----------------------------
Q psy9858         209 SPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KDPSSHG----------------------------  253 (307)
Q Consensus       209 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~~~~f~~----------------------------  253 (307)
                      + ....+..+.|.+|+|||++.+...|+.++|+|   ||++    -+++|-|                            
T Consensus       162 S-kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L  240 (538)
T KOG0661|consen  162 S-KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL  240 (538)
T ss_pred             c-CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence            3 45677889999999999999998999999999   6665    8888888                            


Q ss_pred             --------CCCCCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         254 --------NLFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       254 --------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                              .......+..+.++.+.++.+||.+||++||.+||||+|+|+||||+...
T Consensus       241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~  298 (538)
T KOG0661|consen  241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR  298 (538)
T ss_pred             HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence                    23333445555667899999999999999999999999999999997543

>KOG0581|consensus

Probab=100.00  E-value=1.6e-54  Score=360.79  Aligned_cols=244  Identities=25%  Similarity=0.332  Sum_probs=211.5

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN  131 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  131 (307)
                      ...++.+.++.||+|..|+||+++|+.+++.+|+|++..    ..+....+++.+|+++++.++||+||++|++|.++..
T Consensus        76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~----~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~  151 (364)
T KOG0581|consen   76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL----NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE  151 (364)
T ss_pred             cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc----cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc
Confidence            344578899999999999999999999999999999963    3456667889999999999999999999999999994


Q ss_pred             -EEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         132 -VSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD-HWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       132 -~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                       .+|+|||| +|+|.+.+... +.+++..+..++.+|++||.|||+ .+||||||||+|||++..|.|||||||.++.+.
T Consensus       152 ~isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv  230 (364)
T KOG0581|consen  152 EISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV  230 (364)
T ss_pred             eEEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence             99999999 57777777655 469999999999999999999996 899999999999999999999999999999885


Q ss_pred             CCCcccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCC------------CChhhhccc-c
Q psy9858         209 SPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPG------------IPLNEIFTA-A  268 (307)
Q Consensus       209 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~------------~~~~~~~~~-~  268 (307)
                      +.  ...+.+||..|||||.+.+. .|+.++|||       .+..|+.|+.......            ......+.. .
T Consensus       231 nS--~a~tfvGT~~YMsPERi~g~-~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~f  307 (364)
T KOG0581|consen  231 NS--IANTFVGTSAYMSPERISGE-SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEF  307 (364)
T ss_pred             hh--hcccccccccccChhhhcCC-cCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccC
Confidence            44  67888999999999999999 999999999       3444998987741111            122233343 8


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         269 GDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       269 ~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      |+++.+||..||++||.+|||++|+++|||+++..
T Consensus       308 S~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~  342 (364)
T KOG0581|consen  308 SPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE  342 (364)
T ss_pred             CHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence            99999999999999999999999999999998654

>KOG0600|consensus

Probab=100.00  E-value=2.4e-54  Score=371.05  Aligned_cols=248  Identities=38%  Similarity=0.678  Sum_probs=218.7

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec--
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM--  129 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--  129 (307)
                      ...+.|+.+++||+|+||.||+|++..+|+.||+|.+...   ..++++.....+|+.||++|+||||+++.+...+.  
T Consensus       114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d---~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~  190 (560)
T KOG0600|consen  114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFD---NEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLS  190 (560)
T ss_pred             cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecc---cCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCC
Confidence            4557799999999999999999999999999999999863   34555677788999999999999999999988765  


Q ss_pred             CeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCC
Q psy9858         130 SNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS  209 (307)
Q Consensus       130 ~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  209 (307)
                      ..+|||+||++.+|.-++......+++.+++.++.||+.||.|||++||+|||||.+|||||.+|.+||+|||+|+++..
T Consensus       191 ~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~  270 (560)
T KOG0600|consen  191 GSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP  270 (560)
T ss_pred             ceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence            78999999999999999999888899999999999999999999999999999999999999999999999999998754


Q ss_pred             C-Ccccccceeeceehhhhhhhccccccccccee---eeee----cCCCCCC-------------------CCCC-----
Q psy9858         210 P-TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KDPSSHG-------------------NLFP-----  257 (307)
Q Consensus       210 ~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~~~~f~~-------------------~~~~-----  257 (307)
                      . ....+.++.|++|+|||++.|...|+.++|+|   ||++    |+++|.+                   ..+.     
T Consensus       271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP  350 (560)
T KOG0600|consen  271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP  350 (560)
T ss_pred             CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence            3 34578889999999999999999999999999   6666    9999988                   1111     


Q ss_pred             -----------CCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         258 -----------GIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       258 -----------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                                 ...+.+.+..++....+|+..||..||.+|.||.++|+|+||+..
T Consensus       351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~  406 (560)
T KOG0600|consen  351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE  406 (560)
T ss_pred             cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence                       112333455678999999999999999999999999999999543

>KOG0663|consensus

Probab=100.00  E-value=2.9e-53  Score=347.71  Aligned_cols=252  Identities=37%  Similarity=0.660  Sum_probs=221.3

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY  128 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  128 (307)
                      .-++..++|+++.+|++|+||.||+|+++.+++.||+|.++...   .++++.-..++|+.+|.+++|||||.+-++...
T Consensus        70 ~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek---ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG  146 (419)
T KOG0663|consen   70 GGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK---EKEGFPITSLREINILLKARHPNIVEVKEVVVG  146 (419)
T ss_pred             cCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc---ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEec
Confidence            34577889999999999999999999999999999999998743   556666778899999999999999999988754


Q ss_pred             --cCeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         129 --MSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       129 --~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                        -+.+|+||||++.+|..++..-...+...+++.++.|++.||+|||++.|+|||||++|+|++..|.+||+|||+|+.
T Consensus       147 ~~~d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~  226 (419)
T KOG0663|consen  147 SNMDKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLARE  226 (419)
T ss_pred             cccceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhh
Confidence              467999999999999999988777899999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCcccccceeeceehhhhhhhccccccccccee---eeee----cCCCCCC-------------------CCCCCCC
Q psy9858         207 FGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KDPSSHG-------------------NLFPGIP  260 (307)
Q Consensus       207 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~~~~f~~-------------------~~~~~~~  260 (307)
                      ++++....+..+.|.+|+|||++.+...|+.++|+|   ||++    ++++|.+                   ..++...
T Consensus       227 ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~  306 (419)
T KOG0663|consen  227 YGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS  306 (419)
T ss_pred             hcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence            998888888899999999999999999999999999   7766    8888888                   1111111


Q ss_pred             -----------------hhhhccc--cCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         261 -----------------LNEIFTA--AGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       261 -----------------~~~~~~~--~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                                       +...+..  +++...+|+.++|..||.+|.||+|+|+|+||...+
T Consensus       307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P  368 (419)
T KOG0663|consen  307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP  368 (419)
T ss_pred             ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence                             1111222  458899999999999999999999999999998754

>KOG0598|consensus

Probab=100.00  E-value=2.4e-52  Score=347.55  Aligned_cols=248  Identities=22%  Similarity=0.274  Sum_probs=216.9

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN  131 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  131 (307)
                      ...+.|++++.||+|+||+|+.++...+++.+|+|++++......++  .....+|..||..++||.||+++-.|++...
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e--~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~k   99 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKE--VRHTKAERNILSKIKHPFIVKLIYSFQTEEK   99 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhh--HHHHHHHHHHHHhCCCCcEeeeEEecccCCe
Confidence            45678999999999999999999999999999999999865544432  4667899999999999999999999999999


Q ss_pred             EEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         132 VSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       132 ~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      +|||+||+ +|.|..++.+.+ .+++..++.++..|+.||.|||++|||||||||+|||++.+|+++|+|||+|+..-..
T Consensus       100 LylVld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~  178 (357)
T KOG0598|consen  100 LYLVLDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD  178 (357)
T ss_pred             EEEEEeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence            99999999 678999998776 5999999999999999999999999999999999999999999999999999976555


Q ss_pred             Ccccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCC-------CChhhhccccCHHHHHHH
Q psy9858         211 TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPG-------IPLNEIFTAAGDDLLAVI  276 (307)
Q Consensus       211 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~-------~~~~~~~~~~~~~l~~li  276 (307)
                      .....+.+||+.|||||++.+. .|+.++|.|       .+++|.+||.+.+...       ......+...+.+.++++
T Consensus       179 ~~~t~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll  257 (357)
T KOG0598|consen  179 GDATRTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLL  257 (357)
T ss_pred             CCccccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHH
Confidence            5666778999999999999999 999999999       3455999998844222       222222334899999999


Q ss_pred             HHhhhcCCCCCC----CHHHHhcCcccCCCc
Q psy9858         277 SSLLCLNPTKRA----DCTATLKMDYFSLTK  303 (307)
Q Consensus       277 ~~~l~~dP~~Rp----t~~~il~hp~f~~~~  303 (307)
                      .++|..||++|.    ++++|-+||||+.+.
T Consensus       258 ~~LL~rdp~~RLg~~~d~~~ik~HpfF~~in  288 (357)
T KOG0598|consen  258 KKLLKRDPRQRLGGPGDAEEIKRHPFFKGIN  288 (357)
T ss_pred             HHHhccCHHHhcCCCCChHHhhcCcccccCC
Confidence            999999999996    699999999998764

>KOG0592|consensus

Probab=100.00  E-value=2.8e-52  Score=361.13  Aligned_cols=249  Identities=26%  Similarity=0.299  Sum_probs=217.2

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeeec
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGYM  129 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~  129 (307)
                      ....++|..++.||.|+|++|++|+++.+++.||||++.+...-..  ...+-..+|-.+|..| .||+|++|+-.|+++
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike--~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~  146 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKE--KKVKYVTREKEALTQLSGHPGIVKLYFTFQDE  146 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhh--cccchhhHHHHHHHHhhCCCCeEEEEEEeecc
Confidence            4566789999999999999999999999999999999987654322  2245566899999999 899999999999999


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                      ..+|+|+||+ +|+|++++.+.+ .+++..++.++.+|+.||+|||++|||||||||+|||++.+++++|+|||.|+.++
T Consensus       147 ~sLYFvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~  225 (604)
T KOG0592|consen  147 ESLYFVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILS  225 (604)
T ss_pred             cceEEEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence            9999999999 799999999875 69999999999999999999999999999999999999999999999999999874


Q ss_pred             CCC-------------cccccceeeceehhhhhhhccccccccccee---eeee----cCCCCCCCCCCCCC------hh
Q psy9858         209 SPT-------------RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KDPSSHGNLFPGIP------LN  262 (307)
Q Consensus       209 ~~~-------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~~~~f~~~~~~~~~------~~  262 (307)
                      ...             ....+.+||..|.+||++... ..++.+|+|   ||++    |.+||.+.+.-..-      .-
T Consensus       226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~-~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y  304 (604)
T KOG0592|consen  226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS-PAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDY  304 (604)
T ss_pred             hhhccccCccCcccccCcccceeeeecccCHHHhcCC-CCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcc
Confidence            321             112457999999999999998 999999999   7777    99999984432221      12


Q ss_pred             hhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         263 EIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       263 ~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      .++++.++.+.+||+++|..||.+|+|++||-+||||++++
T Consensus       305 ~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vd  345 (604)
T KOG0592|consen  305 EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVD  345 (604)
T ss_pred             cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCC
Confidence            34567899999999999999999999999999999999876

>KOG0595|consensus

Probab=100.00  E-value=4.7e-51  Score=343.06  Aligned_cols=247  Identities=26%  Similarity=0.380  Sum_probs=210.7

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS  130 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  130 (307)
                      .....+|...+.||+|+||+||+|+++.++..||||.+.+...   .....+-+..|+++|+.++|||||+++++++..+
T Consensus         6 ~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l---~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~   82 (429)
T KOG0595|consen    6 MRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL---NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD   82 (429)
T ss_pred             ccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc---CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC
Confidence            3456789999999999999999999999999999999987543   2222455779999999999999999999999999


Q ss_pred             eEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecC------CcEEEEeecC
Q psy9858         131 NVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ------GVLKIGDFGL  203 (307)
Q Consensus       131 ~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~------~~~kl~Dfg~  203 (307)
                      .+||||||| +|+|.+++++++ .+++..++.++.||+.||++||+++||||||||.|||++.+      -.+||+|||+
T Consensus        83 ~i~lVMEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf  161 (429)
T KOG0595|consen   83 FIYLVMEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGF  161 (429)
T ss_pred             eEEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence            999999999 689999998876 59999999999999999999999999999999999999875      3589999999


Q ss_pred             ccccCCCCcccccceeeceehhhhhhhccccccccccee---eee----ecCCCCCCCCCCC---------CChhhhccc
Q psy9858         204 AKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCF----AKDPSSHGNLFPG---------IPLNEIFTA  267 (307)
Q Consensus       204 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~----~~~~~f~~~~~~~---------~~~~~~~~~  267 (307)
                      |+.+. +.....+.+|++-|||||++..+ +|+.|+|+|   +|+    .|++||......+         .........
T Consensus       162 AR~L~-~~~~a~tlcGSplYMAPEV~~~~-~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~  239 (429)
T KOG0595|consen  162 ARFLQ-PGSMAETLCGSPLYMAPEVIMSQ-QYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAE  239 (429)
T ss_pred             hhhCC-chhHHHHhhCCccccCHHHHHhc-cccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhh
Confidence            99995 44556677999999999999888 999999999   343    3999999522211         112222334


Q ss_pred             cCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         268 AGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       268 ~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      .+..+.+|+...|+.+|.+|.+..+-+.|+++....
T Consensus       240 ~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  240 LSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             ccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence            677788999999999999999999999999987654

>KOG0583|consensus

Probab=100.00  E-value=1.5e-50  Score=354.44  Aligned_cols=250  Identities=23%  Similarity=0.298  Sum_probs=213.3

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-CCCccccceeeeec
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-HENVLGLTDVFGYM  129 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~  129 (307)
                      ....++|.+.+.||+|+||+|++|++..+|..||+|++.+...........+.+.+|+.+++.++ ||||+++++++...
T Consensus        13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~   92 (370)
T KOG0583|consen   13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP   92 (370)
T ss_pred             ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence            34667999999999999999999999999999999987764222111233455668999999998 99999999999999


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecC-CcEEEEeecCcccc
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ-GVLKIGDFGLAKFF  207 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~a~~~  207 (307)
                      ...++||||+ +|+|++++.. .+++.+.+++.+++||++||+|||++||+||||||+|||++.+ +++||+|||++...
T Consensus        93 ~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~  171 (370)
T KOG0583|consen   93 TKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS  171 (370)
T ss_pred             CeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence            9999999999 6799999999 6679999999999999999999999999999999999999999 99999999999987


Q ss_pred             CCCCcccccceeeceehhhhhhhccc-cccccccee-------eeeecCCCCCCCCCCCCC------hhhhcccc-CHHH
Q psy9858         208 GSPTRLYTHQVVTRWYRLIKCLLYCV-QFNVKNVQW-------CCFAKDPSSHGNLFPGIP------LNEIFTAA-GDDL  272 (307)
Q Consensus       208 ~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~Diw-------~i~~~~~~f~~~~~~~~~------~~~~~~~~-~~~l  272 (307)
                      ........+.+||+.|+|||++.+.. ..+.++|||       .+++|..||.........      ...++..+ |+++
T Consensus       172 ~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~  251 (370)
T KOG0583|consen  172 PGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEA  251 (370)
T ss_pred             CCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHHH
Confidence            43344566789999999999999985 446999999       344599999984422111      11233445 9999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHhcCcccCC
Q psy9858         273 LAVISSLLCLNPTKRADCTATLKMDYFSL  301 (307)
Q Consensus       273 ~~li~~~l~~dP~~Rpt~~~il~hp~f~~  301 (307)
                      ..|+.+||..||.+|+|+.++++||||+.
T Consensus       252 ~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  252 RSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             HHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            99999999999999999999999999997

>KOG0660|consensus

Probab=100.00  E-value=7.4e-51  Score=337.53  Aligned_cols=247  Identities=35%  Similarity=0.563  Sum_probs=215.9

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee---
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY---  128 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~---  128 (307)
                      .....|..++.||.|+||.|..|.+..+|+.||||++....   ......++..+|+++|+.++|+||+.+.+++..   
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F---~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~   95 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF---ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR   95 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh---hchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence            34456777899999999999999999999999999987432   222335778899999999999999999998865   


Q ss_pred             --cCeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         129 --MSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       129 --~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                        -+.+|+|+|+++.+|.+.++... .+++..+..+++||+.||+|+|+.+++||||||+|++++.+..+||+|||+|+.
T Consensus        96 ~~f~DvYiV~elMetDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~  174 (359)
T KOG0660|consen   96 DKFNDVYLVFELMETDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARY  174 (359)
T ss_pred             cccceeEEehhHHhhHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceee
Confidence              46799999999999999998775 389999999999999999999999999999999999999999999999999998


Q ss_pred             cCC--CCcccccceeeceehhhhhhhccccccccccee---eeee----cCCCCCC------------------------
Q psy9858         207 FGS--PTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KDPSSHG------------------------  253 (307)
Q Consensus       207 ~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~~~~f~~------------------------  253 (307)
                      ...  .....+..+.|.+|+|||++.....|+.++|||   ||++    |+++|.|                        
T Consensus       175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~  254 (359)
T KOG0660|consen  175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK  254 (359)
T ss_pred             ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence            743  234457789999999999999988999999999   7666    9999998                        


Q ss_pred             -------------CCCCCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         254 -------------NLFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       254 -------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                                   ...+..+....+++.++...+|+.+||..||.+|+|++|+|+||||+..
T Consensus       255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~  316 (359)
T KOG0660|consen  255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY  316 (359)
T ss_pred             hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence                         3445555667778899999999999999999999999999999999764

>KOG0594|consensus

Probab=100.00  E-value=7.8e-50  Score=332.13  Aligned_cols=248  Identities=40%  Similarity=0.658  Sum_probs=214.4

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCC-ccccceeeeecC--
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHEN-VLGLTDVFGYMS--  130 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-i~~~~~~~~~~~--  130 (307)
                      ...|..+++||+|+||+||+|++..+|+.||+|++.....   .++......+|+.+++.++|+| |+.+++++...+  
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~---~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~   86 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFE---EEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNH   86 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccc---ccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccc
Confidence            5678889999999999999999999999999999986432   2445667889999999999999 999999998877  


Q ss_pred             ----eEEEEEEccCCChHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecC
Q psy9858         131 ----NVSLVFEFVDTDLEVIIKDPT---IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGL  203 (307)
Q Consensus       131 ----~~~lv~e~~~g~l~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  203 (307)
                          .+++|+||+.-+|.+++....   ..++...++.+++||+.||+|||++||+||||||.||+|+++|.+||+|||+
T Consensus        87 ~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   87 RGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             cccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccch
Confidence                899999999999999998765   3478889999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCcccccceeeceehhhhhhhccccccccccee---eeee----cCCCCCC-------------------CCCC
Q psy9858         204 AKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KDPSSHG-------------------NLFP  257 (307)
Q Consensus       204 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~~~~f~~-------------------~~~~  257 (307)
                      |+.+.-+....++.++|.+|+|||++.+...|+..+|||   ||++    ++++|.+                   ..++
T Consensus       167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp  246 (323)
T KOG0594|consen  167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP  246 (323)
T ss_pred             HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence            998876777788889999999999999998999999999   6666    8888888                   1111


Q ss_pred             -------------CC----ChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         258 -------------GI----PLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       258 -------------~~----~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                                   ..    ......+..+++..+++.+||+.+|.+|.|++.+|+||||.....
T Consensus       247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~  310 (323)
T KOG0594|consen  247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE  310 (323)
T ss_pred             CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence                         10    111112334568999999999999999999999999999988754

>KOG0588|consensus

Probab=100.00  E-value=2e-50  Score=356.72  Aligned_cols=247  Identities=22%  Similarity=0.281  Sum_probs=216.9

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..+-|++++.||.|+.|.|-+|+|.++|+.+|||++.+..  ...+.....+-+|+-||+-+.||||++++++|+...++
T Consensus        10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~--~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~l   87 (786)
T KOG0588|consen   10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRS--ELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHL   87 (786)
T ss_pred             cccceeccccccCCCCceehhhhcccccceeEEEeecccc--ccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceE
Confidence            4567999999999999999999999999999999998752  12222244567899999999999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT  211 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  211 (307)
                      |+|.||+ +|.|++++..++ .+++.++..++.||+.|+.|||..+|+||||||+|+|++.++.+||+|||+|..-. +.
T Consensus        88 ylvlEyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~-~g  165 (786)
T KOG0588|consen   88 YLVLEYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEV-PG  165 (786)
T ss_pred             EEEEEecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeeccc-CC
Confidence            9999999 788999998876 58999999999999999999999999999999999999999999999999998763 44


Q ss_pred             cccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCCCC------hhhhccccCHHHHHHHHH
Q psy9858         212 RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPGIP------LNEIFTAAGDDLLAVISS  278 (307)
Q Consensus       212 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~~~------~~~~~~~~~~~l~~li~~  278 (307)
                      ....+.+|++.|++||++.|..+.+.++|||       .++.|.+||++.++....      ..+++.+++.++++||.+
T Consensus       166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~  245 (786)
T KOG0588|consen  166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRR  245 (786)
T ss_pred             ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHH
Confidence            5667779999999999999997889999999       234499999985543322      235567899999999999


Q ss_pred             hhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         279 LLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       279 ~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      ||.+||++|+|.+||++|||+.+-.
T Consensus       246 ml~VDp~~RiT~~eI~kHP~l~g~~  270 (786)
T KOG0588|consen  246 MLDVDPSTRITTEEILKHPFLSGYT  270 (786)
T ss_pred             HhccCccccccHHHHhhCchhhcCC
Confidence            9999999999999999999998754

>KOG0578|consensus

Probab=100.00  E-value=5.4e-50  Score=349.20  Aligned_cols=247  Identities=23%  Similarity=0.374  Sum_probs=214.2

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY  128 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  128 (307)
                      ...+....|....+||+|+.|.||.|....+++.||||.+....-.     ...-+.+|+.+|+..+|+|||.+++.|..
T Consensus       267 ~~~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~-----~keLilnEi~Vm~~~~H~NiVnfl~Sylv  341 (550)
T KOG0578|consen  267 SQGDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP-----KKELLLNEILVMRDLHHPNIVNFLDSYLV  341 (550)
T ss_pred             cCCChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC-----chhhhHHHHHHHHhccchHHHHHHHHhcc
Confidence            3456778899999999999999999999999999999999864322     13446799999999999999999999988


Q ss_pred             cCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         129 MSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       129 ~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      .+.+|.||||+ +|+|.+.+....  ++|.++..|++.+++||+|||.+||+|||||.+|||++.+|.+||+|||+|..+
T Consensus       342 ~deLWVVMEym~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi  419 (550)
T KOG0578|consen  342 GDELWVVMEYMEGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQI  419 (550)
T ss_pred             cceeEEEEeecCCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecc
Confidence            89999999999 677888777664  899999999999999999999999999999999999999999999999999998


Q ss_pred             CCCCcccccceeeceehhhhhhhccccccccccee--eeee-----cCCCCCCCC---------CCCCChhhhccccCHH
Q psy9858         208 GSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW--CCFA-----KDPSSHGNL---------FPGIPLNEIFTAAGDD  271 (307)
Q Consensus       208 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw--~i~~-----~~~~f~~~~---------~~~~~~~~~~~~~~~~  271 (307)
                      ........+-+||+.|||||++... .|++++|||  +|++     |++||-.+.         ....+....+..+|+.
T Consensus       420 ~~~~~KR~TmVGTPYWMAPEVvtrk-~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~  498 (550)
T KOG0578|consen  420 SEEQSKRSTMVGTPYWMAPEVVTRK-PYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPE  498 (550)
T ss_pred             ccccCccccccCCCCccchhhhhhc-ccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHH
Confidence            7666567778999999999999998 999999999  5555     999998611         1111122234568999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         272 LLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       272 l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      +++|+.+||+.|+++|++|.++|+||||+.++
T Consensus       499 ~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~  530 (550)
T KOG0578|consen  499 LKDFLDRCLVVDVEQRASAKELLEHPFLKMAK  530 (550)
T ss_pred             HHHHHHHHhhcchhcCCCHHHHhcChhhhhcC
Confidence            99999999999999999999999999997654

>KOG0591|consensus

Probab=100.00  E-value=7.8e-51  Score=326.48  Aligned_cols=236  Identities=25%  Similarity=0.428  Sum_probs=204.2

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccce-eeeec
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTD-VFGYM  129 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~-~~~~~  129 (307)
                      .....+|+++++||+|.||+||++++..+|..+|.|.+.-   ...+....+.+..|+.+|++|+|||||++++ .+..+
T Consensus        15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f---~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~   91 (375)
T KOG0591|consen   15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQF---GMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIED   91 (375)
T ss_pred             cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcch---hhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhcc
Confidence            4456789999999999999999999999999999999984   3333444778999999999999999999998 45455


Q ss_pred             Ce-EEEEEEcc-CCChHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHH--CC--ceeecCCCCcEEEecCCcEEEEe
Q psy9858         130 SN-VSLVFEFV-DTDLEVIIK---DPTIVFTPSNIKAYAIMTLRGLEYLHD--HW--ILHRDLKPNNLLINKQGVLKIGD  200 (307)
Q Consensus       130 ~~-~~lv~e~~-~g~l~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~--ivH~dlkp~Nil~~~~~~~kl~D  200 (307)
                      +. ++|||||| .|+|.++++   +..+.+++..++.++.|++.||.+||+  ..  |+||||||.||+++.+|.|||+|
T Consensus        92 ~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGD  171 (375)
T KOG0591|consen   92 NEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGD  171 (375)
T ss_pred             chhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeecc
Confidence            55 99999999 699888875   455569999999999999999999999  44  99999999999999999999999


Q ss_pred             ecCccccCCCCcccccceeeceehhhhhhhccccccccccee---eeee----cCCCCCCCC-------CCCCChhhhc-
Q psy9858         201 FGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KDPSSHGNL-------FPGIPLNEIF-  265 (307)
Q Consensus       201 fg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~~~~f~~~~-------~~~~~~~~~~-  265 (307)
                      ||+++.+.+......+.+|||.||+||.+.+. .|++++|||   |+++    -.+||.+.+       +.......++ 
T Consensus       172 fGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~-~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~  250 (375)
T KOG0591|consen  172 FGLGRFLSSKTTFAHSLVGTPYYMSPERIHES-GYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD  250 (375)
T ss_pred             chhHhHhcchhHHHHhhcCCCcccCHHHHhcC-CCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH
Confidence            99999998777777888999999999999998 999999999   7666    888998843       3334444455 


Q ss_pred             cccCHHHHHHHHHhhhcCCCCCCCH
Q psy9858         266 TAAGDDLLAVISSLLCLNPTKRADC  290 (307)
Q Consensus       266 ~~~~~~l~~li~~~l~~dP~~Rpt~  290 (307)
                      ..+|.++..||..|+..||+.||+.
T Consensus       251 ~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  251 EHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             HHhhhHHHHHHHHHccCCcccCCCc
Confidence            5689999999999999999999985

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.9e-48  Score=337.24  Aligned_cols=251  Identities=34%  Similarity=0.526  Sum_probs=207.5

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++......    .....+.+|+.+++.++||||+++++++.+....
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   78 (303)
T cd07869           3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE----GTPFTAIREASLLKGLKHANIVLLHDIIHTKETL   78 (303)
T ss_pred             ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc----ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeE
Confidence            347899999999999999999999999999999998753211    1134567899999999999999999999999999


Q ss_pred             EEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc
Q psy9858         133 SLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR  212 (307)
Q Consensus       133 ~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  212 (307)
                      ++||||+++++.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus        79 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  158 (303)
T cd07869          79 TLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH  158 (303)
T ss_pred             EEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc
Confidence            99999999999998887666789999999999999999999999999999999999999999999999999986543333


Q ss_pred             ccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC------------C--------------
Q psy9858         213 LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG------------I--------------  259 (307)
Q Consensus       213 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~------------~--------------  259 (307)
                      ......+++.|+|||.+.+...++.++|||   +    +++|..||.+.....            .              
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T cd07869         159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF  238 (303)
T ss_pred             cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence            344567899999999998765789999999   3    334999997621100            0              


Q ss_pred             -----------Chhhhc--cccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCcccCC
Q psy9858         260 -----------PLNEIF--TAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKEMYW  307 (307)
Q Consensus       260 -----------~~~~~~--~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~~~~  307 (307)
                                 .....+  ...++++.+|+.+||+.||++|||++|+|+||||++.+..-|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~~~~  299 (303)
T cd07869         239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPPRLW  299 (303)
T ss_pred             ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCChhhh
Confidence                       000000  023567899999999999999999999999999999876544

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=7.2e-48  Score=331.25  Aligned_cols=243  Identities=37%  Similarity=0.604  Sum_probs=203.4

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|++.+.||.|+||.||+|.+..++..||+|++......    .....+.+|+++++.++||||+++++++.++...
T Consensus         3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   78 (288)
T cd07871           3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE----GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCL   78 (288)
T ss_pred             ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC----CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence            456899999999999999999999999999999998753211    1234577999999999999999999999999999


Q ss_pred             EEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc
Q psy9858         133 SLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR  212 (307)
Q Consensus       133 ~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  212 (307)
                      ++||||++|+|.+++......+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.......
T Consensus        79 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          79 TLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             EEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            99999999999998877665688999999999999999999999999999999999999999999999999987644333


Q ss_pred             ccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC---------------------------
Q psy9858         213 LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG---------------------------  258 (307)
Q Consensus       213 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~---------------------------  258 (307)
                      ......+++.|+|||.+.+...++.++|||   +    +++|.+||.+.....                           
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07871         159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR  238 (288)
T ss_pred             cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence            344557899999999998765789999999   3    333999987622100                           


Q ss_pred             ---------CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         259 ---------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       259 ---------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                               .........+++++.+||.+||+.||.+|||++|+|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence                     00011123467889999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0582|consensus

Probab=100.00  E-value=7e-48  Score=326.86  Aligned_cols=253  Identities=24%  Similarity=0.264  Sum_probs=211.3

Q ss_pred             ceeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeee
Q psy9858          48 CEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG  127 (307)
Q Consensus        48 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~  127 (307)
                      ..+....+.|++...||.|..++||+|+.+..++.||||++....-    +.....+++|++.+..++||||++++..|.
T Consensus        19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc----~~~ld~l~kE~~~msl~~HPNIv~~~~sFv   94 (516)
T KOG0582|consen   19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKC----NNDLDALRKEVQTMSLIDHPNIVTYHCSFV   94 (516)
T ss_pred             ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhh----hhhHHHHHHHHHHhhhcCCCCcceEEEEEE
Confidence            3455577899999999999999999999999999999999986321    222567889999999999999999999999


Q ss_pred             ecCeEEEEEEcc-CCChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcc
Q psy9858         128 YMSNVSLVFEFV-DTDLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK  205 (307)
Q Consensus       128 ~~~~~~lv~e~~-~g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  205 (307)
                      .+..+|+||.|+ .|++++++... ...++|..+..|+++++.||.|||++|.||||||+.||||+.+|.|||+|||.+.
T Consensus        95 v~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa  174 (516)
T KOG0582|consen   95 VDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSA  174 (516)
T ss_pred             ecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeee
Confidence            999999999999 68999988743 2348999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCCcc---c-ccceeeceehhhhhh-hccccccccccee--eeee-----cCCCCCCCC-----------CCC----
Q psy9858         206 FFGSPTRL---Y-THQVVTRWYRLIKCL-LYCVQFNVKNVQW--CCFA-----KDPSSHGNL-----------FPG----  258 (307)
Q Consensus       206 ~~~~~~~~---~-~~~~~t~~y~aPE~~-~~~~~~~~~~Diw--~i~~-----~~~~f~~~~-----------~~~----  258 (307)
                      .+......   . .+.+||+.|||||++ .....|+.|+|||  +|.+     |..||....           .+.    
T Consensus       175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t  254 (516)
T KOG0582|consen  175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLT  254 (516)
T ss_pred             eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccc
Confidence            66433222   2 556999999999995 4445799999999  3333     999998811           111    


Q ss_pred             -CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         259 -IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       259 -~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                       ....+.....+..+.++|..||+.||.+|||++++|+|+||+.++.
T Consensus       255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~  301 (516)
T KOG0582|consen  255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS  301 (516)
T ss_pred             ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence             1122333456788999999999999999999999999999998764

>KOG0616|consensus

Probab=100.00  E-value=3.9e-49  Score=318.65  Aligned_cols=245  Identities=24%  Similarity=0.281  Sum_probs=212.6

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN  131 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  131 (307)
                      ...++|++++.||.|+||.|.+++++.+|..+|+|++.+......++  .+...+|..+|+.+.||+++++++.+.+.+.
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQ--veH~~nEk~vL~~v~~PFlv~l~~t~~d~~~  118 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQ--VEHTHNEKRVLKAVSHPFLVKLYGTFKDNSN  118 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHH--HHHHhhHHHHHhhccCceeEEEEEeeccCCe
Confidence            56789999999999999999999999999999999998754443332  4567799999999999999999999999999


Q ss_pred             EEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         132 VSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       132 ~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      +|+||||+ +|.|.+++++.+ ++++..++.++.||+.||.|||+.+|++|||||+|||+|.+|.+||+|||+|+.....
T Consensus       119 lymvmeyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r  197 (355)
T KOG0616|consen  119 LYMVMEYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR  197 (355)
T ss_pred             EEEEEeccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence            99999999 678999888765 5999999999999999999999999999999999999999999999999999987432


Q ss_pred             Ccccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCCCC------hhhhccccCHHHHHHHH
Q psy9858         211 TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPGIP------LNEIFTAAGDDLLAVIS  277 (307)
Q Consensus       211 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~~~------~~~~~~~~~~~l~~li~  277 (307)
                         .-+.+||+.|+|||++... .|+.++|.|       .+++|.+||...+.-..-      .-..+...+.++++||.
T Consensus       198 ---T~TlCGTPeYLAPEii~sk-~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~  273 (355)
T KOG0616|consen  198 ---TWTLCGTPEYLAPEIIQSK-GYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLK  273 (355)
T ss_pred             ---EEEecCCccccChHHhhcC-CCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHH
Confidence               4556999999999999998 999999999       556699999884331110      11224467899999999


Q ss_pred             HhhhcCCCCCC-----CHHHHhcCcccCCCc
Q psy9858         278 SLLCLNPTKRA-----DCTATLKMDYFSLTK  303 (307)
Q Consensus       278 ~~l~~dP~~Rp-----t~~~il~hp~f~~~~  303 (307)
                      ++|++|-.+|.     ..++|..||||++++
T Consensus       274 ~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~  304 (355)
T KOG0616|consen  274 KLLQVDLTKRFGNLKNGVEDIKNHPWFKGVD  304 (355)
T ss_pred             HHHhhhhHhhhcCcCCCccccccCccccccc
Confidence            99999999994     578999999999764

>KOG0033|consensus

Probab=100.00  E-value=8.8e-51  Score=320.38  Aligned_cols=247  Identities=22%  Similarity=0.237  Sum_probs=211.0

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS  130 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  130 (307)
                      ....++|++.+.||+|.|+.|+++.+..+|+.+|+|++........   ..+.+.+|++|.+.|+||||+++.+.+....
T Consensus         7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~---~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~   83 (355)
T KOG0033|consen    7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR---DFQKLEREARICRKLQHPNIVRLHDSIQEES   83 (355)
T ss_pred             cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc---cHHHHHHHHHHHHhcCCCcEeehhhhhcccc
Confidence            3466789999999999999999999999999999999986554443   2567889999999999999999999999999


Q ss_pred             eEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecC---CcEEEEeecCccc
Q psy9858         131 NVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ---GVLKIGDFGLAKF  206 (307)
Q Consensus       131 ~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~a~~  206 (307)
                      ..|||+|++ +|+|...+-.+ ..+++..+...++||+.||.|+|.+||||||+||.|+++...   ..+||+|||+|..
T Consensus        84 ~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   84 FHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             eeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEE
Confidence            999999999 56776655544 358999999999999999999999999999999999999643   3589999999999


Q ss_pred             cCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCC----------CCChhhhccccC
Q psy9858         207 FGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFP----------GIPLNEIFTAAG  269 (307)
Q Consensus       207 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~----------~~~~~~~~~~~~  269 (307)
                      .+ .......++|||+|||||++... .|+..+|||   .    ++.|.+||.+....          -.-....+++++
T Consensus       163 l~-~g~~~~G~~GtP~fmaPEvvrkd-py~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is  240 (355)
T KOG0033|consen  163 VN-DGEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVT  240 (355)
T ss_pred             eC-CccccccccCCCcccCHHHhhcC-CCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCC
Confidence            87 55666778999999999999998 999999999   2    33399999982111          111223567899


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         270 DDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       270 ~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      ++.++||.+||..||.+|+|+.|+|+|||+.+..
T Consensus       241 ~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~  274 (355)
T KOG0033|consen  241 PEAKSLIRRMLTVNPKKRITADEALKHPWICNRE  274 (355)
T ss_pred             HHHHHHHHHHhccChhhhccHHHHhCCchhcchH
Confidence            9999999999999999999999999999997653

>KOG0605|consensus

Probab=100.00  E-value=7.5e-49  Score=339.79  Aligned_cols=254  Identities=23%  Similarity=0.289  Sum_probs=213.8

Q ss_pred             CCCceeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccce
Q psy9858          45 LPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTD  124 (307)
Q Consensus        45 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~  124 (307)
                      +.........++|+++..||+|+||.||+|+.+.+|..+|+|++.+......++  ....+.|-.+|...++|.||+++-
T Consensus       131 lR~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Q--v~hV~aERdiL~~~ds~~vVKLyY  208 (550)
T KOG0605|consen  131 LRLRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQ--VEHVRAERDILAEVDSPWVVKLYY  208 (550)
T ss_pred             HHhccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhh--HHHHHHHHHHhhhcCCCcEEEEEE
Confidence            333344567889999999999999999999999999999999999866544433  566788999999999999999999


Q ss_pred             eeeecCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecC
Q psy9858         125 VFGYMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGL  203 (307)
Q Consensus       125 ~~~~~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  203 (307)
                      .|++..++||||||+ +|++..++.+.+ .+++..++.++.+++.||.-||+.|+|||||||+|+|||..|++||+|||+
T Consensus       209 sFQD~~~LYLiMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGL  287 (550)
T KOG0605|consen  209 SFQDKEYLYLIMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGL  287 (550)
T ss_pred             EecCCCeeEEEEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccc
Confidence            999999999999999 788999998776 699999999999999999999999999999999999999999999999999


Q ss_pred             ccccCC----------------------CC-------------------------cccccceeeceehhhhhhhcccccc
Q psy9858         204 AKFFGS----------------------PT-------------------------RLYTHQVVTRWYRLIKCLLYCVQFN  236 (307)
Q Consensus       204 a~~~~~----------------------~~-------------------------~~~~~~~~t~~y~aPE~~~~~~~~~  236 (307)
                      |.-+..                      ..                         ....+.+|||.|+|||++.+. .|+
T Consensus       288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k-gY~  366 (550)
T KOG0605|consen  288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK-GYG  366 (550)
T ss_pred             cchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC-CCC
Confidence            853210                      00                         001145899999999999999 799


Q ss_pred             ccccee---eeee----cCCCCCCCCCCCC----------ChhhhccccCHHHHHHHHHhhhcCCCCCCC---HHHHhcC
Q psy9858         237 VKNVQW---CCFA----KDPSSHGNLFPGI----------PLNEIFTAAGDDLLAVISSLLCLNPTKRAD---CTATLKM  296 (307)
Q Consensus       237 ~~~Diw---~i~~----~~~~f~~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt---~~~il~h  296 (307)
                      ..+|.|   ||++    |-+||.+......          .....-..+++++++||.+||. ||++|..   ++||-+|
T Consensus       367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~H  445 (550)
T KOG0605|consen  367 KECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKH  445 (550)
T ss_pred             ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcC
Confidence            999999   6666    9999998332221          1111123578999999999999 9999996   9999999


Q ss_pred             cccCCCc
Q psy9858         297 DYFSLTK  303 (307)
Q Consensus       297 p~f~~~~  303 (307)
                      |||++++
T Consensus       446 PfF~~v~  452 (550)
T KOG0605|consen  446 PFFKGVD  452 (550)
T ss_pred             CccccCC
Confidence            9999875

>KOG0198|consensus

Probab=100.00  E-value=6.1e-48  Score=325.83  Aligned_cols=246  Identities=23%  Similarity=0.327  Sum_probs=204.7

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC--e
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS--N  131 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--~  131 (307)
                      ..+|...+.||+|+||.||++.+..+|..+|||.+.......     .+.+.+|+++|.+++|||||++++......  .
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-----~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~   90 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-----SESLEREIRILSRLNHPNIVQYYGSSSSRENDE   90 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-----HHHHHHHHHHHHhCCCCCEEeeCCccccccCee
Confidence            557889999999999999999999999999999988641111     455789999999999999999999744333  7


Q ss_pred             EEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEec-CCcEEEEeecCccccCC
Q psy9858         132 VSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK-QGVLKIGDFGLAKFFGS  209 (307)
Q Consensus       132 ~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~a~~~~~  209 (307)
                      ++++|||+ +|+|.+++.+.++.+++..++.+++||+.||.|||++|++|+||||+|||++. ++.+||+|||++.....
T Consensus        91 ~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   91 YNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             eEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            99999999 78999999987767999999999999999999999999999999999999999 79999999999987753


Q ss_pred             ---CCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCC---------CCCCCChhhhccccCH
Q psy9858         210 ---PTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGN---------LFPGIPLNEIFTAAGD  270 (307)
Q Consensus       210 ---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~---------~~~~~~~~~~~~~~~~  270 (307)
                         .........||+.|||||++.++....+++|||   |    +++|..|+...         .......+.++..+|+
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~  250 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSD  250 (313)
T ss_pred             ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCH
Confidence               112234568999999999999642455799999   4    33488887751         1111123366677999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         271 DLLAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       271 ~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                      +++++|.+|+..||++||||+++|+|||.++...
T Consensus       251 ~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  251 EAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             HHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            9999999999999999999999999999977543

>KOG0585|consensus

Probab=100.00  E-value=1.2e-48  Score=333.63  Aligned_cols=253  Identities=23%  Similarity=0.285  Sum_probs=204.6

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccc-----h----hhhHhHHHHHHHHHhcCCCCc
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAK-----D----GINRTALREIKLLQELHHENV  119 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-----~----~~~~~~~~e~~~l~~l~h~ni  119 (307)
                      .-...+++|++.+.||+|.||.|-+|++..+++.||||++.+.......     .    .-.+...+|+.||++|+||||
T Consensus        91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV  170 (576)
T KOG0585|consen   91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV  170 (576)
T ss_pred             ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence            3445678999999999999999999999999999999999874332111     0    112468899999999999999


Q ss_pred             cccceeeeec--CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcE
Q psy9858         120 LGLTDVFGYM--SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVL  196 (307)
Q Consensus       120 ~~~~~~~~~~--~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~  196 (307)
                      |+++++..+.  +.+|||+||| .|.+.+.-.... .+++.+++.++++++.||.|||.+||+||||||+|+|++.+|+|
T Consensus       171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~-els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~V  249 (576)
T KOG0585|consen  171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKP-ELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTV  249 (576)
T ss_pred             eEEEEeecCcccCceEEEEEeccCCccccCCCCcc-cccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcE
Confidence            9999998764  6799999999 455544332221 28999999999999999999999999999999999999999999


Q ss_pred             EEEeecCccccCCC-----Ccccccceeeceehhhhhhhc---cccccccccee-------eeeecCCCCCCCCC-----
Q psy9858         197 KIGDFGLAKFFGSP-----TRLYTHQVVTRWYRLIKCLLY---CVQFNVKNVQW-------CCFAKDPSSHGNLF-----  256 (307)
Q Consensus       197 kl~Dfg~a~~~~~~-----~~~~~~~~~t~~y~aPE~~~~---~~~~~~~~Diw-------~i~~~~~~f~~~~~-----  256 (307)
                      ||+|||.+..+...     .......+||+.|+|||...+   ....+.+.|||       |+++|+.||.+...     
T Consensus       250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~  329 (576)
T KOG0585|consen  250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFD  329 (576)
T ss_pred             EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHH
Confidence            99999999877322     112234689999999999987   33568999999       88889999998221     


Q ss_pred             ---CCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         257 ---PGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       257 ---~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                         .........+.+.+++++||.+||.+||++|+++.+|-.|||....
T Consensus       330 KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  330 KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence               1111112223578999999999999999999999999999998654

>KOG0597|consensus

Probab=100.00  E-value=5.5e-49  Score=341.96  Aligned_cols=243  Identities=25%  Similarity=0.381  Sum_probs=215.3

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ++|-+.+.||+|+||.||+|+.+.+.+.||+|.+.+....+   ...+.+.+|++|++.++||||+.++++|+...++++
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~---k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~v   78 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE---KELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWV   78 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCch---HHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEE
Confidence            57888899999999999999999999999999998754332   235678899999999999999999999999999999


Q ss_pred             EEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCccc
Q psy9858         135 VFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY  214 (307)
Q Consensus       135 v~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  214 (307)
                      |+||+.|+|..++.... .++++.++.++.++++||.|||+.+|+|||+||.|||++.+|++|+||||+|+..+......
T Consensus        79 Vte~a~g~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vl  157 (808)
T KOG0597|consen   79 VTEYAVGDLFTILEQDG-KLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVL  157 (808)
T ss_pred             EehhhhhhHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceee
Confidence            99999999999888765 59999999999999999999999999999999999999999999999999999987777777


Q ss_pred             ccceeeceehhhhhhhccccccccccee---eeee----cCCCCCCCCCCCCC------hhhhccccCHHHHHHHHHhhh
Q psy9858         215 THQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KDPSSHGNLFPGIP------LNEIFTAAGDDLLAVISSLLC  281 (307)
Q Consensus       215 ~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~~~~f~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~  281 (307)
                      +...||+.|||||...+. .|+..+|.|   ||+|    |.+||....+....      ....+...+..+.+|++.+|.
T Consensus       158 tsikGtPlYmAPElv~e~-pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~  236 (808)
T KOG0597|consen  158 TSIKGTPLYMAPELVEEQ-PYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLI  236 (808)
T ss_pred             eeccCcccccCHHHHcCC-CccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhh
Confidence            778999999999999987 999999999   7777    99999883221110      112234789999999999999


Q ss_pred             cCCCCCCCHHHHhcCcccCCC
Q psy9858         282 LNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       282 ~dP~~Rpt~~~il~hp~f~~~  302 (307)
                      +||.+|+|+.+++.|||.++.
T Consensus       237 kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  237 KDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             cChhhcccHHHHhcChHHhhh
Confidence            999999999999999998764

>KOG0658|consensus

Probab=100.00  E-value=4e-48  Score=321.84  Aligned_cols=241  Identities=32%  Similarity=0.519  Sum_probs=202.1

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec----
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM----  129 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~----  129 (307)
                      .-.|.-.+.+|+|+||.||.|...++++.||||..-...         +--.+|+++|+.++|||||++.-+|...    
T Consensus        23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~---------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d   93 (364)
T KOG0658|consen   23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK---------RYKNRELQIMRKLDHPNIVRLLYFFSSSTESD   93 (364)
T ss_pred             EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC---------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCc
Confidence            346899999999999999999999999999999875321         1123799999999999999999888532    


Q ss_pred             -CeEEEEEEccCCChHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecC-CcEEEEeecCc
Q psy9858         130 -SNVSLVFEFVDTDLEVIIKD---PTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ-GVLKIGDFGLA  204 (307)
Q Consensus       130 -~~~~lv~e~~~g~l~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~a  204 (307)
                       -...+||||++.+|.+.++.   .+..++.-.++.++.||+.||+|||+.||+||||||.|+|+|.+ |.+||||||.|
T Consensus        94 ~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSA  173 (364)
T KOG0658|consen   94 EVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSA  173 (364)
T ss_pred             hhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence             24668999999999998874   34468888999999999999999999999999999999999976 88999999999


Q ss_pred             cccCCCCcccccceeeceehhhhhhhccccccccccee---eeee----cCCCCCC------------------------
Q psy9858         205 KFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KDPSSHG------------------------  253 (307)
Q Consensus       205 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~~~~f~~------------------------  253 (307)
                      +.+...+ ...+...|..|+|||.+.|...|+.+.|||   |+++    |.++|.|                        
T Consensus       174 K~L~~~e-pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~  252 (364)
T KOG0658|consen  174 KVLVKGE-PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS  252 (364)
T ss_pred             eeeccCC-CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence            9985443 346779999999999999999999999999   6666    9999988                        


Q ss_pred             -------CCCCC---CChhh-hccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         254 -------NLFPG---IPLNE-IFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       254 -------~~~~~---~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                             ..++.   ..... .....++++.+|+.++|..+|.+|.|+.|++.||||...+.
T Consensus       253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~  314 (364)
T KOG0658|consen  253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD  314 (364)
T ss_pred             cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence                   00111   11111 33567899999999999999999999999999999987654

>KOG0662|consensus

Probab=100.00  E-value=7.7e-48  Score=290.91  Aligned_cols=245  Identities=40%  Similarity=0.665  Sum_probs=217.7

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      .+|...++||+|+||+||+|+++.+++.||+|.++.   .+..++......+|+-+++.++|.|||+++++...++.+.+
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrl---ddddegvpssalreicllkelkhknivrl~dvlhsdkkltl   78 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRL---DDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL   78 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEec---cCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEE
Confidence            367778999999999999999999999999999986   44556667788999999999999999999999999999999


Q ss_pred             EEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCccc
Q psy9858         135 VFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY  214 (307)
Q Consensus       135 v~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  214 (307)
                      |+|||.-+|..++.+-++.++.+.++.++.|++.||.++|++++.||||||.|.+|+.||..|++|||+++.++-+-...
T Consensus        79 vfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcy  158 (292)
T KOG0662|consen   79 VFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY  158 (292)
T ss_pred             eHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEee
Confidence            99999999999999988899999999999999999999999999999999999999999999999999999998887778


Q ss_pred             ccceeeceehhhhhhhccccccccccee---eeee-----cCCCCCCC-------------------CCCCCC-------
Q psy9858         215 THQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA-----KDPSSHGN-------------------LFPGIP-------  260 (307)
Q Consensus       215 ~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~-----~~~~f~~~-------------------~~~~~~-------  260 (307)
                      +..+.|.+|.+|.++.+..-|+...|+|   ||++     |+++|.+.                   .++...       
T Consensus       159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~  238 (292)
T KOG0662|consen  159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP  238 (292)
T ss_pred             eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence            8889999999999999998899999999   7777     99999881                   111110       


Q ss_pred             ---------hhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         261 ---------LNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       261 ---------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                               ...+.+.++..-++|++++|..+|.+|++++.+|+||||...
T Consensus       239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence                     111123345567899999999999999999999999999864

>KOG0032|consensus

Probab=100.00  E-value=1.1e-46  Score=330.02  Aligned_cols=247  Identities=26%  Similarity=0.315  Sum_probs=215.7

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-CCCccccceeeee
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-HENVLGLTDVFGY  128 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~  128 (307)
                      .......|++.+.||+|.||.||+|+++.+|+.+|+|++.+.......  ....+.+|+++|+++. ||||+.++++|++
T Consensus        30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~--~~~~v~~Ev~il~~l~~hpniv~l~~~~e~  107 (382)
T KOG0032|consen   30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKE--DREDVRREVAILQQLSGHPNIVQLKDAFED  107 (382)
T ss_pred             cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccc--cHHHHHHHHHHHHhccCCCCEEEEEEEEEc
Confidence            345667899999999999999999999999999999999876544322  2456889999999998 9999999999999


Q ss_pred             cCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecC----CcEEEEeecC
Q psy9858         129 MSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ----GVLKIGDFGL  203 (307)
Q Consensus       129 ~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~----~~~kl~Dfg~  203 (307)
                      ....++|||++ +|.|.+.+...  .+++..+..++.||+.++.|||+.|++||||||+|+|+...    +.+|++|||+
T Consensus       108 ~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  108 PDSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             CCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            99999999999 68899999877  28999999999999999999999999999999999999643    4799999999


Q ss_pred             ccccCCCCcccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCC----------CChhhhcc
Q psy9858         204 AKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPG----------IPLNEIFT  266 (307)
Q Consensus       204 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~----------~~~~~~~~  266 (307)
                      +..... .......+||+.|+|||++.+. .|+..+|||       .+++|.+||.+.....          .-..+.++
T Consensus       186 a~~~~~-~~~~~~~~Gtp~y~APEvl~~~-~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~  263 (382)
T KOG0032|consen  186 AKFIKP-GERLHTIVGTPEYVAPEVLGGR-PYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWD  263 (382)
T ss_pred             ceEccC-CceEeeecCCccccCchhhcCC-CCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCcc
Confidence            999866 5566778999999999999987 899999999       3444999999944111          12334567


Q ss_pred             ccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         267 AAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       267 ~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                      .++..++++|.+||..||.+|+|+.++|+|||++..
T Consensus       264 ~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  264 DISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             ccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence            789999999999999999999999999999999875

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.4e-46  Score=320.64  Aligned_cols=241  Identities=31%  Similarity=0.499  Sum_probs=200.1

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ++|++.+.||+|+||.||+|++..+++.||+|++.....   .......+.+|+++++.++||||+++++++...+..++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE---NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYL   77 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc---cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEE
Confidence            479999999999999999999999999999999975422   22234567899999999999999999999999999999


Q ss_pred             EEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc-c
Q psy9858         135 VFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR-L  213 (307)
Q Consensus       135 v~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-~  213 (307)
                      ||||+.+++.+.+......+++..++.++.||+.||.|||+.|++||||||+||+++.++.+||+|||++........ .
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  157 (287)
T cd07848          78 VFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN  157 (287)
T ss_pred             EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence            999998777777765555689999999999999999999999999999999999999999999999999987643221 2


Q ss_pred             cccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC----------------------------
Q psy9858         214 YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG----------------------------  258 (307)
Q Consensus       214 ~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~----------------------------  258 (307)
                      .....+++.|+|||.+.+. .++.++|+|   +    +++|++||.+.....                            
T Consensus       158 ~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07848         158 YTEYVATRWYRSPELLLGA-PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG  236 (287)
T ss_pred             ccccccccccCCcHHHcCC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence            2345789999999999887 789999999   3    333999987622100                            


Q ss_pred             CC----------hhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         259 IP----------LNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       259 ~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                      ..          .......++.++.+||++||+.||++|||++++|+||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            00          001112367889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0611|consensus

Probab=100.00  E-value=5.8e-48  Score=324.08  Aligned_cols=244  Identities=19%  Similarity=0.284  Sum_probs=212.1

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ...+|++.+.||.|+||+|-+|.....|+.||||.+.+....+..+  .-.+.+|++||..|+||||+.++++|+..+.+
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqD--lvhIRREIeIMSsLNHPhII~IyEVFENkdKI  128 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQD--LVHIRREIEIMSSLNHPHIIQIYEVFENKDKI  128 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHH--HHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence            3457999999999999999999998999999999999876665444  34578999999999999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT  211 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  211 (307)
                      .|||||. +|.|.+++...+ .+++.+++.+++||++|+.|||+++++|||||.+|||+|.|+++||+|||++..+.. .
T Consensus       129 vivMEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~-~  206 (668)
T KOG0611|consen  129 VIVMEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD-K  206 (668)
T ss_pred             EEEEEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc-c
Confidence            9999999 799999998776 599999999999999999999999999999999999999999999999999998854 4


Q ss_pred             cccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCCC----Chhhhc-cccCHHHHHHHHHh
Q psy9858         212 RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPGI----PLNEIF-TAAGDDLLAVISSL  279 (307)
Q Consensus       212 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~~----~~~~~~-~~~~~~l~~li~~~  279 (307)
                      ....+++|++-|++||++.|.++-++.+|.|       .+++|.+||++......    ...... +.-+.+..-||..|
T Consensus       207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~PSdA~gLIRwm  286 (668)
T KOG0611|consen  207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPETPSDASGLIRWM  286 (668)
T ss_pred             cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCCCchHHHHHHHH
Confidence            5667889999999999999997779999999       34459999999332211    111111 23467789999999


Q ss_pred             hhcCCCCCCCHHHHhcCcccC
Q psy9858         280 LCLNPTKRADCTATLKMDYFS  300 (307)
Q Consensus       280 l~~dP~~Rpt~~~il~hp~f~  300 (307)
                      |.+||++|.|+++|-+|=|..
T Consensus       287 LmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  287 LMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             HhcCcccchhHHHHhhhheee
Confidence            999999999999999998875

>KOG0694|consensus

Probab=100.00  E-value=2.2e-46  Score=332.93  Aligned_cols=248  Identities=23%  Similarity=0.252  Sum_probs=212.2

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeeec
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGYM  129 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~  129 (307)
                      ....++|.+++.||+|.||+|+++..+.+++.+|||++++...-..++  ......|.+|+... +||.++.++.+|+..
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~--Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~  441 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDE--VESLMCEKRIFELANRHPFLVNLFSCFQTK  441 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceecccc--HHHHHHHHHHHHHhccCCeEeecccccccC
Confidence            456789999999999999999999999999999999999876555443  56677898888887 599999999999999


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                      .++|+||||+ +|+ ..++ .+.+.+++..++.++..|+.||+|||++|||+||||.+|||+|.+|++||+|||+|+..-
T Consensus       442 ~~l~fvmey~~Ggd-m~~~-~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m  519 (694)
T KOG0694|consen  442 EHLFFVMEYVAGGD-LMHH-IHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM  519 (694)
T ss_pred             CeEEEEEEecCCCc-EEEE-EecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC
Confidence            9999999999 556 2222 233469999999999999999999999999999999999999999999999999999765


Q ss_pred             CCCcccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCCCC------hhhhccccCHHHHHH
Q psy9858         209 SPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPGIP------LNEIFTAAGDDLLAV  275 (307)
Q Consensus       209 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~~~------~~~~~~~~~~~l~~l  275 (307)
                      ......++.+||+.|+|||++.+. .|+.++|.|       .++.|..||.+......-      ....+..+|.+..++
T Consensus       520 ~~g~~TsTfCGTpey~aPEil~e~-~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~i  598 (694)
T KOG0694|consen  520 GQGDRTSTFCGTPEFLAPEVLTEQ-SYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAI  598 (694)
T ss_pred             CCCCccccccCChhhcChhhhccC-cccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHH
Confidence            556677889999999999999999 999999999       445599999884333211      112234689999999


Q ss_pred             HHHhhhcCCCCCCC-----HHHHhcCcccCCCc
Q psy9858         276 ISSLLCLNPTKRAD-----CTATLKMDYFSLTK  303 (307)
Q Consensus       276 i~~~l~~dP~~Rpt-----~~~il~hp~f~~~~  303 (307)
                      ++++|.+||++|..     +++|..||||+.++
T Consensus       599 l~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~  631 (694)
T KOG0694|consen  599 MRRLLRKNPEKRLGSGERDAEDIKKHPFFRSID  631 (694)
T ss_pred             HHHHhccCcccccCCCCCCchhhhhCCccccCC
Confidence            99999999999996     58999999998764

>KOG0599|consensus

Probab=100.00  E-value=2.3e-48  Score=311.29  Aligned_cols=250  Identities=23%  Similarity=0.295  Sum_probs=210.7

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccc---hhhhHhHHHHHHHHHhc-CCCCcccccee
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAK---DGINRTALREIKLLQEL-HHENVLGLTDV  125 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~~~e~~~l~~l-~h~ni~~~~~~  125 (307)
                      -....++|.-.+.||.|..+.|.++.++.+|+.+|+|++.........   ......-..|+.||+++ .||+|+++.++
T Consensus        12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~   91 (411)
T KOG0599|consen   12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV   91 (411)
T ss_pred             HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence            345667888899999999999999999999999999999764322211   22334456899999998 59999999999


Q ss_pred             eeecCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCc
Q psy9858         126 FGYMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA  204 (307)
Q Consensus       126 ~~~~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  204 (307)
                      ++.+..+++|+|.+ .|.|.|++...- .+++.+.+.+++|++.|+.|||..+||||||||+|||+++|.+++|+|||+|
T Consensus        92 yes~sF~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa  170 (411)
T KOG0599|consen   92 YESDAFVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFA  170 (411)
T ss_pred             ccCcchhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEecccee
Confidence            99999999999999 799999998764 5899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCcccccceeeceehhhhhhhc-----cccccccccee-------eeeecCCCCCCC----------CCCCCChh
Q psy9858         205 KFFGSPTRLYTHQVVTRWYRLIKCLLY-----CVQFNVKNVQW-------CCFAKDPSSHGN----------LFPGIPLN  262 (307)
Q Consensus       205 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~Diw-------~i~~~~~~f~~~----------~~~~~~~~  262 (307)
                      ..+...... ...+|||+|+|||.+..     .+.|+..+|+|       .+++|-+||...          .-.-.-..
T Consensus       171 ~~l~~GekL-relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~s  249 (411)
T KOG0599|consen  171 CQLEPGEKL-RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRS  249 (411)
T ss_pred             eccCCchhH-HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCC
Confidence            998655444 45699999999999864     34689999999       244499999871          11111223


Q ss_pred             hhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCC
Q psy9858         263 EIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSL  301 (307)
Q Consensus       263 ~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~  301 (307)
                      +.+.+++...++||.+||+.||++|+|++|+|.||||..
T Consensus       250 peWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q  288 (411)
T KOG0599|consen  250 PEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ  288 (411)
T ss_pred             cchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence            446789999999999999999999999999999999954

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3e-46  Score=326.26  Aligned_cols=238  Identities=21%  Similarity=0.262  Sum_probs=197.0

Q ss_pred             eEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEEEcc-
Q psy9858          61 RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFV-  139 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~-  139 (307)
                      +.||+|+||.||+|++..+|+.||+|++.+....  .......+.+|+++++.++||||+++++++...+..++||||+ 
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~   78 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVII--AKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYAN   78 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh--hhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCC
Confidence            4699999999999999999999999999753211  1122355778999999999999999999999999999999999 


Q ss_pred             CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCccccccee
Q psy9858         140 DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVV  219 (307)
Q Consensus       140 ~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  219 (307)
                      +|+|.+.+.... .+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.............|
T Consensus        79 ~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g  157 (323)
T cd05571          79 GGELFFHLSRER-VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG  157 (323)
T ss_pred             CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceec
Confidence            577877776543 5899999999999999999999999999999999999999999999999999864333333445578


Q ss_pred             eceehhhhhhhccccccccccee---ee----eecCCCCCCCCCCCC------ChhhhccccCHHHHHHHHHhhhcCCCC
Q psy9858         220 TRWYRLIKCLLYCVQFNVKNVQW---CC----FAKDPSSHGNLFPGI------PLNEIFTAAGDDLLAVISSLLCLNPTK  286 (307)
Q Consensus       220 t~~y~aPE~~~~~~~~~~~~Diw---~i----~~~~~~f~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dP~~  286 (307)
                      |+.|+|||.+.+. .++.++|||   |+    ++|..||.+......      .....+..+++++.+||.+||+.||++
T Consensus       158 t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~  236 (323)
T cd05571         158 TPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQ  236 (323)
T ss_pred             CccccChhhhcCC-CCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence            9999999999887 889999999   33    338888866322110      011233467899999999999999999


Q ss_pred             CC-----CHHHHhcCcccCCC
Q psy9858         287 RA-----DCTATLKMDYFSLT  302 (307)
Q Consensus       287 Rp-----t~~~il~hp~f~~~  302 (307)
                      ||     ++.++++||||++.
T Consensus       237 R~~~~~~~~~~ll~h~~f~~~  257 (323)
T cd05571         237 RLGGGPEDAKEIMEHRFFASI  257 (323)
T ss_pred             cCCCCCCCHHHHHcCCCcCCC
Confidence            99     89999999999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=7.5e-46  Score=321.86  Aligned_cols=247  Identities=34%  Similarity=0.562  Sum_probs=206.4

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|.+.+.||+|+||+||+|++..++..||+|++......    .....+.+|+++++.++|+||+++++++..++..
T Consensus         4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (309)
T cd07872           4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE----GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSL   79 (309)
T ss_pred             CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC----CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeE
Confidence            346899999999999999999999999999999998754321    1234577899999999999999999999999999


Q ss_pred             EEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc
Q psy9858         133 SLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR  212 (307)
Q Consensus       133 ~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  212 (307)
                      ++||||+++++.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus        80 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          80 TLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            99999999999998877666689999999999999999999999999999999999999999999999999987644333


Q ss_pred             ccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCCC--------------------------
Q psy9858         213 LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPGI--------------------------  259 (307)
Q Consensus       213 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~~--------------------------  259 (307)
                      ......++..|+|||.+.+...++.++|||       .+++|..||.+......                          
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07872         160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK  239 (309)
T ss_pred             ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence            334457789999999998765789999999       33449999876321000                          


Q ss_pred             ----------ChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         260 ----------PLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       260 ----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                                ........+++++.+||.+||+.||.+|||++|+++||||+..+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence                      00011234688999999999999999999999999999999765

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=6.5e-46  Score=324.86  Aligned_cols=243  Identities=24%  Similarity=0.242  Sum_probs=203.2

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++......  .......+.+|+++++.++||||+++++++.+++..
T Consensus        16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   93 (329)
T PTZ00263         16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL--KMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV   93 (329)
T ss_pred             CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh--hhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence            467899999999999999999999999999999999753211  112245678999999999999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT  211 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  211 (307)
                      +++|||+ +|+|.+.+.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus        94 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  172 (329)
T PTZ00263         94 YFLLEFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT  172 (329)
T ss_pred             EEEEcCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence            9999999 678888887654 58899999999999999999999999999999999999999999999999998764322


Q ss_pred             cccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCC------ChhhhccccCHHHHHHHHH
Q psy9858         212 RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGI------PLNEIFTAAGDDLLAVISS  278 (307)
Q Consensus       212 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~------~~~~~~~~~~~~l~~li~~  278 (307)
                         ....||+.|+|||.+.+. .++.++|||   +    +++|..||.+......      .....+..++..+.+||.+
T Consensus       173 ---~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~  248 (329)
T PTZ00263        173 ---FTLCGTPEYLAPEVIQSK-GHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKG  248 (329)
T ss_pred             ---ceecCChhhcCHHHHcCC-CCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHH
Confidence               234789999999999887 789999999   3    3349999876321100      0112234578899999999


Q ss_pred             hhhcCCCCCCC-----HHHHhcCcccCCC
Q psy9858         279 LLCLNPTKRAD-----CTATLKMDYFSLT  302 (307)
Q Consensus       279 ~l~~dP~~Rpt-----~~~il~hp~f~~~  302 (307)
                      ||+.||.+|++     ++++++||||++.
T Consensus       249 ~L~~dP~~R~~~~~~~~~~ll~hp~f~~~  277 (329)
T PTZ00263        249 LLQTDHTKRLGTLKGGVADVKNHPYFHGA  277 (329)
T ss_pred             HhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence            99999999997     7999999999874

>KOG0580|consensus

Probab=100.00  E-value=9.7e-48  Score=301.99  Aligned_cols=245  Identities=23%  Similarity=0.284  Sum_probs=214.5

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|++++.||.|-||.||+|+.++++--||+|++.+....  .....+++.+|++|-..|+||||.+++++|.++...
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~--~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri   97 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQIL--KTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI   97 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHH--HhcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence            567899999999999999999999999999999999886533  334467899999999999999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         133 SLVFEFV-DTDLEVIIKD-PTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      ||++||. +|++...+.. ....+++.....++.|++.||.|+|.++++||||||+|+|++..+..||+|||.+...+  
T Consensus        98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--  175 (281)
T KOG0580|consen   98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--  175 (281)
T ss_pred             EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence            9999999 7999888873 34458999999999999999999999999999999999999999999999999998764  


Q ss_pred             Ccccccceeeceehhhhhhhccccccccccee--eee-----ecCCCCCCCCCCCCChh-------hhccccCHHHHHHH
Q psy9858         211 TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW--CCF-----AKDPSSHGNLFPGIPLN-------EIFTAAGDDLLAVI  276 (307)
Q Consensus       211 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw--~i~-----~~~~~f~~~~~~~~~~~-------~~~~~~~~~l~~li  276 (307)
                      .+...+.+||..|.+||...+. .++..+|+|  +++     .|.+||..... .....       ..+..++..+.++|
T Consensus       176 ~~kR~tlcgt~dyl~pEmv~~~-~hd~~Vd~w~lgvl~yeflvg~ppFes~~~-~etYkrI~k~~~~~p~~is~~a~dlI  253 (281)
T KOG0580|consen  176 SNKRKTLCGTLDYLPPEMVEGR-GHDKFVDLWSLGVLCYEFLVGLPPFESQSH-SETYKRIRKVDLKFPSTISGGAADLI  253 (281)
T ss_pred             CCCceeeecccccCCHhhcCCC-CccchhhHHHHHHHHHHHHhcCCchhhhhh-HHHHHHHHHccccCCcccChhHHHHH
Confidence            4556677999999999999998 899999999  444     49999988552 22111       22357899999999


Q ss_pred             HHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         277 SSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       277 ~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      .+||..+|.+|.+..|++.|||+....
T Consensus       254 ~~ll~~~p~~r~~l~~v~~hpwI~a~~  280 (281)
T KOG0580|consen  254 SRLLVKNPIERLALTEVMDHPWIVANG  280 (281)
T ss_pred             HHHhccCccccccHHHHhhhHHHHhcC
Confidence            999999999999999999999997654

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.2e-45  Score=324.40  Aligned_cols=245  Identities=30%  Similarity=0.456  Sum_probs=198.9

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec-----C
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM-----S  130 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~  130 (307)
                      +|++.+.||+|+||.||+|.+..+|+.||||++......   ......+.+|+++++.++||||+++++++...     .
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   77 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH---VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK   77 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc---chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCc
Confidence            589999999999999999999999999999998743211   11234678999999999999999999987543     3


Q ss_pred             eEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         131 NVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       131 ~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      ..|+||||++++|.+.+.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus        78 ~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  156 (338)
T cd07859          78 DIYVVFELMESDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND  156 (338)
T ss_pred             eEEEEEecCCCCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence            589999999999988887554 4899999999999999999999999999999999999999999999999999865322


Q ss_pred             C---cccccceeeceehhhhhhhcc-ccccccccee---e----eeecCCCCCCCCCC----------------------
Q psy9858         211 T---RLYTHQVVTRWYRLIKCLLYC-VQFNVKNVQW---C----CFAKDPSSHGNLFP----------------------  257 (307)
Q Consensus       211 ~---~~~~~~~~t~~y~aPE~~~~~-~~~~~~~Diw---~----i~~~~~~f~~~~~~----------------------  257 (307)
                      .   .......+|+.|+|||++.+. ..++.++|||   +    +++|++||.+....                      
T Consensus       157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~  236 (338)
T cd07859         157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR  236 (338)
T ss_pred             cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence            1   122345789999999998762 3789999999   3    33499998653210                      


Q ss_pred             ---------------CCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         258 ---------------GIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       258 ---------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                                     ........+.+++++.+++.+||+.||++|||++++|+||||++...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence                           01111222356788999999999999999999999999999987654

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.2e-45  Score=316.97  Aligned_cols=244  Identities=22%  Similarity=0.271  Sum_probs=202.3

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEE
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLV  135 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  135 (307)
                      .|+..+.||+|+||+||+|.+..+|+.||+|++........  .....+.+|+++++.++|+||+++++++.+.+..+++
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~--~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv   78 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR--KGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLV   78 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhh--hhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEE
Confidence            47889999999999999999999999999999875432211  1234577899999999999999999999999999999


Q ss_pred             EEcc-CCChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc
Q psy9858         136 FEFV-DTDLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL  213 (307)
Q Consensus       136 ~e~~-~g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  213 (307)
                      |||+ +|+|.+.+... ...+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++....... .
T Consensus        79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~  157 (285)
T cd05631          79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-T  157 (285)
T ss_pred             EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-e
Confidence            9999 57787776543 3358899999999999999999999999999999999999999999999999998764322 2


Q ss_pred             cccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCC----------ChhhhccccCHHHHHHH
Q psy9858         214 YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGI----------PLNEIFTAAGDDLLAVI  276 (307)
Q Consensus       214 ~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~----------~~~~~~~~~~~~l~~li  276 (307)
                      .....|+..|+|||.+.+. .++.++|||   +    +++|..||.+......          .....+..++.++.+|+
T Consensus       158 ~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  236 (285)
T cd05631         158 VRGRVGTVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC  236 (285)
T ss_pred             ecCCCCCCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence            3345789999999999887 889999999   3    3349999987432211          11123346789999999


Q ss_pred             HHhhhcCCCCCCC-----HHHHhcCcccCCCc
Q psy9858         277 SSLLCLNPTKRAD-----CTATLKMDYFSLTK  303 (307)
Q Consensus       277 ~~~l~~dP~~Rpt-----~~~il~hp~f~~~~  303 (307)
                      .+||+.||++|||     ++++++||||++..
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~  268 (285)
T cd05631         237 RMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN  268 (285)
T ss_pred             HHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence            9999999999997     89999999998875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0610|consensus

Probab=100.00  E-value=4.2e-46  Score=313.53  Aligned_cols=252  Identities=22%  Similarity=0.231  Sum_probs=212.4

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY  128 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  128 (307)
                      ......+.|++++.||.|.-|+||+++...++..+|+|++.+......+  ...+...|-+||..++||.++++|..|+.
T Consensus        71 ~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rk--Kl~Ra~tE~eIL~~lDHPFlPTLYa~fet  148 (459)
T KOG0610|consen   71 DGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRK--KLKRAQTEREILSLLDHPFLPTLYASFET  148 (459)
T ss_pred             CCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhh--HHHHHHHHHHHHHhcCCCccchhhheeec
Confidence            3455677899999999999999999999999999999999876554432  25667889999999999999999999999


Q ss_pred             cCeEEEEEEcc-CCChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         129 MSNVSLVFEFV-DTDLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       129 ~~~~~lv~e~~-~g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                      +...|++|||| +|+|..+++++ ++.++++.++.++..++.||+|||-.|||+|||||+||||.++|++.|+||.++..
T Consensus       149 ~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~  228 (459)
T KOG0610|consen  149 DKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLR  228 (459)
T ss_pred             cceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeecccccc
Confidence            99999999999 78898888755 45699999999999999999999999999999999999999999999999998753


Q ss_pred             cCC---------------------------------C-C----------------------cccccceeeceehhhhhhh
Q psy9858         207 FGS---------------------------------P-T----------------------RLYTHQVVTRWYRLIKCLL  230 (307)
Q Consensus       207 ~~~---------------------------------~-~----------------------~~~~~~~~t~~y~aPE~~~  230 (307)
                      +..                                 . .                      ...+..+||-.|.|||++.
T Consensus       229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~  308 (459)
T KOG0610|consen  229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR  308 (459)
T ss_pred             CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence            310                                 0 0                      0122457899999999999


Q ss_pred             ccccccccccee-------eeeecCCCCCCCCCCCCChhhh--------ccccCHHHHHHHHHhhhcCCCCCCC----HH
Q psy9858         231 YCVQFNVKNVQW-------CCFAKDPSSHGNLFPGIPLNEI--------FTAAGDDLLAVISSLLCLNPTKRAD----CT  291 (307)
Q Consensus       231 ~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~~~~~~~--------~~~~~~~l~~li~~~l~~dP~~Rpt----~~  291 (307)
                      |. ..+.++|.|       .+++|..||.+........+-+        .+.++..+++||+++|.+||.+|..    |+
T Consensus       309 G~-GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~  387 (459)
T KOG0610|consen  309 GE-GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAA  387 (459)
T ss_pred             cC-CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchH
Confidence            98 889999999       5677999998844333221111        1256799999999999999999999    99


Q ss_pred             HHhcCcccCCCc
Q psy9858         292 ATLKMDYFSLTK  303 (307)
Q Consensus       292 ~il~hp~f~~~~  303 (307)
                      ||-+||||+++.
T Consensus       388 eIK~HpFF~gVn  399 (459)
T KOG0610|consen  388 EIKRHPFFEGVN  399 (459)
T ss_pred             HhhcCccccCCC
Confidence            999999999875

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-46  Score=320.45  Aligned_cols=242  Identities=23%  Similarity=0.240  Sum_probs=201.5

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ++|++++.||+|+||.||+|.+..+|+.||+|++.......  ......+.+|+++++.++||||+++++++.+....++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   78 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIR--LKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYM   78 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhh--hHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEE
Confidence            47899999999999999999999999999999997532111  1124557899999999999999999999999999999


Q ss_pred             EEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc
Q psy9858         135 VFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL  213 (307)
Q Consensus       135 v~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  213 (307)
                      ||||+ +|+|.+++.... .+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++......   
T Consensus        79 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---  154 (291)
T cd05612          79 LMEYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---  154 (291)
T ss_pred             EEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC---
Confidence            99999 678888887654 5899999999999999999999999999999999999999999999999999876432   


Q ss_pred             cccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCC------ChhhhccccCHHHHHHHHHhh
Q psy9858         214 YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGI------PLNEIFTAAGDDLLAVISSLL  280 (307)
Q Consensus       214 ~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~------~~~~~~~~~~~~l~~li~~~l  280 (307)
                      .....|++.|+|||.+.+. .++.++|||   +    +++|..||.+......      .....+..++..+.+||++||
T Consensus       155 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l  233 (291)
T cd05612         155 TWTLCGTPEYLAPEVIQSK-GHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLL  233 (291)
T ss_pred             cccccCChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHc
Confidence            2234789999999999887 789999999   3    3348999876332110      011223456889999999999


Q ss_pred             hcCCCCCCC-----HHHHhcCcccCCCc
Q psy9858         281 CLNPTKRAD-----CTATLKMDYFSLTK  303 (307)
Q Consensus       281 ~~dP~~Rpt-----~~~il~hp~f~~~~  303 (307)
                      +.||.+|++     ++++++||||....
T Consensus       234 ~~dp~~R~~~~~~~~~~~l~h~~~~~~~  261 (291)
T cd05612         234 VVDRTRRLGNMKNGADDVKNHRWFKSVD  261 (291)
T ss_pred             CCCHHHccCCccCCHHHHhcCccccCCC
Confidence            999999995     99999999998643

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0192|consensus

Probab=100.00  E-value=5.9e-46  Score=322.76  Aligned_cols=242  Identities=23%  Similarity=0.245  Sum_probs=202.9

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEEcCCCcE-EEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeee
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMI-VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG  127 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~-vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~  127 (307)
                      .+........+.+.||+|+||+||+|.+.  |+. ||+|++......+..   .+.|.+|+.+|.+++|||||+++|++.
T Consensus        35 ~~~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~---~~~f~~E~~il~~l~HpNIV~f~G~~~  109 (362)
T KOG0192|consen   35 EEEIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES---RKAFRREASLLSRLRHPNIVQFYGACT  109 (362)
T ss_pred             ceecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH---HHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            34445566677777999999999999974  445 999999864332222   678999999999999999999999998


Q ss_pred             ecC-eEEEEEEcc-CCChHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeecCCCCcEEEecCC-cEEEEeec
Q psy9858         128 YMS-NVSLVFEFV-DTDLEVIIKD-PTIVFTPSNIKAYAIMTLRGLEYLHDHW-ILHRDLKPNNLLINKQG-VLKIGDFG  202 (307)
Q Consensus       128 ~~~-~~~lv~e~~-~g~l~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~-ivH~dlkp~Nil~~~~~-~~kl~Dfg  202 (307)
                      ... .+++||||+ +|+|.+++.. ....++...+..++.||+.||.|||+++ ||||||||+|||++.++ ++||+|||
T Consensus       110 ~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFG  189 (362)
T KOG0192|consen  110 SPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFG  189 (362)
T ss_pred             CCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCc
Confidence            887 799999999 7899999987 4667999999999999999999999999 99999999999999998 99999999


Q ss_pred             CccccCCCCcccccceeeceehhhhhhhc-cccccccccee-------eeeecCCCCCCCCC--------CCCChhhhcc
Q psy9858         203 LAKFFGSPTRLYTHQVVTRWYRLIKCLLY-CVQFNVKNVQW-------CCFAKDPSSHGNLF--------PGIPLNEIFT  266 (307)
Q Consensus       203 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~Diw-------~i~~~~~~f~~~~~--------~~~~~~~~~~  266 (307)
                      +++.........+...||+.|||||++.+ ...|+.++|||       ++++|+.||.+...        .......++.
T Consensus       190 lsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~  269 (362)
T KOG0192|consen  190 LSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPK  269 (362)
T ss_pred             cceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCc
Confidence            99877543334444689999999999995 34899999999       56669999998443        2223334445


Q ss_pred             ccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         267 AAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       267 ~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      .+++.+..|+.+||+.||.+||+..+++.
T Consensus       270 ~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  270 ECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             cCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            58999999999999999999999998875

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.2e-45  Score=316.74  Aligned_cols=250  Identities=35%  Similarity=0.550  Sum_probs=208.6

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|.+++.||+|+||.||+|.+..+++.||+|.+......    .....+.+|+++++.++|+||+++++++......
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~   79 (301)
T cd07873           4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE----GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSL   79 (301)
T ss_pred             cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc----CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeE
Confidence            457899999999999999999999999999999998753211    1234567899999999999999999999999999


Q ss_pred             EEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc
Q psy9858         133 SLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR  212 (307)
Q Consensus       133 ~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  212 (307)
                      ++||||++++|.+++......+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus        80 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          80 TLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             EEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            99999999999998887666689999999999999999999999999999999999999999999999999987644333


Q ss_pred             ccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCC----------------------------
Q psy9858         213 LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFP----------------------------  257 (307)
Q Consensus       213 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~----------------------------  257 (307)
                      ......+++.|+|||.+.+...++.++|||       .+++|.+||.+....                            
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (301)
T cd07873         160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK  239 (301)
T ss_pred             cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence            334456789999999988765788999999       233499888762210                            


Q ss_pred             CCC--------hhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCcccC
Q psy9858         258 GIP--------LNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKEMY  306 (307)
Q Consensus       258 ~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~~~  306 (307)
                      ...        .......+++++.+||.+||+.||.+|||++++|+||||+..++.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~~  296 (301)
T cd07873         240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERI  296 (301)
T ss_pred             ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccchh
Confidence            000        0011234688899999999999999999999999999999887754

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-45  Score=323.08  Aligned_cols=244  Identities=20%  Similarity=0.277  Sum_probs=203.1

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ++|.+++.||+|+||+||+|++..+|+.||+|++.......  ......+.+|++++..++|+||+++++++.+++..++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIK--RNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYL   78 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhh--ccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEE
Confidence            47999999999999999999999999999999997532111  1224567899999999999999999999999999999


Q ss_pred             EEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC--
Q psy9858         135 VFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT--  211 (307)
Q Consensus       135 v~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--  211 (307)
                      ||||+ +|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......  
T Consensus        79 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  157 (350)
T cd05573          79 VMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR  157 (350)
T ss_pred             EEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence            99999 67898888766 468999999999999999999999999999999999999999999999999998764432  


Q ss_pred             ---------------------------cccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCC
Q psy9858         212 ---------------------------RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFP  257 (307)
Q Consensus       212 ---------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~  257 (307)
                                                 .......||+.|+|||.+.+. .++.++|||   |    +++|..||......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~  236 (350)
T cd05573         158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPPFYSDTLQ  236 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence                                       123345789999999999888 899999999   3    33388888763211


Q ss_pred             C----------CChhhhccccCHHHHHHHHHhhhcCCCCCCC-HHHHhcCcccCCCc
Q psy9858         258 G----------IPLNEIFTAAGDDLLAVISSLLCLNPTKRAD-CTATLKMDYFSLTK  303 (307)
Q Consensus       258 ~----------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-~~~il~hp~f~~~~  303 (307)
                      .          .........+++++.+||.+||. ||.+|++ ++++++||||++.+
T Consensus       237 ~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~  292 (350)
T cd05573         237 ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGID  292 (350)
T ss_pred             HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCC
Confidence            1          00111112368999999999997 9999999 99999999998753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-45  Score=320.03  Aligned_cols=241  Identities=22%  Similarity=0.290  Sum_probs=201.7

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ++|++++.||+|+||.||+|.+..+++.||+|++.......  ......+.+|++++..++||||+++++++...+..|+
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l   78 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFK--LNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYL   78 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhh--hhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEE
Confidence            47999999999999999999999999999999997532111  1224567899999999999999999999999999999


Q ss_pred             EEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc
Q psy9858         135 VFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL  213 (307)
Q Consensus       135 v~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  213 (307)
                      ||||+ +|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....   .
T Consensus        79 v~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~  154 (333)
T cd05600          79 AMEYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---Y  154 (333)
T ss_pred             EEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---c
Confidence            99999 678888886543 589999999999999999999999999999999999999999999999999986643   2


Q ss_pred             cccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC----------CChhhh----ccccCHHH
Q psy9858         214 YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG----------IPLNEI----FTAAGDDL  272 (307)
Q Consensus       214 ~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~----------~~~~~~----~~~~~~~l  272 (307)
                      .....||+.|+|||.+.+. .++.++|||   +    +++|..||.......          ......    ...+++++
T Consensus       155 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~  233 (333)
T cd05600         155 ANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEA  233 (333)
T ss_pred             cCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHH
Confidence            3445789999999999888 899999999   3    344889987632111          000000    12468999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         273 LAVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       273 ~~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                      .++|.+||..+|.+|||++++++||||++.
T Consensus       234 ~~li~~~l~~~~~rr~s~~~ll~h~~~~~~  263 (333)
T cd05600         234 WDLITKLINDPSRRFGSLEDIKNHPFFKEV  263 (333)
T ss_pred             HHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence            999999999999999999999999999875

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0201|consensus

Probab=100.00  E-value=4.5e-47  Score=321.51  Aligned_cols=246  Identities=22%  Similarity=0.333  Sum_probs=212.9

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ....|+.++.||+|.||.||+|.+..+++.||+|++......+.    ....+.|+.+|..++++||.++|+.+..+..+
T Consensus        11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~de----Iediqqei~~Ls~~~~~~it~yygsyl~g~~L   86 (467)
T KOG0201|consen   11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDE----IEDIQQEISVLSQCDSPNITEYYGSYLKGTKL   86 (467)
T ss_pred             cccccccchhccccccceeeeeeeccccceEEEEEechhhcchh----hHHHHHHHHHHHhcCcchHHhhhhheeecccH
Confidence            34568888999999999999999999999999999986543332    45678899999999999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT  211 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  211 (307)
                      +++|||+ +|++.+++.... .+.+..+..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||++.......
T Consensus        87 wiiMey~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~  165 (467)
T KOG0201|consen   87 WIIMEYCGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV  165 (467)
T ss_pred             HHHHHHhcCcchhhhhccCC-CCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechh
Confidence            9999999 577787776654 35888899999999999999999999999999999999999999999999999997776


Q ss_pred             cccccceeeceehhhhhhhccccccccccee--eee-----ecCCCCCC-------CCCCCCChhhhccccCHHHHHHHH
Q psy9858         212 RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW--CCF-----AKDPSSHG-------NLFPGIPLNEIFTAAGDDLLAVIS  277 (307)
Q Consensus       212 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw--~i~-----~~~~~f~~-------~~~~~~~~~~~~~~~~~~l~~li~  277 (307)
                      ....+.+||+.|||||++.+. .|+.++|||  +|.     .|++|+..       -.++......+....++.+++||.
T Consensus       166 ~rr~tfvGTPfwMAPEVI~~~-~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~  244 (467)
T KOG0201|consen  166 KRRKTFVGTPFWMAPEVIKQS-GYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVE  244 (467)
T ss_pred             hccccccccccccchhhhccc-cccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHH
Confidence            666888999999999999966 999999999  433     39999988       122333333333478999999999


Q ss_pred             HhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         278 SLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       278 ~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                      .||..||+.||||.++|+|+|+++.+.
T Consensus       245 ~CL~k~P~~RpsA~~LLKh~FIk~a~k  271 (467)
T KOG0201|consen  245 ACLDKNPEFRPSAKELLKHKFIKRAKK  271 (467)
T ss_pred             HHhhcCcccCcCHHHHhhhHHHHhcCC
Confidence            999999999999999999999998663

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.2e-45  Score=323.60  Aligned_cols=243  Identities=25%  Similarity=0.297  Sum_probs=197.9

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS  130 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  130 (307)
                      ....++|+.++.||+|+||.||+|++..+|+.||||++....    .......+.+|+++++.++|+||+++++++...+
T Consensus        70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  145 (353)
T PLN00034         70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH----EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG  145 (353)
T ss_pred             CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC----cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC
Confidence            345678999999999999999999999999999999986432    2333567889999999999999999999999999


Q ss_pred             eEEEEEEccC-CChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCC
Q psy9858         131 NVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS  209 (307)
Q Consensus       131 ~~~lv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  209 (307)
                      ..++||||+. |+|.+.     ....+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       146 ~~~lv~e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~  220 (353)
T PLN00034        146 EIQVLLEFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ  220 (353)
T ss_pred             eEEEEEecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence            9999999995 555432     1356778889999999999999999999999999999999999999999999987654


Q ss_pred             CCcccccceeeceehhhhhhhcc----ccccccccee---e----eeecCCCCCCCCCCCC----------Chhhhcccc
Q psy9858         210 PTRLYTHQVVTRWYRLIKCLLYC----VQFNVKNVQW---C----CFAKDPSSHGNLFPGI----------PLNEIFTAA  268 (307)
Q Consensus       210 ~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~~Diw---~----i~~~~~~f~~~~~~~~----------~~~~~~~~~  268 (307)
                      .........||..|+|||.+...    ...+.++|||   +    +++|+.||........          ........+
T Consensus       221 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (353)
T PLN00034        221 TMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATA  300 (353)
T ss_pred             ccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCcc
Confidence            33334456789999999987432    2456799999   3    3349999874222110          111223457


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         269 GDDLLAVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       269 ~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                      +.++.+||.+||+.||++|||++|+|+||||.+.
T Consensus       301 ~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~  334 (353)
T PLN00034        301 SREFRHFISCCLQREPAKRWSAMQLLQHPFILRA  334 (353)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence            8899999999999999999999999999999876

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3e-45  Score=320.46  Aligned_cols=238  Identities=22%  Similarity=0.284  Sum_probs=197.0

Q ss_pred             eEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEEEcc-
Q psy9858          61 RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFV-  139 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~-  139 (307)
                      +.||+|+||.||++++..+|+.||+|++.+.....  ......+.+|+++++.++||||+++++++...+..++||||+ 
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~   78 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIA--KDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVN   78 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCC
Confidence            46899999999999999999999999997532221  122456788999999999999999999999999999999999 


Q ss_pred             CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCccccccee
Q psy9858         140 DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVV  219 (307)
Q Consensus       140 ~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  219 (307)
                      +|+|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.............|
T Consensus        79 ~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g  157 (328)
T cd05593          79 GGELFFHLSRER-VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCG  157 (328)
T ss_pred             CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccC
Confidence            577877776543 5899999999999999999999999999999999999999999999999999864333333344578


Q ss_pred             eceehhhhhhhccccccccccee---ee----eecCCCCCCCCCCCC------ChhhhccccCHHHHHHHHHhhhcCCCC
Q psy9858         220 TRWYRLIKCLLYCVQFNVKNVQW---CC----FAKDPSSHGNLFPGI------PLNEIFTAAGDDLLAVISSLLCLNPTK  286 (307)
Q Consensus       220 t~~y~aPE~~~~~~~~~~~~Diw---~i----~~~~~~f~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dP~~  286 (307)
                      |+.|+|||.+.+. .++.++|||   ++    ++|..||.+......      .....+..+++++.+||.+||+.||++
T Consensus       158 t~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~  236 (328)
T cd05593         158 TPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNK  236 (328)
T ss_pred             CcCccChhhhcCC-CCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHH
Confidence            9999999999877 889999999   33    339999876322110      111234567899999999999999999


Q ss_pred             CC-----CHHHHhcCcccCCC
Q psy9858         287 RA-----DCTATLKMDYFSLT  302 (307)
Q Consensus       287 Rp-----t~~~il~hp~f~~~  302 (307)
                      |+     +++++++||||.+.
T Consensus       237 R~~~~~~~~~~il~h~~~~~~  257 (328)
T cd05593         237 RLGGGPDDAKEIMRHSFFTGV  257 (328)
T ss_pred             cCCCCCCCHHHHhcCCCcCCC
Confidence            97     89999999999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.1e-44  Score=317.37  Aligned_cols=246  Identities=22%  Similarity=0.214  Sum_probs=202.3

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ++|.+.+.||+|+||+||+|.+..+|+.||+|++......  .....+.+.+|+.+++.++|+||+++++++.+.+..++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~l   78 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLL--AQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYL   78 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEE
Confidence            4799999999999999999999999999999999853211  12234567889999999999999999999999999999


Q ss_pred             EEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc
Q psy9858         135 VFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL  213 (307)
Q Consensus       135 v~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  213 (307)
                      ||||+ +|+|.+++.+....+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.........
T Consensus        79 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  158 (330)
T cd05601          79 VMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV  158 (330)
T ss_pred             EECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence            99999 68899998876567999999999999999999999999999999999999999999999999999876433222


Q ss_pred             -cccceeeceehhhhhhhc-----cccccccccee---eee----ecCCCCCCCCCCC----------CChhhhccccCH
Q psy9858         214 -YTHQVVTRWYRLIKCLLY-----CVQFNVKNVQW---CCF----AKDPSSHGNLFPG----------IPLNEIFTAAGD  270 (307)
Q Consensus       214 -~~~~~~t~~y~aPE~~~~-----~~~~~~~~Diw---~i~----~~~~~f~~~~~~~----------~~~~~~~~~~~~  270 (307)
                       .....+|+.|+|||++..     ...++.++|||   +++    +|..||.......          .........+++
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  238 (330)
T cd05601         159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSS  238 (330)
T ss_pred             eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCH
Confidence             223468999999999873     33678999999   333    3888887632110          000111125789


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         271 DLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       271 ~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      ++.+||.+||+ ||.+|||++++++||||+..+
T Consensus       239 ~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~  270 (330)
T cd05601         239 DFLDLIQSLLC-GQKERLGYEGLCCHPFFSKID  270 (330)
T ss_pred             HHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCC
Confidence            99999999998 999999999999999998743

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.1e-45  Score=326.05  Aligned_cols=241  Identities=23%  Similarity=0.274  Sum_probs=197.5

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN  131 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  131 (307)
                      ....+|++++.||+|+||.||+|.+..+++.||+|....           ..+.+|+++++.++||||+++++++.....
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~  157 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----------GGTATEAHILRAINHPSIIQLKGTFTYNKF  157 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----------hhhHHHHHHHHhCCCCCCCCEeEEEEECCe
Confidence            345689999999999999999999999999999997531           236789999999999999999999999999


Q ss_pred             EEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC-
Q psy9858         132 VSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP-  210 (307)
Q Consensus       132 ~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-  210 (307)
                      .+++||++.++|..++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+|+..... 
T Consensus       158 ~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~  236 (391)
T PHA03212        158 TCLILPRYKTDLYCYLAAKR-NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN  236 (391)
T ss_pred             eEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence            99999999999988887654 4889999999999999999999999999999999999999999999999999754321 


Q ss_pred             Ccccccceeeceehhhhhhhccccccccccee---eeee----cCCCCCCCC-CCC---------------------CC-
Q psy9858         211 TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KDPSSHGNL-FPG---------------------IP-  260 (307)
Q Consensus       211 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~~~~f~~~~-~~~---------------------~~-  260 (307)
                      ........||+.|+|||++.+. .++.++|||   ++++    |..||.... ...                     .. 
T Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~  315 (391)
T PHA03212        237 ANKYYGWAGTIATNAPELLARD-PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI  315 (391)
T ss_pred             ccccccccCccCCCChhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence            1223345789999999999887 899999999   3333    665543211 000                     00 


Q ss_pred             -----hhh--------------------hccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCccc
Q psy9858         261 -----LNE--------------------IFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKEM  305 (307)
Q Consensus       261 -----~~~--------------------~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~~  305 (307)
                           ...                    ....++.++.+||.+||+.||++|||++|+|+||||+...+.
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~  385 (391)
T PHA03212        316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP  385 (391)
T ss_pred             chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence                 000                    001246689999999999999999999999999999987654

>KOG0667|consensus

Probab=100.00  E-value=4.1e-45  Score=324.21  Aligned_cols=237  Identities=28%  Similarity=0.450  Sum_probs=200.0

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-C-----CCccccceeeeec
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-H-----ENVLGLTDVFGYM  129 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~ni~~~~~~~~~~  129 (307)
                      +|.+++.||+|+||.|.+|++..+++.||||+++.      +..+..+...|+.+|..|+ |     -|+|+++++|...
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN------~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr  260 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN------KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR  260 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeecc------ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence            78999999999999999999999999999999984      3344566778999999997 3     5899999999999


Q ss_pred             CeEEEEEEccCCChHHHHhCCCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCC--cEEEEeecCccc
Q psy9858         130 SNVSLVFEFVDTDLEVIIKDPTI-VFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG--VLKIGDFGLAKF  206 (307)
Q Consensus       130 ~~~~lv~e~~~g~l~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~a~~  206 (307)
                      +++|||+|.+.-+|.++++.+.. .++...++.++.||+.||.+||+.||||+||||+|||+..-+  .|||+|||+|..
T Consensus       261 ~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  261 NHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             cceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence            99999999999999999986543 389999999999999999999999999999999999997554  699999999998


Q ss_pred             cCCCCcccccceeeceehhhhhhhccccccccccee---eeee----cCCCCCC--------------------------
Q psy9858         207 FGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KDPSSHG--------------------------  253 (307)
Q Consensus       207 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~~~~f~~--------------------------  253 (307)
                      ....  .+ +.+.+..|+|||++.|. .|+.+.|||   ||++    |.++|.|                          
T Consensus       341 ~~q~--vy-tYiQSRfYRAPEVILGl-pY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~  416 (586)
T KOG0667|consen  341 ESQR--VY-TYIQSRFYRAPEVILGL-PYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK  416 (586)
T ss_pred             cCCc--ce-eeeeccccccchhhccC-CCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            6432  33 67889999999999999 999999999   7776    9999988                          


Q ss_pred             ---CCCCC-C---------C------------------hh-hhc----------c-ccCHHHHHHHHHhhhcCCCCCCCH
Q psy9858         254 ---NLFPG-I---------P------------------LN-EIF----------T-AAGDDLLAVISSLLCLNPTKRADC  290 (307)
Q Consensus       254 ---~~~~~-~---------~------------------~~-~~~----------~-~~~~~l~~li~~~l~~dP~~Rpt~  290 (307)
                         ..+.. .         .                  .. ..+          . .....+.++|++||.+||.+|+|.
T Consensus       417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp  496 (586)
T KOG0667|consen  417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP  496 (586)
T ss_pred             ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence               00000 0         0                  00 000          1 112456899999999999999999


Q ss_pred             HHHhcCcccCCC
Q psy9858         291 TATLKMDYFSLT  302 (307)
Q Consensus       291 ~~il~hp~f~~~  302 (307)
                      .|+|+||||...
T Consensus       497 ~qal~Hpfl~~~  508 (586)
T KOG0667|consen  497 AQALNHPFLTGT  508 (586)
T ss_pred             HHHhcCcccccc
Confidence            999999999843

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-45  Score=323.12  Aligned_cols=244  Identities=20%  Similarity=0.270  Sum_probs=199.2

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ++|++++.||+|+||+||+|++..+|+.||||++......  .......+.+|+++++.++||||+++++++.+....++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l   78 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML--EKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYL   78 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEE
Confidence            4799999999999999999999999999999999753211  12224557789999999999999999999999999999


Q ss_pred             EEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc-
Q psy9858         135 VFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR-  212 (307)
Q Consensus       135 v~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-  212 (307)
                      ||||+ +|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++........ 
T Consensus        79 v~E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  157 (364)
T cd05599          79 IMEYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT  157 (364)
T ss_pred             EECCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence            99999 678888887654 589999999999999999999999999999999999999999999999999875422110 


Q ss_pred             -------------------------------------ccccceeeceehhhhhhhccccccccccee---eee----ecC
Q psy9858         213 -------------------------------------LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCF----AKD  248 (307)
Q Consensus       213 -------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~----~~~  248 (307)
                                                           .....+||+.|+|||++.+. .++.++|||   |++    +|.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT-GYNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC-CCCCeeeeecchhHHHHhhcCC
Confidence                                                 01123689999999999877 889999999   333    399


Q ss_pred             CCCCCCCCCC----------CChhhhccccCHHHHHHHHHhhhcCCCCCCC---HHHHhcCcccCCCc
Q psy9858         249 PSSHGNLFPG----------IPLNEIFTAAGDDLLAVISSLLCLNPTKRAD---CTATLKMDYFSLTK  303 (307)
Q Consensus       249 ~~f~~~~~~~----------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt---~~~il~hp~f~~~~  303 (307)
                      .||.+.....          .........+++++.+||.+||. +|.+|++   ++++++||||++.+
T Consensus       237 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~  303 (364)
T cd05599         237 PPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVD  303 (364)
T ss_pred             CCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence            9987632110          00001112468999999999997 9999998   99999999998753

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=5.2e-45  Score=320.09  Aligned_cols=247  Identities=24%  Similarity=0.242  Sum_probs=203.5

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEcCCC-cEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDIETD-MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY  128 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  128 (307)
                      .....++|.+.+.||+|+||.||+|.+..++ ..||+|++......  .......+.+|+++++.++||||+++++++.+
T Consensus        25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~  102 (340)
T PTZ00426         25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII--KQKQVDHVFSERKILNYINHPFCVNLYGSFKD  102 (340)
T ss_pred             CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh--hhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe
Confidence            3456778999999999999999999876554 78999998753211  12224567899999999999999999999999


Q ss_pred             cCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         129 MSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       129 ~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      .+..++||||+ +|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus       103 ~~~~~lv~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~  181 (340)
T PTZ00426        103 ESYLYLVLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV  181 (340)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence            99999999999 678888887554 5899999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC------CChhhhccccCHHHHH
Q psy9858         208 GSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG------IPLNEIFTAAGDDLLA  274 (307)
Q Consensus       208 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~------~~~~~~~~~~~~~l~~  274 (307)
                      ...   .....||+.|+|||++.+. .++.++|+|   +    +++|..||.+.....      ......+..+++.+.+
T Consensus       182 ~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  257 (340)
T PTZ00426        182 DTR---TYTLCGTPEYIAPEILLNV-GHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKH  257 (340)
T ss_pred             CCC---cceecCChhhcCHHHHhCC-CCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence            432   2345789999999999887 789999999   3    333889987732110      0011224457899999


Q ss_pred             HHHHhhhcCCCCCC-----CHHHHhcCcccCCCc
Q psy9858         275 VISSLLCLNPTKRA-----DCTATLKMDYFSLTK  303 (307)
Q Consensus       275 li~~~l~~dP~~Rp-----t~~~il~hp~f~~~~  303 (307)
                      +|++||+.||++|+     |++++++||||.+..
T Consensus       258 li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~  291 (340)
T PTZ00426        258 LMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNID  291 (340)
T ss_pred             HHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence            99999999999995     899999999998754

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.3e-44  Score=311.19  Aligned_cols=240  Identities=33%  Similarity=0.572  Sum_probs=193.6

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcC-CCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc---CCCCccccceeee---
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIE-TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL---HHENVLGLTDVFG---  127 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~ni~~~~~~~~---  127 (307)
                      ++|++++.||+|+||.||+|++.. +|..||+|++.......   .....+.+|+.+++.+   +||||+++++++.   
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~   77 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE---GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   77 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC---CchHHHHHHHHHHHhhcccCCCCcceEEEEEeccc
Confidence            479999999999999999999854 46889999987543222   1234456777777765   6999999999874   


Q ss_pred             --ecCeEEEEEEccCCChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCc
Q psy9858         128 --YMSNVSLVFEFVDTDLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA  204 (307)
Q Consensus       128 --~~~~~~lv~e~~~g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  204 (307)
                        .....++||||++++|.+++... ...+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++
T Consensus        78 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T cd07862          78 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA  157 (290)
T ss_pred             CCCCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccce
Confidence              34569999999999999988754 334899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCC---------------------
Q psy9858         205 KFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLF---------------------  256 (307)
Q Consensus       205 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~---------------------  256 (307)
                      ...... .......+++.|+|||.+.+. .++.++|||   +    +++|.+||.+...                     
T Consensus       158 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~  235 (290)
T cd07862         158 RIYSFQ-MALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  235 (290)
T ss_pred             EeccCC-cccccccccccccChHHHhCC-CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence            876432 333455789999999999877 789999999   3    3348888876221                     


Q ss_pred             ------------CCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         257 ------------PGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       257 ------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                                  .........+.++..+.+|+.+||+.||++|||+.++|+||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                        0011112234578889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.6e-44  Score=321.83  Aligned_cols=244  Identities=20%  Similarity=0.270  Sum_probs=197.8

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ++|++++.||+|+||.||+|++..+++.||+|++......  .......+.+|+++++.++|+||+++++.+.+++..++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l   78 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL--MRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYF   78 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHH--hhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEE
Confidence            3699999999999999999999999999999998743211  11224557799999999999999999999999999999


Q ss_pred             EEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC---
Q psy9858         135 VFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP---  210 (307)
Q Consensus       135 v~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---  210 (307)
                      ||||+ +|+|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||+|..+...   
T Consensus        79 v~E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~  157 (376)
T cd05598          79 VMDYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (376)
T ss_pred             EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence            99999 678888887654 5889999999999999999999999999999999999999999999999998532100   


Q ss_pred             ----------------------------------------Ccccccceeeceehhhhhhhccccccccccee---eeee-
Q psy9858         211 ----------------------------------------TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA-  246 (307)
Q Consensus       211 ----------------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~-  246 (307)
                                                              ........||+.|+|||++.+. .++.++|||   |+++ 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilye  236 (376)
T cd05598         158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVILYE  236 (376)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC-CCCcceeeeeccceeee
Confidence                                                    0001124689999999999887 889999999   4433 


Q ss_pred             ---cCCCCCCCCCCC----------CChhhhccccCHHHHHHHHHhhhcCCCCCC---CHHHHhcCcccCCCc
Q psy9858         247 ---KDPSSHGNLFPG----------IPLNEIFTAAGDDLLAVISSLLCLNPTKRA---DCTATLKMDYFSLTK  303 (307)
Q Consensus       247 ---~~~~f~~~~~~~----------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp---t~~~il~hp~f~~~~  303 (307)
                         |..||.+.....          .........+++++.++|.+|+ .+|.+|+   |+.++++||||++..
T Consensus       237 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~  308 (376)
T cd05598         237 MLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGID  308 (376)
T ss_pred             hhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence               889987733211          0000112357899999999977 5999999   999999999998753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=9.7e-45  Score=317.00  Aligned_cols=238  Identities=21%  Similarity=0.264  Sum_probs=195.6

Q ss_pred             eEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEEEcc-
Q psy9858          61 RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFV-  139 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~-  139 (307)
                      +.||+|+||.||++++..+|+.||+|++.......  ......+.+|+++++.++||||+++++++......++||||+ 
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~--~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~   78 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA--KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN   78 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence            46999999999999999999999999997532211  112345678999999999999999999999999999999999 


Q ss_pred             CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcccccce
Q psy9858         140 DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD-HWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQV  218 (307)
Q Consensus       140 ~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  218 (307)
                      +|+|.+++.... .+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||+++.............
T Consensus        79 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  157 (325)
T cd05594          79 GGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC  157 (325)
T ss_pred             CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccccc
Confidence            577877766543 58999999999999999999997 7999999999999999999999999999976433333334457


Q ss_pred             eeceehhhhhhhccccccccccee---eee----ecCCCCCCCCCCCC------ChhhhccccCHHHHHHHHHhhhcCCC
Q psy9858         219 VTRWYRLIKCLLYCVQFNVKNVQW---CCF----AKDPSSHGNLFPGI------PLNEIFTAAGDDLLAVISSLLCLNPT  285 (307)
Q Consensus       219 ~t~~y~aPE~~~~~~~~~~~~Diw---~i~----~~~~~f~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dP~  285 (307)
                      ||+.|+|||++.+. .++.++|||   +++    +|..||.+......      .....+..+++++.+||.+||+.||+
T Consensus       158 gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~  236 (325)
T cd05594         158 GTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPK  236 (325)
T ss_pred             CCcccCCHHHHccC-CCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHH
Confidence            89999999999887 889999999   333    38888876332110      01122346789999999999999999


Q ss_pred             CCC-----CHHHHhcCcccCCC
Q psy9858         286 KRA-----DCTATLKMDYFSLT  302 (307)
Q Consensus       286 ~Rp-----t~~~il~hp~f~~~  302 (307)
                      +|+     ++.++++||||.+.
T Consensus       237 ~R~~~~~~~~~~il~h~~~~~~  258 (325)
T cd05594         237 QRLGGGPDDAKEIMQHKFFAGI  258 (325)
T ss_pred             HhCCCCCCCHHHHhcCCCcCCC
Confidence            997     99999999999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-45  Score=317.25  Aligned_cols=236  Identities=23%  Similarity=0.275  Sum_probs=195.8

Q ss_pred             EeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEEEcc-CC
Q psy9858          63 VHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFV-DT  141 (307)
Q Consensus        63 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~-~g  141 (307)
                      ||+|+||.||+|++..+++.||+|++......  .......+.+|+.++++++||||+++++++...+..++||||+ +|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   78 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIV--SRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGG   78 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCC
Confidence            68999999999999999999999998753211  1222456778999999999999999999999999999999999 67


Q ss_pred             ChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcccccceeec
Q psy9858         142 DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTR  221 (307)
Q Consensus       142 ~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~  221 (307)
                      +|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||+++.............||+
T Consensus        79 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  157 (312)
T cd05585          79 ELFHHLQREG-RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTP  157 (312)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCc
Confidence            8888887643 589999999999999999999999999999999999999999999999999986533333344557899


Q ss_pred             eehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCC------ChhhhccccCHHHHHHHHHhhhcCCCCCC
Q psy9858         222 WYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGI------PLNEIFTAAGDDLLAVISSLLCLNPTKRA  288 (307)
Q Consensus       222 ~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dP~~Rp  288 (307)
                      .|+|||.+.+. .++.++|||   +    +++|..||.+......      .....+..+++++.++|.+||+.||.+||
T Consensus       158 ~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~  236 (312)
T cd05585         158 EYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRL  236 (312)
T ss_pred             ccCCHHHHcCC-CCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcC
Confidence            99999999887 889999999   2    3339999876322111      01122346789999999999999999997


Q ss_pred             ---CHHHHhcCcccCCC
Q psy9858         289 ---DCTATLKMDYFSLT  302 (307)
Q Consensus       289 ---t~~~il~hp~f~~~  302 (307)
                         ++.++++||||++.
T Consensus       237 ~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         237 GYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             CCCCHHHHHcCCCcCCC
Confidence               58999999999875

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG4717|consensus

Probab=100.00  E-value=8.8e-46  Score=319.08  Aligned_cols=248  Identities=22%  Similarity=0.267  Sum_probs=216.6

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ...-|.+.+.||+|.|+.|-+|+|..+|.+||||++.+....+..   ...+..|++.|+-++|||||++|++...+..+
T Consensus        16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s---t~hlfqEVRCMKLVQHpNiVRLYEViDTQTKl   92 (864)
T KOG4717|consen   16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS---TGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKL   92 (864)
T ss_pred             eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh---hhHHHHHHHHHHHhcCcCeeeeeehhcccceE
Confidence            345588999999999999999999999999999999986554433   45688999999999999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEE-ecCCcEEEEeecCccccCCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLI-NKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~-~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      |||+|+- +|+|.+++.+....+.++.+++++.||+.|+.|+|+.-+|||||||+|+++ .+-|.|||+|||++..+...
T Consensus        93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            9999999 679999999888889999999999999999999999999999999999876 56789999999999988554


Q ss_pred             Ccccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCCC------hhhhccccCHHHHHHHH
Q psy9858         211 TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGIP------LNEIFTAAGDDLLAVIS  277 (307)
Q Consensus       211 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~------~~~~~~~~~~~l~~li~  277 (307)
                       ...++.+|++.|.|||++.|..+..+++|||   .    +++|.+||+..+.....      ...++.+++.++++||+
T Consensus       173 -~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~  251 (864)
T KOG4717|consen  173 -KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQ  251 (864)
T ss_pred             -chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHH
Confidence             4456679999999999999997778999999   3    33499999885443322      12335678999999999


Q ss_pred             HhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         278 SLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       278 ~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                      +||..||.+|.|.++|.+|+|++..+.
T Consensus       252 sMLvRdPkkRAslEeI~s~~Wlq~~D~  278 (864)
T KOG4717|consen  252 SMLVRDPKKRASLEEIVSTSWLQAGDR  278 (864)
T ss_pred             HHHhcCchhhccHHHHhccccccCCCC
Confidence            999999999999999999999998764

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=8.8e-45  Score=328.67  Aligned_cols=242  Identities=27%  Similarity=0.387  Sum_probs=195.2

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec--
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM--  129 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--  129 (307)
                      ....+|++++.||+|+||.||+|.+..+++.||||++....         ....+|+.+++.++||||+++++++...  
T Consensus        63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~  133 (440)
T PTZ00036         63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---------QYKNRELLIMKNLNHINIIFLKDYYYTECF  133 (440)
T ss_pred             CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---------chHHHHHHHHHhcCCCCCcceeeeEeeccc
Confidence            34568999999999999999999999999999999886321         1234799999999999999998876432  


Q ss_pred             ------CeEEEEEEccCCChHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCC-cEEEE
Q psy9858         130 ------SNVSLVFEFVDTDLEVIIK---DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG-VLKIG  199 (307)
Q Consensus       130 ------~~~~lv~e~~~g~l~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~  199 (307)
                            ..+++||||+++++.+++.   .....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus       134 ~~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~  213 (440)
T PTZ00036        134 KKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLC  213 (440)
T ss_pred             ccCCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeee
Confidence                  3577999999988877664   3445689999999999999999999999999999999999998665 69999


Q ss_pred             eecCccccCCCCcccccceeeceehhhhhhhccccccccccee---eee----ecCCCCCCCCCC---------------
Q psy9858         200 DFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCF----AKDPSSHGNLFP---------------  257 (307)
Q Consensus       200 Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~----~~~~~f~~~~~~---------------  257 (307)
                      |||+|+...... ......+|+.|+|||++.+...++.++|||   |++    +|.+||.+....               
T Consensus       214 DFGla~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~  292 (440)
T PTZ00036        214 DFGSAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE  292 (440)
T ss_pred             ccccchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            999998764322 223457899999999998766799999999   333    399999773210               


Q ss_pred             ----------------CCC---h-hhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         258 ----------------GIP---L-NEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       258 ----------------~~~---~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                                      ...   . ..++...++++.+||.+||+.||.+|||+.|+|+||||....
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~  358 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR  358 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence                            000   0 011234678999999999999999999999999999997654

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.2e-44  Score=321.30  Aligned_cols=244  Identities=21%  Similarity=0.270  Sum_probs=196.7

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEE
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLV  135 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  135 (307)
                      .|++++.||+|+||+||+|++..+++.||+|++......  .......+.+|+++++.++|+||+++++++.+.+..++|
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv   79 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVL--NRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV   79 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh--hhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEE
Confidence            689999999999999999999999999999999753221  122245688999999999999999999999999999999


Q ss_pred             EEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC---
Q psy9858         136 FEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT---  211 (307)
Q Consensus       136 ~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---  211 (307)
                      |||+ +|+|.+++.+.. .+++..++.++.||+.||.|||+.||+||||||+|||++.+++++|+|||++..+....   
T Consensus        80 ~E~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~  158 (381)
T cd05626          80 MDYIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK  158 (381)
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence            9999 678888887654 58899999999999999999999999999999999999999999999999976431100   


Q ss_pred             --------------------------------------------cccccceeeceehhhhhhhccccccccccee---ee
Q psy9858         212 --------------------------------------------RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC  244 (307)
Q Consensus       212 --------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i  244 (307)
                                                                  ......+||+.|+|||.+.+. .++.++|||   |+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlG~i  237 (381)
T cd05626         159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK-GYTQLCDWWSVGVI  237 (381)
T ss_pred             cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC-CCCCccceeehhhH
Confidence                                                        001234689999999999887 789999999   33


Q ss_pred             ee----cCCCCCCCCCCCC----------ChhhhccccCHHHHHHHHHhhh--cCCCCCCCHHHHhcCcccCCCc
Q psy9858         245 FA----KDPSSHGNLFPGI----------PLNEIFTAAGDDLLAVISSLLC--LNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       245 ~~----~~~~f~~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~--~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      ++    |..||........          ........+++++.+||.+|+.  .+|..|+|++++++||||++..
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~  312 (381)
T cd05626         238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVD  312 (381)
T ss_pred             HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCC
Confidence            33    9999976332110          0011122578999999999654  4555699999999999998753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.3e-44  Score=321.37  Aligned_cols=243  Identities=21%  Similarity=0.271  Sum_probs=197.5

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEE
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLV  135 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  135 (307)
                      .|++++.||+|+||+||+|++..+++.||+|++.+...  ........+.+|+++++.++|+||+++++.+.+.+..|+|
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~--~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv   79 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDV--LLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV   79 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHh--hhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEE
Confidence            58999999999999999999999999999999875321  1122345678999999999999999999999999999999


Q ss_pred             EEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC----
Q psy9858         136 FEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP----  210 (307)
Q Consensus       136 ~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----  210 (307)
                      |||+ +|+|.+++.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|..+...    
T Consensus        80 ~E~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~  158 (382)
T cd05625          80 MDYIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (382)
T ss_pred             EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence            9999 678888887653 5889999999999999999999999999999999999999999999999997533100    


Q ss_pred             -------------------------------------------Ccccccceeeceehhhhhhhccccccccccee---ee
Q psy9858         211 -------------------------------------------TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC  244 (307)
Q Consensus       211 -------------------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i  244 (307)
                                                                 .......+||+.|+|||++.+. .++.++|||   |+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvi  237 (382)
T cd05625         159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVI  237 (382)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC-CCCCeeeEEechHH
Confidence                                                       0001224689999999999887 889999999   33


Q ss_pred             ee----cCCCCCCCCCC----------CCChhhhccccCHHHHHHHHHhhhcCCCCCCC---HHHHhcCcccCCCc
Q psy9858         245 FA----KDPSSHGNLFP----------GIPLNEIFTAAGDDLLAVISSLLCLNPTKRAD---CTATLKMDYFSLTK  303 (307)
Q Consensus       245 ~~----~~~~f~~~~~~----------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt---~~~il~hp~f~~~~  303 (307)
                      ++    |..||.+....          ..........+++++.++|.+|+ .||++|++   ++++++||||++..
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~  312 (382)
T cd05625         238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTID  312 (382)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcC
Confidence            33    99999863211          01111112357899999999986 59999997   99999999998753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.2e-44  Score=308.92  Aligned_cols=241  Identities=37%  Similarity=0.633  Sum_probs=200.8

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEE
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLV  135 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  135 (307)
                      +|++++.||+|++|.||+|++..+++.||+|.+....   ..+.....+.+|+.+++.++||||+++++++.++...++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES---EEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLI   77 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEecccc---ccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEE
Confidence            5889999999999999999998999999999987532   1222345678899999999999999999999999999999


Q ss_pred             EEccCCChHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc
Q psy9858         136 FEFVDTDLEVIIKDPT--IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL  213 (307)
Q Consensus       136 ~e~~~g~l~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  213 (307)
                      |||+.+++.+++....  ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.....+...
T Consensus        78 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  157 (285)
T cd07861          78 FEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV  157 (285)
T ss_pred             EecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccc
Confidence            9999989888876432  45899999999999999999999999999999999999999999999999999876544444


Q ss_pred             cccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCC------------------------------
Q psy9858         214 YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLF------------------------------  256 (307)
Q Consensus       214 ~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~------------------------------  256 (307)
                      .....+++.|+|||.+.+...++.++|+|   +    +++|.+||.+...                              
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
T cd07861         158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN  237 (285)
T ss_pred             ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence            44456789999999988765688999999   3    3338888875321                              


Q ss_pred             -----CCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         257 -----PGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       257 -----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                           ...........+++++.++|.+||+.||.+|||++++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                 0011111223578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=5.2e-45  Score=318.34  Aligned_cols=239  Identities=21%  Similarity=0.264  Sum_probs=196.7

Q ss_pred             eEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEEEcc-
Q psy9858          61 RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFV-  139 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~-  139 (307)
                      +.||+|+||.||++++..+|..||+|++.......  ......+.+|+++++.++||||+++++++......|+||||+ 
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~   78 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA--KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN   78 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh--hHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCC
Confidence            46899999999999999999999999997532111  122355778999999999999999999999999999999999 


Q ss_pred             CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCccccccee
Q psy9858         140 DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVV  219 (307)
Q Consensus       140 ~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  219 (307)
                      +|+|..++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..............|
T Consensus        79 ~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  157 (323)
T cd05595          79 GGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG  157 (323)
T ss_pred             CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccC
Confidence            577877776543 5899999999999999999999999999999999999999999999999998764333333334578


Q ss_pred             eceehhhhhhhccccccccccee---ee----eecCCCCCCCCCCCC------ChhhhccccCHHHHHHHHHhhhcCCCC
Q psy9858         220 TRWYRLIKCLLYCVQFNVKNVQW---CC----FAKDPSSHGNLFPGI------PLNEIFTAAGDDLLAVISSLLCLNPTK  286 (307)
Q Consensus       220 t~~y~aPE~~~~~~~~~~~~Diw---~i----~~~~~~f~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dP~~  286 (307)
                      |+.|+|||.+.+. .++.++|||   ++    ++|..||........      .....+..+++++.++|.+||+.||.+
T Consensus       158 t~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~  236 (323)
T cd05595         158 TPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQ  236 (323)
T ss_pred             CcCcCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence            9999999999887 889999999   33    338889876322111      011233567899999999999999999


Q ss_pred             CC-----CHHHHhcCcccCCCc
Q psy9858         287 RA-----DCTATLKMDYFSLTK  303 (307)
Q Consensus       287 Rp-----t~~~il~hp~f~~~~  303 (307)
                      |+     ++.++++||||.+..
T Consensus       237 R~~~~~~~~~~~l~h~~~~~~~  258 (323)
T cd05595         237 RLGGGPSDAKEVMEHRFFLSIN  258 (323)
T ss_pred             hCCCCCCCHHHHHcCCCcCCCC
Confidence            98     899999999998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.1e-44  Score=319.51  Aligned_cols=244  Identities=18%  Similarity=0.222  Sum_probs=196.7

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ++|++++.||+|+||+||+|.+..+++.||+|++.+....  .......+.+|+.++..++|+||+++++.+.+....|+
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~l   78 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML--EKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYL   78 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHH--HhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEE
Confidence            4799999999999999999999999999999999753211  12224567789999999999999999999999999999


Q ss_pred             EEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC--
Q psy9858         135 VFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT--  211 (307)
Q Consensus       135 v~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--  211 (307)
                      ||||+ +|+|.+++.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......  
T Consensus        79 v~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~  157 (363)
T cd05628          79 IMEFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT  157 (363)
T ss_pred             EEcCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence            99999 678888887654 58999999999999999999999999999999999999999999999999987543210  


Q ss_pred             ---------------------------------cccccceeeceehhhhhhhccccccccccee---ee----eecCCCC
Q psy9858         212 ---------------------------------RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FAKDPSS  251 (307)
Q Consensus       212 ---------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~~~~~f  251 (307)
                                                       ......+||+.|+|||++.+. .++.++|||   ++    ++|..||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~Pf  236 (363)
T cd05628         158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPF  236 (363)
T ss_pred             cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC-CCCCchhhhhhHHHHHHHHhCCCCC
Confidence                                             001234789999999999887 889999999   33    3399999


Q ss_pred             CCCCCCCCC--------hhhhc--cccCHHHHHHHHHhhhcCCC---CCCCHHHHhcCcccCCCc
Q psy9858         252 HGNLFPGIP--------LNEIF--TAAGDDLLAVISSLLCLNPT---KRADCTATLKMDYFSLTK  303 (307)
Q Consensus       252 ~~~~~~~~~--------~~~~~--~~~~~~l~~li~~~l~~dP~---~Rpt~~~il~hp~f~~~~  303 (307)
                      .+.......        ....+  ..+++++.++|.+|+. +|.   .||+++|+++||||++.+
T Consensus       237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~  300 (363)
T cd05628         237 CSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVD  300 (363)
T ss_pred             CCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCC
Confidence            773221100        00011  2468899999999775 444   468999999999998764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-44  Score=319.24  Aligned_cols=236  Identities=22%  Similarity=0.225  Sum_probs=194.2

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEE
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVS  133 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  133 (307)
                      ..+|++++.||+|+||.||+|++..++..||+|+....           ....|+.++++++|+||+++++++......+
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  133 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITC  133 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----------ccHHHHHHHHhCCCCCCcChhheEEeCCeeE
Confidence            34699999999999999999999999999999975421           2346999999999999999999999999999


Q ss_pred             EEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc
Q psy9858         134 LVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL  213 (307)
Q Consensus       134 lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  213 (307)
                      +|||++.++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||+++..... ..
T Consensus       134 lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~  212 (357)
T PHA03209        134 MVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-PA  212 (357)
T ss_pred             EEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC-cc
Confidence            99999999999999877677999999999999999999999999999999999999999999999999999754322 22


Q ss_pred             cccceeeceehhhhhhhccccccccccee---eeee-----cCCCCCCCCCC---------------------------C
Q psy9858         214 YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA-----KDPSSHGNLFP---------------------------G  258 (307)
Q Consensus       214 ~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~-----~~~~f~~~~~~---------------------------~  258 (307)
                      .....||..|+|||.+.+. .++.++|||   ++++     +..+|......                           .
T Consensus       213 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  291 (357)
T PHA03209        213 FLGLAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR  291 (357)
T ss_pred             cccccccccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence            2345789999999999887 789999999   3333     44554431110                           0


Q ss_pred             CChh----------------------hhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         259 IPLN----------------------EIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       259 ~~~~----------------------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                      ....                      ....+++.++.+||.+||+.||++|||++|+|+||||++.
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence            0000                      0001346677889999999999999999999999999863

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-44  Score=319.63  Aligned_cols=243  Identities=20%  Similarity=0.229  Sum_probs=196.1

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ++|.+++.||+|+||+||+|.+..+|+.||||++.+....  .......+.+|+++++.++||||+++++++.+....|+
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~l   78 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMF--KKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYL   78 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHH--HhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEE
Confidence            4799999999999999999999999999999998753211  12224567889999999999999999999999999999


Q ss_pred             EEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC--
Q psy9858         135 VFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT--  211 (307)
Q Consensus       135 v~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--  211 (307)
                      ||||+ +|+|.+++.... .+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++......  
T Consensus        79 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  157 (377)
T cd05629          79 IMEFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS  157 (377)
T ss_pred             EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence            99999 688888887543 58999999999999999999999999999999999999999999999999986331100  


Q ss_pred             ----------c-----------------------------------ccccceeeceehhhhhhhccccccccccee---e
Q psy9858         212 ----------R-----------------------------------LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C  243 (307)
Q Consensus       212 ----------~-----------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~  243 (307)
                                .                                   .....+||+.|+|||++.+. .++.++|||   |
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGv  236 (377)
T cd05629         158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ-GYGQECDWWSLGA  236 (377)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC-CCCCceeeEecch
Confidence                      0                                   00124689999999999887 889999999   3


Q ss_pred             ee----ecCCCCCCCCCCCC--------Chhhhc--cccCHHHHHHHHHhhhcCCCCC---CCHHHHhcCcccCCC
Q psy9858         244 CF----AKDPSSHGNLFPGI--------PLNEIF--TAAGDDLLAVISSLLCLNPTKR---ADCTATLKMDYFSLT  302 (307)
Q Consensus       244 i~----~~~~~f~~~~~~~~--------~~~~~~--~~~~~~l~~li~~~l~~dP~~R---pt~~~il~hp~f~~~  302 (307)
                      ++    +|.+||.+......        .....+  ..++.++.+||.+||. +|.+|   +|+.++++||||++.
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~  311 (377)
T cd05629         237 IMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV  311 (377)
T ss_pred             hhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            33    39999976322110        000111  2468899999999997 77765   599999999999865

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.9e-44  Score=314.48  Aligned_cols=238  Identities=22%  Similarity=0.235  Sum_probs=195.3

Q ss_pred             eEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeeecCeEEEEEEcc
Q psy9858          61 RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGYMSNVSLVFEFV  139 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~  139 (307)
                      +.||+|+||.||+|++..+++.||+|++.+.....  ......+.+|..++..+ +||||+++++++.+.+..|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~--~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~   78 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVND--DEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFV   78 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCC
Confidence            46899999999999999999999999998532211  22245577899999998 7999999999999999999999999


Q ss_pred             -CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcccccce
Q psy9858         140 -DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQV  218 (307)
Q Consensus       140 -~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  218 (307)
                       +|+|.+++... +.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||+++.............
T Consensus        79 ~~g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  157 (329)
T cd05588          79 SGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC  157 (329)
T ss_pred             CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcccccc
Confidence             57887777654 3589999999999999999999999999999999999999999999999999975433333344557


Q ss_pred             eeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCC---------------ChhhhccccCHHHHHHH
Q psy9858         219 VTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGI---------------PLNEIFTAAGDDLLAVI  276 (307)
Q Consensus       219 ~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~---------------~~~~~~~~~~~~l~~li  276 (307)
                      ||+.|+|||.+.+. .++.++|+|   +    +++|..||........               .....+..++.++.++|
T Consensus       158 gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li  236 (329)
T cd05588         158 GTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVL  236 (329)
T ss_pred             CCccccCHHHHcCC-CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            89999999999887 889999999   3    3339999964211110               01122345788999999


Q ss_pred             HHhhhcCCCCCCC------HHHHhcCcccCCC
Q psy9858         277 SSLLCLNPTKRAD------CTATLKMDYFSLT  302 (307)
Q Consensus       277 ~~~l~~dP~~Rpt------~~~il~hp~f~~~  302 (307)
                      .+||+.||.+|+|      ++++++||||...
T Consensus       237 ~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~  268 (329)
T cd05588         237 KGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI  268 (329)
T ss_pred             HHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            9999999999997      7899999999864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0666|consensus

Probab=100.00  E-value=6.1e-46  Score=302.12  Aligned_cols=249  Identities=35%  Similarity=0.563  Sum_probs=203.3

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCCC----cEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceee
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIETD----MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVF  126 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~  126 (307)
                      ......|+.++.||+|+||.||+|....++    +.+|+|.+....   ..++.....-+|+.+++.++|||++.+..++
T Consensus        20 ve~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~k---d~tGiS~SAcREiaL~REl~h~nvi~Lv~Vf   96 (438)
T KOG0666|consen   20 VEDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEK---DGTGISMSACREIALLRELKHPNVISLVKVF   96 (438)
T ss_pred             HHHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccC---CCCCcCHHHHHHHHHHHHhcCCcchhHHHHH
Confidence            346678999999999999999999644332    379999997532   2445556678999999999999999999998


Q ss_pred             ee-cCeEEEEEEccCCChHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecC----CcEE
Q psy9858         127 GY-MSNVSLVFEFVDTDLEVIIKDP----TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ----GVLK  197 (307)
Q Consensus       127 ~~-~~~~~lv~e~~~g~l~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~----~~~k  197 (307)
                      .. +..+++++||.+.+|...++-.    ...++...++.++.||+.|+.|||++-|+||||||.||++..+    |.||
T Consensus        97 l~~d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VK  176 (438)
T KOG0666|consen   97 LSHDKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVK  176 (438)
T ss_pred             hccCceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeE
Confidence            76 8899999999999999998632    3458999999999999999999999999999999999999988    8999


Q ss_pred             EEeecCccccCCCCcc---cccceeeceehhhhhhhccccccccccee---eeee----cCCCCCCC-------------
Q psy9858         198 IGDFGLAKFFGSPTRL---YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KDPSSHGN-------------  254 (307)
Q Consensus       198 l~Dfg~a~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~~~~f~~~-------------  254 (307)
                      |+|||+++.+.++-..   ....+.|.+|+|||.+.|...|+++.|||   ||++    .+++|.+.             
T Consensus       177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d  256 (438)
T KOG0666|consen  177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD  256 (438)
T ss_pred             eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence            9999999999765433   23457899999999999999999999999   6655    77777761             


Q ss_pred             ---------------------CCCCCC--hh----hhc------------cccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         255 ---------------------LFPGIP--LN----EIF------------TAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       255 ---------------------~~~~~~--~~----~~~------------~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                                           ..+...  ..    ...            ..-++...+|+.+||+.||.+|+|++|+|+
T Consensus       257 Ql~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle  336 (438)
T KOG0666|consen  257 QLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE  336 (438)
T ss_pred             HHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence                                 001000  00    000            112456889999999999999999999999


Q ss_pred             CcccCCC
Q psy9858         296 MDYFSLT  302 (307)
Q Consensus       296 hp~f~~~  302 (307)
                      |+||...
T Consensus       337 h~yF~~d  343 (438)
T KOG0666|consen  337 HPYFTED  343 (438)
T ss_pred             ccccccC
Confidence            9999865

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=3.7e-44  Score=318.34  Aligned_cols=249  Identities=17%  Similarity=0.200  Sum_probs=203.3

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM  129 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  129 (307)
                      .....++|++.+.||+|+||.||+|++..+++.||+|++.+....  .......+.+|+.+++.++||||+++++++.++
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~  115 (370)
T cd05596          38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI--KRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD  115 (370)
T ss_pred             CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh--hhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            345678999999999999999999999999999999999742211  111234577899999999999999999999999


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                      +..++||||+ +|+|.+++...  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         116 KYLYMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            9999999999 67888887654  37889999999999999999999999999999999999999999999999998764


Q ss_pred             CCCc-ccccceeeceehhhhhhhcc---ccccccccee---e----eeecCCCCCCCCCCCC--------Chhhhc--cc
Q psy9858         209 SPTR-LYTHQVVTRWYRLIKCLLYC---VQFNVKNVQW---C----CFAKDPSSHGNLFPGI--------PLNEIF--TA  267 (307)
Q Consensus       209 ~~~~-~~~~~~~t~~y~aPE~~~~~---~~~~~~~Diw---~----i~~~~~~f~~~~~~~~--------~~~~~~--~~  267 (307)
                      .... ......||+.|+|||.+.+.   ..++.++|||   +    +++|..||.+......        .....+  ..
T Consensus       194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  273 (370)
T cd05596         194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIE  273 (370)
T ss_pred             CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCC
Confidence            3221 23345789999999998754   2478999999   3    3339999987432110        001111  24


Q ss_pred             cCHHHHHHHHHhhhcCCCC--CCCHHHHhcCcccCCC
Q psy9858         268 AGDDLLAVISSLLCLNPTK--RADCTATLKMDYFSLT  302 (307)
Q Consensus       268 ~~~~l~~li~~~l~~dP~~--Rpt~~~il~hp~f~~~  302 (307)
                      ++.++.+||.+||+.+|.+  |+|++++++||||++.
T Consensus       274 ~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~  310 (370)
T cd05596         274 ISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND  310 (370)
T ss_pred             CCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence            7899999999999999988  9999999999999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=4e-44  Score=317.28  Aligned_cols=241  Identities=29%  Similarity=0.416  Sum_probs=196.6

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec---
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM---  129 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---  129 (307)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++.....   .......+.+|+.+++.++||||+++++++...   
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   95 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ---NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL   95 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc---chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCc
Confidence            46899999999999999999999999999999999975321   222245678999999999999999999988644   


Q ss_pred             ---CeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         130 ---SNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       130 ---~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                         ...|+||||+++++.+.+..   .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.
T Consensus        96 ~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~  172 (359)
T cd07876          96 EEFQDVYLVMELMDANLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  172 (359)
T ss_pred             cccceeEEEEeCCCcCHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence               35799999999988887754   378899999999999999999999999999999999999999999999999986


Q ss_pred             cCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCC----------------------
Q psy9858         207 FGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFP----------------------  257 (307)
Q Consensus       207 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~----------------------  257 (307)
                      .... .......+|..|+|||.+.+. .++.++|||   +    +++|..||.+....                      
T Consensus       173 ~~~~-~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (359)
T cd07876         173 ACTN-FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ  250 (359)
T ss_pred             cccC-ccCCCCcccCCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence            5322 233445789999999999887 889999999   3    33399999753210                      


Q ss_pred             --------------CCChhh------------hccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCC
Q psy9858         258 --------------GIPLNE------------IFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSL  301 (307)
Q Consensus       258 --------------~~~~~~------------~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~  301 (307)
                                    .....+            .....++++.+||.+||+.||++|||++|+|+||||..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  320 (359)
T cd07876         251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV  320 (359)
T ss_pred             HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence                          000000            01123577899999999999999999999999999964

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.2e-44  Score=314.58  Aligned_cols=242  Identities=23%  Similarity=0.300  Sum_probs=196.8

Q ss_pred             eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHH---HhcCCCCccccceeeeecCeEE
Q psy9858          57 YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLL---QELHHENVLGLTDVFGYMSNVS  133 (307)
Q Consensus        57 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l---~~l~h~ni~~~~~~~~~~~~~~  133 (307)
                      |++++.||+|+||.||+|.+..+|+.||||++.+.....  ......+.+|.+++   +.++||||+++++++.+.+..|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~   78 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIA--RDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVC   78 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEE
Confidence            688999999999999999999999999999997532111  11234566676655   4667999999999999999999


Q ss_pred             EEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc
Q psy9858         134 LVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR  212 (307)
Q Consensus       134 lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  212 (307)
                      +||||+ +|+|...+...  .+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus        79 lv~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05589          79 FVMEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD  156 (324)
T ss_pred             EEEcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence            999999 56777766543  489999999999999999999999999999999999999999999999999876433333


Q ss_pred             ccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCC------ChhhhccccCHHHHHHHHHh
Q psy9858         213 LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGI------PLNEIFTAAGDDLLAVISSL  279 (307)
Q Consensus       213 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~------~~~~~~~~~~~~l~~li~~~  279 (307)
                      ......|++.|+|||.+.+. .++.++|+|   +    +++|..||.+......      .....+..+++++.++|.+|
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~  235 (324)
T cd05589         157 RTSTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRL  235 (324)
T ss_pred             cccccccCccccCHhHhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence            34456789999999999887 889999999   2    3349999977332110      01122345789999999999


Q ss_pred             hhcCCCCCC-----CHHHHhcCcccCCCc
Q psy9858         280 LCLNPTKRA-----DCTATLKMDYFSLTK  303 (307)
Q Consensus       280 l~~dP~~Rp-----t~~~il~hp~f~~~~  303 (307)
                      |+.||.+||     +++++++||||++..
T Consensus       236 L~~dP~~R~~~~~~~~~~l~~~~~f~~~~  264 (324)
T cd05589         236 LRRNPERRLGSGEKDAEDVKKQPFFRDIN  264 (324)
T ss_pred             hhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence            999999999     799999999998753

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=6.3e-44  Score=306.62  Aligned_cols=239  Identities=34%  Similarity=0.589  Sum_probs=192.8

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc---CCCCccccceeeee----
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL---HHENVLGLTDVFGY----  128 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~ni~~~~~~~~~----  128 (307)
                      +|++++.||+|+||+||+|.+..+|+.||+|.+.......   .....+.+|+++++.+   +||||+++++++..    
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~   77 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED---GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTD   77 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC---CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCC
Confidence            5899999999999999999999999999999987532221   1233456777777665   69999999998754    


Q ss_pred             -cCeEEEEEEccCCChHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         129 -MSNVSLVFEFVDTDLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       129 -~~~~~lv~e~~~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                       ....+++|||+.+++.+++.... ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++..
T Consensus        78 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~  157 (288)
T cd07863          78 RETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARI  157 (288)
T ss_pred             CCceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccc
Confidence             35689999999989988887543 3489999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCC----------------------
Q psy9858         207 FGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFP----------------------  257 (307)
Q Consensus       207 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~----------------------  257 (307)
                      .... .......++..|+|||.+.+. .++.++|||   +    ++.|.+||.+....                      
T Consensus       158 ~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07863         158 YSCQ-MALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV  235 (288)
T ss_pred             ccCc-ccCCCccccccccCchHhhCC-CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence            6432 222344678999999999887 799999999   3    33388887652110                      


Q ss_pred             -----------CCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         258 -----------GIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       258 -----------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                                 ........+.++.++.+++.+||+.||++|||++++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                       001112234578889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.4e-44  Score=308.66  Aligned_cols=241  Identities=37%  Similarity=0.629  Sum_probs=199.7

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEE
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLV  135 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  135 (307)
                      +|++.+.||+|+||.||+|.+..+|+.||+|.+.....   .+.....+.+|+++++.++|+||+++++++.+....+++
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLV   77 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc---cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEE
Confidence            58999999999999999999999999999999975321   222345577899999999999999999999999999999


Q ss_pred             EEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcccc
Q psy9858         136 FEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYT  215 (307)
Q Consensus       136 ~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~  215 (307)
                      +||+++++.+++......+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||+++..........
T Consensus        78 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  157 (284)
T cd07839          78 FEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS  157 (284)
T ss_pred             EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcC
Confidence            99999999998877666799999999999999999999999999999999999999999999999999987654433344


Q ss_pred             cceeeceehhhhhhhccccccccccee---eee----ecCCCC-CCCCCC------------------------------
Q psy9858         216 HQVVTRWYRLIKCLLYCVQFNVKNVQW---CCF----AKDPSS-HGNLFP------------------------------  257 (307)
Q Consensus       216 ~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~----~~~~~f-~~~~~~------------------------------  257 (307)
                      ...++..|+|||.+.+...++.++|||   +++    +|..|+ .+....                              
T Consensus       158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07839         158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY  237 (284)
T ss_pred             CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence            456788999999998875689999999   322    366654 321100                              


Q ss_pred             -C----CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         258 -G----IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       258 -~----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                       .    .......+.+++++.++|.+||+.||.+|||++++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence             0    00011223568899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.8e-44  Score=319.78  Aligned_cols=244  Identities=29%  Similarity=0.435  Sum_probs=200.1

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC-----
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS-----  130 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-----  130 (307)
                      +|++.+.||+|+||.||+|.+..+|+.||+|++....   ......+.+.+|+++++.++|+||+++++++....     
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   77 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF---QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFE   77 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc---cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccc
Confidence            4788899999999999999999999999999986432   11222456889999999999999999999998776     


Q ss_pred             eEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         131 NVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       131 ~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      ..|+||||+.++|.+.+.... .+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus        78 ~~~lv~e~~~~~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~  156 (372)
T cd07853          78 EIYVVTELMQSDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD  156 (372)
T ss_pred             eEEEEeeccccCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence            899999999989888876544 5899999999999999999999999999999999999999999999999999865432


Q ss_pred             C-cccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC------------------------
Q psy9858         211 T-RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG------------------------  258 (307)
Q Consensus       211 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~------------------------  258 (307)
                      . .......+++.|+|||.+.+...++.++|||   |    +++|+.||.+.....                        
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  236 (372)
T cd07853         157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA  236 (372)
T ss_pred             ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence            2 2233446789999999998875789999999   3    334999987632100                        


Q ss_pred             -----------CChh---hhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         259 -----------IPLN---EIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       259 -----------~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                                 ....   ......++++.+||.+||+.||++|||++++|+||||++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence                       0000   11234578899999999999999999999999999998854

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=6.4e-44  Score=312.57  Aligned_cols=243  Identities=23%  Similarity=0.340  Sum_probs=201.0

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|++++.||+|+||.||++++..+|..||+|++....    .......+.+|+++++.++||||+++++++...+..
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (331)
T cd06649           3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI   78 (331)
T ss_pred             CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc----CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence            3578999999999999999999999999999999987531    223356788999999999999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH-WILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      ++||||+ +|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  157 (331)
T cd06649          79 SICMEHMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (331)
T ss_pred             EEEeecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence            9999999 578888876544 589999999999999999999986 6999999999999999999999999999866332


Q ss_pred             Ccccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCC------------------------
Q psy9858         211 TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGI------------------------  259 (307)
Q Consensus       211 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~------------------------  259 (307)
                        ......++..|+|||.+.+. .++.++|||   +    +++|+.||........                        
T Consensus       158 --~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (331)
T cd06649         158 --MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR  234 (331)
T ss_pred             --ccccCCCCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence              23345789999999999887 799999999   3    3349999864110000                        


Q ss_pred             -----------------------------Chhhh-ccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         260 -----------------------------PLNEI-FTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       260 -----------------------------~~~~~-~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                                                   ..... ...+++++.+||.+||+.||++|||++++++||||+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  308 (331)
T cd06649         235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE  308 (331)
T ss_pred             cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence                                         00000 113578899999999999999999999999999998654

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=8.2e-44  Score=311.50  Aligned_cols=238  Identities=22%  Similarity=0.246  Sum_probs=194.5

Q ss_pred             eEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeeecCeEEEEEEcc
Q psy9858          61 RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGYMSNVSLVFEFV  139 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~  139 (307)
                      +.||+|+||.||+|++..+++.||+|++.+.....  ......+.+|+.++.++ +||||+++++++...+..++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~   78 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVND--DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV   78 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcc--hhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCC
Confidence            46999999999999999999999999998643222  22245577899888877 7999999999999999999999999


Q ss_pred             -CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcccccce
Q psy9858         140 -DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQV  218 (307)
Q Consensus       140 -~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  218 (307)
                       +|+|..++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.............
T Consensus        79 ~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~  157 (329)
T cd05618          79 NGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC  157 (329)
T ss_pred             CCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccccc
Confidence             577877765543 589999999999999999999999999999999999999999999999999976433333334557


Q ss_pred             eeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCC---------------CChhhhccccCHHHHHHH
Q psy9858         219 VTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPG---------------IPLNEIFTAAGDDLLAVI  276 (307)
Q Consensus       219 ~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~---------------~~~~~~~~~~~~~l~~li  276 (307)
                      ||..|+|||.+.+. .++.++|+|       .+++|..||.......               ......+..++.++.++|
T Consensus       158 gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll  236 (329)
T cd05618         158 GTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVL  236 (329)
T ss_pred             CCccccCHHHHcCC-CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence            89999999999887 889999999       2334999985311110               001123446788999999


Q ss_pred             HHhhhcCCCCCCC------HHHHhcCcccCCC
Q psy9858         277 SSLLCLNPTKRAD------CTATLKMDYFSLT  302 (307)
Q Consensus       277 ~~~l~~dP~~Rpt------~~~il~hp~f~~~  302 (307)
                      .+||+.||++|||      ++++++||||++.
T Consensus       237 ~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~  268 (329)
T cd05618         237 KSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  268 (329)
T ss_pred             HHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            9999999999998      5899999999875

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0574|consensus

Probab=100.00  E-value=1.6e-46  Score=304.70  Aligned_cols=243  Identities=21%  Similarity=0.317  Sum_probs=211.9

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEE
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVS  133 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  133 (307)
                      ..-|.++++||+|+||.||+|.|+++|+.+|||.+...    ..   .+++..|+.|+++|+.|++|++|+.+.....++
T Consensus        32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sD---LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLW  104 (502)
T KOG0574|consen   32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TD---LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLW  104 (502)
T ss_pred             HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----ch---HHHHHHHHHHHHHcCCchhhhhhhhhccCCceE
Confidence            34588999999999999999999999999999998742    11   567889999999999999999999999999999


Q ss_pred             EEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc
Q psy9858         134 LVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR  212 (307)
Q Consensus       134 lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  212 (307)
                      +||||| .|+..+.++.+++.+++.++..+++..+.||+|||...-+|||||..|||++.+|..||+|||.|..+.+.-.
T Consensus       105 IVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA  184 (502)
T KOG0574|consen  105 IVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA  184 (502)
T ss_pred             eehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence            999999 5999999999988999999999999999999999999999999999999999999999999999998876555


Q ss_pred             ccccceeeceehhhhhhhccccccccccee--eeee-----cCCCCCCC-------CCCCC--ChhhhccccCHHHHHHH
Q psy9858         213 LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW--CCFA-----KDPSSHGN-------LFPGI--PLNEIFTAAGDDLLAVI  276 (307)
Q Consensus       213 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw--~i~~-----~~~~f~~~-------~~~~~--~~~~~~~~~~~~l~~li  276 (307)
                      ..++..||+-|||||++..- .|+.++|||  +|-+     |++||...       .++..  +...-+..-|+++.++|
T Consensus       185 KRNTVIGTPFWMAPEVI~EI-GY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi  263 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEI-GYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFI  263 (502)
T ss_pred             hhCccccCcccccHHHHHHh-ccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHH
Confidence            56778999999999999988 899999999  4333     99999871       01111  11111234588999999


Q ss_pred             HHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         277 SSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       277 ~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                      ++||-++|++|-|+.++++|||+++++-
T Consensus       264 ~~CLiK~PE~R~TA~~L~~H~FiknA~g  291 (502)
T KOG0574|consen  264 RSCLIKKPEERKTALRLCEHTFIKNAPG  291 (502)
T ss_pred             HHHhcCCHHHHHHHHHHhhhhhhcCCCc
Confidence            9999999999999999999999998763

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.3e-43  Score=314.20  Aligned_cols=244  Identities=18%  Similarity=0.228  Sum_probs=198.0

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ++|++++.||+|+||+||+|.+..+++.||+|++.....  ........+.+|+.++..++|+||+++++.+.+.+..++
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l   78 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADM--LEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYL   78 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHH--hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            468999999999999999999999999999999974321  112234567889999999999999999999999999999


Q ss_pred             EEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC--
Q psy9858         135 VFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT--  211 (307)
Q Consensus       135 v~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--  211 (307)
                      ||||+ +|+|.+++.+.. .+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++.......  
T Consensus        79 v~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~  157 (360)
T cd05627          79 IMEFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT  157 (360)
T ss_pred             EEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence            99999 678888887654 58999999999999999999999999999999999999999999999999987542110  


Q ss_pred             ---------------------------------cccccceeeceehhhhhhhccccccccccee---eeee----cCCCC
Q psy9858         212 ---------------------------------RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KDPSS  251 (307)
Q Consensus       212 ---------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~~~~f  251 (307)
                                                       ......+||+.|+|||++.+. .++.++|||   |+++    |..||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyel~tG~~Pf  236 (360)
T cd05627         158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPF  236 (360)
T ss_pred             ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC-CCCCcceeccccceeeecccCCCCC
Confidence                                             001234689999999999887 899999999   4433    89998


Q ss_pred             CCCCCCCC--------Chhhhc--cccCHHHHHHHHHhhhcCCCCCC---CHHHHhcCcccCCCc
Q psy9858         252 HGNLFPGI--------PLNEIF--TAAGDDLLAVISSLLCLNPTKRA---DCTATLKMDYFSLTK  303 (307)
Q Consensus       252 ~~~~~~~~--------~~~~~~--~~~~~~l~~li~~~l~~dP~~Rp---t~~~il~hp~f~~~~  303 (307)
                      .+......        .....+  ..+++++.+||.+|+. ||.+|+   +++++++||||++.+
T Consensus       237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~  300 (360)
T cd05627         237 CSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVD  300 (360)
T ss_pred             CCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCC
Confidence            76322110        000111  2368899999999874 999998   489999999998753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.4e-44  Score=313.82  Aligned_cols=239  Identities=24%  Similarity=0.267  Sum_probs=195.3

Q ss_pred             eEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeeecCeEEEEEEcc
Q psy9858          61 RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGYMSNVSLVFEFV  139 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~  139 (307)
                      +.||+|+||+||+|++..+++.||+|++.+....  .......+.+|..++..+ +||||+++++++...+..|+||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~   78 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL--QDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFV   78 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHh--hccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCC
Confidence            4689999999999999999999999998753211  112245567888888876 6999999999999999999999999


Q ss_pred             -CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcccccce
Q psy9858         140 -DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQV  218 (307)
Q Consensus       140 -~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  218 (307)
                       +|+|.+++.... .+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||+++.............
T Consensus        79 ~~g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~  157 (320)
T cd05590          79 NGGDLMFHIQKSR-RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC  157 (320)
T ss_pred             CCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccc
Confidence             578887776543 589999999999999999999999999999999999999999999999999886533333344557


Q ss_pred             eeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCC------ChhhhccccCHHHHHHHHHhhhcCCC
Q psy9858         219 VTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGI------PLNEIFTAAGDDLLAVISSLLCLNPT  285 (307)
Q Consensus       219 ~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dP~  285 (307)
                      ||+.|+|||.+.+. .++.++|||   +    +++|..||.+......      .....+..++.++.++|.+||+.||+
T Consensus       158 gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~  236 (320)
T cd05590         158 GTPDYIAPEILQEM-LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPT  236 (320)
T ss_pred             cCccccCHHHHcCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHH
Confidence            89999999999877 889999999   3    3339999877332110      00112345789999999999999999


Q ss_pred             CCCCH------HHHhcCcccCCCc
Q psy9858         286 KRADC------TATLKMDYFSLTK  303 (307)
Q Consensus       286 ~Rpt~------~~il~hp~f~~~~  303 (307)
                      +||++      +++++||||+...
T Consensus       237 ~R~~~~~~~~~~~~~~h~~f~~~~  260 (320)
T cd05590         237 MRLGSLTLGGEEAILRHPFFKELD  260 (320)
T ss_pred             HCCCCCCCCCHHHHHcCCCcCCCC
Confidence            99998      9999999998753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0589|consensus

Probab=100.00  E-value=2.3e-45  Score=318.00  Aligned_cols=243  Identities=28%  Similarity=0.478  Sum_probs=215.6

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe-E
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN-V  132 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~-~  132 (307)
                      .++|..++.+|+|+||.+++++++.+++.||+|.+.........   .....+|+.++++++|||||.+.+.|..++. +
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~---r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l   79 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE---RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLL   79 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh---hHHHHHHHHHHHhccCCCeeeeccchhcCCceE
Confidence            46899999999999999999999999999999999875544332   3467899999999999999999999998888 9


Q ss_pred             EEEEEcc-CCChHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      +|||+|+ +|++.+.+.+.. ..++++.+..++.||+.||.|||++.|+|||||+.|||+++++.|+|.|||+|+..++.
T Consensus        80 ~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   80 CIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             EEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999 688998887665 56899999999999999999999999999999999999999999999999999999877


Q ss_pred             Ccccccceeeceehhhhhhhccccccccccee---eeee----cCCCCCCCCCCCC-------ChhhhccccCHHHHHHH
Q psy9858         211 TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KDPSSHGNLFPGI-------PLNEIFTAAGDDLLAVI  276 (307)
Q Consensus       211 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~~~~f~~~~~~~~-------~~~~~~~~~~~~l~~li  276 (307)
                      .....+.+||+.||.||++.+. .|+.++|||   |+++    -++.|...+....       ....++..++.++..+|
T Consensus       160 ~~~a~tvvGTp~YmcPEil~d~-pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv  238 (426)
T KOG0589|consen  160 DSLASTVVGTPYYMCPEILSDI-PYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLV  238 (426)
T ss_pred             hhhhheecCCCcccCHHHhCCC-CCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHH
Confidence            6677888999999999999999 999999999   7777    8888888444332       23445567899999999


Q ss_pred             HHhhhcCCCCCCCHHHHhcCcccC
Q psy9858         277 SSLLCLNPTKRADCTATLKMDYFS  300 (307)
Q Consensus       277 ~~~l~~dP~~Rpt~~~il~hp~f~  300 (307)
                      ..||+.+|+.||++.++|.+|.+.
T Consensus       239 ~~~l~~~P~~RPsa~~LL~~P~l~  262 (426)
T KOG0589|consen  239 KSMLRKNPEHRPSALELLRRPHLL  262 (426)
T ss_pred             HHHhhcCCccCCCHHHHhhChhhh
Confidence            999999999999999999998765

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=9.3e-44  Score=311.77  Aligned_cols=245  Identities=18%  Similarity=0.217  Sum_probs=198.7

Q ss_pred             eeeEEeEEeecCceEEEEEEEc---CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeeecCe
Q psy9858          56 VYYQWRSVHVGRFATVFKARDI---ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGYMSN  131 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~  131 (307)
                      +|++++.||+|+||.||++++.   .+++.||+|++.+..... .......+.+|+++++.+ +|+||+++++++..++.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQ-KAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAK   79 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhh-hhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCE
Confidence            4899999999999999999864   478999999997532111 122245577899999999 59999999999999999


Q ss_pred             EEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         132 VSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       132 ~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      .++||||+ +|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        80 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~  158 (332)
T cd05614          80 LHLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE  158 (332)
T ss_pred             EEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence            99999999 678888886544 4899999999999999999999999999999999999999999999999999865332


Q ss_pred             C-cccccceeeceehhhhhhhccccccccccee---ee----eecCCCCCCCCCCCCC----------hhhhccccCHHH
Q psy9858         211 T-RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FAKDPSSHGNLFPGIP----------LNEIFTAAGDDL  272 (307)
Q Consensus       211 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~~~~~f~~~~~~~~~----------~~~~~~~~~~~l  272 (307)
                      . .......||+.|+|||.+.+...++.++|||   ++    ++|..||.........          ....+..+++.+
T Consensus       159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (332)
T cd05614         159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEA  238 (332)
T ss_pred             CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHH
Confidence            2 2223457899999999998765688999999   33    3388888653221110          112234578899


Q ss_pred             HHHHHHhhhcCCCCCC-----CHHHHhcCcccCCC
Q psy9858         273 LAVISSLLCLNPTKRA-----DCTATLKMDYFSLT  302 (307)
Q Consensus       273 ~~li~~~l~~dP~~Rp-----t~~~il~hp~f~~~  302 (307)
                      .+++.+||+.||++||     +++++++||||++.
T Consensus       239 ~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  273 (332)
T cd05614         239 QDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL  273 (332)
T ss_pred             HHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            9999999999999999     88999999999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3e-44  Score=313.76  Aligned_cols=244  Identities=23%  Similarity=0.276  Sum_probs=199.2

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCC-CCccccceeeeecCeEEE
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH-ENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~~~l  134 (307)
                      +|++++.||+|+||.||+|++..+++.||+|++.+....  .......+..|.+++..+.| ++|+++++++.+.+..|+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVII--QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   78 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEE
Confidence            488999999999999999999999999999999753211  11224567789999999976 568889999999999999


Q ss_pred             EEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc
Q psy9858         135 VFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL  213 (307)
Q Consensus       135 v~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  213 (307)
                      ||||+ +|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.........
T Consensus        79 v~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05587          79 VMEYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT  157 (324)
T ss_pred             EEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence            99999 678888776544 5889999999999999999999999999999999999999999999999998754332333


Q ss_pred             cccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCC------ChhhhccccCHHHHHHHHHhh
Q psy9858         214 YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGI------PLNEIFTAAGDDLLAVISSLL  280 (307)
Q Consensus       214 ~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~------~~~~~~~~~~~~l~~li~~~l  280 (307)
                      .....||+.|+|||++.+. .++.++|||   +    +++|..||.+......      .....+..++.++.+++.+||
T Consensus       158 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l  236 (324)
T cd05587         158 TRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLL  236 (324)
T ss_pred             eeeecCCccccChhhhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence            3445789999999999887 789999999   2    3349999976321110      011223467899999999999


Q ss_pred             hcCCCCCCCH-----HHHhcCcccCCCc
Q psy9858         281 CLNPTKRADC-----TATLKMDYFSLTK  303 (307)
Q Consensus       281 ~~dP~~Rpt~-----~~il~hp~f~~~~  303 (307)
                      +.||.+|+++     +++++||||+..+
T Consensus       237 ~~~P~~R~~~~~~~~~~~~~hp~~~~~~  264 (324)
T cd05587         237 TKHPAKRLGCGPTGERDIREHAFFRRID  264 (324)
T ss_pred             hcCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence            9999999986     8999999998753

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=9e-44  Score=315.61  Aligned_cols=249  Identities=18%  Similarity=0.188  Sum_probs=201.2

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM  129 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  129 (307)
                      .....++|++.+.||+|+||.||+|++..+++.||+|++.+.....  ......+.+|+.+++.++||||+++++++.++
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIK--RSDSAFFWEERDIMAFANSPWVVQLFCAFQDD  115 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhh--hhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            3446688999999999999999999999999999999987532111  11234577899999999999999999999999


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                      ...|+||||+ +|+|.+++...  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|....
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         116 KYLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            9999999999 67898888654  37899999999999999999999999999999999999999999999999998764


Q ss_pred             CCCc-ccccceeeceehhhhhhhccc---cccccccee---e----eeecCCCCCCCCCCC--------CChhhhc--cc
Q psy9858         209 SPTR-LYTHQVVTRWYRLIKCLLYCV---QFNVKNVQW---C----CFAKDPSSHGNLFPG--------IPLNEIF--TA  267 (307)
Q Consensus       209 ~~~~-~~~~~~~t~~y~aPE~~~~~~---~~~~~~Diw---~----i~~~~~~f~~~~~~~--------~~~~~~~--~~  267 (307)
                      .... ......||+.|+|||++.+..   .++.++|+|   +    +++|..||.+.....        ......+  ..
T Consensus       194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  273 (370)
T cd05621         194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVE  273 (370)
T ss_pred             cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCccc
Confidence            3222 233557999999999997642   378999999   3    333999997733210        0001111  24


Q ss_pred             cCHHHHHHHHHhhhcCCCC--CCCHHHHhcCcccCCC
Q psy9858         268 AGDDLLAVISSLLCLNPTK--RADCTATLKMDYFSLT  302 (307)
Q Consensus       268 ~~~~l~~li~~~l~~dP~~--Rpt~~~il~hp~f~~~  302 (307)
                      ++..+.+++.+||..++.+  |+|++++++||||+..
T Consensus       274 ~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         274 ISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             CCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence            6889999999999865544  8999999999999864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-43  Score=309.53  Aligned_cols=247  Identities=17%  Similarity=0.194  Sum_probs=199.6

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ++|++++.||+|+||.||++++..+++.||+|++.+...  ......+.+.+|+.++..++|+||+++++++..++..|+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM--LKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYL   78 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEE
Confidence            479999999999999999999999999999999974211  112224557889999999999999999999999999999


Q ss_pred             EEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc
Q psy9858         135 VFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL  213 (307)
Q Consensus       135 v~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  213 (307)
                      ||||+ +|+|.+++.+....+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++.........
T Consensus        79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  158 (331)
T cd05597          79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV  158 (331)
T ss_pred             EEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence            99999 68899988765556899999999999999999999999999999999999999999999999999766433222


Q ss_pred             -cccceeeceehhhhhhhc----cccccccccee---e----eeecCCCCCCCCCC-----------CCChhhhccccCH
Q psy9858         214 -YTHQVVTRWYRLIKCLLY----CVQFNVKNVQW---C----CFAKDPSSHGNLFP-----------GIPLNEIFTAAGD  270 (307)
Q Consensus       214 -~~~~~~t~~y~aPE~~~~----~~~~~~~~Diw---~----i~~~~~~f~~~~~~-----------~~~~~~~~~~~~~  270 (307)
                       .....||+.|+|||++.+    ...++.++|||   +    +++|..||......           ..........+++
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  238 (331)
T cd05597         159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSE  238 (331)
T ss_pred             cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCH
Confidence             223468999999999874    23578899999   3    33499998763211           1111122234789


Q ss_pred             HHHHHHHHhhhcCCCC--CCCHHHHhcCcccCCCc
Q psy9858         271 DLLAVISSLLCLNPTK--RADCTATLKMDYFSLTK  303 (307)
Q Consensus       271 ~l~~li~~~l~~dP~~--Rpt~~~il~hp~f~~~~  303 (307)
                      ++.++|++||..++++  |++++++++||||++.+
T Consensus       239 ~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~  273 (331)
T cd05597         239 EAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGID  273 (331)
T ss_pred             HHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCC
Confidence            9999999998764443  78999999999998753

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.9e-43  Score=305.10  Aligned_cols=250  Identities=56%  Similarity=0.892  Sum_probs=207.4

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEE
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLV  135 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  135 (307)
                      +|.+.+.||+|++|.||+|.+..+|+.||+|.+...............+.+|+++++.++|+||+++++++.++...++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            58899999999999999999988999999999986543322333456677899999999999999999999999999999


Q ss_pred             EEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcccc
Q psy9858         136 FEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYT  215 (307)
Q Consensus       136 ~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~  215 (307)
                      |||++|+|.+++......+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++...........
T Consensus        81 ~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~  160 (298)
T cd07841          81 FEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMT  160 (298)
T ss_pred             EcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcccc
Confidence            99998899999877654689999999999999999999999999999999999999999999999999988755433344


Q ss_pred             cceeeceehhhhhhhccccccccccee---ee----eecCCCCCCCCC--------------------------------
Q psy9858         216 HQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FAKDPSSHGNLF--------------------------------  256 (307)
Q Consensus       216 ~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~~~~~f~~~~~--------------------------------  256 (307)
                      ...++..|+|||.+.+...++.++|+|   ++    +.|.++|.+...                                
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T cd07841         161 HQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFK  240 (298)
T ss_pred             ccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccccccc
Confidence            446688999999987665789999999   33    337776654211                                


Q ss_pred             --CCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCccc
Q psy9858         257 --PGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKEM  305 (307)
Q Consensus       257 --~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~~  305 (307)
                        ............+.++.++|.+||+.||.+|||++++++||||++..+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~  291 (298)
T cd07841         241 PFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAP  291 (298)
T ss_pred             ccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCC
Confidence              0011112234567889999999999999999999999999999997754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4.3e-44  Score=312.38  Aligned_cols=238  Identities=22%  Similarity=0.244  Sum_probs=194.6

Q ss_pred             eEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeeecCeEEEEEEcc
Q psy9858          61 RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGYMSNVSLVFEFV  139 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~  139 (307)
                      +.||+|+||.||+|++..+++.||+|++.+....  .......+..|.+++..+ +||||+++++++.+.+..|+||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~   78 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL--QDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYV   78 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhh--hhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCC
Confidence            4689999999999999999999999999753211  112234567888988876 7999999999999999999999999


Q ss_pred             -CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcccccce
Q psy9858         140 -DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQV  218 (307)
Q Consensus       140 -~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  218 (307)
                       +|+|...+.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..............
T Consensus        79 ~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  157 (321)
T cd05591          79 NGGDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC  157 (321)
T ss_pred             CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccc
Confidence             578877776543 588999999999999999999999999999999999999999999999999986543333444557


Q ss_pred             eeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCCCC------hhhhccccCHHHHHHHHHhhhcCCC
Q psy9858         219 VTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPGIP------LNEIFTAAGDDLLAVISSLLCLNPT  285 (307)
Q Consensus       219 ~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dP~  285 (307)
                      ||..|+|||.+.+. .++.++|||       .+++|..||.........      ....+..++.++.++|.+||+.||+
T Consensus       158 gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~  236 (321)
T cd05591         158 GTPDYIAPEILQEL-EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPN  236 (321)
T ss_pred             cCccccCHHHHcCC-CCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHH
Confidence            89999999999877 889999999       233489998763321100      0012234689999999999999999


Q ss_pred             CCC-------CHHHHhcCcccCCC
Q psy9858         286 KRA-------DCTATLKMDYFSLT  302 (307)
Q Consensus       286 ~Rp-------t~~~il~hp~f~~~  302 (307)
                      +|+       +++++++||||.+.
T Consensus       237 ~R~~~~~~~~~~~~~~~hp~~~~~  260 (321)
T cd05591         237 KRLGCVASQGGEDAIKQHPFFKEI  260 (321)
T ss_pred             HcCCCCCCCCCHHHHhcCCccCCC
Confidence            999       99999999999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=4.7e-44  Score=306.32  Aligned_cols=237  Identities=21%  Similarity=0.221  Sum_probs=195.0

Q ss_pred             EeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEEEcc-CC
Q psy9858          63 VHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFV-DT  141 (307)
Q Consensus        63 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~-~g  141 (307)
                      ||+|+||+||++.+..+|+.||+|++.......  ......+..|+++++.++|+||+++.+++......++||||+ +|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g   78 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK--RKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGG   78 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhh--hHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCC
Confidence            689999999999999999999999987532221  112345778999999999999999999999999999999999 57


Q ss_pred             ChHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcccccce
Q psy9858         142 DLEVIIKD---PTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQV  218 (307)
Q Consensus       142 ~l~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  218 (307)
                      +|.+.+..   ....+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..............
T Consensus        79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~  158 (280)
T cd05608          79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA  158 (280)
T ss_pred             CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccC
Confidence            78776642   334589999999999999999999999999999999999999999999999999987654433334457


Q ss_pred             eeceehhhhhhhccccccccccee---ee----eecCCCCCCCCCCCC----------ChhhhccccCHHHHHHHHHhhh
Q psy9858         219 VTRWYRLIKCLLYCVQFNVKNVQW---CC----FAKDPSSHGNLFPGI----------PLNEIFTAAGDDLLAVISSLLC  281 (307)
Q Consensus       219 ~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~~~~~f~~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~  281 (307)
                      +++.|+|||.+.+. .++.++|+|   ++    ++|..||........          .....+..+++.+.+++.+||+
T Consensus       159 g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  237 (280)
T cd05608         159 GTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLA  237 (280)
T ss_pred             CCcCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhc
Confidence            89999999999887 889999999   33    339999876322110          0112234578999999999999


Q ss_pred             cCCCCCC-----CHHHHhcCcccCCC
Q psy9858         282 LNPTKRA-----DCTATLKMDYFSLT  302 (307)
Q Consensus       282 ~dP~~Rp-----t~~~il~hp~f~~~  302 (307)
                      .||++||     |++++++||||++.
T Consensus       238 ~~P~~R~~~~~~~~~~~l~h~~~~~~  263 (280)
T cd05608         238 KDPEKRLGFRDGNCDGLRTHPLFRDL  263 (280)
T ss_pred             CCHHHhcCCCCCCHHHHhcChhhhcC
Confidence            9999999     88999999999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-43  Score=304.74  Aligned_cols=243  Identities=21%  Similarity=0.265  Sum_probs=200.7

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEE
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLV  135 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  135 (307)
                      +|++.+.||+|+||+||++.+..+++.||+|++.......  ......+.+|+++++.++|+||+++++.+...+..++|
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK--RKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV   78 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhh--hhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEE
Confidence            4889999999999999999998899999999997532221  11234567899999999999999999999999999999


Q ss_pred             EEcc-CCChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc
Q psy9858         136 FEFV-DTDLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL  213 (307)
Q Consensus       136 ~e~~-~g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  213 (307)
                      |||+ +|+|.+++... ...+++..+..++.|++.||.|||+.|++|+||||+||++++++.++|+|||++....... .
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~  157 (285)
T cd05605          79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-T  157 (285)
T ss_pred             EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-c
Confidence            9999 57787777543 3358999999999999999999999999999999999999999999999999998764322 2


Q ss_pred             cccceeeceehhhhhhhccccccccccee---eee----ecCCCCCCCCCCCC----------ChhhhccccCHHHHHHH
Q psy9858         214 YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCF----AKDPSSHGNLFPGI----------PLNEIFTAAGDDLLAVI  276 (307)
Q Consensus       214 ~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~----~~~~~f~~~~~~~~----------~~~~~~~~~~~~l~~li  276 (307)
                      .....++..|+|||.+.+. .++.++|+|   +++    .|..||.+......          .....+..+++.+.+|+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~-~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05605         158 IRGRVGTVGYMAPEVVKNE-RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC  236 (285)
T ss_pred             cccccCCCCccCcHHhcCC-CCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence            2345789999999999877 789999999   333    39999987432111          01122345789999999


Q ss_pred             HHhhhcCCCCCC-----CHHHHhcCcccCCC
Q psy9858         277 SSLLCLNPTKRA-----DCTATLKMDYFSLT  302 (307)
Q Consensus       277 ~~~l~~dP~~Rp-----t~~~il~hp~f~~~  302 (307)
                      .+||+.||.+||     +++++++||||...
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05605         237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA  267 (285)
T ss_pred             HHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence            999999999999     89999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0197|consensus

Probab=100.00  E-value=1.7e-44  Score=313.79  Aligned_cols=241  Identities=21%  Similarity=0.263  Sum_probs=200.1

Q ss_pred             CceeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceee
Q psy9858          47 DCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVF  126 (307)
Q Consensus        47 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~  126 (307)
                      ...+......+++++.||+|-||.||+|++.. ...||+|.+...      ....+.|.+|+++|++|+|+|||++++++
T Consensus       198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~------~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~  270 (468)
T KOG0197|consen  198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEG------SMSPEAFLREAQIMKKLRHEKLVKLYGVC  270 (468)
T ss_pred             cCCeeecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEecc------ccChhHHHHHHHHHHhCcccCeEEEEEEE
Confidence            44555666778889999999999999999753 346999999854      22246688999999999999999999999


Q ss_pred             eecCeEEEEEEcc-CCChHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCc
Q psy9858         127 GYMSNVSLVFEFV-DTDLEVIIKD-PTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA  204 (307)
Q Consensus       127 ~~~~~~~lv~e~~-~g~l~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  204 (307)
                      ..+.-+||||||+ .|+|+++++. .+..+...+...++.||++|++||+++++|||||.++|||++++..|||+|||+|
T Consensus       271 ~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLA  350 (468)
T KOG0197|consen  271 TKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLA  350 (468)
T ss_pred             ecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccc
Confidence            9988999999999 7999999997 5566899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCcc-cccceeeceehhhhhhhccccccccccee--eeee------cCCCCCCCC-------CCCCChhhhcccc
Q psy9858         205 KFFGSPTRL-YTHQVVTRWYRLIKCLLYCVQFNVKNVQW--CCFA------KDPSSHGNL-------FPGIPLNEIFTAA  268 (307)
Q Consensus       205 ~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~Diw--~i~~------~~~~f~~~~-------~~~~~~~~~~~~~  268 (307)
                      +...++... ........-|.|||.+..+ .++.++|||  +|+.      |+.|+.+..       ....-.-..+..+
T Consensus       351 r~~~d~~Y~~~~~~kfPIkWtAPEa~~~~-~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~C  429 (468)
T KOG0197|consen  351 RLIGDDEYTASEGGKFPIKWTAPEALNYG-KFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGC  429 (468)
T ss_pred             cccCCCceeecCCCCCCceecCHHHHhhC-CcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCC
Confidence            965444332 2222345689999999998 899999999  3333      888887722       2222233446689


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         269 GDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       269 ~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      |+++.+++..||+.+|++|||++.+..
T Consensus       430 P~~vY~lM~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  430 PDEVYELMKSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             CHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence            999999999999999999999986643

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.1e-43  Score=309.38  Aligned_cols=237  Identities=22%  Similarity=0.271  Sum_probs=194.7

Q ss_pred             eEEeecCceEEEEEEEc---CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEEE
Q psy9858          61 RSVHVGRFATVFKARDI---ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFE  137 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  137 (307)
                      +.||+|+||.||++++.   .+|+.||+|++......   ......+.+|++++++++||||+++++++.+++..|+|||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK---VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILD   78 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh---hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEc
Confidence            67999999999999863   57899999999753211   1123456789999999999999999999999999999999


Q ss_pred             cc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCccccc
Q psy9858         138 FV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTH  216 (307)
Q Consensus       138 ~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  216 (307)
                      |+ +|+|.+.+.+.. .+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++............
T Consensus        79 ~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~  157 (318)
T cd05582          79 FLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS  157 (318)
T ss_pred             CCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceec
Confidence            99 678888886543 5899999999999999999999999999999999999999999999999999876444333445


Q ss_pred             ceeeceehhhhhhhccccccccccee---eeee----cCCCCCCCCCCCC------ChhhhccccCHHHHHHHHHhhhcC
Q psy9858         217 QVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KDPSSHGNLFPGI------PLNEIFTAAGDDLLAVISSLLCLN  283 (307)
Q Consensus       217 ~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~~~~f~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~d  283 (307)
                      ..|+..|+|||.+.+. .++.++|||   ++++    |..||........      .....+..+++++.+||.+||+.|
T Consensus       158 ~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~  236 (318)
T cd05582         158 FCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRN  236 (318)
T ss_pred             ccCChhhcCHHHHcCC-CCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcC
Confidence            5789999999999887 789999999   3333    8888876321110      011223457899999999999999


Q ss_pred             CCCCCC-----HHHHhcCcccCCC
Q psy9858         284 PTKRAD-----CTATLKMDYFSLT  302 (307)
Q Consensus       284 P~~Rpt-----~~~il~hp~f~~~  302 (307)
                      |++|||     ++++++||||+..
T Consensus       237 P~~R~~a~~~~~~~~~~~~~~~~~  260 (318)
T cd05582         237 PANRLGAGPDGVEEIKRHPFFSTI  260 (318)
T ss_pred             HhHcCCCCCCCHHHHhCCCCcCCC
Confidence            999999     7889999999865

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.2e-44  Score=314.23  Aligned_cols=243  Identities=33%  Similarity=0.481  Sum_probs=198.0

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec---
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM---  129 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---  129 (307)
                      ..++|.+++.||+|+||.||+|.+..+++.||||++.....   .......+.+|+++++.++|+||+++++++...   
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ---SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI   89 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh---hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence            45789999999999999999999999999999999875321   111235577899999999999999999987533   


Q ss_pred             ---CeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         130 ---SNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       130 ---~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                         ...++++++++++|.+++...  .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus        90 ~~~~~~~~~~~~~~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~  167 (343)
T cd07878          90 ENFNEVYLVTNLMGADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQ  167 (343)
T ss_pred             cccCcEEEEeecCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCcccee
Confidence               457999999999998877643  489999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCcccccceeeceehhhhhhhccccccccccee---eee----ecCCCCCCCCCC----------------------
Q psy9858         207 FGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCF----AKDPSSHGNLFP----------------------  257 (307)
Q Consensus       207 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~----~~~~~f~~~~~~----------------------  257 (307)
                      ...   ......+|+.|+|||.+.+...++.++|||   +++    +|..||.+....                      
T Consensus       168 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd07878         168 ADD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS  244 (343)
T ss_pred             cCC---CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            633   223457899999999998865789999999   333    388888653210                      


Q ss_pred             ---------------CCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         258 ---------------GIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       258 ---------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                                     ...........++.+.+||.+||+.||.+|||++|+|+||||....
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~  305 (343)
T cd07878         245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH  305 (343)
T ss_pred             hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence                           0001111223566789999999999999999999999999998653

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=9.6e-44  Score=314.46  Aligned_cols=242  Identities=28%  Similarity=0.424  Sum_probs=196.7

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec--
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM--  129 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--  129 (307)
                      ...++|++++.||+|+||.||+|.+..+++.||+|++.....   .......+.+|+.+++.++||||+++++++...  
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   90 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ---NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKS   90 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc---ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccc
Confidence            356799999999999999999999999999999999875321   222245677899999999999999999988543  


Q ss_pred             ----CeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcc
Q psy9858         130 ----SNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK  205 (307)
Q Consensus       130 ----~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  205 (307)
                          ...+++|||+++++.+.+..   .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++
T Consensus        91 ~~~~~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~  167 (355)
T cd07874          91 LEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_pred             ccccceeEEEhhhhcccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence                35799999999888887754   37889999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCcccccceeeceehhhhhhhccccccccccee---ee----eecCCCCCCCCCCC--------------------
Q psy9858         206 FFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FAKDPSSHGNLFPG--------------------  258 (307)
Q Consensus       206 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~~~~~f~~~~~~~--------------------  258 (307)
                      ..... .......+|..|+|||.+.+. .++.++|||   ++    ++|..||.+.....                    
T Consensus       168 ~~~~~-~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (355)
T cd07874         168 TAGTS-FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_pred             cCCCc-cccCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            76432 233445789999999999887 889999999   33    33888887622100                    


Q ss_pred             ----------------CCh------------hhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCC
Q psy9858         259 ----------------IPL------------NEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSL  301 (307)
Q Consensus       259 ----------------~~~------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~  301 (307)
                                      ...            .......+.++.+||.+||+.||++|||++|+|+||||..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~  316 (355)
T cd07874         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV  316 (355)
T ss_pred             cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence                            000            0001123567899999999999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0586|consensus

Probab=100.00  E-value=1.2e-43  Score=312.15  Aligned_cols=249  Identities=23%  Similarity=0.281  Sum_probs=220.5

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM  129 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  129 (307)
                      .......|.+.+.||+|.|++|.+|++..+|..||||++.+.......   ...+.+|+++|..++|||||+++.+.+.+
T Consensus        51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~---~~k~~rev~imk~l~HPnIvkl~~v~~t~  127 (596)
T KOG0586|consen   51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK---RQKLGREVDIMKSLNHPNIVKLFSVIETE  127 (596)
T ss_pred             ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH---HHHHHHHHHHHHhcCCcceeeeeeeeeec
Confidence            445678899999999999999999999999999999999986544332   45588999999999999999999999999


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                      ..+|+||||+ +|.+.+++.+.+ .+.+..++.++.|+++|++|||+++|+|||||++||+++.+..+||+|||++..+.
T Consensus       128 ~~lylV~eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~  206 (596)
T KOG0586|consen  128 ATLYLVMEYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD  206 (596)
T ss_pred             ceeEEEEEeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec
Confidence            9999999999 889999998876 47779999999999999999999999999999999999999999999999999985


Q ss_pred             CCCcccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCCCChhhhc------cccCHHHHHH
Q psy9858         209 SPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPGIPLNEIF------TAAGDDLLAV  275 (307)
Q Consensus       209 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~~~~~~~~------~~~~~~l~~l  275 (307)
                       ......+.+|++.|+|||++.+....++.+|+|       .++.|.+||++........+.+.      --++.++.++
T Consensus       207 -~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~l  285 (596)
T KOG0586|consen  207 -YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDL  285 (596)
T ss_pred             -ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHH
Confidence             445566789999999999999997789999999       34449999999877776655433      3478999999


Q ss_pred             HHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         276 ISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       276 i~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      |+++|..+|.+|++++|+++|.|....-
T Consensus       286 Lrk~lvl~Pskr~~~dqim~~~W~n~~~  313 (596)
T KOG0586|consen  286 LRKFLVLNPSKRGPCDQIMKDRWRNDLL  313 (596)
T ss_pred             HHHhhccCccccCCHHHhhhhcccchhh
Confidence            9999999999999999999999986543

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=9.1e-44  Score=310.61  Aligned_cols=239  Identities=21%  Similarity=0.262  Sum_probs=192.2

Q ss_pred             eEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHH-HHHhcCCCCccccceeeeecCeEEEEEEcc
Q psy9858          61 RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIK-LLQELHHENVLGLTDVFGYMSNVSLVFEFV  139 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  139 (307)
                      +.||+|+||+||+|++..+|+.||+|++.+.....  ......+.+|.. +++.++||||+++++.+...+..++||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~   78 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK--KKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYV   78 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh--hhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCC
Confidence            46999999999999999999999999997532111  111234455554 567799999999999999999999999999


Q ss_pred             -CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcccccce
Q psy9858         140 -DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQV  218 (307)
Q Consensus       140 -~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  218 (307)
                       +|+|..++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..............
T Consensus        79 ~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (323)
T cd05575          79 NGGELFFHLQRER-SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC  157 (323)
T ss_pred             CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccccc
Confidence             577877776543 589999999999999999999999999999999999999999999999999976433333334457


Q ss_pred             eeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCC------ChhhhccccCHHHHHHHHHhhhcCCC
Q psy9858         219 VTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGI------PLNEIFTAAGDDLLAVISSLLCLNPT  285 (307)
Q Consensus       219 ~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dP~  285 (307)
                      ||+.|+|||.+.+. .++.++|||   +    +++|..||........      ........++.++.++|.+||+.||.
T Consensus       158 gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~  236 (323)
T cd05575         158 GTPEYLAPEVLRKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRT  236 (323)
T ss_pred             CChhhcChhhhcCC-CCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHH
Confidence            89999999999887 799999999   2    3338888876322110      01122346789999999999999999


Q ss_pred             CCCCH----HHHhcCcccCCCc
Q psy9858         286 KRADC----TATLKMDYFSLTK  303 (307)
Q Consensus       286 ~Rpt~----~~il~hp~f~~~~  303 (307)
                      +||++    .++++||||....
T Consensus       237 ~R~~~~~~~~~il~~~~~~~~~  258 (323)
T cd05575         237 KRLGAKDDFLEIKNHVFFSSIN  258 (323)
T ss_pred             hCCCCCCCHHHHHcCCCcCCCC
Confidence            99997    6999999997643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1e-43  Score=310.33  Aligned_cols=240  Identities=22%  Similarity=0.274  Sum_probs=195.7

Q ss_pred             EeEEeecCceEEEEEEEc---CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEE
Q psy9858          60 WRSVHVGRFATVFKARDI---ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVF  136 (307)
Q Consensus        60 ~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  136 (307)
                      ++.||+|+||.||++++.   .+++.||+|++....... .......+.+|+++++.++||||+++++++..++..|+||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   79 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVR-NQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLIL   79 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHh-hhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEE
Confidence            368999999999999864   478899999997532111 1122345678999999999999999999999999999999


Q ss_pred             Ecc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcccc
Q psy9858         137 EFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYT  215 (307)
Q Consensus       137 e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~  215 (307)
                      ||+ +|+|.+.+.+.. .+.+..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..........
T Consensus        80 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  158 (323)
T cd05584          80 EYLSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH  158 (323)
T ss_pred             eCCCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccc
Confidence            999 577888776554 578899999999999999999999999999999999999999999999999976533333334


Q ss_pred             cceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCCC------ChhhhccccCHHHHHHHHHhhhc
Q psy9858         216 HQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPGI------PLNEIFTAAGDDLLAVISSLLCL  282 (307)
Q Consensus       216 ~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~  282 (307)
                      ...|++.|+|||.+.+. .++.++|||       .+++|..||........      .....+..+++++.++|.+||+.
T Consensus       159 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  237 (323)
T cd05584         159 TFCGTIEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKR  237 (323)
T ss_pred             ccCCCccccChhhccCC-CCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccc
Confidence            45789999999999887 789999999       34449999877332110      01123456789999999999999


Q ss_pred             CCCCCC-----CHHHHhcCcccCCC
Q psy9858         283 NPTKRA-----DCTATLKMDYFSLT  302 (307)
Q Consensus       283 dP~~Rp-----t~~~il~hp~f~~~  302 (307)
                      ||++||     +++++++||||...
T Consensus       238 ~p~~R~~~~~~~~~~l~~h~~~~~~  262 (323)
T cd05584         238 NPSSRLGAGPGDAAEVQSHPFFRHV  262 (323)
T ss_pred             CHhHcCCCCCCCHHHHhcCCCcCCC
Confidence            999999     89999999999764

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-43  Score=303.62  Aligned_cols=243  Identities=34%  Similarity=0.528  Sum_probs=199.7

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|++.+.||+|++|.||+|.+..+++.||+|.+.......    ....+.+|+++++.++|+||+++++++.+....
T Consensus         3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (291)
T cd07844           3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG----APFTAIREASLLKDLKHANIVTLHDIIHTKKTL   78 (291)
T ss_pred             CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC----CchhHHHHHHHHhhCCCcceeeEEEEEecCCeE
Confidence            3578999999999999999999998899999999987532111    123467899999999999999999999999999


Q ss_pred             EEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc
Q psy9858         133 SLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR  212 (307)
Q Consensus       133 ~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  212 (307)
                      ++||||+.++|.+++......+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++.......
T Consensus        79 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          79 TLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            99999999899998877666789999999999999999999999999999999999999999999999999976543322


Q ss_pred             ccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCC----------------------------
Q psy9858         213 LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFP----------------------------  257 (307)
Q Consensus       213 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~----------------------------  257 (307)
                      ......++..|+|||.+.+...++.++|||       ++++|..||.+....                            
T Consensus       159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (291)
T cd07844         159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF  238 (291)
T ss_pred             cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence            223345688999999988765789999999       344488888653200                            


Q ss_pred             ---------CCChhhhccccC--HHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         258 ---------GIPLNEIFTAAG--DDLLAVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       258 ---------~~~~~~~~~~~~--~~l~~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                               ..........++  .++.+++.+||+.||++|||+.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                     000011112234  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.8e-43  Score=312.47  Aligned_cols=241  Identities=27%  Similarity=0.415  Sum_probs=196.1

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec---
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM---  129 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---  129 (307)
                      ..++|.+.+.||+|+||.||+|.+..+++.||||++.....   .......+.+|+.+++.++||||+++++++...   
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~   98 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ---NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL   98 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc---CchhHHHHHHHHHHHHhcCCCCccccceeecccccc
Confidence            46789999999999999999999999999999999875321   122245678999999999999999999987543   


Q ss_pred             ---CeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         130 ---SNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       130 ---~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                         ...|+||||+++++.+.+...   +++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.
T Consensus        99 ~~~~~~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~  175 (364)
T cd07875          99 EEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  175 (364)
T ss_pred             cccCeEEEEEeCCCCCHHHHHHhc---CCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence               458999999999988877543   78899999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCcccccceeeceehhhhhhhccccccccccee---ee----eecCCCCCCCCCC----------------------
Q psy9858         207 FGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FAKDPSSHGNLFP----------------------  257 (307)
Q Consensus       207 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~~~~~f~~~~~~----------------------  257 (307)
                      .... .......+|..|+|||.+.+. .++.++|||   ++    ++|..||.+....                      
T Consensus       176 ~~~~-~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (364)
T cd07875         176 AGTS-FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  253 (364)
T ss_pred             cCCC-CcccCCcccCCcCCHHHHhCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence            6432 223445789999999999887 899999999   33    3388898752100                      


Q ss_pred             --------------CCChhh------------hccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCC
Q psy9858         258 --------------GIPLNE------------IFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSL  301 (307)
Q Consensus       258 --------------~~~~~~------------~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~  301 (307)
                                    ......            .....+.++.+||.+||+.||.+|||++|+|+||||..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~  323 (364)
T cd07875         254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  323 (364)
T ss_pred             HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence                          000000            01113467899999999999999999999999999964

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=6.2e-44  Score=310.63  Aligned_cols=239  Identities=21%  Similarity=0.235  Sum_probs=193.7

Q ss_pred             eEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeeecCeEEEEEEcc
Q psy9858          61 RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGYMSNVSLVFEFV  139 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~  139 (307)
                      +.||+|+||.||+|++..+|+.||+|++.+.....  +........|..++... +||||+++++++.+.+..|+||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~   78 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLI--DDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--cchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCC
Confidence            46999999999999999999999999997532111  11234466788888764 8999999999999999999999999


Q ss_pred             -CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcccccce
Q psy9858         140 -DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQV  218 (307)
Q Consensus       140 -~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  218 (307)
                       +|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||+++.............
T Consensus        79 ~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05620          79 NGGDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC  157 (316)
T ss_pred             CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccC
Confidence             578888776543 588999999999999999999999999999999999999999999999999875433333344567


Q ss_pred             eeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCC------ChhhhccccCHHHHHHHHHhhhcCCC
Q psy9858         219 VTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGI------PLNEIFTAAGDDLLAVISSLLCLNPT  285 (307)
Q Consensus       219 ~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dP~  285 (307)
                      ||..|+|||.+.+. .++.++|||   +    +++|..||.+......      .....+..++.++.++|.+||+.||+
T Consensus       158 gt~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  236 (316)
T cd05620         158 GTPDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPT  236 (316)
T ss_pred             CCcCccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHH
Confidence            89999999999887 889999999   2    3339999876332110      01122335788999999999999999


Q ss_pred             CCCCH-HHHhcCcccCCCc
Q psy9858         286 KRADC-TATLKMDYFSLTK  303 (307)
Q Consensus       286 ~Rpt~-~~il~hp~f~~~~  303 (307)
                      +||++ +++++||||++..
T Consensus       237 ~R~~~~~~~~~h~~f~~~~  255 (316)
T cd05620         237 RRLGVVGNIRGHPFFKTIN  255 (316)
T ss_pred             HcCCChHHHHcCCCcCCCC
Confidence            99997 5899999998764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-43  Score=310.14  Aligned_cols=238  Identities=21%  Similarity=0.236  Sum_probs=190.6

Q ss_pred             EeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc---CCCCccccceeeeecCeEEEEEEcc
Q psy9858          63 VHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL---HHENVLGLTDVFGYMSNVSLVFEFV  139 (307)
Q Consensus        63 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~ni~~~~~~~~~~~~~~lv~e~~  139 (307)
                      ||+|+||+||+|++..+|+.||+|++.+.....  .........|..++..+   +||||+++++.+......|+||||+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~   78 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVA--KKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYM   78 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhh--hhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCC
Confidence            699999999999999999999999987532111  11123345667777665   6999999999999999999999999


Q ss_pred             -CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcccccce
Q psy9858         140 -DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQV  218 (307)
Q Consensus       140 -~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  218 (307)
                       +|+|.+.+.... .+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++..............
T Consensus        79 ~~g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  157 (330)
T cd05586          79 SGGELFWHLQKEG-RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC  157 (330)
T ss_pred             CCChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence             678888776543 589999999999999999999999999999999999999999999999999976533333344567


Q ss_pred             eeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCCCh------hhhc-cccCHHHHHHHHHhhhcCC
Q psy9858         219 VTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGIPL------NEIF-TAAGDDLLAVISSLLCLNP  284 (307)
Q Consensus       219 ~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~~------~~~~-~~~~~~l~~li~~~l~~dP  284 (307)
                      ||..|+|||.+.+...++.++|||   +    +++|..||.+........      ...+ ..+++++.++|.+||+.||
T Consensus       158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P  237 (330)
T cd05586         158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNP  237 (330)
T ss_pred             CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCH
Confidence            899999999998765689999999   3    333888887633211100      0111 2468999999999999999


Q ss_pred             CCCC----CHHHHhcCcccCCCc
Q psy9858         285 TKRA----DCTATLKMDYFSLTK  303 (307)
Q Consensus       285 ~~Rp----t~~~il~hp~f~~~~  303 (307)
                      .+||    +++++++||||+...
T Consensus       238 ~~R~~~~~~~~~ll~h~~~~~~~  260 (330)
T cd05586         238 QHRLGAHRDAVELKEHPFFADID  260 (330)
T ss_pred             HHCCCCCCCHHHHhcCccccCCC
Confidence            9998    799999999998653

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.9e-43  Score=304.79  Aligned_cols=249  Identities=34%  Similarity=0.589  Sum_probs=203.4

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec-
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM-  129 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-  129 (307)
                      +...++|++.+.||+|+||.||+|.+..+|+.||+|++.....   .......+.+|+.++++++|+||+++++++... 
T Consensus         3 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   79 (309)
T cd07845           3 CRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE---RDGIPISSLREITLLLNLRHPNIVELKEVVVGKH   79 (309)
T ss_pred             cccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC---CCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC
Confidence            3467899999999999999999999999999999999875322   122233466899999999999999999998654 


Q ss_pred             -CeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         130 -SNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       130 -~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                       +..++||||++++|.+++......+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus        80 ~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          80 LDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             CCeEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence             5689999999989988887665678999999999999999999999999999999999999999999999999998775


Q ss_pred             CCCcccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCC-----------------------
Q psy9858         209 SPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPG-----------------------  258 (307)
Q Consensus       209 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~-----------------------  258 (307)
                      ..........++..|+|||.+.+...++.++|+|       .+++|.+||.......                       
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07845         160 LPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL  239 (309)
T ss_pred             CccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence            4433334445688899999998765789999999       2334888886521100                       


Q ss_pred             ----------C---ChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         259 ----------I---PLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       259 ----------~---~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                                .   .........++++.++|.+||+.||++|||+++++.||||++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~  296 (309)
T cd07845         240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK  296 (309)
T ss_pred             cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence                      0   0001112358889999999999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=7.6e-43  Score=299.48  Aligned_cols=242  Identities=33%  Similarity=0.522  Sum_probs=199.8

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ++|++.+.||+|++|.||+|.+..+|+.||+|++.....   .....+.+.+|+++++.++|+|++++++++......++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   77 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED---DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHL   77 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc---CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEE
Confidence            479999999999999999999998999999999875321   12224567899999999999999999999999999999


Q ss_pred             EEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCccc
Q psy9858         135 VFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY  214 (307)
Q Consensus       135 v~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  214 (307)
                      +|||+++++++.+......+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++..........
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  157 (286)
T cd07847          78 VFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY  157 (286)
T ss_pred             EEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccc
Confidence            99999777666665555568999999999999999999999999999999999999999999999999998775443233


Q ss_pred             ccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCC-----------------------------
Q psy9858         215 THQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPG-----------------------------  258 (307)
Q Consensus       215 ~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~-----------------------------  258 (307)
                      ....++..|+|||.+.+...++.++|+|       .+++|.+||.+.....                             
T Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07847         158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL  237 (286)
T ss_pred             cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence            3446788999999988765789999999       2334888887532100                             


Q ss_pred             --------CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         259 --------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       259 --------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                              .........++..+.+|+.+||+.||++|||+.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence                    00111223568889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG4236|consensus

Probab=100.00  E-value=9.8e-44  Score=307.16  Aligned_cols=236  Identities=23%  Similarity=0.276  Sum_probs=204.9

Q ss_pred             eEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEEEccC
Q psy9858          61 RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVD  140 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  140 (307)
                      +.||+|-||+||-|+++.+|+.||||++.+......+   ...+++|++||++++||+||.+--.|+..++.+.|||-+.
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq---esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~  646 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ---ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH  646 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCch---HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc
Confidence            7899999999999999999999999999986655544   3678899999999999999999999999999999999999


Q ss_pred             CChHHHHh-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCC---cEEEEeecCccccCCCCccccc
Q psy9858         141 TDLEVIIK-DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG---VLKIGDFGLAKFFGSPTRLYTH  216 (307)
Q Consensus       141 g~l~~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~a~~~~~~~~~~~~  216 (307)
                      |+.+.++. +..+.+++...+.++.||+.||.|||.++|+|+||||+|||+.+..   ++||||||+|+.++.. ....+
T Consensus       647 GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-sFRrs  725 (888)
T KOG4236|consen  647 GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-SFRRS  725 (888)
T ss_pred             chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh-hhhhh
Confidence            99777665 5566799999999999999999999999999999999999997654   7999999999999654 44566


Q ss_pred             ceeeceehhhhhhhccccccccccee---eeee----cCCCCCCCCCCC-C-------ChhhhccccCHHHHHHHHHhhh
Q psy9858         217 QVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KDPSSHGNLFPG-I-------PLNEIFTAAGDDLLAVISSLLC  281 (307)
Q Consensus       217 ~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~~~~f~~~~~~~-~-------~~~~~~~~~~~~l~~li~~~l~  281 (307)
                      .+||+.|+|||++... .|...-|+|   .|+|    |..||.....-. .       -...-|.+++.++.+||..+|+
T Consensus       726 VVGTPAYLaPEVLrnk-GyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLq  804 (888)
T KOG4236|consen  726 VVGTPAYLAPEVLRNK-GYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQ  804 (888)
T ss_pred             hcCCccccCHHHHhhc-cccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHHHHH
Confidence            7999999999999998 999999999   4555    999997722111 1       1112245789999999999999


Q ss_pred             cCCCCCCCHHHHhcCcccCC
Q psy9858         282 LNPTKRADCTATLKMDYFSL  301 (307)
Q Consensus       282 ~dP~~Rpt~~~il~hp~f~~  301 (307)
                      ..-.+|.|+++.|+|||+++
T Consensus       805 Vkm~kRysvdk~lsh~Wlq~  824 (888)
T KOG4236|consen  805 VKMRKRYSVDKSLSHPWLQD  824 (888)
T ss_pred             HHHHHhcchHhhccchhhhc
Confidence            99999999999999999975

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.4e-43  Score=316.46  Aligned_cols=236  Identities=21%  Similarity=0.213  Sum_probs=193.1

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEE
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVS  133 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  133 (307)
                      ...|.+.+.||+|+||.||+|.+..+++.||||...           ...+.+|++++++++|+||+++++++...+..+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~  236 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTC  236 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence            447999999999999999999999999999999643           123568999999999999999999999999999


Q ss_pred             EEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc-
Q psy9858         134 LVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR-  212 (307)
Q Consensus       134 lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-  212 (307)
                      ++||++.++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++....... 
T Consensus       237 lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~  316 (461)
T PHA03211        237 LVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST  316 (461)
T ss_pred             EEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence            9999999999998877666799999999999999999999999999999999999999999999999999987633211 


Q ss_pred             -ccccceeeceehhhhhhhccccccccccee---eeee----cC-CCCCCCCC------------------------CCC
Q psy9858         213 -LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KD-PSSHGNLF------------------------PGI  259 (307)
Q Consensus       213 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~~-~~f~~~~~------------------------~~~  259 (307)
                       ......||..|+|||++.+. .++.++|||   ++++    |. .+|.....                        ...
T Consensus       317 ~~~~~~~GT~~Y~APE~~~~~-~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~  395 (461)
T PHA03211        317 PFHYGIAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH  395 (461)
T ss_pred             ccccccCCCcCCcCHHHHcCC-CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence             12234689999999999887 789999999   3333    22 33332110                        000


Q ss_pred             Ch---------------------h--hhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCC
Q psy9858         260 PL---------------------N--EIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSL  301 (307)
Q Consensus       260 ~~---------------------~--~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~  301 (307)
                      ..                     .  .....++.++.+||.+||+.||.+|||++|+|+||||+.
T Consensus       396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence            00                     0  000134568999999999999999999999999999975

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.9e-43  Score=308.53  Aligned_cols=244  Identities=22%  Similarity=0.264  Sum_probs=199.4

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeeecCeEEE
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~l  134 (307)
                      +|.+.+.||+|+||.||+|.+..+++.||+|++.+.....  ......+..|..++..+ +|++|+++++++.+.+..++
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ--DDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYF   78 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEE
Confidence            4889999999999999999999999999999998532211  11234466788888877 58999999999999999999


Q ss_pred             EEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc
Q psy9858         135 VFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL  213 (307)
Q Consensus       135 v~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  213 (307)
                      ||||+ +|+|.+.+.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus        79 v~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~  157 (323)
T cd05616          79 VMEYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT  157 (323)
T ss_pred             EEcCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence            99999 678888776543 5899999999999999999999999999999999999999999999999999865433333


Q ss_pred             cccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCC------ChhhhccccCHHHHHHHHHhh
Q psy9858         214 YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGI------PLNEIFTAAGDDLLAVISSLL  280 (307)
Q Consensus       214 ~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~------~~~~~~~~~~~~l~~li~~~l  280 (307)
                      .....||+.|+|||++.+. .++.++|||   +    +++|..||.+......      .....+..++.++.+++.+||
T Consensus       158 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l  236 (323)
T cd05616         158 TKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLM  236 (323)
T ss_pred             cccCCCChhhcCHHHhcCC-CCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHc
Confidence            3455789999999999887 899999999   3    3339999977322110      011223468899999999999


Q ss_pred             hcCCCCCCCH-----HHHhcCcccCCCc
Q psy9858         281 CLNPTKRADC-----TATLKMDYFSLTK  303 (307)
Q Consensus       281 ~~dP~~Rpt~-----~~il~hp~f~~~~  303 (307)
                      +.||.+|+++     +++++||||+..+
T Consensus       237 ~~~p~~R~~~~~~~~~~i~~h~~~~~~~  264 (323)
T cd05616         237 TKHPGKRLGCGPEGERDIKEHAFFRYID  264 (323)
T ss_pred             ccCHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence            9999999984     8999999998654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=8.5e-43  Score=305.58  Aligned_cols=247  Identities=16%  Similarity=0.194  Sum_probs=199.9

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ++|++.+.||+|+||.||++++..+++.||+|++.+...  ........+.+|+.++..++|+||+++++++.+....++
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM--LKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYL   78 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHH--HHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEE
Confidence            479999999999999999999999999999999864211  112223457789999999999999999999999999999


Q ss_pred             EEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc-
Q psy9858         135 VFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR-  212 (307)
Q Consensus       135 v~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-  212 (307)
                      ||||+ +|+|.+++.+....+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++........ 
T Consensus        79 v~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~  158 (332)
T cd05623          79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV  158 (332)
T ss_pred             EEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence            99999 6889999987555689999999999999999999999999999999999999999999999999976533222 


Q ss_pred             ccccceeeceehhhhhhhc----cccccccccee-------eeeecCCCCCCCCCC-----------CCChhhhccccCH
Q psy9858         213 LYTHQVVTRWYRLIKCLLY----CVQFNVKNVQW-------CCFAKDPSSHGNLFP-----------GIPLNEIFTAAGD  270 (307)
Q Consensus       213 ~~~~~~~t~~y~aPE~~~~----~~~~~~~~Diw-------~i~~~~~~f~~~~~~-----------~~~~~~~~~~~~~  270 (307)
                      ......||+.|+|||++.+    ...++.++|||       .+++|..||......           ..........+++
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~  238 (332)
T cd05623         159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSE  238 (332)
T ss_pred             eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCH
Confidence            2233578999999999863    33688999999       244499999773210           1111122245789


Q ss_pred             HHHHHHHHhhhcCCCC--CCCHHHHhcCcccCCCc
Q psy9858         271 DLLAVISSLLCLNPTK--RADCTATLKMDYFSLTK  303 (307)
Q Consensus       271 ~l~~li~~~l~~dP~~--Rpt~~~il~hp~f~~~~  303 (307)
                      ++.+|+.+||..++.+  |++++++++||||.+..
T Consensus       239 ~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~  273 (332)
T cd05623         239 DAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID  273 (332)
T ss_pred             HHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence            9999999999765544  78999999999998753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.4e-43  Score=308.43  Aligned_cols=238  Identities=23%  Similarity=0.267  Sum_probs=192.6

Q ss_pred             eEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeeecCeEEEEEEcc
Q psy9858          61 RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGYMSNVSLVFEFV  139 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~  139 (307)
                      +.||+|+||.||+|++..+++.||+|++.......  ......+..|..++..+ +||||+++++++......++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~   78 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLE--DDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--hhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence            46999999999999999999999999997532111  11233455677777654 8999999999999999999999999


Q ss_pred             -CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcccccce
Q psy9858         140 -DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQV  218 (307)
Q Consensus       140 -~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  218 (307)
                       +|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.............
T Consensus        79 ~gg~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~  157 (316)
T cd05592          79 NGGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC  157 (316)
T ss_pred             CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccccc
Confidence             678887776543 589999999999999999999999999999999999999999999999999986543333444557


Q ss_pred             eeceehhhhhhhccccccccccee---ee----eecCCCCCCCCCCCC------ChhhhccccCHHHHHHHHHhhhcCCC
Q psy9858         219 VTRWYRLIKCLLYCVQFNVKNVQW---CC----FAKDPSSHGNLFPGI------PLNEIFTAAGDDLLAVISSLLCLNPT  285 (307)
Q Consensus       219 ~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~~~~~f~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dP~  285 (307)
                      ||+.|+|||.+.+. .++.++|||   ++    ++|..||.+......      .....+..++.++.+|+.+||+.||.
T Consensus       158 gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~  236 (316)
T cd05592         158 GTPDYIAPEILKGQ-KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPT  236 (316)
T ss_pred             CCccccCHHHHcCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHH
Confidence            89999999999887 789999999   33    339999876332110      11122345788999999999999999


Q ss_pred             CCCCH-HHHhcCcccCCC
Q psy9858         286 KRADC-TATLKMDYFSLT  302 (307)
Q Consensus       286 ~Rpt~-~~il~hp~f~~~  302 (307)
                      +||++ +++++||||...
T Consensus       237 ~R~~~~~~l~~h~~~~~~  254 (316)
T cd05592         237 KRLGVDGDIRQHPFFRGI  254 (316)
T ss_pred             HcCCChHHHHcCcccCCC
Confidence            99986 588899999875

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0669|consensus

Probab=100.00  E-value=9.1e-46  Score=293.22  Aligned_cols=252  Identities=37%  Similarity=0.605  Sum_probs=211.4

Q ss_pred             ceeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeee
Q psy9858          48 CEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG  127 (307)
Q Consensus        48 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~  127 (307)
                      +......+.|+.+.+||+|.||.||+|+...+|+.||+|++-.   +..++++.....+|+++|..++|+|++.+++.|.
T Consensus        10 ~P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlm---eneKeGfpitalreikiL~~lkHenv~nliEic~   86 (376)
T KOG0669|consen   10 EPFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLM---ENEKEGFPITALREIKILQLLKHENVVNLIEICR   86 (376)
T ss_pred             CCceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHH---hccccCCcHHHHHHHHHHHHhcchhHHHHHHHHh
Confidence            3455667889999999999999999999999999999987654   3456666777889999999999999999999884


Q ss_pred             --------ecCeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEE
Q psy9858         128 --------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIG  199 (307)
Q Consensus       128 --------~~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~  199 (307)
                              +...+|+|+++|+.+|.-++......++..++..++.+++.||.|+|+..|+|||+|+.|+||+.+|.+||+
T Consensus        87 tk~Tp~~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklA  166 (376)
T KOG0669|consen   87 TKATPTNRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLA  166 (376)
T ss_pred             hccCCcccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEee
Confidence                    234599999999999999999887789999999999999999999999999999999999999999999999


Q ss_pred             eecCccccCCC----Ccccccceeeceehhhhhhhccccccccccee---eeee----cCCCCCC---------------
Q psy9858         200 DFGLAKFFGSP----TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KDPSSHG---------------  253 (307)
Q Consensus       200 Dfg~a~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~~~~f~~---------------  253 (307)
                      |||+++.+...    ....+.++.|.+|++||.+.|...|+++.|+|   ||++    +.+.+.+               
T Consensus       167 DFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG  246 (376)
T KOG0669|consen  167 DFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG  246 (376)
T ss_pred             ccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence            99999877433    23356778999999999999999999999999   6666    7888877               


Q ss_pred             ----CCCCCC-----------------Chhhhcc-----ccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         254 ----NLFPGI-----------------PLNEIFT-----AAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       254 ----~~~~~~-----------------~~~~~~~-----~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                          ..++..                 ..+.+..     .-.++..+|+.++|..||.+|+++.++|+|.||++-
T Consensus       247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd  321 (376)
T KOG0669|consen  247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD  321 (376)
T ss_pred             cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence                111111                 1111100     113578899999999999999999999999999764

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=5.4e-43  Score=306.16  Aligned_cols=239  Identities=22%  Similarity=0.233  Sum_probs=196.0

Q ss_pred             eEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeeecCeEEEEEEcc
Q psy9858          61 RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGYMSNVSLVFEFV  139 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~  139 (307)
                      +.||+|+||+||+|++..+++.||+|++.+.....  ......+.+|..++.++ +||||+++++++...+..++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHD--DEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYV   78 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCC
Confidence            46999999999999999999999999998642221  22245677899999888 6999999999999999999999999


Q ss_pred             -CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcccccce
Q psy9858         140 -DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQV  218 (307)
Q Consensus       140 -~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  218 (307)
                       +|+|..++.... .+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++..............
T Consensus        79 ~~~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (327)
T cd05617          79 NGGDLMFHMQRQR-KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC  157 (327)
T ss_pred             CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceeccc
Confidence             678877776543 589999999999999999999999999999999999999999999999999976433333344567


Q ss_pred             eeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCC--C-----------hhhhccccCHHHHHHHHH
Q psy9858         219 VTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGI--P-----------LNEIFTAAGDDLLAVISS  278 (307)
Q Consensus       219 ~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~--~-----------~~~~~~~~~~~l~~li~~  278 (307)
                      ||+.|+|||.+.+. .++.++|||   +    +++|..||........  .           ....+..++..+.+++.+
T Consensus       158 gt~~y~aPE~~~~~-~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~  236 (327)
T cd05617         158 GTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKG  236 (327)
T ss_pred             CCcccCCHHHHCCC-CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            89999999999887 889999999   2    3349999964221110  0           112334578899999999


Q ss_pred             hhhcCCCCCCC------HHHHhcCcccCCCc
Q psy9858         279 LLCLNPTKRAD------CTATLKMDYFSLTK  303 (307)
Q Consensus       279 ~l~~dP~~Rpt------~~~il~hp~f~~~~  303 (307)
                      ||+.||.+|++      ++++++||||+..+
T Consensus       237 ~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~  267 (327)
T cd05617         237 FLNKDPKERLGCQPQTGFSDIKSHTFFRSID  267 (327)
T ss_pred             HhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence            99999999998      57999999998764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.3e-43  Score=308.95  Aligned_cols=239  Identities=24%  Similarity=0.294  Sum_probs=195.2

Q ss_pred             eEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeeecCeEEEEEEcc
Q psy9858          61 RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGYMSNVSLVFEFV  139 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~  139 (307)
                      +.||+|+||+||+|.+..+++.||+|++.+.....  ......+.+|.++++.+ +||||+++++++.+.+..++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   78 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQ--DDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYV   78 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh--hhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence            46999999999999999999999999998532111  12234567888999888 6999999999999999999999999


Q ss_pred             -CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcccccce
Q psy9858         140 -DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQV  218 (307)
Q Consensus       140 -~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  218 (307)
                       +|+|.+.+.+.. .+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||+++.............
T Consensus        79 ~~~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (318)
T cd05570          79 NGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC  157 (318)
T ss_pred             CCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccccee
Confidence             577877776553 589999999999999999999999999999999999999999999999999975433333334457


Q ss_pred             eeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCC------ChhhhccccCHHHHHHHHHhhhcCCC
Q psy9858         219 VTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGI------PLNEIFTAAGDDLLAVISSLLCLNPT  285 (307)
Q Consensus       219 ~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dP~  285 (307)
                      ++..|+|||.+.+. .++.++|+|   +    +++|..||.+......      .....+..+++++.+||.+||+.||.
T Consensus       158 g~~~y~aPE~~~~~-~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~  236 (318)
T cd05570         158 GTPDYIAPEILSYQ-PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPE  236 (318)
T ss_pred             cCccccCHHHhcCC-CCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHH
Confidence            89999999999887 889999999   2    3338999876321110      01112345789999999999999999


Q ss_pred             CCCCH-----HHHhcCcccCCCc
Q psy9858         286 KRADC-----TATLKMDYFSLTK  303 (307)
Q Consensus       286 ~Rpt~-----~~il~hp~f~~~~  303 (307)
                      +|||+     .++++||||+..+
T Consensus       237 ~R~s~~~~~~~~ll~~~~~~~~~  259 (318)
T cd05570         237 KRLGCLPTGEQDIKGHPFFREID  259 (318)
T ss_pred             HcCCCCCCCHHHHhcCCCcCCCC
Confidence            99999     9999999998753

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4.3e-43  Score=307.44  Aligned_cols=243  Identities=22%  Similarity=0.351  Sum_probs=199.3

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|++.+.||+|+||.||+|.+..++..+|+|++....    .......+.+|+++++.++|+||+++++++.+.+..
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI   78 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc----CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEE
Confidence            3478999999999999999999999999999999987532    222345688999999999999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH-WILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      ++||||+ +|+|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~  157 (333)
T cd06650          79 SICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (333)
T ss_pred             EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence            9999999 678888887543 588999999999999999999985 7999999999999999999999999999765322


Q ss_pred             Ccccccceeeceehhhhhhhccccccccccee---eee----ecCCCCCCCCCCCC------------------------
Q psy9858         211 TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCF----AKDPSSHGNLFPGI------------------------  259 (307)
Q Consensus       211 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~----~~~~~f~~~~~~~~------------------------  259 (307)
                        ......++..|+|||.+.+. .++.++|+|   +++    +|+.||........                        
T Consensus       158 --~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (333)
T cd06650         158 --MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP  234 (333)
T ss_pred             --ccccCCCCccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence              22334688999999999876 789999999   333    38888864211000                        


Q ss_pred             ---------------Ch------------hhh-ccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         260 ---------------PL------------NEI-FTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       260 ---------------~~------------~~~-~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                                     ..            ... ....+.++.+||.+||+.||++|||++|++.||||+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence                           00            000 012467899999999999999999999999999998764

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=8.8e-43  Score=309.51  Aligned_cols=249  Identities=18%  Similarity=0.175  Sum_probs=200.5

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM  129 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  129 (307)
                      .....++|++.+.||+|+||.||+|.+..+++.||+|++.+.....  ......+.+|+.+++.++||||+++++++.+.
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~--~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK--RSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  115 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhh--hHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            3445689999999999999999999999999999999987422111  11234577899999999999999999999999


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                      ...++||||+ +|+|.+++...  .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~  193 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN  193 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence            9999999999 67888887654  37899999999999999999999999999999999999999999999999998764


Q ss_pred             CCCc-ccccceeeceehhhhhhhccc---cccccccee---ee----eecCCCCCCCCCCC--------C--Chhhhccc
Q psy9858         209 SPTR-LYTHQVVTRWYRLIKCLLYCV---QFNVKNVQW---CC----FAKDPSSHGNLFPG--------I--PLNEIFTA  267 (307)
Q Consensus       209 ~~~~-~~~~~~~t~~y~aPE~~~~~~---~~~~~~Diw---~i----~~~~~~f~~~~~~~--------~--~~~~~~~~  267 (307)
                      .... ......||+.|+|||++.+..   .++.++|||   ++    ++|..||.+.....        .  ........
T Consensus       194 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  273 (371)
T cd05622         194 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND  273 (371)
T ss_pred             cCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCC
Confidence            3221 233557999999999997642   378999999   33    33999998733210        0  00111235


Q ss_pred             cCHHHHHHHHHhhhcCCCC--CCCHHHHhcCcccCCC
Q psy9858         268 AGDDLLAVISSLLCLNPTK--RADCTATLKMDYFSLT  302 (307)
Q Consensus       268 ~~~~l~~li~~~l~~dP~~--Rpt~~~il~hp~f~~~  302 (307)
                      ++..+.++|.+||..++.+  |++++++++||||++.
T Consensus       274 ~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~  310 (371)
T cd05622         274 ISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  310 (371)
T ss_pred             CCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence            7899999999999844433  7899999999999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=5.6e-43  Score=304.91  Aligned_cols=233  Identities=33%  Similarity=0.519  Sum_probs=183.9

Q ss_pred             EeEEeecCceEEEEEEEc--CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee--cCeEEEE
Q psy9858          60 WRSVHVGRFATVFKARDI--ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY--MSNVSLV  135 (307)
Q Consensus        60 ~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~lv  135 (307)
                      .++||+|+||.||+|++.  .+++.||+|.+....       ....+.+|++++++++||||+++++++..  +...+++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv   78 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-------ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   78 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-------CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEE
Confidence            468999999999999865  467899999986421       12346789999999999999999998854  4678999


Q ss_pred             EEccCCChHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEE----ecCCcEEEEeecC
Q psy9858         136 FEFVDTDLEVIIKDP--------TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLI----NKQGVLKIGDFGL  203 (307)
Q Consensus       136 ~e~~~g~l~~~~~~~--------~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~----~~~~~~kl~Dfg~  203 (307)
                      |||+++++.+++...        ...+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+
T Consensus        79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          79 FDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             EeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            999999988877532        2248899999999999999999999999999999999999    4567899999999


Q ss_pred             ccccCCCCc---ccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCCCh------------
Q psy9858         204 AKFFGSPTR---LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGIPL------------  261 (307)
Q Consensus       204 a~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~~------------  261 (307)
                      ++.......   ......+|+.|+|||.+.+...++.++|||   |    +++|.+||..........            
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF  238 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence            987643321   223457899999999998865789999999   3    333999986522110000            


Q ss_pred             -----------h------------------------------hhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         262 -----------N------------------------------EIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       262 -----------~------------------------------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                                 .                              ......+.++.+||.+||+.||.+|||++|+|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                       0                              0000124568899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.7e-42  Score=303.48  Aligned_cols=247  Identities=17%  Similarity=0.212  Sum_probs=199.7

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ++|.+.+.||+|+||.||++++..+++.||+|++.+...  ........+.+|..++..++|+||+++++++.+.+..|+
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~l   78 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEM--LKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYL   78 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHH--HhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            479999999999999999999999999999999874211  112223457789999999999999999999999999999


Q ss_pred             EEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc
Q psy9858         135 VFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL  213 (307)
Q Consensus       135 v~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  213 (307)
                      ||||+ +|+|.+++......+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.........
T Consensus        79 v~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  158 (331)
T cd05624          79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV  158 (331)
T ss_pred             EEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence            99999 68899998875556899999999999999999999999999999999999999999999999999876433222


Q ss_pred             -cccceeeceehhhhhhhcc----ccccccccee---ee----eecCCCCCCCCCC-----------CCChhhhccccCH
Q psy9858         214 -YTHQVVTRWYRLIKCLLYC----VQFNVKNVQW---CC----FAKDPSSHGNLFP-----------GIPLNEIFTAAGD  270 (307)
Q Consensus       214 -~~~~~~t~~y~aPE~~~~~----~~~~~~~Diw---~i----~~~~~~f~~~~~~-----------~~~~~~~~~~~~~  270 (307)
                       .....|++.|+|||.+.+.    ..++.++|+|   ++    ++|..||......           ..........++.
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~  238 (331)
T cd05624         159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSE  238 (331)
T ss_pred             eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCH
Confidence             2234689999999998752    2578999999   33    3389998763211           0111122235689


Q ss_pred             HHHHHHHHhhhcCCCC--CCCHHHHhcCcccCCCc
Q psy9858         271 DLLAVISSLLCLNPTK--RADCTATLKMDYFSLTK  303 (307)
Q Consensus       271 ~l~~li~~~l~~dP~~--Rpt~~~il~hp~f~~~~  303 (307)
                      ++.+++.+||..++.+  |++++++++||||+..+
T Consensus       239 ~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~  273 (331)
T cd05624         239 EAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGID  273 (331)
T ss_pred             HHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCC
Confidence            9999999999876654  56999999999998753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=7.1e-43  Score=299.78  Aligned_cols=243  Identities=23%  Similarity=0.276  Sum_probs=200.2

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEE
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLV  135 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  135 (307)
                      .|++.+.||+|+||.||++.+..+++.||+|.+.......  ......+.+|+.+++.++|+||+.+++.+.+.+..+++
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv   78 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK--RKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLV   78 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccc--hHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEE
Confidence            4788899999999999999999999999999987543222  12234567899999999999999999999999999999


Q ss_pred             EEcc-CCChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc
Q psy9858         136 FEFV-DTDLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL  213 (307)
Q Consensus       136 ~e~~-~g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  213 (307)
                      |||+ +|+|.+++... ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....... .
T Consensus        79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~  157 (285)
T cd05630          79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-T  157 (285)
T ss_pred             EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-c
Confidence            9999 57888777543 2348899999999999999999999999999999999999999999999999997654322 2


Q ss_pred             cccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCC----------CChhhhccccCHHHHHHH
Q psy9858         214 YTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPG----------IPLNEIFTAAGDDLLAVI  276 (307)
Q Consensus       214 ~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~----------~~~~~~~~~~~~~l~~li  276 (307)
                      .....++..|+|||.+.+. .++.++|+|       .+++|..||.......          ......+..+++++.+|+
T Consensus       158 ~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05630         158 IKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLC  236 (285)
T ss_pred             ccCCCCCccccChHHHcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHH
Confidence            2334789999999999887 789999999       2334999998632211          011122345788999999


Q ss_pred             HHhhhcCCCCCCC-----HHHHhcCcccCCC
Q psy9858         277 SSLLCLNPTKRAD-----CTATLKMDYFSLT  302 (307)
Q Consensus       277 ~~~l~~dP~~Rpt-----~~~il~hp~f~~~  302 (307)
                      .+||+.||++|||     ++|+++||||++.
T Consensus       237 ~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~  267 (285)
T cd05630         237 KMLLCKDPKERLGCQGGGAREVKEHPLFKQI  267 (285)
T ss_pred             HHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence            9999999999999     9999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.4e-43  Score=306.92  Aligned_cols=239  Identities=23%  Similarity=0.254  Sum_probs=193.1

Q ss_pred             eEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHh-cCCCCccccceeeeecCeEEEEEEcc
Q psy9858          61 RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQE-LHHENVLGLTDVFGYMSNVSLVFEFV  139 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~ni~~~~~~~~~~~~~~lv~e~~  139 (307)
                      +.||+|+||+||+|++..+++.||+|++.......  +.....+..|..++.. ++||||+++++++.+....++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~   78 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLM--DDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh--cchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCC
Confidence            46999999999999999999999999998532111  1113445677888876 48999999999999999999999999


Q ss_pred             -CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcccccce
Q psy9858         140 -DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQV  218 (307)
Q Consensus       140 -~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  218 (307)
                       +|+|.+++.... .+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++..............
T Consensus        79 ~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05619          79 NGGDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC  157 (316)
T ss_pred             CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeec
Confidence             678888886543 488999999999999999999999999999999999999999999999999976433323334457


Q ss_pred             eeceehhhhhhhccccccccccee---ee----eecCCCCCCCCCCCC------ChhhhccccCHHHHHHHHHhhhcCCC
Q psy9858         219 VTRWYRLIKCLLYCVQFNVKNVQW---CC----FAKDPSSHGNLFPGI------PLNEIFTAAGDDLLAVISSLLCLNPT  285 (307)
Q Consensus       219 ~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~~~~~f~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dP~  285 (307)
                      ||..|+|||.+.+. .++.++|||   |+    ++|..||.+......      .....+..++.++.++|.+||+.||+
T Consensus       158 gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~  236 (316)
T cd05619         158 GTPDYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPE  236 (316)
T ss_pred             CCccccCHHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHh
Confidence            89999999999887 789999999   33    339999876321110      00112234788999999999999999


Q ss_pred             CCCCHH-HHhcCcccCCCc
Q psy9858         286 KRADCT-ATLKMDYFSLTK  303 (307)
Q Consensus       286 ~Rpt~~-~il~hp~f~~~~  303 (307)
                      +||++. ++++||||+..+
T Consensus       237 ~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05619         237 RRLGVKGDIRQHPFFREID  255 (316)
T ss_pred             hcCCChHHHHcCcccCCCC
Confidence            999996 999999998754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=3.9e-43  Score=306.89  Aligned_cols=238  Identities=21%  Similarity=0.249  Sum_probs=191.0

Q ss_pred             eEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHH-HHHhcCCCCccccceeeeecCeEEEEEEcc
Q psy9858          61 RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIK-LLQELHHENVLGLTDVFGYMSNVSLVFEFV  139 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  139 (307)
                      +.||+|+||+||+|++..+|+.||+|++.+.....  ......+..|.. +++.++||||+++++++...+..++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~   78 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLN--RKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFV   78 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCC
Confidence            46999999999999999999999999997532111  112344555554 567789999999999999999999999999


Q ss_pred             -CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcccccce
Q psy9858         140 -DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQV  218 (307)
Q Consensus       140 -~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  218 (307)
                       +|+|...+... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.............
T Consensus        79 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~  157 (325)
T cd05604          79 NGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC  157 (325)
T ss_pred             CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccccc
Confidence             56787777654 3589999999999999999999999999999999999999999999999999976433333334557


Q ss_pred             eeceehhhhhhhccccccccccee---eee----ecCCCCCCCCCCCCC------hhhhccccCHHHHHHHHHhhhcCCC
Q psy9858         219 VTRWYRLIKCLLYCVQFNVKNVQW---CCF----AKDPSSHGNLFPGIP------LNEIFTAAGDDLLAVISSLLCLNPT  285 (307)
Q Consensus       219 ~t~~y~aPE~~~~~~~~~~~~Diw---~i~----~~~~~f~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dP~  285 (307)
                      ||+.|+|||.+.+. .++.++|||   +++    +|..||.........      .......++..+.++|.+||+.||+
T Consensus       158 gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~  236 (325)
T cd05604         158 GTPEYLAPEVIRKQ-PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQ  236 (325)
T ss_pred             CChhhCCHHHHcCC-CCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHH
Confidence            89999999999887 789999999   333    388888763221100      0112235788999999999999999


Q ss_pred             CCCCH----HHHhcCcccCCC
Q psy9858         286 KRADC----TATLKMDYFSLT  302 (307)
Q Consensus       286 ~Rpt~----~~il~hp~f~~~  302 (307)
                      +||++    .++++||||+..
T Consensus       237 ~R~~~~~~~~~i~~h~~f~~~  257 (325)
T cd05604         237 RRLGAKEDFLEIQEHPFFESL  257 (325)
T ss_pred             hcCCCCCCHHHHhcCCCcCCC
Confidence            99986    599999999875

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.2e-42  Score=298.17  Aligned_cols=242  Identities=40%  Similarity=0.634  Sum_probs=202.6

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEE
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLV  135 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  135 (307)
                      +|++.+.||+|++|.||+|.+..+|..||+|++......   ......+.+|+.+++.++|+||+++++++..+...++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v   77 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE---GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLV   77 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc---chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEE
Confidence            589999999999999999999999999999999864321   22346688999999999999999999999999999999


Q ss_pred             EEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC-ccc
Q psy9858         136 FEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT-RLY  214 (307)
Q Consensus       136 ~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-~~~  214 (307)
                      |||++++|.+++......+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus        78 ~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~  157 (286)
T cd07832          78 MEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY  157 (286)
T ss_pred             ecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence            9999889999987766679999999999999999999999999999999999999999999999999998775432 123


Q ss_pred             ccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCC-------------------------------
Q psy9858         215 THQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLF-------------------------------  256 (307)
Q Consensus       215 ~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~-------------------------------  256 (307)
                      ....++..|+|||.+.+...++.++|||       .+++|.++|.+...                               
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07832         158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI  237 (286)
T ss_pred             ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence            3457889999999987765679999999       23338777754210                               


Q ss_pred             -----CCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccC
Q psy9858         257 -----PGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS  300 (307)
Q Consensus       257 -----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~  300 (307)
                           .........+..+.++.++|++||+.||++|||++++|+||||.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence                 00011223345678999999999999999999999999999994

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=8.2e-43  Score=299.09  Aligned_cols=241  Identities=37%  Similarity=0.618  Sum_probs=199.6

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEE
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLV  135 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  135 (307)
                      +|+.++.||.|++|.||+|++..+|+.||||.+.....   .......+.+|++++++++||||+++++++.+....+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE---TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV   77 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc---ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEE
Confidence            48899999999999999999999999999999875321   122245688999999999999999999999999999999


Q ss_pred             EEccCCChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCccc
Q psy9858         136 FEFVDTDLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY  214 (307)
Q Consensus       136 ~e~~~g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  214 (307)
                      |||+.++|.+++... ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++..........
T Consensus        78 ~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~  157 (284)
T cd07860          78 FEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY  157 (284)
T ss_pred             eeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccc
Confidence            999988888887643 3458999999999999999999999999999999999999999999999999998765433333


Q ss_pred             ccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCC------------------------------
Q psy9858         215 THQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFP------------------------------  257 (307)
Q Consensus       215 ~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~------------------------------  257 (307)
                      ....++..|+|||.+.+...++.++|+|       .+++|..||.+....                              
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07860         158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS  237 (284)
T ss_pred             ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence            4446788999999988765678999999       234488888653210                              


Q ss_pred             -----CCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         258 -----GIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       258 -----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                           ..........++.++.++|.+||+.||.+|||++++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence                 011112233567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.3e-42  Score=297.50  Aligned_cols=243  Identities=32%  Similarity=0.515  Sum_probs=199.1

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|.+++.||+|+||.||+|.+..+|..||+|++.....    ......+.+|+++++.++|+||+++++++..+...
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   78 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE----EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETL   78 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc----CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeE
Confidence            35789999999999999999999999999999999875421    12234567899999999999999999999999999


Q ss_pred             EEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc
Q psy9858         133 SLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR  212 (307)
Q Consensus       133 ~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  212 (307)
                      ++||||+.+++.+.+......+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||+++.......
T Consensus        79 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          79 TFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             EEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence            99999999898888776555678889999999999999999999999999999999999999999999999986544333


Q ss_pred             ccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCC--------------------------C-
Q psy9858         213 LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFP--------------------------G-  258 (307)
Q Consensus       213 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~--------------------------~-  258 (307)
                      ......++..|+|||.+.+...++.++|+|       .+++|..||.+....                          . 
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (291)
T cd07870         159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY  238 (291)
T ss_pred             CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccc
Confidence            334456789999999988765688899999       334488888652210                          0 


Q ss_pred             ----------CChhhhcc--ccCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         259 ----------IPLNEIFT--AAGDDLLAVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       259 ----------~~~~~~~~--~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                                ......+.  ..+.++.+++.+||+.||.+|||++|++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence                      00000001  125688999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=6.3e-43  Score=305.23  Aligned_cols=244  Identities=21%  Similarity=0.251  Sum_probs=198.4

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-CCCccccceeeeecCeEEE
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-HENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~l  134 (307)
                      +|+..+.||+|+||.||+|++..+|+.||+|++.+....  .......+..|.+++..+. |++|+++++++.+.+..|+
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI--QDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYF   78 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEE
Confidence            478889999999999999999999999999999753211  1122345678899988885 5778889999999999999


Q ss_pred             EEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc
Q psy9858         135 VFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL  213 (307)
Q Consensus       135 v~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  213 (307)
                      ||||+ +|+|.+++.... .+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||+++........
T Consensus        79 v~Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~  157 (323)
T cd05615          79 VMEYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT  157 (323)
T ss_pred             EEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcc
Confidence            99999 678888776543 5899999999999999999999999999999999999999999999999999865333333


Q ss_pred             cccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCCC------ChhhhccccCHHHHHHHHHhh
Q psy9858         214 YTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPGI------PLNEIFTAAGDDLLAVISSLL  280 (307)
Q Consensus       214 ~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~~------~~~~~~~~~~~~l~~li~~~l  280 (307)
                      .....||+.|+|||.+.+. .++.++|+|       .+++|..||.+......      .....+..++.++.+++.+||
T Consensus       158 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l  236 (323)
T cd05615         158 TRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLM  236 (323)
T ss_pred             ccCccCCccccCHHHHcCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHc
Confidence            3345689999999999877 789999999       23349999977432110      001223467899999999999


Q ss_pred             hcCCCCCCC-----HHHHhcCcccCCCc
Q psy9858         281 CLNPTKRAD-----CTATLKMDYFSLTK  303 (307)
Q Consensus       281 ~~dP~~Rpt-----~~~il~hp~f~~~~  303 (307)
                      +.||.+|++     .+++++||||....
T Consensus       237 ~~~p~~R~~~~~~~~~~i~~h~~f~~~~  264 (323)
T cd05615         237 TKHPSKRLGCGPEGERDIREHAFFRRID  264 (323)
T ss_pred             ccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence            999999998     58999999998754

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=7.5e-43  Score=300.77  Aligned_cols=244  Identities=36%  Similarity=0.630  Sum_probs=202.3

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec--C
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM--S  130 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~  130 (307)
                      ..++|++.+.||.|+||.||+|++..+++.||+|.+......   +.....+.+|+.+++.++||||+++++++...  +
T Consensus         3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   79 (293)
T cd07843           3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK---EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLD   79 (293)
T ss_pred             chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc---ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCC
Confidence            457899999999999999999999989999999999754322   22344567899999999999999999998877  8


Q ss_pred             eEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         131 NVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       131 ~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      ..+++|||+.++|.+++......+++..++.++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus        80 ~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  159 (293)
T cd07843          80 KIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP  159 (293)
T ss_pred             cEEEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence            99999999998998888776556899999999999999999999999999999999999999999999999999887654


Q ss_pred             Ccccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCC--------------------------
Q psy9858         211 TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFP--------------------------  257 (307)
Q Consensus       211 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~--------------------------  257 (307)
                      ........++..|+|||.+.+...++.++|+|   +    +++|.+||......                          
T Consensus       160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
T cd07843         160 LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG  239 (293)
T ss_pred             ccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence            33444456788999999988765678999999   2    33488888652110                          


Q ss_pred             -------CC---Chhhhccc--cCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         258 -------GI---PLNEIFTA--AGDDLLAVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       258 -------~~---~~~~~~~~--~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                             ..   .....+..  +++.+.++|++||+.||++|||++|+|+||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                   00   00111122  48889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-42  Score=294.82  Aligned_cols=243  Identities=20%  Similarity=0.289  Sum_probs=200.2

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ++|.+.+.||+|++|.||+|.+..+++.||+|.+...............+.+|++++++++||||+++++++..+...++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            47999999999999999999998999999999987543222222224568899999999999999999999999999999


Q ss_pred             EEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc
Q psy9858         135 VFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL  213 (307)
Q Consensus       135 v~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  213 (307)
                      ++||+ +++|.+.+.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus        82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~  160 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS  160 (263)
T ss_pred             EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence            99999 567888776543 4889999999999999999999999999999999999999999999999999765332111


Q ss_pred             ---cccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCC--------CCChhhhccccCHHHHHH
Q psy9858         214 ---YTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFP--------GIPLNEIFTAAGDDLLAV  275 (307)
Q Consensus       214 ---~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~--------~~~~~~~~~~~~~~l~~l  275 (307)
                         .....++..|+|||.+.+. .++.++|||       .+++|+.||......        .......+..++..+.++
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  239 (263)
T cd06625         161 GTGMKSVTGTPYWMSPEVISGE-GYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNF  239 (263)
T ss_pred             cccccCCCcCccccCcceeccC-CCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHH
Confidence               1234577899999999887 799999999       333488998662211        111122344678999999


Q ss_pred             HHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         276 ISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       276 i~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                      +.+||+.||.+|||+.++++||||
T Consensus       240 i~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         240 LRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHHhhcCcccCCCHHHHhhCCCC
Confidence            999999999999999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG0579|consensus

Probab=100.00  E-value=1.1e-44  Score=318.87  Aligned_cols=247  Identities=21%  Similarity=0.299  Sum_probs=205.4

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN  131 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  131 (307)
                      ++.+-|.++..||.|+||+||+|.++.++...|-|++...     .......+.-|++||..|+||+|++++++|..++.
T Consensus        29 nP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk-----seEELEDylVEIeILa~CdHP~ivkLl~ayy~enk  103 (1187)
T KOG0579|consen   29 NPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK-----SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK  103 (1187)
T ss_pred             CHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc-----chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc
Confidence            3456699999999999999999999999999999998743     23335678899999999999999999999999999


Q ss_pred             EEEEEEccCCC-hHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         132 VSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       132 ~~lv~e~~~g~-l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      ++|+.|||+|. ....+..-+..+.+.++..+++|++.||.|||+++|||||||..|||++-+|.++|+|||.+......
T Consensus       104 LwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t  183 (1187)
T KOG0579|consen  104 LWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST  183 (1187)
T ss_pred             eEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhH
Confidence            99999999655 45555566667999999999999999999999999999999999999999999999999999876555


Q ss_pred             Ccccccceeeceehhhhhhhcc----ccccccccee--eeee-----cCCCCCCCC---------CCCCChhhhccccCH
Q psy9858         211 TRLYTHQVVTRWYRLIKCLLYC----VQFNVKNVQW--CCFA-----KDPSSHGNL---------FPGIPLNEIFTAAGD  270 (307)
Q Consensus       211 ~~~~~~~~~t~~y~aPE~~~~~----~~~~~~~Diw--~i~~-----~~~~f~~~~---------~~~~~~~~~~~~~~~  270 (307)
                      .....+++||++|||||+....    ..|++++|||  +|-.     +++|-..-+         ....+....+..-+.
T Consensus       184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~  263 (1187)
T KOG0579|consen  184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSR  263 (1187)
T ss_pred             HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhh
Confidence            5556778999999999998653    3799999999  3322     777766511         011111112234577


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         271 DLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       271 ~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      .+.+++.+||.+||..||++.|+|+||||.+++
T Consensus       264 ~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~  296 (1187)
T KOG0579|consen  264 SFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP  296 (1187)
T ss_pred             HHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence            899999999999999999999999999999765

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.1e-42  Score=317.97  Aligned_cols=240  Identities=20%  Similarity=0.241  Sum_probs=189.0

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCC------CCcccccee
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH------ENVLGLTDV  125 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h------~ni~~~~~~  125 (307)
                      ...++|++++.||+|+||+||+|.+..+++.||||++....      .....+..|+++++.++|      .++++++++
T Consensus       126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~------~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~  199 (467)
T PTZ00284        126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP------KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY  199 (467)
T ss_pred             cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch------hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence            34578999999999999999999999999999999986421      112345567777777654      458888888


Q ss_pred             eeec-CeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCcEEEecCC---------
Q psy9858         126 FGYM-SNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD-HWILHRDLKPNNLLINKQG---------  194 (307)
Q Consensus       126 ~~~~-~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~---------  194 (307)
                      +..+ .+.++||++++++|.+++.+.. .+++..+..++.||+.||.|||+ .||+||||||+|||++.++         
T Consensus       200 ~~~~~~~~~iv~~~~g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~  278 (467)
T PTZ00284        200 FQNETGHMCIVMPKYGPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNR  278 (467)
T ss_pred             EEcCCceEEEEEeccCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccc
Confidence            8654 5799999999999999887653 58999999999999999999998 5999999999999998766         


Q ss_pred             -------cEEEEeecCccccCCCCcccccceeeceehhhhhhhccccccccccee---ee----eecCCCCCCCCCCC--
Q psy9858         195 -------VLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FAKDPSSHGNLFPG--  258 (307)
Q Consensus       195 -------~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~~~~~f~~~~~~~--  258 (307)
                             .+||+|||.+....   .......+|+.|+|||++.+. .++.++|||   |+    ++|++||.+.....  
T Consensus       279 ~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~  354 (467)
T PTZ00284        279 ALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL  354 (467)
T ss_pred             ccCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhcC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence                   49999999886432   223445889999999999887 899999999   33    33999997622100  


Q ss_pred             ---------CCh-----------hhhc-------------------------c-ccCHHHHHHHHHhhhcCCCCCCCHHH
Q psy9858         259 ---------IPL-----------NEIF-------------------------T-AAGDDLLAVISSLLCLNPTKRADCTA  292 (307)
Q Consensus       259 ---------~~~-----------~~~~-------------------------~-~~~~~l~~li~~~l~~dP~~Rpt~~~  292 (307)
                               ...           ..++                         . ..++.+.+||.+||+.||++|||++|
T Consensus       355 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e  434 (467)
T PTZ00284        355 HLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQ  434 (467)
T ss_pred             HHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHH
Confidence                     000           0000                         0 01355779999999999999999999


Q ss_pred             HhcCcccCCC
Q psy9858         293 TLKMDYFSLT  302 (307)
Q Consensus       293 il~hp~f~~~  302 (307)
                      +|+||||.+.
T Consensus       435 ~L~Hp~~~~~  444 (467)
T PTZ00284        435 MTTHPYVLKY  444 (467)
T ss_pred             HhcCcccccc
Confidence            9999999874

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=7.2e-43  Score=319.92  Aligned_cols=249  Identities=19%  Similarity=0.302  Sum_probs=203.8

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY  128 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  128 (307)
                      ......++|.+.+.||+|+||+||+|++..+|+.||||++......   ......+.+|+.++..++|+||+++++.+..
T Consensus        26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~---~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~  102 (496)
T PTZ00283         26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS---EADKNRAQAEVCCLLNCDFFSIVKCHEDFAK  102 (496)
T ss_pred             cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC---HHHHHHHHHHHHHHhcCCCCcEEEeecceec
Confidence            4445667999999999999999999999999999999999764322   2224567899999999999999999887643


Q ss_pred             cC--------eEEEEEEcc-CCChHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcE
Q psy9858         129 MS--------NVSLVFEFV-DTDLEVIIKDP---TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVL  196 (307)
Q Consensus       129 ~~--------~~~lv~e~~-~g~l~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~  196 (307)
                      ..        ..++||||+ +|+|.+.+...   ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.+
T Consensus       103 ~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~v  182 (496)
T PTZ00283        103 KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLV  182 (496)
T ss_pred             ccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCE
Confidence            22        478999999 68898888642   3458999999999999999999999999999999999999999999


Q ss_pred             EEEeecCccccCCC--Ccccccceeeceehhhhhhhccccccccccee---ee----eecCCCCCCCCCC-------CCC
Q psy9858         197 KIGDFGLAKFFGSP--TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FAKDPSSHGNLFP-------GIP  260 (307)
Q Consensus       197 kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~~~~~f~~~~~~-------~~~  260 (307)
                      ||+|||+++.....  ........||+.|+|||.+.+. .++.++|||   ++    ++|..||.+....       ...
T Consensus       183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~  261 (496)
T PTZ00283        183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK-PYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR  261 (496)
T ss_pred             EEEecccCeeccccccccccccccCCcceeCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC
Confidence            99999999876432  1223345789999999999887 799999999   33    3399999773321       111


Q ss_pred             hhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCC
Q psy9858         261 LNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSL  301 (307)
Q Consensus       261 ~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~  301 (307)
                      ....+..+++++.+++.+||+.||.+|||+.++++|||++.
T Consensus       262 ~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~  302 (496)
T PTZ00283        262 YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL  302 (496)
T ss_pred             CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence            22345578899999999999999999999999999999865

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.1e-42  Score=297.07  Aligned_cols=247  Identities=37%  Similarity=0.614  Sum_probs=202.0

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ++|++.+.||.|++|.||+|.+..+|+.||+|.+.....   .+.....+.+|+++++.++|+||+++++++.+....++
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE---DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYL   78 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc---cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEE
Confidence            679999999999999999999988999999999865321   12234567899999999999999999999999999999


Q ss_pred             EEEccCCChHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEec-CCcEEEEeecCccccCCCCc
Q psy9858         135 VFEFVDTDLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK-QGVLKIGDFGLAKFFGSPTR  212 (307)
Q Consensus       135 v~e~~~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~a~~~~~~~~  212 (307)
                      ||||+++++.+.+.... ..+++..++.++.||+.||+|||++|++|+||+|+||+++. ++.+||+|||++........
T Consensus        79 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~  158 (294)
T PLN00009         79 VFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR  158 (294)
T ss_pred             EEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence            99999888888876543 23678888999999999999999999999999999999985 55799999999987644333


Q ss_pred             ccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCC-----------------------------
Q psy9858         213 LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLF-----------------------------  256 (307)
Q Consensus       213 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~-----------------------------  256 (307)
                      ......++..|+|||.+.+...++.++|+|       .+++|.+||.....                             
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (294)
T PLN00009        159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK  238 (294)
T ss_pred             ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence            334456789999999987755788999999       23348888865211                             


Q ss_pred             ------CCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         257 ------PGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       257 ------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                            ...........+++++.++|.+||+.||++||+++++++||||.+.++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~  292 (294)
T PLN00009        239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD  292 (294)
T ss_pred             hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence                  000111122357889999999999999999999999999999998765

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=6.1e-43  Score=295.82  Aligned_cols=239  Identities=25%  Similarity=0.387  Sum_probs=195.5

Q ss_pred             eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEE
Q psy9858          57 YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVF  136 (307)
Q Consensus        57 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  136 (307)
                      |++++.||+|+||+||++.+..+++.||+|++.......   .......+|+.+++.++|+||+++++++.+....+++|
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~   77 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEE---EEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVM   77 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHH---HHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccc---cccchhhhhhhccccccccccccccccccccccccccc
Confidence            889999999999999999999999999999998643222   11233456999999999999999999999999999999


Q ss_pred             EccCC-ChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcccc
Q psy9858         137 EFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYT  215 (307)
Q Consensus       137 e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~  215 (307)
                      |++.+ +|.+++.. ...+++..+..++.||+.||.+||+.|++|+||||+||+++.++.++|+|||.+...........
T Consensus        78 ~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~  156 (260)
T PF00069_consen   78 EYCPGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFN  156 (260)
T ss_dssp             EEETTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBS
T ss_pred             cccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99965 88888872 23589999999999999999999999999999999999999999999999999986533334455


Q ss_pred             cceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCCC--h-h----hhcc------ccCHHHHHH
Q psy9858         216 HQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGIP--L-N----EIFT------AAGDDLLAV  275 (307)
Q Consensus       216 ~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~--~-~----~~~~------~~~~~l~~l  275 (307)
                      ...++..|+|||.+.....++.++|+|   +    ++.|..||.........  . .    ....      ..+..+.++
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  236 (260)
T PF00069_consen  157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDL  236 (260)
T ss_dssp             SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHH
Confidence            567899999999998333899999999   2    33388888764100000  0 0    0000      113789999


Q ss_pred             HHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         276 ISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       276 i~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                      |.+||+.||++|||++++++||||
T Consensus       237 i~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  237 IKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHccCChhHCcCHHHHhcCCCC
Confidence            999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=7.3e-43  Score=304.68  Aligned_cols=238  Identities=21%  Similarity=0.266  Sum_probs=190.6

Q ss_pred             eEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHH-HHHhcCCCCccccceeeeecCeEEEEEEcc
Q psy9858          61 RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIK-LLQELHHENVLGLTDVFGYMSNVSLVFEFV  139 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  139 (307)
                      +.||+|+||.||+|++..+|+.||+|++.+.....  ......+.+|.. +++.++||||+++++++.+.+..++||||+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILK--KKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYV   78 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH--hhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCC
Confidence            46999999999999999999999999997532111  111334555554 678899999999999999999999999999


Q ss_pred             -CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcccccce
Q psy9858         140 -DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQV  218 (307)
Q Consensus       140 -~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  218 (307)
                       +|+|...+... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.............
T Consensus        79 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (321)
T cd05603          79 NGGELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC  157 (321)
T ss_pred             CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccccc
Confidence             56787776644 3588999999999999999999999999999999999999999999999999876433333334457


Q ss_pred             eeceehhhhhhhccccccccccee---ee----eecCCCCCCCCCCCC------ChhhhccccCHHHHHHHHHhhhcCCC
Q psy9858         219 VTRWYRLIKCLLYCVQFNVKNVQW---CC----FAKDPSSHGNLFPGI------PLNEIFTAAGDDLLAVISSLLCLNPT  285 (307)
Q Consensus       219 ~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~~~~~f~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dP~  285 (307)
                      +|+.|+|||.+.+. .++.++|||   ++    ++|..||.+......      .....+...+.++.++|.+||+.||.
T Consensus       158 gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~  236 (321)
T cd05603         158 GTPEYLAPEVLRKE-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQR  236 (321)
T ss_pred             CCcccCCHHHhcCC-CCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHh
Confidence            89999999999877 789999999   33    338888876432110      01122345788999999999999999


Q ss_pred             CCCCH----HHHhcCcccCCC
Q psy9858         286 KRADC----TATLKMDYFSLT  302 (307)
Q Consensus       286 ~Rpt~----~~il~hp~f~~~  302 (307)
                      +|+++    .++++|+||...
T Consensus       237 ~R~~~~~~~~~~~~~~~~~~~  257 (321)
T cd05603         237 RRLGAKADFLEIKNHVFFSPI  257 (321)
T ss_pred             hcCCCCCCHHHHhCCCCcCCC
Confidence            99975    599999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3e-42  Score=297.60  Aligned_cols=249  Identities=20%  Similarity=0.318  Sum_probs=206.8

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY  128 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  128 (307)
                      ..+...++|.+++.||+|++|.||+|.+..+++.||+|.+......     ....+.+|+.+++.++|+||+++++.+..
T Consensus        13 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   87 (297)
T cd06656          13 SVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP-----KKELIINEILVMRENKNPNIVNYLDSYLV   87 (297)
T ss_pred             ccCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc-----hHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            3455668999999999999999999999899999999998753221     13457789999999999999999999999


Q ss_pred             cCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         129 MSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       129 ~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      ....++||||+ +++|.+++.+.  .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...
T Consensus        88 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~  165 (297)
T cd06656          88 GDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI  165 (297)
T ss_pred             CCEEEEeecccCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEc
Confidence            99999999999 67788877654  3788999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCC---------ChhhhccccCHH
Q psy9858         208 GSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGI---------PLNEIFTAAGDD  271 (307)
Q Consensus       208 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~---------~~~~~~~~~~~~  271 (307)
                      ...........+++.|+|||.+.+. .++.++|+|   +    +++|..||.+......         .....+..++..
T Consensus       166 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (297)
T cd06656         166 TPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAV  244 (297)
T ss_pred             cCCccCcCcccCCccccCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHH
Confidence            4433333445678899999999886 789999999   3    3339999876322111         111123457788


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhcCcccCCCccc
Q psy9858         272 LLAVISSLLCLNPTKRADCTATLKMDYFSLTKEM  305 (307)
Q Consensus       272 l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~~  305 (307)
                      +.+++.+||+.||++|||++++++||||+..++.
T Consensus       245 ~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (297)
T cd06656         245 FRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPL  278 (297)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCchhcccccc
Confidence            9999999999999999999999999999987754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3.1e-42  Score=297.10  Aligned_cols=243  Identities=35%  Similarity=0.556  Sum_probs=197.2

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-CCCccccceeeeecCe--
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-HENVLGLTDVFGYMSN--  131 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~--  131 (307)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.+.....   .......+.+|+.+++.+. |+||+++++++.....  
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~---~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   77 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD---EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNG   77 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc---ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCC
Confidence            479999999999999999999999999999999875321   1222456788999999995 6999999998876655  


Q ss_pred             ---EEEEEEccCCChHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEec-CCcEEEEeecC
Q psy9858         132 ---VSLVFEFVDTDLEVIIKDP----TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK-QGVLKIGDFGL  203 (307)
Q Consensus       132 ---~~lv~e~~~g~l~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~  203 (307)
                         .|++|||+.+++.+++...    ...+++..++.++.||+.||.|||++|++||||+|+||+++. ++.++|+|||+
T Consensus        78 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~  157 (295)
T cd07837          78 KPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGL  157 (295)
T ss_pred             CceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccc
Confidence               8999999988988887643    234799999999999999999999999999999999999998 88999999999


Q ss_pred             ccccCCCCcccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCC-------------------
Q psy9858         204 AKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFP-------------------  257 (307)
Q Consensus       204 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~-------------------  257 (307)
                      +..............+++.|+|||.+.+...++.++|+|       .+++|..||.+....                   
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (295)
T cd07837         158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP  237 (295)
T ss_pred             ceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCc
Confidence            987644333333446788999999988765789999999       233388888652110                   


Q ss_pred             ---------------CCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccC
Q psy9858         258 ---------------GIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS  300 (307)
Q Consensus       258 ---------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~  300 (307)
                                     ........+.++.++.++|.+||+.||.+|||+++++.||||+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                           0011112235788999999999999999999999999999995

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.4e-42  Score=296.44  Aligned_cols=242  Identities=31%  Similarity=0.532  Sum_probs=198.6

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++......   ....+.+.+|+++++.++||||+++++++..+...++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   77 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD---KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYL   77 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc---chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEE
Confidence            4799999999999999999999889999999998753221   1234567899999999999999999999999999999


Q ss_pred             EEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCccc
Q psy9858         135 VFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY  214 (307)
Q Consensus       135 v~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  214 (307)
                      ||||+.+++++.+......+++..++.++.||+.||.|||+.|++|+||+|+||++++++.++|+|||++..........
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~  157 (286)
T cd07846          78 VFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY  157 (286)
T ss_pred             EEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcccc
Confidence            99999766555554444458999999999999999999999999999999999999999999999999998765443334


Q ss_pred             ccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCC------------------------------
Q psy9858         215 THQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFP------------------------------  257 (307)
Q Consensus       215 ~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~------------------------------  257 (307)
                      ....++..|+|||.+.+...++.++|||       .+++|.+||......                              
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07846         158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM  237 (286)
T ss_pred             CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence            4456789999999998765688999999       233388888642210                              


Q ss_pred             -------CCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         258 -------GIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       258 -------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                             ........+.++..+.+|+.+||+.||++|||++++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence                   000111234578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0690|consensus

Probab=100.00  E-value=3.6e-44  Score=293.67  Aligned_cols=247  Identities=21%  Similarity=0.253  Sum_probs=213.9

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|..++.||+|+||+|.+++.+.+|+.+|+|++++...-...+  ...-+.|-++|+.++||.+..+.-.|+..+++
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdE--VAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl  243 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDE--VAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL  243 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHH--hhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence            4567999999999999999999999999999999998766544433  34456899999999999999999899999999


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT  211 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  211 (307)
                      |+||||+ +|.|..++.+.. .+++...+.+-..|++||.|||+++||.||||.+|.++|++|++||+|||+|+.-....
T Consensus       244 CFVMeyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g  322 (516)
T KOG0690|consen  244 CFVMEYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG  322 (516)
T ss_pred             EEEEEEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccccc
Confidence            9999999 677888877655 58999999999999999999999999999999999999999999999999998765555


Q ss_pred             cccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCCCC------hhhhccccCHHHHHHHHH
Q psy9858         212 RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPGIP------LNEIFTAAGDDLLAVISS  278 (307)
Q Consensus       212 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~~~------~~~~~~~~~~~l~~li~~  278 (307)
                      ....+.+||+.|+|||++... .|+.++|.|       .+++|++||........-      .-..+..++++++.|+..
T Consensus       323 ~t~kTFCGTPEYLAPEVleDn-DYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLsG  401 (516)
T KOG0690|consen  323 DTTKTFCGTPEYLAPEVLEDN-DYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLSG  401 (516)
T ss_pred             ceeccccCChhhcCchhhccc-cccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHHH
Confidence            667788999999999999998 999999999       466699999884332211      112345789999999999


Q ss_pred             hhhcCCCCCCC-----HHHHhcCcccCCCc
Q psy9858         279 LLCLNPTKRAD-----CTATLKMDYFSLTK  303 (307)
Q Consensus       279 ~l~~dP~~Rpt-----~~~il~hp~f~~~~  303 (307)
                      +|.+||.+|..     +.+|..|+||..+.
T Consensus       402 LL~kdP~kRLGgGpdDakEi~~h~FF~~v~  431 (516)
T KOG0690|consen  402 LLKKDPKKRLGGGPDDAKEIMRHRFFASVD  431 (516)
T ss_pred             HhhcChHhhcCCCchhHHHHHhhhhhccCC
Confidence            99999999985     89999999998764

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.2e-42  Score=303.81  Aligned_cols=238  Identities=21%  Similarity=0.266  Sum_probs=190.9

Q ss_pred             eEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHH-HHHHhcCCCCccccceeeeecCeEEEEEEcc
Q psy9858          61 RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREI-KLLQELHHENVLGLTDVFGYMSNVSLVFEFV  139 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  139 (307)
                      +.||+|+||+||+|++..+++.||+|++.......  ......+..|. .+++.++|+||+++++++...+..++||||+
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~   78 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILK--KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI   78 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHh--hhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCC
Confidence            46999999999999999999999999997532111  11123344444 4567889999999999999999999999999


Q ss_pred             -CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcccccce
Q psy9858         140 -DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQV  218 (307)
Q Consensus       140 -~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  218 (307)
                       +|+|.+.+.... .+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||+++.............
T Consensus        79 ~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~  157 (325)
T cd05602          79 NGGELFYHLQRER-CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC  157 (325)
T ss_pred             CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccccc
Confidence             567887776543 578899999999999999999999999999999999999999999999999976533333344557


Q ss_pred             eeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCC------ChhhhccccCHHHHHHHHHhhhcCCC
Q psy9858         219 VTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGI------PLNEIFTAAGDDLLAVISSLLCLNPT  285 (307)
Q Consensus       219 ~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dP~  285 (307)
                      ||+.|+|||++.+. .++.++|||   +    +++|..||.+......      ........++..+.++|.+||+.||.
T Consensus       158 gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~  236 (325)
T cd05602         158 GTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRT  236 (325)
T ss_pred             CCccccCHHHHcCC-CCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHH
Confidence            89999999999887 899999999   2    3348889876322110      01122346889999999999999999


Q ss_pred             CCCCHH----HHhcCcccCCC
Q psy9858         286 KRADCT----ATLKMDYFSLT  302 (307)
Q Consensus       286 ~Rpt~~----~il~hp~f~~~  302 (307)
                      +|+++.    ++++|+||...
T Consensus       237 ~R~~~~~~~~~i~~~~~~~~~  257 (325)
T cd05602         237 KRLGAKDDFMEIKNHIFFSPI  257 (325)
T ss_pred             HCCCCCCCHHHHhcCcccCCC
Confidence            999876    89999999754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-42  Score=310.28  Aligned_cols=240  Identities=21%  Similarity=0.257  Sum_probs=196.0

Q ss_pred             cceeeEEeEEeecCceEEEEEEEc--CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDI--ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN  131 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  131 (307)
                      ..+|.+++.||+|+||.||+|...  .++..||+|.+...          ....+|+++++.++||||+++++++.....
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~  160 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----------KTPGREIDILKTISHRAIINLIHAYRWKST  160 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----------ccHHHHHHHHHhcCCCCccceeeeEeeCCE
Confidence            346999999999999999999754  45688999987632          224589999999999999999999999999


Q ss_pred             EEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC
Q psy9858         132 VSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT  211 (307)
Q Consensus       132 ~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  211 (307)
                      .+++||++.+++.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus       161 ~~lv~e~~~~~l~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        161 VCMVMPKYKCDLFTYVDRS-GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP  239 (392)
T ss_pred             EEEEehhcCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence            9999999999999988433 458999999999999999999999999999999999999999999999999998664322


Q ss_pred             c--ccccceeeceehhhhhhhccccccccccee---eee----ecCCCCCCCCCCC---------------------CC-
Q psy9858         212 R--LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCF----AKDPSSHGNLFPG---------------------IP-  260 (307)
Q Consensus       212 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~----~~~~~f~~~~~~~---------------------~~-  260 (307)
                      .  ......||..|+|||++.+. .++.++|||   +++    +|..||.+.....                     .. 
T Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~  318 (392)
T PHA03207        240 DTPQCYGWSGTLETNSPELLALD-PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS  318 (392)
T ss_pred             ccccccccccccCccCHhHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence            1  12235789999999999887 889999999   333    3888886632211                     00 


Q ss_pred             -------------------hhhh--ccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCccc
Q psy9858         261 -------------------LNEI--FTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKEM  305 (307)
Q Consensus       261 -------------------~~~~--~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~~  305 (307)
                                         ....  ...++.++.++|.+||..||++|||+.++|.||||++.+..
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~  384 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPIN  384 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchh
Confidence                               0000  01245678999999999999999999999999999887643

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=3.2e-42  Score=295.40  Aligned_cols=240  Identities=36%  Similarity=0.612  Sum_probs=199.7

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEE
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLV  135 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  135 (307)
                      +|++++.||.|++|.||+|++..+|+.||+|++.....    ......+.+|+++++.++|+||+++++.+.+.+..++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   76 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE----EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLV   76 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc----ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEE
Confidence            58999999999999999999999999999999975432    12235577899999999999999999999999999999


Q ss_pred             EEccCCChHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc
Q psy9858         136 FEFVDTDLEVIIKDPT--IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL  213 (307)
Q Consensus       136 ~e~~~g~l~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  213 (307)
                      |||+.|++.+++....  ..+++..+..++.||+.||.|||+.|++|+||+|+||++++++.++|+|||++.........
T Consensus        77 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~  156 (284)
T cd07836          77 FEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT  156 (284)
T ss_pred             EecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence            9999989988886543  45899999999999999999999999999999999999999999999999999876443333


Q ss_pred             cccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCC----------------------------
Q psy9858         214 YTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPG----------------------------  258 (307)
Q Consensus       214 ~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~----------------------------  258 (307)
                      .....++..|++||.+.+...++.++|+|       .+++|..||.+.....                            
T Consensus       157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07836         157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP  236 (284)
T ss_pred             cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence            34456788999999987765678999999       2333888887532110                            


Q ss_pred             -------CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         259 -------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       259 -------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                             .......+.++.++.+++.+||+.||.+|||++++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                   00011123467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0604|consensus

Probab=100.00  E-value=2.5e-43  Score=285.49  Aligned_cols=239  Identities=22%  Similarity=0.232  Sum_probs=199.4

Q ss_pred             ccceeeEE-eEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeee--
Q psy9858          53 DLLVYYQW-RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGY--  128 (307)
Q Consensus        53 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~--  128 (307)
                      .+++|.+- +.||-|-.|+|..|.++.+|+++|+|++.-          ....++|+++-... .|||||.++++++.  
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D----------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~  128 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD----------SPKARREVELHWMASGHPHIVSIIDVYENSY  128 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc----------CHHHHhHhhhhhhhcCCCceEEeehhhhhhc
Confidence            44556655 578999999999999999999999999862          23467899987776 59999999999864  


Q ss_pred             --cCeEEEEEEcc-CCChHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEec---CCcEEEEee
Q psy9858         129 --MSNVSLVFEFV-DTDLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK---QGVLKIGDF  201 (307)
Q Consensus       129 --~~~~~lv~e~~-~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~---~~~~kl~Df  201 (307)
                        ...+.+|||++ +|.|++.+..++ ..+++.++..|+.||..|+.|||+.+|.||||||+|+|...   |..+||+||
T Consensus       129 ~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDf  208 (400)
T KOG0604|consen  129 QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDF  208 (400)
T ss_pred             cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccc
Confidence              35688999999 688999998654 46999999999999999999999999999999999999975   447899999


Q ss_pred             cCccccCCCCcccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCCC--------------C
Q psy9858         202 GLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPGI--------------P  260 (307)
Q Consensus       202 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~~--------------~  260 (307)
                      |+|+.... .....+.+.|+.|.|||++... .|+...|+|       .+++|-+||..+.-...              .
T Consensus       209 GFAK~t~~-~~~L~TPc~TPyYvaPevlg~e-KydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F  286 (400)
T KOG0604|consen  209 GFAKETQE-PGDLMTPCFTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF  286 (400)
T ss_pred             ccccccCC-CccccCCcccccccCHHHhCch-hcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence            99997643 3455677999999999999888 899999999       34559999987322111              1


Q ss_pred             hhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         261 LNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       261 ~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      ..+.|..+|++.+++|+++|..+|.+|.|++++++|||+.+-.
T Consensus       287 P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~  329 (400)
T KOG0604|consen  287 PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE  329 (400)
T ss_pred             CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence            2234567899999999999999999999999999999997643

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=6e-42  Score=295.60  Aligned_cols=249  Identities=19%  Similarity=0.317  Sum_probs=206.7

Q ss_pred             ceeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeee
Q psy9858          48 CEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG  127 (307)
Q Consensus        48 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~  127 (307)
                      ...+....+|++.+.||+|++|.||+|.+..+++.||+|.+.......     ...+.+|+.+++.+.|+||+++++.+.
T Consensus        13 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~-----~~~~~~e~~~l~~~~h~~v~~~~~~~~   87 (296)
T cd06654          13 VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-----KELIINEILVMRENKNPNIVNYLDSYL   87 (296)
T ss_pred             cccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch-----HHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            345667789999999999999999999999999999999987533221     355789999999999999999999999


Q ss_pred             ecCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         128 YMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       128 ~~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                      .....++||||+ +++|.+++...  .+++.++..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..
T Consensus        88 ~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~  165 (296)
T cd06654          88 VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ  165 (296)
T ss_pred             eCCEEEEeecccCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchh
Confidence            999999999999 57888887654  478899999999999999999999999999999999999999999999999887


Q ss_pred             cCCCCcccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCC---------CChhhhccccCH
Q psy9858         207 FGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPG---------IPLNEIFTAAGD  270 (307)
Q Consensus       207 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~---------~~~~~~~~~~~~  270 (307)
                      ............+++.|+|||.+.+. .++.++|+|       .+++|..||.......         ......+..++.
T Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (296)
T cd06654         166 ITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA  244 (296)
T ss_pred             ccccccccCcccCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCH
Confidence            64333333445788899999998876 788999999       2333999987633211         001112345788


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         271 DLLAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       271 ~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                      .+.+++.+||..||++|||++++++||||...+.
T Consensus       245 ~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~  278 (296)
T cd06654         245 IFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP  278 (296)
T ss_pred             HHHHHHHHHCcCCcccCcCHHHHhhChhhhccCC
Confidence            9999999999999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2e-42  Score=295.76  Aligned_cols=236  Identities=19%  Similarity=0.235  Sum_probs=191.0

Q ss_pred             EeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEEEcc-CC
Q psy9858          63 VHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFV-DT  141 (307)
Q Consensus        63 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~-~g  141 (307)
                      ||+|+||.||++.+..+|+.||+|++.......  ......+..|++++++++||||+++++.+......++||||+ +|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~--~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~   78 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK--KSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGG   78 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc--chhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCC
Confidence            689999999999999999999999987532211  111334567999999999999999999999999999999999 67


Q ss_pred             ChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcccccceee
Q psy9858         142 DLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVT  220 (307)
Q Consensus       142 ~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t  220 (307)
                      +|.+++... ...+++..+..++.||+.||+|||+.|++||||||+||+++.++.++|+|||++....... ......++
T Consensus        79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~  157 (277)
T cd05607          79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGT  157 (277)
T ss_pred             CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCCC
Confidence            787777543 2347889999999999999999999999999999999999999999999999998764322 22344688


Q ss_pred             ceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCC-----------ChhhhccccCHHHHHHHHHhhhc
Q psy9858         221 RWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGI-----------PLNEIFTAAGDDLLAVISSLLCL  282 (307)
Q Consensus       221 ~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~-----------~~~~~~~~~~~~l~~li~~~l~~  282 (307)
                      ..|+|||.+.+. .++.++|+|   +    +++|..||........           ........+++++.+|+.+||+.
T Consensus       158 ~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  236 (277)
T cd05607         158 NGYMAPEILKEE-PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK  236 (277)
T ss_pred             CCccCHHHHccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhcc
Confidence            999999999887 699999999   3    3338999875221110           00011135789999999999999


Q ss_pred             CCCCCCCH----HHHhcCcccCCC
Q psy9858         283 NPTKRADC----TATLKMDYFSLT  302 (307)
Q Consensus       283 dP~~Rpt~----~~il~hp~f~~~  302 (307)
                      ||++|||+    ++++.||||+..
T Consensus       237 ~P~~R~~~~~~~~~~~~h~~f~~~  260 (277)
T cd05607         237 KPEDRLGSREKNDDPRKHEFFKTI  260 (277)
T ss_pred             CHhhCCCCccchhhhhcChhhcCC
Confidence            99999999    778899999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0596|consensus

Probab=100.00  E-value=7.6e-43  Score=303.02  Aligned_cols=247  Identities=27%  Similarity=0.338  Sum_probs=202.8

Q ss_pred             ceeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-CCCccccceee
Q psy9858          48 CEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-HENVLGLTDVF  126 (307)
Q Consensus        48 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~  126 (307)
                      ..+...-..|+++++||+||.+.||++.. .+.+-||+|.+..   ...+......|.+|+..|.+|+ |.+|++++++-
T Consensus       354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~---~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE  429 (677)
T KOG0596|consen  354 EIIKVKGREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVL---LEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE  429 (677)
T ss_pred             eeEEECcchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHH---hhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee
Confidence            34556667899999999999999999984 4556677777653   3344555778999999999995 99999999999


Q ss_pred             eecCeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         127 GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       127 ~~~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                      ..++.+|+||||-+.+|.+++.+....++.-.++.+..||+.|++++|++||||.||||.|+|+ ..|.+||+|||.|..
T Consensus       430 v~d~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~a  508 (677)
T KOG0596|consen  430 VTDGYLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANA  508 (677)
T ss_pred             ccCceEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcc
Confidence            9999999999999999999999887666656889999999999999999999999999999999 688999999999998


Q ss_pred             cCCCC--cccccceeeceehhhhhhhcc----------ccccccccee---eeee----cCCCCCCCC--------C---
Q psy9858         207 FGSPT--RLYTHQVVTRWYRLIKCLLYC----------VQFNVKNVQW---CCFA----KDPSSHGNL--------F---  256 (307)
Q Consensus       207 ~~~~~--~~~~~~~~t~~y~aPE~~~~~----------~~~~~~~Diw---~i~~----~~~~f~~~~--------~---  256 (307)
                      +....  -.....+||..||+||.+...          ...+.++|||   ||+|    |++||+.-.        +   
T Consensus       509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P  588 (677)
T KOG0596|consen  509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDP  588 (677)
T ss_pred             cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCC
Confidence            85432  224456999999999998653          1367999999   7777    999998811        1   


Q ss_pred             -CCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCC
Q psy9858         257 -PGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSL  301 (307)
Q Consensus       257 -~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~  301 (307)
                       ........+.  ..++.++++.||++||.+|||+.++|+|||+.-
T Consensus       589 ~~~Iefp~~~~--~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  589 NHEIEFPDIPE--NDELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             CccccccCCCC--chHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence             1112222211  234999999999999999999999999999975

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.8e-42  Score=316.90  Aligned_cols=243  Identities=19%  Similarity=0.261  Sum_probs=200.0

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCC-CcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIET-DMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ...|.+.+.||+|++|.||+|.+..+ +..||+|.+...     .......+.+|+++++.++||||+++++++..++..
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~-----~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~  140 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN-----DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKL  140 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC-----CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEE
Confidence            44599999999999999999998777 788999976532     112234577899999999999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         133 SLVFEFV-DTDLEVIIKD---PTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                      ||||||+ +|+|.+++..   ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~  220 (478)
T PTZ00267        141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS  220 (478)
T ss_pred             EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence            9999999 6888887653   23458899999999999999999999999999999999999999999999999998764


Q ss_pred             CCCc--ccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC-------CChhhhccccCHHH
Q psy9858         209 SPTR--LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG-------IPLNEIFTAAGDDL  272 (307)
Q Consensus       209 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~-------~~~~~~~~~~~~~l  272 (307)
                      ....  ......||+.|+|||.+.+. .++.++|||   |    +++|..||.+.....       ......+..++.++
T Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~  299 (478)
T PTZ00267        221 DSVSLDVASSFCGTPYYLAPELWERK-RYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGM  299 (478)
T ss_pred             CccccccccccCCCccccCHhHhCCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHH
Confidence            3221  23345689999999999887 899999999   3    334889987632211       11112334678999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         273 LAVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       273 ~~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                      .++|.+||+.||++|||+++++.|||++..
T Consensus       300 ~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        300 KALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             HHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence            999999999999999999999999998654

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=9.1e-42  Score=294.43  Aligned_cols=247  Identities=22%  Similarity=0.340  Sum_probs=205.2

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM  129 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  129 (307)
                      .+....+|++.+.||.|++|.||+|.+..+|+.||+|.+.....     .....+.+|+.+++.++|+||+++++.+...
T Consensus        14 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   88 (296)
T cd06655          14 IGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ-----PKKELIINEILVMKELKNPNIVNFLDSFLVG   88 (296)
T ss_pred             cCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC-----chHHHHHHHHHHHHhcCCCceeeeeeeEecC
Confidence            44556789999999999999999999999999999999875321     1245678999999999999999999999999


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                      ...++|+||+ +++|..++...  .+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus        89 ~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~  166 (296)
T cd06655          89 DELFVVMEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT  166 (296)
T ss_pred             ceEEEEEEecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcc
Confidence            9999999999 56777777654  47999999999999999999999999999999999999999999999999988764


Q ss_pred             CCCcccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCC---------CCChhhhccccCHHH
Q psy9858         209 SPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFP---------GIPLNEIFTAAGDDL  272 (307)
Q Consensus       209 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~---------~~~~~~~~~~~~~~l  272 (307)
                      ..........++..|+|||.+.+. .++.++|+|       .+++|..||.+....         .......+..+++.+
T Consensus       167 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (296)
T cd06655         167 PEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIF  245 (296)
T ss_pred             cccccCCCcCCCccccCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHH
Confidence            433333344678899999998876 788999999       233388888763211         011111234578899


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         273 LAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       273 ~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                      .++|.+||..||++|||+.++++||||+..++
T Consensus       246 ~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~  277 (296)
T cd06655         246 RDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP  277 (296)
T ss_pred             HHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence            99999999999999999999999999987664

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=6.8e-42  Score=294.67  Aligned_cols=246  Identities=21%  Similarity=0.283  Sum_probs=200.7

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..+.|++++.||.|+||.||+|++..+++.|++|++...     .....+.+.+|+++++.++|+||+++++.+..++..
T Consensus        10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   84 (292)
T cd06644          10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-----SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKL   84 (292)
T ss_pred             cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC-----CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeE
Confidence            446799999999999999999999999999999998753     122246688899999999999999999999999999


Q ss_pred             EEEEEccC-CChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC
Q psy9858         133 SLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT  211 (307)
Q Consensus       133 ~lv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  211 (307)
                      ++||||+. +++...+.+....+++..+..++.|++.+|.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus        85 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~  164 (292)
T cd06644          85 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL  164 (292)
T ss_pred             EEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence            99999995 66766666555568999999999999999999999999999999999999999999999999987654332


Q ss_pred             cccccceeeceehhhhhhhc----cccccccccee---ee----eecCCCCCCCCCC---------CCChhhhccccCHH
Q psy9858         212 RLYTHQVVTRWYRLIKCLLY----CVQFNVKNVQW---CC----FAKDPSSHGNLFP---------GIPLNEIFTAAGDD  271 (307)
Q Consensus       212 ~~~~~~~~t~~y~aPE~~~~----~~~~~~~~Diw---~i----~~~~~~f~~~~~~---------~~~~~~~~~~~~~~  271 (307)
                      .......++..|+|||.+.+    ...++.++|+|   ++    ++|..||......         ..........++.+
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (292)
T cd06644         165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSME  244 (292)
T ss_pred             cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHH
Confidence            23334467889999999853    23578899999   33    3388888663210         00111123356789


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         272 LLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       272 l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      +.+++.+||+.||++||+++++++||||...+
T Consensus       245 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  276 (292)
T cd06644         245 FRDFLKTALDKHPETRPSAAQLLEHPFVSSVT  276 (292)
T ss_pred             HHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            99999999999999999999999999998754

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG0577|consensus

Probab=100.00  E-value=2e-43  Score=308.76  Aligned_cols=245  Identities=22%  Similarity=0.328  Sum_probs=202.9

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      +...|.-++.||.|+||.||.|++..+.+.||||.++-.....  ......++.|+..|++++|||++.+.++|..+...
T Consensus        24 PEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs--~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~Ta  101 (948)
T KOG0577|consen   24 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS--NEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTA  101 (948)
T ss_pred             HHHHHHHHHHhcCCccceeEEeeccCccceeeeeecccccccc--HHHHHHHHHHHHHHHhccCCCcccccceeeccchH
Confidence            3456778899999999999999999999999999988644322  22356788999999999999999999999999999


Q ss_pred             EEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc
Q psy9858         133 SLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR  212 (307)
Q Consensus       133 ~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  212 (307)
                      |||||||-|+-.|++.-..+++.+.++..|+.+.++||.|||+.+.||||||..|||+++.|.|||+|||.|....    
T Consensus       102 WLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~----  177 (948)
T KOG0577|consen  102 WLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA----  177 (948)
T ss_pred             HHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC----
Confidence            9999999988888887666679999999999999999999999999999999999999999999999999998763    


Q ss_pred             ccccceeeceehhhhhhhc--cccccccccee--eeee-----cCCCCCCCC-C-------CCCChhhhccccCHHHHHH
Q psy9858         213 LYTHQVVTRWYRLIKCLLY--CVQFNVKNVQW--CCFA-----KDPSSHGNL-F-------PGIPLNEIFTAAGDDLLAV  275 (307)
Q Consensus       213 ~~~~~~~t~~y~aPE~~~~--~~~~~~~~Diw--~i~~-----~~~~f~~~~-~-------~~~~~~~~~~~~~~~l~~l  275 (307)
                      ..++++|||.|||||++..  ...|+=++|||  +|-|     .++|+-..+ .       .....--..+.-|+.+.+|
T Consensus       178 PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~F  257 (948)
T KOG0577|consen  178 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF  257 (948)
T ss_pred             chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHH
Confidence            3466799999999999864  34799999999  4433     555544410 0       0000000123457889999


Q ss_pred             HHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         276 ISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       276 i~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      |.+||++-|.+|||.+++|.|+|...-+
T Consensus       258 vd~CLqKipqeRptse~ll~H~fv~R~R  285 (948)
T KOG0577|consen  258 VDSCLQKIPQERPTSEELLKHRFVLRER  285 (948)
T ss_pred             HHHHHhhCcccCCcHHHHhhcchhccCC
Confidence            9999999999999999999999986543

>KOG0193|consensus

Probab=100.00  E-value=1.1e-42  Score=305.11  Aligned_cols=249  Identities=19%  Similarity=0.200  Sum_probs=207.0

Q ss_pred             hhhccCCCceeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCc
Q psy9858          40 KKQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENV  119 (307)
Q Consensus        40 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni  119 (307)
                      ..+...+..+|....++..+..+||+|.||+||+|+|..+   ||||++......+   +..+.|.+|+.++++-+|.||
T Consensus       377 ~r~~s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~---~qlqaFKnEVa~lkkTRH~NI  450 (678)
T KOG0193|consen  377 NRQASDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTP---EQLQAFKNEVAVLKKTRHENI  450 (678)
T ss_pred             cccCCccccccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCH---HHHHHHHHHHHHHhhcchhhh
Confidence            3445556678888999999999999999999999998654   9999999755443   347889999999999999999


Q ss_pred             cccceeeeecCeEEEEEEccCC-ChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEE
Q psy9858         120 LGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKI  198 (307)
Q Consensus       120 ~~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl  198 (307)
                      +-+.|++..... .||+.+|+| +|..+++.....+.....+.|++||++|+.|||.++|||||||..|||+.++++|||
T Consensus       451 lLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkI  529 (678)
T KOG0193|consen  451 LLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKI  529 (678)
T ss_pred             eeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEE
Confidence            999999988877 999999965 588999887777999999999999999999999999999999999999999999999


Q ss_pred             EeecCccccC--CCCcccccceeeceehhhhhhhcc--ccccccccee-------eeeecCCCCCCCCCCCCC-------
Q psy9858         199 GDFGLAKFFG--SPTRLYTHQVVTRWYRLIKCLLYC--VQFNVKNVQW-------CCFAKDPSSHGNLFPGIP-------  260 (307)
Q Consensus       199 ~Dfg~a~~~~--~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~Diw-------~i~~~~~~f~~~~~~~~~-------  260 (307)
                      +|||++....  ....-.....+...|||||++...  ..|++.+|||       .+++|.+||....-....       
T Consensus       530 gDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~  609 (678)
T KOG0193|consen  530 GDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGY  609 (678)
T ss_pred             ecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccc
Confidence            9999986542  222333455778899999999743  3689999999       345599999863333221       


Q ss_pred             ----hhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         261 ----LNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       261 ----~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                          ......+++.++++|+..||..++++||++.+||.
T Consensus       610 l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  610 LMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             cCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence                22223457789999999999999999999999987

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-42  Score=293.43  Aligned_cols=244  Identities=21%  Similarity=0.272  Sum_probs=204.3

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ++|++.+.||.|++|.||+|.+..+++.||+|++....    .......+.+|+++++.++|+||+++++.+.++...++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   76 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE----AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWI   76 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc----cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEE
Confidence            46889999999999999999999999999999987532    11223567899999999999999999999999999999


Q ss_pred             EEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc
Q psy9858         135 VFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL  213 (307)
Q Consensus       135 v~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  213 (307)
                      |+||+ +++|.+++...  .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus        77 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  154 (274)
T cd06609          77 IMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK  154 (274)
T ss_pred             EEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccc
Confidence            99999 57888888765  5899999999999999999999999999999999999999999999999999887544333


Q ss_pred             cccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCC-------CChhhhccc-cCHHHHHHHHH
Q psy9858         214 YTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPG-------IPLNEIFTA-AGDDLLAVISS  278 (307)
Q Consensus       214 ~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~-------~~~~~~~~~-~~~~l~~li~~  278 (307)
                      .....++..|+|||.+.+. .++.++|+|       .+++|..||.......       ......... ++.++.+++.+
T Consensus       155 ~~~~~~~~~y~~PE~~~~~-~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  233 (274)
T cd06609         155 RNTFVGTPFWMAPEVIKQS-GYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSL  233 (274)
T ss_pred             cccccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHH
Confidence            3445778899999999887 699999999       2334999987632111       111111122 78899999999


Q ss_pred             hhhcCCCCCCCHHHHhcCcccCCCccc
Q psy9858         279 LLCLNPTKRADCTATLKMDYFSLTKEM  305 (307)
Q Consensus       279 ~l~~dP~~Rpt~~~il~hp~f~~~~~~  305 (307)
                      ||+.||++|||++++++||||++.++.
T Consensus       234 ~l~~~p~~Rpt~~~il~~~~~~~~~~~  260 (274)
T cd06609         234 CLNKDPKERPSAKELLKHKFIKKAKKT  260 (274)
T ss_pred             HhhCChhhCcCHHHHhhChhhcCCCcc
Confidence            999999999999999999999998764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=7.2e-42  Score=297.83  Aligned_cols=232  Identities=34%  Similarity=0.549  Sum_probs=183.1

Q ss_pred             eEEeecCceEEEEEEEcC--CCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeee--ecCeEEEEE
Q psy9858          61 RSVHVGRFATVFKARDIE--TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG--YMSNVSLVF  136 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~--~~~~~~lv~  136 (307)
                      .+||+|+||+||+|++..  ++..||+|.+....       ....+.+|+++++.++||||+++++++.  .+...+++|
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-------ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLF   79 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-------CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEE
Confidence            679999999999998653  66889999886421       1234678999999999999999999884  456789999


Q ss_pred             EccCCChHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEE----ecCCcEEEEeecCc
Q psy9858         137 EFVDTDLEVIIKDP--------TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLI----NKQGVLKIGDFGLA  204 (307)
Q Consensus       137 e~~~g~l~~~~~~~--------~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~----~~~~~~kl~Dfg~a  204 (307)
                      ||+++++.+++...        ...+++..++.++.||+.||.|||++|++||||||+||++    +.++.+||+|||++
T Consensus        80 e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          80 DYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             eeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            99999988877421        2247889999999999999999999999999999999999    56678999999999


Q ss_pred             cccCCCCc---ccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCCC--------------
Q psy9858         205 KFFGSPTR---LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGIP--------------  260 (307)
Q Consensus       205 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~--------------  260 (307)
                      +.......   ......+|..|+|||.+.+...++.++|||   +    +++|.+||.........              
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS  239 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence            87643321   223457899999999998765789999999   3    34499998752211000              


Q ss_pred             ---------------------h------------------hhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         261 ---------------------L------------------NEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       261 ---------------------~------------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                                           .                  .......+..+.+|+.+||+.||.+|||++|+|+||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                                 0                  00001234568899999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=6.9e-42  Score=292.77  Aligned_cols=239  Identities=20%  Similarity=0.250  Sum_probs=195.4

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ++|++++.||+|+||.||+|.+..+++.||+|++....    .......+.+|++++++++||||+++++.+...+..++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   76 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI----TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISI   76 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC----ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEE
Confidence            36888999999999999999999999999999987532    12224568899999999999999999999999999999


Q ss_pred             EEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCccc
Q psy9858         135 VFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY  214 (307)
Q Consensus       135 v~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  214 (307)
                      +|||+.+..++...    .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......  ..
T Consensus        77 v~e~~~~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--~~  150 (279)
T cd06619          77 CTEFMDGGSLDVYR----KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IA  150 (279)
T ss_pred             EEecCCCCChHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--cc
Confidence            99999554333322    3678889999999999999999999999999999999999999999999999866432  23


Q ss_pred             ccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCCC---------------hhhhccccCHHH
Q psy9858         215 THQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGIP---------------LNEIFTAAGDDL  272 (307)
Q Consensus       215 ~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~---------------~~~~~~~~~~~l  272 (307)
                      ....++..|+|||.+.+. .++.++|+|   +    +++|..||.........               ........++++
T Consensus       151 ~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (279)
T cd06619         151 KTYVGTNAYMAPERISGE-QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKF  229 (279)
T ss_pred             cCCCCChhhcCceeecCC-CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHH
Confidence            345789999999999887 789999999   3    33389998652211100               000112367889


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         273 LAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       273 ~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                      .+++.+||+.||++||+++++++||||...+.
T Consensus       230 ~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~  261 (279)
T cd06619         230 VHFITQCMRKQPKERPAPENLMDHPFIVQYND  261 (279)
T ss_pred             HHHHHHHhhCChhhCCCHHHHhcCcccccccC
Confidence            99999999999999999999999999987654

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=9e-42  Score=299.75  Aligned_cols=246  Identities=33%  Similarity=0.563  Sum_probs=202.1

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec----
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM----  129 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~----  129 (307)
                      .++|.+.+.||+|+||+||+|.+..+++.||||.+......   ......+.+|+.+++.++|+||+++++++...    
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~   80 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDN---RIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREA   80 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccc---cchhHHHHHHHHHHHhcCCCCccchHHheecccccc
Confidence            45799999999999999999999999999999998753211   11234567899999999999999999987644    


Q ss_pred             -CeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         130 -SNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       130 -~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                       ...++++||++++|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus        81 ~~~~~lv~e~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  159 (337)
T cd07858          81 FNDVYIVYELMDTDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS  159 (337)
T ss_pred             cCcEEEEEeCCCCCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence             3589999999999988887653 58999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCC-------------------------
Q psy9858         209 SPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLF-------------------------  256 (307)
Q Consensus       209 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~-------------------------  256 (307)
                      ..........++..|+|||.+.+...++.++|+|   +    +++|.+||.+...                         
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
T cd07858         160 EKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE  239 (337)
T ss_pred             CCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence            4333334456788999999988754789999999   2    3348888865321                         


Q ss_pred             ------------CCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         257 ------------PGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       257 ------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                                  .........+.+++++.++|++||+.||++|||++++++||||+...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~  298 (337)
T cd07858         240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH  298 (337)
T ss_pred             hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence                        00111223346789999999999999999999999999999998754

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=8e-42  Score=293.25  Aligned_cols=244  Identities=22%  Similarity=0.285  Sum_probs=200.1

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEE
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLV  135 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  135 (307)
                      .|+..+.||+|+||+||+|.+..+++.||+|++.......  ......+.+|+++++.++|+||+.+.+.+..++..+++
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv   78 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKK--RKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLV   78 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhh--hhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEE
Confidence            3788899999999999999999999999999987543221  11234567899999999999999999999999999999


Q ss_pred             EEcc-CCChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc
Q psy9858         136 FEFV-DTDLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL  213 (307)
Q Consensus       136 ~e~~-~g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  213 (307)
                      |||+ +++|.+.+... ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++...... ..
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-~~  157 (285)
T cd05632          79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-ES  157 (285)
T ss_pred             EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC-Cc
Confidence            9999 56787777543 335899999999999999999999999999999999999999999999999999765332 22


Q ss_pred             cccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC----------CChhhhccccCHHHHHHH
Q psy9858         214 YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG----------IPLNEIFTAAGDDLLAVI  276 (307)
Q Consensus       214 ~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~----------~~~~~~~~~~~~~l~~li  276 (307)
                      .....++..|+|||.+.+. .++.++|+|   +    +++|..||.......          .........++.++.+|+
T Consensus       158 ~~~~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05632         158 IRGRVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC  236 (285)
T ss_pred             ccCCCCCcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence            2345789999999999877 789999999   2    333999987632210          001122345788999999


Q ss_pred             HHhhhcCCCCCCC-----HHHHhcCcccCCCc
Q psy9858         277 SSLLCLNPTKRAD-----CTATLKMDYFSLTK  303 (307)
Q Consensus       277 ~~~l~~dP~~Rpt-----~~~il~hp~f~~~~  303 (307)
                      .+||+.||++|||     +.++++||||....
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~  268 (285)
T cd05632         237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN  268 (285)
T ss_pred             HHHccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence            9999999999999     88999999998763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=7.1e-42  Score=293.07  Aligned_cols=245  Identities=22%  Similarity=0.323  Sum_probs=199.3

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      +.|++.+.||+|+||.||+|.+..++..+++|.+....     ......+.+|+++++.++|+||+++++.+...+..++
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~   79 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-----EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI   79 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-----HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEE
Confidence            34788899999999999999999999999999986432     1224568899999999999999999999999999999


Q ss_pred             EEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc
Q psy9858         135 VFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL  213 (307)
Q Consensus       135 v~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  213 (307)
                      ||||+ +|++...+.+....+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus        80 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~  159 (282)
T cd06643          80 LIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR  159 (282)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccc
Confidence            99999 56677766655556899999999999999999999999999999999999999999999999999766433333


Q ss_pred             cccceeeceehhhhhhhc----cccccccccee---eee----ecCCCCCCCCCCC---------CChhhhccccCHHHH
Q psy9858         214 YTHQVVTRWYRLIKCLLY----CVQFNVKNVQW---CCF----AKDPSSHGNLFPG---------IPLNEIFTAAGDDLL  273 (307)
Q Consensus       214 ~~~~~~t~~y~aPE~~~~----~~~~~~~~Diw---~i~----~~~~~f~~~~~~~---------~~~~~~~~~~~~~l~  273 (307)
                      .....++..|+|||.+..    ...++.++|+|   +++    +|.+||.......         ......+..++.++.
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
T cd06643         160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFK  239 (282)
T ss_pred             cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHH
Confidence            344578899999999842    23578899999   233    3888887622100         001112335788999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         274 AVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       274 ~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                      ++|.+||+.||.+|||++++++||||+....
T Consensus       240 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  270 (282)
T cd06643         240 DFLKKCLEKNVDARWTTTQLLQHPFVTVNSN  270 (282)
T ss_pred             HHHHHHccCChhhCcCHHHHhcCCCEeccCC
Confidence            9999999999999999999999999986543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=9.6e-42  Score=288.15  Aligned_cols=240  Identities=22%  Similarity=0.373  Sum_probs=197.6

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee-cCeEEE
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY-MSNVSL  134 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~l  134 (307)
                      .|++.+.||.|++|.||++.+..+++.||+|.+.....   .....+.+.+|++++++++|+|++++++.+.. +...++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l   77 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA---SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYI   77 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc---CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEE
Confidence            48999999999999999999999999999999875321   12224567889999999999999999988764 456899


Q ss_pred             EEEcc-CCChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc
Q psy9858         135 VFEFV-DTDLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR  212 (307)
Q Consensus       135 v~e~~-~g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  212 (307)
                      +|||+ ++++.+.+... ...+++.++..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++........
T Consensus        78 v~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          78 VMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             EecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            99999 57888888653 34589999999999999999999999999999999999999999999999999987754433


Q ss_pred             ccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC-------CChhhhccccCHHHHHHHHH
Q psy9858         213 LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG-------IPLNEIFTAAGDDLLAVISS  278 (307)
Q Consensus       213 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~-------~~~~~~~~~~~~~l~~li~~  278 (307)
                      ......+++.|+|||.+.+. .++.++|+|   +    ++.|+.||.......       .........+++++.+++.+
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  236 (257)
T cd08223         158 MASTLIGTPYYMSPELFSNK-PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIAT  236 (257)
T ss_pred             ccccccCCcCccChhHhcCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence            44445678999999999887 788999999   2    333888887632211       11112334578999999999


Q ss_pred             hhhcCCCCCCCHHHHhcCccc
Q psy9858         279 LLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       279 ~l~~dP~~Rpt~~~il~hp~f  299 (307)
                      ||+.||++|||+.+++.||||
T Consensus       237 ~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         237 MLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HhccCcccCCCHHHHhcCCCC
Confidence            999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-42  Score=294.89  Aligned_cols=246  Identities=23%  Similarity=0.323  Sum_probs=203.3

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|++++.||.|++|.||+|.+..++..||+|++...     .......+.+|++++++++|+||+++++.+......
T Consensus         3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (280)
T cd06611           3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-----SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKL   77 (280)
T ss_pred             chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeE
Confidence            457899999999999999999999889999999998743     122245688999999999999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT  211 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  211 (307)
                      ++||||+ +++|.+++......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (280)
T cd06611          78 WILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL  157 (280)
T ss_pred             EEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence            9999999 567888877665668999999999999999999999999999999999999999999999999987664433


Q ss_pred             cccccceeeceehhhhhhhcc----ccccccccee---e----eeecCCCCCCCCCCC---------CChhhhccccCHH
Q psy9858         212 RLYTHQVVTRWYRLIKCLLYC----VQFNVKNVQW---C----CFAKDPSSHGNLFPG---------IPLNEIFTAAGDD  271 (307)
Q Consensus       212 ~~~~~~~~t~~y~aPE~~~~~----~~~~~~~Diw---~----i~~~~~~f~~~~~~~---------~~~~~~~~~~~~~  271 (307)
                      .......++..|+|||.+...    ..++.++|+|   +    +++|..||.......         ......+..++.+
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (280)
T cd06611         158 QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSS  237 (280)
T ss_pred             cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHH
Confidence            333445688999999998632    2467899999   2    333889987632111         0011122357889


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         272 LLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       272 l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      +.+++.+||+.||.+|||++++++||||.+..
T Consensus       238 ~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (280)
T cd06611         238 FNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS  269 (280)
T ss_pred             HHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence            99999999999999999999999999998754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.2e-41  Score=287.24  Aligned_cols=240  Identities=23%  Similarity=0.314  Sum_probs=201.4

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEE
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLV  135 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  135 (307)
                      +|.+.+.||+|++|.||+|.+..+++.|++|.+......   ......+.+|+++++.++||||+++++++...+..+++
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN---RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIV   77 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC---HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEE
Confidence            488899999999999999999999999999998753222   22356788999999999999999999999999999999


Q ss_pred             EEcc-CCChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc
Q psy9858         136 FEFV-DTDLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL  213 (307)
Q Consensus       136 ~e~~-~g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  213 (307)
                      |||+ +++|.+++... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~  157 (256)
T cd08529          78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF  157 (256)
T ss_pred             EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence            9999 67888888764 446889999999999999999999999999999999999999999999999999877554433


Q ss_pred             cccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC-------CChhhhccccCHHHHHHHHHh
Q psy9858         214 YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG-------IPLNEIFTAAGDDLLAVISSL  279 (307)
Q Consensus       214 ~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~-------~~~~~~~~~~~~~l~~li~~~  279 (307)
                      .....++..|+|||.+.+. .++.++|+|   +    +++|..||.......       .........++.++.+++.+|
T Consensus       158 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  236 (256)
T cd08529         158 ANTIVGTPYYLSPELCEDK-PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQC  236 (256)
T ss_pred             hhccccCccccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence            4445678899999999887 789999999   2    333889987643111       111122235788999999999


Q ss_pred             hhcCCCCCCCHHHHhcCccc
Q psy9858         280 LCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       280 l~~dP~~Rpt~~~il~hp~f  299 (307)
                      |+.+|++||++.+++.|||+
T Consensus       237 l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         237 LTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             ccCCcccCcCHHHHhhCCCC
Confidence            99999999999999999996

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.3e-41  Score=295.13  Aligned_cols=248  Identities=38%  Similarity=0.608  Sum_probs=198.5

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY  128 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  128 (307)
                      .+....++|++.+.||+|+||.||+|.+..+++.||||++.....   .......+.+|++++++++||||+++++++..
T Consensus         6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   82 (310)
T cd07865           6 PFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE---KEGFPITALREIKILQLLKHENVVNLIEICRT   82 (310)
T ss_pred             cccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC---cCCchhHHHHHHHHHHhCCCCCccceEEEEec
Confidence            356678899999999999999999999999999999999875321   22223456689999999999999999998765


Q ss_pred             cC--------eEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEe
Q psy9858         129 MS--------NVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGD  200 (307)
Q Consensus       129 ~~--------~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~D  200 (307)
                      ..        ..++||||+++++.+.+......+++.+++.++.||+.||.|||++|++|+||||+||+++.++.++|+|
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~d  162 (310)
T cd07865          83 KATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLAD  162 (310)
T ss_pred             ccccccCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECc
Confidence            43        4699999999999988887766789999999999999999999999999999999999999999999999


Q ss_pred             ecCccccCCCCc----ccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCC------------
Q psy9858         201 FGLAKFFGSPTR----LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFP------------  257 (307)
Q Consensus       201 fg~a~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~------------  257 (307)
                      ||++........    ......++..|+|||.+.+...++.++|+|       .+++|..||.+....            
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~  242 (310)
T cd07865         163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS  242 (310)
T ss_pred             CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            999987643221    122345678899999987765678999999       233378877652210            


Q ss_pred             -------CC--------------Chhhh-----ccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         258 -------GI--------------PLNEI-----FTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       258 -------~~--------------~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                             ..              .....     ....+..+.++|.+||+.||.+|||++++|+||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence                   00              00000     00135678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-41  Score=292.14  Aligned_cols=240  Identities=41%  Similarity=0.675  Sum_probs=199.0

Q ss_pred             eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEE
Q psy9858          57 YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVF  136 (307)
Q Consensus        57 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  136 (307)
                      |++.+.||.|++|.||+|.+..+|..||+|++.....   .......+.+|+++++.++|+|++++++++.+.+..+++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~   77 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE---DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVF   77 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc---cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEE
Confidence            6788999999999999999999999999999875421   1222356788999999999999999999999999999999


Q ss_pred             EccCCChHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcccc
Q psy9858         137 EFVDTDLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYT  215 (307)
Q Consensus       137 e~~~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~  215 (307)
                      ||++++|.+++.... ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++...........
T Consensus        78 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~  157 (283)
T cd07835          78 EFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYT  157 (283)
T ss_pred             eccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccC
Confidence            999889988886544 3589999999999999999999999999999999999999999999999999987643333334


Q ss_pred             cceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCC--------------------------------
Q psy9858         216 HQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLF--------------------------------  256 (307)
Q Consensus       216 ~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~--------------------------------  256 (307)
                      ...++..|+|||.+.+...++.++|+|       .+++|.+||.....                                
T Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd07835         158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF  237 (283)
T ss_pred             ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence            446688999999887765678999999       33448888864211                                


Q ss_pred             ---CCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         257 ---PGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       257 ---~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                         ...........++.++.++|.+||+.||.+|||++++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             ccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence               0011122234577899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-41  Score=298.84  Aligned_cols=244  Identities=32%  Similarity=0.530  Sum_probs=198.1

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec----
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM----  129 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~----  129 (307)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++....    .......+.+|+.+++.++|+||+++++++...    
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   79 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE----HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFES   79 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc----cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccc
Confidence            468999999999999999999999999999999986421    122345677899999999999999999876543    


Q ss_pred             -CeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         130 -SNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       130 -~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                       ...++++||+.+++.+.+...  .+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++....
T Consensus        80 ~~~~~lv~e~~~~~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849          80 FNDVYIVQELMETDLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD  157 (336)
T ss_pred             cceEEEEehhcccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence             458999999999998887654  48999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCc---ccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC--------------------
Q psy9858         209 SPTR---LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG--------------------  258 (307)
Q Consensus       209 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~--------------------  258 (307)
                      ....   ......++..|+|||.+.+...++.++|||   +    +++|..||.+.....                    
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI  237 (336)
T ss_pred             ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            3221   122346788999999987655789999999   2    333998886532100                    


Q ss_pred             -----------------CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         259 -----------------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       259 -----------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                                       .......+..++++.++|.+||+.||++|||+.++++||||+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence                             000111234678899999999999999999999999999998654

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=7.3e-42  Score=299.14  Aligned_cols=243  Identities=16%  Similarity=0.142  Sum_probs=191.9

Q ss_pred             EEeEEeec--CceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEE
Q psy9858          59 QWRSVHVG--RFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVF  136 (307)
Q Consensus        59 ~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  136 (307)
                      +++.||+|  +|++||++.+..+|+.||+|++.....   .......+.+|+++++.++||||+++++++..++..++||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~   78 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC---TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT   78 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhc---cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEE
Confidence            46789999  788999999999999999999875321   2223456778999999999999999999999999999999


Q ss_pred             Ecc-CCChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc--
Q psy9858         137 EFV-DTDLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR--  212 (307)
Q Consensus       137 e~~-~g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--  212 (307)
                      ||+ +|++.+++... ...+++..+..++.|++.||.|||++|++||||||+||+++.++.++++||+.+........  
T Consensus        79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            999 57888888643 33489999999999999999999999999999999999999999999999987654321111  


Q ss_pred             -----ccccceeeceehhhhhhhcc-ccccccccee---e----eeecCCCCCCCCCCCC--------------------
Q psy9858         213 -----LYTHQVVTRWYRLIKCLLYC-VQFNVKNVQW---C----CFAKDPSSHGNLFPGI--------------------  259 (307)
Q Consensus       213 -----~~~~~~~t~~y~aPE~~~~~-~~~~~~~Diw---~----i~~~~~~f~~~~~~~~--------------------  259 (307)
                           ......++..|+|||.+.+. ..++.++|||   +    +++|..||........                    
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA  238 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence                 11223567789999999764 3689999999   3    3339999865110000                    


Q ss_pred             --------------------------------ChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         260 --------------------------------PLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       260 --------------------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                                                      ........+++++.+||.+||+.||++|||++++++||||++.+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~~  315 (327)
T cd08227         239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR  315 (327)
T ss_pred             hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcch
Confidence                                            000011235678999999999999999999999999999988664

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-41  Score=295.99  Aligned_cols=242  Identities=35%  Similarity=0.565  Sum_probs=196.3

Q ss_pred             eeeEEeEEeecCceEEEEEEEcC--CCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec--Ce
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIE--TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM--SN  131 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~  131 (307)
                      +|.+.+.||+|++|.||+|.+..  ++..||+|.+.....  ........+.+|+.+++.++||||+++++++.+.  ..
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE--QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKS   78 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc--cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCce
Confidence            58899999999999999999888  899999999986421  1222345677899999999999999999999888  88


Q ss_pred             EEEEEEccCCChHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEec----CCcEEEEeecC
Q psy9858         132 VSLVFEFVDTDLEVIIKDP----TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK----QGVLKIGDFGL  203 (307)
Q Consensus       132 ~~lv~e~~~g~l~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~----~~~~kl~Dfg~  203 (307)
                      .++||||+++++.+.+...    ...+++..++.++.||+.||.|||+.|++||||||+||+++.    ++.+||+|||+
T Consensus        79 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~  158 (316)
T cd07842          79 VYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL  158 (316)
T ss_pred             EEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence            9999999998888776432    235889999999999999999999999999999999999999    99999999999


Q ss_pred             ccccCCCCc---ccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCC--------------
Q psy9858         204 AKFFGSPTR---LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGI--------------  259 (307)
Q Consensus       204 a~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~--------------  259 (307)
                      +........   ......++..|+|||.+.+...++.++|+|   +    +++|.+||.+......              
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
T cd07842         159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF  238 (316)
T ss_pred             ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence            987643322   123346788999999988765789999999   2    3338888876432220              


Q ss_pred             -----------------------------------Chhhh---ccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         260 -----------------------------------PLNEI---FTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       260 -----------------------------------~~~~~---~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                                                         .....   ....+.++.+++.+||+.||++|||++++++||||
T Consensus       239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence                                               00000   01456789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-41  Score=292.23  Aligned_cols=242  Identities=31%  Similarity=0.540  Sum_probs=199.9

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ++|++.+.||+|++|.||+|.+..+++.||+|++.....   .......+.+|+++++.++|+||+++++++...+..++
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   77 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED---DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYL   77 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc---cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEE
Confidence            479999999999999999999999999999999875321   22234678899999999999999999999999999999


Q ss_pred             EEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc-c
Q psy9858         135 VFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR-L  213 (307)
Q Consensus       135 v~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-~  213 (307)
                      +|||+++++.+.+......+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........ .
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~  157 (288)
T cd07833          78 VFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP  157 (288)
T ss_pred             EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence            999998777766665555689999999999999999999999999999999999999999999999999987754332 3


Q ss_pred             cccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCC-----------------------------
Q psy9858         214 YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFP-----------------------------  257 (307)
Q Consensus       214 ~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~-----------------------------  257 (307)
                      .....++..|+|||.+.+...++.++|+|   +    ++.|.+||.+....                             
T Consensus       158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07833         158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG  237 (288)
T ss_pred             ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence            34456788999999998775788999999   2    33388887642110                             


Q ss_pred             ----CCC----hh-hhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         258 ----GIP----LN-EIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       258 ----~~~----~~-~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                          ...    .. .....++.++.+||++||+.||++|||++++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence                000    00 1112348899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.7e-41  Score=294.47  Aligned_cols=241  Identities=24%  Similarity=0.323  Sum_probs=197.8

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ++|++.+.||+|+||.||++.+..++..+|+|.+....    .......+.+|++++++++||||+++++++..++..++
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   76 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI----KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISI   76 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEE
Confidence            46999999999999999999999999999999987431    22334568899999999999999999999999999999


Q ss_pred             EEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc
Q psy9858         135 VFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD-HWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR  212 (307)
Q Consensus       135 v~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  212 (307)
                      +|||+ +++|.+++.+. ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++......  
T Consensus        77 v~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  153 (308)
T cd06615          77 CMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  153 (308)
T ss_pred             EeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence            99999 56888888765 358999999999999999999997 59999999999999999999999999998765332  


Q ss_pred             ccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCC-----------CC--------------
Q psy9858         213 LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPG-----------IP--------------  260 (307)
Q Consensus       213 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~-----------~~--------------  260 (307)
                      ......++..|+|||.+.+. .++.++|+|       .+++|..||.......           ..              
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (308)
T cd06615         154 MANSFVGTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPD  232 (308)
T ss_pred             ccccCCCCcCccChhHhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCC
Confidence            22345778999999998776 789999999       2334888886411000           00              


Q ss_pred             ------------------hhhh-ccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         261 ------------------LNEI-FTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       261 ------------------~~~~-~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                                        .... ...++.++.+++.+||+.||++|||++++++||||.+..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  294 (308)
T cd06615         233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE  294 (308)
T ss_pred             ccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcc
Confidence                              0000 012577899999999999999999999999999998754

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.4e-41  Score=292.46  Aligned_cols=242  Identities=25%  Similarity=0.267  Sum_probs=203.2

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ++|++.+.||+|++|.||++.+..+++.||+|++......  .......+.+|++++++++||||+++++++.+....++
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   78 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV--KLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYL   78 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEE
Confidence            4799999999999999999999999999999998753221  12224568899999999999999999999999999999


Q ss_pred             EEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc
Q psy9858         135 VFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL  213 (307)
Q Consensus       135 v~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  213 (307)
                      +|||+ +++|.+++.... .+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......   
T Consensus        79 v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---  154 (290)
T cd05580          79 VMEYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---  154 (290)
T ss_pred             EEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence            99999 788888887653 5899999999999999999999999999999999999999999999999999876443   


Q ss_pred             cccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCC------CChhhhccccCHHHHHHHHHhh
Q psy9858         214 YTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPG------IPLNEIFTAAGDDLLAVISSLL  280 (307)
Q Consensus       214 ~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~------~~~~~~~~~~~~~l~~li~~~l  280 (307)
                      .....+++.|+|||.+.+. ..+.++|+|       .+++|..||.......      ......+..++..+.++|.+||
T Consensus       155 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  233 (290)
T cd05580         155 TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLL  233 (290)
T ss_pred             CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHc
Confidence            2334678999999999877 788999999       3344888987633110      0011233456899999999999


Q ss_pred             hcCCCCCC-----CHHHHhcCcccCCCc
Q psy9858         281 CLNPTKRA-----DCTATLKMDYFSLTK  303 (307)
Q Consensus       281 ~~dP~~Rp-----t~~~il~hp~f~~~~  303 (307)
                      +.||.+|+     +++++++||||+...
T Consensus       234 ~~~p~~R~~~~~~~~~~l~~~~~~~~~~  261 (290)
T cd05580         234 QVDLTKRLGNLKNGVNDIKNHPWFAGID  261 (290)
T ss_pred             cCCHHHccCcccCCHHHHHcCcccccCC
Confidence            99999999     999999999998765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.7e-41  Score=297.60  Aligned_cols=246  Identities=29%  Similarity=0.554  Sum_probs=201.2

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeee----ecC
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG----YMS  130 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~----~~~  130 (307)
                      ++|++.+.||+|++|.||+|.+..+|+.||+|++.....   .......+.+|+.+++.++||||+++++++.    ...
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD---VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK   81 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc---cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence            689999999999999999999999999999999875321   1223456778999999999999999999875    345


Q ss_pred             eEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         131 NVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       131 ~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      ..++||||+.|+|.+.+.... .+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus        82 ~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  160 (334)
T cd07855          82 DVYVVMDLMESDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS  160 (334)
T ss_pred             eEEEEEehhhhhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence            789999999989888886554 4899999999999999999999999999999999999999999999999999765332


Q ss_pred             C----cccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCC----------------------
Q psy9858         211 T----RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFP----------------------  257 (307)
Q Consensus       211 ~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~----------------------  257 (307)
                      .    .......++..|+|||.+.+...++.++|||   +    ++.|..||.+....                      
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~  240 (334)
T cd07855         161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG  240 (334)
T ss_pred             CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence            1    1122346788999999987755789999999   2    33488888653210                      


Q ss_pred             ---------------CCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         258 ---------------GIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       258 ---------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                                     ........+..++++.++|++||+.||.+|||+++++.||||++.+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~  302 (334)
T cd07855         241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD  302 (334)
T ss_pred             hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence                           01111223457899999999999999999999999999999987654

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-41  Score=294.30  Aligned_cols=246  Identities=20%  Similarity=0.213  Sum_probs=201.6

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ++|++.+.||+|++|.||+|.+..+++.||+|.+.......  ....+.+.+|+++++.++|+||+++++.+.+....++
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   78 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK--RNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCL   78 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccch--HHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEE
Confidence            47999999999999999999998899999999998643221  1234668899999999999999999999999999999


Q ss_pred             EEEcc-CCChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc
Q psy9858         135 VFEFV-DTDLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR  212 (307)
Q Consensus       135 v~e~~-~g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  212 (307)
                      +|||+ +++|.+++... ...+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  158 (316)
T cd05574          79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP  158 (316)
T ss_pred             EEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence            99999 67888888653 34589999999999999999999999999999999999999999999999999876532110


Q ss_pred             -----------------------------ccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCC
Q psy9858         213 -----------------------------LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLF  256 (307)
Q Consensus       213 -----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~  256 (307)
                                                   ......|+..|+|||.+.+. .++.++|||       ++++|..||.+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC-CCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence                                         11123578889999999887 789999999       34449999876322


Q ss_pred             CC--------CChhhhccccCHHHHHHHHHhhhcCCCCCCC----HHHHhcCcccCCCc
Q psy9858         257 PG--------IPLNEIFTAAGDDLLAVISSLLCLNPTKRAD----CTATLKMDYFSLTK  303 (307)
Q Consensus       257 ~~--------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt----~~~il~hp~f~~~~  303 (307)
                      ..        .........+++.+.++|.+||+.||++|||    ++++|+||||++.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~  296 (316)
T cd05574         238 DETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN  296 (316)
T ss_pred             HHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence            11        0000111226899999999999999999999    99999999998864

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=5.7e-42  Score=301.17  Aligned_cols=238  Identities=20%  Similarity=0.275  Sum_probs=188.0

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceee
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDI-----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVF  126 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~  126 (307)
                      ..++|++++.||+|+||.||+|.+.     .++..||+|++....    .......+.+|+.++..+ +||||+++++++
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~   80 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA----TASEHKALMSELKILIHIGNHLNVVNLLGAC   80 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc----chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence            4568999999999999999999752     345789999987431    122245688999999999 899999999987


Q ss_pred             eec-CeEEEEEEcc-CCChHHHHhCCC-----------------------------------------------------
Q psy9858         127 GYM-SNVSLVFEFV-DTDLEVIIKDPT-----------------------------------------------------  151 (307)
Q Consensus       127 ~~~-~~~~lv~e~~-~g~l~~~~~~~~-----------------------------------------------------  151 (307)
                      ... ...+++|||+ +|+|.+++....                                                     
T Consensus        81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (338)
T cd05102          81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP  160 (338)
T ss_pred             cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence            654 4689999999 688988886421                                                     


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc--cccceeec
Q psy9858         152 --------IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL--YTHQVVTR  221 (307)
Q Consensus       152 --------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~  221 (307)
                              ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++........  .....++.
T Consensus       161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence                    23677888999999999999999999999999999999999999999999999865322111  12234567


Q ss_pred             eehhhhhhhccccccccccee---ee----ee-cCCCCCCCCCCC--------CChhhhccccCHHHHHHHHHhhhcCCC
Q psy9858         222 WYRLIKCLLYCVQFNVKNVQW---CC----FA-KDPSSHGNLFPG--------IPLNEIFTAAGDDLLAVISSLLCLNPT  285 (307)
Q Consensus       222 ~y~aPE~~~~~~~~~~~~Diw---~i----~~-~~~~f~~~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~dP~  285 (307)
                      .|+|||.+.+. .++.++|||   ++    +. |..||.+.....        ......+..+++++.+++.+||+.||.
T Consensus       241 ~y~aPE~~~~~-~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~  319 (338)
T cd05102         241 KWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPK  319 (338)
T ss_pred             cccCcHHhhcC-CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChh
Confidence            89999999887 889999999   32    32 888987633211        111122346788999999999999999


Q ss_pred             CCCCHHHHhc
Q psy9858         286 KRADCTATLK  295 (307)
Q Consensus       286 ~Rpt~~~il~  295 (307)
                      +|||+.++++
T Consensus       320 ~RPs~~el~~  329 (338)
T cd05102         320 ERPTFSALVE  329 (338)
T ss_pred             hCcCHHHHHH
Confidence            9999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=3.5e-41  Score=288.60  Aligned_cols=237  Identities=31%  Similarity=0.469  Sum_probs=193.8

Q ss_pred             eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-CCCccccceeeeec--CeEE
Q psy9858          57 YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-HENVLGLTDVFGYM--SNVS  133 (307)
Q Consensus        57 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~--~~~~  133 (307)
                      |++++.||+|+||.||+|.+..+++.||+|++.......    ......+|+.+++++. |+|++++++++.+.  +..+
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   76 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL----EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLA   76 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc----hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEE
Confidence            678999999999999999999999999999987532111    1223457899999885 99999999999887  8899


Q ss_pred             EEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc
Q psy9858         134 LVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL  213 (307)
Q Consensus       134 lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  213 (307)
                      +||||++|++.+.+......+++..+..++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||++....... .
T Consensus        77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~-~  154 (282)
T cd07831          77 LVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP-P  154 (282)
T ss_pred             EEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCC-C
Confidence            99999999999988876556899999999999999999999999999999999999999 999999999998764332 2


Q ss_pred             cccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCC----------------------------
Q psy9858         214 YTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPG----------------------------  258 (307)
Q Consensus       214 ~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~----------------------------  258 (307)
                      .....++..|+|||.+.....++.++|+|       .+++|..||.+.....                            
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07831         155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY  234 (282)
T ss_pred             cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence            23345788999999876654788999999       2334888886522100                            


Q ss_pred             -------CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         259 -------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       259 -------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                             .........++.++.++|.+||+.||++|||++++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence                   00111223568999999999999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.2e-41  Score=285.67  Aligned_cols=238  Identities=21%  Similarity=0.309  Sum_probs=200.3

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEE
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVS  133 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  133 (307)
                      .++|++.+.||+|++|.||+|.+..++..|++|.+....    .   .+.+.+|+++++.++|+||+++++.+......+
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~   74 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----D---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLW   74 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----H---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEE
Confidence            468999999999999999999998889999999987421    1   467889999999999999999999999999999


Q ss_pred             EEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc
Q psy9858         134 LVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR  212 (307)
Q Consensus       134 lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  212 (307)
                      +++||+ +++|.+++......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus        75 l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (256)
T cd06612          75 IVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA  154 (256)
T ss_pred             EEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence            999999 5688888876666789999999999999999999999999999999999999999999999999987754433


Q ss_pred             ccccceeeceehhhhhhhccccccccccee--e-----eeecCCCCCCCCCCCC---------ChhhhccccCHHHHHHH
Q psy9858         213 LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW--C-----CFAKDPSSHGNLFPGI---------PLNEIFTAAGDDLLAVI  276 (307)
Q Consensus       213 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw--~-----i~~~~~~f~~~~~~~~---------~~~~~~~~~~~~l~~li  276 (307)
                      ......++..|+|||.+.+. .++.++|||  +     ++.|..||........         ........++.++.+++
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  233 (256)
T cd06612         155 KRNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFV  233 (256)
T ss_pred             ccccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHH
Confidence            33344578899999998877 889999999  2     3338888865221110         00111234678999999


Q ss_pred             HHhhhcCCCCCCCHHHHhcCccc
Q psy9858         277 SSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       277 ~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                      .+||+.||.+|||++|+|+||||
T Consensus       234 ~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         234 KKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHHhcChhhCcCHHHHhcCCCC
Confidence            99999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.1e-41  Score=290.23  Aligned_cols=245  Identities=20%  Similarity=0.297  Sum_probs=195.4

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHH-HHhcCCCCccccceeeeecCeEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKL-LQELHHENVLGLTDVFGYMSNVS  133 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~ni~~~~~~~~~~~~~~  133 (307)
                      ++|++++.||+|+||.||+|.+..+|+.||+|++.......    ....+..|+.+ ++.++||||+++++++...+..+
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~   76 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ----EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVW   76 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH----HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEE
Confidence            47999999999999999999999999999999987542211    13345566665 56678999999999999999999


Q ss_pred             EEEEccCCChHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeecCCCCcEEEecCCcEEEEeecCccccCC
Q psy9858         134 LVFEFVDTDLEVIIKD---PTIVFTPSNIKAYAIMTLRGLEYLHDH-WILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS  209 (307)
Q Consensus       134 lv~e~~~g~l~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  209 (307)
                      ++|||++|+|.+++..   ....+++..+..++.||+.||.|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus        77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          77 ICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             EEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            9999999988777653   334589999999999999999999997 999999999999999999999999999987643


Q ss_pred             CCcccccceeeceehhhhhhhcc---ccccccccee---ee----eecCCCCCCCCCCC--------CChhhh-ccccCH
Q psy9858         210 PTRLYTHQVVTRWYRLIKCLLYC---VQFNVKNVQW---CC----FAKDPSSHGNLFPG--------IPLNEI-FTAAGD  270 (307)
Q Consensus       210 ~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~Diw---~i----~~~~~~f~~~~~~~--------~~~~~~-~~~~~~  270 (307)
                      . .......++..|+|||.+.+.   ..++.++|+|   ++    ++|..||.......        ...... ...++.
T Consensus       157 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd06617         157 S-VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSP  235 (283)
T ss_pred             c-cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCH
Confidence            2 222334678899999988652   2568899999   33    33888886421110        000111 124688


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         271 DLLAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       271 ~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                      ++.++|.+||+.+|.+|||++++++||||.+.+.
T Consensus       236 ~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  269 (283)
T cd06617         236 EFQDFVNKCLKKNYKERPNYPELLQHPFFELHLS  269 (283)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCchhhhccc
Confidence            9999999999999999999999999999988654

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.9e-41  Score=288.76  Aligned_cols=241  Identities=20%  Similarity=0.282  Sum_probs=194.8

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeee---
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGY---  128 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~---  128 (307)
                      ..+.|++.+.||+|+||.||+|.+..+++.||+|++....      .....+.+|+.+++.+ +|+||+++++++..   
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   77 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG------DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP   77 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC------ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCC
Confidence            4567899999999999999999999999999999987532      1134577899999998 69999999998864   


Q ss_pred             ---cCeEEEEEEcc-CCChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecC
Q psy9858         129 ---MSNVSLVFEFV-DTDLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGL  203 (307)
Q Consensus       129 ---~~~~~lv~e~~-~g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  203 (307)
                         ....+++|||+ +|+|.+++... ...+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||+
T Consensus        78 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          78 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             CCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCC
Confidence               35689999999 57888888753 34588999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCcccccceeeceehhhhhhhcc----ccccccccee---e----eeecCCCCCCCCCC--------CCChhhh
Q psy9858         204 AKFFGSPTRLYTHQVVTRWYRLIKCLLYC----VQFNVKNVQW---C----CFAKDPSSHGNLFP--------GIPLNEI  264 (307)
Q Consensus       204 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~~Diw---~----i~~~~~~f~~~~~~--------~~~~~~~  264 (307)
                      +..............++..|+|||.+.+.    ..++.++|+|   +    +++|..||......        .......
T Consensus       158 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  237 (272)
T cd06637         158 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLK  237 (272)
T ss_pred             ceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCC
Confidence            98764333333445788999999998632    2578899999   2    33388888652110        0011111


Q ss_pred             ccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         265 FTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       265 ~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                      ...++.++.+|+.+||+.||.+|||+++++.||||
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         238 SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            23467899999999999999999999999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=4.7e-41  Score=285.60  Aligned_cols=243  Identities=19%  Similarity=0.307  Sum_probs=194.7

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee--cCeE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY--MSNV  132 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~  132 (307)
                      .+|...+.||+|+||.||+|.+..++..||+|++...............+.+|+.+++.++||||+++++.+..  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            47899999999999999999999999999999987543222222334567899999999999999999998865  4678


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT  211 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  211 (307)
                      ++++||+ +++|.+.+.... .+++.....++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC  160 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence            9999999 567888876543 47899999999999999999999999999999999999999999999999997653211


Q ss_pred             ---cccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCC--------CCChhhhccccCHHHH
Q psy9858         212 ---RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFP--------GIPLNEIFTAAGDDLL  273 (307)
Q Consensus       212 ---~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~--------~~~~~~~~~~~~~~l~  273 (307)
                         .......++..|+|||.+.+. .++.++|+|   +    +++|..||......        .......+..+++.+.
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (266)
T cd06651         161 MSGTGIRSVTGTPYWMSPEVISGE-GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHAR  239 (266)
T ss_pred             ccCCccccCCccccccCHHHhCCC-CCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHH
Confidence               112234578899999999876 789999999   2    33388998762111        1111222345678888


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhcCcccC
Q psy9858         274 AVISSLLCLNPTKRADCTATLKMDYFS  300 (307)
Q Consensus       274 ~li~~~l~~dP~~Rpt~~~il~hp~f~  300 (307)
                      +++ +||..||++|||++++++||||+
T Consensus       240 ~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         240 DFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             HHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            998 67788999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.8e-41  Score=284.45  Aligned_cols=240  Identities=22%  Similarity=0.384  Sum_probs=199.4

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEE
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLV  135 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  135 (307)
                      +|++.+.||+|+||.||++++..+|+.||+|.+......   ......+.+|+.+++.++|+||+++++++...+..++|
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS---PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIV   77 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC---hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEE
Confidence            589999999999999999999999999999998753221   22245688999999999999999999999999999999


Q ss_pred             EEcc-CCChHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc
Q psy9858         136 FEFV-DTDLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL  213 (307)
Q Consensus       136 ~e~~-~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  213 (307)
                      |||+ +++|.+.+.... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  157 (256)
T cd08218          78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL  157 (256)
T ss_pred             EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence            9999 678888886543 34789999999999999999999999999999999999999999999999999876544333


Q ss_pred             cccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCC-------CCChhhhccccCHHHHHHHHHh
Q psy9858         214 YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFP-------GIPLNEIFTAAGDDLLAVISSL  279 (307)
Q Consensus       214 ~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~-------~~~~~~~~~~~~~~l~~li~~~  279 (307)
                      .....++..|+|||.+.+. .++.++|+|   +    ++.|..||......       .......+..++.++.++|.+|
T Consensus       158 ~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  236 (256)
T cd08218         158 ARTCIGTPYYLSPEICENR-PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQL  236 (256)
T ss_pred             hhhccCCccccCHHHhCCC-CCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHH
Confidence            3344678899999999877 788999999   2    33388887653211       1111123345788999999999


Q ss_pred             hhcCCCCCCCHHHHhcCccc
Q psy9858         280 LCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       280 l~~dP~~Rpt~~~il~hp~f  299 (307)
                      |+.+|.+||++.++++||||
T Consensus       237 l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         237 FKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             hhCChhhCcCHHHHhhCcCC
Confidence            99999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=6.5e-41  Score=290.87  Aligned_cols=244  Identities=40%  Similarity=0.652  Sum_probs=197.2

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec---
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM---  129 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---  129 (307)
                      ..++|++.+.||+|++|.||+|.+..+++.||+|++......+   .....+.+|+++++.++|+||+++++++...   
T Consensus         6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (311)
T cd07866           6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD---GFPITALREIKILKKLKHPNVVPLIDMAVERPDK   82 (311)
T ss_pred             ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC---CcchhHHHHHHHHHhcCCCCccchhhheeccccc
Confidence            3689999999999999999999999999999999987543222   1234567899999999999999999987433   


Q ss_pred             -----CeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCc
Q psy9858         130 -----SNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA  204 (307)
Q Consensus       130 -----~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  204 (307)
                           ...+++|||+.+++...+......+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++
T Consensus        83 ~~~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          83 SKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             ccccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence                 357999999999998888876667999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCc-----------ccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC--------
Q psy9858         205 KFFGSPTR-----------LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG--------  258 (307)
Q Consensus       205 ~~~~~~~~-----------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~--------  258 (307)
                      ........           ......+++.|+|||.+.+...++.++|||   +    +++|.+||.+.....        
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~  242 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL  242 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            86543211           112335678899999987765789999999   2    333888886521100        


Q ss_pred             ----------------------------CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         259 ----------------------------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       259 ----------------------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                                                  ..........++.+.++|.+||+.||.+|||+.++++||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence                                        00111123455788999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=5.2e-41  Score=296.74  Aligned_cols=241  Identities=29%  Similarity=0.435  Sum_probs=195.2

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec---
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM---  129 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---  129 (307)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++.....   .......+.+|+.+++.++|+||+++++++...   
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ---NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSL   90 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc---ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCc
Confidence            45789999999999999999999999999999999864321   122235577899999999999999999987543   


Q ss_pred             ---CeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         130 ---SNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       130 ---~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                         ...|+||||+.+++.+.+...   +++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++.
T Consensus        91 ~~~~~~~lv~e~~~~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  167 (353)
T cd07850          91 EEFQDVYLVMELMDANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  167 (353)
T ss_pred             cccCcEEEEEeccCCCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCcccee
Confidence               357999999999998887654   78899999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCC----------------------
Q psy9858         207 FGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFP----------------------  257 (307)
Q Consensus       207 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~----------------------  257 (307)
                      ..... ......++..|+|||.+.+. .++.++|||   +    +++|..||......                      
T Consensus       168 ~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (353)
T cd07850         168 AGTSF-MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ  245 (353)
T ss_pred             CCCCC-CCCCCcccccccCHHHHhCC-CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence            64332 23344678899999999887 889999999   2    33388888642100                      


Q ss_pred             --------------CCChhhh-------------ccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCC
Q psy9858         258 --------------GIPLNEI-------------FTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSL  301 (307)
Q Consensus       258 --------------~~~~~~~-------------~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~  301 (307)
                                    .......             ....++.+.++|.+||+.||.+|||+.|+|+||||+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~  316 (353)
T cd07850         246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV  316 (353)
T ss_pred             hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence                          0000000             1124567899999999999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1e-40  Score=283.27  Aligned_cols=241  Identities=23%  Similarity=0.283  Sum_probs=199.3

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ++|++.+.||.|++|+||+|.+..++..+|+|++.......    ..+.+.+|+++++.++|+||+++++.+......++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   76 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT----SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWL   76 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch----HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEE
Confidence            47999999999999999999988899999999987532211    35678899999999999999999999999999999


Q ss_pred             EEEcc-CCChHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC
Q psy9858         135 VFEFV-DTDLEVIIKDP--TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT  211 (307)
Q Consensus       135 v~e~~-~g~l~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  211 (307)
                      +||++ +++|.+++...  ...+++..+..++.|++.||.+||+.|++|+||+|+||++++++.++|+|||++.......
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          77 VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             EEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            99999 57888888653  2358999999999999999999999999999999999999999999999999998765432


Q ss_pred             cc----cccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCCCC----------hhh--hcccc
Q psy9858         212 RL----YTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPGIP----------LNE--IFTAA  268 (307)
Q Consensus       212 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~~~----------~~~--~~~~~  268 (307)
                      ..    .....++..|+|||.+.....++.++|+|       .++.|..||.........          ...  ....+
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKY  236 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccc
Confidence            22    23346788999999988765789999999       233499998763221100          001  11256


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         269 GDDLLAVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       269 ~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                      ++.+.+++.+||+.||++|||++++++||||
T Consensus       237 ~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         237 SKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             cHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            7899999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG1187|consensus

Probab=100.00  E-value=1.6e-41  Score=296.87  Aligned_cols=247  Identities=23%  Similarity=0.274  Sum_probs=196.0

Q ss_pred             ccCCCceeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCcccc
Q psy9858          43 YLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL  122 (307)
Q Consensus        43 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~  122 (307)
                      ..++..++...+++|.....||+|+||.||+|. ..+|..||||.+......    . .++|.+|+.++.+++|||+|++
T Consensus        63 ~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~-l~~~~~vAVK~~~~~~~~----~-~~eF~~Ei~~ls~l~H~Nlv~L  136 (361)
T KOG1187|consen   63 RSFSYDELRKATNNFSESNLIGEGGFGTVYKGV-LSDGTVVAVKRLSSNSGQ----G-EREFLNEVEILSRLRHPNLVKL  136 (361)
T ss_pred             ceeeHHHHHHHHhCCchhcceecCCCeEEEEEE-ECCCCEEEEEEecCCCCc----c-hhHHHHHHHHHhcCCCcCcccE
Confidence            345666777888999999999999999999998 566689999987743211    1 3559999999999999999999


Q ss_pred             ceeeeecC-eEEEEEEcc-CCChHHHHhCCCC-CCCHHHHHHHHHHHHHHHHHHHHCC---ceeecCCCCcEEEecCCcE
Q psy9858         123 TDVFGYMS-NVSLVFEFV-DTDLEVIIKDPTI-VFTPSNIKAYAIMTLRGLEYLHDHW---ILHRDLKPNNLLINKQGVL  196 (307)
Q Consensus       123 ~~~~~~~~-~~~lv~e~~-~g~l~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~  196 (307)
                      +|+|.+.+ +.+||+||+ +|+|.+++..... .++|..+..|+.++|.||+|||...   |+|||||++|||+|.+..+
T Consensus       137 lGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a  216 (361)
T KOG1187|consen  137 LGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA  216 (361)
T ss_pred             EEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence            99999888 599999999 7999999998766 7999999999999999999999853   9999999999999999999


Q ss_pred             EEEeecCccccCCCCcccccc-eeeceehhhhhhhccccccccccee-------eeeecCCCCCCCC-CCCC--------
Q psy9858         197 KIGDFGLAKFFGSPTRLYTHQ-VVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNL-FPGI--------  259 (307)
Q Consensus       197 kl~Dfg~a~~~~~~~~~~~~~-~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~-~~~~--------  259 (307)
                      ||+|||+|+..+......... .||.+|+|||++..+ ..+.++|||       .+++|+.+.+... ....        
T Consensus       217 KlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g-~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~  295 (361)
T KOG1187|consen  217 KLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTG-KLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP  295 (361)
T ss_pred             EccCccCcccCCccccceeeecCCCCccCChhhhccC-CcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence            999999997664312222222 899999999999886 899999999       3444776555421 0000        


Q ss_pred             -----Chhhhc------cccC-----HHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         260 -----PLNEIF------TAAG-----DDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       260 -----~~~~~~------~~~~-----~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                           ...++.      ...+     ..+..+..+|++.+|.+||++.|+++.
T Consensus       296 ~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~  348 (361)
T KOG1187|consen  296 LLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKE  348 (361)
T ss_pred             HHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHH
Confidence                 000110      1122     235678889999999999999997653

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=7.9e-41  Score=284.49  Aligned_cols=242  Identities=23%  Similarity=0.264  Sum_probs=195.6

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++......||+|+||.||+|.+..++..||+|.+....     ....+.+.+|+++++.++|+||+++++++..++..
T Consensus         6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (268)
T cd06624           6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-----SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFF   80 (268)
T ss_pred             ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-----HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEE
Confidence            3445555578999999999999998899999999887532     11245688999999999999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCC--CHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEec-CCcEEEEeecCccccC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVF--TPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK-QGVLKIGDFGLAKFFG  208 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~--~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~a~~~~  208 (307)
                      ++++||+ +++|.+.+......+  ++..+..++.||+.||.|||++||+|+||||+||+++. ++.++|+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          81 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             EEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence            9999999 578888887654445  78888999999999999999999999999999999976 6799999999998664


Q ss_pred             CCCcccccceeeceehhhhhhhcc-ccccccccee-------eeeecCCCCCCCCCCC---------CChhhhccccCHH
Q psy9858         209 SPTRLYTHQVVTRWYRLIKCLLYC-VQFNVKNVQW-------CCFAKDPSSHGNLFPG---------IPLNEIFTAAGDD  271 (307)
Q Consensus       209 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~Diw-------~i~~~~~~f~~~~~~~---------~~~~~~~~~~~~~  271 (307)
                      ..........++..|+|||.+.+. ..++.++|+|       .+++|..||.......         .....++..++++
T Consensus       161 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (268)
T cd06624         161 GINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAE  240 (268)
T ss_pred             cCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHH
Confidence            333333334678899999998664 2478999999       3344888886522111         1112234467889


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         272 LLAVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       272 l~~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                      +.+++.+||+.+|.+|||+++++.||||
T Consensus       241 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         241 AKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence            9999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.7e-40  Score=280.39  Aligned_cols=236  Identities=23%  Similarity=0.370  Sum_probs=196.7

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEE
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLV  135 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  135 (307)
                      +|++.+.||+|+||.||++++..+++.||+|.+....    .....+.+.+|+.+++.++|+||+++++.+.+++..+++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   76 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK----SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIV   76 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc----chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence            5889999999999999999999999999999987432    112245677899999999999999999999999999999


Q ss_pred             EEcc-CCChHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc
Q psy9858         136 FEFV-DTDLEVIIKD-PTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL  213 (307)
Q Consensus       136 ~e~~-~g~l~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  213 (307)
                      |||+ +|++.+++.. ....+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+.........
T Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  156 (255)
T cd08219          77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY  156 (255)
T ss_pred             EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence            9999 5788888764 3445789999999999999999999999999999999999999999999999999876544333


Q ss_pred             cccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCC-------CChhhhccccCHHHHHHHHHh
Q psy9858         214 YTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPG-------IPLNEIFTAAGDDLLAVISSL  279 (307)
Q Consensus       214 ~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~-------~~~~~~~~~~~~~l~~li~~~  279 (307)
                      .....++..|+|||.+.+. .++.++|+|       .+++|..||.......       ......+..++..+.++|.+|
T Consensus       157 ~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  235 (255)
T cd08219         157 ACTYVGTPYYVPPEIWENM-PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM  235 (255)
T ss_pred             cccccCCccccCHHHHccC-CcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHH
Confidence            3445788899999998877 789999999       3333888987633211       112223445788999999999


Q ss_pred             hhcCCCCCCCHHHHhcC
Q psy9858         280 LCLNPTKRADCTATLKM  296 (307)
Q Consensus       280 l~~dP~~Rpt~~~il~h  296 (307)
                      |+.||++|||+.++++-
T Consensus       236 l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         236 FKRNPRSRPSATTILSR  252 (255)
T ss_pred             HhCCcccCCCHHHHhhc
Confidence            99999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.6e-41  Score=285.68  Aligned_cols=242  Identities=21%  Similarity=0.365  Sum_probs=198.1

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCcccc----chhhhHhHHHHHHHHHhcCCCCccccceeeeecCe
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADA----KDGINRTALREIKLLQELHHENVLGLTDVFGYMSN  131 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  131 (307)
                      +|.+.+.||.|++|.||+|.+..+++.||+|.+........    .....+.+.+|+.++++++||||+++++++.....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            47788999999999999999988999999999876433222    12233567899999999999999999999999999


Q ss_pred             EEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         132 VSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       132 ~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      .+++|||+ +++|.+++... +.+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||+++.....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN  159 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence            99999999 56788888654 35889999999999999999999999999999999999999999999999999877422


Q ss_pred             Cc------ccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCC-------CCChhhhccccCH
Q psy9858         211 TR------LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFP-------GIPLNEIFTAAGD  270 (307)
Q Consensus       211 ~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~-------~~~~~~~~~~~~~  270 (307)
                      ..      ......++..|+|||.+.+. .++.++|+|   +    +++|..||......       .......+..++.
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd06628         160 SLSTKTNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISS  238 (267)
T ss_pred             cccCCccccccccCCCcCccChhHhccC-CCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCH
Confidence            11      11223578899999999877 788999999   2    33388898763211       1112233345789


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         271 DLLAVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       271 ~l~~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                      .+.++|++||+.||.+||++.++++||||
T Consensus       239 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         239 EAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             HHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            99999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.5e-41  Score=288.66  Aligned_cols=243  Identities=19%  Similarity=0.285  Sum_probs=198.2

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ++|++++.||+|+||.||+|.+..+|..||+|.+....    .+.....+.+|++++++++|+||+++++.+...+..++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   76 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL----DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYM   76 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc----CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEE
Confidence            46899999999999999999999899999999987421    22224568899999999999999999999999999999


Q ss_pred             EEEccC-CChHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         135 VFEFVD-TDLEVIIKDP--TIVFTPSNIKAYAIMTLRGLEYLHD-HWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       135 v~e~~~-g~l~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      +|||+. ++|.+++...  ...+++..+..++.||+.||.|||+ .|++|+||||+||+++.++.++|+|||++......
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  156 (286)
T cd06622          77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS  156 (286)
T ss_pred             EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence            999994 6777776653  2358999999999999999999997 59999999999999999999999999999766332


Q ss_pred             Ccccccceeeceehhhhhhhccc-----cccccccee---ee----eecCCCCCCCCCCC----------CChhhhcccc
Q psy9858         211 TRLYTHQVVTRWYRLIKCLLYCV-----QFNVKNVQW---CC----FAKDPSSHGNLFPG----------IPLNEIFTAA  268 (307)
Q Consensus       211 ~~~~~~~~~t~~y~aPE~~~~~~-----~~~~~~Diw---~i----~~~~~~f~~~~~~~----------~~~~~~~~~~  268 (307)
                        ......++..|+|||.+.+..     .++.++|+|   ++    ++|..||.......          ......+..+
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd06622         157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY  234 (286)
T ss_pred             --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCccc
Confidence              223346788999999986542     358899999   33    33889986532211          1122334457


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         269 GDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       269 ~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      +.++.++|.+||+.+|.+||+++++++||||....
T Consensus       235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~  269 (286)
T cd06622         235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK  269 (286)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence            89999999999999999999999999999997654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=9.7e-41  Score=283.73  Aligned_cols=240  Identities=22%  Similarity=0.242  Sum_probs=194.3

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|++++.||+|+||.||+|++..+++.||+|++......     ....+.+|+.++++++||||+++++.+......
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~-----~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~   81 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD-----DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKL   81 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc-----hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Confidence            456899999999999999999999999999999998743211     134577899999999999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT  211 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  211 (307)
                      ++||||+ +++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus        82 ~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          82 WICMEYCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI  160 (267)
T ss_pred             EEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence            9999999 467888776543 58999999999999999999999999999999999999999999999999998764333


Q ss_pred             cccccceeeceehhhhhhhc--cccccccccee---ee----eecCCCCCCCCCCC-------C--Ch--hhhccccCHH
Q psy9858         212 RLYTHQVVTRWYRLIKCLLY--CVQFNVKNVQW---CC----FAKDPSSHGNLFPG-------I--PL--NEIFTAAGDD  271 (307)
Q Consensus       212 ~~~~~~~~t~~y~aPE~~~~--~~~~~~~~Diw---~i----~~~~~~f~~~~~~~-------~--~~--~~~~~~~~~~  271 (307)
                      .......++..|+|||.+..  ...++.++|+|   ++    +.|..||.......       .  ..  ......++..
T Consensus       161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (267)
T cd06646         161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSST  240 (267)
T ss_pred             cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHH
Confidence            22334567889999999853  23578899999   22    33777775421100       0  00  0111246789


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhcCcc
Q psy9858         272 LLAVISSLLCLNPTKRADCTATLKMDY  298 (307)
Q Consensus       272 l~~li~~~l~~dP~~Rpt~~~il~hp~  298 (307)
                      +.+++.+||+.||++|||++++|+|+|
T Consensus       241 ~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         241 FHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=7.9e-41  Score=289.30  Aligned_cols=245  Identities=33%  Similarity=0.562  Sum_probs=199.8

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC-
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS-  130 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-  130 (307)
                      ...++|++.+.||+|+||.||+|.+..+|+.||+|++.....   .......+.+|+++++.++||||+++++++.+.. 
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~   80 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE---KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQD   80 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc---ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcch
Confidence            356789999999999999999999999999999999875321   1222345678999999999999999999886554 


Q ss_pred             ---------eEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEee
Q psy9858         131 ---------NVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDF  201 (307)
Q Consensus       131 ---------~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Df  201 (307)
                               ..++++||+++++.+.+......+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~df  160 (302)
T cd07864          81 ALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADF  160 (302)
T ss_pred             hhhccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcc
Confidence                     89999999998988888776556899999999999999999999999999999999999999999999999


Q ss_pred             cCccccCCCC-cccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCC----------------
Q psy9858         202 GLAKFFGSPT-RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFP----------------  257 (307)
Q Consensus       202 g~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~----------------  257 (307)
                      |++....... .......++..|+|||.+.+...++.++|||       .++.|.+||......                
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (302)
T cd07864         161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA  240 (302)
T ss_pred             cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            9998764332 1223345678899999987665678999999       233488888652110                


Q ss_pred             ---C-----------------CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         258 ---G-----------------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       258 ---~-----------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                         .                 ......+..++..+.+++.+||+.||.+|||++++++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             hcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence               0                 00111233568999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-41  Score=287.30  Aligned_cols=240  Identities=47%  Similarity=0.719  Sum_probs=201.4

Q ss_pred             eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEE
Q psy9858          57 YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVF  136 (307)
Q Consensus        57 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  136 (307)
                      |.+.+.||+|++|.||+|.+..+|+.+++|.+......   ......+.+|+++++.++|+||+++++++.++...++++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES---EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVF   77 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc---chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEE
Confidence            67789999999999999999889999999998754322   123456788999999999999999999999999999999


Q ss_pred             EccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCccccc
Q psy9858         137 EFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTH  216 (307)
Q Consensus       137 e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  216 (307)
                      ||+++++.+.+......+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+............
T Consensus        78 e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~  157 (283)
T cd05118          78 EFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH  157 (283)
T ss_pred             eccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccC
Confidence            99999999988876667899999999999999999999999999999999999999999999999999877554323344


Q ss_pred             ceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCC--------------------------------
Q psy9858         217 QVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFP--------------------------------  257 (307)
Q Consensus       217 ~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~--------------------------------  257 (307)
                      ..++..|+|||.+.+...++.++|+|       .+++|..+|......                                
T Consensus       158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd05118         158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF  237 (283)
T ss_pred             ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence            56788999999988765789999999       334488888552210                                


Q ss_pred             ----CCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         258 ----GIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       258 ----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                          ........+.++.++.++|.+||+.||.+||+++++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                001112234578899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.7e-41  Score=286.32  Aligned_cols=241  Identities=21%  Similarity=0.276  Sum_probs=195.1

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN  131 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  131 (307)
                      ...++|.+.+.||+|+||.||+|++..+++.||+|++.....     .....+.+|+.+++.++||||+++++.+...+.
T Consensus         6 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-----~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~   80 (267)
T cd06645           6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-----EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDK   80 (267)
T ss_pred             CcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-----hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Confidence            345689999999999999999999999999999999875321     113457789999999999999999999999999


Q ss_pred             EEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         132 VSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       132 ~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      .+++|||+ +++|.+++.... .+++.+++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06645          81 LWICMEFCGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT  159 (267)
T ss_pred             EEEEEeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence            99999999 567888776544 5899999999999999999999999999999999999999999999999999766433


Q ss_pred             Ccccccceeeceehhhhhhh--ccccccccccee---eeee----cCCCCCCCCCCC---------CChhhh--ccccCH
Q psy9858         211 TRLYTHQVVTRWYRLIKCLL--YCVQFNVKNVQW---CCFA----KDPSSHGNLFPG---------IPLNEI--FTAAGD  270 (307)
Q Consensus       211 ~~~~~~~~~t~~y~aPE~~~--~~~~~~~~~Diw---~i~~----~~~~f~~~~~~~---------~~~~~~--~~~~~~  270 (307)
                      ........++..|+|||.+.  ....++.++|+|   ++++    |..||.......         ......  ...++.
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd06645         160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSN  239 (267)
T ss_pred             ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCH
Confidence            33334457889999999974  223688999999   3332    777765421100         000000  113577


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcCcc
Q psy9858         271 DLLAVISSLLCLNPTKRADCTATLKMDY  298 (307)
Q Consensus       271 ~l~~li~~~l~~dP~~Rpt~~~il~hp~  298 (307)
                      .+.+++.+||+.||++|||++++++|||
T Consensus       240 ~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         240 SFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            8999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=9e-41  Score=287.84  Aligned_cols=246  Identities=20%  Similarity=0.317  Sum_probs=203.8

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM  129 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  129 (307)
                      .+...++|.+.+.||+|+||.||++.+..++..||+|.+....     ......+.+|+.+++.++||||+++++.+...
T Consensus        14 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~   88 (293)
T cd06647          14 VGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-----QPKKELIINEILVMRENKHPNIVNYLDSYLVG   88 (293)
T ss_pred             ccCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-----chHHHHHHHHHHHHhhcCCCCeeehhheeeeC
Confidence            4455689999999999999999999988899999999986421     11235678999999999999999999999999


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                      ...++|+||+ +++|.+++.+.  .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus        89 ~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~  166 (293)
T cd06647          89 DELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  166 (293)
T ss_pred             CcEEEEEecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccc
Confidence            9999999999 67888888654  37889999999999999999999999999999999999999999999999987665


Q ss_pred             CCCcccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCCC---------ChhhhccccCHHH
Q psy9858         209 SPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPGI---------PLNEIFTAAGDDL  272 (307)
Q Consensus       209 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~~---------~~~~~~~~~~~~l  272 (307)
                      ..........+++.|+|||.+.+. .++.++|+|       .+++|..||........         ........++..+
T Consensus       167 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  245 (293)
T cd06647         167 PEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF  245 (293)
T ss_pred             ccccccccccCChhhcCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHH
Confidence            433333444678899999998876 789999999       23349999876322111         0011123467889


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         273 LAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       273 ~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      .+++.+||+.+|++||++.+++.||||+..+
T Consensus       246 ~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         246 RDFLNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence            9999999999999999999999999999876

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.1e-40  Score=281.64  Aligned_cols=240  Identities=25%  Similarity=0.381  Sum_probs=201.0

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEE
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLV  135 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  135 (307)
                      +|+.++.||.|+||.||.+++..+++.+++|.+......   ......+.+|++++++++|+||+++++++.+....+++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~   77 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS---EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIE   77 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc---hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEE
Confidence            589999999999999999999999999999998753322   22245688999999999999999999999999999999


Q ss_pred             EEcc-CCChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc
Q psy9858         136 FEFV-DTDLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL  213 (307)
Q Consensus       136 ~e~~-~g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  213 (307)
                      |||+ +|+|.+.+.+. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~  157 (256)
T cd08221          78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM  157 (256)
T ss_pred             EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccc
Confidence            9999 57899888765 445899999999999999999999999999999999999999999999999999877544333


Q ss_pred             cccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC-------CChhhhccccCHHHHHHHHHh
Q psy9858         214 YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG-------IPLNEIFTAAGDDLLAVISSL  279 (307)
Q Consensus       214 ~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~-------~~~~~~~~~~~~~l~~li~~~  279 (307)
                      .....++..|+|||.+.+. .++.++|+|   +    ++.|..||.......       .........++.++.+++.+|
T Consensus       158 ~~~~~~~~~y~ape~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  236 (256)
T cd08221         158 AETVVGTPYYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSL  236 (256)
T ss_pred             ccccCCCccccCHhhcCCC-CCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence            3455789999999999877 688999999   2    333888886632211       111122245788999999999


Q ss_pred             hhcCCCCCCCHHHHhcCccc
Q psy9858         280 LCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       280 l~~dP~~Rpt~~~il~hp~f  299 (307)
                      |+.||.+|||++++|+|||+
T Consensus       237 l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         237 LQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             cccCcccCCCHHHHhhCcCC
Confidence            99999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-40  Score=281.21  Aligned_cols=240  Identities=23%  Similarity=0.284  Sum_probs=197.9

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEE
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVS  133 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  133 (307)
                      .++|++.+.||.|++|.||+|.+..+++.+++|++......     ..+.+.+|+++++.++||||+++++.+.+....+
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   76 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-----DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLW   76 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-----hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEE
Confidence            46899999999999999999999889999999999754222     2467889999999999999999999999999999


Q ss_pred             EEEEccC-CChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc
Q psy9858         134 LVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR  212 (307)
Q Consensus       134 lv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  212 (307)
                      ++|||++ ++|.+++......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus        77 l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  156 (262)
T cd06613          77 IVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA  156 (262)
T ss_pred             EEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence            9999995 678877776645689999999999999999999999999999999999999999999999999987644332


Q ss_pred             ccccceeeceehhhhhhhcc--ccccccccee---e----eeecCCCCCCCCCCC-----------CChhhhccccCHHH
Q psy9858         213 LYTHQVVTRWYRLIKCLLYC--VQFNVKNVQW---C----CFAKDPSSHGNLFPG-----------IPLNEIFTAAGDDL  272 (307)
Q Consensus       213 ~~~~~~~t~~y~aPE~~~~~--~~~~~~~Diw---~----i~~~~~~f~~~~~~~-----------~~~~~~~~~~~~~l  272 (307)
                      ......++..|+|||.+.+.  ..++.++|+|   +    +++|..||.......           .........++.++
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (262)
T cd06613         157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVF  236 (262)
T ss_pred             ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHH
Confidence            33445678899999998654  2578899999   2    233888887622100           00001122457789


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHhcCcc
Q psy9858         273 LAVISSLLCLNPTKRADCTATLKMDY  298 (307)
Q Consensus       273 ~~li~~~l~~dP~~Rpt~~~il~hp~  298 (307)
                      .+++.+||..||.+|||+++++.|+|
T Consensus       237 ~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         237 HDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            99999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG0607|consensus

Probab=100.00  E-value=6.1e-42  Score=279.77  Aligned_cols=248  Identities=21%  Similarity=0.232  Sum_probs=202.5

Q ss_pred             eccccceeeEE-eEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-CCCccccceeee
Q psy9858          50 VKNDLLVYYQW-RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-HENVLGLTDVFG  127 (307)
Q Consensus        50 ~~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~  127 (307)
                      .+.+.+-|++. +.||+|+|+.|-.+....+|..||||++.+..     ...+.+..+|++++.+++ |+||++++++|+
T Consensus        72 ~g~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~-----gHsR~RvfREVe~f~~Cqgh~nilqLiefFE  146 (463)
T KOG0607|consen   72 SGKFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP-----GHSRSRVFREVETFYQCQGHKNILQLIEFFE  146 (463)
T ss_pred             cchHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC-----chHHHHHHHHHHHHHHhcCCccHHHHHHHhc
Confidence            33455566665 67799999999999999999999999998742     223567889999999996 999999999999


Q ss_pred             ecCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCC---cEEEEeecC
Q psy9858         128 YMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG---VLKIGDFGL  203 (307)
Q Consensus       128 ~~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~  203 (307)
                      ++..+|||||-+ +|.|++++.++. .+++.++..+..+|++||.|||.+||.||||||+|||..+.+   -|||+||.+
T Consensus       147 dd~~FYLVfEKm~GGplLshI~~~~-~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDL  225 (463)
T KOG0607|consen  147 DDTRFYLVFEKMRGGPLLSHIQKRK-HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDL  225 (463)
T ss_pred             ccceEEEEEecccCchHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccc
Confidence            999999999999 788999998765 599999999999999999999999999999999999997655   479999988


Q ss_pred             ccccCC--C-----Ccccccceeeceehhhhhhh----ccccccccccee-------eeeecCCCCCCC-----------
Q psy9858         204 AKFFGS--P-----TRLYTHQVVTRWYRLIKCLL----YCVQFNVKNVQW-------CCFAKDPSSHGN-----------  254 (307)
Q Consensus       204 a~~~~~--~-----~~~~~~~~~t~~y~aPE~~~----~~~~~~~~~Diw-------~i~~~~~~f~~~-----------  254 (307)
                      ..-..-  +     .....+++|+..|||||+..    ....|+.+.|.|       .+++|-+||.+.           
T Consensus       226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe  305 (463)
T KOG0607|consen  226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGE  305 (463)
T ss_pred             ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCC
Confidence            754321  1     12234568899999999864    234799999999       233499999881           


Q ss_pred             -----------CCCC---CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         255 -----------LFPG---IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       255 -----------~~~~---~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                                 .++.   .-...-|..+|.+.+++|..+|..|+.+|.++.++++|||+....
T Consensus       306 ~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~  368 (463)
T KOG0607|consen  306 VCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA  368 (463)
T ss_pred             ccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence                       1111   111233457899999999999999999999999999999998754

>KOG4279|consensus

Probab=100.00  E-value=3.1e-41  Score=299.80  Aligned_cols=239  Identities=23%  Similarity=0.294  Sum_probs=204.8

Q ss_pred             eEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEEEcc-
Q psy9858          61 RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFV-  139 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~-  139 (307)
                      -.||.|+||+||-|++..+...+|||.+...     .....+.+..|+.+-++|+|.|||+++|.+..++++-|+||-+ 
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpek-----dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVP  655 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEK-----DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVP  655 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccc-----cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCC
Confidence            3689999999999999999999999998742     3334567889999999999999999999999999999999999 


Q ss_pred             CCChHHHHhCCCCCC--CHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEe-cCCcEEEEeecCccccCCCCccccc
Q psy9858         140 DTDLEVIIKDPTIVF--TPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLIN-KQGVLKIGDFGLAKFFGSPTRLYTH  216 (307)
Q Consensus       140 ~g~l~~~~~~~~~~~--~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~~~~~~~~  216 (307)
                      +|+|.+++...=+++  ++..+..+.+||++||+|||++.|||||||-+|+|++ ..|.+||+|||.++.+..-.....+
T Consensus       656 GGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET  735 (1226)
T KOG4279|consen  656 GGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET  735 (1226)
T ss_pred             CCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccc
Confidence            788999998876676  8899999999999999999999999999999999996 5778999999999988655556677


Q ss_pred             ceeeceehhhhhhhcc-ccccccccee---e----eeecCCCCCCCCCC------CCC---hhhhccccCHHHHHHHHHh
Q psy9858         217 QVVTRWYRLIKCLLYC-VQFNVKNVQW---C----CFAKDPSSHGNLFP------GIP---LNEIFTAAGDDLLAVISSL  279 (307)
Q Consensus       217 ~~~t~~y~aPE~~~~~-~~~~~~~Diw---~----i~~~~~~f~~~~~~------~~~---~~~~~~~~~~~l~~li~~~  279 (307)
                      ..||..|||||++..+ ..|+.++|||   |    +.+|++||..---+      -..   -.+++..++.+++++|.+|
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Filrc  815 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRC  815 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHH
Confidence            8999999999999754 4699999999   4    33399999762111      111   2244567889999999999


Q ss_pred             hhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         280 LCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       280 l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                      +..||.+||++.++|+.||++..++
T Consensus       816 Fepd~~~R~sA~~LL~DpFlq~~~k  840 (1226)
T KOG4279|consen  816 FEPDPCDRPSAKDLLQDPFLQHNNK  840 (1226)
T ss_pred             cCCCcccCccHHHhccCcccccCCC
Confidence            9999999999999999999987643

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=9.9e-41  Score=283.71  Aligned_cols=243  Identities=24%  Similarity=0.378  Sum_probs=198.5

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccc-cchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHAD-AKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      +|+..+.||+|++|.||+|.+..+++.||+|++....... ......+.+.+|++++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            4788899999999999999999999999999987543222 122235678899999999999999999999999999999


Q ss_pred             EEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCC-cEEEEeecCccccCCCCc
Q psy9858         135 VFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG-VLKIGDFGLAKFFGSPTR  212 (307)
Q Consensus       135 v~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~~~~  212 (307)
                      ||||+ +++|.+++.+.. .+++..+..++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||.+........
T Consensus        81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~  159 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT  159 (268)
T ss_pred             EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence            99999 567888776543 588999999999999999999999999999999999998776 599999999987643211


Q ss_pred             ----ccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCC-----------ChhhhccccCH
Q psy9858         213 ----LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGI-----------PLNEIFTAAGD  270 (307)
Q Consensus       213 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~-----------~~~~~~~~~~~  270 (307)
                          ......++..|+|||.+.+. .++.++|+|   +    +++|..||........           .....+..+++
T Consensus       160 ~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (268)
T cd06630         160 GAGEFQGQLLGTIAFMAPEVLRGE-QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP  238 (268)
T ss_pred             cCCccccccccccceeCHhHhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCH
Confidence                11233578899999999876 789999999   2    3338888865332211           11223345788


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcCcccC
Q psy9858         271 DLLAVISSLLCLNPTKRADCTATLKMDYFS  300 (307)
Q Consensus       271 ~l~~li~~~l~~dP~~Rpt~~~il~hp~f~  300 (307)
                      ++.+++.+||+.||.+|||+.++++||||+
T Consensus       239 ~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         239 GLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            999999999999999999999999999995

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.4e-41  Score=287.03  Aligned_cols=240  Identities=24%  Similarity=0.339  Sum_probs=199.9

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ++|+..+.||+|++|.||++.+..+++.||+|.+.....    ......+.+|+++++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   76 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN----EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISI   76 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC----hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEE
Confidence            368888999999999999999999999999999876422    2335678899999999999999999999999999999


Q ss_pred             EEEccC-CChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc
Q psy9858         135 VFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD-HWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR  212 (307)
Q Consensus       135 v~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  212 (307)
                      ++||+. ++|.+++......+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+........
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          77 CMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             EEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence            999995 78888887654578999999999999999999999 9999999999999999999999999999876633211


Q ss_pred             ccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCCC------------hhhhccc-cCHHH
Q psy9858         213 LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGIP------------LNEIFTA-AGDDL  272 (307)
Q Consensus       213 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~------------~~~~~~~-~~~~l  272 (307)
                        ....++..|+|||.+.+. .++.++|+|   +    +++|..||.........            ....+.. ++.++
T Consensus       157 --~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (265)
T cd06605         157 --KTFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDF  233 (265)
T ss_pred             --hcccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence              125678899999999887 899999999   2    33388888653211111            1111122 68889


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHhcCcccCC
Q psy9858         273 LAVISSLLCLNPTKRADCTATLKMDYFSL  301 (307)
Q Consensus       273 ~~li~~~l~~dP~~Rpt~~~il~hp~f~~  301 (307)
                      .++|.+||..||++|||+.+++.||||++
T Consensus       234 ~~li~~~l~~~p~~Rpt~~~ll~~~~~~~  262 (265)
T cd06605         234 QDFVNLCLIKDPRERPSYKELLEHPFIKK  262 (265)
T ss_pred             HHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence            99999999999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.8e-40  Score=284.49  Aligned_cols=247  Identities=20%  Similarity=0.248  Sum_probs=197.5

Q ss_pred             ceeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceee
Q psy9858          48 CEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVF  126 (307)
Q Consensus        48 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~  126 (307)
                      ..++...++|.+.+.||+|+||.||+|.+..+++.+|+|++....      .....+.+|+.+++++ +|||++++++++
T Consensus        15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~------~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   88 (291)
T cd06639          15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS------DVDEEIEAEYNILQSLPNHPNVVKFYGMF   88 (291)
T ss_pred             ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc------cHHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence            455667889999999999999999999999999999999986421      1134567899999998 799999999988


Q ss_pred             eec-----CeEEEEEEcc-CCChHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEE
Q psy9858         127 GYM-----SNVSLVFEFV-DTDLEVIIKD---PTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLK  197 (307)
Q Consensus       127 ~~~-----~~~~lv~e~~-~g~l~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~k  197 (307)
                      ...     ...++||||+ +|+|.+++..   ....+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++
T Consensus        89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~k  168 (291)
T cd06639          89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVK  168 (291)
T ss_pred             EeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEE
Confidence            643     4689999999 5688777652   334589999999999999999999999999999999999999999999


Q ss_pred             EEeecCccccCCCCcccccceeeceehhhhhhhccc----cccccccee---ee----eecCCCCCCCCCCCC-------
Q psy9858         198 IGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCV----QFNVKNVQW---CC----FAKDPSSHGNLFPGI-------  259 (307)
Q Consensus       198 l~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~~Diw---~i----~~~~~~f~~~~~~~~-------  259 (307)
                      |+|||++..............++..|+|||.+....    .++.++|+|   ++    ++|+.||........       
T Consensus       169 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~  248 (291)
T cd06639         169 LVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN  248 (291)
T ss_pred             EeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC
Confidence            999999987654333333456788999999986542    368899999   33    338888876321110       


Q ss_pred             Chh--hhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccC
Q psy9858         260 PLN--EIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS  300 (307)
Q Consensus       260 ~~~--~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~  300 (307)
                      ...  ......+..+.++|.+||+.||++|||+.++++||||+
T Consensus       249 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         249 PPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             CCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            000  11234567899999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=9.9e-41  Score=282.26  Aligned_cols=239  Identities=26%  Similarity=0.363  Sum_probs=200.4

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEE
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLV  135 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  135 (307)
                      +|++.+.||.|+||.||+|.+..+++.||+|++.......  ....+.+.+|++++++++||||+++++.+......+++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   78 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVE--KGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLV   78 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcc--hhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEE
Confidence            5899999999999999999998899999999998532211  12356788999999999999999999999999999999


Q ss_pred             EEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCccc
Q psy9858         136 FEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY  214 (307)
Q Consensus       136 ~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  214 (307)
                      +||+ +++|.+.+... ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        79 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~  156 (258)
T cd05578          79 VDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LT  156 (258)
T ss_pred             EeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-cc
Confidence            9999 56788877665 468999999999999999999999999999999999999999999999999998764332 23


Q ss_pred             ccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCC---------CCChhhhccccCHHHHHHHHH
Q psy9858         215 THQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFP---------GIPLNEIFTAAGDDLLAVISS  278 (307)
Q Consensus       215 ~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~---------~~~~~~~~~~~~~~l~~li~~  278 (307)
                      ....++..|+|||.+.+. .++.++|+|   +    +++|..||......         .......+...+.++.++|.+
T Consensus       157 ~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  235 (258)
T cd05578         157 TSTSGTPGYMAPEVLCRQ-GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINK  235 (258)
T ss_pred             cccCCChhhcCHHHHccc-CCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHH
Confidence            345678899999999887 689999999   2    23388888764321         001222334578999999999


Q ss_pred             hhhcCCCCCCCH--HHHhcCccc
Q psy9858         279 LLCLNPTKRADC--TATLKMDYF  299 (307)
Q Consensus       279 ~l~~dP~~Rpt~--~~il~hp~f  299 (307)
                      ||+.||.+||++  +++++||||
T Consensus       236 ~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         236 LLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HccCChhHcCCccHHHHhcCCCC
Confidence            999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=8.1e-41  Score=283.35  Aligned_cols=240  Identities=26%  Similarity=0.349  Sum_probs=198.9

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeee--ecCeEE
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG--YMSNVS  133 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~--~~~~~~  133 (307)
                      +|++.+.||.|+||.||++.+..+++.||+|++.....   .....+.+.+|+++++.++|+||+++++.+.  .....+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM---TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC---CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEE
Confidence            58899999999999999999999999999999875432   2223456889999999999999999999775  346789


Q ss_pred             EEEEcc-CCChHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHH-----HCCceeecCCCCcEEEecCCcEEEEeecCc
Q psy9858         134 LVFEFV-DTDLEVIIKDP---TIVFTPSNIKAYAIMTLRGLEYLH-----DHWILHRDLKPNNLLINKQGVLKIGDFGLA  204 (307)
Q Consensus       134 lv~e~~-~g~l~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH-----~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  204 (307)
                      ++|||+ +++|.+++...   ...+++..++.++.||+.||.|||     +.+++|+||+|+||+++.++.++|+|||++
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence            999999 57888887643   446899999999999999999999     899999999999999999999999999999


Q ss_pred             cccCCCCcccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCC-------CCCChhhhccccCH
Q psy9858         205 KFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLF-------PGIPLNEIFTAAGD  270 (307)
Q Consensus       205 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~-------~~~~~~~~~~~~~~  270 (307)
                      ..............++..|+|||.+.+. .++.++|+|       .++.|..||.....       ...........++.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (265)
T cd08217         158 KILGHDSSFAKTYVGTPYYMSPEQLNHM-SYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSS  236 (265)
T ss_pred             ccccCCcccccccccCCCccChhhhcCC-CCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCH
Confidence            9875544334455789999999999887 788999999       23338888876321       11112233446789


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         271 DLLAVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       271 ~l~~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                      ++.+++.+||+.+|.+|||++++++|||+
T Consensus       237 ~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         237 ELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             HHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            99999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.2e-40  Score=288.97  Aligned_cols=246  Identities=23%  Similarity=0.325  Sum_probs=201.7

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN  131 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  131 (307)
                      ...+.|.+.+.||+|+||+||+|.+..+|+.||+|++......  .....+.+.+|+++++.++||||+++.+++.+.+.
T Consensus        12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~   89 (307)
T cd06607          12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ--SNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHT   89 (307)
T ss_pred             CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccC--cHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCe
Confidence            3456799999999999999999999889999999998643211  12224568899999999999999999999999999


Q ss_pred             EEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC
Q psy9858         132 VSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT  211 (307)
Q Consensus       132 ~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  211 (307)
                      .++||||+.|++.+.+......+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++...... 
T Consensus        90 ~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-  168 (307)
T cd06607          90 AWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-  168 (307)
T ss_pred             EEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence            9999999999998888765556899999999999999999999999999999999999999999999999999765322 


Q ss_pred             cccccceeeceehhhhhhhc--cccccccccee-------eeeecCCCCCCCCCCC--------CChhhhccccCHHHHH
Q psy9858         212 RLYTHQVVTRWYRLIKCLLY--CVQFNVKNVQW-------CCFAKDPSSHGNLFPG--------IPLNEIFTAAGDDLLA  274 (307)
Q Consensus       212 ~~~~~~~~t~~y~aPE~~~~--~~~~~~~~Diw-------~i~~~~~~f~~~~~~~--------~~~~~~~~~~~~~l~~  274 (307)
                         ....++..|+|||.+.+  ...++.++|||       .+++|..||.......        ..........+.++.+
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (307)
T cd06607         169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRN  245 (307)
T ss_pred             ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence               23467889999998753  23688999999       2334888886532110        0001112246788999


Q ss_pred             HHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         275 VISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       275 li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      ++.+||+.||.+|||+.+++.||||....
T Consensus       246 li~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         246 FVDSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             HHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence            99999999999999999999999997654

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.7e-41  Score=293.85  Aligned_cols=245  Identities=35%  Similarity=0.559  Sum_probs=203.1

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC-----
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS-----  130 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-----  130 (307)
                      +|++.+.||+|++|.||+|++..+++.||+|++.....   .....+.+.+|+.+++.++|+||+++++++....     
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   77 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD---DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFN   77 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc---cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCccccc
Confidence            58999999999999999999988899999999875321   1223466889999999999999999999987765     


Q ss_pred             eEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         131 NVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       131 ~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      ..|++|||+++++.+.+.... .+++..+..++.||+.||.+||+.|++|+||||+||+++.++.++|+|||++......
T Consensus        78 ~~~lv~e~~~~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~  156 (330)
T cd07834          78 DVYIVTELMETDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD  156 (330)
T ss_pred             ceEEEecchhhhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence            799999999988888887654 6899999999999999999999999999999999999999999999999999887543


Q ss_pred             C---cccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCC-----------------------
Q psy9858         211 T---RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFP-----------------------  257 (307)
Q Consensus       211 ~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~-----------------------  257 (307)
                      .   .......++..|+|||.+.+...++.++|+|   +    +++|.+||.+....                       
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  236 (330)
T cd07834         157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS  236 (330)
T ss_pred             ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence            3   1233456788999999998876789999999   2    33388888653210                       


Q ss_pred             --------------CCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         258 --------------GIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       258 --------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                                    ..........++.++.++|.+||+.||.+|||+++++.||||++.+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence                          00111122346888999999999999999999999999999987654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-40  Score=284.67  Aligned_cols=243  Identities=19%  Similarity=0.296  Sum_probs=200.8

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC---CCCccccceeeeecCeE
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH---HENVLGLTDVFGYMSNV  132 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~ni~~~~~~~~~~~~~  132 (307)
                      .|+..+.||+|+||.||+|.+..++..||+|.+....    .......+.+|+++++.++   |||++++++++..+...
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~   77 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT----PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRL   77 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC----CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEE
Confidence            5788899999999999999999999999999987532    1122456778999999986   99999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT  211 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  211 (307)
                      +++|||+ +++|.+++...  .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus        78 ~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06917          78 WIIMEYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS  155 (277)
T ss_pred             EEEEecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence            9999999 56788777554  58999999999999999999999999999999999999999999999999998775544


Q ss_pred             cccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCCC-------Chhhhcc-ccCHHHHHHH
Q psy9858         212 RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPGI-------PLNEIFT-AAGDDLLAVI  276 (307)
Q Consensus       212 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~~-------~~~~~~~-~~~~~l~~li  276 (307)
                      .......++..|+|||.+.+...++.++|+|       .+++|..||........       ....... .++.++.+++
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  235 (277)
T cd06917         156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFV  235 (277)
T ss_pred             cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHH
Confidence            3344457888999999987765789999999       23349999877322111       1111112 3678999999


Q ss_pred             HHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         277 SSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       277 ~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                      .+||+.||.+|||+.+++.||||++...
T Consensus       236 ~~~l~~~p~~R~~~~~il~~~~~~~~~~  263 (277)
T cd06917         236 AACLDEEPKERLSAEELLKSKWIKAHSK  263 (277)
T ss_pred             HHHcCCCcccCcCHHHHhhChHhhcccc
Confidence            9999999999999999999999987653

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.2e-40  Score=288.56  Aligned_cols=237  Identities=18%  Similarity=0.255  Sum_probs=186.7

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcC----------------CCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCC
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIE----------------TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHE  117 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~  117 (307)
                      .++|.+.+.||+|+||.||+|.+..                ++..||+|++....    .......+.+|++++.+++||
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~   79 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA----NKNARNDFLKEVKILSRLKDP   79 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC----CHHHHHHHHHHHHHHhhcCCC
Confidence            4679999999999999999997532                34579999987532    222356788999999999999


Q ss_pred             CccccceeeeecCeEEEEEEcc-CCChHHHHhCCC------------------CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy9858         118 NVLGLTDVFGYMSNVSLVFEFV-DTDLEVIIKDPT------------------IVFTPSNIKAYAIMTLRGLEYLHDHWI  178 (307)
Q Consensus       118 ni~~~~~~~~~~~~~~lv~e~~-~g~l~~~~~~~~------------------~~~~~~~~~~i~~~i~~~l~~lH~~~i  178 (307)
                      ||+++++++.+.+..+++|||+ +|+|.+++....                  ..+++..+..++.||+.||.|||+.||
T Consensus        80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i  159 (304)
T cd05096          80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF  159 (304)
T ss_pred             CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence            9999999999999999999999 678888875431                  135777889999999999999999999


Q ss_pred             eeecCCCCcEEEecCCcEEEEeecCccccCCCCc--ccccceeeceehhhhhhhccccccccccee---eeee------c
Q psy9858         179 LHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR--LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA------K  247 (307)
Q Consensus       179 vH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~------~  247 (307)
                      +||||||+||+++.++.+||+|||+++.......  ......++..|+|||.+.+. .++.++|||   ++++      +
T Consensus       160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~  238 (304)
T cd05096         160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-KFTTASDVWAFGVTLWEILMLCK  238 (304)
T ss_pred             cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC-CCCchhhhHHHHHHHHHHHHccC
Confidence            9999999999999999999999999986633221  12223457789999999877 799999999   2322      5


Q ss_pred             CCCCCCCCCCCC--------------ChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         248 DPSSHGNLFPGI--------------PLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       248 ~~~f~~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      ..||........              .....+..++..+.+|+.+||+.||++|||++++.+
T Consensus       239 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         239 EQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             CCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            667765221110              001112356789999999999999999999999943

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.2e-40  Score=285.42  Aligned_cols=244  Identities=20%  Similarity=0.284  Sum_probs=195.8

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeee-
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFG-  127 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~-  127 (307)
                      .....+.|++.+.||.|+||.||+|.+..+++.||+|++....      .....+..|+.+++++ +|+||+++++++. 
T Consensus        11 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636          11 LRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE------DEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh------HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            3446678999999999999999999999999999999986421      1234577899999998 6999999999884 


Q ss_pred             -----ecCeEEEEEEcc-CCChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEe
Q psy9858         128 -----YMSNVSLVFEFV-DTDLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGD  200 (307)
Q Consensus       128 -----~~~~~~lv~e~~-~g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~D  200 (307)
                           .....+++|||+ +|+|.+++... ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~d  164 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVD  164 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEee
Confidence                 356799999999 56888888653 33478888999999999999999999999999999999999999999999


Q ss_pred             ecCccccCCCCcccccceeeceehhhhhhhc----cccccccccee---e----eeecCCCCCCCCCCC--------CCh
Q psy9858         201 FGLAKFFGSPTRLYTHQVVTRWYRLIKCLLY----CVQFNVKNVQW---C----CFAKDPSSHGNLFPG--------IPL  261 (307)
Q Consensus       201 fg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~Diw---~----i~~~~~~f~~~~~~~--------~~~  261 (307)
                      ||++..............++..|+|||.+..    ...++.++|+|   +    +++|..||.......        ...
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  244 (282)
T cd06636         165 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPP  244 (282)
T ss_pred             CcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCC
Confidence            9998866433333344578899999999863    22578899999   2    333888886522111        011


Q ss_pred             hhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         262 NEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       262 ~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                      ......++.++.++|.+||+.||.+|||+.++|+||||
T Consensus       245 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         245 KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            11122468899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-40  Score=284.88  Aligned_cols=240  Identities=41%  Similarity=0.655  Sum_probs=200.8

Q ss_pred             eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEE
Q psy9858          57 YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVF  136 (307)
Q Consensus        57 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  136 (307)
                      |+..+.||+|++|.||+|++..+++.||+|++....   ..+.....+.+|+++++.++|+|++++++++.+....++||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~   77 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN---EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVF   77 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccc---ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEe
Confidence            677889999999999999999999999999998643   12233456778999999999999999999999999999999


Q ss_pred             EccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCccccc
Q psy9858         137 EFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTH  216 (307)
Q Consensus       137 e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  216 (307)
                      ||++++|.+++.+....+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+............
T Consensus        78 e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (282)
T cd07829          78 EYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH  157 (282)
T ss_pred             cCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCc
Confidence            99998999999876456899999999999999999999999999999999999999999999999999877544333344


Q ss_pred             ceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCC--------------------------------
Q psy9858         217 QVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFP--------------------------------  257 (307)
Q Consensus       217 ~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~--------------------------------  257 (307)
                      ...+..|+|||.+.+...++.++|+|       .++.|..||.+....                                
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
T cd07829         158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP  237 (282)
T ss_pred             cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence            45678899999987766789999999       334488888653210                                


Q ss_pred             ---CCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         258 ---GIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       258 ---~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                         ........+.++.++.+++.+||..||++||+++++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence               001112223457889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3e-40  Score=283.51  Aligned_cols=245  Identities=20%  Similarity=0.228  Sum_probs=194.8

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeee
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFG  127 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~  127 (307)
                      .+....++|++.+.||+|+||.||+|.+..+++.+|+|++....      .....+.+|+.+++.+ +|+||+++++++.
T Consensus        12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~------~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   85 (286)
T cd06638          12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH------DIDEEIEAEYNILKALSDHPNVVKFYGMYY   85 (286)
T ss_pred             cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc------chHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence            34557789999999999999999999999999999999876421      1124577899999999 6999999999873


Q ss_pred             -----ecCeEEEEEEcc-CCChHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEE
Q psy9858         128 -----YMSNVSLVFEFV-DTDLEVIIK---DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKI  198 (307)
Q Consensus       128 -----~~~~~~lv~e~~-~g~l~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl  198 (307)
                           .+...+++|||+ +++|.+++.   .....+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl  165 (286)
T cd06638          86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKL  165 (286)
T ss_pred             ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEE
Confidence                 456799999999 577877664   23345788999999999999999999999999999999999999999999


Q ss_pred             EeecCccccCCCCcccccceeeceehhhhhhhcc----ccccccccee---ee----eecCCCCCCCCCCCC-------C
Q psy9858         199 GDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYC----VQFNVKNVQW---CC----FAKDPSSHGNLFPGI-------P  260 (307)
Q Consensus       199 ~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~~Diw---~i----~~~~~~f~~~~~~~~-------~  260 (307)
                      +|||++..............++..|+|||.+...    ..++.++|+|   ++    +.|..||........       .
T Consensus       166 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~  245 (286)
T cd06638         166 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP  245 (286)
T ss_pred             ccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC
Confidence            9999998764433333445788999999998532    2578899999   22    238888765321110       0


Q ss_pred             --hhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         261 --LNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       261 --~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                        ....+..++.++.+++.+||+.||++|||+.++++|+||
T Consensus       246 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         246 PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence              001122357789999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.1e-41  Score=317.82  Aligned_cols=250  Identities=24%  Similarity=0.329  Sum_probs=199.8

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee--
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY--  128 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--  128 (307)
                      ....++|.+++.||+|+||+||+|++..++..||+|++......   ......+..|+.+++.++||||++++++|.+  
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~---e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~   85 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK---EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA   85 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC---HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence            44667899999999999999999999999999999998754322   2234668899999999999999999998854  


Q ss_pred             cCeEEEEEEcc-CCChHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHC-------CceeecCCCCcEEEecC----
Q psy9858         129 MSNVSLVFEFV-DTDLEVIIKDP---TIVFTPSNIKAYAIMTLRGLEYLHDH-------WILHRDLKPNNLLINKQ----  193 (307)
Q Consensus       129 ~~~~~lv~e~~-~g~l~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~-------~ivH~dlkp~Nil~~~~----  193 (307)
                      ...+||||||+ +|+|.+++...   ...+++..++.|+.||+.||.|||+.       +|+||||||+||||+..    
T Consensus        86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l  165 (1021)
T PTZ00266         86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI  165 (1021)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence            46799999999 57898888642   34589999999999999999999984       49999999999999642    


Q ss_pred             -------------CcEEEEeecCccccCCCCcccccceeeceehhhhhhhcc-ccccccccee---eeee----cCCCCC
Q psy9858         194 -------------GVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYC-VQFNVKNVQW---CCFA----KDPSSH  252 (307)
Q Consensus       194 -------------~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~Diw---~i~~----~~~~f~  252 (307)
                                   +.+||+|||++...... .......+|+.|+|||++.+. ..++.++|||   |+++    |..||.
T Consensus       166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~-s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~  244 (1021)
T PTZ00266        166 GKITAQANNLNGRPIAKIGDFGLSKNIGIE-SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH  244 (1021)
T ss_pred             ccccccccccCCCCceEEccCCcccccccc-ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence                         34899999999876432 223345789999999998753 2578999999   4443    999997


Q ss_pred             CCCCCCCCh-------hhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         253 GNLFPGIPL-------NEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       253 ~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                      .........       .......+.++.+||..||+.+|.+|||+.|+|.||||+....
T Consensus       245 ~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~  303 (1021)
T PTZ00266        245 KANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP  303 (1021)
T ss_pred             cCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence            532111000       0111346889999999999999999999999999999986643

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.1e-40  Score=285.00  Aligned_cols=243  Identities=20%  Similarity=0.285  Sum_probs=201.5

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ..|+.++.||.|+||.||+|.+..++..||+|++.....    ......+.+|++++++++|+||+++++.+.+....++
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA----EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWI   79 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence            468888999999999999999988999999999875321    2224678899999999999999999999999999999


Q ss_pred             EEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc
Q psy9858         135 VFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL  213 (307)
Q Consensus       135 v~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  213 (307)
                      ||||+ +|+|.+++...  .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.........
T Consensus        80 v~e~~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06640          80 IMEYLGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             EEecCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccc
Confidence            99999 57888887653  4789999999999999999999999999999999999999999999999999876443323


Q ss_pred             cccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCC-------CCChhhhccccCHHHHHHHHHh
Q psy9858         214 YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFP-------GIPLNEIFTAAGDDLLAVISSL  279 (307)
Q Consensus       214 ~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~-------~~~~~~~~~~~~~~l~~li~~~  279 (307)
                      .....++..|+|||.+.+. .++.++|+|   +    +++|..||......       ..........++..+.+++.+|
T Consensus       158 ~~~~~~~~~y~apE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  236 (277)
T cd06640         158 RNTFVGTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDAC  236 (277)
T ss_pred             cccccCcccccCHhHhccC-CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHH
Confidence            3344678899999999877 789999999   2    33398888753211       1111223335678899999999


Q ss_pred             hhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         280 LCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       280 l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                      |+.||++|||++++++||||.+...
T Consensus       237 l~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06640         237 LNKDPSFRPTAKELLKHKFIVKNAK  261 (277)
T ss_pred             cccCcccCcCHHHHHhChHhhhcch
Confidence            9999999999999999999987654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.4e-41  Score=308.93  Aligned_cols=250  Identities=20%  Similarity=0.229  Sum_probs=185.7

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCC-CcEEEEEEeecCC------------ccccchhhhHhHHHHHHHHHhcCCCCc
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIET-DMIVAVKKIKLGT------------HADAKDGINRTALREIKLLQELHHENV  119 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~------------~~~~~~~~~~~~~~e~~~l~~l~h~ni  119 (307)
                      ..++|++++.||+|+||+||+|..... +..++.|.+....            ...........+.+|++++++++|+||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            457899999999999999999875432 2222222111000            000112234567899999999999999


Q ss_pred             cccceeeeecCeEEEEEEccCCChHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCc
Q psy9858         120 LGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPT----IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGV  195 (307)
Q Consensus       120 ~~~~~~~~~~~~~~lv~e~~~g~l~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~  195 (307)
                      +++++++.+.+..|++++++.+++..++....    .......++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~  305 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK  305 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence            99999999999999999999999888775432    12345677889999999999999999999999999999999999


Q ss_pred             EEEEeecCccccCCCCc-ccccceeeceehhhhhhhccccccccccee---eeee----cCC-CCCCCC-----------
Q psy9858         196 LKIGDFGLAKFFGSPTR-LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KDP-SSHGNL-----------  255 (307)
Q Consensus       196 ~kl~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~~~-~f~~~~-----------  255 (307)
                      +||+|||+++.+..... ......||..|+|||.+.+. .++.++|||   |+++    +.. |+....           
T Consensus       306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~  384 (501)
T PHA03210        306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKII  384 (501)
T ss_pred             EEEEeCCCceecCcccccccccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHH
Confidence            99999999987754322 22345789999999999887 899999999   3333    443 333210           


Q ss_pred             ---------CCCC------------------Chhhhc--cccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         256 ---------FPGI------------------PLNEIF--TAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       256 ---------~~~~------------------~~~~~~--~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                               ++..                  ......  ..++.++.++|.+||+.||++|||+.|+|+||||....
T Consensus       385 ~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~  461 (501)
T PHA03210        385 DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE  461 (501)
T ss_pred             HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence                     0000                  000000  13456788899999999999999999999999998754

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.1e-40  Score=283.37  Aligned_cols=238  Identities=16%  Similarity=0.158  Sum_probs=191.9

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEc---CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDI---ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM  129 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  129 (307)
                      ..++|++.+.||+|+||.||+|++.   ..+..||+|++....    .......+.+|+.+++.++||||+++++++...
T Consensus         3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   78 (266)
T cd05064           3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC----SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG   78 (266)
T ss_pred             chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC----CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC
Confidence            3567999999999999999999865   456789999987532    122245688999999999999999999999999


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                      +..++||||+ +|+|.+++......+++..++.++.||+.||+|||++|++||||||+||+++.++.++++|||.+....
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          79 NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             CCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            9999999999 567888887665578999999999999999999999999999999999999999999999999876542


Q ss_pred             CCCcc-cccceeeceehhhhhhhccccccccccee---ee----e-ecCCCCCCCCCC-------CCChhhhccccCHHH
Q psy9858         209 SPTRL-YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----F-AKDPSSHGNLFP-------GIPLNEIFTAAGDDL  272 (307)
Q Consensus       209 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~-~~~~~f~~~~~~-------~~~~~~~~~~~~~~l  272 (307)
                      ..... .....++..|+|||.+.+. .++.++|||   ++    + .|..||......       .......+..++..+
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (266)
T cd05064         159 SEAIYTTMSGKSPVLWAAPEAIQYH-HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLL  237 (266)
T ss_pred             ccchhcccCCCCceeecCHHHHhhC-CccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHH
Confidence            21111 1122345789999999887 889999999   22    3 388898763221       111112345678999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         273 LAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       273 ~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      .+++.+||+.+|.+|||++++++
T Consensus       238 ~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         238 HQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHHHHcCCCchhCCCHHHHHH
Confidence            99999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.9e-40  Score=280.24  Aligned_cols=242  Identities=23%  Similarity=0.338  Sum_probs=199.7

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEE
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLV  135 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  135 (307)
                      +|+..+.||+|++|.||+|.+..++..|++|.+.............+.+.+|+++++.++|+||+++++++......+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            47788999999999999999888999999999876433322233456788999999999999999999999999999999


Q ss_pred             EEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCccc
Q psy9858         136 FEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY  214 (307)
Q Consensus       136 ~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  214 (307)
                      +||+ +++|.+++.+.. .+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++....... ..
T Consensus        81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-~~  158 (258)
T cd06632          81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-FA  158 (258)
T ss_pred             EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-cc
Confidence            9999 567888876543 58899999999999999999999999999999999999999999999999998764332 23


Q ss_pred             ccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC--------CChhhhccccCHHHHHHHHHh
Q psy9858         215 THQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG--------IPLNEIFTAAGDDLLAVISSL  279 (307)
Q Consensus       215 ~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~--------~~~~~~~~~~~~~l~~li~~~  279 (307)
                      ....++..|++||.+.....++.++|+|   +    +++|..||.......        ......+..+++++.+++.+|
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  238 (258)
T cd06632         159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKC  238 (258)
T ss_pred             cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHH
Confidence            3456788999999987763489999999   2    333889986632111        111223345788999999999


Q ss_pred             hhcCCCCCCCHHHHhcCccc
Q psy9858         280 LCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       280 l~~dP~~Rpt~~~il~hp~f  299 (307)
                      |+.||.+|||+++++.|||+
T Consensus       239 l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         239 LQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             hhcCcccCcCHHHHhcCCCC
Confidence            99999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-40  Score=282.23  Aligned_cols=242  Identities=20%  Similarity=0.264  Sum_probs=195.1

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeeecC
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGYMS  130 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~  130 (307)
                      ...++|++.+.||+|++|.||+|.+..+++.|++|++.....      ....+.+|+.+++++ +|+||+++++++....
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   76 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED------EEEEIKEEYNILRKYSNHPNIATFYGAFIKKN   76 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch------hHHHHHHHHHHHHHhcCCCChheEEEEEEecC
Confidence            356899999999999999999999988999999999875321      235688999999999 6999999999986544


Q ss_pred             ------eEEEEEEcc-CCChHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEe
Q psy9858         131 ------NVSLVFEFV-DTDLEVIIKDP---TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGD  200 (307)
Q Consensus       131 ------~~~lv~e~~-~g~l~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~D  200 (307)
                            ..+++|||+ +++|.+++...   +..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|
T Consensus        77 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d  156 (275)
T cd06608          77 PPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVD  156 (275)
T ss_pred             CCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECC
Confidence                  589999999 46777776542   34689999999999999999999999999999999999999999999999


Q ss_pred             ecCccccCCCCcccccceeeceehhhhhhhcc----ccccccccee---e----eeecCCCCCCCCCCC-------CCh-
Q psy9858         201 FGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYC----VQFNVKNVQW---C----CFAKDPSSHGNLFPG-------IPL-  261 (307)
Q Consensus       201 fg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~~Diw---~----i~~~~~~f~~~~~~~-------~~~-  261 (307)
                      ||++..............++..|+|||.+...    ..++.++|||   +    +++|..||.......       ... 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  236 (275)
T cd06608         157 FGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPP  236 (275)
T ss_pred             CccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCC
Confidence            99998764433334455788999999988542    2567899999   2    333888886521100       000 


Q ss_pred             -hhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         262 -NEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       262 -~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                       .......+.++.+++.+||+.||++|||++++++|||+
T Consensus       237 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         237 TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence             01112367889999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.7e-40  Score=280.91  Aligned_cols=243  Identities=21%  Similarity=0.310  Sum_probs=196.2

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCcccc-----chhhhHhHHHHHHHHHhcCCCCccccceeeeecC
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADA-----KDGINRTALREIKLLQELHHENVLGLTDVFGYMS  130 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  130 (307)
                      +|.+.+.||+|++|.||+|.+..+|+.||+|.+........     .....+.+.+|+.+++.++|+|++++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            58889999999999999999888999999998864321111     1112346778999999999999999999999999


Q ss_pred             eEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCC
Q psy9858         131 NVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS  209 (307)
Q Consensus       131 ~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  209 (307)
                      ..++||||+ +|+|.+++... ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~  160 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDD  160 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence            999999999 67888888765 3689999999999999999999999999999999999999999999999999986532


Q ss_pred             CC--cccccceeeceehhhhhhhccc-cccccccee-------eeeecCCCCCCCCCC--------C----CChhhhccc
Q psy9858         210 PT--RLYTHQVVTRWYRLIKCLLYCV-QFNVKNVQW-------CCFAKDPSSHGNLFP--------G----IPLNEIFTA  267 (307)
Q Consensus       210 ~~--~~~~~~~~t~~y~aPE~~~~~~-~~~~~~Diw-------~i~~~~~~f~~~~~~--------~----~~~~~~~~~  267 (307)
                      ..  .......++..|+|||.+.... .++.++|+|       .++.|..||......        .    .........
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (272)
T cd06629         161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMN  240 (272)
T ss_pred             cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccccc
Confidence            21  1123345788999999987763 478999999       333488888652110        0    011122235


Q ss_pred             cCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         268 AGDDLLAVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       268 ~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                      ++.++.++|.+||+.||.+|||++++|+||||
T Consensus       241 ~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         241 LSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             CCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            68899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3.7e-40  Score=279.92  Aligned_cols=243  Identities=19%  Similarity=0.284  Sum_probs=194.6

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee--cCeE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY--MSNV  132 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~  132 (307)
                      .+|++.+.||+|+||.||+|.+..+|..||+|.+...............+.+|++++++++|+||+++++++.+  ....
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            47999999999999999999999999999999986433222222234567889999999999999999998865  3578


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT  211 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  211 (307)
                      +++|||+ +++|.+++.+.. .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~  160 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC  160 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence            8999999 578888876543 47889999999999999999999999999999999999999999999999998653211


Q ss_pred             ---cccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC--------CChhhhccccCHHHH
Q psy9858         212 ---RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG--------IPLNEIFTAAGDDLL  273 (307)
Q Consensus       212 ---~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~--------~~~~~~~~~~~~~l~  273 (307)
                         .......++..|+|||.+.+. .++.++|+|   +    +++|..||.......        ......+..++..+.
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (265)
T cd06652         161 LSGTGMKSVTGTPYWMSPEVISGE-GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCR  239 (265)
T ss_pred             ccccccccCCCCccccChhhhcCC-CCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHH
Confidence               112234578899999999876 789999999   3    333888987521110        111223345678899


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhcCcccC
Q psy9858         274 AVISSLLCLNPTKRADCTATLKMDYFS  300 (307)
Q Consensus       274 ~li~~~l~~dP~~Rpt~~~il~hp~f~  300 (307)
                      +++.+|+. +|++|||++++++|||+.
T Consensus       240 ~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         240 DFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             HHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            99999995 999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.8e-41  Score=287.88  Aligned_cols=241  Identities=19%  Similarity=0.275  Sum_probs=197.5

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      +.|+..+.||+|+||.||+|.+..++..||+|.+....    .....+.+.+|++++++++|+||+++++.+..+...++
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE----AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWI   79 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc----chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEE
Confidence            45777889999999999999998899999999987432    11224568899999999999999999999999999999


Q ss_pred             EEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc
Q psy9858         135 VFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL  213 (307)
Q Consensus       135 v~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  213 (307)
                      ||||+ +++|.+++...  .+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus        80 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06642          80 IMEYLGGGSALDLLKPG--PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             EEEccCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchh
Confidence            99999 56787777543  4789999999999999999999999999999999999999999999999999876443322


Q ss_pred             cccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCC-------CCChhhhccccCHHHHHHHHHh
Q psy9858         214 YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFP-------GIPLNEIFTAAGDDLLAVISSL  279 (307)
Q Consensus       214 ~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~-------~~~~~~~~~~~~~~l~~li~~~  279 (307)
                      .....++..|+|||.+.+. .++.++|+|   +    +++|..||......       ..........++.++.+++.+|
T Consensus       158 ~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  236 (277)
T cd06642         158 RNTFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEAC  236 (277)
T ss_pred             hhcccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHH
Confidence            3334678899999999877 789999999   2    33388887652111       1111122234678899999999


Q ss_pred             hhcCCCCCCCHHHHhcCcccCCC
Q psy9858         280 LCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       280 l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                      |+.+|.+|||+.++++||||...
T Consensus       237 l~~~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06642         237 LNKDPRFRPTAKELLKHKFITRY  259 (277)
T ss_pred             ccCCcccCcCHHHHHHhHHHHHH
Confidence            99999999999999999999754

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.4e-40  Score=290.25  Aligned_cols=242  Identities=32%  Similarity=0.517  Sum_probs=196.9

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec----
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM----  129 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~----  129 (307)
                      .++|.+.+.||+|+||.||+|.+..+|+.||+|++.....   .+.....+.+|+++++.++|+||+++++++...    
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~   90 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ---SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGD   90 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc---cccchhHHHHHHHHHHhcCCCCccchhheecccccCC
Confidence            3689999999999999999999988999999999875321   222345678999999999999999999988654    


Q ss_pred             --CeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         130 --SNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       130 --~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                        ...++++||+..++......   .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++..
T Consensus        91 ~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~  167 (342)
T cd07879          91 EFQDFYLVMPYMQTDLQKIMGH---PLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA  167 (342)
T ss_pred             CCceEEEEecccccCHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence              34699999998777666532   4789999999999999999999999999999999999999999999999999865


Q ss_pred             CCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCC-----------------------
Q psy9858         208 GSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFP-----------------------  257 (307)
Q Consensus       208 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~-----------------------  257 (307)
                      ...   .....++..|+|||.+.+...++.++|+|   +    ++.|+.||.+....                       
T Consensus       168 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (342)
T cd07879         168 DAE---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED  244 (342)
T ss_pred             CCC---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence            321   23346788999999988754789999999   2    33399998763210                       


Q ss_pred             --------------CCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         258 --------------GIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       258 --------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                                    .......++..+.++.+||.+||+.||++|||+++++.||||+..++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence                          00111112356788999999999999999999999999999988764

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.7e-40  Score=279.10  Aligned_cols=239  Identities=26%  Similarity=0.334  Sum_probs=197.5

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEE
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLV  135 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  135 (307)
                      +|+..+.||+|++|.||+|.+..+++.+|+|.+......   ......+.+|+++++.++||||+++++.+...+..++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT---KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIV   77 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc---cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEE
Confidence            589999999999999999999999999999999764322   22356788999999999999999999999999999999


Q ss_pred             EEcc-CCChHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCC-cEEEEeecCccccCCCCc
Q psy9858         136 FEFV-DTDLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG-VLKIGDFGLAKFFGSPTR  212 (307)
Q Consensus       136 ~e~~-~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~~~~  212 (307)
                      |||+ +++|.+++.... ..+++..+..++.|++.+|.|||++|++|+||+|+||+++.++ .++|+|||++....... 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-  156 (256)
T cd08220          78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-  156 (256)
T ss_pred             EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence            9999 568888887643 3488999999999999999999999999999999999998654 57999999998774332 


Q ss_pred             ccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCC-------CChhhhccccCHHHHHHHHH
Q psy9858         213 LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPG-------IPLNEIFTAAGDDLLAVISS  278 (307)
Q Consensus       213 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~-------~~~~~~~~~~~~~l~~li~~  278 (307)
                      ......++..|+|||.+.+. .++.++|+|       .+++|..||.......       .........++.++.+++.+
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  235 (256)
T cd08220         157 KAYTVVGTPCYISPELCEGK-PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS  235 (256)
T ss_pred             cccccccCCcccCchhccCC-CCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHH
Confidence            22234678899999999876 788999999       2333778887643211       11112234578899999999


Q ss_pred             hhhcCCCCCCCHHHHhcCccc
Q psy9858         279 LLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       279 ~l~~dP~~Rpt~~~il~hp~f  299 (307)
                      ||+.||.+|||++|+++||||
T Consensus       236 ~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         236 MLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HccCChhhCCCHHHHhhCCCC
Confidence            999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.3e-40  Score=290.44  Aligned_cols=243  Identities=33%  Similarity=0.489  Sum_probs=198.8

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC--
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS--  130 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--  130 (307)
                      ..++|++++.||+|+||.||+|.+..+|..||||++....   ........+.+|+++++.++|+||+++++++....  
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF---QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL   89 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence            5678999999999999999999999999999999986432   12223456789999999999999999999886553  


Q ss_pred             ----eEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         131 ----NVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       131 ----~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                          ..++||||+++++.+++...  .+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++..
T Consensus        90 ~~~~~~~lv~e~~~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~  167 (343)
T cd07880          90 DRFHDFYLVMPFMGTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  167 (343)
T ss_pred             cccceEEEEEecCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence                46899999988888887654  489999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC---------------------
Q psy9858         207 FGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG---------------------  258 (307)
Q Consensus       207 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~---------------------  258 (307)
                      ....   .....+++.|+|||.+.+...++.++|+|   +    ++.|..||.+.....                     
T Consensus       168 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd07880         168 TDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ  244 (343)
T ss_pred             cccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence            6332   22346688999999988754688999999   2    333999987532100                     


Q ss_pred             ----------------CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         259 ----------------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       259 ----------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                                      .........+++++.++|.+||+.||.+|||+.+++.||||+...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~  305 (343)
T cd07880         245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH  305 (343)
T ss_pred             chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence                            001122245788899999999999999999999999999998754

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.5e-40  Score=280.93  Aligned_cols=241  Identities=20%  Similarity=0.320  Sum_probs=196.4

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccc-cchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHAD-AKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      +|.+.+.||+|+||.||+|.+ .+|+.+|+|.+....... ........+.+|+++++.++|+||+++++++.+....++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            478899999999999999986 578899999987543221 112224568899999999999999999999999999999


Q ss_pred             EEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC---
Q psy9858         135 VFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP---  210 (307)
Q Consensus       135 v~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---  210 (307)
                      +|||+ +++|.+++.+.. .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......   
T Consensus        80 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  158 (265)
T cd06631          80 FMEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH  158 (265)
T ss_pred             EEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence            99999 568888876543 5789999999999999999999999999999999999999999999999998765321   


Q ss_pred             ---Ccccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC---------CChhhhccccCHH
Q psy9858         211 ---TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG---------IPLNEIFTAAGDD  271 (307)
Q Consensus       211 ---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~---------~~~~~~~~~~~~~  271 (307)
                         ........++..|+|||.+.+. .++.++|+|   +    +++|..||.......         .........++.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (265)
T cd06631         159 GTHSNMLKSMHGTPYWMAPEVINES-GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAA  237 (265)
T ss_pred             ccccccccccCCCccccChhhhcCC-CCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHH
Confidence               1122334678899999999876 788999999   2    333999987622111         1122344567899


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         272 LLAVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       272 l~~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                      +.+++++||+.||.+|||+.++++||||
T Consensus       238 ~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         238 AIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             HHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-40  Score=283.63  Aligned_cols=240  Identities=38%  Similarity=0.653  Sum_probs=198.6

Q ss_pred             eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec--CeEEE
Q psy9858          57 YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM--SNVSL  134 (307)
Q Consensus        57 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~l  134 (307)
                      |++++.||+|++|.||+|.+..+|+.+|+|++....   ........+.+|+++++.++|+|++++++++...  ...++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN---EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc---ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEE
Confidence            678999999999999999998899999999998643   1223345678999999999999999999999888  89999


Q ss_pred             EEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc-c
Q psy9858         135 VFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR-L  213 (307)
Q Consensus       135 v~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-~  213 (307)
                      ||||+++++.+++......+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++........ .
T Consensus        78 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~  157 (287)
T cd07840          78 VFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD  157 (287)
T ss_pred             EeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence            999999899998887655789999999999999999999999999999999999999999999999999987754321 2


Q ss_pred             cccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCC-------------------C--------
Q psy9858         214 YTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPG-------------------I--------  259 (307)
Q Consensus       214 ~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~-------------------~--------  259 (307)
                      .....++..|+|||.+.+...++.++|||       .+++|..||.......                   .        
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07840         158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN  237 (287)
T ss_pred             ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence            23346688899999887765789999999       3344888886522100                   0        


Q ss_pred             ---------Chhhhccc-cCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         260 ---------PLNEIFTA-AGDDLLAVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       260 ---------~~~~~~~~-~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                               ........ ++.++.+++.+||+.||.+|||++++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                     00011122 38899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.3e-40  Score=286.67  Aligned_cols=244  Identities=20%  Similarity=0.327  Sum_probs=198.2

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN  131 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  131 (307)
                      ...+.|.....||+|+||.||++.+..++..||||.+....     ......+.+|+.+++.++|+||+++++.+...+.
T Consensus        19 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~   93 (292)
T cd06658          19 DPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-----QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDE   93 (292)
T ss_pred             chHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-----HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCe
Confidence            34456777788999999999999998899999999986422     1224567899999999999999999999999999


Q ss_pred             EEEEEEccC-CChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         132 VSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       132 ~~lv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      .+++|||+. ++|.+++...  .+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus        94 ~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~  171 (292)
T cd06658          94 LWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE  171 (292)
T ss_pred             EEEEEeCCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc
Confidence            999999995 5677766443  4789999999999999999999999999999999999999999999999999766433


Q ss_pred             Ccccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCCC---------ChhhhccccCHHHHH
Q psy9858         211 TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPGI---------PLNEIFTAAGDDLLA  274 (307)
Q Consensus       211 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~~---------~~~~~~~~~~~~l~~  274 (307)
                      ........++..|+|||.+.+. .++.++|+|       .+++|..||........         ........++..+.+
T Consensus       172 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (292)
T cd06658         172 VPKRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRG  250 (292)
T ss_pred             cccCceeecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHH
Confidence            3333445688999999998776 788999999       23338888865321110         000111246788999


Q ss_pred             HHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         275 VISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       275 li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      ++.+||+.||.+|||++++++||||....
T Consensus       251 li~~~l~~~P~~Rpt~~~il~~~~~~~~~  279 (292)
T cd06658         251 FLDLMLVREPSQRATAQELLQHPFLKLAG  279 (292)
T ss_pred             HHHHHccCChhHCcCHHHHhhChhhhccC
Confidence            99999999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG0986|consensus

Probab=100.00  E-value=5.2e-42  Score=291.57  Aligned_cols=248  Identities=22%  Similarity=0.263  Sum_probs=211.4

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN  131 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  131 (307)
                      ...+.|+.-+.||+||||.|+-++...+|+.||+|.+.+......+  -....++|.+||.+++.+.||.+--+|+..+.
T Consensus       182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~--ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~  259 (591)
T KOG0986|consen  182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRK--GETMALNEKQILEKVSSPFIVSLAYAFETKDA  259 (591)
T ss_pred             ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhh--hhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence            3446788889999999999999999999999999999865443322  24557899999999999999999989999999


Q ss_pred             EEEEEEcc-CCChHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCC
Q psy9858         132 VSLVFEFV-DTDLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS  209 (307)
Q Consensus       132 ~~lv~e~~-~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  209 (307)
                      +||||..+ +|+|.-++.+.+ ..+++..++.++.+|+.||.+||+.+||+|||||+|||+|+.|+|.|+|+|+|..+..
T Consensus       260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            99999999 678877776543 3499999999999999999999999999999999999999999999999999999855


Q ss_pred             CCcccccceeeceehhhhhhhccccccccccee---eeee----cCCCCCCCCCCC----------CChhhhccccCHHH
Q psy9858         210 PTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KDPSSHGNLFPG----------IPLNEIFTAAGDDL  272 (307)
Q Consensus       210 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~~~~f~~~~~~~----------~~~~~~~~~~~~~l  272 (307)
                      . .....++||.+|||||++.+. .|+...|.|   |++|    |..||.......          ....+.+...|+++
T Consensus       340 g-~~~~~rvGT~GYMAPEvl~ne-~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~ea  417 (591)
T KOG0986|consen  340 G-KPIRGRVGTVGYMAPEVLQNE-VYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEA  417 (591)
T ss_pred             C-CccccccCcccccCHHHHcCC-cccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHH
Confidence            4 444566999999999999999 699999999   6666    999998822211          12234456789999


Q ss_pred             HHHHHHhhhcCCCCCCC-----HHHHhcCcccCCCc
Q psy9858         273 LAVISSLLCLNPTKRAD-----CTATLKMDYFSLTK  303 (307)
Q Consensus       273 ~~li~~~l~~dP~~Rpt-----~~~il~hp~f~~~~  303 (307)
                      +++...+|++||++|..     ++++-+||||++++
T Consensus       418 kslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ln  453 (591)
T KOG0986|consen  418 KSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLN  453 (591)
T ss_pred             HHHHHHHHccCHHHhccCCCcCcchhhhCcccccCC
Confidence            99999999999999986     67999999999854

>KOG0671|consensus

Probab=100.00  E-value=1.2e-40  Score=277.95  Aligned_cols=241  Identities=25%  Similarity=0.376  Sum_probs=197.2

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCC--C----Cccccceeee
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH--E----NVLGLTDVFG  127 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~----ni~~~~~~~~  127 (307)
                      .++|.+++.+|+|+||.|..+.+.+++..||+|+++.      -..+.....-|+++|.++.+  |    -++++.++|+
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~------V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd  161 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN------VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD  161 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHH------HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence            6889999999999999999999999999999999873      22234556789999999942  2    3678888899


Q ss_pred             ecCeEEEEEEccCCChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEec--------------
Q psy9858         128 YMSNVSLVFEFVDTDLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK--------------  192 (307)
Q Consensus       128 ~~~~~~lv~e~~~g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~--------------  192 (307)
                      ..++.|||+|.++-++.+.+..+ -.+++-..++.++.|+++++++||+.+++|.||||+|||+.+              
T Consensus       162 yrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  162 YRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             ccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccc
Confidence            99999999999999999999874 345899999999999999999999999999999999999832              


Q ss_pred             ------CCcEEEEeecCccccCCCCcccccceeeceehhhhhhhccccccccccee---eeee----cCCCCCCCC----
Q psy9858         193 ------QGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KDPSSHGNL----  255 (307)
Q Consensus       193 ------~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~~~~f~~~~----  255 (307)
                            +..++|+|||.|..-..   ..+..+.|..|+|||++.+- .+++..|||   ||+.    |..+|.+..    
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~e---~hs~iVsTRHYRAPEViLgL-GwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH  317 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDHE---HHSTIVSTRHYRAPEVILGL-GWSQPCDVWSIGCILVELYTGETLFQTHENLEH  317 (415)
T ss_pred             eeccCCCcceEEEecCCcceecc---CcceeeeccccCCchheecc-CcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence                  33589999999987533   23566889999999999998 999999999   6666    999998811    


Q ss_pred             ----------CCCCCh-----------------------------------hhhc---cccCHHHHHHHHHhhhcCCCCC
Q psy9858         256 ----------FPGIPL-----------------------------------NEIF---TAAGDDLLAVISSLLCLNPTKR  287 (307)
Q Consensus       256 ----------~~~~~~-----------------------------------~~~~---~~~~~~l~~li~~~l~~dP~~R  287 (307)
                                ++....                                   ....   .....++.+|+++||..||.+|
T Consensus       318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R  397 (415)
T KOG0671|consen  318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR  397 (415)
T ss_pred             HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence                      000000                                   0000   0112468999999999999999


Q ss_pred             CCHHHHhcCcccCCCcc
Q psy9858         288 ADCTATLKMDYFSLTKE  304 (307)
Q Consensus       288 pt~~~il~hp~f~~~~~  304 (307)
                      +|+.|+|.||||+...+
T Consensus       398 iTl~EAL~HpFF~~~~~  414 (415)
T KOG0671|consen  398 ITLREALSHPFFARLTP  414 (415)
T ss_pred             ccHHHHhcCHHhhcCCC
Confidence            99999999999998654

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=5e-40  Score=278.59  Aligned_cols=243  Identities=25%  Similarity=0.321  Sum_probs=204.9

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ++|++.+.||+|++|.||+|.+..+++.|++|++......    .....+.+|+.++..++|+||+++++++......++
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE----EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISI   76 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch----HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEE
Confidence            4689999999999999999999999999999998754321    235678899999999999999999999999999999


Q ss_pred             EEEccC-CChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc
Q psy9858         135 VFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD-HWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR  212 (307)
Q Consensus       135 v~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  212 (307)
                      +|||+. ++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++........
T Consensus        77 v~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          77 VLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD  155 (264)
T ss_pred             EEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence            999995 7888888765 458999999999999999999999 9999999999999999999999999999987754443


Q ss_pred             ccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCC----------CCCChhhhccc-cCHHHHH
Q psy9858         213 LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLF----------PGIPLNEIFTA-AGDDLLA  274 (307)
Q Consensus       213 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~----------~~~~~~~~~~~-~~~~l~~  274 (307)
                      ......++..|+|||.+.+. .++.++|+|       .+++|..||.....          ........... ++..+.+
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  234 (264)
T cd06623         156 QCNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRD  234 (264)
T ss_pred             cccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHH
Confidence            33355788999999998887 889999999       23448888866431          01111122233 7889999


Q ss_pred             HHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         275 VISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       275 li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      +|++||+.+|++|||++++++||||+..+
T Consensus       235 li~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         235 FISACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             HHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence            99999999999999999999999998765

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.4e-40  Score=290.46  Aligned_cols=251  Identities=35%  Similarity=0.556  Sum_probs=200.0

Q ss_pred             ccceeeE-EeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccc---------hhhhHhHHHHHHHHHhcCCCCcccc
Q psy9858          53 DLLVYYQ-WRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAK---------DGINRTALREIKLLQELHHENVLGL  122 (307)
Q Consensus        53 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---------~~~~~~~~~e~~~l~~l~h~ni~~~  122 (307)
                      ..++|.. .+.||.|+||.||+|.+..+++.||+|++.........         ......+.+|+++++.++|+||+++
T Consensus         6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   85 (335)
T PTZ00024          6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL   85 (335)
T ss_pred             cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence            3456765 47799999999999999999999999998754322111         0112346789999999999999999


Q ss_pred             ceeeeecCeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeec
Q psy9858         123 TDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG  202 (307)
Q Consensus       123 ~~~~~~~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg  202 (307)
                      ++++..+...+++|||+.|+|.+.+.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg  164 (335)
T PTZ00024         86 VDVYVEGDFINLVMDIMASDLKKVVDRKI-RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG  164 (335)
T ss_pred             eEEEecCCcEEEEEeccccCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence            99999999999999999999998887543 48999999999999999999999999999999999999999999999999


Q ss_pred             CccccCCC--------------Ccccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCC----
Q psy9858         203 LAKFFGSP--------------TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFP----  257 (307)
Q Consensus       203 ~a~~~~~~--------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~----  257 (307)
                      ++......              ........++..|+|||.+.+...++.++|+|   +    +++|.+||.+....    
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~  244 (335)
T PTZ00024        165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG  244 (335)
T ss_pred             ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99876411              11122335678899999998765679999999   2    33388888653210    


Q ss_pred             ------------------------------CCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         258 ------------------------------GIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       258 ------------------------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                                                    ...........++++.++|.+||+.||++|||++++|.||||++...
T Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~  321 (335)
T PTZ00024        245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPL  321 (335)
T ss_pred             HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCC
Confidence                                          00111222346788999999999999999999999999999987653

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.3e-40  Score=283.04  Aligned_cols=243  Identities=19%  Similarity=0.270  Sum_probs=199.3

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      +-|++++.||+|+||.||+|.+..++..||+|++.....    ......+.+|+.+++.++||||+++++.+..+...++
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   79 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA----EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI   79 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEE
Confidence            347888999999999999999888999999999864321    1224568899999999999999999999999999999


Q ss_pred             EEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc
Q psy9858         135 VFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL  213 (307)
Q Consensus       135 v~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  213 (307)
                      ||||+ +++|.+++...  .+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus        80 v~e~~~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06641          80 IMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             EEEeCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhh
Confidence            99999 56788777643  4789999999999999999999999999999999999999999999999999776433222


Q ss_pred             cccceeeceehhhhhhhccccccccccee---ee----eecCCCCCCCCCC-------CCChhhhccccCHHHHHHHHHh
Q psy9858         214 YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FAKDPSSHGNLFP-------GIPLNEIFTAAGDDLLAVISSL  279 (307)
Q Consensus       214 ~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~~~~~f~~~~~~-------~~~~~~~~~~~~~~l~~li~~~  279 (307)
                      .....++..|+|||.+.+. ..+.++|+|   ++    +.|..||......       ..........++.++.+++.+|
T Consensus       158 ~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  236 (277)
T cd06641         158 RNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEAC  236 (277)
T ss_pred             hccccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHH
Confidence            3344678899999998876 788999999   23    3388888652211       1111122335688999999999


Q ss_pred             hhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         280 LCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       280 l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                      |+.+|.+||++.++++||||.+...
T Consensus       237 l~~~p~~Rp~~~~~l~~~~~~~~~~  261 (277)
T cd06641         237 LNKEPSFRPTAKELLKHKFIVRFAK  261 (277)
T ss_pred             ccCChhhCcCHHHHHhCHHHhhhhh
Confidence            9999999999999999999987543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1e-40  Score=296.87  Aligned_cols=243  Identities=19%  Similarity=0.280  Sum_probs=191.7

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEE-----cCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCcccc
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARD-----IETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGL  122 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~  122 (307)
                      .+.-..++|++.+.||+|+||.||+|++     ..++..||+|++.....    ....+.+.+|+++++.+ +||||+++
T Consensus        29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~----~~~~~~~~~Ei~il~~l~~HpnIv~l  104 (375)
T cd05104          29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH----LTEREALMSELKVLSYLGNHINIVNL  104 (375)
T ss_pred             ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC----cHHHHHHHHHHHHHHHhcCCcceeee
Confidence            3444566899999999999999999974     34577899999874321    12245688999999999 89999999


Q ss_pred             ceeeeecCeEEEEEEcc-CCChHHHHhCCC--------------------------------------------------
Q psy9858         123 TDVFGYMSNVSLVFEFV-DTDLEVIIKDPT--------------------------------------------------  151 (307)
Q Consensus       123 ~~~~~~~~~~~lv~e~~-~g~l~~~~~~~~--------------------------------------------------  151 (307)
                      ++++......++||||+ +|+|.+++....                                                  
T Consensus       105 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  184 (375)
T cd05104         105 LGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKAD  184 (375)
T ss_pred             eeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccc
Confidence            99999999999999999 688988886432                                                  


Q ss_pred             ------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         152 ------------------------IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       152 ------------------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                                              ..+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||+++..
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~  264 (375)
T cd05104         185 KRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI  264 (375)
T ss_pred             cccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceec
Confidence                                    13677888999999999999999999999999999999999999999999999876


Q ss_pred             CCCCcc--cccceeeceehhhhhhhccccccccccee---ee----ee-cCCCCCCCCCCCC--------ChhhhccccC
Q psy9858         208 GSPTRL--YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FA-KDPSSHGNLFPGI--------PLNEIFTAAG  269 (307)
Q Consensus       208 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~-~~~~f~~~~~~~~--------~~~~~~~~~~  269 (307)
                      ......  .....++..|+|||.+.+. .++.++|||   ++    ++ |..||........        .....+...+
T Consensus       265 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (375)
T cd05104         265 RNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAP  343 (375)
T ss_pred             cCcccccccCCCCCCcceeChhHhcCC-CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCC
Confidence            433221  1122345679999999887 899999999   32    33 7888866322110        0111223467


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         270 DDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       270 ~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      .++.+|+.+||+.||++|||+.++++.
T Consensus       344 ~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         344 SEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=3.9e-40  Score=279.27  Aligned_cols=235  Identities=23%  Similarity=0.293  Sum_probs=195.3

Q ss_pred             EeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEEEcc-CC
Q psy9858          63 VHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFV-DT  141 (307)
Q Consensus        63 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~-~g  141 (307)
                      ||.|++|.||+|.+..+++.||+|++.......  ....+.+.+|+++++.++||||+++++.+.++...+++|||+ ++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVE--TGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGG   78 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchh--hhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCC
Confidence            689999999999998899999999997643222  223467889999999999999999999999999999999999 67


Q ss_pred             ChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcccccceeec
Q psy9858         142 DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTR  221 (307)
Q Consensus       142 ~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~  221 (307)
                      +|.+++.+.. .+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... ......++.
T Consensus        79 ~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~  156 (262)
T cd05572          79 ELWTILRDRG-LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTP  156 (262)
T ss_pred             cHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCc
Confidence            8888887653 48899999999999999999999999999999999999999999999999998775432 223346788


Q ss_pred             eehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC----------CChhhhccccCHHHHHHHHHhhhcCC
Q psy9858         222 WYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG----------IPLNEIFTAAGDDLLAVISSLLCLNP  284 (307)
Q Consensus       222 ~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~----------~~~~~~~~~~~~~l~~li~~~l~~dP  284 (307)
                      .|++||.+.+. .++.++|+|   +    +++|..||.......          ......+...++++.++|.+||+.||
T Consensus       157 ~~~~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p  235 (262)
T cd05572         157 EYVAPEIILNK-GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNP  235 (262)
T ss_pred             CccChhHhcCC-CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCCh
Confidence            99999998776 789999999   2    333999987654110          11112233457899999999999999


Q ss_pred             CCCCC-----HHHHhcCcccCCC
Q psy9858         285 TKRAD-----CTATLKMDYFSLT  302 (307)
Q Consensus       285 ~~Rpt-----~~~il~hp~f~~~  302 (307)
                      .+|||     ++|+++||||+..
T Consensus       236 ~~R~~~~~~~~~~l~~~~~~~~~  258 (262)
T cd05572         236 EERLGNLKGGIKDIKKHKWFNGF  258 (262)
T ss_pred             hhCcCCcccCHHHHhcChhhhCC
Confidence            99999     9999999999864

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.8e-40  Score=279.17  Aligned_cols=240  Identities=25%  Similarity=0.375  Sum_probs=197.8

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEE
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLV  135 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  135 (307)
                      +|.+.+.||+|+||.||+|.+..+|..||+|.+.......   .....+.+|+++++.++|+||+++++.+......+++
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv   77 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV---KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIV   77 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc---hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEE
Confidence            5889999999999999999999999999999987532211   1245677999999999999999999999999999999


Q ss_pred             EEcc-CCChHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCc-EEEEeecCccccCCCCc
Q psy9858         136 FEFV-DTDLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGV-LKIGDFGLAKFFGSPTR  212 (307)
Q Consensus       136 ~e~~-~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~-~kl~Dfg~a~~~~~~~~  212 (307)
                      +||+ +++|.+++.... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||.+........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            9999 678888886543 24789999999999999999999999999999999999998864 69999999987754433


Q ss_pred             ccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCC-------CChhhhccccCHHHHHHHHH
Q psy9858         213 LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPG-------IPLNEIFTAAGDDLLAVISS  278 (307)
Q Consensus       213 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~-------~~~~~~~~~~~~~l~~li~~  278 (307)
                      ......++..|+|||.+.+. .++.++|+|       .+++|..||.......       .......+.++.++.++|.+
T Consensus       158 ~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  236 (257)
T cd08225         158 LAYTCVGTPYYLSPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQ  236 (257)
T ss_pred             cccccCCCccccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHH
Confidence            33344678899999998877 788999999       2333888887532111       11112234567899999999


Q ss_pred             hhhcCCCCCCCHHHHhcCccc
Q psy9858         279 LLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       279 ~l~~dP~~Rpt~~~il~hp~f  299 (307)
                      ||+.+|++|||+++++.||||
T Consensus       237 ~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         237 LFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HhccChhhCcCHHHHhhCCCC
Confidence            999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=5.5e-40  Score=277.06  Aligned_cols=240  Identities=26%  Similarity=0.422  Sum_probs=201.7

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEE
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLV  135 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  135 (307)
                      +|.+.+.||.|++|.||++.+..++..||+|++......   ......+.+|+++++.++|+|++++.+.+......+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv   77 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS---EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIV   77 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC---hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEE
Confidence            588999999999999999999889999999999753321   22356688999999999999999999999999999999


Q ss_pred             EEccC-CChHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC
Q psy9858         136 FEFVD-TDLEVIIKDP---TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT  211 (307)
Q Consensus       136 ~e~~~-g~l~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  211 (307)
                      +|+++ ++|.+.+...   ...+++..+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99995 6888888764   3568999999999999999999999999999999999999999999999999998775543


Q ss_pred             cccccceeeceehhhhhhhccccccccccee--e-----eeecCCCCCCCCCCC-------CChhhhccccCHHHHHHHH
Q psy9858         212 RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW--C-----CFAKDPSSHGNLFPG-------IPLNEIFTAAGDDLLAVIS  277 (307)
Q Consensus       212 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw--~-----i~~~~~~f~~~~~~~-------~~~~~~~~~~~~~l~~li~  277 (307)
                      .......+++.|+|||...+. .++.++|+|  +     +++|..||.......       ......+...+.++.+++.
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  236 (258)
T cd08215         158 DLAKTVVGTPYYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVS  236 (258)
T ss_pred             ceecceeeeecccChhHhccC-CCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence            344445788999999998877 789999999  2     333888886632111       1122233457889999999


Q ss_pred             HhhhcCCCCCCCHHHHhcCccc
Q psy9858         278 SLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       278 ~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                      +||..||.+|||++++|+||||
T Consensus       237 ~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         237 SLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHcCCChhhCcCHHHHhcCCCC
Confidence            9999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.1e-40  Score=286.13  Aligned_cols=243  Identities=19%  Similarity=0.281  Sum_probs=198.4

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ....|.....||+|+||.||+|.+..+++.||+|++.....     .....+.+|+.+++.++||||+++++.+..++..
T Consensus        19 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~   93 (297)
T cd06659          19 PRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-----QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEEL   93 (297)
T ss_pred             chhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-----chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeE
Confidence            33455666789999999999999988999999999864321     1235578999999999999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT  211 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  211 (307)
                      +++|||+ +++|.+++...  .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus        94 ~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~  171 (297)
T cd06659          94 WVLMEFLQGGALTDIVSQT--RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV  171 (297)
T ss_pred             EEEEecCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence            9999999 46777766543  47899999999999999999999999999999999999999999999999997664433


Q ss_pred             cccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC---------CChhhhccccCHHHHHH
Q psy9858         212 RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG---------IPLNEIFTAAGDDLLAV  275 (307)
Q Consensus       212 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~---------~~~~~~~~~~~~~l~~l  275 (307)
                      .......++..|+|||.+.+. .++.++|+|   +    +++|..||.......         .........++..+.++
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  250 (297)
T cd06659         172 PKRKSLVGTPYWMAPEVISRT-PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDF  250 (297)
T ss_pred             ccccceecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHH
Confidence            333445788999999999877 789999999   2    333888886522100         01111223578899999


Q ss_pred             HHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         276 ISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       276 i~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      |.+||+.||++|||++++++||||.+.+
T Consensus       251 i~~~l~~~P~~Rps~~~ll~~~~~~~~~  278 (297)
T cd06659         251 LERMLTREPQERATAQELLDHPFLLQTG  278 (297)
T ss_pred             HHHHhcCCcccCcCHHHHhhChhhccCC
Confidence            9999999999999999999999998764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.8e-40  Score=282.52  Aligned_cols=237  Identities=22%  Similarity=0.248  Sum_probs=193.9

Q ss_pred             EeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEEEcc-CC
Q psy9858          63 VHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFV-DT  141 (307)
Q Consensus        63 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~-~g  141 (307)
                      ||+|+||+||+|.+..+|+.||+|++.......  ......+.+|+++++.++||||+++++.+...+..|+||||+ ++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKK--RKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGG   78 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhh--hhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCC
Confidence            689999999999999999999999987542221  122455678999999999999999999999999999999999 57


Q ss_pred             ChHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcccccceee
Q psy9858         142 DLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVT  220 (307)
Q Consensus       142 ~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t  220 (307)
                      +|.+++.+.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+..... ........++
T Consensus        79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~  157 (277)
T cd05577          79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG-GKKIKGRAGT  157 (277)
T ss_pred             cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc-CCccccccCC
Confidence            8888876543 3589999999999999999999999999999999999999999999999999986643 2222334678


Q ss_pred             ceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCC----------ChhhhccccCHHHHHHHHHhhhcC
Q psy9858         221 RWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGI----------PLNEIFTAAGDDLLAVISSLLCLN  283 (307)
Q Consensus       221 ~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~d  283 (307)
                      ..|+|||.+.+. .++.++|+|   +    +++|..||........          .....+..+++++.++|.+||+.|
T Consensus       158 ~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  236 (277)
T cd05577         158 PGYMAPEVLQGE-VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD  236 (277)
T ss_pred             CCcCCHHHhcCC-CCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence            899999999887 689999999   2    3349999876432110          111223457899999999999999


Q ss_pred             CCCCC-----CHHHHhcCcccCCCc
Q psy9858         284 PTKRA-----DCTATLKMDYFSLTK  303 (307)
Q Consensus       284 P~~Rp-----t~~~il~hp~f~~~~  303 (307)
                      |.+||     ++.++++||||+...
T Consensus       237 p~~R~~~~~~~~~~ll~h~~~~~~~  261 (277)
T cd05577         237 PEKRLGCRGGSADEVREHPLFKDLN  261 (277)
T ss_pred             hhHccCCCcccHHHHHhChhhhcCC
Confidence            99999     899999999997643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=5.5e-40  Score=288.96  Aligned_cols=241  Identities=33%  Similarity=0.554  Sum_probs=194.2

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec----
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM----  129 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~----  129 (307)
                      ..+|.+.+.||.|+||.||+|.+..+|+.||+|++.....     ...+.+.+|+++++.++||||+++++++...    
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-----~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~   78 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-----QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL   78 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-----chHHHHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence            4789999999999999999999999999999999875322     2245678999999999999999999876543    


Q ss_pred             ----------CeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEec-CCcEEE
Q psy9858         130 ----------SNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK-QGVLKI  198 (307)
Q Consensus       130 ----------~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~-~~~~kl  198 (307)
                                ...+++|||++++|.+.+...  .+++..++.++.||+.||.|||+.|++||||||+||+++. ++.++|
T Consensus        79 ~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl  156 (342)
T cd07854          79 TEDVGSLTELNSVYIVQEYMETDLANVLEQG--PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKI  156 (342)
T ss_pred             ccccccccccceEEEEeecccccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEE
Confidence                      358999999998888877643  4889999999999999999999999999999999999974 557899


Q ss_pred             EeecCccccCCCCc---ccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCC------------
Q psy9858         199 GDFGLAKFFGSPTR---LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLF------------  256 (307)
Q Consensus       199 ~Dfg~a~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~------------  256 (307)
                      +|||.+........   ......++..|+|||.+.+...++.++|||   +    +++|..||.+...            
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~  236 (342)
T cd07854         157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP  236 (342)
T ss_pred             CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            99999986532211   112335788999999887655788999999   3    3338888865210            


Q ss_pred             ------------------------CCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCC
Q psy9858         257 ------------------------PGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSL  301 (307)
Q Consensus       257 ------------------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~  301 (307)
                                              ...........++.++.+||.+||+.||++|||++++++||||+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~  305 (342)
T cd07854         237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC  305 (342)
T ss_pred             CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence                                    001111223457889999999999999999999999999999973

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=9.8e-40  Score=280.31  Aligned_cols=242  Identities=19%  Similarity=0.305  Sum_probs=198.3

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ..|...+.||+|++|.||++.+..+++.|++|.+....     ....+.+.+|+.+++.++|+||+++++++...+..++
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-----~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~   93 (285)
T cd06648          19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-----QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWV   93 (285)
T ss_pred             HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-----hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEE
Confidence            45666789999999999999998899999999886421     1124557899999999999999999999999999999


Q ss_pred             EEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc
Q psy9858         135 VFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL  213 (307)
Q Consensus       135 v~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  213 (307)
                      ++||+ +++|.+++..  ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.........
T Consensus        94 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~  171 (285)
T cd06648          94 VMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR  171 (285)
T ss_pred             EEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc
Confidence            99999 6788888776  35889999999999999999999999999999999999999999999999998766433222


Q ss_pred             cccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCC---------CChhhhccccCHHHHHHHH
Q psy9858         214 YTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPG---------IPLNEIFTAAGDDLLAVIS  277 (307)
Q Consensus       214 ~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~---------~~~~~~~~~~~~~l~~li~  277 (307)
                      .....++..|+|||.+.+. .++.++|+|       .+++|..||.......         .........++..+.+++.
T Consensus       172 ~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  250 (285)
T cd06648         172 RKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLD  250 (285)
T ss_pred             cccccCCccccCHHHhcCC-CCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHH
Confidence            3334688999999998877 789999999       2334888886522100         0011112237789999999


Q ss_pred             HhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         278 SLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       278 ~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                      +||+.||++|||++++++||||++...
T Consensus       251 ~~l~~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         251 RMLVRDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             HHcccChhhCcCHHHHccCcccccCCC
Confidence            999999999999999999999987653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG2345|consensus

Probab=100.00  E-value=9.7e-41  Score=263.82  Aligned_cols=245  Identities=23%  Similarity=0.234  Sum_probs=197.9

Q ss_pred             CceeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceee
Q psy9858          47 DCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVF  126 (307)
Q Consensus        47 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~  126 (307)
                      ...+..+.++|++.++||+|||+.||++++..++..||+|++.....     ...+..++|++..++++|||+++++++.
T Consensus        13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~-----~~~e~~~rEid~~rkf~s~~vl~l~dh~   87 (302)
T KOG2345|consen   13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ-----EDIEEALREIDNHRKFNSPNVLRLVDHQ   87 (302)
T ss_pred             CCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccch-----HHHHHHHHHHHHHHhhCCcchHHHHHHH
Confidence            44566678899999999999999999999999999999999976431     2245678999999999999999999977


Q ss_pred             eec-----CeEEEEEEcc-CCChHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeecCCCCcEEEecCCc
Q psy9858         127 GYM-----SNVSLVFEFV-DTDLEVIIKD---PTIVFTPSNIKAYAIMTLRGLEYLHDHW--ILHRDLKPNNLLINKQGV  195 (307)
Q Consensus       127 ~~~-----~~~~lv~e~~-~g~l~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~  195 (307)
                      ..+     ...||+++|. .|+|.+.+..   .+..+++.++..|+.+|+.||++||+..  +.||||||.||++.+.+.
T Consensus        88 l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~  167 (302)
T KOG2345|consen   88 LREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL  167 (302)
T ss_pred             HHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc
Confidence            433     4599999999 7999998864   3335899999999999999999999998  999999999999999999


Q ss_pred             EEEEeecCccccCCCC---------cccccceeeceehhhhhhhccc--cccccccee---eeee----cCCCCCCCCCC
Q psy9858         196 LKIGDFGLAKFFGSPT---------RLYTHQVVTRWYRLIKCLLYCV--QFNVKNVQW---CCFA----KDPSSHGNLFP  257 (307)
Q Consensus       196 ~kl~Dfg~a~~~~~~~---------~~~~~~~~t~~y~aPE~~~~~~--~~~~~~Diw---~i~~----~~~~f~~~~~~  257 (307)
                      ++|.|||.+....-..         ........|..|+|||.+.-..  ..+.++|||   |++|    |.-||+.....
T Consensus       168 ~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~  247 (302)
T KOG2345|consen  168 PVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ  247 (302)
T ss_pred             eEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc
Confidence            9999999998653210         1122345688999999986432  578999999   6555    89999872222


Q ss_pred             CCChh----------hhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         258 GIPLN----------EIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       258 ~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      .....          +....+|+.+.++|++||+.||.+||++.+++++
T Consensus       248 GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  248 GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            11110          0012378999999999999999999999999875

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.3e-40  Score=284.50  Aligned_cols=244  Identities=19%  Similarity=0.239  Sum_probs=195.6

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-CCCccccceeeeecCeEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-HENVLGLTDVFGYMSNVS  133 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~  133 (307)
                      ++|...+.||+|+||.||++.+..+++.||+|.+......    .....+.+|+.++.++. |+||+++++++..+...+
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~   79 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE----KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCW   79 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh----HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEE
Confidence            4566778999999999999999999999999998753221    23456889999999996 999999999999999999


Q ss_pred             EEEEccCCChHHHHh----CCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         134 LVFEFVDTDLEVIIK----DPTIVFTPSNIKAYAIMTLRGLEYLHDH-WILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       134 lv~e~~~g~l~~~~~----~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                      ++|||+.+++.++..    .....+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||++....
T Consensus        80 ~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          80 ICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             EEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            999999877655432    2234689999999999999999999975 99999999999999999999999999998664


Q ss_pred             CCCcccccceeeceehhhhhhhcc--ccccccccee-------eeeecCCCCCCCCC---------CC---CChhhhccc
Q psy9858         209 SPTRLYTHQVVTRWYRLIKCLLYC--VQFNVKNVQW-------CCFAKDPSSHGNLF---------PG---IPLNEIFTA  267 (307)
Q Consensus       209 ~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~Diw-------~i~~~~~~f~~~~~---------~~---~~~~~~~~~  267 (307)
                      ... ......++..|+|||.+.+.  ..++.++|||       .+++|..||.....         ..   .........
T Consensus       160 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd06616         160 DSI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE  238 (288)
T ss_pred             cCC-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCc
Confidence            322 22334678899999998765  3688999999       23349999865220         00   000111134


Q ss_pred             cCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         268 AGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       268 ~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      ++.++.+|+.+||+.||.+|||++++++||||....
T Consensus       239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         239 FSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence            788999999999999999999999999999997643

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.9e-40  Score=283.44  Aligned_cols=242  Identities=23%  Similarity=0.310  Sum_probs=198.6

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEE
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVS  133 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  133 (307)
                      .++|++++.||+|+||+||++.+..+|+.||+|++...    ......+.+.+|+++++.++||||+++++.+...+..+
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIG----AKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNIC   79 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEec----CcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEE
Confidence            46789999999999999999999999999999998743    22333567889999999999999999999999999999


Q ss_pred             EEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCcEEEecCCcEEEEeecCccccCCCC
Q psy9858         134 LVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD-HWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT  211 (307)
Q Consensus       134 lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  211 (307)
                      +||||+ +++|.+++... +.+++..+..++.+++.||.|||+ .|++|+||+|+||+++.++.++|+|||++...... 
T Consensus        80 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-  157 (284)
T cd06620          80 MCMEFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-  157 (284)
T ss_pred             EEEecCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence            999999 56777766553 358999999999999999999997 69999999999999999999999999998765322 


Q ss_pred             cccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC------------------CChhhhc-
Q psy9858         212 RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG------------------IPLNEIF-  265 (307)
Q Consensus       212 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~------------------~~~~~~~-  265 (307)
                       ......++..|+|||.+.+. .++.++|+|   +    +++|..||.......                  ....... 
T Consensus       158 -~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd06620         158 -IADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS  235 (284)
T ss_pred             -ccCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCc
Confidence             12334789999999998877 889999999   3    333999987633210                  0000111 


Q ss_pred             cccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         266 TAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       266 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      ..++.++.+|+.+||+.||.+|||++++++||||....
T Consensus       236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~  273 (284)
T cd06620         236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL  273 (284)
T ss_pred             hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            12677899999999999999999999999999996653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.1e-40  Score=288.78  Aligned_cols=244  Identities=32%  Similarity=0.486  Sum_probs=199.9

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN  131 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  131 (307)
                      ...++|++.+.||+|++|.||+|++..+++.||+|++.....   .......+.+|+.+++.++|+||+++.+++.....
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ---SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS   88 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc---hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence            346689999999999999999999999999999999864321   12224557789999999999999999998866554


Q ss_pred             ------EEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcc
Q psy9858         132 ------VSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK  205 (307)
Q Consensus       132 ------~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  205 (307)
                            .++|+||++++|.+++...  .+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus        89 ~~~~~~~~lv~e~~~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~  166 (343)
T cd07851          89 LEDFQDVYLVTHLMGADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  166 (343)
T ss_pred             ccccccEEEEEecCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccc
Confidence                  9999999999998888764  48999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC--------------------
Q psy9858         206 FFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG--------------------  258 (307)
Q Consensus       206 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~--------------------  258 (307)
                      .....   .....++..|+|||.+.+...++.++|||   +    +++|..||.+.....                    
T Consensus       167 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (343)
T cd07851         167 HTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI  243 (343)
T ss_pred             ccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence            76432   23346788999999987754788999999   2    333888886532110                    


Q ss_pred             -----------------CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         259 -----------------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       259 -----------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                                       .........+++++.++|.+||+.||++|||+.++++||||....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~  305 (343)
T cd07851         244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH  305 (343)
T ss_pred             cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence                             001112234688999999999999999999999999999998654

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=3.9e-40  Score=281.89  Aligned_cols=237  Identities=21%  Similarity=0.294  Sum_probs=187.2

Q ss_pred             EEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHH---hcCCCCccccceeeeecCeEEEEEEc
Q psy9858          62 SVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQ---ELHHENVLGLTDVFGYMSNVSLVFEF  138 (307)
Q Consensus        62 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~---~l~h~ni~~~~~~~~~~~~~~lv~e~  138 (307)
                      .||+|+||.||++.+..+++.||+|++.........  ....+.+|..+++   ..+|+||+.+++.+...+..++||||
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~   78 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--GETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDL   78 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccch--HHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEec
Confidence            489999999999999999999999999764322211  1222344544333   34799999999999999999999999


Q ss_pred             c-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcccccc
Q psy9858         139 V-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQ  217 (307)
Q Consensus       139 ~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  217 (307)
                      + +|+|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......  ....
T Consensus        79 ~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~  155 (279)
T cd05633          79 MNGGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHAS  155 (279)
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--ccCc
Confidence            9 577877776543 58999999999999999999999999999999999999999999999999997653322  2234


Q ss_pred             eeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCC---------ChhhhccccCHHHHHHHHHhhh
Q psy9858         218 VVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGI---------PLNEIFTAAGDDLLAVISSLLC  281 (307)
Q Consensus       218 ~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~  281 (307)
                      .++..|+|||.+.+...++.++|+|   +    +++|..||........         .....+..+++++.++|.+||+
T Consensus       156 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  235 (279)
T cd05633         156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQ  235 (279)
T ss_pred             CCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhc
Confidence            6899999999987554789999999   3    3338889865321110         0112334678999999999999


Q ss_pred             cCCCCCC-----CHHHHhcCcccCCCc
Q psy9858         282 LNPTKRA-----DCTATLKMDYFSLTK  303 (307)
Q Consensus       282 ~dP~~Rp-----t~~~il~hp~f~~~~  303 (307)
                      .||.+|+     |++++++||||++..
T Consensus       236 ~~p~~R~~~~~~~~~~~~~h~~~~~~~  262 (279)
T cd05633         236 RDVSKRLGCLGRGAQEVKEHVFFKGID  262 (279)
T ss_pred             CCHHHhcCCCCCCHHHHHhCccccCCC
Confidence            9999999     699999999998843

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=3.1e-40  Score=290.02  Aligned_cols=247  Identities=32%  Similarity=0.510  Sum_probs=199.9

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeeec--
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGYM--  129 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~--  129 (307)
                      ..++|++.+.||+|+||.||+|.+..+|+.+|+|++.......   .....+.+|+.+++++ +|+||+++++++...  
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~---~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~   81 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA---TDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND   81 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcc---hhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence            4578999999999999999999998899999999986432111   1134567899999999 999999999987643  


Q ss_pred             CeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCC
Q psy9858         130 SNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS  209 (307)
Q Consensus       130 ~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  209 (307)
                      ...++||||++++|..++...  .+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 ~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~  159 (337)
T cd07852          82 KDIYLVFEYMETDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE  159 (337)
T ss_pred             ceEEEEecccccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence            468999999999998888765  578889999999999999999999999999999999999999999999999987643


Q ss_pred             CCc-----ccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCC---------------------
Q psy9858         210 PTR-----LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLF---------------------  256 (307)
Q Consensus       210 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~---------------------  256 (307)
                      ...     ......++..|+|||.+.+...++.++|+|       .+++|..||.+...                     
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
T cd07852         160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES  239 (337)
T ss_pred             ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            221     223346788999999987765788999999       23348888865210                     


Q ss_pred             ----------------CCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         257 ----------------PGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       257 ----------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                                      .........+.++.++.++|.+||+.||.+|||+.++++||||++...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~  303 (337)
T cd07852         240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN  303 (337)
T ss_pred             HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence                            001112223447889999999999999999999999999999987643

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.3e-39  Score=284.92  Aligned_cols=245  Identities=32%  Similarity=0.516  Sum_probs=199.6

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee-cC
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY-MS  130 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~  130 (307)
                      ...++|++++.||.|+||.||+|.+..+++.||+|++.+....   ....+.+.+|+++++.++||||+++.+++.. ..
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   83 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST---PVLAKRTYRELKLLKHLRHENIISLSDIFISPLE   83 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc---cchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence            3567899999999999999999999999999999998753221   2224567789999999999999999998865 56


Q ss_pred             eEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         131 NVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       131 ~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      ..++++||++++|.+++...  .+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+..... 
T Consensus        84 ~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~-  160 (328)
T cd07856          84 DIYFVTELLGTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP-  160 (328)
T ss_pred             cEEEEeehhccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC-
Confidence            79999999988888877654  378888899999999999999999999999999999999999999999999976532 


Q ss_pred             Ccccccceeeceehhhhhhhccccccccccee---ee----eecCCCCCCCCCC--------------------------
Q psy9858         211 TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FAKDPSSHGNLFP--------------------------  257 (307)
Q Consensus       211 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~~~~~f~~~~~~--------------------------  257 (307)
                        ......++..|+|||.+.+...++.++|+|   ++    +.|.+||......                          
T Consensus       161 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd07856         161 --QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT  238 (328)
T ss_pred             --CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhh
Confidence              123346688999999987755789999999   33    3388888653210                          


Q ss_pred             -----------CCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         258 -----------GIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       258 -----------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                                 ........+.+++++.++|++||+.+|++|||+++++.||||+....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~  296 (328)
T cd07856         239 LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHD  296 (328)
T ss_pred             HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccC
Confidence                       00111222356789999999999999999999999999999976554

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.4e-39  Score=275.87  Aligned_cols=240  Identities=23%  Similarity=0.306  Sum_probs=197.3

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEE
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLV  135 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  135 (307)
                      +|.+.+.||+|++|.||+|.+..+++.||+|.+......   ......+.+|+++++.++|+||+++++.+...+..+++
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv   77 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND---PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIF   77 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc---hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEE
Confidence            589999999999999999998889999999999864322   23457788999999999999999999999999999999


Q ss_pred             EEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCccc
Q psy9858         136 FEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY  214 (307)
Q Consensus       136 ~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  214 (307)
                      +||+ +++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..........
T Consensus        78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          78 MEYCSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             EecCCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence            9999 577888776643 47889999999999999999999999999999999999999999999999998775432221


Q ss_pred             c----cceeeceehhhhhhhccc--cccccccee-------eeeecCCCCCCCCCCC--------CChhhhcc--ccCHH
Q psy9858         215 T----HQVVTRWYRLIKCLLYCV--QFNVKNVQW-------CCFAKDPSSHGNLFPG--------IPLNEIFT--AAGDD  271 (307)
Q Consensus       215 ~----~~~~t~~y~aPE~~~~~~--~~~~~~Diw-------~i~~~~~~f~~~~~~~--------~~~~~~~~--~~~~~  271 (307)
                      .    ...++..|+|||.+.+..  .++.++|||       .++.|..||.......        ......+.  .+++.
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPE  236 (264)
T ss_pred             cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHH
Confidence            1    245788999999998762  388999999       2334999986531110        11111112  34889


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         272 LLAVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       272 l~~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                      +.++|.+||+.||.+|||+++++.|||+
T Consensus       237 ~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         237 GKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1e-39  Score=277.43  Aligned_cols=239  Identities=24%  Similarity=0.366  Sum_probs=194.5

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ++|++.+.||+|+||.||+|++..+++.||||.+......  .......+.+|+++++.++||||+++++++...+..++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMM--DAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNI   79 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccC--CHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEE
Confidence            5899999999999999999999999999999988753222  22234568899999999999999999999999999999


Q ss_pred             EEEcc-CCChHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         135 VFEFV-DTDLEVIIKD---PTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       135 v~e~~-~g~l~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      ++||+ +|+|.+++..   ....+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~  159 (267)
T cd08228          80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence            99999 4678777642   3335788999999999999999999999999999999999999999999999999877543


Q ss_pred             Ccccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCCC---------Chh-hhccccCHHHH
Q psy9858         211 TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPGI---------PLN-EIFTAAGDDLL  273 (307)
Q Consensus       211 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~~---------~~~-~~~~~~~~~l~  273 (307)
                      ........++..|+|||.+.+. .++.++|+|       .+++|..||........         ... .....++..+.
T Consensus       160 ~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd08228         160 TTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLR  238 (267)
T ss_pred             hHHHhcCCCCccccChhhhccC-CCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHH
Confidence            3333345678899999999876 788999999       23448888765322110         011 11224678899


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         274 AVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       274 ~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      +++.+||+.+|.+|||++++++.
T Consensus       239 ~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         239 ELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             HHHHHHCCCCcccCcCHHHHHHH
Confidence            99999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.2e-39  Score=278.35  Aligned_cols=243  Identities=21%  Similarity=0.272  Sum_probs=194.9

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee--cCeE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY--MSNV  132 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~  132 (307)
                      ++|...+.||.|++|.||+|.+..+++.||+|.+....    .......+.+|+++++.++||||+++++++..  .+..
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   76 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP----NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSI   76 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC----chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeE
Confidence            46899999999999999999998999999999987532    11235668899999999999999999998854  4578


Q ss_pred             EEEEEcc-CCChHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         133 SLVFEFV-DTDLEVIIK---DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                      ++||||+ +++|.+++.   .....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  156 (287)
T cd06621          77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV  156 (287)
T ss_pred             EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence            9999999 577877654   234458899999999999999999999999999999999999999999999999987653


Q ss_pred             CCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCCCh------------hhhc----
Q psy9858         209 SPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGIPL------------NEIF----  265 (307)
Q Consensus       209 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~~------------~~~~----  265 (307)
                      ...  .....++..|+|||.+.+. .++.++|+|   +    +++|..||.....+....            ....    
T Consensus       157 ~~~--~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd06621         157 NSL--AGTFTGTSFYMAPERIQGK-PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG  233 (287)
T ss_pred             ccc--cccccCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence            321  1233567899999998877 789999999   3    333888987652210000            0000    


Q ss_pred             --cccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         266 --TAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       266 --~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                        ...++.+.+++.+||+.||.+|||+.|++.||||++...
T Consensus       234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~  274 (287)
T cd06621         234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK  274 (287)
T ss_pred             CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence              113467899999999999999999999999999977653

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=5.7e-40  Score=282.17  Aligned_cols=247  Identities=17%  Similarity=0.189  Sum_probs=194.9

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceee
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDI-----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVF  126 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~  126 (307)
                      ...++|++.+.||+|+||.||+|.+.     ..+..||+|.+....    .......+.+|+.+++.++|+||+++++++
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   78 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA----SLRERIEFLNEASVMKGFTCHHVVRLLGVV   78 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence            45678999999999999999999754     235689999876432    111234578899999999999999999999


Q ss_pred             eecCeEEEEEEcc-CCChHHHHhCCC---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcE
Q psy9858         127 GYMSNVSLVFEFV-DTDLEVIIKDPT---------IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVL  196 (307)
Q Consensus       127 ~~~~~~~lv~e~~-~g~l~~~~~~~~---------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~  196 (307)
                      ......+++|||+ +|+|.+++....         .......+..++.|++.||.|||++|++||||||+||+++.++.+
T Consensus        79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~  158 (288)
T cd05061          79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV  158 (288)
T ss_pred             cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcE
Confidence            9999999999999 689999986422         124567788999999999999999999999999999999999999


Q ss_pred             EEEeecCccccCCCCcc--cccceeeceehhhhhhhccccccccccee---eeee-----cCCCCCCCCCCC-------C
Q psy9858         197 KIGDFGLAKFFGSPTRL--YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA-----KDPSSHGNLFPG-------I  259 (307)
Q Consensus       197 kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~-----~~~~f~~~~~~~-------~  259 (307)
                      +|+|||+++........  .....++..|+|||.+.+. .++.++|+|   ++++     +..||.+.....       .
T Consensus       159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~  237 (288)
T cd05061         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG  237 (288)
T ss_pred             EECcCCccccccccccccccCCCcccccccCHHHhccC-CCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            99999999865432211  1122346789999999877 789999999   3333     677876522111       0


Q ss_pred             ChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhc------CcccCCCc
Q psy9858         260 PLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLK------MDYFSLTK  303 (307)
Q Consensus       260 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~------hp~f~~~~  303 (307)
                      ........+++.+.+++.+||+.||++|||+.++++      ||||.+++
T Consensus       238 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~  287 (288)
T cd05061         238 GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS  287 (288)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence            111223356789999999999999999999999988      99999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG0194|consensus

Probab=100.00  E-value=4.8e-40  Score=290.00  Aligned_cols=244  Identities=22%  Similarity=0.236  Sum_probs=195.9

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEEcCCC----cEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccce
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARDIETD----MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTD  124 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~  124 (307)
                      .|....++-.+.++||+|+||.||+|.-...+    ..||+|.....  .........+|.+|++++++++|||||+++|
T Consensus       151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~--~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG  228 (474)
T KOG0194|consen  151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGS--SELTKEQIKEFMKEARVMRQLNHPNVVRFYG  228 (474)
T ss_pred             ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeeccc--ccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence            44455566667799999999999999865432    23899988742  1223344678999999999999999999999


Q ss_pred             eeeecCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecC
Q psy9858         125 VFGYMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGL  203 (307)
Q Consensus       125 ~~~~~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  203 (307)
                      +...+.-+++|||+| +|+|.+++++....++..+...++.+.+.||+|||+++++||||..+|+|+..++.+||+|||+
T Consensus       229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGL  308 (474)
T KOG0194|consen  229 VAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGL  308 (474)
T ss_pred             EEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcccc
Confidence            999999999999999 7899999999887899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCcccccceeeceehhhhhhhccccccccccee--eeee------cCCCCCCCCC--------CCCChhhhccc
Q psy9858         204 AKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW--CCFA------KDPSSHGNLF--------PGIPLNEIFTA  267 (307)
Q Consensus       204 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw--~i~~------~~~~f~~~~~--------~~~~~~~~~~~  267 (307)
                      ++....-............|+|||.+... .|+.++|||  +++.      |..||.+...        ........+..
T Consensus       309 s~~~~~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~  387 (474)
T KOG0194|consen  309 SRAGSQYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSK  387 (474)
T ss_pred             ccCCcceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCC
Confidence            88653111111122356799999999998 999999999  4433      6778877321        11111222335


Q ss_pred             cCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         268 AGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       268 ~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      .+.++..++.+|+..||++|||+.++.+
T Consensus       388 ~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  388 TPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             CHHHHHHHHHHhccCChhhccCHHHHHH
Confidence            6788999999999999999999988764

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.6e-40  Score=293.98  Aligned_cols=241  Identities=20%  Similarity=0.280  Sum_probs=190.4

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEcCC-----CcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccc
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDIET-----DMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLT  123 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~  123 (307)
                      +.-..++|++++.||+|+||.||+|.+...     +..||+|++.....    ......+.+|+++++.+ +|+||++++
T Consensus        33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~il~~l~~h~nIv~~~  108 (374)
T cd05106          33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH----TDEREALMSELKILSHLGQHKNIVNLL  108 (374)
T ss_pred             ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC----HHHHHHHHHHHHHHHhhccCCceeeEe
Confidence            344566899999999999999999986543     35799999975321    12245678999999999 899999999


Q ss_pred             eeeeecCeEEEEEEcc-CCChHHHHhCCC---------------------------------------------------
Q psy9858         124 DVFGYMSNVSLVFEFV-DTDLEVIIKDPT---------------------------------------------------  151 (307)
Q Consensus       124 ~~~~~~~~~~lv~e~~-~g~l~~~~~~~~---------------------------------------------------  151 (307)
                      +++......++||||+ +|+|.+++....                                                   
T Consensus       109 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (374)
T cd05106         109 GACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS  188 (374)
T ss_pred             eEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence            9999999999999999 688888875321                                                   


Q ss_pred             ------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc
Q psy9858         152 ------------------IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL  213 (307)
Q Consensus       152 ------------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  213 (307)
                                        ..+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||+++........
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~  268 (374)
T cd05106         189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY  268 (374)
T ss_pred             ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence                              23677889999999999999999999999999999999999999999999999865432211


Q ss_pred             --cccceeeceehhhhhhhccccccccccee---e----eee-cCCCCCCCCCCCCC--------hhhhccccCHHHHHH
Q psy9858         214 --YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPSSHGNLFPGIP--------LNEIFTAAGDDLLAV  275 (307)
Q Consensus       214 --~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~f~~~~~~~~~--------~~~~~~~~~~~l~~l  275 (307)
                        .....++..|+|||.+.+. .++.++|||   +    +++ |..||.........        ....+..+++++.++
T Consensus       269 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  347 (374)
T cd05106         269 VVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSI  347 (374)
T ss_pred             eeccCCCCccceeCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHH
Confidence              1122345679999999877 899999999   2    333 88898763322111        011123468999999


Q ss_pred             HHHhhhcCCCCCCCHHHHhc
Q psy9858         276 ISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       276 i~~~l~~dP~~Rpt~~~il~  295 (307)
                      +.+||+.||.+|||++++++
T Consensus       348 i~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         348 MKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             HHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999976

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG1989|consensus

Probab=100.00  E-value=2.2e-40  Score=302.76  Aligned_cols=247  Identities=20%  Similarity=0.229  Sum_probs=197.7

Q ss_pred             CCCceeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-CCCccccc
Q psy9858          45 LPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-HENVLGLT  123 (307)
Q Consensus        45 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~  123 (307)
                      +....+.....++++.+.|.+|||+.||+|++...|..||+|++...     ++.....+.+|+.+|+.|. |+|||.++
T Consensus        27 ~~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-----de~~L~~v~~EI~~MK~L~gh~nIV~yi  101 (738)
T KOG1989|consen   27 FVGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-----DEEALNAVKREIDIMKLLSGHKNIVSYI  101 (738)
T ss_pred             CCceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-----CHHHHHHHHHHHHHHHHhcCCCceeeEe
Confidence            44456667778999999999999999999999888899999998753     3334677889999999997 99999999


Q ss_pred             eeee----e---cCeEEEEEEccC-CChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeecCCCCcEEEec
Q psy9858         124 DVFG----Y---MSNVSLVFEFVD-TDLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDHW--ILHRDLKPNNLLINK  192 (307)
Q Consensus       124 ~~~~----~---~~~~~lv~e~~~-g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~  192 (307)
                      +...    .   .-.++|+||||. |+|.+++..+ ...+++.+++.|+.|++.||.+||..+  |||||||-+||||..
T Consensus       102 dss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~  181 (738)
T KOG1989|consen  102 DSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSA  181 (738)
T ss_pred             ccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcC
Confidence            9431    1   235889999995 8999999732 334999999999999999999999887  999999999999999


Q ss_pred             CCcEEEEeecCccccCCCC-cc--------cccceeeceehhhhhhh--ccccccccccee---eeee----cCCCCCCC
Q psy9858         193 QGVLKIGDFGLAKFFGSPT-RL--------YTHQVVTRWYRLIKCLL--YCVQFNVKNVQW---CCFA----KDPSSHGN  254 (307)
Q Consensus       193 ~~~~kl~Dfg~a~~~~~~~-~~--------~~~~~~t~~y~aPE~~~--~~~~~~~~~Diw---~i~~----~~~~f~~~  254 (307)
                      +|+.||||||.|.-.-... ..        .....-|+.|+|||++.  ++...+.|+|||   |++|    +..||+..
T Consensus       182 ~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s  261 (738)
T KOG1989|consen  182 DGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES  261 (738)
T ss_pred             CCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence            9999999999986432111 00        11224589999999874  333789999999   7777    88899884


Q ss_pred             -CCCC---CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         255 -LFPG---IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       255 -~~~~---~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                       ...-   .-...-++.+++.+.+||..||+.||.+||++-|++.+
T Consensus       262 g~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  262 GKLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             cceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence             1111   11111225789999999999999999999999999875

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=9.7e-40  Score=283.03  Aligned_cols=244  Identities=25%  Similarity=0.263  Sum_probs=196.0

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ++|.+.+.||+|+||.||++.+..+++.||+|.+......  .......+.+|+++++.++||||+++++.+..++..++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLI--LRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCM   78 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhh--hHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEE
Confidence            4689999999999999999999999999999998754211  11223567799999999999999999999999999999


Q ss_pred             EEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC--
Q psy9858         135 VFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT--  211 (307)
Q Consensus       135 v~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--  211 (307)
                      +|||+ +++|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||+++......  
T Consensus        79 v~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~  157 (305)
T cd05609          79 VMEYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT  157 (305)
T ss_pred             EEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence            99999 567888876543 58999999999999999999999999999999999999999999999999987421000  


Q ss_pred             -------------cccccceeeceehhhhhhhccccccccccee---ee----eecCCCCCCCCCCCCC---------hh
Q psy9858         212 -------------RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FAKDPSSHGNLFPGIP---------LN  262 (307)
Q Consensus       212 -------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~~~~~f~~~~~~~~~---------~~  262 (307)
                                   .......++..|+|||.+.+. .++.++|+|   ++    ++|..||.+.......         ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  236 (305)
T cd05609         158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP  236 (305)
T ss_pred             cccccccccchhhccccCCccCccccCchhccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC
Confidence                         001123567889999998876 789999999   33    3388888763221100         00


Q ss_pred             hhccccCHHHHHHHHHhhhcCCCCCCC---HHHHhcCcccCCC
Q psy9858         263 EIFTAAGDDLLAVISSLLCLNPTKRAD---CTATLKMDYFSLT  302 (307)
Q Consensus       263 ~~~~~~~~~l~~li~~~l~~dP~~Rpt---~~~il~hp~f~~~  302 (307)
                      .....+++++.++|.+||+.||++|||   +.++|+||||...
T Consensus       237 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~  279 (305)
T cd05609         237 EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL  279 (305)
T ss_pred             CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence            111246889999999999999999998   7999999999654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-39  Score=286.09  Aligned_cols=244  Identities=32%  Similarity=0.481  Sum_probs=196.5

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec--
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM--  129 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--  129 (307)
                      ...++|.+.+.||+|+||.||+|.+..+|+.||+|++.....   .......+.+|+.++++++|+||+++++++...  
T Consensus        14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~   90 (345)
T cd07877          14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ---SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS   90 (345)
T ss_pred             hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch---hhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence            355789999999999999999999989999999999875321   111235577899999999999999999987543  


Q ss_pred             ----CeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcc
Q psy9858         130 ----SNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK  205 (307)
Q Consensus       130 ----~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  205 (307)
                          ...++++++++++|.+++...  .+++..++.++.||+.||+|||+.|++||||||+||+++.++.++|+|||++.
T Consensus        91 ~~~~~~~~lv~~~~~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~  168 (345)
T cd07877          91 LEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR  168 (345)
T ss_pred             ccccccEEEEehhcccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccc
Confidence                457899999988988877654  48999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC--------------------
Q psy9858         206 FFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG--------------------  258 (307)
Q Consensus       206 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~--------------------  258 (307)
                      ....   ......++..|+|||.+.+...++.++|||   +    +++|..||.......                    
T Consensus       169 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (345)
T cd07877         169 HTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI  245 (345)
T ss_pred             cccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence            6532   223346788999999987755788999999   2    333888886421100                    


Q ss_pred             -----------------CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         259 -----------------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       259 -----------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                                       ..........++++.++|.+||+.||.+|||+.+++.||||++..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~  307 (345)
T cd07877         246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  307 (345)
T ss_pred             ccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence                             000111123578899999999999999999999999999998643

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3.7e-40  Score=282.53  Aligned_cols=239  Identities=22%  Similarity=0.307  Sum_probs=193.5

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCC-----cEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeee
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETD-----MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG  127 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~  127 (307)
                      ..++|++.+.||+|+||.||+|.+...+     ..||+|.+....    .......+.+|+++++.++||||+++++++.
T Consensus         3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~   78 (283)
T cd05048           3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA----EPKVQQEFRQEAELMSDLQHPNIVCLLGVCT   78 (283)
T ss_pred             ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC----CHHHHHHHHHHHHHHHhcCCcccceEEEEEc
Confidence            3467999999999999999999876554     789999886432    2223456889999999999999999999999


Q ss_pred             ecCeEEEEEEcc-CCChHHHHhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEe
Q psy9858         128 YMSNVSLVFEFV-DTDLEVIIKDPT---------------IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLIN  191 (307)
Q Consensus       128 ~~~~~~lv~e~~-~g~l~~~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~  191 (307)
                      .....+++|||+ +|+|.+++....               ..+++..+..++.|++.||.|||++|++|+||||+||+++
T Consensus        79 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~  158 (283)
T cd05048          79 KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG  158 (283)
T ss_pred             CCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc
Confidence            999999999999 678988886531               3478889999999999999999999999999999999999


Q ss_pred             cCCcEEEEeecCccccCCCC--cccccceeeceehhhhhhhccccccccccee---e----eee-cCCCCCCCCCC----
Q psy9858         192 KQGVLKIGDFGLAKFFGSPT--RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPSSHGNLFP----  257 (307)
Q Consensus       192 ~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~f~~~~~~----  257 (307)
                      +++.++|+|||++.......  .......+++.|+|||.+.+. .++.++|||   +    +++ |..||.+....    
T Consensus       159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~  237 (283)
T cd05048         159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG-KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE  237 (283)
T ss_pred             CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccC-cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            99999999999998653322  122334567889999998877 789999999   2    233 77887762211    


Q ss_pred             ---CCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         258 ---GIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       258 ---~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                         .......+..+++++.+|+.+||+.||.+|||+.+++++
T Consensus       238 ~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         238 MIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence               111222345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0603|consensus

Probab=100.00  E-value=1.3e-40  Score=294.49  Aligned_cols=265  Identities=20%  Similarity=0.231  Sum_probs=214.4

Q ss_pred             CCCCCCCCcCccccccccceeecceeeeeehhhhhhhccCCCceeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEE
Q psy9858           6 MESTELPLEKSNCFFGGSNIFASSVWYIRVHSALKKQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAV   85 (307)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vav   85 (307)
                      .+|...++.+...++.|.++++++.......              ..+...|.+...+|.|+|+.|-.+.+..+++..++
T Consensus       287 dsp~~~~~~s~~~if~g~sfva~~il~~~~~--------------~~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~v  352 (612)
T KOG0603|consen  287 DSPLLSASGSDHTIFSGPSFVAPGVLEDAVT--------------APFTESYEFREELGEGSFSAVKYCESSPTDQEPAV  352 (612)
T ss_pred             cCCCCCCCccccchhcCCCccChHHhhcccc--------------CCcchhhccccccCCCCccceeeeeccccccchhh
Confidence            3333344444448999999999888764111              12567788889999999999999999999999999


Q ss_pred             EEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeeecCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHH
Q psy9858          86 KKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGYMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYA  163 (307)
Q Consensus        86 K~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~  163 (307)
                      |++.+...         ...+|+.++... +||||+++.+.+.+..+.|+|||.+ ++.+++.+.....  ...++..|+
T Consensus       353 kii~~~~~---------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~--~~~e~~~w~  421 (612)
T KOG0603|consen  353 KIISKRAD---------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPE--FCSEASQWA  421 (612)
T ss_pred             eecccccc---------ccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcch--hHHHHHHHH
Confidence            99986521         123577666665 6999999999999999999999999 4556666665542  237888899


Q ss_pred             HHHHHHHHHHHHCCceeecCCCCcEEE-ecCCcEEEEeecCccccCCCCcccccceeeceehhhhhhhccccccccccee
Q psy9858         164 IMTLRGLEYLHDHWILHRDLKPNNLLI-NKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW  242 (307)
Q Consensus       164 ~~i~~~l~~lH~~~ivH~dlkp~Nil~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw  242 (307)
                      .+|+.|+.|||++|++||||||+|||+ +..++++|+|||.++.....   ..+.+.|..|.|||++... .|+.++|+|
T Consensus       422 ~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---~~tp~~t~~y~APEvl~~~-~yt~acD~W  497 (612)
T KOG0603|consen  422 AELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---CDTPALTLQYVAPEVLAIQ-EYTEACDWW  497 (612)
T ss_pred             HHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh---hcccchhhcccChhhhccC-CCCcchhhH
Confidence            999999999999999999999999999 58899999999999987443   5566889999999999966 999999999


Q ss_pred             -------eeeecCCCCCCCCCCCC-----ChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         243 -------CCFAKDPSSHGNLFPGI-----PLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       243 -------~i~~~~~~f~~~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                             .+++|..||....-...     ........+|+++++||.+||+.||.+|+|+.+++.||||
T Consensus       498 SLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  498 SLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             HHHHHHHHHHhCCCccccCCchHHHHHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence                   45569999988544411     1112225789999999999999999999999999999999

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.9e-39  Score=284.49  Aligned_cols=244  Identities=34%  Similarity=0.544  Sum_probs=195.5

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCC--CcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeee----
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIET--DMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGY----  128 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~----  128 (307)
                      +|.+.+.||+|+||.||++.+..+  +..||+|++....   ......+.+.+|+++++++ +|+||+++++.+..    
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~   77 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF---SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGN   77 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc---ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecccc
Confidence            588999999999999999998877  8999999987422   1122245678899999999 59999999986532    


Q ss_pred             cCeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         129 MSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       129 ~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                      ....++++++++++|.+.+.... .+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus        78 ~~~~~~~~e~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~  156 (332)
T cd07857          78 FNELYLYEELMEADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS  156 (332)
T ss_pred             CCcEEEEEecccCCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence            25688999999999988886543 58999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCc----ccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCC---------------------
Q psy9858         209 SPTR----LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLF---------------------  256 (307)
Q Consensus       209 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~---------------------  256 (307)
                      ....    ......++..|+|||.+.+...++.++|+|   +    ++.|.+||.....                     
T Consensus       157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (332)
T cd07857         157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR  236 (332)
T ss_pred             cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            3211    122346789999999987755789999999   2    3338888875321                     


Q ss_pred             ----------------CCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         257 ----------------PGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       257 ----------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                                      .........+.++..+.+++.+||+.||++|||+++++.||||....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~  299 (332)
T cd07857         237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH  299 (332)
T ss_pred             hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence                            00111222334678999999999999999999999999999997544

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-39  Score=277.93  Aligned_cols=238  Identities=33%  Similarity=0.528  Sum_probs=194.8

Q ss_pred             eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-CCCccccceeeeecCeEEEE
Q psy9858          57 YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-HENVLGLTDVFGYMSNVSLV  135 (307)
Q Consensus        57 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv  135 (307)
                      |.+.+.||+|++|+||+|+...+++.||||.+......    .......+|+..+++++ |+||+++++++.++...++|
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv   76 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS----WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFV   76 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc----hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEE
Confidence            67889999999999999999888999999998753211    11233457999999999 99999999999999999999


Q ss_pred             EEccCCChHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCccc
Q psy9858         136 FEFVDTDLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY  214 (307)
Q Consensus       136 ~e~~~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  214 (307)
                      |||++|++.+.+.... ..+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        77 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-~~  155 (283)
T cd07830          77 FEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-PY  155 (283)
T ss_pred             EecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC-Cc
Confidence            9999999998887654 458999999999999999999999999999999999999999999999999998764322 22


Q ss_pred             ccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCC------------------------------
Q psy9858         215 THQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFP------------------------------  257 (307)
Q Consensus       215 ~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~------------------------------  257 (307)
                      ....++..|+|||.+.+...++.++|+|       .++.|.+||......                              
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd07830         156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF  235 (283)
T ss_pred             CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence            3446788999999987665789999999       233488887542110                              


Q ss_pred             ------CCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         258 ------GIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       258 ------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                            ...........+.++.+++.+||+.||++|||++|++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence                  001112223346889999999999999999999999999998

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=8.5e-40  Score=284.75  Aligned_cols=237  Identities=18%  Similarity=0.254  Sum_probs=190.8

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCc----EEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDM----IVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM  129 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  129 (307)
                      ..+|++.+.||+|+||.||+|.+..++.    .||+|++...    ......+.+.+|+.+++.++||||+++++++...
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~   81 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS   81 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence            3579999999999999999998766655    4899998642    1222356788999999999999999999988764


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                       ..+++++|+ .|+|.+++......+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||+++...
T Consensus        82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             -CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence             567899999 689999998766668899999999999999999999999999999999999999999999999998775


Q ss_pred             CCCccc--ccceeeceehhhhhhhccccccccccee---e----eee-cCCCCCCCCCCC-------CChhhhccccCHH
Q psy9858         209 SPTRLY--THQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPSSHGNLFPG-------IPLNEIFTAAGDD  271 (307)
Q Consensus       209 ~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~f~~~~~~~-------~~~~~~~~~~~~~  271 (307)
                      ......  .....+..|+|||.+.+. .++.++|||   +    +++ |..||.+.....       ......+..++.+
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID  239 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHH
Confidence            332221  122346689999999887 889999999   2    233 888887632211       1111223356789


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         272 LLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       272 l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      +.+++.+||+.||.+|||+.+++.+
T Consensus       240 ~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         240 VYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHH
Confidence            9999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=4e-39  Score=276.43  Aligned_cols=238  Identities=35%  Similarity=0.610  Sum_probs=192.0

Q ss_pred             eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc---CCCCccccceeeeecCe--
Q psy9858          57 YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL---HHENVLGLTDVFGYMSN--  131 (307)
Q Consensus        57 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~ni~~~~~~~~~~~~--  131 (307)
                      |++.+.||+|+||.||+|++..+++.||+|++.....   .+.....+.+|+.+++++   +|+|++++++++.....  
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~   77 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS---EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDR   77 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc---cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCC
Confidence            6789999999999999999988899999999975432   222234566788777666   59999999999987776  


Q ss_pred             ---EEEEEEccCCChHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         132 ---VSLVFEFVDTDLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       132 ---~~lv~e~~~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                         .+++|||+++++.+++.... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus        78 ~~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~  157 (287)
T cd07838          78 ELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIY  157 (287)
T ss_pred             CceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceec
Confidence               99999999888888876543 25899999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC----------------------
Q psy9858         208 GSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG----------------------  258 (307)
Q Consensus       208 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~----------------------  258 (307)
                      ..... .....++..|+|||.+.+. .++.++|+|   +    ++.|.+||.+.....                      
T Consensus       158 ~~~~~-~~~~~~~~~~~~PE~~~~~-~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07838         158 SFEMA-LTSVVVTLWYRAPEVLLQS-SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS  235 (287)
T ss_pred             cCCcc-cccccccccccChHHhccC-CCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence            43322 2233578899999999887 789999999   3    333888876532100                      


Q ss_pred             -----------CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         259 -----------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       259 -----------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                                 .......+.+++.+.++|.+||+.||.+||++++++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                       00111123456788999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.8e-39  Score=281.06  Aligned_cols=243  Identities=22%  Similarity=0.308  Sum_probs=199.1

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      +.|...+.||+|+||+||+|++..+|+.|++|++.......  ......+.+|+++++.++|+|++++++++.+....++
T Consensus        21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   98 (313)
T cd06633          21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQT--NEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWL   98 (313)
T ss_pred             HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCc--hHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence            34777888999999999999998999999999987543221  2223567889999999999999999999999999999


Q ss_pred             EEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCccc
Q psy9858         135 VFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY  214 (307)
Q Consensus       135 v~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  214 (307)
                      +|||+.|++.+.+......+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.....    .
T Consensus        99 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----~  174 (313)
T cd06633          99 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----A  174 (313)
T ss_pred             EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC----C
Confidence            999999999888877666789999999999999999999999999999999999999999999999999865422    2


Q ss_pred             ccceeeceehhhhhhhc--cccccccccee---e----eeecCCCCCCCCCCC--------CChhhhccccCHHHHHHHH
Q psy9858         215 THQVVTRWYRLIKCLLY--CVQFNVKNVQW---C----CFAKDPSSHGNLFPG--------IPLNEIFTAAGDDLLAVIS  277 (307)
Q Consensus       215 ~~~~~t~~y~aPE~~~~--~~~~~~~~Diw---~----i~~~~~~f~~~~~~~--------~~~~~~~~~~~~~l~~li~  277 (307)
                      ....++..|+|||.+..  ...++.++|+|   +    ++.|..||.......        .........++..+.+|+.
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  254 (313)
T cd06633         175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVD  254 (313)
T ss_pred             CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHH
Confidence            34467889999999853  23688899999   2    333888876532111        1111112346788999999


Q ss_pred             HhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         278 SLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       278 ~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      +||+.+|++|||+.+++.||||...+
T Consensus       255 ~~l~~~P~~Rp~~~~~l~~~~~~~~~  280 (313)
T cd06633         255 YCLQKIPQERPASAELLRHDFVRRDR  280 (313)
T ss_pred             HHccCChhhCcCHHHHhcCcccCCCc
Confidence            99999999999999999999998654

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0983|consensus

Probab=100.00  E-value=1.2e-40  Score=266.95  Aligned_cols=248  Identities=19%  Similarity=0.257  Sum_probs=205.8

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-CCCccccceeee
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-HENVLGLTDVFG  127 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~  127 (307)
                      ....+.++.+.+..||+|+.|.|++++.+.+|...|||.+.+..    +.+..+++++.+.++.+.+ .|+||+++|+|.
T Consensus        86 r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~----Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi  161 (391)
T KOG0983|consen   86 RYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG----NKEENKRILMDLDVVLKSHDCPYIVQCFGYFI  161 (391)
T ss_pred             ccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC----CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe
Confidence            34466778888999999999999999999999999999998643    3333677888888877764 899999999999


Q ss_pred             ecCeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         128 YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD-HWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       128 ~~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                      .+...++.||.+..-+..++++-.++++|..+-.+...++.||.||-. +||+|||+||+|||+|..|++||||||.+.+
T Consensus       162 ~n~dV~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGr  241 (391)
T KOG0983|consen  162 TNTDVFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGR  241 (391)
T ss_pred             eCchHHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccce
Confidence            999999999999877777777766679999999999999999999985 5999999999999999999999999999988


Q ss_pred             cCCCCcccccceeeceehhhhhhhc--cccccccccee-------eeeecCCCCCCCCCC----------CCChhhhccc
Q psy9858         207 FGSPTRLYTHQVVTRWYRLIKCLLY--CVQFNVKNVQW-------CCFAKDPSSHGNLFP----------GIPLNEIFTA  267 (307)
Q Consensus       207 ~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~Diw-------~i~~~~~~f~~~~~~----------~~~~~~~~~~  267 (307)
                      +.+. ...+...|-+.|||||.+.-  ...|+.++|||       .+.+|..||.+....          ..+....-..
T Consensus       242 lvdS-kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~g  320 (391)
T KOG0983|consen  242 LVDS-KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMG  320 (391)
T ss_pred             eecc-cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccC
Confidence            7443 34455688999999999864  35799999999       344499999882111          1111111124


Q ss_pred             cCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCC
Q psy9858         268 AGDDLLAVISSLLCLNPTKRADCTATLKMDYFSL  301 (307)
Q Consensus       268 ~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~  301 (307)
                      .|+.+.+|+..||++|+.+||...++|+|||+..
T Consensus       321 FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~  354 (391)
T KOG0983|consen  321 FSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKR  354 (391)
T ss_pred             cCHHHHHHHHHHhhcCcccCcchHHHhcCcceee
Confidence            7999999999999999999999999999999864

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.8e-39  Score=277.73  Aligned_cols=237  Identities=20%  Similarity=0.289  Sum_probs=188.6

Q ss_pred             EEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHH---HHHHhcCCCCccccceeeeecCeEEEEEEc
Q psy9858          62 SVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREI---KLLQELHHENVLGLTDVFGYMSNVSLVFEF  138 (307)
Q Consensus        62 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~---~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  138 (307)
                      .||+|+||.||+|.+..+++.||+|++..........  ...+..|.   ++++...||||+++++++......++||||
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   78 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG--ETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL   78 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchh--HHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEec
Confidence            3799999999999998999999999998643222111  12233343   344456799999999999999999999999


Q ss_pred             c-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcccccc
Q psy9858         139 V-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQ  217 (307)
Q Consensus       139 ~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  217 (307)
                      + +|+|.+++... +.+++..++.++.|++.||.|||+++++|+||||+||+++.++.++|+|||++.......  ....
T Consensus        79 ~~g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--~~~~  155 (278)
T cd05606          79 MNGGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHAS  155 (278)
T ss_pred             CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--CcCc
Confidence            9 57777777554 468999999999999999999999999999999999999999999999999997664322  2334


Q ss_pred             eeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCCC---------ChhhhccccCHHHHHHHHHhhh
Q psy9858         218 VVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPGI---------PLNEIFTAAGDDLLAVISSLLC  281 (307)
Q Consensus       218 ~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~  281 (307)
                      .++..|+|||.+.+...++.++|+|       .++.|..||........         .....+..++.++.+++.+||.
T Consensus       156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~  235 (278)
T cd05606         156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQ  235 (278)
T ss_pred             CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhh
Confidence            7899999999998665789999999       23339999876421111         0112234568999999999999


Q ss_pred             cCCCCCC-----CHHHHhcCcccCCCc
Q psy9858         282 LNPTKRA-----DCTATLKMDYFSLTK  303 (307)
Q Consensus       282 ~dP~~Rp-----t~~~il~hp~f~~~~  303 (307)
                      .||.+||     +++++++||||++..
T Consensus       236 ~~p~~R~~~~~~~~~~ll~~~~~~~~~  262 (278)
T cd05606         236 RDVNRRLGCLGRGAQEVKEHPFFRSLD  262 (278)
T ss_pred             cCHHhccCCCCCCHHHHHhCccccCCC
Confidence            9999999     999999999998753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-39  Score=271.98  Aligned_cols=239  Identities=23%  Similarity=0.352  Sum_probs=200.2

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEE
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLV  135 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  135 (307)
                      +|++.+.||+|++|.||++.+..+++.|++|.+......   +.....+.+|++++++++|+|++++++++.+++..+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK---EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYII   77 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC---HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Confidence            588999999999999999999889999999999864322   22356788999999999999999999999999999999


Q ss_pred             EEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCccc
Q psy9858         136 FEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY  214 (307)
Q Consensus       136 ~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  214 (307)
                      |||+ +++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++..........
T Consensus        78 ~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  156 (254)
T cd06627          78 LEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD  156 (254)
T ss_pred             EecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccc
Confidence            9999 46788777655 458999999999999999999999999999999999999999999999999998875543333


Q ss_pred             ccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCC-------CCChhhhccccCHHHHHHHHHhh
Q psy9858         215 THQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFP-------GIPLNEIFTAAGDDLLAVISSLL  280 (307)
Q Consensus       215 ~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~-------~~~~~~~~~~~~~~l~~li~~~l  280 (307)
                      ....++..|+|||...+. .++.++|+|       .+++|..||......       .......+..+++.+.+++.+||
T Consensus       157 ~~~~~~~~y~~pe~~~~~-~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  235 (254)
T cd06627         157 ASVVGTPYWMAPEVIEMS-GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCF  235 (254)
T ss_pred             cccccchhhcCHhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHH
Confidence            445678899999998877 689999999       233388887652210       11112233467899999999999


Q ss_pred             hcCCCCCCCHHHHhcCccc
Q psy9858         281 CLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       281 ~~dP~~Rpt~~~il~hp~f  299 (307)
                      +.+|++|||+.+++.||||
T Consensus       236 ~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         236 QKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             hCChhhCcCHHHHhcCCCC
Confidence            9999999999999999998

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-39  Score=275.71  Aligned_cols=238  Identities=18%  Similarity=0.253  Sum_probs=192.5

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCC---CcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIET---DMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS  130 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  130 (307)
                      .++|++.+.||+|+||.||+|.+..+   ...||+|.+....    .......+.+|+.+++.++|+||+++++.+....
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS----SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSR   78 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC----ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCC
Confidence            46799999999999999999987643   4689999887432    2223456889999999999999999999999999


Q ss_pred             eEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCC
Q psy9858         131 NVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS  209 (307)
Q Consensus       131 ~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  209 (307)
                      ..+++|||+ +++|.+++....+.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus        79 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          79 PVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             ceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            999999999 6789999887666789999999999999999999999999999999999999999999999999998742


Q ss_pred             CCccc--ccceeeceehhhhhhhccccccccccee---ee----ee-cCCCCCCCCCCC-------CChhhhccccCHHH
Q psy9858         210 PTRLY--THQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FA-KDPSSHGNLFPG-------IPLNEIFTAAGDDL  272 (307)
Q Consensus       210 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~-~~~~f~~~~~~~-------~~~~~~~~~~~~~l  272 (307)
                      .....  ....++..|+|||.+.+. .++.++|+|   ++    +. |..||.......       .........+++.+
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  237 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSAL  237 (266)
T ss_pred             cccceeccCCCCCccccChhhhccC-CCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence            22211  122345689999998877 789999999   22    22 788875522110       00111223568899


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         273 LAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       273 ~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      .+++.+||+.||++|||+++++++
T Consensus       238 ~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         238 YQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHHHHcCCCcccCcCHHHHHHH
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.6e-39  Score=279.12  Aligned_cols=251  Identities=18%  Similarity=0.236  Sum_probs=200.3

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-CCCccccceeee
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-HENVLGLTDVFG  127 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~  127 (307)
                      .+....++|++.+.||+|++|.||+|.+..+++.||||.+......    .....+..|+.++.+.. |+||+++++++.
T Consensus         9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~   84 (296)
T cd06618           9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK----EENKRILMDLDVVLKSHDCPYIVKCYGYFI   84 (296)
T ss_pred             eccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh----HHHHHHHHHHHHHHhccCCCchHhhheeee
Confidence            3445678899999999999999999999888999999999753211    12345667777676664 999999999999


Q ss_pred             ecCeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         128 YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD-HWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       128 ~~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                      +....+++|||+++.+.+++......+++..+..++.||+.||.|||+ .|++||||+|+||+++.++.++|+|||++..
T Consensus        85 ~~~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~  164 (296)
T cd06618          85 TDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGR  164 (296)
T ss_pred             cCCeEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchh
Confidence            999999999999888888877655578999999999999999999997 5999999999999999999999999999987


Q ss_pred             cCCCCcccccceeeceehhhhhhhcc---ccccccccee-------eeeecCCCCCCCCCC---------C-CChhhhcc
Q psy9858         207 FGSPTRLYTHQVVTRWYRLIKCLLYC---VQFNVKNVQW-------CCFAKDPSSHGNLFP---------G-IPLNEIFT  266 (307)
Q Consensus       207 ~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~Diw-------~i~~~~~~f~~~~~~---------~-~~~~~~~~  266 (307)
                      ...... .....++..|+|||.+.+.   ..++.++|+|       .+++|+.||......         . ........
T Consensus       165 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (296)
T cd06618         165 LVDSKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNE  243 (296)
T ss_pred             ccCCCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCC
Confidence            643222 2233567899999998755   2478899999       233499998652110         0 00001112


Q ss_pred             ccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         267 AAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       267 ~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                      .++.++.+|+.+||+.||.+|||+++++.||||.....
T Consensus       244 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  281 (296)
T cd06618         244 GFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET  281 (296)
T ss_pred             CCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence            36889999999999999999999999999999987543

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0612|consensus

Probab=100.00  E-value=3.3e-41  Score=313.18  Aligned_cols=249  Identities=18%  Similarity=0.201  Sum_probs=209.0

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS  130 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  130 (307)
                      ....++|.+++.||+|+||.|.+++++.+++.||+|++++-..  .+......|..|-.+|...+.+=|++++-+|+++.
T Consensus        71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eM--lKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~  148 (1317)
T KOG0612|consen   71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEM--LKRAETACFREERDIMVFGNSEWIVQLHYAFQDER  148 (1317)
T ss_pred             hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHH--hhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence            3455789999999999999999999999999999999986211  11222345778999999999999999999999999


Q ss_pred             eEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC-
Q psy9858         131 NVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG-  208 (307)
Q Consensus       131 ~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~-  208 (307)
                      ++|+||||+ +|+|..++.+-. .+++..++.++..|+.||.-||+.|+|||||||+|||+|..|++||+|||.|.... 
T Consensus       149 ~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~  227 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA  227 (1317)
T ss_pred             ceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence            999999999 899999999887 79999999999999999999999999999999999999999999999999998886 


Q ss_pred             CCCcccccceeeceehhhhhhhc----cccccccccee-------eeeecCCCCCCCC--------CCCCChhhhc--cc
Q psy9858         209 SPTRLYTHQVVTRWYRLIKCLLY----CVQFNVKNVQW-------CCFAKDPSSHGNL--------FPGIPLNEIF--TA  267 (307)
Q Consensus       209 ~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~Diw-------~i~~~~~~f~~~~--------~~~~~~~~~~--~~  267 (307)
                      ++.......+|||.|.+||++..    ...|+..+|.|       .+++|..||....        ........+|  ..
T Consensus       228 dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~  307 (1317)
T KOG0612|consen  228 DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETD  307 (1317)
T ss_pred             CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccc
Confidence            44455667899999999999953    24789999999       4566999998711        1111111111  34


Q ss_pred             cCHHHHHHHHHhhhcCCCCCCC---HHHHhcCcccCCCc
Q psy9858         268 AGDDLLAVISSLLCLNPTKRAD---CTATLKMDYFSLTK  303 (307)
Q Consensus       268 ~~~~l~~li~~~l~~dP~~Rpt---~~~il~hp~f~~~~  303 (307)
                      +|+++++||++++. +|+.|..   ++++-.||||.+.+
T Consensus       308 VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~  345 (1317)
T KOG0612|consen  308 VSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGID  345 (1317)
T ss_pred             cCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCC
Confidence            89999999999886 5788888   99999999999864

>KOG1026|consensus

Probab=100.00  E-value=1.7e-40  Score=302.35  Aligned_cols=238  Identities=24%  Similarity=0.325  Sum_probs=201.4

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceee
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDI-----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVF  126 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~  126 (307)
                      -...+-...+.||+|.||+||+|+-.     ++.+.||||.++.    ........+|++|+++++.++|||||+++|+|
T Consensus       483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd----~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC  558 (774)
T KOG1026|consen  483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKD----KAENQARQDFRREAELLAELQHPNIVRLLGVC  558 (774)
T ss_pred             echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcc----cccHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence            34556777899999999999999743     3457899999983    34444678999999999999999999999999


Q ss_pred             eecCeEEEEEEcc-CCChHHHHhCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEec
Q psy9858         127 GYMSNVSLVFEFV-DTDLEVIIKDP-------------TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK  192 (307)
Q Consensus       127 ~~~~~~~lv~e~~-~g~l~~~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~  192 (307)
                      ..++-.++|+||+ .|+|.+++...             ..+++..+.+.|+.||+.|+.||-++.+|||||..+|+||..
T Consensus       559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge  638 (774)
T KOG1026|consen  559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGE  638 (774)
T ss_pred             ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceecc
Confidence            9999999999999 79999999542             123788999999999999999999999999999999999999


Q ss_pred             CCcEEEEeecCccccCCCCcccc--cceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCC-------C
Q psy9858         193 QGVLKIGDFGLAKFFGSPTRLYT--HQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGN-------L  255 (307)
Q Consensus       193 ~~~~kl~Dfg~a~~~~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~-------~  255 (307)
                      +-.|||+|||+++...+.++...  ...-..+||+||.+... .|+.++|||       .|+. |+.|+.+-       .
T Consensus       639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~-kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~  717 (774)
T KOG1026|consen  639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG-KFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC  717 (774)
T ss_pred             ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcC-cccchhhhhhhhhhhhhhhccccCcccccchHHHHHH
Confidence            99999999999998765544322  33557899999999999 999999999       3443 89998882       2


Q ss_pred             CCCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHh
Q psy9858         256 FPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATL  294 (307)
Q Consensus       256 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il  294 (307)
                      ......-..+.+++.++.+|+..||+.+|.+||++.||-
T Consensus       718 i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  718 IRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             HHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            333444566778999999999999999999999999874

>KOG1035|consensus

Probab=100.00  E-value=2.7e-40  Score=309.25  Aligned_cols=246  Identities=26%  Similarity=0.307  Sum_probs=197.2

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee--
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY--  128 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--  128 (307)
                      .+-..+|+.++.||+||||.||+++++-+|..||||+|....    .+.......+|+..|++|+|||||+++..|..  
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~----s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~  550 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA----SDKLYSKILREVKLLARLNHPNVVRYYSAWVEST  550 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch----HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccC
Confidence            345678899999999999999999999999999999998643    33346778899999999999999999986611  


Q ss_pred             --------------------------------------------------------------------------------
Q psy9858         129 --------------------------------------------------------------------------------  128 (307)
Q Consensus       129 --------------------------------------------------------------------------------  128 (307)
                                                                                                      
T Consensus       551 ~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~  630 (1351)
T KOG1035|consen  551 AELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNL  630 (1351)
T ss_pred             CccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccc
Confidence                                                                                            


Q ss_pred             -----------------------------c--------CeEEEEEEccCCChHHHHhCCCCCC-CHHHHHHHHHHHHHHH
Q psy9858         129 -----------------------------M--------SNVSLVFEFVDTDLEVIIKDPTIVF-TPSNIKAYAIMTLRGL  170 (307)
Q Consensus       129 -----------------------------~--------~~~~lv~e~~~g~l~~~~~~~~~~~-~~~~~~~i~~~i~~~l  170 (307)
                                                   +        ..+||-||||+.++++.+.+.+... ....++.++++|+.||
T Consensus       631 S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGL  710 (1351)
T KOG1035|consen  631 SNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGL  710 (1351)
T ss_pred             ccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHH
Confidence                                         1        3478999999877766666555433 4778999999999999


Q ss_pred             HHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC------------------CCCcccccceeeceehhhhhhhcc
Q psy9858         171 EYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG------------------SPTRLYTHQVVTRWYRLIKCLLYC  232 (307)
Q Consensus       171 ~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~------------------~~~~~~~~~~~t~~y~aPE~~~~~  232 (307)
                      .|+|++|||||||||.||+++..+.|||+|||+|....                  .+....+..+||.-|+|||++.+.
T Consensus       711 aYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  711 AYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             HHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            99999999999999999999999999999999998620                  112245667999999999999887


Q ss_pred             c--cccccccee--eeee--cCCCCCC--------CCCCCCCh---hhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         233 V--QFNVKNVQW--CCFA--KDPSSHG--------NLFPGIPL---NEIFTAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       233 ~--~~~~~~Diw--~i~~--~~~~f~~--------~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      .  .|+.|+|+|  +|+.  --.||..        ........   ..++.+.-+.-..+|++||+.||.+||||.|+|+
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLYPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence            5  699999999  5544  3445655        11111111   2224445567789999999999999999999999


Q ss_pred             CcccC
Q psy9858         296 MDYFS  300 (307)
Q Consensus       296 hp~f~  300 (307)
                      +.||-
T Consensus       871 s~llp  875 (1351)
T KOG1035|consen  871 SELLP  875 (1351)
T ss_pred             ccCCC
Confidence            99986

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.7e-39  Score=279.79  Aligned_cols=240  Identities=20%  Similarity=0.310  Sum_probs=195.4

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEE
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLV  135 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  135 (307)
                      .|.....||+|+||.||++.+..+|+.||+|.+....     ......+.+|+.+++.++|+||+++++.+...+..+++
T Consensus        21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   95 (292)
T cd06657          21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-----QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV   95 (292)
T ss_pred             HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-----hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEE
Confidence            3444578999999999999998999999999885321     12245688999999999999999999999999999999


Q ss_pred             EEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCccc
Q psy9858         136 FEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY  214 (307)
Q Consensus       136 ~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  214 (307)
                      |||+ +++|.+++...  .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++..........
T Consensus        96 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~  173 (292)
T cd06657          96 MEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR  173 (292)
T ss_pred             EecCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccc
Confidence            9999 55677765443  47899999999999999999999999999999999999999999999999987664433223


Q ss_pred             ccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCC---------CChhhhccccCHHHHHHHHH
Q psy9858         215 THQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPG---------IPLNEIFTAAGDDLLAVISS  278 (307)
Q Consensus       215 ~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~---------~~~~~~~~~~~~~l~~li~~  278 (307)
                      ....++..|+|||.+.+. .++.++|+|       .++.|..||.+.....         .........++..+.+++.+
T Consensus       174 ~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  252 (292)
T cd06657         174 KSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDR  252 (292)
T ss_pred             cccccCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHH
Confidence            344678899999998776 788999999       2333888886632110         00111123568899999999


Q ss_pred             hhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         279 LLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       279 ~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      ||+.||.+||++.++++||||..+.
T Consensus       253 ~l~~~P~~R~~~~~ll~~~~~~~~~  277 (292)
T cd06657         253 LLVRDPAQRATAAELLKHPFLAKAG  277 (292)
T ss_pred             HHhCCcccCcCHHHHhcChHHhccC
Confidence            9999999999999999999998765

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.2e-39  Score=273.76  Aligned_cols=234  Identities=18%  Similarity=0.224  Sum_probs=189.3

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEE
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVS  133 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  133 (307)
                      .++|++.+.||+|+||.||++.+. ++..+|+|.+.....      ....+.+|+++++.++||||+++++++......+
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   75 (256)
T cd05114           3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM------SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLY   75 (256)
T ss_pred             HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCc------cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEE
Confidence            467999999999999999999864 566799998764211      1346889999999999999999999999999999


Q ss_pred             EEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc
Q psy9858         134 LVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR  212 (307)
Q Consensus       134 lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  212 (307)
                      ++|||+ +|+|.+++......+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.++.......
T Consensus        76 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~  155 (256)
T cd05114          76 IVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY  155 (256)
T ss_pred             EEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence            999999 6889988876555689999999999999999999999999999999999999999999999999986543222


Q ss_pred             cc-ccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCCC-------CChhhhccccCHHHHHHH
Q psy9858         213 LY-THQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFPG-------IPLNEIFTAAGDDLLAVI  276 (307)
Q Consensus       213 ~~-~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~~-------~~~~~~~~~~~~~l~~li  276 (307)
                      .. ....++..|+|||.+.+. .++.++|+|       .+++ |..||.......       ......+...+.++.+++
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li  234 (256)
T cd05114         156 TSSSGAKFPVKWSPPEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVM  234 (256)
T ss_pred             eccCCCCCchhhCChhhcccC-ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Confidence            11 122345689999998876 789999999       2334 788887632211       111112234578899999


Q ss_pred             HHhhhcCCCCCCCHHHHhc
Q psy9858         277 SSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       277 ~~~l~~dP~~Rpt~~~il~  295 (307)
                      .+||+.||++|||++++++
T Consensus       235 ~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         235 YSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHccCCcccCcCHHHHHH
Confidence            9999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.9e-39  Score=277.46  Aligned_cols=247  Identities=23%  Similarity=0.337  Sum_probs=205.0

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM  129 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  129 (307)
                      .....+.|+..+.||+|++|.||+|.+..++..|++|++.....      ....+.+|+++++.++|+|++++++.+...
T Consensus        14 ~~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   87 (286)
T cd06614          14 EGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ------NKELIINEILIMKDCKHPNIVDYYDSYLVG   87 (286)
T ss_pred             CCCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch------hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC
Confidence            34567789999999999999999999988899999999975321      245678999999999999999999999999


Q ss_pred             CeEEEEEEccC-CChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         130 SNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       130 ~~~~lv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                      ...++++||++ ++|.+++......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  167 (286)
T cd06614          88 DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT  167 (286)
T ss_pred             CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence            99999999995 88998888765468999999999999999999999999999999999999999999999999987664


Q ss_pred             CCCcccccceeeceehhhhhhhccccccccccee---eee----ecCCCCCCCCCCC---------CChhhhccccCHHH
Q psy9858         209 SPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCF----AKDPSSHGNLFPG---------IPLNEIFTAAGDDL  272 (307)
Q Consensus       209 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~----~~~~~f~~~~~~~---------~~~~~~~~~~~~~l  272 (307)
                      ..........++..|++||.+.+. .++.++|+|   +++    .|..||.......         .........++..+
T Consensus       168 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  246 (286)
T cd06614         168 KEKSKRNSVVGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEF  246 (286)
T ss_pred             cchhhhccccCCcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHH
Confidence            332222334567899999998876 789999999   333    3888887632110         00011122378899


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         273 LAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       273 ~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      .++|.+||+.+|.+|||+.++++||||++..
T Consensus       247 ~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  277 (286)
T cd06614         247 KDFLNKCLVKDPEKRPSAEELLQHPFLKKAC  277 (286)
T ss_pred             HHHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence            9999999999999999999999999999854

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.2e-39  Score=274.59  Aligned_cols=230  Identities=19%  Similarity=0.253  Sum_probs=185.3

Q ss_pred             eEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEEEcc-
Q psy9858          61 RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFV-  139 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~-  139 (307)
                      +.||+|+||.||+|.+..+++.||+|.+....    .......+.+|+++++.++||||+++++++......++||||+ 
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   76 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL----PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ   76 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeecc
Confidence            46899999999999998899999999876422    2223456889999999999999999999999999999999999 


Q ss_pred             CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCccc--ccc
Q psy9858         140 DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY--THQ  217 (307)
Q Consensus       140 ~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~--~~~  217 (307)
                      +++|.+++......+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..........  ...
T Consensus        77 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  156 (252)
T cd05084          77 GGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK  156 (252)
T ss_pred             CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence            678888887665568999999999999999999999999999999999999999999999999997653221111  111


Q ss_pred             eeeceehhhhhhhccccccccccee---eeee-----cCCCCCCCCCC-------CCChhhhccccCHHHHHHHHHhhhc
Q psy9858         218 VVTRWYRLIKCLLYCVQFNVKNVQW---CCFA-----KDPSSHGNLFP-------GIPLNEIFTAAGDDLLAVISSLLCL  282 (307)
Q Consensus       218 ~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~-----~~~~f~~~~~~-------~~~~~~~~~~~~~~l~~li~~~l~~  282 (307)
                      ..+..|+|||.+.+. .++.++|+|   ++++     |..||......       .......+..++..+.+++.+||+.
T Consensus       157 ~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  235 (252)
T cd05084         157 QIPVKWTAPEALNYG-RYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEY  235 (252)
T ss_pred             CCceeecCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCC
Confidence            234579999999877 789999999   3332     77777652111       0111122345688999999999999


Q ss_pred             CCCCCCCHHHHhc
Q psy9858         283 NPTKRADCTATLK  295 (307)
Q Consensus       283 dP~~Rpt~~~il~  295 (307)
                      ||++|||+.++++
T Consensus       236 ~p~~Rps~~~~~~  248 (252)
T cd05084         236 DPGQRPSFSTVHQ  248 (252)
T ss_pred             ChhhCcCHHHHHH
Confidence            9999999999975

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.2e-39  Score=278.52  Aligned_cols=241  Identities=25%  Similarity=0.291  Sum_probs=200.2

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-CCCccccceeeeecCeEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-HENVLGLTDVFGYMSNVS  133 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~  133 (307)
                      ++|.+.+.||+|++|.||+|.+..+|+.||+|++......  .......+.+|++++++++ |+||+++++++.+....+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   78 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI--KEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLY   78 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhcc--chHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEE
Confidence            4799999999999999999999999999999998753221  1222456789999999998 999999999999999999


Q ss_pred             EEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc
Q psy9858         134 LVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR  212 (307)
Q Consensus       134 lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  212 (307)
                      ++||++ +++|.+++.+.. .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus        79 lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~  157 (280)
T cd05581          79 FVLEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS  157 (280)
T ss_pred             EEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence            999999 788988887664 589999999999999999999999999999999999999999999999999987643321


Q ss_pred             --------------------ccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCC------C
Q psy9858         213 --------------------LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPG------I  259 (307)
Q Consensus       213 --------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~------~  259 (307)
                                          ......++..|+|||.+.+. .++.++|+|       .+++|..||.......      .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  236 (280)
T cd05581         158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK  236 (280)
T ss_pred             cccCCCCCccccccccccccccccccCCccccCHHHhCCC-CCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh
Confidence                                12233567899999998877 789999999       2333888887643111      0


Q ss_pred             ChhhhccccCHHHHHHHHHhhhcCCCCCCCH----HHHhcCccc
Q psy9858         260 PLNEIFTAAGDDLLAVISSLLCLNPTKRADC----TATLKMDYF  299 (307)
Q Consensus       260 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~----~~il~hp~f  299 (307)
                      .....+..+++.+.+++.+||+.||.+|||+    +++++||||
T Consensus       237 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         237 LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            1112234568899999999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=6.8e-39  Score=272.16  Aligned_cols=238  Identities=27%  Similarity=0.405  Sum_probs=195.1

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ++|++.+.||+|++|.||+|.+..+|+.||+|.+......+  ......+.+|++++++++|+|++++++.+...+..++
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~l   79 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMD--AKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNI   79 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccc--hhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            58999999999999999999998899999999987533222  2224668899999999999999999999999999999


Q ss_pred             EEEcc-CCChHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         135 VFEFV-DTDLEVIIKD---PTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       135 v~e~~-~g~l~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      +|||+ +|+|..++..   ....+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  159 (267)
T cd08224          80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence            99999 5788887753   2345789999999999999999999999999999999999999999999999999876443


Q ss_pred             Ccccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCC---------CCChhhhcc-ccCHHHH
Q psy9858         211 TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFP---------GIPLNEIFT-AAGDDLL  273 (307)
Q Consensus       211 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~---------~~~~~~~~~-~~~~~l~  273 (307)
                      ........++..|+|||.+.+. .++.++|+|       .+++|..||......         .......+. .++..+.
T Consensus       160 ~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd08224         160 TTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELR  238 (267)
T ss_pred             CcccceecCCccccCHHHhccC-CCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHH
Confidence            3333345678899999998876 789999999       233388888653221         111112222 5678999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhc
Q psy9858         274 AVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       274 ~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      ++|.+||..+|++|||+.++++
T Consensus       239 ~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         239 DLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHHcCCCcccCCCHHHHHH
Confidence            9999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.7e-39  Score=304.18  Aligned_cols=238  Identities=21%  Similarity=0.216  Sum_probs=190.7

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ++|++++.||+|+||.||+|.+..+|+.||+|++.....  ......+.+.+|+++++.++||||+++++++.+.+..++
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~--~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyL   79 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLS--ENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYY   79 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccc--cCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEE
Confidence            689999999999999999999999999999999975321  223335678899999999999999999999999999999


Q ss_pred             EEEcc-CCChHHHHhCC----------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecC
Q psy9858         135 VFEFV-DTDLEVIIKDP----------TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGL  203 (307)
Q Consensus       135 v~e~~-~g~l~~~~~~~----------~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  203 (307)
                      +|||+ +|+|.+++...          ....+...+..++.||+.||+|||++||+||||||+||+++.++.++|+|||+
T Consensus        80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGL  159 (932)
T PRK13184         80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGA  159 (932)
T ss_pred             EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCc
Confidence            99999 67888877531          12245667888999999999999999999999999999999999999999999


Q ss_pred             ccccCCCC------------------cccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC
Q psy9858         204 AKFFGSPT------------------RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG  258 (307)
Q Consensus       204 a~~~~~~~------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~  258 (307)
                      ++......                  .......||+.|+|||.+.+. .++.++|||   |    +++|..||.......
T Consensus       160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~-~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC-CCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            98662110                  001124689999999999887 789999999   3    334999997633221


Q ss_pred             CChh---------hhccccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         259 IPLN---------EIFTAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       259 ~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      ....         .....+++.+.+++.+||+.||++|++..+.+.
T Consensus       239 i~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl  284 (932)
T PRK13184        239 ISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK  284 (932)
T ss_pred             hhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            1110         011357889999999999999999988666554

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=8.6e-39  Score=269.81  Aligned_cols=239  Identities=23%  Similarity=0.323  Sum_probs=201.5

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec--CeEE
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM--SNVS  133 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~  133 (307)
                      +|.+.+.||+|++|.||+|.+..+++.|++|++......   ....+.+.+|++++++++|+||+++++.+...  ...+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS---EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc---hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEE
Confidence            478899999999999999999889999999998764322   22356788999999999999999999999888  8999


Q ss_pred             EEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc
Q psy9858         134 LVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR  212 (307)
Q Consensus       134 lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  212 (307)
                      +++||+ +++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus        78 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  156 (260)
T cd06606          78 IFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET  156 (260)
T ss_pred             EEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence            999999 678888887655 689999999999999999999999999999999999999999999999999988754432


Q ss_pred             --ccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCC---------CCCChhhhccccCHHHHH
Q psy9858         213 --LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLF---------PGIPLNEIFTAAGDDLLA  274 (307)
Q Consensus       213 --~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~---------~~~~~~~~~~~~~~~l~~  274 (307)
                        ......++..|+|||.+.+. ..+.++|+|       .+++|..||.....         ........+..++..+.+
T Consensus       157 ~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  235 (260)
T cd06606         157 GEGTGSVRGTPYWMAPEVIRGE-EYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKD  235 (260)
T ss_pred             cccccCCCCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHH
Confidence              13445788899999999887 689999999       23338888876430         011222334566899999


Q ss_pred             HHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         275 VISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       275 li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                      ++.+||+.||.+|||+.+++.||||
T Consensus       236 ~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         236 FLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HHHHhCcCChhhCCCHHHHhhCCCC
Confidence            9999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.6e-39  Score=277.72  Aligned_cols=240  Identities=18%  Similarity=0.199  Sum_probs=190.0

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceee
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDI-----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVF  126 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~  126 (307)
                      ...++|++.+.||+|+||.||+|.+.     .++..||+|++....    .......+.+|+.+++.++|+||+++++++
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~   78 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA----SMRERIEFLNEASVMKEFNCHHVVRLLGVV   78 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence            35678999999999999999999864     245789999886421    112245688999999999999999999999


Q ss_pred             eecCeEEEEEEcc-CCChHHHHhCCC---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcE
Q psy9858         127 GYMSNVSLVFEFV-DTDLEVIIKDPT---------IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVL  196 (307)
Q Consensus       127 ~~~~~~~lv~e~~-~g~l~~~~~~~~---------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~  196 (307)
                      ......++||||+ +|+|.+++.+..         ..++...+..++.|++.||.|||+.|++|+||||+||+++.++.+
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~  158 (277)
T cd05062          79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV  158 (277)
T ss_pred             cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCE
Confidence            9999999999999 678888886432         125677889999999999999999999999999999999999999


Q ss_pred             EEEeecCccccCCCCccc--ccceeeceehhhhhhhccccccccccee---ee----ee-cCCCCCCCCCCC-------C
Q psy9858         197 KIGDFGLAKFFGSPTRLY--THQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FA-KDPSSHGNLFPG-------I  259 (307)
Q Consensus       197 kl~Dfg~a~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~-~~~~f~~~~~~~-------~  259 (307)
                      +|+|||++..........  ....++..|+|||.+.+. .++.++|+|   ++    ++ |..||.+.....       .
T Consensus       159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~  237 (277)
T cd05062         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG  237 (277)
T ss_pred             EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            999999998654322211  123456789999999887 789999999   22    22 677876632111       1


Q ss_pred             ChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         260 PLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       260 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      .....+..+++.+.+++.+||+.||++|||+.+++++
T Consensus       238 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         238 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            1122334578899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8e-39  Score=271.59  Aligned_cols=242  Identities=19%  Similarity=0.303  Sum_probs=195.9

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec--CeE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM--SNV  132 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~  132 (307)
                      .+|++.+.||+|++|.||+|.+..+++.||+|++...............+.+|++++++++|+||+++++.+.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            479999999999999999999999999999999864322222233356788999999999999999999988653  568


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT  211 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  211 (307)
                      ++++||+ +++|.+.+.... .+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||+++......
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  160 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC  160 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence            9999999 567888876543 47899999999999999999999999999999999999999999999999998653211


Q ss_pred             ---cccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCC--------CCCChhhhccccCHHHH
Q psy9858         212 ---RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLF--------PGIPLNEIFTAAGDDLL  273 (307)
Q Consensus       212 ---~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~--------~~~~~~~~~~~~~~~l~  273 (307)
                         .......++..|+|||.+.+. .++.++|+|   +    +++|..||.....        ........+..+++.+.
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~  239 (264)
T cd06653         161 MSGTGIKSVTGTPYWMSPEVISGE-GYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACR  239 (264)
T ss_pred             ccCccccccCCcccccCHhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHH
Confidence               112234678899999999886 788999999   2    3339999876211        11112334556889999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         274 AVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       274 ~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                      +++.+||. +|..|||+.+++.|||.
T Consensus       240 ~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         240 DFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHHHHhc-CcccCccHHHHhcCCCC
Confidence            99999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=4.3e-39  Score=273.75  Aligned_cols=233  Identities=18%  Similarity=0.219  Sum_probs=189.0

Q ss_pred             ccceeeEEeEE--eecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeeec
Q psy9858          53 DLLVYYQWRSV--HVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGYM  129 (307)
Q Consensus        53 ~~~~y~~~~~l--g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~  129 (307)
                      ..++|.+.+.+  |+|+||.||++.+..++..+|+|++.......          .|+.....+ +|+||+++++.+...
T Consensus        12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----------~e~~~~~~~~~h~~iv~~~~~~~~~   81 (267)
T PHA03390         12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----------IEPMVHQLMKDNPNFIKLYYSVTTL   81 (267)
T ss_pred             HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----------hhHHHHHHhhcCCCEEEEEEEEecC
Confidence            44567777776  99999999999999999999999987532111          123222222 699999999999999


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCC-cEEEEeecCcccc
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG-VLKIGDFGLAKFF  207 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a~~~  207 (307)
                      +..++||||+ +|+|.+++.... .+++.++..++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++...
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~  160 (267)
T PHA03390         82 KGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII  160 (267)
T ss_pred             CeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence            9999999999 688999887654 689999999999999999999999999999999999999998 9999999999876


Q ss_pred             CCCCcccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCCCC----------hhhhccccCH
Q psy9858         208 GSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPGIP----------LNEIFTAAGD  270 (307)
Q Consensus       208 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~~~----------~~~~~~~~~~  270 (307)
                      ...    ....++..|+|||.+.+. .++.++|+|       .++.|..||.........          ....+..+++
T Consensus       161 ~~~----~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (267)
T PHA03390        161 GTP----SCYDGTLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSK  235 (267)
T ss_pred             CCC----ccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCH
Confidence            432    223678899999999887 789999999       233399998753322111          1122335789


Q ss_pred             HHHHHHHHhhhcCCCCCCC-HHHHhcCcccCC
Q psy9858         271 DLLAVISSLLCLNPTKRAD-CTATLKMDYFSL  301 (307)
Q Consensus       271 ~l~~li~~~l~~dP~~Rpt-~~~il~hp~f~~  301 (307)
                      .+.++|.+||+.||.+||+ ++++|+||||++
T Consensus       236 ~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        236 NANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             HHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence            9999999999999999996 699999999974

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=4.6e-39  Score=280.25  Aligned_cols=245  Identities=23%  Similarity=0.319  Sum_probs=200.2

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEE
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVS  133 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  133 (307)
                      ...|...+.||+|+||.||+|++..++..||+|++......  .......+.+|+++++.++|+|++++++++.++...+
T Consensus        24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (317)
T cd06635          24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ--SNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAW  101 (317)
T ss_pred             hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCC--chHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEE
Confidence            34588899999999999999999899999999998754222  2223456889999999999999999999999999999


Q ss_pred             EEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc
Q psy9858         134 LVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL  213 (307)
Q Consensus       134 lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  213 (307)
                      +||||+.|++.+.+......+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......   
T Consensus       102 lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---  178 (317)
T cd06635         102 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---  178 (317)
T ss_pred             EEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence            99999999988888766666899999999999999999999999999999999999999999999999998765322   


Q ss_pred             cccceeeceehhhhhhhc--cccccccccee---e----eeecCCCCCCCCCCC--------CChhhhccccCHHHHHHH
Q psy9858         214 YTHQVVTRWYRLIKCLLY--CVQFNVKNVQW---C----CFAKDPSSHGNLFPG--------IPLNEIFTAAGDDLLAVI  276 (307)
Q Consensus       214 ~~~~~~t~~y~aPE~~~~--~~~~~~~~Diw---~----i~~~~~~f~~~~~~~--------~~~~~~~~~~~~~l~~li  276 (307)
                       ....++..|+|||.+..  ...++.++|+|   +    ++.|..||.......        .........+++.+.+++
T Consensus       179 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  257 (317)
T cd06635         179 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV  257 (317)
T ss_pred             -ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHH
Confidence             23467889999999852  23688999999   3    334888876532110        001111234678899999


Q ss_pred             HHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         277 SSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       277 ~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                      .+||+.+|.+|||+.++++|+|+.....
T Consensus       258 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~  285 (317)
T cd06635         258 DSCLQKIPQDRPTSEELLKHMFVLRERP  285 (317)
T ss_pred             HHHccCCcccCcCHHHHHhChhhhccCc
Confidence            9999999999999999999999976543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3.3e-39  Score=274.25  Aligned_cols=238  Identities=25%  Similarity=0.371  Sum_probs=194.0

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ++|.+.+.||+|++|.||+|.+..++..||||.+......  .......+.+|+++++.++|+||+++++++...+..++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   79 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLM--DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI   79 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhh--hHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEE
Confidence            5789999999999999999999899999999988753221  22234678899999999999999999999999999999


Q ss_pred             EEEcc-CCChHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         135 VFEFV-DTDLEVIIKD---PTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       135 v~e~~-~g~l~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      +|||+ +++|.+++..   ....+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd08229          80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence            99999 5688887753   2345899999999999999999999999999999999999999999999999999876543


Q ss_pred             Ccccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCCC---------Chh-hhccccCHHHH
Q psy9858         211 TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPGI---------PLN-EIFTAAGDDLL  273 (307)
Q Consensus       211 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~~---------~~~-~~~~~~~~~l~  273 (307)
                      ........++..|+|||.+.+. .++.++|+|       .+++|..||.+......         ... .....+++++.
T Consensus       160 ~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd08229         160 TTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR  238 (267)
T ss_pred             CcccccccCCcCccCHHHhcCC-CccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHH
Confidence            3333345688899999999876 788999999       23338888865322110         001 11134678999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhc
Q psy9858         274 AVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       274 ~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      +++.+||+.||++|||++++++
T Consensus       239 ~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         239 QLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHHhcCCCcccCCCHHHHHH
Confidence            9999999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.2e-39  Score=274.34  Aligned_cols=242  Identities=22%  Similarity=0.357  Sum_probs=193.4

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEE
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLV  135 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  135 (307)
                      +|.+.+.||+|+||.||++.+...+..+++|++......+........+.+|+.+++.++||||+++++++.+....+++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            58899999999999999999888777777777664332222222234566899999999999999999999999999999


Q ss_pred             EEcc-CCChHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC
Q psy9858         136 FEFV-DTDLEVIIKD---PTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT  211 (307)
Q Consensus       136 ~e~~-~g~l~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  211 (307)
                      |||+ +++|.+.+..   ....+++..++.++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||++.......
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~  159 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC  159 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence            9999 5677776653   3345899999999999999999999999999999999999975 679999999998765443


Q ss_pred             cccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCC-------CChhhhccccCHHHHHHHH
Q psy9858         212 RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPG-------IPLNEIFTAAGDDLLAVIS  277 (307)
Q Consensus       212 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~-------~~~~~~~~~~~~~l~~li~  277 (307)
                      .......++..|+|||.+.+. .++.++|+|       .+++|..||.......       .........++.++.++|.
T Consensus       160 ~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (260)
T cd08222         160 DLATTFTGTPYYMSPEALKHQ-GYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQ  238 (260)
T ss_pred             ccccCCCCCcCccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHH
Confidence            344445678899999998766 788899999       2333788876522111       1111223457889999999


Q ss_pred             HhhhcCCCCCCCHHHHhcCccc
Q psy9858         278 SLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       278 ~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                      +||+.||++||++.++++||||
T Consensus       239 ~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         239 SMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHhcCChhhCcCHHHHhhCCCC
Confidence            9999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=5.5e-39  Score=272.46  Aligned_cols=237  Identities=19%  Similarity=0.223  Sum_probs=192.5

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ...+|.+.+.||+|++|.||+|.+..+++.||+|++....      .....+.+|+++++.++|+||+++++++..+...
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (263)
T cd05052           4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT------MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   77 (263)
T ss_pred             chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc------hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence            4467999999999999999999998899999999986421      1135688999999999999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      +++|||+ +++|.+++... ...+++..++.++.|++.||.|||++|++|+||||+||++++++.++|+|||++......
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~  157 (263)
T cd05052          78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  157 (263)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence            9999999 67898888653 334889999999999999999999999999999999999999999999999999876433


Q ss_pred             Cccc-ccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCCC-------CChhhhccccCHHHHH
Q psy9858         211 TRLY-THQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFPG-------IPLNEIFTAAGDDLLA  274 (307)
Q Consensus       211 ~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~~-------~~~~~~~~~~~~~l~~  274 (307)
                      .... .....+..|+|||.+.+. .++.++|||       .+++ |..||.+.....       ......+..++.++.+
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (263)
T cd05052         158 TYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYE  236 (263)
T ss_pred             eeeccCCCCCccccCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence            2111 112335679999998877 789999999       2333 778876622111       1111233457899999


Q ss_pred             HHHHhhhcCCCCCCCHHHHhcC
Q psy9858         275 VISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       275 li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      ++.+||+.||++|||+.++++.
T Consensus       237 li~~cl~~~p~~Rp~~~~l~~~  258 (263)
T cd05052         237 LMRACWQWNPSDRPSFAEIHQA  258 (263)
T ss_pred             HHHHHccCCcccCCCHHHHHHH
Confidence            9999999999999999999764

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.8e-39  Score=288.85  Aligned_cols=244  Identities=18%  Similarity=0.235  Sum_probs=192.7

Q ss_pred             CceeccccceeeEEeEEeecCceEEEEEEEcCC-----CcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-CCCcc
Q psy9858          47 DCEVKNDLLVYYQWRSVHVGRFATVFKARDIET-----DMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-HENVL  120 (307)
Q Consensus        47 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~  120 (307)
                      +..+....++|.+++.||+|+||.||+|.+...     +..||||++....    .....+.+.+|+++++++. ||||+
T Consensus        29 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~----~~~~~~~~~~Ei~~l~~l~~HpnIv  104 (400)
T cd05105          29 DSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA----RSSEKQALMSELKIMTHLGPHLNIV  104 (400)
T ss_pred             CCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC----ChHHHHHHHHHHHHHHhcCCCCCee
Confidence            445666778999999999999999999986432     4579999997432    2222456889999999996 99999


Q ss_pred             ccceeeeecCeEEEEEEcc-CCChHHHHhCCC------------------------------------------------
Q psy9858         121 GLTDVFGYMSNVSLVFEFV-DTDLEVIIKDPT------------------------------------------------  151 (307)
Q Consensus       121 ~~~~~~~~~~~~~lv~e~~-~g~l~~~~~~~~------------------------------------------------  151 (307)
                      ++++++......+|||||+ +|+|.+++....                                                
T Consensus       105 ~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  184 (400)
T cd05105         105 NLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQAD  184 (400)
T ss_pred             eEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccc
Confidence            9999999999999999999 688888775421                                                


Q ss_pred             -----------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCC
Q psy9858         152 -----------------------------------------------IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK  184 (307)
Q Consensus       152 -----------------------------------------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlk  184 (307)
                                                                     ..+++..+..++.||+.||+|||+.|++|+|||
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dik  264 (400)
T cd05105         185 TTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLA  264 (400)
T ss_pred             ccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCC
Confidence                                                           136777888999999999999999999999999


Q ss_pred             CCcEEEecCCcEEEEeecCccccCCCCcc--cccceeeceehhhhhhhccccccccccee---ee----ee-cCCCCCCC
Q psy9858         185 PNNLLINKQGVLKIGDFGLAKFFGSPTRL--YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FA-KDPSSHGN  254 (307)
Q Consensus       185 p~Nil~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~-~~~~f~~~  254 (307)
                      |+||+++.++.+||+|||+++........  .....++..|+|||.+.+. .++.++|||   ++    +. |..||...
T Consensus       265 p~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlGvil~ellt~g~~P~~~~  343 (400)
T cd05105         265 ARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN-LYTTLSDVWSYGILLWEIFSLGGTPYPGM  343 (400)
T ss_pred             hHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence            99999999999999999999876432211  1223456789999999877 789999999   22    22 77787653


Q ss_pred             CCCCC--------ChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         255 LFPGI--------PLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       255 ~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      .....        ........++.++.+++.+||+.||++|||+.++.+
T Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         344 IVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             chhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            22111        011223467889999999999999999999988875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=6.9e-39  Score=276.05  Aligned_cols=245  Identities=20%  Similarity=0.245  Sum_probs=193.3

Q ss_pred             CceeccccceeeEEeEEeecCceEEEEEEEcCC-----CcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCcc
Q psy9858          47 DCEVKNDLLVYYQWRSVHVGRFATVFKARDIET-----DMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVL  120 (307)
Q Consensus        47 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~  120 (307)
                      +..+....++|++.+.||+|+||.||++.+...     ...+|+|.+....    .......+.+|+++++++ +|+||+
T Consensus         4 ~~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~i~   79 (293)
T cd05053           4 DPEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA----TEKDLSDLVSEMEMMKMIGKHKNII   79 (293)
T ss_pred             CcccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC----CHHHHHHHHHHHHHHHhhcCCCCee
Confidence            334556678899999999999999999987643     3789999987431    122245688999999999 799999


Q ss_pred             ccceeeeecCeEEEEEEcc-CCChHHHHhCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCC
Q psy9858         121 GLTDVFGYMSNVSLVFEFV-DTDLEVIIKDP---------------TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK  184 (307)
Q Consensus       121 ~~~~~~~~~~~~~lv~e~~-~g~l~~~~~~~---------------~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlk  184 (307)
                      ++++++...+..+++|||+ +|+|.+++...               ...+++..+..++.||+.||.|||++|++|+|||
T Consensus        80 ~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlk  159 (293)
T cd05053          80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLA  159 (293)
T ss_pred             eEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccc
Confidence            9999999999999999999 68888888532               3358889999999999999999999999999999


Q ss_pred             CCcEEEecCCcEEEEeecCccccCCCCcc--cccceeeceehhhhhhhccccccccccee---eeee-----cCCCCCCC
Q psy9858         185 PNNLLINKQGVLKIGDFGLAKFFGSPTRL--YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA-----KDPSSHGN  254 (307)
Q Consensus       185 p~Nil~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~-----~~~~f~~~  254 (307)
                      |+||+++.++.++|+|||+++........  .....++..|+|||.+.+. .++.++|||   ++++     |..||.+.
T Consensus       160 p~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~  238 (293)
T cd05053         160 ARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGI  238 (293)
T ss_pred             eeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccC-CcCcccceeehhhHHHHHhcCCCCCCCCC
Confidence            99999999999999999999876432211  1222345679999998777 889999999   3322     66676552


Q ss_pred             CCCC-------CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         255 LFPG-------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       255 ~~~~-------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      ....       ......+..++.++.+|+.+||..||++|||+++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         239 PVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             CHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            2111       11112233567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4.7e-39  Score=275.71  Aligned_cols=227  Identities=16%  Similarity=0.142  Sum_probs=184.5

Q ss_pred             eEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee----cCeEEEEE
Q psy9858          61 RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY----MSNVSLVF  136 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----~~~~~lv~  136 (307)
                      ..|++|+++.||+|..  +|+.||||.+.....  ......+.+.+|++++++++||||+++++++.+    ....+++|
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~  101 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHK--GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL  101 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEecccccc--ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEE
Confidence            5789999999999986  788999999875321  222234667899999999999999999999876    45789999


Q ss_pred             Ecc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeecCCCCcEEEecCCcEEEEeecCccccCCCCccc
Q psy9858         137 EFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH-WILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY  214 (307)
Q Consensus       137 e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  214 (307)
                      ||+ +|+|.+++.... .+++.....++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++......   
T Consensus       102 Ey~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---  177 (283)
T PHA02988        102 EYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---  177 (283)
T ss_pred             EeCCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---
Confidence            999 578888887654 588899999999999999999984 99999999999999999999999999998664321   


Q ss_pred             ccceeeceehhhhhhhcc-ccccccccee-------eeeecCCCCCCCCCCC--------CChhhhccccCHHHHHHHHH
Q psy9858         215 THQVVTRWYRLIKCLLYC-VQFNVKNVQW-------CCFAKDPSSHGNLFPG--------IPLNEIFTAAGDDLLAVISS  278 (307)
Q Consensus       215 ~~~~~t~~y~aPE~~~~~-~~~~~~~Diw-------~i~~~~~~f~~~~~~~--------~~~~~~~~~~~~~l~~li~~  278 (307)
                      ....++..|+|||.+.+. ..++.++|||       .+++|..||.+.....        ......+..+++++.+++.+
T Consensus       178 ~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~  257 (283)
T PHA02988        178 FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEA  257 (283)
T ss_pred             ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHH
Confidence            234678999999999762 3789999999       3344999998743211        11112233578999999999


Q ss_pred             hhhcCCCCCCCHHHHhc
Q psy9858         279 LLCLNPTKRADCTATLK  295 (307)
Q Consensus       279 ~l~~dP~~Rpt~~~il~  295 (307)
                      ||+.||++|||++++++
T Consensus       258 cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        258 CTSHDSIKRPNIKEILY  274 (283)
T ss_pred             HhcCCcccCcCHHHHHH
Confidence            99999999999999986

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=3.5e-39  Score=273.36  Aligned_cols=237  Identities=27%  Similarity=0.337  Sum_probs=192.5

Q ss_pred             EeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEEEcc-CC
Q psy9858          63 VHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFV-DT  141 (307)
Q Consensus        63 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~-~g  141 (307)
                      ||.|+||.||++.+..+|+.|++|++.......  ......+.+|+++++.++|+||+++++.+......|++|||+ ++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIR--KNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGG   78 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhh--hhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCC
Confidence            688999999999998889999999987542211  223566889999999999999999999999999999999999 56


Q ss_pred             ChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc--------c
Q psy9858         142 DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR--------L  213 (307)
Q Consensus       142 ~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--------~  213 (307)
                      +|.+++.+.. .+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++........        .
T Consensus        79 ~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  157 (265)
T cd05579          79 DLASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE  157 (265)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence            8888887654 589999999999999999999999999999999999999999999999999886543211        2


Q ss_pred             cccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCCCC------hhhhcc--ccCHHHHHHHHH
Q psy9858         214 YTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPGIP------LNEIFT--AAGDDLLAVISS  278 (307)
Q Consensus       214 ~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~~~------~~~~~~--~~~~~l~~li~~  278 (307)
                      .....++..|+|||...+. ..+.++|+|       .++.|..||.........      ....+.  .++..+.+++.+
T Consensus       158 ~~~~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  236 (265)
T cd05579         158 DKRIVGTPDYIAPEVILGQ-GHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISK  236 (265)
T ss_pred             ccCcccCccccCHHHhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHH
Confidence            2334567899999999887 689999999       233388888753211100      001111  248999999999


Q ss_pred             hhhcCCCCCCCH---HHHhcCcccCCCc
Q psy9858         279 LLCLNPTKRADC---TATLKMDYFSLTK  303 (307)
Q Consensus       279 ~l~~dP~~Rpt~---~~il~hp~f~~~~  303 (307)
                      ||+.+|.+|||+   .++|+||||++++
T Consensus       237 ~l~~~p~~Rpt~~~~~~~l~~~~~~~~~  264 (265)
T cd05579         237 LLVPDPEKRLGAKSIEEIKNHPFFKGID  264 (265)
T ss_pred             HhcCCHhhcCCCccHHHHhcCccccCCC
Confidence            999999999999   9999999998653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.4e-39  Score=275.73  Aligned_cols=237  Identities=19%  Similarity=0.254  Sum_probs=194.2

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN  131 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  131 (307)
                      +...+|++++.||.|+||.||+|.+.. +..+|+|++.....     .....+.+|+.+++.++|+||+++++++.+...
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   76 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL-----LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEP   76 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch-----hhHHHHHHHHHHHhcCCCcchhheeeeEecCCC
Confidence            455689999999999999999999866 88999999875321     123457899999999999999999999999999


Q ss_pred             EEEEEEcc-CCChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCC
Q psy9858         132 VSLVFEFV-DTDLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS  209 (307)
Q Consensus       132 ~~lv~e~~-~g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  209 (307)
                      .+++|||+ +|+|.+++... ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~  156 (261)
T cd05148          77 VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE  156 (261)
T ss_pred             eEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence            99999999 57899998764 34588999999999999999999999999999999999999999999999999987644


Q ss_pred             CCcccccceeeceehhhhhhhccccccccccee---ee----ee-cCCCCCCCCCCC-------CChhhhccccCHHHHH
Q psy9858         210 PTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FA-KDPSSHGNLFPG-------IPLNEIFTAAGDDLLA  274 (307)
Q Consensus       210 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~-~~~~f~~~~~~~-------~~~~~~~~~~~~~l~~  274 (307)
                      .........++..|+|||.+.+. .++.++|+|   ++    +. |..||.......       ......+..+++.+.+
T Consensus       157 ~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (261)
T cd05148         157 DVYLSSDKKIPYKWTAPEAASHG-TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYK  235 (261)
T ss_pred             ccccccCCCCceEecCHHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHH
Confidence            33223333456789999998876 789999999   22    23 788887632111       0011223467899999


Q ss_pred             HHHHhhhcCCCCCCCHHHHhc
Q psy9858         275 VISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       275 li~~~l~~dP~~Rpt~~~il~  295 (307)
                      ++.+||+.||.+|||+.++++
T Consensus       236 ~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         236 IMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHHHcCCCchhCcCHHHHHH
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.5e-39  Score=284.73  Aligned_cols=242  Identities=18%  Similarity=0.206  Sum_probs=188.0

Q ss_pred             eEEeec--CceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEEEc
Q psy9858          61 RSVHVG--RFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEF  138 (307)
Q Consensus        61 ~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  138 (307)
                      ..||.|  +||+||++++..+|+.||+|++.....   .....+.+.+|+.+++.++||||+++++++..+...+++|||
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~   80 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC---TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPF   80 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEec
Confidence            456666  999999999999999999999875322   222346788999999999999999999999999999999999


Q ss_pred             c-CCChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc---
Q psy9858         139 V-DTDLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL---  213 (307)
Q Consensus       139 ~-~g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~---  213 (307)
                      + .|++.+++.+. ...+++..+..++.||+.||+|||++|++||||||+||+++.++.++++||+.+.........   
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            9 57888877653 234889999999999999999999999999999999999999999999999865433211100   


Q ss_pred             ----cccceeeceehhhhhhhcc-ccccccccee---eee----ecCCCCCCCCCCCC----------------------
Q psy9858         214 ----YTHQVVTRWYRLIKCLLYC-VQFNVKNVQW---CCF----AKDPSSHGNLFPGI----------------------  259 (307)
Q Consensus       214 ----~~~~~~t~~y~aPE~~~~~-~~~~~~~Diw---~i~----~~~~~f~~~~~~~~----------------------  259 (307)
                          .....++..|+|||.+.+. ..++.++|||   |++    +|..||........                      
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE  240 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence                0112345679999999764 2578999999   333    38899875210000                      


Q ss_pred             -------------------------------ChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCccc
Q psy9858         260 -------------------------------PLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKEM  305 (307)
Q Consensus       260 -------------------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~~  305 (307)
                                                     ........+++.+.+|+.+||+.||++|||++++|+||||++.++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~  317 (328)
T cd08226         241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ  317 (328)
T ss_pred             hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence                                           0000112356789999999999999999999999999999887653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=6.6e-39  Score=278.15  Aligned_cols=245  Identities=22%  Similarity=0.329  Sum_probs=199.2

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..+.|...+.||+|++|.||+|++..++..||+|.+......  .......+.+|+++++.++|+|++++++++......
T Consensus        13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   90 (308)
T cd06634          13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ--SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA   90 (308)
T ss_pred             cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccccc--ChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCee
Confidence            455688889999999999999999999999999998743211  122245677899999999999999999999999999


Q ss_pred             EEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc
Q psy9858         133 SLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR  212 (307)
Q Consensus       133 ~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  212 (307)
                      ++||||+.|++.+.+......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......  
T Consensus        91 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--  168 (308)
T cd06634          91 WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (308)
T ss_pred             EEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence            999999998988887665556899999999999999999999999999999999999999999999999998765332  


Q ss_pred             ccccceeeceehhhhhhhc--cccccccccee---e----eeecCCCCCCCCCCC--------CChhhhccccCHHHHHH
Q psy9858         213 LYTHQVVTRWYRLIKCLLY--CVQFNVKNVQW---C----CFAKDPSSHGNLFPG--------IPLNEIFTAAGDDLLAV  275 (307)
Q Consensus       213 ~~~~~~~t~~y~aPE~~~~--~~~~~~~~Diw---~----i~~~~~~f~~~~~~~--------~~~~~~~~~~~~~l~~l  275 (307)
                        ....++..|+|||.+.+  ...++.++|||   +    ++.|..||.......        .........++..+.++
T Consensus       169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  246 (308)
T cd06634         169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF  246 (308)
T ss_pred             --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHH
Confidence              23367889999999853  23678899999   2    333887875521100        00011123577889999


Q ss_pred             HHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         276 ISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       276 i~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      |.+||+.+|++|||++++++|||+....
T Consensus       247 i~~cl~~~P~~Rp~~~~ll~~~~~~~~~  274 (308)
T cd06634         247 VDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (308)
T ss_pred             HHHHhhCCcccCCCHHHHhhCccccccC
Confidence            9999999999999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG4721|consensus

Probab=100.00  E-value=3e-40  Score=287.81  Aligned_cols=234  Identities=22%  Similarity=0.235  Sum_probs=200.9

Q ss_pred             CceeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceee
Q psy9858          47 DCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVF  126 (307)
Q Consensus        47 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~  126 (307)
                      +..|...++...-++-||+|+-|.||+|+  -.++.||||+++-     .+       ..+++-|++|+|+||+.+.++|
T Consensus       116 ~e~WeiPFe~IsELeWlGSGaQGAVF~Gr--l~netVAVKKV~e-----lk-------ETdIKHLRkLkH~NII~FkGVC  181 (904)
T KOG4721|consen  116 EELWEIPFEEISELEWLGSGAQGAVFLGR--LHNETVAVKKVRE-----LK-------ETDIKHLRKLKHPNIITFKGVC  181 (904)
T ss_pred             hhhccCCHHHhhhhhhhccCcccceeeee--ccCceehhHHHhh-----hh-------hhhHHHHHhccCcceeeEeeee
Confidence            44566777778888999999999999998  4577899998752     11       1589999999999999999999


Q ss_pred             eecCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcc
Q psy9858         127 GYMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK  205 (307)
Q Consensus       127 ~~~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  205 (307)
                      .....+||||||| .|.|...++..+ .+.......|..+|+.|+.|||.+.|||||||.-||||..+..|||+|||.++
T Consensus       182 tqsPcyCIiMEfCa~GqL~~VLka~~-~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~  260 (904)
T KOG4721|consen  182 TQSPCYCIIMEFCAQGQLYEVLKAGR-PITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSK  260 (904)
T ss_pred             cCCceeEEeeeccccccHHHHHhccC-ccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchH
Confidence            9999999999999 688999888765 58899999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCcccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCC--------CChhhhccccCH
Q psy9858         206 FFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPG--------IPLNEIFTAAGD  270 (307)
Q Consensus       206 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~--------~~~~~~~~~~~~  270 (307)
                      ..... .....+.||..|||||++... ..+.++|||       .+++|+.||....-..        .....++..+++
T Consensus       261 e~~~~-STkMSFaGTVaWMAPEvIrne-PcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~  338 (904)
T KOG4721|consen  261 ELSDK-STKMSFAGTVAWMAPEVIRNE-PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPD  338 (904)
T ss_pred             hhhhh-hhhhhhhhhHhhhCHHHhhcC-CcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCch
Confidence            87543 445667999999999999998 999999999       5666999998722211        112244567899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcCc
Q psy9858         271 DLLAVISSLLCLNPTKRADCTATLKMD  297 (307)
Q Consensus       271 ~l~~li~~~l~~dP~~Rpt~~~il~hp  297 (307)
                      -++-||++||+..|..||++.|||.|-
T Consensus       339 GfklL~Kqcw~sKpRNRPSFrqil~Hl  365 (904)
T KOG4721|consen  339 GFKLLLKQCWNSKPRNRPSFRQILLHL  365 (904)
T ss_pred             HHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence            999999999999999999999999993

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.7e-39  Score=275.07  Aligned_cols=233  Identities=22%  Similarity=0.291  Sum_probs=183.6

Q ss_pred             eEEeEEeecCceEEEEEEEc----CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEE
Q psy9858          58 YQWRSVHVGRFATVFKARDI----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVS  133 (307)
Q Consensus        58 ~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  133 (307)
                      .+.+.||.|.||.||+|.+.    ..+..|+||.+...    ........+.+|++++++++||||+++++++...+..+
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~----~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~   77 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS----SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF   77 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT----SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc----cccccceeeeeccccccccccccccccccccccccccc
Confidence            46789999999999999987    45688999999532    22223577899999999999999999999999888899


Q ss_pred             EEEEcc-CCChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC
Q psy9858         134 LVFEFV-DTDLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT  211 (307)
Q Consensus       134 lv~e~~-~g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  211 (307)
                      +||||+ .|+|.+++... ...+++..+..++.||+.||.|||+++++|+||+++||+++.++.+||+|||++.......
T Consensus        78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            999999 58999999876 5568999999999999999999999999999999999999999999999999998773222


Q ss_pred             --cccccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCC-------CCChhhhccccCHHHHH
Q psy9858         212 --RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFP-------GIPLNEIFTAAGDDLLA  274 (307)
Q Consensus       212 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~-------~~~~~~~~~~~~~~l~~  274 (307)
                        ...........|+|||.+.+. .++.++|||       .+++ |+.||......       .......+..++..+.+
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKDG-EYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYS  236 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHHS-EESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHH
T ss_pred             ccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccceeccchhHHHHH
Confidence              122334567899999999888 799999999       3444 67887662111       11112233457899999


Q ss_pred             HHHHhhhcCCCCCCCHHHHhc
Q psy9858         275 VISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       275 li~~~l~~dP~~Rpt~~~il~  295 (307)
                      +|.+||+.||++|||++++++
T Consensus       237 li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  237 LIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHHT-SSGGGS--HHHHHH
T ss_pred             HHHHHcCCChhhCcCHHHHHh
Confidence            999999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.9e-38  Score=266.62  Aligned_cols=236  Identities=25%  Similarity=0.352  Sum_probs=197.3

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEE
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLV  135 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  135 (307)
                      .|...+.||+|++|.||++.+..+++.+++|++.....     .....+.+|+++++.++|+|++++++.+......+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-----EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence            47889999999999999999988999999999975322     2356788999999999999999999999999999999


Q ss_pred             EEccC-CChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCccc
Q psy9858         136 FEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY  214 (307)
Q Consensus       136 ~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  214 (307)
                      +||++ ++|.+.+......+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+........ .
T Consensus        76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~  154 (253)
T cd05122          76 MEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-R  154 (253)
T ss_pred             EecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc-c
Confidence            99995 788888877645689999999999999999999999999999999999999999999999999987754332 3


Q ss_pred             ccceeeceehhhhhhhccccccccccee---eee----ecCCCCCCCCCCC-------CChhhhcc--ccCHHHHHHHHH
Q psy9858         215 THQVVTRWYRLIKCLLYCVQFNVKNVQW---CCF----AKDPSSHGNLFPG-------IPLNEIFT--AAGDDLLAVISS  278 (307)
Q Consensus       215 ~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~----~~~~~f~~~~~~~-------~~~~~~~~--~~~~~l~~li~~  278 (307)
                      ....++..|++||.+.+. .++.++|+|   +++    .|..||.......       ........  .++..+.+++.+
T Consensus       155 ~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  233 (253)
T cd05122         155 NTMVGTPYWMAPEVINGK-PYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK  233 (253)
T ss_pred             cceecCCcccCHHHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHH
Confidence            445788899999999887 689999999   233    3888876531100       01111111  237889999999


Q ss_pred             hhhcCCCCCCCHHHHhcCcc
Q psy9858         279 LLCLNPTKRADCTATLKMDY  298 (307)
Q Consensus       279 ~l~~dP~~Rpt~~~il~hp~  298 (307)
                      ||+.||++|||+.++++|||
T Consensus       234 ~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         234 CLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HccCChhhCCCHHHHhcCCC
Confidence            99999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=5.9e-39  Score=275.13  Aligned_cols=239  Identities=21%  Similarity=0.297  Sum_probs=190.5

Q ss_pred             ccceeeEEeEEeecCceEEEEEEE----cCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARD----IETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY  128 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  128 (307)
                      ..+.|++.+.||+|+||.||+|.+    ..++..||+|.+....    .......+.+|+++++.++||||+++++++..
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   78 (283)
T cd05090           3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN----NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ   78 (283)
T ss_pred             ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC----CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec
Confidence            346799999999999999999985    3466889999987422    12224568899999999999999999999999


Q ss_pred             cCeEEEEEEcc-CCChHHHHhCC----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEe
Q psy9858         129 MSNVSLVFEFV-DTDLEVIIKDP----------------TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLIN  191 (307)
Q Consensus       129 ~~~~~lv~e~~-~g~l~~~~~~~----------------~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~  191 (307)
                      ....+++|||+ +|+|.+++...                ...+++..+..++.|++.||.|||++|++|+||||+||+++
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~  158 (283)
T cd05090          79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG  158 (283)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc
Confidence            99999999999 57888887532                12367888999999999999999999999999999999999


Q ss_pred             cCCcEEEEeecCccccCCCC--cccccceeeceehhhhhhhccccccccccee---e----eee-cCCCCCCCCCC----
Q psy9858         192 KQGVLKIGDFGLAKFFGSPT--RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPSSHGNLFP----  257 (307)
Q Consensus       192 ~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~f~~~~~~----  257 (307)
                      .++.++|+|||++.......  .......++..|+|||.+.+. .++.++|+|   +    +++ |..||.+....    
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~  237 (283)
T cd05090         159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG-KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE  237 (283)
T ss_pred             CCCcEEeccccccccccCCcceecccCCCccceecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            99999999999998653321  112233456789999999877 789999999   2    333 77888652211    


Q ss_pred             ---CCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         258 ---GIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       258 ---~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                         .......+..+++.+.+++.+||+.||++||++.+++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         238 MVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence               011112334578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-39  Score=272.08  Aligned_cols=235  Identities=25%  Similarity=0.326  Sum_probs=187.0

Q ss_pred             eEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHH-HhcCCCCccccceeeeecCeEEEEEEcc
Q psy9858          61 RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLL-QELHHENVLGLTDVFGYMSNVSLVFEFV  139 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~ni~~~~~~~~~~~~~~lv~e~~  139 (307)
                      +.||+|++|.||+|.+..+|+.||+|++.+.....  ......+..|..++ ...+|+|++++++++...+..+++|||+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   79 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIA--KNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYL   79 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhH--HHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEecc
Confidence            56899999999999998999999999987532211  11123344555544 4458999999999999999999999999


Q ss_pred             -CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcccccce
Q psy9858         140 -DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQV  218 (307)
Q Consensus       140 -~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  218 (307)
                       +++|.+++.... .+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....    .....
T Consensus        80 ~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~  154 (260)
T cd05611          80 NGGDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFV  154 (260)
T ss_pred             CCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----cccCC
Confidence             577888776543 589999999999999999999999999999999999999999999999999876532    22346


Q ss_pred             eeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCC----------ChhhhccccCHHHHHHHHHhhh
Q psy9858         219 VTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGI----------PLNEIFTAAGDDLLAVISSLLC  281 (307)
Q Consensus       219 ~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~  281 (307)
                      ++..|+|||.+.+. .++.++|+|   +    ++.|..||........          ........+++.+.+++.+||+
T Consensus       155 ~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  233 (260)
T cd05611         155 GTPDYLAPETILGV-GDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLC  233 (260)
T ss_pred             CCcCccChhhhcCC-CCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHcc
Confidence            78899999999887 689999999   2    3338999876322110          0111223578999999999999


Q ss_pred             cCCCCCCC---HHHHhcCcccCCCc
Q psy9858         282 LNPTKRAD---CTATLKMDYFSLTK  303 (307)
Q Consensus       282 ~dP~~Rpt---~~~il~hp~f~~~~  303 (307)
                      .||.+|||   ++|+++||||++.+
T Consensus       234 ~~p~~R~~~~~~~~~l~~~~~~~~~  258 (260)
T cd05611         234 MDPAKRLGANGYQEIKSHPFFKSIN  258 (260)
T ss_pred             CCHHHccCCCcHHHHHcChHhhcCC
Confidence            99999995   58999999998765

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.1e-38  Score=269.15  Aligned_cols=238  Identities=24%  Similarity=0.384  Sum_probs=197.8

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEE
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLV  135 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  135 (307)
                      +|++.+.||+|++|.||++.+..+++.+|+|.+......   ......+.+|+++++.++|+||+++++++.+....+++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS---QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIV   77 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc---HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEE
Confidence            588999999999999999999999999999998754322   22245677899999999999999999999999999999


Q ss_pred             EEcc-CCChHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC
Q psy9858         136 FEFV-DTDLEVIIKDP---TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT  211 (307)
Q Consensus       136 ~e~~-~g~l~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  211 (307)
                      |||+ +++|.+++.+.   ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            9999 56788877552   235789999999999999999999999999999999999999999999999999877543 


Q ss_pred             cccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCC-------CCChhhhccccCHHHHHHHH
Q psy9858         212 RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFP-------GIPLNEIFTAAGDDLLAVIS  277 (307)
Q Consensus       212 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~-------~~~~~~~~~~~~~~l~~li~  277 (307)
                       ......++..|++||.+.+. .++.++|+|       .+++|..||......       ..........++.++.+++.
T Consensus       157 -~~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  234 (256)
T cd08530         157 -MAKTQIGTPHYMAPEVWKGR-PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIR  234 (256)
T ss_pred             -CcccccCCccccCHHHHCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHH
Confidence             22334678899999999876 788999999       233388888763321       11112233457889999999


Q ss_pred             HhhhcCCCCCCCHHHHhcCccc
Q psy9858         278 SLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       278 ~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                      +||+.+|++|||+.++++||++
T Consensus       235 ~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         235 SMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHcCCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=8.3e-39  Score=273.67  Aligned_cols=236  Identities=18%  Similarity=0.220  Sum_probs=189.6

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCc----EEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDM----IVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM  129 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  129 (307)
                      .++|++++.||+|+||+||+|++..+|.    .||+|++....    .......+.+|+.+++.++|+||+++++++.. 
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-   80 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT----SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-   80 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC----CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-
Confidence            4679999999999999999999877776    48999986432    22234568899999999999999999998864 


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                      ...++++||+ .|+|.+++......+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||+++...
T Consensus        81 ~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          81 STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence            4578999999 688999988766678999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCcc--cccceeeceehhhhhhhccccccccccee---ee----ee-cCCCCCCCCC-------CCCChhhhccccCHH
Q psy9858         209 SPTRL--YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FA-KDPSSHGNLF-------PGIPLNEIFTAAGDD  271 (307)
Q Consensus       209 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~-~~~~f~~~~~-------~~~~~~~~~~~~~~~  271 (307)
                      .....  .....++..|+|||.+.+. .++.++|||   ++    ++ |..||.....       ........+..++.+
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTID  239 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHH
Confidence            32221  1222346789999999877 789999999   32    33 7788765221       111111223457889


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         272 LLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       272 l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      +.+++.+||+.||++|||+.++++
T Consensus       240 ~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         240 VYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=7.2e-39  Score=277.29  Aligned_cols=238  Identities=21%  Similarity=0.271  Sum_probs=187.1

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcE--EEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeeec
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMI--VAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGYM  129 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~  129 (307)
                      ..++|++.+.||+|+||.||+|.+..++..  +|+|.+...    ........+.+|++++.++ +|+||+++++++...
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~   80 (303)
T cd05088           5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   80 (303)
T ss_pred             chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc----CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC
Confidence            356899999999999999999998777764  466665432    1222345688899999999 899999999999999


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecC
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPT---------------IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ  193 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~  193 (307)
                      +..+++|||+ +|+|.+++....               ..+++..++.++.||+.||+|||++|++||||||+||+++.+
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~  160 (303)
T cd05088          81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN  160 (303)
T ss_pred             CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence            9999999999 688988886432               247889999999999999999999999999999999999999


Q ss_pred             CcEEEEeecCccccCCCCcccccceeeceehhhhhhhccccccccccee---e----eee-cCCCCCCCCCCC-------
Q psy9858         194 GVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPSSHGNLFPG-------  258 (307)
Q Consensus       194 ~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~f~~~~~~~-------  258 (307)
                      +.++|+|||++...... ........+..|+|||.+.+. .++.++|||   +    +++ |..||.+.....       
T Consensus       161 ~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~  238 (303)
T cd05088         161 YVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  238 (303)
T ss_pred             CcEEeCccccCcccchh-hhcccCCCcccccCHHHHhcc-CCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc
Confidence            99999999998643211 111112345679999998776 789999999   2    332 788886532111       


Q ss_pred             CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         259 IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       259 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      ......+..+++++.+|+.+||+.||++|||+++++++
T Consensus       239 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         239 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            10111223467899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=8.9e-39  Score=270.15  Aligned_cols=235  Identities=21%  Similarity=0.258  Sum_probs=189.2

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEE
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVS  133 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  133 (307)
                      .++|++.+.||+|+||.||+|.+. .+..||+|.+.....      ....+.+|++++++++||||+++++++......+
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   75 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM------SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIY   75 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcc------cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcE
Confidence            457999999999999999999864 455699998864321      1345889999999999999999999999889999


Q ss_pred             EEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc
Q psy9858         134 LVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR  212 (307)
Q Consensus       134 lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  212 (307)
                      ++|||+ +|+|.+++......+++..+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||.++.......
T Consensus        76 lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~  155 (256)
T cd05113          76 IVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY  155 (256)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence            999999 6789988876555689999999999999999999999999999999999999999999999999986643321


Q ss_pred             c-cccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCCC-------CChhhhccccCHHHHHHH
Q psy9858         213 L-YTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFPG-------IPLNEIFTAAGDDLLAVI  276 (307)
Q Consensus       213 ~-~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~~-------~~~~~~~~~~~~~l~~li  276 (307)
                      . .....++..|+|||.+.+. .++.++|+|       .+++ |..||.......       ..........+..+.+++
T Consensus       156 ~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  234 (256)
T cd05113         156 TSSVGSKFPVRWSPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIM  234 (256)
T ss_pred             eecCCCccChhhCCHHHHhcC-cccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence            1 1122345689999999877 789999999       2333 778876522110       011111234578999999


Q ss_pred             HHhhhcCCCCCCCHHHHhcC
Q psy9858         277 SSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       277 ~~~l~~dP~~Rpt~~~il~h  296 (307)
                      .+||+.||.+|||+.+++++
T Consensus       235 ~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         235 YSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHcCCCcccCCCHHHHHHh
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=4.2e-39  Score=275.49  Aligned_cols=237  Identities=22%  Similarity=0.294  Sum_probs=190.9

Q ss_pred             cceeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDI-----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY  128 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  128 (307)
                      .++|.+.+.||+|+||.||+|.+.     .++..||+|++....    .....+.+.+|+++++.++|+||+++++++..
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   79 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA----SNDARKDFEREAELLTNFQHENIVKFYGVCTE   79 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC----CHHHHHHHHHHHHHHHhcCCCCchheeeEEec
Confidence            457899999999999999999864     346789999987432    22234678899999999999999999999999


Q ss_pred             cCeEEEEEEcc-CCChHHHHhCCC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCC
Q psy9858         129 MSNVSLVFEFV-DTDLEVIIKDPT-------------IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG  194 (307)
Q Consensus       129 ~~~~~lv~e~~-~g~l~~~~~~~~-------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~  194 (307)
                      ....+++|||+ +|+|.+++....             ..+++..+..++.||+.||.+||++|++|+||||+||+++.++
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~  159 (280)
T cd05049          80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL  159 (280)
T ss_pred             CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC
Confidence            99999999999 688888886432             2478889999999999999999999999999999999999999


Q ss_pred             cEEEEeecCccccCCCCc--ccccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCCC------
Q psy9858         195 VLKIGDFGLAKFFGSPTR--LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFPG------  258 (307)
Q Consensus       195 ~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~~------  258 (307)
                      .++|+|||++........  ......++..|+|||.+.+. .++.++|||       .+++ |..||.+.....      
T Consensus       160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~  238 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT  238 (280)
T ss_pred             eEEECCcccceecccCcceecCCCCcccceecChhhhccC-CcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            999999999976532221  12233457789999999887 799999999       2333 888876522111      


Q ss_pred             -CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         259 -IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       259 -~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                       ......+..++..+.+++.+||+.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         239 QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence             1111223457899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.2e-39  Score=283.24  Aligned_cols=240  Identities=20%  Similarity=0.271  Sum_probs=187.9

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCcccccee
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDI-----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDV  125 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~  125 (307)
                      .+.++|++++.||+|+||.||+|.+.     .+++.||+|++....    .....+.+.+|++++.++ +|+||++++++
T Consensus         4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~E~~~~~~l~~h~niv~~~~~   79 (337)
T cd05054           4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA----TASEYKALMTELKILIHIGHHLNVVNLLGA   79 (337)
T ss_pred             cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC----CHHHHHHHHHHHHHHHhhccCcchhheeee
Confidence            34568999999999999999999743     345789999986422    112245677899999999 79999999998


Q ss_pred             eee-cCeEEEEEEcc-CCChHHHHhCCC----------------------------------------------------
Q psy9858         126 FGY-MSNVSLVFEFV-DTDLEVIIKDPT----------------------------------------------------  151 (307)
Q Consensus       126 ~~~-~~~~~lv~e~~-~g~l~~~~~~~~----------------------------------------------------  151 (307)
                      +.. +...+++|||+ +|+|.+++....                                                    
T Consensus        80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (337)
T cd05054          80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED  159 (337)
T ss_pred             EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence            754 46789999999 678888775321                                                    


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc--ccccceeec
Q psy9858         152 --------IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR--LYTHQVVTR  221 (307)
Q Consensus       152 --------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~  221 (307)
                              ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++........  ......++.
T Consensus       160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~  239 (337)
T cd05054         160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL  239 (337)
T ss_pred             hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence                    2478889999999999999999999999999999999999999999999999987632211  112234567


Q ss_pred             eehhhhhhhccccccccccee---ee----ee-cCCCCCCCCCCCC--------ChhhhccccCHHHHHHHHHhhhcCCC
Q psy9858         222 WYRLIKCLLYCVQFNVKNVQW---CC----FA-KDPSSHGNLFPGI--------PLNEIFTAAGDDLLAVISSLLCLNPT  285 (307)
Q Consensus       222 ~y~aPE~~~~~~~~~~~~Diw---~i----~~-~~~~f~~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dP~  285 (307)
                      .|+|||.+.+. .++.++|||   |+    +. |..||.+......        .....+...++++.+++.+||+.+|+
T Consensus       240 ~y~aPE~~~~~-~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~  318 (337)
T cd05054         240 KWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPE  318 (337)
T ss_pred             cccCcHHhcCC-CCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChh
Confidence            89999999887 899999999   33    32 8888876322110        11112235678999999999999999


Q ss_pred             CCCCHHHHhcC
Q psy9858         286 KRADCTATLKM  296 (307)
Q Consensus       286 ~Rpt~~~il~h  296 (307)
                      +|||++++++|
T Consensus       319 ~RPs~~ell~~  329 (337)
T cd05054         319 DRPTFSELVEI  329 (337)
T ss_pred             hCcCHHHHHHH
Confidence            99999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.4e-38  Score=270.54  Aligned_cols=237  Identities=19%  Similarity=0.244  Sum_probs=190.9

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCC---cEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETD---MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS  130 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  130 (307)
                      ..+|++.+.||+|+||.||+|.+..++   ..+|+|.+....    .......+.+|+.+++.++||||+++++++..++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY----TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSK   78 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            467999999999999999999876444   379999886432    1222457889999999999999999999999999


Q ss_pred             eEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCC
Q psy9858         131 NVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS  209 (307)
Q Consensus       131 ~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  209 (307)
                      ..+++|||+ +|+|.+++......++..++..++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          79 PVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             ccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            999999999 5789998887666789999999999999999999999999999999999999999999999999987643


Q ss_pred             CCccc---ccceeeceehhhhhhhccccccccccee---e----eee-cCCCCCCCCCC-------CCChhhhccccCHH
Q psy9858         210 PTRLY---THQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPSSHGNLFP-------GIPLNEIFTAAGDD  271 (307)
Q Consensus       210 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~f~~~~~~-------~~~~~~~~~~~~~~  271 (307)
                      .....   ....++..|+|||.+.+. .++.++|+|   +    ++. |..||......       ..........+++.
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAA  237 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccC-ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHH
Confidence            22111   112235689999999887 789999999   2    232 88888653211       00111222356889


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         272 LLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       272 l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      +.+++.+||+.+|.+|||+.++++
T Consensus       238 ~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         238 LHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             HHHHHHHHcccCchhCCCHHHHHH
Confidence            999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-38  Score=270.94  Aligned_cols=239  Identities=18%  Similarity=0.203  Sum_probs=191.2

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCC-----CcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeee
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIET-----DMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG  127 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~  127 (307)
                      ..++|.+.+.||+|+||.||+|.+...     +..||+|.+....    .......+.+|+.+++.++|+||+++++++.
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   79 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA----SMRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence            457899999999999999999987643     4789999986432    2222456889999999999999999999999


Q ss_pred             ecCeEEEEEEcc-CCChHHHHhCCC---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEE
Q psy9858         128 YMSNVSLVFEFV-DTDLEVIIKDPT---------IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLK  197 (307)
Q Consensus       128 ~~~~~~lv~e~~-~g~l~~~~~~~~---------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~k  197 (307)
                      .....+++|||+ +|+|.+++....         ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k  159 (277)
T cd05032          80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK  159 (277)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence            999999999999 688988886422         2367788999999999999999999999999999999999999999


Q ss_pred             EEeecCccccCCCCc--ccccceeeceehhhhhhhccccccccccee---e----eee-cCCCCCCCCCC-------CCC
Q psy9858         198 IGDFGLAKFFGSPTR--LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPSSHGNLFP-------GIP  260 (307)
Q Consensus       198 l~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~f~~~~~~-------~~~  260 (307)
                      |+|||+++.......  ......++..|+|||.+.+. .++.++|||   +    +++ |..||.+....       ...
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~  238 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG  238 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHHhcC-CCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCC
Confidence            999999986643221  12233457889999998877 789999999   2    333 77888652211       111


Q ss_pred             hhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         261 LNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       261 ~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      ....+..++.++.+++.+||+.+|++|||+.++++.
T Consensus       239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~  274 (277)
T cd05032         239 HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSS  274 (277)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            122334568999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=9.6e-39  Score=273.02  Aligned_cols=239  Identities=18%  Similarity=0.231  Sum_probs=191.0

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcC-----CCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeee
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIE-----TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG  127 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~  127 (307)
                      ..++|.+.+.||+|++|.||+|.+..     ++..||+|.+....    .......+.+|+.+++.++|+||+++++++.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   79 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC----SEQDESDFLMEALIMSKFNHQNIVRLIGVSF   79 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            34679999999999999999999876     77889999886422    2222456889999999999999999999998


Q ss_pred             ecCeEEEEEEcc-CCChHHHHhCCC------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCC---cEE
Q psy9858         128 YMSNVSLVFEFV-DTDLEVIIKDPT------IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG---VLK  197 (307)
Q Consensus       128 ~~~~~~lv~e~~-~g~l~~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~---~~k  197 (307)
                      +....+++|||+ +|+|.+++....      ..+++..+..++.||+.||.|||++|++|+||||+||+++.++   .++
T Consensus        80 ~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~k  159 (277)
T cd05036          80 ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAK  159 (277)
T ss_pred             cCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceE
Confidence            889999999999 678988886543      2478899999999999999999999999999999999998765   589


Q ss_pred             EEeecCccccCCCCcc--cccceeeceehhhhhhhccccccccccee---ee----ee-cCCCCCCCCCCC-------CC
Q psy9858         198 IGDFGLAKFFGSPTRL--YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FA-KDPSSHGNLFPG-------IP  260 (307)
Q Consensus       198 l~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~-~~~~f~~~~~~~-------~~  260 (307)
                      |+|||+++........  ......+..|+|||.+.+. .++.++|||   ++    ++ |..||.+.....       ..
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~  238 (277)
T cd05036         160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG-IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG  238 (277)
T ss_pred             eccCccccccCCccceecCCCCCccHhhCCHHHHhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence            9999999876322111  1122335689999999887 799999999   33    32 888887632211       01


Q ss_pred             hhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         261 LNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       261 ~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      ....+..++..+.+++.+||+.||++|||+.++++|
T Consensus       239 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         239 RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            112234578899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.7e-39  Score=270.50  Aligned_cols=235  Identities=19%  Similarity=0.215  Sum_probs=189.5

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEE
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVS  133 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  133 (307)
                      ..+|++.+.||+|+||.||+|.+. ++..+|+|++.....      ....+.+|+++++.++|+||+++++++...+..+
T Consensus         3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (256)
T cd05059           3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM------SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIF   75 (256)
T ss_pred             hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC------CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceE
Confidence            356889999999999999999875 566799999864321      1345778999999999999999999999999999


Q ss_pred             EEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc
Q psy9858         134 LVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR  212 (307)
Q Consensus       134 lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  212 (307)
                      ++|||+ +++|.+++......+++..+..++.||+.||+|||+.|++|+||||+||+++.++.++|+|||+++...+...
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~  155 (256)
T cd05059          76 IVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY  155 (256)
T ss_pred             EEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence            999999 6789998876655789999999999999999999999999999999999999999999999999986643221


Q ss_pred             cc-ccceeeceehhhhhhhccccccccccee---e----eee-cCCCCCCCCCCC-------CChhhhccccCHHHHHHH
Q psy9858         213 LY-THQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPSSHGNLFPG-------IPLNEIFTAAGDDLLAVI  276 (307)
Q Consensus       213 ~~-~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~f~~~~~~~-------~~~~~~~~~~~~~l~~li  276 (307)
                      .. ....++..|+|||.+.+. .++.++|+|   +    +++ |..||.......       ......+..++.++.+++
T Consensus       156 ~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  234 (256)
T cd05059         156 TSSQGTKFPVKWAPPEVFDYS-RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIM  234 (256)
T ss_pred             cccCCCCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHH
Confidence            11 111234579999999887 789999999   2    233 788886532111       001112235789999999


Q ss_pred             HHhhhcCCCCCCCHHHHhcC
Q psy9858         277 SSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       277 ~~~l~~dP~~Rpt~~~il~h  296 (307)
                      .+||+.+|++|||++++++.
T Consensus       235 ~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         235 YSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHhcCChhhCcCHHHHHHH
Confidence            99999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.5e-38  Score=273.38  Aligned_cols=236  Identities=22%  Similarity=0.290  Sum_probs=189.3

Q ss_pred             cceeeEEeEEeecCceEEEEEEE-----cCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARD-----IETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY  128 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  128 (307)
                      .++|.+.+.||+|+||+||++.+     ..++..+|+|.+...     .....+.+.+|++++++++|+||+++++++..
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   78 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-----SDNARKDFHREAELLTNLQHEHIVKFYGVCVE   78 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc-----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            45799999999999999999985     234567999988642     12234568899999999999999999999999


Q ss_pred             cCeEEEEEEcc-CCChHHHHhCCC------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCc
Q psy9858         129 MSNVSLVFEFV-DTDLEVIIKDPT------------IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGV  195 (307)
Q Consensus       129 ~~~~~lv~e~~-~g~l~~~~~~~~------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~  195 (307)
                      .+..+++|||+ +++|.+++....            ..+++..+..++.|++.||+|||++|++||||||+||+++.++.
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~  158 (288)
T cd05093          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL  158 (288)
T ss_pred             CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence            99999999999 588888886432            24899999999999999999999999999999999999999999


Q ss_pred             EEEEeecCccccCCCCc--ccccceeeceehhhhhhhccccccccccee---e----eee-cCCCCCCCCCCC-------
Q psy9858         196 LKIGDFGLAKFFGSPTR--LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPSSHGNLFPG-------  258 (307)
Q Consensus       196 ~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~f~~~~~~~-------  258 (307)
                      ++|+|||++........  ......++..|+|||.+.+. .++.++|+|   +    +++ |..||.......       
T Consensus       159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~  237 (288)
T cd05093         159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ  237 (288)
T ss_pred             EEeccCCccccccCCceeecCCCCCccccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            99999999986643221  12223456789999999877 889999999   2    333 788886632111       


Q ss_pred             CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         259 IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       259 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      .........++.++.+|+.+||+.||.+|||++++++
T Consensus       238 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         238 GRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            1111223457889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-38  Score=268.72  Aligned_cols=231  Identities=23%  Similarity=0.305  Sum_probs=192.0

Q ss_pred             eEEeecCceEEEEEEEcCC---CcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEEE
Q psy9858          61 RSVHVGRFATVFKARDIET---DMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFE  137 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  137 (307)
                      +.||+|+||.||+|.+...   +..|++|++.......    ....+.+|+++++.++|+||+++++++......+++||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   76 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE----ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLE   76 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh----HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEE
Confidence            4689999999999998766   8999999987542221    35678899999999999999999999999999999999


Q ss_pred             cc-CCChHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         138 FV-DTDLEVIIKDP--------TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       138 ~~-~g~l~~~~~~~--------~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                      |+ +++|.+++...        ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus        77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  156 (262)
T cd00192          77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY  156 (262)
T ss_pred             eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccc
Confidence            99 78899998775        4568999999999999999999999999999999999999999999999999998875


Q ss_pred             CCC--cccccceeeceehhhhhhhccccccccccee---eee----e-cCCCCCCCCCCC-------CChhhhccccCHH
Q psy9858         209 SPT--RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCF----A-KDPSSHGNLFPG-------IPLNEIFTAAGDD  271 (307)
Q Consensus       209 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~----~-~~~~f~~~~~~~-------~~~~~~~~~~~~~  271 (307)
                      ...  .......++..|+|||.+... .++.++|||   +++    + |..||.......       ......+..++.+
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (262)
T cd00192         157 DDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDE  235 (262)
T ss_pred             cccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChH
Confidence            432  223344568899999999887 899999999   333    3 688887632111       1112233457899


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         272 LLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       272 l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      +.+++.+||..||.+|||++|++++
T Consensus       236 ~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         236 LYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             HHHHHHHHccCCcccCcCHHHHHHh
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2e-38  Score=268.59  Aligned_cols=235  Identities=18%  Similarity=0.232  Sum_probs=190.2

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|+++++||+|++|.||+|.+ .++..||+|.+.....      ..+.+.+|+.+++.++|+||+++++.+...+..
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   76 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTM------SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPI   76 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCch------hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence            457899999999999999999985 4667899998764211      145688999999999999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      +++|||+ +|+|.+++.+. ...++...+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05072          77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN  156 (261)
T ss_pred             EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence            9999999 68899888653 345788899999999999999999999999999999999999999999999999876432


Q ss_pred             Ccc-cccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCCC-------CChhhhccccCHHHHH
Q psy9858         211 TRL-YTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFPG-------IPLNEIFTAAGDDLLA  274 (307)
Q Consensus       211 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~~-------~~~~~~~~~~~~~l~~  274 (307)
                      ... .....++..|+|||.+.+. .++.++|+|       .+++ |..||.......       .........++.++.+
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (261)
T cd05072         157 EYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYD  235 (261)
T ss_pred             ceeccCCCccceecCCHHHhccC-CCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence            211 1223456789999998876 789999999       2333 888886521110       1111222457889999


Q ss_pred             HHHHhhhcCCCCCCCHHHHhc
Q psy9858         275 VISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       275 li~~~l~~dP~~Rpt~~~il~  295 (307)
                      ++.+||+.||++|||++++++
T Consensus       236 li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         236 IMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHHccCCcccCcCHHHHHH
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.3e-38  Score=273.15  Aligned_cols=238  Identities=18%  Similarity=0.234  Sum_probs=189.0

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCC----------------cEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCC
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETD----------------MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH  116 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~----------------~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h  116 (307)
                      ..++|++++.||+|+||.||+|.+...+                ..||+|.+....    .......+.+|++++++++|
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~e~~~l~~l~~   78 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA----SDNAREDFLKEVKILSRLSD   78 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc----CHHHHHHHHHHHHHHHhcCC
Confidence            3468999999999999999999866533                568999987532    12235678899999999999


Q ss_pred             CCccccceeeeecCeEEEEEEcc-CCChHHHHhCCC----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCC
Q psy9858         117 ENVLGLTDVFGYMSNVSLVFEFV-DTDLEVIIKDPT----------IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP  185 (307)
Q Consensus       117 ~ni~~~~~~~~~~~~~~lv~e~~-~g~l~~~~~~~~----------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp  185 (307)
                      |||+++++++..+...+++||++ +++|.+++....          ..+++..+..++.|++.||.|||+.|++|+||||
T Consensus        79 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp  158 (296)
T cd05051          79 PNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLAT  158 (296)
T ss_pred             CCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccch
Confidence            99999999999999999999999 578888876543          2478999999999999999999999999999999


Q ss_pred             CcEEEecCCcEEEEeecCccccCCCCc--ccccceeeceehhhhhhhccccccccccee---eeee------cCCCCCCC
Q psy9858         186 NNLLINKQGVLKIGDFGLAKFFGSPTR--LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA------KDPSSHGN  254 (307)
Q Consensus       186 ~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~------~~~~f~~~  254 (307)
                      +||+++.++.++|+|||++........  ......++..|+|||.+.+. .++.++|||   ++++      +..||...
T Consensus       159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p~~~~  237 (296)
T cd05051         159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEILTLCREQPYEHL  237 (296)
T ss_pred             hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-CCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence            999999999999999999986543221  12233456789999999887 789999999   3322      66676552


Q ss_pred             CCCC--------------CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         255 LFPG--------------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       255 ~~~~--------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      ....              ......+..++.++.+++.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         238 TDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             ChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            2111              0111122346789999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.6e-38  Score=271.92  Aligned_cols=236  Identities=16%  Similarity=0.245  Sum_probs=186.9

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCc----EEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDM----IVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM  129 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  129 (307)
                      .++|++++.||+|+||+||+|.+..+++    .|++|.+...    ........+..|+.++++++||||+++++++. .
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~   80 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR----SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G   80 (279)
T ss_pred             HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc----cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence            3578999999999999999999877776    4677776421    12222456778888999999999999999875 4


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                      ...++++||+ +|+|.+++......+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||+++...
T Consensus        81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            5678899999 689999998766678999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCc--ccccceeeceehhhhhhhccccccccccee---e----eee-cCCCCCCCCCCC-------CChhhhccccCHH
Q psy9858         209 SPTR--LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPSSHGNLFPG-------IPLNEIFTAAGDD  271 (307)
Q Consensus       209 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~f~~~~~~~-------~~~~~~~~~~~~~  271 (307)
                      ....  ......++..|+|||.+.+. .++.++|||   +    +++ |..||.+.....       ......+..++.+
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFG-RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTID  239 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHH
Confidence            3221  12233466789999999877 789999999   2    333 888887632111       1111112345778


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         272 LLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       272 l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      +.+++.+||..||++|||+.++++
T Consensus       240 ~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         240 VYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHHH
Confidence            999999999999999999999987

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.1e-38  Score=275.69  Aligned_cols=234  Identities=18%  Similarity=0.177  Sum_probs=182.0

Q ss_pred             CceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEEEcc-CCChHH
Q psy9858          67 RFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFV-DTDLEV  145 (307)
Q Consensus        67 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~-~g~l~~  145 (307)
                      +++.||.+++..+++.||+|++....   ........+.+|+++++.++|+||+++++++......+++|||+ .|++.+
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   88 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDS---CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED   88 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccc---cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHH
Confidence            44556666666799999999997532   12223567889999999999999999999999999999999999 577888


Q ss_pred             HHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc-------ccccc
Q psy9858         146 IIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR-------LYTHQ  217 (307)
Q Consensus       146 ~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-------~~~~~  217 (307)
                      ++... ...+++..+..++.|++.||+|||++||+|+||||+||+++.++.++|+|||.+........       .....
T Consensus        89 ~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~  168 (314)
T cd08216          89 LLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSS  168 (314)
T ss_pred             HHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccc
Confidence            87753 33588999999999999999999999999999999999999999999999999875532211       12233


Q ss_pred             eeeceehhhhhhhcc-ccccccccee-------eeeecCCCCCCCCCCCCC-----------------------------
Q psy9858         218 VVTRWYRLIKCLLYC-VQFNVKNVQW-------CCFAKDPSSHGNLFPGIP-----------------------------  260 (307)
Q Consensus       218 ~~t~~y~aPE~~~~~-~~~~~~~Diw-------~i~~~~~~f~~~~~~~~~-----------------------------  260 (307)
                      .++..|+|||.+.+. ..++.++|+|       .++.|..||.........                             
T Consensus       169 ~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
T cd08216         169 VKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRS  248 (314)
T ss_pred             cccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccc
Confidence            567789999998764 2588999999       233388898752110000                             


Q ss_pred             -----------hhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         261 -----------LNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       261 -----------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                                 .......++.++.+|+.+||+.||++|||++++|+||||+..+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         249 SNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             cccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence                       0000112346788999999999999999999999999999874

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=6.6e-39  Score=274.79  Aligned_cols=238  Identities=18%  Similarity=0.260  Sum_probs=189.1

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcC-----CCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIE-----TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY  128 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  128 (307)
                      ..+|++.+.||+|+||.||+|.+..     .++.||+|++....    .......+.+|+.++..++||||+++++++..
T Consensus         4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~   79 (283)
T cd05091           4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA----EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK   79 (283)
T ss_pred             HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC----CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence            4568889999999999999998754     35789999987432    22234568899999999999999999999999


Q ss_pred             cCeEEEEEEcc-CCChHHHHhCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEec
Q psy9858         129 MSNVSLVFEFV-DTDLEVIIKDP---------------TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK  192 (307)
Q Consensus       129 ~~~~~lv~e~~-~g~l~~~~~~~---------------~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~  192 (307)
                      ....++++||+ .++|.+++...               ...+++..+..++.|++.||.|||++|++||||||+||++++
T Consensus        80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~  159 (283)
T cd05091          80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD  159 (283)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence            99999999999 57787777421               224788889999999999999999999999999999999999


Q ss_pred             CCcEEEEeecCccccCCCCc--ccccceeeceehhhhhhhccccccccccee---e----eee-cCCCCCCCCCC-----
Q psy9858         193 QGVLKIGDFGLAKFFGSPTR--LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPSSHGNLFP-----  257 (307)
Q Consensus       193 ~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~f~~~~~~-----  257 (307)
                      ++.+||+|||+++.......  ......+++.|+|||.+.+. .++.++|||   +    +++ |..||.+....     
T Consensus       160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05091         160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM  238 (283)
T ss_pred             CCceEecccccccccccchheeeccCccCCccccCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            99999999999886543221  12233456789999999877 789999999   2    333 77777662111     


Q ss_pred             --CCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         258 --GIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       258 --~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                        ..........++..+.+|+.+||+.+|.+|||++++++.
T Consensus       239 i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         239 IRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence              111122334678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=4.7e-38  Score=270.51  Aligned_cols=246  Identities=19%  Similarity=0.226  Sum_probs=196.7

Q ss_pred             eeeEEeEEeecCceEEEEEEEc---CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeeecCe
Q psy9858          56 VYYQWRSVHVGRFATVFKARDI---ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGYMSN  131 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~  131 (307)
                      +|++.+.||.|+||.||+|++.   .+|..||+|++...... ......+.+.+|+++++.+ +|+||+++++.+..+..
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIV-QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTK   79 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhh-hcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCe
Confidence            4889999999999999999874   47899999998753211 1122245677899999999 59999999999999999


Q ss_pred             EEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         132 VSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       132 ~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      .++||||+ +++|.+++.... .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++......
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  158 (290)
T cd05613          80 LHLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED  158 (290)
T ss_pred             EEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence            99999999 578888887654 4789999999999999999999999999999999999999999999999999876432


Q ss_pred             C-cccccceeeceehhhhhhhcc-ccccccccee-------eeeecCCCCCCCCCCCCC----------hhhhccccCHH
Q psy9858         211 T-RLYTHQVVTRWYRLIKCLLYC-VQFNVKNVQW-------CCFAKDPSSHGNLFPGIP----------LNEIFTAAGDD  271 (307)
Q Consensus       211 ~-~~~~~~~~t~~y~aPE~~~~~-~~~~~~~Diw-------~i~~~~~~f~~~~~~~~~----------~~~~~~~~~~~  271 (307)
                      . .......++..|+|||.+.+. ..++.++|||       .+++|..||.........          ....+..+++.
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (290)
T cd05613         159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL  238 (290)
T ss_pred             cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHH
Confidence            1 112234678899999998764 2467899999       344488888642211110          11123456788


Q ss_pred             HHHHHHHhhhcCCCCCC-----CHHHHhcCcccCCCc
Q psy9858         272 LLAVISSLLCLNPTKRA-----DCTATLKMDYFSLTK  303 (307)
Q Consensus       272 l~~li~~~l~~dP~~Rp-----t~~~il~hp~f~~~~  303 (307)
                      +.+++.+||+.||.+||     +++++++||||+...
T Consensus       239 ~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  275 (290)
T cd05613         239 AKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN  275 (290)
T ss_pred             HHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence            99999999999999997     899999999998875

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3e-38  Score=273.32  Aligned_cols=242  Identities=18%  Similarity=0.281  Sum_probs=192.9

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEE-----cCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCcccc
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARD-----IETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGL  122 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~  122 (307)
                      .+....++|.+.+.||+|+||.||+|.+     ..++..||+|++....    .......+.+|+++++++ +|+||+++
T Consensus        29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~iv~~  104 (302)
T cd05055          29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA----HSSEREALMSELKIMSHLGNHENIVNL  104 (302)
T ss_pred             cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC----ChHHHHHHHHHHHHHHhccCCCCcceE
Confidence            3445567899999999999999999975     2356689999987432    122245688999999999 79999999


Q ss_pred             ceeeeecCeEEEEEEcc-CCChHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEe
Q psy9858         123 TDVFGYMSNVSLVFEFV-DTDLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGD  200 (307)
Q Consensus       123 ~~~~~~~~~~~lv~e~~-~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~D  200 (307)
                      ++.+...+..+++|||+ +|+|.+++.... ..+++.++..++.||+.||.|||++|++|+||||+||+++.++.++|+|
T Consensus       105 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~d  184 (302)
T cd05055         105 LGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICD  184 (302)
T ss_pred             EEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECC
Confidence            99999999999999999 588998887543 3379999999999999999999999999999999999999999999999


Q ss_pred             ecCccccCCCCc--ccccceeeceehhhhhhhccccccccccee---ee----ee-cCCCCCCCCCCCC--------Chh
Q psy9858         201 FGLAKFFGSPTR--LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FA-KDPSSHGNLFPGI--------PLN  262 (307)
Q Consensus       201 fg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~-~~~~f~~~~~~~~--------~~~  262 (307)
                      ||++........  ......++..|+|||.+.+. .++.++|||   ++    ++ |..||.+......        ...
T Consensus       185 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~  263 (302)
T cd05055         185 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM  263 (302)
T ss_pred             CcccccccCCCceeecCCCCcccccCCHhhhccC-CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC
Confidence            999986643221  11122456789999999887 789999999   22    33 7888866332211        011


Q ss_pred             hhccccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         263 EIFTAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       263 ~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      ......++++.+++.+||+.+|++|||+.++++
T Consensus       264 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         264 AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            122346889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.1e-38  Score=272.61  Aligned_cols=236  Identities=19%  Similarity=0.235  Sum_probs=186.6

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCc--EEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeeecCe
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDM--IVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGYMSN  131 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~  131 (307)
                      ++|++.+.||+|+||.||+|....++.  .+++|.+....    .....+.+.+|++++.++ +||||+++++++.....
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~   77 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA----SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY   77 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC----CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc
Confidence            579999999999999999999877664  46888776321    122245688999999999 79999999999999999


Q ss_pred             EEEEEEcc-CCChHHHHhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCc
Q psy9858         132 VSLVFEFV-DTDLEVIIKDPT---------------IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGV  195 (307)
Q Consensus       132 ~~lv~e~~-~g~l~~~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~  195 (307)
                      .+++|||+ .|+|.+++....               ..+++..++.++.||+.||+|||++|++||||||+||+++.++.
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~  157 (297)
T cd05089          78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA  157 (297)
T ss_pred             ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe
Confidence            99999999 688988886432               24788899999999999999999999999999999999999999


Q ss_pred             EEEEeecCccccCCCCcccccceeeceehhhhhhhccccccccccee---e----eee-cCCCCCCCCCCC-------CC
Q psy9858         196 LKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPSSHGNLFPG-------IP  260 (307)
Q Consensus       196 ~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~f~~~~~~~-------~~  260 (307)
                      +||+|||++........ ......+..|+|||.+.+. .++.++|||   +    +++ |..||.......       ..
T Consensus       158 ~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~  235 (297)
T cd05089         158 SKIADFGLSRGEEVYVK-KTMGRLPVRWMAIESLNYS-VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  235 (297)
T ss_pred             EEECCcCCCccccceec-cCCCCcCccccCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence            99999999864321111 1111234579999998877 789999999   2    333 888886632211       11


Q ss_pred             hhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         261 LNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       261 ~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      ....+..++.++.+|+.+||+.||.+|||++++++.
T Consensus       236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            112234578999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4e-38  Score=268.02  Aligned_cols=238  Identities=20%  Similarity=0.273  Sum_probs=190.3

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCc---EEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDM---IVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS  130 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  130 (307)
                      .+.|++.+.||+|+||.||+|.+..++.   .||+|++....    .......+.+|+.+++.++||||+++++++..+.
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   78 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY----TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR   78 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC----CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC
Confidence            4568999999999999999999876664   69999987431    2223467889999999999999999999999999


Q ss_pred             eEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCC
Q psy9858         131 NVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS  209 (307)
Q Consensus       131 ~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  209 (307)
                      ..+++|||+ +|+|.+++....+.+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          79 PVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             ceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence            999999999 5688888877666789999999999999999999999999999999999999999999999999876643


Q ss_pred             CCcc--cccce---eeceehhhhhhhccccccccccee---ee----ee-cCCCCCCCCCCC-------CChhhhccccC
Q psy9858         210 PTRL--YTHQV---VTRWYRLIKCLLYCVQFNVKNVQW---CC----FA-KDPSSHGNLFPG-------IPLNEIFTAAG  269 (307)
Q Consensus       210 ~~~~--~~~~~---~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~-~~~~f~~~~~~~-------~~~~~~~~~~~  269 (307)
                      ....  .....   .+..|+|||.+.+. .++.++|||   ++    +. |..||.......       ......+..++
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~  237 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCP  237 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccC-cccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCC
Confidence            2111  11111   24579999999877 789999999   22    22 778876532111       00111223568


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         270 DDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       270 ~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      ..+.+++.+||+.+|.+|||++++++.
T Consensus       238 ~~~~~li~~~l~~~p~~Rp~~~~i~~~  264 (269)
T cd05065         238 TALHQLMLDCWQKDRNARPKFGQIVST  264 (269)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.1e-38  Score=266.75  Aligned_cols=235  Identities=20%  Similarity=0.242  Sum_probs=190.2

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|++.+.||+|++|.||+|.+. +++.||+|.+.....      ..+.+.+|++++++++|+||+++++++...+..
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   76 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM------DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPI   76 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc------cHHHHHHHHHHHHHCCCCCccceeEEEecCCCe
Confidence            4567999999999999999999864 567899999874321      135688999999999999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      +++|||+ +++|.+++.... ..+++..+..++.|++.||.+||++|++|+||||+||+++.++.++|+|||++......
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05068          77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED  156 (261)
T ss_pred             eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence            9999999 788999887643 45899999999999999999999999999999999999999999999999999877532


Q ss_pred             Ccc-cccceeeceehhhhhhhccccccccccee---e----eee-cCCCCCCCCCCC-------CChhhhccccCHHHHH
Q psy9858         211 TRL-YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPSSHGNLFPG-------IPLNEIFTAAGDDLLA  274 (307)
Q Consensus       211 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~f~~~~~~~-------~~~~~~~~~~~~~l~~  274 (307)
                      ... ......+..|+|||.+.+. .++.++|+|   +    +++ |+.||.+.....       .........++..+.+
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (261)
T cd05068         157 IYEAREGAKFPIKWTAPEAALYN-RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYD  235 (261)
T ss_pred             cccccCCCcCceeccCccccccC-CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence            211 1111224579999998876 889999999   2    333 888887632110       0011123457899999


Q ss_pred             HHHHhhhcCCCCCCCHHHHhc
Q psy9858         275 VISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       275 li~~~l~~dP~~Rpt~~~il~  295 (307)
                      ++.+||+.||.+||+++++++
T Consensus       236 li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         236 IMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHHhhcCcccCCCHHHHHH
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.2e-38  Score=274.74  Aligned_cols=242  Identities=18%  Similarity=0.240  Sum_probs=191.1

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEcC-------CCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccc
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDIE-------TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLG  121 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~  121 (307)
                      +....++|.+.+.||+|+||.||+|.+..       ++..+|+|.+....    .......+.+|+++++.+ +|+||++
T Consensus        13 ~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~e~~~l~~l~~h~~i~~   88 (307)
T cd05098          13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA----TEKDLSDLISEMEMMKMIGKHKNIIN   88 (307)
T ss_pred             ceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC----ChHHHHHHHHHHHHHHHhcCCCCEee
Confidence            34455789999999999999999998643       23579999987431    112235678899999999 7999999


Q ss_pred             cceeeeecCeEEEEEEcc-CCChHHHHhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCC
Q psy9858         122 LTDVFGYMSNVSLVFEFV-DTDLEVIIKDPT---------------IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP  185 (307)
Q Consensus       122 ~~~~~~~~~~~~lv~e~~-~g~l~~~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp  185 (307)
                      +++++...+..++||||+ +|+|.+++....               ..++..++..++.|++.||+|||+.|++|+||||
T Consensus        89 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp  168 (307)
T cd05098          89 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAA  168 (307)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccH
Confidence            999999999999999999 578999887532               2478889999999999999999999999999999


Q ss_pred             CcEEEecCCcEEEEeecCccccCCCCccc--ccceeeceehhhhhhhccccccccccee---ee----ee-cCCCCCCCC
Q psy9858         186 NNLLINKQGVLKIGDFGLAKFFGSPTRLY--THQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FA-KDPSSHGNL  255 (307)
Q Consensus       186 ~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~-~~~~f~~~~  255 (307)
                      +||+++.++.++|+|||++..........  ....++..|+|||.+.+. .++.++|+|   ++    ++ |..||.+..
T Consensus       169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~~g~~p~~~~~  247 (307)
T cd05098         169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  247 (307)
T ss_pred             HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccC-CCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence            99999999999999999998664322111  112334689999999887 789999999   22    22 778876632


Q ss_pred             CCC-------CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         256 FPG-------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       256 ~~~-------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      ...       ......+..++.++.+++.+||+.+|++|||+.+++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         248 VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            211       11112334578899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.2e-38  Score=268.95  Aligned_cols=237  Identities=21%  Similarity=0.299  Sum_probs=185.8

Q ss_pred             ceeeEEeEEeecCceEEEEEEE----cCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec-
Q psy9858          55 LVYYQWRSVHVGRFATVFKARD----IETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM-  129 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-  129 (307)
                      ..|++++.||+|+||.||+|+.    ..++..||+|.+....    .......+.+|+++++.++||||+++.+++... 
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   79 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES----GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG   79 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc----cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence            4578999999999999999974    4578899999986431    222345688999999999999999999988765 


Q ss_pred             -CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         130 -SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       130 -~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                       ...+++|||+ +++|.+++.+....+++..+..++.||+.||+|||+.|++||||||+||+++.++.++|+|||++...
T Consensus        80 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05079          80 GNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  159 (284)
T ss_pred             CCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence             5689999999 67888888765556899999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCcc---cccceeeceehhhhhhhccccccccccee--e-eee----cCCCCCCCC----------CCC---------
Q psy9858         208 GSPTRL---YTHQVVTRWYRLIKCLLYCVQFNVKNVQW--C-CFA----KDPSSHGNL----------FPG---------  258 (307)
Q Consensus       208 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Diw--~-i~~----~~~~f~~~~----------~~~---------  258 (307)
                      ......   .....++..|+|||.+.+. .++.++|||  + +++    +..+.....          ...         
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         160 ETDKEYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             ccCccceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            433221   1233456789999998876 789999999  3 332    322221100          000         


Q ss_pred             ---CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         259 ---IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       259 ---~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                         ......+..++.++.+|+.+||+.||.+|||+++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         239 LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             HHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence               00111234578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG0584|consensus

Probab=100.00  E-value=1.2e-39  Score=287.46  Aligned_cols=238  Identities=24%  Similarity=0.319  Sum_probs=192.8

Q ss_pred             eEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe--EEEE
Q psy9858          58 YQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN--VSLV  135 (307)
Q Consensus        58 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~--~~lv  135 (307)
                      +....||+|+|-+||+|.|..+|..||.-.++...... .....++|..|+.+|+.|+|+||+++++.|.+...  +-+|
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q-~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i  121 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQ-SPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI  121 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhc-ChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence            34478999999999999999999999876554322222 22234779999999999999999999999987654  8899


Q ss_pred             EEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC--CceeecCCCCcEEEe-cCCcEEEEeecCccccCCCC
Q psy9858         136 FEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH--WILHRDLKPNNLLIN-KQGVLKIGDFGLAKFFGSPT  211 (307)
Q Consensus       136 ~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~ivH~dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~~~  211 (307)
                      +|.+ .|+|..++++.+ .++...++.|++||+.||.|||++  .|+|||||.+||+|+ ..|.|||+|+|+|...... 
T Consensus       122 TEL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s-  199 (632)
T KOG0584|consen  122 TELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS-  199 (632)
T ss_pred             eecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc-
Confidence            9999 799999998765 489999999999999999999987  599999999999997 4568999999999987533 


Q ss_pred             cccccceeeceehhhhhhhccccccccccee----eeee---cCCCCCCCCC---------CCCChhhhccccCHHHHHH
Q psy9858         212 RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW----CCFA---KDPSSHGNLF---------PGIPLNEIFTAAGDDLLAV  275 (307)
Q Consensus       212 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw----~i~~---~~~~f~~~~~---------~~~~~~~~~~~~~~~l~~l  275 (307)
                       .....+|||.|||||++..  .|+..+|||    |++-   ++.||..=.-         .......+..--.++++++
T Consensus       200 -~aksvIGTPEFMAPEmYEE--~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~f  276 (632)
T KOG0584|consen  200 -HAKSVIGTPEFMAPEMYEE--NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREF  276 (632)
T ss_pred             -ccceeccCccccChHHHhh--hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHH
Confidence             2334699999999999874  799999999    5444   9999876111         1111122222236889999


Q ss_pred             HHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         276 ISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       276 i~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                      |.+||.. ..+|+|+.|+|+||||...
T Consensus       277 IekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  277 IEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             HHHHhcC-chhccCHHHHhhChhhccc
Confidence            9999999 8899999999999999864

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=4.1e-38  Score=266.24  Aligned_cols=228  Identities=20%  Similarity=0.294  Sum_probs=181.0

Q ss_pred             EEeecCceEEEEEEEc--CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEEEcc
Q psy9858          62 SVHVGRFATVFKARDI--ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFV  139 (307)
Q Consensus        62 ~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  139 (307)
                      .||+|+||.||+|.+.  ..+..||+|++....    .....+.+.+|+.++++++|+||+++++++. ....++||||+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~----~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~   76 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN----EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMA   76 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc----ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeC
Confidence            3899999999999765  445679999986432    2223456889999999999999999999875 45789999999


Q ss_pred             -CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCccc---c
Q psy9858         140 -DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY---T  215 (307)
Q Consensus       140 -~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~---~  215 (307)
                       +|+|.+++......+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..........   .
T Consensus        77 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          77 SGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence             678888887666678999999999999999999999999999999999999999999999999998654332211   1


Q ss_pred             cceeeceehhhhhhhccccccccccee---e----eee-cCCCCCCCCCC-------CCChhhhccccCHHHHHHHHHhh
Q psy9858         216 HQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPSSHGNLFP-------GIPLNEIFTAAGDDLLAVISSLL  280 (307)
Q Consensus       216 ~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~f~~~~~~-------~~~~~~~~~~~~~~l~~li~~~l  280 (307)
                      ...++..|+|||.+.+. .++.++|+|   +    ++. |..||......       .......+..+++++.+++.+||
T Consensus       157 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~  235 (257)
T cd05115         157 AGKWPLKWYAPECINFR-KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCW  235 (257)
T ss_pred             CCCCCcccCCHHHHccC-CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHc
Confidence            12235689999998876 789999999   2    332 88888663211       11112233457899999999999


Q ss_pred             hcCCCCCCCHHHHhc
Q psy9858         281 CLNPTKRADCTATLK  295 (307)
Q Consensus       281 ~~dP~~Rpt~~~il~  295 (307)
                      +.||++||++.++.+
T Consensus       236 ~~~~~~Rp~~~~i~~  250 (257)
T cd05115         236 IYKWEDRPNFAKVEE  250 (257)
T ss_pred             CCChhhCcCHHHHHH
Confidence            999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>KOG0695|consensus

Probab=100.00  E-value=1e-38  Score=262.89  Aligned_cols=254  Identities=20%  Similarity=0.230  Sum_probs=213.3

Q ss_pred             CCceeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccce
Q psy9858          46 PDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTD  124 (307)
Q Consensus        46 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~  124 (307)
                      ....+....++|.+++.||+|+|++|.+++..++.+.+|+|++++.-..+..+  ..=.+.|-.+..+- +||.+|.++.
T Consensus       241 ~~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndded--idwvqtek~vfe~asn~pflvglhs  318 (593)
T KOG0695|consen  241 IKISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDED--IDWVQTEKHVFEQASNNPFLVGLHS  318 (593)
T ss_pred             cccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCccc--chhHHhhHHHHHhccCCCeEEehhh
Confidence            34566778899999999999999999999999999999999998765544332  22245677776665 7999999999


Q ss_pred             eeeecCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecC
Q psy9858         125 VFGYMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGL  203 (307)
Q Consensus       125 ~~~~~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  203 (307)
                      +|+.+.++++|.||+ +|+|.-++.+++ .++++.++.+...|..||.|||+.||+.||||.+|+|++..|++||+|+|+
T Consensus       319 cfqtesrlffvieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygm  397 (593)
T KOG0695|consen  319 CFQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGM  397 (593)
T ss_pred             hhcccceEEEEEEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccch
Confidence            999999999999999 677877776655 599999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCcccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCCCC--hh------------
Q psy9858         204 AKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPGIP--LN------------  262 (307)
Q Consensus       204 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~~~--~~------------  262 (307)
                      ++.--.+....++.+||+.|.|||++.+. .|++.+|.|       .+++|+.||+-.-.....  .+            
T Consensus       398 cke~l~~gd~tstfcgtpnyiapeilrge-eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi  476 (593)
T KOG0695|consen  398 CKEGLGPGDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI  476 (593)
T ss_pred             hhcCCCCCcccccccCCCcccchhhhccc-ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc
Confidence            99776677778889999999999999998 999999999       566799999862222111  11            


Q ss_pred             hhccccCHHHHHHHHHhhhcCCCCCCC------HHHHhcCcccCCCc
Q psy9858         263 EIFTAAGDDLLAVISSLLCLNPTKRAD------CTATLKMDYFSLTK  303 (307)
Q Consensus       263 ~~~~~~~~~l~~li~~~l~~dP~~Rpt------~~~il~hp~f~~~~  303 (307)
                      .++..+|.....+++..|++||.+|..      ..++-+|+||..++
T Consensus       477 riprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~id  523 (593)
T KOG0695|consen  477 RIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSID  523 (593)
T ss_pred             cccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCC
Confidence            123346778889999999999999975      68999999998653

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-38  Score=264.06  Aligned_cols=233  Identities=25%  Similarity=0.309  Sum_probs=194.0

Q ss_pred             EeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEEEcc-CC
Q psy9858          63 VHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFV-DT  141 (307)
Q Consensus        63 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~-~g  141 (307)
                      ||+|+||.||++.+..+++.||+|++........  .....+.+|+++++.++|+||+++++.+..+...+++|||+ ++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~   78 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKR--KEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGG   78 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcch--HHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCC
Confidence            6899999999999988899999999886432221  12456889999999999999999999999999999999999 78


Q ss_pred             ChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcccccceeec
Q psy9858         142 DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTR  221 (307)
Q Consensus       142 ~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~  221 (307)
                      +|.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..............++.
T Consensus        79 ~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~  157 (250)
T cd05123          79 ELFSHLSKEG-RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTP  157 (250)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCc
Confidence            8988887654 489999999999999999999999999999999999999999999999999987654323344456788


Q ss_pred             eehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCC------ChhhhccccCHHHHHHHHHhhhcCCCCCC
Q psy9858         222 WYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGI------PLNEIFTAAGDDLLAVISSLLCLNPTKRA  288 (307)
Q Consensus       222 ~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dP~~Rp  288 (307)
                      .|++||.+.+. ..+.++|+|   +    +++|..||........      .....+...+..+.+++++||..||++||
T Consensus       158 ~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~  236 (250)
T cd05123         158 EYLAPEVLLGK-GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRL  236 (250)
T ss_pred             cccChHHhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCC
Confidence            99999999877 688999999   2    3338888866432110      11123344688999999999999999999


Q ss_pred             CH---HHHhcCccc
Q psy9858         289 DC---TATLKMDYF  299 (307)
Q Consensus       289 t~---~~il~hp~f  299 (307)
                      |+   +++++||||
T Consensus       237 ~~~~~~~l~~~~~f  250 (250)
T cd05123         237 GSGGAEEIKAHPFF  250 (250)
T ss_pred             CcccHHHHHhCCCC
Confidence            99   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=5.3e-38  Score=270.33  Aligned_cols=237  Identities=23%  Similarity=0.298  Sum_probs=190.2

Q ss_pred             cceeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDI-----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY  128 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  128 (307)
                      ..+|.+.+.||+|+||.||+|++.     .++..+++|.+....     ....+.+.+|++++++++|+||+++++++..
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   78 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-----LAARKDFQREAELLTNLQHEHIVKFYGVCGD   78 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-----HHHHHHHHHHHHHHhcCCCCCcceEEEEEcc
Confidence            457899999999999999999853     345678999876321     1224568899999999999999999999999


Q ss_pred             cCeEEEEEEcc-CCChHHHHhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEec
Q psy9858         129 MSNVSLVFEFV-DTDLEVIIKDPT---------------IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK  192 (307)
Q Consensus       129 ~~~~~lv~e~~-~g~l~~~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~  192 (307)
                      ....++||||+ +++|.+++....               ..+++..++.++.||+.||.|||++|++||||||+||+++.
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~  158 (291)
T cd05094          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA  158 (291)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence            99999999999 688988886432               34788999999999999999999999999999999999999


Q ss_pred             CCcEEEEeecCccccCCCCc--ccccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCC------
Q psy9858         193 QGVLKIGDFGLAKFFGSPTR--LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLF------  256 (307)
Q Consensus       193 ~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~------  256 (307)
                      ++.++|+|||++........  ......++..|+|||.+.+. .++.++|||       .+++ |..||.....      
T Consensus       159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  237 (291)
T cd05094         159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC  237 (291)
T ss_pred             CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            99999999999986543221  12234567889999999887 889999999       2343 8888765221      


Q ss_pred             -CCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         257 -PGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       257 -~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                       ...........++..+.+++.+||+.||++|||++++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~  278 (291)
T cd05094         238 ITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKI  278 (291)
T ss_pred             HhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence             1111112234568899999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=5.3e-38  Score=265.92  Aligned_cols=234  Identities=19%  Similarity=0.264  Sum_probs=188.2

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|+++++||+|+||.||+|.. .+++.||+|.+.....      ....+.+|+.+++.++|+||+++++++ .....
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~   75 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSM------SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPI   75 (260)
T ss_pred             chHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCC------cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCc
Confidence            456899999999999999999985 5678899999874321      134678999999999999999999876 45678


Q ss_pred             EEEEEcc-CCChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      +++|||+ +|+|.+++... ...+++.++..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05067          76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN  155 (260)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence            9999999 68898887653 345889999999999999999999999999999999999999999999999999876422


Q ss_pred             Cc-ccccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCCC-------CChhhhccccCHHHHH
Q psy9858         211 TR-LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFPG-------IPLNEIFTAAGDDLLA  274 (307)
Q Consensus       211 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~~-------~~~~~~~~~~~~~l~~  274 (307)
                      .. ......++..|+|||.+.+. .++.++|+|       .+++ |++||.+.....       ......+...+.++.+
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (260)
T cd05067         156 EYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYE  234 (260)
T ss_pred             CcccccCCcccccccCHHHhccC-CcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence            21 11223456789999998877 789999999       2344 899987632211       1111223456789999


Q ss_pred             HHHHhhhcCCCCCCCHHHHhc
Q psy9858         275 VISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       275 li~~~l~~dP~~Rpt~~~il~  295 (307)
                      ++.+||+.||++|||++++++
T Consensus       235 li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         235 LMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHHccCChhhCCCHHHHHH
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=7.9e-38  Score=272.14  Aligned_cols=242  Identities=19%  Similarity=0.265  Sum_probs=189.8

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEEc-------CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCcc
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARDI-------ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVL  120 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~  120 (307)
                      .+....++|.+.+.||+|+||.||+|++.       .....||+|++....    .......+.+|+++++.+ +||||+
T Consensus         6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~iv   81 (314)
T cd05099           6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA----TDKDLADLISEMELMKLIGKHKNII   81 (314)
T ss_pred             cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC----ChHHHHHHHHHHHHHHhccCCCCee
Confidence            34455678999999999999999999853       234579999887431    122245678999999999 699999


Q ss_pred             ccceeeeecCeEEEEEEcc-CCChHHHHhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCC
Q psy9858         121 GLTDVFGYMSNVSLVFEFV-DTDLEVIIKDPT---------------IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK  184 (307)
Q Consensus       121 ~~~~~~~~~~~~~lv~e~~-~g~l~~~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlk  184 (307)
                      ++++++.+....+++|||+ +|+|.+++....               ..++..++..++.||+.||.|||++|++|+|||
T Consensus        82 ~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlk  161 (314)
T cd05099          82 NLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLA  161 (314)
T ss_pred             eEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccc
Confidence            9999999999999999999 688988886532               347888999999999999999999999999999


Q ss_pred             CCcEEEecCCcEEEEeecCccccCCCCcc--cccceeeceehhhhhhhccccccccccee---ee----ee-cCCCCCCC
Q psy9858         185 PNNLLINKQGVLKIGDFGLAKFFGSPTRL--YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FA-KDPSSHGN  254 (307)
Q Consensus       185 p~Nil~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~-~~~~f~~~  254 (307)
                      |+||+++.++.+||+|||+++........  .....++..|+|||.+.+. .++.++|||   ++    ++ |..||.+.
T Consensus       162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~~g~~p~~~~  240 (314)
T cd05099         162 ARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR-VYTHQSDVWSFGILMWEIFTLGGSPYPGI  240 (314)
T ss_pred             ceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccC-CcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999876432211  1112234579999999876 889999999   22    22 77787663


Q ss_pred             CCC-------CCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         255 LFP-------GIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       255 ~~~-------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      ...       .......+..++.++.+++.+||+.||++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         241 PVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             CHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            211       11111223456789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.6e-38  Score=278.33  Aligned_cols=240  Identities=20%  Similarity=0.273  Sum_probs=186.3

Q ss_pred             cccceeeEEeEEeecCceEEEEEEE-----cCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCcccccee
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARD-----IETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDV  125 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~  125 (307)
                      -..++|++++.||+|+||.||+|.+     ..+++.||||++....    .......+.+|+.++.++ +|+||++++++
T Consensus         4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~niv~~~~~   79 (343)
T cd05103           4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVNLLGA   79 (343)
T ss_pred             cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC----ChHHHHHHHHHHHHHHhccCCccHhhhcce
Confidence            3456899999999999999999984     3467899999987432    112245678999999999 68999999998


Q ss_pred             eee-cCeEEEEEEcc-CCChHHHHhCCC----------------------------------------------------
Q psy9858         126 FGY-MSNVSLVFEFV-DTDLEVIIKDPT----------------------------------------------------  151 (307)
Q Consensus       126 ~~~-~~~~~lv~e~~-~g~l~~~~~~~~----------------------------------------------------  151 (307)
                      +.. +...+++|||+ +|+|.+++....                                                    
T Consensus        80 ~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (343)
T cd05103          80 CTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS  159 (343)
T ss_pred             eecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence            754 45689999999 688888876421                                                    


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc--cc
Q psy9858         152 --------------IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL--YT  215 (307)
Q Consensus       152 --------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~--~~  215 (307)
                                    ..++...+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.........  ..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  239 (343)
T cd05103         160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG  239 (343)
T ss_pred             cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence                          12567778889999999999999999999999999999999999999999999865322111  11


Q ss_pred             cceeeceehhhhhhhccccccccccee---e----eee-cCCCCCCCCCCC--------CChhhhccccCHHHHHHHHHh
Q psy9858         216 HQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPSSHGNLFPG--------IPLNEIFTAAGDDLLAVISSL  279 (307)
Q Consensus       216 ~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~f~~~~~~~--------~~~~~~~~~~~~~l~~li~~~  279 (307)
                      ...++..|+|||.+.+. .++.++|+|   +    ++. |..||.......        ......+...++++.+++.+|
T Consensus       240 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c  318 (343)
T cd05103         240 DARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC  318 (343)
T ss_pred             CCCCCcceECcHHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHH
Confidence            22345679999998877 889999999   2    232 788876532211        111112234678899999999


Q ss_pred             hhcCCCCCCCHHHHhcC
Q psy9858         280 LCLNPTKRADCTATLKM  296 (307)
Q Consensus       280 l~~dP~~Rpt~~~il~h  296 (307)
                      |+.||++|||+.++++|
T Consensus       319 l~~~p~~Rps~~eil~~  335 (343)
T cd05103         319 WHGEPSQRPTFSELVEH  335 (343)
T ss_pred             ccCChhhCcCHHHHHHH
Confidence            99999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=7.6e-38  Score=265.35  Aligned_cols=234  Identities=20%  Similarity=0.237  Sum_probs=186.4

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|++.++||+|+||.||+|++..+ ..||+|++.....      ....+.+|++++++++|+||+++++.+. ....
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~------~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~   75 (262)
T cd05071           4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM------SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPI   75 (262)
T ss_pred             ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc------CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCc
Confidence            456799999999999999999987655 4699999874221      1346889999999999999999998764 4568


Q ss_pred             EEEEEcc-CCChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      +++|||+ +|+|.+++... ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+......
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~  155 (262)
T cd05071          76 YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  155 (262)
T ss_pred             EEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence            9999999 57899988753 334788999999999999999999999999999999999999999999999999876433


Q ss_pred             Ccc-cccceeeceehhhhhhhccccccccccee---e----eee-cCCCCCCCCCCCC-------ChhhhccccCHHHHH
Q psy9858         211 TRL-YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPSSHGNLFPGI-------PLNEIFTAAGDDLLA  274 (307)
Q Consensus       211 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~f~~~~~~~~-------~~~~~~~~~~~~l~~  274 (307)
                      ... .....++..|+|||...+. .++.++|+|   +    +++ |..||.+......       ........++..+.+
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  234 (262)
T cd05071         156 EYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD  234 (262)
T ss_pred             ccccccCCcccceecCHhHhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHH
Confidence            221 1223456789999998877 789999999   2    233 7778765321110       001123457889999


Q ss_pred             HHHHhhhcCCCCCCCHHHHhc
Q psy9858         275 VISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       275 li~~~l~~dP~~Rpt~~~il~  295 (307)
                      ++.+||+.||++|||++++++
T Consensus       235 li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         235 LMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHHHccCCcccCCCHHHHHH
Confidence            999999999999999999876

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.4e-38  Score=281.78  Aligned_cols=247  Identities=18%  Similarity=0.214  Sum_probs=194.6

Q ss_pred             CCCceeccccceeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-CCC
Q psy9858          45 LPDCEVKNDLLVYYQWRSVHVGRFATVFKARDI-----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-HEN  118 (307)
Q Consensus        45 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~n  118 (307)
                      ..+..+....++|.+++.||+|+||.||+|++.     .+++.||+|++....    .......+.+|++++..+. |||
T Consensus        27 ~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~----~~~~~~~~~~E~~~l~~l~~H~n  102 (401)
T cd05107          27 PYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA----RSSEKQALMSELKIMSHLGPHLN  102 (401)
T ss_pred             CCCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC----ChhHHHHHHHHHHHHHhcCCCCC
Confidence            344556777889999999999999999999854     355789999997532    1222346889999999997 999


Q ss_pred             ccccceeeeecCeEEEEEEcc-CCChHHHHhCCC----------------------------------------------
Q psy9858         119 VLGLTDVFGYMSNVSLVFEFV-DTDLEVIIKDPT----------------------------------------------  151 (307)
Q Consensus       119 i~~~~~~~~~~~~~~lv~e~~-~g~l~~~~~~~~----------------------------------------------  151 (307)
                      |+++++++...+..++||||+ +|+|.+++....                                              
T Consensus       103 iv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (401)
T cd05107         103 IVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMS  182 (401)
T ss_pred             eEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccC
Confidence            999999999999999999999 689998886431                                              


Q ss_pred             ---------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy9858         152 ---------------------------------------------------IVFTPSNIKAYAIMTLRGLEYLHDHWILH  180 (307)
Q Consensus       152 ---------------------------------------------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH  180 (307)
                                                                         ..+++..+..++.||+.||.|||+.|++|
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH  262 (401)
T cd05107         183 KDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVH  262 (401)
T ss_pred             CccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCc
Confidence                                                               12566778889999999999999999999


Q ss_pred             ecCCCCcEEEecCCcEEEEeecCccccCCCCc--ccccceeeceehhhhhhhccccccccccee---ee----ee-cCCC
Q psy9858         181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR--LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FA-KDPS  250 (307)
Q Consensus       181 ~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~-~~~~  250 (307)
                      |||||+||+++.++.++|+|||+++.......  ......++..|+|||.+.+. .++.++|+|   ++    +. |..|
T Consensus       263 rdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~e~l~~g~~P  341 (401)
T cd05107         263 RDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN-LYTTLSDVWSFGILLWEIFTLGGTP  341 (401)
T ss_pred             ccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC-CCCcHhHHHHHHHHHHHHHHcCCCC
Confidence            99999999999999999999999986533221  11223567889999999877 789999999   22    32 7778


Q ss_pred             CCCCCCCCCC--------hhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         251 SHGNLFPGIP--------LNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       251 f~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      |.........        ....+..++.++.+|+.+||+.||.+||+++++++.
T Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         342 YPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             CCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            7653211110        111234578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=6.1e-38  Score=264.96  Aligned_cols=231  Identities=19%  Similarity=0.232  Sum_probs=186.5

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceee-eecC
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVF-GYMS  130 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-~~~~  130 (307)
                      ...++|.+.+.||+|+||.||++..  .|..||+|.+...       ...+.+.+|+.+++.++|+|++++++++ ....
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (256)
T cd05082           3 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG   73 (256)
T ss_pred             ccHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC-------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCC
Confidence            3456899999999999999999975  4778999988532       1135688999999999999999999875 4556


Q ss_pred             eEEEEEEcc-CCChHHHHhCCCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         131 NVSLVFEFV-DTDLEVIIKDPTI-VFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       131 ~~~lv~e~~-~g~l~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                      ..+++|||+ +|+|.+++..... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....
T Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  153 (256)
T cd05082          74 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  153 (256)
T ss_pred             ceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecc
Confidence            799999999 5789998876443 47889999999999999999999999999999999999999999999999988653


Q ss_pred             CCCcccccceeeceehhhhhhhccccccccccee---eee----e-cCCCCCCCCCCC-------CChhhhccccCHHHH
Q psy9858         209 SPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCF----A-KDPSSHGNLFPG-------IPLNEIFTAAGDDLL  273 (307)
Q Consensus       209 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~----~-~~~~f~~~~~~~-------~~~~~~~~~~~~~l~  273 (307)
                      ...   .....+..|+|||.+.+. .++.++|||   +++    + |+.||.......       .........+++.+.
T Consensus       154 ~~~---~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (256)
T cd05082         154 STQ---DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVY  229 (256)
T ss_pred             ccC---CCCccceeecCHHHHccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence            321   223446689999998776 789999999   333    2 888886532211       111122345789999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhc
Q psy9858         274 AVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       274 ~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      +++.+||+.||++|||+.++++
T Consensus       230 ~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         230 DVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHHHHhcCChhhCcCHHHHHH
Confidence            9999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=7.4e-38  Score=271.11  Aligned_cols=243  Identities=18%  Similarity=0.243  Sum_probs=191.3

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEEc-------CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCcc
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARDI-------ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVL  120 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~  120 (307)
                      .+.....+|.+.+.||+|+||.||+|++.       .++..||+|.+....    .......+.+|+.+++.+ +||||+
T Consensus         9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~i~   84 (304)
T cd05101           9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA----TEKDLSDLVSEMEMMKMIGKHKNII   84 (304)
T ss_pred             cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc----chHHHHHHHHHHHHHHhhccCCCch
Confidence            34556788999999999999999999752       235579999886421    122245688999999999 899999


Q ss_pred             ccceeeeecCeEEEEEEcc-CCChHHHHhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCC
Q psy9858         121 GLTDVFGYMSNVSLVFEFV-DTDLEVIIKDPT---------------IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK  184 (307)
Q Consensus       121 ~~~~~~~~~~~~~lv~e~~-~g~l~~~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlk  184 (307)
                      ++++.+......+++|||+ +|+|.+++.+..               ..++...+..++.||+.||.|||++|++|||||
T Consensus        85 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlk  164 (304)
T cd05101          85 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLA  164 (304)
T ss_pred             heeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccc
Confidence            9999999999999999999 678988886532               246778889999999999999999999999999


Q ss_pred             CCcEEEecCCcEEEEeecCccccCCCCcc--cccceeeceehhhhhhhccccccccccee---ee----ee-cCCCCCCC
Q psy9858         185 PNNLLINKQGVLKIGDFGLAKFFGSPTRL--YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FA-KDPSSHGN  254 (307)
Q Consensus       185 p~Nil~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~-~~~~f~~~  254 (307)
                      |+||+++.++.++|+|||+++........  .....++..|+|||.+.+. .++.++|||   ++    ++ |..||.+.
T Consensus       165 p~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~  243 (304)
T cd05101         165 ARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGI  243 (304)
T ss_pred             cceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence            99999999999999999999876432211  1223456789999999876 789999999   22    22 67777652


Q ss_pred             CCCC-------CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         255 LFPG-------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       255 ~~~~-------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      ....       ......+..++.++.+++.+||+.+|.+|||+.++++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         244 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             CHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            2111       11111234578899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.3e-38  Score=270.40  Aligned_cols=237  Identities=17%  Similarity=0.226  Sum_probs=185.5

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCC--------------CcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCc
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIET--------------DMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENV  119 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~--------------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni  119 (307)
                      .++|++.+.||+|+||.||+|++..+              ...||+|.+....    .......+.+|++++++++|+|+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~ei~~l~~l~h~~i   79 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV----TKTARNDFLKEIKIMSRLKNPNI   79 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC----CHHHHHHHHHHHHHHHhCCCCCc
Confidence            46899999999999999999986432              2358999987432    12224568899999999999999


Q ss_pred             cccceeeeecCeEEEEEEcc-CCChHHHHhCCC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCc
Q psy9858         120 LGLTDVFGYMSNVSLVFEFV-DTDLEVIIKDPT-----------IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNN  187 (307)
Q Consensus       120 ~~~~~~~~~~~~~~lv~e~~-~g~l~~~~~~~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~N  187 (307)
                      +++++++......++||||+ +++|.+++....           ..+++..+..++.|++.||.|||+.|++|+||||+|
T Consensus        80 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~N  159 (295)
T cd05097          80 IRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRN  159 (295)
T ss_pred             CeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhh
Confidence            99999999999999999999 678888875432           125788889999999999999999999999999999


Q ss_pred             EEEecCCcEEEEeecCccccCCCCc--ccccceeeceehhhhhhhccccccccccee---eeee------cCCCCCCCCC
Q psy9858         188 LLINKQGVLKIGDFGLAKFFGSPTR--LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA------KDPSSHGNLF  256 (307)
Q Consensus       188 il~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~------~~~~f~~~~~  256 (307)
                      |+++.++.+||+|||++........  ......++..|+|||.+.+. .++.++|+|   ++++      +..||.....
T Consensus       160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~  238 (295)
T cd05097         160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD  238 (295)
T ss_pred             EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccC-CcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence            9999999999999999986533221  11223446789999998877 789999999   2222      5667665211


Q ss_pred             CC--------------CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         257 PG--------------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       257 ~~--------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      ..              .........+++.+.+|+.+||+.||++|||++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         239 EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            10              0011123346789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG1094|consensus

Probab=100.00  E-value=2e-38  Score=276.98  Aligned_cols=237  Identities=19%  Similarity=0.261  Sum_probs=195.9

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..+...++++||+|-||.|.+|. ...+.+||||+++..    .....+..|.+|+++|.+|+||||+.++++|..++.+
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCe-veg~lkVAVK~Lr~~----a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi  610 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCE-VEGPLKVAVKILRPD----ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL  610 (807)
T ss_pred             chhheehhhhhcCcccceeEEEE-ecCceEEEEeecCcc----cchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence            44568899999999999999998 456799999999843    3444468899999999999999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhCCCCC-CCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIV-FTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~-~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      ++++||+ .|+|.+++....-+ ........|+.||++|++||.+.++|||||.++|+|++.++++||+|||+++.+.+.
T Consensus       611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg  690 (807)
T KOG1094|consen  611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG  690 (807)
T ss_pred             HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccC
Confidence            9999999 79999999876332 245556679999999999999999999999999999999999999999999977554


Q ss_pred             Cccc--ccceeeceehhhhhhhccccccccccee---------eeeecCCCCCC-----------CCCCCC---Chhhhc
Q psy9858         211 TRLY--THQVVTRWYRLIKCLLYCVQFNVKNVQW---------CCFAKDPSSHG-----------NLFPGI---PLNEIF  265 (307)
Q Consensus       211 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~Diw---------~i~~~~~~f~~-----------~~~~~~---~~~~~~  265 (307)
                      +...  ...+...+|||||.+.-+ .++.++|+|         ..++.+.||..           ..+...   .....+
T Consensus       691 ~yy~vqgr~vlpiRwmawEsillg-kFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P  769 (807)
T KOG1094|consen  691 DYYRVQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRP  769 (807)
T ss_pred             CceeeecceeeeeeehhHHHHHhc-cccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCC
Confidence            4332  234567899999999988 899999999         23347788876           111111   122334


Q ss_pred             cccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         266 TAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       266 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      +-++..+.+++.+||+.|-++|||++++..
T Consensus       770 ~~cp~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  770 PACPQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             CcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence            568899999999999999999999999854

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=8.3e-38  Score=274.31  Aligned_cols=243  Identities=19%  Similarity=0.244  Sum_probs=190.4

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEEcCC-------CcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCcc
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARDIET-------DMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVL  120 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~  120 (307)
                      .+.....+|.+++.||+|+||.||+|++...       +..||+|.+...    ........+.+|+++++++ +|+||+
T Consensus         6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~iv   81 (334)
T cd05100           6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD----ATDKDLSDLVSEMEMMKMIGKHKNII   81 (334)
T ss_pred             ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc----cCHHHHHHHHHHHHHHHhhcCCCCee
Confidence            3444556899999999999999999986432       246899987642    1222346788999999999 799999


Q ss_pred             ccceeeeecCeEEEEEEcc-CCChHHHHhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCC
Q psy9858         121 GLTDVFGYMSNVSLVFEFV-DTDLEVIIKDPT---------------IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK  184 (307)
Q Consensus       121 ~~~~~~~~~~~~~lv~e~~-~g~l~~~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlk  184 (307)
                      ++++++...+..+++|||+ +|+|.+++....               ..++...+..++.||+.||.|||++|++|||||
T Consensus        82 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlk  161 (334)
T cd05100          82 NLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLA  161 (334)
T ss_pred             eeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccc
Confidence            9999999999999999999 678988886432               236778889999999999999999999999999


Q ss_pred             CCcEEEecCCcEEEEeecCccccCCCCcc--cccceeeceehhhhhhhccccccccccee---eee----e-cCCCCCCC
Q psy9858         185 PNNLLINKQGVLKIGDFGLAKFFGSPTRL--YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCF----A-KDPSSHGN  254 (307)
Q Consensus       185 p~Nil~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~----~-~~~~f~~~  254 (307)
                      |+||+++.++.++|+|||+++........  .....++..|+|||.+.+. .++.++|||   +++    + |..||.+.
T Consensus       162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~  240 (334)
T cd05100         162 ARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGI  240 (334)
T ss_pred             cceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccC-CcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence            99999999999999999999866432211  1122334679999999887 889999999   332    2 77777663


Q ss_pred             CCCC-------CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         255 LFPG-------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       255 ~~~~-------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      ....       ......+..++.++.+++.+||+.+|++|||+.+++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         241 PVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             CHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            2111       11112234567899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.3e-37  Score=268.53  Aligned_cols=237  Identities=19%  Similarity=0.250  Sum_probs=186.6

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcC----------------CCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCC
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIE----------------TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHE  117 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~  117 (307)
                      .++|++.+.||+|+||.||++.+..                ++..||+|++....    .......+.+|+++++.++|+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~~~E~~~l~~l~~~   79 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA----NKNARNDFLKEIKIMSRLKDP   79 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC----CHHHHHHHHHHHHHHHhCCCC
Confidence            4579999999999999999986432                34579999987431    222345788999999999999


Q ss_pred             CccccceeeeecCeEEEEEEcc-CCChHHHHhCCC----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCC
Q psy9858         118 NVLGLTDVFGYMSNVSLVFEFV-DTDLEVIIKDPT----------IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPN  186 (307)
Q Consensus       118 ni~~~~~~~~~~~~~~lv~e~~-~g~l~~~~~~~~----------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~  186 (307)
                      ||+++++++......+++|||+ +|+|.+++....          ..+++..+..++.||+.||+|||+.|++|+||||+
T Consensus        80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~  159 (296)
T cd05095          80 NIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATR  159 (296)
T ss_pred             CcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChh
Confidence            9999999999999999999999 578988886532          23667789999999999999999999999999999


Q ss_pred             cEEEecCCcEEEEeecCccccCCCCc--ccccceeeceehhhhhhhccccccccccee---eeee------cCCCCCCCC
Q psy9858         187 NLLINKQGVLKIGDFGLAKFFGSPTR--LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA------KDPSSHGNL  255 (307)
Q Consensus       187 Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~------~~~~f~~~~  255 (307)
                      ||+++.++.++|+|||++........  ......++..|++||...+. .++.++|+|   ++++      +..||....
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05095         160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEILTLCKEQPYSQLS  238 (296)
T ss_pred             eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence            99999999999999999986633221  11222346789999998877 789999999   3332      677776532


Q ss_pred             CCCC--------------ChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         256 FPGI--------------PLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       256 ~~~~--------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      ....              .....+..+++.+.+|+.+||+.||.+|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         239 DEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             hHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            1110              011122456789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.3e-37  Score=264.71  Aligned_cols=237  Identities=16%  Similarity=0.237  Sum_probs=189.7

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCc---EEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDM---IVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS  130 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  130 (307)
                      .++|+..+.||+|+||.||+|.+..++.   .+|+|.+....    .......+.+|++++++++|+||+++.+++.+.+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   79 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY----TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK   79 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC----CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence            4578899999999999999999776554   79999886432    1222456889999999999999999999999999


Q ss_pred             eEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCC
Q psy9858         131 NVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS  209 (307)
Q Consensus       131 ~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  209 (307)
                      ..+++|||+ +++|.+++......+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          80 PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            999999999 5788888876666789999999999999999999999999999999999999999999999999986643


Q ss_pred             CCccc---ccceeeceehhhhhhhccccccccccee---e----eee-cCCCCCCCCCCC-------CChhhhccccCHH
Q psy9858         210 PTRLY---THQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPSSHGNLFPG-------IPLNEIFTAAGDD  271 (307)
Q Consensus       210 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~f~~~~~~~-------~~~~~~~~~~~~~  271 (307)
                      .....   .....+..|+|||.+.+. .++.++|+|   +    +++ |..||.......       .........++.+
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~  238 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSA  238 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhcC-CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHH
Confidence            22111   111234579999999876 789999999   2    233 888886522110       0111112346889


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         272 LLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       272 l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      +.+++.+||+.||++||++.++++
T Consensus       239 ~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         239 VYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHHH
Confidence            999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.3e-37  Score=266.88  Aligned_cols=237  Identities=22%  Similarity=0.291  Sum_probs=184.0

Q ss_pred             cceeeEEeEEeecCceEEEEEE----EcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee-
Q psy9858          54 LLVYYQWRSVHVGRFATVFKAR----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY-  128 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-  128 (307)
                      ...|++++.||+|+||.||+|.    +..++..||+|.+....     ....+.+.+|+++++.++||||+++++++.. 
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   77 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-----AEHLRDFEREIEILKSLQHDNIVKYKGVCYSA   77 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-----HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC
Confidence            3578999999999999999997    34578899999986432     2224568899999999999999999997643 


Q ss_pred             -cCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         129 -MSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       129 -~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                       ....++||||+ +|+|.+++......+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..
T Consensus        78 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          78 GRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             CCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccc
Confidence             45689999999 6889999876655689999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCcc---cccceeeceehhhhhhhccccccccccee---eeee----cCCCCCCCCCC-------CC----------
Q psy9858         207 FGSPTRL---YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KDPSSHGNLFP-------GI----------  259 (307)
Q Consensus       207 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~~~~f~~~~~~-------~~----------  259 (307)
                      .......   .....++..|+|||.+.+. .++.++|+|   ++++    +..++......       ..          
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05081         158 LPQDKEYYKVREPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI  236 (284)
T ss_pred             ccCCCcceeecCCCCCceEeeCHHHhccC-CcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence            6432221   1112234569999999876 789999999   2222    43333221000       00          


Q ss_pred             ------ChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         260 ------PLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       260 ------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                            ........++.++.+|+.+||+.+|++|||++++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  279 (284)
T cd05081         237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ  279 (284)
T ss_pred             HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence                  0001123467899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=6.2e-38  Score=265.11  Aligned_cols=228  Identities=23%  Similarity=0.314  Sum_probs=181.3

Q ss_pred             EEeecCceEEEEEEE--cCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEEEcc
Q psy9858          62 SVHVGRFATVFKARD--IETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFV  139 (307)
Q Consensus        62 ~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  139 (307)
                      .||+|+||.||+|.+  ..++..+|+|++....   ......+.+.+|+.+++.++|+||+++++++. ....+++|||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~   77 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN---NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELA   77 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCC---CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecC
Confidence            589999999999964  4678899999986432   22234567889999999999999999999875 45678999999


Q ss_pred             -CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCccc---c
Q psy9858         140 -DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY---T  215 (307)
Q Consensus       140 -~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~---~  215 (307)
                       .|+|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..........   .
T Consensus        78 ~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          78 ELGPLNKFLQKNK-HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence             477888876543 58999999999999999999999999999999999999999999999999998764432221   1


Q ss_pred             cceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCC-------CCCChhhhccccCHHHHHHHHHhh
Q psy9858         216 HQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLF-------PGIPLNEIFTAAGDDLLAVISSLL  280 (307)
Q Consensus       216 ~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~-------~~~~~~~~~~~~~~~l~~li~~~l  280 (307)
                      ...++..|+|||.+... .++.++|+|       .+++ |..||.....       ........+..+++++.++|.+||
T Consensus       157 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~  235 (257)
T cd05116         157 HGKWPVKWYAPECMNYY-KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCW  235 (257)
T ss_pred             CCCCCccccCHhHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHh
Confidence            12335789999998776 788999999       3343 8888876211       111112234568899999999999


Q ss_pred             hcCCCCCCCHHHHhc
Q psy9858         281 CLNPTKRADCTATLK  295 (307)
Q Consensus       281 ~~dP~~Rpt~~~il~  295 (307)
                      +.||++|||+++|.+
T Consensus       236 ~~~p~~Rp~~~~i~~  250 (257)
T cd05116         236 TYGVDERPGFAVVEL  250 (257)
T ss_pred             ccCchhCcCHHHHHH
Confidence            999999999999865

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=5.9e-38  Score=267.26  Aligned_cols=235  Identities=20%  Similarity=0.221  Sum_probs=182.5

Q ss_pred             eEEeEEeecCceEEEEEEEcCCCc--EEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee------c
Q psy9858          58 YQWRSVHVGRFATVFKARDIETDM--IVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY------M  129 (307)
Q Consensus        58 ~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~------~  129 (307)
                      .+.+.||+|+||.||+|++..++.  .||+|.+.....   .......+.+|+++++.++|+||+++++.+..      .
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   78 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC---TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGY   78 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCC
Confidence            467899999999999999877664  699998875321   22224668899999999999999999987632      2


Q ss_pred             CeEEEEEEcc-CCChHHHHhC-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecC
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKD-----PTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGL  203 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  203 (307)
                      ...+++|||+ +|+|.+++..     ....+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||+
T Consensus        79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCc
Confidence            3578999999 5788777632     223478999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCcc--cccceeeceehhhhhhhccccccccccee---e----eee-cCCCCCCCCCCC-------CChhhhcc
Q psy9858         204 AKFFGSPTRL--YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPSSHGNLFPG-------IPLNEIFT  266 (307)
Q Consensus       204 a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~f~~~~~~~-------~~~~~~~~  266 (307)
                      ++........  ......+..|+|||.+.+. .++.++|+|   +    +++ |..||.+.....       ........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  237 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADR-VYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPP  237 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCC-CcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            9876432211  1122356789999999887 889999999   2    233 788886621110       01112234


Q ss_pred             ccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         267 AAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       267 ~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      .++..+.+++.+||+.||++|||+++++++
T Consensus       238 ~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         238 DCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            577899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.7e-38  Score=266.94  Aligned_cols=236  Identities=20%  Similarity=0.228  Sum_probs=184.5

Q ss_pred             eeEEeEEeecCceEEEEEEEcC---CCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe--
Q psy9858          57 YYQWRSVHVGRFATVFKARDIE---TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN--  131 (307)
Q Consensus        57 y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~--  131 (307)
                      |.+++.||+|+||.||+|....   ++..||+|.+.....   .......+.+|+++++.++|+||+++++++.....  
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   77 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH---TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQ   77 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC---CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccc
Confidence            5678999999999999998654   347899999875321   12224568899999999999999999998755443  


Q ss_pred             ----EEEEEEcc-CCChHHHHhCC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEee
Q psy9858         132 ----VSLVFEFV-DTDLEVIIKDP-----TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDF  201 (307)
Q Consensus       132 ----~~lv~e~~-~g~l~~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Df  201 (307)
                          .+++|||+ .|+|..++...     ...+++..+..++.|++.||.|||+.|++|+||||+||++++++.+||+||
T Consensus        78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCc
Confidence                89999999 67887777432     235889999999999999999999999999999999999999999999999


Q ss_pred             cCccccCCCCcc--cccceeeceehhhhhhhccccccccccee---ee----ee-cCCCCCCCCCCC-------CChhhh
Q psy9858         202 GLAKFFGSPTRL--YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FA-KDPSSHGNLFPG-------IPLNEI  264 (307)
Q Consensus       202 g~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~-~~~~f~~~~~~~-------~~~~~~  264 (307)
                      |+++........  ......+..|+|||.+.+. .++.++|||   ++    +. |..||.+.....       ......
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~  236 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQ  236 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            999876433211  1112345689999998776 889999999   32    33 778876622111       111123


Q ss_pred             ccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         265 FTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       265 ~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      +..++.++.+++.+||+.||.+|||+.+++++
T Consensus       237 ~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         237 PEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            44678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>KOG0668|consensus

Probab=100.00  E-value=9.9e-40  Score=255.59  Aligned_cols=238  Identities=27%  Similarity=0.492  Sum_probs=196.4

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-CCCccccceeeeec--
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-HENVLGLTDVFGYM--  129 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~--  129 (307)
                      ..++|++++++|+|-++.||.|.+..+.++++||++.+..        .+.+.+|+.||+.|. ||||++++++..+.  
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S  107 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--------KKKIKREIKILQNLRGGPNIIKLLDIVKDPES  107 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--------HHHHHHHHHHHHhccCCCCeeehhhhhcCccc
Confidence            6789999999999999999999999999999999997521        356789999999997 99999999998764  


Q ss_pred             CeEEEEEEccC-CChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCC-cEEEEeecCcccc
Q psy9858         130 SNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG-VLKIGDFGLAKFF  207 (307)
Q Consensus       130 ~~~~lv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a~~~  207 (307)
                      ....|++||++ .+...+..    .++.-.++.++.+++.||.|||++||.|||+||.|++|+... .++|+|+|+|-+.
T Consensus       108 ktpaLiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY  183 (338)
T KOG0668|consen  108 KTPSLIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  183 (338)
T ss_pred             cCchhHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhc
Confidence            56889999995 44444443    267788999999999999999999999999999999999655 6899999999987


Q ss_pred             CCCCcccccceeeceehhhhhhhccccccccccee---eeee-----cCCCCCC--------------------------
Q psy9858         208 GSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA-----KDPSSHG--------------------------  253 (307)
Q Consensus       208 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~-----~~~~f~~--------------------------  253 (307)
                      . +....+-++.+..|.-||.+.....|++.-|+|   |+++     .++.|.|                          
T Consensus       184 H-p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY  262 (338)
T KOG0668|consen  184 H-PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY  262 (338)
T ss_pred             C-CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence            4 445667778899999999999988999999999   6666     6667766                          


Q ss_pred             C------------CCCCCChhhh-----ccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         254 N------------LFPGIPLNEI-----FTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       254 ~------------~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      .            .........+     ..-.++++.+|+.++|..|-++|+|++|++.||||....
T Consensus       263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~  329 (338)
T KOG0668|consen  263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR  329 (338)
T ss_pred             ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence            0            0000000100     012468999999999999999999999999999997654

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-37  Score=265.50  Aligned_cols=236  Identities=19%  Similarity=0.253  Sum_probs=189.7

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCc----EEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDM----IVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM  129 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  129 (307)
                      ..+|++++.||+|+||.||+|.+..+|.    .||+|.+.....    ......+.+|+++++.++|+||+++++++.. 
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-   80 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS----PKANKEILDEAYVMASVDHPHVVRLLGICLS-   80 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC----HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence            3679999999999999999999776654    689998764321    2234568899999999999999999998876 


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                      ...+++|||+ +|+|.+++......+++..+..++.||+.||+|||+.|++|+||||+||+++.++.++|+|||+++...
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence            7899999999 688999988776678999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCcccc--cceeeceehhhhhhhccccccccccee---e----eee-cCCCCCCCCCCC-------CChhhhccccCHH
Q psy9858         209 SPTRLYT--HQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPSSHGNLFPG-------IPLNEIFTAAGDD  271 (307)
Q Consensus       209 ~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~f~~~~~~~-------~~~~~~~~~~~~~  271 (307)
                      .......  ...++..|+|||.+... .++.++|+|   +    +++ |..||.+.....       ......+...+.+
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHR-IYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTID  239 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcC-CcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHH
Confidence            3322211  11235679999998776 789999999   2    333 888887632211       1111122346788


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         272 LLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       272 l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      +.+++.+||..||.+|||+.++++
T Consensus       240 ~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         240 VYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             HHHHHHHHcCCChhhCCCHHHHHH
Confidence            999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.6e-38  Score=265.38  Aligned_cols=227  Identities=15%  Similarity=0.226  Sum_probs=177.6

Q ss_pred             eEEeecCceEEEEEEEcC------------CCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee
Q psy9858          61 RSVHVGRFATVFKARDIE------------TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY  128 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~------------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  128 (307)
                      +.||+|+||.||+|+...            ....|++|.+...     .......+.+|+.+++.++||||+++++++..
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-----~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~   75 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS-----HRDISLAFFETASMMRQVSHKHIVLLYGVCVR   75 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh-----hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            468999999999998432            2346888987642     12224567889999999999999999999999


Q ss_pred             cCeEEEEEEccC-CChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCc-------EEEEe
Q psy9858         129 MSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGV-------LKIGD  200 (307)
Q Consensus       129 ~~~~~lv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~-------~kl~D  200 (307)
                      ....+++|||++ |+|..++......+++..+..++.||+.||.|||++|++||||||+||+++.++.       ++++|
T Consensus        76 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          76 DVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             CCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            999999999995 6676666655556899999999999999999999999999999999999987664       89999


Q ss_pred             ecCccccCCCCcccccceeeceehhhhhhhccccccccccee---eee-----ecCCCCCCCCCCCCC-----hhhhccc
Q psy9858         201 FGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCF-----AKDPSSHGNLFPGIP-----LNEIFTA  267 (307)
Q Consensus       201 fg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~-----~~~~~f~~~~~~~~~-----~~~~~~~  267 (307)
                      ||++......    ....++..|+|||.+.....++.++|||   +++     .|..|+.........     .......
T Consensus       156 ~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  231 (262)
T cd05077         156 PGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVTP  231 (262)
T ss_pred             CCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcCccCCCC
Confidence            9998765322    2335778899999987555789999999   222     277777653321110     0011123


Q ss_pred             cCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         268 AGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       268 ~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      .++++.+|+.+||+.||++||++.+++.+
T Consensus       232 ~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         232 SCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             ChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            46789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG0670|consensus

Probab=100.00  E-value=2.8e-38  Score=272.83  Aligned_cols=240  Identities=27%  Similarity=0.407  Sum_probs=200.3

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC------CCCccccceee
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH------HENVLGLTDVF  126 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~ni~~~~~~~  126 (307)
                      ...+|.+....|+|-|++|.+|.+..-|+.||||+|..      ++.+.+.-+.|++||++|+      --++++++..|
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn------NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F  503 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN------NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF  503 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec------chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence            34679999999999999999999999999999999984      4455677789999999996      35799999999


Q ss_pred             eecCeEEEEEEccCCChHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCC-cEEEEeecC
Q psy9858         127 GYMSNVSLVFEFVDTDLEVIIKDPT--IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG-VLKIGDFGL  203 (307)
Q Consensus       127 ~~~~~~~lv~e~~~g~l~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~  203 (307)
                      .+.+++|||+|-+.-+|..++++-+  ..+....++.++.|++.||..|-..||+|.||||.|||++... .+||||||.
T Consensus       504 ~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS  583 (752)
T KOG0670|consen  504 KHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGS  583 (752)
T ss_pred             hhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcc
Confidence            9999999999999999999987643  3478889999999999999999999999999999999998765 579999999


Q ss_pred             ccccCCCCcccccceeeceehhhhhhhccccccccccee---eeee----cCCCCCC-----------------------
Q psy9858         204 AKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KDPSSHG-----------------------  253 (307)
Q Consensus       204 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~~~~f~~-----------------------  253 (307)
                      |...+.  +..+....+.-|.|||++.|. .|+...|+|   |++|    |+.+|.|                       
T Consensus       584 A~~~~e--neitPYLVSRFYRaPEIiLG~-~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlR  660 (752)
T KOG0670|consen  584 ASFASE--NEITPYLVSRFYRAPEIILGL-PYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLR  660 (752)
T ss_pred             cccccc--ccccHHHHHHhccCcceeecC-cccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhh
Confidence            998743  445566778899999999999 999999999   7777    9999988                       


Q ss_pred             ---------------------------------CCCCCCChhhhc----------cccCHHHHHHHHHhhhcCCCCCCCH
Q psy9858         254 ---------------------------------NLFPGIPLNEIF----------TAAGDDLLAVISSLLCLNPTKRADC  290 (307)
Q Consensus       254 ---------------------------------~~~~~~~~~~~~----------~~~~~~l~~li~~~l~~dP~~Rpt~  290 (307)
                                                       ...+...+....          ..+-.++.+|+.+||..||++|.|+
T Consensus       661 KgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~  740 (752)
T KOG0670|consen  661 KGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITV  740 (752)
T ss_pred             hcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCH
Confidence                                             000000000000          0122468899999999999999999


Q ss_pred             HHHhcCcccCC
Q psy9858         291 TATLKMDYFSL  301 (307)
Q Consensus       291 ~~il~hp~f~~  301 (307)
                      .|+|.||||..
T Consensus       741 nqAL~HpFi~~  751 (752)
T KOG0670|consen  741 NQALKHPFITE  751 (752)
T ss_pred             HHHhcCCcccC
Confidence            99999999975

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.4e-37  Score=261.70  Aligned_cols=230  Identities=21%  Similarity=0.284  Sum_probs=184.1

Q ss_pred             eEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEEEcc-
Q psy9858          61 RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFV-  139 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~-  139 (307)
                      +.||+|+||.||+|.. .++..||+|.+....    .......+.+|+++++.++||||+++++++......++||||+ 
T Consensus         1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   75 (250)
T cd05085           1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL----PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVP   75 (250)
T ss_pred             CccCCCCCceEEEEEe-cCCcEEEEEecCCcC----CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCC
Confidence            3689999999999985 578899999987432    1222346889999999999999999999999999999999999 


Q ss_pred             CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc-cccce
Q psy9858         140 DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL-YTHQV  218 (307)
Q Consensus       140 ~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~  218 (307)
                      +++|.+++......+++..+..++.|++.||.|+|++|++|+||+|+||+++.++.++|+|||++......... .....
T Consensus        76 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (250)
T cd05085          76 GGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ  155 (250)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence            68888888766556889999999999999999999999999999999999999999999999999765322111 11123


Q ss_pred             eeceehhhhhhhccccccccccee---e----eee-cCCCCCCCCCCC-------CChhhhccccCHHHHHHHHHhhhcC
Q psy9858         219 VTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPSSHGNLFPG-------IPLNEIFTAAGDDLLAVISSLLCLN  283 (307)
Q Consensus       219 ~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~f~~~~~~~-------~~~~~~~~~~~~~l~~li~~~l~~d  283 (307)
                      ++..|+|||.+.+. .++.++|+|   +    +++ |..||.......       ......+..++.++.+++.+||+.+
T Consensus       156 ~~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  234 (250)
T cd05085         156 IPIKWTAPEALNYG-RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYK  234 (250)
T ss_pred             CcccccCHHHhccC-CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccC
Confidence            35679999999876 789999999   2    233 777886532111       1111223457899999999999999


Q ss_pred             CCCCCCHHHHhcC
Q psy9858         284 PTKRADCTATLKM  296 (307)
Q Consensus       284 P~~Rpt~~~il~h  296 (307)
                      |++|||+.++++.
T Consensus       235 p~~Rp~~~~l~~~  247 (250)
T cd05085         235 PENRPKFSELQKE  247 (250)
T ss_pred             cccCCCHHHHHHH
Confidence            9999999999764

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1e-37  Score=263.49  Aligned_cols=234  Identities=21%  Similarity=0.280  Sum_probs=189.9

Q ss_pred             eEEeEEeecCceEEEEEEEcCCC----cEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEE
Q psy9858          58 YQWRSVHVGRFATVFKARDIETD----MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVS  133 (307)
Q Consensus        58 ~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  133 (307)
                      .+.+.||.|+||.||+|.+..++    ..||+|++.....    ....+.+.+|+++++.++|+||+++++.+.+.+..+
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   77 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD----EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLM   77 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC----hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeE
Confidence            56789999999999999988766    8999999864321    113567889999999999999999999999999999


Q ss_pred             EEEEcc-CCChHHHHhCCCCC-CCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC
Q psy9858         134 LVFEFV-DTDLEVIIKDPTIV-FTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT  211 (307)
Q Consensus       134 lv~e~~-~g~l~~~~~~~~~~-~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  211 (307)
                      ++|||+ +++|.+++...... +++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus        78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            999999 57888888765444 8999999999999999999999999999999999999999999999999998775432


Q ss_pred             cccc-cceeeceehhhhhhhccccccccccee---eee----e-cCCCCCCCCCC-------CCChhhhccccCHHHHHH
Q psy9858         212 RLYT-HQVVTRWYRLIKCLLYCVQFNVKNVQW---CCF----A-KDPSSHGNLFP-------GIPLNEIFTAAGDDLLAV  275 (307)
Q Consensus       212 ~~~~-~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~----~-~~~~f~~~~~~-------~~~~~~~~~~~~~~l~~l  275 (307)
                      .... ...++..|+|||.+.+. .++.++|+|   +++    . |..||......       ..........++.++.++
T Consensus       158 ~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (258)
T smart00219      158 YYKKKGGKLPIRWMAPESLKDG-KFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKL  236 (258)
T ss_pred             ccccccCCCcccccChHHhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHH
Confidence            2211 12367899999998665 889999999   332    2 77887652111       111112234578999999


Q ss_pred             HHHhhhcCCCCCCCHHHHhcC
Q psy9858         276 ISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       276 i~~~l~~dP~~Rpt~~~il~h  296 (307)
                      +.+||..||++|||+.|+++.
T Consensus       237 i~~~l~~~p~~Rpt~~~ll~~  257 (258)
T smart00219      237 MLQCWAEDPEDRPTFSELVEI  257 (258)
T ss_pred             HHHHCcCChhhCcCHHHHHhh
Confidence            999999999999999999863

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=9.9e-38  Score=267.19  Aligned_cols=236  Identities=22%  Similarity=0.263  Sum_probs=188.1

Q ss_pred             cceeeEEeEEeecCceEEEEEEE-----cCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARD-----IETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY  128 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  128 (307)
                      .++|.+.++||+|+||.||++..     ..++..+|+|.+...     .......+.+|+++++.++|+||+++++++.+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   78 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-----SESARQDFQREAELLTVLQHQHIVRFYGVCTE   78 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC-----CHHHHHHHHHHHHHHhcCCCCCCceEEEEEec
Confidence            45788899999999999999964     235678999987642     22234568899999999999999999999999


Q ss_pred             cCeEEEEEEcc-CCChHHHHhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecC
Q psy9858         129 MSNVSLVFEFV-DTDLEVIIKDPT--------------IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ  193 (307)
Q Consensus       129 ~~~~~lv~e~~-~g~l~~~~~~~~--------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~  193 (307)
                      ....+++|||+ +|+|.+++....              ..+++..+..++.||+.||+|||+.|++|+||||+||+++++
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~  158 (280)
T cd05092          79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG  158 (280)
T ss_pred             CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC
Confidence            99999999999 678888886532              237889999999999999999999999999999999999999


Q ss_pred             CcEEEEeecCccccCCCCc--ccccceeeceehhhhhhhccccccccccee---e----eee-cCCCCCCCCCC------
Q psy9858         194 GVLKIGDFGLAKFFGSPTR--LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPSSHGNLFP------  257 (307)
Q Consensus       194 ~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~f~~~~~~------  257 (307)
                      +.++|+|||++........  ......++..|+|||.+.+. .++.++|||   +    +++ |.+||......      
T Consensus       159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  237 (280)
T cd05092         159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI  237 (280)
T ss_pred             CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence            9999999999976532211  12223446789999999887 789999999   2    333 77887552111      


Q ss_pred             -CCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         258 -GIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       258 -~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                       .......+..+++.+.+++.+||+.||++||+++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         238 TQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence             11111223457899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG1095|consensus

Probab=100.00  E-value=3.9e-38  Score=296.48  Aligned_cols=239  Identities=20%  Similarity=0.262  Sum_probs=200.0

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCC-----cEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceee
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETD-----MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVF  126 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~  126 (307)
                      ....+-.+.+.||+|.||.||.|.-....     ..||||.+.+.    .+.+....|.+|..+|++++||||++++|++
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~----~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~  764 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL----SSEQEVSDFLKEALLMSKFDHPNIVSLIGVC  764 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc----CCHHHHHHHHHHHHHHhcCCCcceeeEEEee
Confidence            34567888999999999999999865432     34999998853    3344467899999999999999999999999


Q ss_pred             eecCeEEEEEEcc-CCChHHHHhCC------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEE
Q psy9858         127 GYMSNVSLVFEFV-DTDLEVIIKDP------TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIG  199 (307)
Q Consensus       127 ~~~~~~~lv~e~~-~g~l~~~~~~~------~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~  199 (307)
                      -+....+|++||| +|+|..+++..      ...++..+...++.||+.|+.||+++++|||||..+|+|++....|||+
T Consensus       765 l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIa  844 (1025)
T KOG1095|consen  765 LDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIA  844 (1025)
T ss_pred             cCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEc
Confidence            9999999999999 79999999877      5568999999999999999999999999999999999999999999999


Q ss_pred             eecCccccCCCCccccc-c-eeeceehhhhhhhccccccccccee--e-----eee-cCCCCCCCCCC-------CCChh
Q psy9858         200 DFGLAKFFGSPTRLYTH-Q-VVTRWYRLIKCLLYCVQFNVKNVQW--C-----CFA-KDPSSHGNLFP-------GIPLN  262 (307)
Q Consensus       200 Dfg~a~~~~~~~~~~~~-~-~~t~~y~aPE~~~~~~~~~~~~Diw--~-----i~~-~~~~f~~~~~~-------~~~~~  262 (307)
                      |||+|+.+...+..... . .-...|||||.+..+ .++.++|||  +     |+. |..||.+..-.       ..-.-
T Consensus       845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~-iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL  923 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDG-IFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRL  923 (1025)
T ss_pred             ccchhHhhhhchheeccCccccceecCCHHHHhhc-ccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCcc
Confidence            99999965443333222 2 334689999999997 999999999  3     333 99999883221       11233


Q ss_pred             hhccccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         263 EIFTAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       263 ~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      +.+..+++.+.+++..||+.+|++||++..+++
T Consensus       924 ~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  924 DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             CCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            456789999999999999999999999999987

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=9.5e-38  Score=268.32  Aligned_cols=238  Identities=21%  Similarity=0.292  Sum_probs=188.0

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeee
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDI-----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG  127 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~  127 (307)
                      ..++|++.+.||+|+||.||+|.+.     .++..||+|++....    .......+.+|+.++++++||||+++++++.
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~   78 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA----SADMQADFQREAALMAEFDHPNIVKLLGVCA   78 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc----CHHHHHHHHHHHHHHHhcCCCchheEEEEEc
Confidence            4568999999999999999999864     367889999987432    1223456889999999999999999999999


Q ss_pred             ecCeEEEEEEcc-CCChHHHHhCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCC
Q psy9858         128 YMSNVSLVFEFV-DTDLEVIIKDPT---------------------IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP  185 (307)
Q Consensus       128 ~~~~~~lv~e~~-~g~l~~~~~~~~---------------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp  185 (307)
                      .....+++|||+ +|+|.+++....                     ..+++..+..++.||+.||.|||++|++||||||
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p  158 (288)
T cd05050          79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLAT  158 (288)
T ss_pred             CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccH
Confidence            999999999999 578888886321                     1367788899999999999999999999999999


Q ss_pred             CcEEEecCCcEEEEeecCccccCCCCc--ccccceeeceehhhhhhhccccccccccee---eee----e-cCCCCCCCC
Q psy9858         186 NNLLINKQGVLKIGDFGLAKFFGSPTR--LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCF----A-KDPSSHGNL  255 (307)
Q Consensus       186 ~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~----~-~~~~f~~~~  255 (307)
                      +||+++.++.++|+|||++........  .......+..|+|||.+.+. .++.++|||   +++    + |..||.+..
T Consensus       159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~~~~p~~~~~  237 (288)
T cd05050         159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPYYGMA  237 (288)
T ss_pred             hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            999999999999999999986533211  11222345679999998877 799999999   222    2 666765421


Q ss_pred             CCC-------CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         256 FPG-------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       256 ~~~-------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      ...       ......+..++.++.+++.+||+.||.+|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         238 HEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            111       1111123457889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.2e-37  Score=263.69  Aligned_cols=234  Identities=21%  Similarity=0.239  Sum_probs=186.4

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|++.+.||+|+||.||+|.+. ++..||+|.+.....      ....+.+|+.++++++|+|++++++++. ....
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~------~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~   75 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM------SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPI   75 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC------CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCc
Confidence            4568999999999999999999864 667799999875321      1345889999999999999999999875 4568


Q ss_pred             EEEEEcc-CCChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      +++|||+ +++|.+++... ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05070          76 YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN  155 (260)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence            9999999 57898888753 335889999999999999999999999999999999999999999999999999876432


Q ss_pred             Ccc-cccceeeceehhhhhhhccccccccccee---e----eee-cCCCCCCCCCCC-------CChhhhccccCHHHHH
Q psy9858         211 TRL-YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPSSHGNLFPG-------IPLNEIFTAAGDDLLA  274 (307)
Q Consensus       211 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~f~~~~~~~-------~~~~~~~~~~~~~l~~  274 (307)
                      ... .....++..|+|||.+.+. .++.++|+|   +    +++ |.+||.+.....       ......+...+..+.+
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (260)
T cd05070         156 EYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHE  234 (260)
T ss_pred             ccccccCCCCCccccChHHHhcC-CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence            211 1122345689999998876 789999999   2    334 788886632111       0011223456789999


Q ss_pred             HHHHhhhcCCCCCCCHHHHhc
Q psy9858         275 VISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       275 li~~~l~~dP~~Rpt~~~il~  295 (307)
                      |+.+||..||.+|||+.++++
T Consensus       235 li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         235 LMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHHHcccCcccCcCHHHHHH
Confidence            999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=3e-37  Score=265.26  Aligned_cols=246  Identities=19%  Similarity=0.230  Sum_probs=194.3

Q ss_pred             eeeEEeEEeecCceEEEEEEEc---CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeeecCe
Q psy9858          56 VYYQWRSVHVGRFATVFKARDI---ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGYMSN  131 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~  131 (307)
                      +|++.+.||+|++|.||++++.   .+++.||||++...... ......+.+.+|++++.++ +|+||+++++.+.....
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~-~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~   79 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIV-QKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTK   79 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHH-hhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCE
Confidence            4889999999999999999854   46789999998753211 1222345678999999999 59999999999999999


Q ss_pred             EEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         132 VSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       132 ~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      .++||||+ +|+|.+.+.... .+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||+++.....
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  158 (288)
T cd05583          80 LHLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE  158 (288)
T ss_pred             EEEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence            99999999 578888876543 5889999999999999999999999999999999999999999999999998876433


Q ss_pred             Ccc-cccceeeceehhhhhhhccc-cccccccee-------eeeecCCCCCCCCCCCC----------ChhhhccccCHH
Q psy9858         211 TRL-YTHQVVTRWYRLIKCLLYCV-QFNVKNVQW-------CCFAKDPSSHGNLFPGI----------PLNEIFTAAGDD  271 (307)
Q Consensus       211 ~~~-~~~~~~t~~y~aPE~~~~~~-~~~~~~Diw-------~i~~~~~~f~~~~~~~~----------~~~~~~~~~~~~  271 (307)
                      ... .....++..|+|||.+.+.. ..+.++|+|       .+++|..||........          .....+..++..
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd05583         159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAE  238 (288)
T ss_pred             cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHH
Confidence            221 22335788999999987652 378899999       23338888854221110          001122346889


Q ss_pred             HHHHHHHhhhcCCCCCCC---HHHHhcCcccCCCc
Q psy9858         272 LLAVISSLLCLNPTKRAD---CTATLKMDYFSLTK  303 (307)
Q Consensus       272 l~~li~~~l~~dP~~Rpt---~~~il~hp~f~~~~  303 (307)
                      +.+++.+||+.||++|||   +.++|+||||++..
T Consensus       239 l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~  273 (288)
T cd05583         239 ARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID  273 (288)
T ss_pred             HHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence            999999999999999998   57789999998754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.5e-38  Score=267.48  Aligned_cols=226  Identities=18%  Similarity=0.210  Sum_probs=177.4

Q ss_pred             EEeecCceEEEEEEEcC------------------------CCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCC
Q psy9858          62 SVHVGRFATVFKARDIE------------------------TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHE  117 (307)
Q Consensus        62 ~lg~G~~g~V~~~~~~~------------------------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~  117 (307)
                      .||+|+||.||+|....                        ....||+|++...     .......+.+|+.+++.++||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-----~~~~~~~~~~~~~~~~~l~h~   76 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS-----HRDIALAFFETASLMSQVSHI   76 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH-----HHHHHHHHHHHHHHHhcCCCC
Confidence            58999999999997432                        1246889988642     122345688899999999999


Q ss_pred             CccccceeeeecCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCC--
Q psy9858         118 NVLGLTDVFGYMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG--  194 (307)
Q Consensus       118 ni~~~~~~~~~~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~--  194 (307)
                      ||+++++++......++||||+ +|+|..++......+++..+..++.||+.||+|||++|++||||||+||+++..+  
T Consensus        77 niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          77 HLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             CeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcc
Confidence            9999999999999999999999 5677777766556689999999999999999999999999999999999998654  


Q ss_pred             -----cEEEEeecCccccCCCCcccccceeeceehhhhhhhccccccccccee---ee-----eecCCCCCCCCCCCC--
Q psy9858         195 -----VLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC-----FAKDPSSHGNLFPGI--  259 (307)
Q Consensus       195 -----~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i-----~~~~~~f~~~~~~~~--  259 (307)
                           .++++|||++......    ....++..|+|||.+.+...++.++|+|   ++     +.|..||........  
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~  232 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER  232 (274)
T ss_pred             cCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence                 3899999998654221    2235678899999987755789999999   22     237888866322110  


Q ss_pred             ---ChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         260 ---PLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       260 ---~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                         .....+...++++.+++.+||+.+|++|||++++|++
T Consensus       233 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         233 FYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence               0011223356789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.7e-37  Score=264.88  Aligned_cols=234  Identities=21%  Similarity=0.280  Sum_probs=183.2

Q ss_pred             cee-eEEeEEeecCceEEEEEE----EcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee-
Q psy9858          55 LVY-YQWRSVHVGRFATVFKAR----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY-  128 (307)
Q Consensus        55 ~~y-~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-  128 (307)
                      ++| ++++.||+|+||+||++.    ...++..||+|++....    .......+.+|++++++++||||+++++++.. 
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   78 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC----GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ   78 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc----ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            345 899999999999998764    33578899999987432    11234567899999999999999999998765 


Q ss_pred             -cCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         129 -MSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       129 -~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                       ....+++|||+ .|+|.+++...  .+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..
T Consensus        79 ~~~~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  156 (283)
T cd05080          79 GGKGLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  156 (283)
T ss_pred             CCceEEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccc
Confidence             34689999999 57888888664  389999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCcc---cccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCC-------------CCC---
Q psy9858         207 FGSPTRL---YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFP-------------GIP---  260 (307)
Q Consensus       207 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~-------------~~~---  260 (307)
                      .......   .....++..|+|||.+.+. .++.++|||   +    +++|..|+......             ...   
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd05080         157 VPEGHEYYRVREDGDSPVFWYAVECLKEN-KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE  235 (283)
T ss_pred             cCCcchhhccCCCCCCCceeeCHhHhccc-CCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhh
Confidence            6432221   1222456679999998876 789999999   2    33377776541100             000   


Q ss_pred             ------hhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         261 ------LNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       261 ------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                            ....+..++.++.+++.+||+.||++|||++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                  00112346789999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.1e-37  Score=262.28  Aligned_cols=234  Identities=20%  Similarity=0.237  Sum_probs=185.7

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|++.+.||+|++|.||+|.+..+ ..+|+|.+....      .....+.+|+++++.++|+|++++++++. .+..
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~   75 (260)
T cd05069           4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT------MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPI   75 (260)
T ss_pred             ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC------ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCc
Confidence            346799999999999999999987544 469999876421      12356789999999999999999998875 4568


Q ss_pred             EEEEEcc-CCChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      +++|||+ +|+|.+++... ...+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++......
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05069          76 YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN  155 (260)
T ss_pred             EEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence            9999999 57899988754 334788999999999999999999999999999999999999999999999999876432


Q ss_pred             Cc-ccccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCCC-------CChhhhccccCHHHHH
Q psy9858         211 TR-LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFPG-------IPLNEIFTAAGDDLLA  274 (307)
Q Consensus       211 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~~-------~~~~~~~~~~~~~l~~  274 (307)
                      .. ......++..|+|||...+. .++.++|+|       .+++ |..||.+.....       ......+...+..+.+
T Consensus       156 ~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (260)
T cd05069         156 EYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHE  234 (260)
T ss_pred             cccccCCCccchhhCCHHHhccC-CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence            21 11223456789999998877 789999999       2334 788887632111       0011223457889999


Q ss_pred             HHHHhhhcCCCCCCCHHHHhc
Q psy9858         275 VISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       275 li~~~l~~dP~~Rpt~~~il~  295 (307)
                      ++.+||+.||++|||++++++
T Consensus       235 li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         235 LMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHHccCCcccCcCHHHHHH
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-37  Score=262.03  Aligned_cols=232  Identities=21%  Similarity=0.242  Sum_probs=189.8

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|++.+.||.|++|.||+|..  .|+.||+|.+.....      ..+.+.+|+.+++.++|+||+++++++.+....
T Consensus         4 ~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   75 (256)
T cd05039           4 NSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST------AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPL   75 (256)
T ss_pred             ChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh------HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCe
Confidence            456899999999999999999985  478899999874321      246788999999999999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      ++||||+ +++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.++.....
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~  155 (256)
T cd05039          76 YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG  155 (256)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc
Confidence            9999999 478998887554 25899999999999999999999999999999999999999999999999999876322


Q ss_pred             Ccccccceeeceehhhhhhhccccccccccee---ee----ee-cCCCCCCCCCCC-------CChhhhccccCHHHHHH
Q psy9858         211 TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FA-KDPSSHGNLFPG-------IPLNEIFTAAGDDLLAV  275 (307)
Q Consensus       211 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~-~~~~f~~~~~~~-------~~~~~~~~~~~~~l~~l  275 (307)
                      .   .....+..|+|||.+.+. .++.++|+|   ++    ++ |..||.......       ......+..+++.+.++
T Consensus       156 ~---~~~~~~~~~~ape~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  231 (256)
T cd05039         156 Q---DSGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKV  231 (256)
T ss_pred             c---ccCCCcccccCchhhcCC-cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHH
Confidence            1   122445679999998876 788999999   22    22 788876632211       00112234578999999


Q ss_pred             HHHhhhcCCCCCCCHHHHhcC
Q psy9858         276 ISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       276 i~~~l~~dP~~Rpt~~~il~h  296 (307)
                      |.+||+.+|++|||++++++.
T Consensus       232 i~~~l~~~p~~Rp~~~~l~~~  252 (256)
T cd05039         232 MKDCWELDPAKRPTFKQLREQ  252 (256)
T ss_pred             HHHHhccChhhCcCHHHHHHH
Confidence            999999999999999999863

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.2e-37  Score=267.93  Aligned_cols=235  Identities=20%  Similarity=0.276  Sum_probs=185.4

Q ss_pred             eeeEEeEEeecCceEEEEEEEcC-----CCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIE-----TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS  130 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  130 (307)
                      +|++.+.||+|+||.||+|.+..     ....+++|.+....    .......+.+|+.+++.++||||+++++.+...+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   76 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA----SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG   76 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC----CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence            47889999999999999998643     23578888886432    1222456889999999999999999999999999


Q ss_pred             eEEEEEEcc-CCChHHHHhCC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCC
Q psy9858         131 NVSLVFEFV-DTDLEVIIKDP-----------------------TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPN  186 (307)
Q Consensus       131 ~~~lv~e~~-~g~l~~~~~~~-----------------------~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~  186 (307)
                      ..+++|||+ +|+|.+++...                       ...+++..+..++.|++.||.|||+.|++||||||+
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~  156 (290)
T cd05045          77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAAR  156 (290)
T ss_pred             CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhh
Confidence            999999999 58888877532                       123778899999999999999999999999999999


Q ss_pred             cEEEecCCcEEEEeecCccccCCCCcc--cccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCC
Q psy9858         187 NLLINKQGVLKIGDFGLAKFFGSPTRL--YTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLF  256 (307)
Q Consensus       187 Nil~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~  256 (307)
                      ||++++++.++|+|||+++........  .....++..|+|||.+.+. .++.++|||       .+++ |..||.+...
T Consensus       157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~  235 (290)
T cd05045         157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP  235 (290)
T ss_pred             eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC-CcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence            999999999999999999865322211  1222456789999998776 789999999       2333 8888866321


Q ss_pred             CC-------CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         257 PG-------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       257 ~~-------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      ..       ......+..++.++.+++.+||+.||++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         236 ERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            11       0011123457889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG4645|consensus

Probab=100.00  E-value=3.6e-39  Score=303.16  Aligned_cols=248  Identities=21%  Similarity=0.289  Sum_probs=205.1

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN  131 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  131 (307)
                      ...-+|.....||.|.||.||.|.+..+|...|+|.+......   ....+...+|..++..++|||+|+++++-.+...
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~---~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek 1308 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD---HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK 1308 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc---cccCcchHHHHHHHHhccCccccccCceeecHHH
Confidence            3445788889999999999999999999999999998764322   3345667899999999999999999999999999


Q ss_pred             EEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         132 VSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       132 ~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      .+|.|||| +|+|.++....+ ..++...+.+..|++.|++|||++|||||||||.||+++.+|.+|++|||.|..+..+
T Consensus      1309 v~IFMEyC~~GsLa~ll~~gr-i~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEHGR-IEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred             HHHHHHHhccCcHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCc
Confidence            99999999 677877776543 4678888889999999999999999999999999999999999999999999988544


Q ss_pred             Cc----ccccceeeceehhhhhhhccc--cccccccee---eeee----cCCCCCCC--------CCCCCChhhhccccC
Q psy9858         211 TR----LYTHQVVTRWYRLIKCLLYCV--QFNVKNVQW---CCFA----KDPSSHGN--------LFPGIPLNEIFTAAG  269 (307)
Q Consensus       211 ~~----~~~~~~~t~~y~aPE~~~~~~--~~~~~~Diw---~i~~----~~~~f~~~--------~~~~~~~~~~~~~~~  269 (307)
                      ..    ......||+.|||||++.+..  ...-++|||   |++.    |+.|+..-        .........++..+|
T Consensus      1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls 1467 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLS 1467 (1509)
T ss_pred             hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhh
Confidence            21    223568999999999998753  356799999   4433    88887661        111222334455689


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         270 DDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       270 ~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      .+..++|.+||..||++|.++.|+++|-|=+...
T Consensus      1468 ~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~ 1501 (1509)
T KOG4645|consen 1468 SEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCT 1501 (1509)
T ss_pred             HhHHHHHHHHHhcCchhhhHHHHHHHhhcccccc
Confidence            9999999999999999999999999998866543

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-37  Score=261.96  Aligned_cols=236  Identities=20%  Similarity=0.227  Sum_probs=190.0

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN  131 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  131 (307)
                      ...++|.+.+.||+|+||.||+|.+. +++.||+|.+.....      ....+.+|+.+++.++|+||+++++++.....
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM------SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEP   75 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc------CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCc
Confidence            35678999999999999999999964 567899999874321      13568899999999999999999999998899


Q ss_pred             EEEEEEcc-CCChHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCC
Q psy9858         132 VSLVFEFV-DTDLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS  209 (307)
Q Consensus       132 ~~lv~e~~-~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  209 (307)
                      .+++|||+ +++|.+++.... ..++...+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus        76 ~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~  155 (261)
T cd05034          76 IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIED  155 (261)
T ss_pred             eEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccc
Confidence            99999999 578988887643 4589999999999999999999999999999999999999999999999999987643


Q ss_pred             CCcc-cccceeeceehhhhhhhccccccccccee---e----eee-cCCCCCCCCCCC-------CChhhhccccCHHHH
Q psy9858         210 PTRL-YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPSSHGNLFPG-------IPLNEIFTAAGDDLL  273 (307)
Q Consensus       210 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~f~~~~~~~-------~~~~~~~~~~~~~l~  273 (307)
                      .... ......+..|+|||.+.+. .++.++|+|   +    +++ |..||.+.....       ......+...+.++.
T Consensus       156 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (261)
T cd05034         156 DEYTAREGAKFPIKWTAPEAANYG-RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELY  234 (261)
T ss_pred             hhhhhhhccCCCccccCHHHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence            2111 1112235689999999877 789999999   2    233 888886632111       001112234678999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhc
Q psy9858         274 AVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       274 ~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      +++.+||+.||.+|||++++++
T Consensus       235 ~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         235 DLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHHHcccCcccCCCHHHHHH
Confidence            9999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.7e-37  Score=260.86  Aligned_cols=235  Identities=19%  Similarity=0.267  Sum_probs=189.1

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEE
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVS  133 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  133 (307)
                      ..+|++.+.||+|+||.||+|.+. ++..+|+|.+......      ...+.+|++++++++|||++++++++......+
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS------EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPIC   75 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC------HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceE
Confidence            457899999999999999999874 4678999988643211      345789999999999999999999999999999


Q ss_pred             EEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc
Q psy9858         134 LVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR  212 (307)
Q Consensus       134 lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  212 (307)
                      ++|||+ +++|.+++......+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++........
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  155 (256)
T cd05112          76 LVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY  155 (256)
T ss_pred             EEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence            999999 5788888876655688999999999999999999999999999999999999999999999999986643211


Q ss_pred             c-cccceeeceehhhhhhhccccccccccee---ee----ee-cCCCCCCCCCCC-------CChhhhccccCHHHHHHH
Q psy9858         213 L-YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FA-KDPSSHGNLFPG-------IPLNEIFTAAGDDLLAVI  276 (307)
Q Consensus       213 ~-~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~-~~~~f~~~~~~~-------~~~~~~~~~~~~~l~~li  276 (307)
                      . .....++..|+|||.+.+. .++.++|+|   ++    ++ |..||.......       ......+...++.+.+|+
T Consensus       156 ~~~~~~~~~~~~~aPe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  234 (256)
T cd05112         156 TSSTGTKFPVKWSSPEVFSFS-KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELM  234 (256)
T ss_pred             cccCCCccchhhcCHhHhccC-CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHH
Confidence            1 1122345789999999876 789999999   22    33 788886532111       001111233688999999


Q ss_pred             HHhhhcCCCCCCCHHHHhcC
Q psy9858         277 SSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       277 ~~~l~~dP~~Rpt~~~il~h  296 (307)
                      .+||+.+|++|||+++++++
T Consensus       235 ~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         235 QHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHHcccChhhCCCHHHHHHh
Confidence            99999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=9.6e-38  Score=260.85  Aligned_cols=219  Identities=18%  Similarity=0.176  Sum_probs=178.5

Q ss_pred             cCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEEEcc-CCChH
Q psy9858          66 GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFV-DTDLE  144 (307)
Q Consensus        66 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~-~g~l~  144 (307)
                      |.+|.||++++..+++.||+|.+....          .+.+|...+....||||+++++++......+++|||+ +|+|.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   73 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS----------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLW   73 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh----------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHH
Confidence            899999999999999999999987531          1234555556667999999999999999999999999 57888


Q ss_pred             HHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcccccceeeceeh
Q psy9858         145 VIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYR  224 (307)
Q Consensus       145 ~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~  224 (307)
                      +++.+.. .+++..+..++.|++.||.|||+.|++||||||+||+++.++.++++|||.+......   .....++..|+
T Consensus        74 ~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y~  149 (237)
T cd05576          74 SHISKFL-NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMYC  149 (237)
T ss_pred             HHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCcccc
Confidence            8886554 4899999999999999999999999999999999999999999999999988765432   12334567899


Q ss_pred             hhhhhhccccccccccee---ee----eecCCCCCCCCCCC--CChhhhccccCHHHHHHHHHhhhcCCCCCCCH-----
Q psy9858         225 LIKCLLYCVQFNVKNVQW---CC----FAKDPSSHGNLFPG--IPLNEIFTAAGDDLLAVISSLLCLNPTKRADC-----  290 (307)
Q Consensus       225 aPE~~~~~~~~~~~~Diw---~i----~~~~~~f~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----  290 (307)
                      |||.+.+. .++.++|+|   ++    +.|..++.......  ......+..+++.+.++|.+||+.||.+|||+     
T Consensus       150 aPE~~~~~-~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~  228 (237)
T cd05576         150 APEVGGIS-EETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGV  228 (237)
T ss_pred             CCcccCCC-CCCchhhHHHHHHHHHHHHHCcchhhcCchhcccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccch
Confidence            99998776 788999999   23    33777765432211  11112345678999999999999999999996     


Q ss_pred             HHHhcCccc
Q psy9858         291 TATLKMDYF  299 (307)
Q Consensus       291 ~~il~hp~f  299 (307)
                      +++++||||
T Consensus       229 ~~~~~h~~~  237 (237)
T cd05576         229 EDIKSHPFF  237 (237)
T ss_pred             HHHHcCCCC
Confidence            999999998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-37  Score=261.46  Aligned_cols=228  Identities=22%  Similarity=0.297  Sum_probs=182.0

Q ss_pred             eEEeecCceEEEEEEEcCCC---cEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEEE
Q psy9858          61 RSVHVGRFATVFKARDIETD---MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFE  137 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  137 (307)
                      +.||+|+||.||+|.+...+   ..||+|.+......    ...+.+.+|+++++.+.|+||+++++++. ....+++||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e   75 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA----AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVME   75 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch----HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEE
Confidence            46999999999999865544   78999998754322    23467889999999999999999999775 456899999


Q ss_pred             cc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCccccc
Q psy9858         138 FV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTH  216 (307)
Q Consensus       138 ~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  216 (307)
                      |+ +|+|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||+++...........
T Consensus        76 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~  154 (257)
T cd05060          76 LAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA  154 (257)
T ss_pred             eCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence            99 578998887654 5899999999999999999999999999999999999999999999999999876433322211


Q ss_pred             ---ceeeceehhhhhhhccccccccccee---e----eee-cCCCCCCCCCC-------CCChhhhccccCHHHHHHHHH
Q psy9858         217 ---QVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPSSHGNLFP-------GIPLNEIFTAAGDDLLAVISS  278 (307)
Q Consensus       217 ---~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~f~~~~~~-------~~~~~~~~~~~~~~l~~li~~  278 (307)
                         ..++..|+|||.+.+. .++.++|||   +    +++ |..||......       .......+..++..+.+++.+
T Consensus       155 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  233 (257)
T cd05060         155 TTAGRWPLKWYAPECINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLS  233 (257)
T ss_pred             ccCccccccccCHHHhcCC-CCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence               1224579999999877 799999999   2    333 78888652211       111112334678899999999


Q ss_pred             hhhcCCCCCCCHHHHhc
Q psy9858         279 LLCLNPTKRADCTATLK  295 (307)
Q Consensus       279 ~l~~dP~~Rpt~~~il~  295 (307)
                      ||..||++|||+.++++
T Consensus       234 cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         234 CWKYRPEDRPTFSELES  250 (257)
T ss_pred             HhcCChhhCcCHHHHHH
Confidence            99999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=4.4e-37  Score=290.85  Aligned_cols=149  Identities=28%  Similarity=0.419  Sum_probs=133.0

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEE
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVS  133 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  133 (307)
                      .++|.+++.||+|+||+||+|.+..+++.||||++......  .......+.+|+.+++.++|+||+++++++......|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~--~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~   80 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMI--NKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVY   80 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhcc--CHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEE
Confidence            57899999999999999999999999999999999754322  2223466889999999999999999999999999999


Q ss_pred             EEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcc
Q psy9858         134 LVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK  205 (307)
Q Consensus       134 lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  205 (307)
                      +||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++
T Consensus        81 lVmEy~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          81 LVMEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999 678888886543 58899999999999999999999999999999999999999999999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0696|consensus

Probab=100.00  E-value=6.9e-39  Score=270.07  Aligned_cols=247  Identities=23%  Similarity=0.263  Sum_probs=209.2

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeeecCe
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGYMSN  131 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~  131 (307)
                      ...+|..+..||.|+||+|.+|..+.+.+.+|||++++...-...+.  .--..|-++|+-. +-|.+++++.+|+..++
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDv--ectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDV--ECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcc--cceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            34578899999999999999999999999999999987655443332  2234677887766 57899999999999999


Q ss_pred             EEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         132 VSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       132 ~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      +|+||||+ +|+|...+++-+ .+.+..+..++..|+.||-+||++||++||||.+||+++.+|++||+|||+++..--+
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~  503 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD  503 (683)
T ss_pred             eeeEEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC
Confidence            99999999 688888887765 4889999999999999999999999999999999999999999999999999876555


Q ss_pred             Ccccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCCCCh------hhhccccCHHHHHHHH
Q psy9858         211 TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPGIPL------NEIFTAAGDDLLAVIS  277 (307)
Q Consensus       211 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~~~~------~~~~~~~~~~l~~li~  277 (307)
                      .....+.+||+.|+|||++... .|+..+|.|       .+++|.+||++......-.      -..+..+|.++.++.+
T Consensus       504 ~~TTkTFCGTPdYiAPEIi~Yq-PYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ick  582 (683)
T KOG0696|consen  504 GVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAICK  582 (683)
T ss_pred             CcceeeecCCCcccccceEEec-ccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHHH
Confidence            5566778999999999999999 999999999       5666999999954432211      1234568999999999


Q ss_pred             HhhhcCCCCCCCH-----HHHhcCcccCCCc
Q psy9858         278 SLLCLNPTKRADC-----TATLKMDYFSLTK  303 (307)
Q Consensus       278 ~~l~~dP~~Rpt~-----~~il~hp~f~~~~  303 (307)
                      ..|.+.|.+|..+     .+|-+||||..++
T Consensus       583 g~ltK~P~kRLGcg~~ge~di~~H~FFR~iD  613 (683)
T KOG0696|consen  583 GLLTKHPGKRLGCGPEGERDIREHPFFRRID  613 (683)
T ss_pred             HHhhcCCccccCCCCccccchhhCcchhhcc
Confidence            9999999999874     7899999998764

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.2e-37  Score=262.60  Aligned_cols=238  Identities=18%  Similarity=0.291  Sum_probs=189.2

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCC---CcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIET---DMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM  129 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  129 (307)
                      ..++|.+.+.||+|+||.||+|.+...   ...||+|......    .....+.+.+|+++++.++|+||+++++++.+ 
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~----~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-   78 (270)
T cd05056           4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT----SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-   78 (270)
T ss_pred             chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC----CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-
Confidence            345789999999999999999986543   3568999886432    12234578899999999999999999998865 


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                      ...+++|||+ .|+|.+++......+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          79 NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecc
Confidence            5578999999 688999987765568999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCcc-cccceeeceehhhhhhhccccccccccee---ee----e-ecCCCCCCCCCCC-------CChhhhccccCHHH
Q psy9858         209 SPTRL-YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----F-AKDPSSHGNLFPG-------IPLNEIFTAAGDDL  272 (307)
Q Consensus       209 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~-~~~~~f~~~~~~~-------~~~~~~~~~~~~~l  272 (307)
                      ..... .....++..|+|||.+... .++.++|||   ++    + .|..||.......       ......+..++.++
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (270)
T cd05056         159 DESYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL  237 (270)
T ss_pred             cccceecCCCCccccccChhhhccC-CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHH
Confidence            33211 1122334679999998776 789999999   22    2 3888887632211       11112335678999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         273 LAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       273 ~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      .+++.+||..+|.+|||+.++++.
T Consensus       238 ~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         238 YSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG0587|consensus

Probab=100.00  E-value=8.8e-37  Score=277.69  Aligned_cols=248  Identities=19%  Similarity=0.272  Sum_probs=205.4

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeee
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFG  127 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~  127 (307)
                      .+....+.|++.+.||.|.+|.||++++..+|+.+|+|+.......      ..+...|..+|+.. +|||++.+++++.
T Consensus        13 ~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~------deEiE~eynil~~~~~hpnv~~fyg~~~   86 (953)
T KOG0587|consen   13 SLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE------EEEIELEYNMLKKYSHHPNVATFYGAFI   86 (953)
T ss_pred             hCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc------cHHHHHHHHHHHhccCCCCcceEEEEEE
Confidence            3445677899999999999999999999999999999998864322      23345688888887 6999999999985


Q ss_pred             -----ecCeEEEEEEcc-CCChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEe
Q psy9858         128 -----YMSNVSLVFEFV-DTDLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGD  200 (307)
Q Consensus       128 -----~~~~~~lv~e~~-~g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~D  200 (307)
                           .++.+||||||| +|+.-|+++.. +..+.|..+..|++.++.||.|||+..++|||||-.|||++.++.|||+|
T Consensus        87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvD  166 (953)
T KOG0587|consen   87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVD  166 (953)
T ss_pred             EecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEee
Confidence                 357899999999 67777777642 55689999999999999999999999999999999999999999999999


Q ss_pred             ecCccccCCCCcccccceeeceehhhhhhhcc----ccccccccee--eeee-----cCCCCCCC--------CCCCCC-
Q psy9858         201 FGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYC----VQFNVKNVQW--CCFA-----KDPSSHGN--------LFPGIP-  260 (307)
Q Consensus       201 fg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~~Diw--~i~~-----~~~~f~~~--------~~~~~~-  260 (307)
                      ||++..........++.+||+.|||||++...    ..|+..+|+|  +|.+     |.+|+...        .....+ 
T Consensus       167 FGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPP  246 (953)
T KOG0587|consen  167 FGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPP  246 (953)
T ss_pred             eeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCc
Confidence            99999987776777888999999999999754    3578899999  5544     88888771        111111 


Q ss_pred             hhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         261 LNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       261 ~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                      ....++.=+.++.++|..||.+|-++||+..++|+|||++..
T Consensus       247 kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~  288 (953)
T KOG0587|consen  247 KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ  288 (953)
T ss_pred             cccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence            111134557899999999999999999999999999999843

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-37  Score=259.65  Aligned_cols=229  Identities=20%  Similarity=0.294  Sum_probs=184.6

Q ss_pred             eEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEEEcc-
Q psy9858          61 RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFV-  139 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~-  139 (307)
                      +.||+|++|.||+|.+.. ++.||+|++......    .....+.+|++++++++|+||+++++++......+++|||+ 
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   75 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP----DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVP   75 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCH----HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCC
Confidence            468999999999999876 999999988753221    23467889999999999999999999999999999999999 


Q ss_pred             CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCccc--ccc
Q psy9858         140 DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY--THQ  217 (307)
Q Consensus       140 ~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~--~~~  217 (307)
                      +++|.+++......++...+..++.+++.||.|||++|++||||+|+||+++.++.++|+|||++..........  ...
T Consensus        76 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          76 GGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            677888887665568899999999999999999999999999999999999999999999999998654221111  112


Q ss_pred             eeeceehhhhhhhccccccccccee---ee----ee-cCCCCCCCCCCC-------CChhhhccccCHHHHHHHHHhhhc
Q psy9858         218 VVTRWYRLIKCLLYCVQFNVKNVQW---CC----FA-KDPSSHGNLFPG-------IPLNEIFTAAGDDLLAVISSLLCL  282 (307)
Q Consensus       218 ~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~-~~~~f~~~~~~~-------~~~~~~~~~~~~~l~~li~~~l~~  282 (307)
                      ..+..|+|||.+.+. .++.++|+|   ++    ++ |..||.......       ......+..++.++.+++.+||+.
T Consensus       156 ~~~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  234 (251)
T cd05041         156 QIPIKWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAY  234 (251)
T ss_pred             cceeccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhcc
Confidence            335679999998877 789999999   22    32 777776522110       001112335678999999999999


Q ss_pred             CCCCCCCHHHHhc
Q psy9858         283 NPTKRADCTATLK  295 (307)
Q Consensus       283 dP~~Rpt~~~il~  295 (307)
                      +|.+|||++++++
T Consensus       235 ~p~~Rp~~~ell~  247 (251)
T cd05041         235 DPENRPSFSEIYN  247 (251)
T ss_pred             ChhhCcCHHHHHH
Confidence            9999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG1290|consensus

Probab=100.00  E-value=7.3e-37  Score=262.29  Aligned_cols=130  Identities=36%  Similarity=0.474  Sum_probs=113.9

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-----C---CCccccceee
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-----H---ENVLGLTDVF  126 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~ni~~~~~~~  126 (307)
                      .+|-+.++||.|-|++||+|++..+.+.||+|+.+.      -+.+.+....|+++|++++     |   ..||+|++.|
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS------AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F  151 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS------AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF  151 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh------hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence            699999999999999999999999999999999873      2334566789999999984     2   4699999999


Q ss_pred             ee----cCeEEEEEEccCCChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC-CceeecCCCCcEEE
Q psy9858         127 GY----MSNVSLVFEFVDTDLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDH-WILHRDLKPNNLLI  190 (307)
Q Consensus       127 ~~----~~~~~lv~e~~~g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~  190 (307)
                      ..    +.++|+|+|+++.+|+.++... .+.++...+++|++||+.||.|||.. ||||.||||+|||+
T Consensus       152 khsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  152 KHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL  221 (590)
T ss_pred             eecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence            64    5689999999999999999754 33489999999999999999999976 99999999999994

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=5.4e-37  Score=262.56  Aligned_cols=238  Identities=18%  Similarity=0.188  Sum_probs=188.5

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcC----CCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIE----TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY  128 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  128 (307)
                      ..++|.+.+.||+|+||.||+|.+..    ++..|++|++...    ........+.+|+.+++.++|+||+++++++..
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~   79 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH----ASEIQVTLLLQESCLLYGLSHQNILPILHVCIE   79 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            45789999999999999999999765    3688999987632    222335668899999999999999999998655


Q ss_pred             -cCeEEEEEEcc-CCChHHHHhCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEE
Q psy9858         129 -MSNVSLVFEFV-DTDLEVIIKDPT-------IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIG  199 (307)
Q Consensus       129 -~~~~~lv~e~~-~g~l~~~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~  199 (307)
                       ....+++++|+ .|+|.+++....       ..+++..+..++.||+.||.|||+++++|+||||+||+++.++.+||+
T Consensus        80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEEC
Confidence             57789999999 588888876432       348899999999999999999999999999999999999999999999


Q ss_pred             eecCccccCCCCc--ccccceeeceehhhhhhhccccccccccee---e----eee-cCCCCCCCCCCC-------CChh
Q psy9858         200 DFGLAKFFGSPTR--LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPSSHGNLFPG-------IPLN  262 (307)
Q Consensus       200 Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~f~~~~~~~-------~~~~  262 (307)
                      |||+++.......  ......++..|+|||.+.+. .++.++|||   +    ++. |++||.......       ....
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~  238 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK-EYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRL  238 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhcC-CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCC
Confidence            9999986533221  11223456789999999877 789999999   2    233 888887622100       0001


Q ss_pred             hhccccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         263 EIFTAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       263 ~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      .....+++++.+++.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         239 AQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            122356889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.6e-36  Score=259.93  Aligned_cols=237  Identities=20%  Similarity=0.279  Sum_probs=189.4

Q ss_pred             ceeeEEeEEeecCceEEEEEEEc----CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee--
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDI----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY--  128 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--  128 (307)
                      ..|++.+.||+|+||.||+|.+.    .+++.||+|++......    .....+.+|+++++.++|+||+++++++..  
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~   79 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE----QHRSDFEREIEILRTLDHENIVKYKGVCEKPG   79 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch----HHHHHHHHHHHHHHhCCCCChheEEeeeecCC
Confidence            46888899999999999999854    34889999999754221    235678899999999999999999998877  


Q ss_pred             cCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         129 MSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       129 ~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      ....+++|||+ +++|.+++......+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||.+...
T Consensus        80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL  159 (284)
T ss_pred             CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence            56899999999 67899988776656899999999999999999999999999999999999999999999999999887


Q ss_pred             CCCCcc---cccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCCCC-----------------
Q psy9858         208 GSPTRL---YTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPGIP-----------------  260 (307)
Q Consensus       208 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~~~-----------------  260 (307)
                      ......   .....++..|+|||.+.+. .++.++|+|       .+++|..|+.........                 
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05038         160 PEDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL  238 (284)
T ss_pred             ccCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence            532211   1122445679999999877 889999999       344477776552211100                 


Q ss_pred             -----hhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         261 -----LNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       261 -----~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                           ....+..++.++.+++.+||+.||++|||+.++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  279 (284)
T cd05038         239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILI  279 (284)
T ss_pred             HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence                 001123456889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3e-37  Score=267.21  Aligned_cols=237  Identities=17%  Similarity=0.233  Sum_probs=187.2

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCc----EEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDM----IVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM  129 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  129 (307)
                      .++|+..+.||+|+||.||+|.+..+|.    .||+|.+....    .......+.+|+.+++.++||||+++++++...
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~   81 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT----GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP   81 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC----CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence            4578899999999999999999877775    57888876422    222234678999999999999999999988654


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                       ..++++||+ +|+|.+++......+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||+++...
T Consensus        82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence             567899999 588999988766568999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCcc--cccceeeceehhhhhhhccccccccccee---ee----ee-cCCCCCCCCCCC-------CChhhhccccCHH
Q psy9858         209 SPTRL--YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FA-KDPSSHGNLFPG-------IPLNEIFTAAGDD  271 (307)
Q Consensus       209 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~-~~~~f~~~~~~~-------~~~~~~~~~~~~~  271 (307)
                      .....  .....++..|+|||.+.+. .++.++|||   ++    ++ |..||.+.....       ......+..++..
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYR-KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTID  239 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccC-CCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHH
Confidence            32221  1223456789999998876 789999999   22    22 777876522110       0111122346788


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         272 LLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       272 l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      +.+++.+||..||++|||++++++.
T Consensus       240 ~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         240 VYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999998874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-37  Score=261.87  Aligned_cols=229  Identities=21%  Similarity=0.299  Sum_probs=179.6

Q ss_pred             eEEeecCceEEEEEEEcCCCc--EEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeeecCeEEEEEE
Q psy9858          61 RSVHVGRFATVFKARDIETDM--IVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGYMSNVSLVFE  137 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e  137 (307)
                      +.||+|+||.||+|++..++.  .+++|.+....    .......+.+|++++.++ +||||+++++++...+..+++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e   76 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE   76 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC----CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEE
Confidence            358999999999999877775  46888776321    122245678999999999 79999999999999999999999


Q ss_pred             cc-CCChHHHHhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEee
Q psy9858         138 FV-DTDLEVIIKDPT---------------IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDF  201 (307)
Q Consensus       138 ~~-~g~l~~~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Df  201 (307)
                      |+ +|+|.+++....               ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+||
T Consensus        77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~df  156 (270)
T cd05047          77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF  156 (270)
T ss_pred             eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCC
Confidence            99 688999886432               23788899999999999999999999999999999999999999999999


Q ss_pred             cCccccCCCCcccccceeeceehhhhhhhccccccccccee---e----eee-cCCCCCCCCCCC-------CChhhhcc
Q psy9858         202 GLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPSSHGNLFPG-------IPLNEIFT  266 (307)
Q Consensus       202 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~f~~~~~~~-------~~~~~~~~  266 (307)
                      |++....... .......+..|+|||.+.+. .++.++|+|   +    +++ |..||.+.....       ........
T Consensus       157 gl~~~~~~~~-~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  234 (270)
T cd05047         157 GLSRGQEVYV-KKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL  234 (270)
T ss_pred             CCccccchhh-hccCCCCccccCChHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCC
Confidence            9986432111 11112335679999998776 789999999   2    332 888886532111       11112233


Q ss_pred             ccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         267 AAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       267 ~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      .++.++.+++.+||+.||.+|||+.++++
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         235 NCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             cCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            56789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=8.3e-37  Score=260.68  Aligned_cols=238  Identities=17%  Similarity=0.233  Sum_probs=189.9

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcC-----CCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIE-----TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY  128 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  128 (307)
                      .++|++++.||+|+||.||+|++..     +.+.|++|.+...    ........+.+|++++++++|+||+++++++.+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   79 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT----KDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE   79 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc----cchHHHHHHHHHHHHHHhcCCcceeeeEEEECC
Confidence            3679999999999999999999653     3467999987642    122234668899999999999999999999999


Q ss_pred             cCeEEEEEEcc-CCChHHHHhCCC--------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEE
Q psy9858         129 MSNVSLVFEFV-DTDLEVIIKDPT--------IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIG  199 (307)
Q Consensus       129 ~~~~~lv~e~~-~g~l~~~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~  199 (307)
                      ....++||||+ .|+|.+++....        ..+++..+..++.||+.||+|||+.|++|+||||+||+++.++.++++
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~  159 (275)
T cd05046          80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVS  159 (275)
T ss_pred             CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEc
Confidence            99999999999 578988886543        147899999999999999999999999999999999999999999999


Q ss_pred             eecCccccCCCC-cccccceeeceehhhhhhhccccccccccee---ee----ee-cCCCCCCCCCCC--------CChh
Q psy9858         200 DFGLAKFFGSPT-RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FA-KDPSSHGNLFPG--------IPLN  262 (307)
Q Consensus       200 Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~-~~~~f~~~~~~~--------~~~~  262 (307)
                      |||++....... .......++..|+|||.+.+. ..+.++|||   ++    ++ |..||.......        ....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~  238 (275)
T cd05046         160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQED-DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL  238 (275)
T ss_pred             ccccccccCcccccccCCceeEEeecChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC
Confidence            999987543221 122334667889999998877 688999999   22    22 777876522111        0001


Q ss_pred             hhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         263 EIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       263 ~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      .....++..+.+++.+||+.||++|||+.+++++
T Consensus       239 ~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         239 PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            1234578899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.3e-36  Score=257.50  Aligned_cols=235  Identities=18%  Similarity=0.228  Sum_probs=187.7

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN  131 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  131 (307)
                      ...++|++.+.||+|+||.||++.+. .+..+|+|.+...      ......+.+|+++++.++|+||+++++.+.+ ..
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~   74 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG------SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EP   74 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC------hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CC
Confidence            35678999999999999999999854 5567999988642      1124568899999999999999999998877 78


Q ss_pred             EEEEEEcc-CCChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCC
Q psy9858         132 VSLVFEFV-DTDLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS  209 (307)
Q Consensus       132 ~~lv~e~~-~g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  209 (307)
                      .+++|||+ +|+|.+++... ...++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  154 (260)
T cd05073          75 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED  154 (260)
T ss_pred             eEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence            89999999 57899988753 34578888999999999999999999999999999999999999999999999987643


Q ss_pred             CCcc-cccceeeceehhhhhhhccccccccccee---e----eee-cCCCCCCCCCC-------CCChhhhccccCHHHH
Q psy9858         210 PTRL-YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPSSHGNLFP-------GIPLNEIFTAAGDDLL  273 (307)
Q Consensus       210 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~f~~~~~~-------~~~~~~~~~~~~~~l~  273 (307)
                      .... .....++..|+|||.+.+. .++.++|+|   +    +++ |..||.+....       ...........+.++.
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (260)
T cd05073         155 NEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELY  233 (260)
T ss_pred             CCcccccCCcccccccCHhHhccC-CcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHH
Confidence            2221 1222445679999999876 789999999   2    333 88888763211       1111122345788999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhc
Q psy9858         274 AVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       274 ~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      +++.+||+.||++||++.++++
T Consensus       234 ~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         234 NIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHHHcccCcccCcCHHHHHH
Confidence            9999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=4.8e-37  Score=260.22  Aligned_cols=231  Identities=21%  Similarity=0.247  Sum_probs=178.2

Q ss_pred             eEEeecCceEEEEEEEcC---CCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeee-ecCeEEEEE
Q psy9858          61 RSVHVGRFATVFKARDIE---TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG-YMSNVSLVF  136 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-~~~~~~lv~  136 (307)
                      +.||+|+||.||+|.+..   .+..||+|.+...    ........+.+|+.+++.++||||+++++++. .+...+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI----TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc----CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEE
Confidence            468999999999998653   3467999987532    11222456789999999999999999999764 566789999


Q ss_pred             Ecc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc---
Q psy9858         137 EFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR---  212 (307)
Q Consensus       137 e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~---  212 (307)
                      ||+ +|+|.+++.+.....+...+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||+++.......   
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~  156 (262)
T cd05058          77 PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV  156 (262)
T ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence            999 6889999876655567888889999999999999999999999999999999999999999999976532211   


Q ss_pred             -ccccceeeceehhhhhhhccccccccccee---ee----ee-cCCCCCCCCCCC-------CChhhhccccCHHHHHHH
Q psy9858         213 -LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FA-KDPSSHGNLFPG-------IPLNEIFTAAGDDLLAVI  276 (307)
Q Consensus       213 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~-~~~~f~~~~~~~-------~~~~~~~~~~~~~l~~li  276 (307)
                       ......++..|+|||.+.+. .++.++|||   ++    ++ |.+||.......       .........+++.+.+++
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  235 (262)
T cd05058         157 HNHTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVM  235 (262)
T ss_pred             cccccCcCCccccChhHhccC-ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHH
Confidence             11122446789999998876 789999999   23    23 566665421100       001111234678999999


Q ss_pred             HHhhhcCCCCCCCHHHHhcC
Q psy9858         277 SSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       277 ~~~l~~dP~~Rpt~~~il~h  296 (307)
                      .+||+.+|++|||+.++++.
T Consensus       236 ~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         236 LSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             HHHcCCChhhCCCHHHHHHH
Confidence            99999999999999999864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=8e-37  Score=258.14  Aligned_cols=229  Identities=24%  Similarity=0.281  Sum_probs=184.6

Q ss_pred             eEEeecCceEEEEEEEcC-CC--cEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEEE
Q psy9858          61 RSVHVGRFATVFKARDIE-TD--MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFE  137 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~-~~--~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  137 (307)
                      +.||+|++|.||+|.+.. .+  ..||+|.+......    ...+.+.+|++++++++|+||+++++.+.. ...+++||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e   75 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS----DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTE   75 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH----HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEE
Confidence            468999999999998755 33  36999998754322    345678899999999999999999999888 89999999


Q ss_pred             cc-CCChHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc--
Q psy9858         138 FV-DTDLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL--  213 (307)
Q Consensus       138 ~~-~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~--  213 (307)
                      |+ .|+|.+.+.... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++.........  
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            99 688999887654 46899999999999999999999999999999999999999999999999999877542211  


Q ss_pred             -cccceeeceehhhhhhhccccccccccee---ee----ee-cCCCCCCCCCCC--------CChhhhccccCHHHHHHH
Q psy9858         214 -YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FA-KDPSSHGNLFPG--------IPLNEIFTAAGDDLLAVI  276 (307)
Q Consensus       214 -~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~-~~~~f~~~~~~~--------~~~~~~~~~~~~~l~~li  276 (307)
                       .....++..|+|||.+.+. .++.++|||   ++    +. |..||.......        ......+..++..+.+++
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  234 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTR-TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVM  234 (257)
T ss_pred             cccCCCCCceecCHHHhccc-CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHH
Confidence             1123567789999998877 789999999   22    33 888886521110        111112235678999999


Q ss_pred             HHhhhcCCCCCCCHHHHhc
Q psy9858         277 SSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       277 ~~~l~~dP~~Rpt~~~il~  295 (307)
                      .+||+.+|++|||+.++++
T Consensus       235 ~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         235 LQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHCCCCcccCCCHHHHHH
Confidence            9999999999999999975

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7.9e-38  Score=264.62  Aligned_cols=227  Identities=15%  Similarity=0.170  Sum_probs=179.5

Q ss_pred             eEEeecCceEEEEEEEcCCCc-------EEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEE
Q psy9858          61 RSVHVGRFATVFKARDIETDM-------IVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVS  133 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  133 (307)
                      +.||+|+||.||+|.+...+.       .||+|.+...     .......+.+|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS-----HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch-----hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcE
Confidence            468999999999998765443       4888887532     1223456788999999999999999999999989999


Q ss_pred             EEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCc--------EEEEeecCc
Q psy9858         134 LVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGV--------LKIGDFGLA  204 (307)
Q Consensus       134 lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--------~kl~Dfg~a  204 (307)
                      +||||+ +|+|.+++......+++..+..++.||+.||.|||++||+||||||+||+++.++.        ++++|||++
T Consensus        76 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          76 MVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             EEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence            999999 57888888776656899999999999999999999999999999999999987765        699999998


Q ss_pred             cccCCCCcccccceeeceehhhhhhhccccccccccee---eee----ec-CCCCCCCCCCC-----CChhhhccccCHH
Q psy9858         205 KFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCF----AK-DPSSHGNLFPG-----IPLNEIFTAAGDD  271 (307)
Q Consensus       205 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~----~~-~~~f~~~~~~~-----~~~~~~~~~~~~~  271 (307)
                      ......    ....++..|+|||.+.+...++.++|+|   +++    .| .+|+.......     ......+...+.+
T Consensus       156 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (258)
T cd05078         156 ITVLPK----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWTE  231 (258)
T ss_pred             cccCCc----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHccccCCCCCcHH
Confidence            765322    2235778899999998765689999999   332    25 45654421110     0011223345688


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         272 LLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       272 l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      +.+++.+||+.||++|||++++++.
T Consensus       232 ~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         232 LANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             HHHHHHHHhccChhhCCCHHHHHHh
Confidence            9999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG0196|consensus

Probab=100.00  E-value=1.4e-37  Score=279.53  Aligned_cols=240  Identities=19%  Similarity=0.255  Sum_probs=202.5

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCC---cEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETD---MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY  128 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  128 (307)
                      .+.+.-.+.+.||.|.||.|++|+-+..|   ..||||.++..    ..+..+..|+.|..||.+++||||++|.|+...
T Consensus       626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G----ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk  701 (996)
T KOG0196|consen  626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG----YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK  701 (996)
T ss_pred             cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC----ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec
Confidence            34456788899999999999999866554   67999999854    334446789999999999999999999999999


Q ss_pred             cCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         129 MSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       129 ~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      ..-..||+||+ +|+|..+++.+.+++...++..+++.|++|++||-++|+|||||..+|||++.|-.||++|||+++.+
T Consensus       702 s~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvl  781 (996)
T KOG0196|consen  702 SKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  781 (996)
T ss_pred             CceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeec
Confidence            99999999999 89999999999999999999999999999999999999999999999999999999999999999988


Q ss_pred             CCCCc-ccccce--eeceehhhhhhhccccccccccee--eee------ecCCCCCCCCCCC-------CChhhhccccC
Q psy9858         208 GSPTR-LYTHQV--VTRWYRLIKCLLYCVQFNVKNVQW--CCF------AKDPSSHGNLFPG-------IPLNEIFTAAG  269 (307)
Q Consensus       208 ~~~~~-~~~~~~--~t~~y~aPE~~~~~~~~~~~~Diw--~i~------~~~~~f~~~~~~~-------~~~~~~~~~~~  269 (307)
                      .+... ..++..  -..+|.|||.+... .++.++|||  +|+      +|+.||.....++       .-...-+-.++
T Consensus       782 edd~~~~ytt~GGKIPiRWTAPEAIa~R-KFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP  860 (996)
T KOG0196|consen  782 EDDPEAAYTTLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCP  860 (996)
T ss_pred             ccCCCccccccCCccceeecChhHhhhc-ccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCc
Confidence            65432 222222  25699999999988 999999999  332      3999998832222       11112234689


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         270 DDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       270 ~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      ..|.+|+..||++|-.+||++.||+++
T Consensus       861 ~aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  861 AALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             HHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence            999999999999999999999999874

>KOG1006|consensus

Probab=100.00  E-value=2.3e-38  Score=252.86  Aligned_cols=243  Identities=17%  Similarity=0.247  Sum_probs=198.1

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHh-cCCCCccccceeeeecCe
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQE-LHHENVLGLTDVFGYMSN  131 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~ni~~~~~~~~~~~~  131 (307)
                      ..++.+-+..||.|+||+|++..++.+|+..|||.++....    +...++++.|.+...+ -+.||||+++|+...++.
T Consensus        62 ~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~----~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd  137 (361)
T KOG1006|consen   62 TSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI----EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD  137 (361)
T ss_pred             ccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc----hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc
Confidence            34556777899999999999999999999999999986543    2235778889876555 479999999999999999


Q ss_pred             EEEEEEccCCChHHHHhC----CCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         132 VSLVFEFVDTDLEVIIKD----PTIVFTPSNIKAYAIMTLRGLEYLHDH-WILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       132 ~~lv~e~~~g~l~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                      +|+.||.++-++..+.+.    +...+++..+..|....+.||.||-.. .|+|||+||+|||++..|.+||||||.+..
T Consensus       138 cWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGq  217 (361)
T KOG1006|consen  138 CWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQ  217 (361)
T ss_pred             eeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHh
Confidence            999999998876655532    233589999999999999999999865 899999999999999999999999999987


Q ss_pred             cCCCCcccccceeeceehhhhhhhcccc-ccccccee-------eeeecCCCCCC-------------CCCCCCChhhhc
Q psy9858         207 FGSPTRLYTHQVVTRWYRLIKCLLYCVQ-FNVKNVQW-------CCFAKDPSSHG-------------NLFPGIPLNEIF  265 (307)
Q Consensus       207 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~~Diw-------~i~~~~~~f~~-------------~~~~~~~~~~~~  265 (307)
                      +.+ +...+...|-..|||||.+..... |+.++|+|       .+.+|+.|+.+             ...+......-.
T Consensus       218 Lv~-SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~  296 (361)
T KOG1006|consen  218 LVD-SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKEC  296 (361)
T ss_pred             HHH-HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccc
Confidence            743 344566688899999999976655 99999999       34449999988             111111111112


Q ss_pred             cccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccC
Q psy9858         266 TAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS  300 (307)
Q Consensus       266 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~  300 (307)
                      -+.+..+..+|.-||.+|...||...+++++||+.
T Consensus       297 ~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr  331 (361)
T KOG1006|consen  297 VHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYR  331 (361)
T ss_pred             cccCHHHHHHHHHHhhcccccCcchhhhhcCchhh
Confidence            25789999999999999999999999999999985

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.7e-36  Score=257.96  Aligned_cols=231  Identities=20%  Similarity=0.209  Sum_probs=175.2

Q ss_pred             eEEeecCceEEEEEEEcC--CCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEEEc
Q psy9858          61 RSVHVGRFATVFKARDIE--TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEF  138 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  138 (307)
                      +.||+|+||.||+|....  ....+|+|.+....    .......+.+|+++++.++|+||+++++.+......++||||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~   76 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA----TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEF   76 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccC----ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEe
Confidence            368999999999996432  44578888775321    222245678999999999999999999999999999999999


Q ss_pred             c-CCChHHHHhCCCC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc
Q psy9858         139 V-DTDLEVIIKDPTI----VFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL  213 (307)
Q Consensus       139 ~-~g~l~~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  213 (307)
                      + +|+|.+++.....    ..++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.........
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  156 (269)
T cd05042          77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY  156 (269)
T ss_pred             CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence            9 5789888865432    2467788899999999999999999999999999999999999999999998754322111


Q ss_pred             --cccceeeceehhhhhhhc------cccccccccee---ee----ee-cCCCCCCCCCC------------CCChhhhc
Q psy9858         214 --YTHQVVTRWYRLIKCLLY------CVQFNVKNVQW---CC----FA-KDPSSHGNLFP------------GIPLNEIF  265 (307)
Q Consensus       214 --~~~~~~t~~y~aPE~~~~------~~~~~~~~Diw---~i----~~-~~~~f~~~~~~------------~~~~~~~~  265 (307)
                        .....++..|+|||.+..      ...++.++|||   ++    ++ |..||......            ........
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (269)
T cd05042         157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLD  236 (269)
T ss_pred             eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccc
Confidence              122345678999999753      22578899999   33    22 77777652210            11111223


Q ss_pred             cccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         266 TAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       266 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      ..++..+.+++..|+ .||++|||++++++.
T Consensus       237 ~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~  266 (269)
T cd05042         237 LKYSDRWYEVMQFCW-LDPETRPTAEEVHEL  266 (269)
T ss_pred             ccCCHHHHHHHHHHh-cCcccccCHHHHHHH
Confidence            356788899999998 599999999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.1e-36  Score=256.92  Aligned_cols=229  Identities=22%  Similarity=0.312  Sum_probs=184.5

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|++.+.||+|+||.||++.  .+++.||+|.+....       ....+.+|+.+++.++|||++++++++..+ ..
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~   73 (254)
T cd05083           4 NLQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-------TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GL   73 (254)
T ss_pred             cHHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-------hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-Cc
Confidence            45789999999999999999987  477889999986321       135688999999999999999999988654 47


Q ss_pred             EEEEEcc-CCChHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      +++|||+ +|+|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus        74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~  153 (254)
T cd05083          74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG  153 (254)
T ss_pred             EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence            9999999 578998887543 34789999999999999999999999999999999999999999999999999765322


Q ss_pred             Ccccccceeeceehhhhhhhccccccccccee---e----eee-cCCCCCCCCCCC-------CChhhhccccCHHHHHH
Q psy9858         211 TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPSSHGNLFPG-------IPLNEIFTAAGDDLLAV  275 (307)
Q Consensus       211 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~f~~~~~~~-------~~~~~~~~~~~~~l~~l  275 (307)
                         ......+..|+|||.+.+. .++.++|+|   +    +++ |.+||.......       .........++..+.++
T Consensus       154 ---~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  229 (254)
T cd05083         154 ---VDNSKLPVKWTAPEALKHK-KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVL  229 (254)
T ss_pred             ---CCCCCCCceecCHHHhccC-CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHH
Confidence               1122345689999998876 789999999   2    232 888886632211       01111234578899999


Q ss_pred             HHHhhhcCCCCCCCHHHHhc
Q psy9858         276 ISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       276 i~~~l~~dP~~Rpt~~~il~  295 (307)
                      +.+||+.+|++|||++++++
T Consensus       230 i~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         230 MTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG0614|consensus

Probab=100.00  E-value=4.9e-39  Score=276.87  Aligned_cols=249  Identities=25%  Similarity=0.294  Sum_probs=214.6

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM  129 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  129 (307)
                      ....+.+++++..||-|+||.|-+++.......+|+|++++....+.++  ......|-.||..++.|.||++|..|.++
T Consensus       415 a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQ--qeHv~sEr~Im~~~~s~fIvrLYrTfrd~  492 (732)
T KOG0614|consen  415 AQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQ--QEHVFSERNIMMECRSDFIVRLYRTFRDS  492 (732)
T ss_pred             cccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhH--HHHHHhHHHHHHhcCchHHHHHHHHhccc
Confidence            3456678899999999999999999866555568999998876665544  45677899999999999999999999999


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                      .++|++||-| +|.+...+..++ .+.+..++.++..+++|+.|||++|||+|||||+|.+++.+|-+||.|||+|+.++
T Consensus       493 kyvYmLmEaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~  571 (732)
T KOG0614|consen  493 KYVYMLMEACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG  571 (732)
T ss_pred             hhhhhhHHhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc
Confidence            9999999999 888988887765 69999999999999999999999999999999999999999999999999999997


Q ss_pred             CCCcccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCC--------CCCCChhhhccccCHHHH
Q psy9858         209 SPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNL--------FPGIPLNEIFTAAGDDLL  273 (307)
Q Consensus       209 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~--------~~~~~~~~~~~~~~~~l~  273 (307)
                      +.... -+.+||+.|.|||++... ..+.++|.|       .++.|.+||.+..        ......-+++..++....
T Consensus       572 ~g~KT-wTFcGTpEYVAPEIILnK-GHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~  649 (732)
T KOG0614|consen  572 SGRKT-WTFCGTPEYVAPEIILNK-GHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTAT  649 (732)
T ss_pred             cCCce-eeecCCcccccchhhhcc-CcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHH
Confidence            65443 457999999999999998 889999999       4555999999821        222233345567899999


Q ss_pred             HHHHHhhhcCCCCCCC-----HHHHhcCcccCCCc
Q psy9858         274 AVISSLLCLNPTKRAD-----CTATLKMDYFSLTK  303 (307)
Q Consensus       274 ~li~~~l~~dP~~Rpt-----~~~il~hp~f~~~~  303 (307)
                      +||+++...+|.+|..     +.+|-.|.||.+.+
T Consensus       650 ~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfd  684 (732)
T KOG0614|consen  650 DLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFD  684 (732)
T ss_pred             HHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCC
Confidence            9999999999999997     89999999998754

>KOG1027|consensus

Probab=100.00  E-value=2.6e-37  Score=279.85  Aligned_cols=238  Identities=24%  Similarity=0.241  Sum_probs=188.3

Q ss_pred             eeEEeEEeecCceE-EEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeeecCeEEE
Q psy9858          57 YYQWRSVHVGRFAT-VFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        57 y~~~~~lg~G~~g~-V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~l  134 (307)
                      |.-.+.+|.|+.|+ ||+|.  ..|+.||||.+-..        ......+|+..|+.. +||||+++++.-.+....||
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~e--------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YI  580 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGV--YEGREVAVKRLLEE--------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYI  580 (903)
T ss_pred             eccHHHcccCCCCcEEEEEe--eCCceehHHHHhhH--------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEE
Confidence            34446778888886 78997  57889999987531        244567999999998 59999999999899999999


Q ss_pred             EEEccCCChHHHHhCC--CCCC-CHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEec---CC--cEEEEeecCccc
Q psy9858         135 VFEFVDTDLEVIIKDP--TIVF-TPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK---QG--VLKIGDFGLAKF  206 (307)
Q Consensus       135 v~e~~~g~l~~~~~~~--~~~~-~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~---~~--~~kl~Dfg~a~~  206 (307)
                      ..|.|..+|.+++...  .... .....+.++.|+++||+|||+.+||||||||.||||+.   ++  .++|+|||+++.
T Consensus       581 alELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk  660 (903)
T KOG1027|consen  581 ALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK  660 (903)
T ss_pred             EehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence            9999999999999874  1111 11345788999999999999999999999999999986   33  689999999998


Q ss_pred             cCCCCc---ccccceeeceehhhhhhhccccccccccee---eeee-----cCCCCCCCCCCCCC-------hhhhcccc
Q psy9858         207 FGSPTR---LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA-----KDPSSHGNLFPGIP-------LNEIFTAA  268 (307)
Q Consensus       207 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~-----~~~~f~~~~~~~~~-------~~~~~~~~  268 (307)
                      ......   ......||-+|+|||++... .-+.++|||   |+++     |.+||+.....+..       ...+.+.-
T Consensus       661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~-~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~~~  739 (903)
T KOG1027|consen  661 LAGGKSSFSRLSGGSGTSGWQAPEQLRED-RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEPLP  739 (903)
T ss_pred             cCCCcchhhcccCCCCcccccCHHHHhcc-ccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeeccCc
Confidence            864332   23456789999999999988 667799999   7776     89999983332211       11111111


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCccc
Q psy9858         269 GDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKEM  305 (307)
Q Consensus       269 ~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~~  305 (307)
                      ..++.+||.+|++.||..||+|.++|.||+|+...++
T Consensus       740 d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekr  776 (903)
T KOG1027|consen  740 DCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKR  776 (903)
T ss_pred             hHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHH
Confidence            2288999999999999999999999999999876544

>KOG0608|consensus

Probab=100.00  E-value=3.6e-37  Score=271.50  Aligned_cols=245  Identities=20%  Similarity=0.290  Sum_probs=198.9

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEE
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVS  133 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  133 (307)
                      ..-|-.++.||-|+||+|.++....+...||+|.+.+......++  ......|-.||..-+.+=||+|+-.|++.+.+|
T Consensus       628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQ--vaHVKAERDILAEADn~WVVrLyySFQDkdnLY  705 (1034)
T KOG0608|consen  628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQ--VAHVKAERDILAEADNEWVVRLYYSFQDKDNLY  705 (1034)
T ss_pred             ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhh--hhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence            345889999999999999999988899999999998753332222  334567899999999999999999999999999


Q ss_pred             EEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC--
Q psy9858         134 LVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP--  210 (307)
Q Consensus       134 lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--  210 (307)
                      +||+|+ +|++..++.+.+ .+.|+.++.++..+..|+++.|..|+|||||||+|||||.+|++||+|||+|.-+...  
T Consensus       706 FVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd  784 (1034)
T KOG0608|consen  706 FVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  784 (1034)
T ss_pred             EEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccc
Confidence            999999 789999888776 5899999999999999999999999999999999999999999999999998643110  


Q ss_pred             -------C---------------------------------cccccceeeceehhhhhhhccccccccccee---e----
Q psy9858         211 -------T---------------------------------RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----  243 (307)
Q Consensus       211 -------~---------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----  243 (307)
                             +                                 -.....+||+.|+|||++... .|+...|.|   .    
T Consensus       785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~-g~~q~cdwws~gvil~e  863 (1034)
T KOG0608|consen  785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART-GYTQLCDWWSVGVILYE  863 (1034)
T ss_pred             cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc-CccccchhhHhhHHHHH
Confidence                   0                                 001234799999999999988 899999999   2    


Q ss_pred             eeecCCCCCCCCCCCCC----------hhhhccccCHHHHHHHHHhhhcCCCCCCC---HHHHhcCcccCCCc
Q psy9858         244 CFAKDPSSHGNLFPGIP----------LNEIFTAAGDDLLAVISSLLCLNPTKRAD---CTATLKMDYFSLTK  303 (307)
Q Consensus       244 i~~~~~~f~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt---~~~il~hp~f~~~~  303 (307)
                      ++.|.+||....-....          --....+++.++.++|.++.. +++.|+.   ++|+-.||||++++
T Consensus       864 m~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgID  935 (1034)
T KOG0608|consen  864 MLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGID  935 (1034)
T ss_pred             HhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccc
Confidence            33388888773222211          112234689999999998654 5677875   78899999999876

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4.8e-36  Score=255.21  Aligned_cols=230  Identities=20%  Similarity=0.207  Sum_probs=175.5

Q ss_pred             eEEeecCceEEEEEEEc--CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEEEc
Q psy9858          61 RSVHVGRFATVFKARDI--ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEF  138 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  138 (307)
                      +.||+|+||.||+|.+.  .++..+|+|.+....    .......+.+|+.+++.++||||+++++++.+....++||||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   76 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA----SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEF   76 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCC----ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEEC
Confidence            36899999999999854  345679999886432    112234688999999999999999999999999999999999


Q ss_pred             c-CCChHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc
Q psy9858         139 V-DTDLEVIIKDPT----IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL  213 (307)
Q Consensus       139 ~-~g~l~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  213 (307)
                      + +|+|.+++....    ...++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~  156 (269)
T cd05087          77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY  156 (269)
T ss_pred             CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence            9 588888886422    23566778889999999999999999999999999999999999999999999754332211


Q ss_pred             --cccceeeceehhhhhhhcc------ccccccccee-------eeee-cCCCCCCCCCCC------------CChhhhc
Q psy9858         214 --YTHQVVTRWYRLIKCLLYC------VQFNVKNVQW-------CCFA-KDPSSHGNLFPG------------IPLNEIF  265 (307)
Q Consensus       214 --~~~~~~t~~y~aPE~~~~~------~~~~~~~Diw-------~i~~-~~~~f~~~~~~~------------~~~~~~~  265 (307)
                        .....++..|+|||.+.+.      ..++.++|+|       .+++ |..||.......            .......
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (269)
T cd05087         157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLK  236 (269)
T ss_pred             ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccC
Confidence              1223467789999998643      1357899999       2333 888886521110            0111111


Q ss_pred             cccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         266 TAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       266 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      ...++.+.+++.+|+ .+|++|||+++++.
T Consensus       237 ~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         237 LPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             CCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            235778899999998 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.5e-36  Score=256.94  Aligned_cols=239  Identities=23%  Similarity=0.324  Sum_probs=189.9

Q ss_pred             eeeEEeEEeecCceEEEEEEEcC-CCcEEEEEEeecCCccc-----cchhhhHhHHHHHHHHHh-cCCCCccccceeeee
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIE-TDMIVAVKKIKLGTHAD-----AKDGINRTALREIKLLQE-LHHENVLGLTDVFGY  128 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~~~~~e~~~l~~-l~h~ni~~~~~~~~~  128 (307)
                      .|++.+.||+|+||.||+|.+.. +++.+|+|.+.......     ........+.+|+.++.+ ++|+||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999999877 68899999987533221     122234556788888875 799999999999999


Q ss_pred             cCeEEEEEEcc-CCChHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCcEEEecCCcEEEEeecC
Q psy9858         129 MSNVSLVFEFV-DTDLEVIIK---DPTIVFTPSNIKAYAIMTLRGLEYLHD-HWILHRDLKPNNLLINKQGVLKIGDFGL  203 (307)
Q Consensus       129 ~~~~~lv~e~~-~g~l~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  203 (307)
                      .+..+++|||+ +++|.+++.   .....+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence            99999999999 567877763   234458999999999999999999996 6899999999999999999999999999


Q ss_pred             ccccCCCCcccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCC-------CChhhh-cccc
Q psy9858         204 AKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPG-------IPLNEI-FTAA  268 (307)
Q Consensus       204 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~-------~~~~~~-~~~~  268 (307)
                      +....... ......++..|+|||.+.+. .++.++|+|       .++.|..||.......       ...... ...+
T Consensus       161 ~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd08528         161 AKQKQPES-KLTSVVGTILYSCPEIVKNE-PYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMY  238 (269)
T ss_pred             eeeccccc-ccccccCcccCcChhhhcCC-CCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccC
Confidence            98765433 33445688899999999876 789999999       2333888886632211       111111 1246


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         269 GDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       269 ~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      ++++.+++.+||+.||++|||+.|+.++
T Consensus       239 ~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         239 SEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             CHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            7899999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG1151|consensus

Probab=100.00  E-value=1.2e-37  Score=264.81  Aligned_cols=247  Identities=24%  Similarity=0.338  Sum_probs=202.9

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecC--CccccchhhhHhHHHHHHHHHhcCCCCccccceeee-ecC
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG--THADAKDGINRTALREIKLLQELHHENVLGLTDVFG-YMS  130 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-~~~  130 (307)
                      .++|.++.+||+|||+.||+|.+....+.||||+-..+  .....++.+.+..-+|.+|-+.|+||.||++|++|. +..
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            35799999999999999999999999999999986543  333445556777889999999999999999999996 556


Q ss_pred             eEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC--CceeecCCCCcEEEec---CCcEEEEeecCcc
Q psy9858         131 NVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH--WILHRDLKPNNLLINK---QGVLKIGDFGLAK  205 (307)
Q Consensus       131 ~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~ivH~dlkp~Nil~~~---~~~~kl~Dfg~a~  205 (307)
                      .+|-|+|||+|+-+++..+..+.+++.+++.|+.||+.||.||...  .|||=||||.|||+..   .|.+||+|||+++
T Consensus       542 sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK  621 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK  621 (775)
T ss_pred             cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence            7899999998887777777777899999999999999999999976  6999999999999954   4568999999999


Q ss_pred             ccCCCC-------cccccceeeceehhhhhhhcc---ccccccccee-------eeeecCCCCCCCCCCCCChh------
Q psy9858         206 FFGSPT-------RLYTHQVVTRWYRLIKCLLYC---VQFNVKNVQW-------CCFAKDPSSHGNLFPGIPLN------  262 (307)
Q Consensus       206 ~~~~~~-------~~~~~~~~t~~y~aPE~~~~~---~~~~~~~Diw-------~i~~~~~~f~~~~~~~~~~~------  262 (307)
                      ......       .+.+...||.+|++||.+.-.   +..+.++|||       -|+||+-||+...-....+.      
T Consensus       622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlk  701 (775)
T KOG1151|consen  622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILK  701 (775)
T ss_pred             hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhc
Confidence            875432       234566899999999998643   4678999999       34559999988332221111      


Q ss_pred             ------hhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccC
Q psy9858         263 ------EIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS  300 (307)
Q Consensus       263 ------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~  300 (307)
                            ..-+.++.+.+++|.+||+.--++|..+.++-.||||-
T Consensus       702 AtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll  745 (775)
T KOG1151|consen  702 ATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL  745 (775)
T ss_pred             ceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence                  11135789999999999999999999999999999985

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=8.9e-36  Score=256.86  Aligned_cols=241  Identities=16%  Similarity=0.122  Sum_probs=178.8

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCC---CcEEEEEEeecCCccccchhh------hHhHHHHHHHHHhcCCCCccccc
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIET---DMIVAVKKIKLGTHADAKDGI------NRTALREIKLLQELHHENVLGLT  123 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~------~~~~~~e~~~l~~l~h~ni~~~~  123 (307)
                      ..++|++.+.||+|+||+||+|.+..+   +..+|+|+..........+..      ......+...+..++|+|+++++
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~   89 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY   89 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence            346899999999999999999998777   667788765432211100000      01122333455667899999999


Q ss_pred             eeeeecC----eEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEE
Q psy9858         124 DVFGYMS----NVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIG  199 (307)
Q Consensus       124 ~~~~~~~----~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~  199 (307)
                      +++....    ..+++++++..++.+.+.... ..++..+..++.|++.||.|||++|++||||||+||+++.++.++|+
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~  168 (294)
T PHA02882         90 GCGSFKRCRMYYRFILLEKLVENTKEIFKRIK-CKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYII  168 (294)
T ss_pred             EeeeEecCCceEEEEEEehhccCHHHHHHhhc-cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEE
Confidence            8765443    457888988777776665432 35788899999999999999999999999999999999999999999


Q ss_pred             eecCccccCCCC-------cccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCC------
Q psy9858         200 DFGLAKFFGSPT-------RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGI------  259 (307)
Q Consensus       200 Dfg~a~~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~------  259 (307)
                      |||+|+.+....       .......||+.|+|||.+.+. .++.++|||   +    +++|..||.+......      
T Consensus       169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~-~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~  247 (294)
T PHA02882        169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA-CVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK  247 (294)
T ss_pred             EcCCceeeccCCcccccccccccccCCCccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence            999998763221       112234689999999999887 899999999   3    3339999977422110      


Q ss_pred             -------C-hhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         260 -------P-LNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       260 -------~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                             . ......+.++.+.+++..|+..+|++||+++++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        248 CDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence                   0 01113456889999999999999999999999875

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.4e-36  Score=254.43  Aligned_cols=224  Identities=17%  Similarity=0.223  Sum_probs=177.1

Q ss_pred             eEEeecCceEEEEEEEcCCC----------cEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC
Q psy9858          61 RSVHVGRFATVFKARDIETD----------MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS  130 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  130 (307)
                      +.||+|+||.||+|.+..++          ..|++|++....    . . ...+.+|+.+++.++|+||+++++++.. .
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~-~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   73 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----R-D-SLAFFETASLMSQLSHKHLVKLYGVCVR-D   73 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----h-h-HHHHHHHHHHHHcCCCcchhheeeEEec-C
Confidence            46899999999999987666          457888765321    1 1 4668899999999999999999999877 7


Q ss_pred             eEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCC-------cEEEEeec
Q psy9858         131 NVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG-------VLKIGDFG  202 (307)
Q Consensus       131 ~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-------~~kl~Dfg  202 (307)
                      ..++||||+ +|+|.+++......++...+..++.||+.||+|||++|++|+||||+||+++.++       .++|+|||
T Consensus        74 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          74 ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             CcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence            789999999 5788888876654689999999999999999999999999999999999999888       79999999


Q ss_pred             CccccCCCCcccccceeeceehhhhhhhcc-ccccccccee--e-----eee-cCCCCCCCCCCCCC-----hhhhcccc
Q psy9858         203 LAKFFGSPTRLYTHQVVTRWYRLIKCLLYC-VQFNVKNVQW--C-----CFA-KDPSSHGNLFPGIP-----LNEIFTAA  268 (307)
Q Consensus       203 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~Diw--~-----i~~-~~~~f~~~~~~~~~-----~~~~~~~~  268 (307)
                      ++.....    .....++..|+|||.+.+. ..++.++|+|  +     +++ +..||.........     ....+...
T Consensus       154 ~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  229 (259)
T cd05037         154 IPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPD  229 (259)
T ss_pred             ccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCCCCCC
Confidence            9987643    2233566789999998765 4788999999  2     223 56666553211100     00111122


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         269 GDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       269 ~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      ...+.+++.+||..||.+|||+.++++
T Consensus       230 ~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         230 CAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             chHHHHHHHHHhccChhhCCCHHHHHH
Confidence            478999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.9e-36  Score=257.54  Aligned_cols=230  Identities=20%  Similarity=0.313  Sum_probs=181.2

Q ss_pred             eEEeecCceEEEEEEEcCCC------cEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          61 RSVHVGRFATVFKARDIETD------MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      +.||+|+||.||+|++....      +.||+|.+....    .......+.+|+++++.++||||+++++++......++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   76 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA----TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYI   76 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc----chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEE
Confidence            36899999999999876433      789999886431    11224568899999999999999999999999999999


Q ss_pred             EEEcc-CCChHHHHhCC------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCC-----cEEEEeec
Q psy9858         135 VFEFV-DTDLEVIIKDP------TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG-----VLKIGDFG  202 (307)
Q Consensus       135 v~e~~-~g~l~~~~~~~------~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-----~~kl~Dfg  202 (307)
                      +|||+ +|+|.+++...      ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++     .++|+|||
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg  156 (269)
T cd05044          77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG  156 (269)
T ss_pred             EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence            99999 68898888642      23378889999999999999999999999999999999999888     89999999


Q ss_pred             CccccCCCCc--ccccceeeceehhhhhhhccccccccccee---ee----ee-cCCCCCCCCCCC-------CChhhhc
Q psy9858         203 LAKFFGSPTR--LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FA-KDPSSHGNLFPG-------IPLNEIF  265 (307)
Q Consensus       203 ~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~-~~~~f~~~~~~~-------~~~~~~~  265 (307)
                      ++........  ......++..|+|||.+.+. .++.++|||   ++    ++ |..||.......       .......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~  235 (269)
T cd05044         157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDG-KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKP  235 (269)
T ss_pred             cccccccccccccCcccCCCccccCHHHHccC-CcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCc
Confidence            9976533221  11223456789999999887 789999999   22    32 788876521100       1111223


Q ss_pred             cccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         266 TAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       266 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      ..++..+.+++.+||+.+|.+|||++++++
T Consensus       236 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         236 ENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             ccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            457889999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG0665|consensus

Probab=100.00  E-value=1.9e-37  Score=253.42  Aligned_cols=241  Identities=29%  Similarity=0.416  Sum_probs=197.5

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec-
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM-  129 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-  129 (307)
                      .....+|.-+..+|.|.- .|..|.+.-.++.||+|...... ..  ....++..+|+.++..++|+||++++.+|.-. 
T Consensus        13 ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf-~n--~~~akra~rel~l~~~v~~~nii~l~n~ftP~~   88 (369)
T KOG0665|consen   13 FTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPF-QN--QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQK   88 (369)
T ss_pred             eeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcc-cc--CccchhhhhhhhhhhhhcccceeeeeeccCccc
Confidence            345567888899999987 78888888899999999987652 22  22356788999999999999999999998543 


Q ss_pred             -----CeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCc
Q psy9858         130 -----SNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA  204 (307)
Q Consensus       130 -----~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  204 (307)
                           ...|+|||++.++|...+...   ++.+.+..++.|++.|++|||+.||+||||||+||++..+..+||.|||+|
T Consensus        89 ~l~~~~e~y~v~e~m~~nl~~vi~~e---lDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~a  165 (369)
T KOG0665|consen   89 TLEEFQEVYLVMELMDANLCQVILME---LDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLA  165 (369)
T ss_pred             cHHHHHhHHHHHHhhhhHHHHHHHHh---cchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhh
Confidence                 458999999999999988843   688999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCcccccceeeceehhhhhhhccccccccccee---eeee----cCCCCCC------------------------
Q psy9858         205 KFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KDPSSHG------------------------  253 (307)
Q Consensus       205 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~~~~f~~------------------------  253 (307)
                      +..... -..+..+.|..|.|||++.+. .|...+|||   |+++    |..+|.+                        
T Consensus       166 r~e~~~-~~mtpyVvtRyyrapevil~~-~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q  243 (369)
T KOG0665|consen  166 RTEDTD-FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ  243 (369)
T ss_pred             cccCcc-cccCchhheeeccCchheecc-CCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence            976433 466778999999999999999 699999999   5444    7777776                        


Q ss_pred             ------------CCCCCCChhhhcc------------ccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccC
Q psy9858         254 ------------NLFPGIPLNEIFT------------AAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS  300 (307)
Q Consensus       254 ------------~~~~~~~~~~~~~------------~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~  300 (307)
                                  .........+.++            --+..+.+++.+||..||++|.+++++|.||||+
T Consensus       244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                        0001111111111            1134678999999999999999999999999997

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=5.5e-36  Score=277.10  Aligned_cols=243  Identities=18%  Similarity=0.205  Sum_probs=164.6

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCC----CcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCcccccee--
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIET----DMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV--  125 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~--  125 (307)
                      ...++|.+.+.||+|+||.||+|++..+    +..||+|++.....       .....++  .++...+.++..+...  
T Consensus       129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-------~e~~~~e--~l~~~~~~~~~~~~~~~~  199 (566)
T PLN03225        129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-------VEIWMNE--RVRRACPNSCADFVYGFL  199 (566)
T ss_pred             CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-------hHHHHHH--HHHhhchhhHHHHHHhhh
Confidence            3667899999999999999999999888    89999998763210       0111111  1122223333333222  


Q ss_pred             ----eeecCeEEEEEEcc-CCChHHHHhCCCCC-------------------CCHHHHHHHHHHHHHHHHHHHHCCceee
Q psy9858         126 ----FGYMSNVSLVFEFV-DTDLEVIIKDPTIV-------------------FTPSNIKAYAIMTLRGLEYLHDHWILHR  181 (307)
Q Consensus       126 ----~~~~~~~~lv~e~~-~g~l~~~~~~~~~~-------------------~~~~~~~~i~~~i~~~l~~lH~~~ivH~  181 (307)
                          .......++||||+ +++|.+++......                   .....+..++.||+.||.|||++||+||
T Consensus       200 ~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHR  279 (566)
T PLN03225        200 EPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHR  279 (566)
T ss_pred             cccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence                23567799999999 57788887654311                   1234466799999999999999999999


Q ss_pred             cCCCCcEEEec-CCcEEEEeecCccccCCC-Ccccccceeeceehhhhhhhccc---------------------ccccc
Q psy9858         182 DLKPNNLLINK-QGVLKIGDFGLAKFFGSP-TRLYTHQVVTRWYRLIKCLLYCV---------------------QFNVK  238 (307)
Q Consensus       182 dlkp~Nil~~~-~~~~kl~Dfg~a~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~---------------------~~~~~  238 (307)
                      ||||+|||++. ++.+||+|||+|+..... ........+++.|+|||.+....                     .++.+
T Consensus       280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k  359 (566)
T PLN03225        280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR  359 (566)
T ss_pred             cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence            99999999985 579999999999865332 22234457899999999764321                     23456


Q ss_pred             ccee---eeee----cCCCCCCCC------CC--CCChh------------------hhccccCHHHHHHHHHhhhcCCC
Q psy9858         239 NVQW---CCFA----KDPSSHGNL------FP--GIPLN------------------EIFTAAGDDLLAVISSLLCLNPT  285 (307)
Q Consensus       239 ~Diw---~i~~----~~~~f~~~~------~~--~~~~~------------------~~~~~~~~~l~~li~~~l~~dP~  285 (307)
                      +|||   |+++    +..++....      +.  .....                  ...........+||.+||+.||+
T Consensus       360 ~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~  439 (566)
T PLN03225        360 FDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR  439 (566)
T ss_pred             cccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence            7999   4433    333322200      00  00000                  00111223456899999999999


Q ss_pred             CCCCHHHHhcCcccCCCc
Q psy9858         286 KRADCTATLKMDYFSLTK  303 (307)
Q Consensus       286 ~Rpt~~~il~hp~f~~~~  303 (307)
                      +|||++|+|+||||.+..
T Consensus       440 kR~ta~e~L~Hpff~~~~  457 (566)
T PLN03225        440 QRISAKAALAHPYFDREG  457 (566)
T ss_pred             cCCCHHHHhCCcCcCCCC
Confidence            999999999999998754

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.5e-35  Score=250.70  Aligned_cols=229  Identities=17%  Similarity=0.146  Sum_probs=172.4

Q ss_pred             EEeecCceEEEEEEEcCC--CcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEEEcc
Q psy9858          62 SVHVGRFATVFKARDIET--DMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFV  139 (307)
Q Consensus        62 ~lg~G~~g~V~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  139 (307)
                      .||+|+||.||+|....+  ...+++|.+....    .......+.+|+.+++.++||||+++++.+.+....++||||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~   77 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA----SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYC   77 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC----ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecC
Confidence            589999999999975432  3456677665422    1223467889999999999999999999999999999999999


Q ss_pred             -CCChHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc--c
Q psy9858         140 -DTDLEVIIKDPT---IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR--L  213 (307)
Q Consensus       140 -~g~l~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~  213 (307)
                       +|+|.+++.+..   ...+...+..++.||+.||+|||+.+++|+||||+||+++.++.++|+|||++........  .
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence             578988886532   2356677889999999999999999999999999999999999999999999864322111  1


Q ss_pred             cccceeeceehhhhhhhcc------ccccccccee---eeee-----cCCCCCCCCCC------------CCChhhhccc
Q psy9858         214 YTHQVVTRWYRLIKCLLYC------VQFNVKNVQW---CCFA-----KDPSSHGNLFP------------GIPLNEIFTA  267 (307)
Q Consensus       214 ~~~~~~t~~y~aPE~~~~~------~~~~~~~Diw---~i~~-----~~~~f~~~~~~------------~~~~~~~~~~  267 (307)
                      .....++..|+|||.+...      ..++.++|||   ++++     +..||......            ..........
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELP  237 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCC
Confidence            2234678899999987532      1457899999   2222     56677542111            0011122234


Q ss_pred             cCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         268 AGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       268 ~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      +++.+.+++..|| .+|.+|||++++++
T Consensus       238 ~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         238 YSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             CcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            6788999999999 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG4257|consensus

Probab=100.00  E-value=3.1e-36  Score=265.25  Aligned_cols=235  Identities=18%  Similarity=0.293  Sum_probs=195.6

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcC----CCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIE----TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS  130 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  130 (307)
                      ..-.+.++||.|-||.||.|....    ....||||+.+.....+    ..+.|+.|..+|++++||||++++|++.+ .
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d----~tekflqEa~iMrnfdHphIikLIGv~~e-~  463 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPD----DTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q  463 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChh----hHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence            334455889999999999997432    34569999988533222    25679999999999999999999999854 5


Q ss_pred             eEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCC
Q psy9858         131 NVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS  209 (307)
Q Consensus       131 ~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  209 (307)
                      -.+||||.+ -|.|..++..+...++......++.||..||.|||+..+|||||..+|||+....-|||+|||+++....
T Consensus       464 P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed  543 (974)
T KOG4257|consen  464 PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLED  543 (974)
T ss_pred             ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccc
Confidence            679999999 5999999998888899999999999999999999999999999999999999999999999999999866


Q ss_pred             CCccccc-ceeeceehhhhhhhccccccccccee----e---eee-cCCCCCC-------CCCCCCChhhhccccCHHHH
Q psy9858         210 PTRLYTH-QVVTRWYRLIKCLLYCVQFNVKNVQW----C---CFA-KDPSSHG-------NLFPGIPLNEIFTAAGDDLL  273 (307)
Q Consensus       210 ~~~~~~~-~~~t~~y~aPE~~~~~~~~~~~~Diw----~---i~~-~~~~f~~-------~~~~~~~~~~~~~~~~~~l~  273 (307)
                      ......+ .....-|||||.+.-. .++.++|||    |   |+. |.-||.+       ...+.......++++++.+.
T Consensus       544 ~~yYkaS~~kLPIKWmaPESINfR-rFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LY  622 (974)
T KOG4257|consen  544 DAYYKASRGKLPIKWMAPESINFR-RFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALY  622 (974)
T ss_pred             cchhhccccccceeecCccccchh-cccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHH
Confidence            5544333 2335689999999887 899999999    3   232 9999988       33445556677889999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhc
Q psy9858         274 AVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       274 ~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      .|+.+||+.||.+||++.++..
T Consensus       623 slmskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  623 SLMSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             HHHHHHhccCcccCCcHHHHHH
Confidence            9999999999999999877643

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=9.8e-36  Score=253.73  Aligned_cols=236  Identities=19%  Similarity=0.209  Sum_probs=181.5

Q ss_pred             eeEEeEEeecCceEEEEEEEc---CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC---
Q psy9858          57 YYQWRSVHVGRFATVFKARDI---ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS---  130 (307)
Q Consensus        57 y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---  130 (307)
                      |.+.+.||+|+||.||+|.+.   .+++.||||++.....   .....+.+.+|+++++.++||||+++++++....   
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF---SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG   77 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC---ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC
Confidence            567889999999999999854   3578999999875321   1222456889999999999999999999875432   


Q ss_pred             ---eEEEEEEcc-CCChHHHHhCC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEee
Q psy9858         131 ---NVSLVFEFV-DTDLEVIIKDP-----TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDF  201 (307)
Q Consensus       131 ---~~~lv~e~~-~g~l~~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Df  201 (307)
                         ..+++++|+ .|++.+++...     ...++...+..++.||+.||+|||+.|++|+||||+||+++.++.++|+||
T Consensus        78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcc
Confidence               347889999 57877766421     224788899999999999999999999999999999999999999999999


Q ss_pred             cCccccCCCCcc--cccceeeceehhhhhhhccccccccccee---eee----e-cCCCCCCCCCCC-------CChhhh
Q psy9858         202 GLAKFFGSPTRL--YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCF----A-KDPSSHGNLFPG-------IPLNEI  264 (307)
Q Consensus       202 g~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~----~-~~~~f~~~~~~~-------~~~~~~  264 (307)
                      |+++........  .....++..|++||.+.+. .++.++|||   +++    + |.+||.+.....       ......
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~  236 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADN-VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQ  236 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcC-ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence            999876432211  1222445789999998877 788999999   333    2 778876532111       011111


Q ss_pred             ccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         265 FTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       265 ~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      ....++.+.+++.+||+.+|.+|||+.+++++
T Consensus       237 ~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         237 PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            23567899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0664|consensus

Probab=100.00  E-value=1.5e-37  Score=249.49  Aligned_cols=244  Identities=30%  Similarity=0.503  Sum_probs=195.7

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC-----
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS-----  130 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-----  130 (307)
                      +.+-.+.||.|+||.||-+++..+|+.||+|++....   .+-...+.+.+|+++|..++|.|+...+++.+...     
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf---q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFq  130 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF---QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQ  130 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHH---HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHH
Confidence            3444588999999999999999999999999886421   12223577889999999999999999999775443     


Q ss_pred             eEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCC-
Q psy9858         131 NVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS-  209 (307)
Q Consensus       131 ~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~-  209 (307)
                      .+|.++|.+..+|...+.+.. .++...++-+++||+.||+|||+.||.||||||.|.|++.|-..||||||+|+.-.. 
T Consensus       131 EiYV~TELmQSDLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d  209 (449)
T KOG0664|consen  131 ELYVLTELMQSDLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR  209 (449)
T ss_pred             HHHHHHHHHHhhhhheeccCC-CCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchh
Confidence            467788888888888877665 588899999999999999999999999999999999999999999999999997643 


Q ss_pred             CCcccccceeeceehhhhhhhccccccccccee---eeee----cCCCCCC-----------------------------
Q psy9858         210 PTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KDPSSHG-----------------------------  253 (307)
Q Consensus       210 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~~~~f~~-----------------------------  253 (307)
                      ....++..+.|..|+|||++.|...|+.++|||   ||++    .+.+|..                             
T Consensus       210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA  289 (449)
T KOG0664|consen  210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA  289 (449)
T ss_pred             hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence            234566778899999999999999999999999   6665    5566665                             


Q ss_pred             ------CCCCCCChhhhc-----cccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         254 ------NLFPGIPLNEIF-----TAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       254 ------~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                            ..........+.     ..-..+..++++++|..||.+|.+.++++.|+|....+
T Consensus       290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R  350 (449)
T KOG0664|consen  290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR  350 (449)
T ss_pred             HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence                  000011111111     12234678899999999999999999999999987654

>KOG4250|consensus

Probab=100.00  E-value=3.7e-36  Score=268.64  Aligned_cols=194  Identities=24%  Similarity=0.336  Sum_probs=163.9

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec-----
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM-----  129 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----  129 (307)
                      ..|...+.||+|+||.||+|+++++|+.||||.+.....    ..-....-+|+++|++++|+|||+++++-+..     
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~----~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~   88 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS----LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLV   88 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcc----cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcc
Confidence            346677899999999999999999999999999986431    11245567999999999999999999976544     


Q ss_pred             -CeEEEEEEcc-CCChHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecC--C--cEEEEee
Q psy9858         130 -SNVSLVFEFV-DTDLEVIIKDP--TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ--G--VLKIGDF  201 (307)
Q Consensus       130 -~~~~lv~e~~-~g~l~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~--~--~~kl~Df  201 (307)
                       ....+||||| +|+|...+.+.  ...+++.+++.++.++..||.|||++||+||||||.||++-..  |  --||+||
T Consensus        89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDf  168 (732)
T KOG4250|consen   89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDF  168 (732)
T ss_pred             cccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecc
Confidence             3578999999 78999999764  3349999999999999999999999999999999999998533  3  3599999


Q ss_pred             cCccccCCCCcccccceeeceehhhhhhhccccccccccee---eeee----cCCCCCC
Q psy9858         202 GLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KDPSSHG  253 (307)
Q Consensus       202 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~~~~f~~  253 (307)
                      |.|+-..+. ....+.+||..|.+||++.....|+..+|.|   |++|    |+.||..
T Consensus       169 G~Arel~d~-s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p  226 (732)
T KOG4250|consen  169 GAARELDDN-SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP  226 (732)
T ss_pred             cccccCCCC-CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence            999998554 4778889999999999999644899999999   4443    9999976

>KOG4278|consensus

Probab=100.00  E-value=4.3e-36  Score=264.40  Aligned_cols=241  Identities=17%  Similarity=0.209  Sum_probs=199.5

Q ss_pred             ceeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeee
Q psy9858          48 CEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG  127 (307)
Q Consensus        48 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~  127 (307)
                      ..|.....+.....+||-|-||.||.|.|+.-...||||.++      .+.+...+|+.|..+|+.++|||+|+++++|.
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK------EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT  333 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT  333 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhh------hcchhHHHHHHHHHHHHhhcCccHHHHhhhhc
Confidence            345555566777899999999999999999988999999987      23444788999999999999999999999999


Q ss_pred             ecCeEEEEEEcc-CCChHHHHhCCCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcc
Q psy9858         128 YMSNVSLVFEFV-DTDLEVIIKDPTI-VFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK  205 (307)
Q Consensus       128 ~~~~~~lv~e~~-~g~l~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  205 (307)
                      .+.-+|||+||+ .|+|++++...+. .++.-.+..++.||.+|+.||..+++|||||..+|+|+..+..||++|||+++
T Consensus       334 ~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsR  413 (1157)
T KOG4278|consen  334 HEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSR  413 (1157)
T ss_pred             cCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhh
Confidence            999999999999 7999999986543 36777888999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCcccc-cceeeceehhhhhhhccccccccccee--eeee------cCCCCCCCCC-------CCCChhhhccccC
Q psy9858         206 FFGSPTRLYT-HQVVTRWYRLIKCLLYCVQFNVKNVQW--CCFA------KDPSSHGNLF-------PGIPLNEIFTAAG  269 (307)
Q Consensus       206 ~~~~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~~Diw--~i~~------~~~~f~~~~~-------~~~~~~~~~~~~~  269 (307)
                      +.....+... ......-|.|||.+... .++.++|||  +++.      |..||.+...       ...-.-+.+.+++
T Consensus       414 lMtgDTYTAHAGAKFPIKWTAPEsLAyN-tFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCP  492 (1157)
T KOG4278|consen  414 LMTGDTYTAHAGAKFPIKWTAPESLAYN-TFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCP  492 (1157)
T ss_pred             hhcCCceecccCccCcccccCccccccc-ccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCC
Confidence            9854432211 12335679999999888 899999999  3332      8888877221       1111223356899


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         270 DDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       270 ~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      +.+.+|+..||+++|.+||++.++-+
T Consensus       493 pkVYeLMraCW~WsPsDRPsFaeiHq  518 (1157)
T KOG4278|consen  493 PKVYELMRACWNWSPSDRPSFAEIHQ  518 (1157)
T ss_pred             HHHHHHHHHHhcCCcccCccHHHHHH
Confidence            99999999999999999999888743

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3e-34  Score=259.75  Aligned_cols=250  Identities=17%  Similarity=0.179  Sum_probs=174.7

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEc----------------CCCcEEEEEEeecCCccccc---------hhhhHhHHH
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDI----------------ETDMIVAVKKIKLGTHADAK---------DGINRTALR  106 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~----------------~~~~~vavK~~~~~~~~~~~---------~~~~~~~~~  106 (307)
                      ...++|.+.++||+|+||+||+|...                ..++.||||.+.........         ....+....
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            35678999999999999999999642                34568999998643211100         001223445


Q ss_pred             HHHHHHhcCCCCc-----cccceeeee--------cCeEEEEEEcc-CCChHHHHhCCCC--------------------
Q psy9858         107 EIKLLQELHHENV-----LGLTDVFGY--------MSNVSLVFEFV-DTDLEVIIKDPTI--------------------  152 (307)
Q Consensus       107 e~~~l~~l~h~ni-----~~~~~~~~~--------~~~~~lv~e~~-~g~l~~~~~~~~~--------------------  152 (307)
                      |+.++.+++|.++     +++++++..        ....+|||||+ +|+|.+++.....                    
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            7777777876554     667776642        35689999999 6888888764211                    


Q ss_pred             ---CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCccc-ccceeeceehhhhh
Q psy9858         153 ---VFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY-THQVVTRWYRLIKC  228 (307)
Q Consensus       153 ---~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~t~~y~aPE~  228 (307)
                         .+++..++.++.|++.+|.|||+.+|+||||||+||+++.++.++|+|||++.......... ....+++.|+|||.
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~  381 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE  381 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence               13566788899999999999999999999999999999999999999999997653322111 11234789999999


Q ss_pred             hhcccc-------------------cc--ccccee---eeee----cCC-CCCCCCCC-------------------CCC
Q psy9858         229 LLYCVQ-------------------FN--VKNVQW---CCFA----KDP-SSHGNLFP-------------------GIP  260 (307)
Q Consensus       229 ~~~~~~-------------------~~--~~~Diw---~i~~----~~~-~f~~~~~~-------------------~~~  260 (307)
                      +.....                   ++  .+.|+|   ++++    +.. ||......                   ...
T Consensus       382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~  461 (507)
T PLN03224        382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKY  461 (507)
T ss_pred             hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCC
Confidence            864311                   12  247999   4433    443 44331000                   000


Q ss_pred             hhhhccccCHHHHHHHHHhhhcCC---CCCCCHHHHhcCcccCC
Q psy9858         261 LNEIFTAAGDDLLAVISSLLCLNP---TKRADCTATLKMDYFSL  301 (307)
Q Consensus       261 ~~~~~~~~~~~l~~li~~~l~~dP---~~Rpt~~~il~hp~f~~  301 (307)
                      ....+...++..++|+.+||..+|   .+|+|++|+|+||||..
T Consensus       462 ~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        462 DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            011234578999999999999876   68999999999999964

>KOG2052|consensus

Probab=100.00  E-value=1e-34  Score=246.75  Aligned_cols=229  Identities=24%  Similarity=0.244  Sum_probs=178.2

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHh--cCCCCccccceeeeec-
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQE--LHHENVLGLTDVFGYM-  129 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~ni~~~~~~~~~~-  129 (307)
                      ...+-.+++.||+|.||.||+|.+.  |+.||||++...     +   +..+.+|.+|++.  |+|+||+.+++.-..+ 
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr-----d---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~  278 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR-----D---ERSWFRETEIYQTVMLRHENILGFIAADNKDN  278 (513)
T ss_pred             hhheeEEEEEecCccccceeecccc--CCceEEEEeccc-----c---hhhhhhHHHHHHHHHhccchhhhhhhccccCC
Confidence            4467899999999999999999975  678999999742     1   3456788887776  5999999999875322 


Q ss_pred             ---CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeecCCCCcEEEecCCcEE
Q psy9858         130 ---SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH--------WILHRDLKPNNLLINKQGVLK  197 (307)
Q Consensus       130 ---~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--------~ivH~dlkp~Nil~~~~~~~k  197 (307)
                         ..++||++|. .|+|.|++.+.  .++.+....++..+++||+|||-.        .|.|||||..|||+.+++++.
T Consensus       279 gs~TQLwLvTdYHe~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~  356 (513)
T KOG2052|consen  279 GSWTQLWLVTDYHEHGSLYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  356 (513)
T ss_pred             CceEEEEEeeecccCCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence               4699999999 69999999986  489999999999999999999942        599999999999999999999


Q ss_pred             EEeecCccccCCCC----cccccceeeceehhhhhhhccccc-----cccccee------------eeee-----cCCCC
Q psy9858         198 IGDFGLAKFFGSPT----RLYTHQVVTRWYRLIKCLLYCVQF-----NVKNVQW------------CCFA-----KDPSS  251 (307)
Q Consensus       198 l~Dfg~a~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~-----~~~~Diw------------~i~~-----~~~~f  251 (307)
                      |+|+|+|....+..    -..+.++||.+|||||++....+.     -..+|||            |...     ..+||
T Consensus       357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py  436 (513)
T KOG2052|consen  357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY  436 (513)
T ss_pred             EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence            99999998875442    235677999999999999654221     2567888            2222     67788


Q ss_pred             CCCCCCCCChhhhcc------------------ccCHHHHHHHHHhhhcCCCCCCCHHHH
Q psy9858         252 HGNLFPGIPLNEIFT------------------AAGDDLLAVISSLLCLNPTKRADCTAT  293 (307)
Q Consensus       252 ~~~~~~~~~~~~~~~------------------~~~~~l~~li~~~l~~dP~~Rpt~~~i  293 (307)
                      .+..-.....+++.+                  ..-..+.++++.||..||..|.|+--+
T Consensus       437 yd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALri  496 (513)
T KOG2052|consen  437 YDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRI  496 (513)
T ss_pred             ccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence            773333333333221                  122456789999999999999997443

>KOG0199|consensus

Probab=100.00  E-value=1.5e-35  Score=263.87  Aligned_cols=239  Identities=21%  Similarity=0.276  Sum_probs=199.2

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcC-CC--cEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIE-TD--MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY  128 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~--~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  128 (307)
                      ...++..+.++||+|.||.|++|.|.. +|  ..||||++....    .......|++|+.+|.+|+|+|++++||+..+
T Consensus       107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~----l~~~mddflrEas~M~~L~H~hliRLyGvVl~  182 (1039)
T KOG0199|consen  107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDS----LNAIMDDFLREASHMLKLQHPHLIRLYGVVLD  182 (1039)
T ss_pred             ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCc----cchhHHHHHHHHHHHHhccCcceeEEeeeecc
Confidence            345567788999999999999998864 33  579999998533    22246789999999999999999999998876


Q ss_pred             cCeEEEEEEcc-CCChHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         129 MSNVSLVFEFV-DTDLEVIIKD-PTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       129 ~~~~~lv~e~~-~g~l~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                       ....+|||++ .|+|++.+++ ....+.-..+-.++.||+.|+.||.++++|||||..+|+++-....|||+|||+.+.
T Consensus       183 -qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRa  261 (1039)
T KOG0199|consen  183 -QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRA  261 (1039)
T ss_pred             -chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceec
Confidence             7788999999 6999999987 455578888899999999999999999999999999999999999999999999999


Q ss_pred             cCCCCccc---ccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCC-------CCCCCCChhhhcccc
Q psy9858         207 FGSPTRLY---THQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHG-------NLFPGIPLNEIFTAA  268 (307)
Q Consensus       207 ~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~-------~~~~~~~~~~~~~~~  268 (307)
                      ++..+..+   ........|+|||.+... .++-++|||       .+|. |+.|+.+       ..+........++.+
T Consensus       262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~-kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~c  340 (1039)
T KOG0199|consen  262 LGENEDMYVMAPQRKVPFAWCAPESLRHR-KFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYC  340 (1039)
T ss_pred             cCCCCcceEecCCCcCcccccCHhHhccc-cccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCC
Confidence            87655443   233456789999999988 899999999       3444 8888888       333344444556789


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         269 GDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       269 ~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      ++++.++++.||..+|++|||+..|.+.
T Consensus       341 sedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  341 SEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             hHHHHHHHHHhccCCccccccHHHHHHh
Confidence            9999999999999999999999888654

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=3.7e-34  Score=238.89  Aligned_cols=226  Identities=32%  Similarity=0.430  Sum_probs=185.2

Q ss_pred             CceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEEEccCC-ChHH
Q psy9858          67 RFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT-DLEV  145 (307)
Q Consensus        67 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~g-~l~~  145 (307)
                      +||.||+|.+..+|+.+|+|++........    .+.+.+|++.++.++|+||+++++.+......++++|++++ +|.+
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~   76 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK----RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFD   76 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH----HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHH
Confidence            589999999988899999999975432211    46788999999999999999999999999999999999955 8888


Q ss_pred             HHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcccccceeeceehh
Q psy9858         146 IIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRL  225 (307)
Q Consensus       146 ~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~a  225 (307)
                      ++..... ++...+..++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+....... ......++..|++
T Consensus        77 ~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~  154 (244)
T smart00220       77 LLKKRGR-LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMA  154 (244)
T ss_pred             HHHhccC-CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCC
Confidence            8876543 7899999999999999999999999999999999999999999999999998875432 3344567889999


Q ss_pred             hhhhhccccccccccee-------eeeecCCCCCCCCCCCC--------Chhhhc--cccCHHHHHHHHHhhhcCCCCCC
Q psy9858         226 IKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPGI--------PLNEIF--TAAGDDLLAVISSLLCLNPTKRA  288 (307)
Q Consensus       226 PE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~~--------~~~~~~--~~~~~~l~~li~~~l~~dP~~Rp  288 (307)
                      ||.+.+. .++.++|+|       .+++|..||........        ......  ..++.++.+++.+||..||++||
T Consensus       155 pE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp  233 (244)
T smart00220      155 PEVLLGK-GYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRL  233 (244)
T ss_pred             HHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhcc
Confidence            9999876 788899999       23337777765211110        000000  11778999999999999999999


Q ss_pred             CHHHHhcCccc
Q psy9858         289 DCTATLKMDYF  299 (307)
Q Consensus       289 t~~~il~hp~f  299 (307)
                      ++.++++||||
T Consensus       234 ~~~~~~~~~~~  244 (244)
T smart00220      234 TAEEALQHPFF  244 (244)
T ss_pred             CHHHHhhCCCC
Confidence            99999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0576|consensus

Probab=100.00  E-value=1.3e-35  Score=263.04  Aligned_cols=244  Identities=24%  Similarity=0.299  Sum_probs=199.8

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN  131 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  131 (307)
                      +..++|+++.++|+|+||.||+++++.+++..|+|+++.....+     .+..+.|+-+++.++||||+.+++.+-....
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd-----~~~iqqei~~~~dc~h~nivay~gsylr~dk   86 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD-----FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK   86 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc-----ccccccceeeeecCCCcChHHHHhhhhhhcC
Confidence            56788999999999999999999999999999999998754333     3456789999999999999999999999999


Q ss_pred             EEEEEEccC-CChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         132 VSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       132 ~~lv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      +++.||||+ |+|.+..+ -.+.+++.++..+++..++||+|||++|=+|||||-.||++++.|.+|++|||.+..++..
T Consensus        87 lwicMEycgggslQdiy~-~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat  165 (829)
T KOG0576|consen   87 LWICMEYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT  165 (829)
T ss_pred             cEEEEEecCCCcccceee-ecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhh
Confidence            999999996 55555444 4457999999999999999999999999999999999999999999999999999988765


Q ss_pred             Ccccccceeeceehhhhhhh--ccccccccccee--eeee---cC--CC-CCC-----------CCCCCCChhhhccccC
Q psy9858         211 TRLYTHQVVTRWYRLIKCLL--YCVQFNVKNVQW--CCFA---KD--PS-SHG-----------NLFPGIPLNEIFTAAG  269 (307)
Q Consensus       211 ~~~~~~~~~t~~y~aPE~~~--~~~~~~~~~Diw--~i~~---~~--~~-f~~-----------~~~~~~~~~~~~~~~~  269 (307)
                      -.......||+.|||||+-.  ....|...+|+|  ++-+   ++  +| |+.           ..++...+ +-...-+
T Consensus       166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~l-kDk~kws  244 (829)
T KOG0576|consen  166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTL-KDKTKWS  244 (829)
T ss_pred             hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcc-cCCccch
Confidence            55566779999999999864  233689999999  4333   21  11 222           11111111 1123346


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         270 DDLLAVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       270 ~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                      +-+-+|++.+|.++|++|||++.+|+|||....
T Consensus       245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             HHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence            778999999999999999999999999998653

>KOG1167|consensus

Probab=100.00  E-value=2e-34  Score=243.70  Aligned_cols=241  Identities=25%  Similarity=0.366  Sum_probs=190.4

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcC---CCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-CCCccccceeeee
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIE---TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-HENVLGLTDVFGY  128 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~  128 (307)
                      ..+.|..+++||+|+|++||++.+..   ....||+|.+.....       .....+|+++|..+. +.||+++.+++..
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-------p~ri~~El~~L~~~gG~~ni~~~~~~~rn  106 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-------PSRILNELEMLYRLGGSDNIIKLNGCFRN  106 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-------chHHHHHHHHHHHhccchhhhcchhhhcc
Confidence            45679999999999999999999877   788999999875422       345789999999995 9999999999999


Q ss_pred             cCeEEEEEEccC-CChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEec-CCcEEEEeecCccc
Q psy9858         129 MSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK-QGVLKIGDFGLAKF  206 (307)
Q Consensus       129 ~~~~~lv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~a~~  206 (307)
                      ++...+|+||++ ....+++..    ++-.+++.+++.++.||.++|.+|||||||||+|++.+. .+.-.|+|||+|..
T Consensus       107 nd~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~  182 (418)
T KOG1167|consen  107 NDQVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR  182 (418)
T ss_pred             CCeeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHH
Confidence            999999999995 455555554    567889999999999999999999999999999999975 55789999999862


Q ss_pred             cC-----------------C----------------CC-----------cccccceeeceehhhhhhhccccccccccee
Q psy9858         207 FG-----------------S----------------PT-----------RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW  242 (307)
Q Consensus       207 ~~-----------------~----------------~~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw  242 (307)
                      ..                 .                +.           ...-.+.||++|+|||++..++.-+.++|||
T Consensus       183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw  262 (418)
T KOG1167|consen  183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW  262 (418)
T ss_pred             HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence            10                 0                00           0011357899999999999998889999999


Q ss_pred             --e-----eeecCCCCCC----------------------------C--CCC---------------CC-----------
Q psy9858         243 --C-----CFAKDPSSHG----------------------------N--LFP---------------GI-----------  259 (307)
Q Consensus       243 --~-----i~~~~~~f~~----------------------------~--~~~---------------~~-----------  259 (307)
                        +     ++.+..||-.                            .  .+.               ..           
T Consensus       263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~  342 (418)
T KOG1167|consen  263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP  342 (418)
T ss_pred             eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence              2     3337777765                            1  001               00           


Q ss_pred             --ChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         260 --PLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       260 --~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                        ......+..+..+.+|+.+||..||.+|.|++++|+||||...++
T Consensus       343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~  389 (418)
T KOG1167|consen  343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADR  389 (418)
T ss_pred             ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhh
Confidence              001111224568999999999999999999999999999986653

>KOG3653|consensus

Probab=100.00  E-value=3.3e-34  Score=245.29  Aligned_cols=229  Identities=25%  Similarity=0.219  Sum_probs=179.4

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHh--cCCCCccccceeeeecC
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQE--LHHENVLGLTDVFGYMS  130 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~ni~~~~~~~~~~~  130 (307)
                      ......+.+.||+|.||.||+|+  -+++.||||++...        ..+.|++|-.|.+.  ++|+||++++++-+...
T Consensus       208 ~l~pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~~--------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t  277 (534)
T KOG3653|consen  208 ELDPLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPEQ--------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT  277 (534)
T ss_pred             cCCchhhHHHhhcCccceeehhh--ccCceeEEEecCHH--------HHHHHHhHHHHHhccCccchhHHHhhchhccCC
Confidence            45678888999999999999998  45689999999732        14568888888776  47999999999876555


Q ss_pred             ----eEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---------CceeecCCCCcEEEecCCcE
Q psy9858         131 ----NVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH---------WILHRDLKPNNLLINKQGVL  196 (307)
Q Consensus       131 ----~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---------~ivH~dlkp~Nil~~~~~~~  196 (307)
                          ..+||++|. .|+|.++++..-  +++.+...++..++.||+|||+.         .|+|||||.+|||+..++++
T Consensus       278 ~~~~eywLVt~fh~kGsL~dyL~~nt--isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTc  355 (534)
T KOG3653|consen  278 ADRMEYWLVTEFHPKGSLCDYLKANT--ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTC  355 (534)
T ss_pred             ccccceeEEeeeccCCcHHHHHHhcc--ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcE
Confidence                799999999 799999999874  89999999999999999999953         59999999999999999999


Q ss_pred             EEEeecCccccCCC--Ccccccceeeceehhhhhhhcccccc-----ccccee------------eeee-------cCCC
Q psy9858         197 KIGDFGLAKFFGSP--TRLYTHQVVTRWYRLIKCLLYCVQFN-----VKNVQW------------CCFA-------KDPS  250 (307)
Q Consensus       197 kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~-----~~~Diw------------~i~~-------~~~~  250 (307)
                      .|+|||+|..+...  .......+||.+|||||++.+...+.     .++|||            |-..       ..+|
T Consensus       356 cIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlp  435 (534)
T KOG3653|consen  356 CIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLP  435 (534)
T ss_pred             EeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCc
Confidence            99999999988532  22333479999999999998765444     578998            1111       3445


Q ss_pred             CCCCCCCCCChhhhcc------------------ccCHHHHHHHHHhhhcCCCCCCCHHHH
Q psy9858         251 SHGNLFPGIPLNEIFT------------------AAGDDLLAVISSLLCLNPTKRADCTAT  293 (307)
Q Consensus       251 f~~~~~~~~~~~~~~~------------------~~~~~l~~li~~~l~~dP~~Rpt~~~i  293 (307)
                      |+...-......++..                  .....+.+.+..||..||+.|.|+.-+
T Consensus       436 fe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv  496 (534)
T KOG3653|consen  436 FEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV  496 (534)
T ss_pred             hhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence            5542222222222211                  123568899999999999999998644

>KOG1152|consensus

Probab=100.00  E-value=1.1e-33  Score=247.27  Aligned_cols=198  Identities=25%  Similarity=0.251  Sum_probs=167.9

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCcccc---chhhhHhHHHHHHHHHhcC---CCCcccccee
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADA---KDGINRTALREIKLLQELH---HENVLGLTDV  125 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~~~e~~~l~~l~---h~ni~~~~~~  125 (307)
                      .....|..++.+|+|+||.|++|.++++...|+||.+.+...-..   .+...-..-.|++||..++   |+||++++++
T Consensus       558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf  637 (772)
T KOG1152|consen  558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF  637 (772)
T ss_pred             cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence            344569999999999999999999999999999999987543211   1111223446999999997   9999999999


Q ss_pred             eeecCeEEEEEEccC--CChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecC
Q psy9858         126 FGYMSNVSLVFEFVD--TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGL  203 (307)
Q Consensus       126 ~~~~~~~~lv~e~~~--g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  203 (307)
                      |+++++.||+||-.+  -+|.+++..+. .++|.+++.|++|++.|+++||++||||||||-+|++++.+|-+||+|||.
T Consensus       638 FEddd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgs  716 (772)
T KOG1152|consen  638 FEDDDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGS  716 (772)
T ss_pred             eecCCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccc
Confidence            999999999999984  36899888765 489999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCcccccceeeceehhhhhhhccccccccccee-------eeeecCCCCC
Q psy9858         204 AKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSH  252 (307)
Q Consensus       204 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~  252 (307)
                      |....+.  .....+||..|+|||++.|..+.+..-|||       .|++.+.||.
T Consensus       717 aa~~ksg--pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  717 AAYTKSG--PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hhhhcCC--CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9887443  456679999999999999997789999999       3444665553

>KOG0200|consensus

Probab=100.00  E-value=1e-32  Score=257.68  Aligned_cols=242  Identities=22%  Similarity=0.278  Sum_probs=198.1

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEEc----C---CCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCcc
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARDI----E---TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVL  120 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----~---~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~  120 (307)
                      .+....++..+.+.||+|.||.|++|.-.    .   ....||||.+......    ...+.+..|+++|+.+ +|+||+
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~----~~~~~~~~El~~m~~~g~H~niv  365 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS----SEKKDLMSELNVLKELGKHPNIV  365 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc----HHHHHHHHHHHHHHHhcCCcchh
Confidence            56666677778889999999999999622    1   2568999998854322    3357788999999998 699999


Q ss_pred             ccceeeeecCeEEEEEEcc-CCChHHHHhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCC
Q psy9858         121 GLTDVFGYMSNVSLVFEFV-DTDLEVIIKDPT---------------IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK  184 (307)
Q Consensus       121 ~~~~~~~~~~~~~lv~e~~-~g~l~~~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlk  184 (307)
                      .+++++...+..++|+||+ .|+|..+++..+               ..+.......++.||+.|+.||++.+++||||.
T Consensus       366 ~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLA  445 (609)
T KOG0200|consen  366 NLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLA  445 (609)
T ss_pred             hheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhh
Confidence            9999999999999999999 799999998766               348889999999999999999999999999999


Q ss_pred             CCcEEEecCCcEEEEeecCccccCCCCccc-ccce--eeceehhhhhhhccccccccccee-------eeee-cCCCCCC
Q psy9858         185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLY-THQV--VTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHG  253 (307)
Q Consensus       185 p~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~--~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~  253 (307)
                      .+|||+..+..+||+|||+|+......... ....  -...|||||.+... .|+.++|||       +|+. |..|+.+
T Consensus       446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~-~ft~kSDVWSfGI~L~EifsLG~~PYp~  524 (609)
T KOG0200|consen  446 ARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDR-VFTSKSDVWSFGILLWEIFTLGGTPYPG  524 (609)
T ss_pred             hhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccC-cccccchhhHHHHHHHHHhhCCCCCCCC
Confidence            999999999999999999999765443332 1112  34569999999996 999999999       3333 8888887


Q ss_pred             CC--------CCCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         254 NL--------FPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       254 ~~--------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      ..        .......+.+..+++++.++++.||+.+|++||++.++.+
T Consensus       525 ~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  525 IPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             CCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            33        2233333556678999999999999999999999988764

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.5e-32  Score=271.90  Aligned_cols=223  Identities=15%  Similarity=0.209  Sum_probs=175.8

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ..+...+.||+|+||.||+|++..+|..||+|.+.....         ....|++++++++||||+++++++.+....++
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~l  760 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYL  760 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEE
Confidence            456677899999999999999989999999998864211         11246889999999999999999999999999


Q ss_pred             EEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         135 VFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH---DHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       135 v~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      ||||+ +|+|.+++..    +++..+..++.||+.||+|||   +.+++||||||+||+++.++.+++. ||.+..... 
T Consensus       761 v~Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-  834 (968)
T PLN00113        761 IHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-  834 (968)
T ss_pred             EEeCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-
Confidence            99999 6889888853    688999999999999999999   6699999999999999998888775 666544321 


Q ss_pred             Ccccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCCCCh-------------hh-------
Q psy9858         211 TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPGIPL-------------NE-------  263 (307)
Q Consensus       211 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~~~~-------------~~-------  263 (307)
                         .....++..|+|||.+.+. .++.++|||       .+++|+.||..........             ..       
T Consensus       835 ---~~~~~~t~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  910 (968)
T PLN00113        835 ---DTKCFISSAYVAPETRETK-DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIR  910 (968)
T ss_pred             ---CCCccccccccCcccccCC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcccc
Confidence               1223678999999998877 899999999       3444888885421111000             00       


Q ss_pred             ----hccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         264 ----IFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       264 ----~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                          .......++.+++.+||+.||++|||++|+++.
T Consensus       911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence                001123457789999999999999999999874

>KOG1025|consensus

Probab=100.00  E-value=4.5e-33  Score=251.86  Aligned_cols=233  Identities=19%  Similarity=0.240  Sum_probs=193.5

Q ss_pred             eeEEeEEeecCceEEEEEEEcCCC----cEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          57 YYQWRSVHVGRFATVFKARDIETD----MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        57 y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      .+..++||+|+||+||+|.+...|    .+||+|++....    ......+++.|+.+|.+++|||++++++++.... +
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t----~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~  772 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT----SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-L  772 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC----CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-H
Confidence            455689999999999999987665    478888887432    2333567899999999999999999999987665 8


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT  211 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  211 (307)
                      .||++|+ .|.|+++++..+..+-.+..+.|+.||++|+.|||+++++||||..+|+|+..-..+||+|||+++......
T Consensus       773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~  852 (1177)
T KOG1025|consen  773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE  852 (1177)
T ss_pred             HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence            8999999 699999999888889999999999999999999999999999999999999999999999999999986554


Q ss_pred             cccccce--eeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCC-------CCChhhhccccCHHHHH
Q psy9858         212 RLYTHQV--VTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFP-------GIPLNEIFTAAGDDLLA  274 (307)
Q Consensus       212 ~~~~~~~--~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~-------~~~~~~~~~~~~~~l~~  274 (307)
                      .......  ..+-|||-|.+... .|+.++|||       .+++ |.-|+.+....       .......++.++.++.-
T Consensus       853 ~ey~~~~gK~pikwmale~i~~~-~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~  931 (1177)
T KOG1025|consen  853 KEYSAPGGKVPIKWMALESIRIR-KYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYM  931 (1177)
T ss_pred             ccccccccccCcHHHHHHHhhcc-CCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHH
Confidence            4443333  35679999999888 899999999       2333 88888873322       22233445678999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHhc
Q psy9858         275 VISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       275 li~~~l~~dP~~Rpt~~~il~  295 (307)
                      ++.+||..|+..||+++++.+
T Consensus       932 ~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  932 VMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHHHHhccCcccCccHHHHHH
Confidence            999999999999999988754

>KOG0984|consensus

Probab=99.98  E-value=6.3e-33  Score=214.19  Aligned_cols=197  Identities=21%  Similarity=0.281  Sum_probs=164.1

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeeecC
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGYMS  130 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~  130 (307)
                      ...+...-+..||+|++|.|-+.++..+|+..|+|.+....    +....++.++|+.+..+. .+|.+|.+++...++.
T Consensus        43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv----n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg  118 (282)
T KOG0984|consen   43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV----NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG  118 (282)
T ss_pred             cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc----ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence            34445566788999999999999999999999999998543    344467788999877765 6999999999999999


Q ss_pred             eEEEEEEccCCChHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         131 NVSLVFEFVDTDLEVIIK---DPTIVFTPSNIKAYAIMTLRGLEYLHDH-WILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       131 ~~~lv~e~~~g~l~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                      ..++.||.+.-+|..+..   ++++.++|..+-.|+..++.||.|||++ .++|||+||+||||+..|+||+||||.+..
T Consensus       119 dvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~  198 (282)
T KOG0984|consen  119 DVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGY  198 (282)
T ss_pred             cEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccccccee
Confidence            999999999888766664   5677799999999999999999999987 899999999999999999999999999988


Q ss_pred             cCCCCcccccceeeceehhhhhhhcc---ccccccccee-------eeeecCCCCCC
Q psy9858         207 FGSPTRLYTHQVVTRWYRLIKCLLYC---VQFNVKNVQW-------CCFAKDPSSHG  253 (307)
Q Consensus       207 ~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~Diw-------~i~~~~~~f~~  253 (307)
                      +.+. -..+-..|-..|||||.+...   ..|+.++|||       .+..++.||..
T Consensus       199 L~dS-iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  199 LVDS-IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             ehhh-hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence            7432 233335788899999998643   3689999999       23337788766

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=9.9e-31  Score=213.21  Aligned_cols=211  Identities=33%  Similarity=0.485  Sum_probs=179.7

Q ss_pred             EeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEEEccC-C
Q psy9858          63 VHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVD-T  141 (307)
Q Consensus        63 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-g  141 (307)
                      ||+|.+|.||++.+..+++.+++|++.......    ....+.+|++.++.++|++|+++++++......++++|+++ +
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~   76 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS----LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGG   76 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh----HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCC
Confidence            689999999999988889999999998543221    24568899999999999999999999999999999999996 8


Q ss_pred             ChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEec-CCcEEEEeecCccccCCCCcccccceee
Q psy9858         142 DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK-QGVLKIGDFGLAKFFGSPTRLYTHQVVT  220 (307)
Q Consensus       142 ~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~t  220 (307)
                      +|.+++......++...+..++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+..............+.
T Consensus        77 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  156 (215)
T cd00180          77 SLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGT  156 (215)
T ss_pred             cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCC
Confidence            888888765345899999999999999999999999999999999999999 8999999999998775433223345678


Q ss_pred             ceehhhhhhhccccccccccee--eeeecCCCCCCCCCCCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCc
Q psy9858         221 RWYRLIKCLLYCVQFNVKNVQW--CCFAKDPSSHGNLFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMD  297 (307)
Q Consensus       221 ~~y~aPE~~~~~~~~~~~~Diw--~i~~~~~~f~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp  297 (307)
                      ..|++||.+.....++.++|+|  +++....                    ..+.+++.+|++.||.+|||++++++|+
T Consensus       157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             CCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence            8999999987754678999999  3222222                    7899999999999999999999999885

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.96  E-value=6.4e-28  Score=210.01  Aligned_cols=183  Identities=21%  Similarity=0.169  Sum_probs=136.0

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEEcC-CCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccc-cceee
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARDIE-TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG-LTDVF  126 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~-~~~~~  126 (307)
                      ......++|.+.+.||+|+||+||+|++.. +++.||||++...............+.+|+++|+.++|+|++. +++  
T Consensus        12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~--   89 (365)
T PRK09188         12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA--   89 (365)
T ss_pred             ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE--
Confidence            334456789999999999999999998876 6788899987632111112223556889999999999999985 443  


Q ss_pred             eecCeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecC-CCCcEEEecCCcEEEEeecCcc
Q psy9858         127 GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDL-KPNNLLINKQGVLKIGDFGLAK  205 (307)
Q Consensus       127 ~~~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dl-kp~Nil~~~~~~~kl~Dfg~a~  205 (307)
                        .+..|+||||+.|..+......    .   ...++.|++.+|.|||++||+|||| ||+|||++.++.++|+|||+|+
T Consensus        90 --~~~~~LVmE~~~G~~L~~~~~~----~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~  160 (365)
T PRK09188         90 --TGKDGLVRGWTEGVPLHLARPH----G---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLAS  160 (365)
T ss_pred             --cCCcEEEEEccCCCCHHHhCcc----c---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence              2468999999965433332211    1   1467899999999999999999999 9999999999999999999999


Q ss_pred             ccCCCCcc--------cccceeeceehhhhhhhcc-----ccccccccee
Q psy9858         206 FFGSPTRL--------YTHQVVTRWYRLIKCLLYC-----VQFNVKNVQW  242 (307)
Q Consensus       206 ~~~~~~~~--------~~~~~~t~~y~aPE~~~~~-----~~~~~~~Diw  242 (307)
                      .+......        .....++..|+|||.+...     ...+...|.|
T Consensus       161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             ecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            77433211        1234677789999988643     2345667888

>KOG1345|consensus

Probab=99.96  E-value=1.4e-28  Score=197.44  Aligned_cols=239  Identities=20%  Similarity=0.228  Sum_probs=185.7

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCcccccee-ee
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDV-FG  127 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~-~~  127 (307)
                      .....+.|.+.+.||+|.||.+-++.|+.+++.+|+|-+.+..      ...++|.+|..---.| .|.||+.-|++ |+
T Consensus        19 kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~------tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq   92 (378)
T KOG1345|consen   19 KVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ------TTQADFVREFHYSFFLSPHQHIIDTYEVAFQ   92 (378)
T ss_pred             ccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch------hhHHHHHHHhccceeeccchhhhHHHHHHhh
Confidence            3456678999999999999999999999999999999987532      2256788888766666 48999987774 67


Q ss_pred             ecCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEec--CCcEEEEeecCc
Q psy9858         128 YMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK--QGVLKIGDFGLA  204 (307)
Q Consensus       128 ~~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~a  204 (307)
                      ..+..++++||+ -|+|.+-+...+  +-+.-.+.++.|+++||.|||++++||||||.+||||-.  ..+|||||||..
T Consensus        93 t~d~YvF~qE~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t  170 (378)
T KOG1345|consen   93 TSDAYVFVQEFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLT  170 (378)
T ss_pred             cCceEEEeeccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccc
Confidence            788899999999 599988888765  788889999999999999999999999999999999953  338999999999


Q ss_pred             cccCCCCcccccceeeceehhhhhhhc----cccccccccee-------eeeecCCCCCCCCCCCC--------------
Q psy9858         205 KFFGSPTRLYTHQVVTRWYRLIKCLLY----CVQFNVKNVQW-------CCFAKDPSSHGNLFPGI--------------  259 (307)
Q Consensus       205 ~~~~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~Diw-------~i~~~~~~f~~~~~~~~--------------  259 (307)
                      +..+..-   .....+..|.+||....    .-...+.+|+|       .|+.|.+|++.......              
T Consensus       171 ~k~g~tV---~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~  247 (378)
T KOG1345|consen  171 RKVGTTV---KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP  247 (378)
T ss_pred             cccCcee---hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc
Confidence            8764321   11233567889997643    22467889999       34449999887222221              


Q ss_pred             ChhhhccccCHHHHHHHHHhhhcCCCCC---CCHHHHhcCccc
Q psy9858         260 PLNEIFTAAGDDLLAVISSLLCLNPTKR---ADCTATLKMDYF  299 (307)
Q Consensus       260 ~~~~~~~~~~~~l~~li~~~l~~dP~~R---pt~~~il~hp~f  299 (307)
                      .....+...++.+..+.++-|..+|++|   -+++....-.|.
T Consensus       248 ~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~  290 (378)
T KOG1345|consen  248 ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK  290 (378)
T ss_pred             cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence            2333445678999999999999999999   555555544443

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=1.4e-29  Score=244.95  Aligned_cols=189  Identities=12%  Similarity=0.069  Sum_probs=136.0

Q ss_pred             hcCC-CCccccceee-------eecCeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCC
Q psy9858         113 ELHH-ENVLGLTDVF-------GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK  184 (307)
Q Consensus       113 ~l~h-~ni~~~~~~~-------~~~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlk  184 (307)
                      .++| +||.+++++|       .....+++++|+++++|.+++......+++.+++.++.||+.||.|||++||+|||||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK  107 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR  107 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence            3445 5788888877       2234678889999999999998766669999999999999999999999999999999


Q ss_pred             CCcEEEecCC-------------------cEEEEeecCccccCCCC----------------cccccceeeceehhhhhh
Q psy9858         185 PNNLLINKQG-------------------VLKIGDFGLAKFFGSPT----------------RLYTHQVVTRWYRLIKCL  229 (307)
Q Consensus       185 p~Nil~~~~~-------------------~~kl~Dfg~a~~~~~~~----------------~~~~~~~~t~~y~aPE~~  229 (307)
                      |+|||++..+                   .+|++|||+++......                .......+|+.|+|||++
T Consensus       108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~  187 (793)
T PLN00181        108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED  187 (793)
T ss_pred             chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence            9999996544                   45555666554321100                001113578889999999


Q ss_pred             hccccccccccee---eeee----cCCCCCCCCCC--CC---ChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCc
Q psy9858         230 LYCVQFNVKNVQW---CCFA----KDPSSHGNLFP--GI---PLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMD  297 (307)
Q Consensus       230 ~~~~~~~~~~Diw---~i~~----~~~~f~~~~~~--~~---~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp  297 (307)
                      .+. .++.++|||   |+++    +.+|+......  ..   ..........+...+++.+||+.||.+|||+.|+|+||
T Consensus       188 ~~~-~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~  266 (793)
T PLN00181        188 NGS-SSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQSE  266 (793)
T ss_pred             ccC-CCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhch
Confidence            887 789999999   3333    55554431100  00   00000111245677899999999999999999999999


Q ss_pred             ccCCC
Q psy9858         298 YFSLT  302 (307)
Q Consensus       298 ~f~~~  302 (307)
                      ||...
T Consensus       267 ~~~~~  271 (793)
T PLN00181        267 FINEP  271 (793)
T ss_pred             hhhhh
Confidence            99764

>KOG1024|consensus

Probab=99.95  E-value=1.1e-28  Score=207.29  Aligned_cols=239  Identities=17%  Similarity=0.151  Sum_probs=185.3

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCC-----CcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceee
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIET-----DMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVF  126 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~  126 (307)
                      ....+++....+.+|+||.||+|.+++.     .+.|-+|.+..    ...+.....++.|.-.+..+.|||+..+.++.
T Consensus       281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~----~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ----HASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh----cccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            3445688888999999999999976643     34566777653    23333456678899999999999999999987


Q ss_pred             e-ecCeEEEEEEccC-CChHHHHh-----CC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEE
Q psy9858         127 G-YMSNVSLVFEFVD-TDLEVIIK-----DP--TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLK  197 (307)
Q Consensus       127 ~-~~~~~~lv~e~~~-g~l~~~~~-----~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~k  197 (307)
                      . +....+.++.+.+ |+|..++.     +.  ...++..+...++.|++.|++|||+.|+||.||..+|.+|++.-+||
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVk  436 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVK  436 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEE
Confidence            4 4567888889995 88988887     22  22367778889999999999999999999999999999999999999


Q ss_pred             EEeecCccccCCCCcccc--cceeeceehhhhhhhccccccccccee--eeee------cCCCCCCCC-------CCCCC
Q psy9858         198 IGDFGLAKFFGSPTRLYT--HQVVTRWYRLIKCLLYCVQFNVKNVQW--CCFA------KDPSSHGNL-------FPGIP  260 (307)
Q Consensus       198 l~Dfg~a~~~~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~Diw--~i~~------~~~~f~~~~-------~~~~~  260 (307)
                      |+|=.+++.+-..+..+-  ..-....||+||.+... .|+.++|+|  +++.      |..|+....       ....-
T Consensus       437 ltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~-~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy  515 (563)
T KOG1024|consen  437 LTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNS-HYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY  515 (563)
T ss_pred             eccchhccccCcccccccCCCCCCcccccCHHHHhhh-hhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc
Confidence            999999987644333322  22335689999999998 999999999  3322      777776511       11111


Q ss_pred             hhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         261 LNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       261 ~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      .-..+-++++++..++.-||+.+|++||+.+|+..
T Consensus       516 RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  516 RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            22334589999999999999999999999999864

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=1.2e-26  Score=191.46  Aligned_cols=193  Identities=31%  Similarity=0.437  Sum_probs=161.5

Q ss_pred             eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEE
Q psy9858          57 YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVF  136 (307)
Q Consensus        57 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  136 (307)
                      |.+.+.||+|++|.||++.+..+++.+|+|.+......    ...+.+.+|++.++.++|+|++++++.+......++++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   76 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE----KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVM   76 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch----HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEE
Confidence            56789999999999999999888999999999864322    13567889999999999999999999999889999999


Q ss_pred             EccCC-ChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC-ccc
Q psy9858         137 EFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT-RLY  214 (307)
Q Consensus       137 e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-~~~  214 (307)
                      |++.+ +|.+++......+++..+..++.+++.+|.+||+.|++|+||+|.||+++.++.++|+|||.+....... ...
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~  156 (225)
T smart00221       77 EYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL  156 (225)
T ss_pred             eccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence            99954 8988887655337899999999999999999999999999999999999999999999999998775432 122


Q ss_pred             ccceeeceehhhhhhhccccccccccee-------eeeecCCCCCC
Q psy9858         215 THQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHG  253 (307)
Q Consensus       215 ~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~  253 (307)
                      ....++..|++||.+.....++.++|+|       .++.|+.||..
T Consensus       157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            3446788899999984333777899999       23348888755

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0590|consensus

Probab=99.95  E-value=1.4e-27  Score=220.87  Aligned_cols=248  Identities=22%  Similarity=0.264  Sum_probs=189.4

Q ss_pred             cee-eEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCC-ccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          55 LVY-YQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGT-HADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        55 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..| ...+.+|.|.+|.|+.+......+..+.|.+.... ...........+..|+-+-..+.|+|++.....+.+....
T Consensus       317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~  396 (601)
T KOG0590|consen  317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI  396 (601)
T ss_pred             cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence            345 45678899999988888876666666666554210 1111222222355677778888999998888877666665


Q ss_pred             EEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC-
Q psy9858         133 SLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT-  211 (307)
Q Consensus       133 ~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-  211 (307)
                      .-.||||.++|...+.... .+...++-.++.|++.||+|+|+.||.|||||++|+++..+|.+||+|||.+..+..+. 
T Consensus       397 ~~~mE~~~~Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  397 LQSMEYCPYDLFSLVMSNG-KLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             hhhhhcccHHHHHHHhccc-ccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence            6669999779988888763 48889999999999999999999999999999999999999999999999998775332 


Q ss_pred             ---cccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCCCC---------------hhhhcc
Q psy9858         212 ---RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPGIP---------------LNEIFT  266 (307)
Q Consensus       212 ---~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~~~---------------~~~~~~  266 (307)
                         ......+|+..|+|||.+.+.......+|||       |++.|+.|+.........               ...+..
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~  555 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLS  555 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHH
Confidence               2345668999999999999985566788999       444477777653222221               112223


Q ss_pred             ccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         267 AAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       267 ~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      .++...+.+|.+||+.||.+|.|+++|++.+||+.++
T Consensus       556 ~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~  592 (601)
T KOG0590|consen  556 LLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE  592 (601)
T ss_pred             hchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence            4577889999999999999999999999999998765

>KOG1163|consensus

Probab=99.95  E-value=2.7e-26  Score=181.55  Aligned_cols=229  Identities=20%  Similarity=0.178  Sum_probs=179.8

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-CCCccccceeeeecCe
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-HENVLGLTDVFGYMSN  131 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~  131 (307)
                      ...+|+++++||+|+||.+|+|.+..+|..||||+-+..       ....++..|.++.+.|+ ..+|..+..+..+..+
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-------a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y   85 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-------AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDY   85 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-------CCCcchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence            457899999999999999999999999999999986532       12456778999999997 5888888888888999


Q ss_pred             EEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecC---CcEEEEeecCccccC
Q psy9858         132 VSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ---GVLKIGDFGLAKFFG  208 (307)
Q Consensus       132 ~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~a~~~~  208 (307)
                      -.+||+.++.+|.+++.-....++..+++.++-|++.-++|+|.++++||||||+|+|..-+   .++.|+|||+|+.+.
T Consensus        86 nvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   86 NVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             ceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            99999999999999998766679999999999999999999999999999999999999643   468999999999875


Q ss_pred             CCC-------cccccceeeceehhhhhhhccccccccccee----eeee---cCCCCCCC--------------CCCCCC
Q psy9858         209 SPT-------RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW----CCFA---KDPSSHGN--------------LFPGIP  260 (307)
Q Consensus       209 ~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw----~i~~---~~~~f~~~--------------~~~~~~  260 (307)
                      +..       .......||.+|++--...+. .-+.+.|+=    ++++   |.+|+++.              ..-..+
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~-eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~  244 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGI-EQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP  244 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhh-hhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence            421       122344789999998887765 455555654    6666   99999982              222233


Q ss_pred             hhhhccccCHHHHHHHHHhhhcCCCCCCC
Q psy9858         261 LNEIFTAAGDDLLAVISSLLCLNPTKRAD  289 (307)
Q Consensus       261 ~~~~~~~~~~~l~~li~~~l~~dP~~Rpt  289 (307)
                      .+.+..+.+.+..-.+.-|=..-=++-|.
T Consensus       245 ie~LC~G~P~EF~myl~Y~R~L~F~E~Pd  273 (341)
T KOG1163|consen  245 IEVLCKGFPAEFAMYLNYCRGLGFEEKPD  273 (341)
T ss_pred             HHHHhCCCcHHHHHHHHHHhhcCCCCCCc
Confidence            44445566777777666664444444454

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.93  E-value=1.2e-25  Score=180.46  Aligned_cols=145  Identities=20%  Similarity=0.210  Sum_probs=108.8

Q ss_pred             EeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccch--------h-------------hhHhHHHHHHHHHhcCCCC
Q psy9858          60 WRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKD--------G-------------INRTALREIKLLQELHHEN  118 (307)
Q Consensus        60 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~--------~-------------~~~~~~~e~~~l~~l~h~n  118 (307)
                      .+.||+|++|.||+|.+. +|+.||||++..........        .             ......+|.+++.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            467999999999999975 89999999998643211110        0             0112345999999998887


Q ss_pred             ccccceeeeecCeEEEEEEccCCCh-HHHHhCCCCCCCHHHHHHHHHHHHHHHHHH-HHCCceeecCCCCcEEEecCCcE
Q psy9858         119 VLGLTDVFGYMSNVSLVFEFVDTDL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYL-HDHWILHRDLKPNNLLINKQGVL  196 (307)
Q Consensus       119 i~~~~~~~~~~~~~~lv~e~~~g~l-~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l-H~~~ivH~dlkp~Nil~~~~~~~  196 (307)
                      +....... .. ..+|||||++|+. ...... ...++...+..++.|++.+|.++ |+.||+||||||+||+++ ++.+
T Consensus        81 v~~p~~~~-~~-~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v  156 (190)
T cd05147          81 IPCPEPIL-LK-SHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKL  156 (190)
T ss_pred             CCCCcEEE-ec-CCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcE
Confidence            75443322 22 2389999997653 333222 34588999999999999999999 799999999999999998 5789


Q ss_pred             EEEeecCccccCC
Q psy9858         197 KIGDFGLAKFFGS  209 (307)
Q Consensus       197 kl~Dfg~a~~~~~  209 (307)
                      +|+|||+|.....
T Consensus       157 ~LiDFG~a~~~~~  169 (190)
T cd05147         157 YIIDVSQSVEHDH  169 (190)
T ss_pred             EEEEccccccCCC
Confidence            9999999986533

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1164|consensus

Probab=99.93  E-value=1.1e-24  Score=189.84  Aligned_cols=234  Identities=20%  Similarity=0.184  Sum_probs=177.5

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCC-cEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCC----CCccccceee-eec
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETD-MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH----ENVLGLTDVF-GYM  129 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h----~ni~~~~~~~-~~~  129 (307)
                      +|.+.+.||+|+||.||+|.+..++ ..+|+|.-.......     ...+..|..++..+..    +++..+++.. ..+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~-----~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~   93 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK-----PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE   93 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC-----CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence            8999999999999999999987764 678888876432111     1246789999998873    6889999888 578


Q ss_pred             CeEEEEEEccCCChHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecC-----CcEEEEeecC
Q psy9858         130 SNVSLVFEFVDTDLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ-----GVLKIGDFGL  203 (307)
Q Consensus       130 ~~~~lv~e~~~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~-----~~~kl~Dfg~  203 (307)
                      ...++||+.++.+|.++..... +.++..++..++.|++.+|.+||+.|++||||||+|+.+...     ..+.|.|||+
T Consensus        94 ~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   94 DFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             ceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            8999999999999999886544 679999999999999999999999999999999999999865     3699999999


Q ss_pred             cc--ccCCCC-------cc-cccceeeceehhhhhhhcccccccccceeeeee-------cCCCCCCCCCCCCC------
Q psy9858         204 AK--FFGSPT-------RL-YTHQVVTRWYRLIKCLLYCVQFNVKNVQWCCFA-------KDPSSHGNLFPGIP------  260 (307)
Q Consensus       204 a~--~~~~~~-------~~-~~~~~~t~~y~aPE~~~~~~~~~~~~Diw~i~~-------~~~~f~~~~~~~~~------  260 (307)
                      |+  ......       .. .....||..|+++....+. ..+.+.|+|.++|       |.+|..+.......      
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~-e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~  252 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI-EQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD  252 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCC-ccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence            99  321111       01 1234599999999999998 8999999993333       77776552211100      


Q ss_pred             -hhh----hccccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         261 -LNE----IFTAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       261 -~~~----~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                       ...    .....+.++.++...+-..+...+|....+..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~  292 (322)
T KOG1164|consen  253 PRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE  292 (322)
T ss_pred             hhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence             000    11123456777777777788888898766644

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.93  E-value=7.7e-25  Score=176.38  Aligned_cols=145  Identities=21%  Similarity=0.157  Sum_probs=111.6

Q ss_pred             EeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccc---------------------hhhhHhHHHHHHHHHhcCCCC
Q psy9858          60 WRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAK---------------------DGINRTALREIKLLQELHHEN  118 (307)
Q Consensus        60 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---------------------~~~~~~~~~e~~~l~~l~h~n  118 (307)
                      .+.||+|++|.||+|.+. +|+.||||++.........                     ......+.+|.+.+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            578999999999999976 8999999999875321110                     000122457899999999998


Q ss_pred             ccccceeeeecCeEEEEEEccCCC-hHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCcEEEecCCcE
Q psy9858         119 VLGLTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD-HWILHRDLKPNNLLINKQGVL  196 (307)
Q Consensus       119 i~~~~~~~~~~~~~~lv~e~~~g~-l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~  196 (307)
                      +.....+...  ..+|||||++|. +...... ...++...+..++.|++.+|.++|+ .||+||||||+||+++ ++.+
T Consensus        81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~  156 (190)
T cd05145          81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP  156 (190)
T ss_pred             CCCceEEEec--CCEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence            8555443332  248999999764 3332222 2347888999999999999999999 9999999999999998 8999


Q ss_pred             EEEeecCccccCC
Q psy9858         197 KIGDFGLAKFFGS  209 (307)
Q Consensus       197 kl~Dfg~a~~~~~  209 (307)
                      +|+|||++.....
T Consensus       157 ~liDFG~a~~~~~  169 (190)
T cd05145         157 YIIDVSQAVELDH  169 (190)
T ss_pred             EEEEcccceecCC
Confidence            9999999987743

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1165|consensus

Probab=99.92  E-value=3.4e-24  Score=176.91  Aligned_cols=215  Identities=19%  Similarity=0.223  Sum_probs=172.6

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-CCCccccceeeeecCeEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-HENVLGLTDVFGYMSNVS  133 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~  133 (307)
                      -.|+++++||+|+||.++.|++.-+++.||||.-....       ...++..|.+..+.|. .++|..++-+...+.+-.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-------~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni  100 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-------EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI  100 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccC-------CcchHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence            37999999999999999999999999999999754321       1345778999888884 799999988778888899


Q ss_pred             EEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCC-----cEEEEeecCccccC
Q psy9858         134 LVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG-----VLKIGDFGLAKFFG  208 (307)
Q Consensus       134 lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-----~~kl~Dfg~a~~~~  208 (307)
                      ||||+++.+|+|++.-.+..++..++..++.|++.-+.++|++.+|.|||||+|+||..-+     .+-|+|||+|+...
T Consensus       101 LVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr  180 (449)
T KOG1165|consen  101 LVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR  180 (449)
T ss_pred             hhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence            9999999999999987777899999999999999999999999999999999999997544     58999999999886


Q ss_pred             CCCc-------ccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCC--------------CCCCCCC
Q psy9858         209 SPTR-------LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHG--------------NLFPGIP  260 (307)
Q Consensus       209 ~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~--------------~~~~~~~  260 (307)
                      ++..       ...+..||.+||+--...|. .-+.+.|+=       ..+-|.+|+.+              ......+
T Consensus       181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGr-EQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~  259 (449)
T KOG1165|consen  181 DPKTKQHIPYREHKSLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTP  259 (449)
T ss_pred             CccccccCccccccccccceeeeEeeccccc-hhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCC
Confidence            5431       23345789999999999887 667777766       22239999998              2233344


Q ss_pred             hhhhccccCHHHHHHHH
Q psy9858         261 LNEIFTAAGDDLLAVIS  277 (307)
Q Consensus       261 ~~~~~~~~~~~l~~li~  277 (307)
                      ...+..+++.+...-+.
T Consensus       260 i~~Lc~g~P~efa~Yl~  276 (449)
T KOG1165|consen  260 IEVLCEGFPEEFATYLR  276 (449)
T ss_pred             HHHHHhcCHHHHHHHHH
Confidence            45555556655544444

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.92  E-value=2.1e-25  Score=177.61  Aligned_cols=148  Identities=16%  Similarity=0.140  Sum_probs=118.3

Q ss_pred             CChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcccccceee
Q psy9858         141 TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVT  220 (307)
Q Consensus       141 g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t  220 (307)
                      |+|.+++......+++..++.++.||+.||.|||+++      ||+||+++.++.+++  ||++.......     ..++
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-----~~g~   67 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-----SRVD   67 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc-----CCCc
Confidence            6888988876667999999999999999999999999      999999999999999  99998764321     2678


Q ss_pred             ceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCCChhh--------------hccccCH--HHHHHHH
Q psy9858         221 RWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGIPLNE--------------IFTAAGD--DLLAVIS  277 (307)
Q Consensus       221 ~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~~~~--------------~~~~~~~--~l~~li~  277 (307)
                      +.|+|||++.+. .++.++|||   +    +++|+.||............              ....++.  ++.+++.
T Consensus        68 ~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  146 (176)
T smart00750       68 PYFMAPEVIQGQ-SYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMR  146 (176)
T ss_pred             ccccChHHhcCC-CCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHH
Confidence            999999999887 889999999   3    33488898763221111100              1112333  6999999


Q ss_pred             HhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         278 SLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       278 ~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                      +||+.||.+|||+.++++|+|+...
T Consensus       147 ~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      147 VCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             HHHhcccccccCHHHHHHHHHHHHH
Confidence            9999999999999999999998643

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.91  E-value=5.3e-23  Score=178.86  Aligned_cols=240  Identities=29%  Similarity=0.414  Sum_probs=188.6

Q ss_pred             eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCC-CccccceeeeecCeEEEE
Q psy9858          57 YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHE-NVLGLTDVFGYMSNVSLV  135 (307)
Q Consensus        57 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-ni~~~~~~~~~~~~~~lv  135 (307)
                      |.+.+.||.|+||.||++.+.   ..+++|.+........  .....+.+|+.+++.+.|+ +++++.+.+......+++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~   76 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKS--KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLV   76 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccch--hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEE
Confidence            788999999999999999976   7799999986432221  2356788999999999988 799999999888889999


Q ss_pred             EEcc-CCChHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCC-cEEEEeecCccccCCCC
Q psy9858         136 FEFV-DTDLEVIIKDPT--IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG-VLKIGDFGLAKFFGSPT  211 (307)
Q Consensus       136 ~e~~-~g~l~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~~~  211 (307)
                      ++++ ++++.+.+....  ..+.......++.|++.++.++|+.|++|||+||+||+++..+ .++++|||.+.......
T Consensus        77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            9999 466775555543  2589999999999999999999999999999999999999998 79999999998664332


Q ss_pred             c------ccccceeeceehhhhhhhcc--ccccccccee--e-----eeecCCCCCCCCCC---CCChhh--------hc
Q psy9858         212 R------LYTHQVVTRWYRLIKCLLYC--VQFNVKNVQW--C-----CFAKDPSSHGNLFP---GIPLNE--------IF  265 (307)
Q Consensus       212 ~------~~~~~~~t~~y~aPE~~~~~--~~~~~~~Diw--~-----i~~~~~~f~~~~~~---~~~~~~--------~~  265 (307)
                      .      ......++..|++||.+.+.  ..+....|+|  +     .+.+..||......   ......        ..
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA  236 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence            1      34567899999999999884  3889999999  2     23377776554321   000000        00


Q ss_pred             ccc--------CHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCC
Q psy9858         266 TAA--------GDDLLAVISSLLCLNPTKRADCTATLKMDYFSL  301 (307)
Q Consensus       266 ~~~--------~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~  301 (307)
                      ...        ...+.+++.+++..+|..|.+..+...+++...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~  280 (384)
T COG0515         237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH  280 (384)
T ss_pred             cccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence            011        147899999999999999999999998866644

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=9.9e-23  Score=165.66  Aligned_cols=162  Identities=14%  Similarity=0.105  Sum_probs=122.7

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHh------HHHHHHHHHhcCCCCccccceeee
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRT------ALREIKLLQELHHENVLGLTDVFG  127 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~------~~~e~~~l~~l~h~ni~~~~~~~~  127 (307)
                      .++|+.++.+|.|+||.||++..  ++..+|+|++.......  +.....      +.+|++.+.++.|++|..+.+++.
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~--~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~  105 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRT--ERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL  105 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCch--HHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence            46899999999999999999764  46689999997543222  222222      578999999999999999998865


Q ss_pred             ec--------CeEEEEEEccCC-ChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEE
Q psy9858         128 YM--------SNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKI  198 (307)
Q Consensus       128 ~~--------~~~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl  198 (307)
                      ..        +..+|+|||++| +|.+..     .+++    ....+++.+|..+|+.|++|||++|+||+++++| ++|
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~l  175 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMP-----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRI  175 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhh-----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEE
Confidence            33        468999999976 565542     1233    2456899999999999999999999999999988 999


Q ss_pred             EeecCccccCCCCcccccceeeceehhhh-hhhcccccccccceee
Q psy9858         199 GDFGLAKFFGSPTRLYTHQVVTRWYRLIK-CLLYCVQFNVKNVQWC  243 (307)
Q Consensus       199 ~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE-~~~~~~~~~~~~Diw~  243 (307)
                      +|||.........             |-+ ++... .|+.++|+|.
T Consensus       176 iDfg~~~~~~e~~-------------a~d~~vler-~y~~~~di~~  207 (232)
T PRK10359        176 IDLSGKRCTAQRK-------------AKDRIDLER-HYGIKNEIKD  207 (232)
T ss_pred             EECCCcccccchh-------------hHHHHHHHh-Hhcccccccc
Confidence            9999987652211             111 33333 6778999993

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.89  E-value=6.8e-23  Score=171.48  Aligned_cols=231  Identities=19%  Similarity=0.202  Sum_probs=148.9

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCC----------CCcc
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH----------ENVL  120 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h----------~ni~  120 (307)
                      +....++...+.||.|+++.||.+++.++|+.+|+|++.....  ......+.+.+|.-....+.+          -.++
T Consensus         8 ~~~~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~--~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l   85 (288)
T PF14531_consen    8 GQRPRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPAD--ASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFL   85 (288)
T ss_dssp             S--EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESST--THTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B-
T ss_pred             CCCceEEEEccccccCCceEEEEEEEccCCceEEEEEEecccc--cchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEE
Confidence            3455678899999999999999999999999999999986552  222234556666654444322          1222


Q ss_pred             ccceeee---------e---cC-----eEEEEEEccCCChHHHHhC---CCC---CCCHHHHHHHHHHHHHHHHHHHHCC
Q psy9858         121 GLTDVFG---------Y---MS-----NVSLVFEFVDTDLEVIIKD---PTI---VFTPSNIKAYAIMTLRGLEYLHDHW  177 (307)
Q Consensus       121 ~~~~~~~---------~---~~-----~~~lv~e~~~g~l~~~~~~---~~~---~~~~~~~~~i~~~i~~~l~~lH~~~  177 (307)
                      ..++...         .   ..     ..+++|+-+.++|.+++..   ...   .+.......+..|++..+++||+.|
T Consensus        86 ~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G  165 (288)
T PF14531_consen   86 VPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG  165 (288)
T ss_dssp             --SEEEEETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eeeEEEEEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc
Confidence            2222221         1   11     2468888888888777642   111   1223344566799999999999999


Q ss_pred             ceeecCCCCcEEEecCCcEEEEeecCccccCCCCcccccceeeceehhhhhhhcc-------ccccccccee-------e
Q psy9858         178 ILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYC-------VQFNVKNVQW-------C  243 (307)
Q Consensus       178 ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~~Diw-------~  243 (307)
                      ++|+||+|+|++++.+|.+.|+||+.....+.....   ...+..|.+||.....       ..++.+.|.|       .
T Consensus       166 lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~  242 (288)
T PF14531_consen  166 LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS  242 (288)
T ss_dssp             EEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred             eEecccceeeEEEcCCCCEEEcChHHHeecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence            999999999999999999999999998876432211   3456789999977542       3578999999       4


Q ss_pred             eeecCCCCCCCCCCCCC---hhhhccccCHHHHHHHHHhhhcCCCCC
Q psy9858         244 CFAKDPSSHGNLFPGIP---LNEIFTAAGDDLLAVISSLLCLNPTKR  287 (307)
Q Consensus       244 i~~~~~~f~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~R  287 (307)
                      +.+++.||+........   .... .++++.++.||.++|+.||++|
T Consensus       243 lWC~~lPf~~~~~~~~~~~~f~~C-~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  243 LWCGRLPFGLSSPEADPEWDFSRC-RDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHSS-STCCCGGGSTSGGGGTTS-S---HHHHHHHHHHT-SSGGGS
T ss_pred             HHHccCCCCCCCccccccccchhc-CCcCHHHHHHHHHHccCCcccC
Confidence            44599999974333322   2232 3789999999999999999988

>KOG1240|consensus

Probab=99.89  E-value=3.7e-24  Score=199.92  Aligned_cols=236  Identities=19%  Similarity=0.181  Sum_probs=181.3

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEE
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLV  135 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  135 (307)
                      +|...+.||++.|=+|.+|++. .|. |+||++-+....-.-+. ..+-+.|++ ....++||++.+.-+.+.+...|||
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~-~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylv   99 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRP-FKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLV   99 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchH-HHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHH
Confidence            7888999999999999999964 455 99999987543222222 222334444 5556899999999988888999999


Q ss_pred             EEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC----
Q psy9858         136 FEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT----  211 (307)
Q Consensus       136 ~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----  211 (307)
                      -+|+..+|.|.+.-+. .+..-+.+.|+.||+.||..+|..||+|||||.+||||+.-+-+.|+||..-+..--+.    
T Consensus       100 RqyvkhnLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa  178 (1431)
T KOG1240|consen  100 RQYVKHNLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA  178 (1431)
T ss_pred             HHHHhhhhhhhhccch-HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence            9999999999998765 36777888999999999999999999999999999999999999999999876542111    


Q ss_pred             ---cccccceeeceehhhhhhhccc----------cccccccee---eeee-----cCCCCCCCCCC------CCChhhh
Q psy9858         212 ---RLYTHQVVTRWYRLIKCLLYCV----------QFNVKNVQW---CCFA-----KDPSSHGNLFP------GIPLNEI  264 (307)
Q Consensus       212 ---~~~~~~~~t~~y~aPE~~~~~~----------~~~~~~Diw---~i~~-----~~~~f~~~~~~------~~~~~~~  264 (307)
                         ....+......|.|||.+....          ..++++|||   |+++     |.++|.-...-      ....+..
T Consensus       179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~  258 (1431)
T KOG1240|consen  179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQL  258 (1431)
T ss_pred             cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHH
Confidence               1123334566899999986521          257899999   7666     89998762111      2222222


Q ss_pred             cccc-CHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         265 FTAA-GDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       265 ~~~~-~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      ...+ +..++++|..|++.||.+|.+|++.|+-
T Consensus       259 Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  259 LEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            3333 4579999999999999999999999984

>smart00090 RIO RIO-like kinase

Probab=99.89  E-value=1.4e-22  Score=168.11  Aligned_cols=149  Identities=21%  Similarity=0.163  Sum_probs=112.3

Q ss_pred             eeeEEeEEeecCceEEEEEE-EcCCCcEEEEEEeecCCccccc-------------------hhhhHhHHHHHHHHHhcC
Q psy9858          56 VYYQWRSVHVGRFATVFKAR-DIETDMIVAVKKIKLGTHADAK-------------------DGINRTALREIKLLQELH  115 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~~~~~~~-------------------~~~~~~~~~e~~~l~~l~  115 (307)
                      -|.+.+.||+|++|.||+|. +..+|+.||+|++.........                   ......+.+|.+++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47788999999999999998 6779999999999864321100                   011233568999999997


Q ss_pred             CCC--ccccceeeeecCeEEEEEEccCCC-hHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeecCCCCcEEEe
Q psy9858         116 HEN--VLGLTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHW-ILHRDLKPNNLLIN  191 (307)
Q Consensus       116 h~n--i~~~~~~~~~~~~~~lv~e~~~g~-l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-ivH~dlkp~Nil~~  191 (307)
                      +.+  +.++++   . ...++||||++|. +....... .......+..++.||+.+|.+||+.| ++|+||||+||+++
T Consensus       109 ~~~i~~p~~~~---~-~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~  183 (237)
T smart00090      109 EAGVPVPKPIA---W-RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH  183 (237)
T ss_pred             hcCCCCCeeeE---e-cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence            533  333433   2 2358999999764 44433222 23566677899999999999999999 99999999999999


Q ss_pred             cCCcEEEEeecCccccCCC
Q psy9858         192 KQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       192 ~~~~~kl~Dfg~a~~~~~~  210 (307)
                       ++.++|+|||.+.....+
T Consensus       184 -~~~i~LiDFg~a~~~~~~  201 (237)
T smart00090      184 -DGKVVIIDVSQSVELDHP  201 (237)
T ss_pred             -CCCEEEEEChhhhccCCc
Confidence             889999999999876443

>PRK10345 hypothetical protein; Provisional

Probab=99.88  E-value=5.7e-22  Score=160.64  Aligned_cols=136  Identities=18%  Similarity=0.246  Sum_probs=106.2

Q ss_pred             EEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-----CCCCccccceeeeecC---
Q psy9858          59 QWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-----HHENVLGLTDVFGYMS---  130 (307)
Q Consensus        59 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~ni~~~~~~~~~~~---  130 (307)
                      -.+.||+|+||.||.  +..++.. +||++......     ..+.+.+|+.+++.+     +||||++++++++++.   
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~-----~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g   77 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG-----GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG   77 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCe-EEEEEeccccc-----hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence            347899999999995  6777776 69998753211     245688999999999     5799999999998763   


Q ss_pred             e-EEEEEEccC---CChHHHHhCCCCCCCHHHHHHHHHHHHHHH-HHHHHCCceeecCCCCcEEEecC----CcEEEEe-
Q psy9858         131 N-VSLVFEFVD---TDLEVIIKDPTIVFTPSNIKAYAIMTLRGL-EYLHDHWILHRDLKPNNLLINKQ----GVLKIGD-  200 (307)
Q Consensus       131 ~-~~lv~e~~~---g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l-~~lH~~~ivH~dlkp~Nil~~~~----~~~kl~D-  200 (307)
                      . ..+|+||.+   |+|.+++.+.  .+++.  ..++.|++.++ +|||+++|+||||||+||+++.+    +.++|+| 
T Consensus        78 ~v~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         78 YVYDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             EEEEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            4 337899954   7899999664  25555  35678888777 89999999999999999999753    3799999 


Q ss_pred             ecCccc
Q psy9858         201 FGLAKF  206 (307)
Q Consensus       201 fg~a~~  206 (307)
                      ||....
T Consensus       154 ~G~~~~  159 (210)
T PRK10345        154 IGESTF  159 (210)
T ss_pred             CCCcce
Confidence            554443

>KOG4158|consensus

Probab=99.88  E-value=6.1e-23  Score=173.39  Aligned_cols=237  Identities=18%  Similarity=0.135  Sum_probs=171.0

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCC-----------------------------------cEEEEEEeecCCcccc
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETD-----------------------------------MIVAVKKIKLGTHADA   96 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----------------------------------~~vavK~~~~~~~~~~   96 (307)
                      -.+++|++++.||+|....||.|.-..+|                                   -+.|||.+-.-...+.
T Consensus       154 FtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~  233 (598)
T KOG4158|consen  154 FTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSG  233 (598)
T ss_pred             cchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCc
Confidence            34567999999999999999987633211                                   1445665543332333


Q ss_pred             chhhhHhHHHHH------HHH--------H-------hc-CCCCccccceeeee--------------------------
Q psy9858          97 KDGINRTALREI------KLL--------Q-------EL-HHENVLGLTDVFGY--------------------------  128 (307)
Q Consensus        97 ~~~~~~~~~~e~------~~l--------~-------~l-~h~ni~~~~~~~~~--------------------------  128 (307)
                      ...+.+...+|+      ..+        +       ++ +|||||++.++|.+                          
T Consensus       234 ~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g  313 (598)
T KOG4158|consen  234 DAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAG  313 (598)
T ss_pred             hHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccC
Confidence            333444444443      111        1       11 49999999998732                          


Q ss_pred             -cCeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEec--CC--cEEEEeecC
Q psy9858         129 -MSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK--QG--VLKIGDFGL  203 (307)
Q Consensus       129 -~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~--~~--~~kl~Dfg~  203 (307)
                       ...+|+||..+..+|..++..+.  .+....+-++.|+++|+.|||++|+.|||+|.+|||+.-  ++  ..+|+|||.
T Consensus       314 ~~~tlylvMkrY~~tLr~yl~~~~--~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGC  391 (598)
T KOG4158|consen  314 EPKTLYLVMKRYRQTLREYLWTRH--RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGC  391 (598)
T ss_pred             CCceEEEehhcchhhHHHHHhcCC--CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccce
Confidence             45799999999999999998775  578888999999999999999999999999999999953  33  478999998


Q ss_pred             ccccCC------CCcccccceeeceehhhhhhhcccc-----ccccccee-------eeeecCCCCCC--------CCCC
Q psy9858         204 AKFFGS------PTRLYTHQVVTRWYRLIKCLLYCVQ-----FNVKNVQW-------CCFAKDPSSHG--------NLFP  257 (307)
Q Consensus       204 a~~~~~------~~~~~~~~~~t~~y~aPE~~~~~~~-----~~~~~Diw-------~i~~~~~~f~~--------~~~~  257 (307)
                      |---..      -....-...|+..-||||+....+.     .-.++|.|       .|+....||.+        ..++
T Consensus       392 cLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yq  471 (598)
T KOG4158|consen  392 CLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQ  471 (598)
T ss_pred             eeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhh
Confidence            753311      1122334567788899999875421     12588999       35554455544        5566


Q ss_pred             CCChhhhccccCHHHHHHHHHhhhcCCCCCCCH
Q psy9858         258 GIPLNEIFTAAGDDLLAVISSLLCLNPTKRADC  290 (307)
Q Consensus       258 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~  290 (307)
                      +..+..++..+++.+.+||-.+|+.||.+|++.
T Consensus       472 e~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp  504 (598)
T KOG4158|consen  472 ESQLPALPSRVPPVARQLVFDLLKRDPSKRVSP  504 (598)
T ss_pred             hhhCCCCcccCChHHHHHHHHHhcCCccccCCc
Confidence            666777778899999999999999999999994

>KOG0603|consensus

Probab=99.86  E-value=1.2e-23  Score=187.09  Aligned_cols=230  Identities=20%  Similarity=0.237  Sum_probs=184.9

Q ss_pred             EeecCceEEEEEEE---cCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-CCCccccceeeeecCeEEEEEEc
Q psy9858          63 VHVGRFATVFKARD---IETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-HENVLGLTDVFGYMSNVSLVFEF  138 (307)
Q Consensus        63 lg~G~~g~V~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~  138 (307)
                      +|+|.||.|+++..   ...|..+|+|++.+........   .....|..++..++ ||.++++.-.++.+...++++++
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~---~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~   78 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDR---THTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDF   78 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccc---cccccHHHHHhhccCCCceeeeeeeeccccchhHhhhh
Confidence            68999999998642   3467889999998765444332   14456888899987 99999999999999999999999


Q ss_pred             c-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcccccc
Q psy9858         139 V-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQ  217 (307)
Q Consensus       139 ~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  217 (307)
                      . +|++.....+.. .+.+.....+...++.+++++|+.|++|||+|++||+++.+|++++.|||+++..-...    ..
T Consensus        79 ~rgg~lft~l~~~~-~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~----~~  153 (612)
T KOG0603|consen   79 LRGGDLFTRLSKEV-MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK----IA  153 (612)
T ss_pred             cccchhhhccccCC-chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh----hc
Confidence            9 567877776655 36788888899999999999999999999999999999999999999999998764322    12


Q ss_pred             eeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCCCCh--hhhccccCHHHHHHHHHhhhcCCCCCC
Q psy9858         218 VVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPGIPL--NEIFTAAGDDLLAVISSLLCLNPTKRA  288 (307)
Q Consensus       218 ~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rp  288 (307)
                      +||..|||||++.+   ...++|.|       .++.|..||.+........  ..++...+..+.+++..++..+|.+|.
T Consensus       154 cgt~eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrL  230 (612)
T KOG0603|consen  154 CGTYEYRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGGDTMKRILKAELEMPRELSAEARSLFRQLFKRNPENRL  230 (612)
T ss_pred             ccchhhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCchHHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHh
Confidence            89999999999984   46789999       3444888888722211111  133456788999999999999999998


Q ss_pred             C-----HHHHhcCcccCCCc
Q psy9858         289 D-----CTATLKMDYFSLTK  303 (307)
Q Consensus       289 t-----~~~il~hp~f~~~~  303 (307)
                      -     +.++++|+||+...
T Consensus       231 g~~~~~~~eik~h~f~~~i~  250 (612)
T KOG0603|consen  231 GAGPDGVDEIKQHEFFQSID  250 (612)
T ss_pred             ccCcchhHHHhccchheeee
Confidence            6     58999999998764

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=2.2e-20  Score=153.20  Aligned_cols=139  Identities=19%  Similarity=0.218  Sum_probs=112.7

Q ss_pred             eEEeecCceEEEEEEEcCCCcEEEEEEeecCCcccc---chhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEEE
Q psy9858          61 RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADA---KDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFE  137 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  137 (307)
                      +.||+|++|.||+|.+  .|..|++|+.........   .......+.+|++++..+.|+++.....++.+....+++||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            5789999999999986  677899998654321111   11112457789999999999999888777777888999999


Q ss_pred             ccC-CChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         138 FVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       138 ~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      |++ ++|.+.+....    . ....++.+++.+|.++|+.|++|+|++|.||+++ ++.++|+|||.+...
T Consensus        80 ~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~  144 (211)
T PRK14879         80 YIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS  144 (211)
T ss_pred             EeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence            995 57777765432    2 7788999999999999999999999999999999 889999999998764

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=2.7e-20  Score=148.40  Aligned_cols=170  Identities=16%  Similarity=0.066  Sum_probs=119.5

Q ss_pred             eEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-CCCccccceeeeecCeEEEEE
Q psy9858          58 YQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-HENVLGLTDVFGYMSNVSLVF  136 (307)
Q Consensus        58 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~  136 (307)
                      .+...|++|+||+|+.+..  .+.+++.+.+....... .......+.+|+++|++|. |+++++++++    +..+++|
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~-~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm   77 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWL-RGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR   77 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhh-hhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence            4568899999999998763  67788888776432211 1111235789999999995 5889999885    4569999


Q ss_pred             EccCCC-hHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecC-CCCcEEEecCCcEEEEeecCccccCCCCcc-
Q psy9858         137 EFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDL-KPNNLLINKQGVLKIGDFGLAKFFGSPTRL-  213 (307)
Q Consensus       137 e~~~g~-l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dl-kp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~-  213 (307)
                      ||+.|. |.+...       .. ...++.|++.+|.++|++||+|||| ||+||+++.++.++|+|||+|......... 
T Consensus        78 eyI~G~~L~~~~~-------~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~  149 (218)
T PRK12274         78 SYLAGAAMYQRPP-------RG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM  149 (218)
T ss_pred             eeecCccHHhhhh-------hh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence            999665 433211       11 2357789999999999999999999 799999999999999999999866433211 


Q ss_pred             ------------cccceeeceehhhhhhhccccccccccee
Q psy9858         214 ------------YTHQVVTRWYRLIKCLLYCVQFNVKNVQW  242 (307)
Q Consensus       214 ------------~~~~~~t~~y~aPE~~~~~~~~~~~~Diw  242 (307)
                                  ......++.|++|+...--...+...-+|
T Consensus       150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w  190 (218)
T PRK12274        150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELW  190 (218)
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHH
Confidence                        11123566777777654332334334455

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.83  E-value=6.4e-20  Score=149.00  Aligned_cols=135  Identities=19%  Similarity=0.204  Sum_probs=105.6

Q ss_pred             EEeecCceEEEEEEEcCCCcEEEEEEeecCCcccc---chhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEEEc
Q psy9858          62 SVHVGRFATVFKARDIETDMIVAVKKIKLGTHADA---KDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEF  138 (307)
Q Consensus        62 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  138 (307)
                      .||+|++|.||+|.  .+|..|++|+.........   ......++.+|++++..++|+++.....++......+++|||
T Consensus         1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            37999999999998  4678899998654321111   111135577899999999988766655556667778999999


Q ss_pred             c-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         139 V-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       139 ~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      + ++++.+.+....    .    .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||++...
T Consensus        79 ~~g~~l~~~~~~~~----~----~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        79 IEGKPLKDVIEEGN----D----ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             ECCccHHHHHhhcH----H----HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            9 456766654321    0    7899999999999999999999999999999 889999999998764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.82  E-value=8.6e-20  Score=148.10  Aligned_cols=142  Identities=23%  Similarity=0.194  Sum_probs=106.6

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccc-----------------hhhhHhHHHHHHHHHhcCCCC
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAK-----------------DGINRTALREIKLLQELHHEN  118 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-----------------~~~~~~~~~e~~~l~~l~h~n  118 (307)
                      .|.+.+.||+|+||.||+|.+ .+|+.||||++.........                 ......+.+|..++..+.|++
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             hhhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            477889999999999999986 48999999998754311000                 001123567899999988774


Q ss_pred             --ccccceeeeecCeEEEEEEccCC-ChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCc
Q psy9858         119 --VLGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGV  195 (307)
Q Consensus       119 --i~~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~  195 (307)
                        ++..++    ....+++|||++| ++..... .      .....++.+++.++.++|+.|++|+||+|+||+++.++.
T Consensus        95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~-~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~  163 (198)
T cd05144          95 FPVPKPID----WNRHAVVMEYIDGVELYRVRV-L------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK  163 (198)
T ss_pred             CCCCceee----cCCceEEEEEeCCcchhhccc-c------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc
Confidence              444433    3455899999965 4443321 1      345678899999999999999999999999999999999


Q ss_pred             EEEEeecCccccCC
Q psy9858         196 LKIGDFGLAKFFGS  209 (307)
Q Consensus       196 ~kl~Dfg~a~~~~~  209 (307)
                      ++|+|||.+.....
T Consensus       164 ~~liDfg~~~~~~~  177 (198)
T cd05144         164 IYIIDWPQMVSTDH  177 (198)
T ss_pred             EEEEECCccccCCC
Confidence            99999999976643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1166|consensus

Probab=99.82  E-value=6e-20  Score=174.13  Aligned_cols=184  Identities=17%  Similarity=0.190  Sum_probs=146.6

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC---CCCccccceee
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH---HENVLGLTDVF  126 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~ni~~~~~~~  126 (307)
                      .......|.+-+.||+|+||+||+|.+.. |+.||+|+=......        +|.--.+++.+|+   -+.|+.+..++
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W--------EfYI~~q~~~RLk~~~~~~~~~~~~a~  763 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW--------EFYICLQVMERLKPQMLPSIMHISSAH  763 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce--------eeeehHHHHHhhchhhhcchHHHHHHH
Confidence            34455689999999999999999999755 999999987654321        1333344445554   35677777777


Q ss_pred             eecCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEec-------CCcEEE
Q psy9858         127 GYMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK-------QGVLKI  198 (307)
Q Consensus       127 ~~~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~-------~~~~kl  198 (307)
                      ...+..+||+||. -|+|++++. ..+.+++..+..+..|++..|.+||..+|||+||||+|++|..       +..++|
T Consensus       764 ~~~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~l  842 (974)
T KOG1166|consen  764 VFQNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYL  842 (974)
T ss_pred             ccCCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEE
Confidence            8889999999999 599999998 4456999999999999999999999999999999999999942       335899


Q ss_pred             EeecCccccC--CCCcccccceeeceehhhhhhhcccccccccceeee
Q psy9858         199 GDFGLAKFFG--SPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWCC  244 (307)
Q Consensus       199 ~Dfg~a~~~~--~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw~i  244 (307)
                      +|||.+....  .+.........|..+--+|+..|. ..++.+|.||+
T Consensus       843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~gr-pWtYq~DyfGl  889 (974)
T KOG1166|consen  843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGR-PWTYQIDYFGL  889 (974)
T ss_pred             EecccceeeeEcCCCcEEeeeeccccchhHHHhcCC-CCchhhhhHHH
Confidence            9999986542  222345556788899999999998 99999999943

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.81  E-value=2.2e-19  Score=166.61  Aligned_cols=141  Identities=18%  Similarity=0.153  Sum_probs=110.3

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccc---cchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHAD---AKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN  131 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  131 (307)
                      ..|...+.||+|+||+||+|.+...  .+++|+........   ........+.+|+++++.++|++++....+..+...
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            3456789999999999999986433  35555433211111   111223567899999999999999988777777778


Q ss_pred             EEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         132 VSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       132 ~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      .++||||+ +++|.+.+.         ....++.+++.+|.+||+.|++||||||+||++ .++.++|+|||+++..
T Consensus       411 ~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             CEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            89999999 567777664         346789999999999999999999999999999 6789999999999875

>KOG1033|consensus

Probab=99.81  E-value=1.4e-21  Score=170.96  Aligned_cols=165  Identities=19%  Similarity=0.199  Sum_probs=125.6

Q ss_pred             eEEEEEEcc-CCChHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         131 NVSLVFEFV-DTDLEVIIKDP--TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       131 ~~~lv~e~~-~g~l~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      ++||.|++| .++|.+++..+  ....+......++.|++.|+.|   +|.+|+|+||.||++..+..+||.|||+....
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~  406 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ  406 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence            477889999 68899998643  3346777889999999999999   99999999999999999999999999998766


Q ss_pred             CCCC------cccccceeeceehhhhhhhccccccccccee--eeeecCCC--CCC--------CCCCCCChhhhccccC
Q psy9858         208 GSPT------RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW--CCFAKDPS--SHG--------NLFPGIPLNEIFTAAG  269 (307)
Q Consensus       208 ~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw--~i~~~~~~--f~~--------~~~~~~~~~~~~~~~~  269 (307)
                      ....      ...+...||.+||+||.+.+. .|+.++|||  +++..++.  |..        ..+....+.+.+..-.
T Consensus       407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~-~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d~r~g~ip~~~~~d~  485 (516)
T KOG1033|consen  407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQ-QYSEKVDIYALGLILAELLIQFSTQFERIATLTDIRDGIIPPEFLQDY  485 (516)
T ss_pred             ccCCcccchhhhhhhcccccccCCHHHHhhh-hhhhhcchhhHHHHHHHHHHHhccHHHHHHhhhhhhcCCCChHHhhcC
Confidence            4332      234566899999999999998 999999999  55542222  333        1222222222222233


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         270 DDLLAVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       270 ~~l~~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                      ++-..|+++||+..|.+||++.+.--|+|.
T Consensus       486 p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  486 PEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            456799999999999999988777777664

>KOG0606|consensus

Probab=99.80  E-value=2.9e-20  Score=173.84  Aligned_cols=208  Identities=25%  Similarity=0.260  Sum_probs=150.0

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ....|..++.|..|+||.||.++|+.+.+.+|+|+ ++..          -+.+.  ++.....|.+|            
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~----------lilRn--ilt~a~npfvv------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN----------LILRN--ILTFAGNPFVV------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhcc-cccc----------hhhhc--cccccCCccee------------
Confidence            44679999999999999999999999999999953 3210          01111  23333334333            


Q ss_pred             EEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC--
Q psy9858         133 SLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP--  210 (307)
Q Consensus       133 ~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--  210 (307)
                              |+....++..+ .++-.        ++.+++|+|+.||+|||+||+|.+|+.-|++|++|||+.+...-.  
T Consensus       136 --------gDc~tllk~~g-~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  136 --------GDCATLLKNIG-PLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             --------chhhhhcccCC-CCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence                    55555555433 22222        278899999999999999999999999999999999998754110  


Q ss_pred             -------------Ccccccceeeceehhhhhhhccccccccccee---eeee----cCCCCCCCCC---------CCCCh
Q psy9858         211 -------------TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KDPSSHGNLF---------PGIPL  261 (307)
Q Consensus       211 -------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~~~~f~~~~~---------~~~~~  261 (307)
                                   +-.....+||+.|.|||++... .|+..+|.|   .|+|    |..||.+..-         .....
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrq-gygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w  277 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW  277 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhhhh-ccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc
Confidence                         0011234789999999999998 899999999   3333    8888877411         11111


Q ss_pred             hhhccccCHHHHHHHHHhhhcCCCCCCC---HHHHhcCcccCCCc
Q psy9858         262 NEIFTAAGDDLLAVISSLLCLNPTKRAD---CTATLKMDYFSLTK  303 (307)
Q Consensus       262 ~~~~~~~~~~l~~li~~~l~~dP~~Rpt---~~~il~hp~f~~~~  303 (307)
                      .+-....++++++++.++|+.+|..|.-   +-++.+|+||+..+
T Consensus       278 pE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LD  322 (1205)
T KOG0606|consen  278 PEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLD  322 (1205)
T ss_pred             cccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecc
Confidence            1223457899999999999999999974   78889999998765

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.79  E-value=9.4e-19  Score=140.71  Aligned_cols=140  Identities=24%  Similarity=0.215  Sum_probs=97.8

Q ss_pred             EeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhh-------------------hHhHHHHHHHHHhcCCCC--
Q psy9858          60 WRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGI-------------------NRTALREIKLLQELHHEN--  118 (307)
Q Consensus        60 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~-------------------~~~~~~e~~~l~~l~h~n--  118 (307)
                      .+.||+|+||+||+|.+. +|+.||||++............                   ......|.+.+..+.+.+  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999965 8999999998754322111000                   001135566666664432  


Q ss_pred             ccccceeeeecCeEEEEEEccCC-ChHH-HHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCcEEEecCCc
Q psy9858         119 VLGLTDVFGYMSNVSLVFEFVDT-DLEV-IIKDPTIVFTPSNIKAYAIMTLRGLEYLHD-HWILHRDLKPNNLLINKQGV  195 (307)
Q Consensus       119 i~~~~~~~~~~~~~~lv~e~~~g-~l~~-~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~  195 (307)
                      +.+.+++    ...+++|||++| .+.. .+....  . ...+..++.+++.++.++|. .|++|+||||+||+++ ++.
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~  152 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK  152 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence            3444432    345899999965 2211 111111  1 15678899999999999999 9999999999999999 899


Q ss_pred             EEEEeecCccccC
Q psy9858         196 LKIGDFGLAKFFG  208 (307)
Q Consensus       196 ~kl~Dfg~a~~~~  208 (307)
                      ++|+|||.+....
T Consensus       153 ~~liDfg~a~~~~  165 (187)
T cd05119         153 VYIIDVPQAVEID  165 (187)
T ss_pred             EEEEECccccccc
Confidence            9999999997653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0195|consensus

Probab=99.78  E-value=7.9e-20  Score=147.59  Aligned_cols=231  Identities=13%  Similarity=0.116  Sum_probs=179.0

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN  131 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  131 (307)
                      .+.....+.-+|.+...|..|+|++..+  .++.|++....   ......+.|..|.-.|+.+.||||+.+++.|.....
T Consensus       187 id~~~lnl~tkl~e~hsgelwrgrwqgn--divakil~vr~---~t~risrdfneefp~lrifshpnilpvlgacnsppn  261 (448)
T KOG0195|consen  187 IDVSSLNLITKLAESHSGELWRGRWQGN--DIVAKILNVRE---VTARISRDFNEEFPALRIFSHPNILPVLGACNSPPN  261 (448)
T ss_pred             cchhhhhhhhhhccCCCcccccccccCc--chhhhhhhhhh---cchhhcchhhhhCcceeeecCCchhhhhhhccCCCC
Confidence            3455667778899999999999998654  47888887643   233345678899999999999999999999999999


Q ss_pred             EEEEEEcc-CCChHHHHhCCCC-CCCHHHHHHHHHHHHHHHHHHHHCC--ceeecCCCCcEEEecCCcEEEE--eecCcc
Q psy9858         132 VSLVFEFV-DTDLEVIIKDPTI-VFTPSNIKAYAIMTLRGLEYLHDHW--ILHRDLKPNNLLINKQGVLKIG--DFGLAK  205 (307)
Q Consensus       132 ~~lv~e~~-~g~l~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~--Dfg~a~  205 (307)
                      +.++..|+ -|+|...++.... ..+..++..++.+|+.|++|||+..  |----|+...+++|++-+.+|+  |--++-
T Consensus       262 lv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf  341 (448)
T KOG0195|consen  262 LVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF  341 (448)
T ss_pred             ceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee
Confidence            99999999 5999999986543 4688899999999999999999874  4455788899999998877654  322221


Q ss_pred             ccCCCCcccccceeeceehhhhhhhccccc--cccccee-------eeeecCCCCCCC--------CCCCCChhhhcccc
Q psy9858         206 FFGSPTRLYTHQVVTRWYRLIKCLLYCVQF--NVKNVQW-------CCFAKDPSSHGN--------LFPGIPLNEIFTAA  268 (307)
Q Consensus       206 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~--~~~~Diw-------~i~~~~~~f~~~--------~~~~~~~~~~~~~~  268 (307)
                      .       ...+...+.||+||.+......  -.+.|+|       .+.+.+.||..-        ..-+.....+++++
T Consensus       342 q-------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgi  414 (448)
T KOG0195|consen  342 Q-------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGI  414 (448)
T ss_pred             e-------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCc
Confidence            1       1233567899999999876332  3678999       344488999872        22223344567889


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHh
Q psy9858         269 GDDLLAVISSLLCLNPTKRADCTATL  294 (307)
Q Consensus       269 ~~~l~~li~~~l~~dP~~Rpt~~~il  294 (307)
                      +.....|+.-|++.||.+||.++.++
T Consensus       415 s~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  415 SRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             cHHHHHHHHHHhcCCCCcCCCcceeh
Confidence            99999999999999999999988764

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.77  E-value=5.9e-18  Score=140.71  Aligned_cols=140  Identities=16%  Similarity=0.203  Sum_probs=104.1

Q ss_pred             eEEe-ecCceEEEEEEEcCCCcEEEEEEeecCCc-----cc---cchhhhHhHHHHHHHHHhcCCCCc--cccceeeeec
Q psy9858          61 RSVH-VGRFATVFKARDIETDMIVAVKKIKLGTH-----AD---AKDGINRTALREIKLLQELHHENV--LGLTDVFGYM  129 (307)
Q Consensus        61 ~~lg-~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~---~~~~~~~~~~~e~~~l~~l~h~ni--~~~~~~~~~~  129 (307)
                      ..|| .||.|+||.+..  .+..+++|.+.....     .+   ........+.+|++++..++|++|  ++.+++....
T Consensus        37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4577 788889998874  377899998865321     10   011223567899999999998775  6666654332


Q ss_pred             -C---eEEEEEEccCC--ChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecC
Q psy9858         130 -S---NVSLVFEFVDT--DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGL  203 (307)
Q Consensus       130 -~---~~~lv~e~~~g--~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  203 (307)
                       .   ..++|||+++|  +|.+++...  .+++.    .+.+|+.+|.+||++||+|+||||.|||++.++.++|+|||.
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~  188 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR  188 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence             2   24599999964  677776543  34544    357899999999999999999999999999999999999999


Q ss_pred             ccccC
Q psy9858         204 AKFFG  208 (307)
Q Consensus       204 a~~~~  208 (307)
                      +....
T Consensus       189 ~~~~~  193 (239)
T PRK01723        189 GELRT  193 (239)
T ss_pred             cccCC
Confidence            98753

>KOG0601|consensus

Probab=99.75  E-value=3.1e-18  Score=152.56  Aligned_cols=246  Identities=19%  Similarity=0.131  Sum_probs=191.5

Q ss_pred             cccceeeEEeEEee--cCceEEEEEEE--cCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-CCCccccceee
Q psy9858          52 NDLLVYYQWRSVHV--GRFATVFKARD--IETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-HENVLGLTDVF  126 (307)
Q Consensus        52 ~~~~~y~~~~~lg~--G~~g~V~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~  126 (307)
                      -....+.+.+.+|.  |.+|.||.+..  ..++..+|+|.-....... .  ....-.+|+..-++++ |+|.++.+..+
T Consensus       111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p-~--~~~~k~~~~~s~~~i~~~~~~v~~~~~~  187 (524)
T KOG0601|consen  111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPP-L--DSKRKLREFLSHHKIDSHENPVRDSPAW  187 (524)
T ss_pred             hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCc-c--ccccccchhhcccccCccccccccCccc
Confidence            34456788899999  99999999987  7899999999844322111 0  0122336777777774 99999999999


Q ss_pred             eecCeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHH----HHHHHHHCCceeecCCCCcEEEecC-CcEEEEee
Q psy9858         127 GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLR----GLEYLHDHWILHRDLKPNNLLINKQ-GVLKIGDF  201 (307)
Q Consensus       127 ~~~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~----~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Df  201 (307)
                      +..+..++-+|+++.++.++.......+++..++..+.+..+    ||.++|..+++|.|+||.||+...+ ..++++||
T Consensus       188 e~~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  188 EGSGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             ccCCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCc
Confidence            999999999999999999999888777899999999999999    9999999999999999999999999 78999999


Q ss_pred             cCccccCCCCcccc-----cceeeceehhhhhhhccccccccccee---eeee----cCCCCCC-------CCCCCCChh
Q psy9858         202 GLAKFFGSPTRLYT-----HQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KDPSSHG-------NLFPGIPLN  262 (307)
Q Consensus       202 g~a~~~~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~~~~f~~-------~~~~~~~~~  262 (307)
                      |+...+++..-...     ...+...|++||.+.+-  ++...|++   .++.    +..+...       .........
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~  345 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPL  345 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCch
Confidence            99998865432221     22667789999998774  78889999   1111    2222222       111222334


Q ss_pred             hhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         263 EIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       263 ~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                      +...+.+.++...+..|+..+|..|++++.+++|+++...
T Consensus       346 e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  346 EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK  385 (524)
T ss_pred             hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence            4555678888889999999999999999999999998743

>KOG0590|consensus

Probab=99.74  E-value=3.2e-19  Score=165.44  Aligned_cols=245  Identities=20%  Similarity=0.223  Sum_probs=190.0

Q ss_pred             cceeeEEeEEeecCceEEEEEEEc-CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-CCCccccceeeeecCe
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDI-ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-HENVLGLTDVFGYMSN  131 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~  131 (307)
                      ...|.+.+.||+|+|+.|-..... .....+|+|.+.....   ..........|..+-..+. |.|++.+++...+...
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~---~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~   95 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPK---SEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRS   95 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCC---ccchhhhcCccccccccccccccccccCCccCCCcc
Confidence            456888888999999999988753 3445677777765431   1111233445777777776 9999999999999999


Q ss_pred             EEEEEEcc-CCChHHHH-hCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCceeecCCCCcEEEecCC-cEEEEeecCcccc
Q psy9858         132 VSLVFEFV-DTDLEVII-KDPTIVFTPSNIKAYAIMTLRGLEYLH-DHWILHRDLKPNNLLINKQG-VLKIGDFGLAKFF  207 (307)
Q Consensus       132 ~~lv~e~~-~g~l~~~~-~~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a~~~  207 (307)
                      .++++++. +|++...+ .......+...+..++.|+..++.|+| ..++.|+||||+|.+++..+ ..+++|||+|..+
T Consensus        96 ~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen   96 YLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             cccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccc
Confidence            99999999 56777777 433325777888999999999999999 99999999999999999999 9999999999877


Q ss_pred             CC---CCccccccee-eceehhhhhhhccccccccccee--e-----eeecCCCCCCCCCCCCC-----------hhhhc
Q psy9858         208 GS---PTRLYTHQVV-TRWYRLIKCLLYCVQFNVKNVQW--C-----CFAKDPSSHGNLFPGIP-----------LNEIF  265 (307)
Q Consensus       208 ~~---~~~~~~~~~~-t~~y~aPE~~~~~~~~~~~~Diw--~-----i~~~~~~f~~~~~~~~~-----------~~~~~  265 (307)
                      ..   ........+| ++.|+|||...+.....+..|+|  +     .+.|..|..........           ....+
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPW  255 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcc
Confidence            54   2333455678 99999999999965778999999  2     22266665552111111           12334


Q ss_pred             cccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCC
Q psy9858         266 TAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSL  301 (307)
Q Consensus       266 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~  301 (307)
                      ..++....+++.+++..+|..|.+.+++-.+||+..
T Consensus       256 ~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  256 NSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ccCChhhhhcccccccCCchhccccccccccccccc
Confidence            567899999999999999999999999999999987

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.73  E-value=3.3e-17  Score=126.61  Aligned_cols=133  Identities=19%  Similarity=0.151  Sum_probs=109.3

Q ss_pred             EEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCC--CCccccceeeeecCeEEEEE
Q psy9858          59 QWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH--ENVLGLTDVFGYMSNVSLVF  136 (307)
Q Consensus        59 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~ni~~~~~~~~~~~~~~lv~  136 (307)
                      +++.||+|.++.||++....  ..+++|.......       ...+.+|+.+++.++|  .++++++.+....+..+++|
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~   72 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLM   72 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc-------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEE
Confidence            45789999999999999643  6799998864321       3457899999999976  58999998888888999999


Q ss_pred             EccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         137 EFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH---WILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       137 e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      ||+.|.....+       +......++.+++.+|+.+|..   +++|+|++|+||+++..+.++++|||.+...
T Consensus        73 e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          73 EWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             EecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            99965432222       4456677889999999999985   7999999999999999899999999999764

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1023|consensus

Probab=99.72  E-value=1.9e-17  Score=147.38  Aligned_cols=185  Identities=19%  Similarity=0.211  Sum_probs=143.9

Q ss_pred             HHhcCCCCccccceeeeecCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCc-eeecCCCCcE
Q psy9858         111 LQELHHENVLGLTDVFGYMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI-LHRDLKPNNL  188 (307)
Q Consensus       111 l~~l~h~ni~~~~~~~~~~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i-vH~dlkp~Ni  188 (307)
                      |+.+.|.|+.++++.+.++...+.|.+|| .|+|.+.+......+++.-...++++|+.||.|+|+..| .|+.|+..|.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            35688999999999999999999999999 799999999877778999999999999999999998866 9999999999


Q ss_pred             EEecCCcEEEEeecCccccCC--CCcccccceeeceehhhhhhhccc------cccccccee--e-----eeecCCCCCC
Q psy9858         189 LINKQGVLKIGDFGLAKFFGS--PTRLYTHQVVTRWYRLIKCLLYCV------QFNVKNVQW--C-----CFAKDPSSHG  253 (307)
Q Consensus       189 l~~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~------~~~~~~Diw--~-----i~~~~~~f~~  253 (307)
                      +++....+||+|||+......  ............-|.|||.+.+..      ..+.+.|+|  +     ++....||..
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            999999999999999987742  111122223456799999997731      146789999  3     3336666655


Q ss_pred             CCCCCCC---------------hhhhc--cccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         254 NLFPGIP---------------LNEIF--TAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       254 ~~~~~~~---------------~~~~~--~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      .......               ...+.  ....+++..++..||..+|++||+++++-.
T Consensus       161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            2221110               01111  144567999999999999999999988754

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.62  E-value=7.7e-15  Score=116.98  Aligned_cols=143  Identities=17%  Similarity=0.163  Sum_probs=102.7

Q ss_pred             EeEEeecCceEEEEEEEcC------CCcEEEEEEeecCCccccc-----------------hhhhHhHH----HHHHHHH
Q psy9858          60 WRSVHVGRFATVFKARDIE------TDMIVAVKKIKLGTHADAK-----------------DGINRTAL----REIKLLQ  112 (307)
Q Consensus        60 ~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~-----------------~~~~~~~~----~e~~~l~  112 (307)
                      ...||.|--+.||.|....      .+..+|||+.......-.+                 ....+.+.    +|.+.|.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3578999999999998543      3578999998754321000                 00112233    7999999


Q ss_pred             hcC--CCCccccceeeeecCeEEEEEEccCCC-hH-HHHhCCCCCCCHHHHHHHHHHHHHHHHHH-HHCCceeecCCCCc
Q psy9858         113 ELH--HENVLGLTDVFGYMSNVSLVFEFVDTD-LE-VIIKDPTIVFTPSNIKAYAIMTLRGLEYL-HDHWILHRDLKPNN  187 (307)
Q Consensus       113 ~l~--h~ni~~~~~~~~~~~~~~lv~e~~~g~-l~-~~~~~~~~~~~~~~~~~i~~~i~~~l~~l-H~~~ivH~dlkp~N  187 (307)
                      ++.  .-++++.+++    ..-+|||||++|+ +. ..+...  .++......+..+++.+|..| |+.|++|+||++.|
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~--~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N  155 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA--KLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN  155 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc--ccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence            985  4567777754    5678999999764 21 122221  245566778889999999998 89999999999999


Q ss_pred             EEEecCCcEEEEeecCccccCC
Q psy9858         188 LLINKQGVLKIGDFGLAKFFGS  209 (307)
Q Consensus       188 il~~~~~~~kl~Dfg~a~~~~~  209 (307)
                      |++. ++.+.|+|||.+.....
T Consensus       156 IL~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         156 MLWH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             EEEE-CCcEEEEECCCceeCCC
Confidence            9996 57899999999987643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.61  E-value=3.4e-15  Score=134.57  Aligned_cols=144  Identities=24%  Similarity=0.242  Sum_probs=95.7

Q ss_pred             eEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccc-----------------------------hhhh------HhHH
Q psy9858          61 RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAK-----------------------------DGIN------RTAL  105 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-----------------------------~~~~------~~~~  105 (307)
                      +.||+|++|.||+|+. .+|+.||||+.+++....-.                             +.+.      -.+.
T Consensus       123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            6799999999999984 68999999998764211100                             0000      1244


Q ss_pred             HHHHHHHhcC-----CCCccccceeeeecCeEEEEEEccCC-ChHHHHhCCCCCCCHHHHHHHHHHHHH-HHHHHHHCCc
Q psy9858         106 REIKLLQELH-----HENVLGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLR-GLEYLHDHWI  178 (307)
Q Consensus       106 ~e~~~l~~l~-----h~ni~~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~-~l~~lH~~~i  178 (307)
                      +|.+.+.++.     ++++.--.-++......+|||||++| ++.+.........   ....++.+++. .+..+|..|+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~  278 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGF  278 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCc
Confidence            5565555542     23322222223345567999999954 5555543221112   22345555555 4788999999


Q ss_pred             eeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         179 LHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       179 vH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                      +|+|++|.||+++.++.++++|||++....
T Consensus       279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       279 FHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             eeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            999999999999999999999999998774

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.58  E-value=3.5e-15  Score=136.13  Aligned_cols=150  Identities=16%  Similarity=0.237  Sum_probs=94.3

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccc-----------------------------cchhhhH
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHAD-----------------------------AKDGINR  102 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------------------------~~~~~~~  102 (307)
                      ..+..|+. +.||+|++|.||+|+...+|+.||||+.+++....                             .-+++.+
T Consensus       117 ~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~  195 (537)
T PRK04750        117 EWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEK  195 (537)
T ss_pred             HHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHH
Confidence            34556776 78999999999999987779999999998642110                             0001122


Q ss_pred             hH------HHHHHHHHhcC----CCCccccceee-eecCeEEEEEEccCC-ChHHHH--hCCCC---CCCHHHHHHHHHH
Q psy9858         103 TA------LREIKLLQELH----HENVLGLTDVF-GYMSNVSLVFEFVDT-DLEVII--KDPTI---VFTPSNIKAYAIM  165 (307)
Q Consensus       103 ~~------~~e~~~l~~l~----h~ni~~~~~~~-~~~~~~~lv~e~~~g-~l~~~~--~~~~~---~~~~~~~~~i~~~  165 (307)
                      .+      .+|+..+.+++    +.+.+.+-.++ +.....+|||||+.| .+.+..  ...+.   .+.+..+..++. 
T Consensus       196 ~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~-  274 (537)
T PRK04750        196 TLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT-  274 (537)
T ss_pred             HHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH-
Confidence            23      33443333332    33223322222 235567799999955 555432  22211   122333333333 


Q ss_pred             HHHHHHHHHHCCceeecCCCCcEEEecCC----cEEEEeecCccccCC
Q psy9858         166 TLRGLEYLHDHWILHRDLKPNNLLINKQG----VLKIGDFGLAKFFGS  209 (307)
Q Consensus       166 i~~~l~~lH~~~ivH~dlkp~Nil~~~~~----~~kl~Dfg~a~~~~~  209 (307)
                            .+...|++|+|++|.||+++.++    .++++|||++.....
T Consensus       275 ------Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        275 ------QVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             ------HHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                  34569999999999999999988    999999999987743

>KOG3087|consensus

Probab=99.54  E-value=1.7e-13  Score=105.42  Aligned_cols=147  Identities=18%  Similarity=0.170  Sum_probs=111.0

Q ss_pred             EEeEEeecCceEEEEEEEcCCCcEEEEEEeec-CCccc--cchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEE
Q psy9858          59 QWRSVHVGRFATVFKARDIETDMIVAVKKIKL-GTHAD--AKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLV  135 (307)
Q Consensus        59 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  135 (307)
                      .+..|-+|+-+.|+++.  ..|+.++||.-.. .....  ...-..++..+|+++|.++.--+|.--.-++.+...-+|+
T Consensus        11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            56788999999999997  4688888886432 22111  1122356678899999999766666655567788888999


Q ss_pred             EEccCC--ChHHHHhCCCCC-CCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCC---cEEEEeecCcccc
Q psy9858         136 FEFVDT--DLEVIIKDPTIV-FTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG---VLKIGDFGLAKFF  207 (307)
Q Consensus       136 ~e~~~g--~l~~~~~~~~~~-~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~a~~~  207 (307)
                      |||++|  ++.+++...... ........+++.|-+.|.-||..+|+|+||..+||++.+++   .+.++|||++...
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            999988  677777654222 23333478899999999999999999999999999997766   4589999998653

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.54  E-value=5.6e-14  Score=111.00  Aligned_cols=129  Identities=17%  Similarity=0.117  Sum_probs=93.7

Q ss_pred             EeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCc-cccceeeeecCeEEEEEEc
Q psy9858          60 WRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENV-LGLTDVFGYMSNVSLVFEF  138 (307)
Q Consensus        60 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-~~~~~~~~~~~~~~lv~e~  138 (307)
                      ++.|+.|.++.||+++.  .+..|++|+......      ....+.+|+++++.+.+.++ .+++..  +....++|||+
T Consensus         3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~------~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~   72 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE------LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEF   72 (170)
T ss_pred             eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc------cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEe
Confidence            46788999999999985  377899998764321      12235689999998865454 445543  33345899999


Q ss_pred             cCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCc-----eeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         139 VDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI-----LHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       139 ~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i-----vH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      ++|.......        .....++.+++.+|..||+.++     +|+|++|.||+++ ++.++++||+.+...
T Consensus        73 i~G~~l~~~~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~  137 (170)
T cd05151          73 IEGSELLTED--------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN  137 (170)
T ss_pred             cCCCcccccc--------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence            9764322110        1113456789999999999885     9999999999998 678999999999754

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.48  E-value=6.8e-13  Score=102.52  Aligned_cols=136  Identities=18%  Similarity=0.164  Sum_probs=98.6

Q ss_pred             eEEeecCceEEEEEEEcCCCcEEEEEEeecC-Cccc-cc-hhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEEE
Q psy9858          61 RSVHVGRFATVFKARDIETDMIVAVKKIKLG-THAD-AK-DGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFE  137 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~-~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  137 (307)
                      ..+.+|+-+.+|.+.+  -|..+++|.-.+. .... .. .-...+..+|++++.+++--+|..-+-+..+.....|+||
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            3578899999999865  3445777764332 2111 11 1123456789999999975555555555567888899999


Q ss_pred             ccCCChHH-HHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         138 FVDTDLEV-IIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       138 ~~~g~l~~-~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      |++|.++. .+...        ...++..+-.-+.-||..||+|+||.++||++...+ +.++|||++...
T Consensus        80 ~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          80 YIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             EeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            99887655 55443        145667777888999999999999999999996555 999999999864

>KOG1243|consensus

Probab=99.41  E-value=2.1e-12  Score=117.01  Aligned_cols=217  Identities=18%  Similarity=0.190  Sum_probs=138.0

Q ss_pred             EE-EEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEEEccCCChHHHHhC
Q psy9858          71 VF-KARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKD  149 (307)
Q Consensus        71 V~-~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~g~l~~~~~~  149 (307)
                      +| .|..+.++.+|.|........     .......+-++-|+.++||||+++++.++.++..|||+|.+.. |..++..
T Consensus        27 ~~~~~t~k~~~~~vsVF~~~~~~~-----~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P-l~~~lk~  100 (690)
T KOG1243|consen   27 LWPDGTRKADGGPVSVFVYKRSNG-----EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP-LETVLKE  100 (690)
T ss_pred             cccccceeccCCceEEEEEeCCCc-----hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc-HHHHHHH
Confidence            44 355578899999999876432     2234466788999999999999999999999999999999831 2222222


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHH-HCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcccccceeeceehhhhh
Q psy9858         150 PTIVFTPSNIKAYAIMTLRGLEYLH-DHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKC  228 (307)
Q Consensus       150 ~~~~~~~~~~~~i~~~i~~~l~~lH-~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~  228 (307)
                          +....+..-+.||+.||.||| +.+++|++|.-..|+++..|..||.+|.++...............--.|..|+.
T Consensus       101 ----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~  176 (690)
T KOG1243|consen  101 ----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEE  176 (690)
T ss_pred             ----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhh
Confidence                235667778999999999998 568999999999999999999999999998766432211111122234555655


Q ss_pred             hhccccccccccee--eeeecCCCCCCCCCCCCChhhhccccCHHHHHHHHHhhhcCCCCCCCH-----HHHhcCcccCC
Q psy9858         229 LLYCVQFNVKNVQW--CCFAKDPSSHGNLFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADC-----TATLKMDYFSL  301 (307)
Q Consensus       229 ~~~~~~~~~~~Diw--~i~~~~~~f~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~~il~hp~f~~  301 (307)
                      +... .  -..|.|  +++.++.. .+ .............++.....+..+-+-..+..||..     .-.+-|.||++
T Consensus       177 ~~~s-~--~s~D~~~Lg~li~el~-ng-~~~~~~~~~~~~~ipk~~~~~~~k~~~~~~~~r~n~~~~~~~~~~~~gff~n  251 (690)
T KOG1243|consen  177 IDPS-E--WSIDSWGLGCLIEELF-NG-SLLTKTDLSNTGKIPKALIELYCKKLGATELKRPNKLRFILECRLLGGFFRN  251 (690)
T ss_pred             cCcc-c--cchhhhhHHHHHHHHh-Cc-ccCcchhhhccCccchhHHHHHHHHhccccccccchhhHHHHHHhccccccc
Confidence            4333 1  345777  33332111 11 111111111223345455555545454555555552     22344788765


Q ss_pred             C
Q psy9858         302 T  302 (307)
Q Consensus       302 ~  302 (307)
                      .
T Consensus       252 ~  252 (690)
T KOG1243|consen  252 D  252 (690)
T ss_pred             h
Confidence            3

>KOG0601|consensus

Probab=99.37  E-value=8.4e-13  Score=118.17  Aligned_cols=245  Identities=18%  Similarity=0.171  Sum_probs=172.3

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEc-CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeee
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDI-ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFG  127 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~  127 (307)
                      ......+|..+..||.|.|+.|+..... .++..|++|.+.........   ...-..|+.+...+ .|.++++.+..|.
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~---di~sl~ev~l~~~l~~~~~~~g~~~~W~  336 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFAS---DIFSLGEVILEAILGSHLPSVGKNSSWS  336 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHh---hhcchhhhhHhhHhhcccccCCCCCCcc
Confidence            4556778999999999999999987655 67888999987654322221   12234677777777 4999999999999


Q ss_pred             ecCeEEEEEEccC-CChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecC-CcEEEEeecCcc
Q psy9858         128 YMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ-GVLKIGDFGLAK  205 (307)
Q Consensus       128 ~~~~~~lv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~a~  205 (307)
                      .....|+=.||+. +++.... .....+.+...+.+..|++.++.++|++.++|+|++|+||++..+ +..++.|||.+.
T Consensus       337 ~~r~~~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t  415 (524)
T KOG0601|consen  337 QLRQGYIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWT  415 (524)
T ss_pred             ccccccCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccc
Confidence            8889999999995 4433333 332347888899999999999999999999999999999999886 678999999986


Q ss_pred             ccCCCCcccccceeeceeh-hhhhhhccccccccccee-------eeeecCCCCCC-CCCCCCChh--hhccccCHHHHH
Q psy9858         206 FFGSPTRLYTHQVVTRWYR-LIKCLLYCVQFNVKNVQW-------CCFAKDPSSHG-NLFPGIPLN--EIFTAAGDDLLA  274 (307)
Q Consensus       206 ~~~~~~~~~~~~~~t~~y~-aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~-~~~~~~~~~--~~~~~~~~~l~~  274 (307)
                      .+.-.   ........++. ..|++.....+-.++|++       +.+.+..+-.. .........  ........++..
T Consensus       416 ~~~~~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i~~~~~p~~~~~~~~~q~  492 (524)
T KOG0601|consen  416 RLAFS---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTIRSGDTPNLPGLKLQLQV  492 (524)
T ss_pred             cccee---cccccccccccccchhhccccccccccccccccccccccccCcccCcccccceeeecccccCCCchHHhhhh
Confidence            53211   11112233344 356655554777888888       33334333332 111111111  111233478889


Q ss_pred             HHHHhhhcCCCCCCCHHHHhcCcccCC
Q psy9858         275 VISSLLCLNPTKRADCTATLKMDYFSL  301 (307)
Q Consensus       275 li~~~l~~dP~~Rpt~~~il~hp~f~~  301 (307)
                      +.+.+...++..|+.+.+...|+=|..
T Consensus       493 ~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  493 LLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             hhhhhcCCccccchhhhhhcccchhhh
Confidence            999999999999999999988876643

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.36  E-value=4.9e-12  Score=100.57  Aligned_cols=132  Identities=27%  Similarity=0.250  Sum_probs=86.2

Q ss_pred             EEEEEEEcCCCcEEEEEEeecCCcc---------------------ccchhhhHhHHHHHHHHHhcCCC--Cccccceee
Q psy9858          70 TVFKARDIETDMIVAVKKIKLGTHA---------------------DAKDGINRTALREIKLLQELHHE--NVLGLTDVF  126 (307)
Q Consensus        70 ~V~~~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~~~~~e~~~l~~l~h~--ni~~~~~~~  126 (307)
                      .||.|.. .+|..+|+|+.......                     ...........+|.+.|.++..-  ++++.+++.
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            3899984 67889999998763211                     11111234466899999999754  567776542


Q ss_pred             eecCeEEEEEEccC--CChHHHHhCCCCCCCHHHHHHHHHHHHHHHHH-HHHCCceeecCCCCcEEEecCCcEEEEeecC
Q psy9858         127 GYMSNVSLVFEFVD--TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEY-LHDHWILHRDLKPNNLLINKQGVLKIGDFGL  203 (307)
Q Consensus       127 ~~~~~~~lv~e~~~--g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~-lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  203 (307)
                          .-+|||||++  |.....+....  ++......++.+++..+.. +|..||+|+||.+.||+++.+ .+.|+|||.
T Consensus        80 ----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q  152 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ  152 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred             ----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence                3469999997  76555554432  2244556777888886555 579999999999999999877 899999999


Q ss_pred             ccccCC
Q psy9858         204 AKFFGS  209 (307)
Q Consensus       204 a~~~~~  209 (307)
                      +.....
T Consensus       153 av~~~~  158 (188)
T PF01163_consen  153 AVDSSH  158 (188)
T ss_dssp             EEETTS
T ss_pred             ceecCC
Confidence            987643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.33  E-value=1.8e-11  Score=100.81  Aligned_cols=140  Identities=19%  Similarity=0.187  Sum_probs=101.4

Q ss_pred             eEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCC--CCccccceeeeec---CeEEEE
Q psy9858          61 RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH--ENVLGLTDVFGYM---SNVSLV  135 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~ni~~~~~~~~~~---~~~~lv  135 (307)
                      +.|+.|..+.||++.. .+|..+++|+.......    .....+.+|.++++.+.+  .++.+++.+....   +..++|
T Consensus         4 ~~l~~G~~n~~~~v~~-~~g~~~ilK~~~~~~~~----~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v   78 (223)
T cd05154           4 RQLSGGQSNLTYLLTA-GGGRRLVLRRPPPGALL----PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYV   78 (223)
T ss_pred             eecCCCccceEEEEEe-cCCcceEEEeCCCcccC----cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEE
Confidence            6789999999999985 34678999997643211    123457899999999975  4467777766543   367899


Q ss_pred             EEccCCC-hHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q psy9858         136 FEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD---------------------------------------  175 (307)
Q Consensus       136 ~e~~~g~-l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---------------------------------------  175 (307)
                      |||++|. +.+.+..  ..+++.....++.+++.+|..||+                                       
T Consensus        79 ~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (223)
T cd05154          79 MERVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA  156 (223)
T ss_pred             EEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence            9999654 4333321  235666667777777777777773                                       


Q ss_pred             -----------------CCceeecCCCCcEEEec--CCcEEEEeecCcccc
Q psy9858         176 -----------------HWILHRDLKPNNLLINK--QGVLKIGDFGLAKFF  207 (307)
Q Consensus       176 -----------------~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~a~~~  207 (307)
                                       ..++|+|+++.||+++.  ++.+.|+||+.+...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g  207 (223)
T cd05154         157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG  207 (223)
T ss_pred             HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence                             23689999999999998  567899999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG1266|consensus

Probab=99.33  E-value=7.8e-14  Score=116.03  Aligned_cols=231  Identities=16%  Similarity=0.185  Sum_probs=142.8

Q ss_pred             EEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec-----CeEEEEEEcc-CCCh
Q psy9858          70 TVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM-----SNVSLVFEFV-DTDL  143 (307)
Q Consensus        70 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~~~~lv~e~~-~g~l  143 (307)
                      .||++-+.+.|.+|+.-.+.-....+...+ ......=..-|-.+.|.||++++.+|.+.     .+..+++||+ .|++
T Consensus        81 ~v~lamd~e~g~evvwneVq~~~rK~~~~q-eek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~  159 (458)
T KOG1266|consen   81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQ-EEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSL  159 (458)
T ss_pred             HHHHHhhhccCchhhHHHHHHHHhcChhhC-HHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhH
Confidence            366666666666655433321111111110 00011112334455699999999999654     4588999999 6888


Q ss_pred             HHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHC--CceeecCCCCcEEEecCCcEEEEeecCccccCCC----Cccc
Q psy9858         144 EVIIKD---PTIVFTPSNIKAYAIMTLRGLEYLHDH--WILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP----TRLY  214 (307)
Q Consensus       144 ~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~~  214 (307)
                      .+++++   ....+.....++|+.||++||.|||+.  .|+|+++..+.|++..+|-+|+.--.-.......    ....
T Consensus       160 ~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek  239 (458)
T KOG1266|consen  160 KQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEK  239 (458)
T ss_pred             HHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhh
Confidence            777764   445688889999999999999999976  5999999999999999998887542222111110    0111


Q ss_pred             ccceeeceehhhhhhhccccccccccee----eeee---cCCC-CCCCCC--CCCC-hhhhccccCHHHHHHHHHhhhcC
Q psy9858         215 THQVVTRWYRLIKCLLYCVQFNVKNVQW----CCFA---KDPS-SHGNLF--PGIP-LNEIFTAAGDDLLAVISSLLCLN  283 (307)
Q Consensus       215 ~~~~~t~~y~aPE~~~~~~~~~~~~Diw----~i~~---~~~~-f~~~~~--~~~~-~~~~~~~~~~~l~~li~~~l~~d  283 (307)
                      ....+-++|.+||.=... +.+-++|||    |-+-   ++.- ..+...  .... ......-....-.+++.+||+-.
T Consensus       240 ~~~~~~~g~~a~~sg~~t-n~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~len~lqr~~i~kcl~~e  318 (458)
T KOG1266|consen  240 SVNTSLPGFSAPESGTTT-NTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLENGLQRGSITKCLEGE  318 (458)
T ss_pred             hccccCCccccCCcCccc-ccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeeccCccccCcCcccccCC
Confidence            122346789999975444 667789999    2222   2221 111000  0000 00111111223367999999999


Q ss_pred             CCCCCCHHHHhcCcccCCC
Q psy9858         284 PTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       284 P~~Rpt~~~il~hp~f~~~  302 (307)
                      |+.||++.+++-||-+-++
T Consensus       319 P~~rp~ar~llfHpllfeV  337 (458)
T KOG1266|consen  319 PNGRPDARLLLFHPLLFEV  337 (458)
T ss_pred             CCCCcchhhhhcCceeeec
Confidence            9999999999999976544

>KOG0606|consensus

Probab=99.29  E-value=7e-13  Score=125.10  Aligned_cols=250  Identities=20%  Similarity=0.204  Sum_probs=182.2

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM  129 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  129 (307)
                      .....+.+.+.+-+.+|.++.++.+.-..+|...++|+......-..++  .+....+-.++-..++|-+++..-.+...
T Consensus       799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~--~~s~r~~s~~~i~p~~P~v~~~~~s~~~r  876 (1205)
T KOG0606|consen  799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTND--YESIRSKSNILITPRSPAVVRSFPSFPCR  876 (1205)
T ss_pred             ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhcccc--ccccCCccCccccCCCCceecccCCCCCC
Confidence            3456677888889999999999999877777666666554322111110  22233344444444567777766555667


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                      ...+|+++|+ ++++...++... ..+++-++..+..+.+++++||...+.|+|++|.|.++..++..+++|||.....+
T Consensus       877 sP~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg  955 (1205)
T KOG0606|consen  877 SPLPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG  955 (1205)
T ss_pred             CCcchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccc
Confidence            7899999999 577888777665 46777788888999999999999999999999999999999999999998432211


Q ss_pred             C---------------------C----------Ccccccceeeceehhhhhhhccccccccccee-------eeeecCCC
Q psy9858         209 S---------------------P----------TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPS  250 (307)
Q Consensus       209 ~---------------------~----------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~  250 (307)
                      -                     .          ........+|+.|.+||.+.+. .....+|.|       ..++|.+|
T Consensus       956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~-~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen  956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR-RHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred             cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccc-cCCCcchhhhhhhhhhhhhcCCCC
Confidence            0                     0          0112234678999999999998 888899988       34448899


Q ss_pred             CCCCCCCCC---------ChhhhccccCHHHHHHHHHhhhcCCCCCCCHH---HHhcCcccCCCc
Q psy9858         251 SHGNLFPGI---------PLNEIFTAAGDDLLAVISSLLCLNPTKRADCT---ATLKMDYFSLTK  303 (307)
Q Consensus       251 f~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~---~il~hp~f~~~~  303 (307)
                      |....-+..         .....+...+....+++..+|..+|.+|..+.   ++-.|+||+.++
T Consensus      1035 ~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1035 FNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVD 1099 (1205)
T ss_pred             CCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCC
Confidence            887222111         12222345788999999999999999999988   899999998764

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.28  E-value=1.4e-10  Score=97.71  Aligned_cols=135  Identities=17%  Similarity=0.029  Sum_probs=93.5

Q ss_pred             EEEEEEcCCCcEEEEEEeecCCccc-cch-----hhhHhHHHHHHHHHhcCCCCc--cccceeeee-----cCeEEEEEE
Q psy9858          71 VFKARDIETDMIVAVKKIKLGTHAD-AKD-----GINRTALREIKLLQELHHENV--LGLTDVFGY-----MSNVSLVFE  137 (307)
Q Consensus        71 V~~~~~~~~~~~vavK~~~~~~~~~-~~~-----~~~~~~~~e~~~l~~l~h~ni--~~~~~~~~~-----~~~~~lv~e  137 (307)
                      |++..  -.|+.|.||......... .+.     .-...+.+|.+.+..|..-+|  +..+.+.+.     ....+||||
T Consensus        38 vvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte  115 (268)
T PRK15123         38 TLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE  115 (268)
T ss_pred             EEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence            55554  356789999764322110 000     001137789999988854343  444444433     345889999


Q ss_pred             ccCC--ChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEec-------CCcEEEEeecCcccc
Q psy9858         138 FVDT--DLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK-------QGVLKIGDFGLAKFF  207 (307)
Q Consensus       138 ~~~g--~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~-------~~~~kl~Dfg~a~~~  207 (307)
                      +++|  +|.+++... ....+......++.+++..+..||++||+|+|++++|||++.       +..+.++||+.+...
T Consensus       116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~~  195 (268)
T PRK15123        116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQIR  195 (268)
T ss_pred             eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccccc
Confidence            9976  577776421 223566777899999999999999999999999999999985       468999999998643

>KOG3741|consensus

Probab=99.25  E-value=2e-10  Score=101.47  Aligned_cols=209  Identities=16%  Similarity=0.143  Sum_probs=144.4

Q ss_pred             CceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeee----ecCeEEEEEEccC--
Q psy9858          67 RFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG----YMSNVSLVFEFVD--  140 (307)
Q Consensus        67 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~----~~~~~~lv~e~~~--  140 (307)
                      -..+.|++....+|..|++|+++.......     .....-+++++++.|.|+|++.++|.    .+..+++|++|++  
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~-----nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s  362 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQST-----NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSS  362 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCc-----ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCC
Confidence            446789999999999999999954322221     12335688999999999999999986    4567999999995  


Q ss_pred             CChHHHHhC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         141 TDLEVIIKD--------------PTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       141 g~l~~~~~~--------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                      ++|.++.-.              .+...++..++.++.|+..||.++|+.|+.-+-|.|.+|+++.+.+++|+..|....
T Consensus       363 ~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dv  442 (655)
T KOG3741|consen  363 PTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDV  442 (655)
T ss_pred             chHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceee
Confidence            567776632              122368899999999999999999999999999999999999998999999888776


Q ss_pred             cCCCCcccccceeeceehhhhhhhccccccccccee----eeeecCCCC-CCCCCCCCChhhhccccCHHHHHHHHHhhh
Q psy9858         207 FGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW----CCFAKDPSS-HGNLFPGIPLNEIFTAAGDDLLAVISSLLC  281 (307)
Q Consensus       207 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw----~i~~~~~~f-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  281 (307)
                      ......              |.+.+..+.+. .|+=    .+-+|..-- ............+...++.++.++|.-+..
T Consensus       443 l~~d~~--------------~~le~~Qq~D~-~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~~~yS~D~rn~v~yl~s  507 (655)
T KOG3741|consen  443 LQEDPT--------------EPLESQQQNDL-RDLGLLLLALATGTENSNRTDSTQSSHLTRITTTYSTDLRNVVEYLES  507 (655)
T ss_pred             ecCCCC--------------cchhHHhhhhH-HHHHHHHHHHhhcccccccccchHHHHHHHhhhhhhHHHHHHHHHHHh
Confidence            643320              11111100000 0000    000010000 001122223455567789999999999999


Q ss_pred             cCCCCCCCHHHHhcC
Q psy9858         282 LNPTKRADCTATLKM  296 (307)
Q Consensus       282 ~dP~~Rpt~~~il~h  296 (307)
                      .++++ -++++++.|
T Consensus       508 ~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  508 LNFRE-KSIQDLLPM  521 (655)
T ss_pred             cCccc-ccHHHHHHH
Confidence            99886 688888775

>KOG2137|consensus

Probab=99.23  E-value=3.2e-11  Score=109.84  Aligned_cols=140  Identities=16%  Similarity=0.126  Sum_probs=107.0

Q ss_pred             HHHHHHHHHHHHHC-CceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc---------cccceeeceehhhhhhhcc
Q psy9858         163 AIMTLRGLEYLHDH-WILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL---------YTHQVVTRWYRLIKCLLYC  232 (307)
Q Consensus       163 ~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~---------~~~~~~t~~y~aPE~~~~~  232 (307)
                      +.+++.|+.|+|.. ++||++|.|++|.++.++..||+.|+++.....+...         .........|.|||++.+.
T Consensus       105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             hhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            34455899999965 8999999999999999999999999999876542211         1112346789999999995


Q ss_pred             ccccccccee---eeee-----cCCCCCCCCCC----------CCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHh
Q psy9858         233 VQFNVKNVQW---CCFA-----KDPSSHGNLFP----------GIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATL  294 (307)
Q Consensus       233 ~~~~~~~Diw---~i~~-----~~~~f~~~~~~----------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il  294 (307)
                       ..+.++|++   +.++     |+..+......          .........+++.++.+-+.++|..++..||++.+++
T Consensus       185 -~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  185 -TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL  263 (700)
T ss_pred             -cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence             889999999   3333     66666552111          1112223357899999999999999999999999999


Q ss_pred             cCcccCCCc
Q psy9858         295 KMDYFSLTK  303 (307)
Q Consensus       295 ~hp~f~~~~  303 (307)
                      ..|||.+..
T Consensus       264 ~~~ff~D~~  272 (700)
T KOG2137|consen  264 SIPFFSDPG  272 (700)
T ss_pred             cccccCCch
Confidence            999998754

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.20  E-value=2.1e-10  Score=94.08  Aligned_cols=142  Identities=23%  Similarity=0.174  Sum_probs=104.8

Q ss_pred             eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCc-----------------cccchhhhHhHHHHHHHHHhcCCC--
Q psy9858          57 YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTH-----------------ADAKDGINRTALREIKLLQELHHE--  117 (307)
Q Consensus        57 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------------~~~~~~~~~~~~~e~~~l~~l~h~--  117 (307)
                      +.++..||-|--+.||.|.+ ..|.++|||.=+.+..                 ..+.........+|.++|.+|...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            45678999999999999995 5788999996433211                 011122234567899999999644  


Q ss_pred             CccccceeeeecCeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEE
Q psy9858         118 NVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLK  197 (307)
Q Consensus       118 ni~~~~~~~~~~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~k  197 (307)
                      .|.+.+++    ++-.+|||+++|..+.-+.     ++.+....++..|+.-+.-+-..|+||+|+++-||+++.+|.+.
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~  242 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV  242 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence            77777753    6778999999885433332     13444556677777777777799999999999999999999999


Q ss_pred             EEeecCccccC
Q psy9858         198 IGDFGLAKFFG  208 (307)
Q Consensus       198 l~Dfg~a~~~~  208 (307)
                      ++||--+....
T Consensus       243 vIDwPQ~v~~~  253 (304)
T COG0478         243 VIDWPQAVPIS  253 (304)
T ss_pred             EEeCcccccCC
Confidence            99998776553

>PRK09902 hypothetical protein; Provisional

Probab=99.12  E-value=2.3e-09  Score=85.93  Aligned_cols=141  Identities=12%  Similarity=0.030  Sum_probs=101.8

Q ss_pred             eecCceEEEEEEEcCCCcEEEEEEeecCCccccc-hhhhHhHHHHHHHHHhcCC--CCccccceeee-e----cCeEEEE
Q psy9858          64 HVGRFATVFKARDIETDMIVAVKKIKLGTHADAK-DGINRTALREIKLLQELHH--ENVLGLTDVFG-Y----MSNVSLV  135 (307)
Q Consensus        64 g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h--~ni~~~~~~~~-~----~~~~~lv  135 (307)
                      |+||-+.|+....  .|+.+-+|.-......... ..-...|.+|...+..|..  -.+.+.. ++. .    .-+.+||
T Consensus        27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            4588888998663  4446888876522111111 2235679999999999853  3355554 222 1    2358899


Q ss_pred             EEccC--CChHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCc--EEEEeecCcccc
Q psy9858         136 FEFVD--TDLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGV--LKIGDFGLAKFF  207 (307)
Q Consensus       136 ~e~~~--g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~a~~~  207 (307)
                      +|-++  -+|.+++.... ...+......++.+++..+.-||+.|+.|+|+.+.||+++.++.  ++++||.-++..
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~~  180 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR  180 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence            99997  46877775432 23577777899999999999999999999999999999987777  999999988754

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.12  E-value=1.1e-09  Score=89.27  Aligned_cols=107  Identities=23%  Similarity=0.228  Sum_probs=83.8

Q ss_pred             hHhHHHHHHHHHhcCC--CCccccceeeeec----CeEEEEEEccCC--ChHHHHhCCCCCCCHHHHHHHHHHHHHHHHH
Q psy9858         101 NRTALREIKLLQELHH--ENVLGLTDVFGYM----SNVSLVFEFVDT--DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEY  172 (307)
Q Consensus       101 ~~~~~~e~~~l~~l~h--~ni~~~~~~~~~~----~~~~lv~e~~~g--~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~  172 (307)
                      ...+.+|...+..|..  -.+++.+++.+..    ...+||+|+++|  +|.+++..... .+......++.+++..+.-
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAK  133 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHH
Confidence            3457789988888853  3345555555432    356899999965  57777765332 5677788999999999999


Q ss_pred             HHHCCceeecCCCCcEEEecCC---cEEEEeecCccccC
Q psy9858         173 LHDHWILHRDLKPNNLLINKQG---VLKIGDFGLAKFFG  208 (307)
Q Consensus       173 lH~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~a~~~~  208 (307)
                      ||++||+|+|+++.|||++.++   .+.++||+-++...
T Consensus       134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~  172 (206)
T PF06293_consen  134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP  172 (206)
T ss_pred             HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence            9999999999999999999887   89999999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.96  E-value=2.8e-08  Score=80.91  Aligned_cols=143  Identities=20%  Similarity=0.151  Sum_probs=93.9

Q ss_pred             eEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccc-------------------hhhhHhHHHHHHHHHhcC--CCCc
Q psy9858          61 RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAK-------------------DGINRTALREIKLLQELH--HENV  119 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-------------------~~~~~~~~~e~~~l~~l~--h~ni  119 (307)
                      ..|.+|--+.||+|. ..++..+|+|++.........                   .....=..+|..-|+++.  +-.+
T Consensus        54 g~istGKEA~Vy~a~-~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv  132 (268)
T COG1718          54 GCISTGKEANVYLAE-TGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV  132 (268)
T ss_pred             eeecCCcceEEEeec-cCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence            467788888999998 467889999999864322111                   000000124555555552  3444


Q ss_pred             cccceeeeecCeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCcEEEecCCcEEE
Q psy9858         120 LGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD-HWILHRDLKPNNLLINKQGVLKI  198 (307)
Q Consensus       120 ~~~~~~~~~~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kl  198 (307)
                      .+-+.+    ..-.|||||++....-.-.-..-.+..+++..+..+++..+.-|-. .|+||+||+.-|||+. ++.+.|
T Consensus       133 P~Pi~~----~~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~i  207 (268)
T COG1718         133 PEPIAF----RNNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYI  207 (268)
T ss_pred             CCceee----cCCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEE
Confidence            444433    2346999999644111111111123444678888899999988876 8999999999999998 889999


Q ss_pred             EeecCccccCC
Q psy9858         199 GDFGLAKFFGS  209 (307)
Q Consensus       199 ~Dfg~a~~~~~  209 (307)
                      +|+|-|.....
T Consensus       208 ID~~QaV~~~h  218 (268)
T COG1718         208 IDVSQAVTIDH  218 (268)
T ss_pred             EECccccccCC
Confidence            99999987643

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.92  E-value=3.3e-08  Score=79.63  Aligned_cols=140  Identities=16%  Similarity=0.137  Sum_probs=89.4

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhH------HHHHHHHHhcCCCCc---cccce
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTA------LREIKLLQELHHENV---LGLTD  124 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~------~~e~~~l~~l~h~ni---~~~~~  124 (307)
                      ..+|...+.+-......|.+-.  .+|+.+++|........  .+.....|      .+.+..+..++..++   ..++-
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r--~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl  105 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRR--PERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL  105 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhh--HHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence            3578888888888888787765  56788999987753211  11111112      234444444432222   22222


Q ss_pred             ee-----eecCeEEEEEEccCCC-hHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEE
Q psy9858         125 VF-----GYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKI  198 (307)
Q Consensus       125 ~~-----~~~~~~~lv~e~~~g~-l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl  198 (307)
                      +.     ......+++|||++|. +.+...     +++    .+...|++++..+|+.|+.|+|.+|.|++++.+ .+++
T Consensus       106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~i  175 (229)
T PF06176_consen  106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRI  175 (229)
T ss_pred             eeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEE
Confidence            22     2234567899999774 333221     222    244567788999999999999999999999855 5999


Q ss_pred             EeecCcccc
Q psy9858         199 GDFGLAKFF  207 (307)
Q Consensus       199 ~Dfg~a~~~  207 (307)
                      +||+..+..
T Consensus       176 ID~~~k~~~  184 (229)
T PF06176_consen  176 IDTQGKRMS  184 (229)
T ss_pred             EECcccccc
Confidence            999887653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.86  E-value=1.2e-08  Score=93.10  Aligned_cols=145  Identities=21%  Similarity=0.289  Sum_probs=90.8

Q ss_pred             eEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccc-----------------------------hhhhH------hHH
Q psy9858          61 RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAK-----------------------------DGINR------TAL  105 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-----------------------------~~~~~------~~~  105 (307)
                      ..|+.++-|.||+|+ ..+|+.||||+.+++-...-.                             +++.+      .+.
T Consensus       131 ~PiAsASIaQVH~A~-L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAV-LKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEE-ecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            678999999999999 467999999998874221100                             00001      122


Q ss_pred             HHHHHHHhcC-----CCCccccceeeeecCeEEEEEEccCCC-hHHHHhCCCCCCCHHHHHHHHHHHHHH-HHHHHHCCc
Q psy9858         106 REIKLLQELH-----HENVLGLTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRG-LEYLHDHWI  178 (307)
Q Consensus       106 ~e~~~l~~l~-----h~ni~~~~~~~~~~~~~~lv~e~~~g~-l~~~~~~~~~~~~~~~~~~i~~~i~~~-l~~lH~~~i  178 (307)
                      +|...+.+++     .+++.--.-+++..+.-.|+|||++|. +.+....+....+...   ++..++.+ +..+-..|+
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~---ia~~~~~~f~~q~~~dgf  286 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKE---LAELLVRAFLRQLLRDGF  286 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHH---HHHHHHHHHHHHHHhcCc
Confidence            3333333331     233222222345567788999999875 3333211111244333   33333332 455556899


Q ss_pred             eeecCCCCcEEEecCCcEEEEeecCccccCC
Q psy9858         179 LHRDLKPNNLLINKQGVLKIGDFGLAKFFGS  209 (307)
Q Consensus       179 vH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  209 (307)
                      .|.|.+|.||+++.+|++.+.|||+...+..
T Consensus       287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         287 FHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             cccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            9999999999999999999999999987743

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.75  E-value=2.9e-07  Score=80.09  Aligned_cols=222  Identities=12%  Similarity=0.014  Sum_probs=142.0

Q ss_pred             EEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceee-------eecC
Q psy9858          59 QWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVF-------GYMS  130 (307)
Q Consensus        59 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~-------~~~~  130 (307)
                      ..+.||+|+-+.+|-.-   .-...+-|++........        ...+..|.+. .||-+..-+.+=       ..+.
T Consensus        15 ~gr~LgqGgea~ly~l~---e~~d~VAKIYh~Pppa~~--------aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~   83 (637)
T COG4248          15 PGRPLGQGGEADLYTLG---EVRDQVAKIYHAPPPAAQ--------AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGK   83 (637)
T ss_pred             CCccccCCccceeeecc---hhhchhheeecCCCchHH--------HHHHHHhccCCCCcchhhhhcccHHHhhCCCccc
Confidence            34779999999999643   222346688876443221        1234444444 466544311111       1223


Q ss_pred             eEEEEEEccCCC--hHHHHh---C--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecC
Q psy9858         131 NVSLVFEFVDTD--LEVIIK---D--PTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGL  203 (307)
Q Consensus       131 ~~~lv~e~~~g~--l~~~~~---~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  203 (307)
                      ..-++|+.+.|-  ...++.   +  .-....+.-+...++.++.+-+.||..|.+-+|++++|+|+.+++.|.|.|-..
T Consensus        84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs  163 (637)
T COG4248          84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS  163 (637)
T ss_pred             eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence            377889988543  333332   1  111267888999999999999999999999999999999999999999998554


Q ss_pred             ccccCCCCcccccceeeceehhhhhhhcc----ccccccccee--------eeeecCCCCCCCCCCC-------------
Q psy9858         204 AKFFGSPTRLYTHQVVTRWYRLIKCLLYC----VQFNVKNVQW--------CCFAKDPSSHGNLFPG-------------  258 (307)
Q Consensus       204 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~~Diw--------~i~~~~~~f~~~~~~~-------------  258 (307)
                      -... .......-.+|...|.+||.-.-.    -.-+...|-|        -++.|++||.+...-.             
T Consensus       164 fqi~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g  242 (637)
T COG4248         164 FQIN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG  242 (637)
T ss_pred             eeec-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence            4333 233344455889999999976521    1335667777        2333799999811100             


Q ss_pred             --------------CChhhhccccCHHHHHHHHHhhhc--CCCCCCCHHH
Q psy9858         259 --------------IPLNEIFTAAGDDLLAVISSLLCL--NPTKRADCTA  292 (307)
Q Consensus       259 --------------~~~~~~~~~~~~~l~~li~~~l~~--dP~~Rpt~~~  292 (307)
                                    .+...-+.-+++++..|..+|+..  ++.-|||++.
T Consensus       243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence                          000011123578899999999874  4668999754

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.70  E-value=3.5e-07  Score=75.51  Aligned_cols=135  Identities=15%  Similarity=0.101  Sum_probs=83.1

Q ss_pred             eEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCC--CccccceeeeecCeEEEEEEc
Q psy9858          61 RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHE--NVLGLTDVFGYMSNVSLVFEF  138 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--ni~~~~~~~~~~~~~~lv~e~  138 (307)
                      ..||+|..+.||+.    .|..+++|......    .   .....+|.++++.+..-  .+.+.+++..+.+...++||+
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~----~---~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~   75 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF----D---KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYEL   75 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC----C---HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeee
Confidence            57899999999983    24457889876422    1   23357899999988643  357778877788888999999


Q ss_pred             cCCC--hHHHH---------------------hCCC-CCCCHHH-HHHHHH----------HHHHH-HHHHH----HCCc
Q psy9858         139 VDTD--LEVII---------------------KDPT-IVFTPSN-IKAYAI----------MTLRG-LEYLH----DHWI  178 (307)
Q Consensus       139 ~~g~--l~~~~---------------------~~~~-~~~~~~~-~~~i~~----------~i~~~-l~~lH----~~~i  178 (307)
                      ++|.  +...+                     +... ....... ...+..          .+... ..+|.    ...+
T Consensus        76 i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~  155 (226)
T TIGR02172        76 IVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTC  155 (226)
T ss_pred             cCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCce
Confidence            9774  11111                     1100 0001000 000100          11111 12222    1247


Q ss_pred             eeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         179 LHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       179 vH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      +|+|+.|.||+++.++ +.++||+.+..-
T Consensus       156 ~HgD~~~~Nii~~~~~-~~iIDwe~a~~G  183 (226)
T TIGR02172       156 LHGDFQIGNLITSGKG-TYWIDLGDFGYG  183 (226)
T ss_pred             EecCCCCCcEEEcCCC-cEEEechhcCcC
Confidence            8999999999999888 999999998643

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.59  E-value=2.2e-06  Score=71.01  Aligned_cols=139  Identities=18%  Similarity=0.174  Sum_probs=79.4

Q ss_pred             EeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCC--Cccccceee---eecCeEEE
Q psy9858          60 WRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHE--NVLGLTDVF---GYMSNVSL  134 (307)
Q Consensus        60 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--ni~~~~~~~---~~~~~~~l  134 (307)
                      ++.|+.|..+.||+.....  ..+++|.....       .....+.+|..+++.+...  .+.+++...   ......++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~   72 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYL   72 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH-------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceE
Confidence            5789999999999998543  48999987531       2245577899888888533  355666533   23345899


Q ss_pred             EEEccCCChHHH-----------------H---hCC---CCCCCHHH---------HHHH------------HHHHHH-H
Q psy9858         135 VFEFVDTDLEVI-----------------I---KDP---TIVFTPSN---------IKAY------------AIMTLR-G  169 (307)
Q Consensus       135 v~e~~~g~l~~~-----------------~---~~~---~~~~~~~~---------~~~i------------~~~i~~-~  169 (307)
                      +|+++.|.....                 +   +..   ........         ....            ...+.. .
T Consensus        73 ~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (239)
T PF01636_consen   73 LMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERL  152 (239)
T ss_dssp             EEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHH
T ss_pred             EEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHH
Confidence            999997653333                 0   111   00000000         0000            011222 2


Q ss_pred             HHHHHH-------CCceeecCCCCcEEEe-cCCcEEEEeecCcccc
Q psy9858         170 LEYLHD-------HWILHRDLKPNNLLIN-KQGVLKIGDFGLAKFF  207 (307)
Q Consensus       170 l~~lH~-------~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~a~~~  207 (307)
                      +..+++       ..++|+|+.|.||+++ .++.+.|+||+.+...
T Consensus       153 ~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~  198 (239)
T PF01636_consen  153 LQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG  198 (239)
T ss_dssp             HHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred             HHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence            333332       3599999999999999 6666789999998654

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.57  E-value=1.1e-06  Score=73.60  Aligned_cols=136  Identities=18%  Similarity=0.068  Sum_probs=81.5

Q ss_pred             EEeecCc-eEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-CCCccccceeeeecCeEEEEEEcc
Q psy9858          62 SVHVGRF-ATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-HENVLGLTDVFGYMSNVSLVFEFV  139 (307)
Q Consensus        62 ~lg~G~~-g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~  139 (307)
                      .|..|.. +.||+...  .+..+++|+.....        .....+|+++++.+. +--+.+++++....+..++||+++
T Consensus         5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~--------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i   74 (244)
T cd05150           5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGP--------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAV   74 (244)
T ss_pred             ecCCCCCcCeEEEEcC--CCCcEEEEecCCCc--------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEee
Confidence            4545555 78999873  34678889876421        123567999888884 455677787776667789999999


Q ss_pred             CCChHH-HH-------------------hCCCC---CCCHH--HHHHHHH--------------------HHHHHHHHHH
Q psy9858         140 DTDLEV-II-------------------KDPTI---VFTPS--NIKAYAI--------------------MTLRGLEYLH  174 (307)
Q Consensus       140 ~g~l~~-~~-------------------~~~~~---~~~~~--~~~~i~~--------------------~i~~~l~~lH  174 (307)
                      +|.... ..                   +....   .+...  .......                    .+...+..|-
T Consensus        75 ~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  154 (244)
T cd05150          75 PGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELE  154 (244)
T ss_pred             CCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHH
Confidence            764222 11                   11100   01000  0000000                    0111122221


Q ss_pred             -------HCCceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         175 -------DHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       175 -------~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                             ...++|+|+.|.||+++.++.+.|+||+.+...
T Consensus       155 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~g  194 (244)
T cd05150         155 ATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGVA  194 (244)
T ss_pred             hhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccccc
Confidence                   234899999999999998777889999988643

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG0576|consensus

Probab=98.50  E-value=2.3e-08  Score=90.82  Aligned_cols=239  Identities=12%  Similarity=0.008  Sum_probs=163.9

Q ss_pred             CCceeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCC-ccccce
Q psy9858          46 PDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHEN-VLGLTD  124 (307)
Q Consensus        46 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-i~~~~~  124 (307)
                      ....+.....-|......++|+++++++.+...+...+ .+.+...          -...-++++|.+++||| .+..++
T Consensus       233 qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~----------l~~rl~~eLLdK~n~P~~~v~~~~  301 (829)
T KOG0576|consen  233 QPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT----------LSRRLAIELLDKVNNPNPVVRYLE  301 (829)
T ss_pred             CCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc----------hhhHHHHHHHHHccCCCCcccccc
Confidence            33455566677888888899999999998865554443 6666531          12346889999999999 777777


Q ss_pred             eeeecCeEEEEEEccCCC--hHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeec
Q psy9858         125 VFGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG  202 (307)
Q Consensus       125 ~~~~~~~~~lv~e~~~g~--l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg  202 (307)
                      -++.+...++.++++.+.  ...........+.+-+...+++.-+.+++++|+.-=+|+|    ||+.. ++..+..||+
T Consensus       302 d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-~~~~~~~~~~  376 (829)
T KOG0576|consen  302 DYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-EEEVKLLDFA  376 (829)
T ss_pred             cCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-cccccccccc
Confidence            777888999999999533  3333333333344555666777788899999998888998    77764 4789999999


Q ss_pred             CccccCCCCcccccceeeceehhhhhhhccccccccccee--e----eee-cCCCCCCCCCCCCChh------hhcc---
Q psy9858         203 LAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW--C----CFA-KDPSSHGNLFPGIPLN------EIFT---  266 (307)
Q Consensus       203 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw--~----i~~-~~~~f~~~~~~~~~~~------~~~~---  266 (307)
                      ....+.... ..++..+++.++|||..... .+.-+.|.|  .    .++ |.+|-....-......      .+..   
T Consensus       377 v~~~L~~~~-~~~t~~~~~~~~~pev~~~~-~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~~~~~g~~p~s~~L~~~~a  454 (829)
T KOG0576|consen  377 VPPQLTRTM-KPRTAIGTPEPLAPEVIQEN-TIDGCPDSGSLAVSAIQMAPGLPPRSSPPAVLPMIGNGPNSPMLTDKSA  454 (829)
T ss_pred             CCcccCccc-ccccCCCCCCCCCchhhccc-ccccCCCccCCCcchhhcCCCCCCCCCCccccCCCCCCCCccccchhhh
Confidence            998774332 34556889999999998887 888899999  2    233 4444333111000000      0000   


Q ss_pred             ccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         267 AAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       267 ~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                      .-+..-.++...|+...|..|++...++.|.+|.+-
T Consensus       455 w~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngC  490 (829)
T KOG0576|consen  455 WSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGC  490 (829)
T ss_pred             cCcccccCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence            001111257889999999999999999999888764

>PLN02876 acyl-CoA dehydrogenase

Probab=98.48  E-value=2.8e-06  Score=83.22  Aligned_cols=80  Identities=14%  Similarity=0.131  Sum_probs=55.4

Q ss_pred             EEeEEeecCceEEEEEEEcCCC--cEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-CCCc--cccceeeeec---C
Q psy9858          59 QWRSVHVGRFATVFKARDIETD--MIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-HENV--LGLTDVFGYM---S  130 (307)
Q Consensus        59 ~~~~lg~G~~g~V~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni--~~~~~~~~~~---~  130 (307)
                      .++.++.|.+..+|+......+  ..+++|+........    ....+.+|.++++.+. |.++  .+++.++.+.   +
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~----~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G  117 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ----SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIG  117 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc----cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCC
Confidence            3577899999999998754322  467888765322111    1235779999999995 6654  7777776654   4


Q ss_pred             eEEEEEEccCCC
Q psy9858         131 NVSLVFEFVDTD  142 (307)
Q Consensus       131 ~~~lv~e~~~g~  142 (307)
                      ..|+||||++|.
T Consensus       118 ~~flVME~v~G~  129 (822)
T PLN02876        118 TAFYIMEYLEGR  129 (822)
T ss_pred             CceEEEEecCCc
Confidence            689999999765

>KOG1235|consensus

Probab=98.47  E-value=1.6e-06  Score=79.14  Aligned_cols=140  Identities=22%  Similarity=0.257  Sum_probs=89.0

Q ss_pred             eEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccc--------------------------hhhh------HhHHHHH
Q psy9858          61 RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAK--------------------------DGIN------RTALREI  108 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~--------------------------~~~~------~~~~~e~  108 (307)
                      +.||..+.|.|++|+ ..+|+.||||+-++.-.....                          ++..      =.|.+|.
T Consensus       167 ~piaaASlaQVhrA~-L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRAR-LKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEE-ecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            678999999999999 456999999997753211100                          0001      1133344


Q ss_pred             HHHHhc----CCCC------ccccceeeeecCeEEEEEEccCCC---hHHHHhCCCCCCCHHHHHHHHHHHHHH-HHHHH
Q psy9858         109 KLLQEL----HHEN------VLGLTDVFGYMSNVSLVFEFVDTD---LEVIIKDPTIVFTPSNIKAYAIMTLRG-LEYLH  174 (307)
Q Consensus       109 ~~l~~l----~h~n------i~~~~~~~~~~~~~~lv~e~~~g~---l~~~~~~~~~~~~~~~~~~i~~~i~~~-l~~lH  174 (307)
                      +-..++    .|-+      |.+++  +.......|+|||++|-   -.+.+.+.+  ++...+   +..+.++ +..|-
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~~g--i~~~~i---~~~l~~~~~~qIf  318 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDKRG--ISPHDI---LNKLVEAYLEQIF  318 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHHcC--CCHHHH---HHHHHHHHHHHHH
Confidence            333332    3444      33333  34556788999999763   234444443  555543   3334443 33355


Q ss_pred             HCCceeecCCCCcEEEec----CCcEEEEeecCccccC
Q psy9858         175 DHWILHRDLKPNNLLINK----QGVLKIGDFGLAKFFG  208 (307)
Q Consensus       175 ~~~ivH~dlkp~Nil~~~----~~~~kl~Dfg~a~~~~  208 (307)
                      ..|++|.|-.|.||++.+    ++.+.+-|||+...+.
T Consensus       319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             hcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            679999999999999984    5689999999998764

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.45  E-value=1.9e-06  Score=66.69  Aligned_cols=135  Identities=21%  Similarity=0.163  Sum_probs=91.0

Q ss_pred             eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccc-cceeeeecCeEEEE
Q psy9858          57 YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG-LTDVFGYMSNVSLV  135 (307)
Q Consensus        57 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~-~~~~~~~~~~~~lv  135 (307)
                      -+..+.|+.|++|.||+|.+  .|..+|+|+-..       +.....+..|+++|..+...++.. ++.+    +..++.
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~-------ds~r~~l~kEakiLeil~g~~~~p~vy~y----g~~~i~   90 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEW--RGGEVALKVRRR-------DSPRRNLEKEAKILEILAGEGVTPEVYFY----GEDFIR   90 (201)
T ss_pred             hhhhhhhhcccccEEEEeec--cCceEEEEEecC-------CcchhhHHHHHHHHHHhhhcCCCceEEEe----chhhhh
Confidence            44568899999999999985  455899998653       222566889999999998766644 4433    223455


Q ss_pred             EEccCC-ChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCC-CCcEEEecCCcEEEEeecCccccCCCCc
Q psy9858         136 FEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK-PNNLLINKQGVLKIGDFGLAKFFGSPTR  212 (307)
Q Consensus       136 ~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlk-p~Nil~~~~~~~kl~Dfg~a~~~~~~~~  212 (307)
                      |||+.| .|.+.....    +    +.-+..++..---|-..||-|+.|+ |..+++..++.+.|+||..|.....+.+
T Consensus        91 me~i~G~~L~~~~~~~----~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~~p~N  161 (201)
T COG2112          91 MEYIDGRPLGKLEIGG----D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKKKPRN  161 (201)
T ss_pred             hhhhcCcchhhhhhcc----c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhccCCch
Confidence            999977 554443321    1    2223445555444667899999996 4445555566999999999986544443

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.40  E-value=5.6e-06  Score=66.10  Aligned_cols=130  Identities=22%  Similarity=0.176  Sum_probs=91.0

Q ss_pred             ceeeEEeEEeecCc-eEEEEEEEcCCCcEEEEEEeec---CCc-------cccc------hhhhHhHHHHHHHHHhcC--
Q psy9858          55 LVYYQWRSVHVGRF-ATVFKARDIETDMIVAVKKIKL---GTH-------ADAK------DGINRTALREIKLLQELH--  115 (307)
Q Consensus        55 ~~y~~~~~lg~G~~-g~V~~~~~~~~~~~vavK~~~~---~~~-------~~~~------~~~~~~~~~e~~~l~~l~--  115 (307)
                      .+++.++.||.|.- |.||+++  ..|+.+|+|++..   ...       ....      ......|..|.+...+|+  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            68999999999999 9999998  5678999999332   110       0000      023346788888888775  


Q ss_pred             -CCCc--cccceeeeec------------------CeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy9858         116 -HENV--LGLTDVFGYM------------------SNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH  174 (307)
Q Consensus       116 -h~ni--~~~~~~~~~~------------------~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH  174 (307)
                       +.++  ++++|+..-.                  ....||.||+...-         .+.    ..-+.+|++-|..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~----~~~~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQ----IRDIPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccc----hhHHHHHHHHHHHHH
Confidence             4556  8898887211                  12457777764322         122    233566778899999


Q ss_pred             HCCceeecCCCCcEEEecCCcEEEEeecCc
Q psy9858         175 DHWILHRDLKPNNLLINKQGVLKIGDFGLA  204 (307)
Q Consensus       175 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  204 (307)
                      ..||+-+|+++.|..=     -+|+|||.+
T Consensus       182 k~gI~~~Dv~~~ny~~-----G~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYRG-----GKLVDFSSS  206 (207)
T ss_pred             HCCeeeccCccccccC-----CEEEecccC
Confidence            9999999999999872     588999875

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.28  E-value=4.2e-05  Score=61.48  Aligned_cols=135  Identities=21%  Similarity=0.302  Sum_probs=93.1

Q ss_pred             eEEeecCceEEEEEEEcCCCcEEEEEEeecCCcccc-----------chhhhHhHHHHHHHHHhcC------CCCccccc
Q psy9858          61 RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADA-----------KDGINRTALREIKLLQELH------HENVLGLT  123 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~~~~~e~~~l~~l~------h~ni~~~~  123 (307)
                      ..||+|+.-.||.-   ......+||+.........           .....++..+|+.-...+.      +..|.+++
T Consensus         7 ~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            56899999999963   3334468999886541000           0112455667776666655      88999999


Q ss_pred             eeeeecCeEEEEEEcc-C--C----ChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCC--
Q psy9858         124 DVFGYMSNVSLVFEFV-D--T----DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG--  194 (307)
Q Consensus       124 ~~~~~~~~~~lv~e~~-~--g----~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~--  194 (307)
                      |+.+++.-.-+|+|.+ +  |    +|.+++....  +++ ..   ...+-.-..+|-+.+|+.+|++|.||++..++  
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~--~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~  157 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG--LTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG  157 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC--ccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence            9999999999999988 3  3    4777775443  554 32   33334446688899999999999999996544  


Q ss_pred             --cEEEEe-ecCc
Q psy9858         195 --VLKIGD-FGLA  204 (307)
Q Consensus       195 --~~kl~D-fg~a  204 (307)
                        .+.|+| ||..
T Consensus       158 ~~~lvlIDG~G~~  170 (199)
T PF10707_consen  158 EFRLVLIDGLGEK  170 (199)
T ss_pred             ceEEEEEeCCCCc
Confidence              577887 4443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.14  E-value=7.7e-05  Score=61.98  Aligned_cols=73  Identities=19%  Similarity=0.228  Sum_probs=44.9

Q ss_pred             EeEEeecCceEEEEEEEcC-CCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCC-ccccceeeeecCeEEEEEE
Q psy9858          60 WRSVHVGRFATVFKARDIE-TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHEN-VLGLTDVFGYMSNVSLVFE  137 (307)
Q Consensus        60 ~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-i~~~~~~~~~~~~~~lv~e  137 (307)
                      ++.|..|-...+|+..... .+..|++|+.......      .....+|+.+++.+...+ .++++....    -.++||
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~------~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e   72 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL------IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYE   72 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc------eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEE
Confidence            4567778888999987432 3578999976532111      112236888888885333 444444332    247999


Q ss_pred             ccCCC
Q psy9858         138 FVDTD  142 (307)
Q Consensus       138 ~~~g~  142 (307)
                      |++|.
T Consensus        73 ~i~G~   77 (235)
T cd05157          73 FIPGR   77 (235)
T ss_pred             eeCCC
Confidence            99653

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.14  E-value=2e-05  Score=65.55  Aligned_cols=31  Identities=32%  Similarity=0.434  Sum_probs=26.5

Q ss_pred             CceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         177 WILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       177 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      +++|+|+.+.||+++.++...|+||+.+..-
T Consensus       165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~g  195 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGVG  195 (235)
T ss_pred             eEEeCCCCCCcEEEECCCEEEEEeCcccCcC
Confidence            5899999999999987665679999998653

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.03  E-value=2.9e-05  Score=65.45  Aligned_cols=133  Identities=19%  Similarity=0.197  Sum_probs=74.7

Q ss_pred             EeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCc-cccceeeeecCeEEEEEEccCC
Q psy9858          63 VHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENV-LGLTDVFGYMSNVSLVFEFVDT  141 (307)
Q Consensus        63 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-~~~~~~~~~~~~~~lv~e~~~g  141 (307)
                      +..|-.+.+|+..  .++..+++|........     ..-...+|.++++.+...++ .+++...  .  -++||||++|
T Consensus         4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~-----~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G   72 (256)
T TIGR02721         4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKA-----LGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEG   72 (256)
T ss_pred             CCCcCcCCeEEEE--eCCccEEEeeCCccccc-----ccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccC
Confidence            4567778899886  45667889975432111     00124578889988864333 3444332  2  3689999976


Q ss_pred             ChHHH------------------HhCCC---CCCCH-HHHHHHHHHH---------HHHHHHHHH--------CCceeec
Q psy9858         142 DLEVI------------------IKDPT---IVFTP-SNIKAYAIMT---------LRGLEYLHD--------HWILHRD  182 (307)
Q Consensus       142 ~l~~~------------------~~~~~---~~~~~-~~~~~i~~~i---------~~~l~~lH~--------~~ivH~d  182 (307)
                      ...+.                  ++...   ..++. ..+..+..++         ...+..+-.        ..++|+|
T Consensus        73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D  152 (256)
T TIGR02721        73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD  152 (256)
T ss_pred             cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence            32210                  11111   01111 1111211111         111222221        2489999


Q ss_pred             CCCCcEEEecCCcEEEEeecCcccc
Q psy9858         183 LKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       183 lkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      +.|.||+++.++ +.|+||+.|..-
T Consensus       153 l~~~Nil~~~~~-~~lIDwE~a~~g  176 (256)
T TIGR02721       153 VHAYNLVVTPQG-LKLIDWEYASDG  176 (256)
T ss_pred             CCcCcEEEeCCC-CEEEeccccCcC
Confidence            999999999877 789999998754

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=98.00  E-value=0.00018  Score=64.05  Aligned_cols=80  Identities=19%  Similarity=0.049  Sum_probs=53.3

Q ss_pred             EeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccc--hhhhHhHHHHHHHHHhcC---CCCccccceeeeecCeEEE
Q psy9858          60 WRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAK--DGINRTALREIKLLQELH---HENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        60 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~~~e~~~l~~l~---h~ni~~~~~~~~~~~~~~l  134 (307)
                      .+.||.|.+..||++.....++.|+||.-.........  .....++..|.+.|+.+.   -..+++++.+  +....++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            46799999999999997433358999985422110000  112455677888888763   3457777765  5566889


Q ss_pred             EEEccCC
Q psy9858         135 VFEFVDT  141 (307)
Q Consensus       135 v~e~~~g  141 (307)
                      |||++++
T Consensus       109 VME~L~~  115 (401)
T PRK09550        109 VMEDLSD  115 (401)
T ss_pred             EEecCCC
Confidence            9999953

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.99  E-value=3.9e-05  Score=61.34  Aligned_cols=98  Identities=27%  Similarity=0.222  Sum_probs=76.6

Q ss_pred             HHHHHHHhcCC-CCccccceeeeecCeEEEEEEccC-CChHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHH---CCc
Q psy9858         106 REIKLLQELHH-ENVLGLTDVFGYMSNVSLVFEFVD-TDLEVIIK--DPTIVFTPSNIKAYAIMTLRGLEYLHD---HWI  178 (307)
Q Consensus       106 ~e~~~l~~l~h-~ni~~~~~~~~~~~~~~lv~e~~~-g~l~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i  178 (307)
                      +|.-+++.+++ +++++++|+|.+    +++.||.+ +++.....  ..-...++..+..++.+++..+.+++.   ..+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            58888888875 699999998743    56889996 44432110  010125889999999999999999997   357


Q ss_pred             eeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         179 LHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       179 vH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      .-.|++++|+-+++++++|++|...+...
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcchh
Confidence            88999999999999999999999887654

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG1035|consensus

Probab=97.97  E-value=1.1e-05  Score=78.57  Aligned_cols=196  Identities=15%  Similarity=0.163  Sum_probs=125.6

Q ss_pred             HHHHHHHHhcCCCCccccceeeeecCeE----EEEEEccC-CChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy9858         105 LREIKLLQELHHENVLGLTDVFGYMSNV----SLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWIL  179 (307)
Q Consensus       105 ~~e~~~l~~l~h~ni~~~~~~~~~~~~~----~lv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~iv  179 (307)
                      ..|...+.++.|+|++.++.+.......    .+.-+++. -++.+.+.... ..+....+.+..+++.||.++|+....
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~-~i~~~~~r~~~~~~~~GL~~~h~~~l~  308 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG-SIPLETLRILHQKLLEGLAYLHSLSLE  308 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc-ccCHHHHHHHHHHHhhhHHHHHHhccc
Confidence            3567788888999999998876433222    22335553 44555555443 478899999999999999999999666


Q ss_pred             eecCCCC---cEEEecCCcEEEE--eecCccccCCCCcccccceeeceehhhhhhhccccc--ccccceeeeee--cCCC
Q psy9858         180 HRDLKPN---NLLINKQGVLKIG--DFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQF--NVKNVQWCCFA--KDPS  250 (307)
Q Consensus       180 H~dlkp~---Nil~~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~--~~~~Diw~i~~--~~~~  250 (307)
                      |.-+..+   +--.+..+.+.++  ||+..+......... .......+.++|..... .+  ....|+||.-.  ....
T Consensus       309 ~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~-~~~~~~~~~~~e~~~~~-~~~~~r~~dL~~lgll~~~~~  386 (1351)
T KOG1035|consen  309 HVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF-SDLLAEIRNADEDLKEN-TAKKSRLTDLWCLGLLLLQLS  386 (1351)
T ss_pred             eeEEecccccccccCccceeecchhhhcccccCCCcccch-hhcCccccccccccccc-cchhhhhhHHHHHHHHHhhhh
Confidence            6655555   4444556666666  999888775443332 23445667778876655 33  34479993222  1111


Q ss_pred             CCC-CCCCCCChhhhccccC-HHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         251 SHG-NLFPGIPLNEIFTAAG-DDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       251 f~~-~~~~~~~~~~~~~~~~-~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      -.. ..........+....+ ....+.+.+|+..++++|+++.+++.|+|.+...
T Consensus       387 ~~~~i~~~~~~~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~  441 (1351)
T KOG1035|consen  387 QGEDISEKSAVPVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPT  441 (1351)
T ss_pred             hcCcccccccchhhhhccccchhhhhhhhhhcchhhhhccchhhhhhchhccccc
Confidence            100 0111111112222222 2788999999999999999999999999987543

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.95  E-value=8.3e-05  Score=64.11  Aligned_cols=137  Identities=13%  Similarity=0.041  Sum_probs=80.6

Q ss_pred             EeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCC--Ccccccee------eeecCe
Q psy9858          60 WRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHE--NVLGLTDV------FGYMSN  131 (307)
Q Consensus        60 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--ni~~~~~~------~~~~~~  131 (307)
                      ++.|..|....+|+...  ++..+++|+....    .    ......|++++..+.+.  .+.+++..      ....+.
T Consensus        19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~----~----~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~   88 (296)
T cd05153          19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKV----S----AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGK   88 (296)
T ss_pred             eecccCccccceEEEEe--CCCcEEEEEcCCC----C----hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCc
Confidence            56777788889999863  3346889987531    1    22355688888877432  24454442      123456


Q ss_pred             EEEEEEccCCChHHH-----H----------hC--CC--CC------CCHHHH--H--------HHHHHHHHHHHHHHH-
Q psy9858         132 VSLVFEFVDTDLEVI-----I----------KD--PT--IV------FTPSNI--K--------AYAIMTLRGLEYLHD-  175 (307)
Q Consensus       132 ~~lv~e~~~g~l~~~-----~----------~~--~~--~~------~~~~~~--~--------~i~~~i~~~l~~lH~-  175 (307)
                      .++++++++|.....     .          +.  ..  ..      ..+...  .        .....+..++.++.+ 
T Consensus        89 ~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~  168 (296)
T cd05153          89 PAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAF  168 (296)
T ss_pred             eEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhh
Confidence            789999997642211     1          10  00  00      000000  0        011112333444443 


Q ss_pred             ------CCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         176 ------HWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       176 ------~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                            .+++|+|+.|.||+++.++.+.|+||+.+..
T Consensus       169 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         169 DPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             hhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence                  3799999999999999887779999999865

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK10593 hypothetical protein; Provisional

Probab=97.94  E-value=0.00025  Score=61.14  Aligned_cols=75  Identities=12%  Similarity=0.008  Sum_probs=52.9

Q ss_pred             eEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCC---CCccccceeeee---cCe
Q psy9858          58 YQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH---ENVLGLTDVFGY---MSN  131 (307)
Q Consensus        58 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h---~ni~~~~~~~~~---~~~  131 (307)
                      .-.+.||.|..+.||.... .++ .+++|..+.    ...   ...+.+|.+.|+.+.-   ..+.++++++.+   .+.
T Consensus        17 ~~~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~~----~~~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~   87 (297)
T PRK10593         17 SRVECISEQPYAALWALYD-SQG-NPMPLMARS----FST---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGP   87 (297)
T ss_pred             heeeecCCccceeEEEEEc-CCC-CEEEEEecc----ccc---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCC
Confidence            4457899999999999863 334 467777432    001   2357789999998853   467888877654   367


Q ss_pred             EEEEEEccCC
Q psy9858         132 VSLVFEFVDT  141 (307)
Q Consensus       132 ~~lv~e~~~g  141 (307)
                      .+||||+++|
T Consensus        88 ~~LVmE~i~G   97 (297)
T PRK10593         88 DVLLLERLRG   97 (297)
T ss_pred             eEEEEeccCC
Confidence            9999999965

>KOG2268|consensus

Probab=97.92  E-value=2.2e-05  Score=66.76  Aligned_cols=140  Identities=18%  Similarity=0.156  Sum_probs=96.2

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCc-----------------cccchhhhHhHHHHHHHHHhcCC--
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTH-----------------ADAKDGINRTALREIKLLQELHH--  116 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------------~~~~~~~~~~~~~e~~~l~~l~h--  116 (307)
                      -+.+++.||-|--+.||.+-+ +.|.+.++|.=+.+..                 ..+..-.+-.+.+|...|+.|..  
T Consensus        93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            367889999999999999985 6788888885332111                 00111112335578888888852  


Q ss_pred             CCccccceeeeecCeEEEEEEccCCC-hHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCc
Q psy9858         117 ENVLGLTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGV  195 (307)
Q Consensus       117 ~ni~~~~~~~~~~~~~~lv~e~~~g~-l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~  195 (307)
                      --+.+.++    .++-++|||++.|- |.+..+-.       ....+...+..-+.-|..+|+||+|.+-=||++++++.
T Consensus       172 fpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v~-------d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~  240 (465)
T KOG2268|consen  172 FPVPKPID----HNRHCVVMELVDGYPLRQVRHVE-------DPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK  240 (465)
T ss_pred             CCCCCccc----ccceeeHHHhhcccceeeeeecC-------ChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCC
Confidence            34455543    46778999999664 43332222       12334555666677889999999999999999999999


Q ss_pred             EEEEeecCcccc
Q psy9858         196 LKIGDFGLAKFF  207 (307)
Q Consensus       196 ~kl~Dfg~a~~~  207 (307)
                      ++++||--+...
T Consensus       241 i~vIDFPQmvS~  252 (465)
T KOG2268|consen  241 IVVIDFPQMVST  252 (465)
T ss_pred             EEEeechHhhcc
Confidence            999999776554

>KOG2270|consensus

Probab=97.89  E-value=0.00023  Score=61.68  Aligned_cols=146  Identities=23%  Similarity=0.230  Sum_probs=95.9

Q ss_pred             eEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCcc--ccc------------------hhhhHh-HHHHHHHHHhcCC
Q psy9858          58 YQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHA--DAK------------------DGINRT-ALREIKLLQELHH  116 (307)
Q Consensus        58 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~------------------~~~~~~-~~~e~~~l~~l~h  116 (307)
                      .+..+|..|--+-||.|. ..+|..+|||++.-+-..  +..                  ....+. .-.|++-|.+++.
T Consensus       147 ~inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~  225 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN  225 (520)
T ss_pred             ecccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence            445778888889999998 578999999998643221  100                  000111 1246666776655


Q ss_pred             CCccccceeeeecCeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCceeecCCCCcEEEecCCc
Q psy9858         117 ENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH-DHWILHRDLKPNNLLINKQGV  195 (307)
Q Consensus       117 ~ni~~~~~~~~~~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~ivH~dlkp~Nil~~~~~~  195 (307)
                      .+|..---+.  -..-.|||+|++++-.-.-.-+.-.++...+..+-.+++.-+.-|- ..++||.||.--|+|+ .+|.
T Consensus       226 aGIP~PePIl--Lk~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~  302 (520)
T KOG2270|consen  226 AGIPCPEPIL--LKNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGK  302 (520)
T ss_pred             cCCCCCCcee--eecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCE
Confidence            4432221111  1234699999975533333333334777788888888887777664 5699999999999999 6788


Q ss_pred             EEEEeecCcccc
Q psy9858         196 LKIGDFGLAKFF  207 (307)
Q Consensus       196 ~kl~Dfg~a~~~  207 (307)
                      +.|+|-+-+.-.
T Consensus       303 lyiIDVSQSVE~  314 (520)
T KOG2270|consen  303 LYIIDVSQSVEH  314 (520)
T ss_pred             EEEEEccccccC
Confidence            999999887654

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.86  E-value=0.00024  Score=61.67  Aligned_cols=141  Identities=16%  Similarity=0.124  Sum_probs=80.8

Q ss_pred             eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCC--CCccccceee------ee
Q psy9858          57 YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH--ENVLGLTDVF------GY  128 (307)
Q Consensus        57 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~ni~~~~~~~------~~  128 (307)
                      ...++.++.|....+|+... .+| .+++|+.....    .   ......|.+++..|..  -.+++++...      ..
T Consensus        24 ~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~----~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~   94 (307)
T TIGR00938        24 LLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV----K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTL   94 (307)
T ss_pred             ceeccccCCccccceEEEEe-CCC-cEEEEEecCCC----C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhc
Confidence            33456677787789999863 344 57889875421    0   1234466777777742  2244544422      23


Q ss_pred             cCeEEEEEEccCCChH-----HH----------HhCCCCCC--------CHH---HH--H----------HHHHHHHHHH
Q psy9858         129 MSNVSLVFEFVDTDLE-----VI----------IKDPTIVF--------TPS---NI--K----------AYAIMTLRGL  170 (307)
Q Consensus       129 ~~~~~lv~e~~~g~l~-----~~----------~~~~~~~~--------~~~---~~--~----------~i~~~i~~~l  170 (307)
                      .+..+++++|++|...     ..          ++.....+        ...   ..  .          .....+...+
T Consensus        95 ~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~  174 (307)
T TIGR00938        95 AGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKEL  174 (307)
T ss_pred             CCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHH
Confidence            4567899999966211     11          11100000        000   00  0          0011223345


Q ss_pred             HHHHH-------CCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         171 EYLHD-------HWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       171 ~~lH~-------~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                      +++..       .+++|+|+++.||+++.++.+.|+||+.+..
T Consensus       175 ~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       175 DYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             HHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            55532       5899999999999999888778999999864

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=97.78  E-value=0.00069  Score=59.07  Aligned_cols=31  Identities=26%  Similarity=0.283  Sum_probs=26.8

Q ss_pred             CCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         176 HWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       176 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                      .|++|+|+.|.||+++.+....|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            3899999999999998665568999999864

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.77  E-value=0.00045  Score=59.72  Aligned_cols=31  Identities=29%  Similarity=0.404  Sum_probs=27.7

Q ss_pred             CceeecCCCCcEEEecC----CcEEEEeecCcccc
Q psy9858         177 WILHRDLKPNNLLINKQ----GVLKIGDFGLAKFF  207 (307)
Q Consensus       177 ~ivH~dlkp~Nil~~~~----~~~kl~Dfg~a~~~  207 (307)
                      +++|+|+.+.||+++.+    +.+.++||..|...
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~  214 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN  214 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence            58999999999999875    88999999999754

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.62  E-value=0.00051  Score=60.05  Aligned_cols=77  Identities=19%  Similarity=0.005  Sum_probs=48.9

Q ss_pred             EEeecCceEEEEEEEcCCCcEEEEEEeecCCcc--ccchhhhHhHHHHHHHHHhcC--CC-CccccceeeeecCeEEEEE
Q psy9858          62 SVHVGRFATVFKARDIETDMIVAVKKIKLGTHA--DAKDGINRTALREIKLLQELH--HE-NVLGLTDVFGYMSNVSLVF  136 (307)
Q Consensus        62 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~~~e~~~l~~l~--h~-ni~~~~~~~~~~~~~~lv~  136 (307)
                      .||.|....||++.+...++.|+||.-......  ..-.....+..-|.+.|+...  -| .+++++.  .+.....++|
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence            578899999999997543468999975422111  111122345567888887763  23 4555653  3666677999


Q ss_pred             EccC
Q psy9858         137 EFVD  140 (307)
Q Consensus       137 e~~~  140 (307)
                      |+++
T Consensus        80 EdL~   83 (370)
T TIGR01767        80 EDLS   83 (370)
T ss_pred             hhCc
Confidence            9983

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02236 choline kinase

Probab=97.56  E-value=0.0022  Score=56.59  Aligned_cols=140  Identities=16%  Similarity=0.137  Sum_probs=78.5

Q ss_pred             eEEeEEeecCceEEEEEEEcC----CCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCc-cccceeeeecCeE
Q psy9858          58 YQWRSVHVGRFATVFKARDIE----TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENV-LGLTDVFGYMSNV  132 (307)
Q Consensus        58 ~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-~~~~~~~~~~~~~  132 (307)
                      .-+..+..|-...+|++....    .++.|++|+.....    . . .-.-.+|.++++.+..-++ .++++.+...   
T Consensus        39 ~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t----~-~-~idR~~E~~~~~~l~~~gl~P~~~~~~~~g---  109 (344)
T PLN02236         39 LQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV----E-L-FFDRDDEIRTFECMSRHGQGPRLLGRFPNG---  109 (344)
T ss_pred             EEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC----C-e-eechHHHHHHHHHHHHcCCCCceEEEECCc---
Confidence            334455558888999987432    24689999876432    1 1 1112578888888854333 3555555332   


Q ss_pred             EEEEEccCCChHHH------------------HhCCCC-----CCCHHHHHHHHHHH-----------------HHHHHH
Q psy9858         133 SLVFEFVDTDLEVI------------------IKDPTI-----VFTPSNIKAYAIMT-----------------LRGLEY  172 (307)
Q Consensus       133 ~lv~e~~~g~l~~~------------------~~~~~~-----~~~~~~~~~i~~~i-----------------~~~l~~  172 (307)
                       .|.+|++|...+.                  +++...     ......+..+..++                 ...+..
T Consensus       110 -~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~  188 (344)
T PLN02236        110 -RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINL  188 (344)
T ss_pred             -eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHH
Confidence             5788885532110                  111110     01122222322111                 111222


Q ss_pred             HH--------HCCceeecCCCCcEEEec-CCcEEEEeecCcccc
Q psy9858         173 LH--------DHWILHRDLKPNNLLINK-QGVLKIGDFGLAKFF  207 (307)
Q Consensus       173 lH--------~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~a~~~  207 (307)
                      |.        ...++|+|+++.||+++. ++.+.++||..|...
T Consensus       189 L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~  232 (344)
T PLN02236        189 LEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN  232 (344)
T ss_pred             HHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence            21        125899999999999986 468999999998754

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.41  E-value=0.0035  Score=54.10  Aligned_cols=145  Identities=16%  Similarity=0.161  Sum_probs=80.8

Q ss_pred             eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC--CCCccccceeeeecC--eE
Q psy9858          57 YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH--HENVLGLTDVFGYMS--NV  132 (307)
Q Consensus        57 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~ni~~~~~~~~~~~--~~  132 (307)
                      ..+++.+..|....+|....  +++++++. ....   ...........+|.++++.+.  -.-+...++.+.++.  ..
T Consensus        27 ~~~v~~~~~G~sn~t~~~~~--~~~~~vlR-~P~~---~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~p  100 (321)
T COG3173          27 LLIVEEISGGWSNDTFRLGD--TGQKYVLR-KPPR---GDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTP  100 (321)
T ss_pred             CceeeeccCCcccceEEEec--CCceEEEe-cCCc---cccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCc
Confidence            34445554444445555543  37778888 3311   111112345667888888874  344455566665555  78


Q ss_pred             EEEEEccCCC-hHH----------HHh-----------CC-------CC---CCCHHHHHHHHHH--------------H
Q psy9858         133 SLVFEFVDTD-LEV----------IIK-----------DP-------TI---VFTPSNIKAYAIM--------------T  166 (307)
Q Consensus       133 ~lv~e~~~g~-l~~----------~~~-----------~~-------~~---~~~~~~~~~i~~~--------------i  166 (307)
                      |.||+++.|. ..+          ...           +-       .+   .....++..+..+              .
T Consensus       101 f~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~  180 (321)
T COG3173         101 FYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA  180 (321)
T ss_pred             eEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence            9999999762 111          111           00       00   0001111111111              1


Q ss_pred             HHHHHHHHHC--------CceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         167 LRGLEYLHDH--------WILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       167 ~~~l~~lH~~--------~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      ..-..|++.+        .++|+|+.+.|++++.++.+-+.||+++..-
T Consensus       181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence            1223444432        4899999999999999999999999999764

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.41  E-value=0.0035  Score=54.91  Aligned_cols=30  Identities=33%  Similarity=0.564  Sum_probs=26.5

Q ss_pred             ceeecCCCCcEEEec-CCcEEEEeecCcccc
Q psy9858         178 ILHRDLKPNNLLINK-QGVLKIGDFGLAKFF  207 (307)
Q Consensus       178 ivH~dlkp~Nil~~~-~~~~kl~Dfg~a~~~  207 (307)
                      ++|+|+.+.||++++ ++.++++||..|...
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~n  214 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS  214 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence            799999999999975 578999999999754

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.40  E-value=0.0028  Score=54.06  Aligned_cols=31  Identities=29%  Similarity=0.430  Sum_probs=26.2

Q ss_pred             CceeecCCCCcEEEecCCc-EEEEeecCcccc
Q psy9858         177 WILHRDLKPNNLLINKQGV-LKIGDFGLAKFF  207 (307)
Q Consensus       177 ~ivH~dlkp~Nil~~~~~~-~kl~Dfg~a~~~  207 (307)
                      .++|+|+++.||++++++. .-|+||+.+..-
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            4899999999999997555 569999998754

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.34  E-value=0.0072  Score=52.41  Aligned_cols=30  Identities=20%  Similarity=0.345  Sum_probs=26.5

Q ss_pred             CCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         176 HWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       176 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                      .+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            47899999999999987 6789999998764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.32  E-value=0.0014  Score=58.02  Aligned_cols=79  Identities=18%  Similarity=0.037  Sum_probs=51.8

Q ss_pred             EeEEeecCceEEEEEEEcCCCcEEEEEEeecCCcc-ccchhhhHhHHHHHHHHHhcC--CC-CccccceeeeecCeEEEE
Q psy9858          60 WRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHA-DAKDGINRTALREIKLLQELH--HE-NVLGLTDVFGYMSNVSLV  135 (307)
Q Consensus        60 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~e~~~l~~l~--h~-ni~~~~~~~~~~~~~~lv  135 (307)
                      ++.||-|.-..||++.+...++.|+||.-...... ..-.....+..-|.++|+...  -| .+++++.  .+.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence            67889999999999997434567999975422111 111222456677888888763  33 4666664  366667788


Q ss_pred             EEccC
Q psy9858         136 FEFVD  140 (307)
Q Consensus       136 ~e~~~  140 (307)
                      ||++.
T Consensus       112 MEdL~  116 (409)
T PRK12396        112 MEDLS  116 (409)
T ss_pred             HHhCc
Confidence            88873

>KOG1826|consensus

Probab=97.17  E-value=4.9e-05  Score=76.23  Aligned_cols=197  Identities=14%  Similarity=0.008  Sum_probs=131.8

Q ss_pred             HHHHHHHHHhcCCCCccccceeee--ecCeEEEEEEcc-CCChHHHHhCCCCC---CCHHHHHHHHHHHHHHHHHHHHC-
Q psy9858         104 ALREIKLLQELHHENVLGLTDVFG--YMSNVSLVFEFV-DTDLEVIIKDPTIV---FTPSNIKAYAIMTLRGLEYLHDH-  176 (307)
Q Consensus       104 ~~~e~~~l~~l~h~ni~~~~~~~~--~~~~~~lv~e~~-~g~l~~~~~~~~~~---~~~~~~~~i~~~i~~~l~~lH~~-  176 (307)
                      ...|..-++...|+++.....-..  .....+..++|+ .|.+.+.+.+....   +...-+.....+.+.+..-+|+. 
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            334555556678888877665443  345578889999 68888888654322   33333444444446777777754 


Q ss_pred             ----CceeecCCCCcEEEecCCcEEEEeecCccccCCCCcccccceeeceehhhhhhhccccccccccee---eeee---
Q psy9858         177 ----WILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA---  246 (307)
Q Consensus       177 ----~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~---  246 (307)
                          --+|++||+-|.+|..+..+++.++|+.+.............+++.|++|++...- .++.++|+|   +-++   
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~i-k~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEI-KFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHH-hhhhHHHHHHHHHHHHHHh
Confidence                27899999999999999999999999999544444455566788899999998887 888889999   2222   


Q ss_pred             -cCCCCCC-------CCCCCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCC
Q psy9858         247 -KDPSSHG-------NLFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSL  301 (307)
Q Consensus       247 -~~~~f~~-------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~  301 (307)
                       |+.+|-.       ..........+..-.+.+.......+|-+.-..||.-...++-+.|.-
T Consensus      1435 ~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1435 DGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAV 1497 (2724)
T ss_pred             cccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccccc
Confidence             4444433       222333333332223455556666666666678999988888877753

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=97.12  E-value=0.002  Score=56.01  Aligned_cols=102  Identities=18%  Similarity=0.140  Sum_probs=67.5

Q ss_pred             ecCeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         128 YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH-WILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       128 ~~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                      ...+.|++|++-++.+.. +..    ...+++..++.+-+..+.-+..+ ..-|||+...||||+ +|+|.|+||-+++.
T Consensus       297 e~~y~yl~~kdhgt~is~-ik~----~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl  370 (488)
T COG5072         297 ETLYLYLHFKDHGTPISI-IKA----DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL  370 (488)
T ss_pred             CceEEEEEEecCCceeee-eec----ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence            345678888887766533 221    34667777777766666555544 689999999999999 99999999999995


Q ss_pred             cCCCCcccccceeeceehhhhhhhccccccccccee
Q psy9858         207 FGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW  242 (307)
Q Consensus       207 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw  242 (307)
                      ......     +.....--|-.+.|.  .+...+||
T Consensus       371 ~~~q~~-----isy~rldhp~lF~G~--dd~QFeIY  399 (488)
T COG5072         371 SYSQGI-----ISYNRLDHPDLFNGV--DDYQFEIY  399 (488)
T ss_pred             ccCCce-----eeccccCchhhhcCc--cceeeeHH
Confidence            433221     122223344455543  36666777

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.12  E-value=0.014  Score=52.19  Aligned_cols=79  Identities=11%  Similarity=0.071  Sum_probs=50.0

Q ss_pred             EEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccc--hhhhHhHHHHHHHHHhcC---CCCccccceeeeecCeEE
Q psy9858          59 QWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAK--DGINRTALREIKLLQELH---HENVLGLTDVFGYMSNVS  133 (307)
Q Consensus        59 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~~~e~~~l~~l~---h~ni~~~~~~~~~~~~~~  133 (307)
                      ..+.||.|....||+..+  .+..++||.-.........  .....+-..|.+.|+.+.   -..+++++.++.  ...+
T Consensus        36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v  111 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL  111 (418)
T ss_pred             eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence            467889999999999885  3456999986532211000  001233345566666553   357888887655  5567


Q ss_pred             EEEEccCC
Q psy9858         134 LVFEFVDT  141 (307)
Q Consensus       134 lv~e~~~g  141 (307)
                      ++||++++
T Consensus       112 lvME~L~~  119 (418)
T PLN02756        112 IGMRYLEP  119 (418)
T ss_pred             EEEeecCC
Confidence            88999955

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.98  E-value=0.0099  Score=51.61  Aligned_cols=31  Identities=19%  Similarity=0.209  Sum_probs=28.5

Q ss_pred             CceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         177 WILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       177 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      +++|+|+.+.|++++.++.+.++||..+..-
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~d  227 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASFA  227 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhcccC
Confidence            7999999999999999999999999998753

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.91  E-value=0.025  Score=48.37  Aligned_cols=73  Identities=16%  Similarity=0.072  Sum_probs=47.9

Q ss_pred             eEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC---CCCccccceeeeecCeEEE
Q psy9858          58 YQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH---HENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        58 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~ni~~~~~~~~~~~~~~l  134 (307)
                      +-.+.++.|....+|+..  .+++.+.||+-..        .....|..|.+-|+.|.   --.+++++++....+..+|
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~--------~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fL   89 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE--------SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFL   89 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG--------GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEE
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecCh--------hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceE
Confidence            445778889999999987  6788899998652        11234678888888873   4557788888777777899


Q ss_pred             EEEccC
Q psy9858         135 VFEFVD  140 (307)
Q Consensus       135 v~e~~~  140 (307)
                      +|||++
T Consensus        90 lle~l~   95 (288)
T PF03881_consen   90 LLEFLE   95 (288)
T ss_dssp             EEE---
T ss_pred             EEEeec
Confidence            999984

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PTZ00384 choline kinase; Provisional

Probab=96.87  E-value=0.027  Score=50.30  Aligned_cols=30  Identities=30%  Similarity=0.275  Sum_probs=25.2

Q ss_pred             CCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         176 HWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       176 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                      ...+|.|+.+.||+.+ ++.+.++||..|..
T Consensus       227 ~VfCHNDL~~gNIL~~-~~~l~lID~EYA~~  256 (383)
T PTZ00384        227 VLFCHNDLFFTNILDF-NQGIYFIDFDFAGF  256 (383)
T ss_pred             eeeeeccCCcccEEec-CCCEEEEEeccccC
Confidence            3579999999999875 45699999998864

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=96.58  E-value=0.017  Score=49.68  Aligned_cols=30  Identities=30%  Similarity=0.444  Sum_probs=26.1

Q ss_pred             ceeecCCCCcEEEecCC-----cEEEEeecCcccc
Q psy9858         178 ILHRDLKPNNLLINKQG-----VLKIGDFGLAKFF  207 (307)
Q Consensus       178 ivH~dlkp~Nil~~~~~-----~~kl~Dfg~a~~~  207 (307)
                      ++|||+...||++..++     .++++||-.++..
T Consensus       217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~g  251 (294)
T PF02958_consen  217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARYG  251 (294)
T ss_pred             EEcCccCHHhEeEccccccccccceeeccccccCC
Confidence            89999999999997653     5899999998865

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.35  E-value=0.2  Score=43.85  Aligned_cols=30  Identities=27%  Similarity=0.255  Sum_probs=25.3

Q ss_pred             CCceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         176 HWILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       176 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      .+++|+|+.+.||+++ + .+.|+||+.+..-
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~g  225 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARMG  225 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCCCC
Confidence            3689999999999995 4 5789999998753

>KOG1236|consensus

Probab=96.30  E-value=0.022  Score=50.48  Aligned_cols=61  Identities=23%  Similarity=0.219  Sum_probs=40.1

Q ss_pred             EEEEEccCC-ChHHHHhCCCCCCCHHHHHHHHHHHHHHHHH-HHHCCceeecCCCCcEEEecCCc
Q psy9858         133 SLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEY-LHDHWILHRDLKPNNLLINKQGV  195 (307)
Q Consensus       133 ~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~-lH~~~ivH~dlkp~Nil~~~~~~  195 (307)
                      .|+-+|..| ++..++....  .+++..+.++.-.+.|+.- +--.+++|.|+.|.||++..+.+
T Consensus       321 vl~E~~~~Gl~v~~~v~~~~--~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~~t  383 (565)
T KOG1236|consen  321 VLVETYERGLSVLRFVKWKS--QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFNKT  383 (565)
T ss_pred             eeeeeccccccHHhhhhccc--ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEecCC
Confidence            344455544 5666666554  3555666666666666544 44678999999999999965443

>PRK06148 hypothetical protein; Provisional

Probab=96.29  E-value=0.083  Score=53.40  Aligned_cols=32  Identities=25%  Similarity=0.409  Sum_probs=27.1

Q ss_pred             CCceeecCCCCcEEEecCC--cEE-EEeecCcccc
Q psy9858         176 HWILHRDLKPNNLLINKQG--VLK-IGDFGLAKFF  207 (307)
Q Consensus       176 ~~ivH~dlkp~Nil~~~~~--~~k-l~Dfg~a~~~  207 (307)
                      .++||+|+++.||+++.++  .+. |+|||.+...
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~~  237 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVHA  237 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECcccccc
Confidence            4799999999999999875  554 9999998753

>PTZ00296 choline kinase; Provisional

Probab=96.27  E-value=0.074  Score=48.51  Aligned_cols=74  Identities=12%  Similarity=0.171  Sum_probs=44.2

Q ss_pred             EEeEEeecCceEEEEEEEcC--------CCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCcc-ccceeeeec
Q psy9858          59 QWRSVHVGRFATVFKARDIE--------TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL-GLTDVFGYM  129 (307)
Q Consensus        59 ~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~-~~~~~~~~~  129 (307)
                      -++.|..|-.-.+|++....        .++.|++++.-...    .. . -.-.+|..+++.+...+|. ++++.+.  
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t----e~-l-IdR~~E~~v~~~ls~~gi~P~l~~~f~--  180 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV----DE-L-YNPISEFEVYKTMSKYRIAPQLLNTFS--  180 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc----cc-e-eCHHHHHHHHHHHHHCCCCCceEEEeC--
Confidence            56677777788899987432        15678888875322    11 1 1234688888877544443 4555442  


Q ss_pred             CeEEEEEEccCCC
Q psy9858         130 SNVSLVFEFVDTD  142 (307)
Q Consensus       130 ~~~~lv~e~~~g~  142 (307)
                        -..+.+|+.|.
T Consensus       181 --gg~I~efi~g~  191 (442)
T PTZ00296        181 --GGRIEEWLYGD  191 (442)
T ss_pred             --CCEEEEeeCCc
Confidence              23568888653

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=95.39  E-value=0.032  Score=46.71  Aligned_cols=68  Identities=15%  Similarity=0.035  Sum_probs=49.5

Q ss_pred             eEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHH---HHHHhcCCCCccccceeeeecCeEEEEEE
Q psy9858          61 RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREI---KLLQELHHENVLGLTDVFGYMSNVSLVFE  137 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~---~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  137 (307)
                      ..+..|..+.|+.+. ..+|.++++|+......          +..|.   ..|+..+-.+.|++++.  +.....+++|
T Consensus         8 ~~~~~g~~s~V~pv~-~~dG~~avLKl~~p~~~----------~~~E~~g~~~L~~w~G~GaVrll~~--d~~~~AlLLE   74 (253)
T PF04655_consen    8 GPPAHGSSSLVVPVR-RADGTPAVLKLAPPHAE----------AEHEARGEAALRWWNGRGAVRLLAA--DPERGALLLE   74 (253)
T ss_pred             CCCCCCcceEEEEEE-cCCCCeEEEEecCCccc----------chhhhhHHhHhheeCCCCceeeecc--ccccchhhhh
Confidence            445678899999998 67899999998764321          11343   55777788888999875  4556778899


Q ss_pred             cc-CC
Q psy9858         138 FV-DT  141 (307)
Q Consensus       138 ~~-~g  141 (307)
                      .+ +|
T Consensus        75 rl~~g   79 (253)
T PF04655_consen   75 RLDPG   79 (253)
T ss_pred             hccCC
Confidence            98 54

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.29  E-value=0.089  Score=42.90  Aligned_cols=116  Identities=17%  Similarity=0.233  Sum_probs=68.8

Q ss_pred             cCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEEEccCCChHH
Q psy9858          66 GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEV  145 (307)
Q Consensus        66 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~g~l~~  145 (307)
                      ++.++.-.++... |. ..+|++...... ..   ..-+.++.++++++.  +|+++..  ...-..-++.|+|..--  
T Consensus        73 ~gNsTl~~~kt~i-G~-L~lKKi~slp~~-~~---~~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~~--  140 (308)
T PF07387_consen   73 NGNSTLLIGKTKI-GP-LFLKKIRSLPCC-IN---DALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKIK--  140 (308)
T ss_pred             CCceEEEEecccc-ch-hhhhhccCCCcc-cc---hhhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCcc--
Confidence            4556666655333 43 345655432211 01   234668888888775  5666652  12333557888872210  


Q ss_pred             HHhCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCceeecCCCCcEEEecCCcEEEEeecCc
Q psy9858         146 IIKDPTIVFTPSNIKAYAIMTLRGLEYLHD--HWILHRDLKPNNLLINKQGVLKIGDFGLA  204 (307)
Q Consensus       146 ~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  204 (307)
                              ...   ..++..=+.+|.-.|+  .+.+|+|-.|+||+-|..|.+||.|-+.-
T Consensus       141 --------i~~---~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  141 --------INF---SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             --------cch---hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence                    000   1111111356777784  37999999999999999999999997653

The function of this family is unknown.

>PRK10271 thiK thiamine kinase; Provisional

Probab=95.25  E-value=0.017  Score=45.93  Aligned_cols=30  Identities=30%  Similarity=0.320  Sum_probs=26.2

Q ss_pred             CceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         177 WILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       177 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      -.+|+|+.|.||++++++ ++++||+.|...
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~g  107 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAGDG  107 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCcccCC
Confidence            369999999999998777 899999998754

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	307
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-77
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-40
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-40
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-39
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		6e-39
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		6e-39
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		6e-39
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		6e-39
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		7e-39
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		7e-39
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		8e-39
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-38
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-38
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-38
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-38
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-38
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-38
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-38
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-38
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-38
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-38
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-38
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-38
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-38
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-38
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-38
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-38
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-38
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-38
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-38
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-38
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-38
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-38
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-38
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-38
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-38
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		9e-38
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-37
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-37
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-37
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-36
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		7e-35
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-33
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-33
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-33
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-29
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-29
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-29
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-29
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-29
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-26
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-25
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-24
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-24
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-24
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		8e-24
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-23
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		5e-23
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		8e-23
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		9e-23
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-22
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-22
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-22
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-22
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-22
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-22
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-22
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-22
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		5e-22
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		5e-22
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-22
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		7e-22
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		7e-22
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		7e-22
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		7e-22
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		8e-22
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		8e-22
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		9e-22
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-21
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-21
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-21
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-21
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-21
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-21
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-21
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-21
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-21
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-21
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-21
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-21
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-21
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-21
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-21
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-21
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-21
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-21
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-21
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-21
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-21
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-21
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-21
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-21
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-21
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-21
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-21
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-21
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-21
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-21
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-21
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-21
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-21
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-21
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-21
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-21
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-21
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-21
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-21
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-21
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-21
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-21
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-21
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-21
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-21
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-21
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-21
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-21
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-21
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-21
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-21
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-21
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-21
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-21
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-21
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-21
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-21
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-21
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		6e-21
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		6e-21
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		7e-21
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		8e-21
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		8e-21
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		8e-21
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		8e-21
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		9e-21
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-20
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-20
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-20
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-20
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-20
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-20
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-20
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-20
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		8e-20
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-19
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-19
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-19
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		4e-18
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-17
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-17
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		5e-17
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-16
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-16
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-16
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-16
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-16
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-16
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-16
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-16
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		5e-16
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-16
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		7e-16
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		7e-16
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		8e-16
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		8e-16
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		8e-16
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		9e-16
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		9e-16
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		9e-16
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		9e-16
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		9e-16
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		9e-16
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-15
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-15
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-15
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-15
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-15
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-15
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-15
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-15
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-15
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-15
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		5e-15
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		5e-15
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-15
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		7e-15
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-15
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		7e-15
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-14
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-14
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		5e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-14
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-13
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-13
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-13
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-13
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-13
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-13
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-13
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-13
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-13
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-13
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-13
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-13
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-13
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-13
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-13
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-13
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-13
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-13
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-13
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-13
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-13
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-13
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		6e-13
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		6e-13
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-13
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		6e-13
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		6e-13
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-13
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		6e-13
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		6e-13
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		7e-13
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		7e-13
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		8e-13
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		9e-13
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-12
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-12
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		3e-12
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-12
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		4e-12
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-12
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-12
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-12
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		5e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		5e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		6e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		6e-12
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		6e-12
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		6e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		6e-12
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		8e-12
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		8e-12
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		8e-12
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		8e-12
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		8e-12
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		8e-12
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		9e-12
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		9e-12
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-11
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-11
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-11
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-11
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-11
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-11
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-11
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-11
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-11
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-11
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-11
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-11
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-11
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-11
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-11
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-11
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-11
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-11
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-11
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-11
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		4e-11
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		5e-11
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		6e-11
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		7e-11
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		8e-11
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		8e-11
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		8e-11
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		8e-11
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		9e-11
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		9e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-10
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-10
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-10
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-10
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-10
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-10
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		2e-10
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		2e-10
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		2e-10
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		2e-10
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		2e-10
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		2e-10
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		2e-10
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		2e-10
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-10
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-10
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		3e-10
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-10
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-10
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-10
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-10
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		3e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-10
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		4e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-10
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		7e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		7e-10
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		8e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		8e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		8e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		8e-10
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		8e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		8e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		9e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		9e-10
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		9e-10
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		9e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-09
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-09
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-09
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-09
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-09
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-09
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-09
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-09
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-09
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-09
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-09
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-09
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-09
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-09
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-09
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-09
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-09
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-09
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-09
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-09
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-09
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-09
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-09
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-09
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-09
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-09
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-09
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-09
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-09
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-09
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-09
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-09
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-09
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-09
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-09
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-09
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-09
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-09
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-09
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-09
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-09
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-09
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-09
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-09
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		4e-09
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-09
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-09
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-09
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-09
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-09
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-09
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		5e-09
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		5e-09
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-09
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-09
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		5e-09
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		5e-09
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		5e-09
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		5e-09
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-09
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		5e-09
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-09
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		6e-09
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		6e-09
3g51_A	325	Structural Diversity Of The Active Conformation Of		6e-09
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		6e-09
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		7e-09
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		7e-09
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		7e-09
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		7e-09
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		7e-09
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-09
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		7e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		7e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		7e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-09
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		8e-09
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-09
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		8e-09
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		8e-09
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		8e-09
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		8e-09
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		8e-09
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		8e-09
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-09
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		8e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		8e-09
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		8e-09
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		8e-09
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		8e-09
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		9e-09
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		9e-09
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		9e-09
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		9e-09
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		9e-09
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		9e-09
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		9e-09
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		9e-09
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-08
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-08
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-08
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-08
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-08
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-08
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-08
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		1e-08
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-08
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-08
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-08
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-08
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		1e-08
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-08
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-08
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		1e-08
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-08
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		1e-08
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-08
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		1e-08
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		1e-08
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-08
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-08
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		1e-08
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-08
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		1e-08
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		1e-08
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		1e-08
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		1e-08
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-08
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-08
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		1e-08
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-08
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-08
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-08
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-08
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-08
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		2e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-08
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-08
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-08
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-08
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-08
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-08
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-08
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-08
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-08
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-08
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-08
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		4e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-08
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		5e-08
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		5e-08
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-08
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		5e-08
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		5e-08
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		5e-08
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		5e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		5e-08
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		5e-08
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		5e-08
1fvr_A	327	Tie2 Kinase Domain Length = 327		5e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-08
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		5e-08
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		6e-08
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		6e-08
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		6e-08
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		6e-08
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		6e-08
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		6e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		6e-08
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		6e-08
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		7e-08
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		8e-08
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		8e-08
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		9e-08
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-07
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-07
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-07
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-07
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-07
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-07
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-07
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-07
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-07
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-07
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-07
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-07
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-07
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-07
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-07
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-07
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-07
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-07
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-07
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-07
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-07
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-07
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-07
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-07
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-07
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-07
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-07
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-07
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-07
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-07
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-07
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-07
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-07
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-07
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-07
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-07
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-07
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-07
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-07
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-07
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-07
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-07
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-07
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-07
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-07
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-07
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-07
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-07
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-07
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-07
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-07
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-07
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-07
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		4e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-07
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-07
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-07
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-07
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		5e-07
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		5e-07
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-07
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-07
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-07
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		5e-07
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-07
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-07
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-07
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-07
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		6e-07
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		6e-07
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		6e-07
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		6e-07
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		6e-07
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		7e-07
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		7e-07
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		7e-07
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		7e-07
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		7e-07
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		7e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		7e-07
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		7e-07
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		7e-07
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-07
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		8e-07
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-07
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		8e-07
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-07
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		8e-07
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		8e-07
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		8e-07
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-07
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-07
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-07
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		9e-07
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		9e-07
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		9e-07
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		9e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		9e-07
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		9e-07
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		9e-07
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		9e-07
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-06
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-06
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-06
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-06
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-06
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-06
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-06
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-06
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-06
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-06
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-06
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-06
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-06
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-06
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-06
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		1e-06
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		1e-06
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-06
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-06
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		1e-06
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-06
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-06
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-06
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-06
2cmw_A	310	Structure Of Human Casein Kinase 1 Gamma-1 In Compl		2e-06
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-06
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-06
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-06
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		2e-06
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-06
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-06
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-06
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-06
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-06
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-06
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-06
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-06
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-06
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-06
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-06
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-06
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-06
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-06
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-06
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-06
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-06
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-06
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-06
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-06
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-06
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-06
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-06
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-06
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-06
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-06
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-06
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-06
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-06
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-06
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-06
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-06
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-06
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-06
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-06
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-06
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-06
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-06
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-06
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-06
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-06
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-06
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-06
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-06
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-06
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-06
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-06
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-06
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-06
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-06
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-06
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-06
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-06
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		4e-06
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-06
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-06
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		4e-06
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-06
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-06
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-06
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-06
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-06
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		4e-06
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-06
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		4e-06
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		5e-06
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-06
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		5e-06
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-06
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-06
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		6e-06
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		6e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		7e-06
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		7e-06
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		7e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		8e-06
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		8e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		8e-06
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		8e-06
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		8e-06
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		8e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		8e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		8e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		9e-06
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-05
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-05
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-05
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-05
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-05
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-05
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-05
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-05
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-05
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-05
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-05
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-05
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-05
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-05
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-05
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-05
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-05
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-05
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-05
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-05
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-05
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-05
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-05
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-05
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-05
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-05
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-05
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-05
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-05
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-05
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-05
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-05
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-05
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-05
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-05
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-05
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-05
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-05
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-05
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-05
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-05
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-05
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-05
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-05
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-05
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-05
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-05
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-05
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-05
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-05
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-05
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-05
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-05
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-05
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-05
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-05
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-05
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-05
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-05
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-05
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-05
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-05
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-05
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-05
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-05
4hgl_A	330	Crystal Structure Of Ck1g3 With Compound 1 Length =		4e-05
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-05
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-05
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-05
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-05
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		5e-05
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		5e-05
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-05
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		5e-05
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		5e-05
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		6e-05
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		6e-05
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-05
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		7e-05
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		7e-05
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-05
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		7e-05
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-05
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-05
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		8e-05
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		8e-05
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-05
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		8e-05
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		9e-05
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		9e-05
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		9e-05
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		9e-05
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		9e-05
2c47_A	313	Structure Of Casein Kinase 1 Gamma 2 Length = 313		1e-04
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-04
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-04
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-04
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-04
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-04
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-04
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-04
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-04
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-04
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-04
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		1e-04
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-04
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-04
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-04
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-04
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-04
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-04
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-04
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-04
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-04
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-04
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-04
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-04
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-04
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-04
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-04
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-04
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-04
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-04
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-04
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-04
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-04
3soa_A	444	Full-Length Human Camkii Length = 444		2e-04
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-04
2izr_A	330	Structure Of Casein Kinase Gamma 3 In Complex With		2e-04
2chl_A	351	Structure Of Casein Kinase 1 Gamma 3 Length = 351		2e-04
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-04
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-04
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-04
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-04
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		3e-04
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-04
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-04
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-04
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-04
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-04
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-04
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-04
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-04
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-04
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-04
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-04
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-04
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-04
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-04
1eh4_A	298	Binary Complex Of Casein Kinase-1 From S. Pombe Wit		4e-04
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		4e-04
2csn_A	297	Binary Complex Of Casein Kinase-1 With Cki7 Length		4e-04
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-04
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-04
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		5e-04
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		5e-04
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		5e-04
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-04
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		5e-04
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-04
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		6e-04
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		6e-04
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		6e-04
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		6e-04
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		6e-04
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		6e-04
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		7e-04
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		7e-04
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		7e-04
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		9e-04

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  286 bits (731), Expect = 1e-77,   Method: Compositional matrix adjust.
 Identities = 153/293 (52%), Positives = 186/293 (63%), Gaps = 41/293 (13%)
Query: 49  EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREI 108
           +VK+    Y +   +  G+FATV+KARD  T+ IVA+KKIKLG  ++AKDGINRTALREI
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 109 KLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLR 168
           KLLQEL H N++GL D FG+ SN+SLVF+F++TDLEVIIKD ++V TPS+IKAY +MTL+
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123
Query: 169 GLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKC 228
           GLEYLH HWILHRDLKPNNLL+++ GVLK+ DFGLAK FGSP R Y HQVVTRWYR  + 
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPEL 183
Query: 229 LLYCVQFNVKNVQW---CCFAK-------------------------DPSSHG------- 253
           L     + V    W   C  A+                          P+          
Sbjct: 184 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 243
Query: 254 ------NLFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                   FPGIPL+ IF+AAGDDLL +I  L   NP  R   T  LKM YFS
Sbjct: 244 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 296

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 104/288 (36%), Positives = 147/288 (51%), Gaps = 51/288 (17%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKD-GINRTALREIKLLQELH 115
           Y +   V  G +  V+KA+D +   IVA+K+I+L    DA+D GI  TA+REI LL+ELH
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQG-RIVALKRIRL----DAEDEGIPSTAIREISLLKELH 77
Query: 116 HENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
           H N++ L DV      ++LVFEF++ DL+ ++ +       S IK Y    LRG+ + H 
Sbjct: 78  HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ 137
Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQF 235
           H ILHRDLKP NLLIN  G LK+ DFGLA+ FG P R YTH+VVT WYR    L+   ++
Sbjct: 138 HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKY 197
Query: 236 NVKNVQW---CCFAKDPSSHGNLFPGI----PLNEIFTAAG------------------- 269
           +     W   C FA+  +    LFPG+     L +IF+  G                   
Sbjct: 198 STSVDIWSIGCIFAEMITGK-PLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQR 256
Query: 270 ------------------DDLLAVISSLLCLNPTKRADCTATLKMDYF 299
                              + + ++S++LC +P KR      +   YF
Sbjct: 257 TFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF 304

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 104/288 (36%), Positives = 147/288 (51%), Gaps = 51/288 (17%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKD-GINRTALREIKLLQELH 115
           Y +   V  G +  V+KA+D +   IVA+K+I+L    DA+D GI  TA+REI LL+ELH
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQG-RIVALKRIRL----DAEDEGIPSTAIREISLLKELH 77
Query: 116 HENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
           H N++ L DV      ++LVFEF++ DL+ ++ +       S IK Y    LRG+ + H 
Sbjct: 78  HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ 137
Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQF 235
           H ILHRDLKP NLLIN  G LK+ DFGLA+ FG P R YTH+VVT WYR    L+   ++
Sbjct: 138 HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKY 197
Query: 236 NVKNVQW---CCFAKDPSSHGNLFPGI----PLNEIFTAAG------------------- 269
           +     W   C FA+  +    LFPG+     L +IF+  G                   
Sbjct: 198 STSVDIWSIGCIFAEMITGK-PLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQR 256
Query: 270 ------------------DDLLAVISSLLCLNPTKRADCTATLKMDYF 299
                              + + ++S++LC +P KR      +   YF
Sbjct: 257 TFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF 304

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  157 bits (398), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 87/197 (44%), Positives = 120/197 (60%), Gaps = 8/197 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KAR+  T  +VA+KKI+L T  +   G+  TA+REI LL+EL+H N++ L DV
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKIRLDTETE---GVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTP-SNIKAYAIMTLRGLEYLHDHWILHRDLK 184
               + + LVFEF+  DL+  +    +   P   IK+Y    L+GL + H H +LHRDLK
Sbjct: 71  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHRVLHRDLK 130
Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-- 242
           P NLLIN +G +K+ DFGLA+ FG P R YTH+VVT WYR  + LL C  ++     W  
Sbjct: 131 PQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSL 190
Query: 243 -CCFAKDPSSHGNLFPG 258
            C FA+  +    LFPG
Sbjct: 191 GCIFAEMVTRRA-LFPG 206

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  157 bits (397), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 88/210 (41%), Positives = 125/210 (59%), Gaps = 8/210 (3%)
Query: 53  DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQ 112
           D+  + +   +  G +  V+KAR+  T  +VA+KKI+L T  +   G+  TA+REI LL+
Sbjct: 5   DMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE---GVPSTAIREISLLK 61
Query: 113 ELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTP-SNIKAYAIMTLRGLE 171
           EL+H N++ L DV    + + LVFEF+  DL+  +    +   P   IK+Y    L+GL 
Sbjct: 62  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 121
Query: 172 YLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLY 231
           + H H +LHRDLKP NLLIN +G +K+ DFGLA+ FG P R YTH+VVT WYR  + LL 
Sbjct: 122 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 181
Query: 232 CVQFNVKNVQW---CCFAKDPSSHGNLFPG 258
           C  ++     W   C FA+  +    LFPG
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRRA-LFPG 210

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  157 bits (397), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 87/197 (44%), Positives = 120/197 (60%), Gaps = 8/197 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KAR+  T  +VA+KKI+L T  +   G+  TA+REI LL+EL+H N++ L DV
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKIRLDTETE---GVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTP-SNIKAYAIMTLRGLEYLHDHWILHRDLK 184
               + + LVFEF+  DL+  +    +   P   IK+Y    L+GL + H H +LHRDLK
Sbjct: 71  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 130
Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-- 242
           P NLLIN +G +K+ DFGLA+ FG P R YTH+VVT WYR  + LL C  ++     W  
Sbjct: 131 PQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSL 190
Query: 243 -CCFAKDPSSHGNLFPG 258
            C FA+  +    LFPG
Sbjct: 191 GCIFAEMVTRRA-LFPG 206

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  157 bits (397), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 87/197 (44%), Positives = 120/197 (60%), Gaps = 8/197 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KAR+  T  +VA+KKI+L T  +   G+  TA+REI LL+EL+H N++ L DV
Sbjct: 13  GTYGVVYKARNKLTGEVVALKKIRLDTETE---GVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTP-SNIKAYAIMTLRGLEYLHDHWILHRDLK 184
               + + LVFEF+  DL+  +    +   P   IK+Y    L+GL + H H +LHRDLK
Sbjct: 70  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 129
Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-- 242
           P NLLIN +G +K+ DFGLA+ FG P R YTH+VVT WYR  + LL C  ++     W  
Sbjct: 130 PQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSL 189
Query: 243 -CCFAKDPSSHGNLFPG 258
            C FA+  +    LFPG
Sbjct: 190 GCIFAEMVTRRA-LFPG 205

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  157 bits (397), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 87/197 (44%), Positives = 120/197 (60%), Gaps = 8/197 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KAR+  T  +VA+KKI+L T  +   G+  TA+REI LL+EL+H N++ L DV
Sbjct: 13  GTYGVVYKARNKLTGEVVALKKIRLDTETE---GVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTP-SNIKAYAIMTLRGLEYLHDHWILHRDLK 184
               + + LVFEF+  DL+  +    +   P   IK+Y    L+GL + H H +LHRDLK
Sbjct: 70  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 129
Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-- 242
           P NLLIN +G +K+ DFGLA+ FG P R YTH+VVT WYR  + LL C  ++     W  
Sbjct: 130 PQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSL 189
Query: 243 -CCFAKDPSSHGNLFPG 258
            C FA+  +    LFPG
Sbjct: 190 GCIFAEMVTRRA-LFPG 205

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  157 bits (397), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 87/197 (44%), Positives = 120/197 (60%), Gaps = 8/197 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KAR+  T  +VA+KKI+L T  +   G+  TA+REI LL+EL+H N++ L DV
Sbjct: 15  GTYGVVYKARNKLTGEVVALKKIRLDTETE---GVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTP-SNIKAYAIMTLRGLEYLHDHWILHRDLK 184
               + + LVFEF+  DL+  +    +   P   IK+Y    L+GL + H H +LHRDLK
Sbjct: 72  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 131
Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-- 242
           P NLLIN +G +K+ DFGLA+ FG P R YTH+VVT WYR  + LL C  ++     W  
Sbjct: 132 PQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSL 191
Query: 243 -CCFAKDPSSHGNLFPG 258
            C FA+  +    LFPG
Sbjct: 192 GCIFAEMVTRRA-LFPG 207

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  157 bits (397), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 87/197 (44%), Positives = 120/197 (60%), Gaps = 8/197 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KAR+  T  +VA+KKI+L T  +   G+  TA+REI LL+EL+H N++ L DV
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKIRLDTETE---GVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTP-SNIKAYAIMTLRGLEYLHDHWILHRDLK 184
               + + LVFEF+  DL+  +    +   P   IK+Y    L+GL + H H +LHRDLK
Sbjct: 71  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 130
Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-- 242
           P NLLIN +G +K+ DFGLA+ FG P R YTH+VVT WYR  + LL C  ++     W  
Sbjct: 131 PQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSL 190
Query: 243 -CCFAKDPSSHGNLFPG 258
            C FA+  +    LFPG
Sbjct: 191 GCIFAEMVTRRA-LFPG 206

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  157 bits (396), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 87/197 (44%), Positives = 120/197 (60%), Gaps = 8/197 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KAR+  T  +VA+KKI+L T  +   G+  TA+REI LL+EL+H N++ L DV
Sbjct: 21  GTYGVVYKARNKLTGEVVALKKIRLDTETE---GVPSTAIREISLLKELNHPNIVKLLDV 77
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTP-SNIKAYAIMTLRGLEYLHDHWILHRDLK 184
               + + LVFEF+  DL+  +    +   P   IK+Y    L+GL + H H +LHRDLK
Sbjct: 78  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 137
Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-- 242
           P NLLIN +G +K+ DFGLA+ FG P R YTH+VVT WYR  + LL C  ++     W  
Sbjct: 138 PQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSL 197
Query: 243 -CCFAKDPSSHGNLFPG 258
            C FA+  +    LFPG
Sbjct: 198 GCIFAEMVTRRA-LFPG 213

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 87/197 (44%), Positives = 119/197 (60%), Gaps = 8/197 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KAR+  T  +VA+KKI+L T  +   G+  TA+REI LL+EL+H N++ L DV
Sbjct: 13  GTYGVVYKARNKLTGEVVALKKIRLDTETE---GVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTP-SNIKAYAIMTLRGLEYLHDHWILHRDLK 184
               + + LVFE V  DL+  +    +   P   IK+Y    L+GL + H H +LHRDLK
Sbjct: 70  IHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 129
Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-- 242
           P NLLIN +G +K+ DFGLA+ FG P R YTH+VVT WYR  + LL C  ++     W  
Sbjct: 130 PQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSL 189
Query: 243 -CCFAKDPSSHGNLFPG 258
            C FA+  +    LFPG
Sbjct: 190 GCIFAEMVTRRA-LFPG 205

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  156 bits (395), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 87/197 (44%), Positives = 119/197 (60%), Gaps = 8/197 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KAR+  T  +VA+KKI+L T  +   G+  TA+REI LL+EL+H N++ L DV
Sbjct: 17  GTYGVVYKARNKLTGEVVALKKIRLDTETE---GVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTP-SNIKAYAIMTLRGLEYLHDHWILHRDLK 184
               + + LVFE VD DL+  +    +   P   IK+Y    L+GL + H H +LHRDLK
Sbjct: 74  IHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 133
Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-- 242
           P NLLIN +G +K+ DFGLA+ FG P R Y H+VVT WYR  + LL C  ++     W  
Sbjct: 134 PQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 193
Query: 243 -CCFAKDPSSHGNLFPG 258
            C FA+  +    LFPG
Sbjct: 194 GCIFAEMVTRRA-LFPG 209

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 86/197 (43%), Positives = 119/197 (60%), Gaps = 8/197 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KAR+  T  +VA+KKI+L T  +   G+  TA+REI LL+EL+H N++ L DV
Sbjct: 17  GTYGVVYKARNKLTGEVVALKKIRLDTETE---GVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTP-SNIKAYAIMTLRGLEYLHDHWILHRDLK 184
               + + LVFEF+  DL+  +    +   P   IK+Y    L+GL + H H +LHRDLK
Sbjct: 74  IHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 133
Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-- 242
           P NLLIN +G +K+ DFGLA+ FG P R Y H+VVT WYR  + LL C  ++     W  
Sbjct: 134 PQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 193
Query: 243 -CCFAKDPSSHGNLFPG 258
            C FA+  +    LFPG
Sbjct: 194 GCIFAEMVTRRA-LFPG 209

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 86/197 (43%), Positives = 119/197 (60%), Gaps = 8/197 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KAR+  T  +VA+KKI+L T  +   G+  TA+REI LL+EL+H N++ L DV
Sbjct: 17  GTYGVVYKARNKLTGEVVALKKIRLDTETE---GVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTP-SNIKAYAIMTLRGLEYLHDHWILHRDLK 184
               + + LVFEF+  DL+  +    +   P   IK+Y    L+GL + H H +LHRDLK
Sbjct: 74  IHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 133
Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-- 242
           P NLLIN +G +K+ DFGLA+ FG P R Y H+VVT WYR  + LL C  ++     W  
Sbjct: 134 PENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 193
Query: 243 -CCFAKDPSSHGNLFPG 258
            C FA+  +    LFPG
Sbjct: 194 GCIFAEMVTRRA-LFPG 209

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 86/197 (43%), Positives = 119/197 (60%), Gaps = 8/197 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KAR+  T  +VA+KKI+L T  +   G+  TA+REI LL+EL+H N++ L DV
Sbjct: 15  GTYGVVYKARNKLTGEVVALKKIRLDTETE---GVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTP-SNIKAYAIMTLRGLEYLHDHWILHRDLK 184
               + + LVFEF+  DL+  +    +   P   IK+Y    L+GL + H H +LHRDLK
Sbjct: 72  IHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 131
Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-- 242
           P NLLIN +G +K+ DFGLA+ FG P R Y H+VVT WYR  + LL C  ++     W  
Sbjct: 132 PENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 191
Query: 243 -CCFAKDPSSHGNLFPG 258
            C FA+  +    LFPG
Sbjct: 192 GCIFAEMVTRRA-LFPG 207

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 86/197 (43%), Positives = 119/197 (60%), Gaps = 8/197 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KAR+  T  +VA+KKI+L T  +   G+  TA+REI LL+EL+H N++ L DV
Sbjct: 17  GTYGVVYKARNKLTGEVVALKKIRLDTETE---GVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTP-SNIKAYAIMTLRGLEYLHDHWILHRDLK 184
               + + LVFEF+  DL+  +    +   P   IK+Y    L+GL + H H +LHRDLK
Sbjct: 74  IHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 133
Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-- 242
           P NLLIN +G +K+ DFGLA+ FG P R Y H+VVT WYR  + LL C  ++     W  
Sbjct: 134 PQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 193
Query: 243 -CCFAKDPSSHGNLFPG 258
            C FA+  +    LFPG
Sbjct: 194 GCIFAEMVTRRA-LFPG 209

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  155 bits (392), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 86/197 (43%), Positives = 119/197 (60%), Gaps = 8/197 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KAR+  T  +VA+KKI+L T  +   G+  TA+REI LL+EL+H N++ L DV
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKIRLDTETE---GVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTP-SNIKAYAIMTLRGLEYLHDHWILHRDLK 184
               + + LVFEF+  DL+  +    +   P   IK+Y    L+GL + H H +LHRDLK
Sbjct: 71  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 130
Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-- 242
           P NLLIN +G +K+ DFGLA+ FG P R Y H+VVT WYR  + LL C  ++     W  
Sbjct: 131 PQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 190
Query: 243 -CCFAKDPSSHGNLFPG 258
            C FA+  +    LFPG
Sbjct: 191 GCIFAEMVTRRA-LFPG 206

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 86/197 (43%), Positives = 119/197 (60%), Gaps = 8/197 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KAR+  T  +VA+KKI+L T  +   G+  TA+REI LL+EL+H N++ L DV
Sbjct: 16  GTYGVVYKARNKLTGEVVALKKIRLDTETE---GVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTP-SNIKAYAIMTLRGLEYLHDHWILHRDLK 184
               + + LVFEF+  DL+  +    +   P   IK+Y    L+GL + H H +LHRDLK
Sbjct: 73  IHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 132
Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-- 242
           P NLLIN +G +K+ DFGLA+ FG P R Y H+VVT WYR  + LL C  ++     W  
Sbjct: 133 PQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 192
Query: 243 -CCFAKDPSSHGNLFPG 258
            C FA+  +    LFPG
Sbjct: 193 GCIFAEMVTRRA-LFPG 208

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 86/197 (43%), Positives = 119/197 (60%), Gaps = 8/197 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KAR+  T  +VA+ KI+L T  +   G+  TA+REI LL+EL+H N++ L DV
Sbjct: 14  GTYGVVYKARNKLTGEVVALXKIRLDTETE---GVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTP-SNIKAYAIMTLRGLEYLHDHWILHRDLK 184
               + + LVFEF+  DL+  +    +   P   IK+Y    L+GL + H H +LHRDLK
Sbjct: 71  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 130
Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-- 242
           P NLLIN +G +K+ DFGLA+ FG P R YTH+VVT WYR  + LL C  ++     W  
Sbjct: 131 PQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSL 190
Query: 243 -CCFAKDPSSHGNLFPG 258
            C FA+  +    LFPG
Sbjct: 191 GCIFAEMVTRRA-LFPG 206

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 86/197 (43%), Positives = 119/197 (60%), Gaps = 8/197 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KAR+  T  +VA+ KI+L T  +   G+  TA+REI LL+EL+H N++ L DV
Sbjct: 13  GTYGVVYKARNKLTGEVVALXKIRLDTETE---GVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTP-SNIKAYAIMTLRGLEYLHDHWILHRDLK 184
               + + LVFEF+  DL+  +    +   P   IK+Y    L+GL + H H +LHRDLK
Sbjct: 70  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 129
Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-- 242
           P NLLIN +G +K+ DFGLA+ FG P R YTH+VVT WYR  + LL C  ++     W  
Sbjct: 130 PQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSL 189
Query: 243 -CCFAKDPSSHGNLFPG 258
            C FA+  +    LFPG
Sbjct: 190 GCIFAEMVTRRA-LFPG 205

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 86/197 (43%), Positives = 119/197 (60%), Gaps = 8/197 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KAR+  T  +VA+KKI+L T  +   G+  TA+REI LL+EL+H N++ L DV
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKIRLDTETE---GVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTP-SNIKAYAIMTLRGLEYLHDHWILHRDLK 184
               + + LVFEF+  DL+  +    +   P   IK+Y    L+GL + H H +LHRDLK
Sbjct: 71  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 130
Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-- 242
           P NLLIN +G +K+ DFGLA+ FG P R Y H+VVT WYR  + LL C  ++     W  
Sbjct: 131 PQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 190
Query: 243 -CCFAKDPSSHGNLFPG 258
            C FA+  +    LFPG
Sbjct: 191 GCIFAEMVTRRA-LFPG 206

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 86/197 (43%), Positives = 119/197 (60%), Gaps = 8/197 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KAR+  T  +VA+KKI+L T  +   G+  TA+REI LL+EL+H N++ L DV
Sbjct: 17  GTYGVVYKARNKLTGEVVALKKIRLDTETE---GVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTP-SNIKAYAIMTLRGLEYLHDHWILHRDLK 184
               + + LVFEF+  DL+  +    +   P   IK+Y    L+GL + H H +LHRDLK
Sbjct: 74  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 133
Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-- 242
           P NLLIN +G +K+ DFGLA+ FG P R Y H+VVT WYR  + LL C  ++     W  
Sbjct: 134 PQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 193
Query: 243 -CCFAKDPSSHGNLFPG 258
            C FA+  +    LFPG
Sbjct: 194 GCIFAEMVTRRA-LFPG 209

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 86/197 (43%), Positives = 119/197 (60%), Gaps = 8/197 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KAR+  T  +VA+KKI+L T  +   G+  TA+REI LL+EL+H N++ L DV
Sbjct: 16  GTYGVVYKARNKLTGEVVALKKIRLDTETE---GVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTP-SNIKAYAIMTLRGLEYLHDHWILHRDLK 184
               + + LVFEF+  DL+  +    +   P   IK+Y    L+GL + H H +LHRDLK
Sbjct: 73  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 132
Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-- 242
           P NLLIN +G +K+ DFGLA+ FG P R Y H+VVT WYR  + LL C  ++     W  
Sbjct: 133 PQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 192
Query: 243 -CCFAKDPSSHGNLFPG 258
            C FA+  +    LFPG
Sbjct: 193 GCIFAEMVTRRA-LFPG 208

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 86/197 (43%), Positives = 119/197 (60%), Gaps = 8/197 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KAR+  T  +VA+KKI+L T  +   G+  TA+REI LL+EL+H N++ L DV
Sbjct: 15  GTYGVVYKARNKLTGEVVALKKIRLDTETE---GVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTP-SNIKAYAIMTLRGLEYLHDHWILHRDLK 184
               + + LVFEF+  DL+  +    +   P   IK+Y    L+GL + H H +LHRDLK
Sbjct: 72  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 131
Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-- 242
           P NLLIN +G +K+ DFGLA+ FG P R Y H+VVT WYR  + LL C  ++     W  
Sbjct: 132 PQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 191
Query: 243 -CCFAKDPSSHGNLFPG 258
            C FA+  +    LFPG
Sbjct: 192 GCIFAEMVTRRA-LFPG 207

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 86/197 (43%), Positives = 119/197 (60%), Gaps = 8/197 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KAR+  T  +VA+KKI+L T  +   G+  TA+REI LL+EL+H N++ L DV
Sbjct: 13  GTYGVVYKARNKLTGEVVALKKIRLDTETE---GVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTP-SNIKAYAIMTLRGLEYLHDHWILHRDLK 184
               + + LVFEF+  DL+  +    +   P   IK+Y    L+GL + H H +LHRDLK
Sbjct: 70  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 129
Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-- 242
           P NLLIN +G +K+ DFGLA+ FG P R Y H+VVT WYR  + LL C  ++     W  
Sbjct: 130 PQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 189
Query: 243 -CCFAKDPSSHGNLFPG 258
            C FA+  +    LFPG
Sbjct: 190 GCIFAEMVTRRA-LFPG 205

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 86/197 (43%), Positives = 119/197 (60%), Gaps = 8/197 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KAR+  T  +VA+KKI+L T  +   G+  TA+REI LL+EL+H N++ L DV
Sbjct: 16  GTYGVVYKARNKLTGEVVALKKIRLDTETE---GVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTP-SNIKAYAIMTLRGLEYLHDHWILHRDLK 184
               + + LVFEF+  DL+  +    +   P   IK+Y    L+GL + H H +LHRDLK
Sbjct: 73  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 132
Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-- 242
           P NLLIN +G +K+ DFGLA+ FG P R Y H+VVT WYR  + LL C  ++     W  
Sbjct: 133 PQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 192
Query: 243 -CCFAKDPSSHGNLFPG 258
            C FA+  +    LFPG
Sbjct: 193 GCIFAEMVTRRA-LFPG 208

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 86/197 (43%), Positives = 119/197 (60%), Gaps = 8/197 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KAR+  T  +VA+KKI+L T  +   G+  TA+REI LL+EL+H N++ L DV
Sbjct: 13  GTYGVVYKARNKLTGEVVALKKIRLDTETE---GVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTP-SNIKAYAIMTLRGLEYLHDHWILHRDLK 184
               + + LVFEF+  DL+  +    +   P   IK+Y    L+GL + H H +LHRDLK
Sbjct: 70  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 129
Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-- 242
           P NLLIN +G +K+ DFGLA+ FG P R Y H+VVT WYR  + LL C  ++     W  
Sbjct: 130 PQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 189
Query: 243 -CCFAKDPSSHGNLFPG 258
            C FA+  +    LFPG
Sbjct: 190 GCIFAEMVTRRA-LFPG 205

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 86/197 (43%), Positives = 119/197 (60%), Gaps = 8/197 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KAR+  T  +VA+KKI+L T  +   G+  TA+REI LL+EL+H N++ L DV
Sbjct: 16  GTYGVVYKARNKLTGEVVALKKIRLDTETE---GVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTP-SNIKAYAIMTLRGLEYLHDHWILHRDLK 184
               + + LVFEF+  DL+  +    +   P   IK+Y    L+GL + H H +LHRDLK
Sbjct: 73  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 132
Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-- 242
           P NLLIN +G +K+ DFGLA+ FG P R Y H+VVT WYR  + LL C  ++     W  
Sbjct: 133 PENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 192
Query: 243 -CCFAKDPSSHGNLFPG 258
            C FA+  +    LFPG
Sbjct: 193 GCIFAEMVTRRA-LFPG 208

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 86/197 (43%), Positives = 119/197 (60%), Gaps = 8/197 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KAR+  T  +VA+KKI+L T  +   G+  TA+REI LL+EL+H N++ L DV
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKIRLDTETE---GVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTP-SNIKAYAIMTLRGLEYLHDHWILHRDLK 184
               + + LVFEF+  DL+  +    +   P   IK+Y    L+GL + H H +LHRDLK
Sbjct: 71  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 130
Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-- 242
           P NLLIN +G +K+ DFGLA+ FG P R Y H+VVT WYR  + LL C  ++     W  
Sbjct: 131 PQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 190
Query: 243 -CCFAKDPSSHGNLFPG 258
            C FA+  +    LFPG
Sbjct: 191 GCIFAEMVTRRA-LFPG 206

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 86/197 (43%), Positives = 119/197 (60%), Gaps = 8/197 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KAR+  T  +VA+KKI+L T  +   G+  TA+REI LL+EL+H N++ L DV
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKIRLDTETE---GVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTP-SNIKAYAIMTLRGLEYLHDHWILHRDLK 184
               + + LVFEF+  DL+  +    +   P   IK+Y    L+GL + H H +LHRDLK
Sbjct: 71  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 130
Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-- 242
           P NLLIN +G +K+ DFGLA+ FG P R Y H+VVT WYR  + LL C  ++     W  
Sbjct: 131 PQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 190
Query: 243 -CCFAKDPSSHGNLFPG 258
            C FA+  +    LFPG
Sbjct: 191 GCIFAEMVTRRA-LFPG 206

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 86/197 (43%), Positives = 119/197 (60%), Gaps = 8/197 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KAR+  T  +VA+KKI+L T  +   G+  TA+REI LL+EL+H N++ L DV
Sbjct: 18  GTYGVVYKARNKLTGEVVALKKIRLDTETE---GVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTP-SNIKAYAIMTLRGLEYLHDHWILHRDLK 184
               + + LVFEF+  DL+  +    +   P   IK+Y    L+GL + H H +LHRDLK
Sbjct: 75  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 134
Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-- 242
           P NLLIN +G +K+ DFGLA+ FG P R Y H+VVT WYR  + LL C  ++     W  
Sbjct: 135 PQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 194
Query: 243 -CCFAKDPSSHGNLFPG 258
            C FA+  +    LFPG
Sbjct: 195 GCIFAEMVTRRA-LFPG 210

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 86/197 (43%), Positives = 119/197 (60%), Gaps = 8/197 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KAR+  T  +VA+KKI+L T  +   G+  TA+REI LL+EL+H N++ L DV
Sbjct: 15  GTYGVVYKARNKLTGEVVALKKIRLDTETE---GVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTP-SNIKAYAIMTLRGLEYLHDHWILHRDLK 184
               + + LVFEF+  DL+  +    +   P   IK+Y    L+GL + H H +LHRDLK
Sbjct: 72  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 131
Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-- 242
           P NLLIN +G +K+ DFGLA+ FG P R Y H+VVT WYR  + LL C  ++     W  
Sbjct: 132 PENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 191
Query: 243 -CCFAKDPSSHGNLFPG 258
            C FA+  +    LFPG
Sbjct: 192 GCIFAEMVTRRA-LFPG 207

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 86/197 (43%), Positives = 119/197 (60%), Gaps = 8/197 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KAR+  T  +VA+KKI+L T  +   G+  TA+REI LL+EL+H N++ L DV
Sbjct: 17  GTYGVVYKARNKLTGEVVALKKIRLDTETE---GVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTP-SNIKAYAIMTLRGLEYLHDHWILHRDLK 184
               + + LVFEF+  DL+  +    +   P   IK+Y    L+GL + H H +LHRDLK
Sbjct: 74  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 133
Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-- 242
           P NLLIN +G +K+ DFGLA+ FG P R Y H+VVT WYR  + LL C  ++     W  
Sbjct: 134 PQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 193
Query: 243 -CCFAKDPSSHGNLFPG 258
            C FA+  +    LFPG
Sbjct: 194 GCIFAEMVTRRA-LFPG 209

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  155 bits (391), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 86/197 (43%), Positives = 119/197 (60%), Gaps = 8/197 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KAR+  T  +VA+KKI+L T  +   G+  TA+REI LL+EL+H N++ L DV
Sbjct: 15  GTYGVVYKARNKLTGEVVALKKIRLDTETE---GVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTP-SNIKAYAIMTLRGLEYLHDHWILHRDLK 184
               + + LVFEF+  DL+  +    +   P   IK+Y    L+GL + H H +LHRDLK
Sbjct: 72  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 131
Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-- 242
           P NLLIN +G +K+ DFGLA+ FG P R Y H+VVT WYR  + LL C  ++     W  
Sbjct: 132 PQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 191
Query: 243 -CCFAKDPSSHGNLFPG 258
            C FA+  +    LFPG
Sbjct: 192 GCIFAEMVTRRA-LFPG 207

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  155 bits (391), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 86/197 (43%), Positives = 119/197 (60%), Gaps = 8/197 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KAR+  T  +VA+KKI+L T  +   G+  TA+REI LL+EL+H N++ L DV
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKIRLDTETE---GVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTP-SNIKAYAIMTLRGLEYLHDHWILHRDLK 184
               + + LVFEF+  DL+  +    +   P   IK+Y    L+GL + H H +LHRDLK
Sbjct: 71  IHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 130
Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-- 242
           P NLLIN +G +K+ DFGLA+ FG P R Y H+VVT WYR  + LL C  ++     W  
Sbjct: 131 PENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 190
Query: 243 -CCFAKDPSSHGNLFPG 258
            C FA+  +    LFPG
Sbjct: 191 GCIFAEMVTRRA-LFPG 206

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  153 bits (387), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 96/245 (39%), Positives = 135/245 (55%), Gaps = 15/245 (6%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y +   +  G + TVFKA++ ET  IVA+K+++L    D  +G+  +ALREI LL+EL H
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLD---DDDEGVPSSALREICLLKELKH 60
Query: 117 ENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH 176
           +N++ L DV      ++LVFEF D DL+           P  +K++    L+GL + H  
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFN 236
            +LHRDLKP NLLIN+ G LK+ DFGLA+ FG P R Y+ +VVT WYR    L     ++
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 237 VKNVQW---CCFAKDPSSHGNLFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTAT 293
                W   C FA+  ++   LFPG   N++     DD L  I  LL   PT+    + T
Sbjct: 181 TSIDMWSAGCIFAELANAARPLFPG---NDV-----DDQLKRIFRLLG-TPTEEQWPSMT 231
Query: 294 LKMDY 298
              DY
Sbjct: 232 KLPDY 236

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 86/197 (43%), Positives = 119/197 (60%), Gaps = 8/197 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KAR+  T  +VA+KKI+L T  +   G+  TA+REI LL+EL+H N++ L DV
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKIRLDTETE---GVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTP-SNIKAYAIMTLRGLEYLHDHWILHRDLK 184
               + + LVFEF+  DL+  +    +   P   IK+Y    L+GL + H H +LHRDLK
Sbjct: 71  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 130
Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-- 242
           P NLLIN +G +K+ DFGLA+ FG P R YTH+VVT WYR  + LL    ++     W  
Sbjct: 131 PQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSL 190
Query: 243 -CCFAKDPSSHGNLFPG 258
            C FA+  +    LFPG
Sbjct: 191 GCIFAEMVTRRA-LFPG 206

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 86/197 (43%), Positives = 119/197 (60%), Gaps = 8/197 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KAR+  T  +VA+KKI+L T  +   G+  TA+REI LL+EL+H N++ L DV
Sbjct: 21  GTYGVVYKARNKLTGEVVALKKIRLDTETE---GVPSTAIREISLLKELNHPNIVKLLDV 77
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTP-SNIKAYAIMTLRGLEYLHDHWILHRDLK 184
               + + LVFEF+  DL+  +    +   P   IK+Y    L+GL + H H +LHRDLK
Sbjct: 78  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 137
Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-- 242
           P NLLIN +G +K+ DFGLA+ FG P R YTH+VVT WYR  + LL    ++     W  
Sbjct: 138 PQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSL 197
Query: 243 -CCFAKDPSSHGNLFPG 258
            C FA+  +    LFPG
Sbjct: 198 GCIFAEMVTRRA-LFPG 213

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  151 bits (382), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 95/245 (38%), Positives = 135/245 (55%), Gaps = 15/245 (6%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y +   +  G + TVFKA++ ET  IVA+K+++L    D  +G+  +ALREI LL+EL H
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLD---DDDEGVPSSALREICLLKELKH 60
Query: 117 ENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH 176
           +N++ L DV      ++LVFEF D DL+           P  +K++    L+GL + H  
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFN 236
            +LHRDLKP NLLIN+ G LK+ +FGLA+ FG P R Y+ +VVT WYR    L     ++
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 237 VKNVQW---CCFAKDPSSHGNLFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTAT 293
                W   C FA+  ++   LFPG   N++     DD L  I  LL   PT+    + T
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPG---NDV-----DDQLKRIFRLLG-TPTEEQWPSMT 231
Query: 294 LKMDY 298
              DY
Sbjct: 232 KLPDY 236

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  149 bits (375), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 93/262 (35%), Positives = 139/262 (53%), Gaps = 18/262 (6%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           + Q   +  G +ATV+K  +  T + VA+K++KL    D+++G   TA+REI L++EL H
Sbjct: 7   FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKL----DSEEGTPSTAIREISLMKELKH 62
Query: 117 ENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSN-----IKAYAIMTLRGLE 171
           EN++ L DV    + ++LVFEF+D DL+  +   T+  TP       +K +    L+GL 
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122
Query: 172 YLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLY 231
           + H++ ILHRDLKP NLLINK+G LK+GDFGLA+ FG P   ++ +VVT WYR    L+ 
Sbjct: 123 FCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMG 182
Query: 232 CVQFNVKNVQWC--CFAKDPSSHGNLFPGIPLNE-------IFTAAGDDLLAVISSLLCL 282
              ++     W   C   +  +   LFPG    E       I     + L   ++ L   
Sbjct: 183 SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKY 242
Query: 283 NPTKRADCTATLKMDYFSLTKE 304
           NP  +      L+      TKE
Sbjct: 243 NPNIQQRPPRDLRQVLQPHTKE 264

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  144 bits (363), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 79/210 (37%), Positives = 123/210 (58%), Gaps = 6/210 (2%)
Query: 56  VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH 115
            Y +   +  G +ATV+K +   TD +VA+K+I+L    + ++G   TA+RE+ LL++L 
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRL----EHEEGAPCTAIREVSLLKDLK 58
Query: 116 HENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
           H N++ L D+     +++LVFE++D DL+  + D   +    N+K +    LRGL Y H 
Sbjct: 59  HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR 118
Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQF 235
             +LHRDLKP NLLIN++G LK+ DFGLA+    PT+ Y ++VVT WYR    LL    +
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDY 178
Query: 236 NVKNVQW--CCFAKDPSSHGNLFPGIPLNE 263
           + +   W   C   + ++   LFPG  + E
Sbjct: 179 STQIDMWGVGCIFYEMATGRPLFPGSTVEE 208

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 89/255 (34%), Positives = 133/255 (52%), Gaps = 16/255 (6%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y+    +  G +  V+KA++   +   A+KKI+L       +GI  T +REI +L+EL H
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETF-ALKKIRL---EKEDEGIPSTTIREISILKELKH 59
Query: 117 ENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH 176
            N++ L DV      + LVFE +D DL+ ++            K++ +  L G+ Y HD 
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFN 236
            +LHRDLKP NLLIN++G LKI DFGLA+ FG P R YTH+VVT WYR    L+   +++
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYS 179
Query: 237 VKNVQW---CCFAKDPSSHGNLFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTAT 293
                W   C FA +  +   LFPG+       +  D L+ +   L   N     + T  
Sbjct: 180 TTIDIWSVGCIFA-EMVNGAPLFPGV-------SEADQLMRIFRILGTPNSKNWPNVTEL 231
Query: 294 LKMD-YFSLTKEMYW 307
            K D  F++ + + W
Sbjct: 232 PKYDPNFTVYEPLPW 246

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 89/255 (34%), Positives = 133/255 (52%), Gaps = 16/255 (6%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y+    +  G +  V+KA++   +   A+KKI+L       +GI  T +REI +L+EL H
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETF-ALKKIRL---EKEDEGIPSTTIREISILKELKH 59
Query: 117 ENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH 176
            N++ L DV      + LVFE +D DL+ ++            K++ +  L G+ Y HD 
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFN 236
            +LHRDLKP NLLIN++G LKI DFGLA+ FG P R YTH+VVT WYR    L+   +++
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYS 179
Query: 237 VKNVQW---CCFAKDPSSHGNLFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTAT 293
                W   C FA +  +   LFPG+       +  D L+ +   L   N     + T  
Sbjct: 180 TTIDIWSVGCIFA-EMVNGTPLFPGV-------SEADQLMRIFRILGTPNSKNWPNVTEL 231
Query: 294 LKMD-YFSLTKEMYW 307
            K D  F++ + + W
Sbjct: 232 PKYDPNFTVYEPLPW 246

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 88/255 (34%), Positives = 133/255 (52%), Gaps = 16/255 (6%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y+    +  G +  V+KA++   +   A+KKI+L       +GI  T +REI +L+EL H
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETF-ALKKIRL---EKEDEGIPSTTIREISILKELKH 59
Query: 117 ENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH 176
            N++ L DV      + LVFE +D DL+ ++            K++ +  L G+ Y HD 
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFN 236
            +LHRDLKP NLLIN++G LKI DFGLA+ FG P R YTH++VT WYR    L+   +++
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179
Query: 237 VKNVQW---CCFAKDPSSHGNLFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTAT 293
                W   C FA +  +   LFPG+       +  D L+ +   L   N     + T  
Sbjct: 180 TTIDIWSVGCIFA-EMVNGTPLFPGV-------SEADQLMRIFRILGTPNSKNWPNVTEL 231
Query: 294 LKMD-YFSLTKEMYW 307
            K D  F++ + + W
Sbjct: 232 PKYDPNFTVYEPLPW 246

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 81/205 (39%), Positives = 117/205 (57%), Gaps = 17/205 (8%)
Query: 39  LKKQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKD 98
           + KQY   +C   +++  Y +   +  G F  VFKAR  +T   VA+KK+ +    + K+
Sbjct: 1   MAKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM---ENEKE 57
Query: 99  GINRTALREIKLLQELHHENVLGLTDVFGYMSN--------VSLVFEFVDTDLEVIIKDP 150
           G   TALREIK+LQ L HENV+ L ++    ++        + LVF+F + DL  ++ + 
Sbjct: 58  GFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV 117
Query: 151 TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF--- 207
            + FT S IK    M L GL Y+H + ILHRD+K  N+LI + GVLK+ DFGLA+ F   
Sbjct: 118 LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLA 177
Query: 208 --GSPTRLYTHQVVTRWYRLIKCLL 230
               P R Y ++VVT WYR  + LL
Sbjct: 178 KNSQPNR-YXNRVVTLWYRPPELLL 201

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 81/203 (39%), Positives = 116/203 (57%), Gaps = 17/203 (8%)
Query: 41  KQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGI 100
           KQY   +C   +++  Y +   +  G F  VFKAR  +T   VA+KK+ +    + K+G 
Sbjct: 4   KQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM---ENEKEGF 60
Query: 101 NRTALREIKLLQELHHENVLGLTDVFGYMSN--------VSLVFEFVDTDLEVIIKDPTI 152
             TALREIK+LQ L HENV+ L ++    ++        + LVF+F + DL  ++ +  +
Sbjct: 61  PITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV 120
Query: 153 VFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF----- 207
            FT S IK    M L GL Y+H + ILHRD+K  N+LI + GVLK+ DFGLA+ F     
Sbjct: 121 KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 180
Query: 208 GSPTRLYTHQVVTRWYRLIKCLL 230
             P R Y ++VVT WYR  + LL
Sbjct: 181 SQPNR-YXNRVVTLWYRPPELLL 202

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 73/201 (36%), Positives = 113/201 (56%), Gaps = 13/201 (6%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KA D  T+  VA+K+I+L      ++G+  TA+RE+ LL+EL H N++ L  V
Sbjct: 45  GTYGEVYKAIDTVTNETVAIKRIRL---EHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 126 FGYMSNVSLVFEFVDTDLEVII-KDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
             +   + L+FE+ + DL+  + K+P +      IK++    + G+ + H    LHRDLK
Sbjct: 102 IHHNHRLHLIFEYAENDLKKYMDKNPDVSM--RVIKSFLYQLINGVNFCHSRRCLHRDLK 159
Query: 185 PNNLLIN-----KQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKN 239
           P NLL++     +  VLKIGDFGLA+ FG P R +TH+++T WYR  + LL    ++   
Sbjct: 160 PQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSV 219
Query: 240 VQW--CCFAKDPSSHGNLFPG 258
             W   C   +      LFPG
Sbjct: 220 DIWSIACIWAEMLMKTPLFPG 240

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 81/203 (39%), Positives = 116/203 (57%), Gaps = 17/203 (8%)
Query: 41  KQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGI 100
           KQY   +C   +++  Y +   +  G F  VFKAR  +T   VA+KK+ +    + K+G 
Sbjct: 4   KQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM---ENEKEGF 60
Query: 101 NRTALREIKLLQELHHENVLGLTDVFGYMSN--------VSLVFEFVDTDLEVIIKDPTI 152
             TALREIK+LQ L HENV+ L ++    ++        + LVF+F + DL  ++ +  +
Sbjct: 61  PITALREIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLV 120
Query: 153 VFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF----- 207
            FT S IK    M L GL Y+H + ILHRD+K  N+LI + GVLK+ DFGLA+ F     
Sbjct: 121 KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 180
Query: 208 GSPTRLYTHQVVTRWYRLIKCLL 230
             P R Y ++VVT WYR  + LL
Sbjct: 181 SQPNR-YXNRVVTLWYRPPELLL 202

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  125 bits (315), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 81/203 (39%), Positives = 116/203 (57%), Gaps = 17/203 (8%)
Query: 41  KQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGI 100
           KQY   +C   +++  Y +   +  G F  VFKAR  +T   VA+KK+ +    + K+G 
Sbjct: 4   KQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM---ENEKEGF 60
Query: 101 NRTALREIKLLQELHHENVLGLTDVFGYMSN--------VSLVFEFVDTDLEVIIKDPTI 152
             TALREIK+LQ L HENV+ L ++    ++        + LVF+F + DL  ++ +  +
Sbjct: 61  PITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV 120
Query: 153 VFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF----- 207
            FT S IK    M L GL Y+H + ILHRD+K  N+LI + GVLK+ DFGLA+ F     
Sbjct: 121 KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 180
Query: 208 GSPTRLYTHQVVTRWYRLIKCLL 230
             P R Y ++VVT WYR  + LL
Sbjct: 181 SQPNR-YXNRVVTLWYRPPELLL 202

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  116 bits (291), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 70/202 (34%), Positives = 106/202 (52%), Gaps = 13/202 (6%)
Query: 63  VHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL 122
           V  G +  V K R+ +T  IVA+KK      +D    + + A+REIKLL++L HEN++ L
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKF---LESDDDKMVKKIAMREIKLLKQLRHENLVNL 89
Query: 123 TDVFGYMSNVSLVFEFVD----TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
            +V        LVFEFVD     DLE+             ++ Y    + G+ + H H I
Sbjct: 90  LEVCKKKKRWYLVFEFVDHTILDDLELFPNG----LDYQVVQKYLFQIINGIGFCHSHNI 145
Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVK 238
           +HRD+KP N+L+++ GV+K+ DFG A+   +P  +Y  +V TRWYR  + L+  V++   
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKA 205
Query: 239 NVQWC--CFAKDPSSHGNLFPG 258
              W   C   +      LFPG
Sbjct: 206 VDVWAIGCLVTEMFMGEPLFPG 227

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  VFK R+ +T  IVA+KK      ++    I + ALREI++L++L H N++ L +V
Sbjct: 14  GSYGVVFKCRNRDTGQIVAIKKF---LESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
           F     + LVFE+ D  +   +           +K+    TL+ + + H H  +HRD+KP
Sbjct: 71  FRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKP 130
Query: 186 NNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW--- 242
            N+LI K  V+K+ DFG A+    P+  Y  +V TRWYR  + L+   Q+      W   
Sbjct: 131 ENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIG 190
Query: 243 CCFAKDPSSHGNLFPGIPL 261
           C FA+       L  G+PL
Sbjct: 191 CVFAE-------LLSGVPL 202

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 73/203 (35%), Positives = 108/203 (53%), Gaps = 17/203 (8%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH- 115
           Y     + VG + TV+KARD  +   VA+K +++    + ++G+  + +RE+ LL+ L  
Sbjct: 6   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV---PNGEEGLPISTVREVALLRRLEA 62
Query: 116 --HENVLGLTDVFGYMSN-----VSLVFEFVDTDLEVII-KDPTIVFTPSNIKAYAIMTL 167
             H NV+ L DV           V+LVFE VD DL   + K P        IK      L
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL 122
Query: 168 RGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIK 227
           RGL++LH + I+HRDLKP N+L+   G +K+ DFGLA+ +     L+   VVT WYR  +
Sbjct: 123 RGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFP-VVVTLWYRAPE 181
Query: 228 CLL---YCVQFNVKNVQWCCFAK 247
            LL   Y    ++ +V  C FA+
Sbjct: 182 VLLQSTYATPVDMWSV-GCIFAE 203

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  108 bits (271), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 75/209 (35%), Positives = 110/209 (52%), Gaps = 29/209 (13%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH- 115
           Y     + VG + TV+KARD  +   VA+K +++    + ++G+  + +RE+ LL+ L  
Sbjct: 6   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV---PNGEEGLPISTVREVALLRRLEA 62
Query: 116 --HENVLGLTDVFGYMSN-----VSLVFEFVDTDLEVII-KDPTIVFTPSNIKAYAIMTL 167
             H NV+ L DV           V+LVFE VD DL   + K P        IK      L
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL 122
Query: 168 RGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQ------VVTR 221
           RGL++LH + I+HRDLKP N+L+   G +K+ DFGLA       R+Y++Q      VVT 
Sbjct: 123 RGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA-------RIYSYQMALAPVVVTL 175
Query: 222 WYRLIKCLL---YCVQFNVKNVQWCCFAK 247
           WYR  + LL   Y    ++ +V  C FA+
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSV-GCIFAE 203

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 75/209 (35%), Positives = 110/209 (52%), Gaps = 29/209 (13%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH- 115
           Y     + VG + TV+KARD  +   VA+K +++    + ++G+  + +RE+ LL+ L  
Sbjct: 6   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV---PNGEEGLPISTVREVALLRRLEA 62
Query: 116 --HENVLGLTDVFGYMSN-----VSLVFEFVDTDLEVII-KDPTIVFTPSNIKAYAIMTL 167
             H NV+ L DV           V+LVFE VD DL   + K P        IK      L
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL 122
Query: 168 RGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQ------VVTR 221
           RGL++LH + I+HRDLKP N+L+   G +K+ DFGLA       R+Y++Q      VVT 
Sbjct: 123 RGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA-------RIYSYQMALDPVVVTL 175
Query: 222 WYRLIKCLL---YCVQFNVKNVQWCCFAK 247
           WYR  + LL   Y    ++ +V  C FA+
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSV-GCIFAE 203

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  107 bits (267), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 74/203 (36%), Positives = 105/203 (51%), Gaps = 14/203 (6%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH- 115
           Y     + VG + TV+KARD  +   VA+K +++        G+  + +RE+ LL+ L  
Sbjct: 11  YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA 70
Query: 116 --HENVLGLTDVFGYMSN-----VSLVFEFVDTDLEVII-KDPTIVFTPSNIKAYAIMTL 167
             H NV+ L DV           V+LVFE VD DL   + K P        IK      L
Sbjct: 71  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL 130
Query: 168 RGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIK 227
           RGL++LH + I+HRDLKP N+L+   G +K+ DFGLA+ +     L T  VVT WYR  +
Sbjct: 131 RGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL-TPVVVTLWYRAPE 189
Query: 228 CLL---YCVQFNVKNVQWCCFAK 247
            LL   Y    ++ +V  C FA+
Sbjct: 190 VLLQSTYATPVDMWSV-GCIFAE 211

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  105 bits (261), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 106/205 (51%), Gaps = 16/205 (7%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  AR   T   VA+KKI      D      RT LRE+K+L+   H+N++ + D+
Sbjct: 65  GAYGVVSSARRRLTGQQVAIKKIP--NAFDVVTNAKRT-LRELKILKHFKHDNIIAIKDI 121
Query: 126 ------FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWIL 179
                 +G   +V +V + +++DL  II   +   T  +++ +    LRGL+Y+H   ++
Sbjct: 122 LRPTVPYGEFKSVYVVLDLMESDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVI 180
Query: 180 HRDLKPNNLLINKQGVLKIGDFGLAKFF-GSPTR---LYTHQVVTRWYRLIKCLLYCVQF 235
           HRDLKP+NLL+N+   LKIGDFG+A+    SP       T  V TRWYR  + +L   ++
Sbjct: 181 HRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEY 240
Query: 236 NVKNVQWC--CFAKDPSSHGNLFPG 258
                 W   C   +  +   LFPG
Sbjct: 241 TQAIDLWSVGCIFGEMLARRQLFPG 265

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 106/205 (51%), Gaps = 16/205 (7%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  AR   T   VA+KKI      D      RT LRE+K+L+   H+N++ + D+
Sbjct: 66  GAYGVVSSARRRLTGQQVAIKKIP--NAFDVVTNAKRT-LRELKILKHFKHDNIIAIKDI 122
Query: 126 ------FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWIL 179
                 +G   +V +V + +++DL  II   +   T  +++ +    LRGL+Y+H   ++
Sbjct: 123 LRPTVPYGEFKSVYVVLDLMESDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVI 181
Query: 180 HRDLKPNNLLINKQGVLKIGDFGLAKFF-GSPTR---LYTHQVVTRWYRLIKCLLYCVQF 235
           HRDLKP+NLL+N+   LKIGDFG+A+    SP       T  V TRWYR  + +L   ++
Sbjct: 182 HRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEY 241
Query: 236 NVKNVQWC--CFAKDPSSHGNLFPG 258
                 W   C   +  +   LFPG
Sbjct: 242 TQAIDLWSVGCIFGEMLARRQLFPG 266

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 71/195 (36%), Positives = 107/195 (54%), Gaps = 18/195 (9%)
Query: 66  GRFATVFKARDIETD-MIVAVKKIKLGTHADAKDGINRTALREIKLLQELH---HENVLG 121
           G +  VFKARD++     VA+K++++ T    ++G+  + +RE+ +L+ L    H NV+ 
Sbjct: 22  GAYGKVFKARDLKNGGRFVALKRVRVQT---GEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 122 LTDV-----FGYMSNVSLVFEFVDTDLEVII-KDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
           L DV         + ++LVFE VD DL   + K P        IK      LRGL++LH 
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 138
Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLL---YC 232
           H ++HRDLKP N+L+   G +K+ DFGLA+ +     L T  VVT WYR  + LL   Y 
Sbjct: 139 HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-TSVVVTLWYRAPEVLLQSSYA 197
Query: 233 VQFNVKNVQWCCFAK 247
              ++ +V  C FA+
Sbjct: 198 TPVDLWSV-GCIFAE 211

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  103 bits (258), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 71/195 (36%), Positives = 107/195 (54%), Gaps = 18/195 (9%)
Query: 66  GRFATVFKARDIETD-MIVAVKKIKLGTHADAKDGINRTALREIKLLQELH---HENVLG 121
           G +  VFKARD++     VA+K++++ T    ++G+  + +RE+ +L+ L    H NV+ 
Sbjct: 22  GAYGKVFKARDLKNGGRFVALKRVRVQT---GEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 122 LTDV-----FGYMSNVSLVFEFVDTDLEVII-KDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
           L DV         + ++LVFE VD DL   + K P        IK      LRGL++LH 
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 138
Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLL---YC 232
           H ++HRDLKP N+L+   G +K+ DFGLA+ +     L T  VVT WYR  + LL   Y 
Sbjct: 139 HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-TSVVVTLWYRAPEVLLQSSYA 197
Query: 233 VQFNVKNVQWCCFAK 247
              ++ +V  C FA+
Sbjct: 198 TPVDLWSV-GCIFAE 211

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 71/195 (36%), Positives = 107/195 (54%), Gaps = 18/195 (9%)
Query: 66  GRFATVFKARDIETD-MIVAVKKIKLGTHADAKDGINRTALREIKLLQELH---HENVLG 121
           G +  VFKARD++     VA+K++++ T    ++G+  + +RE+ +L+ L    H NV+ 
Sbjct: 22  GAYGKVFKARDLKNGGRFVALKRVRVQT---GEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 122 LTDV-----FGYMSNVSLVFEFVDTDLEVII-KDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
           L DV         + ++LVFE VD DL   + K P        IK      LRGL++LH 
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 138
Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLL---YC 232
           H ++HRDLKP N+L+   G +K+ DFGLA+ +     L T  VVT WYR  + LL   Y 
Sbjct: 139 HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-TSVVVTLWYRAPEVLLQSSYA 197
Query: 233 VQFNVKNVQWCCFAK 247
              ++ +V  C FA+
Sbjct: 198 TPVDLWSV-GCIFAE 211

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 70/204 (34%), Positives = 105/204 (51%), Gaps = 17/204 (8%)
Query: 63  VHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL 122
           V  G + +V  A D  +   VA+KK+     ++      + A RE+ LL+ + HENV+GL
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI---FAKRAYRELLLLKHMQHENVIGL 88
Query: 123 TDVFGYMSNVS------LVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH 176
            DVF   S++       LV  F+ TDL+ I+    + F+   I+      L+GL+Y+H  
Sbjct: 89  LDVFTPASSLRNFYDFYLVMPFMQTDLQKIM---GLKFSEEKIQYLVYQMLKGLKYIHSA 145
Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFN 236
            ++HRDLKP NL +N+   LKI DFGLA+   +    Y   VVTRWYR  + +L  + +N
Sbjct: 146 GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY---VVTRWYRAPEVILSWMHYN 202
Query: 237 VKNVQWC--CFAKDPSSHGNLFPG 258
                W   C   +  +   LF G
Sbjct: 203 QTVDIWSVGCIMAEMLTGKTLFKG 226

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 70/204 (34%), Positives = 105/204 (51%), Gaps = 17/204 (8%)
Query: 63  VHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL 122
           V  G + +V  A D  +   VA+KK+     ++      + A RE+ LL+ + HENV+GL
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI---FAKRAYRELLLLKHMQHENVIGL 106
Query: 123 TDVFGYMSNVS------LVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH 176
            DVF   S++       LV  F+ TDL+ I+    + F+   I+      L+GL+Y+H  
Sbjct: 107 LDVFTPASSLRNFYDFYLVMPFMQTDLQKIM---GMEFSEEKIQYLVYQMLKGLKYIHSA 163
Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFN 236
            ++HRDLKP NL +N+   LKI DFGLA+   +    Y   VVTRWYR  + +L  + +N
Sbjct: 164 GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY---VVTRWYRAPEVILSWMHYN 220
Query: 237 VKNVQWC--CFAKDPSSHGNLFPG 258
                W   C   +  +   LF G
Sbjct: 221 QTVDIWSVGCIMAEMLTGKTLFKG 244

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 77/239 (32%), Positives = 116/239 (48%), Gaps = 28/239 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  + D+++ + +AVKK+        HA       +   RE++LL+
Sbjct: 53  YQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHA-------KRTYRELRLLK 105
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K      T  +++      
Sbjct: 106 HMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQI 163
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 164 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAP 220
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPGI----PLNEIFTAAGDDLLAVISSL 279
           + +L  + +N+    W   C   +  +   LFPG      L +I    G    +VIS +
Sbjct: 221 EIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRM 279

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 82/260 (31%), Positives = 119/260 (45%), Gaps = 37/260 (14%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQELHH 116
           R V  G + +V  A D      VAVKK+        HA       R   RE++LL+ L H
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHA-------RRTYRELRLLKHLKH 86
Query: 117 ENVLGLTDVFGY------MSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGL 170
           ENV+GL DVF         S V LV   +  DL  I+K  +   +  +++      LRGL
Sbjct: 87  ENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVK--SQALSDEHVQFLVYQLLRGL 144
Query: 171 EYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLL 230
           +Y+H   I+HRDLKP+N+ +N+   L+I DFGLA+         T  V TRWYR  + +L
Sbjct: 145 KYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLAR---QADEEMTGYVATRWYRAPEIML 201
Query: 231 YCVQFNVKNVQWC--CFAKDPSSHGNLFPGIP-------LNEIFTAAGDDLLAVISS--- 278
             + +N     W   C   +      LFPG         + E+      ++LA ISS   
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHA 261
Query: 279 ---LLCLNPTKRADCTATLK 295
              +  L P  + D ++  +
Sbjct: 262 RTYIQSLPPMPQKDLSSIFR 281

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 76
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKL--TDDHVQFLIYQI 134
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY---VATRWYRAP 191
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  101 bits (252), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 78
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 79  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 136
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 137 LRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGY---VATRWYRAP 193
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 227

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 76
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 134
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAP 191
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 192 EIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 82
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 83  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 140
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 141 LRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGY---VATRWYRAP 197
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 231

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  101 bits (251), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 82/260 (31%), Positives = 118/260 (45%), Gaps = 37/260 (14%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQELHH 116
           R V  G + +V  A D      VAVKK+        HA       R   RE++LL+ L H
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHA-------RRTYRELRLLKHLKH 86
Query: 117 ENVLGLTDVFGY------MSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGL 170
           ENV+GL DVF         S V LV   +  DL  I+K      +  +++      LRGL
Sbjct: 87  ENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVK--CQALSDEHVQFLVYQLLRGL 144
Query: 171 EYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLL 230
           +Y+H   I+HRDLKP+N+ +N+   L+I DFGLA+         T  V TRWYR  + +L
Sbjct: 145 KYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLAR---QADEEMTGYVATRWYRAPEIML 201
Query: 231 YCVQFNVKNVQWC--CFAKDPSSHGNLFPGIP-------LNEIFTAAGDDLLAVISS--- 278
             + +N     W   C   +      LFPG         + E+      ++LA ISS   
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHA 261
Query: 279 ---LLCLNPTKRADCTATLK 295
              +  L P  + D ++  +
Sbjct: 262 RTYIQSLPPMPQKDLSSIFR 281

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  101 bits (251), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 76
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKL--TDDHVQFLIYQI 134
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAP 191
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  100 bits (250), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 83
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 141
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY---VATRWYRAP 198
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  100 bits (250), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 83
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 141
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY---VATRWYRAP 198
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  100 bits (250), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 83
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 141
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY---VATRWYRAP 198
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  100 bits (250), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 73/214 (34%), Positives = 105/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 76
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKL--TDDHVQFLIYQI 134
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGL +        Y   V TRWYR  
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGY---VATRWYRAP 191
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  100 bits (250), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 35  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 87
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 88  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 145
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 146 LRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY---VATRWYRAP 202
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 236

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  100 bits (250), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 29  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 81
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 82  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 139
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 140 LRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY---VATRWYRAP 196
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 230

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  100 bits (249), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 47  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 99
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 100 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 157
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 158 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGY---VATRWYRAP 214
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 215 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 248

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 76
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 134
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAP 191
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 83
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 141
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAP 198
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 76
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 134
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAP 191
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 76
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 134
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAP 191
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 76
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 134
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAP 191
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 78
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 79  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 136
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 137 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAP 193
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 227

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 36  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 88
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 89  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 146
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 147 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAP 203
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 237

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 78
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 79  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 136
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 137 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAP 193
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 227

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 36  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 88
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 89  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 146
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 147 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAP 203
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 237

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 76
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 134
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAP 191
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 82
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 83  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 140
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 141 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAP 197
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 231

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 78
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 79  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 136
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 137 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAP 193
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 227

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 29  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 81
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 82  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 139
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 140 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAP 196
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 230

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 29  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 81
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 82  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 139
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 140 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAP 196
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 230

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 23  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 75
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 76  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 133
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 134 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAP 190
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 191 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 224

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 76
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 134
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAP 191
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/214 (34%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     +  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 29  YQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 81
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 82  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 139
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 140 LRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY---VATRWYRAP 196
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 230

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 44  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 96
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 97  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 154
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 155 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAP 211
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 245

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 47  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 99
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 100 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 157
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 158 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAP 214
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 215 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 248

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 21  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 73
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 74  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 131
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 132 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAP 188
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 189 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 222

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 82/260 (31%), Positives = 118/260 (45%), Gaps = 37/260 (14%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQELHH 116
           R V  G + +V  A D      VAVKK+        HA       R   RE++LL+ L H
Sbjct: 26  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHA-------RRTYRELRLLKHLKH 78
Query: 117 ENVLGLTDVFGY------MSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGL 170
           ENV+GL DVF         S V LV   +  DL  I+K      +  +++      LRGL
Sbjct: 79  ENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVK--CQALSDEHVQFLVYQLLRGL 136
Query: 171 EYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLL 230
           +Y+H   I+HRDLKP+N+ +N+   L+I DFGLA+         T  V TRWYR  + +L
Sbjct: 137 KYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADEEMTGYVATRWYRAPEIML 193
Query: 231 YCVQFNVKNVQWC--CFAKDPSSHGNLFPGIP-------LNEIFTAAGDDLLAVISS--- 278
             + +N     W   C   +      LFPG         + E+      ++LA ISS   
Sbjct: 194 NWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHA 253
Query: 279 ---LLCLNPTKRADCTATLK 295
              +  L P  + D ++  +
Sbjct: 254 RTYIQSLPPMPQKDLSSIFR 273

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 76
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 134
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAP 191
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 72
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 130
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAP 187
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 35  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 87
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 88  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 145
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 146 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAP 202
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 236

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 82
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 83  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 140
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 141 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAP 197
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 231

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 36  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHA-------KRTYRELRLLK 88
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 89  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 146
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 147 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAP 203
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 237

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 43  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 95
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 96  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 153
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 154 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAP 210
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 211 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 244

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 76
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 134
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+         T  V TRWYR  
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGXVATRWYRAP 191
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 122/288 (42%), Gaps = 60/288 (20%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A D    + VA+KKI    H   +    RT LREIK+L    HEN++G+ D+
Sbjct: 34  GAYGMVCSAYDNVNKVRVAIKKISPFEH---QTYCQRT-LREIKILLRFRHENIIGINDI 89
Query: 126 F-----GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
                   M +V +V + ++TDL  ++K  T   +  +I  +    LRGL+Y+H   +LH
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLKYIHSANVLH 147
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSP----TRLYTHQVVTRWYRLIKCLLYCVQFN 236
           RDLKP+NLL+N    LKI DFGLA+    P    T   T  V TRWYR  + +L    + 
Sbjct: 148 RDLKPSNLLLNTTXDLKIXDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 206
Query: 237 VKNVQWC--CFAKDPSSHGNLFPG------------------------------------ 258
                W   C   +  S+  +FPG                                    
Sbjct: 207 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARNYLLS 266
Query: 259 ------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                 +P N +F  A    L ++  +L  NP KR +    L   Y  
Sbjct: 267 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 314

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 123/288 (42%), Gaps = 60/288 (20%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A D    + VA+KKI    H   +    RT LREIK+L    HEN++G+ D+
Sbjct: 36  GAYGMVCSAYDNVNKVRVAIKKISPFEH---QTYCQRT-LREIKILLAFRHENIIGINDI 91
Query: 126 F-----GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
                   M +V +V + ++TDL  ++K  T   +  +I  +    LRGL+Y+H   +LH
Sbjct: 92  IRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLKYIHSANVLH 149
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSP----TRLYTHQVVTRWYRLIKCLLYCVQFN 236
           RDLKP+NLL+N    LKI DFGLA+    P    T   T  V TRWYR  + +L    + 
Sbjct: 150 RDLKPSNLLLNTTSDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 208
Query: 237 VKNVQWC--CFAKDPSSHGNLFPG------------------------------------ 258
                W   C   +  S+  +FPG                                    
Sbjct: 209 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINLKARNYLLS 268
Query: 259 ------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                 +P N +F  A    L ++  +L  NP KR +    L   Y +
Sbjct: 269 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLA 316

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 21  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 73
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 74  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 131
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 132 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAP 188
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 189 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 222

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 22  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 74
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 75  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 132
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 133 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAP 189
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 190 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 223

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 120/288 (41%), Gaps = 60/288 (20%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A D    + VA+KKI    H        +  LREIK+L    HEN++G+ D+
Sbjct: 38  GAYGMVCSAYDNLNKVRVAIKKISPFEHQ----TYXQRTLREIKILLRFRHENIIGINDI 93
Query: 126 F-----GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
                   M +V +V + ++TDL  ++K  T   +  +I  +    LRGL+Y+H   +LH
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLKYIHSANVLH 151
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSP----TRLYTHQVVTRWYRLIKCLLYCVQFN 236
           RDLKP+NLL+N    LKI DFGLA+    P    T   T  V TRWYR  + +L    + 
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 210
Query: 237 VKNVQWC--CFAKDPSSHGNLFPG------------------------------------ 258
                W   C   +  S+  +FPG                                    
Sbjct: 211 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 270
Query: 259 ------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                 +P N +F  A    L ++  +L  NP KR +    L   Y  
Sbjct: 271 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 122/288 (42%), Gaps = 60/288 (20%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A D    + VA+KKI    H   +    RT LREIK+L    HEN++G+ D+
Sbjct: 34  GAYGMVCSAYDNVNKVRVAIKKISPFEH---QTYCQRT-LREIKILLRFRHENIIGINDI 89
Query: 126 F-----GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
                   M +V +V + ++TDL  ++K  T   +  +I  +    LRGL+Y+H   +LH
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLKYIHSANVLH 147
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSP----TRLYTHQVVTRWYRLIKCLLYCVQFN 236
           RDLKP+NLL+N    LKI DFGLA+    P    T   T  V TRWYR  + +L    + 
Sbjct: 148 RDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 206
Query: 237 VKNVQWC--CFAKDPSSHGNLFPG------------------------------------ 258
                W   C   +  S+  +FPG                                    
Sbjct: 207 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARNYLLS 266
Query: 259 ------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                 +P N +F  A    L ++  +L  NP KR +    L   Y  
Sbjct: 267 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 314

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 122/288 (42%), Gaps = 60/288 (20%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A D    + VA+KKI    H   +    RT LREIK+L    HEN++G+ D+
Sbjct: 34  GAYGMVCSAYDNVNKVRVAIKKISPFEH---QTYCQRT-LREIKILLRFRHENIIGINDI 89
Query: 126 F-----GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
                   M +V +V + ++TDL  ++K  T   +  +I  +    LRGL+Y+H   +LH
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLKYIHSANVLH 147
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSP----TRLYTHQVVTRWYRLIKCLLYCVQFN 236
           RDLKP+NLL+N    LKI DFGLA+    P    T   T  V TRWYR  + +L    + 
Sbjct: 148 RDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 206
Query: 237 VKNVQWC--CFAKDPSSHGNLFPG------------------------------------ 258
                W   C   +  S+  +FPG                                    
Sbjct: 207 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 266
Query: 259 ------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                 +P N +F  A    L ++  +L  NP KR +    L   Y  
Sbjct: 267 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 314

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 74/212 (34%), Positives = 106/212 (50%), Gaps = 16/212 (7%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y Q + +  G +  V  A D      VA+KKI    H   +    RT LREI++L    H
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEH---QTYCQRT-LREIQILLRFRH 100
Query: 117 ENVLGLTDVF-----GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLE 171
           ENV+G+ D+        M +V +V + ++TDL  ++K   +  +  +I  +    LRGL+
Sbjct: 101 ENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQL--SNDHICYFLYQILRGLK 158
Query: 172 YLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP---TRLYTHQVVTRWYRLIKC 228
           Y+H   +LHRDLKP+NLLIN    LKI DFGLA+        T   T  V TRWYR  + 
Sbjct: 159 YIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEI 218
Query: 229 LLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           +L    +      W   C   +  S+  +FPG
Sbjct: 219 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 250

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 122/288 (42%), Gaps = 60/288 (20%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A D    + VA+KKI    H   +    RT LREIK+L    HEN++G+ D+
Sbjct: 34  GAYGMVCSAYDNVNKVRVAIKKISPFEH---QTYCQRT-LREIKILLRFRHENIIGINDI 89
Query: 126 F-----GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
                   M +V +V + ++TDL  ++K  T   +  +I  +    LRGL+Y+H   +LH
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLKYIHSANVLH 147
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSP----TRLYTHQVVTRWYRLIKCLLYCVQFN 236
           RDLKP+NLL+N    LKI DFGLA+    P    T   T  V TRWYR  + +L    + 
Sbjct: 148 RDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 206
Query: 237 VKNVQWC--CFAKDPSSHGNLFPG------------------------------------ 258
                W   C   +  S+  +FPG                                    
Sbjct: 207 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 266
Query: 259 ------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                 +P N +F  A    L ++  +L  NP KR +    L   Y  
Sbjct: 267 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 314

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 122/288 (42%), Gaps = 60/288 (20%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A D    + VA+KKI    H   +    RT LREIK+L    HEN++G+ D+
Sbjct: 38  GAYGMVCSAYDNLNKVRVAIKKISPFEH---QTYCQRT-LREIKILLRFRHENIIGINDI 93
Query: 126 F-----GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
                   M +V +V + ++TDL  ++K  T   +  +I  +    LRGL+Y+H   +LH
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLKYIHSANVLH 151
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSP----TRLYTHQVVTRWYRLIKCLLYCVQFN 236
           RDLKP+NLL+N    LKI DFGLA+    P    T   T  V TRWYR  + +L    + 
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 210
Query: 237 VKNVQWC--CFAKDPSSHGNLFPG------------------------------------ 258
                W   C   +  S+  +FPG                                    
Sbjct: 211 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 270
Query: 259 ------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                 +P N +F  A    L ++  +L  NP KR +    L   Y  
Sbjct: 271 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 104/214 (48%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T   VAVKK+        HA       +   RE++LL+
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 72
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K      T  +++      
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CAKLTDDHVQFLIYQI 130
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAP 187
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/214 (34%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 76
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 134
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI D+GLA+        Y   V TRWYR  
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGY---VATRWYRAP 191
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 122/288 (42%), Gaps = 60/288 (20%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A D    + VA+KKI    H   +    RT LREIK+L    HEN++G+ D+
Sbjct: 36  GAYGMVCSAYDNVNKVRVAIKKISPFEH---QTYCQRT-LREIKILLRFRHENIIGINDI 91
Query: 126 F-----GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
                   M +V +V + ++TDL  ++K  T   +  +I  +    LRGL+Y+H   +LH
Sbjct: 92  IRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLKYIHSANVLH 149
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSP----TRLYTHQVVTRWYRLIKCLLYCVQFN 236
           RDLKP+NLL+N    LKI DFGLA+    P    T   T  V TRWYR  + +L    + 
Sbjct: 150 RDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 208
Query: 237 VKNVQWC--CFAKDPSSHGNLFPG------------------------------------ 258
                W   C   +  S+  +FPG                                    
Sbjct: 209 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 268
Query: 259 ------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                 +P N +F  A    L ++  +L  NP KR +    L   Y  
Sbjct: 269 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 316

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 123/288 (42%), Gaps = 60/288 (20%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A D    + VA+KKI    H   +    RT LREIK+L    HEN++G+ D+
Sbjct: 36  GAYGMVCSAYDNVNKVRVAIKKISPFEH---QTYCQRT-LREIKILLAFRHENIIGINDI 91
Query: 126 F-----GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
                   M +V +V + ++TDL  ++K  T   +  +I  +    LRGL+Y+H   +LH
Sbjct: 92  IRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLKYIHSANVLH 149
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSP----TRLYTHQVVTRWYRLIKCLLYCVQFN 236
           RDLKP+NLL+N    LKI DFGLA+    P    T   T  V TRWYR  + +L    + 
Sbjct: 150 RDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 208
Query: 237 VKNVQWC--CFAKDPSSHGNLFPG------------------------------------ 258
                W   C   +  S+  +FPG                                    
Sbjct: 209 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 268
Query: 259 ------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                 +P N +F  A    L ++  +L  NP KR +    L   Y +
Sbjct: 269 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLA 316

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 105/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T   VAVKK+        HA       +   RE++LL+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 76
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 134
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAP 191
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 122/288 (42%), Gaps = 60/288 (20%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A D    + VA+KKI    H   +    RT LREIK+L    HEN++G+ D+
Sbjct: 42  GAYGMVCSAYDNVNKVRVAIKKISPFEH---QTYCQRT-LREIKILLRFRHENIIGINDI 97
Query: 126 F-----GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
                   M +V +V + ++TDL  ++K  T   +  +I  +    LRGL+Y+H   +LH
Sbjct: 98  IRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLKYIHSANVLH 155
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSP----TRLYTHQVVTRWYRLIKCLLYCVQFN 236
           RDLKP+NLL+N    LKI DFGLA+    P    T   T  V TRWYR  + +L    + 
Sbjct: 156 RDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 214
Query: 237 VKNVQWC--CFAKDPSSHGNLFPG------------------------------------ 258
                W   C   +  S+  +FPG                                    
Sbjct: 215 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 274
Query: 259 ------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                 +P N +F  A    L ++  +L  NP KR +    L   Y  
Sbjct: 275 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 322

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 122/288 (42%), Gaps = 60/288 (20%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A D    + VA+KKI    H   +    RT LREIK+L    HEN++G+ D+
Sbjct: 34  GAYGMVCSAYDNVNKVRVAIKKISPFEH---QTYCQRT-LREIKILLRFRHENIIGINDI 89
Query: 126 F-----GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
                   M +V +V + ++TDL  ++K  T   +  +I  +    LRGL+Y+H   +LH
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLKYIHSANVLH 147
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSP----TRLYTHQVVTRWYRLIKCLLYCVQFN 236
           RDLKP+NLL+N    LKI DFGLA+    P    T   T  V TRWYR  + +L    + 
Sbjct: 148 RDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 206
Query: 237 VKNVQWC--CFAKDPSSHGNLFPG------------------------------------ 258
                W   C   +  S+  +FPG                                    
Sbjct: 207 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 266
Query: 259 ------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                 +P N +F  A    L ++  +L  NP KR +    L   Y  
Sbjct: 267 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 314

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 105/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T   VAVKK+        HA       +   RE++LL+
Sbjct: 43  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 95
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 96  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 153
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 154 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAP 210
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 211 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 244

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 105/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T   VAVKK+        HA       +   RE++LL+
Sbjct: 44  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 96
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 97  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 154
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 155 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAP 211
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 245

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 105/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T   VAVKK+        HA       +   RE++LL+
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 82
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 83  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 140
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 141 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAP 197
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 231

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 122/288 (42%), Gaps = 60/288 (20%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A D    + VA+KKI    H   +    RT LREIK+L    HEN++G+ D+
Sbjct: 39  GAYGMVCSAYDNLNKVRVAIKKISPFEH---QTYCQRT-LREIKILLRFRHENIIGINDI 94
Query: 126 F-----GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
                   M +V +V + ++TDL  ++K  T   +  +I  +    LRGL+Y+H   +LH
Sbjct: 95  IRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLKYIHSANVLH 152
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSP----TRLYTHQVVTRWYRLIKCLLYCVQFN 236
           RDLKP+NLL+N    LKI DFGLA+    P    T   T  V TRWYR  + +L    + 
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 211
Query: 237 VKNVQWC--CFAKDPSSHGNLFPG------------------------------------ 258
                W   C   +  S+  +FPG                                    
Sbjct: 212 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 271
Query: 259 ------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                 +P N +F  A    L ++  +L  NP KR +    L   Y  
Sbjct: 272 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 319

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 122/288 (42%), Gaps = 60/288 (20%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A D    + VA+KKI    H   +    RT LREIK+L    HEN++G+ D+
Sbjct: 40  GAYGMVCSAYDNLNKVRVAIKKISPFEH---QTYCQRT-LREIKILLRFRHENIIGINDI 95
Query: 126 F-----GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
                   M +V +V + ++TDL  ++K  T   +  +I  +    LRGL+Y+H   +LH
Sbjct: 96  IRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLKYIHSANVLH 153
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSP----TRLYTHQVVTRWYRLIKCLLYCVQFN 236
           RDLKP+NLL+N    LKI DFGLA+    P    T   T  V TRWYR  + +L    + 
Sbjct: 154 RDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 212
Query: 237 VKNVQWC--CFAKDPSSHGNLFPG------------------------------------ 258
                W   C   +  S+  +FPG                                    
Sbjct: 213 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 272
Query: 259 ------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                 +P N +F  A    L ++  +L  NP KR +    L   Y  
Sbjct: 273 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 320

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 122/288 (42%), Gaps = 60/288 (20%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A D    + VA+KKI    H   +    RT LREIK+L    HEN++G+ D+
Sbjct: 31  GAYGMVCSAYDNLNKVRVAIKKISPFEH---QTYCQRT-LREIKILLRFRHENIIGINDI 86
Query: 126 F-----GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
                   M +V +V + ++TDL  ++K  T   +  +I  +    LRGL+Y+H   +LH
Sbjct: 87  IRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLKYIHSANVLH 144
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSP----TRLYTHQVVTRWYRLIKCLLYCVQFN 236
           RDLKP+NLL+N    LKI DFGLA+    P    T   T  V TRWYR  + +L    + 
Sbjct: 145 RDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 203
Query: 237 VKNVQWC--CFAKDPSSHGNLFPG------------------------------------ 258
                W   C   +  S+  +FPG                                    
Sbjct: 204 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 263
Query: 259 ------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                 +P N +F  A    L ++  +L  NP KR +    L   Y  
Sbjct: 264 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 311

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 122/288 (42%), Gaps = 60/288 (20%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A D    + VA+KKI    H   +    RT LREIK+L    HEN++G+ D+
Sbjct: 38  GAYGMVCSAYDNLNKVRVAIKKISPFEH---QTYCQRT-LREIKILLRFRHENIIGINDI 93
Query: 126 F-----GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
                   M +V +V + ++TDL  ++K  T   +  +I  +    LRGL+Y+H   +LH
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLKYIHSANVLH 151
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSP----TRLYTHQVVTRWYRLIKCLLYCVQFN 236
           RDLKP+NLL+N    LKI DFGLA+    P    T   T  V TRWYR  + +L    + 
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 210
Query: 237 VKNVQWC--CFAKDPSSHGNLFPG------------------------------------ 258
                W   C   +  S+  +FPG                                    
Sbjct: 211 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 270
Query: 259 ------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                 +P N +F  A    L ++  +L  NP KR +    L   Y  
Sbjct: 271 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 122/288 (42%), Gaps = 60/288 (20%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A D    + VA+KKI    H   +    RT LREIK+L    HEN++G+ D+
Sbjct: 54  GAYGMVCSAYDNVNKVRVAIKKISPFEH---QTYCQRT-LREIKILLRFRHENIIGINDI 109
Query: 126 F-----GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
                   M +V +V + ++TDL  ++K  T   +  +I  +    LRGL+Y+H   +LH
Sbjct: 110 IRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLKYIHSANVLH 167
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSP----TRLYTHQVVTRWYRLIKCLLYCVQFN 236
           RDLKP+NLL+N    LKI DFGLA+    P    T   T  V TRWYR  + +L    + 
Sbjct: 168 RDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 226
Query: 237 VKNVQWC--CFAKDPSSHGNLFPG------------------------------------ 258
                W   C   +  S+  +FPG                                    
Sbjct: 227 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 286
Query: 259 ------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                 +P N +F  A    L ++  +L  NP KR +    L   Y  
Sbjct: 287 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 334

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 122/288 (42%), Gaps = 60/288 (20%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A D    + VA+KKI    H   +    RT LREIK+L    HEN++G+ D+
Sbjct: 32  GAYGMVCSAYDNLNKVRVAIKKISPFEH---QTYCQRT-LREIKILLRFRHENIIGINDI 87
Query: 126 F-----GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
                   M +V +V + ++TDL  ++K  T   +  +I  +    LRGL+Y+H   +LH
Sbjct: 88  IRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLKYIHSANVLH 145
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSP----TRLYTHQVVTRWYRLIKCLLYCVQFN 236
           RDLKP+NLL+N    LKI DFGLA+    P    T   T  V TRWYR  + +L    + 
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 204
Query: 237 VKNVQWC--CFAKDPSSHGNLFPG------------------------------------ 258
                W   C   +  S+  +FPG                                    
Sbjct: 205 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 264
Query: 259 ------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                 +P N +F  A    L ++  +L  NP KR +    L   Y  
Sbjct: 265 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 312

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 98.6 bits (244), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 122/288 (42%), Gaps = 60/288 (20%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A D    + VA+KKI    H   +    RT LREIK+L    HEN++G+ D+
Sbjct: 32  GAYGMVCSAYDNLNKVRVAIKKISPFEH---QTYCQRT-LREIKILLRFRHENIIGINDI 87
Query: 126 F-----GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
                   M +V +V + ++TDL  ++K  T   +  +I  +    LRGL+Y+H   +LH
Sbjct: 88  IRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLKYIHSANVLH 145
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSP----TRLYTHQVVTRWYRLIKCLLYCVQFN 236
           RDLKP+NLL+N    LKI DFGLA+    P    T   T  V TRWYR  + +L    + 
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 204
Query: 237 VKNVQWC--CFAKDPSSHGNLFPG------------------------------------ 258
                W   C   +  S+  +FPG                                    
Sbjct: 205 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINLKARNYLLS 264
Query: 259 ------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                 +P N +F  A    L ++  +L  NP KR +    L   Y  
Sbjct: 265 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 312

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 105/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T   VAVKK+        HA       +   RE++LL+
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 72
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 130
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAP 187
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 71/215 (33%), Positives = 111/215 (51%), Gaps = 34/215 (15%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y   + +  G    VF A D + D  VA+KKI L      K      ALREIK+++ L H
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKH-----ALREIKIIRRLDH 67
Query: 117 ENVLGLTDVFG--------------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAY 162
           +N++ + ++ G               +++V +V E+++TDL  +++   ++   + +  Y
Sbjct: 68  DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMY 127
Query: 163 AIMTLRGLEYLHDHWILHRDLKPNNLLINKQG-VLKIGDFGLAKFFGSPTRLYTHQ---- 217
            +  LRGL+Y+H   +LHRDLKP NL IN +  VLKIGDFGLA+        Y+H+    
Sbjct: 128 QL--LRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPH---YSHKGHLS 182
Query: 218 --VVTRWYRLIKCLLYCVQFNVKNVQW---CCFAK 247
             +VT+WYR  + LL    +      W   C FA+
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAE 217

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 105/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T   VAVKK+        HA       +   RE++LL+
Sbjct: 34  YQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 86
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 87  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 144
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        Y   V TRWYR  
Sbjct: 145 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAP 201
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 202 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 235

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 97.8 bits (242), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 75/226 (33%), Positives = 107/226 (47%), Gaps = 20/226 (8%)
Query: 56  VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH 115
           VY   + V  G +  V  A D  T   VA+KK+     ++      + A RE++LL+ + 
Sbjct: 26  VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL---FAKRAYRELRLLKHMR 82
Query: 116 HENVLGLTDVF------GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRG 169
           HENV+GL DVF         ++  LV  F+ TDL  ++K   +      I+      L+G
Sbjct: 83  HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKL--GEDRIQFLVYQMLKG 140
Query: 170 LEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCL 229
           L Y+H   I+HRDLKP NL +N+   LKI DFGLA+   S        VVTRWYR  + +
Sbjct: 141 LRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM---XGXVVTRWYRAPEVI 197
Query: 230 LYCVQFNVKNVQWC--CFAKDPSSHGNLFPGI----PLNEIFTAAG 269
           L  +++      W   C   +  +   LF G      L EI    G
Sbjct: 198 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 243

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 97.8 bits (242), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 122/288 (42%), Gaps = 60/288 (20%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A D    + VA++KI    H   +    RT LREIK+L    HEN++G+ D+
Sbjct: 38  GAYGMVCSAYDNLNKVRVAIRKISPFEH---QTYCQRT-LREIKILLRFRHENIIGINDI 93
Query: 126 F-----GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
                   M +V +V + ++TDL  ++K  T   +  +I  +    LRGL+Y+H   +LH
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLKYIHSANVLH 151
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSP----TRLYTHQVVTRWYRLIKCLLYCVQFN 236
           RDLKP+NLL+N    LKI DFGLA+    P    T   T  V TRWYR  + +L    + 
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 210
Query: 237 VKNVQWC--CFAKDPSSHGNLFPG------------------------------------ 258
                W   C   +  S+  +FPG                                    
Sbjct: 211 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 270
Query: 259 ------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                 +P N +F  A    L ++  +L  NP KR +    L   Y  
Sbjct: 271 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 73/214 (34%), Positives = 105/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 76
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 134
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI  FGLA+        Y   V TRWYR  
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGY---VATRWYRAP 191
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 97.4 bits (241), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 73/214 (34%), Positives = 105/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T   VAVKK+        HA       +   RE++LL+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 76
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 134
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        +   V TRWYR  
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGF---VATRWYRAP 191
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 97.4 bits (241), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 73/214 (34%), Positives = 105/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T   VAVKK+        HA       +   RE++LL+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 76
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 134
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        +   V TRWYR  
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGF---VATRWYRAP 191
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 97.4 bits (241), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 122/288 (42%), Gaps = 60/288 (20%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A D    + VA+KKI    H   +    RT LREIK+L    HEN++G+ D+
Sbjct: 38  GAYGMVCSAYDNLNKVRVAIKKISPFEH---QTYCQRT-LREIKILLRFRHENIIGINDI 93
Query: 126 F-----GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
                   M +V +V + ++TDL  ++K  T   +  +I  +    LRGL+Y+H   +LH
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLKYIHSANVLH 151
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYT----HQVVTRWYRLIKCLLYCVQFN 236
           RDLKP+NLL+N    LKI DFGLA+    P   +T      V TRWYR  + +L    + 
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYT 210
Query: 237 VKNVQWC--CFAKDPSSHGNLFPG------------------------------------ 258
                W   C   +  S+  +FPG                                    
Sbjct: 211 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 270
Query: 259 ------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                 +P N +F  A    L ++  +L  NP KR +    L   Y  
Sbjct: 271 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 97.4 bits (241), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 122/288 (42%), Gaps = 60/288 (20%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A D    + VA+KKI    H   +    RT LREIK+L    HEN++G+ D+
Sbjct: 39  GAYGMVCSAYDNLNKVRVAIKKISPFEH---QTYCQRT-LREIKILLRFRHENIIGINDI 94
Query: 126 F-----GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
                   M +V +V + ++TDL  ++K  T   +  +I  +    LRGL+Y+H   +LH
Sbjct: 95  IRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLKYIHSANVLH 152
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYT----HQVVTRWYRLIKCLLYCVQFN 236
           RDLKP+NLL+N    LKI DFGLA+    P   +T      V TRWYR  + +L    + 
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYT 211
Query: 237 VKNVQWC--CFAKDPSSHGNLFPG------------------------------------ 258
                W   C   +  S+  +FPG                                    
Sbjct: 212 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 271
Query: 259 ------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                 +P N +F  A    L ++  +L  NP KR +    L   Y  
Sbjct: 272 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 319

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 97.4 bits (241), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 73/214 (34%), Positives = 105/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 76
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 134
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI D GLA+        Y   V TRWYR  
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGY---VATRWYRAP 191
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/214 (34%), Positives = 105/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 76
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 134
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI D GLA+        Y   V TRWYR  
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGY---VATRWYRAP 191
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/214 (34%), Positives = 105/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T   VAVKK+        HA       +   RE++LL+
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 72
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 130
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+        +   V TRWYR  
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGF---VATRWYRAP 187
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/214 (34%), Positives = 105/214 (49%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T + VAVKK+        HA       +   RE++LL+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 76
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 134
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI D GLA+        Y   V TRWYR  
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGY---VATRWYRAP 191
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 119/288 (41%), Gaps = 60/288 (20%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A D    + VA+KKI    H   +    RT LREIK+L    HEN++G+ D+
Sbjct: 54  GAYGMVCSAYDNVNKVRVAIKKISPFEH---QTYCQRT-LREIKILLRFRHENIIGINDI 109
Query: 126 F-----GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
                   M +V LV   +  DL  ++K  T   +  +I  +    LRGL+Y+H   +LH
Sbjct: 110 IRAPTIEQMKDVYLVTHLMGADLYKLLK--TQHLSNDHICYFLYQILRGLKYIHSANVLH 167
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSP----TRLYTHQVVTRWYRLIKCLLYCVQFN 236
           RDLKP+NLL+N    LKI DFGLA+    P    T   T  V TRWYR  + +L    + 
Sbjct: 168 RDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 226
Query: 237 VKNVQWC--CFAKDPSSHGNLFPG------------------------------------ 258
                W   C   +  S+  +FPG                                    
Sbjct: 227 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 286
Query: 259 ------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                 +P N +F  A    L ++  +L  NP KR +    L   Y  
Sbjct: 287 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 334

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/214 (34%), Positives = 104/214 (48%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T   VAVKK+        HA       +   RE++LL+
Sbjct: 44  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 96
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 97  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 154
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+            V TRWYR  
Sbjct: 155 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---XGXVATRWYRAP 211
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 245

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 121/288 (42%), Gaps = 60/288 (20%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A D    + VA+KKI    H   +    RT LREIK+L    HEN++G+ D+
Sbjct: 38  GAYGMVCSAYDNLNKVRVAIKKISPFEH---QTYCQRT-LREIKILLRFRHENIIGINDI 93
Query: 126 F-----GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
                   M +V +V + ++TDL  ++K      +  +I  +    LRGL+Y+H   +LH
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLK--CQHLSNDHICYFLYQILRGLKYIHSANVLH 151
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSP----TRLYTHQVVTRWYRLIKCLLYCVQFN 236
           RDLKP+NLL+N    LKI DFGLA+    P    T   T  V TRWYR  + +L    + 
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 210
Query: 237 VKNVQWC--CFAKDPSSHGNLFPG------------------------------------ 258
                W   C   +  S+  +FPG                                    
Sbjct: 211 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 270
Query: 259 ------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                 +P N +F  A    L ++  +L  NP KR +    L   Y  
Sbjct: 271 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 73/214 (34%), Positives = 104/214 (48%), Gaps = 24/214 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLG----THADAKDGINRTALREIKLLQ 112
           Y     V  G + +V  A D +T   VAVKK+        HA       +   RE++LL+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA-------KRTYRELRLLK 76
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            + HENV+GL DVF         ++V LV   +  DL  I+K   +  T  +++      
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQI 134
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           LRGL+Y+H   I+HRDLKP+NL +N+   LKI DF LA+        Y   V TRWYR  
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGY---VATRWYRAP 191
Query: 227 KCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           + +L  + +N     W   C   +  +   LFPG
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 121/295 (41%), Gaps = 66/295 (22%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL--- 122
           G +  V  A    T  IVA+KKI+       K       LREIK+L+   HEN++ +   
Sbjct: 22  GAYGVVCSATHKPTGEIVAIKKIE----PFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 123 --TDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
              D F   + V ++ E + TDL  +I   T + +  +I+ +   TLR ++ LH   ++H
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVIS--TQMLSDDHIQYFIYQTLRAVKVLHGSNVIH 135
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFF-------GSPTRLY---THQVVTRWYRLIKCLL 230
           RDLKP+NLLIN    LK+ DFGLA+           PT      T  V TRWYR  + +L
Sbjct: 136 RDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEVML 195
Query: 231 YCVQFNVKNVQWCC-------FAKDP-------------------SSHGN---------- 254
              +++     W C       F + P                   + H +          
Sbjct: 196 TSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPR 255
Query: 255 ---------LFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                    ++P  PL ++F       + ++  +L  +P KR      L+  Y  
Sbjct: 256 AREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQ 310

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 121/295 (41%), Gaps = 66/295 (22%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL--- 122
           G +  V  A    T  IVA+KKI+       K       LREIK+L+   HEN++ +   
Sbjct: 22  GAYGVVCSATHKPTGEIVAIKKIE----PFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 123 --TDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
              D F   + V ++ E + TDL  +I   T + +  +I+ +   TLR ++ LH   ++H
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVIS--TQMLSDDHIQYFIYQTLRAVKVLHGSNVIH 135
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFF-------GSPTRLY---THQVVTRWYRLIKCLL 230
           RDLKP+NLLIN    LK+ DFGLA+           PT      T  V TRWYR  + +L
Sbjct: 136 RDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEVML 195
Query: 231 YCVQFNVKNVQWCC-------FAKDP-------------------SSHGN---------- 254
              +++     W C       F + P                   + H +          
Sbjct: 196 TSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPR 255
Query: 255 ---------LFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                    ++P  PL ++F       + ++  +L  +P KR      L+  Y  
Sbjct: 256 AREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQ 310

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 121/295 (41%), Gaps = 66/295 (22%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL--- 122
           G +  V  A    T  IVA+KKI+       K       LREIK+L+   HEN++ +   
Sbjct: 22  GAYGVVCSATHKPTGEIVAIKKIE----PFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 123 --TDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
              D F   + V ++ E + TDL  +I   T + +  +I+ +   TLR ++ LH   ++H
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVIS--TQMLSDDHIQYFIYQTLRAVKVLHGSNVIH 135
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFF-------GSPTRLYTHQ---VVTRWYRLIKCLL 230
           RDLKP+NLLIN    LK+ DFGLA+           PT   +     V TRWYR  + +L
Sbjct: 136 RDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVML 195
Query: 231 YCVQFNVKNVQWCC-------FAKDP-------------------SSHGN---------- 254
              +++     W C       F + P                   + H +          
Sbjct: 196 TSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPR 255
Query: 255 ---------LFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                    ++P  PL ++F       + ++  +L  +P KR      L+  Y  
Sbjct: 256 AREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQ 310

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/232 (31%), Positives = 108/232 (46%), Gaps = 23/232 (9%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGIN--------RTALREI 108
           Y   R +  G +  V    D E  + VA+K++   T +D +  +N        +  LREI
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEG-IPVAIKRV-FNTVSDGR-TVNILSDSFLCKRVLREI 80
Query: 109 KLLQELHHENVLGLTDVFGY-----MSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYA 163
           +LL   HH N+LGL D+F +     M  + LV E + TDL  +I D  IV +P +I+ + 
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM 140
Query: 164 IMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWY 223
              L GL  LH+  ++HRDL P N+L+     + I DF LA+   +     TH V  RWY
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN-KTHYVTHRWY 199
Query: 224 RLIKCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPGI----PLNEIFTAAG 269
           R  + ++    F      W   C   +  +   LF G      LN+I    G
Sbjct: 200 RAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVG 251

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/232 (31%), Positives = 108/232 (46%), Gaps = 23/232 (9%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGIN--------RTALREI 108
           Y   R +  G +  V    D E  + VA+K++   T +D +  +N        +  LREI
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEG-IPVAIKRV-FNTVSDGR-TVNILSDSFLCKRVLREI 80
Query: 109 KLLQELHHENVLGLTDVFGY-----MSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYA 163
           +LL   HH N+LGL D+F +     M  + LV E + TDL  +I D  IV +P +I+ + 
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM 140
Query: 164 IMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWY 223
              L GL  LH+  ++HRDL P N+L+     + I DF LA+   +     TH V  RWY
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN-KTHYVTHRWY 199
Query: 224 RLIKCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPGI----PLNEIFTAAG 269
           R  + ++    F      W   C   +  +   LF G      LN+I    G
Sbjct: 200 RAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVG 251

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 61/169 (36%), Positives = 87/169 (51%), Gaps = 20/169 (11%)
Query: 99  GINRTALREIKLLQELHHENVLGLTDVFGYMSN--VSLVFEFVDTDLEVIIK-------- 148
           GI+ +A REI LL+EL H NV+ L  VF   ++  V L+F++ + DL  IIK        
Sbjct: 60  GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN 119
Query: 149 DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLI----NKQGVLKIGDFGLA 204
              +      +K+     L G+ YLH +W+LHRDLKP N+L+     ++G +KI D G A
Sbjct: 120 KKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 179
Query: 205 KFFGSPTRLYTH---QVVTRWYRLIKCLLYCVQFNVKNVQW---CCFAK 247
           + F SP +        VVT WYR  + LL    +      W   C FA+
Sbjct: 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAE 228

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 108/219 (49%), Gaps = 31/219 (14%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-HENVLGLTD 124
           G +  V+K+ D  T  +VAVKKI      ++ D   +   REI +L EL  HEN++ L +
Sbjct: 20  GAYGIVWKSIDRRTGEVVAVKKI-FDAFQNSTDA--QRTFREIMILTELSGHENIVNLLN 76
Query: 125 VFGYMSN--VSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
           V    ++  V LVF++++TDL  +I+    +  P + +      ++ ++YLH   +LHRD
Sbjct: 77  VLRADNDRDVYLVFDYMETDLHAVIR--ANILEPVHKQYVVYQLIKVIKYLHSGGLLHRD 134
Query: 183 LKPNNLLINKQGVLKIGDFGLAKFFGSPTR---------------------LYTHQVVTR 221
           +KP+N+L+N +  +K+ DFGL++ F +  R                     + T  V TR
Sbjct: 135 MKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATR 194
Query: 222 WYRLIKCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
           WYR  + LL   ++      W   C   +      +FPG
Sbjct: 195 WYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 100/195 (51%), Gaps = 7/195 (3%)
Query: 52  NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLL 111
           N L  +   + +  G+F+ V++A  +   + VA+KK+++    DAK   +   ++EI LL
Sbjct: 29  NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARAD--CIKEIDLL 86
Query: 112 QELHHENVLGLTDVFGYMSNVSLVFEFVDT-DLEVIIK---DPTIVFTPSNIKAYAIMTL 167
           ++L+H NV+     F   + +++V E  D  DL  +IK       +     +  Y +   
Sbjct: 87  KQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLC 146
Query: 168 RGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIK 227
             LE++H   ++HRD+KP N+ I   GV+K+GD GL +FF S T    H +V   Y +  
Sbjct: 147 SALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA-AHSLVGTPYYMSP 205
Query: 228 CLLYCVQFNVKNVQW 242
             ++   +N K+  W
Sbjct: 206 ERIHENGYNFKSDIW 220

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 22/213 (10%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKI----KLGTHADAKDGINRTALREIKLLQ 112
           Y   + +  G    V  A D   D  VA+KK+    +  THA       + A RE+ L++
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA-------KRAYRELVLMK 78
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            ++H+N++ L +VF          +V LV E +D +L  +I+   +      +       
Sbjct: 79  XVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ---MELDHERMSYLLYQM 135
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           L G+++LH   I+HRDLKP+N+++     LKI DFGLA+  G+ + + T  VVTR+YR  
Sbjct: 136 LXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT-SFMMTPYVVTRYYRAP 194
Query: 227 KCLL-YCVQFNVKNVQWCCFAKDPSSHGNLFPG 258
           + +L    + NV      C   +   H  LFPG
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 227

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 22/213 (10%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKI----KLGTHADAKDGINRTALREIKLLQ 112
           Y   + +  G    V  A D   D  VA+KK+    +  THA       + A RE+ L++
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA-------KRAYRELVLMK 78
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            ++H+N++ L +VF          +V LV E +D +L  +I+   +      +       
Sbjct: 79  XVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ---MELDHERMSYLLYQM 135
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           L G+++LH   I+HRDLKP+N+++     LKI DFGLA+  G+ + + T  VVTR+YR  
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT-SFMMTPYVVTRYYRAP 194
Query: 227 KCLL-YCVQFNVKNVQWCCFAKDPSSHGNLFPG 258
           + +L    + NV      C   +   H  LFPG
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 227

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 22/213 (10%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKI----KLGTHADAKDGINRTALREIKLLQ 112
           Y   + +  G    V  A D   D  VA+KK+    +  THA       + A RE+ L++
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA-------KRAYRELVLMK 78
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            ++H+N++ L +VF          +V LV E +D +L  +I+   +      +       
Sbjct: 79  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ---MELDHERMSYLLYQM 135
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           L G+++LH   I+HRDLKP+N+++     LKI DFGLA+  G+ + + T  VVTR+YR  
Sbjct: 136 LXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT-SFMMTPYVVTRYYRAP 194
Query: 227 KCLL-YCVQFNVKNVQWCCFAKDPSSHGNLFPG 258
           + +L    + NV      C   +   H  LFPG
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 227

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 106/213 (49%), Gaps = 22/213 (10%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKI----KLGTHADAKDGINRTALREIKLLQ 112
           Y   + +  G    V  A D   +  VA+KK+    +  THA       + A RE+ L++
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA-------KRAYRELVLMK 78
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            ++H+N++GL +VF          +V +V E +D +L  +I+   +      +       
Sbjct: 79  VVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ---MELDHERMSYLLYQM 135
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           L G+++LH   I+HRDLKP+N+++     LKI DFGLA+  G+ + + T  VVTR+YR  
Sbjct: 136 LVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGT-SFMMTPYVVTRYYRAP 194
Query: 227 KCLL-YCVQFNVKNVQWCCFAKDPSSHGNLFPG 258
           + +L    + NV      C   +    G LFPG
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 22/213 (10%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKI----KLGTHADAKDGINRTALREIKLLQ 112
           Y   + +  G    V  A D   D  VA+KK+    +  THA       + A RE+ L++
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA-------KRAYRELVLMK 71
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            ++H+N++ L +VF          +V LV E +D +L  +I+   +      +       
Sbjct: 72  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ---MELDHERMSYLLYQM 128
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           L G+++LH   I+HRDLKP+N+++     LKI DFGLA+  G+ + + T  VVTR+YR  
Sbjct: 129 LXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT-SFMMTPYVVTRYYRAP 187
Query: 227 KCLL-YCVQFNVKNVQWCCFAKDPSSHGNLFPG 258
           + +L    + NV      C   +   H  LFPG
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 106/213 (49%), Gaps = 22/213 (10%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKI----KLGTHADAKDGINRTALREIKLLQ 112
           Y   + +  G    V  A D   +  VA+KK+    +  THA       + A RE+ L++
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA-------KRAYRELVLMK 78
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            ++H+N++GL +VF          +V +V E +D +L  +I+   +      +       
Sbjct: 79  VVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ---MELDHERMSYLLYQM 135
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           L G+++LH   I+HRDLKP+N+++     LKI DFGLA+  G+ + + T  VVTR+YR  
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGT-SFMMTPYVVTRYYRAP 194
Query: 227 KCLL-YCVQFNVKNVQWCCFAKDPSSHGNLFPG 258
           + +L    + NV      C   +    G LFPG
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 106/213 (49%), Gaps = 22/213 (10%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKI----KLGTHADAKDGINRTALREIKLLQ 112
           Y   + +  G    V  A D   +  VA+KK+    +  THA       + A RE+ L++
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA-------KRAYRELVLMK 78
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            ++H+N++GL +VF          +V +V E +D +L  +I+   +      +       
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ---MELDHERMSYLLYQM 135
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           L G+++LH   I+HRDLKP+N+++     LKI DFGLA+  G+ + + T  VVTR+YR  
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGT-SFMMTPYVVTRYYRAP 194
Query: 227 KCLL-YCVQFNVKNVQWCCFAKDPSSHGNLFPG 258
           + +L    + NV      C   +    G LFPG
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 22/213 (10%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKI----KLGTHADAKDGINRTALREIKLLQ 112
           Y   + +  G    V  A D   D  VA+KK+    +  THA       + A RE+ L++
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA-------KRAYRELVLMK 78
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            ++H+N++ L +VF          +V LV E +D +L  +I+   +      +       
Sbjct: 79  XVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQM 135
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           L G+++LH   I+HRDLKP+N+++     LKI DFGLA+  G+ + + T  VVTR+YR  
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT-SFMMTPYVVTRYYRAP 194
Query: 227 KCLL-YCVQFNVKNVQWCCFAKDPSSHGNLFPG 258
           + +L    + NV      C   +   H  LFPG
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 227

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 107/213 (50%), Gaps = 22/213 (10%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKI----KLGTHADAKDGINRTALREIKLLQ 112
           Y   + +  G    V  A D   +  VA+KK+    +  THA       + A RE+ L++
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA-------KRAYRELVLMK 78
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            ++H+N++GL +VF          +V +V E +D +L  +I+   +      +       
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQM 135
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           L G+++LH   I+HRDLKP+N+++     LKI DFGLA+  G+ + + T +VVTR+YR  
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPEVVTRYYRAP 194
Query: 227 KCLL-YCVQFNVKNVQWCCFAKDPSSHGNLFPG 258
           + +L    + NV      C   +    G LFPG
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 22/213 (10%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKI----KLGTHADAKDGINRTALREIKLLQ 112
           Y   + +  G    V  A D   D  VA+KK+    +  THA       + A RE+ L++
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA-------KRAYRELVLMK 116
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            ++H+N++ L +VF          +V LV E +D +L  +I+   +      +       
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQM 173
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           L G+++LH   I+HRDLKP+N+++     LKI DFGLA+  G+ + + T  VVTR+YR  
Sbjct: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAP 232
Query: 227 KCLL-YCVQFNVKNVQWCCFAKDPSSHGNLFPG 258
           + +L    + NV      C   +   H  LFPG
Sbjct: 233 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 265

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 106/213 (49%), Gaps = 22/213 (10%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKI----KLGTHADAKDGINRTALREIKLLQ 112
           Y   + +  G    V  A D   +  VA+KK+    +  THA       + A RE+ L++
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA-------KRAYRELVLMK 78
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            ++H+N++GL +VF          +V +V E +D +L  +I+   +      +       
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ---MELDHERMSYLLYQM 135
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           L G+++LH   I+HRDLKP+N+++     LKI DFGLA+  G+ + + T  VVTR+YR  
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAP 194
Query: 227 KCLL-YCVQFNVKNVQWCCFAKDPSSHGNLFPG 258
           + +L    + NV      C   +    G LFPG
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 22/213 (10%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKI----KLGTHADAKDGINRTALREIKLLQ 112
           Y   + +  G    V  A D   D  VA+KK+    +  THA       + A RE+ L++
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA-------KRAYRELVLMK 116
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            ++H+N++ L +VF          +V LV E +D +L  +I+   +      +       
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQM 173
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           L G+++LH   I+HRDLKP+N+++     LKI DFGLA+  G+ + + T  VVTR+YR  
Sbjct: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAP 232
Query: 227 KCLL-YCVQFNVKNVQWCCFAKDPSSHGNLFPG 258
           + +L    + NV      C   +   H  LFPG
Sbjct: 233 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 265

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 22/213 (10%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKI----KLGTHADAKDGINRTALREIKLLQ 112
           Y   + +  G    V  A D   +  VA+KK+    +  THA       + A RE+ L++
Sbjct: 26  YQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHA-------KRAYRELVLMK 78
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            ++H+N++GL +VF          +V +V E +D +L  +I+   +      +       
Sbjct: 79  VVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ---MELDHERMSYLLYQM 135
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           L G+++LH   I+HRDLKP+N+++     LKI DFGLA+  G+ + + T  VVTR+YR  
Sbjct: 136 LVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGT-SFMMTPYVVTRYYRAP 194
Query: 227 KCLL-YCVQFNVKNVQWCCFAKDPSSHGNLFPG 258
           + +L    + NV          +    G LFPG
Sbjct: 195 EVILGMGYKENVDIWSVGVIMGEMIKGGVLFPG 227

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 22/213 (10%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKI----KLGTHADAKDGINRTALREIKLLQ 112
           Y   + +  G    V  A D   D  VA+KK+    +  THA       + A RE+ L++
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA-------KRAYRELVLMK 79
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            ++H+N++ L +VF          +V LV E +D +L  +I+   +      +       
Sbjct: 80  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQM 136
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           L G+++LH   I+HRDLKP+N+++     LKI DFGLA+  G+ + + T  VVTR+YR  
Sbjct: 137 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAP 195
Query: 227 KCLL-YCVQFNVKNVQWCCFAKDPSSHGNLFPG 258
           + +L    + NV      C   +   H  LFPG
Sbjct: 196 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 228

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 22/213 (10%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKI----KLGTHADAKDGINRTALREIKLLQ 112
           Y   + +  G    V  A D   D  VA+KK+    +  THA       + A RE+ L++
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA-------KRAYRELVLMK 78
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            ++H+N++ L +VF          +V LV E +D +L  +I+   +      +       
Sbjct: 79  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQM 135
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           L G+++LH   I+HRDLKP+N+++     LKI DFGLA+  G+ + + T  VVTR+YR  
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAP 194
Query: 227 KCLL-YCVQFNVKNVQWCCFAKDPSSHGNLFPG 258
           + +L    + NV      C   +   H  LFPG
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 227

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 22/213 (10%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKI----KLGTHADAKDGINRTALREIKLLQ 112
           Y   + +  G    V  A D   D  VA+KK+    +  THA       + A RE+ L++
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA-------KRAYRELVLMK 79
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            ++H+N++ L +VF          +V LV E +D +L  +I+   +      +       
Sbjct: 80  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQM 136
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           L G+++LH   I+HRDLKP+N+++     LKI DFGLA+  G+ + + T  VVTR+YR  
Sbjct: 137 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAP 195
Query: 227 KCLL-YCVQFNVKNVQWCCFAKDPSSHGNLFPG 258
           + +L    + NV      C   +   H  LFPG
Sbjct: 196 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 228

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 102/233 (43%), Gaps = 44/233 (18%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+ A D  T+  VA+KK+      D  D   +  LREI +L  L  + ++ L D+
Sbjct: 37  GSYGYVYLAYDKNTEKNVAIKKVN-RMFEDLIDC--KRILREITILNRLKSDYIIRLYDL 93
Query: 126 -----FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
                      + +V E  D+DL+ + K P I  T  +IK      L G  ++H+  I+H
Sbjct: 94  IIPDDLLKFDELYIVLEIADSDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHESGIIH 152
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSP----------------------TRLYTHQV 218
           RDLKP N L+N+   +K+ DFGLA+   S                        +  T  V
Sbjct: 153 RDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHV 212
Query: 219 VTRWYRLIKCLLYCVQFNVKNVQW---CCFAK----------DPSSHGNLFPG 258
           VTRWYR  + +L    +      W   C FA+          DP++   LFPG
Sbjct: 213 VTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPG 265

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 22/213 (10%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKI----KLGTHADAKDGINRTALREIKLLQ 112
           Y   + +  G    V  A D   D  VA+KK+    +  THA       + A RE+ L++
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA-------KRAYRELVLMK 78
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            ++H+N++ L +VF          +V LV E +D +L  +I+   +      +       
Sbjct: 79  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQM 135
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           L G+++LH   I+HRDLKP+N+++     LKI DFGLA+  G+ + + T  VVTR+YR  
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAP 194
Query: 227 KCLL-YCVQFNVKNVQWCCFAKDPSSHGNLFPG 258
           + +L    + NV      C   +   H  LFPG
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 227

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 22/213 (10%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKI----KLGTHADAKDGINRTALREIKLLQ 112
           Y   + +  G    V  A D   D  VA+KK+    +  THA       + A RE+ L++
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA-------KRAYRELVLMK 72
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            ++H+N++ L +VF          +V LV E +D +L  +I+   +      +       
Sbjct: 73  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQM 129
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           L G+++LH   I+HRDLKP+N+++     LKI DFGLA+  G+ + + T  VVTR+YR  
Sbjct: 130 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAP 188
Query: 227 KCLL-YCVQFNVKNVQWCCFAKDPSSHGNLFPG 258
           + +L    + NV      C   +   H  LFPG
Sbjct: 189 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 221

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 22/213 (10%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKI----KLGTHADAKDGINRTALREIKLLQ 112
           Y   + +  G    V  A D   D  VA+KK+    +  THA       + A RE+ L++
Sbjct: 25  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA-------KRAYRELVLMK 77
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            ++H+N++ L +VF          +V LV E +D +L  +I+   +      +       
Sbjct: 78  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQM 134
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           L G+++LH   I+HRDLKP+N+++     LKI DFGLA+  G+ + + T  VVTR+YR  
Sbjct: 135 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAP 193
Query: 227 KCLL-YCVQFNVKNVQWCCFAKDPSSHGNLFPG 258
           + +L    + NV      C   +   H  LFPG
Sbjct: 194 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 226

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 22/213 (10%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKI----KLGTHADAKDGINRTALREIKLLQ 112
           Y   + +  G    V  A D   D  VA+KK+    +  THA       + A RE+ L++
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA-------KRAYRELVLMK 72
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            ++H+N++ L +VF          +V LV E +D +L  +I+   +      +       
Sbjct: 73  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQM 129
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           L G+++LH   I+HRDLKP+N+++     LKI DFGLA+  G+ + + T  VVTR+YR  
Sbjct: 130 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAP 188
Query: 227 KCLL-YCVQFNVKNVQWCCFAKDPSSHGNLFPG 258
           + +L    + NV      C   +   H  LFPG
Sbjct: 189 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 221

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 22/213 (10%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKI----KLGTHADAKDGINRTALREIKLLQ 112
           Y   + +  G    V  A D   D  VA+KK+    +  THA       + A RE+ L++
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA-------KRAYRELVLMK 71
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            ++H+N++ L +VF          +V LV E +D +L  +I+   +      +       
Sbjct: 72  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQM 128
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           L G+++LH   I+HRDLKP+N+++     LKI DFGLA+  G+ + + T  VVTR+YR  
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAP 187
Query: 227 KCLL-YCVQFNVKNVQWCCFAKDPSSHGNLFPG 258
           + +L    + NV      C   +   H  LFPG
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 106/213 (49%), Gaps = 22/213 (10%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKI----KLGTHADAKDGINRTALREIKLLQ 112
           Y   + +  G    V  A D   +  VA+KK+    +  THA       + A RE+ L++
Sbjct: 31  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA-------KRAYRELVLMK 83
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            ++H+N++GL +VF          +V +V E +D +L  +I+   +      +       
Sbjct: 84  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQM 140
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           L G+++LH   I+HRDLKP+N+++     LKI DFGLA+  G+ + + T  VVTR+YR  
Sbjct: 141 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAP 199
Query: 227 KCLL-YCVQFNVKNVQWCCFAKDPSSHGNLFPG 258
           + +L    + NV      C   +   H  LFPG
Sbjct: 200 EVILGMGYKENVDLWSVGCIMGEMVCHKILFPG 232

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/256 (28%), Positives = 109/256 (42%), Gaps = 52/256 (20%)
Query: 63  VHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL 122
           +  G +  V +A D     +VA+KKI L    D  D   +  LREI +L  L+H++V+ +
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKI-LRVFEDLIDC--KRILREIAILNRLNHDHVVKV 117
Query: 123 TDVF-----GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHW 177
            D+           + +V E  D+D + + + P +  T  +IK      L G++Y+H   
Sbjct: 118 LDIVIPKDVEKFDELYVVLEIADSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSAG 176
Query: 178 ILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT-------------------------- 211
           ILHRDLKP N L+N+   +K+ DFGLA+    P                           
Sbjct: 177 ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNL 236
Query: 212 -RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFAK----------DPSSHGNLFP 257
            R  T  VVTRWYR  + +L    +      W   C FA+            +  G LFP
Sbjct: 237 KRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFP 296
Query: 258 G---IPLNEIFTAAGD 270
           G    PL+    A  D
Sbjct: 297 GSSCFPLSPDQKAGND 312

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 106/213 (49%), Gaps = 22/213 (10%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKI----KLGTHADAKDGINRTALREIKLLQ 112
           Y   + +  G    V  A D   +  VA+KK+    +  THA       + A RE+ L++
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA-------KRAYRELVLMK 72
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            ++H+N++GL +VF          +V +V E +D +L  +I+   +      +       
Sbjct: 73  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQM 129
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           L G+++LH   I+HRDLKP+N+++     LKI DFGLA+  G+ + + T  VVTR+YR  
Sbjct: 130 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAP 188
Query: 227 KCLL-YCVQFNVKNVQWCCFAKDPSSHGNLFPG 258
           + +L    + NV      C   +   H  LFPG
Sbjct: 189 EVILGMGYKENVDLWSVGCIMGEMVCHKILFPG 221

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 22/213 (10%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKI----KLGTHADAKDGINRTALREIKLLQ 112
           Y   + +  G    V  A D   +  VA+KK+    +  THA       + A RE+ L++
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA-------KRAYRELVLMK 78
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            ++H+N++GL +VF          +V +V E +D +L  +I+   +      +       
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQM 135
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           L G+++LH   I+HRDLKP+N+++     LKI DFGLA+  G+ + +   +VVTR+YR  
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMEPEVVTRYYRAP 194
Query: 227 KCLL-YCVQFNVKNVQWCCFAKDPSSHGNLFPG 258
           + +L    + NV      C   +   H  LFPG
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMVCHKILFPG 227

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 106/213 (49%), Gaps = 22/213 (10%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKI----KLGTHADAKDGINRTALREIKLLQ 112
           Y   + +  G    V  A D   +  VA+KK+    +  THA       + A RE+ L++
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA-------KRAYRELVLMK 79
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            ++H+N++GL +VF          +V +V E +D +L  +I+   +      +       
Sbjct: 80  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQM 136
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           L G+++LH   I+HRDLKP+N+++     LKI DFGLA+  G+ + + T  VVTR+YR  
Sbjct: 137 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAP 195
Query: 227 KCLL-YCVQFNVKNVQWCCFAKDPSSHGNLFPG 258
           + +L    + NV      C   +    G LFPG
Sbjct: 196 EVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 228

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 22/213 (10%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKI----KLGTHADAKDGINRTALREIKLLQ 112
           Y   + +  G    V  A D   +  VA+KK+    +  THA       + A RE+ L++
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA-------KRAYRELVLMK 78
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            ++H+N++GL +VF          +V +V E +D +L  +I+   +      +       
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQM 135
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           L G+++LH   I+HRDLKP+N+++     LKI DFGLA+  G+ + +   +VVTR+YR  
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMEPEVVTRYYRAP 194
Query: 227 KCLL-YCVQFNVKNVQWCCFAKDPSSHGNLFPG 258
           + +L    + NV      C   +   H  LFPG
Sbjct: 195 EVILGMGYKENVDLWSVGCIMGEMVCHKILFPG 227

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 22/213 (10%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKI----KLGTHADAKDGINRTALREIKLLQ 112
           Y   + +  G    V  A D   +  VA+KK+    +  THA       + A RE+ L++
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA-------KRAYRELVLMK 78
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            ++H+N++GL +VF          +V +V E +D +L  +I+   +      +       
Sbjct: 79  VVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ---MELDHERMSYLLYQM 135
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           L G+++LH   I+HRDLKP+N+++     LKI DFGLA+  G+ + + T  VVTR+YR  
Sbjct: 136 LVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGT-SFMMTPYVVTRYYRAP 194
Query: 227 KCLL-YCVQFNVKNVQWCCFAKDPSSHGNLFPG 258
           + +L    + NV          +    G LFPG
Sbjct: 195 EVILGMGYKENVDIWSVGVIMGEMIKGGVLFPG 227

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 106/213 (49%), Gaps = 22/213 (10%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKI----KLGTHADAKDGINRTALREIKLLQ 112
           Y   + +  G    V  A D   +  VA+KK+    +  THA       + A RE+ L++
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA-------KRAYRELVLMK 78
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            ++H+N++GL +VF          +V +V E +D +L  +I+   +      +       
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQM 135
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           L G+++LH   I+HRDLKP+N+++     LKI DFGLA+  G+ + + T  VVTR+YR  
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAP 194
Query: 227 KCLL-YCVQFNVKNVQWCCFAKDPSSHGNLFPG 258
           + +L    + NV      C   +    G LFPG
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 106/213 (49%), Gaps = 22/213 (10%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKI----KLGTHADAKDGINRTALREIKLLQ 112
           Y   + +  G    V  A D   +  VA+KK+    +  THA       + A RE+ L++
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA-------KRAYRELVLMK 78
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            ++H+N++GL +VF          +V +V E +D +L  +I+   +      +       
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQM 135
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           L G+++LH   I+HRDLKP+N+++     LKI DFGLA+  G+ + + T  VVTR+YR  
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAP 194
Query: 227 KCLL-YCVQFNVKNVQWCCFAKDPSSHGNLFPG 258
           + +L    + NV      C   +    G LFPG
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 119/277 (42%), Gaps = 56/277 (20%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+ A D   +  VA+KK+      D  D   +  LREI +L  L  + ++ L D+
Sbjct: 39  GSYGYVYLAYDKNANKNVAIKKVN-RMFEDLIDC--KRILREITILNRLKSDYIIRLHDL 95
Query: 126 -----FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
                      + +V E  D+DL+ + K P I  T  ++K      L G +++H+  I+H
Sbjct: 96  IIPEDLLKFDELYIVLEIADSDLKKLFKTP-IFLTEQHVKTILYNLLLGEKFIHESGIIH 154
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY-------------------------T 215
           RDLKP N L+N+   +KI DFGLA+   S   ++                         T
Sbjct: 155 RDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHNKNLKKQLT 214
Query: 216 HQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFAK----------DPSSHGNLFPG---I 259
             VVTRWYR  + +L    +      W   C FA+          +P++   LFPG    
Sbjct: 215 SHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHINNPTNRFPLFPGSSCF 274
Query: 260 PLN------EIFTAAGDDLLAVISSLLCLNPTKRADC 290
           PL+      ++   +  D L +I +++   P +   C
Sbjct: 275 PLSPDHNSKKVHEKSNRDQLNIIFNVIGTPPEEDLKC 311

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 82/161 (50%), Gaps = 17/161 (10%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKL-GTHADAKDGINRTALREIKLLQELHHENV 119
           R +  G F  V+ ARD+    +VA+KK+   G  ++ K    +  ++E++ LQ+L H N 
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK---WQDIIKEVRFLQKLRHPNT 116
Query: 120 LGLTDVFGYMSNVSLVFEFV---DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH 176
           +     +       LV E+     +DL  + K P        I A     L+GL YLH H
Sbjct: 117 IQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAYLHSH 173
Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAK-------FFGSP 210
            ++HRD+K  N+L+++ G++K+GDFG A        F G+P
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTP 214

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 82/161 (50%), Gaps = 17/161 (10%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKL-GTHADAKDGINRTALREIKLLQELHHENV 119
           R +  G F  V+ ARD+    +VA+KK+   G  ++ K    +  ++E++ LQ+L H N 
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK---WQDIIKEVRFLQKLRHPNT 77
Query: 120 LGLTDVFGYMSNVSLVFEFV---DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH 176
           +     +       LV E+     +DL  + K P        I A     L+GL YLH H
Sbjct: 78  IQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAYLHSH 134
Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAK-------FFGSP 210
            ++HRD+K  N+L+++ G++K+GDFG A        F G+P
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTP 175

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 79/157 (50%), Gaps = 17/157 (10%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V+KA++ ET ++ A K I   +  + +D      + EI +L    H N++ L D 
Sbjct: 48  GAFGKVYKAQNKETSVLAAAKVIDTKSEEELED-----YMVEIDILASCDHPNIVKLLDA 102
Query: 126 FGYMSNVSLVFEF-VDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           F Y +N+ ++ EF     ++ ++ +     T S I+     TL  L YLHD+ I+HRDLK
Sbjct: 103 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLK 162
Query: 185 PNNLLINKQGVLKIGDFGLA-----------KFFGSP 210
             N+L    G +K+ DFG++            F G+P
Sbjct: 163 AGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTP 199

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 79/157 (50%), Gaps = 17/157 (10%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V+KA++ ET ++ A K I   +  + +D      + EI +L    H N++ L D 
Sbjct: 48  GAFGKVYKAQNKETSVLAAAKVIDTKSEEELED-----YMVEIDILASCDHPNIVKLLDA 102
Query: 126 FGYMSNVSLVFEF-VDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           F Y +N+ ++ EF     ++ ++ +     T S I+     TL  L YLHD+ I+HRDLK
Sbjct: 103 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLK 162
Query: 185 PNNLLINKQGVLKIGDFGLA-----------KFFGSP 210
             N+L    G +K+ DFG++            F G+P
Sbjct: 163 AGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTP 199

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 75/140 (53%), Gaps = 6/140 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V+KA++ ET ++ A K I   +  + +D      + EI +L    H N++ L D 
Sbjct: 48  GAFGKVYKAQNKETSVLAAAKVIDTKSEEELED-----YMVEIDILASCDHPNIVKLLDA 102
Query: 126 FGYMSNVSLVFEF-VDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           F Y +N+ ++ EF     ++ ++ +     T S I+     TL  L YLHD+ I+HRDLK
Sbjct: 103 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLK 162
Query: 185 PNNLLINKQGVLKIGDFGLA 204
             N+L    G +K+ DFG++
Sbjct: 163 AGNILFTLDGDIKLADFGVS 182

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 22/213 (10%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKI----KLGTHADAKDGINRTALREIKLLQ 112
           Y   + +  G    V  A D   +  VA+KK+    +  THA       + A RE+ L++
Sbjct: 28  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA-------KRAYRELVLMK 80
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            ++H+N++GL +VF          +V +V E +D +L  +I+   +      +       
Sbjct: 81  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQM 137
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           L G+++LH   I+HRDLKP+N+++     LKI DFGLA+  G+ + +    VVTR+YR  
Sbjct: 138 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMVPFVVTRYYRAP 196
Query: 227 KCLL-YCVQFNVKNVQWCCFAKDPSSHGNLFPG 258
           + +L    + NV      C   +    G LFPG
Sbjct: 197 EVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 229

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 49/146 (33%), Positives = 77/146 (52%), Gaps = 3/146 (2%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G FA V++A  I T + VA+K I     A  K G+ +    E+K+  +L H ++L L + 
Sbjct: 22  GSFAGVYRAESIHTGLEVAIKMID--KKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNY 79
Query: 126 FGYMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           F   + V LV E   + ++   +K+    F+ +  + +    + G+ YLH H ILHRDL 
Sbjct: 80  FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLT 139
Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSP 210
            +NLL+ +   +KI DFGLA     P
Sbjct: 140 LSNLLLTRNMNIKIADFGLATQLKMP 165

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 21/184 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKI----KLGTHADAKDGINRTALREIKLLQ 112
           Y Q + +  G    V  A D    + VAVKK+    +  THA       + A RE+ LL+
Sbjct: 24  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHA-------KRAYRELVLLK 76
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            ++H+N++ L +VF          +V LV E +D +L  +I    +      +       
Sbjct: 77  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIH---MELDHERMSYLLYQM 133
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           L G+++LH   I+HRDLKP+N+++     LKI DFGLA+   S   + T  VVTR+YR  
Sbjct: 134 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TASTNFMMTPYVVTRYYRAP 192
Query: 227 KCLL 230
           + +L
Sbjct: 193 EVIL 196

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 81/175 (46%), Gaps = 27/175 (15%)
Query: 36  HSALKKQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVK---KIKLGT 92
           H + K+Q+ L D E+          R +  G+F  V+ AR+ ++  I+A+K   K +L  
Sbjct: 3   HMSKKRQWALEDFEIG---------RPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-- 51
Query: 93  HADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEF-----VDTDLEVII 147
               K G+     RE+++   L H N+L L   F   + V L+ E+     V  +L+ + 
Sbjct: 52  ---EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 108
Query: 148 KDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG 202
           K     F       Y       L Y H   ++HRD+KP NLL+   G LKI DFG
Sbjct: 109 K-----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 158

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 80/172 (46%), Gaps = 27/172 (15%)
Query: 39  LKKQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVK---KIKLGTHAD 95
           +K+Q+ L D E+          R +  G+F  V+ AR+ ++  I+A+K   K +L     
Sbjct: 1   MKRQWALEDFEIG---------RPLGKGKFGNVYLAREKQSKFILALKVLFKAQL----- 46
Query: 96  AKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEF-----VDTDLEVIIKDP 150
            K G+     RE+++   L H N+L L   F   + V L+ E+     V  +L+ + K  
Sbjct: 47  EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-- 104
Query: 151 TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG 202
              F       Y       L Y H   ++HRD+KP NLL+   G LKI DFG
Sbjct: 105 ---FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 92/184 (50%), Gaps = 21/184 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKI----KLGTHADAKDGINRTALREIKLLQ 112
           Y Q + +  G    V  A D    + VAVKK+    +  THA       + A RE+ LL+
Sbjct: 26  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHA-------KRAYRELVLLK 78
Query: 113 ELHHENVLGLTDVFG------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
            ++H+N++ L +VF          +V LV E +D +L  +I    +      +       
Sbjct: 79  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIH---MELDHERMSYLLYQM 135
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           L G+++LH   I+HRDLKP+N+++     LKI DFGLA+       + T  VVTR+YR  
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TACTNFMMTPYVVTRYYRAP 194
Query: 227 KCLL 230
           + +L
Sbjct: 195 EVIL 198

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 79/171 (46%), Gaps = 27/171 (15%)
Query: 40  KKQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVK---KIKLGTHADA 96
           K+Q+ L D E+          R +  G+F  V+ AR+ ++  I+A+K   K +L      
Sbjct: 7   KRQWALEDFEIG---------RPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-----E 52
Query: 97  KDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEF-----VDTDLEVIIKDPT 151
           K G+     RE+++   L H N+L L   F   + V L+ E+     V  +L+ + K   
Sbjct: 53  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--- 109
Query: 152 IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG 202
             F       Y       L Y H   ++HRD+KP NLL+   G LKI DFG
Sbjct: 110 --FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 158

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 79/171 (46%), Gaps = 27/171 (15%)
Query: 40  KKQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVK---KIKLGTHADA 96
           K+Q+ L D E+          R +  G+F  V+ AR+ ++  I+A+K   K +L      
Sbjct: 7   KRQWALEDFEIG---------RPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-----E 52
Query: 97  KDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEF-----VDTDLEVIIKDPT 151
           K G+     RE+++   L H N+L L   F   + V L+ E+     V  +L+ + K   
Sbjct: 53  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK--- 109
Query: 152 IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG 202
             F       Y       L Y H   ++HRD+KP NLL+   G LKI DFG
Sbjct: 110 --FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 158

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 79/171 (46%), Gaps = 27/171 (15%)
Query: 40  KKQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVK---KIKLGTHADA 96
           K+Q+ L D E+          R +  G+F  V+ AR+ ++  I+A+K   K +L      
Sbjct: 3   KRQWALEDFEIG---------RPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-----E 48
Query: 97  KDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEF-----VDTDLEVIIKDPT 151
           K G+     RE+++   L H N+L L   F   + V L+ E+     V  +L+ + K   
Sbjct: 49  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--- 105
Query: 152 IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG 202
             F       Y       L Y H   ++HRD+KP NLL+   G LKI DFG
Sbjct: 106 --FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 154

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 79/171 (46%), Gaps = 27/171 (15%)
Query: 40  KKQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVK---KIKLGTHADA 96
           K+Q+ L D E+          R +  G+F  V+ AR+ ++  I+A+K   K +L      
Sbjct: 28  KRQWALEDFEI---------GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-----E 73
Query: 97  KDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEF-----VDTDLEVIIKDPT 151
           K G+     RE+++   L H N+L L   F   + V L+ E+     V  +L+ + K   
Sbjct: 74  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--- 130
Query: 152 IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG 202
             F       Y       L Y H   ++HRD+KP NLL+   G LKI DFG
Sbjct: 131 --FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 179

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 79/171 (46%), Gaps = 27/171 (15%)
Query: 40  KKQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVK---KIKLGTHADA 96
           K+Q+ L D E+          R +  G+F  V+ AR+ ++  I+A+K   K +L      
Sbjct: 5   KRQWALEDFEIG---------RPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-----E 50
Query: 97  KDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEF-----VDTDLEVIIKDPT 151
           K G+     RE+++   L H N+L L   F   + V L+ E+     V  +L+ + K   
Sbjct: 51  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--- 107
Query: 152 IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG 202
             F       Y       L Y H   ++HRD+KP NLL+   G LKI DFG
Sbjct: 108 --FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 79/171 (46%), Gaps = 27/171 (15%)
Query: 40  KKQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVK---KIKLGTHADA 96
           K+Q+ L D E+          R +  G+F  V+ AR+ ++  I+A+K   K +L      
Sbjct: 7   KRQWALEDFEIG---------RPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-----E 52
Query: 97  KDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEF-----VDTDLEVIIKDPT 151
           K G+     RE+++   L H N+L L   F   + V L+ E+     V  +L+ + K   
Sbjct: 53  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--- 109
Query: 152 IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG 202
             F       Y       L Y H   ++HRD+KP NLL+   G LKI DFG
Sbjct: 110 --FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 158

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 79/171 (46%), Gaps = 27/171 (15%)
Query: 40  KKQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVK---KIKLGTHADA 96
           K+Q+ L D E+          R +  G+F  V+ AR+ ++  I+A+K   K +L      
Sbjct: 6   KRQWALEDFEIG---------RPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-----E 51
Query: 97  KDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEF-----VDTDLEVIIKDPT 151
           K G+     RE+++   L H N+L L   F   + V L+ E+     V  +L+ + K   
Sbjct: 52  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--- 108
Query: 152 IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG 202
             F       Y       L Y H   ++HRD+KP NLL+   G LKI DFG
Sbjct: 109 --FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 157

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 79/171 (46%), Gaps = 27/171 (15%)
Query: 40  KKQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVK---KIKLGTHADA 96
           K+Q+ L D E+          R +  G+F  V+ AR+ ++  I+A+K   K +L      
Sbjct: 19  KRQWALEDFEI---------GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-----E 64
Query: 97  KDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEF-----VDTDLEVIIKDPT 151
           K G+     RE+++   L H N+L L   F   + V L+ E+     V  +L+ + K   
Sbjct: 65  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--- 121
Query: 152 IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG 202
             F       Y       L Y H   ++HRD+KP NLL+   G LKI DFG
Sbjct: 122 --FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 170

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 79/171 (46%), Gaps = 27/171 (15%)
Query: 40  KKQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVK---KIKLGTHADA 96
           K+Q+ L D E+          R +  G+F  V+ AR+ ++  I+A+K   K +L      
Sbjct: 2   KRQWALEDFEIG---------RPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-----E 47
Query: 97  KDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEF-----VDTDLEVIIKDPT 151
           K G+     RE+++   L H N+L L   F   + V L+ E+     V  +L+ + K   
Sbjct: 48  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--- 104
Query: 152 IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG 202
             F       Y       L Y H   ++HRD+KP NLL+   G LKI DFG
Sbjct: 105 --FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 79/171 (46%), Gaps = 27/171 (15%)
Query: 40  KKQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVK---KIKLGTHADA 96
           K+Q+ L D E+          R +  G+F  V+ AR+ ++  I+A+K   K +L      
Sbjct: 28  KRQWALEDFEI---------GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-----E 73
Query: 97  KDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEF-----VDTDLEVIIKDPT 151
           K G+     RE+++   L H N+L L   F   + V L+ E+     V  +L+ + K   
Sbjct: 74  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--- 130
Query: 152 IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG 202
             F       Y       L Y H   ++HRD+KP NLL+   G LKI DFG
Sbjct: 131 --FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 179

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 79/171 (46%), Gaps = 27/171 (15%)
Query: 40  KKQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVK---KIKLGTHADA 96
           K+Q+ L D E+          R +  G+F  V+ AR+ ++  I+A+K   K +L      
Sbjct: 3   KRQWALEDFEIG---------RPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-----E 48
Query: 97  KDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEF-----VDTDLEVIIKDPT 151
           K G+     RE+++   L H N+L L   F   + V L+ E+     V  +L+ + K   
Sbjct: 49  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--- 105
Query: 152 IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG 202
             F       Y       L Y H   ++HRD+KP NLL+   G LKI DFG
Sbjct: 106 --FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 154

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 79/171 (46%), Gaps = 27/171 (15%)
Query: 40  KKQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVK---KIKLGTHADA 96
           K+Q+ L D E+          R +  G+F  V+ AR+ ++  I+A+K   K +L      
Sbjct: 3   KRQWALEDFEIG---------RPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-----E 48
Query: 97  KDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEF-----VDTDLEVIIKDPT 151
           K G+     RE+++   L H N+L L   F   + V L+ E+     V  +L+ + K   
Sbjct: 49  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--- 105
Query: 152 IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG 202
             F       Y       L Y H   ++HRD+KP NLL+   G LKI DFG
Sbjct: 106 --FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 154

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 79/171 (46%), Gaps = 27/171 (15%)
Query: 40  KKQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVK---KIKLGTHADA 96
           K+Q+ L D E+          R +  G+F  V+ AR+ ++  I+A+K   K +L      
Sbjct: 4   KRQWALEDFEIG---------RPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-----E 49
Query: 97  KDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEF-----VDTDLEVIIKDPT 151
           K G+     RE+++   L H N+L L   F   + V L+ E+     V  +L+ + K   
Sbjct: 50  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--- 106
Query: 152 IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG 202
             F       Y       L Y H   ++HRD+KP NLL+   G LKI DFG
Sbjct: 107 --FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 155

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 79/171 (46%), Gaps = 27/171 (15%)
Query: 40  KKQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVK---KIKLGTHADA 96
           K+Q+ L D E+          R +  G+F  V+ AR+ ++  I+A+K   K +L      
Sbjct: 7   KRQWALEDFEIG---------RPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-----E 52
Query: 97  KDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEF-----VDTDLEVIIKDPT 151
           K G+     RE+++   L H N+L L   F   + V L+ E+     V  +L+ + K   
Sbjct: 53  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK--- 109
Query: 152 IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG 202
             F       Y       L Y H   ++HRD+KP NLL+   G LKI DFG
Sbjct: 110 --FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 158

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 79/171 (46%), Gaps = 27/171 (15%)
Query: 40  KKQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVK---KIKLGTHADA 96
           K+Q+ L D E+          R +  G+F  V+ AR+ ++  I+A+K   K +L      
Sbjct: 2   KRQWALEDFEIG---------RPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-----E 47
Query: 97  KDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEF-----VDTDLEVIIKDPT 151
           K G+     RE+++   L H N+L L   F   + V L+ E+     V  +L+ + K   
Sbjct: 48  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--- 104
Query: 152 IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG 202
             F       Y       L Y H   ++HRD+KP NLL+   G LKI DFG
Sbjct: 105 --FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 79/171 (46%), Gaps = 27/171 (15%)
Query: 40  KKQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVK---KIKLGTHADA 96
           K+Q+ L D E+          R +  G+F  V+ AR+ ++  I+A+K   K +L      
Sbjct: 2   KRQWALEDFEIG---------RPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-----E 47
Query: 97  KDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEF-----VDTDLEVIIKDPT 151
           K G+     RE+++   L H N+L L   F   + V L+ E+     V  +L+ + K   
Sbjct: 48  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--- 104
Query: 152 IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG 202
             F       Y       L Y H   ++HRD+KP NLL+   G LKI DFG
Sbjct: 105 --FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 79/171 (46%), Gaps = 27/171 (15%)
Query: 40  KKQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVK---KIKLGTHADA 96
           K+Q+ L D E+          R +  G+F  V+ AR+ ++  I+A+K   K +L      
Sbjct: 1   KRQWALEDFEIG---------RPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-----E 46
Query: 97  KDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEF-----VDTDLEVIIKDPT 151
           K G+     RE+++   L H N+L L   F   + V L+ E+     V  +L+ + K   
Sbjct: 47  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--- 103
Query: 152 IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG 202
             F       Y       L Y H   ++HRD+KP NLL+   G LKI DFG
Sbjct: 104 --FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 152

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 79/171 (46%), Gaps = 27/171 (15%)
Query: 40  KKQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVK---KIKLGTHADA 96
           K+Q+ L D E+          R +  G+F  V+ AR+ ++  I+A+K   K +L      
Sbjct: 5   KRQWALEDFEIG---------RPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-----E 50
Query: 97  KDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEF-----VDTDLEVIIKDPT 151
           K G+     RE+++   L H N+L L   F   + V L+ E+     V  +L+ + K   
Sbjct: 51  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--- 107
Query: 152 IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG 202
             F       Y       L Y H   ++HRD+KP NLL+   G LKI DFG
Sbjct: 108 --FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 79/171 (46%), Gaps = 27/171 (15%)
Query: 40  KKQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVK---KIKLGTHADA 96
           K+Q+ L D E+          R +  G+F  V+ AR+ ++  I+A+K   K +L      
Sbjct: 5   KRQWALEDFEIG---------RPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-----E 50
Query: 97  KDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEF-----VDTDLEVIIKDPT 151
           K G+     RE+++   L H N+L L   F   + V L+ E+     V  +L+ + K   
Sbjct: 51  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--- 107
Query: 152 IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG 202
             F       Y       L Y H   ++HRD+KP NLL+   G LKI DFG
Sbjct: 108 --FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 79/171 (46%), Gaps = 27/171 (15%)
Query: 40  KKQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVK---KIKLGTHADA 96
           K+Q+ L D E+          R +  G+F  V+ AR+ ++  I+A+K   K +L      
Sbjct: 2   KRQWALEDFEIG---------RPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-----E 47
Query: 97  KDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEF-----VDTDLEVIIKDPT 151
           K G+     RE+++   L H N+L L   F   + V L+ E+     V  +L+ + K   
Sbjct: 48  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--- 104
Query: 152 IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG 202
             F       Y       L Y H   ++HRD+KP NLL+   G LKI DFG
Sbjct: 105 --FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 78/171 (45%), Gaps = 27/171 (15%)
Query: 40  KKQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVK---KIKLGTHADA 96
           K+Q+ L D E+          R +  G+F  V+ AR+  +  I+A+K   K +L      
Sbjct: 2   KRQWALEDFEIG---------RPLGKGKFGNVYLAREKNSKFILALKVLFKAQL-----E 47
Query: 97  KDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEF-----VDTDLEVIIKDPT 151
           K G+     RE+++   L H N+L L   F   + V L+ E+     V  +L+ + K   
Sbjct: 48  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSK--- 104
Query: 152 IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG 202
             F       Y       L Y H   ++HRD+KP NLL+   G LKI DFG
Sbjct: 105 --FDEQRTATYITELANALSYCHSKKVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 78/170 (45%), Gaps = 27/170 (15%)
Query: 41  KQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVK---KIKLGTHADAK 97
           +Q+ L D E+          R +  G+F  V+ AR+ ++  I+A+K   K +L      K
Sbjct: 6   RQWALEDFEIG---------RPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-----EK 51
Query: 98  DGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEF-----VDTDLEVIIKDPTI 152
            G+     RE+++   L H N+L L   F   + V L+ E+     V  +L+ + K    
Sbjct: 52  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---- 107
Query: 153 VFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG 202
            F       Y       L Y H   ++HRD+KP NLL+   G LKI DFG
Sbjct: 108 -FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 54/163 (33%), Positives = 81/163 (49%), Gaps = 11/163 (6%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V K +D  T    AVK I     A AK+    T LRE++LL++L H N++ L ++
Sbjct: 33  GSFGEVLKCKDRITQQEYAVKVI---NKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 126 FGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
               S+  +V E        + IIK     F+  +          G+ Y+H H I+HRDL
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKHNIVHRDL 147
Query: 184 KPNNLLI---NKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWY 223
           KP N+L+    K   +KI DFGL+  F   T++   ++ T +Y
Sbjct: 148 KPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-KDRIGTAYY 189

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 54/163 (33%), Positives = 81/163 (49%), Gaps = 11/163 (6%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V K +D  T    AVK I     A AK+    T LRE++LL++L H N++ L ++
Sbjct: 33  GSFGEVLKCKDRITQQEYAVKVI---NKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 126 FGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
               S+  +V E        + IIK     F+  +          G+ Y+H H I+HRDL
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKHNIVHRDL 147
Query: 184 KPNNLLI---NKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWY 223
           KP N+L+    K   +KI DFGL+  F   T++   ++ T +Y
Sbjct: 148 KPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-KDRIGTAYY 189

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 78/170 (45%), Gaps = 27/170 (15%)
Query: 41  KQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVK---KIKLGTHADAK 97
           +Q+ L D E+          R +  G+F  V+ AR+ ++  I+A+K   K +L      K
Sbjct: 3   RQWALEDFEIG---------RPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-----EK 48
Query: 98  DGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEF-----VDTDLEVIIKDPTI 152
            G+     RE+++   L H N+L L   F   + V L+ E+     V  +L+ + K    
Sbjct: 49  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---- 104
Query: 153 VFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG 202
            F       Y       L Y H   ++HRD+KP NLL+   G LKI DFG
Sbjct: 105 -FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 78/170 (45%), Gaps = 27/170 (15%)
Query: 41  KQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVK---KIKLGTHADAK 97
           +Q+ L D E+          R +  G+F  V+ AR+ ++  I+A+K   K +L      K
Sbjct: 3   RQWALEDFEIG---------RPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-----EK 48
Query: 98  DGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEF-----VDTDLEVIIKDPTI 152
            G+     RE+++   L H N+L L   F   + V L+ E+     V  +L+ + K    
Sbjct: 49  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---- 104
Query: 153 VFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG 202
            F       Y       L Y H   ++HRD+KP NLL+   G LKI DFG
Sbjct: 105 -FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 79/171 (46%), Gaps = 27/171 (15%)
Query: 40  KKQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVK---KIKLGTHADA 96
           K+Q+ L D E+          R +  G+F  V+ AR+ ++  I+A+K   K +L      
Sbjct: 4   KRQWALEDFEIG---------RPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-----E 49
Query: 97  KDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEF-----VDTDLEVIIKDPT 151
           K G+     RE+++   L H N+L L   F   + V L+ E+     V  +L+ + K   
Sbjct: 50  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--- 106
Query: 152 IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG 202
             F       Y       L Y H   ++HRD+KP NLL+   G LKI +FG
Sbjct: 107 --FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFG 155

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 73/163 (44%), Gaps = 11/163 (6%)
Query: 40  KKQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDG 99
           K+Q+ L D ++          R +  G+F  V+ AR+ ++  I+A+K +   T  + K G
Sbjct: 6   KRQWTLEDFDIG---------RPLGKGKFGNVYLARERQSKFILALK-VLFKTQLE-KAG 54
Query: 100 INRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNI 159
           +     RE+++   L H N+L L   F   + V L+ E+               F     
Sbjct: 55  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRT 114
Query: 160 KAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG 202
             Y       L Y H   ++HRD+KP NLL+   G LKI DFG
Sbjct: 115 ATYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFG 157

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 73/163 (44%), Gaps = 11/163 (6%)
Query: 40  KKQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDG 99
           K+Q+ L D ++          R +  G+F  V+ AR+ ++  I+A+K +   T  + K G
Sbjct: 6   KRQWTLEDFDIG---------RPLGKGKFGNVYLARERQSKFILALK-VLFKTQLE-KAG 54
Query: 100 INRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNI 159
           +     RE+++   L H N+L L   F   + V L+ E+               F     
Sbjct: 55  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRT 114
Query: 160 KAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG 202
             Y       L Y H   ++HRD+KP NLL+   G LKI DFG
Sbjct: 115 ATYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFG 157

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 99/222 (44%), Gaps = 35/222 (15%)
Query: 55  LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL 114
           + Y   + +  G F  VF+A+ +E+D  VA+KK+        +D   R   RE+++++ +
Sbjct: 40  IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKV-------LQD--KRFKNRELQIMRIV 89
Query: 115 HHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSN-------------IKA 161
            H NV+ L   F Y +       F++  LE +   P  V+  S              IK 
Sbjct: 90  KHPNVVDLKAFF-YSNGDKKDEVFLNLVLEYV---PETVYRASRHYAKLKQTMPMLLIKL 145
Query: 162 YAIMTLRGLEYLHDHWILHRDLKPNNLLIN-KQGVLKIGDFGLAKFF--GSPTRLYTHQV 218
           Y    LR L Y+H   I HRD+KP NLL++   GVLK+ DFG AK    G P       +
Sbjct: 146 YMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN---VSXI 202
Query: 219 VTRWYRLIKCLLYCVQFNVKNVQWC--CFAKDPSSHGNLFPG 258
            +R+YR  + +     +      W   C   +      LFPG
Sbjct: 203 CSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPG 244

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 79/171 (46%), Gaps = 27/171 (15%)
Query: 40  KKQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVK---KIKLGTHADA 96
           K+Q+ L D E+          R +  G+F  V+ AR+ ++  I+A+K   K +L      
Sbjct: 5   KRQWALEDFEIG---------RPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-----E 50
Query: 97  KDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEF-----VDTDLEVIIKDPT 151
           K G+     RE+++   L H N+L L   F   + V L+ E+     V  +L+ + K   
Sbjct: 51  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--- 107
Query: 152 IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG 202
             F       Y       L Y H   ++HRD+KP NLL+   G LKI +FG
Sbjct: 108 --FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFG 156

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 78/170 (45%), Gaps = 27/170 (15%)
Query: 41  KQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVK---KIKLGTHADAK 97
           +Q+ L D E+          R +  G+F  V+ AR+ ++  I+A+K   K +L      K
Sbjct: 6   RQWALEDFEIG---------RPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-----EK 51
Query: 98  DGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEF-----VDTDLEVIIKDPTI 152
            G+     RE+++   L H N+L L   F   + V L+ E+     V  +L+ + K    
Sbjct: 52  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---- 107
Query: 153 VFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG 202
            F       Y       L Y H   ++HRD+KP NLL+   G LKI DFG
Sbjct: 108 -FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 84/163 (51%), Gaps = 11/163 (6%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V K +D  T    AVK I     A AK+    T LRE++LL++L H N++ L ++
Sbjct: 33  GSFGEVLKCKDRITQQEYAVKVI---NKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 126 FGYMSNVSLVFE-FVDTDL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
               S+  +V E +   +L + IIK     F+  +          G+ Y+H H I+HRDL
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKHNIVHRDL 147
Query: 184 KPNNLLI---NKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWY 223
           KP N+L+    K   +KI DFGL+  F   T++   ++ T +Y
Sbjct: 148 KPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-KDRIGTAYY 189

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 85/159 (53%), Gaps = 11/159 (6%)
Query: 49  EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREI 108
           E+K+D   + +   +  G    V K +   + +I+A K I    H + K  I    +RE+
Sbjct: 12  ELKDD--DFERISELGAGNGGVVTKVQHRPSGLIMARKLI----HLEIKPAIRNQIIREL 65
Query: 109 KLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNI-KAYAIMT 166
           ++L E +   ++G    F     +S+  E +D   L+ ++K+   +  P  I    +I  
Sbjct: 66  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRI--PEEILGKVSIAV 123
Query: 167 LRGLEYLHD-HWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           LRGL YL + H I+HRD+KP+N+L+N +G +K+ DFG++
Sbjct: 124 LRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVS 162

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 70/150 (46%), Gaps = 18/150 (12%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVK---KIKLGTHADAKDGINRTALREIKLLQELHHE 117
           R +  G+F  V+ AR+ +   I+A+K   K +L      K G+     RE+++   L H 
Sbjct: 11  RPLGKGKFGNVYLAREKQRKFILALKVLFKAQL-----EKAGVEHQLRREVEIQSHLRHP 65
Query: 118 NVLGLTDVFGYMSNVSLVFEF-----VDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEY 172
           N+L L   F   + V L+ E+     V  +L+ + K     F       Y       L Y
Sbjct: 66  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSY 120
Query: 173 LHDHWILHRDLKPNNLLINKQGVLKIGDFG 202
            H   ++HRD+KP NLL+   G LKI DFG
Sbjct: 121 CHSKRVIHRDIKPENLLLGSAGELKIADFG 150

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/271 (21%), Positives = 113/271 (41%), Gaps = 30/271 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y + + +  G F      +  E      +K+I +   +  +   +R   RE+ +L  + H
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESR---REVAVLANMKH 82
Query: 117 ENVLGLTDVFGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH 174
            N++   + F    ++ +V ++ +     + I     ++F    I  + +     L+++H
Sbjct: 83  PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 175 DHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQ 234
           D  ILHRD+K  N+ + K G +++GDFG+A+   S   L    + T +Y L   +     
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYY-LSPEICENKP 201
Query: 235 FNVKNVQWC--------CFAKDPSSHGNL-----------FPGIPLNEIFTAAGDDLLAV 275
           +N K+  W         C  K     G++           FP + L+  +     DL ++
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSY-----DLRSL 256
Query: 276 ISSLLCLNPTKRADCTATLKMDYFSLTKEMY 306
           +S L   NP  R    + L+  + +   E +
Sbjct: 257 VSQLFKRNPRDRPSVNSILEKGFIAKRIEKF 287

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 123/255 (48%), Gaps = 34/255 (13%)
Query: 56  VYYQWRSVHV---GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQ 112
           V Y++  + V   G F  V KA D +    VA+K ++       +   +R A  EI++L+
Sbjct: 95  VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR------NEKRFHRQAAEEIRILE 148
Query: 113 ELHHE------NVLGLTDVFGYMSNVSLVFEFVDTDL-EVIIKDPTIVFTPSNIKAYAIM 165
            L  +      NV+ + + F + +++ + FE +  +L E+I K+    F+   ++ +A  
Sbjct: 149 HLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHS 208
Query: 166 TLRGLEYLHDHWILHRDLKPNNLLINKQGV--LKIGDFGLAKFFGSPTRLYTHQVVTRWY 223
            L+ L+ LH + I+H DLKP N+L+ +QG   +K+ DFG + +     R+YT  + +R+Y
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY--EHQRVYT-XIQSRFY 265
Query: 224 RLIKCLLYCVQFNVKNVQW---CCFAKDPSSHGNLFPGIPLNEIFTAAGDDLLAVISSLL 280
           R  + +L   ++ +    W   C  A+       L  G PL  +      D LA +  LL
Sbjct: 266 RAPEVIL-GARYGMPIDMWSLGCILAE-------LLTGYPL--LPGEDEGDQLACMIELL 315
Query: 281 CLNPTKRADCTATLK 295
            +   K  D +   K
Sbjct: 316 GMPSQKLLDASKRAK 330

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 123/255 (48%), Gaps = 34/255 (13%)
Query: 56  VYYQWRSVHV---GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQ 112
           V Y++  + V   G F  V KA D +    VA+K ++       +   +R A  EI++L+
Sbjct: 95  VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR------NEKRFHRQAAEEIRILE 148
Query: 113 ELHHE------NVLGLTDVFGYMSNVSLVFEFVDTDL-EVIIKDPTIVFTPSNIKAYAIM 165
            L  +      NV+ + + F + +++ + FE +  +L E+I K+    F+   ++ +A  
Sbjct: 149 HLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHS 208
Query: 166 TLRGLEYLHDHWILHRDLKPNNLLINKQGV--LKIGDFGLAKFFGSPTRLYTHQVVTRWY 223
            L+ L+ LH + I+H DLKP N+L+ +QG   +K+ DFG + +     R+YT  + +R+Y
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY--EHQRVYT-XIQSRFY 265
Query: 224 RLIKCLLYCVQFNVKNVQW---CCFAKDPSSHGNLFPGIPLNEIFTAAGDDLLAVISSLL 280
           R  + +L   ++ +    W   C  A+       L  G PL  +      D LA +  LL
Sbjct: 266 RAPEVIL-GARYGMPIDMWSLGCILAE-------LLTGYPL--LPGEDEGDQLACMIELL 315
Query: 281 CLNPTKRADCTATLK 295
            +   K  D +   K
Sbjct: 316 GMPSQKLLDASKRAK 330

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 105/207 (50%), Gaps = 26/207 (12%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH-ENV 119
           R +  G+++ VF+A +I  +  V VK +K       K        REIK+L+ L    N+
Sbjct: 43  RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIK--------REIKILENLRGGPNI 94
Query: 120 LGLTDVFG--YMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH 176
           + L D+         +LVFE V+ TD + + +      T  +I+ Y    L+ L+Y H  
Sbjct: 95  ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSM 150
Query: 177 WILHRDLKPNNLLINKQGV-LKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQF 235
            I+HRD+KP+N++I+ +   L++ D+GLA+F+  P + Y  +V +R+++  + L+    +
Sbjct: 151 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLVDYQMY 209
Query: 236 NVKNVQWC--------CFAKDPSSHGN 254
           +     W          F K+P  HG+
Sbjct: 210 DYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 34/208 (16%)
Query: 106 REIKLLQELHHENVLGLTDVFG--YMSNVSLVFEFVDTDLEVIIKDPTI-VFTPSNIKAY 162
           +EI +L++L H NV+ L +V       ++ +VFE V+     +++ PT+   +    + Y
Sbjct: 85  QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQG--PVMEVPTLKPLSEDQARFY 142
Query: 163 AIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW 222
               ++G+EYLH   I+HRD+KP+NLL+ + G +KI DFG++  F     L ++ V T  
Sbjct: 143 FQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPA 202
Query: 223 YRLIKCL--------------------LYCVQFN---VKNVQWCCFAKDPSSHGNLFPGI 259
           +   + L                    LYC  F      + +  C      S    FP  
Sbjct: 203 FMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQ 262
Query: 260 PLNEIFTAAGDDLLAVISSLLCLNPTKR 287
           P         +DL  +I+ +L  NP  R
Sbjct: 263 P------DIAEDLKDLITRMLDKNPESR 284

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 78/151 (51%), Gaps = 8/151 (5%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           GRF  V K  +  T + +A K IK     D ++  N     EI ++ +L H N++ L D 
Sbjct: 100 GRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKN-----EISVMNQLDHANLIQLYDA 154
Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           F   +++ LV E+VD  +L   I D +   T  +   +      G+ ++H  +ILH DLK
Sbjct: 155 FESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLK 214
Query: 185 PNNLL-INKQG-VLKIGDFGLAKFFGSPTRL 213
           P N+L +N+    +KI DFGLA+ +    +L
Sbjct: 215 PENILCVNRDAKQIKIIDFGLARRYKPREKL 245

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 76/160 (47%), Gaps = 15/160 (9%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL-REIKLLQELHHENVLGLTD 124
           G+FA V K R+  T +  A K IK      ++ G++R  + RE+ +L+E+ H NV+ L +
Sbjct: 22  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81
Query: 125 VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           V+   ++V L+ E V               T      +    L G+ YLH   I H DLK
Sbjct: 82  VYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLK 141
Query: 185 PNNLLINKQGV----LKIGDFGLA----------KFFGSP 210
           P N+++  + V    +KI DFGLA            FG+P
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 181

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 76/161 (47%), Gaps = 15/161 (9%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL-REIKLLQELHHENVLGLTD 124
           G+FA V K R+  T +  A K IK      ++ G++R  + RE+ +L+E+ H NV+ L +
Sbjct: 22  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81
Query: 125 VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           V+   ++V L+ E V               T      +    L G+ YLH   I H DLK
Sbjct: 82  VYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLK 141
Query: 185 PNNLLINKQGV----LKIGDFGLA----------KFFGSPT 211
           P N+++  + V    +KI DFGLA            FG+P 
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPA 182

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 84/159 (52%), Gaps = 11/159 (6%)
Query: 49  EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREI 108
           E+K+D   + +   +  G    VFK     + +++A K I    H + K  I    +RE+
Sbjct: 2   ELKDD--DFEKISELGAGNGGVVFKVSHKPSGLVMARKLI----HLEIKPAIRNQIIREL 55
Query: 109 KLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNI-KAYAIMT 166
           ++L E +   ++G    F     +S+  E +D   L+ ++K    +  P  I    +I  
Sbjct: 56  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI--PEQILGKVSIAV 113
Query: 167 LRGLEYLHD-HWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           ++GL YL + H I+HRD+KP+N+L+N +G +K+ DFG++
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 152

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 84/159 (52%), Gaps = 11/159 (6%)
Query: 49  EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREI 108
           E+K+D   + +   +  G    VFK     + +++A K I    H + K  I    +RE+
Sbjct: 2   ELKDD--DFEKISELGAGNGGVVFKVSHKPSGLVMARKLI----HLEIKPAIRNQIIREL 55
Query: 109 KLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNI-KAYAIMT 166
           ++L E +   ++G    F     +S+  E +D   L+ ++K    +  P  I    +I  
Sbjct: 56  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI--PEQILGKVSIAV 113
Query: 167 LRGLEYLHD-HWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           ++GL YL + H I+HRD+KP+N+L+N +G +K+ DFG++
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 152

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 84/159 (52%), Gaps = 11/159 (6%)
Query: 49  EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREI 108
           E+K+D   + +   +  G    VFK     + +++A K I    H + K  I    +RE+
Sbjct: 64  ELKDD--DFEKISELGAGNGGVVFKVSHKPSGLVMARKLI----HLEIKPAIRNQIIREL 117
Query: 109 KLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNI-KAYAIMT 166
           ++L E +   ++G    F     +S+  E +D   L+ ++K    +  P  I    +I  
Sbjct: 118 QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI--PEQILGKVSIAV 175
Query: 167 LRGLEYLHD-HWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           ++GL YL + H I+HRD+KP+N+L+N +G +K+ DFG++
Sbjct: 176 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 214

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 84/159 (52%), Gaps = 11/159 (6%)
Query: 49  EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREI 108
           E+K+D   + +   +  G    VFK     + +++A K I    H + K  I    +RE+
Sbjct: 2   ELKDD--DFEKISELGAGNGGVVFKVSHKPSGLVMARKLI----HLEIKPAIRNQIIREL 55
Query: 109 KLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNI-KAYAIMT 166
           ++L E +   ++G    F     +S+  E +D   L+ ++K    +  P  I    +I  
Sbjct: 56  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI--PEQILGKVSIAV 113
Query: 167 LRGLEYLHD-HWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           ++GL YL + H I+HRD+KP+N+L+N +G +K+ DFG++
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 152

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 84/159 (52%), Gaps = 11/159 (6%)
Query: 49  EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREI 108
           E+K+D   + +   +  G    VFK     + +++A K I    H + K  I    +RE+
Sbjct: 2   ELKDD--DFEKISELGAGNGGVVFKVSHKPSGLVMARKLI----HLEIKPAIRNQIIREL 55
Query: 109 KLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNI-KAYAIMT 166
           ++L E +   ++G    F     +S+  E +D   L+ ++K    +  P  I    +I  
Sbjct: 56  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI--PEQILGKVSIAV 113
Query: 167 LRGLEYLHD-HWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           ++GL YL + H I+HRD+KP+N+L+N +G +K+ DFG++
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 152

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 84/159 (52%), Gaps = 11/159 (6%)
Query: 49  EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREI 108
           E+K+D   + +   +  G    VFK     + +++A K I    H + K  I    +RE+
Sbjct: 2   ELKDD--DFEKISELGAGNGGVVFKVSHKPSGLVMARKLI----HLEIKPAIRNQIIREL 55
Query: 109 KLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNI-KAYAIMT 166
           ++L E +   ++G    F     +S+  E +D   L+ ++K    +  P  I    +I  
Sbjct: 56  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI--PEQILGKVSIAV 113
Query: 167 LRGLEYLHD-HWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           ++GL YL + H I+HRD+KP+N+L+N +G +K+ DFG++
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 152

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 76/160 (47%), Gaps = 15/160 (9%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL-REIKLLQELHHENVLGLTD 124
           G+FA V K R+  T +  A K IK      ++ G++R  + RE+ +L+E+ H NV+ L +
Sbjct: 22  GKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81
Query: 125 VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           V+   ++V L+ E V               T      +    L G+ YLH   I H DLK
Sbjct: 82  VYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLK 141
Query: 185 PNNLLINKQGV----LKIGDFGLA----------KFFGSP 210
           P N+++  + V    +KI DFGLA            FG+P
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 181

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 84/159 (52%), Gaps = 11/159 (6%)
Query: 49  EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREI 108
           E+K+D   + +   +  G    VFK     + +++A K I    H + K  I    +RE+
Sbjct: 29  ELKDD--DFEKISELGAGNGGVVFKVSHKPSGLVMARKLI----HLEIKPAIRNQIIREL 82
Query: 109 KLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNI-KAYAIMT 166
           ++L E +   ++G    F     +S+  E +D   L+ ++K    +  P  I    +I  
Sbjct: 83  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI--PEQILGKVSIAV 140
Query: 167 LRGLEYLHD-HWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           ++GL YL + H I+HRD+KP+N+L+N +G +K+ DFG++
Sbjct: 141 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 179

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 84/159 (52%), Gaps = 11/159 (6%)
Query: 49  EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREI 108
           E+K+D   + +   +  G    VFK     + +++A K I    H + K  I    +RE+
Sbjct: 5   ELKDD--DFEKISELGAGNGGVVFKVSHKPSGLVMARKLI----HLEIKPAIRNQIIREL 58
Query: 109 KLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNI-KAYAIMT 166
           ++L E +   ++G    F     +S+  E +D   L+ ++K    +  P  I    +I  
Sbjct: 59  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI--PEQILGKVSIAV 116
Query: 167 LRGLEYLHD-HWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           ++GL YL + H I+HRD+KP+N+L+N +G +K+ DFG++
Sbjct: 117 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 155

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 84/159 (52%), Gaps = 11/159 (6%)
Query: 49  EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREI 108
           E+K+D   + +   +  G    VFK     + +++A K I    H + K  I    +RE+
Sbjct: 21  ELKDD--DFEKISELGAGNGGVVFKVSHKPSGLVMARKLI----HLEIKPAIRNQIIREL 74
Query: 109 KLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNI-KAYAIMT 166
           ++L E +   ++G    F     +S+  E +D   L+ ++K    +  P  I    +I  
Sbjct: 75  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI--PEQILGKVSIAV 132
Query: 167 LRGLEYLHD-HWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           ++GL YL + H I+HRD+KP+N+L+N +G +K+ DFG++
Sbjct: 133 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 171

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 76/160 (47%), Gaps = 15/160 (9%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL-REIKLLQELHHENVLGLTD 124
           G+FA V K R+  T +  A K IK      ++ G++R  + RE+ +L+E+ H NV+ L +
Sbjct: 21  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 80
Query: 125 VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           V+   ++V L+ E V               T      +    L G+ YLH   I H DLK
Sbjct: 81  VYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLK 140
Query: 185 PNNLLINKQGV----LKIGDFGLA----------KFFGSP 210
           P N+++  + V    +KI DFGLA            FG+P
Sbjct: 141 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 180

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 76/160 (47%), Gaps = 15/160 (9%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL-REIKLLQELHHENVLGLTD 124
           G+FA V K R+  T +  A K IK      ++ G++R  + RE+ +L+E+ H NV+ L +
Sbjct: 22  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81
Query: 125 VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           V+   ++V L+ E V               T      +    L G+ YLH   I H DLK
Sbjct: 82  VYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLK 141
Query: 185 PNNLLINKQGV----LKIGDFGLA----------KFFGSP 210
           P N+++  + V    +KI DFGLA            FG+P
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 181

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 76/160 (47%), Gaps = 15/160 (9%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL-REIKLLQELHHENVLGLTD 124
           G+FA V K R+  T +  A K IK      ++ G++R  + RE+ +L+E+ H NV+ L +
Sbjct: 21  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 80
Query: 125 VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           V+   ++V L+ E V               T      +    L G+ YLH   I H DLK
Sbjct: 81  VYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLK 140
Query: 185 PNNLLINKQGV----LKIGDFGLA----------KFFGSP 210
           P N+++  + V    +KI DFGLA            FG+P
Sbjct: 141 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 180

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 76/160 (47%), Gaps = 15/160 (9%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL-REIKLLQELHHENVLGLTD 124
           G+FA V K R+  T +  A K IK      ++ G++R  + RE+ +L+E+ H NV+ L +
Sbjct: 22  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81
Query: 125 VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           V+   ++V L+ E V               T      +    L G+ YLH   I H DLK
Sbjct: 82  VYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLK 141
Query: 185 PNNLLINKQGV----LKIGDFGLA----------KFFGSP 210
           P N+++  + V    +KI DFGLA            FG+P
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 181

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 85/170 (50%), Gaps = 18/170 (10%)
Query: 47  DCEVKNDLLVY-YQWRS------VHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDG 99
           DCE  +DLL Y Y++        +  G +  V+  RD+   + +A+K+I      D++  
Sbjct: 9   DCE--SDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEI---PERDSR-- 61
Query: 100 INRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFV-DTDLEVIIKDP--TIVFTP 156
            ++    EI L + L H+N++     F     + +  E V    L  +++     +    
Sbjct: 62  YSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNE 121
Query: 157 SNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK-QGVLKIGDFGLAK 205
             I  Y    L GL+YLHD+ I+HRD+K +N+LIN   GVLKI DFG +K
Sbjct: 122 QTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSK 171

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 76/160 (47%), Gaps = 15/160 (9%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL-REIKLLQELHHENVLGLTD 124
           G+FA V K R+  T +  A K IK      ++ G++R  + RE+ +L+E+ H NV+ L +
Sbjct: 22  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81
Query: 125 VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           V+   ++V L+ E V               T      +    L G+ YLH   I H DLK
Sbjct: 82  VYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLK 141
Query: 185 PNNLLINKQGV----LKIGDFGLA----------KFFGSP 210
           P N+++  + V    +KI DFGLA            FG+P
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 181

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 76/160 (47%), Gaps = 15/160 (9%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL-REIKLLQELHHENVLGLTD 124
           G+FA V K R+  T +  A K IK      ++ G++R  + RE+ +L+E+ H NV+ L +
Sbjct: 22  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81
Query: 125 VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           V+   ++V L+ E V               T      +    L G+ YLH   I H DLK
Sbjct: 82  VYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLK 141
Query: 185 PNNLLINKQGV----LKIGDFGLA----------KFFGSP 210
           P N+++  + V    +KI DFGLA            FG+P
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 181

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 76/160 (47%), Gaps = 15/160 (9%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL-REIKLLQELHHENVLGLTD 124
           G+FA V K R+  T +  A K IK      ++ G++R  + RE+ +L+E+ H NV+ L +
Sbjct: 22  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81
Query: 125 VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           V+   ++V L+ E V               T      +    L G+ YLH   I H DLK
Sbjct: 82  VYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLK 141
Query: 185 PNNLLINKQGV----LKIGDFGLA----------KFFGSP 210
           P N+++  + V    +KI DFGLA            FG+P
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 181

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 76/160 (47%), Gaps = 15/160 (9%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL-REIKLLQELHHENVLGLTD 124
           G+FA V K R+  T +  A K IK      ++ G++R  + RE+ +L+E+ H NV+ L +
Sbjct: 22  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81
Query: 125 VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           V+   ++V L+ E V               T      +    L G+ YLH   I H DLK
Sbjct: 82  VYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLK 141
Query: 185 PNNLLINKQGV----LKIGDFGLA----------KFFGSP 210
           P N+++  + V    +KI DFGLA            FG+P
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 181

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 85/176 (48%), Gaps = 12/176 (6%)
Query: 46  PDCEVKNDLLVYYQWRSV-HVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTA 104
           P  +   D+   Y +R V   G F+ V  A D  T  +VA+K I      +A +G   + 
Sbjct: 8   PRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA----KEALEGKEGSM 63
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAY 162
             EI +L ++ H N++ L D++    ++ L+ + V      + I++     +T  +    
Sbjct: 64  ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRL 121
Query: 163 AIMTLRGLEYLHDHWILHRDLKPNNLL---INKQGVLKIGDFGLAKFFGSPTRLYT 215
               L  ++YLHD  I+HRDLKP NLL   +++   + I DFGL+K     + L T
Sbjct: 122 IFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST 177

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 121/260 (46%), Gaps = 44/260 (16%)
Query: 56  VYYQWRSVHV---GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQ 112
           V Y++  + V   G F  V KA D +    VA+K ++       +   +R A  EI++L+
Sbjct: 95  VAYRYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVR------NEKRFHRQAAEEIRILE 148
Query: 113 ELHHE------NVLGLTDVFGYMSNVSLVFEFVDTDL-EVIIKDPTIVFTPSNIKAYAIM 165
            L  +      NV+ + + F + +++ + FE +  +L E+I K+    F+   ++ +A  
Sbjct: 149 HLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHS 208
Query: 166 TLRGLEYLHDHWILHRDLKPNNLLINKQGV--LKIGDFGLAKFFGSPTRLYTHQVV---- 219
            L+ L+ LH + I+H DLKP N+L+ +QG   +K+ DFG        +  Y HQ V    
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG--------SSCYEHQRVYXXI 260
Query: 220 -TRWYRLIKCLLYCVQFNVKNVQW---CCFAKDPSSHGNLFPGIPLNEIFTAAGDDLLAV 275
            +R+YR  + +L   ++ +    W   C  A+       L  G PL  +      D LA 
Sbjct: 261 QSRFYRAPEVIL-GARYGMPIDMWSLGCILAE-------LLTGYPL--LPGEDEGDQLAC 310
Query: 276 ISSLLCLNPTKRADCTATLK 295
           +  LL +   K  D +   K
Sbjct: 311 MIELLGMPXQKLLDASKRAK 330

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKL-----GTHADAKDGINR---TALREI 108
           Y++ R +  G +  V   ++       A+K IK      G ++D    I +       EI
Sbjct: 38  YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97
Query: 109 KLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAIMT 166
            LL+ L H N++ L DVF       LV EF +     E II      F   +        
Sbjct: 98  SLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK--FDECDAANIMKQI 155
Query: 167 LRGLEYLHDHWILHRDLKPNNLLI-NKQGVL--KIGDFGLAKFFGSPTRLYTHQVVTRWY 223
           L G+ YLH H I+HRD+KP N+L+ NK  +L  KI DFGL+ FF    +L   ++ T +Y
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL-RDRLGTAYY 214
Query: 224 RLIKCLLYCVQFNVKNVQWCC 244
             I   +   ++N K   W C
Sbjct: 215 --IAPEVLKKKYNEKCDVWSC 233

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 65/142 (45%), Gaps = 2/142 (1%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           R +  G+F  V+ AR+ +   I+A+K   L      K+G+     REI++   L H N+L
Sbjct: 21  RPLGKGKFGNVYLAREKQNKFIMALKV--LFKSQLEKEGVEHQLRREIEIQSHLRHPNIL 78
Query: 121 GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
            + + F     + L+ EF               F       +       L Y H+  ++H
Sbjct: 79  RMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIH 138
Query: 181 RDLKPNNLLINKQGVLKIGDFG 202
           RD+KP NLL+  +G LKI DFG
Sbjct: 139 RDIKPENLLMGYKGELKIADFG 160

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 85/176 (48%), Gaps = 12/176 (6%)
Query: 46  PDCEVKNDLLVYYQWRSV-HVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTA 104
           P  +   D+   Y +R V   G F+ V  A D  T  +VA+K I      +A +G   + 
Sbjct: 8   PRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA----KEALEGKEGSM 63
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAY 162
             EI +L ++ H N++ L D++    ++ L+ + V      + I++     +T  +    
Sbjct: 64  ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRL 121
Query: 163 AIMTLRGLEYLHDHWILHRDLKPNNLL---INKQGVLKIGDFGLAKFFGSPTRLYT 215
               L  ++YLHD  I+HRDLKP NLL   +++   + I DFGL+K     + L T
Sbjct: 122 IFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST 177

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 65/142 (45%), Gaps = 2/142 (1%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           R +  G+F  V+ AR+ +   I+A+K   L      K+G+     REI++   L H N+L
Sbjct: 20  RPLGKGKFGNVYLAREKQNKFIMALKV--LFKSQLEKEGVEHQLRREIEIQSHLRHPNIL 77
Query: 121 GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
            + + F     + L+ EF               F       +       L Y H+  ++H
Sbjct: 78  RMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIH 137
Query: 181 RDLKPNNLLINKQGVLKIGDFG 202
           RD+KP NLL+  +G LKI DFG
Sbjct: 138 RDIKPENLLMGYKGELKIADFG 159

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 85/176 (48%), Gaps = 12/176 (6%)
Query: 46  PDCEVKNDLLVYYQWRSV-HVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTA 104
           P  +   D+   Y +R V   G F+ V  A D  T  +VA+K I      +A +G   + 
Sbjct: 8   PRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA----KEALEGKEGSM 63
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAY 162
             EI +L ++ H N++ L D++    ++ L+ + V      + I++     +T  +    
Sbjct: 64  ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRL 121
Query: 163 AIMTLRGLEYLHDHWILHRDLKPNNLL---INKQGVLKIGDFGLAKFFGSPTRLYT 215
               L  ++YLHD  I+HRDLKP NLL   +++   + I DFGL+K     + L T
Sbjct: 122 IFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST 177

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 76/160 (47%), Gaps = 15/160 (9%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL-REIKLLQELHHENVLGLTD 124
           G+FA V K R+  T +  A K IK      ++ G++R  + RE+ +L+E+ H NV+ L +
Sbjct: 22  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81
Query: 125 VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           V+   ++V L+ E V               T      +    L G+ YLH   I H DLK
Sbjct: 82  VYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLK 141
Query: 185 PNNLLINKQGV----LKIGDFGLA----------KFFGSP 210
           P N+++  + V    +KI DFGLA            FG+P
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 181

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 15/169 (8%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL-REIKLLQELH 115
           Y     +  G+FA V K R   T    A K IK    + ++ G++R  + RE+ +L+E+ 
Sbjct: 14  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 73
Query: 116 HENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
           H N++ L D+F   ++V L+ E V               T      +    L G+ YLH 
Sbjct: 74  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 133
Query: 176 HWILHRDLKPNNLLINKQGV----LKIGDFGLA----------KFFGSP 210
             I H DLKP N+++  + V    +K+ DFG+A            FG+P
Sbjct: 134 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTP 182

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 15/169 (8%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL-REIKLLQELH 115
           Y     +  G+FA V K R   T    A K IK    + ++ G++R  + RE+ +L+E+ 
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 116 HENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
           H N++ L D+F   ++V L+ E V               T      +    L G+ YLH 
Sbjct: 67  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 126
Query: 176 HWILHRDLKPNNLLINKQGV----LKIGDFGLA----------KFFGSP 210
             I H DLKP N+++  + V    +K+ DFG+A            FG+P
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTP 175

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 76/160 (47%), Gaps = 15/160 (9%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL-REIKLLQELHHENVLGLTD 124
           G+FA V K R+  T +  A K IK      ++ G++R  + RE+ +L+E+ H NV+ L +
Sbjct: 22  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81
Query: 125 VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           V+   ++V L+ E V               T      +    L G+ YLH   I H DLK
Sbjct: 82  VYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLK 141
Query: 185 PNNLLINKQGV----LKIGDFGLA----------KFFGSP 210
           P N+++  + V    +KI DFGLA            FG+P
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 181

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 12/167 (7%)
Query: 46  PDCEVKNDLLVYYQWRSV-HVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTA 104
           P  +   D+   Y +R V   G F+ V  A D  T  +VA+K I       A +G   + 
Sbjct: 8   PRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA----KKALEGKEGSM 63
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAY 162
             EI +L ++ H N++ L D++    ++ L+ + V      + I++     +T  +    
Sbjct: 64  ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRL 121
Query: 163 AIMTLRGLEYLHDHWILHRDLKPNNLL---INKQGVLKIGDFGLAKF 206
               L  ++YLHD  I+HRDLKP NLL   +++   + I DFGL+K 
Sbjct: 122 IFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 168

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 75/160 (46%), Gaps = 15/160 (9%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL-REIKLLQELHHENVLGLTD 124
           G FA V K R+  T +  A K IK      ++ G++R  + RE+ +L+E+ H NV+ L +
Sbjct: 22  GVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81
Query: 125 VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           V+   ++V L+ E V               T      +    L G+ YLH   I H DLK
Sbjct: 82  VYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLK 141
Query: 185 PNNLLINKQGV----LKIGDFGLA----------KFFGSP 210
           P N+++  + V    +KI DFGLA            FG+P
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 181

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 15/169 (8%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL-REIKLLQELH 115
           Y     +  G+FA V K R   T    A K IK      ++ G++R  + RE+ +L+E+ 
Sbjct: 28  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIR 87
Query: 116 HENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
           H N++ L D+F   ++V L+ E V               T      +    L G+ YLH 
Sbjct: 88  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 147
Query: 176 HWILHRDLKPNNLLINKQGV----LKIGDFGLA----------KFFGSP 210
             I H DLKP N+++  + V    +K+ DFG+A            FG+P
Sbjct: 148 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTP 196

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 87/174 (50%), Gaps = 13/174 (7%)
Query: 56  VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH 115
           +Y + + +  G +  V   RD  T +  A+K I+  + + +    N   L E+ +L+ L 
Sbjct: 38  MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS---NSKLLEEVAVLKLLD 94
Query: 116 HENVLGLTDVFGYMSNVSLVFE-FVDTDL--EVIIKDPTIVFTPSNIKAYAIMTLRGLEY 172
           H N++ L D F    N  LV E +   +L  E+I +   + F   +        L G+ Y
Sbjct: 95  HPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTY 151
Query: 173 LHDHWILHRDLKPNNLLI---NKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWY 223
           LH H I+HRDLKP NLL+    K  ++KI DFGL+  F +  ++   ++ T +Y
Sbjct: 152 LHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM-KERLGTAYY 204

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 77/160 (48%), Gaps = 15/160 (9%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL-REIKLLQELHHENVLGLTD 124
           G+FA V K R+  T +  A K IK      ++ G++R  + RE+ +L+++ H NV+ L D
Sbjct: 23  GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHD 82
Query: 125 VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           V+   ++V L+ E V               +     ++    L G+ YLH   I H DLK
Sbjct: 83  VYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLK 142
Query: 185 PNNLLINKQGV----LKIGDFGLA----------KFFGSP 210
           P N+++  + +    +K+ DFGLA            FG+P
Sbjct: 143 PENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP 182

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 77/160 (48%), Gaps = 15/160 (9%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL-REIKLLQELHHENVLGLTD 124
           G+FA V K R+  T +  A K IK      ++ G++R  + RE+ +L+++ H NV+ L D
Sbjct: 23  GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHD 82
Query: 125 VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           V+   ++V L+ E V               +     ++    L G+ YLH   I H DLK
Sbjct: 83  VYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLK 142
Query: 185 PNNLLINKQGV----LKIGDFGLA----------KFFGSP 210
           P N+++  + +    +K+ DFGLA            FG+P
Sbjct: 143 PENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP 182

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 77/160 (48%), Gaps = 15/160 (9%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL-REIKLLQELHHENVLGLTD 124
           G+FA V K R+  T +  A K IK      ++ G++R  + RE+ +L+++ H NV+ L D
Sbjct: 23  GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHD 82
Query: 125 VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           V+   ++V L+ E V               +     ++    L G+ YLH   I H DLK
Sbjct: 83  VYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLK 142
Query: 185 PNNLLINKQGV----LKIGDFGLA----------KFFGSP 210
           P N+++  + +    +K+ DFGLA            FG+P
Sbjct: 143 PENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP 182

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 77/160 (48%), Gaps = 15/160 (9%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL-REIKLLQELHHENVLGLTD 124
           G+FA V K R+  T +  A K IK      ++ G++R  + RE+ +L+++ H NV+ L D
Sbjct: 23  GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHD 82
Query: 125 VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           V+   ++V L+ E V               +     ++    L G+ YLH   I H DLK
Sbjct: 83  VYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLK 142
Query: 185 PNNLLINKQGV----LKIGDFGLA----------KFFGSP 210
           P N+++  + +    +K+ DFGLA            FG+P
Sbjct: 143 PENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP 182

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 77/160 (48%), Gaps = 15/160 (9%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL-REIKLLQELHHENVLGLTD 124
           G+FA V K R+  T +  A K IK      ++ G++R  + RE+ +L+++ H NV+ L D
Sbjct: 23  GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHD 82
Query: 125 VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           V+   ++V L+ E V               +     ++    L G+ YLH   I H DLK
Sbjct: 83  VYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLK 142
Query: 185 PNNLLINKQGV----LKIGDFGLA----------KFFGSP 210
           P N+++  + +    +K+ DFGLA            FG+P
Sbjct: 143 PENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP 182

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 73/144 (50%), Gaps = 9/144 (6%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+  RD+   + +A+K+I      D++   ++    EI L + L H+N++     
Sbjct: 19  GTYGIVYAGRDLSNQVRIAIKEI---PERDSR--YSQPLHEEIALHKHLKHKNIVQYLGS 73
Query: 126 FGYMSNVSLVFEFV-DTDLEVIIKDP--TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
           F     + +  E V    L  +++     +      I  Y    L GL+YLHD+ I+HRD
Sbjct: 74  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRD 133
Query: 183 LKPNNLLINK-QGVLKIGDFGLAK 205
           +K +N+LIN   GVLKI DFG +K
Sbjct: 134 IKGDNVLINTYSGVLKISDFGTSK 157

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 103/216 (47%), Gaps = 26/216 (12%)
Query: 16  SNCFFGGSNIFASSVWYIRVHSALKKQYLLPDCEV----KNDLLVYYQWRSVHVGRFAT- 70
           S    G  N++  S+  +   +A     L+PD  +    ++ L  +++  S  +GR AT 
Sbjct: 9   SGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVES-ELGRGATS 67
Query: 71  -VFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM 129
            V++ +   T    A+K +K     D K  I RT   EI +L  L H N++ L ++F   
Sbjct: 68  IVYRCKQKGTQKPYALKVLK--KTVDKK--IVRT---EIGVLLRLSHPNIIKLKEIFETP 120
Query: 130 SNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAI-MTLRGLEYLHDHWILHRDLKPNNL 188
           + +SLV E V T  E+  +     +      A A+   L  + YLH++ I+HRDLKP NL
Sbjct: 121 TEISLVLELV-TGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENL 179
Query: 189 LINK---QGVLKIGDFGLAKFFGSPTRLYTHQVVTR 221
           L         LKI DFGL+K       +  HQV+ +
Sbjct: 180 LYATPAPDAPLKIADFGLSK-------IVEHQVLMK 208

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 110/266 (41%), Gaps = 33/266 (12%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y   +++  G F  V  A    T   VA+K I       AK  +     REI  L+ L H
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTTTGQKVALKII--NKKVLAKSDMQGRIEREISYLRLLRH 63
Query: 117 ENVLGLTDVFGYMSNVSLVFEFVDTDL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
            +++ L DV      + +V E+   +L + I++   +  +    + +    +  +EY H 
Sbjct: 64  PHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKM--SEQEARRFFQQIISAVEYCHR 121
Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFGLAKFF----------GSPT---------RLYTH 216
           H I+HRDLKP NLL+++   +KI DFGL+             GSP          +LY  
Sbjct: 122 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 181
Query: 217 QVVTRWY-RLIKCLLYCVQFNVKNVQWCCFAKDPSSHGNLFPGIPLNEIFTAAGDDLLAV 275
             V  W   +I  ++ C +    +       K+ S+     P       F + G     +
Sbjct: 182 PEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK------FLSPG--AAGL 233
Query: 276 ISSLLCLNPTKRADCTATLKMDYFSL 301
           I  +L +NP  R      ++ D+F +
Sbjct: 234 IKRMLIVNPLNRISIHEIMQDDWFKV 259

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 69/143 (48%), Gaps = 4/143 (2%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V +  D ET    AVK +K        +G      +EI+LL+ L H+NV+ L DV
Sbjct: 16  GSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNG-EANVKKEIQLLRRLRHKNVIQLVDV 74
Query: 126 F--GYMSNVSLVFEFVDTDLEVIIKD-PTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
                   + +V E+    ++ ++   P   F       Y    + GLEYLH   I+H+D
Sbjct: 75  LYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKD 134
Query: 183 LKPNNLLINKQGVLKIGDFGLAK 205
           +KP NLL+   G LKI   G+A+
Sbjct: 135 IKPGNLLLTTGGTLKISALGVAE 157

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 110/266 (41%), Gaps = 33/266 (12%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y   +++  G F  V  A    T   VA+K I       AK  +     REI  L+ L H
Sbjct: 16  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKII--NKKVLAKSDMQGRIEREISYLRLLRH 73
Query: 117 ENVLGLTDVFGYMSNVSLVFEFVDTDL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
            +++ L DV      + +V E+   +L + I++   +  +    + +    +  +EY H 
Sbjct: 74  PHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKM--SEQEARRFFQQIISAVEYCHR 131
Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFGLAKFF----------GSPT---------RLYTH 216
           H I+HRDLKP NLL+++   +KI DFGL+             GSP          +LY  
Sbjct: 132 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 191
Query: 217 QVVTRWY-RLIKCLLYCVQFNVKNVQWCCFAKDPSSHGNLFPGIPLNEIFTAAGDDLLAV 275
             V  W   +I  ++ C +    +       K+ S+     P       F + G     +
Sbjct: 192 PEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK------FLSPG--AAGL 243
Query: 276 ISSLLCLNPTKRADCTATLKMDYFSL 301
           I  +L +NP  R      ++ D+F +
Sbjct: 244 IKRMLIVNPLNRISIHEIMQDDWFKV 269

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 75/140 (53%), Gaps = 8/140 (5%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G + +V+KA   ET  IVA+K++ +   +D ++      ++EI ++Q+    +V+     
Sbjct: 40  GSYGSVYKAIHKETGQIVAIKQVPV--ESDLQE-----IIKEISIMQQCDSPHVVKYYGS 92
Query: 126 FGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           +   +++ +V E+     +  II+      T   I      TL+GLEYLH    +HRD+K
Sbjct: 93  YFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIK 152
Query: 185 PNNLLINKQGVLKIGDFGLA 204
             N+L+N +G  K+ DFG+A
Sbjct: 153 AGNILLNTEGHAKLADFGVA 172

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 110/266 (41%), Gaps = 33/266 (12%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y   +++  G F  V  A    T   VA+K I       AK  +     REI  L+ L H
Sbjct: 10  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKII--NKKVLAKSDMQGRIEREISYLRLLRH 67
Query: 117 ENVLGLTDVFGYMSNVSLVFEFVDTDL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
            +++ L DV      + +V E+   +L + I++   +  +    + +    +  +EY H 
Sbjct: 68  PHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKM--SEQEARRFFQQIISAVEYCHR 125
Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFGLAKFF----------GSPT---------RLYTH 216
           H I+HRDLKP NLL+++   +KI DFGL+             GSP          +LY  
Sbjct: 126 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 185
Query: 217 QVVTRWY-RLIKCLLYCVQFNVKNVQWCCFAKDPSSHGNLFPGIPLNEIFTAAGDDLLAV 275
             V  W   +I  ++ C +    +       K+ S+     P       F + G     +
Sbjct: 186 PEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK------FLSPG--AAGL 237
Query: 276 ISSLLCLNPTKRADCTATLKMDYFSL 301
           I  +L +NP  R      ++ D+F +
Sbjct: 238 IKRMLIVNPLNRISIHEIMQDDWFKV 263

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 110/266 (41%), Gaps = 33/266 (12%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y   +++  G F  V  A    T   VA+K I       AK  +     REI  L+ L H
Sbjct: 15  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKII--NKKVLAKSDMQGRIEREISYLRLLRH 72
Query: 117 ENVLGLTDVFGYMSNVSLVFEFVDTDL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
            +++ L DV      + +V E+   +L + I++   +  +    + +    +  +EY H 
Sbjct: 73  PHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKM--SEQEARRFFQQIISAVEYCHR 130
Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFGLAKFF----------GSPT---------RLYTH 216
           H I+HRDLKP NLL+++   +KI DFGL+             GSP          +LY  
Sbjct: 131 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 190
Query: 217 QVVTRWY-RLIKCLLYCVQFNVKNVQWCCFAKDPSSHGNLFPGIPLNEIFTAAGDDLLAV 275
             V  W   +I  ++ C +    +       K+ S+     P       F + G     +
Sbjct: 191 PEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK------FLSPG--AAGL 242
Query: 276 ISSLLCLNPTKRADCTATLKMDYFSL 301
           I  +L +NP  R      ++ D+F +
Sbjct: 243 IKRMLIVNPLNRISIHEIMQDDWFKV 268

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 77/161 (47%), Gaps = 7/161 (4%)
Query: 56  VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH 115
           VY     +  G F+ V +  + ET    AVK + +     +         RE  +   L 
Sbjct: 25  VYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 116 HENVLGLTDVFGYMSNVSLVFEFVD-TDL--EVIIK-DPTIVFTPSNIKAYAIMTLRGLE 171
           H +++ L + +     + +VFEF+D  DL  E++ + D   V++ +    Y    L  L 
Sbjct: 85  HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 172 YLHDHWILHRDLKPNNLLINKQ---GVLKIGDFGLAKFFGS 209
           Y HD+ I+HRD+KP N+L+  +     +K+GDFG+A   G 
Sbjct: 145 YCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGE 185

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 83/173 (47%), Gaps = 12/173 (6%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y   R +  G F  V   +D  T    AVK I         D    + LRE++LL++L H
Sbjct: 34  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD--KESLLREVQLLKQLDH 91
Query: 117 ENVLGLTDVF---GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYL 173
            N++ L + F   GY   V  V+   +   E+I +     F+  +        L G+ Y+
Sbjct: 92  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR---FSEVDAARIIRQVLSGITYM 148
Query: 174 HDHWILHRDLKPNNLLI---NKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWY 223
           H + I+HRDLKP NLL+   +K   ++I DFGL+  F +  ++   ++ T +Y
Sbjct: 149 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM-KDKIGTAYY 200

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 76/160 (47%), Gaps = 15/160 (9%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL-REIKLLQELHHENVLGLTD 124
           G+FA V K R+  T +  A K IK      ++ G+ R  + RE+ +L+++ H N++ L D
Sbjct: 23  GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHD 82
Query: 125 VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           V+   ++V L+ E V               +     ++    L G+ YLH   I H DLK
Sbjct: 83  VYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLK 142
Query: 185 PNNLLINKQGV----LKIGDFGLA----------KFFGSP 210
           P N+++  + +    +K+ DFGLA            FG+P
Sbjct: 143 PENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP 182

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 80/159 (50%), Gaps = 15/159 (9%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y + + +  G +  V   +D  T    A+K IK  +     +  +   L E+ +L++L H
Sbjct: 23  YQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSN--SGALLDEVAVLKQLDH 80
Query: 117 ENVLGLTDVFGYMSNVSLVFE-FVDTDL--EVIIKDPTIVFTPSNIKAYAIM--TLRGLE 171
            N++ L + F    N  LV E +   +L  E+I++        S + A  IM   L G  
Sbjct: 81  PNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKF-----SEVDAAVIMKQVLSGTT 135
Query: 172 YLHDHWILHRDLKPNNLLI---NKQGVLKIGDFGLAKFF 207
           YLH H I+HRDLKP NLL+   ++  ++KI DFGL+  F
Sbjct: 136 YLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF 174

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 83/173 (47%), Gaps = 12/173 (6%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y   R +  G F  V   +D  T    AVK I         D    + LRE++LL++L H
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD--KESLLREVQLLKQLDH 85
Query: 117 ENVLGLTDVF---GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYL 173
            N++ L + F   GY   V  V+   +   E+I +     F+  +        L G+ Y+
Sbjct: 86  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR---FSEVDAARIIRQVLSGITYM 142
Query: 174 HDHWILHRDLKPNNLLI---NKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWY 223
           H + I+HRDLKP NLL+   +K   ++I DFGL+  F +  ++   ++ T +Y
Sbjct: 143 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM-KDKIGTAYY 194

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 83/173 (47%), Gaps = 12/173 (6%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y   R +  G F  V   +D  T    AVK I         D    + LRE++LL++L H
Sbjct: 51  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD--KESLLREVQLLKQLDH 108
Query: 117 ENVLGLTDVF---GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYL 173
            N++ L + F   GY   V  V+   +   E+I +     F+  +        L G+ Y+
Sbjct: 109 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR---FSEVDAARIIRQVLSGITYM 165
Query: 174 HDHWILHRDLKPNNLLI---NKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWY 223
           H + I+HRDLKP NLL+   +K   ++I DFGL+  F +  ++   ++ T +Y
Sbjct: 166 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM-KDKIGTAYY 217

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 83/173 (47%), Gaps = 12/173 (6%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y   R +  G F  V   +D  T    AVK I         D    + LRE++LL++L H
Sbjct: 52  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD--KESLLREVQLLKQLDH 109
Query: 117 ENVLGLTDVF---GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYL 173
            N++ L + F   GY   V  V+   +   E+I +     F+  +        L G+ Y+
Sbjct: 110 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR---FSEVDAARIIRQVLSGITYM 166
Query: 174 HDHWILHRDLKPNNLLI---NKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWY 223
           H + I+HRDLKP NLL+   +K   ++I DFGL+  F +  ++   ++ T +Y
Sbjct: 167 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM-KDKIGTAYY 218

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 85/149 (57%), Gaps = 17/149 (11%)
Query: 118 NVLGLTDVF--GYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH 174
           N++ L D+    +    SL+FE+V+ TD +V+   PT+  T  +I+ Y    L+ L+Y H
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY--PTL--TDYDIRYYIYELLKALDYCH 142
Query: 175 DHWILHRDLKPNNLLINKQ-GVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCV 233
              I+HRD+KP+N++I+ +   L++ D+GLA+F+  P + Y  +V +R+++  + L+   
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 234 QFNVKNVQW---CCFA-----KDPSSHGN 254
            ++     W   C FA     K+P  +G+
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGH 230

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 85/149 (57%), Gaps = 17/149 (11%)
Query: 118 NVLGLTDVF--GYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH 174
           N++ L D+    +    SL+FE+V+ TD +V+   PT+  T  +I+ Y    L+ L+Y H
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY--PTL--TDYDIRYYIYELLKALDYCH 143
Query: 175 DHWILHRDLKPNNLLINKQ-GVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCV 233
              I+HRD+KP+N++I+ +   L++ D+GLA+F+  P + Y  +V +R+++  + L+   
Sbjct: 144 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVDLQ 202
Query: 234 QFNVKNVQW---CCFA-----KDPSSHGN 254
            ++     W   C FA     K+P  +G+
Sbjct: 203 DYDYSLDMWSLGCMFAGMIFRKEPFFYGH 231

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 85/149 (57%), Gaps = 17/149 (11%)
Query: 118 NVLGLTDVF--GYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH 174
           N++ L D+    +    SL+FE+V+ TD +V+   PT+  T  +I+ Y    L+ L+Y H
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY--PTL--TDYDIRYYIYELLKALDYCH 143
Query: 175 DHWILHRDLKPNNLLINKQ-GVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCV 233
              I+HRD+KP+N++I+ +   L++ D+GLA+F+  P + Y  +V +R+++  + L+   
Sbjct: 144 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVDLQ 202
Query: 234 QFNVKNVQW---CCFA-----KDPSSHGN 254
            ++     W   C FA     K+P  +G+
Sbjct: 203 DYDYSLDMWSLGCMFAGMIFRKEPFFYGH 231

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 85/149 (57%), Gaps = 17/149 (11%)
Query: 118 NVLGLTDVF--GYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH 174
           N++ L D+    +    SL+FE+V+ TD +V+   PT+  T  +I+ Y    L+ L+Y H
Sbjct: 108 NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY--PTL--TDYDIRYYIYELLKALDYCH 163
Query: 175 DHWILHRDLKPNNLLINKQ-GVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCV 233
              I+HRD+KP+N++I+ +   L++ D+GLA+F+  P + Y  +V +R+++  + L+   
Sbjct: 164 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVDLQ 222
Query: 234 QFNVKNVQW---CCFA-----KDPSSHGN 254
            ++     W   C FA     K+P  +G+
Sbjct: 223 DYDYSLDMWSLGCMFAGMIFRKEPFFYGH 251

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 85/149 (57%), Gaps = 17/149 (11%)
Query: 118 NVLGLTDVF--GYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH 174
           N++ L D+    +    SL+FE+V+ TD +V+   PT+  T  +I+ Y    L+ L+Y H
Sbjct: 89  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY--PTL--TDYDIRYYIYELLKALDYCH 144
Query: 175 DHWILHRDLKPNNLLINKQ-GVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCV 233
              I+HRD+KP+N++I+ +   L++ D+GLA+F+  P + Y  +V +R+++  + L+   
Sbjct: 145 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVDLQ 203
Query: 234 QFNVKNVQW---CCFA-----KDPSSHGN 254
            ++     W   C FA     K+P  +G+
Sbjct: 204 DYDYSLDMWSLGCMFAGMIFRKEPFFYGH 232

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 85/149 (57%), Gaps = 17/149 (11%)
Query: 118 NVLGLTDVF--GYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH 174
           N++ L D+    +    SL+FE+V+ TD +V+   PT+  T  +I+ Y    L+ L+Y H
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY--PTL--TDYDIRYYIYELLKALDYCH 142
Query: 175 DHWILHRDLKPNNLLINKQ-GVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCV 233
              I+HRD+KP+N++I+ +   L++ D+GLA+F+  P + Y  +V +R+++  + L+   
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 234 QFNVKNVQW---CCFA-----KDPSSHGN 254
            ++     W   C FA     K+P  +G+
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGH 230

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 83/156 (53%), Gaps = 23/156 (14%)
Query: 117 ENVLGLTDVFGYMSNV--------SLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTL 167
           EN+ G T++   +  V        +LVFE+++ TD + + +    + T  +I+ Y    L
Sbjct: 87  ENLRGGTNIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQ----ILTDFDIRFYMYELL 142
Query: 168 RGLEYLHDHWILHRDLKPNNLLIN-KQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           + L+Y H   I+HRD+KP+N++I+ +Q  L++ D+GLA+F+  P + Y  +V +R+++  
Sbjct: 143 KALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFY-HPAQEYNVRVASRYFKGP 201
Query: 227 KCLLYCVQFNVKNVQWC--------CFAKDPSSHGN 254
           + L+    ++     W          F ++P  HG 
Sbjct: 202 ELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQ 237

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 85/149 (57%), Gaps = 17/149 (11%)
Query: 118 NVLGLTDVF--GYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH 174
           N++ L D+    +    SL+FE+V+ TD +V+   PT+  T  +I+ Y    L+ L+Y H
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY--PTL--TDYDIRYYIYELLKALDYCH 142
Query: 175 DHWILHRDLKPNNLLINKQ-GVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCV 233
              I+HRD+KP+N++I+ +   L++ D+GLA+F+  P + Y  +V +R+++  + L+   
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 234 QFNVKNVQW---CCFA-----KDPSSHGN 254
            ++     W   C FA     K+P  +G+
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGH 230

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 85/149 (57%), Gaps = 17/149 (11%)
Query: 118 NVLGLTDVF--GYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH 174
           N++ L D+    +    SL+FE+V+ TD +V+   PT+  T  +I+ Y    L+ L+Y H
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY--PTL--TDYDIRYYIYELLKALDYCH 142
Query: 175 DHWILHRDLKPNNLLINKQ-GVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCV 233
              I+HRD+KP+N++I+ +   L++ D+GLA+F+  P + Y  +V +R+++  + L+   
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 234 QFNVKNVQW---CCFA-----KDPSSHGN 254
            ++     W   C FA     K+P  +G+
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGH 230

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 85/149 (57%), Gaps = 17/149 (11%)
Query: 118 NVLGLTDVF--GYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH 174
           N++ L D+    +    SL+FE+V+ TD +V+   PT+  T  +I+ Y    L+ L+Y H
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY--PTL--TDYDIRYYIYELLKALDYCH 142
Query: 175 DHWILHRDLKPNNLLINKQ-GVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCV 233
              I+HRD+KP+N++I+ +   L++ D+GLA+F+  P + Y  +V +R+++  + L+   
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 234 QFNVKNVQW---CCFA-----KDPSSHGN 254
            ++     W   C FA     K+P  +G+
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGH 230

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 85/149 (57%), Gaps = 17/149 (11%)
Query: 118 NVLGLTDVF--GYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH 174
           N++ L D+    +    SL+FE+V+ TD +V+   PT+  T  +I+ Y    L+ L+Y H
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY--PTL--TDYDIRYYIYELLKALDYCH 142
Query: 175 DHWILHRDLKPNNLLINKQ-GVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCV 233
              I+HRD+KP+N++I+ +   L++ D+GLA+F+  P + Y  +V +R+++  + L+   
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 234 QFNVKNVQW---CCFA-----KDPSSHGN 254
            ++     W   C FA     K+P  +G+
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGH 230

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 87/186 (46%), Gaps = 36/186 (19%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y   + +  G F  V++A+  ++  +VA+KK+  G              RE++++++L H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN---------RELQIMRKLDH 72
Query: 117 ENVLGLTDVFGYMSN-------VSLVFEFVDTDLEVIIKD--------PTIVFTPSNIKA 161
            N++ L   F Y S        ++LV ++V   +  + +         P I      +K 
Sbjct: 73  CNIVRLRYFF-YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-----VKL 126
Query: 162 YAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ-GVLKIGDFGLAKFF--GSPTRLYTHQV 218
           Y     R L Y+H   I HRD+KP NLL++    VLK+ DFG AK    G P   Y   +
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---I 183
Query: 219 VTRWYR 224
            +R+YR
Sbjct: 184 CSRYYR 189

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 80/159 (50%), Gaps = 15/159 (9%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y + + +  G +  V   +D  T    A+K IK  +     +  +   L E+ +L++L H
Sbjct: 6   YQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSN--SGALLDEVAVLKQLDH 63
Query: 117 ENVLGLTDVFGYMSNVSLVFE-FVDTDL--EVIIKDPTIVFTPSNIKAYAIM--TLRGLE 171
            N++ L + F    N  LV E +   +L  E+I++        S + A  IM   L G  
Sbjct: 64  PNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKF-----SEVDAAVIMKQVLSGTT 118
Query: 172 YLHDHWILHRDLKPNNLLI---NKQGVLKIGDFGLAKFF 207
           YLH H I+HRDLKP NLL+   ++  ++KI DFGL+  F
Sbjct: 119 YLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF 157

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 87/186 (46%), Gaps = 36/186 (19%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y   + +  G F  V++A+  ++  +VA+KK+  G              RE++++++L H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN---------RELQIMRKLDH 72
Query: 117 ENVLGLTDVFGYMSN-------VSLVFEFVDTDLEVIIKD--------PTIVFTPSNIKA 161
            N++ L   F Y S        ++LV ++V   +  + +         P I      +K 
Sbjct: 73  CNIVRLRYFF-YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-----VKL 126
Query: 162 YAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ-GVLKIGDFGLAKFF--GSPTRLYTHQV 218
           Y     R L Y+H   I HRD+KP NLL++    VLK+ DFG AK    G P   Y   +
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---I 183
Query: 219 VTRWYR 224
            +R+YR
Sbjct: 184 CSRYYR 189

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 29/206 (14%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL---HHE 117
           R    G F TV   ++  T M VA+KK+        +D   R   RE++++Q+L   HH 
Sbjct: 29  RMAGQGTFGTVQLGKEKSTGMSVAIKKV-------IQDPRFRN--RELQIMQDLAVLHHP 79
Query: 118 NVLGLTDVFGYMSN-------VSLVFEFVDTDLEVIIKD---PTIVFTPSNIKAYAIMTL 167
           N++ L   F  +         +++V E+V   L    ++     +   P  IK +    +
Sbjct: 80  NIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 168 RGLEYLH--DHWILHRDLKPNNLLINK-QGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYR 224
           R +  LH     + HRD+KP+N+L+N+  G LK+ DFG AK   SP+      + +R+YR
Sbjct: 140 RSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL-SPSEPNVAYICSRYYR 198
Query: 225 LIKCLLYCVQFNVKNVQW---CCFAK 247
             + +     +      W   C FA+
Sbjct: 199 APELIFGNQHYTTAVDIWSVGCIFAE 224

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 83/156 (53%), Gaps = 23/156 (14%)
Query: 117 ENVLGLTDVFGYMSNV--------SLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTL 167
           EN+ G T++   +  V        +LVFE+++ TD + + +    + T  +I+ Y    L
Sbjct: 92  ENLRGGTNIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQ----ILTDFDIRFYMYELL 147
Query: 168 RGLEYLHDHWILHRDLKPNNLLIN-KQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
           + L+Y H   I+HRD+KP+N++I+ +Q  L++ D+GLA+F+  P + Y  +V +R+++  
Sbjct: 148 KALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFY-HPAQEYNVRVASRYFKGP 206
Query: 227 KCLLYCVQFNVKNVQWC--------CFAKDPSSHGN 254
           + L+    ++     W          F ++P  HG 
Sbjct: 207 ELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQ 242

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 36/186 (19%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y   + +  G F  V++A+  ++  +VA+KK+        +D   R   RE++++++L H
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQD--KRFKNRELQIMRKLDH 108
Query: 117 ENVLGLTDVFGYMSN-------VSLVFEFVDTDLEVIIKD--------PTIVFTPSNIKA 161
            N++ L   F Y S        ++LV ++V   +  + +         P I      +K 
Sbjct: 109 CNIVRLRYFF-YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-----VKL 162
Query: 162 YAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ-GVLKIGDFGLAKFF--GSPTRLYTHQV 218
           Y     R L Y+H   I HRD+KP NLL++    VLK+ DFG AK    G P   Y   +
Sbjct: 163 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---I 219
Query: 219 VTRWYR 224
            +R+YR
Sbjct: 220 CSRYYR 225

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 36/186 (19%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y   + +  G F  V++A+  ++  +VA+KK+        +D   R   RE++++++L H
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQD--KRFKNRELQIMRKLDH 100
Query: 117 ENVLGLTDVFGYMSN-------VSLVFEFVDTDLEVIIKD--------PTIVFTPSNIKA 161
            N++ L   F Y S        ++LV ++V   +  + +         P I      +K 
Sbjct: 101 CNIVRLRYFF-YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-----VKL 154
Query: 162 YAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ-GVLKIGDFGLAKFF--GSPTRLYTHQV 218
           Y     R L Y+H   I HRD+KP NLL++    VLK+ DFG AK    G P   Y   +
Sbjct: 155 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---I 211
Query: 219 VTRWYR 224
            +R+YR
Sbjct: 212 CSRYYR 217

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 36/186 (19%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y   + +  G F  V++A+  ++  +VA+KK+        +D   R   RE++++++L H
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQD--KRFKNRELQIMRKLDH 106
Query: 117 ENVLGLTDVFGYMSN-------VSLVFEFVDTDLEVIIKD--------PTIVFTPSNIKA 161
            N++ L   F Y S        ++LV ++V   +  + +         P I      +K 
Sbjct: 107 CNIVRLRYFF-YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-----VKL 160
Query: 162 YAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ-GVLKIGDFGLAKFF--GSPTRLYTHQV 218
           Y     R L Y+H   I HRD+KP NLL++    VLK+ DFG AK    G P   Y   +
Sbjct: 161 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---I 217
Query: 219 VTRWYR 224
            +R+YR
Sbjct: 218 CSRYYR 223

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 36/186 (19%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y   + +  G F  V++A+  ++  +VA+KK+        +D   R   RE++++++L H
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQD--KRFKNRELQIMRKLDH 110
Query: 117 ENVLGLTDVFGYMSN-------VSLVFEFVDTDLEVIIKD--------PTIVFTPSNIKA 161
            N++ L   F Y S        ++LV ++V   +  + +         P I      +K 
Sbjct: 111 CNIVRLRYFF-YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-----VKL 164
Query: 162 YAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ-GVLKIGDFGLAKFF--GSPTRLYTHQV 218
           Y     R L Y+H   I HRD+KP NLL++    VLK+ DFG AK    G P   Y   +
Sbjct: 165 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---I 221
Query: 219 VTRWYR 224
            +R+YR
Sbjct: 222 CSRYYR 227

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 36/186 (19%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y   + +  G F  V++A+  ++  +VA+KK+        +D   R   RE++++++L H
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQD--KRFKNRELQIMRKLDH 151
Query: 117 ENVLGLTDVFGYMSN-------VSLVFEFVDTDLEVIIKD--------PTIVFTPSNIKA 161
            N++ L   F Y S        ++LV ++V   +  + +         P I      +K 
Sbjct: 152 CNIVRLRYFF-YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-----VKL 205
Query: 162 YAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ-GVLKIGDFGLAKFF--GSPTRLYTHQV 218
           Y     R L Y+H   I HRD+KP NLL++    VLK+ DFG AK    G P   Y   +
Sbjct: 206 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---I 262
Query: 219 VTRWYR 224
            +R+YR
Sbjct: 263 CSRYYR 268

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 79/157 (50%), Gaps = 8/157 (5%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G  +TV+ A D   ++ VA+K I +      K+   +   RE+    +L H+N++ + DV
Sbjct: 22  GGMSTVYLAEDTILNIKVAIKAIFIPPRE--KEETLKRFEREVHNSSQLSHQNIVSMIDV 79
Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKD--PTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
                   LV E+++   L   I+   P  V T  N   +    L G+++ HD  I+HRD
Sbjct: 80  DEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAIN---FTNQILDGIKHAHDMRIVHRD 136
Query: 183 LKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVV 219
           +KP N+LI+    LKI DFG+AK     +   T+ V+
Sbjct: 137 IKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL 173

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 36/186 (19%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y   + +  G F  V++A+  ++  +VA+KK+        +D   R   RE++++++L H
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQD--KRFKNRELQIMRKLDH 77
Query: 117 ENVLGLTDVFGYMSN-------VSLVFEFVDTDLEVIIKD--------PTIVFTPSNIKA 161
            N++ L   F Y S        ++LV ++V   +  + +         P I      +K 
Sbjct: 78  CNIVRLRYFF-YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-----VKL 131
Query: 162 YAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ-GVLKIGDFGLAKFF--GSPTRLYTHQV 218
           Y     R L Y+H   I HRD+KP NLL++    VLK+ DFG AK    G P   Y   +
Sbjct: 132 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---I 188
Query: 219 VTRWYR 224
            +R+YR
Sbjct: 189 CSRYYR 194

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 36/186 (19%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y   + +  G F  V++A+  ++  +VA+KK+        +D   R   RE++++++L H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQD--KRFKNRELQIMRKLDH 72
Query: 117 ENVLGLTDVFGYMSN-------VSLVFEFVDTDLEVIIKD--------PTIVFTPSNIKA 161
            N++ L   F Y S        ++LV ++V   +  + +         P I      +K 
Sbjct: 73  CNIVRLRYFF-YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-----VKL 126
Query: 162 YAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ-GVLKIGDFGLAKFF--GSPTRLYTHQV 218
           Y     R L Y+H   I HRD+KP NLL++    VLK+ DFG AK    G P   Y   +
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---I 183
Query: 219 VTRWYR 224
            +R+YR
Sbjct: 184 CSRYYR 189

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 36/186 (19%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y   + +  G F  V++A+  ++  +VA+KK+        +D   R   RE++++++L H
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQD--KRFKNRELQIMRKLDH 85
Query: 117 ENVLGLTDVFGYMSN-------VSLVFEFVDTDLEVIIKD--------PTIVFTPSNIKA 161
            N++ L   F Y S        ++LV ++V   +  + +         P I      +K 
Sbjct: 86  CNIVRLRYFF-YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-----VKL 139
Query: 162 YAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ-GVLKIGDFGLAKFF--GSPTRLYTHQV 218
           Y     R L Y+H   I HRD+KP NLL++    VLK+ DFG AK    G P   Y   +
Sbjct: 140 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---I 196
Query: 219 VTRWYR 224
            +R+YR
Sbjct: 197 CSRYYR 202

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 76/170 (44%), Gaps = 12/170 (7%)
Query: 61  RSVHVGRFATVFKAR---DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHE 117
           R +  G F  V   R     + D+ VA+K +K+G     +    R  L E  ++ +  H 
Sbjct: 49  RVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQR----RDFLCEASIMGQFDHP 104
Query: 118 NVLGLTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH 176
           NV+ L  V      V +V EF++   L+  ++     FT   +         G+ YL D 
Sbjct: 105 NVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADM 164
Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAKFF-GSPTRLYT---HQVVTRW 222
             +HRDL   N+L+N   V K+ DFGL++     P  +YT    ++  RW
Sbjct: 165 GYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRW 214

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 86/186 (46%), Gaps = 36/186 (19%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y   + +  G F  V++A+  ++  +VA+KK+  G              RE++++++L H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN---------RELQIMRKLDH 72
Query: 117 ENVLGLTDVFGYMSN-------VSLVFEFVDTDLEVIIKD--------PTIVFTPSNIKA 161
            N++ L   F Y S        ++LV ++V   +  + +         P I      +K 
Sbjct: 73  CNIVRLRYFF-YSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIY-----VKL 126
Query: 162 YAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ-GVLKIGDFGLAKFF--GSPTRLYTHQV 218
           Y     R L Y+H   I HRD+KP NLL++    VLK+ DFG AK    G P       +
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXI 183
Query: 219 VTRWYR 224
            +R+YR
Sbjct: 184 CSRYYR 189

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 78/163 (47%), Gaps = 17/163 (10%)
Query: 63  VHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL 122
           + +G F  V++A  I  +  VAVK  +     D    I     +E KL   L H N++ L
Sbjct: 15  IGIGGFGKVYRAFWIGDE--VAVKAARHDPDEDISQTIENVR-QEAKLFAMLKHPNIIAL 71
Query: 123 TDVFGYMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHW---I 178
             V     N+ LV EF     L  ++    I   P  +  +A+   RG+ YLHD     I
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVLSGKRI--PPDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 179 LHRDLKPNNLLINKQ--------GVLKIGDFGLAKFFGSPTRL 213
           +HRDLK +N+LI ++         +LKI DFGLA+ +   T++
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM 172

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 75/143 (52%), Gaps = 6/143 (4%)
Query: 66  GRFATVFKARDI---ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL 122
           G F  VF  R +   ++  + A+K +K  T    +D +     R+I  L +++H  V+ L
Sbjct: 39  GSFGKVFLVRKVTRPDSGHLYAMKVLKKAT-LKVRDRVRTKMERDI--LADVNHPFVVKL 95
Query: 123 TDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
              F     + L+ +F+            ++FT  ++K Y      GL++LH   I++RD
Sbjct: 96  HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHSLGIIYRD 155
Query: 183 LKPNNLLINKQGVLKIGDFGLAK 205
           LKP N+L++++G +K+ DFGL+K
Sbjct: 156 LKPENILLDEEGHIKLTDFGLSK 178

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 76/145 (52%), Gaps = 10/145 (6%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A +  T+  VAVK + +    D  + I +    EI + + L+HENV+     
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EIXINKMLNHENVVKF--- 69
Query: 126 FGYMSNVSLVFEFVD--TDLEVIIK-DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
           +G+    ++ + F++  +  E+  + +P I     + + +    + G+ YLH   I HRD
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 129
Query: 183 LKPNNLLINKQGVLKIGDFGLAKFF 207
           +KP NLL++++  LKI DFGLA  F
Sbjct: 130 IKPENLLLDERDNLKISDFGLATVF 154

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/140 (31%), Positives = 71/140 (50%), Gaps = 5/140 (3%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V  A   +T   VA+K I        K  ++    REI  L+ L H +++ L DV
Sbjct: 20  GSFGKVKLATHYKTQQKVALKFI--SRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDV 77
Query: 126 FGYMSNVSLVFEFVDTDL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
               +++ +V E+   +L + I++   +  T    + +    +  +EY H H I+HRDLK
Sbjct: 78  ITTPTDIVMVIEYAGGELFDYIVEKKRM--TEDEGRRFFQQIICAIEYCHRHKIVHRDLK 135
Query: 185 PNNLLINKQGVLKIGDFGLA 204
           P NLL++    +KI DFGL+
Sbjct: 136 PENLLLDDNLNVKIADFGLS 155

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 88/186 (47%), Gaps = 36/186 (19%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y   + +  G F  V++A+  ++  +VA+KK+        +D   R   RE++++++L H
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQD--KRFKNRELQIMRKLDH 84
Query: 117 ENVLGLTDVFGYMSN-------VSLVFEFVDTDLEVIIKD--------PTIVFTPSNIKA 161
            N++ L   F Y S        ++LV ++V   +  + +         P I      +K 
Sbjct: 85  CNIVRLRYFF-YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-----VKL 138
Query: 162 YAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ-GVLKIGDFGLAKFF--GSPTRLYTHQV 218
           Y     R L Y+H   I HRD+KP NLL++    VLK+ DFG AK    G P       +
Sbjct: 139 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXI 195
Query: 219 VTRWYR 224
            +R+YR
Sbjct: 196 CSRYYR 201

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 88/186 (47%), Gaps = 36/186 (19%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y   + +  G F  V++A+  ++  +VA+KK+        +D   R   RE++++++L H
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQD--KRFKNRELQIMRKLDH 76
Query: 117 ENVLGLTDVFGYMSN-------VSLVFEFVDTDLEVIIKD--------PTIVFTPSNIKA 161
            N++ L   F Y S        ++LV ++V   +  + +         P I      +K 
Sbjct: 77  CNIVRLRYFF-YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-----VKL 130
Query: 162 YAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ-GVLKIGDFGLAKFF--GSPTRLYTHQV 218
           Y     R L Y+H   I HRD+KP NLL++    VLK+ DFG AK    G P       +
Sbjct: 131 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXI 187
Query: 219 VTRWYR 224
            +R+YR
Sbjct: 188 CSRYYR 193

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 88/185 (47%), Gaps = 34/185 (18%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y   + +  G F  V++A+  ++  +VA+KK+        +D   R   RE++++++L H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQD--KRFKNRELQIMRKLDH 72
Query: 117 ENVLGLTDVF---GYMSNV---SLVFEFVDTDLEVIIKD--------PTIVFTPSNIKAY 162
            N++ L   F   G   +V   +LV ++V   +  + +         P I      +K Y
Sbjct: 73  CNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-----VKLY 127
Query: 163 AIMTLRGLEYLHDHWILHRDLKPNNLLINKQ-GVLKIGDFGLAKFF--GSPTRLYTHQVV 219
                R L Y+H   I HRD+KP NLL++    VLK+ DFG AK    G P       + 
Sbjct: 128 MYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXIC 184
Query: 220 TRWYR 224
           +R+YR
Sbjct: 185 SRYYR 189

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 88/186 (47%), Gaps = 36/186 (19%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y   + +  G F  V++A+  ++  +VA+KK+        +D   R   RE++++++L H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQD--KRFKNRELQIMRKLDH 72
Query: 117 ENVLGLTDVFGYMSN-------VSLVFEFVDTDLEVIIKD--------PTIVFTPSNIKA 161
            N++ L   F Y S        ++LV ++V   +  + +         P I      +K 
Sbjct: 73  CNIVRLRYFF-YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-----VKL 126
Query: 162 YAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ-GVLKIGDFGLAKFF--GSPTRLYTHQV 218
           Y     R L Y+H   I HRD+KP NLL++    VLK+ DFG AK    G P       +
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXI 183
Query: 219 VTRWYR 224
            +R+YR
Sbjct: 184 CSRYYR 189

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 88/186 (47%), Gaps = 36/186 (19%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y   + +  G F  V++A+  ++  +VA+KK+        +D   R   RE++++++L H
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQD--KRFKNRELQIMRKLDH 106
Query: 117 ENVLGLTDVFGYMSN-------VSLVFEFVDTDLEVIIKD--------PTIVFTPSNIKA 161
            N++ L   F Y S        ++LV ++V   +  + +         P I      +K 
Sbjct: 107 CNIVRLRYFF-YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-----VKL 160
Query: 162 YAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ-GVLKIGDFGLAKFF--GSPTRLYTHQV 218
           Y     R L Y+H   I HRD+KP NLL++    VLK+ DFG AK    G P       +
Sbjct: 161 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXI 217
Query: 219 VTRWYR 224
            +R+YR
Sbjct: 218 CSRYYR 223

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 88/186 (47%), Gaps = 36/186 (19%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y   + +  G F  V++A+  ++  +VA+KK+        +D   R   RE++++++L H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQD--KRFKNRELQIMRKLDH 72
Query: 117 ENVLGLTDVFGYMSN-------VSLVFEFVDTDLEVIIKD--------PTIVFTPSNIKA 161
            N++ L   F Y S        ++LV ++V   +  + +         P I      +K 
Sbjct: 73  CNIVRLRYFF-YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-----VKL 126
Query: 162 YAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ-GVLKIGDFGLAKFF--GSPTRLYTHQV 218
           Y     R L Y+H   I HRD+KP NLL++    VLK+ DFG AK    G P       +
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXI 183
Query: 219 VTRWYR 224
            +R+YR
Sbjct: 184 CSRYYR 189

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 88/186 (47%), Gaps = 36/186 (19%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y   + +  G F  V++A+  ++  +VA+KK+        +D   R   RE++++++L H
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQD--KRFKNRELQIMRKLDH 73
Query: 117 ENVLGLTDVFGYMSN-------VSLVFEFVDTDLEVIIKD--------PTIVFTPSNIKA 161
            N++ L   F Y S        ++LV ++V   +  + +         P I      +K 
Sbjct: 74  CNIVRLRYFF-YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-----VKL 127
Query: 162 YAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ-GVLKIGDFGLAKFF--GSPTRLYTHQV 218
           Y     R L Y+H   I HRD+KP NLL++    VLK+ DFG AK    G P       +
Sbjct: 128 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXI 184
Query: 219 VTRWYR 224
            +R+YR
Sbjct: 185 CSRYYR 190

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 91/185 (49%), Gaps = 14/185 (7%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A +  T+  VAVK + +    D  + I +    EI + + L+HENV+     
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EIXINKMLNHENVVKF--- 69
Query: 126 FGYMSNVSLVFEFVD--TDLEVIIK-DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
           +G+    ++ + F++  +  E+  + +P I     + + +    + G+ YLH   I HRD
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 129
Query: 183 LKPNNLLINKQGVLKIGDFGLAKFF--GSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNV 240
           +KP NLL++++  LKI DFGLA  F   +  RL      T  Y +   LL   +F+ + V
Sbjct: 130 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY-VAPELLKRREFHAEPV 188
Query: 241 Q-WCC 244
             W C
Sbjct: 189 DVWSC 193

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 91/185 (49%), Gaps = 14/185 (7%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A +  T+  VAVK + +    D  + I +    EI + + L+HENV+     
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EIXINKMLNHENVVKF--- 70
Query: 126 FGYMSNVSLVFEFVD--TDLEVIIK-DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
           +G+    ++ + F++  +  E+  + +P I     + + +    + G+ YLH   I HRD
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 130
Query: 183 LKPNNLLINKQGVLKIGDFGLAKFF--GSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNV 240
           +KP NLL++++  LKI DFGLA  F   +  RL      T  Y +   LL   +F+ + V
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY-VAPELLKRREFHAEPV 189
Query: 241 Q-WCC 244
             W C
Sbjct: 190 DVWSC 194

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 88/186 (47%), Gaps = 36/186 (19%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y   + +  G F  V++A+  ++  +VA+KK+        +D   R   RE++++++L H
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQD--KRFKNRELQIMRKLDH 91
Query: 117 ENVLGLTDVFGYMSN-------VSLVFEFVDTDLEVIIKD--------PTIVFTPSNIKA 161
            N++ L   F Y S        ++LV ++V   +  + +         P I      +K 
Sbjct: 92  CNIVRLRYFF-YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-----VKL 145
Query: 162 YAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ-GVLKIGDFGLAKFF--GSPTRLYTHQV 218
           Y     R L Y+H   I HRD+KP NLL++    VLK+ DFG AK    G P       +
Sbjct: 146 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXI 202
Query: 219 VTRWYR 224
            +R+YR
Sbjct: 203 CSRYYR 208

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 88/186 (47%), Gaps = 36/186 (19%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y   + +  G F  V++A+  ++  +VA+KK+        +D   R   RE++++++L H
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQD--KRFKNRELQIMRKLDH 84
Query: 117 ENVLGLTDVFGYMSN-------VSLVFEFVDTDLEVIIKD--------PTIVFTPSNIKA 161
            N++ L   F Y S        ++LV ++V   +  + +         P I      +K 
Sbjct: 85  CNIVRLRYFF-YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-----VKL 138
Query: 162 YAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ-GVLKIGDFGLAKFF--GSPTRLYTHQV 218
           Y     R L Y+H   I HRD+KP NLL++    VLK+ DFG AK    G P       +
Sbjct: 139 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXI 195
Query: 219 VTRWYR 224
            +R+YR
Sbjct: 196 CSRYYR 201

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 88/186 (47%), Gaps = 36/186 (19%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y   + +  G F  V++A+  ++  +VA+KK+        +D   R   RE++++++L H
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQD--KRFKNRELQIMRKLDH 80
Query: 117 ENVLGLTDVFGYMSN-------VSLVFEFVDTDLEVIIKD--------PTIVFTPSNIKA 161
            N++ L   F Y S        ++LV ++V   +  + +         P I      +K 
Sbjct: 81  CNIVRLRYFF-YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-----VKL 134
Query: 162 YAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ-GVLKIGDFGLAKFF--GSPTRLYTHQV 218
           Y     R L Y+H   I HRD+KP NLL++    VLK+ DFG AK    G P       +
Sbjct: 135 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXI 191
Query: 219 VTRWYR 224
            +R+YR
Sbjct: 192 CSRYYR 197

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 75/153 (49%), Gaps = 11/153 (7%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
            ++  G F+ V  A +  T  + AVK I       A  G   +   EI +L+++ HEN++
Sbjct: 28  ETLGTGAFSEVVLAEEKATGKLFAVKCIP----KKALKGKESSIENEIAVLRKIKHENIV 83
Query: 121 GLTDVFGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
            L D++   +++ LV + V      + I++     +T  +        L  + YLH   I
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGELFDRIVEKG--FYTEKDASTLIRQVLDAVYYLHRMGI 141
Query: 179 LHRDLKPNNLLI---NKQGVLKIGDFGLAKFFG 208
           +HRDLKP NLL    +++  + I DFGL+K  G
Sbjct: 142 VHRDLKPENLLYYSQDEESKIMISDFGLSKMEG 174

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 81/171 (47%), Gaps = 10/171 (5%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           +++  G F  V   + +ET    A+K +        K  I  T L E ++LQ ++   ++
Sbjct: 47  KTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHT-LNEKRILQAVNFPFLV 104
Query: 121 GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
            L   F   SN+ +V E+V              F+  + + YA   +   EYLH   +++
Sbjct: 105 KLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTHQVVTRWY 223
           RDLKP NLLI++QG +K+ DFG AK          G+P  L    ++++ Y
Sbjct: 165 RDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 81/165 (49%), Gaps = 15/165 (9%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL----REIKLLQ 112
           Y   +++  G FA V  AR + T   VAVK I        K  +N T+L    RE+++++
Sbjct: 17  YRLQKTIGKGNFAKVKLARHVLTGREVAVKIID-------KTQLNPTSLQKLFREVRIMK 69
Query: 113 ELHHENVLGLTDVFGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAIMTLRGL 170
            L+H N++ L +V      + LV E+       + ++    +    +  K   I++   +
Sbjct: 70  ILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS--AV 127
Query: 171 EYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYT 215
           +Y H  +I+HRDLK  NLL++    +KI DFG +  F    +L T
Sbjct: 128 QYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT 172

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 76/145 (52%), Gaps = 10/145 (6%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A +  T+  VAVK + +    D  + I +    EI + + L+HENV+     
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVKF--- 69
Query: 126 FGYMSNVSLVFEFVD--TDLEVIIK-DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
           +G+    ++ + F++  +  E+  + +P I     + + +    + G+ YLH   I HRD
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 129
Query: 183 LKPNNLLINKQGVLKIGDFGLAKFF 207
           +KP NLL++++  LKI DFGLA  F
Sbjct: 130 IKPENLLLDERDNLKISDFGLATVF 154

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 76/145 (52%), Gaps = 10/145 (6%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A +  T+  VAVK + +    D  + I +    EI + + L+HENV+     
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVKF--- 70
Query: 126 FGYMSNVSLVFEFVD--TDLEVIIK-DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
           +G+    ++ + F++  +  E+  + +P I     + + +    + G+ YLH   I HRD
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 130
Query: 183 LKPNNLLINKQGVLKIGDFGLAKFF 207
           +KP NLL++++  LKI DFGLA  F
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVF 155

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 76/145 (52%), Gaps = 10/145 (6%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A +  T+  VAVK + +    D  + I +    EI + + L+HENV+     
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVKF--- 70
Query: 126 FGYMSNVSLVFEFVD--TDLEVIIK-DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
           +G+    ++ + F++  +  E+  + +P I     + + +    + G+ YLH   I HRD
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 130
Query: 183 LKPNNLLINKQGVLKIGDFGLAKFF 207
           +KP NLL++++  LKI DFGLA  F
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVF 155

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 76/145 (52%), Gaps = 10/145 (6%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A +  T+  VAVK + +    D  + I +    EI + + L+HENV+     
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVKF--- 70
Query: 126 FGYMSNVSLVFEFVD--TDLEVIIK-DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
           +G+    ++ + F++  +  E+  + +P I     + + +    + G+ YLH   I HRD
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 130
Query: 183 LKPNNLLINKQGVLKIGDFGLAKFF 207
           +KP NLL++++  LKI DFGLA  F
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVF 155

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 76/145 (52%), Gaps = 10/145 (6%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A +  T+  VAVK + +    D  + I +    EI + + L+HENV+     
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVKF--- 70
Query: 126 FGYMSNVSLVFEFVD--TDLEVIIK-DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
           +G+    ++ + F++  +  E+  + +P I     + + +    + G+ YLH   I HRD
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 130
Query: 183 LKPNNLLINKQGVLKIGDFGLAKFF 207
           +KP NLL++++  LKI DFGLA  F
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVF 155

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 76/145 (52%), Gaps = 10/145 (6%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A +  T+  VAVK + +    D  + I +    EI + + L+HENV+     
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVKF--- 69
Query: 126 FGYMSNVSLVFEFVD--TDLEVIIK-DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
           +G+    ++ + F++  +  E+  + +P I     + + +    + G+ YLH   I HRD
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 129
Query: 183 LKPNNLLINKQGVLKIGDFGLAKFF 207
           +KP NLL++++  LKI DFGLA  F
Sbjct: 130 IKPENLLLDERDNLKISDFGLATVF 154

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 81/165 (49%), Gaps = 15/165 (9%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL----REIKLLQ 112
           Y   +++  G FA V  AR I T   VAVK I        K  +N ++L    RE+++++
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIID-------KTQLNSSSLQKLFREVRIMK 68
Query: 113 ELHHENVLGLTDVFGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAIMTLRGL 170
            L+H N++ L +V      + LV E+       + ++    +    +  K   I++   +
Sbjct: 69  VLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS--AV 126
Query: 171 EYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYT 215
           +Y H  +I+HRDLK  NLL++    +KI DFG +  F    +L T
Sbjct: 127 QYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT 171

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 76/145 (52%), Gaps = 10/145 (6%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A +  T+  VAVK + +    D  + I +    EI + + L+HENV+     
Sbjct: 16  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVKF--- 68
Query: 126 FGYMSNVSLVFEFVD--TDLEVIIK-DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
           +G+    ++ + F++  +  E+  + +P I     + + +    + G+ YLH   I HRD
Sbjct: 69  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 128
Query: 183 LKPNNLLINKQGVLKIGDFGLAKFF 207
           +KP NLL++++  LKI DFGLA  F
Sbjct: 129 IKPENLLLDERDNLKISDFGLATVF 153

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 76/145 (52%), Gaps = 10/145 (6%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A +  T+  VAVK + +    D  + I +    EI + + L+HENV+     
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVKF--- 70
Query: 126 FGYMSNVSLVFEFVD--TDLEVIIK-DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
           +G+    ++ + F++  +  E+  + +P I     + + +    + G+ YLH   I HRD
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 130
Query: 183 LKPNNLLINKQGVLKIGDFGLAKFF 207
           +KP NLL++++  LKI DFGLA  F
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVF 155

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 81/165 (49%), Gaps = 15/165 (9%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL----REIKLLQ 112
           Y   +++  G FA V  AR I T   VAVK I        K  +N ++L    RE+++++
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIID-------KTQLNSSSLQKLFREVRIMK 68
Query: 113 ELHHENVLGLTDVFGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAIMTLRGL 170
            L+H N++ L +V      + LV E+       + ++    +    +  K   I++   +
Sbjct: 69  VLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS--AV 126
Query: 171 EYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYT 215
           +Y H  +I+HRDLK  NLL++    +KI DFG +  F    +L T
Sbjct: 127 QYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT 171

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 75/154 (48%), Gaps = 17/154 (11%)
Query: 61  RSVHVGRFATV----FKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           R +  G F  V    +   +  T  +VAVK +K G     + G  R    EI++L+ L+H
Sbjct: 14  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQR----EIEILRTLYH 69
Query: 117 ENVL---GLTDVFGYMSNVSLVFEFVDTDLEVIIKD--PTIVFTPSNIKAYAIMTLRGLE 171
           E+++   G  +  G  S V LV E+V       ++D  P      + +  +A     G+ 
Sbjct: 70  EHIVKYKGCCEDQGEKS-VQLVMEYVPLG---SLRDYLPRHCVGLAQLLLFAQQICEGMA 125
Query: 172 YLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           YLH    +HR L   N+L++   ++KIGDFGLAK
Sbjct: 126 YLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAK 159

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 75/168 (44%), Gaps = 12/168 (7%)
Query: 63  VHVGRFATVFKAR---DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENV 119
           V  G F  V   R     + ++ VA+K +K+G     +    R  L E  ++ +  H N+
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR----RDFLGEASIMGQFDHPNI 108
Query: 120 LGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
           + L  V      V +V E+++   L+  ++     FT   +         G++YL D   
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAKFF-GSPTRLYT---HQVVTRW 222
           +HRDL   N+LIN   V K+ DFGLA+     P   YT    ++  RW
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRW 216

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 75/154 (48%), Gaps = 17/154 (11%)
Query: 61  RSVHVGRFATV----FKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           R +  G F  V    +   +  T  +VAVK +K G     + G  R    EI++L+ L+H
Sbjct: 15  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQR----EIEILRTLYH 70
Query: 117 ENVL---GLTDVFGYMSNVSLVFEFVDTDLEVIIKD--PTIVFTPSNIKAYAIMTLRGLE 171
           E+++   G  +  G  S V LV E+V       ++D  P      + +  +A     G+ 
Sbjct: 71  EHIVKYKGCCEDQGEKS-VQLVMEYVPLG---SLRDYLPRHCVGLAQLLLFAQQICEGMA 126
Query: 172 YLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           YLH    +HR L   N+L++   ++KIGDFGLAK
Sbjct: 127 YLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAK 160

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 76/145 (52%), Gaps = 10/145 (6%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A +  T+  VAVK + +    D  + I +    EI + + L+HENV+     
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVKF--- 69
Query: 126 FGYMSNVSLVFEFVD--TDLEVIIK-DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
           +G+    ++ + F++  +  E+  + +P I     + + +    + G+ YLH   I HRD
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 129
Query: 183 LKPNNLLINKQGVLKIGDFGLAKFF 207
           +KP NLL++++  LKI DFGLA  F
Sbjct: 130 IKPENLLLDERDNLKISDFGLATVF 154

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 76/145 (52%), Gaps = 10/145 (6%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A +  T+  VAVK + +    D  + I +    EI + + L+HENV+     
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVKF--- 69
Query: 126 FGYMSNVSLVFEFVD--TDLEVIIK-DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
           +G+    ++ + F++  +  E+  + +P I     + + +    + G+ YLH   I HRD
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 129
Query: 183 LKPNNLLINKQGVLKIGDFGLAKFF 207
           +KP NLL++++  LKI DFGLA  F
Sbjct: 130 IKPENLLLDERDNLKISDFGLATVF 154

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 76/170 (44%), Gaps = 12/170 (7%)
Query: 61  RSVHVGRFATVFKAR---DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHE 117
           R +  G F  V   R     + ++ VA+K +K+G     +    R  L E  ++ +  H 
Sbjct: 28  RVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQR----RDFLGEASIMGQFDHP 83
Query: 118 NVLGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH 176
           N++ L  V      V +V E+++   L+  +K     FT   +         G++YL D 
Sbjct: 84  NIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDM 143
Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAKFF-GSPTRLYT---HQVVTRW 222
             +HRDL   N+LIN   V K+ DFGL++     P   YT    ++  RW
Sbjct: 144 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 193

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 76/145 (52%), Gaps = 10/145 (6%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A +  T+  VAVK + +    D  + I +    EI + + L+HENV+     
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVKF--- 69
Query: 126 FGYMSNVSLVFEFVD--TDLEVIIK-DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
           +G+    ++ + F++  +  E+  + +P I     + + +    + G+ YLH   I HRD
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 129
Query: 183 LKPNNLLINKQGVLKIGDFGLAKFF 207
           +KP NLL++++  LKI DFGLA  F
Sbjct: 130 IKPENLLLDERDNLKISDFGLATVF 154

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 76/145 (52%), Gaps = 10/145 (6%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A +  T+  VAVK + +    D  + I +    EI + + L+HENV+     
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVKF--- 70
Query: 126 FGYMSNVSLVFEFVD--TDLEVIIK-DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
           +G+    ++ + F++  +  E+  + +P I     + + +    + G+ YLH   I HRD
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 130
Query: 183 LKPNNLLINKQGVLKIGDFGLAKFF 207
           +KP NLL++++  LKI DFGLA  F
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVF 155

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 79/156 (50%), Gaps = 19/156 (12%)
Query: 61  RSVHVGRFATVFKAR-DIETDMI---VAVKKIKLGTHADAKDGINRTA--LREIKLLQEL 114
           R +  G F  V   R D E D     VAVK +K       + G N  A   +EI++L+ L
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK------PESGGNHIADLKKEIEILRNL 80
Query: 115 HHENVL---GLTDVFGYMSNVSLVFEFVDTDL--EVIIKDPTIVFTPSNIKAYAIMTLRG 169
           +HEN++   G+    G  + + L+ EF+ +    E + K+   +     +K YA+   +G
Sbjct: 81  YHENIVKYKGICTEDG-GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLK-YAVQICKG 138
Query: 170 LEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           ++YL     +HRDL   N+L+  +  +KIGDFGL K
Sbjct: 139 MDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK 174

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 79/156 (50%), Gaps = 19/156 (12%)
Query: 61  RSVHVGRFATVFKAR-DIETDMI---VAVKKIKLGTHADAKDGINRTA--LREIKLLQEL 114
           R +  G F  V   R D E D     VAVK +K       + G N  A   +EI++L+ L
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK------PESGGNHIADLKKEIEILRNL 68
Query: 115 HHENVL---GLTDVFGYMSNVSLVFEFVDTDL--EVIIKDPTIVFTPSNIKAYAIMTLRG 169
           +HEN++   G+    G  + + L+ EF+ +    E + K+   +     +K YA+   +G
Sbjct: 69  YHENIVKYKGICTEDG-GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLK-YAVQICKG 126
Query: 170 LEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           ++YL     +HRDL   N+L+  +  +KIGDFGL K
Sbjct: 127 MDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK 162

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 76/145 (52%), Gaps = 10/145 (6%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A +  T+  VAVK + +    D  + I +    EI + + L+HENV+     
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVKF--- 69
Query: 126 FGYMSNVSLVFEFVD--TDLEVIIK-DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
           +G+    ++ + F++  +  E+  + +P I     + + +    + G+ YLH   I HRD
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 129
Query: 183 LKPNNLLINKQGVLKIGDFGLAKFF 207
           +KP NLL++++  LKI DFGLA  F
Sbjct: 130 IKPENLLLDERDNLKISDFGLATVF 154

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 76/145 (52%), Gaps = 10/145 (6%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A +  T+  VAVK + +    D  + I +    EI + + L+HENV+     
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVKF--- 69
Query: 126 FGYMSNVSLVFEFVD--TDLEVIIK-DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
           +G+    ++ + F++  +  E+  + +P I     + + +    + G+ YLH   I HRD
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 129
Query: 183 LKPNNLLINKQGVLKIGDFGLAKFF 207
           +KP NLL++++  LKI DFGLA  F
Sbjct: 130 IKPENLLLDERDNLKISDFGLATVF 154

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 70/152 (46%), Gaps = 12/152 (7%)
Query: 61  RSVHVGRFATVFKAR----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           R +  G F +V   R       T  +VAVKK++  T    +D       REI++L+ L H
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----FEREIEILKSLQH 73
Query: 117 ENVLGLTDV--FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYL 173
           +N++    V       N+ L+ EF+    L   ++          +  Y     +G+EYL
Sbjct: 74  DNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYL 133
Query: 174 HDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
                +HRDL   N+L+  +  +KIGDFGL K
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTK 165

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 76/145 (52%), Gaps = 10/145 (6%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A +  T+  VAVK + +    D  + I +    EI + + L+HENV+     
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVKF--- 69
Query: 126 FGYMSNVSLVFEFVD--TDLEVIIK-DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
           +G+    ++ + F++  +  E+  + +P I     + + +    + G+ YLH   I HRD
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 129
Query: 183 LKPNNLLINKQGVLKIGDFGLAKFF 207
           +KP NLL++++  LKI DFGLA  F
Sbjct: 130 IKPENLLLDERDNLKISDFGLATVF 154

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 78/157 (49%), Gaps = 15/157 (9%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL----REIKLLQ 112
           Y   +++  G FA V  AR I T   VAVK I        K  +N ++L    RE+++++
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIID-------KTQLNSSSLQKLFREVRIMK 68
Query: 113 ELHHENVLGLTDVFGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAIMTLRGL 170
            L+H N++ L +V      + LV E+       + ++    +    +  K   I++   +
Sbjct: 69  VLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS--AV 126
Query: 171 EYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF 207
           +Y H  +I+HRDLK  NLL++    +KI DFG +  F
Sbjct: 127 QYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF 163

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 91/185 (49%), Gaps = 14/185 (7%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A +  T+  VAVK + +    D  + I +    EI + + L+HENV+     
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVKF--- 69
Query: 126 FGYMSNVSLVFEFVD--TDLEVIIK-DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
           +G+    ++ + F++  +  E+  + +P I     + + +    + G+ YLH   I HRD
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 129
Query: 183 LKPNNLLINKQGVLKIGDFGLAKFF--GSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNV 240
           +KP NLL++++  LKI DFGLA  F   +  RL      T  Y +   LL   +F+ + V
Sbjct: 130 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY-VAPELLKRREFHAEPV 188
Query: 241 Q-WCC 244
             W C
Sbjct: 189 DVWSC 193

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 75/168 (44%), Gaps = 12/168 (7%)
Query: 63  VHVGRFATVFKAR---DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENV 119
           V  G F  V   R     + ++ VA+K +K+G     +    R  L E  ++ +  H N+
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR----RDFLGEASIMGQFDHPNI 79
Query: 120 LGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
           + L  V      V +V E+++   L+  ++     FT   +         G++YL D   
Sbjct: 80  IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 139
Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAKFF-GSPTRLYT---HQVVTRW 222
           +HRDL   N+LIN   V K+ DFGL++     P   YT    ++  RW
Sbjct: 140 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 187

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 80/173 (46%), Gaps = 12/173 (6%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y   R +  G F  V   +D  T    AVK I         D    + LRE++LL++L H
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD--KESLLREVQLLKQLDH 85
Query: 117 ENVLGLTDVF---GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYL 173
            N+  L + F   GY   V  V+   +   E+I +     F+  +        L G+ Y 
Sbjct: 86  PNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR---FSEVDAARIIRQVLSGITYX 142
Query: 174 HDHWILHRDLKPNNLLI---NKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWY 223
           H + I+HRDLKP NLL+   +K   ++I DFGL+  F   ++    ++ T +Y
Sbjct: 143 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-EASKKXKDKIGTAYY 194

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 75/168 (44%), Gaps = 12/168 (7%)
Query: 63  VHVGRFATVFKAR---DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENV 119
           V  G F  V   R     + ++ VA+K +K+G     +    R  L E  ++ +  H N+
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR----RDFLGEASIMGQFDHPNI 108
Query: 120 LGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
           + L  V      V +V E+++   L+  ++     FT   +         G++YL D   
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGF 168
Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAKFF-GSPTRLYT---HQVVTRW 222
           +HRDL   N+LIN   V K+ DFGL++     P   YT    ++  RW
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 216

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 75/168 (44%), Gaps = 12/168 (7%)
Query: 63  VHVGRFATVFKAR---DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENV 119
           V  G F  V   R     + ++ VA+K +K+G     +    R  L E  ++ +  H N+
Sbjct: 41  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR----RDFLGEASIMGQFDHPNI 96
Query: 120 LGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
           + L  V      V +V E+++   L+  ++     FT   +         G++YL D   
Sbjct: 97  IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 156
Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAKFF-GSPTRLYT---HQVVTRW 222
           +HRDL   N+LIN   V K+ DFGL++     P   YT    ++  RW
Sbjct: 157 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 204

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 75/145 (51%), Gaps = 10/145 (6%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A +  T+  VAVK + +    D  + I +    EI +   L+HENV+     
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINAMLNHENVVKF--- 70
Query: 126 FGYMSNVSLVFEFVD--TDLEVIIK-DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
           +G+    ++ + F++  +  E+  + +P I     + + +    + G+ YLH   I HRD
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 130
Query: 183 LKPNNLLINKQGVLKIGDFGLAKFF 207
           +KP NLL++++  LKI DFGLA  F
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVF 155

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 81/165 (49%), Gaps = 15/165 (9%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL----REIKLLQ 112
           Y   +++  G FA V  AR I T   VAV+ I        K  +N ++L    RE+++++
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIID-------KTQLNSSSLQKLFREVRIMK 68
Query: 113 ELHHENVLGLTDVFGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAIMTLRGL 170
            L+H N++ L +V      + LV E+       + ++    +    +  K   I++   +
Sbjct: 69  VLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS--AV 126
Query: 171 EYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYT 215
           +Y H  +I+HRDLK  NLL++    +KI DFG +  F    +L T
Sbjct: 127 QYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT 171

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 81/165 (49%), Gaps = 15/165 (9%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL----REIKLLQ 112
           Y   +++  G FA V  AR I T   VAVK I        K  +N ++L    RE+++++
Sbjct: 9   YRLLKTIGKGNFAKVKLARHILTGKEVAVKIID-------KTQLNSSSLQKLFREVRIMK 61
Query: 113 ELHHENVLGLTDVFGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAIMTLRGL 170
            L+H N++ L +V      + LV E+       + ++    +    +  K   I++   +
Sbjct: 62  VLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVS--AV 119
Query: 171 EYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYT 215
           +Y H  +I+HRDLK  NLL++    +KI DFG +  F    +L T
Sbjct: 120 QYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT 164

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 75/168 (44%), Gaps = 12/168 (7%)
Query: 63  VHVGRFATVFKAR---DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENV 119
           V  G F  V   R     + ++ VA+K +K+G     +    R  L E  ++ +  H N+
Sbjct: 51  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR----RDFLGEASIMGQFDHPNI 106
Query: 120 LGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
           + L  V      V +V E+++   L+  ++     FT   +         G++YL D   
Sbjct: 107 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 166
Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAKFF-GSPTRLYT---HQVVTRW 222
           +HRDL   N+LIN   V K+ DFGL++     P   YT    ++  RW
Sbjct: 167 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 214

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 75/168 (44%), Gaps = 12/168 (7%)
Query: 63  VHVGRFATVFKAR---DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENV 119
           V  G F  V   R     + ++ VA+K +K+G     +    R  L E  ++ +  H N+
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR----RDFLGEASIMGQFDHPNI 108
Query: 120 LGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
           + L  V      V +V E+++   L+  ++     FT   +         G++YL D   
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAKFF-GSPTRLYT---HQVVTRW 222
           +HRDL   N+LIN   V K+ DFGL++     P   YT    ++  RW
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 216

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 71/144 (49%), Gaps = 12/144 (8%)
Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTD 142
           VA+K+I L     + D +    L+EI+ + + HH N++     F     + LV + +   
Sbjct: 38  VAIKRINLEKCQTSMDEL----LKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGG 93
Query: 143 --LEVII------KDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG 194
             L++I       +  + V   S I       L GLEYLH +  +HRD+K  N+L+ + G
Sbjct: 94  SVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG 153
Query: 195 VLKIGDFGLAKFFGSPTRLYTHQV 218
            ++I DFG++ F  +   +  ++V
Sbjct: 154 SVQIADFGVSAFLATGGDITRNKV 177

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 71/144 (49%), Gaps = 12/144 (8%)
Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTD 142
           VA+K+I L     + D +    L+EI+ + + HH N++     F     + LV + +   
Sbjct: 43  VAIKRINLEKCQTSMDEL----LKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGG 98
Query: 143 --LEVII------KDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG 194
             L++I       +  + V   S I       L GLEYLH +  +HRD+K  N+L+ + G
Sbjct: 99  SVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG 158
Query: 195 VLKIGDFGLAKFFGSPTRLYTHQV 218
            ++I DFG++ F  +   +  ++V
Sbjct: 159 SVQIADFGVSAFLATGGDITRNKV 182

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 75/168 (44%), Gaps = 12/168 (7%)
Query: 63  VHVGRFATVFKAR---DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENV 119
           V  G F  V   R     + ++ VA+K +K+G     +    R  L E  ++ +  H N+
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR----RDFLGEASIMGQFDHPNI 108
Query: 120 LGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
           + L  V      V +V E+++   L+  ++     FT   +         G++YL D   
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAKFF-GSPTRLYT---HQVVTRW 222
           +HRDL   N+LIN   V K+ DFGL++     P   YT    ++  RW
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 216

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 75/168 (44%), Gaps = 12/168 (7%)
Query: 63  VHVGRFATVFKAR---DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENV 119
           V  G F  V   R     + ++ VA+K +K+G     +    R  L E  ++ +  H N+
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR----RDFLGEASIMGQFDHPNI 108
Query: 120 LGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
           + L  V      V +V E+++   L+  ++     FT   +         G++YL D   
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAKFF-GSPTRLYT---HQVVTRW 222
           +HRDL   N+LIN   V K+ DFGL++     P   YT    ++  RW
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 216

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 75/168 (44%), Gaps = 12/168 (7%)
Query: 63  VHVGRFATVFKAR---DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENV 119
           V  G F  V   R     + ++ VA+K +K+G     +    R  L E  ++ +  H N+
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR----RDFLGEASIMGQFDHPNI 108
Query: 120 LGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
           + L  V      V +V E+++   L+  ++     FT   +         G++YL D   
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAKFF-GSPTRLYT---HQVVTRW 222
           +HRDL   N+LIN   V K+ DFGL++     P   YT    ++  RW
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 216

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 85/176 (48%), Gaps = 20/176 (11%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           +++  G F  V   + +ET    A+K +        K  I  T L E ++LQ ++   ++
Sbjct: 47  KTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHT-LNEKRILQAVNFPFLV 104
Query: 121 GLTDVFGYMSNVSLVFEFVD-----TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
            L   F   SN+ +V E++      + L  I +     F+  + + YA   +   EYLH 
Sbjct: 105 KLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGR-----FSEPHARFYAAQIVLTFEYLHS 159
Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTHQVVTRWY 223
             +++RDLKP NLLI++QG +K+ DFG AK          G+P  L    ++++ Y
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 74/168 (44%), Gaps = 12/168 (7%)
Query: 63  VHVGRFATVFKAR---DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENV 119
           V  G F  V   R     + ++ VA+K +K+G     +    R  L E  ++ +  H N+
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR----RDFLGEASIMGQFDHPNI 108
Query: 120 LGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
           + L  V      V +V E+++   L+  ++     FT   +         G++YL D   
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAKFF-GSPTRLYT---HQVVTRW 222
           +HRDL   N+LIN   V K+ DFGL +     P   YT    ++  RW
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRW 216

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 82/171 (47%), Gaps = 10/171 (5%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           +++  G F  V   + +ET    A+K +        K+ I  T L E ++LQ ++   ++
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKE-IEHT-LNEKRILQAVNFPFLV 104
Query: 121 GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
            L   F   SN+ +V E+               F+  + + YA   +   EYLH   +++
Sbjct: 105 KLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTHQVVTRWY 223
           RDLKP NL+I++QG +K+ DFGLAK          G+P  L    ++++ Y
Sbjct: 165 RDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLCGTPEYLAPEIILSKGY 215

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 85/176 (48%), Gaps = 20/176 (11%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           +++  G F  V   + +ET    A+K +        K  I  T L E ++LQ ++   ++
Sbjct: 47  KTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHT-LNEKRILQAVNFPFLV 104
Query: 121 GLTDVFGYMSNVSLVFEFVD-----TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
            L   F   SN+ +V E++      + L  I +     F+  + + YA   +   EYLH 
Sbjct: 105 KLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGR-----FSEPHARFYAAQIVLTFEYLHS 159
Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTHQVVTRWY 223
             +++RDLKP NLLI++QG +K+ DFG AK          G+P  L    ++++ Y
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 78/157 (49%), Gaps = 15/157 (9%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL----REIKLLQ 112
           Y   +++  G FA V  AR I T   VAV+ I        K  +N ++L    RE+++++
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIID-------KTQLNSSSLQKLFREVRIMK 68
Query: 113 ELHHENVLGLTDVFGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAIMTLRGL 170
            L+H N++ L +V      + LV E+       + ++    +    +  K   I++   +
Sbjct: 69  VLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS--AV 126
Query: 171 EYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF 207
           +Y H  +I+HRDLK  NLL++    +KI DFG +  F
Sbjct: 127 QYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF 163

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 71/132 (53%), Gaps = 10/132 (7%)
Query: 79  TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEF 138
           T+  VAVK + +    D  + I +    EI + + L+HENV+     +G+    ++ + F
Sbjct: 30  TEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVKF---YGHRREGNIQYLF 82
Query: 139 VD--TDLEVIIK-DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGV 195
           ++  +  E+  + +P I     + + +    + G+ YLH   I HRD+KP NLL++++  
Sbjct: 83  LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN 142
Query: 196 LKIGDFGLAKFF 207
           LKI DFGLA  F
Sbjct: 143 LKISDFGLATVF 154

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 74/157 (47%), Gaps = 17/157 (10%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V+KA++ ET  + A K I+  +  + +D I      EI++L    H  ++ L   
Sbjct: 30  GAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIV-----EIEILATCDHPYIVKLLGA 84
Query: 126 FGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           + +   + ++ EF     ++ I+ +     T   I+      L  L +LH   I+HRDLK
Sbjct: 85  YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLK 144
Query: 185 PNNLLINKQGVLKIGDFGLA-----------KFFGSP 210
             N+L+  +G +++ DFG++            F G+P
Sbjct: 145 AGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTP 181

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 109/243 (44%), Gaps = 39/243 (16%)
Query: 82  IVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT 141
           I++ +K  +G+  +A   +N     EI++L++L+H  ++ + + F    +  +V E ++ 
Sbjct: 181 IISKRKFAIGSAREADPALNVET--EIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEG 237
Query: 142 D--LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG---VL 196
               + ++ +  +    +  K Y    L  ++YLH++ I+HRDLKP N+L++ Q    ++
Sbjct: 238 GELFDKVVGNKRL--KEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLI 295
Query: 197 KIGDFGLAKFF----------GSPTRLYTHQVVT----RWYRLIKC------LLYCVQ-- 234
           KI DFG +K            G+PT L    +V+     + R + C      L  C+   
Sbjct: 296 KITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 355
Query: 235 --FNVKNVQWCCFAKDPSSHGNLFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTA 292
             F+    Q     +  S   N  P     E++    +  L ++  LL ++P  R     
Sbjct: 356 PPFSEHRTQVSLKDQITSGKYNFIP-----EVWAEVSEKALDLVKKLLVVDPKARFTTEE 410
Query: 293 TLK 295
            L+
Sbjct: 411 ALR 413

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 71/152 (46%), Gaps = 10/152 (6%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIK----LGTHADAKDGINRTALREIKLLQ 112
           Y + R +  G FA  ++  D++T  + A K +     L  H   K         EI + +
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMST------EIAIHK 97
Query: 113 ELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEY 172
            L + +V+G    F     V +V E       + +       T    + +   T++G++Y
Sbjct: 98  SLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQY 157
Query: 173 LHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           LH++ ++HRDLK  NL +N    +KIGDFGLA
Sbjct: 158 LHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLA 189

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 71/152 (46%), Gaps = 10/152 (6%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIK----LGTHADAKDGINRTALREIKLLQ 112
           Y + R +  G FA  ++  D++T  + A K +     L  H   K         EI + +
Sbjct: 28  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMST------EIAIHK 81
Query: 113 ELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEY 172
            L + +V+G    F     V +V E       + +       T    + +   T++G++Y
Sbjct: 82  SLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQY 141
Query: 173 LHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           LH++ ++HRDLK  NL +N    +KIGDFGLA
Sbjct: 142 LHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLA 173

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 74/146 (50%), Gaps = 14/146 (9%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALR-EIKLLQELHHENVLGLTD 124
           G F+ VF  +   T  + A+K IK             ++L  EI +L+++ HEN++ L D
Sbjct: 20  GAFSEVFLVKQRLTGKLFALKCIK------KSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 125 VFGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
           ++   ++  LV + V      + I++    V+T  +        L  ++YLH++ I+HRD
Sbjct: 74  IYESTTHYYLVMQLVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHENGIVHRD 131
Query: 183 LKPNNLLI---NKQGVLKIGDFGLAK 205
           LKP NLL     +   + I DFGL+K
Sbjct: 132 LKPENLLYLTPEENSKIMITDFGLSK 157

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 71/152 (46%), Gaps = 10/152 (6%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIK----LGTHADAKDGINRTALREIKLLQ 112
           Y + R +  G FA  ++  D++T  + A K +     L  H   K         EI + +
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMST------EIAIHK 97
Query: 113 ELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEY 172
            L + +V+G    F     V +V E       + +       T    + +   T++G++Y
Sbjct: 98  SLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQY 157
Query: 173 LHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           LH++ ++HRDLK  NL +N    +KIGDFGLA
Sbjct: 158 LHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLA 189

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 71/152 (46%), Gaps = 10/152 (6%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIK----LGTHADAKDGINRTALREIKLLQ 112
           Y + R +  G FA  ++  D++T  + A K +     L  H   K         EI + +
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMST------EIAIHK 97
Query: 113 ELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEY 172
            L + +V+G    F     V +V E       + +       T    + +   T++G++Y
Sbjct: 98  SLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQY 157
Query: 173 LHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           LH++ ++HRDLK  NL +N    +KIGDFGLA
Sbjct: 158 LHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLA 189

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 109/243 (44%), Gaps = 39/243 (16%)
Query: 82  IVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT 141
           I++ +K  +G+  +A   +N     EI++L++L+H  ++ + + F    +  +V E ++ 
Sbjct: 167 IISKRKFAIGSAREADPALNVET--EIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEG 223
Query: 142 D--LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG---VL 196
               + ++ +  +    +  K Y    L  ++YLH++ I+HRDLKP N+L++ Q    ++
Sbjct: 224 GELFDKVVGNKRL--KEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLI 281
Query: 197 KIGDFGLAKFF----------GSPTRLYTHQVVT----RWYRLIKC------LLYCVQ-- 234
           KI DFG +K            G+PT L    +V+     + R + C      L  C+   
Sbjct: 282 KITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 341
Query: 235 --FNVKNVQWCCFAKDPSSHGNLFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTA 292
             F+    Q     +  S   N  P     E++    +  L ++  LL ++P  R     
Sbjct: 342 PPFSEHRTQVSLKDQITSGKYNFIP-----EVWAEVSEKALDLVKKLLVVDPKARFTTEE 396
Query: 293 TLK 295
            L+
Sbjct: 397 ALR 399

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 74/157 (47%), Gaps = 17/157 (10%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V+KA++ ET  + A K I+  +  + +D I      EI++L    H  ++ L   
Sbjct: 22  GAFGKVYKAKNKETGALAAAKVIETKSEEELEDYI-----VEIEILATCDHPYIVKLLGA 76
Query: 126 FGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           + +   + ++ EF     ++ I+ +     T   I+      L  L +LH   I+HRDLK
Sbjct: 77  YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLK 136
Query: 185 PNNLLINKQGVLKIGDFGLA-----------KFFGSP 210
             N+L+  +G +++ DFG++            F G+P
Sbjct: 137 AGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTP 173

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/235 (23%), Positives = 107/235 (45%), Gaps = 39/235 (16%)
Query: 82  IVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT 141
           I++ +K  +G+  +A   +N     EI++L++L+H  ++ + + F    +  +V E ++ 
Sbjct: 41  IISKRKFAIGSAREADPALNVET--EIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEG 97
Query: 142 D--LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG---VL 196
               + ++ +  +    +  K Y    L  ++YLH++ I+HRDLKP N+L++ Q    ++
Sbjct: 98  GELFDKVVGNKRL--KEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLI 155
Query: 197 KIGDFGLAKFF----------GSPTRLYTHQVVT----RWYRLIKC------LLYCVQ-- 234
           KI DFG +K            G+PT L    +V+     + R + C      L  C+   
Sbjct: 156 KITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 215
Query: 235 --FNVKNVQWCCFAKDPSSHGNLFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKR 287
             F+    Q     +  S   N  P     E++    +  L ++  LL ++P  R
Sbjct: 216 PPFSEHRTQVSLKDQITSGKYNFIP-----EVWAEVSEKALDLVKKLLVVDPKAR 265

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 80/172 (46%), Gaps = 7/172 (4%)
Query: 56  VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH 115
           VY     +  G F+ V +  + ET    AVK + +     +         RE  +   L 
Sbjct: 27  VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 86
Query: 116 HENVLGLTDVFGYMSNVSLVFEFVD-TDL--EVIIK-DPTIVFTPSNIKAYAIMTLRGLE 171
           H +++ L + +     + +VFEF+D  DL  E++ + D   V++ +    Y    L  L 
Sbjct: 87  HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 146
Query: 172 YLHDHWILHRDLKPNNLLINKQ---GVLKIGDFGLAKFFGSPTRLYTHQVVT 220
           Y HD+ I+HRD+KP+ +L+  +     +K+G FG+A   G    +   +V T
Sbjct: 147 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGT 198

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 73/147 (49%), Gaps = 8/147 (5%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y ++  +  G   TV+ A D+ T   VA++++ L      +  IN     EI +++E  +
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-----EILVMRENKN 76
Query: 117 ENVLGLTDVFGYMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
            N++   D +     + +V E++    L  ++ +         I A     L+ LE+LH 
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHS 134
Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFG 202
           + ++HRD+K +N+L+   G +K+ DFG
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFG 161

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/235 (23%), Positives = 107/235 (45%), Gaps = 39/235 (16%)
Query: 82  IVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT 141
           I++ +K  +G+  +A   +N     EI++L++L+H  ++ + + F    +  +V E ++ 
Sbjct: 42  IISKRKFAIGSAREADPALNVET--EIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEG 98
Query: 142 D--LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG---VL 196
               + ++ +  +    +  K Y    L  ++YLH++ I+HRDLKP N+L++ Q    ++
Sbjct: 99  GELFDKVVGNKRL--KEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLI 156
Query: 197 KIGDFGLAKFF----------GSPTRLYTHQVVT----RWYRLIKC------LLYCVQ-- 234
           KI DFG +K            G+PT L    +V+     + R + C      L  C+   
Sbjct: 157 KITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 216
Query: 235 --FNVKNVQWCCFAKDPSSHGNLFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKR 287
             F+    Q     +  S   N  P     E++    +  L ++  LL ++P  R
Sbjct: 217 PPFSEHRTQVSLKDQITSGKYNFIP-----EVWAEVSEKALDLVKKLLVVDPKAR 266

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/235 (23%), Positives = 107/235 (45%), Gaps = 39/235 (16%)
Query: 82  IVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT 141
           I++ +K  +G+  +A   +N     EI++L++L+H  ++ + + F    +  +V E ++ 
Sbjct: 42  IISKRKFAIGSAREADPALNVET--EIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEG 98
Query: 142 D--LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG---VL 196
               + ++ +  +    +  K Y    L  ++YLH++ I+HRDLKP N+L++ Q    ++
Sbjct: 99  GELFDKVVGNKRL--KEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLI 156
Query: 197 KIGDFGLAKFF----------GSPTRLYTHQVVT----RWYRLIKC------LLYCVQ-- 234
           KI DFG +K            G+PT L    +V+     + R + C      L  C+   
Sbjct: 157 KITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 216
Query: 235 --FNVKNVQWCCFAKDPSSHGNLFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKR 287
             F+    Q     +  S   N  P     E++    +  L ++  LL ++P  R
Sbjct: 217 PPFSEHRTQVSLKDQITSGKYNFIP-----EVWAEVSEKALDLVKKLLVVDPKAR 266

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 73/147 (49%), Gaps = 8/147 (5%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y ++  +  G   TV+ A D+ T   VA++++ L      +  IN     EI +++E  +
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-----EILVMRENKN 76
Query: 117 ENVLGLTDVFGYMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
            N++   D +     + +V E++    L  ++ +         I A     L+ LE+LH 
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHS 134
Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFG 202
           + ++HRD+K +N+L+   G +K+ DFG
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFG 161

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 76/161 (47%), Gaps = 7/161 (4%)
Query: 56  VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH 115
           VY     +  G F+ V +  + ET    AVK + +     +         RE  +   L 
Sbjct: 25  VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 116 HENVLGLTDVFGYMSNVSLVFEFVD-TDL--EVIIK-DPTIVFTPSNIKAYAIMTLRGLE 171
           H +++ L + +     + +VFEF+D  DL  E++ + D   V++ +    Y    L  L 
Sbjct: 85  HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 172 YLHDHWILHRDLKPNNLLINKQ---GVLKIGDFGLAKFFGS 209
           Y HD+ I+HRD+KP+ +L+  +     +K+G FG+A   G 
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE 185

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 73/147 (49%), Gaps = 8/147 (5%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y ++  +  G   TV+ A D+ T   VA++++ L      +  IN     EI +++E  +
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-----EILVMRENKN 77
Query: 117 ENVLGLTDVFGYMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
            N++   D +     + +V E++    L  ++ +         I A     L+ LE+LH 
Sbjct: 78  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHS 135
Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFG 202
           + ++HRD+K +N+L+   G +K+ DFG
Sbjct: 136 NQVIHRDIKSDNILLGMDGSVKLTDFG 162

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/235 (23%), Positives = 107/235 (45%), Gaps = 39/235 (16%)
Query: 82  IVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT 141
           I++ +K  +G+  +A   +N     EI++L++L+H  ++ + + F    +  +V E ++ 
Sbjct: 42  IISKRKFAIGSAREADPALNVET--EIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEG 98
Query: 142 D--LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG---VL 196
               + ++ +  +    +  K Y    L  ++YLH++ I+HRDLKP N+L++ Q    ++
Sbjct: 99  GELFDKVVGNKRL--KEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLI 156
Query: 197 KIGDFGLAKFF----------GSPTRLYTHQVVT----RWYRLIKC------LLYCVQ-- 234
           KI DFG +K            G+PT L    +V+     + R + C      L  C+   
Sbjct: 157 KITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 216
Query: 235 --FNVKNVQWCCFAKDPSSHGNLFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKR 287
             F+    Q     +  S   N  P     E++    +  L ++  LL ++P  R
Sbjct: 217 PPFSEHRTQVSLKDQITSGKYNFIP-----EVWAEVSEKALDLVKKLLVVDPKAR 266

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 73/147 (49%), Gaps = 8/147 (5%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y ++  +  G   TV+ A D+ T   VA++++ L      +  IN     EI +++E  +
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-----EILVMRENKN 76
Query: 117 ENVLGLTDVFGYMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
            N++   D +     + +V E++    L  ++ +         I A     L+ LE+LH 
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHS 134
Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFG 202
           + ++HRD+K +N+L+   G +K+ DFG
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFG 161

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 109/243 (44%), Gaps = 39/243 (16%)
Query: 82  IVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT 141
           I++ +K  +G+  +A   +N     EI++L++L+H  ++ + + F    +  +V E ++ 
Sbjct: 48  IISKRKFAIGSAREADPALNVET--EIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEG 104
Query: 142 D--LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG---VL 196
               + ++ +  +    +  K Y    L  ++YLH++ I+HRDLKP N+L++ Q    ++
Sbjct: 105 GELFDKVVGNKRL--KEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLI 162
Query: 197 KIGDFGLAKFF----------GSPTRLYTHQVVT----RWYRLIKC------LLYCVQ-- 234
           KI DFG +K            G+PT L    +V+     + R + C      L  C+   
Sbjct: 163 KITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 222
Query: 235 --FNVKNVQWCCFAKDPSSHGNLFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTA 292
             F+    Q     +  S   N  P     E++    +  L ++  LL ++P  R     
Sbjct: 223 PPFSEHRTQVSLKDQITSGKYNFIP-----EVWAEVSEKALDLVKKLLVVDPKARFTTEE 277
Query: 293 TLK 295
            L+
Sbjct: 278 ALR 280

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 75/168 (44%), Gaps = 12/168 (7%)
Query: 63  VHVGRFATVFKAR---DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENV 119
           + VG F  V   R     + ++ VA+K +K G      D   R  L E  ++ +  H N+
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGY----TDKQRRDFLSEASIMGQFDHPNI 92
Query: 120 LGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
           + L  V      V ++ E+++   L+  ++     FT   +         G++YL D   
Sbjct: 93  IHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSA 152
Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAKFF-GSPTRLYT---HQVVTRW 222
           +HRDL   N+L+N   V K+ DFG+++     P   YT    ++  RW
Sbjct: 153 VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRW 200

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 75/168 (44%), Gaps = 12/168 (7%)
Query: 63  VHVGRFATVFKAR---DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENV 119
           + VG F  V   R     + ++ VA+K +K G      D   R  L E  ++ +  H N+
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGY----TDKQRRDFLSEASIMGQFDHPNI 71
Query: 120 LGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
           + L  V      V ++ E+++   L+  ++     FT   +         G++YL D   
Sbjct: 72  IHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSY 131
Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAKFF-GSPTRLYT---HQVVTRW 222
           +HRDL   N+L+N   V K+ DFG+++     P   YT    ++  RW
Sbjct: 132 VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRW 179

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 73/143 (51%), Gaps = 6/143 (4%)
Query: 66  GRFATVFKARDI---ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL 122
           G F  VF  + I   +   + A+K +K  T    +D +     R+I  L E++H  ++ L
Sbjct: 35  GSFGKVFLVKKISGSDARQLYAMKVLKKAT-LKVRDRVRTKMERDI--LVEVNHPFIVKL 91
Query: 123 TDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
              F     + L+ +F+            ++FT  ++K Y       L++LH   I++RD
Sbjct: 92  HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRD 151
Query: 183 LKPNNLLINKQGVLKIGDFGLAK 205
           LKP N+L++++G +K+ DFGL+K
Sbjct: 152 LKPENILLDEEGHIKLTDFGLSK 174

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 65/143 (45%), Gaps = 10/143 (6%)
Query: 66  GRFATVFKARDIETDMIVA----VKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G FA  F+  D +T  + A     K + L  H   K  +      EI + + L H++V+G
Sbjct: 26  GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM------EISIHRSLAHQHVVG 79
Query: 122 LTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
               F     V +V E       + +       T    + Y    + G +YLH + ++HR
Sbjct: 80  FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHR 139
Query: 182 DLKPNNLLINKQGVLKIGDFGLA 204
           DLK  NL +N+   +KIGDFGLA
Sbjct: 140 DLKLGNLFLNEDLEVKIGDFGLA 162

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 75/168 (44%), Gaps = 12/168 (7%)
Query: 63  VHVGRFATVFKAR---DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENV 119
           + VG F  V   R     + ++ VA+K +K G      D   R  L E  ++ +  H N+
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGY----TDKQRRDFLSEASIMGQFDHPNI 77
Query: 120 LGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
           + L  V      V ++ E+++   L+  ++     FT   +         G++YL D   
Sbjct: 78  IHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSY 137
Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAKFF-GSPTRLYT---HQVVTRW 222
           +HRDL   N+L+N   V K+ DFG+++     P   YT    ++  RW
Sbjct: 138 VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRW 185

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 62/141 (43%), Gaps = 5/141 (3%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  VF  R    + +VAVK  +     D K       L+E ++L++  H N++ L  V
Sbjct: 125 GNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKF----LQEARILKQYSHPNIVRLIGV 180
Query: 126 FGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
                 + +V E V   D    ++          +         G+EYL     +HRDL 
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLA 240
Query: 185 PNNLLINKQGVLKIGDFGLAK 205
             N L+ ++ VLKI DFG+++
Sbjct: 241 ARNCLVTEKNVLKISDFGMSR 261

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 66/142 (46%), Gaps = 2/142 (1%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           R +  G+F  V+ AR+ ++  IVA+K   L      K+G+     REI++   LHH N+L
Sbjct: 29  RPLGKGKFGNVYLAREKKSHFIVALKV--LFKSQIEKEGVEHQLRREIEIQAHLHHPNIL 86
Query: 121 GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
            L + F     + L+ E+            +  F               L Y H   ++H
Sbjct: 87  RLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGKKVIH 146
Query: 181 RDLKPNNLLINKQGVLKIGDFG 202
           RD+KP NLL+  +G LKI DFG
Sbjct: 147 RDIKPENLLLGLKGELKIADFG 168

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 71/149 (47%), Gaps = 6/149 (4%)
Query: 61  RSVHVGRFATVFKARDI---ETDMIVAVKKIKLGTHA-DAKDGINRTALREIKLLQELHH 116
           R +  G +  VF+ R +    T  I A+K +K      +AKD  +  A R I  L+E+ H
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNI--LEEVKH 80
Query: 117 ENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH 176
             ++ L   F     + L+ E++      +  +   +F       Y       L +LH  
Sbjct: 81  PFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQK 140
Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAK 205
            I++RDLKP N+++N QG +K+ DFGL K
Sbjct: 141 GIIYRDLKPENIMLNHQGHVKLTDFGLCK 169

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 62/141 (43%), Gaps = 5/141 (3%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  VF  R    + +VAVK  +     D K       L+E ++L++  H N++ L  V
Sbjct: 125 GNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKF----LQEARILKQYSHPNIVRLIGV 180
Query: 126 FGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
                 + +V E V   D    ++          +         G+EYL     +HRDL 
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLA 240
Query: 185 PNNLLINKQGVLKIGDFGLAK 205
             N L+ ++ VLKI DFG+++
Sbjct: 241 ARNCLVTEKNVLKISDFGMSR 261

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 65/143 (45%), Gaps = 10/143 (6%)
Query: 66  GRFATVFKARDIETDMIVA----VKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G FA  F+  D +T  + A     K + L  H   K  +      EI + + L H++V+G
Sbjct: 28  GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM------EISIHRSLAHQHVVG 81
Query: 122 LTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
               F     V +V E       + +       T    + Y    + G +YLH + ++HR
Sbjct: 82  FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHR 141
Query: 182 DLKPNNLLINKQGVLKIGDFGLA 204
           DLK  NL +N+   +KIGDFGLA
Sbjct: 142 DLKLGNLFLNEDLEVKIGDFGLA 164

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 73/143 (51%), Gaps = 6/143 (4%)
Query: 66  GRFATVFKARDI---ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL 122
           G F  VF  + I   +   + A+K +K  T    +D +     R+I  L E++H  ++ L
Sbjct: 36  GSFGKVFLVKKISGSDARQLYAMKVLKKAT-LKVRDRVRTKMERDI--LVEVNHPFIVKL 92
Query: 123 TDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
              F     + L+ +F+            ++FT  ++K Y       L++LH   I++RD
Sbjct: 93  HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRD 152
Query: 183 LKPNNLLINKQGVLKIGDFGLAK 205
           LKP N+L++++G +K+ DFGL+K
Sbjct: 153 LKPENILLDEEGHIKLTDFGLSK 175

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 71/149 (47%), Gaps = 6/149 (4%)
Query: 61  RSVHVGRFATVFKARDI---ETDMIVAVKKIKLGTHA-DAKDGINRTALREIKLLQELHH 116
           R +  G +  VF+ R +    T  I A+K +K      +AKD  +  A R I  L+E+ H
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNI--LEEVKH 80
Query: 117 ENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH 176
             ++ L   F     + L+ E++      +  +   +F       Y       L +LH  
Sbjct: 81  PFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQK 140
Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAK 205
            I++RDLKP N+++N QG +K+ DFGL K
Sbjct: 141 GIIYRDLKPENIMLNHQGHVKLTDFGLCK 169

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 65/143 (45%), Gaps = 10/143 (6%)
Query: 66  GRFATVFKARDIETDMIVA----VKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G FA  F+  D +T  + A     K + L  H   K  +      EI + + L H++V+G
Sbjct: 32  GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM------EISIHRSLAHQHVVG 85
Query: 122 LTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
               F     V +V E       + +       T    + Y    + G +YLH + ++HR
Sbjct: 86  FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHR 145
Query: 182 DLKPNNLLINKQGVLKIGDFGLA 204
           DLK  NL +N+   +KIGDFGLA
Sbjct: 146 DLKLGNLFLNEDLEVKIGDFGLA 168

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 10/171 (5%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           +++  G F  V   + +ET    A+K +        K  I  T L E ++LQ ++   ++
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHT-LNEKRILQAVNFPFLV 105
Query: 121 GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
            L   F   SN+ +V E+V              F+  + + YA   +   EYLH   +++
Sbjct: 106 KLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 165
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTHQVVTRWY 223
           RDLKP NLLI++QG +++ DFG AK          G+P  L    ++++ Y
Sbjct: 166 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 73/143 (51%), Gaps = 6/143 (4%)
Query: 66  GRFATVFKARDI---ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL 122
           G F  VF  + I   +   + A+K +K  T    +D +     R+I  L E++H  ++ L
Sbjct: 35  GSFGKVFLVKKISGSDARQLYAMKVLKKAT-LKVRDRVRTKMERDI--LVEVNHPFIVKL 91
Query: 123 TDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
              F     + L+ +F+            ++FT  ++K Y       L++LH   I++RD
Sbjct: 92  HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRD 151
Query: 183 LKPNNLLINKQGVLKIGDFGLAK 205
           LKP N+L++++G +K+ DFGL+K
Sbjct: 152 LKPENILLDEEGHIKLTDFGLSK 174

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 65/143 (45%), Gaps = 10/143 (6%)
Query: 66  GRFATVFKARDIETDMIVA----VKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G FA  F+  D +T  + A     K + L  H   K  +      EI + + L H++V+G
Sbjct: 28  GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM------EISIHRSLAHQHVVG 81
Query: 122 LTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
               F     V +V E       + +       T    + Y    + G +YLH + ++HR
Sbjct: 82  FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHR 141
Query: 182 DLKPNNLLINKQGVLKIGDFGLA 204
           DLK  NL +N+   +KIGDFGLA
Sbjct: 142 DLKLGNLFLNEDLEVKIGDFGLA 164

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 74/168 (44%), Gaps = 12/168 (7%)
Query: 63  VHVGRFATVFKAR---DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENV 119
           V  G F  V   R     + ++ VA+K +K+G     +    R  L E  ++ +  H N+
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR----RDFLGEASIMGQFDHPNI 79
Query: 120 LGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
           + L  V      V +V E ++   L+  ++     FT   +         G++YL D   
Sbjct: 80  IRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 139
Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAKFF-GSPTRLYT---HQVVTRW 222
           +HRDL   N+LIN   V K+ DFGL++     P   YT    ++  RW
Sbjct: 140 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 187

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 10/171 (5%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           +++  G F  V   + +ET    A+K +        K  I  T L E ++LQ ++   ++
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHT-LNEKRILQAVNFPFLV 105
Query: 121 GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
            L   F   SN+ +V E+V              F+  + + YA   +   EYLH   +++
Sbjct: 106 KLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 165
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTHQVVTRWY 223
           RDLKP NLLI++QG +++ DFG AK          G+P  L    ++++ Y
Sbjct: 166 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGY 216

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 72/132 (54%), Gaps = 15/132 (11%)
Query: 133 SLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLIN 191
           +LVFE V+ TD + + +      T  +I+ Y    L+ L+Y H   I+HRD+KP+N+LI+
Sbjct: 110 ALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVLID 165
Query: 192 KQGV-LKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWC------- 243
            +   L++ D+GLA+F+  P + Y  +V +R+++  + L+    ++     W        
Sbjct: 166 HEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 224
Query: 244 -CFAKDPSSHGN 254
             F K+P  HG+
Sbjct: 225 MIFRKEPFFHGH 236

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 65/143 (45%), Gaps = 10/143 (6%)
Query: 66  GRFATVFKARDIETDMIVA----VKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G FA  F+  D +T  + A     K + L  H   K  +      EI + + L H++V+G
Sbjct: 50  GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM------EISIHRSLAHQHVVG 103
Query: 122 LTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
               F     V +V E       + +       T    + Y    + G +YLH + ++HR
Sbjct: 104 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHR 163
Query: 182 DLKPNNLLINKQGVLKIGDFGLA 204
           DLK  NL +N+   +KIGDFGLA
Sbjct: 164 DLKLGNLFLNEDLEVKIGDFGLA 186

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 10/171 (5%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           +++  G F  V   + +ET    A+K +        K  I  T L E ++LQ ++   ++
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHT-LNEKRILQAVNFPFLV 104
Query: 121 GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
            L   F   SN+ +V E+V              F+  + + YA   +   EYLH   +++
Sbjct: 105 KLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTHQVVTRWY 223
           RDLKP NLLI++QG +++ DFG AK          G+P  L    ++++ Y
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 10/171 (5%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           +++  G F  V   + +ET    A+K +        K  I  T L E ++LQ ++   ++
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHT-LNEKRILQAVNFPFLV 104
Query: 121 GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
            L   F   SN+ +V E+V              F+  + + YA   +   EYLH   +++
Sbjct: 105 KLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTHQVVTRWY 223
           RDLKP NLLI++QG +++ DFG AK          G+P  L    ++++ Y
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 74/168 (44%), Gaps = 12/168 (7%)
Query: 63  VHVGRFATVFKAR---DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENV 119
           V  G F  V   R     + ++ VA+K +K+G     +    R  L E  ++ +  H N+
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR----RDFLGEASIMGQFDHPNI 108
Query: 120 LGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
           + L  V      V +V E ++   L+  ++     FT   +         G++YL D   
Sbjct: 109 IRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGA 168
Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAKFF-GSPTRLYT---HQVVTRW 222
           +HRDL   N+LIN   V K+ DFGL++     P   YT    ++  RW
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 216

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 65/143 (45%), Gaps = 10/143 (6%)
Query: 66  GRFATVFKARDIETDMIVA----VKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G FA  F+  D +T  + A     K + L  H   K  +      EI + + L H++V+G
Sbjct: 52  GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM------EISIHRSLAHQHVVG 105
Query: 122 LTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
               F     V +V E       + +       T    + Y    + G +YLH + ++HR
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHR 165
Query: 182 DLKPNNLLINKQGVLKIGDFGLA 204
           DLK  NL +N+   +KIGDFGLA
Sbjct: 166 DLKLGNLFLNEDLEVKIGDFGLA 188

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 72/145 (49%), Gaps = 2/145 (1%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           +++  G F  V   + +ET    A+K +        K  I  T L E ++LQ ++   ++
Sbjct: 33  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHT-LNEKRILQAVNFPFLV 90
Query: 121 GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
            L   F   SN+ +V E+V              F+  + + YA   +   EYLH   +++
Sbjct: 91  KLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 150
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAK 205
           RDLKP NLLI++QG +++ DFG AK
Sbjct: 151 RDLKPENLLIDQQGYIQVTDFGFAK 175

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 80/165 (48%), Gaps = 15/165 (9%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL----REIKLLQ 112
           Y   +++  G FA V  AR I T   VA+K I        K  +N T+L    RE+++++
Sbjct: 14  YRLLKTIGKGNFAKVKLARHILTGREVAIKIID-------KTQLNPTSLQKLFREVRIMK 66
Query: 113 ELHHENVLGLTDVFGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAIMTLRGL 170
            L+H N++ L +V      + L+ E+       + ++    +    +  K   I++   +
Sbjct: 67  ILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS--AV 124
Query: 171 EYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYT 215
           +Y H   I+HRDLK  NLL++    +KI DFG +  F    +L T
Sbjct: 125 QYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT 169

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 64/140 (45%), Gaps = 2/140 (1%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V   R+  T    A+K ++      AKD +  T + E ++LQ   H  +  L   
Sbjct: 16  GTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHT-VTESRVLQNTRHPFLTALKYA 73
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
           F     +  V E+ +            VFT    + Y    +  LEYLH   +++RD+K 
Sbjct: 74  FQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKL 133
Query: 186 NNLLINKQGVLKIGDFGLAK 205
            NL+++K G +KI DFGL K
Sbjct: 134 ENLMLDKDGHIKITDFGLCK 153

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 69/152 (45%), Gaps = 19/152 (12%)
Query: 69  ATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFG 127
           AT F     +  + VAVK +K   HAD K+ +    + E+K++  L  HEN++ L     
Sbjct: 65  ATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL----MSELKIMSHLGQHENIVNLLGACT 120
Query: 128 YMSNVSLVFE---------FVDTDLEVIIKDPTIVFTPSNIKA-----YAIMTLRGLEYL 173
           +   V ++ E         F+     V+  DP      S +       ++    +G+ +L
Sbjct: 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFL 180
Query: 174 HDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
                +HRD+   N+L+    V KIGDFGLA+
Sbjct: 181 ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 82/171 (47%), Gaps = 10/171 (5%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           +++  G F  V   + +ET    A+K +        K+ I  T L E ++LQ ++   ++
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKE-IEHT-LNEKRILQAVNFPFLV 104
Query: 121 GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
            L   F   SN+ +V E+               F+  + + YA   +   EYLH   +++
Sbjct: 105 KLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTHQVVTRWY 223
           RDLKP NL+I++QG +++ DFGLAK          G+P  L    ++++ Y
Sbjct: 165 RDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLCGTPEYLAPEIILSKGY 215

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 10/171 (5%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           +++  G F  V   + +ET    A+K +        K  I  T L E ++LQ ++   ++
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHT-LNEKRILQAVNFPFLV 104
Query: 121 GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
            L   F   SN+ +V E+V              F+  + + YA   +   EYLH   +++
Sbjct: 105 KLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTHQVVTRWY 223
           RDLKP NLLI++QG +++ DFG AK          G+P  L    ++++ Y
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 64/140 (45%), Gaps = 2/140 (1%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V   R+  T    A+K ++      AKD +  T + E ++LQ   H  +  L   
Sbjct: 19  GTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHT-VTESRVLQNTRHPFLTALKYA 76
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
           F     +  V E+ +            VFT    + Y    +  LEYLH   +++RD+K 
Sbjct: 77  FQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKL 136
Query: 186 NNLLINKQGVLKIGDFGLAK 205
            NL+++K G +KI DFGL K
Sbjct: 137 ENLMLDKDGHIKITDFGLCK 156

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 76/157 (48%), Gaps = 15/157 (9%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL----REIKLLQ 112
           Y   +++  G FA V  AR I T   VAVK I        K  +N ++L    RE+++ +
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIID-------KTQLNSSSLQKLFREVRIXK 68
Query: 113 ELHHENVLGLTDVFGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAIMTLRGL 170
            L+H N++ L +V      + LV E+       + ++         +  K   I++   +
Sbjct: 69  VLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVS--AV 126
Query: 171 EYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF 207
           +Y H  +I+HRDLK  NLL++    +KI DFG +  F
Sbjct: 127 QYCHQKFIVHRDLKAENLLLDADXNIKIADFGFSNEF 163

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 10/171 (5%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           +++  G F  V   + +ET    A+K +        K  I  T L E ++LQ ++   ++
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHT-LNEKRILQAVNFPFLV 104
Query: 121 GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
            L   F   SN+ +V E+V              F+  + + YA   +   EYLH   +++
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTHQVVTRWY 223
           RDLKP NLLI++QG +++ DFG AK          G+P  L    ++++ Y
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 76/154 (49%), Gaps = 17/154 (11%)
Query: 61  RSVHVGRFATV----FKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           R +  G F  V    +   +  T  +VAVK +K    ADA         +EI +L+ L+H
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK----ADAGPQHRSGWKQEIDILRTLYH 92
Query: 117 ENVL---GLTDVFGYMSNVSLVFEFVDTDLEVIIKD--PTIVFTPSNIKAYAIMTLRGLE 171
           E+++   G  +  G  +++ LV E+V       ++D  P      + +  +A     G+ 
Sbjct: 93  EHIIKYKGCCEDAG-AASLQLVMEYVPLG---SLRDYLPRHSIGLAQLLLFAQQICEGMA 148
Query: 172 YLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           YLH    +HRDL   N+L++   ++KIGDFGLAK
Sbjct: 149 YLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 73/163 (44%), Gaps = 23/163 (14%)
Query: 61  RSVHVGRFATVFKAR-----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH 115
           R +  G F  VF A        +  ++VAVK +K     DA D   +   RE +LL  L 
Sbjct: 19  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLK-----DASDNARKDFHREAELLTNLQ 73
Query: 116 HENVLGLTDVFGYMSNVSLVFEFVD-TDLEVIIK------------DPTIVFTPSNIKAY 162
           HE+++    V      + +VFE++   DL   ++            +P    T S +   
Sbjct: 74  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHI 133
Query: 163 AIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           A     G+ YL     +HRDL   N L+ +  ++KIGDFG+++
Sbjct: 134 AQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 176

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 64/140 (45%), Gaps = 2/140 (1%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V   R+  T    A+K ++      AKD +  T + E ++LQ   H  +  L   
Sbjct: 16  GTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHT-VTESRVLQNTRHPFLTALKYA 73
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
           F     +  V E+ +            VFT    + Y    +  LEYLH   +++RD+K 
Sbjct: 74  FQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKL 133
Query: 186 NNLLINKQGVLKIGDFGLAK 205
            NL+++K G +KI DFGL K
Sbjct: 134 ENLMLDKDGHIKITDFGLCK 153

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 64/140 (45%), Gaps = 2/140 (1%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V   R+  T    A+K ++      AKD +  T + E ++LQ   H  +  L   
Sbjct: 16  GTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHT-VTESRVLQNTRHPFLTALKYA 73
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
           F     +  V E+ +            VFT    + Y    +  LEYLH   +++RD+K 
Sbjct: 74  FQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKL 133
Query: 186 NNLLINKQGVLKIGDFGLAK 205
            NL+++K G +KI DFGL K
Sbjct: 134 ENLMLDKDGHIKITDFGLCK 153

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 70/150 (46%), Gaps = 11/150 (7%)
Query: 80  DMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFV 139
           ++ VA+K +K G     +    R  L E  ++ +  H NV+ L  V    + V ++ EF+
Sbjct: 61  EIFVAIKTLKSGYTEKQR----RDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFM 116
Query: 140 DT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKI 198
           +   L+  ++     FT   +         G++YL D   +HRDL   N+L+N   V K+
Sbjct: 117 ENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKV 176
Query: 199 GDFGLAKFFGSPTRLYTH------QVVTRW 222
            DFGL++F    T   T+      ++  RW
Sbjct: 177 SDFGLSRFLEDDTSDPTYTSALGGKIPIRW 206

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 77/157 (49%), Gaps = 15/157 (9%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL----REIKLLQ 112
           Y   +++  G FA V  AR I T   VA+K I        K  +N T+L    RE+++++
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKIID-------KTQLNPTSLQKLFREVRIMK 69
Query: 113 ELHHENVLGLTDVFGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAIMTLRGL 170
            L+H N++ L +V      + L+ E+       + ++    +    +  K   I++   +
Sbjct: 70  ILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS--AV 127
Query: 171 EYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF 207
           +Y H   I+HRDLK  NLL++    +KI DFG +  F
Sbjct: 128 QYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEF 164

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 64/140 (45%), Gaps = 2/140 (1%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V   R+  T    A+K ++      AKD +  T + E ++LQ   H  +  L   
Sbjct: 16  GTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHT-VTESRVLQNTRHPFLTALKYA 73
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
           F     +  V E+ +            VFT    + Y    +  LEYLH   +++RD+K 
Sbjct: 74  FQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKL 133
Query: 186 NNLLINKQGVLKIGDFGLAK 205
            NL+++K G +KI DFGL K
Sbjct: 134 ENLMLDKDGHIKITDFGLCK 153

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 67/143 (46%), Gaps = 6/143 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F    K    ET  ++ +K++         +   RT L+E+K+++ L H NVL    V
Sbjct: 21  GCFGQAIKVTHRETGEVMVMKEL-----IRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 126 FGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
                 ++ + E++    L  IIK     +  S   ++A     G+ YLH   I+HRDL 
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLN 135
Query: 185 PNNLLINKQGVLKIGDFGLAKFF 207
            +N L+ +   + + DFGLA+  
Sbjct: 136 SHNCLVRENKNVVVADFGLARLM 158

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 74/168 (44%), Gaps = 12/168 (7%)
Query: 63  VHVGRFATVFKAR---DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENV 119
           V  G F  V   R     + ++ VA+K +K+G     +    R  L E  ++ +  H N+
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR----RDFLGEASIMGQFDHPNI 108
Query: 120 LGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
           + L  V      V +V E ++   L+  ++     FT   +         G++YL D   
Sbjct: 109 IRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAKFF-GSPTRLYT---HQVVTRW 222
           +HRDL   N+LIN   V K+ DFGL++     P   YT    ++  RW
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 216

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 64/140 (45%), Gaps = 2/140 (1%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V   R+  T    A+K ++      AKD +  T + E ++LQ   H  +  L   
Sbjct: 16  GTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHT-VTESRVLQNTRHPFLTALKYA 73
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
           F     +  V E+ +            VFT    + Y    +  LEYLH   +++RD+K 
Sbjct: 74  FQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKL 133
Query: 186 NNLLINKQGVLKIGDFGLAK 205
            NL+++K G +KI DFGL K
Sbjct: 134 ENLMLDKDGHIKITDFGLCK 153

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 68/147 (46%), Gaps = 12/147 (8%)
Query: 66  GRFATVFKAR----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F +V   R       T  +VAVKK++  T    +D       REI++L+ L H+N++ 
Sbjct: 39  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----FEREIEILKSLQHDNIVK 93
Query: 122 LTDV--FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
              V       N+ L+ E++    L   ++          +  Y     +G+EYL     
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 153
Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAK 205
           +HRDL   N+L+  +  +KIGDFGL K
Sbjct: 154 IHRDLATRNILVENENRVKIGDFGLTK 180

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 78/165 (47%), Gaps = 11/165 (6%)
Query: 47  DCEVKNDLLVYYQWRSVHVGRFATVFKARDI---ETDMIVAVKKIKLGTHADAKDGINRT 103
           D  + ++ +V +  R +  G F  V+    I   +  +  A+K +   T     +     
Sbjct: 13  DVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAF--- 69
Query: 104 ALREIKLLQELHHENVLGLTDVF---GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIK 160
            LRE  L++ L+H NVL L  +      + +V L +     DL   I+ P    T  ++ 
Sbjct: 70  -LREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPY-MCHGDLLQFIRSPQRNPTVKDLI 127
Query: 161 AYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           ++ +   RG+EYL +   +HRDL   N ++++   +K+ DFGLA+
Sbjct: 128 SFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLAR 172

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 72/132 (54%), Gaps = 15/132 (11%)
Query: 133 SLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLIN 191
           +LVFE V+ TD + + +      T  +I+ Y    L+ L+Y H   I+HRD+KP+N++I+
Sbjct: 115 ALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 170
Query: 192 KQGV-LKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWC------- 243
            +   L++ D+GLA+F+  P + Y  +V +R+++  + L+    ++     W        
Sbjct: 171 HEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 229
Query: 244 -CFAKDPSSHGN 254
             F K+P  HG+
Sbjct: 230 MIFRKEPFFHGH 241

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 68/147 (46%), Gaps = 12/147 (8%)
Query: 66  GRFATVFKAR----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F +V   R       T  +VAVKK++  T    +D       REI++L+ L H+N++ 
Sbjct: 52  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----FEREIEILKSLQHDNIVK 106
Query: 122 LTDV--FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
              V       N+ L+ E++    L   ++          +  Y     +G+EYL     
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 166
Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAK 205
           +HRDL   N+L+  +  +KIGDFGL K
Sbjct: 167 IHRDLATRNILVENENRVKIGDFGLTK 193

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 68/147 (46%), Gaps = 12/147 (8%)
Query: 66  GRFATVFKAR----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F +V   R       T  +VAVKK++  T    +D       REI++L+ L H+N++ 
Sbjct: 28  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----FEREIEILKSLQHDNIVK 82
Query: 122 LTDV--FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
              V       N+ L+ E++    L   ++          +  Y     +G+EYL     
Sbjct: 83  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 142
Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAK 205
           +HRDL   N+L+  +  +KIGDFGL K
Sbjct: 143 IHRDLATRNILVENENRVKIGDFGLTK 169

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 68/147 (46%), Gaps = 12/147 (8%)
Query: 66  GRFATVFKAR----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F +V   R       T  +VAVKK++  T    +D       REI++L+ L H+N++ 
Sbjct: 20  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----FEREIEILKSLQHDNIVK 74
Query: 122 LTDV--FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
              V       N+ L+ E++    L   ++          +  Y     +G+EYL     
Sbjct: 75  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 134
Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAK 205
           +HRDL   N+L+  +  +KIGDFGL K
Sbjct: 135 IHRDLATRNILVENENRVKIGDFGLTK 161

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 68/147 (46%), Gaps = 12/147 (8%)
Query: 66  GRFATVFKAR----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F +V   R       T  +VAVKK++  T    +D       REI++L+ L H+N++ 
Sbjct: 21  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----FEREIEILKSLQHDNIVK 75
Query: 122 LTDV--FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
              V       N+ L+ E++    L   ++          +  Y     +G+EYL     
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 135
Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAK 205
           +HRDL   N+L+  +  +KIGDFGL K
Sbjct: 136 IHRDLATRNILVENENRVKIGDFGLTK 162

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 78/149 (52%), Gaps = 17/149 (11%)
Query: 118 NVLGLTDVFG--YMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH 174
           N++ L D+         +LVFE V+ TD + + +      T  +I+ Y    L+ L+Y H
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH 148
Query: 175 DHWILHRDLKPNNLLINKQGV-LKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCV 233
              I+HRD+KP+N++I+ +   L++ D+GLA+F+  P + Y  +V +R+++  + L+   
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 234 QFNVKNVQWC--------CFAKDPSSHGN 254
            ++     W          F K+P  HG+
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 68/147 (46%), Gaps = 12/147 (8%)
Query: 66  GRFATVFKAR----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F +V   R       T  +VAVKK++  T    +D       REI++L+ L H+N++ 
Sbjct: 39  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----FEREIEILKSLQHDNIVK 93
Query: 122 LTDV--FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
              V       N+ L+ E++    L   ++          +  Y     +G+EYL     
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 153
Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAK 205
           +HRDL   N+L+  +  +KIGDFGL K
Sbjct: 154 IHRDLATRNILVENENRVKIGDFGLTK 180

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 64/140 (45%), Gaps = 2/140 (1%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V   R+  T    A+K ++      AKD +  T + E ++LQ   H  +  L   
Sbjct: 21  GTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHT-VTESRVLQNTRHPFLTALKYA 78
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
           F     +  V E+ +            VFT    + Y    +  LEYLH   +++RD+K 
Sbjct: 79  FQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKL 138
Query: 186 NNLLINKQGVLKIGDFGLAK 205
            NL+++K G +KI DFGL K
Sbjct: 139 ENLMLDKDGHIKITDFGLCK 158

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 72/132 (54%), Gaps = 15/132 (11%)
Query: 133 SLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLIN 191
           +LVFE V+ TD + + +      T  +I+ Y    L+ L+Y H   I+HRD+KP+N++I+
Sbjct: 110 ALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 165
Query: 192 KQGV-LKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWC------- 243
            +   L++ D+GLA+F+  P + Y  +V +R+++  + L+    ++     W        
Sbjct: 166 HEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 224
Query: 244 -CFAKDPSSHGN 254
             F K+P  HG+
Sbjct: 225 MIFRKEPFFHGH 236

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 68/147 (46%), Gaps = 12/147 (8%)
Query: 66  GRFATVFKAR----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F +V   R       T  +VAVKK++  T    +D       REI++L+ L H+N++ 
Sbjct: 19  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----FEREIEILKSLQHDNIVK 73
Query: 122 LTDV--FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
              V       N+ L+ E++    L   ++          +  Y     +G+EYL     
Sbjct: 74  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 133
Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAK 205
           +HRDL   N+L+  +  +KIGDFGL K
Sbjct: 134 IHRDLATRNILVENENRVKIGDFGLTK 160

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 72/132 (54%), Gaps = 15/132 (11%)
Query: 133 SLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLIN 191
           +LVFE V+ TD + + +      T  +I+ Y    L+ L+Y H   I+HRD+KP+N++I+
Sbjct: 110 ALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 165
Query: 192 KQGV-LKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWC------- 243
            +   L++ D+GLA+F+  P + Y  +V +R+++  + L+    ++     W        
Sbjct: 166 HEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 224
Query: 244 -CFAKDPSSHGN 254
             F K+P  HG+
Sbjct: 225 MIFRKEPFFHGH 236

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 68/147 (46%), Gaps = 12/147 (8%)
Query: 66  GRFATVFKAR----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F +V   R       T  +VAVKK++  T    +D       REI++L+ L H+N++ 
Sbjct: 21  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----FEREIEILKSLQHDNIVK 75
Query: 122 LTDV--FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
              V       N+ L+ E++    L   ++          +  Y     +G+EYL     
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 135
Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAK 205
           +HRDL   N+L+  +  +KIGDFGL K
Sbjct: 136 IHRDLATRNILVENENRVKIGDFGLTK 162

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 72/132 (54%), Gaps = 15/132 (11%)
Query: 133 SLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLIN 191
           +LVFE V+ TD + + +      T  +I+ Y    L+ L+Y H   I+HRD+KP+N++I+
Sbjct: 110 ALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 165
Query: 192 KQGV-LKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWC------- 243
            +   L++ D+GLA+F+  P + Y  +V +R+++  + L+    ++     W        
Sbjct: 166 HEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 224
Query: 244 -CFAKDPSSHGN 254
             F K+P  HG+
Sbjct: 225 MIFRKEPFFHGH 236

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 72/132 (54%), Gaps = 15/132 (11%)
Query: 133 SLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLIN 191
           +LVFE V+ TD + + +      T  +I+ Y    L+ L+Y H   I+HRD+KP+N++I+
Sbjct: 110 ALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 165
Query: 192 KQGV-LKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWC------- 243
            +   L++ D+GLA+F+  P + Y  +V +R+++  + L+    ++     W        
Sbjct: 166 HEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 224
Query: 244 -CFAKDPSSHGN 254
             F K+P  HG+
Sbjct: 225 MIFRKEPFFHGH 236

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 68/147 (46%), Gaps = 12/147 (8%)
Query: 66  GRFATVFKAR----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F +V   R       T  +VAVKK++  T    +D       REI++L+ L H+N++ 
Sbjct: 21  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----FEREIEILKSLQHDNIVK 75
Query: 122 LTDV--FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
              V       N+ L+ E++    L   ++          +  Y     +G+EYL     
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 135
Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAK 205
           +HRDL   N+L+  +  +KIGDFGL K
Sbjct: 136 IHRDLATRNILVENENRVKIGDFGLTK 162

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 71/147 (48%), Gaps = 8/147 (5%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           + +  G+F  V     +  D  VA+K IK G+ ++         + E +++ +L H  ++
Sbjct: 33  QEIGSGQFGLVHLGYWLNKDK-VAIKTIKEGSMSEDD------FIEEAEVMMKLSHPKLV 85
Query: 121 GLTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWIL 179
            L  V    + + LVFEF++   L   ++    +F    +    +    G+ YL +  ++
Sbjct: 86  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 145
Query: 180 HRDLKPNNLLINKQGVLKIGDFGLAKF 206
           HRDL   N L+ +  V+K+ DFG+ +F
Sbjct: 146 HRDLAARNCLVGENQVIKVSDFGMTRF 172

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 72/132 (54%), Gaps = 15/132 (11%)
Query: 133 SLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLIN 191
           +LVFE V+ TD + + +      T  +I+ Y    L+ L+Y H   I+HRD+KP+N++I+
Sbjct: 109 ALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 164
Query: 192 KQGV-LKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWC------- 243
            +   L++ D+GLA+F+  P + Y  +V +R+++  + L+    ++     W        
Sbjct: 165 HEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 223
Query: 244 -CFAKDPSSHGN 254
             F K+P  HG+
Sbjct: 224 MIFRKEPFFHGH 235

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 68/147 (46%), Gaps = 12/147 (8%)
Query: 66  GRFATVFKAR----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F +V   R       T  +VAVKK++  T    +D       REI++L+ L H+N++ 
Sbjct: 26  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----FEREIEILKSLQHDNIVK 80
Query: 122 LTDV--FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
              V       N+ L+ E++    L   ++          +  Y     +G+EYL     
Sbjct: 81  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 140
Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAK 205
           +HRDL   N+L+  +  +KIGDFGL K
Sbjct: 141 IHRDLATRNILVENENRVKIGDFGLTK 167

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 72/132 (54%), Gaps = 15/132 (11%)
Query: 133 SLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLIN 191
           +LVFE V+ TD + + +      T  +I+ Y    L+ L+Y H   I+HRD+KP+N++I+
Sbjct: 110 ALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 165
Query: 192 KQGV-LKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWC------- 243
            +   L++ D+GLA+F+  P + Y  +V +R+++  + L+    ++     W        
Sbjct: 166 HEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 224
Query: 244 -CFAKDPSSHGN 254
             F K+P  HG+
Sbjct: 225 MIFRKEPFFHGH 236

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 72/132 (54%), Gaps = 15/132 (11%)
Query: 133 SLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLIN 191
           +LVFE V+ TD + + +      T  +I+ Y    L+ L+Y H   I+HRD+KP+N++I+
Sbjct: 110 ALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 165
Query: 192 KQGV-LKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWC------- 243
            +   L++ D+GLA+F+  P + Y  +V +R+++  + L+    ++     W        
Sbjct: 166 HEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 224
Query: 244 -CFAKDPSSHGN 254
             F K+P  HG+
Sbjct: 225 MIFRKEPFFHGH 236

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 72/132 (54%), Gaps = 15/132 (11%)
Query: 133 SLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLIN 191
           +LVFE V+ TD + + +      T  +I+ Y    L+ L+Y H   I+HRD+KP+N++I+
Sbjct: 110 ALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 165
Query: 192 KQGV-LKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWC------- 243
            +   L++ D+GLA+F+  P + Y  +V +R+++  + L+    ++     W        
Sbjct: 166 HEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 224
Query: 244 -CFAKDPSSHGN 254
             F K+P  HG+
Sbjct: 225 MIFRKEPFFHGH 236

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 72/132 (54%), Gaps = 15/132 (11%)
Query: 133 SLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLIN 191
           +LVFE V+ TD + + +      T  +I+ Y    L+ L+Y H   I+HRD+KP+N++I+
Sbjct: 108 ALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 163
Query: 192 KQGV-LKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWC------- 243
            +   L++ D+GLA+F+  P + Y  +V +R+++  + L+    ++     W        
Sbjct: 164 HEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 222
Query: 244 -CFAKDPSSHGN 254
             F K+P  HG+
Sbjct: 223 MIFRKEPFFHGH 234

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 68/147 (46%), Gaps = 12/147 (8%)
Query: 66  GRFATVFKAR----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F +V   R       T  +VAVKK++  T    +D       REI++L+ L H+N++ 
Sbjct: 25  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----FEREIEILKSLQHDNIVK 79
Query: 122 LTDV--FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
              V       N+ L+ E++    L   ++          +  Y     +G+EYL     
Sbjct: 80  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 139
Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAK 205
           +HRDL   N+L+  +  +KIGDFGL K
Sbjct: 140 IHRDLATRNILVENENRVKIGDFGLTK 166

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 68/147 (46%), Gaps = 12/147 (8%)
Query: 66  GRFATVFKAR----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F +V   R       T  +VAVKK++  T    +D       REI++L+ L H+N++ 
Sbjct: 24  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----FEREIEILKSLQHDNIVK 78
Query: 122 LTDV--FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
              V       N+ L+ E++    L   ++          +  Y     +G+EYL     
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 138
Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAK 205
           +HRDL   N+L+  +  +KIGDFGL K
Sbjct: 139 IHRDLATRNILVENENRVKIGDFGLTK 165

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 72/132 (54%), Gaps = 15/132 (11%)
Query: 133 SLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLIN 191
           +LVFE V+ TD + + +      T  +I+ Y    L+ L+Y H   I+HRD+KP+N++I+
Sbjct: 109 ALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 164
Query: 192 KQGV-LKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWC------- 243
            +   L++ D+GLA+F+  P + Y  +V +R+++  + L+    ++     W        
Sbjct: 165 HEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 223
Query: 244 -CFAKDPSSHGN 254
             F K+P  HG+
Sbjct: 224 MIFRKEPFFHGH 235

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 68/147 (46%), Gaps = 12/147 (8%)
Query: 66  GRFATVFKAR----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F +V   R       T  +VAVKK++  T    +D       REI++L+ L H+N++ 
Sbjct: 27  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----FEREIEILKSLQHDNIVK 81
Query: 122 LTDV--FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
              V       N+ L+ E++    L   ++          +  Y     +G+EYL     
Sbjct: 82  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 141
Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAK 205
           +HRDL   N+L+  +  +KIGDFGL K
Sbjct: 142 IHRDLATRNILVENENRVKIGDFGLTK 168

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 68/152 (44%), Gaps = 19/152 (12%)
Query: 69  ATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFG 127
           AT F     +  + VAVK +K   HAD K+ +    + E+K++  L  HEN++ L     
Sbjct: 65  ATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL----MSELKIMSHLGQHENIVNLLGACT 120
Query: 128 YMSNVSLVFE---------FVDTDLEVIIKDPTIVFTPSNIKA-----YAIMTLRGLEYL 173
           +   V ++ E         F+     V+  DP      S         ++    +G+ +L
Sbjct: 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL 180
Query: 174 HDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
                +HRD+   N+L+    V KIGDFGLA+
Sbjct: 181 ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 80/171 (46%), Gaps = 10/171 (5%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           +++  G F  V   + +ET    A+K +        K  I  T L E ++LQ ++   ++
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHT-LNEKRILQAVNFPFLV 104
Query: 121 GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
            L   F   SN+ +V E+V              F   + + YA   +   EYLH   +++
Sbjct: 105 KLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTHQVVTRWY 223
           RDLKP NLLI++QG +++ DFG AK          G+P  L    ++++ Y
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 68/147 (46%), Gaps = 12/147 (8%)
Query: 66  GRFATVFKAR----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F +V   R       T  +VAVKK++  T    +D       REI++L+ L H+N++ 
Sbjct: 24  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----FEREIEILKSLQHDNIVK 78
Query: 122 LTDV--FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
              V       N+ L+ E++    L   ++          +  Y     +G+EYL     
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGTKRY 138
Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAK 205
           +HRDL   N+L+  +  +KIGDFGL K
Sbjct: 139 IHRDLATRNILVENENRVKIGDFGLTK 165

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 80/171 (46%), Gaps = 10/171 (5%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           +++  G F  V   + +ET    A+K +        K  I  T L E ++LQ ++   ++
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHT-LNEKRILQAVNFPFLV 105
Query: 121 GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
            L   F   SN+ +V E+V              F   + + YA   +   EYLH   +++
Sbjct: 106 KLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIY 165
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTHQVVTRWY 223
           RDLKP NLLI++QG +++ DFG AK          G+P  L    ++++ Y
Sbjct: 166 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 80/171 (46%), Gaps = 10/171 (5%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           +++  G F  V   + +ET    A+K +        K  I  T L E ++LQ ++   ++
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHT-LNEKRILQAVNFPFLV 104
Query: 121 GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
            L   F   SN+ +V E+V              F   + + YA   +   EYLH   +++
Sbjct: 105 KLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTHQVVTRWY 223
           RDLKP NLLI++QG +++ DFG AK          G+P  L    ++++ Y
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 80/171 (46%), Gaps = 10/171 (5%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           +++  G F  V   + +ET    A+K +        K  I  T L E ++LQ ++   ++
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHT-LNEKRILQAVNFPFLV 104
Query: 121 GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
            L   F   SN+ +V E+               F+  + + YA   +   EYLH   +++
Sbjct: 105 KLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTHQVVTRWY 223
           RDLKP NL+I++QG +K+ DFG AK          G+P  L    ++++ Y
Sbjct: 165 RDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 79/178 (44%), Gaps = 10/178 (5%)
Query: 32  YIRVHSALKKQYLLPDCEVKN-DLLVYYQ-WRSVHVGRFATVFKARDIETDMIVAVKKIK 89
           Y + +  + K+Y+    EVK   +  YY     +  G F  V +  +  T  +   K I 
Sbjct: 26  YDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFIN 85
Query: 90  LGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT-DLEVIIK 148
                D       T   EI ++ +LHH  ++ L D F     + L+ EF+   +L   I 
Sbjct: 86  TPYPLD-----KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA 140
Query: 149 DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLL--INKQGVLKIGDFGLA 204
                 + + +  Y      GL+++H+H I+H D+KP N++    K   +KI DFGLA
Sbjct: 141 AEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLA 198

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 64/127 (50%), Gaps = 8/127 (6%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAI 164
           L E ++LQ ++   ++ L   F   SN+ +V E+V              F+  + + YA 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 165 MTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTH 216
             +   EYLH   +++RDLKP NLLI++QG +++ DFG AK          G+P  L   
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLXGTPEYLAPE 208
Query: 217 QVVTRWY 223
            ++++ Y
Sbjct: 209 IILSKGY 215

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 80/171 (46%), Gaps = 10/171 (5%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           +++  G F  V   +  ET    A+K +        K  I  T L E ++LQ ++   ++
Sbjct: 47  KTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQ-IEHT-LNEKRILQAVNFPFLV 104
Query: 121 GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
            L   F   SN+ +V E+V              F+  + + YA   +   EYLH   +++
Sbjct: 105 KLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTHQVVTRWY 223
           RDLKP NLLI++QG +++ DFG AK          G+P  L    ++++ Y
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 70/147 (47%), Gaps = 8/147 (5%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           + +  G+F  V     +  D  VA+K I+ G  ++         + E +++ +L H  ++
Sbjct: 16  QEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSE------EDFIEEAEVMMKLSHPKLV 68
Query: 121 GLTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWIL 179
            L  V    + + LVFEF++   L   ++    +F    +    +    G+ YL +  ++
Sbjct: 69  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 128
Query: 180 HRDLKPNNLLINKQGVLKIGDFGLAKF 206
           HRDL   N L+ +  V+K+ DFG+ +F
Sbjct: 129 HRDLAARNCLVGENQVIKVSDFGMTRF 155

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 72/132 (54%), Gaps = 15/132 (11%)
Query: 133 SLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLIN 191
           +LVFE V+ TD + + +      T  +I+ Y    L+ L+Y H   I+HRD+KP+N++I+
Sbjct: 110 ALVFEHVNNTDFKQLRQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 165
Query: 192 KQGV-LKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWC------- 243
            +   L++ D+GLA+F+  P + Y  +V +R+++  + L+    ++     W        
Sbjct: 166 HEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 224
Query: 244 -CFAKDPSSHGN 254
             F K+P  HG+
Sbjct: 225 MIFRKEPFFHGH 236

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 80/171 (46%), Gaps = 10/171 (5%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           +++  G F  V   +  ET    A+K +        K  I  T L E ++LQ ++   ++
Sbjct: 47  KTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQ-IEHT-LNEKRILQAVNFPFLV 104
Query: 121 GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
            L   F   SN+ +V E+V              F+  + + YA   +   EYLH   +++
Sbjct: 105 KLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTHQVVTRWY 223
           RDLKP NLLI++QG +++ DFG AK          G+P  L    ++++ Y
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 73/147 (49%), Gaps = 8/147 (5%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y ++  +  G   TV+ A D+ T   VA++++ L      +  IN     EI +++E  +
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-----EILVMRENKN 77
Query: 117 ENVLGLTDVFGYMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
            N++   D +     + +V E++    L  ++ +         I A     L+ LE+LH 
Sbjct: 78  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHS 135
Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFG 202
           + ++HR++K +N+L+   G +K+ DFG
Sbjct: 136 NQVIHRNIKSDNILLGMDGSVKLTDFG 162

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 80/171 (46%), Gaps = 10/171 (5%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           +++  G F  V   +  ET    A+K +        K  I  T L E ++LQ ++   ++
Sbjct: 47  KTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQ-IEHT-LNEKRILQAVNFPFLV 104
Query: 121 GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
            L   F   SN+ +V E+V              F+  + + YA   +   EYLH   +++
Sbjct: 105 KLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTHQVVTRWY 223
           RDLKP NLLI++QG +++ DFG AK          G+P  L    ++++ Y
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 70/147 (47%), Gaps = 8/147 (5%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           + +  G+F  V     +  D  VA+K I+ G  ++         + E +++ +L H  ++
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSE------EDFIEEAEVMMKLSHPKLV 63
Query: 121 GLTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWIL 179
            L  V    + + LVFEF++   L   ++    +F    +    +    G+ YL +  ++
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 123
Query: 180 HRDLKPNNLLINKQGVLKIGDFGLAKF 206
           HRDL   N L+ +  V+K+ DFG+ +F
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRF 150

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 70/147 (47%), Gaps = 8/147 (5%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           + +  G+F  V     +  D  VA+K I+ G  ++         + E +++ +L H  ++
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSE------EDFIEEAEVMMKLSHPKLV 65
Query: 121 GLTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWIL 179
            L  V    + + LVFEF++   L   ++    +F    +    +    G+ YL +  ++
Sbjct: 66  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 125
Query: 180 HRDLKPNNLLINKQGVLKIGDFGLAKF 206
           HRDL   N L+ +  V+K+ DFG+ +F
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRF 152

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 64/127 (50%), Gaps = 8/127 (6%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAI 164
           L E ++LQ ++   ++ L   F   SN+ +V E+V              F+  + + YA 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 165 MTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTH 216
             +   EYLH   +++RDLKP NLLI++QG +++ DFG AK          G+P  L   
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEALAPE 208
Query: 217 QVVTRWY 223
            ++++ Y
Sbjct: 209 IILSKGY 215

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 80/171 (46%), Gaps = 10/171 (5%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           +++  G F  V   +  ET    A+K +        K  I  T L E ++LQ ++   ++
Sbjct: 40  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQ-IEHT-LNEKRILQAVNFPFLV 97
Query: 121 GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
            L   F   SN+ +V E+V              F+  + + YA   +   EYLH   +++
Sbjct: 98  KLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 157
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTHQVVTRWY 223
           RDLKP NLLI++QG +++ DFG AK          G+P  L    ++++ Y
Sbjct: 158 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 208

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 80/171 (46%), Gaps = 10/171 (5%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           +++  G F  V   +  ET    A+K +        K  I  T L E ++LQ ++   ++
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQ-IEHT-LNEKRILQAVNFPFLV 105
Query: 121 GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
            L   F   SN+ +V E+V              F+  + + YA   +   EYLH   +++
Sbjct: 106 KLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 165
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTHQVVTRWY 223
           RDLKP NLLI++QG +++ DFG AK          G+P  L    ++++ Y
Sbjct: 166 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 80/171 (46%), Gaps = 10/171 (5%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           +++  G F  V   +  ET    A+K +        K  I  T L E ++LQ ++   ++
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQ-IEHT-LNEKRILQAVNFPFLV 105
Query: 121 GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
            L   F   SN+ +V E+V              F+  + + YA   +   EYLH   +++
Sbjct: 106 KLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 165
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTHQVVTRWY 223
           RDLKP NLLI++QG +++ DFG AK          G+P  L    ++++ Y
Sbjct: 166 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 64/127 (50%), Gaps = 8/127 (6%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAI 164
           L E ++LQ ++   ++ L   F   SN+ +V E+V              F+  + + YA 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 165 MTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTH 216
             +   EYLH   +++RDLKP NLLI++QG +++ DFG AK          G+P  L   
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLAGTPEYLAPE 208
Query: 217 QVVTRWY 223
            ++++ Y
Sbjct: 209 IILSKGY 215

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 80/171 (46%), Gaps = 10/171 (5%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           +++  G F  V   +  ET    A+K +        K  I  T L E ++LQ ++   ++
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQ-IEHT-LNEKRILQAVNFPFLV 105
Query: 121 GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
            L   F   SN+ +V E+V              F+  + + YA   +   EYLH   +++
Sbjct: 106 KLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 165
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTHQVVTRWY 223
           RDLKP NLLI++QG +++ DFG AK          G+P  L    ++++ Y
Sbjct: 166 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 80/171 (46%), Gaps = 10/171 (5%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           +++  G F  V   +  ET    A+K +        K  I  T L E ++LQ ++   ++
Sbjct: 68  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQ-IEHT-LNEKRILQAVNFPFLV 125
Query: 121 GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
            L   F   SN+ +V E+V              F+  + + YA   +   EYLH   +++
Sbjct: 126 KLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 185
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTHQVVTRWY 223
           RDLKP NLLI++QG +++ DFG AK          G+P  L    ++++ Y
Sbjct: 186 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 236

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 64/127 (50%), Gaps = 8/127 (6%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAI 164
           L E ++LQ ++   ++ L   F   SN+ +V E+V              F+  + + YA 
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 149
Query: 165 MTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTH 216
             +   EYLH   +++RDLKP NLLI++QG +++ DFG AK          G+P  L   
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPE 209
Query: 217 QVVTRWY 223
            ++++ Y
Sbjct: 210 IILSKGY 216

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 78/171 (45%), Gaps = 10/171 (5%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           R++  G F  V   +  ET    A+K +        K  I  T L E ++ Q ++   ++
Sbjct: 48  RTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQ-IEHT-LNEKRIQQAVNFPFLV 105
Query: 121 GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
            L   F   SN+ +V E+               F+  + + YA   +   EYLH   +++
Sbjct: 106 KLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 165
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTHQVVTRWY 223
           RDLKP NLLI++QG +K+ DFG AK          G+P  L    ++++ Y
Sbjct: 166 RDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 64/127 (50%), Gaps = 8/127 (6%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAI 164
           L E ++LQ ++   ++ L   F   SN+ +V E+V              F+  + + YA 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 165 MTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTH 216
             +   EYLH   +++RDLKP NLLI++QG +++ DFG AK          G+P  L   
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPE 208
Query: 217 QVVTRWY 223
            ++++ Y
Sbjct: 209 IILSKGY 215

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 64/127 (50%), Gaps = 8/127 (6%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAI 164
           L E ++LQ ++   ++ L   F   SN+ +V E+V              F+  + + YA 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 165 MTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTH 216
             +   EYLH   +++RDLKP NLLI++QG +++ DFG AK          G+P  L   
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPE 208
Query: 217 QVVTRWY 223
            ++++ Y
Sbjct: 209 IILSKGY 215

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 64/127 (50%), Gaps = 8/127 (6%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAI 164
           L E ++LQ ++   ++ L   F   SN+ +V E+V              F+  + + YA 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 165 MTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTH 216
             +   EYLH   +++RDLKP NLLI++QG +++ DFG AK          G+P  L   
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPE 208
Query: 217 QVVTRWY 223
            ++++ Y
Sbjct: 209 IILSKGY 215

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 64/127 (50%), Gaps = 8/127 (6%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAI 164
           L E ++LQ ++   ++ L   F   SN+ +V E+V              F+  + + YA 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 165 MTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTH 216
             +   EYLH   +++RDLKP NLLI++QG +++ DFG AK          G+P  L   
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPE 208
Query: 217 QVVTRWY 223
            ++++ Y
Sbjct: 209 IILSKGY 215

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 64/127 (50%), Gaps = 8/127 (6%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAI 164
           L E ++LQ ++   ++ L   F   SN+ +V E+V              F+  + + YA 
Sbjct: 110 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 169
Query: 165 MTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTH 216
             +   EYLH   +++RDLKP NLLI++QG +++ DFG AK          G+P  L   
Sbjct: 170 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLCGTPEYLAPE 229
Query: 217 QVVTRWY 223
            ++++ Y
Sbjct: 230 IILSKGY 236

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 64/127 (50%), Gaps = 8/127 (6%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAI 164
           L E ++LQ ++   ++ L   F   SN+ +V E+V              F+  + + YA 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 165 MTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTH 216
             +   EYLH   +++RDLKP NLLI++QG +++ DFG AK          G+P  L   
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPE 208
Query: 217 QVVTRWY 223
            ++++ Y
Sbjct: 209 IILSKGY 215

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 64/127 (50%), Gaps = 8/127 (6%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAI 164
           L E ++LQ ++   ++ L   F   SN+ +V E+V              F+  + + YA 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 165 MTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTH 216
             +   EYLH   +++RDLKP NLLI++QG +++ DFG AK          G+P  L   
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPE 208
Query: 217 QVVTRWY 223
            ++++ Y
Sbjct: 209 IILSKGY 215

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 55/101 (54%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAI 164
           L E ++LQ ++   ++ L   F   SN+ +V E+V              F+  + + YA 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 165 MTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
             +   EYLH   +++RDLKP NLLI++QG +++ DFG AK
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 79/171 (46%), Gaps = 10/171 (5%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           +++  G F  V   + +ET    A+K +        K  I  T L E ++LQ ++   + 
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHT-LNEKRILQAVNFPFLT 105
Query: 121 GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
            L   F   SN+ +V E+               F+  + + YA   +   EYLH   +++
Sbjct: 106 KLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 165
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTHQVVTRWY 223
           RDLKP NL+I++QG +K+ DFG AK          G+P  L    ++++ Y
Sbjct: 166 RDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 79/171 (46%), Gaps = 10/171 (5%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           +++  G F  V   + +ET    A+K +        K  I  T L E ++LQ ++   + 
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHT-LNEKRILQAVNFPFLT 105
Query: 121 GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
            L   F   SN+ +V E+               F+  + + YA   +   EYLH   +++
Sbjct: 106 KLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 165
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTHQVVTRWY 223
           RDLKP NL+I++QG +K+ DFG AK          G+P  L    ++++ Y
Sbjct: 166 RDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 68/133 (51%), Gaps = 10/133 (7%)
Query: 79  TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL---GLTDVFGYMSNVSLV 135
           T  +VAVK+++   H+       R   REI++L+ LH + ++   G++   G  S + LV
Sbjct: 51  TGALVAVKQLQ---HSGPDQ--QRDFQREIQILKALHSDFIVKYRGVSYGPGRQS-LRLV 104
Query: 136 FEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG 194
            E++ +  L   ++        S +  Y+    +G+EYL     +HRDL   N+L+  + 
Sbjct: 105 MEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEA 164
Query: 195 VLKIGDFGLAKFF 207
            +KI DFGLAK  
Sbjct: 165 HVKIADFGLAKLL 177

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 70/147 (47%), Gaps = 8/147 (5%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           + +  G+F  V     +  D  VA+K I+ G  ++         + E +++ +L H  ++
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSE------EDFIEEAEVMMKLSHPKLV 65
Query: 121 GLTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWIL 179
            L  V    + + LVFEF++   L   ++    +F    +    +    G+ YL +  ++
Sbjct: 66  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVI 125
Query: 180 HRDLKPNNLLINKQGVLKIGDFGLAKF 206
           HRDL   N L+ +  V+K+ DFG+ +F
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRF 152

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 64/127 (50%), Gaps = 8/127 (6%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAI 164
           L E ++LQ ++   ++ L   F   SN+ +V E+V              F+  + + YA 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 165 MTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTH 216
             +   EYLH   +++RDLKP NL+I++QG +++ DFG AK          G+P  L   
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPE 208
Query: 217 QVVTRWY 223
            ++++ Y
Sbjct: 209 IIISKGY 215

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 79/171 (46%), Gaps = 10/171 (5%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           +++  G F  V   + +ET    A+K +        K  I  T L E ++LQ ++   ++
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHT-LNEKRILQAVNFPFLV 104
Query: 121 GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
            L   F   SN+ +V E+               F   + + YA   +   EYLH   +++
Sbjct: 105 KLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTHQVVTRWY 223
           RDLKP NL+I++QG +K+ DFG AK          G+P  L    ++++ Y
Sbjct: 165 RDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 68/133 (51%), Gaps = 10/133 (7%)
Query: 79  TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL---GLTDVFGYMSNVSLV 135
           T  +VAVK+++   H+       R   REI++L+ LH + ++   G++   G  S + LV
Sbjct: 39  TGALVAVKQLQ---HSGPDQ--QRDFQREIQILKALHSDFIVKYRGVSYGPGRQS-LRLV 92
Query: 136 FEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG 194
            E++ +  L   ++        S +  Y+    +G+EYL     +HRDL   N+L+  + 
Sbjct: 93  MEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEA 152
Query: 195 VLKIGDFGLAKFF 207
            +KI DFGLAK  
Sbjct: 153 HVKIADFGLAKLL 165

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 69/156 (44%), Gaps = 12/156 (7%)
Query: 66  GRFATVFKAR----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F +V   R       T  +VAVKK++  T    +D       REI++L+ L H+N++ 
Sbjct: 22  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----FEREIEILKSLQHDNIVK 76
Query: 122 LTDV--FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
              V       N+ L+ E++    L   ++          +  Y     +G+EYL     
Sbjct: 77  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 136
Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY 214
           +HR+L   N+L+  +  +KIGDFGL K        Y
Sbjct: 137 IHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYY 172

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 64/137 (46%), Gaps = 6/137 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G    V  A +  T   VAVKK+ L      K         E+ ++++ HH+NV+ +   
Sbjct: 56  GSTGIVCIATEKHTGKQVAVKKMDL-----RKQQRRELLFNEVVIMRDYHHDNVVDMYSS 110
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
           +     + +V EF++      I   T       I    +  LR L YLH+  ++HRD+K 
Sbjct: 111 YLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKS 169
Query: 186 NNLLINKQGVLKIGDFG 202
           +++L+   G +K+ DFG
Sbjct: 170 DSILLTSDGRIKLSDFG 186

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 72/151 (47%), Gaps = 9/151 (5%)
Query: 56  VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH 115
           ++ +   +  G F  VFK  D  T  +VA+K I L    D          +EI +L +  
Sbjct: 24  LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE----IEDIQQEITVLSQCD 79
Query: 116 HENVLGLTDVFGYMSNVSLVFEFVD--TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYL 173
              V      +   S + ++ E++   + L+++   P   F    I       L+GL+YL
Sbjct: 80  SSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGP---FDEFQIATMLKEILKGLDYL 136
Query: 174 HDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           H    +HRD+K  N+L+++QG +K+ DFG+A
Sbjct: 137 HSEKKIHRDIKAANVLLSEQGDVKLADFGVA 167

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/138 (29%), Positives = 66/138 (47%), Gaps = 14/138 (10%)
Query: 83  VAVKKIKLGTHADAKDGINRTALR----------EIKLLQELHHENVLGLTDVFGYMSNV 132
           V V K +L  H  A   +NR  +R          EI+ L+   H +++ L  V    S++
Sbjct: 32  VKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI 91
Query: 133 SLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLI 190
            +V E+V      + I K+  +    S      I++  G++Y H H ++HRDLKP N+L+
Sbjct: 92  FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS--GVDYCHRHMVVHRDLKPENVLL 149
Query: 191 NKQGVLKIGDFGLAKFFG 208
           +     KI DFGL+    
Sbjct: 150 DAHMNAKIADFGLSNMMS 167

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 55/101 (54%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAI 164
           L E ++LQ ++   ++ L   F   SN+ +V E+V              F+  + + YA 
Sbjct: 76  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 135
Query: 165 MTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
             +   EYLH   +++RDLKP NLLI++QG +++ DFG AK
Sbjct: 136 QIVLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAK 176

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 68/133 (51%), Gaps = 10/133 (7%)
Query: 79  TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL---GLTDVFGYMSNVSLV 135
           T  +VAVK+++   H+       R   REI++L+ LH + ++   G++   G  S + LV
Sbjct: 38  TGALVAVKQLQ---HSGPDQ--QRDFQREIQILKALHSDFIVKYRGVSYGPGRQS-LRLV 91
Query: 136 FEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG 194
            E++ +  L   ++        S +  Y+    +G+EYL     +HRDL   N+L+  + 
Sbjct: 92  MEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEA 151
Query: 195 VLKIGDFGLAKFF 207
            +KI DFGLAK  
Sbjct: 152 HVKIADFGLAKLL 164

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 63/127 (49%), Gaps = 8/127 (6%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAI 164
           L E ++LQ ++   ++ L   F   SN+ +V E+V              F   + + YA 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAA 148
Query: 165 MTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTH 216
             +   EYLH   +++RDLKP NLLI++QG +++ DFG AK          G+P  L   
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPE 208
Query: 217 QVVTRWY 223
            ++++ Y
Sbjct: 209 IILSKGY 215

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 80/171 (46%), Gaps = 10/171 (5%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           +++  G F  V   + +ET    A+K +        K  I  T L E ++LQ ++   ++
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHT-LNEKRILQAVNFPFLV 104
Query: 121 GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
            L   F   SN+ +V E+               F+  + + YA   +   EYLH   +++
Sbjct: 105 KLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTHQVVTRWY 223
           RDLKP NL+I++QG +++ DFG AK          G+P  L    ++++ Y
Sbjct: 165 RDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 63/127 (49%), Gaps = 8/127 (6%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAI 164
           L E ++LQ ++   ++ L   F   SN+ +V E+V              F   + + YA 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAA 148
Query: 165 MTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTH 216
             +   EYLH   +++RDLKP NLLI++QG +++ DFG AK          G+P  L   
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPE 208
Query: 217 QVVTRWY 223
            ++++ Y
Sbjct: 209 IILSKGY 215

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 79/171 (46%), Gaps = 10/171 (5%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           +++  G F  V   +  ET    A+K +        K  I  T L E ++LQ ++   ++
Sbjct: 40  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQ-IEHT-LNEKRILQAVNFPFLV 97
Query: 121 GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
            L   F   SN+ +V E+V              F   + + YA   +   EYLH   +++
Sbjct: 98  KLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIY 157
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTHQVVTRWY 223
           RDLKP NLLI++QG +++ DFG AK          G+P  L    ++++ Y
Sbjct: 158 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 208

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 63/127 (49%), Gaps = 8/127 (6%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAI 164
           L E ++LQ ++   ++ L   F   SN+ +V E+V              F   + + YA 
Sbjct: 110 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAA 169
Query: 165 MTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTH 216
             +   EYLH   +++RDLKP NLLI++QG +++ DFG AK          G+P  L   
Sbjct: 170 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPE 229
Query: 217 QVVTRWY 223
            ++++ Y
Sbjct: 230 IILSKGY 236

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 63/127 (49%), Gaps = 8/127 (6%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAI 164
           L E ++LQ ++   ++ L   F   SN+ +V E+               F+  + + YA 
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAA 149
Query: 165 MTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTH 216
             +   EYLH   +++RDLKP NL+I++QG +K+ DFG AK          G+P  L   
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPE 209
Query: 217 QVVTRWY 223
            ++++ Y
Sbjct: 210 IILSKGY 216

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 63/127 (49%), Gaps = 8/127 (6%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAI 164
           L E ++LQ ++   ++ L   F   SN+ +V E+V              F   + + YA 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAA 148
Query: 165 MTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTH 216
             +   EYLH   +++RDLKP NLLI++QG +++ DFG AK          G+P  L   
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPE 208
Query: 217 QVVTRWY 223
            ++++ Y
Sbjct: 209 IILSKGY 215

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 63/127 (49%), Gaps = 8/127 (6%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAI 164
           L E ++LQ ++   ++ L   F   SN+ +V E+V              F   + + YA 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAA 148
Query: 165 MTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTH 216
             +   EYLH   +++RDLKP NLLI++QG +++ DFG AK          G+P  L   
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPE 208
Query: 217 QVVTRWY 223
            ++++ Y
Sbjct: 209 IILSKGY 215

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 66/132 (50%), Gaps = 8/132 (6%)
Query: 79  TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV-FGY-MSNVSLVF 136
           T  +VAVK+++   H+       R   REI++L+ LH + ++    V +G     + LV 
Sbjct: 35  TGALVAVKQLQ---HSGPDQ--QRDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVM 89
Query: 137 EFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGV 195
           E++ +  L   ++        S +  Y+    +G+EYL     +HRDL   N+L+  +  
Sbjct: 90  EYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH 149
Query: 196 LKIGDFGLAKFF 207
           +KI DFGLAK  
Sbjct: 150 VKIADFGLAKLL 161

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 68/147 (46%), Gaps = 8/147 (5%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           + +  G+F  V K         VA+K IK G+ ++ +       + E K++  L HE ++
Sbjct: 15  KELGTGQFGVV-KYGKWRGQYDVAIKMIKEGSMSEDE------FIEEAKVMMNLSHEKLV 67
Query: 121 GLTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWIL 179
            L  V      + ++ E++    L   +++    F    +          +EYL     L
Sbjct: 68  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 127
Query: 180 HRDLKPNNLLINKQGVLKIGDFGLAKF 206
           HRDL   N L+N QGV+K+ DFGL+++
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSRY 154

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 78/171 (45%), Gaps = 10/171 (5%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           +++  G F  V   + +ET    A+K +        K  I  T L E ++LQ ++   + 
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHT-LNEKRILQAVNFPFLT 105
Query: 121 GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
            L   F   SN+ +V E+               F   + + YA   +   EYLH   +++
Sbjct: 106 KLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIY 165
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTHQVVTRWY 223
           RDLKP NL+I++QG +K+ DFG AK          G+P  L    ++++ Y
Sbjct: 166 RDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 68/147 (46%), Gaps = 8/147 (5%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           + +  G+F  V K         VA+K IK G+ ++ +       + E K++  L HE ++
Sbjct: 15  KELGTGQFGVV-KYGKWRGQYDVAIKMIKEGSMSEDE------FIEEAKVMMNLSHEKLV 67
Query: 121 GLTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWIL 179
            L  V      + ++ E++    L   +++    F    +          +EYL     L
Sbjct: 68  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 127
Query: 180 HRDLKPNNLLINKQGVLKIGDFGLAKF 206
           HRDL   N L+N QGV+K+ DFGL+++
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSRY 154

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 68/147 (46%), Gaps = 8/147 (5%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           + +  G+F  V K         VA+K IK G+ ++ +       + E K++  L HE ++
Sbjct: 21  KELGTGQFGVV-KYGKWRGQYDVAIKMIKEGSMSEDE------FIEEAKVMMNLSHEKLV 73
Query: 121 GLTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWIL 179
            L  V      + ++ E++    L   +++    F    +          +EYL     L
Sbjct: 74  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 133
Query: 180 HRDLKPNNLLINKQGVLKIGDFGLAKF 206
           HRDL   N L+N QGV+K+ DFGL+++
Sbjct: 134 HRDLAARNCLVNDQGVVKVSDFGLSRY 160

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 80/171 (46%), Gaps = 24/171 (14%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           RS H GR+   +  + ++ +++V +K+++   H +           E  +L  + H  ++
Sbjct: 26  RSRHNGRY---YAMKVLKKEIVVRLKQVE---HTND----------ERLMLSIVTHPFII 69
Query: 121 GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
            +   F     + ++ ++++      +   +  F     K YA      LEYLH   I++
Sbjct: 70  RMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIY 129
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFF--------GSPTRLYTHQVVTRWY 223
           RDLKP N+L++K G +KI DFG AK+         G+P  +    V T+ Y
Sbjct: 130 RDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLCGTPDYIAPEVVSTKPY 180

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 68/147 (46%), Gaps = 8/147 (5%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           + +  G+F  V K         VA+K IK G+ ++ +       + E K++  L HE ++
Sbjct: 14  KELGTGQFGVV-KYGKWRGQYDVAIKMIKEGSMSEDE------FIEEAKVMMNLSHEKLV 66
Query: 121 GLTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWIL 179
            L  V      + ++ E++    L   +++    F    +          +EYL     L
Sbjct: 67  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 126
Query: 180 HRDLKPNNLLINKQGVLKIGDFGLAKF 206
           HRDL   N L+N QGV+K+ DFGL+++
Sbjct: 127 HRDLAARNCLVNDQGVVKVSDFGLSRY 153

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 37/156 (23%), Positives = 77/156 (49%), Gaps = 4/156 (2%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           R++  G F  V   +  +T  + A+K +      +  +   R   +E++++Q L H  ++
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEV--RNVFKELQIMQGLEHPFLV 78
Query: 121 GLTDVFGYMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWIL 179
            L   F    ++ +V + +   DL   ++   + F    +K +    +  L+YL +  I+
Sbjct: 79  NLWYSFQDEEDMFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRII 137
Query: 180 HRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYT 215
           HRD+KP+N+L+++ G + I DF +A      T++ T
Sbjct: 138 HRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT 173

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 68/147 (46%), Gaps = 8/147 (5%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           + +  G+F  V K         VA+K IK G+ ++ +       + E K++  L HE ++
Sbjct: 30  KELGTGQFGVV-KYGKWRGQYDVAIKMIKEGSMSEDE------FIEEAKVMMNLSHEKLV 82
Query: 121 GLTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWIL 179
            L  V      + ++ E++    L   +++    F    +          +EYL     L
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 142
Query: 180 HRDLKPNNLLINKQGVLKIGDFGLAKF 206
           HRDL   N L+N QGV+K+ DFGL+++
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRY 169

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 61/125 (48%), Gaps = 7/125 (5%)
Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTD 142
           VA+K IK G+ ++ +       + E K++  L HE ++ L  V      + ++ E++   
Sbjct: 31  VAIKMIKEGSMSEDE------FIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANG 84
Query: 143 -LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDF 201
            L   +++    F    +          +EYL     LHRDL   N L+N QGV+K+ DF
Sbjct: 85  CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDF 144
Query: 202 GLAKF 206
           GL+++
Sbjct: 145 GLSRY 149

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 85/188 (45%), Gaps = 26/188 (13%)
Query: 66  GRFATVFKARDIETD---MIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLG 121
           G F  V KAR I+ D   M  A+K++K   +A   D  +R    E+++L +L HH N++ 
Sbjct: 36  GNFGQVLKAR-IKKDGLRMDAAIKRMK--EYASKDD--HRDFAGELEVLCKLGHHPNIIN 90
Query: 122 LTDVFGYMSNVSLVFEF---------------VDTDLEVIIKDPTI-VFTPSNIKAYAIM 165
           L     +   + L  E+               ++TD    I + T    +   +  +A  
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 166 TLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRL 225
             RG++YL     +HRDL   N+L+ +  V KI DFGL++      +    ++  RW   
Sbjct: 151 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM-A 209
Query: 226 IKCLLYCV 233
           I+ L Y V
Sbjct: 210 IESLNYSV 217

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 63/127 (49%), Gaps = 8/127 (6%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAI 164
           L E ++LQ ++   ++ L   F   SN+ +V E+V              F   + + YA 
Sbjct: 84  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAA 143
Query: 165 MTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK--------FFGSPTRLYTH 216
             +   EYLH   +++RDLKP NLLI++QG +++ DFG AK          G+P  L   
Sbjct: 144 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPE 203
Query: 217 QVVTRWY 223
            ++++ Y
Sbjct: 204 IILSKGY 210

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 68/147 (46%), Gaps = 8/147 (5%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           + +  G+F  V K         VA+K IK G+ ++ +       + E K++  L HE ++
Sbjct: 30  KELGTGQFGVV-KYGKWRGQYDVAIKMIKEGSMSEDE------FIEEAKVMMNLSHEKLV 82
Query: 121 GLTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWIL 179
            L  V      + ++ E++    L   +++    F    +          +EYL     L
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 142
Query: 180 HRDLKPNNLLINKQGVLKIGDFGLAKF 206
           HRDL   N L+N QGV+K+ DFGL+++
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRY 169

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 21/52 (40%), Positives = 40/52 (76%)
Query: 153 VFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           VF+ ++++ YA   + GLE++H+ ++++RDLKP N+L+++ G ++I D GLA
Sbjct: 288 VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 339

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 21/52 (40%), Positives = 40/52 (76%)
Query: 153 VFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           VF+ ++++ YA   + GLE++H+ ++++RDLKP N+L+++ G ++I D GLA
Sbjct: 288 VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 339

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 17/154 (11%)
Query: 61  RSVHVGRFATV----FKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           R +  G F  V    +   +  T  +VAVK +K       + G  +    EI +L+ L+H
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQ----EIDILRTLYH 75
Query: 117 ENVL---GLTDVFGYMSNVSLVFEFVDTDLEVIIKD--PTIVFTPSNIKAYAIMTLRGLE 171
           E+++   G  +  G  S + LV E+V       ++D  P      + +  +A     G+ 
Sbjct: 76  EHIIKYKGCCEDQGEKS-LQLVMEYVPLG---SLRDYLPRHSIGLAQLLLFAQQICEGMA 131
Query: 172 YLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           YLH    +HR+L   N+L++   ++KIGDFGLAK
Sbjct: 132 YLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAK 165

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 21/52 (40%), Positives = 40/52 (76%)
Query: 153 VFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           VF+ ++++ YA   + GLE++H+ ++++RDLKP N+L+++ G ++I D GLA
Sbjct: 287 VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 338

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 21/52 (40%), Positives = 40/52 (76%)
Query: 153 VFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           VF+ ++++ YA   + GLE++H+ ++++RDLKP N+L+++ G ++I D GLA
Sbjct: 288 VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 339

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 85/188 (45%), Gaps = 26/188 (13%)
Query: 66  GRFATVFKARDIETD---MIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLG 121
           G F  V KAR I+ D   M  A+K++K   +A   D  +R    E+++L +L HH N++ 
Sbjct: 26  GNFGQVLKAR-IKKDGLRMDAAIKRMK--EYASKDD--HRDFAGELEVLCKLGHHPNIIN 80
Query: 122 LTDVFGYMSNVSLVFEF---------------VDTDLEVIIKDPTI-VFTPSNIKAYAIM 165
           L     +   + L  E+               ++TD    I + T    +   +  +A  
Sbjct: 81  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 140
Query: 166 TLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRL 225
             RG++YL     +HRDL   N+L+ +  V KI DFGL++      +    ++  RW   
Sbjct: 141 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM-A 199
Query: 226 IKCLLYCV 233
           I+ L Y V
Sbjct: 200 IESLNYSV 207

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 74/157 (47%), Gaps = 28/157 (17%)
Query: 69  ATVFKARDIETDMIVAVKKIKLG-THADAKDGINRTALREIKLLQEL-HHENVLGLTDV- 125
           A  F      T   VAVK +K G TH++     +R  + E+K+L  + HH NV+ L    
Sbjct: 48  ADAFGIDKTATXRTVAVKMLKEGATHSE-----HRALMSELKILIHIGHHLNVVNLLGAC 102
Query: 126 ---------------FGYMSNV--SLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLR 168
                          FG +S    S   EFV    E + KD     T  ++  Y+    +
Sbjct: 103 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKD---FLTLEHLIXYSFQVAK 159
Query: 169 GLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           G+E+L     +HRDL   N+L++++ V+KI DFGLA+
Sbjct: 160 GMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLAR 196

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 111/276 (40%), Gaps = 65/276 (23%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y   +++  G F  V +  DIE+    A+KK+        +D   R   RE+ +++ L H
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKV-------LQDP--RYKNRELDIMKVLDH 59
Query: 117 ENVLGLTDVF--------------------GYMSN------------------VSLVFEF 138
            N++ L D F                    G  +N                  ++++ E+
Sbjct: 60  VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 139 VDTDLEVIIKD--PTIVFTPSN-IKAYAIMTLRGLEYLHDHWILHRDLKPNNLLIN-KQG 194
           V   L  ++K    +    P N I  Y     R + ++H   I HRD+KP NLL+N K  
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179
Query: 195 VLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFAKDPSS 251
            LK+ DFG AK    P+      + +R+YR  + +L   ++      W   C F      
Sbjct: 180 TLKLCDFGSAKKL-IPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVF------ 232
Query: 252 HGNLFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKR 287
            G L  G PL    T+  D L+ +I   +   PTK 
Sbjct: 233 -GELILGKPLFSGETSI-DQLVRIIQ--IMGTPTKE 264

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 69/150 (46%), Gaps = 11/150 (7%)
Query: 80  DMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFV 139
           ++ VA+K +K G     +    R  L E  ++ +  H NV+ L  V    + V ++ EF+
Sbjct: 35  EIFVAIKTLKSGYTEKQR----RDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFM 90
Query: 140 DT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKI 198
           +   L+  ++     FT   +         G++YL D   +HR L   N+L+N   V K+
Sbjct: 91  ENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRALAARNILVNSNLVCKV 150
Query: 199 GDFGLAKFFGSPTRLYTH------QVVTRW 222
            DFGL++F    T   T+      ++  RW
Sbjct: 151 SDFGLSRFLEDDTSDPTYTSALGGKIPIRW 180

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 77/155 (49%), Gaps = 16/155 (10%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIK-LLQELH 115
           Y    ++ VG ++   +     T+M  AVK I         D   R    EI+ LL+   
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVI---------DKSKRDPSEEIEILLRYGQ 79
Query: 116 HENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTL-RGLEYLH 174
           H N++ L DV+    +V LV E +    E++ K     F      ++ + T+ + +EYLH
Sbjct: 80  HPNIITLKDVYDDGKHVYLVTELMRGG-ELLDKILRQKFFSEREASFVLHTIGKTVEYLH 138
Query: 175 DHWILHRDLKPNNLL-INKQG---VLKIGDFGLAK 205
              ++HRDLKP+N+L +++ G    L+I DFG AK
Sbjct: 139 SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAK 173

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 17/154 (11%)
Query: 61  RSVHVGRFATV----FKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           R +  G F  V    +   +  T  +VAVK +K       + G  +    EI +L+ L+H
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQ----EIDILRTLYH 75
Query: 117 ENVL---GLTDVFGYMSNVSLVFEFVDTDLEVIIKD--PTIVFTPSNIKAYAIMTLRGLE 171
           E+++   G  +  G  S + LV E+V       ++D  P      + +  +A     G+ 
Sbjct: 76  EHIIKYKGCCEDQGEKS-LQLVMEYVPLG---SLRDYLPRHSIGLAQLLLFAQQICEGMA 131
Query: 172 YLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           YLH    +HR+L   N+L++   ++KIGDFGLAK
Sbjct: 132 YLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAK 165

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 77/155 (49%), Gaps = 16/155 (10%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIK-LLQELH 115
           Y    ++ VG ++   +     T+M  AVK I         D   R    EI+ LL+   
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVI---------DKSKRDPSEEIEILLRYGQ 79
Query: 116 HENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTL-RGLEYLH 174
           H N++ L DV+    +V LV E +    E++ K     F      ++ + T+ + +EYLH
Sbjct: 80  HPNIITLKDVYDDGKHVYLVTELMRGG-ELLDKILRQKFFSEREASFVLHTIGKTVEYLH 138
Query: 175 DHWILHRDLKPNNLL-INKQG---VLKIGDFGLAK 205
              ++HRDLKP+N+L +++ G    L+I DFG AK
Sbjct: 139 SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAK 173

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 82/174 (47%), Gaps = 16/174 (9%)
Query: 62  SVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           ++  G +    K R      I+  K++  G+  +A+    +  + E+ LL+EL H N++ 
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE---KQMLVSEVNLLRELKHPNIVR 69
Query: 122 LTDVFGYMSNVSL--VFEFVDT-DLEVII----KDPTIVFTPSNIKAYAIMTLRGLEYLH 174
             D     +N +L  V E+ +  DL  +I    K+   +     ++    +TL  L+  H
Sbjct: 70  YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL-ALKECH 128
Query: 175 -----DHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWY 223
                 H +LHRDLKP N+ ++ +  +K+GDFGLA+     T      V T +Y
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYY 182

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 77/159 (48%), Gaps = 10/159 (6%)
Query: 47  DCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALR 106
           D E+ +  +   Q   +  G F TV+K +    D+ V +  +   T    +   N     
Sbjct: 18  DWEIPDGQITVGQ--RIGSGSFGTVYKGK-WHGDVAVKMLNVTAPTPQQLQAFKN----- 69
Query: 107 EIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIM 165
           E+ +L++  H N+L L   +     +++V ++ + + L   +      F    +   A  
Sbjct: 70  EVGVLRKTRHVNIL-LFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQ 128
Query: 166 TLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           T RG++YLH   I+HRDLK NN+ +++   +KIGDFGLA
Sbjct: 129 TARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA 167

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 73/142 (51%), Gaps = 12/142 (8%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F TV+K +    D+ V + K+      D      +    E+ +L++  H N+L     
Sbjct: 47  GSFGTVYKGK-WHGDVAVKILKV-----VDPTPEQFQAFRNEVAVLRKTRHVNILLF--- 97
Query: 126 FGYMS--NVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
            GYM+  N+++V ++ + + L   +      F    +   A  T +G++YLH   I+HRD
Sbjct: 98  MGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRD 157
Query: 183 LKPNNLLINKQGVLKIGDFGLA 204
           +K NN+ +++   +KIGDFGLA
Sbjct: 158 MKSNNIFLHEGLTVKIGDFGLA 179

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 82/174 (47%), Gaps = 16/174 (9%)
Query: 62  SVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           ++  G +    K R      I+  K++  G+  +A+    +  + E+ LL+EL H N++ 
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE---KQMLVSEVNLLRELKHPNIVR 69
Query: 122 LTDVFGYMSNVSL--VFEFVDT-DLEVII----KDPTIVFTPSNIKAYAIMTLRGLEYLH 174
             D     +N +L  V E+ +  DL  +I    K+   +     ++    +TL  L+  H
Sbjct: 70  YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL-ALKECH 128
Query: 175 -----DHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWY 223
                 H +LHRDLKP N+ ++ +  +K+GDFGLA+     T      V T +Y
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYY 182

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 67/149 (44%), Gaps = 8/149 (5%)
Query: 63  VHVGRFATVFKAR---DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENV 119
           +  G F  V + R     + +  VA+K +K G     +    R  L E  ++ +  H N+
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR----REFLSEASIMGQFEHPNI 77
Query: 120 LGLTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
           + L  V      V ++ EF++   L+  ++     FT   +         G+ YL +   
Sbjct: 78  IRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSY 137
Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAKFF 207
           +HRDL   N+L+N   V K+ DFGL++F 
Sbjct: 138 VHRDLAARNILVNSNLVCKVSDFGLSRFL 166

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 72/145 (49%), Gaps = 8/145 (5%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           + +  G F TV+K +    D+ V +  +   T    +   N     E+ +L++  H N+L
Sbjct: 18  QRIGSGSFGTVYKGK-WHGDVAVKMLNVTAPTPQQLQAFKN-----EVGVLRKTRHVNIL 71
Query: 121 GLTDVFGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWIL 179
            L   +     +++V ++ + + L   +      F    +   A  T RG++YLH   I+
Sbjct: 72  -LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSII 130
Query: 180 HRDLKPNNLLINKQGVLKIGDFGLA 204
           HRDLK NN+ +++   +KIGDFGLA
Sbjct: 131 HRDLKSNNIFLHEDNTVKIGDFGLA 155

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 77/159 (48%), Gaps = 10/159 (6%)
Query: 47  DCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALR 106
           D E+ +  +   Q   +  G F TV+K +    D+ V +  +   T    +   N     
Sbjct: 18  DWEIPDGQITVGQ--RIGSGSFGTVYKGK-WHGDVAVKMLNVTAPTPQQLQAFKN----- 69
Query: 107 EIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIM 165
           E+ +L++  H N+L L   +     +++V ++ + + L   +      F    +   A  
Sbjct: 70  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQ 128
Query: 166 TLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           T RG++YLH   I+HRDLK NN+ +++   +KIGDFGLA
Sbjct: 129 TARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA 167

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 74/166 (44%), Gaps = 26/166 (15%)
Query: 61  RSVHVGRFATVFKAR-----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH 115
           R +  G F  VF A        +  M+VAVK +K  T A  KD       RE +LL  L 
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD-----FQREAELLTNLQ 75
Query: 116 HENVLGLTDVFGYMSNVSLVFEFVD-TDLEVIIK----DPTIVFTPSNIKAYAIMTLR-- 168
           HE+++    V G    + +VFE++   DL   ++    D  I+      +A   + L   
Sbjct: 76  HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135
Query: 169 ---------GLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
                    G+ YL     +HRDL   N L+    ++KIGDFG+++
Sbjct: 136 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 70/145 (48%), Gaps = 1/145 (0%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           R +  G +A V   R  +TD I A+K +K     D +D I+     +    Q  +H  ++
Sbjct: 26  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDED-IDWVQTEKHVFEQASNHPFLV 84
Query: 121 GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
           GL   F   S +  V E+V+    +            + + Y+      L YLH+  I++
Sbjct: 85  GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIY 144
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAK 205
           RDLK +N+L++ +G +K+ D+G+ K
Sbjct: 145 RDLKLDNVLLDSEGHIKLTDYGMCK 169

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 75/153 (49%), Gaps = 19/153 (12%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  VF+A++   D   A+K+I+L     A++ +    +RE+K L +L H  ++   + 
Sbjct: 16  GGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKV----MREVKALAKLEHPGIVRYFNA 71
Query: 126 F-------GYMSNVSLVFEFVDTDL--EVIIKD-----PTIVFTPSNIKAYAIMTL-RGL 170
           +           +   V+ ++   L  +  +KD      TI     ++  +  + +   +
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131
Query: 171 EYLHDHWILHRDLKPNNLLINKQGVLKIGDFGL 203
           E+LH   ++HRDLKP+N+      V+K+GDFGL
Sbjct: 132 EFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGL 164

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 87/186 (46%), Gaps = 26/186 (13%)
Query: 35  VHSALKKQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHA 94
           VH    K++ L + +V +D   +     +  G F  V+K R +    +VAVK++K     
Sbjct: 12  VHLGQLKRFSLRELQVASD--NFXNKNILGRGGFGKVYKGR-LADGXLVAVKRLK----E 64
Query: 95  DAKDGINRTALREIKLLQELHHENVLGLTD----------VFGYMSNVSLVFEFVDTDLE 144
           +   G       E++++    H N+L L            V+ YM+N S     V + L 
Sbjct: 65  ERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS-----VASCLR 119
Query: 145 VIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH---WILHRDLKPNNLLINKQGVLKIGDF 201
              +    +  P   +  A+ + RGL YLHDH    I+HRD+K  N+L++++    +GDF
Sbjct: 120 ERPESQPPLDWPKR-QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 178
Query: 202 GLAKFF 207
           GLAK  
Sbjct: 179 GLAKLM 184

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 70/145 (48%), Gaps = 1/145 (0%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           R +  G +A V   R  +TD I A+K +K     D +D I+     +    Q  +H  ++
Sbjct: 11  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDED-IDWVQTEKHVFEQASNHPFLV 69
Query: 121 GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
           GL   F   S +  V E+V+    +            + + Y+      L YLH+  I++
Sbjct: 70  GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIY 129
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAK 205
           RDLK +N+L++ +G +K+ D+G+ K
Sbjct: 130 RDLKLDNVLLDSEGHIKLTDYGMCK 154

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 86/186 (46%), Gaps = 26/186 (13%)
Query: 35  VHSALKKQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHA 94
           VH    K++ L + +V +D   +     +  G F  V+K R +    +VAVK++K     
Sbjct: 20  VHLGQLKRFSLRELQVASD--NFSNKNILGRGGFGKVYKGR-LADGTLVAVKRLK----E 72
Query: 95  DAKDGINRTALREIKLLQELHHENVLGLTD----------VFGYMSNVSLVFEFVDTDLE 144
           +   G       E++++    H N+L L            V+ YM+N S+         E
Sbjct: 73  ERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCL----RE 128
Query: 145 VIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH---WILHRDLKPNNLLINKQGVLKIGDF 201
                P + +     +  A+ + RGL YLHDH    I+HRD+K  N+L++++    +GDF
Sbjct: 129 RPESQPPLDWPKR--QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 186
Query: 202 GLAKFF 207
           GLAK  
Sbjct: 187 GLAKLM 192

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 70/145 (48%), Gaps = 1/145 (0%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           R +  G +A V   R  +TD I A+K +K     D +D I+     +    Q  +H  ++
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDED-IDWVQTEKHVFEQASNHPFLV 73
Query: 121 GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
           GL   F   S +  V E+V+    +            + + Y+      L YLH+  I++
Sbjct: 74  GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIY 133
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAK 205
           RDLK +N+L++ +G +K+ D+G+ K
Sbjct: 134 RDLKLDNVLLDSEGHIKLTDYGMCK 158

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 72/148 (48%), Gaps = 15/148 (10%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTD 124
           G +  V+K R ++T  + A+K + +    D ++ I +    EI +L++  HH N+     
Sbjct: 35  GTYGQVYKGRHVKTGQLAAIKVMDVT--GDEEEEIKQ----EINMLKKYSHHRNIATYYG 88
Query: 125 VF------GYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMT-LRGLEYLHDH 176
            F      G    + LV EF     +  +IK+           AY     LRGL +LH H
Sbjct: 89  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 148
Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLA 204
            ++HRD+K  N+L+ +   +K+ DFG++
Sbjct: 149 KVIHRDIKGQNVLLTENAEVKLVDFGVS 176

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 67/149 (44%), Gaps = 8/149 (5%)
Query: 63  VHVGRFATVFKAR---DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENV 119
           +  G F  V + R     + +  VA+K +K G     +    R  L E  ++ +  H N+
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR----REFLSEASIMGQFEHPNI 79
Query: 120 LGLTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
           + L  V      V ++ EF++   L+  ++     FT   +         G+ YL +   
Sbjct: 80  IRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSY 139
Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAKFF 207
           +HRDL   N+L+N   V K+ DFGL++F 
Sbjct: 140 VHRDLAARNILVNSNLVCKVSDFGLSRFL 168

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/147 (23%), Positives = 69/147 (46%), Gaps = 8/147 (5%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           + +  G+F  V     +  D  VA+K I+ G  ++         + E +++ +L H  ++
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSE------EDFIEEAEVMMKLSHPKLV 66
Query: 121 GLTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWIL 179
            L  V    + + LV EF++   L   ++    +F    +    +    G+ YL +  ++
Sbjct: 67  QLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 126
Query: 180 HRDLKPNNLLINKQGVLKIGDFGLAKF 206
           HRDL   N L+ +  V+K+ DFG+ +F
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRF 153

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 106 REIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVF--TPSNIKAYA 163
           +EI +L    H N+L L + F  M  + ++FEF+ + L++  +  T  F      I +Y 
Sbjct: 50  KEISILNIARHRNILHLHESFESMEELVMIFEFI-SGLDIFERINTSAFELNEREIVSYV 108
Query: 164 IMTLRGLEYLHDHWILHRDLKPNNLL--INKQGVLKIGDFGLAK 205
                 L++LH H I H D++P N++    +   +KI +FG A+
Sbjct: 109 HQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 74/149 (49%), Gaps = 18/149 (12%)
Query: 63  VHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL 122
           V  G F  V KA+    D  VA+K+I+        +   +  + E++ L  ++H N++ L
Sbjct: 17  VGRGAFGVVCKAKWRAKD--VAIKQIE-------SESERKAFIVELRQLSRVNHPNIVKL 67
Query: 123 TDVFGYMSNVSLVFEFVDTDLEVII---KDPTIVFTPSNIKAYAIMTLRGLEYLHD---H 176
                 ++ V LV E+ +      +    +P   +T ++  ++ +   +G+ YLH     
Sbjct: 68  YGAC--LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 125
Query: 177 WILHRDLKPNNLLINKQG-VLKIGDFGLA 204
            ++HRDLKP NLL+   G VLKI DFG A
Sbjct: 126 ALIHRDLKPPNLLLVAGGTVLKICDFGTA 154

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 26/188 (13%)
Query: 66  GRFATVFKARDIETD---MIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLG 121
           G F  V KAR I+ D   M  A+K++K   +A   D  +R    E+++L +L HH N++ 
Sbjct: 33  GNFGQVLKAR-IKKDGLRMDAAIKRMK--EYASKDD--HRDFAGELEVLCKLGHHPNIIN 87
Query: 122 LTDVFGYMSNVSLVFEF---------------VDTDLEVIIKDPTI-VFTPSNIKAYAIM 165
           L     +   + L  E+               ++TD    I + T    +   +  +A  
Sbjct: 88  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 147
Query: 166 TLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRL 225
             RG++YL     +HR+L   N+L+ +  V KI DFGL++      +    ++  RW   
Sbjct: 148 VARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM-A 206
Query: 226 IKCLLYCV 233
           I+ L Y V
Sbjct: 207 IESLNYSV 214

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 74/149 (49%), Gaps = 18/149 (12%)
Query: 63  VHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL 122
           V  G F  V KA+    D  VA+K+I+        +   +  + E++ L  ++H N++ L
Sbjct: 16  VGRGAFGVVCKAKWRAKD--VAIKQIE-------SESERKAFIVELRQLSRVNHPNIVKL 66
Query: 123 TDVFGYMSNVSLVFEFVDTDLEVII---KDPTIVFTPSNIKAYAIMTLRGLEYLHD---H 176
                 ++ V LV E+ +      +    +P   +T ++  ++ +   +G+ YLH     
Sbjct: 67  YGAC--LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124
Query: 177 WILHRDLKPNNLLINKQG-VLKIGDFGLA 204
            ++HRDLKP NLL+   G VLKI DFG A
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTA 153

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 70/145 (48%), Gaps = 1/145 (0%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           R +  G +A V   R  +TD I A++ +K     D +D I+     +    Q  +H  ++
Sbjct: 58  RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDED-IDWVQTEKHVFEQASNHPFLV 116
Query: 121 GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
           GL   F   S +  V E+V+    +            + + Y+      L YLH+  I++
Sbjct: 117 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIY 176
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAK 205
           RDLK +N+L++ +G +K+ D+G+ K
Sbjct: 177 RDLKLDNVLLDSEGHIKLTDYGMCK 201

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 76/161 (47%), Gaps = 3/161 (1%)
Query: 46  PDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL 105
           P  ++K  +  +   + +  G F  VF A   +T+   A+K +K        D +  T +
Sbjct: 8   PSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDV-VLMDDDVECTMV 66
Query: 106 REIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAI 164
            +  L     H  +  +   F    N+  V E+++  DL   I+     F  S    YA 
Sbjct: 67  EKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAA 125
Query: 165 MTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
             + GL++LH   I++RDLK +N+L++K G +KI DFG+ K
Sbjct: 126 EIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK 166

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 90/199 (45%), Gaps = 33/199 (16%)
Query: 62  SVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           ++  G +    K R      I+  K++  G+  +A+    +  + E+ LL+EL H N++ 
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE---KQMLVSEVNLLRELKHPNIVR 69
Query: 122 LTDVFGYMSNVSL--VFEFVDT-DLEVII----KDPTIVFTPSNIKAYAIMTLRGLEYLH 174
             D     +N +L  V E+ +  DL  +I    K+   +     ++    +TL  L+  H
Sbjct: 70  YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL-ALKECH 128
Query: 175 -----DHWILHRDLKPNNLLINKQGVLKIGDFGLAK-----------FFGSPTRLYTHQV 218
                 H +LHRDLKP N+ ++ +  +K+GDFGLA+           F G+P  +   Q+
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQM 188
Query: 219 VTRWYR------LIKCLLY 231
               Y        + CLLY
Sbjct: 189 NRMSYNEKSDIWSLGCLLY 207

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F+TV  AR++ T    A+K ++   H   ++ +     RE  ++  L H   + L   
Sbjct: 40  GSFSTVVLARELATSREYAIKILE-KRHIIKENKVPYVT-RERDVMSRLDHPFFVKL--Y 95
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIV--FTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
           F +  +  L F         ++K    +  F  +  + Y    +  LEYLH   I+HRDL
Sbjct: 96  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 155
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTR 212
           KP N+L+N+   ++I DFG AK     ++
Sbjct: 156 KPENILLNEDMHIQITDFGTAKVLSPESK 184

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 75/174 (43%), Gaps = 33/174 (18%)
Query: 61  RSVHVGRFATVFKAR-----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH 115
           R +  G F  VF+AR       E   +VAVK +K    AD +    R    E  L+ E  
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR----EAALMAEFD 108
Query: 116 HENVLGLTDVFGYMSNVSLVFEFVD-TDLEVIIKD--PTIV--FTPSNIKAYAIMT---- 166
           + N++ L  V      + L+FE++   DL   ++   P  V   + S++   A ++    
Sbjct: 109 NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 168
Query: 167 ---------------LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
                            G+ YL +   +HRDL   N L+ +  V+KI DFGL++
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR 222

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F+TV  AR++ T    A+K ++   H   ++ +     RE  ++  L H   + L   
Sbjct: 18  GSFSTVVLARELATSREYAIKILE-KRHIIKENKVPYVT-RERDVMSRLDHPFFVKL--Y 73
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIV--FTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
           F +  +  L F         ++K    +  F  +  + Y    +  LEYLH   I+HRDL
Sbjct: 74  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 133
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTR 212
           KP N+L+N+   ++I DFG AK     ++
Sbjct: 134 KPENILLNEDMHIQITDFGTAKVLSPESK 162

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F+TV  AR++ T    A+K ++   H   ++ +     RE  ++  L H   + L   
Sbjct: 25  GSFSTVVLARELATSREYAIKILE-KRHIIKENKVPYVT-RERDVMSRLDHPFFVKL--Y 80
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIV--FTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
           F +  +  L F         ++K    +  F  +  + Y    +  LEYLH   I+HRDL
Sbjct: 81  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 140
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTR 212
           KP N+L+N+   ++I DFG AK     ++
Sbjct: 141 KPENILLNEDMHIQITDFGTAKVLSPESK 169

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 64/140 (45%), Gaps = 1/140 (0%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V  AR    ++  AVK ++       K+  +  + R + LL+ + H  ++GL   
Sbjct: 49  GSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNV-LLKNVKHPFLVGLHFS 107
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
           F     +  V ++++             F     + YA      L YLH   I++RDLKP
Sbjct: 108 FQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKP 167
Query: 186 NNLLINKQGVLKIGDFGLAK 205
            N+L++ QG + + DFGL K
Sbjct: 168 ENILLDSQGHIVLTDFGLCK 187

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 76/161 (47%), Gaps = 3/161 (1%)
Query: 46  PDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL 105
           P  ++K  +  +   + +  G F  VF A   +T+   A+K +K        D +  T +
Sbjct: 9   PSLQIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDV-VLMDDDVECTMV 67
Query: 106 REIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAI 164
            +  L     H  +  +   F    N+  V E+++  DL   I+     F  S    YA 
Sbjct: 68  EKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAA 126
Query: 165 MTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
             + GL++LH   I++RDLK +N+L++K G +KI DFG+ K
Sbjct: 127 EIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK 167

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F+TV  AR++ T    A+K ++   H   ++ +     RE  ++  L H   + L   
Sbjct: 40  GSFSTVVLARELATSREYAIKILE-KRHIIKENKVPYVT-RERDVMSRLDHPFFVKL--Y 95
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIV--FTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
           F +  +  L F         ++K    +  F  +  + Y    +  LEYLH   I+HRDL
Sbjct: 96  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 155
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTR 212
           KP N+L+N+   ++I DFG AK     ++
Sbjct: 156 KPENILLNEDMHIQITDFGTAKVLSPESK 184

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F+TV  AR++ T    A+K ++   H   ++ +     RE  ++  L H   + L   
Sbjct: 19  GSFSTVVLARELATSREYAIKILE-KRHIIKENKVPYVT-RERDVMSRLDHPFFVKL--Y 74
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIV--FTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
           F +  +  L F         ++K    +  F  +  + Y    +  LEYLH   I+HRDL
Sbjct: 75  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 134
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTR 212
           KP N+L+N+   ++I DFG AK     ++
Sbjct: 135 KPENILLNEDMHIQITDFGTAKVLSPESK 163

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F+TV  AR++ T    A+K ++   H   ++ +     RE  ++  L H   + L   
Sbjct: 43  GSFSTVVLARELATSREYAIKILE-KRHIIKENKVPYVT-RERDVMSRLDHPFFVKL--Y 98
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIV--FTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
           F +  +  L F         ++K    +  F  +  + Y    +  LEYLH   I+HRDL
Sbjct: 99  FTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 158
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTR 212
           KP N+L+N+   ++I DFG AK     ++
Sbjct: 159 KPENILLNEDMHIQITDFGTAKVLSPESK 187

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F+TV  AR++ T    A+K ++   H   ++ +     RE  ++  L H   + L   
Sbjct: 20  GSFSTVVLARELATSREYAIKILE-KRHIIKENKVPYVT-RERDVMSRLDHPFFVKL--Y 75
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIV--FTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
           F +  +  L F         ++K    +  F  +  + Y    +  LEYLH   I+HRDL
Sbjct: 76  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 135
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTR 212
           KP N+L+N+   ++I DFG AK     ++
Sbjct: 136 KPENILLNEDMHIQITDFGTAKVLSPESK 164

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/151 (26%), Positives = 70/151 (46%), Gaps = 21/151 (13%)
Query: 69  ATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFG 127
           AT F     +  + VAVK +K   HAD K+ +    + E+K++  L  HEN++ L     
Sbjct: 57  ATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL----MSELKIMSHLGQHENIVNLLGACT 112
Query: 128 YMSNVSLVFEF-------------VDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH 174
           +   V ++ E+              + DL+   K+        ++  ++    +G+ +L 
Sbjct: 113 HGGPVLVITEYCCYGDLLNFLRRKAEADLD---KEDGRPLELRDLLHFSSQVAQGMAFLA 169
Query: 175 DHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
               +HRD+   N+L+    V KIGDFGLA+
Sbjct: 170 SKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 200

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/261 (23%), Positives = 107/261 (40%), Gaps = 26/261 (9%)
Query: 56  VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH 115
           ++ +   +  G F  VFK  D  T  +VA+K I L    D          +EI +L +  
Sbjct: 23  LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE----IEDIQQEITVLSQCD 78
Query: 116 HENVLGLTDVFG-YMSNVSL--VFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEY 172
              V   T  +G Y+ +  L  + E++     + + +P      + I       L+GL+Y
Sbjct: 79  SPYV---TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-PLDETQIATILREILKGLDY 134
Query: 173 LHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYC 232
           LH    +HRD+K  N+L+++ G +K+ DFG+A    + T++  +  V   + +   ++  
Sbjct: 135 LHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNXFVGTPFWMAPEVIKQ 193
Query: 233 VQFNVKNVQWCC------FAKDPSSHGNLFPG-----IPLNEIFTAAGD---DLLAVISS 278
             ++ K   W         A+    H  L P      IP N   T  G+    L   + +
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA 253
Query: 279 LLCLNPTKRADCTATLKMDYF 299
            L   P+ R      LK  + 
Sbjct: 254 CLNKEPSFRPTAKELLKHKFI 274

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F+TV  AR++ T    A+K ++   H   ++ +     RE  ++  L H   + L   
Sbjct: 21  GSFSTVVLARELATSREYAIKILE-KRHIIKENKVPYVT-RERDVMSRLDHPFFVKL--Y 76
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIV--FTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
           F +  +  L F         ++K    +  F  +  + Y    +  LEYLH   I+HRDL
Sbjct: 77  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 136
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTR 212
           KP N+L+N+   ++I DFG AK     ++
Sbjct: 137 KPENILLNEDMHIQITDFGTAKVLSPESK 165

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 72/152 (47%), Gaps = 11/152 (7%)
Query: 56  VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH 115
           ++ +   +  G F  VFK  D  T  +VA+K I L    D          +EI +L +  
Sbjct: 28  LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE----IEDIQQEITVLSQCD 83
Query: 116 HENVLGLTDVFG-YMSNVSL--VFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEY 172
              V   T  +G Y+ +  L  + E++     + + +P      + I       L+GL+Y
Sbjct: 84  SPYV---TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-PLDETQIATILREILKGLDY 139
Query: 173 LHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           LH    +HRD+K  N+L+++ G +K+ DFG+A
Sbjct: 140 LHSEKKIHRDIKAANVLLSEHGEVKLADFGVA 171

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 32/220 (14%)
Query: 69  ATVFKARDIETDMIVAVKKIKLG-THADAKDGINRTALREIKLLQEL-HHENVLGLTDVF 126
           A  F      T   VAVK +K G TH++     +R  + E+K+L  + HH NV+ L    
Sbjct: 46  ADAFGIDKTATXRTVAVKMLKEGATHSE-----HRALMSELKILIHIGHHLNVVNLLGAC 100
Query: 127 GYMSN-VSLVFEFVD-TDLEVIIKDPTIVFTP-----------SNIKAYAIMTLRGLEYL 173
                 + ++ EF    +L   ++     F P            ++  Y+    +G+E+L
Sbjct: 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFL 160
Query: 174 HDHWILHRDLKPNNLLINKQGVLKIGDFGLAK-FFGSP--TRLYTHQVVTRWY--RLIKC 228
                +HRDL   N+L++++ V+KI DFGLA+  +  P   R    ++  +W     I  
Sbjct: 161 ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 220
Query: 229 LLYCVQFNVKN---VQWCCFAKDPSSHGNLFPGIPLNEIF 265
            +Y +Q +V +   + W  F+   S     +PG+ ++E F
Sbjct: 221 RVYTIQSDVWSFGVLLWEIFSLGASP----YPGVKIDEEF 256

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/261 (23%), Positives = 109/261 (41%), Gaps = 26/261 (9%)
Query: 56  VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH 115
           ++ +   +  G F  VFK  D  T  +VA+K I L    D  + I +    EI +L +  
Sbjct: 8   LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ----EITVLSQCD 63
Query: 116 HENVLGLTDVFG-YMSNVSL--VFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEY 172
              V   T  +G Y+ +  L  + E++     + + +P      + I       L+GL+Y
Sbjct: 64  SPYV---TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-PLDETQIATILREILKGLDY 119
Query: 173 LHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYC 232
           LH    +HRD+K  N+L+++ G +K+ DFG+A    + T++  +  V   + +   ++  
Sbjct: 120 LHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNXFVGTPFWMAPEVIKQ 178
Query: 233 VQFNVKNVQWCC------FAKDPSSHGNLFPG-----IPLNEIFTAAGD---DLLAVISS 278
             ++ K   W         A+    H  L P      IP N   T  G+    L   + +
Sbjct: 179 SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA 238
Query: 279 LLCLNPTKRADCTATLKMDYF 299
            L   P+ R      LK  + 
Sbjct: 239 CLNKEPSFRPTAKELLKHKFI 259

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/151 (26%), Positives = 70/151 (46%), Gaps = 21/151 (13%)
Query: 69  ATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFG 127
           AT F     +  + VAVK +K   HAD K+ +    + E+K++  L  HEN++ L     
Sbjct: 65  ATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL----MSELKIMSHLGQHENIVNLLGACT 120
Query: 128 YMSNVSLVFEF-------------VDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH 174
           +   V ++ E+              + DL+   K+        ++  ++    +G+ +L 
Sbjct: 121 HGGPVLVITEYCCYGDLLNFLRRKAEADLD---KEDGRPLELRDLLHFSSQVAQGMAFLA 177
Query: 175 DHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
               +HRD+   N+L+    V KIGDFGLA+
Sbjct: 178 SKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 208

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F+TV  AR++ T    A+K ++   H   ++ +     RE  ++  L H   + L   
Sbjct: 43  GSFSTVVLARELATSREYAIKILE-KRHIIKENKVPYVT-RERDVMSRLDHPFFVKL--Y 98
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIV--FTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
           F +  +  L F         ++K    +  F  +  + Y    +  LEYLH   I+HRDL
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 158
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTR 212
           KP N+L+N+   ++I DFG AK     ++
Sbjct: 159 KPENILLNEDMHIQITDFGTAKVLSPESK 187

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 89/223 (39%), Gaps = 40/223 (17%)
Query: 107 EIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTD--LEVIIKDPT--IVFTPSNIKAY 162
           EI++L+ L H N++ + +VF    N+ +V E  +    LE I+         +   +   
Sbjct: 70  EIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAEL 129
Query: 163 AIMTLRGLEYLHDHWILHRDLKPNNLLI---NKQGVLKIGDFGLAKFFGSP--------T 211
               +  L Y H   ++H+DLKP N+L    +    +KI DFGLA+ F S         T
Sbjct: 130 MKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGT 189
Query: 212 RLYTHQVVTRWYRLIKC------------LLYCVQF---NVKNVQWCCFAKDPSSHGNLF 256
            LY    V +     KC            L  C+ F   +++ VQ     K+P+      
Sbjct: 190 ALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECR 249
Query: 257 PGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF 299
           P        T    DLL     +L  +P +R      L  ++F
Sbjct: 250 P-------LTPQAVDLL---KQMLTKDPERRPSAAQVLHHEWF 282

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 77/150 (51%), Gaps = 15/150 (10%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKL-LQELHHENVLGLTD 124
           G +  V K R + +  I+AVK+I+   ++  +    +  L ++ + ++ +     +    
Sbjct: 62  GAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQ----KRLLMDLDISMRTVDCPFTVTFYG 117
Query: 125 VFGYMSNVSLVFEFVDTDL-----EVIIKDPTIVFTPSNI-KAYAIMTLRGLEYLHDHW- 177
                 +V +  E +DT L     +VI K  TI   P +I    A+  ++ LE+LH    
Sbjct: 118 ALFREGDVWICMELMDTSLDKFYKQVIDKGQTI---PEDILGKIAVSIVKALEHLHSKLS 174
Query: 178 ILHRDLKPNNLLINKQGVLKIGDFGLAKFF 207
           ++HRD+KP+N+LIN  G +K+ DFG++ + 
Sbjct: 175 VIHRDVKPSNVLINALGQVKMCDFGISGYL 204

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 62/261 (23%), Positives = 109/261 (41%), Gaps = 26/261 (9%)
Query: 56  VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH 115
           ++ +   +  G F  VFK  D  T  +VA+K I L    D  + I +    EI +L +  
Sbjct: 8   LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ----EITVLSQCD 63
Query: 116 HENVLGLTDVFG-YMSNVSL--VFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEY 172
              V   T  +G Y+ +  L  + E++     + + +P      + I       L+GL+Y
Sbjct: 64  SPYV---TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-PLDETQIATILREILKGLDY 119
Query: 173 LHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYC 232
           LH    +HRD+K  N+L+++ G +K+ DFG+A    + T++  +  V   + +   ++  
Sbjct: 120 LHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNTFVGTPFWMAPEVIKQ 178
Query: 233 VQFNVKNVQWCC------FAKDPSSHGNLFPG-----IPLNEIFTAAGD---DLLAVISS 278
             ++ K   W         A+    H  L P      IP N   T  G+    L   + +
Sbjct: 179 SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA 238
Query: 279 LLCLNPTKRADCTATLKMDYF 299
            L   P+ R      LK  + 
Sbjct: 239 CLNKEPSFRPTAKELLKHKFI 259

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F+TV  AR++ T    A+K ++   H   ++ +     RE  ++  L H   + L   
Sbjct: 44  GSFSTVVLARELATSREYAIKILE-KRHIIKENKVPYVT-RERDVMSRLDHPFFVKL--Y 99
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIV--FTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
           F +  +  L F         ++K    +  F  +  + Y    +  LEYLH   I+HRDL
Sbjct: 100 FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 159
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTR 212
           KP N+L+N+   ++I DFG AK     ++
Sbjct: 160 KPENILLNEDMHIQITDFGTAKVLSPESK 188

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F+TV  AR++ T    A+K ++   H   ++ +     RE  ++  L H   + L   
Sbjct: 41  GSFSTVVLARELATSREYAIKILE-KRHIIKENKVPYVT-RERDVMSRLDHPFFVKL--Y 96
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIV--FTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
           F +  +  L F         ++K    +  F  +  + Y    +  LEYLH   I+HRDL
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 156
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTR 212
           KP N+L+N+   ++I DFG AK     ++
Sbjct: 157 KPENILLNEDMHIQITDFGTAKVLSPESK 185

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 72/163 (44%), Gaps = 12/163 (7%)
Query: 47  DCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALR 106
           D  + +D   Y   + +  G F      RD + + +VAVK I+ G      + I+    R
Sbjct: 11  DLPIMHDSDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERG------EKIDENVKR 64
Query: 107 EIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAI 164
           EI   + L H N++   +V    +++++V E+       E I       F+    + +  
Sbjct: 65  EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQ 122
Query: 165 MTLRGLEYLHDHWILHRDLKPNNLLINKQGV--LKIGDFGLAK 205
             + G+ Y H   + HRDLK  N L++      LKI DFG +K
Sbjct: 123 QLISGVSYAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSK 165

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 71/154 (46%), Gaps = 21/154 (13%)
Query: 69  ATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFG 127
           AT F     +  + VAVK +K   HAD K+ +    + E+K++  L  HEN++ L     
Sbjct: 65  ATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL----MSELKIMSHLGQHENIVNLLGACT 120
Query: 128 YMSNVSLVFEFV-DTDLEVIIK---------------DPTIVFTPSNIKAYAIMTLRGLE 171
           +   V ++ E+    DL   ++               +P    +  ++  ++    +G+ 
Sbjct: 121 HGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMA 180
Query: 172 YLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           +L     +HRD+   N+L+    V KIGDFGLA+
Sbjct: 181 FLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 214

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F+TV  AR++ T    A+K ++   H   ++ +     RE  ++  L H   + L   
Sbjct: 41  GSFSTVVLARELATSREYAIKILE-KRHIIKENKVPYVT-RERDVMSRLDHPFFVKL--Y 96
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIV--FTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
           F +  +  L F         ++K    +  F  +  + Y    +  LEYLH   I+HRDL
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 156
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTR 212
           KP N+L+N+   ++I DFG AK     ++
Sbjct: 157 KPENILLNEDMHIQITDFGTAKVLSPESK 185

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 66/154 (42%), Gaps = 20/154 (12%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHE-------- 117
           G F  V KAR+       A+KKI+   H + K     T L E+ LL  L+H+        
Sbjct: 17  GAFGQVVKARNALDSRYYAIKKIR---HTEEKLS---TILSEVMLLASLNHQYVVRYYAA 70
Query: 118 -----NVLGLTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLE 171
                N +         S + +  E+ +   L  +I    +              L  L 
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALS 130
Query: 172 YLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           Y+H   I+HRDLKP N+ I++   +KIGDFGLAK
Sbjct: 131 YIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F+TV  AR++ T    A+K ++   H   ++ +     RE  ++  L H   + L   
Sbjct: 41  GSFSTVVLARELATSREYAIKILE-KRHIIKENKVPYVT-RERDVMSRLDHPFFVKL--Y 96
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIV--FTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
           F +  +  L F         ++K    +  F  +  + Y    +  LEYLH   I+HRDL
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 156
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTR 212
           KP N+L+N+   ++I DFG AK     ++
Sbjct: 157 KPENILLNEDMHIQITDFGTAKVLSPESK 185

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F+TV  AR++ T    A+K ++   H   ++ +     RE  ++  L H   + L   
Sbjct: 43  GSFSTVVLARELATSREYAIKILE-KRHIIKENKVPYVT-RERDVMSRLDHPFFVKL--Y 98
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIV--FTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
           F +  +  L F         ++K    +  F  +  + Y    +  LEYLH   I+HRDL
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 158
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTR 212
           KP N+L+N+   ++I DFG AK     ++
Sbjct: 159 KPENILLNEDMHIQITDFGTAKVLSPESK 187

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 32/220 (14%)
Query: 69  ATVFKARDIETDMIVAVKKIKLG-THADAKDGINRTALREIKLLQEL-HHENVLGLTDVF 126
           A  F      T   VAVK +K G TH++     +R  + E+K+L  + HH NV+ L    
Sbjct: 46  ADAFGIDKTATXRTVAVKMLKEGATHSE-----HRALMSELKILIHIGHHLNVVNLLGAC 100
Query: 127 GYMSN-VSLVFEFVD-TDLEVIIKDPTIVFTP-----------SNIKAYAIMTLRGLEYL 173
                 + ++ EF    +L   ++     F P            ++  Y+    +G+E+L
Sbjct: 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFL 160
Query: 174 HDHWILHRDLKPNNLLINKQGVLKIGDFGLAK-FFGSP--TRLYTHQVVTRWY--RLIKC 228
                +HRDL   N+L++++ V+KI DFGLA+  +  P   R    ++  +W     I  
Sbjct: 161 ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 220
Query: 229 LLYCVQFNVKN---VQWCCFAKDPSSHGNLFPGIPLNEIF 265
            +Y +Q +V +   + W  F+   S     +PG+ ++E F
Sbjct: 221 RVYTIQSDVWSFGVLLWEIFSLGASP----YPGVKIDEEF 256

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F+TV  AR++ T    A+K ++   H   ++ +     RE  ++  L H   + L   
Sbjct: 43  GSFSTVVLARELATSREYAIKILE-KRHIIKENKVPYVT-RERDVMSRLDHPFFVKL--Y 98
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIV--FTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
           F +  +  L F         ++K    +  F  +  + Y    +  LEYLH   I+HRDL
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 158
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTR 212
           KP N+L+N+   ++I DFG AK     ++
Sbjct: 159 KPENILLNEDMHIQITDFGTAKVLSPESK 187

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 77/150 (51%), Gaps = 15/150 (10%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKL-LQELHHENVLGLTD 124
           G +  V K R + +  I+AVK+I+   ++  +    +  L ++ + ++ +     +    
Sbjct: 18  GAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQ----KRLLMDLDISMRTVDCPFTVTFYG 73
Query: 125 VFGYMSNVSLVFEFVDTDL-----EVIIKDPTIVFTPSNI-KAYAIMTLRGLEYLHDHW- 177
                 +V +  E +DT L     +VI K  TI   P +I    A+  ++ LE+LH    
Sbjct: 74  ALFREGDVWICMELMDTSLDKFYKQVIDKGQTI---PEDILGKIAVSIVKALEHLHSKLS 130
Query: 178 ILHRDLKPNNLLINKQGVLKIGDFGLAKFF 207
           ++HRD+KP+N+LIN  G +K+ DFG++ + 
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYL 160

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 66/154 (42%), Gaps = 20/154 (12%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHE-------- 117
           G F  V KAR+       A+KKI+   H + K     T L E+ LL  L+H+        
Sbjct: 17  GAFGQVVKARNALDSRYYAIKKIR---HTEEKLS---TILSEVMLLASLNHQYVVRYYAA 70
Query: 118 -----NVLGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLE 171
                N +         S + +  E+ +   L  +I    +              L  L 
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALS 130
Query: 172 YLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           Y+H   I+HRDLKP N+ I++   +KIGDFGLAK
Sbjct: 131 YIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F+TV  AR++ T    A+K ++   H   ++ +     RE  ++  L H   + L   
Sbjct: 46  GSFSTVVLARELATSREYAIKILE-KRHIIKENKVPYVT-RERDVMSRLDHPFFVKL--Y 101
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIV--FTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
           F +  +  L F         ++K    +  F  +  + Y    +  LEYLH   I+HRDL
Sbjct: 102 FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 161
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTR 212
           KP N+L+N+   ++I DFG AK     ++
Sbjct: 162 KPENILLNEDMHIQITDFGTAKVLSPESK 190

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F+TV  AR++ T    A+K ++   H   ++ +     RE  ++  L H   + L   
Sbjct: 44  GSFSTVVLARELATSREYAIKILE-KRHIIKENKVPYVT-RERDVMSRLDHPFFVKL--Y 99
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIV--FTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
           F +  +  L F         ++K    +  F  +  + Y    +  LEYLH   I+HRDL
Sbjct: 100 FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 159
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTR 212
           KP N+L+N+   ++I DFG AK     ++
Sbjct: 160 KPENILLNEDMHIQITDFGTAKVLSPESK 188

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 66  GRFATVFKARDI----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F TV+K   I    +  + VA+K+++  T   A    N+  L E  ++  + + +V  
Sbjct: 27  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA----NKEILDEAYVMASVDNPHVCR 82
Query: 122 LTDVFGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
           L  +    S V L+ + +    L   +++         +  + +   +G+ YL D  ++H
Sbjct: 83  LLGIC-LTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 141
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQ---VVTRWYRLIKCL--LYCVQ- 234
           RDL   N+L+     +KI DFGLAK  G+  + Y  +   V  +W  L   L  +Y  Q 
Sbjct: 142 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 201
Query: 235 ----FNVKNVQWCCFAKDPSSHGNLFPGIPLNEI 264
               + V   +   F   P      + GIP +EI
Sbjct: 202 DVWSYGVTVWELMTFGSKP------YDGIPASEI 229

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 66  GRFATVFKARDI----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F TV+K   I    +  + VA+K+++  T   A    N+  L E  ++  + + +V  
Sbjct: 33  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA----NKEILDEAYVMASVDNPHVCR 88
Query: 122 LTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
           L  +    S V L+ + +    L   +++         +  + +   +G+ YL D  ++H
Sbjct: 89  LLGIC-LTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 147
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY---THQVVTRWYRLIKCL--LYCVQ- 234
           RDL   N+L+     +KI DFGLAK  G+  + Y     +V  +W  L   L  +Y  Q 
Sbjct: 148 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 207
Query: 235 ----FNVKNVQWCCFAKDPSSHGNLFPGIPLNEI 264
               + V   +   F   P      + GIP +EI
Sbjct: 208 DVWSYGVTVWELMTFGSKP------YDGIPASEI 235

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 66  GRFATVFKARDI----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F TV+K   I    +  + VA+K+++  T   A    N+  L E  ++  + + +V  
Sbjct: 30  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA----NKEILDEAYVMASVDNPHVCR 85
Query: 122 LTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
           L  +    S V L+ + +    L   +++         +  + +   +G+ YL D  ++H
Sbjct: 86  LLGIC-LTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 144
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY---THQVVTRWYRLIKCL--LYCVQ- 234
           RDL   N+L+     +KI DFGLAK  G+  + Y     +V  +W  L   L  +Y  Q 
Sbjct: 145 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 204
Query: 235 ----FNVKNVQWCCFAKDPSSHGNLFPGIPLNEI 264
               + V   +   F   P      + GIP +EI
Sbjct: 205 DVWSYGVTVWELMTFGSKP------YDGIPASEI 232

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 71/154 (46%), Gaps = 10/154 (6%)
Query: 71  VFKARDIETDMIVAVKKIKLGTH-ADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM 129
           V++ R  + D  VA+K +K GT  AD ++      +RE +++ +L +  ++ L  V    
Sbjct: 30  VYRMRKKQID--VAIKVLKQGTEKADTEE-----MMREAQIMHQLDNPYIVRLIGVC-QA 81
Query: 130 SNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNL 188
             + LV E      L   +         SN+         G++YL +   +HRDL   N+
Sbjct: 82  EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNV 141
Query: 189 LINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW 222
           L+  +   KI DFGL+K  G+    YT +   +W
Sbjct: 142 LLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 175

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 66  GRFATVFKARDI----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F TV+K   I    +  + VA+K+++  T   A    N+  L E  ++  + + +V  
Sbjct: 27  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA----NKEILDEAYVMASVDNPHVCR 82
Query: 122 LTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
           L  +    S V L+ + +    L   +++         +  + +   +G+ YL D  ++H
Sbjct: 83  LLGIC-LTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 141
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQ---VVTRWYRLIKCL--LYCVQ- 234
           RDL   N+L+     +KI DFGLAK  G+  + Y  +   V  +W  L   L  +Y  Q 
Sbjct: 142 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 201
Query: 235 ----FNVKNVQWCCFAKDPSSHGNLFPGIPLNEI 264
               + V   +   F   P      + GIP +EI
Sbjct: 202 DVWSYGVTVWELMTFGSKP------YDGIPASEI 229

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 66  GRFATVFKARDI----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F TV+K   I    +  + VA+K+++  T   A    N+  L E  ++  + + +V  
Sbjct: 28  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA----NKEILDEAYVMASVDNPHVCR 83
Query: 122 LTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
           L  +    S V L+ + +    L   +++         +  + +   +G+ YL D  ++H
Sbjct: 84  LLGIC-LTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 142
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY---THQVVTRWYRLIKCL--LYCVQ- 234
           RDL   N+L+     +KI DFGLAK  G+  + Y     +V  +W  L   L  +Y  Q 
Sbjct: 143 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 202
Query: 235 ----FNVKNVQWCCFAKDPSSHGNLFPGIPLNEI 264
               + V   +   F   P      + GIP +EI
Sbjct: 203 DVWSYGVTVWELMTFGSKP------YDGIPASEI 230

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F+TV  AR++ T    A+K ++   H   ++ +     RE  ++  L H   + L   
Sbjct: 48  GSFSTVVLARELATSREYAIKILE-KRHIIKENKVPYVT-RERDVMSRLDHPFFVKL--Y 103
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIV--FTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
           F +  +  L F         ++K    +  F  +  + Y    +  LEYLH   I+HRDL
Sbjct: 104 FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 163
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTR 212
           KP N+L+N+   ++I DFG AK     ++
Sbjct: 164 KPENILLNEDMHIQITDFGTAKVLSPESK 192

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 66  GRFATVFKARDI----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F TV+K   I    +  + VA+K+++  T   A    N+  L E  ++  + + +V  
Sbjct: 29  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA----NKEILDEAYVMASVDNPHVCR 84
Query: 122 LTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
           L  +    S V L+ + +    L   +++         +  + +   +G+ YL D  ++H
Sbjct: 85  LLGIC-LTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 143
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY---THQVVTRWYRLIKCL--LYCVQ- 234
           RDL   N+L+     +KI DFGLAK  G+  + Y     +V  +W  L   L  +Y  Q 
Sbjct: 144 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 203
Query: 235 ----FNVKNVQWCCFAKDPSSHGNLFPGIPLNEI 264
               + V   +   F   P      + GIP +EI
Sbjct: 204 DVWSYGVTVWELMTFGSKP------YDGIPASEI 231

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F+TV  AR++ T    A+K ++   H   ++ +     RE  ++  L H   + L   
Sbjct: 43  GSFSTVVLARELATSREYAIKILE-KRHIIKENKVPYVT-RERDVMSRLDHPFFVKL--Y 98
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIV--FTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
           F +  +  L F         ++K    +  F  +  + Y    +  LEYLH   I+HRDL
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 158
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTR 212
           KP N+L+N+   ++I DFG AK     ++
Sbjct: 159 KPENILLNEDMHIQITDFGTAKVLSPESK 187

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 66  GRFATVFKARDI----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F TV+K   I    +  + VA+K+++  T   A    N+  L E  ++  + + +V  
Sbjct: 26  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA----NKEILDEAYVMASVDNPHVCR 81
Query: 122 LTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
           L  +    S V L+ + +    L   +++         +  + +   +G+ YL D  ++H
Sbjct: 82  LLGIC-LTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQ---VVTRWYRLIKCL--LYCVQ- 234
           RDL   N+L+     +KI DFGLAK  G+  + Y  +   V  +W  L   L  +Y  Q 
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 200
Query: 235 ----FNVKNVQWCCFAKDPSSHGNLFPGIPLNEI 264
               + V   +   F   P      + GIP +EI
Sbjct: 201 DVWSYGVTVWELMTFGSKP------YDGIPASEI 228

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/182 (21%), Positives = 80/182 (43%), Gaps = 13/182 (7%)
Query: 46  PDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL 105
           P C  +  ++   ++  V+ G   T    +++     VA+K +K G     +       L
Sbjct: 43  PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVP----VAIKTLKAGYTEKQRVDF----L 94
Query: 106 REIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAI 164
            E  ++ +  H N++ L  V      + ++ E+++   L+  +++    F+   +     
Sbjct: 95  GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR 154
Query: 165 MTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF-GSPTRLYT---HQVVT 220
               G++YL +   +HRDL   N+L+N   V K+ DFGL++     P   YT    ++  
Sbjct: 155 GIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 214
Query: 221 RW 222
           RW
Sbjct: 215 RW 216

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 75/152 (49%), Gaps = 10/152 (6%)
Query: 63  VHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL 122
           +  G F TV +A    +D+ V +  ++   HA+  +      LRE+ +++ L H N++  
Sbjct: 45  IGAGSFGTVHRAEWHGSDVAVKIL-MEQDFHAERVNEF----LREVAIMKRLRHPNIVLF 99
Query: 123 TDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIK---AYAIMTLRGLEYLHDH--W 177
                   N+S+V E++       +   +      + +   + A    +G+ YLH+    
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPP 159
Query: 178 ILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS 209
           I+HRDLK  NLL++K+  +K+ DFGL++   S
Sbjct: 160 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAS 191

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 65/141 (46%), Gaps = 3/141 (2%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V   ++  T    A+K +K      AKD +  T L E ++LQ   H  +  L   
Sbjct: 20  GTFGKVILVKEKATGRYYAMKILKKEVIV-AKDEVAHT-LTENRVLQNSRHPFLTALKYS 77
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH-DHWILHRDLK 184
           F     +  V E+ +            VF+    + Y    +  L+YLH +  +++RDLK
Sbjct: 78  FQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLK 137
Query: 185 PNNLLINKQGVLKIGDFGLAK 205
             NL+++K G +KI DFGL K
Sbjct: 138 LENLMLDKDGHIKITDFGLCK 158

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 65/141 (46%), Gaps = 3/141 (2%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V   ++  T    A+K +K      AKD +  T L E ++LQ   H  +  L   
Sbjct: 21  GTFGKVILVKEKATGRYYAMKILKKEVIV-AKDEVAHT-LTENRVLQNSRHPFLTALKYS 78
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH-DHWILHRDLK 184
           F     +  V E+ +            VF+    + Y    +  L+YLH +  +++RDLK
Sbjct: 79  FQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLK 138
Query: 185 PNNLLINKQGVLKIGDFGLAK 205
             NL+++K G +KI DFGL K
Sbjct: 139 LENLMLDKDGHIKITDFGLCK 159

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 67/133 (50%), Gaps = 23/133 (17%)
Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG---------YMSNVS 133
           VA+K +K GT +          L+E +++++L HE ++ L  V           YMS  S
Sbjct: 34  VAIKTLKPGTMSP------EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGS 87
Query: 134 LVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ 193
           L+ +F+  ++   ++ P +V   + I +       G+ Y+     +HRDL+  N+L+ + 
Sbjct: 88  LL-DFLKGEMGKYLRLPQLVDMAAQIAS-------GMAYVERMNYVHRDLRAANILVGEN 139
Query: 194 GVLKIGDFGLAKF 206
            V K+ DFGLA+ 
Sbjct: 140 LVCKVADFGLARL 152

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 65/141 (46%), Gaps = 3/141 (2%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V   ++  T    A+K +K      AKD +  T L E ++LQ   H  +  L   
Sbjct: 19  GTFGKVILVKEKATGRYYAMKILKKEVIV-AKDEVAHT-LTENRVLQNSRHPFLTALKYS 76
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH-DHWILHRDLK 184
           F     +  V E+ +            VF+    + Y    +  L+YLH +  +++RDLK
Sbjct: 77  FQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLK 136
Query: 185 PNNLLINKQGVLKIGDFGLAK 205
             NL+++K G +KI DFGL K
Sbjct: 137 LENLMLDKDGHIKITDFGLCK 157

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 67/134 (50%), Gaps = 23/134 (17%)
Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG---------YMSNVS 133
           VA+K +K GT +          L+E +++++L HE ++ L  V           YMS  S
Sbjct: 45  VAIKTLKPGTMSP------EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVCEYMSKGS 98
Query: 134 LVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ 193
           L+ +F+  ++   ++ P +V   + I +       G+ Y+     +HRDL+  N+L+ + 
Sbjct: 99  LL-DFLKGEMGKYLRLPQLVDMAAQIAS-------GMAYVERMNYVHRDLRAANILVGEN 150
Query: 194 GVLKIGDFGLAKFF 207
            V K+ DFGLA+  
Sbjct: 151 LVCKVADFGLARLI 164

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 67/133 (50%), Gaps = 23/133 (17%)
Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG---------YMSNVS 133
           VA+K +K GT +          L+E +++++L HE ++ L  V           YMS  S
Sbjct: 36  VAIKTLKPGTMSP------EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGS 89
Query: 134 LVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ 193
           L+ +F+  ++   ++ P +V   + I +       G+ Y+     +HRDL+  N+L+ + 
Sbjct: 90  LL-DFLKGEMGKYLRLPQLVDMAAQIAS-------GMAYVERMNYVHRDLRAANILVGEN 141
Query: 194 GVLKIGDFGLAKF 206
            V K+ DFGLA+ 
Sbjct: 142 LVCKVADFGLARL 154

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 67/134 (50%), Gaps = 23/134 (17%)
Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG---------YMSNVS 133
           VA+K +K GT +          L+E +++++L HE ++ L  V           YMS  S
Sbjct: 45  VAIKTLKPGTMSP------EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGS 98
Query: 134 LVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ 193
           L+ +F+  ++   ++ P +V   + I +       G+ Y+     +HRDL+  N+L+ + 
Sbjct: 99  LL-DFLKGEMGKYLRLPQLVDMAAQIAS-------GMAYVERMNYVHRDLRAANILVGEN 150
Query: 194 GVLKIGDFGLAKFF 207
            V K+ DFGLA+  
Sbjct: 151 LVCKVADFGLARLI 164

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F+TV  AR++ T    A+K ++   H   ++ +     RE  ++  L H   + L   
Sbjct: 43  GSFSTVVLARELATSREYAIKILE-KRHIIKENKVPYVT-RERDVMSRLDHPFFVKL--Y 98
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIV--FTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
           F +  +  L F         ++K    +  F  +  + Y    +  LEYLH   I+HRDL
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 158
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTR 212
           KP N+L+N+   ++I DFG AK     ++
Sbjct: 159 KPENILLNEDMHIQITDFGTAKVLSPESK 187

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 65/141 (46%), Gaps = 3/141 (2%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V   ++  T    A+K +K      AKD +  T L E ++LQ   H  +  L   
Sbjct: 159 GTFGKVILVKEKATGRYYAMKILKKEVIV-AKDEVAHT-LTENRVLQNSRHPFLTALKYS 216
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH-DHWILHRDLK 184
           F     +  V E+ +            VF+    + Y    +  L+YLH +  +++RDLK
Sbjct: 217 FQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLK 276
Query: 185 PNNLLINKQGVLKIGDFGLAK 205
             NL+++K G +KI DFGL K
Sbjct: 277 LENLMLDKDGHIKITDFGLCK 297

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 61/134 (45%), Gaps = 26/134 (19%)
Query: 102 RTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEF------------VDTDLEVIIKD 149
           + A+ E K+L ++H   ++ L   F   +++ LV               VD D     ++
Sbjct: 230 QGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDED-NPGFQE 288
Query: 150 PTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS 209
           P  +F       Y    + GLE+LH   I++RDLKP N+L++  G ++I D GLA     
Sbjct: 289 PRAIF-------YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLA----- 336
Query: 210 PTRLYTHQVVTRWY 223
              L   Q  T+ Y
Sbjct: 337 -VELKAGQTKTKGY 349

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 65/141 (46%), Gaps = 3/141 (2%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V   ++  T    A+K +K      AKD +  T L E ++LQ   H  +  L   
Sbjct: 162 GTFGKVILVKEKATGRYYAMKILKKEVIV-AKDEVAHT-LTENRVLQNSRHPFLTALKYS 219
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH-DHWILHRDLK 184
           F     +  V E+ +            VF+    + Y    +  L+YLH +  +++RDLK
Sbjct: 220 FQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLK 279
Query: 185 PNNLLINKQGVLKIGDFGLAK 205
             NL+++K G +KI DFGL K
Sbjct: 280 LENLMLDKDGHIKITDFGLCK 300

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 76/164 (46%), Gaps = 27/164 (16%)
Query: 49  EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREI 108
           EVK D         + VG ++   +     T+M  AVK I         D   R    EI
Sbjct: 25  EVKED---------IGVGSYSVCKRCIHKATNMEFAVKII---------DKSKRDPTEEI 66
Query: 109 K-LLQELHHENVLGLTDVFGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAIM 165
           + LL+   H N++ L DV+     V +V E +     L+ I++     F+     A    
Sbjct: 67  EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK--FFSEREASAVLFT 124
Query: 166 TLRGLEYLHDHWILHRDLKPNNLL-INKQG---VLKIGDFGLAK 205
             + +EYLH   ++HRDLKP+N+L +++ G    ++I DFG AK
Sbjct: 125 ITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 61/134 (45%), Gaps = 26/134 (19%)
Query: 102 RTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEF------------VDTDLEVIIKD 149
           + A+ E K+L ++H   ++ L   F   +++ LV               VD D     ++
Sbjct: 230 QGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDED-NPGFQE 288
Query: 150 PTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS 209
           P  +F       Y    + GLE+LH   I++RDLKP N+L++  G ++I D GLA     
Sbjct: 289 PRAIF-------YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLA----- 336
Query: 210 PTRLYTHQVVTRWY 223
              L   Q  T+ Y
Sbjct: 337 -VELKAGQTKTKGY 349

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 67/134 (50%), Gaps = 23/134 (17%)
Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG---------YMSNVS 133
           VA+K +K GT +          L+E +++++L HE ++ L  V           YMS  S
Sbjct: 45  VAIKTLKPGTMSP------EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVIEYMSKGS 98
Query: 134 LVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ 193
           L+ +F+  ++   ++ P +V   + I +       G+ Y+     +HRDL+  N+L+ + 
Sbjct: 99  LL-DFLKGEMGKYLRLPQLVDMAAQIAS-------GMAYVERMNYVHRDLRAANILVGEN 150
Query: 194 GVLKIGDFGLAKFF 207
            V K+ DFGLA+  
Sbjct: 151 LVCKVADFGLARLI 164

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 66  GRFATVFKARDI----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F TV+K   I    +  + VA+K+++  T   A    N+  L E  ++  + + +V  
Sbjct: 26  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA----NKEILDEAYVMASVDNPHVCR 81
Query: 122 LTDVFGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
           L  +    S V L+ + +    L   +++         +  + +   +G+ YL D  ++H
Sbjct: 82  LLGIC-LTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQ---VVTRWYRLIKCL--LYCVQ- 234
           RDL   N+L+     +KI DFGLAK  G+  + Y  +   V  +W  L   L  +Y  Q 
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 200
Query: 235 ----FNVKNVQWCCFAKDPSSHGNLFPGIPLNEI 264
               + V   +   F   P      + GIP +EI
Sbjct: 201 DVWSYGVTVWELMTFGSKP------YDGIPASEI 228

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 67/134 (50%), Gaps = 23/134 (17%)
Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG---------YMSNVS 133
           VA+K +K GT +          L+E +++++L HE ++ L  V           YMS  S
Sbjct: 45  VAIKTLKPGTMSP------EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVIEYMSKGS 98
Query: 134 LVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ 193
           L+ +F+  ++   ++ P +V   + I +       G+ Y+     +HRDL+  N+L+ + 
Sbjct: 99  LL-DFLKGEMGKYLRLPQLVDMAAQIAS-------GMAYVERMNYVHRDLRAANILVGEN 150
Query: 194 GVLKIGDFGLAKFF 207
            V K+ DFGLA+  
Sbjct: 151 LVCKVADFGLARLI 164

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 42/227 (18%)
Query: 69  ATVFKARDIETDMIVAVKKIKLG-THADAKDGINRTALREIKLLQEL-HHENVLGLTDV- 125
           A  F      T   VAVK +K G TH++     +R  + E+K+L  + HH NV+ L    
Sbjct: 37  ADAFGIDKTATCRTVAVKMLKEGATHSE-----HRALMSELKILIHIGHHLNVVNLLGAC 91
Query: 126 ---------------FGYMSNV--SLVFEFVDTDL--EVIIKDPTIVFTPSNIKAYAIMT 166
                          FG +S    S   EFV   +  E + KD     T  ++  Y+   
Sbjct: 92  TKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD---FLTLEHLICYSFQV 148
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK-FFGSP--TRLYTHQVVTRWY 223
            +G+E+L     +HRDL   N+L++++ V+KI DFGLA+  +  P   R    ++  +W 
Sbjct: 149 AKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 208
Query: 224 --RLIKCLLYCVQFNVKN---VQWCCFAKDPSSHGNLFPGIPLNEIF 265
               I   +Y +Q +V +   + W  F+   S     +PG+ ++E F
Sbjct: 209 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP----YPGVKIDEEF 251

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 66  GRFATVFKARDI----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F TV+K   I    +  + VA+K+++  T   A    N+  L E  ++  + + +V  
Sbjct: 29  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA----NKEILDEAYVMASVDNPHVCR 84
Query: 122 LTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
           L  +    S V L+ + +    L   +++         +  + +   +G+ YL D  ++H
Sbjct: 85  LLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 143
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY---THQVVTRWYRLIKCL--LYCVQ- 234
           RDL   N+L+     +KI DFGLAK  G+  + Y     +V  +W  L   L  +Y  Q 
Sbjct: 144 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 203
Query: 235 ----FNVKNVQWCCFAKDPSSHGNLFPGIPLNEI 264
               + V   +   F   P      + GIP +EI
Sbjct: 204 DVWSYGVTVWELMTFGSKP------YDGIPASEI 231

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 42/227 (18%)
Query: 69  ATVFKARDIETDMIVAVKKIKLG-THADAKDGINRTALREIKLLQEL-HHENVLGLTDV- 125
           A  F      T   VAVK +K G TH++     +R  + E+K+L  + HH NV+ L    
Sbjct: 37  ADAFGIDKTATCRTVAVKMLKEGATHSE-----HRALMSELKILIHIGHHLNVVNLLGAC 91
Query: 126 ---------------FGYMSNV--SLVFEFVDTDL--EVIIKDPTIVFTPSNIKAYAIMT 166
                          FG +S    S   EFV   +  E + KD     T  ++  Y+   
Sbjct: 92  TKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD---FLTLEHLICYSFQV 148
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK-FFGSP--TRLYTHQVVTRWY 223
            +G+E+L     +HRDL   N+L++++ V+KI DFGLA+  +  P   R    ++  +W 
Sbjct: 149 AKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 208
Query: 224 --RLIKCLLYCVQFNVKN---VQWCCFAKDPSSHGNLFPGIPLNEIF 265
               I   +Y +Q +V +   + W  F+   S     +PG+ ++E F
Sbjct: 209 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP----YPGVKIDEEF 251

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 106/235 (45%), Gaps = 47/235 (20%)
Query: 66  GRFATVFKARDIETD-----MIVAVKKIKLG-THADAKDGINRTALREIKLLQEL-HHEN 118
           G F  V +A     D       VAVK +K G TH++     +R  + E+K+L  + HH N
Sbjct: 75  GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-----HRALMSELKILIHIGHHLN 129
Query: 119 VLGLTDV----------------FGYMSNV--SLVFEFVDTDL--EVIIKDPTIVFTPSN 158
           V+ L                   FG +S    S   EFV   +  E + KD     T  +
Sbjct: 130 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD---FLTLEH 186
Query: 159 IKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK-FFGSP--TRLYT 215
           +  Y+    +G+E+L     +HRDL   N+L++++ V+KI DFGLA+  +  P   R   
Sbjct: 187 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 246
Query: 216 HQVVTRWY--RLIKCLLYCVQFNVKN---VQWCCFAKDPSSHGNLFPGIPLNEIF 265
            ++  +W     I   +Y +Q +V +   + W  F+   S     +PG+ ++E F
Sbjct: 247 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP----YPGVKIDEEF 297

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 106/235 (45%), Gaps = 47/235 (20%)
Query: 66  GRFATVFKARDIETD-----MIVAVKKIKLG-THADAKDGINRTALREIKLLQEL-HHEN 118
           G F  V +A     D       VAVK +K G TH++     +R  + E+K+L  + HH N
Sbjct: 38  GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-----HRALMSELKILIHIGHHLN 92
Query: 119 VLGLTDV----------------FGYMSNV--SLVFEFVDTDL--EVIIKDPTIVFTPSN 158
           V+ L                   FG +S    S   EFV   +  E + KD     T  +
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD---FLTLEH 149
Query: 159 IKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK-FFGSP--TRLYT 215
           +  Y+    +G+E+L     +HRDL   N+L++++ V+KI DFGLA+  +  P   R   
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGD 209
Query: 216 HQVVTRWY--RLIKCLLYCVQFNVKN---VQWCCFAKDPSSHGNLFPGIPLNEIF 265
            ++  +W     I   +Y +Q +V +   + W  F+   S     +PG+ ++E F
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP----YPGVKIDEEF 260

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 66  GRFATVFKARDI----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F TV+K   I    +  + VA+K+++  T   A    N+  L E  ++  + + +V  
Sbjct: 32  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA----NKEILDEAYVMASVDNPHVCR 87
Query: 122 LTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
           L  +    S V L+ + +    L   +++         +  + +   +G+ YL D  ++H
Sbjct: 88  LLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 146
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQ---VVTRWYRLIKCL--LYCVQ- 234
           RDL   N+L+     +KI DFGLAK  G+  + Y  +   V  +W  L   L  +Y  Q 
Sbjct: 147 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 206
Query: 235 ----FNVKNVQWCCFAKDPSSHGNLFPGIPLNEI 264
               + V   +   F   P      + GIP +EI
Sbjct: 207 DVWSYGVTVWELMTFGSKP------YDGIPASEI 234

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 106/235 (45%), Gaps = 47/235 (20%)
Query: 66  GRFATVFKARDIETD-----MIVAVKKIKLG-THADAKDGINRTALREIKLLQEL-HHEN 118
           G F  V +A     D       VAVK +K G TH++     +R  + E+K+L  + HH N
Sbjct: 38  GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-----HRALMSELKILIHIGHHLN 92
Query: 119 VLGLTDV----------------FGYMSNV--SLVFEFVDTDL--EVIIKDPTIVFTPSN 158
           V+ L                   FG +S    S   EFV   +  E + KD     T  +
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD---FLTLEH 149
Query: 159 IKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK-FFGSP--TRLYT 215
           +  Y+    +G+E+L     +HRDL   N+L++++ V+KI DFGLA+  +  P   R   
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 216 HQVVTRWY--RLIKCLLYCVQFNVKN---VQWCCFAKDPSSHGNLFPGIPLNEIF 265
            ++  +W     I   +Y +Q +V +   + W  F+   S     +PG+ ++E F
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP----YPGVKIDEEF 260

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 61/134 (45%), Gaps = 26/134 (19%)
Query: 102 RTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEF------------VDTDLEVIIKD 149
           + A+ E K+L ++H   ++ L   F   +++ LV               VD D     ++
Sbjct: 230 QGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDED-NPGFQE 288
Query: 150 PTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS 209
           P  +F       Y    + GLE+LH   I++RDLKP N+L++  G ++I D GLA     
Sbjct: 289 PRAIF-------YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLA----- 336
Query: 210 PTRLYTHQVVTRWY 223
              L   Q  T+ Y
Sbjct: 337 -VELKAGQTKTKGY 349

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 61/134 (45%), Gaps = 26/134 (19%)
Query: 102 RTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEF------------VDTDLEVIIKD 149
           + A+ E K+L ++H   ++ L   F   +++ LV               VD D     ++
Sbjct: 230 QGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDED-NPGFQE 288
Query: 150 PTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS 209
           P  +F       Y    + GLE+LH   I++RDLKP N+L++  G ++I D GLA     
Sbjct: 289 PRAIF-------YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLA----- 336
Query: 210 PTRLYTHQVVTRWY 223
              L   Q  T+ Y
Sbjct: 337 -VELKAGQTKTKGY 349

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 66  GRFATVFKARDI----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F TV+K   I    +  + VA+K+++  T   A    N+  L E  ++  + + +V  
Sbjct: 29  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA----NKEILDEAYVMASVDNPHVCR 84
Query: 122 LTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
           L  +    S V L+ + +    L   +++         +  + +   +G+ YL D  ++H
Sbjct: 85  LLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 143
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQ---VVTRWYRLIKCL--LYCVQ- 234
           RDL   N+L+     +KI DFGLAK  G+  + Y  +   V  +W  L   L  +Y  Q 
Sbjct: 144 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 203
Query: 235 ----FNVKNVQWCCFAKDPSSHGNLFPGIPLNEI 264
               + V   +   F   P      + GIP +EI
Sbjct: 204 DVWSYGVTVWELMTFGSKP------YDGIPASEI 231

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 66  GRFATVFKARDI----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F TV+K   I    +  + VA+K+++  T   A    N+  L E  ++  + + +V  
Sbjct: 29  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA----NKEILDEAYVMASVDNPHVCR 84
Query: 122 LTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
           L  +    S V L+ + +    L   +++         +  + +   +G+ YL D  ++H
Sbjct: 85  LLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 143
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY---THQVVTRWYRLIKCL--LYCVQ- 234
           RDL   N+L+     +KI DFGLAK  G+  + Y     +V  +W  L   L  +Y  Q 
Sbjct: 144 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 203
Query: 235 ----FNVKNVQWCCFAKDPSSHGNLFPGIPLNEI 264
               + V   +   F   P      + GIP +EI
Sbjct: 204 DVWSYGVTVWELMTFGSKP------YDGIPASEI 231

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 66  GRFATVFKARDI----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F TV+K   I    +  + VA+K+++  T   A    N+  L E  ++  + + +V  
Sbjct: 33  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA----NKEILDEAYVMASVDNPHVCR 88
Query: 122 LTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
           L  +    S V L+ + +    L   +++         +  + +   +G+ YL D  ++H
Sbjct: 89  LLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 147
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY---THQVVTRWYRLIKCL--LYCVQ- 234
           RDL   N+L+     +KI DFGLAK  G+  + Y     +V  +W  L   L  +Y  Q 
Sbjct: 148 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 207
Query: 235 ----FNVKNVQWCCFAKDPSSHGNLFPGIPLNEI 264
               + V   +   F   P      + GIP +EI
Sbjct: 208 DVWSYGVTVWELMTFGSKP------YDGIPASEI 235

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 66  GRFATVFKARDI----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F TV+K   I    +  + VA+K+++  T   A    N+  L E  ++  + + +V  
Sbjct: 28  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA----NKEILDEAYVMASVDNPHVCR 83
Query: 122 LTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
           L  +    S V L+ + +    L   +++         +  + +   +G+ YL D  ++H
Sbjct: 84  LLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 142
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY---THQVVTRWYRLIKCL--LYCVQ- 234
           RDL   N+L+     +KI DFGLAK  G+  + Y     +V  +W  L   L  +Y  Q 
Sbjct: 143 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 202
Query: 235 ----FNVKNVQWCCFAKDPSSHGNLFPGIPLNEI 264
               + V   +   F   P      + GIP +EI
Sbjct: 203 DVWSYGVTVWELMTFGSKP------YDGIPASEI 230

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 73/163 (44%), Gaps = 12/163 (7%)
Query: 47  DCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALR 106
           D  + +D   Y   + +  G F      RD +++ +VAVK I+ G      + I+    R
Sbjct: 10  DLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG------EKIDENVKR 63
Query: 107 EIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAI 164
           EI   + L H N++   +V    +++++V E+       E I       F+    + +  
Sbjct: 64  EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQ 121
Query: 165 MTLRGLEYLHDHWILHRDLKPNNLLINKQGV--LKIGDFGLAK 205
             + G+ Y H   + HRDLK  N L++      LKI DFG +K
Sbjct: 122 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 164

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 75/159 (47%), Gaps = 30/159 (18%)
Query: 69  ATVFKARDIETDMIVAVKKIKLG-THADAKDGINRTALREIKLLQEL-HHENVLGLTDV- 125
           A  F      T   VAVK +K G TH++     +R  + E+K+L  + HH NV+ L    
Sbjct: 37  ADAFGIDKTATCRTVAVKMLKEGATHSE-----HRALMSELKILIHIGHHLNVVNLLGAC 91
Query: 126 ---------------FGYMSNV--SLVFEFVDTDL--EVIIKDPTIVFTPSNIKAYAIMT 166
                          FG +S    S   EFV   +  E + KD     T  ++  Y+   
Sbjct: 92  TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD---FLTLEHLICYSFQV 148
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
            +G+E+L     +HRDL   N+L++++ V+KI DFGLA+
Sbjct: 149 AKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 66  GRFATVFKARDI----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F TV+K   I    +  + VA+K+++  T   A    N+  L E  ++  + + +V  
Sbjct: 33  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA----NKEILDEAYVMASVDNPHVCR 88
Query: 122 LTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
           L  +    S V L+ + +    L   +++         +  + +   +G+ YL D  ++H
Sbjct: 89  LLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 147
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY---THQVVTRWYRLIKCL--LYCVQ- 234
           RDL   N+L+     +KI DFGLAK  G+  + Y     +V  +W  L   L  +Y  Q 
Sbjct: 148 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 207
Query: 235 ----FNVKNVQWCCFAKDPSSHGNLFPGIPLNEI 264
               + V   +   F   P      + GIP +EI
Sbjct: 208 DVWSYGVTVWELMTFGSKP------YDGIPASEI 235

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 66  GRFATVFKARDI----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F TV+K   I    +  + VA+K+++  T   A    N+  L E  ++  + + +V  
Sbjct: 51  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA----NKEILDEAYVMASVDNPHVCR 106
Query: 122 LTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
           L  +    S V L+ + +    L   +++         +  + +   +G+ YL D  ++H
Sbjct: 107 LLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 165
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQ---VVTRWYRLIKCL--LYCVQ- 234
           RDL   N+L+     +KI DFGLAK  G+  + Y  +   V  +W  L   L  +Y  Q 
Sbjct: 166 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 225
Query: 235 ----FNVKNVQWCCFAKDPSSHGNLFPGIPLNEI 264
               + V   +   F   P      + GIP +EI
Sbjct: 226 DVWSYGVTVWELMTFGSKP------YDGIPASEI 253

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 66  GRFATVFKARDI----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F TV+K   I    +  + VA+K+++  T   A    N+  L E  ++  + + +V  
Sbjct: 26  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA----NKEILDEAYVMASVDNPHVCR 81
Query: 122 LTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
           L  +    S V L+ + +    L   +++         +  + +   +G+ YL D  ++H
Sbjct: 82  LLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQ---VVTRWYRLIKCL--LYCVQ- 234
           RDL   N+L+     +KI DFGLAK  G+  + Y  +   V  +W  L   L  +Y  Q 
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 200
Query: 235 ----FNVKNVQWCCFAKDPSSHGNLFPGIPLNEI 264
               + V   +   F   P      + GIP +EI
Sbjct: 201 DVWSYGVTVWELMTFGSKP------YDGIPASEI 228

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 66  GRFATVFKARDI----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F TV+K   I    +  + VA+K+++  T   A    N+  L E  ++  + + +V  
Sbjct: 26  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA----NKEILDEAYVMASVDNPHVCR 81
Query: 122 LTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
           L  +    S V L+ + +    L   +++         +  + +   +G+ YL D  ++H
Sbjct: 82  LLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQ---VVTRWYRLIKCL--LYCVQ- 234
           RDL   N+L+     +KI DFGLAK  G+  + Y  +   V  +W  L   L  +Y  Q 
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 200
Query: 235 ----FNVKNVQWCCFAKDPSSHGNLFPGIPLNEI 264
               + V   +   F   P      + GIP +EI
Sbjct: 201 DVWSYGVTVWELMTFGSKP------YDGIPASEI 228

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 75/159 (47%), Gaps = 30/159 (18%)
Query: 69  ATVFKARDIETDMIVAVKKIKLG-THADAKDGINRTALREIKLLQEL-HHENVLGLTDV- 125
           A  F      T   VAVK +K G TH++     +R  + E+K+L  + HH NV+ L    
Sbjct: 37  ADAFGIDKTATCRTVAVKMLKEGATHSE-----HRALMSELKILIHIGHHLNVVNLLGAC 91
Query: 126 ---------------FGYMSNV--SLVFEFVDTDL--EVIIKDPTIVFTPSNIKAYAIMT 166
                          FG +S    S   EFV   +  E + KD     T  ++  Y+   
Sbjct: 92  TKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD---FLTLEHLICYSFQV 148
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
            +G+E+L     +HRDL   N+L++++ V+KI DFGLA+
Sbjct: 149 AKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 66  GRFATVFKARDI----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F TV+K   I    +  + VA+K+++  T   A    N+  L E  ++  + + +V  
Sbjct: 36  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA----NKEILDEAYVMASVDNPHVCR 91
Query: 122 LTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
           L  +    S V L+ + +    L   +++         +  + +   +G+ YL D  ++H
Sbjct: 92  LLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 150
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQ---VVTRWYRLIKCL--LYCVQ- 234
           RDL   N+L+     +KI DFGLAK  G+  + Y  +   V  +W  L   L  +Y  Q 
Sbjct: 151 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 210
Query: 235 ----FNVKNVQWCCFAKDPSSHGNLFPGIPLNEI 264
               + V   +   F   P      + GIP +EI
Sbjct: 211 DVWSYGVTVWELMTFGSKP------YDGIPASEI 238

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 66  GRFATVFKARDI----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F TV+K   I    +  + VA+K+++  T   A    N+  L E  ++  + + +V  
Sbjct: 20  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA----NKEILDEAYVMASVDNPHVCR 75
Query: 122 LTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
           L  +    S V L+ + +    L   +++         +  + +   +G+ YL D  ++H
Sbjct: 76  LLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 134
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQ---VVTRWYRLIKCL--LYCVQ- 234
           RDL   N+L+     +KI DFGLAK  G+  + Y  +   V  +W  L   L  +Y  Q 
Sbjct: 135 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 194
Query: 235 ----FNVKNVQWCCFAKDPSSHGNLFPGIPLNEI 264
               + V   +   F   P      + GIP +EI
Sbjct: 195 DVWSYGVTVWELMTFGSKP------YDGIPASEI 222

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 66  GRFATVFKARDI----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F TV+K   I    +  + VA+K+++  T   A    N+  L E  ++  + + +V  
Sbjct: 26  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA----NKEILDEAYVMASVDNPHVCR 81
Query: 122 LTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
           L  +    S V L+ + +    L   +++         +  + +   +G+ YL D  ++H
Sbjct: 82  LLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY---THQVVTRWYRLIKCL--LYCVQ- 234
           RDL   N+L+     +KI DFGLAK  G+  + Y     +V  +W  L   L  +Y  Q 
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 200
Query: 235 ----FNVKNVQWCCFAKDPSSHGNLFPGIPLNEI 264
               + V   +   F   P      + GIP +EI
Sbjct: 201 DVWSYGVTVWELMTFGSKP------YDGIPASEI 228

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 35/167 (20%)
Query: 66  GRFATVFKARDIETD-----MIVAVKKIKLG-THADAKDGINRTALREIKLLQEL-HHEN 118
           G F  V +A     D       VAVK +K G TH++     +R  + E+K+L  + HH N
Sbjct: 38  GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-----HRALMSELKILIHIGHHLN 92
Query: 119 VLGLTDV----------------FGYMSNV--SLVFEFVDTDL--EVIIKDPTIVFTPSN 158
           V+ L                   FG +S    S   EFV   +  E + KD     T  +
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD---FLTLEH 149
Query: 159 IKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           +  Y+    +G+E+L     +HRDL   N+L++++ V+KI DFGLA+
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 67/150 (44%), Gaps = 9/150 (6%)
Query: 78  ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFE 137
           + D+ VA+K +K G     +    R  L E  ++ +  H N++ L  V        +V E
Sbjct: 75  QRDVPVAIKALKAGYTERQR----RDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTE 130
Query: 138 FVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVL 196
           +++   L+  ++     FT   +         G+ YL D   +HRDL   N+L++   V 
Sbjct: 131 YMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVC 190
Query: 197 KIGDFGLAKFF-GSPTRLYT---HQVVTRW 222
           K+ DFGL++     P   YT    ++  RW
Sbjct: 191 KVSDFGLSRVLEDDPDAAYTTTGGKIPIRW 220

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 67/160 (41%), Gaps = 32/160 (20%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V KAR+       A+KKI+   H + K     T L E+ LL  L+H+ V+     
Sbjct: 17  GAFGQVVKARNALDSRYYAIKKIR---HTEEKLS---TILSEVXLLASLNHQYVVRYYAA 70
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTP--SNIKAYAIM------------------ 165
           +    N      FV     V  K    +      N   Y ++                  
Sbjct: 71  WLERRN------FVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQ 124
Query: 166 TLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
            L  L Y+H   I+HR+LKP N+ I++   +KIGDFGLAK
Sbjct: 125 ILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAK 164

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 66/145 (45%), Gaps = 1/145 (0%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           R +  G F  V  AR  ET  + AVK +K        D +  T   +  L    +H  + 
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL-QDDDVECTMTEKRILSLARNHPFLT 87
Query: 121 GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
            L   F     +  V EFV+    +     +  F  +  + YA   +  L +LHD  I++
Sbjct: 88  QLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIY 147
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAK 205
           RDLK +N+L++ +G  K+ DFG+ K
Sbjct: 148 RDLKLDNVLLDHEGHCKLADFGMCK 172

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 69/149 (46%), Gaps = 6/149 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F+T   AR++ T    A+K ++   H   ++ +     RE  ++  L H   + L   
Sbjct: 41  GSFSTTVLARELATSREYAIKILE-KRHIIKENKVPYVT-RERDVMSRLDHPFFVKL--Y 96
Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIV--FTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
           F +  +  L F         ++K    +  F  +  + Y    +  LEYLH   I+HRDL
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 156
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTR 212
           KP N+L+N+   ++I DFG AK     ++
Sbjct: 157 KPENILLNEDMHIQITDFGTAKVLSPESK 185

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 74/149 (49%), Gaps = 15/149 (10%)
Query: 127 GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPN 186
           G+  + SL     + D +   K+P    T  ++ +Y+    RG+E+L     +HRDL   
Sbjct: 172 GFQEDKSLSDVEEEEDSDGFYKEP---ITMEDLISYSFQVARGMEFLSSRKCIHRDLAAR 228
Query: 187 NLLINKQGVLKIGDFGLAK-FFGSP--TRLYTHQVVTRWY--RLIKCLLYCVQFNVKN-- 239
           N+L+++  V+KI DFGLA+  + +P   R    ++  +W     I   +Y  + +V +  
Sbjct: 229 NILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYG 288
Query: 240 -VQWCCFAKDPSSHGNLFPGIPLNEIFTA 267
            + W  F    S  G+ +PG+ ++E F +
Sbjct: 289 VLLWEIF----SLGGSPYPGVQMDEDFCS 313

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 70/163 (42%), Gaps = 12/163 (7%)
Query: 47  DCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALR 106
           D  + +D   Y   + +  G F      RD  T  +VAVK I+ G        I+    R
Sbjct: 12  DMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA------AIDENVQR 65
Query: 107 EIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAI 164
           EI   + L H N++   +V    ++++++ E+       E I       F+    + +  
Sbjct: 66  EIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICN--AGRFSEDEARFFFQ 123
Query: 165 MTLRGLEYLHDHWILHRDLKPNNLLINKQGV--LKIGDFGLAK 205
             L G+ Y H   I HRDLK  N L++      LKI DFG +K
Sbjct: 124 QLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK 166

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/134 (26%), Positives = 67/134 (50%), Gaps = 23/134 (17%)
Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG---------YMSNVS 133
           VA+K +K GT +          L+E ++++++ HE ++ L  V           YMS  S
Sbjct: 45  VAIKTLKPGTMSP------EAFLQEAQVMKKIRHEKLVQLYAVVSEEPIYIVTEYMSKGS 98
Query: 134 LVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ 193
           L+ +F+  ++   ++ P +V   + I +       G+ Y+     +HRDL+  N+L+ + 
Sbjct: 99  LL-DFLKGEMGKYLRLPQLVDMAAQIAS-------GMAYVERMNYVHRDLRAANILVGEN 150
Query: 194 GVLKIGDFGLAKFF 207
            V K+ DFGLA+  
Sbjct: 151 LVCKVADFGLARLI 164

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 102/227 (44%), Gaps = 42/227 (18%)
Query: 69  ATVFKARDIETDMIVAVKKIKLG-THADAKDGINRTALREIKLLQEL-HHENVLGLTDV- 125
           A  F      T   VAVK +K G TH++     +R  + E+K+L  + HH NV+ L    
Sbjct: 48  ADAFGIDKTATCRTVAVKMLKEGATHSE-----HRALMSELKILIHIGHHLNVVNLLGAC 102
Query: 126 ---------------FGYMSNV--SLVFEFV--DTDLEVIIKDPTIVFTPSNIKAYAIMT 166
                          FG +S    S   EFV      E + KD     T  ++  Y+   
Sbjct: 103 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKD---FLTLEHLICYSFQV 159
Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK-FFGSP--TRLYTHQVVTRWY 223
            +G+E+L     +HRDL   N+L++++ V+KI DFGLA+  +  P   R    ++  +W 
Sbjct: 160 AKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 219
Query: 224 --RLIKCLLYCVQFNVKN---VQWCCFAKDPSSHGNLFPGIPLNEIF 265
               I   +Y +Q +V +   + W  F+   S     +PG+ ++E F
Sbjct: 220 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP----YPGVKIDEEF 262

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 66/134 (49%), Gaps = 23/134 (17%)
Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG---------YMSNVS 133
           VA+K +K GT +          L+E +++++L HE ++ L  V           YMS  S
Sbjct: 38  VAIKTLKPGTMSP------EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGS 91
Query: 134 LVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ 193
           L+ +F+  +    ++ P +V   + I +       G+ Y+     +HRDL+  N+L+ + 
Sbjct: 92  LL-DFLKGETGKYLRLPQLVDMAAQIAS-------GMAYVERMNYVHRDLRAANILVGEN 143
Query: 194 GVLKIGDFGLAKFF 207
            V K+ DFGLA+  
Sbjct: 144 LVCKVADFGLARLI 157

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 73/144 (50%), Gaps = 15/144 (10%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V+K  D  T  +VA+K I L    D  + I +    EI +L +     +   T  
Sbjct: 30  GSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQ----EITVLSQCDSPYI---TRY 82
Query: 126 FG-YMSNVSL--VFEFVD--TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
           FG Y+ +  L  + E++   + L+++   P      + I       L+GL+YLH    +H
Sbjct: 83  FGSYLKSTKLWIIMEYLGGGSALDLLKPGP---LEETYIATILREILKGLDYLHSERKIH 139
Query: 181 RDLKPNNLLINKQGVLKIGDFGLA 204
           RD+K  N+L+++QG +K+ DFG+A
Sbjct: 140 RDIKAANVLLSEQGDVKLADFGVA 163

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 40/209 (19%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHEN-- 118
           R +  G F+TV+ A+D+  +  VA+K ++              A  EIKLLQ ++  +  
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIVR------GDKVYTEAAEDEIKLLQRVNDADNT 78
Query: 119 ---------VLGLTDVFGYMS----NVSLVFEFVDTDLEVIIKDPTIVFTP-SNIKAYAI 164
                    +L L D F +      +V +VFE +  +L  +IK       P   +K  + 
Sbjct: 79  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 138
Query: 165 MTLRGLEYLHDH-WILHRDLKPNNLLINKQGV------LKIGDFGLAKFFGSPTRLYTHQ 217
             L GL+Y+H    I+H D+KP N+L+           +KI D G A ++      YT+ 
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY---DEHYTNS 195
Query: 218 VVTRWYRLIKCLLYCVQFNVKNVQWCCFA 246
           + TR YR  + LL           W C A
Sbjct: 196 IQTREYRSPEVLL--------GAPWGCGA 216

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 40/209 (19%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHEN-- 118
           R +  G F+TV+ A+D+  +  VA+K ++              A  EIKLLQ ++  +  
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIVR------GDKVYTEAAEDEIKLLQRVNDADNT 78
Query: 119 ---------VLGLTDVFGYMS----NVSLVFEFVDTDLEVIIKDPTIVFTP-SNIKAYAI 164
                    +L L D F +      +V +VFE +  +L  +IK       P   +K  + 
Sbjct: 79  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 138
Query: 165 MTLRGLEYLHDH-WILHRDLKPNNLLINKQGV------LKIGDFGLAKFFGSPTRLYTHQ 217
             L GL+Y+H    I+H D+KP N+L+           +KI D G A ++      YT+ 
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY---DEHYTNS 195
Query: 218 VVTRWYRLIKCLLYCVQFNVKNVQWCCFA 246
           + TR YR  + LL           W C A
Sbjct: 196 IQTREYRSPEVLL--------GAPWGCGA 216

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 70/160 (43%), Gaps = 25/160 (15%)
Query: 66  GRFATVFKAR-----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           G F  VF A        +  M+VAVK +K     +A +   +   RE +LL  L H++++
Sbjct: 52  GAFGKVFLAECHNLLPEQDKMLVAVKALK-----EASESARQDFQREAELLTMLQHQHIV 106
Query: 121 GLTDVFGYMSNVSLVFEFV------------DTDLEVIIKDPTIVFTP---SNIKAYAIM 165
               V      + +VFE++              D +++     +   P     + A A  
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 166 TLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
              G+ YL     +HRDL   N L+ +  V+KIGDFG+++
Sbjct: 167 VAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 206

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 69/161 (42%), Gaps = 28/161 (17%)
Query: 69  ATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFG 127
           AT F     +  + VAVK +K   HAD K+ +    + E+K++  L  HEN++ L     
Sbjct: 50  ATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL----MSELKIMSHLGQHENIVNLLGACT 105
Query: 128 YMSNVSLVFEFV-----------------------DTDLEVIIKDPTIVFTPSNIKAYAI 164
           +   V ++ E+                          D E + K+        ++  ++ 
Sbjct: 106 HGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSS 165
Query: 165 MTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
              +G+ +L     +HRD+   N+L+    V KIGDFGLA+
Sbjct: 166 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 206

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 78/159 (49%), Gaps = 22/159 (13%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-- 114
           Y+  R +  G F+TV+ + DI+    VA+K +K   H         TAL EI+LL+ +  
Sbjct: 23  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEH------YTETALDEIRLLKSVRN 76
Query: 115 ------HHENVLGLTDVFGYM----SNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYA 163
                 + E V+ L D F       +++ +VFE +    L+ IIK          +K   
Sbjct: 77  SDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKII 136
Query: 164 IMTLRGLEYLHDH-WILHRDLKPNNLL--INKQGVLKIG 199
              L+GL+YLH    I+H D+KP N+L  +N+Q + ++ 
Sbjct: 137 QQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 175

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 92/214 (42%), Gaps = 26/214 (12%)
Query: 66  GRFATVFKARDI----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F TV+K   I    +  + VA+K+++  T   A    N+  L E  ++  + + +V  
Sbjct: 23  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA----NKEILDEAYVMASVDNPHVCR 78
Query: 122 LTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
           L  +    S V L+ + +    L   +++         +  + +    G+ YL D  ++H
Sbjct: 79  LLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLEDRRLVH 137
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQ---VVTRWYRLIKCL--LYCVQ- 234
           RDL   N+L+     +KI DFGLAK  G+  + Y  +   V  +W  L   L  +Y  Q 
Sbjct: 138 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 197
Query: 235 ----FNVKNVQWCCFAKDPSSHGNLFPGIPLNEI 264
               + V   +   F   P      + GIP +EI
Sbjct: 198 DVWSYGVTVWELMTFGSKP------YDGIPASEI 225

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 77/166 (46%), Gaps = 34/166 (20%)
Query: 66  GRFATVFKARDIETD-----MIVAVKKIKLG-THADAKDGINRTALREIKLLQEL-HHEN 118
           G F  V +A     D       VAVK +K G TH++     +R  + E+K+L  + HH N
Sbjct: 39  GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-----HRALMSELKILIHIGHHLN 93
Query: 119 VLGLTDV----------------FGYMSNV--SLVFEFVDTDL-EVIIKDPTIVFTPSNI 159
           V+ L                   FG +S    S   EFV     E + KD     T  ++
Sbjct: 94  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKD---FLTLEHL 150
Query: 160 KAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
             Y+    +G+E+L     +HRDL   N+L++++ V+KI DFGLA+
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 66/134 (49%), Gaps = 23/134 (17%)
Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG---------YMSNVS 133
           VA+K +K GT +          L+E +++++L HE ++ L  V           YMS  S
Sbjct: 45  VAIKTLKPGTMSP------EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGS 98
Query: 134 LVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ 193
           L+ +F+  ++   ++ P +V   + I +       G+ Y+     +HRDL   N+L+ + 
Sbjct: 99  LL-DFLKGEMGKYLRLPQLVDMAAQIAS-------GMAYVERMNYVHRDLAAANILVGEN 150
Query: 194 GVLKIGDFGLAKFF 207
            V K+ DFGLA+  
Sbjct: 151 LVCKVADFGLARLI 164

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 77/169 (45%), Gaps = 10/169 (5%)
Query: 41  KQYLLPDCEVKND-LLVYYQ-WRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKD 98
           KQY     E+K+D +L +Y     +  G F  V +  +  T    A K +     +D + 
Sbjct: 35  KQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE- 93
Query: 99  GINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPS 157
               T  +EI+ +  L H  ++ L D F   + + +++EF+   +L   + D     +  
Sbjct: 94  ----TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED 149
Query: 158 NIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLI--NKQGVLKIGDFGLA 204
               Y     +GL ++H++  +H DLKP N++    +   LK+ DFGL 
Sbjct: 150 EAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLT 198

>pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/83 (36%), Positives = 44/83 (53%), Gaps = 5/83 (6%)
Query: 133 SLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK 192
           ++V E +   LE +       FT   +   AI  L  +EY+H   +++RD+KP N LI +
Sbjct: 73  AMVLELLGPSLEDLFDLCDRTFTLKTVLMIAIQLLSRMEYVHSKNLIYRDVKPENFLIGR 132
Query: 193 QG-----VLKIGDFGLAKFFGSP 210
           QG     V+ I DFGLAK +  P
Sbjct: 133 QGNKKEHVIHIIDFGLAKEYIDP 155

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 43/81 (53%), Gaps = 6/81 (7%)
Query: 125 VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           ++ YM N +L      +DL      PT+  +        I   RGL YLH   I+HRD+K
Sbjct: 113 IYKYMENGNLKRHLYGSDL------PTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVK 166
Query: 185 PNNLLINKQGVLKIGDFGLAK 205
             N+L+++  V KI DFG++K
Sbjct: 167 SINILLDENFVPKITDFGISK 187

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 77/168 (45%), Gaps = 10/168 (5%)
Query: 41  KQYLLPDCEVKND-LLVYYQ-WRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKD 98
           KQY     E+K+D +L +Y     +  G F  V +  +  T    A K +     +D + 
Sbjct: 141 KQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE- 199
Query: 99  GINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPS 157
               T  +EI+ +  L H  ++ L D F   + + +++EF+   +L   + D     +  
Sbjct: 200 ----TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED 255
Query: 158 NIKAYAIMTLRGLEYLHDHWILHRDLKPNNLL--INKQGVLKIGDFGL 203
               Y     +GL ++H++  +H DLKP N++    +   LK+ DFGL
Sbjct: 256 EAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGL 303

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 43/81 (53%), Gaps = 6/81 (7%)
Query: 125 VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           ++ YM N +L      +DL      PT+  +        I   RGL YLH   I+HRD+K
Sbjct: 113 IYKYMENGNLKRHLYGSDL------PTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVK 166
Query: 185 PNNLLINKQGVLKIGDFGLAK 205
             N+L+++  V KI DFG++K
Sbjct: 167 SINILLDENFVPKITDFGISK 187

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 78/159 (49%), Gaps = 22/159 (13%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-- 114
           Y+  R +  G F+TV+ + DI+    VA+K +K   H         TAL EI+LL+ +  
Sbjct: 39  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEH------YTETALDEIRLLKSVRN 92
Query: 115 ------HHENVLGLTDVFGYM----SNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYA 163
                 + E V+ L D F       +++ +VFE +    L+ IIK          +K   
Sbjct: 93  SDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKII 152
Query: 164 IMTLRGLEYLHDH-WILHRDLKPNNLL--INKQGVLKIG 199
              L+GL+YLH    I+H D+KP N+L  +N+Q + ++ 
Sbjct: 153 QQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 66/134 (49%), Gaps = 23/134 (17%)
Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG---------YMSNVS 133
           VA+K +K GT +          L+E +++++L HE ++ L  V           YMS  S
Sbjct: 35  VAIKTLKPGTMSP------EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIXIVTEYMSKGS 88
Query: 134 LVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ 193
           L+ +F+  +    ++ P +V   + I +       G+ Y+     +HRDL+  N+L+ + 
Sbjct: 89  LL-DFLKGETGKYLRLPQLVDMAAQIAS-------GMAYVERMNYVHRDLRAANILVGEN 140
Query: 194 GVLKIGDFGLAKFF 207
            V K+ DFGLA+  
Sbjct: 141 LVCKVADFGLARLI 154

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 54/106 (50%), Gaps = 12/106 (11%)
Query: 168 RGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS---PTRLYTHQVVTRWY- 223
           RG+EYL     +HRDL   N+L+ +  V+KI DFGLA+   +     +    ++  +W  
Sbjct: 168 RGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMA 227
Query: 224 -RLIKCLLYCVQFNVKN---VQWCCFAKDPSSHGNLFPGIPLNEIF 265
              +   +Y  Q +V +   + W  F    +  G+ +PGIP+ E+F
Sbjct: 228 PEALFDRVYTHQSDVWSFGVLMWEIF----TLGGSPYPGIPVEELF 269

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 66/133 (49%), Gaps = 23/133 (17%)
Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG---------YMSNVS 133
           VA+K +K GT +          L+E +++++L HE ++ L  V           YMS  S
Sbjct: 211 VAIKTLKPGTMSP------EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGS 264
Query: 134 LVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ 193
           L+ +F+  +    ++ P +V   + I +       G+ Y+     +HRDL+  N+L+ + 
Sbjct: 265 LL-DFLKGETGKYLRLPQLVDMAAQIAS-------GMAYVERMNYVHRDLRAANILVGEN 316
Query: 194 GVLKIGDFGLAKF 206
            V K+ DFGLA+ 
Sbjct: 317 LVCKVADFGLARL 329

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 22/42 (52%), Positives = 31/42 (73%)
Query: 163 AIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           A  T +G++YLH   I+HRDLK NN+ +++   +KIGDFGLA
Sbjct: 137 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA 178

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 22/42 (52%), Positives = 31/42 (73%)
Query: 163 AIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           A  T +G++YLH   I+HRDLK NN+ +++   +KIGDFGLA
Sbjct: 112 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA 153

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 54/106 (50%), Gaps = 12/106 (11%)
Query: 168 RGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS---PTRLYTHQVVTRWY- 223
           RG+EYL     +HRDL   N+L+ +  V+KI DFGLA+   +     +    ++  +W  
Sbjct: 168 RGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMA 227
Query: 224 -RLIKCLLYCVQFNVKN---VQWCCFAKDPSSHGNLFPGIPLNEIF 265
              +   +Y  Q +V +   + W  F    +  G+ +PGIP+ E+F
Sbjct: 228 PEALFDRVYTHQSDVWSFGVLMWEIF----TLGGSPYPGIPVEELF 269

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 22/42 (52%), Positives = 31/42 (73%)
Query: 163 AIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           A  T +G++YLH   I+HRDLK NN+ +++   +KIGDFGLA
Sbjct: 115 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA 156

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 22/42 (52%), Positives = 31/42 (73%)
Query: 163 AIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           A  T +G++YLH   I+HRDLK NN+ +++   +KIGDFGLA
Sbjct: 138 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA 179

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 22/42 (52%), Positives = 31/42 (73%)
Query: 163 AIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           A  T +G++YLH   I+HRDLK NN+ +++   +KIGDFGLA
Sbjct: 130 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA 171

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 53/120 (44%), Gaps = 40/120 (33%)
Query: 168 RGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK------FFGSPT---------- 211
           RG+EYL     +HRDL   N+L+ +  V+KI DFGLA+      ++   T          
Sbjct: 214 RGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMA 273
Query: 212 ------RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWCCFAKDPSSHGNLFPGIPLNEIF 265
                 R+YTHQ    W            F V  + W  F    +  G+ +PGIP+ E+F
Sbjct: 274 PEALFDRVYTHQSDV-W-----------SFGV--LMWEIF----TLGGSPYPGIPVEELF 315

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 66/133 (49%), Gaps = 23/133 (17%)
Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG---------YMSNVS 133
           VA+K +K GT +          L+E +++++L HE ++ L  V           YMS  S
Sbjct: 211 VAIKTLKPGTMSP------EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGS 264
Query: 134 LVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ 193
           L+ +F+  +    ++ P +V   + I +       G+ Y+     +HRDL+  N+L+ + 
Sbjct: 265 LL-DFLKGETGKYLRLPQLVDMAAQIAS-------GMAYVERMNYVHRDLRAANILVGEN 316
Query: 194 GVLKIGDFGLAKF 206
            V K+ DFGLA+ 
Sbjct: 317 LVCKVADFGLARL 329

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 22/42 (52%), Positives = 31/42 (73%)
Query: 163 AIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           A  T +G++YLH   I+HRDLK NN+ +++   +KIGDFGLA
Sbjct: 138 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA 179

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 66/133 (49%), Gaps = 23/133 (17%)
Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG---------YMSNVS 133
           VA+K +K GT +          L+E +++++L HE ++ L  V           YMS  S
Sbjct: 211 VAIKTLKPGTMSP------EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVGEYMSKGS 264
Query: 134 LVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ 193
           L+ +F+  +    ++ P +V   + I +       G+ Y+     +HRDL+  N+L+ + 
Sbjct: 265 LL-DFLKGETGKYLRLPQLVDMAAQIAS-------GMAYVERMNYVHRDLRAANILVGEN 316
Query: 194 GVLKIGDFGLAKF 206
            V K+ DFGLA+ 
Sbjct: 317 LVCKVADFGLARL 329

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 22/42 (52%), Positives = 31/42 (73%)
Query: 163 AIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           A  T +G++YLH   I+HRDLK NN+ +++   +KIGDFGLA
Sbjct: 115 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA 156

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 22/42 (52%), Positives = 31/42 (73%)
Query: 163 AIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           A  T +G++YLH   I+HRDLK NN+ +++   +KIGDFGLA
Sbjct: 110 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA 151

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 70/160 (43%), Gaps = 25/160 (15%)
Query: 66  GRFATVFKAR-----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           G F  VF A        +  M+VAVK +K     +A +   +   RE +LL  L H++++
Sbjct: 23  GAFGKVFLAECHNLLPEQDKMLVAVKALK-----EASESARQDFQREAELLTMLQHQHIV 77
Query: 121 GLTDVFGYMSNVSLVFEFV------------DTDLEVIIKDPTIVFTP---SNIKAYAIM 165
               V      + +VFE++              D +++     +   P     + A A  
Sbjct: 78  RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 137
Query: 166 TLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
              G+ YL     +HRDL   N L+ +  V+KIGDFG+++
Sbjct: 138 VAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 177

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 70/160 (43%), Gaps = 25/160 (15%)
Query: 66  GRFATVFKAR-----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           G F  VF A        +  M+VAVK +K     +A +   +   RE +LL  L H++++
Sbjct: 29  GAFGKVFLAECHNLLPEQDKMLVAVKALK-----EASESARQDFQREAELLTMLQHQHIV 83
Query: 121 GLTDVFGYMSNVSLVFEFV------------DTDLEVIIKDPTIVFTP---SNIKAYAIM 165
               V      + +VFE++              D +++     +   P     + A A  
Sbjct: 84  RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 143
Query: 166 TLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
              G+ YL     +HRDL   N L+ +  V+KIGDFG+++
Sbjct: 144 VAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 183

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 75/152 (49%), Gaps = 10/152 (6%)
Query: 63  VHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL 122
           +  G F TV +A    +D+ V +  ++   HA+  +      LRE+ +++ L H N++  
Sbjct: 45  IGAGSFGTVHRAEWHGSDVAVKIL-MEQDFHAERVNEF----LREVAIMKRLRHPNIVLF 99
Query: 123 TDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIK---AYAIMTLRGLEYLHDH--W 177
                   N+S+V E++       +   +      + +   + A    +G+ YLH+    
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPP 159
Query: 178 ILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS 209
           I+HR+LK  NLL++K+  +K+ DFGL++   S
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 54/120 (45%), Gaps = 40/120 (33%)
Query: 168 RGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK------FFGSPT---------- 211
           RG+EYL     +HRDL   N+L+ +  V+KI DFGLA+      ++ + T          
Sbjct: 168 RGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPVKWMA 227
Query: 212 ------RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWCCFAKDPSSHGNLFPGIPLNEIF 265
                 R+YTHQ    W            F V  + W  F    +  G+ +PGIP+ E+F
Sbjct: 228 PEALFDRVYTHQSDV-W-----------SFGV--LMWEIF----TLGGSPYPGIPVEELF 269

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 22/42 (52%), Positives = 31/42 (73%)
Query: 163 AIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           A  T +G++YLH   I+HRDLK NN+ +++   +KIGDFGLA
Sbjct: 110 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA 151

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 60/129 (46%), Gaps = 5/129 (3%)
Query: 78  ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFE 137
           + D+ VA+K +K G     +    R  L E  ++ +  H N++ L  V        +V E
Sbjct: 75  QRDVPVAIKALKAGYTERQR----RDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTE 130
Query: 138 FVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVL 196
           +++   L+  ++     FT   +         G+ YL D   +HRDL   N+L++   V 
Sbjct: 131 YMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVC 190
Query: 197 KIGDFGLAK 205
           K+ DFGL++
Sbjct: 191 KVSDFGLSR 199

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 22/42 (52%), Positives = 31/42 (73%)
Query: 163 AIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           A  T +G++YLH   I+HRDLK NN+ +++   +KIGDFGLA
Sbjct: 110 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA 151

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 53/120 (44%), Gaps = 40/120 (33%)
Query: 168 RGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK------FFGSPT---------- 211
           RG+EYL     +HRDL   N+L+ +  V+KI DFGLA+      ++   T          
Sbjct: 168 RGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMA 227
Query: 212 ------RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWCCFAKDPSSHGNLFPGIPLNEIF 265
                 R+YTHQ    W            F V  + W  F    +  G+ +PGIP+ E+F
Sbjct: 228 PEALFDRVYTHQSDV-W-----------SFGV--LMWEIF----TLGGSPYPGIPVEELF 269

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/125 (26%), Positives = 60/125 (48%), Gaps = 12/125 (9%)
Query: 149 DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK--- 205
           +P    +  ++ + A    RG+EYL     +HRDL   N+L+ +  V+KI DFGLA+   
Sbjct: 142 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 201
Query: 206 FFGSPTRLYTHQVVTRWY--RLIKCLLYCVQFNVKN---VQWCCFAKDPSSHGNLFPGIP 260
                 +    ++  +W     +   +Y  Q +V +   + W  F    +  G+ +PG+P
Sbjct: 202 HIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF----TLGGSPYPGVP 257
Query: 261 LNEIF 265
           + E+F
Sbjct: 258 VEELF 262

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 53/120 (44%), Gaps = 40/120 (33%)
Query: 168 RGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK------FFGSPT---------- 211
           RG+EYL     +HRDL   N+L+ +  V+KI DFGLA+      ++   T          
Sbjct: 168 RGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMA 227
Query: 212 ------RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWCCFAKDPSSHGNLFPGIPLNEIF 265
                 R+YTHQ    W            F V  + W  F    +  G+ +PGIP+ E+F
Sbjct: 228 PEALFDRVYTHQSDV-W-----------SFGV--LMWEIF----TLGGSPYPGIPVEELF 269

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 53/120 (44%), Gaps = 40/120 (33%)
Query: 168 RGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK------FFGSPT---------- 211
           RG+EYL     +HRDL   N+L+ +  V+KI DFGLA+      ++   T          
Sbjct: 168 RGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMA 227
Query: 212 ------RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWCCFAKDPSSHGNLFPGIPLNEIF 265
                 R+YTHQ    W            F V  + W  F    +  G+ +PGIP+ E+F
Sbjct: 228 PEALFDRVYTHQSDV-W-----------SFGV--LMWEIF----TLGGSPYPGIPVEELF 269

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 53/120 (44%), Gaps = 40/120 (33%)
Query: 168 RGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK------FFGSPT---------- 211
           RG+EYL     +HRDL   N+L+ +  V+KI DFGLA+      ++   T          
Sbjct: 160 RGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMA 219
Query: 212 ------RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWCCFAKDPSSHGNLFPGIPLNEIF 265
                 R+YTHQ    W            F V  + W  F    +  G+ +PGIP+ E+F
Sbjct: 220 PEALFDRVYTHQSDV-W-----------SFGV--LMWEIF----TLGGSPYPGIPVEELF 261

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 92/214 (42%), Gaps = 26/214 (12%)
Query: 66  GRFATVFKARDI----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F TV+K   I    +  + VA+K+++  T   A    N+  L E  ++  + + +V  
Sbjct: 30  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA----NKEILDEAYVMASVDNPHVCR 85
Query: 122 LTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
           L  +    S V L+ + +    L   +++         +  + +   +G+ YL D  ++H
Sbjct: 86  LLGIC-LTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 144
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQ---VVTRWYRLIKCL--LYCVQ- 234
           RDL   N+L+     +KI DFG AK  G+  + Y  +   V  +W  L   L  +Y  Q 
Sbjct: 145 RDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 204
Query: 235 ----FNVKNVQWCCFAKDPSSHGNLFPGIPLNEI 264
               + V   +   F   P      + GIP +EI
Sbjct: 205 DVWSYGVTVWELMTFGSKP------YDGIPASEI 232

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 53/120 (44%), Gaps = 40/120 (33%)
Query: 168 RGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK------FFGSPT---------- 211
           RG+EYL     +HRDL   N+L+ +  V+KI DFGLA+      ++   T          
Sbjct: 168 RGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMA 227
Query: 212 ------RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWCCFAKDPSSHGNLFPGIPLNEIF 265
                 R+YTHQ    W            F V  + W  F    +  G+ +PGIP+ E+F
Sbjct: 228 PEALFDRVYTHQSDV-W-----------SFGV--LMWEIF----TLGGSPYPGIPVEELF 269

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 92/214 (42%), Gaps = 26/214 (12%)
Query: 66  GRFATVFKARDI----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F TV+K   I    +  + VA+K+++  T   A    N+  L E  ++  + + +V  
Sbjct: 28  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA----NKEILDEAYVMASVDNPHVCR 83
Query: 122 LTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
           L  +    S V L+ + +    L   +++         +  + +   +G+ YL D  ++H
Sbjct: 84  LLGIC-LTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 142
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQ---VVTRWYRLIKCL--LYCVQ- 234
           RDL   N+L+     +KI DFG AK  G+  + Y  +   V  +W  L   L  +Y  Q 
Sbjct: 143 RDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 202
Query: 235 ----FNVKNVQWCCFAKDPSSHGNLFPGIPLNEI 264
               + V   +   F   P      + GIP +EI
Sbjct: 203 DVWSYGVTVWELMTFGSKP------YDGIPASEI 230

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 53/120 (44%), Gaps = 40/120 (33%)
Query: 168 RGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK------FFGSPT---------- 211
           RG+EYL     +HRDL   N+L+ +  V+KI DFGLA+      ++   T          
Sbjct: 157 RGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMA 216
Query: 212 ------RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWCCFAKDPSSHGNLFPGIPLNEIF 265
                 R+YTHQ    W            F V  + W  F    +  G+ +PGIP+ E+F
Sbjct: 217 PEALFDRVYTHQSDV-W-----------SFGV--LMWEIF----TLGGSPYPGIPVEELF 258

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 53/120 (44%), Gaps = 40/120 (33%)
Query: 168 RGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK------FFGSPT---------- 211
           RG+EYL     +HRDL   N+L+ +  V+KI DFGLA+      ++   T          
Sbjct: 168 RGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMA 227
Query: 212 ------RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWCCFAKDPSSHGNLFPGIPLNEIF 265
                 R+YTHQ    W            F V  + W  F    +  G+ +PGIP+ E+F
Sbjct: 228 PEALFDRVYTHQSDV-W-----------SFGV--LMWEIF----TLGGSPYPGIPVEELF 269

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 26/216 (12%)
Query: 66  GRFATVFKARDI----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F TV+K   I    +  + VA+K+++  T   A    N+  L E  ++  + + +V  
Sbjct: 28  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA----NKEILDEAYVMASVDNPHVCR 83
Query: 122 LTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
           L  +    S V L+ + +    L   +++         +  + +   +G+ YL D  ++H
Sbjct: 84  LLGIC-LTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 142
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY---THQVVTRWYRLIKCL--LYCVQ- 234
           RDL   N+L+     +KI DFG AK  G+  + Y     +V  +W  L   L  +Y  Q 
Sbjct: 143 RDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 202
Query: 235 ----FNVKNVQWCCFAKDPSSHGNLFPGIPLNEIFT 266
               + V   +   F   P      + GIP +EI +
Sbjct: 203 DVWSYGVTVWELMTFGSKP------YDGIPASEISS 232

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 66/133 (49%), Gaps = 23/133 (17%)
Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG---------YMSNVS 133
           VA+K +K GT +          L+E +++++L HE ++ L  V           YMS  S
Sbjct: 294 VAIKTLKPGTMSP------EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGS 347
Query: 134 LVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ 193
           L+ +F+  +    ++ P +V   + I +       G+ Y+     +HRDL+  N+L+ + 
Sbjct: 348 LL-DFLKGETGKYLRLPQLVDMAAQIAS-------GMAYVERMNYVHRDLRAANILVGEN 399
Query: 194 GVLKIGDFGLAKF 206
            V K+ DFGLA+ 
Sbjct: 400 LVCKVADFGLARL 412

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 60/139 (43%), Gaps = 40/139 (28%)
Query: 149 DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK--- 205
           +P    +  ++ + A    RG+EYL     +HRDL   N+L+ +  V+KI DFGLA+   
Sbjct: 135 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 194
Query: 206 ---FFGSPT----------------RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWCCFA 246
              ++   T                R+YTHQ    W            F V  + W  F 
Sbjct: 195 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV-W-----------SFGV--LLWEIF- 239
Query: 247 KDPSSHGNLFPGIPLNEIF 265
              +  G+ +PG+P+ E+F
Sbjct: 240 ---TLGGSPYPGVPVEELF 255

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/134 (26%), Positives = 66/134 (49%), Gaps = 23/134 (17%)
Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG---------YMSNVS 133
           VA+K +K GT +          L+E +++++L HE ++ L  V           YMS   
Sbjct: 45  VAIKTLKPGTMSP------EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGC 98
Query: 134 LVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ 193
           L+ +F+  ++   ++ P +V   + I +       G+ Y+     +HRDL+  N+L+ + 
Sbjct: 99  LL-DFLKGEMGKYLRLPQLVDMAAQIAS-------GMAYVERMNYVHRDLRAANILVGEN 150
Query: 194 GVLKIGDFGLAKFF 207
            V K+ DFGLA+  
Sbjct: 151 LVCKVADFGLARLI 164

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 71/154 (46%), Gaps = 10/154 (6%)
Query: 71  VFKARDIETDMIVAVKKIKLGTH-ADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM 129
           V++ R  + D  VA+K +K GT  AD ++      +RE +++ +L +  ++ L  V    
Sbjct: 356 VYRMRKKQID--VAIKVLKQGTEKADTEE-----MMREAQIMHQLDNPYIVRLIGVC-QA 407
Query: 130 SNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNL 188
             + LV E      L   +         SN+         G++YL +   +HR+L   N+
Sbjct: 408 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNV 467
Query: 189 LINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW 222
           L+  +   KI DFGL+K  G+    YT +   +W
Sbjct: 468 LLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 501

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 60/139 (43%), Gaps = 40/139 (28%)
Query: 149 DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK--- 205
           +P    +  ++ + A    RG+EYL     +HRDL   N+L+ +  V+KI DFGLA+   
Sbjct: 142 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 201
Query: 206 ---FFGSPT----------------RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWCCFA 246
              ++   T                R+YTHQ    W            F V  + W  F 
Sbjct: 202 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV-W-----------SFGV--LLWEIF- 246
Query: 247 KDPSSHGNLFPGIPLNEIF 265
              +  G+ +PG+P+ E+F
Sbjct: 247 ---TLGGSPYPGVPVEELF 262

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 60/139 (43%), Gaps = 40/139 (28%)
Query: 149 DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK--- 205
           +P    +  ++ + A    RG+EYL     +HRDL   N+L+ +  V+KI DFGLA+   
Sbjct: 142 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 201
Query: 206 ---FFGSPT----------------RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWCCFA 246
              ++   T                R+YTHQ    W            F V  + W  F 
Sbjct: 202 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV-W-----------SFGV--LLWEIF- 246
Query: 247 KDPSSHGNLFPGIPLNEIF 265
              +  G+ +PG+P+ E+F
Sbjct: 247 ---TLGGSPYPGVPVEELF 262

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 53/120 (44%), Gaps = 40/120 (33%)
Query: 168 RGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK------FFGSPT---------- 211
           RG+EYL     +HRDL   N+L+ +  V+KI DFGLA+      ++   T          
Sbjct: 155 RGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMA 214
Query: 212 ------RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWCCFAKDPSSHGNLFPGIPLNEIF 265
                 R+YTHQ    W            F V  + W  F    +  G+ +PGIP+ E+F
Sbjct: 215 PEALFDRVYTHQSDV-W-----------SFGV--LMWEIF----TLGGSPYPGIPVEELF 256

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 59/123 (47%), Gaps = 8/123 (6%)
Query: 106 REIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYA 163
           +EI++++ L H N++ L + F   +++ LV E        E ++     VF  S+     
Sbjct: 55  QEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVH--KRVFRESDAARIM 112
Query: 164 IMTLRGLEYLHDHWILHRDLKPNNLLI---NKQGVLKIGDFGLAKFFGSPTRLYTHQVVT 220
              L  + Y H   + HRDLKP N L    +    LK+ DFGLA  F  P ++   +V T
Sbjct: 113 KDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF-KPGKMMRTKVGT 171
Query: 221 RWY 223
            +Y
Sbjct: 172 PYY 174

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/134 (26%), Positives = 66/134 (49%), Gaps = 23/134 (17%)
Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG---------YMSNVS 133
           VA+K +K GT +          L+E +++++L HE ++ L  V           YMS   
Sbjct: 45  VAIKTLKPGTMSP------EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVMEYMSKGC 98
Query: 134 LVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ 193
           L+ +F+  ++   ++ P +V   + I +       G+ Y+     +HRDL+  N+L+ + 
Sbjct: 99  LL-DFLKGEMGKYLRLPQLVDMAAQIAS-------GMAYVERMNYVHRDLRAANILVGEN 150
Query: 194 GVLKIGDFGLAKFF 207
            V K+ DFGLA+  
Sbjct: 151 LVCKVADFGLARLI 164

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 60/139 (43%), Gaps = 40/139 (28%)
Query: 149 DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK--- 205
           +P    +  ++ + A    RG+EYL     +HRDL   N+L+ +  V+KI DFGLA+   
Sbjct: 142 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 201
Query: 206 ---FFGSPT----------------RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWCCFA 246
              ++   T                R+YTHQ    W            F V  + W  F 
Sbjct: 202 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV-W-----------SFGV--LLWEIF- 246
Query: 247 KDPSSHGNLFPGIPLNEIF 265
              +  G+ +PG+P+ E+F
Sbjct: 247 ---TLGGSPYPGVPVEELF 262

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 60/139 (43%), Gaps = 40/139 (28%)
Query: 149 DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK--- 205
           +P    +  ++ + A    RG+EYL     +HRDL   N+L+ +  V+KI DFGLA+   
Sbjct: 131 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 190
Query: 206 ---FFGSPT----------------RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWCCFA 246
              ++   T                R+YTHQ    W            F V  + W  F 
Sbjct: 191 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV-W-----------SFGV--LLWEIF- 235
Query: 247 KDPSSHGNLFPGIPLNEIF 265
              +  G+ +PG+P+ E+F
Sbjct: 236 ---TLGGSPYPGVPVEELF 251

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 60/139 (43%), Gaps = 40/139 (28%)
Query: 149 DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK--- 205
           +P    +  ++ + A    RG+EYL     +HRDL   N+L+ +  V+KI DFGLA+   
Sbjct: 134 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 193
Query: 206 ---FFGSPT----------------RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWCCFA 246
              ++   T                R+YTHQ    W            F V  + W  F 
Sbjct: 194 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV-W-----------SFGV--LLWEIF- 238
Query: 247 KDPSSHGNLFPGIPLNEIF 265
              +  G+ +PG+P+ E+F
Sbjct: 239 ---TLGGSPYPGVPVEELF 254

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 72/163 (44%), Gaps = 12/163 (7%)
Query: 47  DCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALR 106
           D  + +D   Y   + +  G F      RD +++ +VAVK I+ G      + I     R
Sbjct: 11  DLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG------EKIAANVKR 64
Query: 107 EIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAI 164
           EI   + L H N++   +V    +++++V E+       E I       F+    + +  
Sbjct: 65  EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQ 122
Query: 165 MTLRGLEYLHDHWILHRDLKPNNLLINKQGV--LKIGDFGLAK 205
             + G+ Y H   + HRDLK  N L++      LKI DFG +K
Sbjct: 123 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 165

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 60/139 (43%), Gaps = 40/139 (28%)
Query: 149 DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK--- 205
           +P    +  ++ + A    RG+EYL     +HRDL   N+L+ +  V+KI DFGLA+   
Sbjct: 127 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186
Query: 206 ---FFGSPT----------------RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWCCFA 246
              ++   T                R+YTHQ    W            F V  + W  F 
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV-W-----------SFGV--LLWEIF- 231
Query: 247 KDPSSHGNLFPGIPLNEIF 265
              +  G+ +PG+P+ E+F
Sbjct: 232 ---TLGGSPYPGVPVEELF 247

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 59/123 (47%), Gaps = 8/123 (6%)
Query: 106 REIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYA 163
           +EI++++ L H N++ L + F   +++ LV E        E ++     VF  S+     
Sbjct: 72  QEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVH--KRVFRESDAARIM 129
Query: 164 IMTLRGLEYLHDHWILHRDLKPNNLLI---NKQGVLKIGDFGLAKFFGSPTRLYTHQVVT 220
              L  + Y H   + HRDLKP N L    +    LK+ DFGLA  F  P ++   +V T
Sbjct: 130 KDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF-KPGKMMRTKVGT 188
Query: 221 RWY 223
            +Y
Sbjct: 189 PYY 191

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 70/190 (36%), Gaps = 55/190 (28%)
Query: 63  VHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL-- 120
           +  G F  VFKA+         ++++K           N  A RE+K L +L H N++  
Sbjct: 20  IGSGGFGQVFKAKHRIDGKTYVIRRVKYN---------NEKAEREVKALAKLDHVNIVHY 70
Query: 121 -GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAI--------------- 164
            G  D F Y    S      D  LE    DP      S  K   +               
Sbjct: 71  NGCWDGFDYDPETS------DDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQW 124
Query: 165 -------------------MTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA- 204
                                 +G++Y+H   ++HRDLKP+N+ +     +KIGDFGL  
Sbjct: 125 IEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVT 184
Query: 205 --KFFGSPTR 212
             K  G  TR
Sbjct: 185 SLKNDGKRTR 194

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 52/103 (50%), Gaps = 5/103 (4%)
Query: 106 REIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIM 165
           RE ++ ++L H N++ L D     S   LVF+ V T  E+        F      ++ I 
Sbjct: 53  REARICRKLQHPNIVRLHDSIQEESFHYLVFDLV-TGGELFEDIVAREFYSEADASHCIQ 111
Query: 166 T-LRGLEYLHDHWILHRDLKPNNLLI---NKQGVLKIGDFGLA 204
             L  + Y H + I+HR+LKP NLL+    K   +K+ DFGLA
Sbjct: 112 QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 154

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/121 (27%), Positives = 59/121 (48%), Gaps = 6/121 (4%)
Query: 82  IVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT 141
           +VAVKK+ L      K         E+ ++++  HENV+ + + +     + +V EF++ 
Sbjct: 47  LVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101
Query: 142 DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDF 201
                I   T       I A  +  L+ L  LH   ++HRD+K +++L+   G +K+ DF
Sbjct: 102 GALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDF 160
Query: 202 G 202
           G
Sbjct: 161 G 161

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/121 (27%), Positives = 59/121 (48%), Gaps = 6/121 (4%)
Query: 82  IVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT 141
           +VAVKK+ L      K         E+ ++++  HENV+ + + +     + +V EF++ 
Sbjct: 51  LVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 105
Query: 142 DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDF 201
                I   T       I A  +  L+ L  LH   ++HRD+K +++L+   G +K+ DF
Sbjct: 106 GALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDF 164
Query: 202 G 202
           G
Sbjct: 165 G 165

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 52/103 (50%), Gaps = 5/103 (4%)
Query: 106 REIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIM 165
           RE ++ ++L H N++ L D     S   LVF+ V T  E+        F      ++ I 
Sbjct: 54  REARICRKLQHPNIVRLHDSIQEESFHYLVFDLV-TGGELFEDIVAREFYSEADASHCIQ 112
Query: 166 T-LRGLEYLHDHWILHRDLKPNNLLI---NKQGVLKIGDFGLA 204
             L  + Y H + I+HR+LKP NLL+    K   +K+ DFGLA
Sbjct: 113 QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 155

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/121 (27%), Positives = 59/121 (48%), Gaps = 6/121 (4%)
Query: 82  IVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT 141
           +VAVKK+ L      K         E+ ++++  HENV+ + + +     + +V EF++ 
Sbjct: 56  LVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 110
Query: 142 DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDF 201
                I   T       I A  +  L+ L  LH   ++HRD+K +++L+   G +K+ DF
Sbjct: 111 GALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDF 169
Query: 202 G 202
           G
Sbjct: 170 G 170

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 52/103 (50%), Gaps = 5/103 (4%)
Query: 106 REIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIM 165
           RE ++ ++L H N++ L D     S   LVF+ V T  E+        F      ++ I 
Sbjct: 54  REARICRKLQHPNIVRLHDSIQEESFHYLVFDLV-TGGELFEDIVAREFYSEADASHCIQ 112
Query: 166 T-LRGLEYLHDHWILHRDLKPNNLLI---NKQGVLKIGDFGLA 204
             L  + Y H + I+HR+LKP NLL+    K   +K+ DFGLA
Sbjct: 113 QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 155

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 52/113 (46%), Gaps = 16/113 (14%)
Query: 162 YAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQ---V 218
           + +   +G+ YL D  ++HRDL   N+L+     +KI DFGLAK  G+  + Y  +   V
Sbjct: 156 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 215
Query: 219 VTRWYRLIKCL--LYCVQ-----FNVKNVQWCCFAKDPSSHGNLFPGIPLNEI 264
             +W  L   L  +Y  Q     + V   +   F   P      + GIP +EI
Sbjct: 216 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP------YDGIPASEI 262

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/121 (27%), Positives = 59/121 (48%), Gaps = 6/121 (4%)
Query: 82  IVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT 141
           +VAVKK+ L      K         E+ ++++  HENV+ + + +     + +V EF++ 
Sbjct: 58  LVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 112
Query: 142 DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDF 201
                I   T       I A  +  L+ L  LH   ++HRD+K +++L+   G +K+ DF
Sbjct: 113 GALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDF 171
Query: 202 G 202
           G
Sbjct: 172 G 172

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 52/103 (50%), Gaps = 5/103 (4%)
Query: 106 REIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIM 165
           RE ++ ++L H N++ L D     S   LVF+ V T  E+        F      ++ I 
Sbjct: 77  REARICRKLQHPNIVRLHDSIQEESFHYLVFDLV-TGGELFEDIVAREFYSEADASHCIQ 135
Query: 166 T-LRGLEYLHDHWILHRDLKPNNLLI---NKQGVLKIGDFGLA 204
             L  + Y H + I+HR+LKP NLL+    K   +K+ DFGLA
Sbjct: 136 QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 178

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 65/270 (24%), Positives = 101/270 (37%), Gaps = 55/270 (20%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G  + V  ARD+     VAVK ++     D          RE +    L+H  ++ + D 
Sbjct: 23  GGMSEVHLARDLRDHRDVAVKVLRADLARDPS--FYLRFRREAQNAAALNHPAIVAVYDT 80
Query: 126 FGYMSNVS----LVFEFVDTDLEVIIKDPTIV-----FTPSNIKAYAIMTLRGLEYLHDH 176
               +       +V E+VD    V ++D  IV      TP           + L + H +
Sbjct: 81  GEAETPAGPLPYIVMEYVDG---VTLRD--IVHTEGPMTPKRAIEVIADACQALNFSHQN 135
Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAKFFG-------------------SPTRLYTHQ 217
            I+HRD+KP N++I+    +K+ DFG+A+                      SP +     
Sbjct: 136 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 195
Query: 218 VVTRW--YRLIKCLLYCV--------QFNVKNVQWCCFAKDPSSHGNLFPGIPLNEIFTA 267
           V  R   Y L  C+LY V          +  +V +    +DP         IP +     
Sbjct: 196 VDARSDVYSL-GCVLYEVLTGEPPFTGDSPDSVAYQHVREDP---------IPPSARHEG 245
Query: 268 AGDDLLAVISSLLCLNPTKRADCTATLKMD 297
              DL AV+   L  NP  R    A ++ D
Sbjct: 246 LSADLDAVVLKALAKNPENRYQTAAEMRAD 275

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 92/214 (42%), Gaps = 26/214 (12%)
Query: 66  GRFATVFKARDI----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F TV+K   I    +  + VA+K+++  T   A    N+  L E  ++  + + +V  
Sbjct: 26  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA----NKEILDEAYVMASVDNPHVCR 81
Query: 122 LTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
           L  +    S V L+ + +    L   +++         +  + +   +G+ YL D  ++H
Sbjct: 82  LLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQ---VVTRWYRLIKCL--LYCVQ- 234
           RDL   N+L+     +KI DFG AK  G+  + Y  +   V  +W  L   L  +Y  Q 
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 200
Query: 235 ----FNVKNVQWCCFAKDPSSHGNLFPGIPLNEI 264
               + V   +   F   P      + GIP +EI
Sbjct: 201 DVWSYGVTVWELMTFGSKP------YDGIPASEI 228

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 30/162 (18%)
Query: 69  ATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL-REIKLLQEL-HHENVLGLTDVF 126
           AT +        + VAVK +K     +  D   R AL  E+K++ +L  HEN++ L    
Sbjct: 64  ATAYGISKTGVSIQVAVKMLK-----EKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118
Query: 127 GYMSNVSLVFE-----------------FVDTDLE------VIIKDPTIVFTPSNIKAYA 163
                + L+FE                 F + ++E      +  ++   V T  ++  +A
Sbjct: 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFA 178
Query: 164 IMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
               +G+E+L     +HRDL   N+L+    V+KI DFGLA+
Sbjct: 179 YQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 220

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 26/216 (12%)
Query: 66  GRFATVFKARDI----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F TV+K   I    +  + VA+K+++  T   A    N+  L E  ++  + + +V  
Sbjct: 33  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA----NKEILDEAYVMASVDNPHVCR 88
Query: 122 LTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
           L  +    S V L+ + +    L   +++         +  + +   +G+ YL D  ++H
Sbjct: 89  LLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 147
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY---THQVVTRWYRLIKCL--LYCVQ- 234
           RDL   N+L+     +KI DFG AK  G+  + Y     +V  +W  L   L  +Y  Q 
Sbjct: 148 RDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 207
Query: 235 ----FNVKNVQWCCFAKDPSSHGNLFPGIPLNEIFT 266
               + V   +   F   P      + GIP +EI +
Sbjct: 208 DVWSYGVTVWELMTFGSKP------YDGIPASEISS 237

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 26/216 (12%)
Query: 66  GRFATVFKARDI----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F TV+K   I    +  + VA+K+++  T   A    N+  L E  ++  + + +V  
Sbjct: 28  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA----NKEILDEAYVMASVDNPHVCR 83
Query: 122 LTDVFGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
           L  +    S V L+ + +    L   +++         +  + +   +G+ YL D  ++H
Sbjct: 84  LLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 142
Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQ---VVTRWYRLIKCL--LYCVQ- 234
           RDL   N+L+     +KI DFG AK  G+  + Y  +   V  +W  L   L  +Y  Q 
Sbjct: 143 RDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 202
Query: 235 ----FNVKNVQWCCFAKDPSSHGNLFPGIPLNEIFT 266
               + V   +   F   P      + GIP +EI +
Sbjct: 203 DVWSYGVTVWELMTFGSKP------YDGIPASEISS 232

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 53/120 (44%), Gaps = 40/120 (33%)
Query: 168 RGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK------FFGSPT---------- 211
           RG+EYL     +HRDL   N+L+ +  V++I DFGLA+      ++   T          
Sbjct: 168 RGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMA 227
Query: 212 ------RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWCCFAKDPSSHGNLFPGIPLNEIF 265
                 R+YTHQ    W            F V  + W  F    +  G+ +PGIP+ E+F
Sbjct: 228 PEALFDRVYTHQSDV-W-----------SFGV--LMWEIF----TLGGSPYPGIPVEELF 269

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 73/150 (48%), Gaps = 15/150 (10%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKL-LQELHHENVLGLTD 124
           G +  V K R + +  I AVK+I+   ++  +    +  L ++ +  + +     +    
Sbjct: 45  GAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQ----KRLLXDLDISXRTVDCPFTVTFYG 100
Query: 125 VFGYMSNVSLVFEFVDTDL-----EVIIKDPTIVFTPSNI-KAYAIMTLRGLEYLHDHW- 177
                 +V +  E  DT L     +VI K  TI   P +I    A+  ++ LE+LH    
Sbjct: 101 ALFREGDVWICXELXDTSLDKFYKQVIDKGQTI---PEDILGKIAVSIVKALEHLHSKLS 157
Query: 178 ILHRDLKPNNLLINKQGVLKIGDFGLAKFF 207
           ++HRD+KP+N+LIN  G +K  DFG++ + 
Sbjct: 158 VIHRDVKPSNVLINALGQVKXCDFGISGYL 187

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/134 (26%), Positives = 66/134 (49%), Gaps = 23/134 (17%)
Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG---------YMSNVS 133
           VA+K +K GT +          L+E +++++L HE ++ L  V           YM+  S
Sbjct: 42  VAIKTLKPGTMSP------EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMNKGS 95
Query: 134 LVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ 193
           L+ +F+  +    ++ P +V   + I +       G+ Y+     +HRDL+  N+L+ + 
Sbjct: 96  LL-DFLKGETGKYLRLPQLVDMSAQIAS-------GMAYVERMNYVHRDLRAANILVGEN 147
Query: 194 GVLKIGDFGLAKFF 207
            V K+ DFGLA+  
Sbjct: 148 LVCKVADFGLARLI 161

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 58/115 (50%), Gaps = 9/115 (7%)
Query: 98  DGINRTALREIK-LLQELHHENVLGLTDVFGYMSNVSLVFEFVDTD--LEVIIKDPTIVF 154
           D   R    EI+ LL+   H N++ L DV+     V +V E       L+ I++     F
Sbjct: 56  DKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQK--FF 113
Query: 155 TPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLL-INKQG---VLKIGDFGLAK 205
           +     A      + +EYLH   ++HRDLKP+N+L +++ G    ++I DFG AK
Sbjct: 114 SEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 60/139 (43%), Gaps = 40/139 (28%)
Query: 149 DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK--- 205
           +P    +  ++ + A    RG+EYL     +HRDL   N+L+ +  V+KI DFGLA+   
Sbjct: 183 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 242
Query: 206 ---FFGSPT----------------RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWCCFA 246
              ++   T                R+YTHQ    W            F V  + W  F 
Sbjct: 243 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV-W-----------SFGV--LLWEIF- 287
Query: 247 KDPSSHGNLFPGIPLNEIF 265
              +  G+ +PG+P+ E+F
Sbjct: 288 ---TLGGSPYPGVPVEELF 303

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 100/270 (37%), Gaps = 55/270 (20%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G  + V  ARD+     VAVK ++     D          RE +    L+H  ++ + D 
Sbjct: 23  GGMSEVHLARDLRDHRDVAVKVLRADLARDPS--FYLRFRREAQNAAALNHPAIVAVYDT 80
Query: 126 FGYMSNVS----LVFEFVDTDLEVIIKDPTIV-----FTPSNIKAYAIMTLRGLEYLHDH 176
               +       +V E+VD    V ++D  IV      TP           + L + H +
Sbjct: 81  GEAETPAGPLPYIVMEYVDG---VTLRD--IVHTEGPMTPKRAIEVIADACQALNFSHQN 135
Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAKFFG-------------------SPTRLYTHQ 217
            I+HRD+KP N+LI+    +K+ DFG+A+                      SP +     
Sbjct: 136 GIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDS 195
Query: 218 VVTRW--YRLIKCLLYCVQFNVK--------NVQWCCFAKDPSSHGNLFPGIPLNEIFTA 267
           V  R   Y L  C+LY V             +V +    +DP         IP +     
Sbjct: 196 VDARSDVYSL-GCVLYEVLTGEPPFTGDSPVSVAYQHVREDP---------IPPSARHEG 245
Query: 268 AGDDLLAVISSLLCLNPTKRADCTATLKMD 297
              DL AV+   L  NP  R    A ++ D
Sbjct: 246 LSADLDAVVLKALAKNPENRYQTAAEMRAD 275

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/134 (26%), Positives = 66/134 (49%), Gaps = 23/134 (17%)
Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG---------YMSNVS 133
           VA+K +K GT +          L+E +++++L HE ++ L  V           YM+  S
Sbjct: 42  VAIKTLKPGTMSP------EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMNKGS 95
Query: 134 LVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ 193
           L+ +F+  +    ++ P +V   + I +       G+ Y+     +HRDL+  N+L+ + 
Sbjct: 96  LL-DFLKGETGKYLRLPQLVDMSAQIAS-------GMAYVERMNYVHRDLRAANILVGEN 147
Query: 194 GVLKIGDFGLAKFF 207
            V K+ DFGLA+  
Sbjct: 148 LVCKVADFGLARLI 161

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/121 (27%), Positives = 59/121 (48%), Gaps = 6/121 (4%)
Query: 82  IVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT 141
           +VAVKK+ L      K         E+ ++++  HENV+ + + +     + +V EF++ 
Sbjct: 101 LVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 155
Query: 142 DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDF 201
                I   T       I A  +  L+ L  LH   ++HRD+K +++L+   G +K+ DF
Sbjct: 156 GALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDF 214
Query: 202 G 202
           G
Sbjct: 215 G 215

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/125 (26%), Positives = 61/125 (48%), Gaps = 14/125 (11%)
Query: 82  IVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVD- 140
           +VAVKK+ L      K         E+ ++++  HENV+ + + +     + +V EF++ 
Sbjct: 178 LVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 232
Query: 141 ---TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLK 197
              TD+    +          I A  +  L+ L  LH   ++HRD+K +++L+   G +K
Sbjct: 233 GALTDIVTHTR-----MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVK 287
Query: 198 IGDFG 202
           + DFG
Sbjct: 288 LSDFG 292

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 33/114 (28%), Positives = 55/114 (48%), Gaps = 8/114 (7%)
Query: 106 REIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYA 163
           REI+ L+   H +++ L  V    ++  +V E+V      + I K   +      ++A  
Sbjct: 60  REIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRV----EEMEARR 115
Query: 164 IMT--LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYT 215
           +    L  ++Y H H ++HRDLKP N+L++     KI DFGL+        L T
Sbjct: 116 LFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT 169

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 70/148 (47%), Gaps = 20/148 (13%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y+  R +  G F+TV+   D++    VA+K +K   H         TAL EIKLL+ +  
Sbjct: 33  YHVIRKLGWGHFSTVWLCWDMQGKRFVAMKVVKSAQH------YTETALDEIKLLKCVRE 86
Query: 117 EN--------VLGLTDVFGYMS----NVSLVFEFVDTDL-EVIIKDPTIVFTPSNIKAYA 163
            +        V+ L D F        +V +VFE +   L + IIK          +K+  
Sbjct: 87  SDPSDPNKDMVVQLIDDFKISGMNGIHVCMVFEVLGHHLLKWIIKSNYQGLPVRCVKSII 146
Query: 164 IMTLRGLEYLHDHW-ILHRDLKPNNLLI 190
              L+GL+YLH    I+H D+KP N+L+
Sbjct: 147 RQVLQGLDYLHSKCKIIHTDIKPENILM 174

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 69/149 (46%), Gaps = 4/149 (2%)
Query: 56  VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH 115
           +Y   + +  G  + VF+  + E   I A+K + L    +      R  +  +  LQ+ H
Sbjct: 13  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ-H 70
Query: 116 HENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
            + ++ L D       + +V E  + DL   +K    +  P   K+Y    L  +  +H 
Sbjct: 71  SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQ 129
Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           H I+H DLKP N LI   G+LK+ DFG+A
Sbjct: 130 HGIVHSDLKPANFLI-VDGMLKLIDFGIA 157

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 65/270 (24%), Positives = 100/270 (37%), Gaps = 55/270 (20%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G  + V  ARD+     VAVK ++     D          RE +    L+H  ++ + D 
Sbjct: 23  GGMSEVHLARDLRDHRDVAVKVLRADLARDPS--FYLRFRREAQNAAALNHPAIVAVYDT 80
Query: 126 FGYMSNVS----LVFEFVDTDLEVIIKDPTIV-----FTPSNIKAYAIMTLRGLEYLHDH 176
               +       +V E+VD    V ++D  IV      TP           + L + H +
Sbjct: 81  GEAETPAGPLPYIVMEYVDG---VTLRD--IVHTEGPMTPKRAIEVIADACQALNFSHQN 135
Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAKFFG-------------------SPTRLYTHQ 217
            I+HRD+KP N++I+    +K+ DFG+A+                      SP +     
Sbjct: 136 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 195
Query: 218 VVTRW--YRLIKCLLYCVQFNVK--------NVQWCCFAKDPSSHGNLFPGIPLNEIFTA 267
           V  R   Y L  C+LY V             +V +    +DP         IP +     
Sbjct: 196 VDARSDVYSL-GCVLYEVLTGEPPFTGDSPVSVAYQHVREDP---------IPPSARHEG 245
Query: 268 AGDDLLAVISSLLCLNPTKRADCTATLKMD 297
              DL AV+   L  NP  R    A ++ D
Sbjct: 246 LSADLDAVVLKALAKNPENRYQTAAEMRAD 275

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 70/165 (42%), Gaps = 39/165 (23%)
Query: 63  VHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL-- 120
           +  G F  VFKA+         +K++K           N  A RE+K L +L H N++  
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVKYN---------NEKAEREVKALAKLDHVNIVHY 69
Query: 121 -GLTDVFGYMSNVS-------------LVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIM 165
            G  D F Y    S             +  EF D   LE  I+           K   ++
Sbjct: 70  NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE------KRRGEKLDKVL 123
Query: 166 TL-------RGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGL 203
            L       +G++Y+H   +++RDLKP+N+ +     +KIGDFGL
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGL 168

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 72/163 (44%), Gaps = 12/163 (7%)
Query: 47  DCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALR 106
           D  + +D   Y   + +  G F      RD +++ +VAVK I+ G      + I+    R
Sbjct: 11  DLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG------EKIDENVKR 64
Query: 107 EIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAI 164
           EI   + L H N++   +V    +++++V E+       E I       F+    + +  
Sbjct: 65  EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQ 122
Query: 165 MTLRGLEYLHDHWILHRDLKPNNLLINKQGV--LKIGDFGLAK 205
             + G+ Y H   + HRDLK  N L++      LKI  FG +K
Sbjct: 123 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSK 165

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 59/132 (44%), Gaps = 18/132 (13%)
Query: 106 REIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYA 163
           REI+ L+   H +++ L  V    ++  +V E+V      + I K   +      ++A  
Sbjct: 60  REIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRV----EEMEARR 115
Query: 164 IMT--LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF----------GSPT 211
           +    L  ++Y H H ++HRDLKP N+L++     KI DFGL+             GSP 
Sbjct: 116 LFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPN 175
Query: 212 RLYTHQVVTRWY 223
                 +  R Y
Sbjct: 176 YAAPEVISGRLY 187

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 51/104 (49%), Gaps = 7/104 (6%)
Query: 106 REIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYA 163
           RE ++ + L H N++ L D         LVF+ V      E I+      ++ ++     
Sbjct: 79  REARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE--YYSEADASHCI 136
Query: 164 IMTLRGLEYLHDHWILHRDLKPNNLLIN---KQGVLKIGDFGLA 204
              L  + ++H H I+HRDLKP NLL+    K   +K+ DFGLA
Sbjct: 137 HQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLA 180

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 69/149 (46%), Gaps = 4/149 (2%)
Query: 56  VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH 115
           +Y   + +  G  + VF+  + E   I A+K + L    +      R  +  +  LQ+ H
Sbjct: 29  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ-H 86
Query: 116 HENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
            + ++ L D       + +V E  + DL   +K    +  P   K+Y    L  +  +H 
Sbjct: 87  SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQ 145
Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           H I+H DLKP N LI   G+LK+ DFG+A
Sbjct: 146 HGIVHSDLKPANFLI-VDGMLKLIDFGIA 173

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 65/270 (24%), Positives = 100/270 (37%), Gaps = 55/270 (20%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G  + V  ARD+     VAVK ++     D          RE +    L+H  ++ + D 
Sbjct: 23  GGMSEVHLARDLRLHRDVAVKVLRADLARDPS--FYLRFRREAQNAAALNHPAIVAVYDT 80
Query: 126 FGYMSNVS----LVFEFVDTDLEVIIKDPTIV-----FTPSNIKAYAIMTLRGLEYLHDH 176
               +       +V E+VD    V ++D  IV      TP           + L + H +
Sbjct: 81  GEAETPAGPLPYIVMEYVDG---VTLRD--IVHTEGPMTPKRAIEVIADACQALNFSHQN 135
Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAKFFG-------------------SPTRLYTHQ 217
            I+HRD+KP N++I+    +K+ DFG+A+                      SP +     
Sbjct: 136 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 195
Query: 218 VVTRW--YRLIKCLLYCVQFNVK--------NVQWCCFAKDPSSHGNLFPGIPLNEIFTA 267
           V  R   Y L  C+LY V             +V +    +DP         IP +     
Sbjct: 196 VDARSDVYSL-GCVLYEVLTGEPPFTGDSPVSVAYQHVREDP---------IPPSARHEG 245
Query: 268 AGDDLLAVISSLLCLNPTKRADCTATLKMD 297
              DL AV+   L  NP  R    A ++ D
Sbjct: 246 LSADLDAVVLKALAKNPENRYQTAAEMRAD 275

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 35/133 (26%), Positives = 65/133 (48%), Gaps = 23/133 (17%)
Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG---------YMSNVS 133
           VA+K +K G  +          L+E +++++L HE ++ L  V           YMS  S
Sbjct: 212 VAIKTLKPGNMSP------EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGS 265
Query: 134 LVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ 193
           L+ +F+  ++   ++ P +V   + I +       G+ Y+     +HRDL+  N+L+ + 
Sbjct: 266 LL-DFLKGEMGKYLRLPQLVDMAAQIAS-------GMAYVERMNYVHRDLRAANILVGEN 317
Query: 194 GVLKIGDFGLAKF 206
            V K+ DFGL + 
Sbjct: 318 LVCKVADFGLGRL 330

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 72/163 (44%), Gaps = 12/163 (7%)
Query: 47  DCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALR 106
           D  + +D   Y   + +  G F      RD +++ +VAVK I+ G      + I+    R
Sbjct: 11  DLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG------EKIDENVKR 64
Query: 107 EIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAI 164
           EI   + L H N++   +V    +++++V E+       E I       F+    + +  
Sbjct: 65  EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQ 122
Query: 165 MTLRGLEYLHDHWILHRDLKPNNLLINKQGV--LKIGDFGLAK 205
             + G+ Y H   + HRDLK  N L++      LKI  FG +K
Sbjct: 123 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSK 165

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 69/149 (46%), Gaps = 4/149 (2%)
Query: 56  VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH 115
           +Y   + +  G  + VF+  + E   I A+K + L    +      R  +  +  LQ+ H
Sbjct: 10  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ-H 67
Query: 116 HENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
            + ++ L D       + +V E  + DL   +K    +  P   K+Y    L  +  +H 
Sbjct: 68  SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQ 126
Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           H I+H DLKP N LI   G+LK+ DFG+A
Sbjct: 127 HGIVHSDLKPANFLI-VDGMLKLIDFGIA 154

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 69/149 (46%), Gaps = 4/149 (2%)
Query: 56  VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH 115
           +Y   + +  G  + VF+  + E   I A+K + L    +      R  +  +  LQ+ H
Sbjct: 9   IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ-H 66
Query: 116 HENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
            + ++ L D       + +V E  + DL   +K    +  P   K+Y    L  +  +H 
Sbjct: 67  SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQ 125
Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           H I+H DLKP N LI   G+LK+ DFG+A
Sbjct: 126 HGIVHSDLKPANFLI-VDGMLKLIDFGIA 153

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 69/149 (46%), Gaps = 4/149 (2%)
Query: 56  VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH 115
           +Y   + +  G  + VF+  + E   I A+K + L    +      R  +  +  LQ+ H
Sbjct: 29  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ-H 86
Query: 116 HENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
            + ++ L D       + +V E  + DL   +K    +  P   K+Y    L  +  +H 
Sbjct: 87  SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQ 145
Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           H I+H DLKP N LI   G+LK+ DFG+A
Sbjct: 146 HGIVHSDLKPANFLI-VDGMLKLIDFGIA 173

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 53/103 (51%), Gaps = 2/103 (1%)
Query: 104 ALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT-DLEV-IIKDPTIVFTPSNIKA 161
           AL E ++L++++   V+ L   +     + LV   ++  DL+  I       F  +    
Sbjct: 231 ALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF 290
Query: 162 YAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           YA     GLE LH   I++RDLKP N+L++  G ++I D GLA
Sbjct: 291 YAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA 333

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 65/270 (24%), Positives = 100/270 (37%), Gaps = 55/270 (20%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G  + V  ARD+     VAVK ++     D          RE +    L+H  ++ + D 
Sbjct: 40  GGMSEVHLARDLRLHRDVAVKVLRADLARDPS--FYLRFRREAQNAAALNHPAIVAVYDT 97
Query: 126 FGYMSNVS----LVFEFVDTDLEVIIKDPTIV-----FTPSNIKAYAIMTLRGLEYLHDH 176
               +       +V E+VD    V ++D  IV      TP           + L + H +
Sbjct: 98  GEAETPAGPLPYIVMEYVDG---VTLRD--IVHTEGPMTPKRAIEVIADACQALNFSHQN 152
Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAKFFG-------------------SPTRLYTHQ 217
            I+HRD+KP N++I+    +K+ DFG+A+                      SP +     
Sbjct: 153 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 212
Query: 218 VVTRW--YRLIKCLLYCVQFNVK--------NVQWCCFAKDPSSHGNLFPGIPLNEIFTA 267
           V  R   Y L  C+LY V             +V +    +DP         IP +     
Sbjct: 213 VDARSDVYSL-GCVLYEVLTGEPPFTGDSPVSVAYQHVREDP---------IPPSARHEG 262
Query: 268 AGDDLLAVISSLLCLNPTKRADCTATLKMD 297
              DL AV+   L  NP  R    A ++ D
Sbjct: 263 LSADLDAVVLKALAKNPENRYQTAAEMRAD 292

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/144 (27%), Positives = 59/144 (40%), Gaps = 14/144 (9%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENV------ 119
           G +  VFK R  E   + AVK+  +      KD       R  KL +   HE V      
Sbjct: 68  GSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPKD-------RARKLAEVGSHEKVGQHPCC 119
Query: 120 LGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWIL 179
           + L   +     + L  E     L+   +        + +  Y   TL  L +LH   ++
Sbjct: 120 VRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLV 179
Query: 180 HRDLKPNNLLINKQGVLKIGDFGL 203
           H D+KP N+ +  +G  K+GDFGL
Sbjct: 180 HLDVKPANIFLGPRGRCKLGDFGL 203

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 53/103 (51%), Gaps = 2/103 (1%)
Query: 104 ALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT-DLEV-IIKDPTIVFTPSNIKA 161
           AL E ++L++++   V+ L   +     + LV   ++  DL+  I       F  +    
Sbjct: 231 ALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF 290
Query: 162 YAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           YA     GLE LH   I++RDLKP N+L++  G ++I D GLA
Sbjct: 291 YAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA 333

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/109 (25%), Positives = 56/109 (51%), Gaps = 9/109 (8%)
Query: 107 EIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTD--------LEVIIKDPTIVFTPSN 158
           E++++ ++ +E  L    +      V +++E+++ D          V+ K+ T       
Sbjct: 93  ELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152
Query: 159 IKAYAIMTLRGLEYLHDHW-ILHRDLKPNNLLINKQGVLKIGDFGLAKF 206
           IK      L    Y+H+   I HRD+KP+N+L++K G +K+ DFG +++
Sbjct: 153 IKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEY 201

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/143 (23%), Positives = 74/143 (51%), Gaps = 10/143 (6%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G    V+K R  +T  ++AVK+++   + +     N+  L ++ ++ + H  +   +   
Sbjct: 36  GTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE----NKRILMDLDVVLKSH--DCPYIVQC 89
Query: 126 FGYM---SNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD-HWILHR 181
           FG     ++V +  E + T  E + K          +    +  ++ L YL + H ++HR
Sbjct: 90  FGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHR 149
Query: 182 DLKPNNLLINKQGVLKIGDFGLA 204
           D+KP+N+L++++G +K+ DFG++
Sbjct: 150 DVKPSNILLDERGQIKLCDFGIS 172

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 69/149 (46%), Gaps = 4/149 (2%)
Query: 56  VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH 115
           +Y   + +  G  + VF+  + E   I A+K + L    +      R  +  +  LQ+ H
Sbjct: 57  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ-H 114
Query: 116 HENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
            + ++ L D       + +V E  + DL   +K    +  P   K+Y    L  +  +H 
Sbjct: 115 SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQ 173
Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           H I+H DLKP N LI   G+LK+ DFG+A
Sbjct: 174 HGIVHSDLKPANFLI-VDGMLKLIDFGIA 201

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 69/149 (46%), Gaps = 4/149 (2%)
Query: 56  VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH 115
           +Y   + +  G  + VF+  + E   I A+K + L    +      R  +  +  LQ+ H
Sbjct: 57  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ-H 114
Query: 116 HENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
            + ++ L D       + +V E  + DL   +K    +  P   K+Y    L  +  +H 
Sbjct: 115 SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQ 173
Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           H I+H DLKP N LI   G+LK+ DFG+A
Sbjct: 174 HGIVHSDLKPANFLI-VDGMLKLIDFGIA 201

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 69/149 (46%), Gaps = 4/149 (2%)
Query: 56  VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH 115
           +Y   + +  G  + VF+  + E   I A+K + L    +      R  +  +  LQ+ H
Sbjct: 57  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ-H 114
Query: 116 HENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
            + ++ L D       + +V E  + DL   +K    +  P   K+Y    L  +  +H 
Sbjct: 115 SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQ 173
Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           H I+H DLKP N LI   G+LK+ DFG+A
Sbjct: 174 HGIVHSDLKPANFLI-VDGMLKLIDFGIA 201

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/102 (29%), Positives = 48/102 (47%), Gaps = 2/102 (1%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYA 163
           +RE+  +  L H N++ L  V      + +V E      L   ++     F    +  YA
Sbjct: 69  IREVNAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA 127
Query: 164 IMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           +    G+ YL     +HRDL   NLL+  + ++KIGDFGL +
Sbjct: 128 VQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMR 169

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G++  V++    +  + VAVK +K  T    +       L+E  +++E+ H N++ L  V
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGV 77
Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAY-AIMTLRGLEYLHDHWILHRDL 183
                   ++ EF+   +L   +++       + +  Y A      +EYL     +HRDL
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 137
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW---YRLIKCLLYCVQFNVKNV 240
              N L+ +  ++K+ DFGL++     T  YT     ++   +   + L Y  +F++K+ 
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN-KFSIKSD 194
Query: 241 QWC--CFAKDPSSHG-NLFPGIPLNEIF 265
            W       + +++G + +PGI L++++
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQVY 222

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/102 (29%), Positives = 48/102 (47%), Gaps = 2/102 (1%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYA 163
           +RE+  +  L H N++ L  V      + +V E      L   ++     F    +  YA
Sbjct: 63  IREVNAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA 121
Query: 164 IMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           +    G+ YL     +HRDL   NLL+  + ++KIGDFGL +
Sbjct: 122 VQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMR 163

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/102 (29%), Positives = 48/102 (47%), Gaps = 2/102 (1%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYA 163
           +RE+  +  L H N++ L  V      + +V E      L   ++     F    +  YA
Sbjct: 69  IREVNAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA 127
Query: 164 IMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           +    G+ YL     +HRDL   NLL+  + ++KIGDFGL +
Sbjct: 128 VQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMR 169

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G++  V++    +  + VAVK +K  T    +       L+E  +++E+ H N++ L  V
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGV 77
Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAY-AIMTLRGLEYLHDHWILHRDL 183
                   ++ EF+   +L   +++       + +  Y A      +EYL     +HRDL
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 137
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW---YRLIKCLLYCVQFNVKNV 240
              N L+ +  ++K+ DFGL++     T  YT     ++   +   + L Y  +F++K+ 
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN-KFSIKSD 194
Query: 241 QWC--CFAKDPSSHG-NLFPGIPLNEIF 265
            W       + +++G + +PGI L++++
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQVY 222

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/102 (29%), Positives = 48/102 (47%), Gaps = 2/102 (1%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYA 163
           +RE+  +  L H N++ L  V      + +V E      L   ++     F    +  YA
Sbjct: 63  IREVNAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA 121
Query: 164 IMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           +    G+ YL     +HRDL   NLL+  + ++KIGDFGL +
Sbjct: 122 VQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMR 163

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/102 (29%), Positives = 48/102 (47%), Gaps = 2/102 (1%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYA 163
           +RE+  +  L H N++ L  V      + +V E      L   ++     F    +  YA
Sbjct: 59  IREVNAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA 117
Query: 164 IMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           +    G+ YL     +HRDL   NLL+  + ++KIGDFGL +
Sbjct: 118 VQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMR 159

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/144 (27%), Positives = 67/144 (46%), Gaps = 8/144 (5%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           GRF  V+  R       VA++ I +    D +D + +   RE+   ++  HENV+     
Sbjct: 44  GRFGQVYHGR---WHGEVAIRLIDI--ERDNEDQL-KAFKREVMAYRQTRHENVVLFMGA 97
Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
                +++++        L  +++D  IV   +  +  A   ++G+ YLH   ILH+DLK
Sbjct: 98  CMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLK 157
Query: 185 PNNLLINKQGVLKIGDFGLAKFFG 208
             N+  +  G + I DFGL    G
Sbjct: 158 SKNVFYD-NGKVVITDFGLFSISG 180

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/102 (29%), Positives = 48/102 (47%), Gaps = 2/102 (1%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYA 163
           +RE+  +  L H N++ L  V      + +V E      L   ++     F    +  YA
Sbjct: 59  IREVNAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA 117
Query: 164 IMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           +    G+ YL     +HRDL   NLL+  + ++KIGDFGL +
Sbjct: 118 VQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMR 159

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 69/153 (45%), Gaps = 10/153 (6%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y  +  +  G F+ V +   I T    A K I       A+D  ++   RE ++ + L H
Sbjct: 6   YQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINT-KKLSARD--HQKLEREARICRLLKH 62
Query: 117 ENVLGLTDVFGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH 174
            N++ L D         LVF+ V      E I+      ++ ++        L  + + H
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE--YYSEADASHCIQQILESVNHCH 120
Query: 175 DHWILHRDLKPNNLLI---NKQGVLKIGDFGLA 204
            + I+HRDLKP NLL+   +K   +K+ DFGLA
Sbjct: 121 LNGIVHRDLKPENLLLASKSKGAAVKLADFGLA 153

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 67/147 (45%), Gaps = 9/147 (6%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           + +  G+F  V+          VAVK +K GT +       +  L E  L++ L H+ ++
Sbjct: 18  KKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMS------VQAFLEEANLMKTLQHDKLV 70
Query: 121 GLTDVFGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
            L  V      + ++ EF+     L+ +  D         +  ++     G+ Y+     
Sbjct: 71  RLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY 130
Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAK 205
           +HRDL+  N+L+++  + KI DFGLA+
Sbjct: 131 IHRDLRAANVLVSESLMCKIADFGLAR 157

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/102 (29%), Positives = 48/102 (47%), Gaps = 2/102 (1%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYA 163
           +RE+  +  L H N++ L  V      + +V E      L   ++     F    +  YA
Sbjct: 59  IREVNAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA 117
Query: 164 IMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           +    G+ YL     +HRDL   NLL+  + ++KIGDFGL +
Sbjct: 118 VQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMR 159

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 69/153 (45%), Gaps = 10/153 (6%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y  +  +  G F+ V +   I T    A K I       A+D  ++   RE ++ + L H
Sbjct: 6   YQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINT-KKLSARD--HQKLEREARICRLLKH 62
Query: 117 ENVLGLTDVFGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH 174
            N++ L D         LVF+ V      E I+      ++ ++        L  + + H
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE--YYSEADASHCIQQILESVNHCH 120
Query: 175 DHWILHRDLKPNNLLI---NKQGVLKIGDFGLA 204
            + I+HRDLKP NLL+   +K   +K+ DFGLA
Sbjct: 121 LNGIVHRDLKPENLLLASKSKGAAVKLADFGLA 153

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 58/134 (43%), Gaps = 26/134 (19%)
Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL-----------GLTDVFGYMSN 131
           VAVK IK        D   +  L E  ++ +L H N++           GL  V  YM+ 
Sbjct: 219 VAVKCIK-------NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 271
Query: 132 VSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLIN 191
            SLV         V+  D  + F+        +     +EYL  +  +HRDL   N+L++
Sbjct: 272 GSLVDYLRSRGRSVLGGDCLLKFS--------LDVCEAMEYLEGNNFVHRDLAARNVLVS 323
Query: 192 KQGVLKIGDFGLAK 205
           +  V K+ DFGL K
Sbjct: 324 EDNVAKVSDFGLTK 337

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 82/202 (40%), Gaps = 45/202 (22%)
Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL-----------GLTDVFGYMSN 131
           VAVK IK        D   +  L E  ++ +L H N++           GL  V  YM+ 
Sbjct: 47  VAVKCIK-------NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 99
Query: 132 VSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLIN 191
            SLV         V+  D  + F+    +A        +EYL  +  +HRDL   N+L++
Sbjct: 100 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEA--------MEYLEGNNFVHRDLAARNVLVS 151
Query: 192 KQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWC-------- 243
           +  V K+ DFGL K   S     T ++  +W       L   +F+ K+  W         
Sbjct: 152 EDNVAKVSDFGLTKEASSTQD--TGKLPVKW--TAPEALREKKFSTKSDVWSFGILLWEI 207
Query: 244 -CFAKDPSSHGNLFPGIPLNEI 264
             F + P      +P IPL ++
Sbjct: 208 YSFGRVP------YPRIPLKDV 223

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 60/154 (38%), Gaps = 17/154 (11%)
Query: 67  RFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALR-EIKLLQELHHENVLGLTDV 125
           RF  V+K            + + + T  D  +G  R   R E  L   L H NV+ L  V
Sbjct: 21  RFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGV 80
Query: 126 FGYMSNVSLVFEFVD--------------TDLEVIIKDPTI--VFTPSNIKAYAIMTLRG 169
                 +S++F +                +D+     D T+     P +          G
Sbjct: 81  VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAG 140
Query: 170 LEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGL 203
           +EYL  H ++H+DL   N+L+  +  +KI D GL
Sbjct: 141 MEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGL 174

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 81/202 (40%), Gaps = 45/202 (22%)
Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL-----------GLTDVFGYMSN 131
           VAVK IK        D   +  L E  ++ +L H N++           GL  V  YM+ 
Sbjct: 38  VAVKCIK-------NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 90
Query: 132 VSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLIN 191
            SLV         V+  D  + F+    +A        +EYL  +  +HRDL   N+L++
Sbjct: 91  GSLVDYLRSRGRSVLGGDCLLKFSLDVCEA--------MEYLEGNNFVHRDLAARNVLVS 142
Query: 192 KQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWC-------- 243
           +  V K+ DFGL K   S     T ++  +W       L    F+ K+  W         
Sbjct: 143 EDNVAKVSDFGLTKEASSTQD--TGKLPVKW--TAPEALREAAFSTKSDVWSFGILLWEI 198
Query: 244 -CFAKDPSSHGNLFPGIPLNEI 264
             F + P      +P IPL ++
Sbjct: 199 YSFGRVP------YPRIPLKDV 214

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 60/154 (38%), Gaps = 17/154 (11%)
Query: 67  RFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALR-EIKLLQELHHENVLGLTDV 125
           RF  V+K            + + + T  D  +G  R   R E  L   L H NV+ L  V
Sbjct: 38  RFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGV 97
Query: 126 FGYMSNVSLVFEFVD--------------TDLEVIIKDPTI--VFTPSNIKAYAIMTLRG 169
                 +S++F +                +D+     D T+     P +          G
Sbjct: 98  VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAG 157
Query: 170 LEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGL 203
           +EYL  H ++H+DL   N+L+  +  +KI D GL
Sbjct: 158 MEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGL 191

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G++  V++    +  + VAVK +K  T    +       L+E  +++E+ H N++ L  V
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGV 82
Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAY-AIMTLRGLEYLHDHWILHRDL 183
                   ++ EF+   +L   +++       + +  Y A      +EYL     +HRDL
Sbjct: 83  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 142
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW---YRLIKCLLYCVQFNVKNV 240
              N L+ +  ++K+ DFGL++     T  YT     ++   +   + L Y  +F++K+ 
Sbjct: 143 AARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN-KFSIKSD 199
Query: 241 QWC--CFAKDPSSHG-NLFPGIPLNEIF 265
            W       + +++G + +PGI L++++
Sbjct: 200 VWAFGVLLWEIATYGMSPYPGIDLSQVY 227

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G++  V++    +  + VAVK +K  T    +       L+E  +++E+ H N++ L  V
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGV 77
Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAY-AIMTLRGLEYLHDHWILHRDL 183
                   ++ EF+   +L   +++       + +  Y A      +EYL     +HRDL
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 137
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW---YRLIKCLLYCVQFNVKNV 240
              N L+ +  ++K+ DFGL++     T  YT     ++   +   + L Y  +F++K+ 
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN-KFSIKSD 194
Query: 241 QWC--CFAKDPSSHG-NLFPGIPLNEIF 265
            W       + +++G + +PGI L++++
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQVY 222

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G++  V++    +  + VAVK +K  T    +       L+E  +++E+ H N++ L  V
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGV 82
Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAY-AIMTLRGLEYLHDHWILHRDL 183
                   ++ EF+   +L   +++       + +  Y A      +EYL     +HRDL
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 142
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW---YRLIKCLLYCVQFNVKNV 240
              N L+ +  ++K+ DFGL++     T  YT     ++   +   + L Y  +F++K+ 
Sbjct: 143 AARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN-KFSIKSD 199
Query: 241 QWC--CFAKDPSSHG-NLFPGIPLNEIF 265
            W       + +++G + +PGI L++++
Sbjct: 200 VWAFGVLLWEIATYGMSPYPGIDLSQVY 227

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G++  V++    +  + VAVK +K  T    +       L+E  +++E+ H N++ L  V
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGV 77
Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAY-AIMTLRGLEYLHDHWILHRDL 183
                   ++ EF+   +L   +++       + +  Y A      +EYL     +HRDL
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 137
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW---YRLIKCLLYCVQFNVKNV 240
              N L+ +  ++K+ DFGL++     T  YT     ++   +   + L Y  +F++K+ 
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN-KFSIKSD 194
Query: 241 QWC--CFAKDPSSHG-NLFPGIPLNEIF 265
            W       + +++G + +PGI L++++
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQVY 222

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 75/162 (46%), Gaps = 28/162 (17%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           R +  G FA V++A+D+ +    A+K++        ++  NR  ++E+  +++L      
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRL-----LSNEEEKNRAIIQEVCFMKKLS----- 83
Query: 121 GLTDVFGYMSNVSLVFEFVDTD------LEVIIKDPTIVF----------TPSNIKAYAI 164
           G  ++  + S  S+  E  DT       L  + K   + F          +   +     
Sbjct: 84  GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFY 143
Query: 165 MTLRGLEYLHDHW--ILHRDLKPNNLLINKQGVLKIGDFGLA 204
            T R ++++H     I+HRDLK  NLL++ QG +K+ DFG A
Sbjct: 144 QTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 82/202 (40%), Gaps = 45/202 (22%)
Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL-----------GLTDVFGYMSN 131
           VAVK IK        D   +  L E  ++ +L H N++           GL  V  YM+ 
Sbjct: 32  VAVKCIK-------NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 84
Query: 132 VSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLIN 191
            SLV         V+  D  + F+    +A        +EYL  +  +HRDL   N+L++
Sbjct: 85  GSLVDYLRSRGRSVLGGDCLLKFSLDVCEA--------MEYLEGNNFVHRDLAARNVLVS 136
Query: 192 KQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWC-------- 243
           +  V K+ DFGL K   S     T ++  +W       L   +F+ K+  W         
Sbjct: 137 EDNVAKVSDFGLTKEASSTQD--TGKLPVKW--TAPEALREKKFSTKSDVWSFGILLWEI 192
Query: 244 -CFAKDPSSHGNLFPGIPLNEI 264
             F + P      +P IPL ++
Sbjct: 193 YSFGRVP------YPRIPLKDV 208

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 75/198 (37%), Gaps = 49/198 (24%)
Query: 134 LVFEFVDTDLEVIIKDPTIV-----FTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNL 188
           +V E+VD    V ++D  IV      TP           + L + H + I+HRD+KP N+
Sbjct: 93  IVMEYVDG---VTLRD--IVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANI 147
Query: 189 LINKQGVLKIGDFGLAKFFG-------------------SPTRLYTHQVVTRW--YRLIK 227
           +I+    +K+ DFG+A+                      SP +     V  R   Y L  
Sbjct: 148 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL-G 206
Query: 228 CLLYCVQFNVK--------NVQWCCFAKDPSSHGNLFPGIPLNEIFTAAGDDLLAVISSL 279
           C+LY V             +V +    +DP         IP +        DL AV+   
Sbjct: 207 CVLYEVLTGEPPFTGDSPVSVAYQHVREDP---------IPPSARHEGLSADLDAVVLKA 257
Query: 280 LCLNPTKRADCTATLKMD 297
           L  NP  R    A ++ D
Sbjct: 258 LAKNPENRYQTAAEMRAD 275

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/103 (27%), Positives = 51/103 (49%), Gaps = 2/103 (1%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVF--EFVDTDLEVIIKDPTIVFTPSNIKAY 162
           L E  ++++  H NVL L  +        LV        DL   I++ T   T  ++  +
Sbjct: 71  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 130
Query: 163 AIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
            +   +G++YL     +HRDL   N +++++  +K+ DFGLA+
Sbjct: 131 GLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 173

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/134 (26%), Positives = 64/134 (47%), Gaps = 23/134 (17%)
Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG---------YMSNVS 133
           VA+K +K GT +        + L E +++++L H+ ++ L  V           YM+  S
Sbjct: 36  VAIKTLKPGTMSP------ESFLEEAQIMKKLKHDKLVQLYAVVSEEPIYIVTEYMNKGS 89
Query: 134 LVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ 193
           L+ +F+       +K P +V   + + A       G+ Y+     +HRDL+  N+L+   
Sbjct: 90  LL-DFLKDGEGRALKLPNLVDMAAQVAA-------GMAYIERMNYIHRDLRSANILVGNG 141
Query: 194 GVLKIGDFGLAKFF 207
            + KI DFGLA+  
Sbjct: 142 LICKIADFGLARLI 155

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/155 (23%), Positives = 69/155 (44%), Gaps = 9/155 (5%)
Query: 61  RSVHVGRFATVFKARDIETD---MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHE 117
           R +  G+F  V +   +  +   M VA+K  K  T     D +    L+E   +++  H 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT----SDSVREKFLQEALTMRQFDHP 71
Query: 118 NVLGLTDVFGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH 176
           +++ L  V    + V ++ E     +L   ++        +++  YA      L YL   
Sbjct: 72  HIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK 130
Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT 211
             +HRD+   N+L++    +K+GDFGL+++    T
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 165

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/155 (23%), Positives = 69/155 (44%), Gaps = 9/155 (5%)
Query: 61  RSVHVGRFATVFKARDIETD---MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHE 117
           R +  G+F  V +   +  +   M VA+K  K  T     D +    L+E   +++  H 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT----SDSVREKFLQEALTMRQFDHP 71
Query: 118 NVLGLTDVFGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH 176
           +++ L  V    + V ++ E     +L   ++        +++  YA      L YL   
Sbjct: 72  HIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK 130
Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT 211
             +HRD+   N+L++    +K+GDFGL+++    T
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 165

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 18/40 (45%), Positives = 26/40 (65%)
Query: 164 IMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGL 203
           I     +E+LH   ++HRDLKP+N+      V+K+GDFGL
Sbjct: 171 IQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGL 210

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/103 (27%), Positives = 51/103 (49%), Gaps = 2/103 (1%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVF--EFVDTDLEVIIKDPTIVFTPSNIKAY 162
           L E  ++++  H NVL L  +        LV        DL   I++ T   T  ++  +
Sbjct: 74  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 133
Query: 163 AIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
            +   +G++YL     +HRDL   N +++++  +K+ DFGLA+
Sbjct: 134 GLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/103 (27%), Positives = 51/103 (49%), Gaps = 2/103 (1%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVF--EFVDTDLEVIIKDPTIVFTPSNIKAY 162
           L E  ++++  H NVL L  +        LV        DL   I++ T   T  ++  +
Sbjct: 79  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 138
Query: 163 AIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
            +   +G++YL     +HRDL   N +++++  +K+ DFGLA+
Sbjct: 139 GLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/103 (27%), Positives = 51/103 (49%), Gaps = 2/103 (1%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVF--EFVDTDLEVIIKDPTIVFTPSNIKAY 162
           L E  ++++  H NVL L  +        LV        DL   I++ T   T  ++  +
Sbjct: 77  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 136
Query: 163 AIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
            +   +G++YL     +HRDL   N +++++  +K+ DFGLA+
Sbjct: 137 GLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 179

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/103 (27%), Positives = 51/103 (49%), Gaps = 2/103 (1%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVF--EFVDTDLEVIIKDPTIVFTPSNIKAY 162
           L E  ++++  H NVL L  +        LV        DL   I++ T   T  ++  +
Sbjct: 79  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 138
Query: 163 AIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
            +   +G++YL     +HRDL   N +++++  +K+ DFGLA+
Sbjct: 139 GLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/103 (27%), Positives = 51/103 (49%), Gaps = 2/103 (1%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVF--EFVDTDLEVIIKDPTIVFTPSNIKAY 162
           L E  ++++  H NVL L  +        LV        DL   I++ T   T  ++  +
Sbjct: 78  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 137
Query: 163 AIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
            +   +G++YL     +HRDL   N +++++  +K+ DFGLA+
Sbjct: 138 GLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 180

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/103 (27%), Positives = 51/103 (49%), Gaps = 2/103 (1%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVF--EFVDTDLEVIIKDPTIVFTPSNIKAY 162
           L E  ++++  H NVL L  +        LV        DL   I++ T   T  ++  +
Sbjct: 76  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 135
Query: 163 AIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
            +   +G++YL     +HRDL   N +++++  +K+ DFGLA+
Sbjct: 136 GLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/103 (27%), Positives = 51/103 (49%), Gaps = 2/103 (1%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVF--EFVDTDLEVIIKDPTIVFTPSNIKAY 162
           L E  ++++  H NVL L  +        LV        DL   I++ T   T  ++  +
Sbjct: 98  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 157
Query: 163 AIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
            +   +G++YL     +HRDL   N +++++  +K+ DFGLA+
Sbjct: 158 GLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 200

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/103 (27%), Positives = 51/103 (49%), Gaps = 2/103 (1%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVF--EFVDTDLEVIIKDPTIVFTPSNIKAY 162
           L E  ++++  H NVL L  +        LV        DL   I++ T   T  ++  +
Sbjct: 78  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 137
Query: 163 AIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
            +   +G++YL     +HRDL   N +++++  +K+ DFGLA+
Sbjct: 138 GLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 180

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 65/127 (51%), Gaps = 11/127 (8%)
Query: 83  VAVKKIKLGTHA-DAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT 141
           VAVK +K G+ + DA        L E  L+++L H+ ++ L  V      + ++ E+++ 
Sbjct: 46  VAVKSLKQGSMSPDA-------FLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMEN 97
Query: 142 -DLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIG 199
             L   +K P+ I  T + +   A     G+ ++ +   +HRDL+  N+L++     KI 
Sbjct: 98  GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIA 157
Query: 200 DFGLAKF 206
           DFGLA+ 
Sbjct: 158 DFGLARL 164

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/103 (27%), Positives = 51/103 (49%), Gaps = 2/103 (1%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVF--EFVDTDLEVIIKDPTIVFTPSNIKAY 162
           L E  ++++  H NVL L  +        LV        DL   I++ T   T  ++  +
Sbjct: 97  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 156
Query: 163 AIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
            +   +G++YL     +HRDL   N +++++  +K+ DFGLA+
Sbjct: 157 GLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 199

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G++  V++    +  + VAVK +K  T    +       L+E  +++E+ H N++ L  V
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGV 82
Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAY-AIMTLRGLEYLHDHWILHRDL 183
                   ++ EF+   +L   +++       + +  Y A      +EYL     +HRDL
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 142
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW---YRLIKCLLYCVQFNVKNV 240
              N L+ +  ++K+ DFGL++     T  YT     ++   +   + L Y  +F++K+ 
Sbjct: 143 AARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN-KFSIKSD 199
Query: 241 QWC--CFAKDPSSHG-NLFPGIPLNEIF 265
            W       + +++G + +PGI L++++
Sbjct: 200 VWAFGVLLWEIATYGMSPYPGIDLSQVY 227

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 65/127 (51%), Gaps = 11/127 (8%)
Query: 83  VAVKKIKLGTHA-DAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT 141
           VAVK +K G+ + DA        L E  L+++L H+ ++ L  V      + ++ E+++ 
Sbjct: 35  VAVKSLKQGSMSPDA-------FLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMEN 86
Query: 142 -DLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIG 199
             L   +K P+ I  T + +   A     G+ ++ +   +HRDL+  N+L++     KI 
Sbjct: 87  GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIA 146
Query: 200 DFGLAKF 206
           DFGLA+ 
Sbjct: 147 DFGLARL 153

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/155 (23%), Positives = 69/155 (44%), Gaps = 9/155 (5%)
Query: 61  RSVHVGRFATVFKARDIETD---MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHE 117
           R +  G+F  V +   +  +   M VA+K  K  T     D +    L+E   +++  H 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT----SDSVREKFLQEALTMRQFDHP 71
Query: 118 NVLGLTDVFGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH 176
           +++ L  V    + V ++ E     +L   ++        +++  YA      L YL   
Sbjct: 72  HIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK 130
Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT 211
             +HRD+   N+L++    +K+GDFGL+++    T
Sbjct: 131 RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDST 165

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G++  V++    +  + VAVK +K  T    +       L+E  +++E+ H N++ L  V
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGV 77
Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAY-AIMTLRGLEYLHDHWILHRDL 183
                   ++ EF+   +L   +++       + +  Y A      +EYL     +HRDL
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 137
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW---YRLIKCLLYCVQFNVKNV 240
              N L+ +  ++K+ DFGL++     T  YT     ++   +   + L Y  +F++K+ 
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN-KFSIKSD 194
Query: 241 QWC--CFAKDPSSHG-NLFPGIPLNEIF 265
            W       + +++G + +PGI L++++
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQVY 222

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/128 (28%), Positives = 65/128 (50%), Gaps = 11/128 (8%)
Query: 83  VAVKKIKLGTHA-DAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT 141
           VAVK +K G+ + DA        L E  L+++L H+ ++ L  V      + ++ E+++ 
Sbjct: 40  VAVKSLKQGSMSPDA-------FLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMEN 91
Query: 142 -DLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIG 199
             L   +K P+ I  T + +   A     G+ ++ +   +HRDL+  N+L++     KI 
Sbjct: 92  GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIA 151
Query: 200 DFGLAKFF 207
           DFGLA+  
Sbjct: 152 DFGLARLI 159

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G++  V++    +  + VAVK +K  T    +       L+E  +++E+ H N++ L  V
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGV 82
Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAY-AIMTLRGLEYLHDHWILHRDL 183
                   ++ EF+   +L   +++       + +  Y A      +EYL     +HRDL
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 142
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW---YRLIKCLLYCVQFNVKNV 240
              N L+ +  ++K+ DFGL++     T  YT     ++   +   + L Y  +F++K+ 
Sbjct: 143 AARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN-KFSIKSD 199
Query: 241 QWC--CFAKDPSSHG-NLFPGIPLNEIF 265
            W       + +++G + +PGI L++++
Sbjct: 200 VWAFGVLLWEIATYGMSPYPGIDLSQVY 227

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 65/127 (51%), Gaps = 11/127 (8%)
Query: 83  VAVKKIKLGTHA-DAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT 141
           VAVK +K G+ + DA        L E  L+++L H+ ++ L  V      + ++ E+++ 
Sbjct: 46  VAVKSLKQGSMSPDA-------FLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMEN 97
Query: 142 -DLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIG 199
             L   +K P+ I  T + +   A     G+ ++ +   +HRDL+  N+L++     KI 
Sbjct: 98  GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIA 157
Query: 200 DFGLAKF 206
           DFGLA+ 
Sbjct: 158 DFGLARL 164

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 65/127 (51%), Gaps = 11/127 (8%)
Query: 83  VAVKKIKLGTHA-DAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT 141
           VAVK +K G+ + DA        L E  L+++L H+ ++ L  V      + ++ E+++ 
Sbjct: 45  VAVKSLKQGSMSPDA-------FLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMEN 96
Query: 142 -DLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIG 199
             L   +K P+ I  T + +   A     G+ ++ +   +HRDL+  N+L++     KI 
Sbjct: 97  GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIA 156
Query: 200 DFGLAKF 206
           DFGLA+ 
Sbjct: 157 DFGLARL 163

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 65/127 (51%), Gaps = 11/127 (8%)
Query: 83  VAVKKIKLGTHA-DAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT 141
           VAVK +K G+ + DA        L E  L+++L H+ ++ L  V      + ++ E+++ 
Sbjct: 48  VAVKSLKQGSMSPDA-------FLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMEN 99
Query: 142 -DLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIG 199
             L   +K P+ I  T + +   A     G+ ++ +   +HRDL+  N+L++     KI 
Sbjct: 100 GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIA 159
Query: 200 DFGLAKF 206
           DFGLA+ 
Sbjct: 160 DFGLARL 166

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G++  V++    +  + VAVK +K  T    +       L+E  +++E+ H N++ L  V
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGV 77
Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAY-AIMTLRGLEYLHDHWILHRDL 183
                   ++ EF+   +L   +++       + +  Y A      +EYL     +HRDL
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 137
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW---YRLIKCLLYCVQFNVKNV 240
              N L+ +  ++K+ DFGL++     T  YT     ++   +   + L Y  +F++K+ 
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN-KFSIKSD 194
Query: 241 QWC--CFAKDPSSHG-NLFPGIPLNEIF 265
            W       + +++G + +PGI L++++
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQVY 222

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G++  V++    +  + VAVK +K  T    +       L+E  +++E+ H N++ L  V
Sbjct: 28  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGV 81
Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAY-AIMTLRGLEYLHDHWILHRDL 183
                   ++ EF+   +L   +++       + +  Y A      +EYL     +HRDL
Sbjct: 82  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 141
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW---YRLIKCLLYCVQFNVKNV 240
              N L+ +  ++K+ DFGL++     T  YT     ++   +   + L Y  +F++K+ 
Sbjct: 142 AARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN-KFSIKSD 198
Query: 241 QWC--CFAKDPSSHG-NLFPGIPLNEIF 265
            W       + +++G + +PGI L++++
Sbjct: 199 VWAFGVLLWEIATYGMSPYPGIDLSQVY 226

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G++  V++    +  + VAVK +K  T    +       L+E  +++E+ H N++ L  V
Sbjct: 26  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGV 79
Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAY-AIMTLRGLEYLHDHWILHRDL 183
                   ++ EF+   +L   +++       + +  Y A      +EYL     +HRDL
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 139
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW---YRLIKCLLYCVQFNVKNV 240
              N L+ +  ++K+ DFGL++     T  YT     ++   +   + L Y  +F++K+ 
Sbjct: 140 AARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN-KFSIKSD 196
Query: 241 QWC--CFAKDPSSHG-NLFPGIPLNEIF 265
            W       + +++G + +PGI L++++
Sbjct: 197 VWAFGVLLWEIATYGMSPYPGIDLSQVY 224

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 65/127 (51%), Gaps = 11/127 (8%)
Query: 83  VAVKKIKLGTHA-DAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT 141
           VAVK +K G+ + DA        L E  L+++L H+ ++ L  V      + ++ E+++ 
Sbjct: 40  VAVKSLKQGSMSPDA-------FLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMEN 91
Query: 142 -DLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIG 199
             L   +K P+ I  T + +   A     G+ ++ +   +HRDL+  N+L++     KI 
Sbjct: 92  GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIA 151
Query: 200 DFGLAKF 206
           DFGLA+ 
Sbjct: 152 DFGLARL 158

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 65/127 (51%), Gaps = 11/127 (8%)
Query: 83  VAVKKIKLGTHA-DAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT 141
           VAVK +K G+ + DA        L E  L+++L H+ ++ L  V      + ++ E+++ 
Sbjct: 40  VAVKSLKQGSMSPDA-------FLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMEN 91
Query: 142 -DLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIG 199
             L   +K P+ I  T + +   A     G+ ++ +   +HRDL+  N+L++     KI 
Sbjct: 92  GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIA 151
Query: 200 DFGLAKF 206
           DFGLA+ 
Sbjct: 152 DFGLARL 158

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/125 (25%), Positives = 60/125 (48%), Gaps = 8/125 (6%)
Query: 83  VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTD 142
           VAVK +K GT +       +  L E  L++ L H+ ++ L  V      + ++ E++   
Sbjct: 40  VAVKTLKPGTMS------VQAFLEEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKG 93
Query: 143 --LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGD 200
             L+ +  D         +  ++     G+ Y+     +HRDL+  N+L+++  + KI D
Sbjct: 94  SLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIAD 153
Query: 201 FGLAK 205
           FGLA+
Sbjct: 154 FGLAR 158

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 65/127 (51%), Gaps = 11/127 (8%)
Query: 83  VAVKKIKLGTHA-DAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT 141
           VAVK +K G+ + DA        L E  L+++L H+ ++ L  V      + ++ E+++ 
Sbjct: 40  VAVKSLKQGSMSPDA-------FLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMEN 91
Query: 142 -DLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIG 199
             L   +K P+ I  T + +   A     G+ ++ +   +HRDL+  N+L++     KI 
Sbjct: 92  GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIA 151
Query: 200 DFGLAKF 206
           DFGLA+ 
Sbjct: 152 DFGLARL 158

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 65/127 (51%), Gaps = 11/127 (8%)
Query: 83  VAVKKIKLGTHA-DAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT 141
           VAVK +K G+ + DA        L E  L+++L H+ ++ L  V      + ++ E+++ 
Sbjct: 49  VAVKSLKQGSMSPDA-------FLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMEN 100
Query: 142 -DLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIG 199
             L   +K P+ I  T + +   A     G+ ++ +   +HRDL+  N+L++     KI 
Sbjct: 101 GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIA 160
Query: 200 DFGLAKF 206
           DFGLA+ 
Sbjct: 161 DFGLARL 167

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G++  V++    +  + VAVK +K  T    +       L+E  +++E+ H N++ L  V
Sbjct: 26  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGV 79
Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAY-AIMTLRGLEYLHDHWILHRDL 183
                   ++ EF+   +L   +++       + +  Y A      +EYL     +HRDL
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 139
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW---YRLIKCLLYCVQFNVKNV 240
              N L+ +  ++K+ DFGL++     T  YT     ++   +   + L Y  +F++K+ 
Sbjct: 140 AARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN-KFSIKSD 196
Query: 241 QWC--CFAKDPSSHG-NLFPGIPLNEIF 265
            W       + +++G + +PGI L++++
Sbjct: 197 VWAFGVLLWEIATYGMSPYPGIDLSQVY 224

>pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/83 (32%), Positives = 43/83 (51%), Gaps = 5/83 (6%)
Query: 133 SLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK 192
           ++V E +   LE +       F+   +   AI  +  +EY+H   +++RD+KP N LI +
Sbjct: 81  AMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGR 140
Query: 193 QG-----VLKIGDFGLAKFFGSP 210
            G     V+ I DFGLAK +  P
Sbjct: 141 PGNKTQQVIHIIDFGLAKEYIDP 163

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 65/127 (51%), Gaps = 11/127 (8%)
Query: 83  VAVKKIKLGTHA-DAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT 141
           VAVK +K G+ + DA        L E  L+++L H+ ++ L  V      + ++ E+++ 
Sbjct: 50  VAVKSLKQGSMSPDA-------FLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMEN 101
Query: 142 -DLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIG 199
             L   +K P+ I  T + +   A     G+ ++ +   +HRDL+  N+L++     KI 
Sbjct: 102 GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIA 161
Query: 200 DFGLAKF 206
           DFGLA+ 
Sbjct: 162 DFGLARL 168

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G++  V++    +  + VAVK +K  T    +       L+E  +++E+ H N++ L  V
Sbjct: 37  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGV 90
Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAY-AIMTLRGLEYLHDHWILHRDL 183
                   ++ EF+   +L   +++       + +  Y A      +EYL     +HRDL
Sbjct: 91  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 150
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW---YRLIKCLLYCVQFNVKNV 240
              N L+ +  ++K+ DFGL++     T  YT     ++   +   + L Y  +F++K+ 
Sbjct: 151 AARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN-KFSIKSD 207
Query: 241 QWC--CFAKDPSSHG-NLFPGIPLNEIF 265
            W       + +++G + +PGI L++++
Sbjct: 208 VWAFGVLLWEIATYGMSPYPGIDLSQVY 235

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 65/127 (51%), Gaps = 11/127 (8%)
Query: 83  VAVKKIKLGTHA-DAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT 141
           VAVK +K G+ + DA        L E  L+++L H+ ++ L  V      + ++ E+++ 
Sbjct: 41  VAVKSLKQGSMSPDA-------FLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMEN 92
Query: 142 -DLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIG 199
             L   +K P+ I  T + +   A     G+ ++ +   +HRDL+  N+L++     KI 
Sbjct: 93  GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIA 152
Query: 200 DFGLAKF 206
           DFGLA+ 
Sbjct: 153 DFGLARL 159

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 65/127 (51%), Gaps = 11/127 (8%)
Query: 83  VAVKKIKLGTHA-DAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT 141
           VAVK +K G+ + DA        L E  L+++L H+ ++ L  V      + ++ E+++ 
Sbjct: 42  VAVKSLKQGSMSPDA-------FLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMEN 93
Query: 142 -DLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIG 199
             L   +K P+ I  T + +   A     G+ ++ +   +HRDL+  N+L++     KI 
Sbjct: 94  GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIA 153
Query: 200 DFGLAKF 206
           DFGLA+ 
Sbjct: 154 DFGLARL 160

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 75/149 (50%), Gaps = 13/149 (8%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G  A VF+ R  +T  + A+K     +     D      +RE ++L++L+H+N++ L  +
Sbjct: 20  GATANVFRGRHKKTGDLFAIKVFNNISFLRPVD----VQMREFEVLKKLNHKNIVKLFAI 75
Query: 126 FGYMSNVS--LVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIM--TLRGLEYLHDHWILH 180
               +     L+ EF     L  ++++P+  +     +   ++   + G+ +L ++ I+H
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVH 135
Query: 181 RDLKPNNLLI----NKQGVLKIGDFGLAK 205
           R++KP N++     + Q V K+ DFG A+
Sbjct: 136 RNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/142 (23%), Positives = 63/142 (44%), Gaps = 8/142 (5%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G+F  V K    +    VAVK IK G+ ++ +        +E + + +L H  ++    V
Sbjct: 19  GQFGVV-KLGKWKGQYDVAVKMIKEGSMSEDE------FFQEAQTMMKLSHPKLVKFYGV 71
Query: 126 FGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
                 + +V E++    L   ++       PS +         G+ +L  H  +HRDL 
Sbjct: 72  CSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLA 131
Query: 185 PNNLLINKQGVLKIGDFGLAKF 206
             N L+++   +K+ DFG+ ++
Sbjct: 132 ARNCLVDRDLCVKVSDFGMTRY 153

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 94/208 (45%), Gaps = 17/208 (8%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G++  V+     +  + VAVK +K  T    +       L+E  +++E+ H N++ L  V
Sbjct: 43  GQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGV 96
Query: 126 FGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
                   +V E++     L+ + +      T   +   A      +EYL     +HRDL
Sbjct: 97  CTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKNFIHRDL 156
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW---YRLIKCLLYCVQFNVKNV 240
              N L+ +  V+K+ DFGL++     T  YT     ++   +   + L Y   F++K+ 
Sbjct: 157 AARNCLVGENHVVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNT-FSIKSD 213
Query: 241 QWC--CFAKDPSSHG-NLFPGIPLNEIF 265
            W       + +++G + +PGI L++++
Sbjct: 214 VWAFGVLLWEIATYGMSPYPGIDLSQVY 241

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 75/149 (50%), Gaps = 13/149 (8%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G  A VF+ R  +T  + A+K     +     D      +RE ++L++L+H+N++ L  +
Sbjct: 20  GATANVFRGRHKKTGDLFAIKVFNNISFLRPVD----VQMREFEVLKKLNHKNIVKLFAI 75
Query: 126 FGYMSNVS--LVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIM--TLRGLEYLHDHWILH 180
               +     L+ EF     L  ++++P+  +     +   ++   + G+ +L ++ I+H
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVH 135
Query: 181 RDLKPNNLLI----NKQGVLKIGDFGLAK 205
           R++KP N++     + Q V K+ DFG A+
Sbjct: 136 RNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 25/108 (23%), Positives = 53/108 (49%), Gaps = 1/108 (0%)
Query: 98  DGINRTALREIKLLQELH-HENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTP 156
           + +     RE  +L+++  H +++ L D +   S + LVF+ +            +  + 
Sbjct: 140 EEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSE 199
Query: 157 SNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
              ++     L  + +LH + I+HRDLKP N+L++    +++ DFG +
Sbjct: 200 KETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFS 247

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G++  V++    +  + VAVK +K  T    +       L+E  +++E+ H N++ L  V
Sbjct: 25  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGV 78
Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAY-AIMTLRGLEYLHDHWILHRDL 183
                   ++ EF+   +L   +++       + +  Y A      +EYL     +HRDL
Sbjct: 79  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 138
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW---YRLIKCLLYCVQFNVKNV 240
              N L+ +  ++K+ DFGL++     T  YT     ++   +   + L Y  +F++K+ 
Sbjct: 139 AARNCLVGENHLVKVADFGLSRLMTGDT--YTAPAGAKFPIKWTAPESLAYN-KFSIKSD 195
Query: 241 QWC--CFAKDPSSHG-NLFPGIPLNEIF 265
            W       + +++G + +PGI L++++
Sbjct: 196 VWAFGVLLWEIATYGMSPYPGIDLSQVY 223

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 78/195 (40%), Gaps = 46/195 (23%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGT--HADAKDGINRTALREIKLLQEL 114
           Y+   ++  G +  V  A + +T  I A+K +        + KD + R    E++L+++L
Sbjct: 28  YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKD-VERIKT-EVRLMKKL 85
Query: 115 HHENVLGLTDVFGYMSNVSLVFEFVD-----TDLEVIIKDPT-----------IVFTPSN 158
           HH N+  L +V+     + LV E          L V I D T           I   P  
Sbjct: 86  HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145
Query: 159 IKAYAIMTLRG------------------------LEYLHDHWILHRDLKPNNLLI--NK 192
            +     ++ G                        L YLH+  I HRD+KP N L   NK
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205
Query: 193 QGVLKIGDFGLAKFF 207
              +K+ DFGL+K F
Sbjct: 206 SFEIKLVDFGLSKEF 220

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G++  V++    +  + VAVK +K  T    +       L+E  +++E+ H N++ L  V
Sbjct: 26  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGV 79
Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAY-AIMTLRGLEYLHDHWILHRDL 183
                   ++ EF+   +L   +++       + +  Y A      +EYL     +HRDL
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 139
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW---YRLIKCLLYCVQFNVKNV 240
              N L+ +  ++K+ DFGL++     T  YT     ++   +   + L Y  +F++K+ 
Sbjct: 140 AARNCLVGENHLVKVADFGLSRLMTGDT--YTAPAGAKFPIKWTAPESLAYN-KFSIKSD 196
Query: 241 QWC--CFAKDPSSHG-NLFPGIPLNEIF 265
            W       + +++G + +PGI L++++
Sbjct: 197 VWAFGVLLWEIATYGMSPYPGIDLSQVY 224

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 61/120 (50%), Gaps = 12/120 (10%)
Query: 154 FTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK-FFGSP-- 210
            T  ++  Y+    +G+E+L     +HRDL   N+L++++ V+KI DFGLA+  +  P  
Sbjct: 195 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 254
Query: 211 TRLYTHQVVTRWY--RLIKCLLYCVQFNVKN---VQWCCFAKDPSSHGNLFPGIPLNEIF 265
            R    ++  +W     I   +Y +Q +V +   + W  F+   S     +PG+ ++E F
Sbjct: 255 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP----YPGVKIDEEF 310

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 77/189 (40%), Gaps = 28/189 (14%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           GRF  V+KA+ +     VAVK   L      +D  +  + REI     + HEN+L     
Sbjct: 26  GRFGCVWKAQLMND--FVAVKIFPL------QDKQSWQSEREIFSTPGMKHENLLQFIAA 77
Query: 126 FGYMSNVS----LVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH--W- 177
               SN+     L+  F D   L   +K   I +  + +   A    RGL YLH+   W 
Sbjct: 78  EKRGSNLEVELWLITAFHDKGSLTDYLKGNIITW--NELCHVAETMSRGLSYLHEDVPWC 135
Query: 178 --------ILHRDLKPNNLLINKQGVLKIGDFGLAKFF--GSPTRLYTHQVVTRWYRLIK 227
                   I HRD K  N+L+       + DFGLA  F  G P      QV TR Y   +
Sbjct: 136 RGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPE 195
Query: 228 CLLYCVQFN 236
            L   + F 
Sbjct: 196 VLEGAINFQ 204

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 61/120 (50%), Gaps = 12/120 (10%)
Query: 154 FTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK-FFGSP-- 210
            T  ++  Y+    +G+E+L     +HRDL   N+L++++ V+KI DFGLA+  +  P  
Sbjct: 197 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 256
Query: 211 TRLYTHQVVTRWY--RLIKCLLYCVQFNVKN---VQWCCFAKDPSSHGNLFPGIPLNEIF 265
            R    ++  +W     I   +Y +Q +V +   + W  F+   S     +PG+ ++E F
Sbjct: 257 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP----YPGVKIDEEF 312

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 88/176 (50%), Gaps = 20/176 (11%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHEN------V 119
           G F  V KA D      VA+K IK     + K  +N+  + E++LL+ ++  +      +
Sbjct: 65  GSFGQVVKAYDRVEQEWVAIKIIK-----NKKAFLNQAQI-EVRLLELMNKHDTEMKYYI 118
Query: 120 LGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNI-KAYAIMTLRGLEYLH--DH 176
           + L   F + +++ LVFE +  +L  ++++        N+ + +A      L +L   + 
Sbjct: 119 VHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPEL 178
Query: 177 WILHRDLKPNNLLI--NKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLL 230
            I+H DLKP N+L+   K+  +KI DFG +   G   R+Y   + +R+YR  + LL
Sbjct: 179 SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ--RIY-QXIQSRFYRSPEVLL 231

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 61/120 (50%), Gaps = 12/120 (10%)
Query: 154 FTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK-FFGSP-- 210
            T  ++  Y+    +G+E+L     +HRDL   N+L++++ V+KI DFGLA+  +  P  
Sbjct: 188 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 247
Query: 211 TRLYTHQVVTRWY--RLIKCLLYCVQFNVKN---VQWCCFAKDPSSHGNLFPGIPLNEIF 265
            R    ++  +W     I   +Y +Q +V +   + W  F+   S     +PG+ ++E F
Sbjct: 248 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP----YPGVKIDEEF 303

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 61/120 (50%), Gaps = 12/120 (10%)
Query: 154 FTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK-FFGSP-- 210
            T  ++  Y+    +G+E+L     +HRDL   N+L++++ V+KI DFGLA+  +  P  
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249
Query: 211 TRLYTHQVVTRWY--RLIKCLLYCVQFNVKN---VQWCCFAKDPSSHGNLFPGIPLNEIF 265
            R    ++  +W     I   +Y +Q +V +   + W  F+   S     +PG+ ++E F
Sbjct: 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP----YPGVKIDEEF 305

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 88/176 (50%), Gaps = 20/176 (11%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHEN------V 119
           G F  V KA D      VA+K IK     + K  +N+  + E++LL+ ++  +      +
Sbjct: 46  GSFGQVVKAYDRVEQEWVAIKIIK-----NKKAFLNQAQI-EVRLLELMNKHDTEMKYYI 99
Query: 120 LGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNI-KAYAIMTLRGLEYLH--DH 176
           + L   F + +++ LVFE +  +L  ++++        N+ + +A      L +L   + 
Sbjct: 100 VHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPEL 159
Query: 177 WILHRDLKPNNLLI--NKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLL 230
            I+H DLKP N+L+   K+  +KI DFG +   G   R+Y   + +R+YR  + LL
Sbjct: 160 SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ--RIY-QXIQSRFYRSPEVLL 212

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 20/150 (13%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENV---LGL 122
           G F  V+K      +  VAVKK+        ++ + +   +EIK++ +  HEN+   LG 
Sbjct: 36  GGFGVVYKG--YVNNTTVAVKKLAAMVDITTEE-LKQQFDQEIKVMAKCQHENLVELLGF 92
Query: 123 TD-------VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
           +        V+ YM N SL+       L  +   P + +      A       G+ +LH+
Sbjct: 93  SSDGDDLCLVYVYMPNGSLL-----DRLSCLDGTPPLSWHMRCKIAQG--AANGINFLHE 145
Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           +  +HRD+K  N+L+++    KI DFGLA+
Sbjct: 146 NHHIHRDIKSANILLDEAFTAKISDFGLAR 175

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 36/155 (23%), Positives = 69/155 (44%), Gaps = 9/155 (5%)
Query: 61  RSVHVGRFATVFKARDIETD---MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHE 117
           R +  G+F  V +   +  +   M VA+K  K  T     D +    L+E   +++  H 
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT----SDSVREKFLQEALTMRQFDHP 451
Query: 118 NVLGLTDVFGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH 176
           +++ L  V    + V ++ E     +L   ++        +++  YA      L YL   
Sbjct: 452 HIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK 510
Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT 211
             +HRD+   N+L++    +K+GDFGL+++    T
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 27/103 (26%), Positives = 51/103 (49%), Gaps = 2/103 (1%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVF--EFVDTDLEVIIKDPTIVFTPSNIKAY 162
           L E  ++++  H NVL L  +        LV        DL   I++ T   T  ++  +
Sbjct: 138 LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 197
Query: 163 AIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
            +   +G+++L     +HRDL   N +++++  +K+ DFGLA+
Sbjct: 198 GLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 71/171 (41%), Gaps = 28/171 (16%)
Query: 165 MTLRGLEYLHDHWILHRDLKPNNLLI---NKQGVLK--IGDFGLAKFFG----------- 208
            T  GL +LH   I+HRDLKP+N+LI   N  G +K  I DFGL K              
Sbjct: 126 QTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG 185
Query: 209 --------SPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWCCFAKDPSSHGNLFPGI- 259
                   +P  L         Y +      CV + V +     F K      N+  G  
Sbjct: 186 VPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGAC 245
Query: 260 PLNEIFTAAGDDLLA--VISSLLCLNPTKRADCTATLKMDYF-SLTKEMYW 307
            L+ +     +D++A  +I  ++ ++P KR      LK  +F SL K++ +
Sbjct: 246 SLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQF 296

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 20/150 (13%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENV---LGL 122
           G F  V+K      +  VAVKK+        ++ + +   +EIK++ +  HEN+   LG 
Sbjct: 42  GGFGVVYKG--YVNNTTVAVKKLAAMVDITTEE-LKQQFDQEIKVMAKCQHENLVELLGF 98
Query: 123 TD-------VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
           +        V+ YM N SL+       L  +   P + +      A       G+ +LH+
Sbjct: 99  SSDGDDLCLVYVYMPNGSLL-----DRLSCLDGTPPLSWHMRCKIAQG--AANGINFLHE 151
Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           +  +HRD+K  N+L+++    KI DFGLA+
Sbjct: 152 NHHIHRDIKSANILLDEAFTAKISDFGLAR 181

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 23/58 (39%), Positives = 35/58 (60%), Gaps = 7/58 (12%)
Query: 148 KDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           K+P  VF       YA     GL +LH   I++RDLK +N++++ +G +KI DFG+ K
Sbjct: 118 KEPQAVF-------YAAEISIGLFFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCK 168

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 35/155 (22%), Positives = 69/155 (44%), Gaps = 9/155 (5%)
Query: 61  RSVHVGRFATVFKARDIETD---MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHE 117
           R +  G+F  V +   +  +   + VA+K  K  T     D +    L+E   +++  H 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT----SDSVREKFLQEALTMRQFDHP 71
Query: 118 NVLGLTDVFGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH 176
           +++ L  V    + V ++ E     +L   ++        +++  YA      L YL   
Sbjct: 72  HIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK 130
Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT 211
             +HRD+   N+L++    +K+GDFGL+++    T
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 165

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 20/150 (13%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENV---LGL 122
           G F  V+K      +  VAVKK+        ++ + +   +EIK++ +  HEN+   LG 
Sbjct: 42  GGFGVVYKG--YVNNTTVAVKKLAAMVDITTEE-LKQQFDQEIKVMAKCQHENLVELLGF 98
Query: 123 TD-------VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
           +        V+ YM N SL+       L  +   P + +      A       G+ +LH+
Sbjct: 99  SSDGDDLCLVYVYMPNGSLL-----DRLSCLDGTPPLSWHMRCKIAQG--AANGINFLHE 151
Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           +  +HRD+K  N+L+++    KI DFGLA+
Sbjct: 152 NHHIHRDIKSANILLDEAFTAKISDFGLAR 181

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 68/151 (45%), Gaps = 12/151 (7%)
Query: 63  VHVGR--FATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           + +GR  F TV+K  D ET + VA    +L      K    R    E + L+ L H N++
Sbjct: 32  IEIGRGSFKTVYKGLDTETTVEVAW--CELQDRKLTKSERQRFK-EEAEXLKGLQHPNIV 88
Query: 121 GLTDVFGYMSN----VSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH 176
              D +         + LV E   +           V     ++++    L+GL++LH  
Sbjct: 89  RFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTR 148
Query: 177 W--ILHRDLKPNNLLI-NKQGVLKIGDFGLA 204
              I+HRDLK +N+ I    G +KIGD GLA
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179

>pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 42/83 (50%), Gaps = 5/83 (6%)
Query: 133 SLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK 192
           ++V E +   LE +       FT   +   AI  +  +EY+H   +++RD+KP N L+ +
Sbjct: 76  AMVLELLGPSLEDLFDLCDRTFTLKTVLMIAIQLITRMEYVHTKSLIYRDVKPENFLVGR 135
Query: 193 QG-----VLKIGDFGLAKFFGSP 210
            G      + I DFGLAK +  P
Sbjct: 136 PGTKRQHAIHIIDFGLAKEYIDP 158

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/155 (22%), Positives = 69/155 (44%), Gaps = 9/155 (5%)
Query: 61  RSVHVGRFATVFKARDIETD---MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHE 117
           R +  G+F  V +   +  +   + VA+K  K  T     D +    L+E   +++  H 
Sbjct: 18  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT----SDSVREKFLQEALTMRQFDHP 73
Query: 118 NVLGLTDVFGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH 176
           +++ L  V    + V ++ E     +L   ++        +++  YA      L YL   
Sbjct: 74  HIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK 132
Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT 211
             +HRD+   N+L++    +K+GDFGL+++    T
Sbjct: 133 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 167

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/155 (22%), Positives = 69/155 (44%), Gaps = 9/155 (5%)
Query: 61  RSVHVGRFATVFKARDIETD---MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHE 117
           R +  G+F  V +   +  +   + VA+K  K  T     D +    L+E   +++  H 
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT----SDSVREKFLQEALTMRQFDHP 68
Query: 118 NVLGLTDVFGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH 176
           +++ L  V    + V ++ E     +L   ++        +++  YA      L YL   
Sbjct: 69  HIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK 127
Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT 211
             +HRD+   N+L++    +K+GDFGL+++    T
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/155 (22%), Positives = 69/155 (44%), Gaps = 9/155 (5%)
Query: 61  RSVHVGRFATVFKARDIETD---MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHE 117
           R +  G+F  V +   +  +   + VA+K  K  T     D +    L+E   +++  H 
Sbjct: 44  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT----SDSVREKFLQEALTMRQFDHP 99
Query: 118 NVLGLTDVFGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH 176
           +++ L  V    + V ++ E     +L   ++        +++  YA      L YL   
Sbjct: 100 HIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK 158
Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT 211
             +HRD+   N+L++    +K+GDFGL+++    T
Sbjct: 159 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 193

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/103 (26%), Positives = 51/103 (49%), Gaps = 2/103 (1%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVF--EFVDTDLEVIIKDPTIVFTPSNIKAY 162
           L E  ++++  H NVL L  +        LV        DL   I++ T   T  ++  +
Sbjct: 79  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 138
Query: 163 AIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
            +   +G+++L     +HRDL   N +++++  +K+ DFGLA+
Sbjct: 139 GLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 18/43 (41%), Positives = 29/43 (67%)
Query: 160 KAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG 202
           K Y    +  L+ +H   ++HRD+KP+N+L++K G LK+ DFG
Sbjct: 177 KFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG 219

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/103 (26%), Positives = 51/103 (49%), Gaps = 2/103 (1%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVF--EFVDTDLEVIIKDPTIVFTPSNIKAY 162
           L E  ++++  H NVL L  +        LV        DL   I++ T   T  ++  +
Sbjct: 79  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 138
Query: 163 AIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
            +   +G+++L     +HRDL   N +++++  +K+ DFGLA+
Sbjct: 139 GLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/227 (21%), Positives = 93/227 (40%), Gaps = 34/227 (14%)
Query: 69  ATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY 128
           AT F  +       VAVK +K     +A     R  L E  +L++++H +V+ L      
Sbjct: 42  ATAFHLKGRAGYTTVAVKMLK----ENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97
Query: 129 MSNVSLVFEFVD-TDLEVIIKDPTIV-----------------------FTPSNIKAYAI 164
              + L+ E+     L   +++   V                        T  ++ ++A 
Sbjct: 98  DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAW 157
Query: 165 MTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF---GSPTRLYTHQVVTR 221
              +G++YL +  ++HRDL   N+L+ +   +KI DFGL++      S  +    ++  +
Sbjct: 158 QISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVK 217
Query: 222 WYRLIKCL--LYCVQFNVKNVQWCCFAKDPSSHGNLFPGIPLNEIFT 266
           W  +      +Y  Q +V +       +  +  GN +PGIP   +F 
Sbjct: 218 WMAIESLFDHIYTTQSDVWSFG-VLLWEIVTLGGNPYPGIPPERLFN 263

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/155 (22%), Positives = 69/155 (44%), Gaps = 9/155 (5%)
Query: 61  RSVHVGRFATVFKARDIETD---MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHE 117
           R +  G+F  V +   +  +   + VA+K  K  T     D +    L+E   +++  H 
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT----SDSVREKFLQEALTMRQFDHP 76
Query: 118 NVLGLTDVFGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH 176
           +++ L  V    + V ++ E     +L   ++        +++  YA      L YL   
Sbjct: 77  HIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK 135
Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT 211
             +HRD+   N+L++    +K+GDFGL+++    T
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/227 (21%), Positives = 93/227 (40%), Gaps = 34/227 (14%)
Query: 69  ATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY 128
           AT F  +       VAVK +K     +A     R  L E  +L++++H +V+ L      
Sbjct: 42  ATAFHLKGRAGYTTVAVKMLK----ENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97
Query: 129 MSNVSLVFEFVD-TDLEVIIKDPTIV-----------------------FTPSNIKAYAI 164
              + L+ E+     L   +++   V                        T  ++ ++A 
Sbjct: 98  DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAW 157
Query: 165 MTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF---GSPTRLYTHQVVTR 221
              +G++YL +  ++HRDL   N+L+ +   +KI DFGL++      S  +    ++  +
Sbjct: 158 QISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVK 217
Query: 222 WYRLIKCL--LYCVQFNVKNVQWCCFAKDPSSHGNLFPGIPLNEIFT 266
           W  +      +Y  Q +V +       +  +  GN +PGIP   +F 
Sbjct: 218 WMAIESLFDHIYTTQSDVWSFG-VLLWEIVTLGGNPYPGIPPERLFN 263

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/155 (22%), Positives = 69/155 (44%), Gaps = 9/155 (5%)
Query: 61  RSVHVGRFATVFKARDIETD---MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHE 117
           R +  G+F  V +   +  +   + VA+K  K  T     D +    L+E   +++  H 
Sbjct: 19  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT----SDSVREKFLQEALTMRQFDHP 74
Query: 118 NVLGLTDVFGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH 176
           +++ L  V    + V ++ E     +L   ++        +++  YA      L YL   
Sbjct: 75  HIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK 133
Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT 211
             +HRD+   N+L++    +K+GDFGL+++    T
Sbjct: 134 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 168

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 88/176 (50%), Gaps = 20/176 (11%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHEN------V 119
           G F  V KA D      VA+K IK     + K  +N+  + E++LL+ ++  +      +
Sbjct: 65  GSFGQVVKAYDRVEQEWVAIKIIK-----NKKAFLNQAQI-EVRLLELMNKHDTEMKYYI 118
Query: 120 LGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNI-KAYAIMTLRGLEYLH--DH 176
           + L   F + +++ LVFE +  +L  ++++        N+ + +A      L +L   + 
Sbjct: 119 VHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPEL 178
Query: 177 WILHRDLKPNNLLI--NKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLL 230
            I+H DLKP N+L+   K+  +KI DFG +   G   R+Y   + +R+YR  + LL
Sbjct: 179 SIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQ--RIY-QXIQSRFYRSPEVLL 231

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/103 (26%), Positives = 51/103 (49%), Gaps = 2/103 (1%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVF--EFVDTDLEVIIKDPTIVFTPSNIKAY 162
           L E  ++++  H NVL L  +        LV        DL   I++ T   T  ++  +
Sbjct: 77  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 136
Query: 163 AIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
            +   +G+++L     +HRDL   N +++++  +K+ DFGLA+
Sbjct: 137 GLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 179

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/155 (23%), Positives = 69/155 (44%), Gaps = 9/155 (5%)
Query: 61  RSVHVGRFATVFKARDIETD---MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHE 117
           R +  G+F  V +   +  +   M VA+K  K  T     D +    L+E   +++  H 
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT----SDSVREKFLQEALTMRQFDHP 451
Query: 118 NVLGLTDVFGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH 176
           +++ L  V    + V ++ E     +L   ++        +++  YA      L YL   
Sbjct: 452 HIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK 510
Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT 211
             +HRD+   N+L++    +K+GDFGL+++    T
Sbjct: 511 RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDST 545

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/103 (26%), Positives = 51/103 (49%), Gaps = 2/103 (1%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVF--EFVDTDLEVIIKDPTIVFTPSNIKAY 162
           L E  ++++  H NVL L  +        LV        DL   I++ T   T  ++  +
Sbjct: 80  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 139
Query: 163 AIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
            +   +G+++L     +HRDL   N +++++  +K+ DFGLA+
Sbjct: 140 GLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 182

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/103 (26%), Positives = 51/103 (49%), Gaps = 2/103 (1%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVF--EFVDTDLEVIIKDPTIVFTPSNIKAY 162
           L E  ++++  H NVL L  +        LV        DL   I++ T   T  ++  +
Sbjct: 84  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 143
Query: 163 AIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
            +   +G+++L     +HRDL   N +++++  +K+ DFGLA+
Sbjct: 144 GLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 186

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/103 (26%), Positives = 51/103 (49%), Gaps = 2/103 (1%)
Query: 105 LREIKLLQELHHENVLGLTDVFGYMSNVSLVF--EFVDTDLEVIIKDPTIVFTPSNIKAY 162
           L E  ++++  H NVL L  +        LV        DL   I++ T   T  ++  +
Sbjct: 80  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 139
Query: 163 AIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
            +   +G+++L     +HRDL   N +++++  +K+ DFGLA+
Sbjct: 140 GLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 182

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/148 (24%), Positives = 68/148 (45%), Gaps = 8/148 (5%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G+F  V++    +  + VAVK +K  T    +       L+E  +++E+ H N++ L  V
Sbjct: 22  GQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGV 75
Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAY-AIMTLRGLEYLHDHWILHRDL 183
                   ++ EF+   +L   +++       + +  Y A      +EYL     +HRDL
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 135
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPT 211
              N L+ +  ++K+ DFGL++     T
Sbjct: 136 AARNCLVGENHLVKVADFGLSRLMTGDT 163

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 65/147 (44%), Gaps = 15/147 (10%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V  +    TD + AVK +K        D +  T + +  L        +  L   
Sbjct: 352 GSFGKVMLSERKGTDELYAVKILKKDV-VIQDDDVECTMVEKRVLALPGKPPFLTQLHSC 410
Query: 126 FGYMSNVSLVFEFVDT-DLEVII------KDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
           F  M  +  V E+V+  DL   I      K+P  VF       YA     GL +L    I
Sbjct: 411 FQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF-------YAAEIAIGLFFLQSKGI 463
Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAK 205
           ++RDLK +N++++ +G +KI DFG+ K
Sbjct: 464 IYRDLKLDNVMLDSEGHIKIADFGMCK 490

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 65/148 (43%), Gaps = 18/148 (12%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F+   K    +++   AVK I     A+ +  I    L E        H N++ L +V
Sbjct: 22  GSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCE-------GHPNIVKLHEV 74
Query: 126 FGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAIMT--LRGLEYLHDHWILHR 181
           F    +  LV E ++     E I K        S  +A  IM   +  + ++HD  ++HR
Sbjct: 75  FHDQLHTFLVMELLNGGELFERIKKKKHF----SETEASYIMRKLVSAVSHMHDVGVVHR 130
Query: 182 DLKPNNLLI---NKQGVLKIGDFGLAKF 206
           DLKP NLL    N    +KI DFG A+ 
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARL 158

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 21/40 (52%), Positives = 26/40 (65%), Gaps = 3/40 (7%)
Query: 169 GLEYLHDHWILHRDLKPNNLLI---NKQGVLKIGDFGLAK 205
            +++LH H I HRD+KP NLL     K  VLK+ DFG AK
Sbjct: 140 AIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 21/40 (52%), Positives = 26/40 (65%), Gaps = 3/40 (7%)
Query: 169 GLEYLHDHWILHRDLKPNNLLI---NKQGVLKIGDFGLAK 205
            +++LH H I HRD+KP NLL     K  VLK+ DFG AK
Sbjct: 121 AIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 160

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 67/153 (43%), Gaps = 10/153 (6%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y  +  +  G F+ V +   + T    A K I       A+D  ++   RE ++ + L H
Sbjct: 6   YQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINT-KKLSARD--HQKLEREARICRLLKH 62
Query: 117 ENVLGLTDVFGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH 174
            N++ L D         LVF+ V      E I+      ++ ++        L  + + H
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCH 120
Query: 175 DHWILHRDLKPNNLLIN---KQGVLKIGDFGLA 204
              ++HRDLKP NLL+    K   +K+ DFGLA
Sbjct: 121 QMGVVHRDLKPENLLLASKCKGAAVKLADFGLA 153

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 62/264 (23%), Positives = 100/264 (37%), Gaps = 53/264 (20%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V  +    TD + AVK +K        D +  T + +  L        +  L   
Sbjct: 31  GSFGKVMLSERKGTDELYAVKILKKDV-VIQDDDVECTMVEKRVLALPGKPPFLTQLHSC 89
Query: 126 FGYMSNVSLVFEFVDT-DLEVII------KDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
           F  M  +  V E+V+  DL   I      K+P  VF       YA     GL +L    I
Sbjct: 90  FQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF-------YAAEIAIGLFFLQSKGI 142
Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAK-----------FFGSPTRLYTHQVVTRWYRLIK 227
           ++RDLK +N++++ +G +KI DFG+ K           F G+P  +    +  + Y    
Sbjct: 143 IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYG--- 199
Query: 228 CLLYCVQFNVKNVQWCCFA---KDPSSHGNLFPGIPLNEIFT-----------AAGDDLL 273
                     K+V W  F     +  +    F G   +E+F            +   + +
Sbjct: 200 ----------KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAV 249
Query: 274 AVISSLLCLNPTKRADCTATLKMD 297
           A+   L+  +P KR  C    + D
Sbjct: 250 AICKGLMTKHPGKRLGCGPEGERD 273

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 65/127 (51%), Gaps = 11/127 (8%)
Query: 83  VAVKKIKLGTHA-DAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT 141
           VAVK +K G+ + DA        L E  L+++L H+ ++ L  V      + ++ E+++ 
Sbjct: 36  VAVKSLKQGSMSPDA-------FLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMEN 87
Query: 142 -DLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIG 199
             L   +K P+ I  T + +   A     G+ ++ +   +HR+L+  N+L++     KI 
Sbjct: 88  GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRNLRAANILVSDTLSCKIA 147
Query: 200 DFGLAKF 206
           DFGLA+ 
Sbjct: 148 DFGLARL 154

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 69/157 (43%), Gaps = 10/157 (6%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHAD---AKDGINRTALREIKLLQELHHENVLGL 122
           G F  V+ A D E +  V VK IK     +    +D        EI +L  + H N++ +
Sbjct: 35  GAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKV 94
Query: 123 TDVFGYMSNVSLVFEFVDTDLEV---IIKDPTIVFTPSNIKAYAIMTL-RGLEYLHDHWI 178
            D+F       LV E   + L++   I + P +      + +Y    L   + YL    I
Sbjct: 95  LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRL---DEPLASYIFRQLVSAVGYLRLKDI 151
Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYT 215
           +HRD+K  N++I +   +K+ DFG A +       YT
Sbjct: 152 IHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT 188

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/206 (21%), Positives = 95/206 (46%), Gaps = 13/206 (6%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G++  V++    +  + VAVK +K  T    +       L+E  +++E+ H N++ L  V
Sbjct: 25  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGV 78
Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAY-AIMTLRGLEYLHDHWILHRDL 183
                   ++ EF+   +L   +++       + +  Y A      +EYL     +HRDL
Sbjct: 79  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 138
Query: 184 KPNNLLINKQGVLKIGDFGLAKFF-GSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW 242
              N L+ +  ++K+ DFGL++   G     +        +   + L Y  +F++K+  W
Sbjct: 139 AARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYN-KFSIKSDVW 197
Query: 243 C--CFAKDPSSHG-NLFPGIPLNEIF 265
                  + +++G + +PGI L++++
Sbjct: 198 AFGVLLWEIATYGMSPYPGIDLSQVY 223

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/208 (22%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G++  V++    +  + VAVK +K  T    +       L+E  +++E+ H N++ L  V
Sbjct: 231 GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGV 284
Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAY-AIMTLRGLEYLHDHWILHRDL 183
                   ++ EF+   +L   +++       + +  Y A      +EYL     +HR+L
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNL 344
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW---YRLIKCLLYCVQFNVKNV 240
              N L+ +  ++K+ DFGL++     T  YT     ++   +   + L Y  +F++K+ 
Sbjct: 345 AARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN-KFSIKSD 401
Query: 241 QWC--CFAKDPSSHG-NLFPGIPLNEIF 265
            W       + +++G + +PGI L++++
Sbjct: 402 VWAFGVLLWEIATYGMSPYPGIDLSQVY 429

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/148 (23%), Positives = 68/148 (45%), Gaps = 8/148 (5%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G++  V++    +  + VAVK +K  T    +       L+E  +++E+ H N++ L  V
Sbjct: 22  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGV 75
Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAY-AIMTLRGLEYLHDHWILHRDL 183
                   ++ EF+   +L   +++       + +  Y A      +EYL     +HRDL
Sbjct: 76  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 135
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPT 211
              N L+ +  ++K+ DFGL++     T
Sbjct: 136 AARNCLVGENHLVKVADFGLSRLMTGDT 163

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 50/104 (48%), Gaps = 7/104 (6%)
Query: 106 REIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYA 163
           RE ++ + L H N++ L D      +  L+F+ V      E I+      ++ ++     
Sbjct: 70  REARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE--YYSEADASHCI 127
Query: 164 IMTLRGLEYLHDHWILHRDLKPNNLLIN---KQGVLKIGDFGLA 204
              L  + + H   ++HRDLKP NLL+    K   +K+ DFGLA
Sbjct: 128 QQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLA 171

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/141 (24%), Positives = 62/141 (43%), Gaps = 14/141 (9%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G    V  AR+  +   VAVK + L      K         E+ ++++  H NV+ +   
Sbjct: 56  GSTGIVCLAREKHSGRQVAVKMMDL-----RKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 126 FGYMSNVSLVFEFVD----TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
           +     + ++ EF+     TD+   ++          I       L+ L YLH   ++HR
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIVSQVR-----LNEEQIATVCEAVLQALAYLHAQGVIHR 165
Query: 182 DLKPNNLLINKQGVLKIGDFG 202
           D+K +++L+   G +K+ DFG
Sbjct: 166 DIKSDSILLTLDGRVKLSDFG 186

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/227 (21%), Positives = 93/227 (40%), Gaps = 34/227 (14%)
Query: 69  ATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY 128
           AT F  +       VAVK +K     +A     R  L E  +L++++H +V+ L      
Sbjct: 42  ATAFHLKGRAGYTTVAVKMLK----ENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97
Query: 129 MSNVSLVFEFVD-TDLEVIIKDPTIV-----------------------FTPSNIKAYAI 164
              + L+ E+     L   +++   V                        T  ++ ++A 
Sbjct: 98  DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAW 157
Query: 165 MTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF---GSPTRLYTHQVVTR 221
              +G++YL +  ++HRDL   N+L+ +   +KI DFGL++      S  +    ++  +
Sbjct: 158 QISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVK 217
Query: 222 WYRLIKCL--LYCVQFNVKNVQWCCFAKDPSSHGNLFPGIPLNEIFT 266
           W  +      +Y  Q +V +       +  +  GN +PGIP   +F 
Sbjct: 218 WMAIESLFDHIYTTQSDVWSFG-VLLWEIVTLGGNPYPGIPPERLFN 263

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 71/155 (45%), Gaps = 11/155 (7%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHA-DAKDGINRTALREIKLLQELHH-ENVLGLT 123
           G+FA V +     T    A K +K      D +  I    L EI +L+       V+ L 
Sbjct: 40  GKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEI----LHEIAVLELAKSCPRVINLH 95
Query: 124 DVFGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
           +V+   S + L+ E+        + + +   + + +++       L G+ YLH + I+H 
Sbjct: 96  EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHL 155
Query: 182 DLKPNNLLINK---QGVLKIGDFGLAKFFGSPTRL 213
           DLKP N+L++     G +KI DFG+++  G    L
Sbjct: 156 DLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL 190

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 58/129 (44%), Gaps = 15/129 (11%)
Query: 81  MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVD 140
           MI+  KK+    H   +        RE ++ + L H N++ L D      +  L+F+ V 
Sbjct: 42  MIINTKKLSARDHQKLE--------REARICRLLKHPNIVRLHDSISEEGHHYLIFDLVT 93
Query: 141 TD--LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLIN---KQGV 195
                E I+      ++ ++        L  + + H   ++HR+LKP NLL+    K   
Sbjct: 94  GGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAA 151
Query: 196 LKIGDFGLA 204
           +K+ DFGLA
Sbjct: 152 VKLADFGLA 160

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/206 (21%), Positives = 95/206 (46%), Gaps = 13/206 (6%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G++  V++    +  + VAVK +K  T    +       L+E  +++E+ H N++ L  V
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGV 82
Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAY-AIMTLRGLEYLHDHWILHRDL 183
                   ++ EF+   +L   +++       + +  Y A      +EYL     +HRDL
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 142
Query: 184 KPNNLLINKQGVLKIGDFGLAKFF-GSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW 242
              N L+ +  ++K+ DFGL++   G     +        +   + L Y  +F++K+  W
Sbjct: 143 AARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYN-KFSIKSDVW 201
Query: 243 C--CFAKDPSSHG-NLFPGIPLNEIF 265
                  + +++G + +PGI L++++
Sbjct: 202 AFGVLLWEIATYGMSPYPGIDLSQVY 227

>pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 42/83 (50%), Gaps = 5/83 (6%)
Query: 133 SLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK 192
           ++V E +   LE +       F+   +   AI  +  +EY+H   +++RD+KP N LI +
Sbjct: 81  AMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGR 140
Query: 193 QG-----VLKIGDFGLAKFFGSP 210
            G     V+ I DF LAK +  P
Sbjct: 141 PGNKTQQVIHIIDFALAKEYIDP 163

>pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 42/83 (50%), Gaps = 5/83 (6%)
Query: 133 SLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK 192
           ++V E +   LE +       F+   +   AI  +  +EY+H   +++RD+KP N LI +
Sbjct: 102 AMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGR 161
Query: 193 QG-----VLKIGDFGLAKFFGSP 210
            G     V+ I DF LAK +  P
Sbjct: 162 PGNKTQQVIHIIDFALAKEYIDP 184

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/77 (32%), Positives = 40/77 (51%), Gaps = 4/77 (5%)
Query: 169 GLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW---YRL 225
           G++YL +   +HRDL   N+L+  Q   KI DFGL+K   +    Y  Q   +W   +  
Sbjct: 139 GMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 198
Query: 226 IKCLLYCVQFNVKNVQW 242
            +C+ Y  +F+ K+  W
Sbjct: 199 PECINY-YKFSSKSDVW 214

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/77 (32%), Positives = 40/77 (51%), Gaps = 4/77 (5%)
Query: 169 GLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW---YRL 225
           G++YL +   +HRDL   N+L+  Q   KI DFGL+K   +    Y  Q   +W   +  
Sbjct: 139 GMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 198
Query: 226 IKCLLYCVQFNVKNVQW 242
            +C+ Y  +F+ K+  W
Sbjct: 199 PECINY-YKFSSKSDVW 214

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 79/193 (40%), Gaps = 37/193 (19%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           GRF  V+KA+ +   + V +  I+     D +   N     E+  L  + HEN+L     
Sbjct: 35  GRFGCVWKAQLLNEYVAVKIFPIQ-----DKQSWQNEY---EVYSLPGMKHENILQFIGA 86
Query: 126 FGYMSNVSLVFEFVDTDLEVII----KDPTIVFTPSNIKAY------AIMTLRGLEYLHD 175
               ++V       D DL +I     K     F  +N+ ++      A    RGL YLH+
Sbjct: 87  EKRGTSV-------DVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHE 139
Query: 176 H----------WILHRDLKPNNLLINKQGVLKIGDFGLA-KFFGSPTRLYTH-QVVTRWY 223
                       I HRD+K  N+L+       I DFGLA KF    +   TH QV TR Y
Sbjct: 140 DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRY 199
Query: 224 RLIKCLLYCVQFN 236
              + L   + F 
Sbjct: 200 MAPEVLEGAINFQ 212

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/77 (32%), Positives = 40/77 (51%), Gaps = 4/77 (5%)
Query: 169 GLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW---YRL 225
           G++YL +   +HRDL   N+L+  Q   KI DFGL+K   +    Y  Q   +W   +  
Sbjct: 137 GMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 196
Query: 226 IKCLLYCVQFNVKNVQW 242
            +C+ Y  +F+ K+  W
Sbjct: 197 PECINY-YKFSSKSDVW 212

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 75/178 (42%), Gaps = 18/178 (10%)
Query: 15  KSNCFFGGSNIFASSVWYIRVHSALKKQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKA 74
           + N +F G +          VH + KK  LL      N  LV    R +  G F  V   
Sbjct: 11  RENLYFQGDDEI--------VHFSWKKGMLL-----NNAFLVI---RKMGDGTFGRVLLC 54
Query: 75  RDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL 134
           + I+     AVK ++          I    L++I+     ++  V      F Y  ++ L
Sbjct: 55  QHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIV-KYHGKFMYYDHMCL 113
Query: 135 VFEFVDTDL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLIN 191
           +FE +   L E+I ++    F   +IK Y I  L+ L YL    + H DLKP N+L++
Sbjct: 114 IFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLD 171

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 40/78 (51%), Gaps = 4/78 (5%)
Query: 169 GLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW---YRL 225
           G++YL +   +HRDL   N+L+  Q   KI DFGL+K   +    Y  Q   +W   +  
Sbjct: 481 GMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 540
Query: 226 IKCLLYCVQFNVKNVQWC 243
            +C+ Y  +F+ K+  W 
Sbjct: 541 PECINY-YKFSSKSDVWS 557

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 20/54 (37%), Positives = 29/54 (53%)
Query: 169 GLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW 222
           G++YL +   +HRDL   N+L+  Q   KI DFGL+K   +    Y  Q   +W
Sbjct: 129 GMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 182

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 40/78 (51%), Gaps = 4/78 (5%)
Query: 169 GLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW---YRL 225
           G++YL +   +HRDL   N+L+  Q   KI DFGL+K   +    Y  Q   +W   +  
Sbjct: 482 GMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 541
Query: 226 IKCLLYCVQFNVKNVQWC 243
            +C+ Y  +F+ K+  W 
Sbjct: 542 PECINY-YKFSSKSDVWS 558

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 20/54 (37%), Positives = 29/54 (53%)
Query: 169 GLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW 222
           G++YL +   +HRDL   N+L+  Q   KI DFGL+K   +    Y  Q   +W
Sbjct: 119 GMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 172

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 17/41 (41%), Positives = 27/41 (65%)
Query: 162 YAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG 202
           Y    +  L+ +H    +HRD+KP+N+L++K G LK+ DFG
Sbjct: 173 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG 213

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 17/41 (41%), Positives = 27/41 (65%)
Query: 162 YAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG 202
           Y    +  L+ +H    +HRD+KP+N+L++K G LK+ DFG
Sbjct: 178 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG 218

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/148 (23%), Positives = 68/148 (45%), Gaps = 8/148 (5%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G++  V++    +  + VAVK +K  T    +       L+E  +++E+ H N++ L  V
Sbjct: 22  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGV 75
Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAY-AIMTLRGLEYLHDHWILHRDL 183
                   ++ EF+   +L   +++       + +  Y A      +EYL     +HRDL
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 135
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPT 211
              N L+ +  ++K+ DFGL++     T
Sbjct: 136 AARNCLVGENHLVKVADFGLSRLMTGDT 163

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 17/41 (41%), Positives = 27/41 (65%)
Query: 162 YAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG 202
           Y    +  L+ +H    +HRD+KP+N+L++K G LK+ DFG
Sbjct: 178 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG 218

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 20/54 (37%), Positives = 29/54 (53%)
Query: 169 GLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW 222
           G++YL +   +HRDL   N+L+  Q   KI DFGL+K   +    Y  Q   +W
Sbjct: 123 GMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKW 176

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 20/54 (37%), Positives = 29/54 (53%)
Query: 169 GLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW 222
           G++YL +   +HRDL   N+L+  Q   KI DFGL+K   +    Y  Q   +W
Sbjct: 117 GMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 170

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 20/54 (37%), Positives = 29/54 (53%)
Query: 169 GLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW 222
           G++YL +   +HRDL   N+L+  Q   KI DFGL+K   +    Y  Q   +W
Sbjct: 123 GMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 176

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 46/208 (22%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G++  V++    +  + VAVK +K  T    +       L+E  +++E+ H N++ L  V
Sbjct: 270 GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGV 323
Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAY-AIMTLRGLEYLHDHWILHRDL 183
                   ++ EF+   +L   +++       + +  Y A      +EYL     +HR+L
Sbjct: 324 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRNL 383
Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW---YRLIKCLLYCVQFNVKNV 240
              N L+ +  ++K+ DFGL++     T  YT     ++   +   + L Y  +F++K+ 
Sbjct: 384 AARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN-KFSIKSD 440
Query: 241 QWC--CFAKDPSSHG-NLFPGIPLNEIF 265
            W       + +++G + +PGI L++++
Sbjct: 441 VWAFGVLLWEIATYGMSPYPGIDLSQVY 468

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 87/215 (40%), Gaps = 39/215 (18%)
Query: 17  NCFFGGSNIFAS-------SVWYIRVHSALKKQYLLPDCEVKNDLL-------VYYQWRS 62
           N +F GS   +S       S+       + K Q L P+ E    +L       V Y++R 
Sbjct: 10  NLYFQGSGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYRE 69
Query: 63  -VH---------VGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQ 112
            VH          G F  V + +D +T    AVKK++L              + E+    
Sbjct: 70  EVHWMTHQPRLGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR----------VEELVACA 119
Query: 113 ELHHENVLGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAI-MTLRGL 170
            L    ++ L         V++  E ++   L  +IK   +   P +   Y +   L GL
Sbjct: 120 GLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQ--MGCLPEDRALYYLGQALEGL 177
Query: 171 EYLHDHWILHRDLKPNNLLINKQGV-LKIGDFGLA 204
           EYLH   ILH D+K +N+L++  G    + DFG A
Sbjct: 178 EYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHA 212

>pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 73/163 (44%), Gaps = 19/163 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y   R +  G F  +F+  ++  +  VA+K     + A       R   R  KLL     
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQL----RDEYRTYKLLA---- 63
Query: 117 ENVLGLTDVFGY----MSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEY 172
               G+ +V+ +    + NV LV + +   LE ++      F+   +   A   L  ++ 
Sbjct: 64  -GCTGIPNVYYFGQEGLHNV-LVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 121
Query: 173 LHDHWILHRDLKPNNLLINK-----QGVLKIGDFGLAKFFGSP 210
           +H+  +++RD+KP+N LI +       ++ + DFG+ KF+  P
Sbjct: 122 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 73/180 (40%), Gaps = 29/180 (16%)
Query: 62  SVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQE--LHHENV 119
           S+  GRF  V++ +    ++ V +   +            R+  RE ++ Q   L HEN+
Sbjct: 16  SIGKGRFGEVWRGKWRGEEVAVKIFSSRE----------ERSWFREAEIYQTVMLRHENI 65
Query: 120 LGLTDV----FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH- 174
           LG         G  + + LV ++ +        +   V     IK  A+ T  GL +LH 
Sbjct: 66  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK-LALSTASGLAHLHM 124
Query: 175 -------DHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY----THQVVTRWY 223
                     I HRDLK  N+L+ K G   I D GLA    S T        H+V T+ Y
Sbjct: 125 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 184

>pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 73/163 (44%), Gaps = 19/163 (11%)
Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH 116
           Y   R +  G F  +F+  ++  +  VA+K     + A       R   R  KLL     
Sbjct: 11  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQL----RDEYRTYKLLA---- 62
Query: 117 ENVLGLTDVFGY----MSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEY 172
               G+ +V+ +    + NV LV + +   LE ++      F+   +   A   L  ++ 
Sbjct: 63  -GCTGIPNVYYFGQEGLHNV-LVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 120
Query: 173 LHDHWILHRDLKPNNLLINK-----QGVLKIGDFGLAKFFGSP 210
           +H+  +++RD+KP+N LI +       ++ + DFG+ KF+  P
Sbjct: 121 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 163

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 73/180 (40%), Gaps = 29/180 (16%)
Query: 62  SVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQE--LHHENV 119
           S+  GRF  V++ +    ++ V +   +            R+  RE ++ Q   L HEN+
Sbjct: 11  SIGKGRFGEVWRGKWRGEEVAVKIFSSRE----------ERSWFREAEIYQTVMLRHENI 60
Query: 120 LGLTDV----FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH- 174
           LG         G  + + LV ++ +        +   V     IK  A+ T  GL +LH 
Sbjct: 61  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK-LALSTASGLAHLHM 119
Query: 175 -------DHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY----THQVVTRWY 223
                     I HRDLK  N+L+ K G   I D GLA    S T        H+V T+ Y
Sbjct: 120 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 179

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 77/188 (40%), Gaps = 32/188 (17%)
Query: 37  SALKKQYLLPDCEVKNDLL-------VYYQWRS----------VHVGRFATVFKARDIET 79
            + K Q L P+ E    +L       V Y++R           V  G F  V + +D +T
Sbjct: 23  GSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQT 82
Query: 80  DMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFV 139
               AVKK++L              + E+     L    ++ L         V++  E +
Sbjct: 83  GFQCAVKKVRLEVFR----------VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132
Query: 140 DT-DLEVIIKDPTIVFTPSNIKAYAI-MTLRGLEYLHDHWILHRDLKPNNLLINKQGV-L 196
           +   L  +IK   +   P +   Y +   L GLEYLH   ILH D+K +N+L++  G   
Sbjct: 133 EGGSLGQLIKQ--MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRA 190
Query: 197 KIGDFGLA 204
            + DFG A
Sbjct: 191 ALCDFGHA 198

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 73/180 (40%), Gaps = 29/180 (16%)
Query: 62  SVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQE--LHHENV 119
           S+  GRF  V++ +    ++ V +   +            R+  RE ++ Q   L HEN+
Sbjct: 10  SIGKGRFGEVWRGKWRGEEVAVKIFSSRE----------ERSWFREAEIYQTVMLRHENI 59
Query: 120 LGLTDV----FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH- 174
           LG         G  + + LV ++ +        +   V     IK  A+ T  GL +LH 
Sbjct: 60  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK-LALSTASGLAHLHM 118
Query: 175 -------DHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY----THQVVTRWY 223
                     I HRDLK  N+L+ K G   I D GLA    S T        H+V T+ Y
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 66/143 (46%), Gaps = 6/143 (4%)
Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V+K      +  VAVKK+        ++ + +   +EIK+  +  HEN++ L   
Sbjct: 33  GGFGVVYKG--YVNNTTVAVKKLAAMVDITTEE-LKQQFDQEIKVXAKCQHENLVELLGF 89
Query: 126 FGYMSNVSLVFEFVDTDL---EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
                ++ LV+ +         +   D T   +       A     G+ +LH++  +HRD
Sbjct: 90  SSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHHIHRD 149
Query: 183 LKPNNLLINKQGVLKIGDFGLAK 205
           +K  N+L+++    KI DFGLA+
Sbjct: 150 IKSANILLDEAFTAKISDFGLAR 172

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 73/180 (40%), Gaps = 29/180 (16%)
Query: 62  SVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQE--LHHENV 119
           S+  GRF  V++ +    ++ V +   +            R+  RE ++ Q   L HEN+
Sbjct: 13  SIGKGRFGEVWRGKWRGEEVAVKIFSSRE----------ERSWFREAEIYQTVMLRHENI 62
Query: 120 LGLTDV----FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH- 174
           LG         G  + + LV ++ +        +   V     IK  A+ T  GL +LH 
Sbjct: 63  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK-LALSTASGLAHLHM 121
Query: 175 -------DHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY----THQVVTRWY 223
                     I HRDLK  N+L+ K G   I D GLA    S T        H+V T+ Y
Sbjct: 122 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 181

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 73/180 (40%), Gaps = 29/180 (16%)
Query: 62  SVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQE--LHHENV 119
           S+  GRF  V++ +    ++ V +   +            R+  RE ++ Q   L HEN+
Sbjct: 36  SIGKGRFGEVWRGKWRGEEVAVKIFSSRE----------ERSWFREAEIYQTVMLRHENI 85
Query: 120 LGLTDV----FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH- 174
           LG         G  + + LV ++ +        +   V     IK  A+ T  GL +LH 
Sbjct: 86  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK-LALSTASGLAHLHM 144
Query: 175 -------DHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY----THQVVTRWY 223
                     I HRDLK  N+L+ K G   I D GLA    S T        H+V T+ Y
Sbjct: 145 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 204

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 20/54 (37%), Positives = 33/54 (61%)
Query: 154 FTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF 207
           FT   ++ Y    +  LE+LH   I++RD+K  N+L++  G + + DFGL+K F
Sbjct: 156 FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/112 (24%), Positives = 52/112 (46%), Gaps = 1/112 (0%)
Query: 94  ADAKDGINRTALREIKLLQELH-HENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTI 152
           A+    +    L+E+ +L+++  H N++ L D +   +   LVF+ +            +
Sbjct: 47  AEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV 106
Query: 153 VFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
             +    +      L  +  LH   I+HRDLKP N+L++    +K+ DFG +
Sbjct: 107 TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 158

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 80/188 (42%), Gaps = 32/188 (17%)
Query: 37  SALKKQYLLPDCEVKNDLL-------VYYQWRS-VH-------VGR--FATVFKARDIET 79
            + K Q L P+ E    +L       V Y++R  VH       VGR  F  V + +D +T
Sbjct: 39  GSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQT 98
Query: 80  DMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFV 139
               AVKK++L              + E+     L    ++ L         V++  E +
Sbjct: 99  GFQCAVKKVRLEVFR----------VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 148
Query: 140 DT-DLEVIIKDPTIVFTPSNIKAYAI-MTLRGLEYLHDHWILHRDLKPNNLLINKQGV-L 196
           +   L  +IK   +   P +   Y +   L GLEYLH   ILH D+K +N+L++  G   
Sbjct: 149 EGGSLGQLIKQ--MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRA 206
Query: 197 KIGDFGLA 204
            + DFG A
Sbjct: 207 ALCDFGHA 214

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/109 (26%), Positives = 52/109 (47%), Gaps = 8/109 (7%)
Query: 162 YAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTH---QV 218
           + +   +G+ YL +  ++HRDL   N+L+     +KI DFGLA+      + Y     ++
Sbjct: 122 WCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM 181
Query: 219 VTRWYRLIKCLLYCVQFNVKNVQWC---CFAKDPSSHGNLFPGIPLNEI 264
             +W  L +C+ Y  +F  ++  W       +  +  G  + GIP  EI
Sbjct: 182 PIKWMAL-ECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 228

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 73/180 (40%), Gaps = 29/180 (16%)
Query: 62  SVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQE--LHHENV 119
           S+  GRF  V++ +    ++ V +   +            R+  RE ++ Q   L HEN+
Sbjct: 49  SIGKGRFGEVWRGKWRGEEVAVKIFSSRE----------ERSWFREAEIYQTVMLRHENI 98
Query: 120 LGLTDV----FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH- 174
           LG         G  + + LV ++ +        +   V     IK  A+ T  GL +LH 
Sbjct: 99  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK-LALSTASGLAHLHM 157
Query: 175 -------DHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY----THQVVTRWY 223
                     I HRDLK  N+L+ K G   I D GLA    S T        H+V T+ Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 27/112 (24%), Positives = 52/112 (46%), Gaps = 1/112 (0%)
Query: 94  ADAKDGINRTALREIKLLQELH-HENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTI 152
           A+    +    L+E+ +L+++  H N++ L D +   +   LVF+ +            +
Sbjct: 60  AEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV 119
Query: 153 VFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
             +    +      L  +  LH   I+HRDLKP N+L++    +K+ DFG +
Sbjct: 120 TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 171

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 27/112 (24%), Positives = 52/112 (46%), Gaps = 1/112 (0%)
Query: 94  ADAKDGINRTALREIKLLQELH-HENVLGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTI 152
           A+    +    L+E+ +L+++  H N++ L D +   +   LVF+ +            +
Sbjct: 60  AEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV 119
Query: 153 VFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
             +    +      L  +  LH   I+HRDLKP N+L++    +K+ DFG +
Sbjct: 120 TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 171

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 77/178 (43%), Gaps = 19/178 (10%)
Query: 42  QYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKA---RDIETDMIVAVKKIKLGTHADAKD 98
           Q  L D  +  +LL+    + +  G F +V +    ++  T + VAVK +KL   +  + 
Sbjct: 23  QNKLEDVVIDRNLLIL--GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQRE- 79
Query: 99  GINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL-----VFEFVD-TDLEVIIKDPTI 152
                 L E   +++  H NV+ L  V   MS+  +     +  F+   DL   +    +
Sbjct: 80  --IEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRL 137
Query: 153 VFTPSNIKAYAIMTLR-----GLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
              P +I    ++        G+EYL +   LHRDL   N ++     + + DFGL+K
Sbjct: 138 ETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 83/186 (44%), Gaps = 20/186 (10%)
Query: 61  RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           R +  G F  ++   +I+T+  VA+K   + T        +   L E K+ + L  +   
Sbjct: 13  RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-------HPQLLYESKIYRIL--QGGT 63
Query: 121 GLTDV--FGYMSNVS-LVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHW 177
           G+ +V  FG   + + LV + +   LE +    +   +   +   A   +  +E++H   
Sbjct: 64  GIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
Query: 178 ILHRDLKPNNLLIN---KQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQ 234
            LHRD+KP+N L+    +   + I DFGLAK +   +   THQ +   YR  K L    +
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS---THQHIP--YRENKNLTGTAR 178
Query: 235 FNVKNV 240
           +   N 
Sbjct: 179 YASVNT 184

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 16/43 (37%), Positives = 33/43 (76%), Gaps = 1/43 (2%)
Query: 163 AIMTLRGLEYLHDHW-ILHRDLKPNNLLINKQGVLKIGDFGLA 204
            + T++ L +L ++  I+HRD+KP+N+L+++ G +K+ DFG++
Sbjct: 131 TLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS 173

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 29/109 (26%), Positives = 52/109 (47%), Gaps = 8/109 (7%)
Query: 162 YAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYT---HQV 218
           + +   +G+ YL +  ++HRDL   N+L+     +KI DFGLA+      + Y     ++
Sbjct: 145 WCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM 204
Query: 219 VTRWYRLIKCLLYCVQFNVKNVQWC---CFAKDPSSHGNLFPGIPLNEI 264
             +W  L +C+ Y  +F  ++  W       +  +  G  + GIP  EI
Sbjct: 205 PIKWMAL-ECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 251

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 40.8 bits (94), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 65/146 (44%), Gaps = 24/146 (16%)
Query: 169 GLEYLHDHWILHRDLKPNNLLINKQ---GVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRL 225
            ++YLH   I HRD+KP NLL   +    +LK+ DFG AK   S   L T    T +Y  
Sbjct: 127 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL-TEPCYTPYYVA 185
Query: 226 IKCL------LYCVQFNVKNVQW---CCFAKDPSSHG-NLFPGIPL----------NEIF 265
            + L        C  +++  + +   C +    S+HG  + PG+            N  +
Sbjct: 186 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 245
Query: 266 TAAGDDLLAVISSLLCLNPTKRADCT 291
           +   +++  +I +LL   PT+R   T
Sbjct: 246 SEVSEEVKMLIRNLLKTEPTQRMTIT 271

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	307
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-105
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-93
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	9e-92
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	7e-91
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-90
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-90
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	7e-90
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-88
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-87
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	6e-85
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-84
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-78
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-77
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-65
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-53
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-51
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-48
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-47
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-46
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	5e-46
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	7e-46
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	9e-46
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-45
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-44
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-44
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-44
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	5e-44
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	8e-44
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-43
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-41
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-39
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-39
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-38
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-38
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	8e-38
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	8e-36
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	7e-35
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-31
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-31
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-31
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	9e-31
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-30
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-30
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	7e-30
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-29
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-28
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-28
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-28
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-28
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-28
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-28
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-28
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-28
3bhy_A	283	Death-associated protein kinase 3; death associate	7e-28
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-27
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-27
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-27
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-27
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-27
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-27
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	6e-27
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-27
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	8e-27
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	9e-27
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	9e-27
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	9e-27
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-26
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-26
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-26
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-26
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-26
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-26
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-26
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-26
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-25
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-25
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-25
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-25
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-25
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-25
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-25
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	6e-25
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	6e-25
2dyl_A	318	Dual specificity mitogen-activated protein kinase	7e-25
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	8e-25
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	8e-25
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	9e-25
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-24
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-24
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-24
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-24
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-24
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-24
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-24
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-24
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-24
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-24
3an0_A	340	Dual specificity mitogen-activated protein kinase;	6e-24
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	6e-24
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	6e-24
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	7e-24
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	7e-24
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	8e-24
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-23
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-23
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-23
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-23
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-23
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-23
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-23
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	7e-23
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-22
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-22
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-22
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-22
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-22
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-22
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-21
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-21
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-21
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-21
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-21
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-21
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-21
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-21
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-21
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-21
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-21
3uqc_A	286	Probable conserved transmembrane protein; structur	6e-21
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	8e-21
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-20
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-20
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-20
3ork_A	311	Serine/threonine protein kinase; structural genomi	5e-20
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	6e-20
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	8e-20
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	9e-20
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	9e-20
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-19
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-19
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-19
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-08
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-19
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-19
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	7e-19
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-18
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	4e-18
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-18
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-17
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-17
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-17
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-17
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-17
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	5e-17
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	5e-17
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-16
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	5e-16
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	5e-16
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	6e-16
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	9e-16
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	9e-16
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-15
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-15
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-15
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-15
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-15
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-15
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-15
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-15
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-15
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-15
4aoj_A	329	High affinity nerve growth factor receptor; transf	6e-15
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	8e-15
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	9e-15
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	9e-15
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-14
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-14
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-14
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-14
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-14
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-14
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-14
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-14
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-14
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-14
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-14
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-14
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	6e-14
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-14
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	6e-14
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	8e-14
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	9e-14
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	9e-14
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-13
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-13
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-13
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-13
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-13
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-13
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-13
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-13
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-13
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-13
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-13
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-13
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-13
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-13
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-13
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-13
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-13
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-13
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-13
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-13
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	6e-13
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	7e-13
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	7e-13
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	8e-13
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-12
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-12
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-12
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-12
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-12
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-12
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-12
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-12
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-12
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	5e-12
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	5e-12
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-11
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-11
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-11
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	6e-11
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	7e-11
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	8e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	7e-09
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-07

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  308 bits (792), Expect = e-105
 Identities = 151/285 (52%), Positives = 180/285 (63%), Gaps = 59/285 (20%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G+FATV+KARD  T+ IVA+KKIKLG  ++AKDGINRTALREIKLLQEL H N++GL D 
Sbjct: 21  GQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDA 80

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
           FG+ SN+SLVF+F++TDLEVIIKD ++V TPS+IKAY +MTL+GLEYLH HWILHRDLKP
Sbjct: 81  FGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKP 140

Query: 186 NNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYR----LIKCLLYCVQFNVKNVQ 241
           NNLL+++ GVLK+ DFGLAK FGSP R YTHQVVTRWYR    L    +Y V  ++    
Sbjct: 141 NNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDM---- 196

Query: 242 W---CCFA----KDPSSHGNLFPG------------------------------------ 258
           W   C  A    + P       PG                                    
Sbjct: 197 WAVGCILAELLLRVP-----FLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 251

Query: 259 ---IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
              IPL+ IF+AAGDDLL +I  L   NP  R   T  LKM YFS
Sbjct: 252 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 296

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  278 bits (713), Expect = 1e-93
 Identities = 92/278 (33%), Positives = 132/278 (47%), Gaps = 46/278 (16%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G + TVFKA++ ET  IVA+K+++L    D  +G+  +ALREI LL+EL H+N++ L DV
Sbjct: 13  GTYGTVFKAKNRETHEIVALKRVRLD---DDDEGVPSSALREICLLKELKHKNIVRLHDV 69

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
                 ++LVFEF D DL+           P  +K++    L+GL + H   +LHRDLKP
Sbjct: 70  LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKP 129

Query: 186 NNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW--- 242
            NLLIN+ G LK+ +FGLA+ FG P R Y+ +VVT WYR    L     ++     W   
Sbjct: 130 QNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAG 189

Query: 243 CCFAKDPSSHGNLFPG----------------------------------------IPLN 262
           C FA+  ++   LFPG                                          L 
Sbjct: 190 CIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLV 249

Query: 263 EIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
            +          ++ +LL  NP +R      L+  YFS
Sbjct: 250 NVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  274 bits (704), Expect = 9e-92
 Identities = 87/287 (30%), Positives = 130/287 (45%), Gaps = 65/287 (22%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +ATV+K +   TD +VA+K+I+L    + ++G   TA+RE+ LL++L H N++ L D+
Sbjct: 13  GTYATVYKGKSKLTDNLVALKEIRL----EHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
                +++LVFE++D DL+  + D   +    N+K +    LRGL Y H   +LHRDLKP
Sbjct: 69  IHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKP 128

Query: 186 NNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYR----LIKCLLYCVQFNVKNVQ 241
            NLLIN++G LK+ DFGLA+    PT+ Y ++VVT WYR    L+    Y  Q ++    
Sbjct: 129 QNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDM---- 184

Query: 242 W---CCFA----KDPSSHGNLFPG------------------------------------ 258
           W   C F       P     LFPG                                    
Sbjct: 185 WGVGCIFYEMATGRP-----LFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNY 239

Query: 259 -----IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                  L         D   +++ LL      R      +K  +F 
Sbjct: 240 PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  271 bits (695), Expect = 1e-90
 Identities = 77/279 (27%), Positives = 116/279 (41%), Gaps = 47/279 (16%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  VFK R+ +T  IVA+KK      ++    I + ALREI++L++L H N++ L +V
Sbjct: 14  GSYGVVFKCRNRDTGQIVAIKKFLE---SEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
           F     + LVFE+ D  +   +           +K+    TL+ + + H H  +HRD+KP
Sbjct: 71  FRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKP 130

Query: 186 NNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYR----LIKCLLY---------- 231
            N+LI K  V+K+ DFG A+    P+  Y  +V TRWYR    L+    Y          
Sbjct: 131 ENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIG 190

Query: 232 CV------------------Q----FNV----KNVQWCCFAKDPSSHGNLFP----GIPL 261
           CV                  Q                  F+ +    G   P      PL
Sbjct: 191 CVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPL 250

Query: 262 NEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
              F       L ++   L ++PT+R  C   L   YF 
Sbjct: 251 ELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE 289

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  270 bits (694), Expect = 2e-90
 Identities = 99/287 (34%), Positives = 135/287 (47%), Gaps = 65/287 (22%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KA+D     IVA+K+I+L       +GI  TA+REI LL+ELHH N++ L DV
Sbjct: 32  GTYGVVYKAKD-SQGRIVALKRIRLDA---EDEGIPSTAIREISLLKELHHPNIVSLIDV 87

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
                 ++LVFEF++ DL+ ++ +       S IK Y    LRG+ + H H ILHRDLKP
Sbjct: 88  IHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKP 147

Query: 186 NNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYR----LIKCLLYCVQFNVKNVQ 241
            NLLIN  G LK+ DFGLA+ FG P R YTH+VVT WYR    L+    Y    ++    
Sbjct: 148 QNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDI---- 203

Query: 242 W---CCFA----KDPSSHGNLFPG------------------------------------ 258
           W   C FA      P     LFPG                                    
Sbjct: 204 WSIGCIFAEMITGKP-----LFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTF 258

Query: 259 -----IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                 P + I      + + ++S++LC +P KR      +   YF 
Sbjct: 259 QVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK 305

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  268 bits (688), Expect = 7e-90
 Identities = 89/286 (31%), Positives = 128/286 (44%), Gaps = 64/286 (22%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KA++       A+KKI+L       +GI  T +REI +L+EL H N++ L DV
Sbjct: 13  GTYGVVYKAQN-NYGETFALKKIRLE---KEDEGIPSTTIREISILKELKHSNIVKLYDV 68

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
                 + LVFE +D DL+ ++            K++ +  L G+ Y HD  +LHRDLKP
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKP 128

Query: 186 NNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYR----LIKCLLYCVQFNVKNVQ 241
            NLLIN++G LKI DFGLA+ FG P R YTH++VT WYR    L+    Y    ++    
Sbjct: 129 QNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDI---- 184

Query: 242 W---CCFA----KDPSSHGNLFPG------------------------------------ 258
           W   C FA      P     LFPG                                    
Sbjct: 185 WSVGCIFAEMVNGTP-----LFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239

Query: 259 ----IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
               +P         +  + ++S +L L+P +R      L+  YF 
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  266 bits (683), Expect = 2e-88
 Identities = 77/279 (27%), Positives = 121/279 (43%), Gaps = 47/279 (16%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V K R+ +T  IVA+KK       D    + + A+REIKLL++L HEN++ L +V
Sbjct: 36  GSYGMVMKCRNKDTGRIVAIKKFLES---DDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
                   LVFEFVD  +   ++          ++ Y    + G+ + H H I+HRD+KP
Sbjct: 93  CKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKP 152

Query: 186 NNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYR----LIKCLLY---------- 231
            N+L+++ GV+K+ DFG A+   +P  +Y  +V TRWYR    L+  + Y          
Sbjct: 153 ENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIG 212

Query: 232 CV------------------Q----FNV----KNVQWCCFAKDPSSHGNLFP----GIPL 261
           C+                  Q                  F K+P   G   P      PL
Sbjct: 213 CLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPL 272

Query: 262 NEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
              +    + ++ +    L ++P KR  C   L  D+F 
Sbjct: 273 ERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  262 bits (673), Expect = 3e-87
 Identities = 94/299 (31%), Positives = 136/299 (45%), Gaps = 80/299 (26%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +ATV+K  +  T + VA+K++KL    D+++G   TA+REI L++EL HEN++ L DV
Sbjct: 16  GTYATVYKGLNKTTGVYVALKEVKL----DSEEGTPSTAIREISLMKELKHENIVRLYDV 71

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIV-----FTPSNIKAYAIMTLRGLEYLHDHWILH 180
               + ++LVFEF+D DL+  +   T+         + +K +    L+GL + H++ ILH
Sbjct: 72  IHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILH 131

Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYR----LIKCLLYCVQFN 236
           RDLKP NLLINK+G LK+GDFGLA+ FG P   ++ +VVT WYR    L+    Y    +
Sbjct: 132 RDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSID 191

Query: 237 VKNVQW---CCFA----KDPSSHGNLFPG------------------------------- 258
           +    W   C  A      P     LFPG                               
Sbjct: 192 I----WSCGCILAEMITGKP-----LFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKY 242

Query: 259 ---------IPLNEIFTA--------AGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                      L ++              D L     LL LNP  R      L   +F+
Sbjct: 243 NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFL---HGLLQLNPDMRLSAKQALHHPWFA 298

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  257 bits (659), Expect = 6e-85
 Identities = 90/291 (30%), Positives = 136/291 (46%), Gaps = 68/291 (23%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KA D  T+  VA+K+I+L      ++G+  TA+RE+ LL+EL H N++ L  V
Sbjct: 45  GTYGEVYKAIDTVTNETVAIKRIRLEH---EEEGVPGTAIREVSLLKELQHRNIIELKSV 101

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
             +   + L+FE+ + DL+  + D     +   IK++    + G+ + H    LHRDLKP
Sbjct: 102 IHHNHRLHLIFEYAENDLKKYM-DKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKP 160

Query: 186 NNLLIN-----KQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNV 240
            NLL++     +  VLKIGDFGLA+ FG P R +TH+++T WYR  + LL    ++    
Sbjct: 161 QNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVD 220

Query: 241 QW---CCFA----KDPSSHGNLFPGIP----LNEIF------------------------ 265
            W   C +A    K P     LFPG      L +IF                        
Sbjct: 221 IWSIACIWAEMLMKTP-----LFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSF 275

Query: 266 ----------------TAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                              G DLL   +++L ++P KR      L+  YFS
Sbjct: 276 PKFRGKTLKRVLGALLDDEGLDLL---TAMLEMDPVKRISAKNALEHPYFS 323

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  255 bits (654), Expect = 2e-84
 Identities = 82/292 (28%), Positives = 118/292 (40%), Gaps = 67/292 (22%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH---HENVLGL 122
           G + TV+KARD  +   VA+K +++        G+  + +RE+ LL+ L    H NV+ L
Sbjct: 20  GAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRL 79

Query: 123 TDVF-----GYMSNVSLVFEFVDTDLEVIIKD-PTIVFTPSNIKAYAIMTLRGLEYLHDH 176
            DV           V+LVFE VD DL   +   P        IK      LRGL++LH +
Sbjct: 80  MDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN 139

Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLL---YCV 233
            I+HRDLKP N+L+   G +K+ DFGLA+ +       T  VVT WYR  + LL   Y  
Sbjct: 140 CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LTPVVVTLWYRAPEVLLQSTYAT 198

Query: 234 QFNVKNVQW---CCFA----KDPSSHGNLFPG---------------------------- 258
             ++    W   C FA    + P     LF G                            
Sbjct: 199 PVDM----WSVGCIFAEMFRRKP-----LFCGNSEADQLGKIFDLIGLPPEDDWPRDVSL 249

Query: 259 ----------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                      P+  +     +    ++  +L  NP KR      L+  Y  
Sbjct: 250 PRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH 301

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  240 bits (615), Expect = 3e-78
 Identities = 83/293 (28%), Positives = 123/293 (41%), Gaps = 71/293 (24%)

Query: 66  GRFATVFKARDI-ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH---HENVLG 121
           G +  VFKARD+      VA+K++++ T    ++G+  + +RE+ +L+ L    H NV+ 
Sbjct: 22  GAYGKVFKARDLKNGGRFVALKRVRVQT---GEEGMPLSTIREVAVLRHLETFEHPNVVR 78

Query: 122 LTDVF-----GYMSNVSLVFEFVDTDLEVIIKD-PTIVFTPSNIKAYAIMTLRGLEYLHD 175
           L DV         + ++LVFE VD DL   +   P        IK      LRGL++LH 
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 138

Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLL---YC 232
           H ++HRDLKP N+L+   G +K+ DFGLA+ +       T  VVT WYR  + LL   Y 
Sbjct: 139 HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSVVVTLWYRAPEVLLQSSYA 197

Query: 233 VQFNVKNVQW---CCFA----KDPSSHGNLFPG--------------------------- 258
              ++    W   C FA    + P     LF G                           
Sbjct: 198 TPVDL----WSVGCIFAEMFRRKP-----LFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 248

Query: 259 -----------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                       P+ +  T   +    ++   L  NP KR    + L   YF 
Sbjct: 249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  239 bits (611), Expect = 2e-77
 Identities = 94/301 (31%), Positives = 132/301 (43%), Gaps = 78/301 (25%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  VFKAR  +T   VA+KK+ +    + K+G   TALREIK+LQ L HENV+ L ++
Sbjct: 28  GTFGEVFKARHRKTGQKVALKKVLME---NEKEGFPITALREIKILQLLKHENVVNLIEI 84

Query: 126 F--------GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHW 177
                        ++ LVF+F + DL  ++ +  + FT S IK    M L GL Y+H + 
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK 144

Query: 178 ILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR----LYTHQVVTRWYR----LIKCL 229
           ILHRD+K  N+LI + GVLK+ DFGLA+ F          YT++VVT WYR    L+   
Sbjct: 145 ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGER 204

Query: 230 LYCVQFNVKNVQW---CCFA----KDPSSHGNLFPG---------I-------------- 259
            Y    ++    W   C  A    + P     +  G         I              
Sbjct: 205 DYGPPIDL----WGAGCIMAEMWTRSP-----IMQGNTEQHQLALISQLCGSITPEVWPN 255

Query: 260 ------------------PLNEIFTAAGDDLLAV--ISSLLCLNPTKRADCTATLKMDYF 299
                              + +   A   D  A+  I  LL L+P +R D    L  D+F
Sbjct: 256 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 315

Query: 300 S 300
            
Sbjct: 316 W 316

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  210 bits (535), Expect = 2e-65
 Identities = 64/178 (35%), Positives = 92/178 (51%), Gaps = 26/178 (14%)

Query: 66  GRFATVFKAR--DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLT 123
           G +  V+KA+  D + D   A+K+I+         GI+ +A REI LL+EL H NV+ L 
Sbjct: 32  GTYGHVYKAKRKDGKDDKDYALKQIE-------GTGISMSACREIALLRELKHPNVISLQ 84

Query: 124 DVFGY--MSNVSLVFEFVDTDLEVIIK--------DPTIVFTPSNIKAYAIMTLRGLEYL 173
            VF       V L+F++ + DL  IIK           +      +K+     L G+ YL
Sbjct: 85  KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144

Query: 174 HDHWILHRDLKPNNLLI----NKQGVLKIGDFGLAKFFGSPTRLYTH---QVVTRWYR 224
           H +W+LHRDLKP N+L+     ++G +KI D G A+ F SP +        VVT WYR
Sbjct: 145 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 202

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  178 bits (453), Expect = 4e-53
 Identities = 64/296 (21%), Positives = 106/296 (35%), Gaps = 80/296 (27%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V++A+  ++  +VA+KK+      D +        RE++++++L H N++ L   
Sbjct: 65  GSFGVVYQAKLCDSGELVAIKKVLQ----DKRF-----KNRELQIMRKLDHCNIVRLRYF 115

Query: 126 FGYMSN------VSLVFEFVDTDLEVIIKD---PTIVFTPSNIKAYAIMTLRGLEYLHDH 176
           F           ++LV ++V   +  + +             +K Y     R L Y+H  
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 175

Query: 177 WILHRDLKPNNLLINKQ-GVLKIGDFGLAKFFGSPTRLYTHQVVTRWYR----LIKCLLY 231
            I HRD+KP NLL++    VLK+ DFG AK            + +R+YR    +     Y
Sbjct: 176 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSYICSRYYRAPELIFGATDY 234

Query: 232 CVQFNVKNVQW---CCFA----KDPSSHGNLFPG-------------------------- 258
               +V    W   C  A      P     +FPG                          
Sbjct: 235 TSSIDV----WSAGCVLAELLLGQP-----IFPGDSGVDQLVEIIKVLGTPTREQIREMN 285

Query: 259 -------------IPLNEIFTA-AGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                         P  ++F      + +A+ S LL   PT R          +F 
Sbjct: 286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 341

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  173 bits (441), Expect = 1e-51
 Identities = 72/296 (24%), Positives = 109/296 (36%), Gaps = 81/296 (27%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  VF+A+ +E+D  VA+KK+      D +        RE+++++ + H NV+ L   
Sbjct: 51  GSFGVVFQAKLVESDE-VAIKKVLQ----DKRF-----KNRELQIMRIVKHPNVVDLKAF 100

Query: 126 F------GYMSNVSLVFEFVDTDLEVIIKD---PTIVFTPSNIKAYAIMTLRGLEYLHDH 176
           F           ++LV E+V   +    +             IK Y    LR L Y+H  
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI 160

Query: 177 WILHRDLKPNNLLINKQ-GVLKIGDFGLAKFFGSPTRLYTHQVVTRWYR----LIKCLLY 231
            I HRD+KP NLL++   GVLK+ DFG AK            + +R+YR    +     Y
Sbjct: 161 GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL-IAGEPNVSYICSRYYRAPELIFGATNY 219

Query: 232 CVQFNVKNVQW---CCFA----KDPSSHGNLFPG-------------------------- 258
               ++    W   C  A      P     LFPG                          
Sbjct: 220 TTNIDI----WSTGCVMAELMQGQP-----LFPGESGIDQLVEIIKVLGTPSREQIKTMN 270

Query: 259 -------------IPLNEIFTA-AGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                         P +++F      D + +IS LL   P+ R      L   +F 
Sbjct: 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFD 326

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  164 bits (417), Expect = 1e-48
 Identities = 61/215 (28%), Positives = 106/215 (49%), Gaps = 31/215 (14%)

Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-H 115
           Y   R +  G+++ VF+A +I  +  V VK +K       K    +   REIK+L+ L  
Sbjct: 38  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKK----KI-KREIKILENLRG 89

Query: 116 HENVLGLTDVFGYMS--NVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEY 172
             N++ L D+         +LVFE V+ TD + + +      T  +I+ Y    L+ L+Y
Sbjct: 90  GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDY 145

Query: 173 LHDHWILHRDLKPNNLLIN-KQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLY 231
            H   I+HRD+KP+N++I+ +   L++ D+GLA+ F  P + Y  +V +R+++  + L+ 
Sbjct: 146 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVD 204

Query: 232 CVQFNVKNVQW---CCFA-----KDPSSHGNLFPG 258
              ++     W   C  A     K+P      F G
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEP-----FFHG 234

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  162 bits (412), Expect = 7e-47
 Identities = 59/193 (30%), Positives = 86/193 (44%), Gaps = 40/193 (20%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKL--GTHADAKDGINRTALREIKLLQELHHENVLGLT 123
           G +  V +A D     +VA+KKI        D K       LREI +L  L+H++V+ + 
Sbjct: 64  GSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCK-----RILREIAILNRLNHDHVVKVL 118

Query: 124 DVF-----GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
           D+           + +V E  D+D + + + P +  T  +IK      L G++Y+H   I
Sbjct: 119 DIVIPKDVEKFDELYVVLEIADSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSAGI 177

Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP---------------------------T 211
           LHRDLKP N L+N+   +K+ DFGLA+    P                            
Sbjct: 178 LHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLK 237

Query: 212 RLYTHQVVTRWYR 224
           R  T  VVTRWYR
Sbjct: 238 RQLTGHVVTRWYR 250

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  157 bits (398), Expect = 5e-46
 Identities = 75/296 (25%), Positives = 117/296 (39%), Gaps = 68/296 (22%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G    VF A D + D  VA+KKI L      K       LREIK+++ L H+N++ + ++
Sbjct: 22  GGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVK----HA-LREIKIIRRLDHDNIVKVFEI 76

Query: 126 F--------------GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLE 171
                            +++V +V E+++TDL  +++   +     + + +    LRGL+
Sbjct: 77  LGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPL--LEEHARLFMYQLLRGLK 134

Query: 172 YLHDHWILHRDLKPNNLLINKQG-VLKIGDFGLAKFFGSP---TRLYTHQVVTRWYRLIK 227
           Y+H   +LHRDLKP NL IN +  VLKIGDFGLA+            +  +VT+WYR  +
Sbjct: 135 YIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPR 194

Query: 228 CLLYCVQFNVKNVQW---CCFA-----------KDPSSHGNL------------------ 255
            LL    +      W   C FA                   L                  
Sbjct: 195 LLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLS 254

Query: 256 -----------FPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                       P  PL ++      + +  +  +L  +P  R      L   Y S
Sbjct: 255 VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMS 310

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  157 bits (400), Expect = 5e-46
 Identities = 81/296 (27%), Positives = 117/296 (39%), Gaps = 63/296 (21%)

Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIK--LGTHADAKDGINRTALREIKLLQEL 114
           Y     V  G + +V  A D  +   VA+KK+     +   AK    R   RE+ LL+ +
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK----RA-YRELLLLKHM 80

Query: 115 HHENVLGLTDVF------GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLR 168
            HENV+GL DVF          +  LV  F+ TDL+ I+      F+   I+      L+
Sbjct: 81  QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK---FSEEKIQYLVYQMLK 137

Query: 169 GLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKC 228
           GL+Y+H   ++HRDLKP NL +N+   LKI DFGLA+   +     T  VVTRWYR  + 
Sbjct: 138 GLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM---TGYVVTRWYRAPEV 194

Query: 229 LLYCVQFNVKNVQW---CCFA-----------KDPSSHGNL------------------- 255
           +L  + +N     W   C  A           KD                          
Sbjct: 195 ILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 254

Query: 256 -----------FPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                       P     ++F  A      ++  +L L+  KR      L   +F 
Sbjct: 255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 310

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  157 bits (400), Expect = 7e-46
 Identities = 83/301 (27%), Positives = 116/301 (38%), Gaps = 72/301 (23%)

Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIK--LGTHADAKDGINRTALREIKLLQEL 114
           Y   + V  G +  V  A D  T   VA+KK+     +   AK    R   RE++LL+ +
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK----RA-YRELRLLKHM 81

Query: 115 HHENVLGLTDVF------GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLR 168
            HENV+GL DVF         ++  LV  F+ TDL  ++K          I+      L+
Sbjct: 82  RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK--HEKLGEDRIQFLVYQMLK 139

Query: 169 GLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKC 228
           GL Y+H   I+HRDLKP NL +N+   LKI DFGLA+   S     T  VVTRWYR  + 
Sbjct: 140 GLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM---TGYVVTRWYRAPEV 196

Query: 229 LLYCVQFNVKNVQW---CCFA----KDPSSHGNLFPG----------------------- 258
           +L  +++      W   C  A            LF G                       
Sbjct: 197 ILNWMRYTQTVDIWSVGCIMAEMITGKT-----LFKGSDHLDQLKEIMKVTGTPPAEFVQ 251

Query: 259 -------------------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF 299
                                   I T A    + ++  +L L+  +R      L   YF
Sbjct: 252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311

Query: 300 S 300
            
Sbjct: 312 E 312

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  157 bits (399), Expect = 9e-46
 Identities = 75/291 (25%), Positives = 108/291 (37%), Gaps = 58/291 (19%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGI--NRT----ALREIKLLQELHHENV 119
           G +  V    D E    VA+K++           I  +       LREI+LL   HH N+
Sbjct: 33  GSYGAVCAGVDSEGIP-VAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91

Query: 120 LGLTDVF-----GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH 174
           LGL D+F       M  + LV E + TDL  +I D  IV +P +I+ +    L GL  LH
Sbjct: 92  LGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH 151

Query: 175 DHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQ 234
           +  ++HRDL P N+L+     + I DF LA+   +     TH V  RWYR  + ++    
Sbjct: 152 EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK-THYVTHRWYRAPELVMQFKG 210

Query: 235 FNVKNVQW---CCFA-----------KDPSSHGNL------------------------- 255
           F      W   C  A               +  N                          
Sbjct: 211 FTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYL 270

Query: 256 ------FPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                  P      +   A    L +I+ +L  NP +R      L+  YF 
Sbjct: 271 RNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFE 321

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  155 bits (395), Expect = 4e-45
 Identities = 71/302 (23%), Positives = 113/302 (37%), Gaps = 83/302 (27%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F TV   ++  T M VA+KK+      D +   NR  L+ ++ L  LHH N++ L   
Sbjct: 34  GTFGTVQLGKEKSTGMSVAIKKV----IQDPRFR-NRE-LQIMQDLAVLHHPNIVQLQSY 87

Query: 126 FGYMSNVS-------LVFEFVDTDLEVIIKDPTIV---FTPSNIKAYAIMTLRGLEYLHD 175
           F  +           +V E+V   L    ++         P  IK +    +R +  LH 
Sbjct: 88  FYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL 147

Query: 176 HW--ILHRDLKPNNLLINKQ-GVLKIGDFGLAKFFGSPTRLYTHQVVTRWYR----LIKC 228
               + HRD+KP+N+L+N+  G LK+ DFG AK   SP+      + +R+YR    +   
Sbjct: 148 PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL-SPSEPNVAYICSRYYRAPELIFGN 206

Query: 229 LLYCVQFNVKNVQW---CCFA----KDPSSHGNLFPG----------------------- 258
             Y    ++    W   C FA     +P     +F G                       
Sbjct: 207 QHYTTAVDI----WSVGCIFAEMMLGEP-----IFRGDNSAGQLHEIVRVLGCPSREVLR 257

Query: 259 ----------------IPLNEIFTA----AGDDLLAVISSLLCLNPTKRADCTATLKMDY 298
                           IP + +F+        +   ++S+LL   P +R      L   Y
Sbjct: 258 KLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPY 317

Query: 299 FS 300
           F 
Sbjct: 318 FD 319

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  157 bits (398), Expect = 1e-44
 Identities = 56/176 (31%), Positives = 87/176 (49%), Gaps = 17/176 (9%)

Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIK--LGTHADAKDGINRTALREIKLLQEL 114
           Y   + +  G    V  A D   D  VA+KK+         AK    R   RE+ L++ +
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK----RA-YRELVLMKCV 118

Query: 115 HHENVLGLTDVF------GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLR 168
           +H+N++ L +VF          +V LV E +D +L  +I+          +       L 
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQMLC 175

Query: 169 GLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYR 224
           G+++LH   I+HRDLKP+N+++     LKI DFGLA+  G+   + T  VVTR+YR
Sbjct: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-TPYVVTRYYR 230

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  153 bits (390), Expect = 2e-44
 Identities = 87/303 (28%), Positives = 125/303 (41%), Gaps = 72/303 (23%)

Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHA-DAKDGINRTALREIKLLQELH 115
           Y     +  G +  V  A D    + VA+KKI    H    +    RT LREIK+L    
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ----RT-LREIKILLRFR 83

Query: 116 HENVLGLTDVF-----GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGL 170
           HEN++G+ D+        M +V +V + ++TDL  ++K  T   +  +I  +    LRGL
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGL 141

Query: 171 EYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF---GSPTRLYTHQVVTRWYRLIK 227
           +Y+H   +LHRDLKP+NLL+N    LKI DFGLA+        T   T  V TRWYR  +
Sbjct: 142 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201

Query: 228 CLLYCVQFNVKNVQ-W---CCFA----KDPSSHGNLFPG--------------------- 258
            +L    +  K++  W   C  A      P     +FPG                     
Sbjct: 202 IMLNSKGYT-KSIDIWSVGCILAEMLSNRP-----IFPGKHYLDQLNHILGILGSPSQED 255

Query: 259 ---------------------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMD 297
                                +P N +F  A    L ++  +L  NP KR +    L   
Sbjct: 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315

Query: 298 YFS 300
           Y  
Sbjct: 316 YLE 318

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  153 bits (388), Expect = 4e-44
 Identities = 54/167 (32%), Positives = 85/167 (50%), Gaps = 17/167 (10%)

Query: 66  GRFATVFKARDIETDMIVAVKKIK--LGTHADAKDGINRTALREIKLLQELHHENVLGLT 123
           G    V  A D   +  VA+KK+         AK    R   RE+ L++ ++H+N++GL 
Sbjct: 36  GAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK----RA-YRELVLMKCVNHKNIIGLL 90

Query: 124 DVF------GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHW 177
           +VF          +V +V E +D +L  +I+          +       L G+++LH   
Sbjct: 91  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLHSAG 147

Query: 178 ILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYR 224
           I+HRDLKP+N+++     LKI DFGLA+  G+   + T  VVTR+YR
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-TPYVVTRYYR 193

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  152 bits (387), Expect = 5e-44
 Identities = 77/297 (25%), Positives = 121/297 (40%), Gaps = 70/297 (23%)

Query: 66  GRFATVFKARDIETDMIVAVKKIK-LGTHADAKDGINRTALREIKLLQELHHENVLGLTD 124
           G +  V  A    T  IVA+KKI+       A     RT LREIK+L+   HEN++ + +
Sbjct: 22  GAYGVVCSATHKPTGEIVAIKKIEPFDKPLFAL----RT-LREIKILKHFKHENIITIFN 76

Query: 125 VF-----GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWIL 179
           +         + V ++ E + TDL  +I   T + +  +I+ +   TLR ++ LH   ++
Sbjct: 77  IQRPDSFENFNEVYIIQELMQTDLHRVIS--TQMLSDDHIQYFIYQTLRAVKVLHGSNVI 134

Query: 180 HRDLKPNNLLINKQGVLKIGDFGLA----------KFFGSPTRLYTHQVVTRWYRLIKCL 229
           HRDLKP+NLLIN    LK+ DFGLA                       V TRWYR  + +
Sbjct: 135 HRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVM 194

Query: 230 LYCVQFNVKNVQ-W---CCFA-----------KD--------------PSSHGNL----- 255
           L   +++ + +  W   C  A           +D              P S  +L     
Sbjct: 195 LTSAKYS-RAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIES 253

Query: 256 ------------FPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                       +P  PL ++F       + ++  +L  +P KR      L+  Y  
Sbjct: 254 PRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQ 310

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  152 bits (387), Expect = 8e-44
 Identities = 61/328 (18%), Positives = 103/328 (31%), Gaps = 112/328 (34%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V +  DIE+    A+KK+      D      R   RE+ +++ L H N++ L D 
Sbjct: 18  GSFGIVCEVFDIESGKRFALKKVLQ----DP-----RYKNRELDIMKVLDHVNIIKLVDY 68

Query: 126 FGYMSN--------------------------------------VSLVFEFVDTDLEVII 147
           F    +                                      ++++ E+V   L  ++
Sbjct: 69  FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128

Query: 148 KDPTI---VFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ-GVLKIGDFGL 203
           K           + I  Y     R + ++H   I HRD+KP NLL+N +   LK+ DFG 
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGS 188

Query: 204 AKFFGSPTRLYTHQVVTRWYR----LIKCLLYCVQFNVKNVQW---CCFA----KDPSSH 252
           AK    P+      + +R+YR    ++    Y    ++    W   C F       P   
Sbjct: 189 AKKL-IPSEPSVAYICSRFYRAPELMLGATEYTPSIDL----WSIGCVFGELILGKP--- 240

Query: 253 GNLFPG---------------------------------------IPLNEIFTAAGD-DL 272
             LF G                                           +I         
Sbjct: 241 --LFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLA 298

Query: 273 LAVISSLLCLNPTKRADCTATLKMDYFS 300
           + ++  +L   P  R +    +   +F 
Sbjct: 299 IDLLEQILRYEPDLRINPYEAMAHPFFD 326

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  151 bits (384), Expect = 2e-43
 Identities = 85/296 (28%), Positives = 122/296 (41%), Gaps = 62/296 (20%)

Query: 57  YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKL--GTHADAKDGINRTALREIKLLQEL 114
           Y     V  G + +V  A D +T + VAVKK+     +   AK    RT  RE++LL+ +
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RT-YRELRLLKHM 85

Query: 115 HHENVLGLTDVF------GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLR 168
            HENV+GL DVF         ++V LV   +  DL  I+K      T  +++      LR
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 143

Query: 169 GLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKC 228
           GL+Y+H   I+HRDLKP+NL +N+   LKI DFGLA+         T  V TRWYR  + 
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGYVATRWYRAPEI 200

Query: 229 LLYCVQFNVKNVQW---CCFA-----------KDPSSHGNL------------------- 255
           +L  + +N     W   C  A            D      L                   
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260

Query: 256 -----------FPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                       P +    +F  A    + ++  +L L+  KR      L   YF+
Sbjct: 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 316

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  147 bits (373), Expect = 2e-41
 Identities = 59/188 (31%), Positives = 84/188 (44%), Gaps = 35/188 (18%)

Query: 66  GRFATVFKARDIETDMIVAVKKIK--LGTHADAKDGINRTALREIKLLQELHHENVLGLT 123
           G +  V+ A D  T+  VA+KK+        D K    R  LREI +L  L  + ++ L 
Sbjct: 37  GSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCK----RI-LREITILNRLKSDYIIRLY 91

Query: 124 DVF-----GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
           D+           + +V E  D+DL+ + K P I  T  +IK      L G  ++H+  I
Sbjct: 92  DLIIPDDLLKFDELYIVLEIADSDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHESGI 150

Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY----------------------TH 216
           +HRDLKP N L+N+   +K+ DFGLA+   S                           T 
Sbjct: 151 IHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTS 210

Query: 217 QVVTRWYR 224
            VVTRWYR
Sbjct: 211 HVVTRWYR 218

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  140 bits (354), Expect = 1e-39
 Identities = 54/254 (21%), Positives = 87/254 (34%), Gaps = 33/254 (12%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTD 124
           G +  VFK R  E   + AVK+         KD      L E+   +++  H   + L  
Sbjct: 68  GSYGEVFKVRSKEDGRLYAVKRSMS-PFRGPKDRAR--KLAEVGSHEKVGQHPCCVRLEQ 124

Query: 125 VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
            +     + L  E     L+   +        + +  Y   TL  L +LH   ++H D+K
Sbjct: 125 AWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVK 184

Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWY---RLIK-------------C 228
           P N+ +  +G  K+GDFGL    G+       Q     Y    L++              
Sbjct: 185 PANIFLGPRGRCKLGDFGLLVELGTAGAGEV-QEGDPRYMAPELLQGSYGTAADVFSLGL 243

Query: 229 LLYCVQFNVKNVQWCCFAKDPS---SHGNLFPGIPLNEIFTAAGDDLLAVISSLLCLNPT 285
            +  V          C  + P        L  G    E       +L +V+  +L  +P 
Sbjct: 244 TILEV---------ACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPK 294

Query: 286 KRADCTATLKMDYF 299
            RA   A L +   
Sbjct: 295 LRATAEALLALPVL 308

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  141 bits (358), Expect = 1e-39
 Identities = 61/185 (32%), Positives = 96/185 (51%), Gaps = 33/185 (17%)

Query: 66  GRFATVFKARDIETDMIVAVKKIK--LGTHADAKDGINRTALREIKLLQELH-HENVLGL 122
           G +  V+K+ D  T  +VAVKKI        DA+    RT  REI +L EL  HEN++ L
Sbjct: 20  GAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ----RT-FREIMILTELSGHENIVNL 74

Query: 123 TDVF--GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
            +V       +V LVF++++TDL  +I+    +  P + +      ++ ++YLH   +LH
Sbjct: 75  LNVLRADNDRDVYLVFDYMETDLHAVIR--ANILEPVHKQYVVYQLIKVIKYLHSGGLLH 132

Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY---------------------THQVV 219
           RD+KP+N+L+N +  +K+ DFGL++ F +  R+                      T  V 
Sbjct: 133 RDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVA 192

Query: 220 TRWYR 224
           TRWYR
Sbjct: 193 TRWYR 197

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  137 bits (347), Expect = 1e-38
 Identities = 69/263 (26%), Positives = 118/263 (44%), Gaps = 46/263 (17%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G+F+ V++A  +   + VA+KK+++    DAK       ++EI LL++L+H NV+     
Sbjct: 43  GQFSEVYRAACLLDGVPVALKKVQIFDLMDAKA--RADCIKEIDLLKQLNHPNVIKYYAS 100

Query: 126 FGYMSNVSLVFEFVDT-DLEVIIKD---PTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
           F   + +++V E  D  DL  +IK       +     +  Y +     LE++H   ++HR
Sbjct: 101 FIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHR 160

Query: 182 DLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWY---RLIK----------- 227
           D+KP N+ I   GV+K+GD GL +FF S T      V T +Y     I            
Sbjct: 161 DIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIW 220

Query: 228 ---CLLYCVQFNVKNVQWCC----FAKDPSSHGNLFPGI------PL-NEIFTAAGDDLL 273
              CLLY         +       F  D  +  +L   I      PL ++ ++   ++L 
Sbjct: 221 SLGCLLY---------EMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS---EELR 268

Query: 274 AVISSLLCLNPTKRADCTATLKM 296
            +++  +  +P KR D T    +
Sbjct: 269 QLVNMCINPDPEKRPDVTYVYDV 291

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  135 bits (343), Expect = 3e-38
 Identities = 51/272 (18%), Positives = 87/272 (31%), Gaps = 60/272 (22%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  VFKA+         +K++K           N  A RE+K L +L H N++     
Sbjct: 22  GGFGQVFKAKHRIDGKTYVIKRVKYN---------NEKAEREVKALAKLDHVNIVHYNGC 72

Query: 126 F----------------GYMSNVSLVFEFVDT-DLEVIIKD-PTIVFTPSNIKAYAIMTL 167
           +                     + +  EF D   LE  I+                    
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132

Query: 168 RGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYR--- 224
           +G++Y+H   +++RDLKP+N+ +     +KIGDFGL     +  +       T  Y    
Sbjct: 133 KGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR-SKGTLRYMSPE 191

Query: 225 LIK--------------CLLYCVQFNVKNVQWCCFAKDPSSHGNLFPGI---PLNEIFTA 267
            I                +L          +              F  +    +++IF  
Sbjct: 192 QISSQDYGKEVDLYALGLILA---------ELLHVCDTAFETSKFFTDLRDGIISDIFD- 241

Query: 268 AGDDLLAVISSLLCLNPTKRADCTATLKMDYF 299
                  ++  LL   P  R + +  L+    
Sbjct: 242 --KKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  136 bits (344), Expect = 8e-38
 Identities = 56/261 (21%), Positives = 107/261 (40%), Gaps = 42/261 (16%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F      +  E      +K+I +     +K+     + RE+ +L  + H N++   + 
Sbjct: 35  GSFGKAILVKSTEDGRQYVIKEINIS-RMSSKE--REESRREVAVLANMKHPNIVQYRES 91

Query: 126 FGYMSNVSLVFEFVDT-DLEVIIKD-PTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
           F    ++ +V ++ +  DL   I     ++F    I  + +     L+++HD  ILHRD+
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDI 151

Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWY---RLIK------------- 227
           K  N+ + K G +++GDFG+A+   S   L    + T +Y    + +             
Sbjct: 152 KSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWAL 211

Query: 228 -CLLYCVQFNVKNVQWCCFAK--DPSSHGNLFPGI------PLNEIFTAAGDDLLAVISS 278
            C+LY         + C      +  S  NL   I      P++  ++    DL +++S 
Sbjct: 212 GCVLY---------ELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYS---YDLRSLVSQ 259

Query: 279 LLCLNPTKRADCTATLKMDYF 299
           L   NP  R    + L+  + 
Sbjct: 260 LFKRNPRDRPSVNSILEKGFI 280

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  129 bits (326), Expect = 8e-36
 Identities = 59/270 (21%), Positives = 96/270 (35%), Gaps = 51/270 (18%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +    K R      I+  K++  G      +   +  + E+ LL+EL H N++   D 
Sbjct: 17  GSYGRCQKIRRKSDGKILVWKELDYG-SMTEAE--KQMLVSEVNLLRELKHPNIVRYYDR 73

Query: 126 FGYMSNVSL--VFEFVDT-DLEVIIKDPT---IVFTPSNIKAYAIMTLRGLEYLHD---- 175
               +N +L  V E+ +  DL  +I   T          +          L+  H     
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133

Query: 176 -HWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWY---RLIK---- 227
            H +LHRDLKP N+ ++ +  +K+GDFGLA+     T      V T +Y     +     
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSY 193

Query: 228 ----------CLLYCVQFNVKNVQWCCFAK--DPSSHGNLFPGI------PLNEIFTAAG 269
                     CLLY         + C         S   L   I       +   ++   
Sbjct: 194 NEKSDIWSLGCLLY---------ELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS--- 241

Query: 270 DDLLAVISSLLCLNPTKRADCTATLKMDYF 299
           D+L  +I+ +L L    R      L+    
Sbjct: 242 DELNEIITRMLNLKDYHRPSVEEILENPLI 271

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  127 bits (320), Expect = 7e-35
 Identities = 52/280 (18%), Positives = 98/280 (35%), Gaps = 58/280 (20%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  VF+A++   D   A+K+I+L     A+       +RE+K L +L H  ++   + 
Sbjct: 16  GGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR----EKVMREVKALAKLEHPGIVRYFNA 71

Query: 126 FGYMSNVS------------LVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMT--LRGL 170
           +   +               +  +     +L+  +     +          I       +
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131

Query: 171 EYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT------------RLYTHQV 218
           E+LH   ++HRDLKP+N+      V+K+GDFGL                      +T QV
Sbjct: 132 EFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQV 191

Query: 219 VTRWY---RLIK--------------CLLY--CVQFNVKNVQWCCFAKDPSSHGNLFPGI 259
            T+ Y     I                +L+     F+ +  +        +     FP  
Sbjct: 192 GTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLK---FP-- 246

Query: 260 PLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF 299
               +FT        ++  +L  +P +R +    ++   F
Sbjct: 247 ---PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVF 283

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  118 bits (299), Expect = 1e-31
 Identities = 44/148 (29%), Positives = 67/148 (45%), Gaps = 8/148 (5%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL--HHENVLGLT 123
           G  + VF+  + E   I A+K + L    +A +    +   EI  L +L  H + ++ L 
Sbjct: 39  GGSSKVFQVLN-EKKQIYAIKYVNL---EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94

Query: 124 DVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
           D       + +V E  + DL   +K       P   K+Y    L  +  +H H I+H DL
Sbjct: 95  DYEITDQYIYMVMECGNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIHQHGIVHSDL 153

Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPT 211
           KP N LI   G+LK+ DFG+A      T
Sbjct: 154 KPANFLIVD-GMLKLIDFGIANQMQPDT 180

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  117 bits (296), Expect = 2e-31
 Identities = 44/162 (27%), Positives = 65/162 (40%), Gaps = 20/162 (12%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V KAR+       A+KKI+        +    T L E+ LL  L+H+ V+     
Sbjct: 17  GAFGQVVKARNALDSRYYAIKKIRH------TEEKLSTILSEVMLLASLNHQYVVRYYAA 70

Query: 126 FGYMSNVS-------------LVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLE 171
           +    N               +  E+ +   L  +I    +              L  L 
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALS 130

Query: 172 YLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL 213
           Y+H   I+HRDLKP N+ I++   +KIGDFGLAK       +
Sbjct: 131 YIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  118 bits (297), Expect = 3e-31
 Identities = 56/278 (20%), Positives = 88/278 (31%), Gaps = 66/278 (23%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F+ V     +      A+K+I      D ++     A RE  + +  +H N+L L   
Sbjct: 40  GGFSYVDLVEGLHDGHFYALKRILCHEQQDREE-----AQREADMHRLFNHPNILRLVAY 94

Query: 126 F----GYMSNVSLVFEFVDT-DLEVIIK---DPTIVFTPSNIKAYAIMTLRGLEYLHDHW 177
                G      L+  F     L   I+   D     T   I    +   RGLE +H   
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG 154

Query: 178 ILHRDLKPNNLLINKQGVLKIGDFGLAK-----FFGSPTRLYTHQVVTR----WYR---L 225
             HRDLKP N+L+  +G   + D G          GS   L       +     YR   L
Sbjct: 155 YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPEL 214

Query: 226 IK-----------------CLLYCVQFNVKNVQWCCFAKDP----SSHGNLFPGI----- 259
                              C+LY             F + P       G+          
Sbjct: 215 FSVQSHCVIDERTDVWSLGCVLYA----------MMFGEGPYDMVFQKGDSVALAVQNQL 264

Query: 260 --PLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLK 295
             P +   +     L  +++S++ ++P +R      L 
Sbjct: 265 SIPQSPRHS---SALWQLLNSMMTVDPHQRPHIPLLLS 299

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  116 bits (293), Expect = 9e-31
 Identities = 36/159 (22%), Positives = 77/159 (48%), Gaps = 13/159 (8%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G  A VF+ R  +T  + A+K     +     D      +RE ++L++L+H+N++ L  +
Sbjct: 20  GATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ----MREFEVLKKLNHKNIVKLFAI 75

Query: 126 F--GYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMT--LRGLEYLHDHWILH 180
                  +  L+ EF     L  ++++P+  +     +   ++   + G+ +L ++ I+H
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVH 135

Query: 181 RDLKPNNLLI----NKQGVLKIGDFGLAKFFGSPTRLYT 215
           R++KP N++     + Q V K+ DFG A+      +  +
Sbjct: 136 RNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS 174

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  117 bits (294), Expect = 1e-30
 Identities = 44/148 (29%), Positives = 67/148 (45%), Gaps = 8/148 (5%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL--HHENVLGLT 123
           G  + VF+  + E   I A+K + L    +A +    +   EI  L +L  H + ++ L 
Sbjct: 20  GGSSKVFQVLN-EKKQIYAIKYVNL---EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75

Query: 124 DVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
           D       + +V E  + DL   +K       P   K+Y    L  +  +H H I+H DL
Sbjct: 76  DYEITDQYIYMVMECGNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIHQHGIVHSDL 134

Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPT 211
           KP N LI   G+LK+ DFG+A      T
Sbjct: 135 KPANFLIVD-GMLKLIDFGIANQMQPDT 161

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  116 bits (292), Expect = 3e-30
 Identities = 43/148 (29%), Positives = 66/148 (44%), Gaps = 8/148 (5%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH--ENVLGLT 123
           G  + VF+  + E   I A+K + L    +A +    +   EI  L +L    + ++ L 
Sbjct: 67  GGSSKVFQVLN-EKKQIYAIKYVNL---EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122

Query: 124 DVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
           D       + +V E  + DL   +K       P   K+Y    L  +  +H H I+H DL
Sbjct: 123 DYEITDQYIYMVMECGNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIHQHGIVHSDL 181

Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPT 211
           KP N LI   G+LK+ DFG+A      T
Sbjct: 182 KPANFLIVD-GMLKLIDFGIANQMQPDT 208

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  115 bits (290), Expect = 7e-30
 Identities = 36/159 (22%), Positives = 78/159 (49%), Gaps = 13/159 (8%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G  A VF+ R  +T  + A+K     +     D      +RE ++L++L+H+N++ L  +
Sbjct: 20  GATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ----MREFEVLKKLNHKNIVKLFAI 75

Query: 126 FGYMS--NVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMT--LRGLEYLHDHWILH 180
               +  +  L+ EF     L  ++++P+  +     +   ++   + G+ +L ++ I+H
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVH 135

Query: 181 RDLKPNNLLI----NKQGVLKIGDFGLAKFFGSPTRLYT 215
           R++KP N++     + Q V K+ DFG A+      +  +
Sbjct: 136 RNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS 174

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  114 bits (286), Expect = 2e-29
 Identities = 47/297 (15%), Positives = 75/297 (25%), Gaps = 76/297 (25%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G  + VF  RD+E     A+K   +G      +               L  E+     D 
Sbjct: 73  GDRSVVFLVRDVERLEDFALKVFTMGAENSRSEL--ERLHEATFAAARLLGESPEEARDR 130

Query: 126 FGYMS--------------------------NVSLVFEFVDTDLEVIIK---DPTIVFTP 156
              +                           N  L+      DLE++        +    
Sbjct: 131 RRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGD 190

Query: 157 SNIKAYAIMT---LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL 213
             I A  I+T   +R    L    ++H    P+NL I   G L +GD       G+    
Sbjct: 191 EGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPA 250

Query: 214 YTHQVVTRWYR---LIK----------------CLLYCVQFNVKNVQWCC---FAKDPSS 251
                V   Y     +                   +Y V        WC    F      
Sbjct: 251 S---SVPVTYAPREFLNASTATFTHALNAWQLGLSIYRV--------WCLFLPFGLVTPG 299

Query: 252 HGNLFPGIPLNEIFTAAG---------DDLLAVISSLLCLNPTKRADCTATLKMDYF 299
               +    L    T +          D +  +I   L  +  +R      ++   F
Sbjct: 300 IKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF 356

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  111 bits (279), Expect = 1e-28
 Identities = 46/156 (29%), Positives = 67/156 (42%), Gaps = 13/156 (8%)

Query: 66  GRFATVFKARDIETDMIVAVK---KIKLGTHADAKDGINRTALREIKLLQELHHENVLGL 122
           G FA  F+  D +T  + A K   K  L      K         EI + + L H++V+G 
Sbjct: 52  GGFAKCFEISDADTKEVFAGKIVPKSLL-----LKPHQREKMSMEISIHRSLAHQHVVGF 106

Query: 123 TDVFGYMSNVSLVFEFVD--TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
              F     V +V E     + LE+  +      T    + Y    + G +YLH + ++H
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELHKRRKA--LTEPEARYYLRQIVLGCQYLHRNRVIH 164

Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSP-TRLYT 215
           RDLK  NL +N+   +KIGDFGLA        R   
Sbjct: 165 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV 200

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  109 bits (276), Expect = 2e-28
 Identities = 50/155 (32%), Positives = 79/155 (50%), Gaps = 10/155 (6%)

Query: 66  GRFATVFKARDIETDMIVAVK---KIKLGTHADAKDGINRTALREIKLLQELHHENVLGL 122
           G FA V++A  I T + VA+K   K  +      K G+ +    E+K+  +L H ++L L
Sbjct: 22  GSFAGVYRAESIHTGLEVAIKMIDKKAM-----YKAGMVQRVQNEVKIHCQLKHPSILEL 76

Query: 123 TDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
            + F   + V LV E     ++   +K+    F+ +  + +    + G+ YLH H ILHR
Sbjct: 77  YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHR 136

Query: 182 DLKPNNLLINKQGVLKIGDFGLAKFFGSPT-RLYT 215
           DL  +NLL+ +   +KI DFGLA     P  + YT
Sbjct: 137 DLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT 171

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  110 bits (277), Expect = 2e-28
 Identities = 45/157 (28%), Positives = 77/157 (49%), Gaps = 9/157 (5%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL-REIKLLQELHHENVLGLTD 124
           G+FA V K R+  T +  A K IK      ++ G++R  + RE+ +L+++ H NV+ L D
Sbjct: 23  GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHD 82

Query: 125 VFGYMSNVSLVFEFVDT-DL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
           V+   ++V L+ E V   +L + + +  +   +     ++    L G+ YLH   I H D
Sbjct: 83  VYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHTKKIAHFD 140

Query: 183 LKPNNLLI----NKQGVLKIGDFGLAKFFGSPTRLYT 215
           LKP N+++         +K+ DFGLA           
Sbjct: 141 LKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  109 bits (275), Expect = 2e-28
 Identities = 46/156 (29%), Positives = 67/156 (42%), Gaps = 13/156 (8%)

Query: 66  GRFATVFKARDIETDMIVAVK---KIKLGTHADAKDGINRTALREIKLLQELHHENVLGL 122
           G FA  F+  D +T  + A K   K  L      K         EI + + L H++V+G 
Sbjct: 26  GGFAKCFEISDADTKEVFAGKIVPKSLL-----LKPHQREKMSMEISIHRSLAHQHVVGF 80

Query: 123 TDVFGYMSNVSLVFEFVD--TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
              F     V +V E     + LE+  +      T    + Y    + G +YLH + ++H
Sbjct: 81  HGFFEDNDFVFVVLELCRRRSLLELHKRRKA--LTEPEARYYLRQIVLGCQYLHRNRVIH 138

Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPT-RLYT 215
           RDLK  NL +N+   +KIGDFGLA        R   
Sbjct: 139 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV 174

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  110 bits (278), Expect = 3e-28
 Identities = 48/154 (31%), Positives = 79/154 (51%), Gaps = 10/154 (6%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           GRF  V K  +  T + +A K IK     D ++        EI ++ +L H N++ L D 
Sbjct: 100 GRFGQVHKCEETATGLKLAAKIIKTRGMKDKEE-----VKNEISVMNQLDHANLIQLYDA 154

Query: 126 FGYMSNVSLVFEFVDT-DL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
           F   +++ LV E+VD  +L + II + +   T  +   +      G+ ++H  +ILH DL
Sbjct: 155 FESKNDIVLVMEYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMYILHLDL 213

Query: 184 KPNNLL-INKQG-VLKIGDFGLAKFFGSPTRLYT 215
           KP N+L +N+    +KI DFGLA+ +    +L  
Sbjct: 214 KPENILCVNRDAKQIKIIDFGLARRYKPREKLKV 247

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  109 bits (275), Expect = 4e-28
 Identities = 36/154 (23%), Positives = 62/154 (40%), Gaps = 11/154 (7%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V +  +  +      K +K       +  +     +EI +L    H N+L L + 
Sbjct: 16  GEFGIVHRCVETSSKKTYMAKFVK--VKGTDQVLV----KKEISILNIARHRNILHLHES 69

Query: 126 FGYMSNVSLVFEFVD-TDL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
           F  M  + ++FEF+   D+ E I            I +Y       L++LH H I H D+
Sbjct: 70  FESMEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDI 128

Query: 184 KPNNLLI--NKQGVLKIGDFGLAKFFGSPTRLYT 215
           +P N++    +   +KI +FG A+          
Sbjct: 129 RPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL 162

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  110 bits (278), Expect = 4e-28
 Identities = 39/154 (25%), Positives = 66/154 (42%), Gaps = 10/154 (6%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V +  +  T  +   K I      D           EI ++ +LHH  ++ L D 
Sbjct: 62  GAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT-----VKNEISIMNQLHHPKLINLHDA 116

Query: 126 FGYMSNVSLVFEFVD-TDL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
           F     + L+ EF+   +L + I  +     + + +  Y      GL+++H+H I+H D+
Sbjct: 117 FEDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDI 175

Query: 184 KPNNLLI--NKQGVLKIGDFGLAKFFGSPTRLYT 215
           KP N++    K   +KI DFGLA        +  
Sbjct: 176 KPENIMCETKKASSVKIIDFGLATKLNPDEIVKV 209

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  110 bits (276), Expect = 5e-28
 Identities = 44/157 (28%), Positives = 76/157 (48%), Gaps = 9/157 (5%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL-REIKLLQELHHENVLGLTD 124
           G+FA V K R+  T +  A K IK      ++ G+ R  + RE+ +L+++ H N++ L D
Sbjct: 23  GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHD 82

Query: 125 VFGYMSNVSLVFEFVDT-DL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
           V+   ++V L+ E V   +L + + +  +   +     ++    L G+ YLH   I H D
Sbjct: 83  VYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHTKKIAHFD 140

Query: 183 LKPNNLLI----NKQGVLKIGDFGLAKFFGSPTRLYT 215
           LKP N+++         +K+ DFGLA           
Sbjct: 141 LKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  108 bits (271), Expect = 7e-28
 Identities = 45/157 (28%), Positives = 76/157 (48%), Gaps = 9/157 (5%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL-REIKLLQELHHENVLGLTD 124
           G+FA V K R   T    A K IK    + ++ G++R  + RE+ +L+E+ H N++ L D
Sbjct: 16  GQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHD 75

Query: 125 VFGYMSNVSLVFEFVDT-DL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
           +F   ++V L+ E V   +L + + +  +   T      +    L G+ YLH   I H D
Sbjct: 76  IFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFLKQILDGVHYLHSKRIAHFD 133

Query: 183 LKPNNLLI----NKQGVLKIGDFGLAKFFGSPTRLYT 215
           LKP N+++         +K+ DFG+A    +      
Sbjct: 134 LKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN 170

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  109 bits (274), Expect = 1e-27
 Identities = 33/156 (21%), Positives = 69/156 (44%), Gaps = 8/156 (5%)

Query: 66  GRFATVFKARDIETDMIVAVKKI---KLGTHADAKDGINRTALREIKLLQELH-HENVLG 121
           G  + V +     T    AVK +         +  + +     RE  +L+++  H +++ 
Sbjct: 105 GVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164

Query: 122 LTDVFGYMSNVSLVFEFVDT-DL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWIL 179
           L D +   S + LVF+ +   +L + + +      +    ++     L  + +LH + I+
Sbjct: 165 LIDSYESSSFMFLVFDLMRKGELFDYLTEKVA--LSEKETRSIMRSLLEAVSFLHANNIV 222

Query: 180 HRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYT 215
           HRDLKP N+L++    +++ DFG +       +L  
Sbjct: 223 HRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE 258

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  111 bits (279), Expect = 1e-27
 Identities = 34/154 (22%), Positives = 65/154 (42%), Gaps = 10/154 (6%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V +  +  T    A K +     +D +        +EI+ +  L H  ++ L D 
Sbjct: 168 GAFGVVHRVTERATGNNFAAKFVMTPHESDKET-----VRKEIQTMSVLRHPTLVNLHDA 222

Query: 126 FGYMSNVSLVFEFVDTDLEVI--IKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
           F   + + +++EF+ +  E+   + D     +      Y     +GL ++H++  +H DL
Sbjct: 223 FEDDNEMVMIYEFM-SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDL 281

Query: 184 KPNNLLI--NKQGVLKIGDFGLAKFFGSPTRLYT 215
           KP N++    +   LK+ DFGL         +  
Sbjct: 282 KPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV 315

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  108 bits (273), Expect = 1e-27
 Identities = 48/166 (28%), Positives = 78/166 (46%), Gaps = 9/166 (5%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL-REIKLLQELHHENVLGLTD 124
           G F+ V +  + ET    AVK + +     +  G++   L RE  +   L H +++ L +
Sbjct: 35  GPFSVVRRCINRETGQQFAVKIVDV-AKFTSSPGLSTEDLKREASICHMLKHPHIVELLE 93

Query: 125 VFGYMSNVSLVFEFVD-TDL-EVIIKDPTIVFTPSNIKAYAIM--TLRGLEYLHDHWILH 180
            +     + +VFEF+D  DL   I+K     F  S   A   M   L  L Y HD+ I+H
Sbjct: 94  TYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIH 153

Query: 181 RDLKPNNLLI---NKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWY 223
           RD+KP+ +L+        +K+G FG+A   G    +   +V T  +
Sbjct: 154 RDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHF 199

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  109 bits (275), Expect = 1e-27
 Identities = 40/158 (25%), Positives = 78/158 (49%), Gaps = 11/158 (6%)

Query: 66  GRFATVFKARDIETDMIVAVKKI---KLGTHADAKDGINRTALREIKLLQELHHENVLGL 122
           G    V  A + +T   VA++ I   K    +  +         EI++L++L+H  ++ +
Sbjct: 146 GACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI 205

Query: 123 TDVFGYMSNVSLVFEFVDT-DL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
            + F    +  +V E ++  +L + ++ +       +  K Y    L  ++YLH++ I+H
Sbjct: 206 KNFF-DAEDYYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQMLLAVQYLHENGIIH 262

Query: 181 RDLKPNNLLI---NKQGVLKIGDFGLAKFFGSPTRLYT 215
           RDLKP N+L+    +  ++KI DFG +K  G  + + T
Sbjct: 263 RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT 300

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  107 bits (268), Expect = 2e-27
 Identities = 54/277 (19%), Positives = 96/277 (34%), Gaps = 66/277 (23%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTD 124
           G F +VFK        I A+K+ K      A     + ALRE+     L  H +V+    
Sbjct: 22  GEFGSVFKCVKRLDGCIYAIKRSKK---PLAGSVDEQNALREVYAHAVLGQHSHVVRYFS 78

Query: 125 VFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTP---SNIKAYAIMTLRGLEYLHDHWILH 180
            +    ++ +  E+ +   L   I +   + +    + +K   +   RGL Y+H   ++H
Sbjct: 79  AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVH 138

Query: 181 RDLKPNNLLINKQGVL-------------------KIGDFGLAKFFGSPTRLYTHQVVT- 220
            D+KP+N+ I++  +                    KIGD G      SP      QV   
Sbjct: 139 MDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP------QVEEG 192

Query: 221 --RW----------YRLIK-------CLLYCVQFNVKNVQWCCFAKDPSSHGNLFPGI-- 259
             R+            L K         + C             A+    +G+ +  I  
Sbjct: 193 DSRFLANEVLQENYTHLPKADIFALALTVVCA----------AGAEPLPRNGDQWHEIRQ 242

Query: 260 -PLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLK 295
             L  I      +   ++  ++  +P +R    A +K
Sbjct: 243 GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  107 bits (270), Expect = 2e-27
 Identities = 47/157 (29%), Positives = 77/157 (49%), Gaps = 9/157 (5%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL-REIKLLQELHHENVLGLTD 124
           G+FA V K R+  T +  A K IK      ++ G++R  + RE+ +L+E+ H NV+ L +
Sbjct: 22  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81

Query: 125 VFGYMSNVSLVFEFVD-TDL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
           V+   ++V L+ E V   +L + + +  +   T      +    L G+ YLH   I H D
Sbjct: 82  VYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSLQIAHFD 139

Query: 183 LKPNNLLI----NKQGVLKIGDFGLAKFFGSPTRLYT 215
           LKP N+++      +  +KI DFGLA           
Sbjct: 140 LKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  106 bits (266), Expect = 6e-27
 Identities = 44/144 (30%), Positives = 72/144 (50%), Gaps = 9/144 (6%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+  RD+   + +A+K+I       ++  ++     EI L + L H+N++     
Sbjct: 33  GTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQP-LHE----EIALHKHLKHKNIVQYLGS 87

Query: 126 FGYMSNVSLVFEFVDTD-LEVIIKDP--TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
           F     + +  E V    L  +++     +      I  Y    L GL+YLHD+ I+HRD
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRD 147

Query: 183 LKPNNLLIN-KQGVLKIGDFGLAK 205
           +K +N+LIN   GVLKI DFG +K
Sbjct: 148 IKGDNVLINTYSGVLKISDFGTSK 171

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  109 bits (274), Expect = 6e-27
 Identities = 37/162 (22%), Positives = 68/162 (41%), Gaps = 16/162 (9%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V +    +T   VA+K+ +       ++        EI+++++L+H NV+   +V
Sbjct: 25  GGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERW----CLEIQIMKKLNHPNVVSAREV 80

Query: 126 FGYMSNVS------LVFEFVDT-DLEVIIKDP--TIVFTPSNIKAYAIMTLRGLEYLHDH 176
              +  ++      L  E+ +  DL   +             I+         L YLH++
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140

Query: 177 WILHRDLKPNNLLI---NKQGVLKIGDFGLAKFFGSPTRLYT 215
            I+HRDLKP N+++    ++ + KI D G AK          
Sbjct: 141 RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE 182

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  105 bits (264), Expect = 8e-27
 Identities = 45/155 (29%), Positives = 73/155 (47%), Gaps = 12/155 (7%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F TV+K  D ET + VA  +++       K    R    E ++L+ L H N++   D 
Sbjct: 37  GSFKTVYKGLDTETTVEVAWCELQD--RKLTKSERQR-FKEEAEMLKGLQHPNIVRFYDS 93

Query: 126 FGYM----SNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH--WI 178
           +         + LV E + +  L+  +K    V     ++++    L+GL++LH     I
Sbjct: 94  WESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTPPI 152

Query: 179 LHRDLKPNNLLIN-KQGVLKIGDFGLAKFFGSPTR 212
           +HRDLK +N+ I    G +KIGD GLA    +   
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA 187

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  106 bits (266), Expect = 9e-27
 Identities = 40/156 (25%), Positives = 71/156 (45%), Gaps = 9/156 (5%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTD 124
           G+FA V +     T    A K +K       +D      L EI +L+       V+ L +
Sbjct: 40  GKFAVVRQCISKSTGQEYAAKFLK--KRRRGQDCRAEI-LHEIAVLELAKSCPRVINLHE 96

Query: 125 VFGYMSNVSLVFEFVDT-DL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
           V+   S + L+ E+    ++  + + +   + + +++       L G+ YLH + I+H D
Sbjct: 97  VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLD 156

Query: 183 LKPNNLLI---NKQGVLKIGDFGLAKFFGSPTRLYT 215
           LKP N+L+      G +KI DFG+++  G    L  
Sbjct: 157 LKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE 192

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  106 bits (266), Expect = 9e-27
 Identities = 42/158 (26%), Positives = 79/158 (50%), Gaps = 11/158 (6%)

Query: 66  GRFATVFKARDIETDMIVAVKKI---KLGTHADAKDGINRTALREIKLLQELHHENVLGL 122
           G    V  A + +T   VA+K I   K    +  +         EI++L++L+H  ++ +
Sbjct: 21  GACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI 80

Query: 123 TDVFGYMSNVSLVFEFVDT-DL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
            + F    +  +V E ++  +L + ++ +       +  K Y    L  ++YLH++ I+H
Sbjct: 81  KNFFD-AEDYYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQMLLAVQYLHENGIIH 137

Query: 181 RDLKPNNLLINKQG---VLKIGDFGLAKFFGSPTRLYT 215
           RDLKP N+L++ Q    ++KI DFG +K  G  + + T
Sbjct: 138 RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT 175

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  104 bits (263), Expect = 9e-27
 Identities = 43/154 (27%), Positives = 68/154 (44%), Gaps = 16/154 (10%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL-----REIKLLQELHHENVL 120
           G+F  V+ AR+ ++  I+A+K +        K  + +  +     RE+++   L H N+L
Sbjct: 20  GKFGNVYLAREKQSKFILALKVLF-------KAQLEKAGVEHQLRREVEIQSHLRHPNIL 72

Query: 121 GLTDVFGYMSNVSLVFEFVDT-DL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
            L   F   + V L+ E+     +   + K     F       Y       L Y H   +
Sbjct: 73  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSKRV 130

Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR 212
           +HRD+KP NLL+   G LKI DFG +    S  R
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 164

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  105 bits (264), Expect = 1e-26
 Identities = 41/184 (22%), Positives = 78/184 (42%), Gaps = 12/184 (6%)

Query: 41  KQYLLPDCEVKNDLLVYYQWRSVHVGR--FATVFKARDIETDMIVAVKKIK----LGTHA 94
           +   LP     +     Y+ + + +GR   + V +     T    AVK I         A
Sbjct: 2   RDAALPGSHSTHGFYENYEPKEI-LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSA 60

Query: 95  DAKDGINRTALREIKLLQEL-HHENVLGLTDVFGYMSNVSLVFEFVDT-DL-EVIIKDPT 151
           +    +    L+E+ +L+++  H N++ L D +   +   LVF+ +   +L + + +  T
Sbjct: 61  EEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT 120

Query: 152 IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT 211
              +    +      L  +  LH   I+HRDLKP N+L++    +K+ DFG +       
Sbjct: 121 --LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 178

Query: 212 RLYT 215
           +L  
Sbjct: 179 KLRE 182

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  107 bits (268), Expect = 2e-26
 Identities = 56/273 (20%), Positives = 87/273 (31%), Gaps = 67/273 (24%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTD 124
           G   T+   R +  +  VAVK+I     + A         RE++LL+E   H NV+    
Sbjct: 35  GAEGTIVY-RGMFDNRDVAVKRILPECFSFAD--------REVQLLRESDEHPNVIRYFC 85

Query: 125 VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
                    +  E     L+  ++                 T  GL +LH   I+HRDLK
Sbjct: 86  TEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLK 145

Query: 185 PNNLLINKQG-----VLKIGDFGLAKFFGSPTRLYTH---QVVTRWYR---LIK------ 227
           P+N+LI+           I DFGL K        ++       T  +    ++       
Sbjct: 146 PHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKEN 205

Query: 228 -----------CLLYCV--------------QFNVKNVQWCCFAKDPSSHGNLFPGIPLN 262
                      C+ Y V              Q N+                +L    P  
Sbjct: 206 PTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL-----------GACSLDCLHPEK 254

Query: 263 EIFTAAGDDLLAVISSLLCLNPTKRADCTATLK 295
                A  +L   I  ++ ++P KR      LK
Sbjct: 255 HEDVIA-REL---IEKMIAMDPQKRPSAKHVLK 283

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  104 bits (261), Expect = 3e-26
 Identities = 38/142 (26%), Positives = 65/142 (45%), Gaps = 6/142 (4%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F    K    ET  ++ +K++        +       L+E+K+++ L H NVL    V
Sbjct: 21  GCFGQAIKVTHRETGEVMVMKELIRFDEETQRT-----FLKEVKVMRCLEHPNVLKFIGV 75

Query: 126 FGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
                 ++ + E++    L  IIK     +  S   ++A     G+ YLH   I+HRDL 
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLN 135

Query: 185 PNNLLINKQGVLKIGDFGLAKF 206
            +N L+ +   + + DFGLA+ 
Sbjct: 136 SHNCLVRENKNVVVADFGLARL 157

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  103 bits (260), Expect = 4e-26
 Identities = 43/157 (27%), Positives = 69/157 (43%), Gaps = 14/157 (8%)

Query: 66  GRFATVFKARDIETDMIVAVKKI--KLGTHADAKDGINRTALREIKLLQELHHENVLGLT 123
           G F+ V +     T +  A K I  K  +  D +        RE ++ ++L H N++ L 
Sbjct: 17  GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-----LEREARICRKLQHPNIVRLH 71

Query: 124 DVFGYMSNVSLVFEFVDT-DL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
           D     S   LVF+ V   +L E I+      ++ ++        L  + Y H + I+HR
Sbjct: 72  DSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESIAYCHSNGIVHR 129

Query: 182 DLKPNNLLI---NKQGVLKIGDFGLAKFFGSPTRLYT 215
           +LKP NLL+    K   +K+ DFGLA         + 
Sbjct: 130 NLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG 166

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  103 bits (259), Expect = 4e-26
 Identities = 40/152 (26%), Positives = 68/152 (44%), Gaps = 14/152 (9%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTA--LREIKLLQELHHENVLGLT 123
           G F  V K R ++   +VA+K + LG      + I +     RE+ ++  L+H N++ L 
Sbjct: 30  GGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKL- 88

Query: 124 DVFGY-MSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH--WIL 179
             +G   +   +V EFV   DL   + D       S      +    G+EY+ +    I+
Sbjct: 89  --YGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIV 146

Query: 180 HRDLKPNNLLINKQG-----VLKIGDFGLAKF 206
           HRDL+  N+ +           K+ DFGL++ 
Sbjct: 147 HRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ 178

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  104 bits (262), Expect = 4e-26
 Identities = 38/145 (26%), Positives = 57/145 (39%), Gaps = 19/145 (13%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V + +D +T    AVKK++L              + E+     L    ++ L   
Sbjct: 69  GSFGEVHRMKDKQTGFQCAVKKVRL----------EVFRVEELVACAGLSSPRIVPLYGA 118

Query: 126 FGYMSNVSLVFEFVD----TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
                 V++  E ++      L   IK             Y    L GLEYLH   ILH 
Sbjct: 119 VREGPWVNIFMELLEGGSLGQL---IK-QMGCLPEDRALYYLGQALEGLEYLHTRRILHG 174

Query: 182 DLKPNNLLINKQGVL-KIGDFGLAK 205
           D+K +N+L++  G    + DFG A 
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHAL 199

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  104 bits (262), Expect = 4e-26
 Identities = 44/152 (28%), Positives = 76/152 (50%), Gaps = 9/152 (5%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V+ ARD+    +VA+KK+   +   + +      ++E++ LQ+L H N +     
Sbjct: 65  GSFGAVYFARDVRNSEVVAIKKMSY-SGKQSNEKWQ-DIIKEVRFLQKLRHPNTIQYRGC 122

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
           +       LV E+       +++          I A     L+GL YLH H ++HRD+K 
Sbjct: 123 YLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKA 182

Query: 186 NNLLINKQGVLKIGDFG----LAK---FFGSP 210
            N+L+++ G++K+GDFG    +A    F G+P
Sbjct: 183 GNILLSEPGLVKLGDFGSASIMAPANSFVGTP 214

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  103 bits (260), Expect = 4e-26
 Identities = 38/143 (26%), Positives = 68/143 (47%), Gaps = 12/143 (8%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V+KA++ ET  + A K I+  +  + +D I      EI++L    H  ++ L   
Sbjct: 30  GAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIV-----EIEILATCDHPYIVKLLGA 84

Query: 126 FGYMSNVSLVFEFVD----TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
           + +   + ++ EF           I+ +     T   I+      L  L +LH   I+HR
Sbjct: 85  YYHDGKLWIMIEFCPGGAVDA---IMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHR 141

Query: 182 DLKPNNLLINKQGVLKIGDFGLA 204
           DLK  N+L+  +G +++ DFG++
Sbjct: 142 DLKAGNVLMTLEGDIRLADFGVS 164

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  103 bits (257), Expect = 2e-25
 Identities = 43/142 (30%), Positives = 76/142 (53%), Gaps = 9/142 (6%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G    VFK     + +++A K I L    + K  I    +RE+++L E +   ++G    
Sbjct: 44  GNGGVVFKVSHKPSGLVMARKLIHL----EIKPAIRNQIIRELQVLHECNSPYIVGFYGA 99

Query: 126 FGYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAY-AIMTLRGLEYLHD-HWILHRD 182
           F     +S+  E +D   L+ ++K    +  P  I    +I  ++GL YL + H I+HRD
Sbjct: 100 FYSDGEISICMEHMDGGSLDQVLKKAGRI--PEQILGKVSIAVIKGLTYLREKHKIMHRD 157

Query: 183 LKPNNLLINKQGVLKIGDFGLA 204
           +KP+N+L+N +G +K+ DFG++
Sbjct: 158 VKPSNILVNSRGEIKLCDFGVS 179

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  103 bits (258), Expect = 2e-25
 Identities = 43/157 (27%), Positives = 69/157 (43%), Gaps = 14/157 (8%)

Query: 66  GRFATVFKARDIETDMIVAVKKI--KLGTHADAKDGINRTALREIKLLQELHHENVLGLT 123
           G F+ V +     T +  A K I  K  +  D +        RE ++ ++L H N++ L 
Sbjct: 40  GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-----LEREARICRKLQHPNIVRLH 94

Query: 124 DVFGYMSNVSLVFEFVDT-DL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
           D     S   LVF+ V   +L E I+      ++ ++        L  + Y H + I+HR
Sbjct: 95  DSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESIAYCHSNGIVHR 152

Query: 182 DLKPNNLLI---NKQGVLKIGDFGLAKFFGSPTRLYT 215
           +LKP NLL+    K   +K+ DFGLA         + 
Sbjct: 153 NLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG 189

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  102 bits (255), Expect = 2e-25
 Identities = 40/143 (27%), Positives = 67/143 (46%), Gaps = 13/143 (9%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  VFK  D  T  +VA+K I L    D  + I     +EI +L +     V      
Sbjct: 33  GSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI----QQEITVLSQCDSPYVTKYYGS 88

Query: 126 FGYMSNVSLVFEFVD----TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
           +   + + ++ E++      DL   ++        + I       L+GL+YLH    +HR
Sbjct: 89  YLKDTKLWIIMEYLGGGSALDL---LE--PGPLDETQIATILREILKGLDYLHSEKKIHR 143

Query: 182 DLKPNNLLINKQGVLKIGDFGLA 204
           D+K  N+L+++ G +K+ DFG+A
Sbjct: 144 DIKAANVLLSEHGEVKLADFGVA 166

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  101 bits (254), Expect = 2e-25
 Identities = 52/190 (27%), Positives = 83/190 (43%), Gaps = 17/190 (8%)

Query: 35  VHSALKKQYLLPDCEVKNDLLVYYQWRSVHVGR--FATVFKARDIETDMIVAVKKI--KL 90
           +H          +   +      Y    + +G+  F  V K +D  T    AVK I    
Sbjct: 1   MHHHHHHSSGRENLYFQGTFAERYNIVCM-LGKGSFGEVLKCKDRITQQEYAVKVINKAS 59

Query: 91  GTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT-DL-EVIIK 148
             + D         LRE++LL++L H N++ L ++    S+  +V E     +L + IIK
Sbjct: 60  AKNKDTST-----ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK 114

Query: 149 DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLI---NKQGVLKIGDFGLAK 205
                F+  +          G+ Y+H H I+HRDLKP N+L+    K   +KI DFGL+ 
Sbjct: 115 RKR--FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172

Query: 206 FFGSPTRLYT 215
            F   T++  
Sbjct: 173 CFQQNTKMKD 182

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  101 bits (253), Expect = 3e-25
 Identities = 41/157 (26%), Positives = 66/157 (42%), Gaps = 11/157 (7%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V    +  + +   +K I         + I      EI++L+ L H N++ + +V
Sbjct: 33  GAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQI----EAEIEVLKSLDHPNIIKIFEV 88

Query: 126 FGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAIMT--LRGLEYLHDHWILHR 181
           F    N+ +V E  +    LE I+         S      +M   +  L Y H   ++H+
Sbjct: 89  FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHK 148

Query: 182 DLKPNNLLI---NKQGVLKIGDFGLAKFFGSPTRLYT 215
           DLKP N+L    +    +KI DFGLA+ F S      
Sbjct: 149 DLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN 185

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  101 bits (253), Expect = 4e-25
 Identities = 39/148 (26%), Positives = 65/148 (43%), Gaps = 14/148 (9%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G  A V  A        VA+K+I L     + D +    L+EI+ + + HH N++     
Sbjct: 26  GATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDEL----LKEIQAMSQCHHPNIVSYYTS 81

Query: 126 FGYMSNVSLVFEFVD----TDLEVIIKDPTIVFTPSNIKAYAIM-----TLRGLEYLHDH 176
           F     + LV + +      D+ +             +    I       L GLEYLH +
Sbjct: 82  FVVKDELWLVMKLLSGGSVLDI-IKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 140

Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLA 204
             +HRD+K  N+L+ + G ++I DFG++
Sbjct: 141 GQIHRDVKAGNILLGEDGSVQIADFGVS 168

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  102 bits (255), Expect = 4e-25
 Identities = 47/156 (30%), Positives = 72/156 (46%), Gaps = 16/156 (10%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G  + V++ +   T    A+K +K     D K         EI +L  L H N++ L ++
Sbjct: 64  GATSIVYRCKQKGTQKPYALKVLK--KTVDKKI-----VRTEIGVLLRLSHPNIIKLKEI 116

Query: 126 FGYMSNVSLVFEFVDTDLEV---IIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
           F   + +SLV E V T  E+   I++     ++  +        L  + YLH++ I+HRD
Sbjct: 117 FETPTEISLVLELV-TGGELFDRIVEKGY--YSERDAADAVKQILEAVAYLHENGIVHRD 173

Query: 183 LKPNNLLI---NKQGVLKIGDFGLAKFFGSPTRLYT 215
           LKP NLL         LKI DFGL+K       + T
Sbjct: 174 LKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT 209

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  100 bits (252), Expect = 6e-25
 Identities = 43/147 (29%), Positives = 75/147 (51%), Gaps = 12/147 (8%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F+ VF  +   T  + A+K IK      +    + +   EI +L+++ HEN++ L D+
Sbjct: 20  GAFSEVFLVKQRLTGKLFALKCIKK-----SPAFRDSSLENEIAVLKKIKHENIVTLEDI 74

Query: 126 FGYMSNVSLVFEFVDT-DL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
           +   ++  LV + V   +L + I++     +T  +        L  ++YLH++ I+HRDL
Sbjct: 75  YESTTHYYLVMQLVSGGELFDRILERGV--YTEKDASLVIQQVLSAVKYLHENGIVHRDL 132

Query: 184 KPNNLLI---NKQGVLKIGDFGLAKFF 207
           KP NLL     +   + I DFGL+K  
Sbjct: 133 KPENLLYLTPEENSKIMITDFGLSKME 159

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  102 bits (257), Expect = 6e-25
 Identities = 39/165 (23%), Positives = 68/165 (41%), Gaps = 14/165 (8%)

Query: 66  GRFATVFKARDIETDMIVAVKKI--KLGTHADAKDGINRTALREIKLLQELHHENVLGLT 123
           G F+ V +   +      A   I  K  +  D +        RE ++ + L H N++ L 
Sbjct: 22  GAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK-----LEREARICRLLKHPNIVRLH 76

Query: 124 DVFGYMSNVSLVFEFVD-TDL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
           D      +  L+F+ V   +L E I+      ++ ++        L  + + H   ++HR
Sbjct: 77  DSISEEGHHYLIFDLVTGGELFEDIVAREY--YSEADASHCIQQILEAVLHCHQMGVVHR 134

Query: 182 DLKPNNLLI---NKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWY 223
           +LKP NLL+    K   +K+ DFGLA       + +     T  Y
Sbjct: 135 NLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGY 179

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  100 bits (252), Expect = 7e-25
 Identities = 33/141 (23%), Positives = 69/141 (48%), Gaps = 6/141 (4%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIK-LLQELHHENVLGLTD 124
           G    V+K R  +T  ++AVK++            N+  L ++  +L+      ++    
Sbjct: 36  GTCGQVWKMRFRKTGHVIAVKQM----RRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91

Query: 125 VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD-HWILHRDL 183
            F   ++V +  E + T  E + K          +    +  ++ L YL + H ++HRD+
Sbjct: 92  TFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDV 151

Query: 184 KPNNLLINKQGVLKIGDFGLA 204
           KP+N+L++++G +K+ DFG++
Sbjct: 152 KPSNILLDERGQIKLCDFGIS 172

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =   99 bits (250), Expect = 8e-25
 Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 17/157 (10%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL-----REIKLLQELHHENVL 120
           G+F  V+ AR+ +   I+A+K +        K  + +  +     REI++   L H N+L
Sbjct: 25  GKFGNVYLAREKQNKFIMALKVLF-------KSQLEKEGVEHQLRREIEIQSHLRHPNIL 77

Query: 121 GLTDVFGYMSNVSLVFEFVDT-DL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
            + + F     + L+ EF    +L + + K     F       +       L Y H+  +
Sbjct: 78  RMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR--FDEQRSATFMEELADALHYCHERKV 135

Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYT 215
           +HRD+KP NLL+  +G LKI DFG +    S  R  T
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWSVHAPS-LRRRT 171

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  100 bits (251), Expect = 8e-25
 Identities = 45/149 (30%), Positives = 77/149 (51%), Gaps = 20/149 (13%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V KA+    D  VA+K+I+        +   +  + E++ L  ++H N++ L   
Sbjct: 19  GAFGVVCKAKWRAKD--VAIKQIE-------SESERKAFIVELRQLSRVNHPNIVKL--- 66

Query: 126 FGY-MSNVSLVFEFVDT-DLEVII--KDPTIVFTPSNIKAYAIMTLRGLEYLHDHW---I 178
           +G  ++ V LV E+ +   L  ++   +P   +T ++  ++ +   +G+ YLH      +
Sbjct: 67  YGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126

Query: 179 LHRDLKPNNLLINKQG-VLKIGDFGLAKF 206
           +HRDLKP NLL+   G VLKI DFG A  
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTACD 155

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  100 bits (251), Expect = 9e-25
 Identities = 43/168 (25%), Positives = 78/168 (46%), Gaps = 18/168 (10%)

Query: 47  DCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALR 106
           D ++    L   +   +  G F TV +A    +D  VAVK +        +       LR
Sbjct: 31  DMDIPWCDLNIKEK--IGAGSFGTVHRAEWHGSD--VAVKILMEQDFHAERV---NEFLR 83

Query: 107 EIKLLQELHHENVLGLTDVFGYMS---NVSLVFEFVD-TDLEVII--KDPTIVFTPSNIK 160
           E+ +++ L H N++      G ++   N+S+V E++    L  ++               
Sbjct: 84  EVAIMKRLRHPNIVLF---MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRL 140

Query: 161 AYAIMTLRGLEYLHDH--WILHRDLKPNNLLINKQGVLKIGDFGLAKF 206
           + A    +G+ YLH+    I+HR+LK  NLL++K+  +K+ DFGL++ 
Sbjct: 141 SMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 99.6 bits (249), Expect = 1e-24
 Identities = 35/144 (24%), Positives = 64/144 (44%), Gaps = 9/144 (6%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIK-LLQELHHENVLGLTD 124
           G +  V K R + +  I+AVK+I     A       +  L ++   ++ +     +    
Sbjct: 18  GAYGVVEKMRHVPSGQIMAVKRI----RATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73

Query: 125 VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT---LRGLEYLHD-HWILH 180
                 +V +  E +DT L+   K                +    ++ LE+LH    ++H
Sbjct: 74  ALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIH 133

Query: 181 RDLKPNNLLINKQGVLKIGDFGLA 204
           RD+KP+N+LIN  G +K+ DFG++
Sbjct: 134 RDVKPSNVLINALGQVKMCDFGIS 157

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 99.7 bits (249), Expect = 2e-24
 Identities = 34/143 (23%), Positives = 64/143 (44%), Gaps = 14/143 (9%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G    V  AR+  +   VAVK + L      ++ +      E+ ++++  H NV+ +   
Sbjct: 56  GSTGIVCLAREKHSGRQVAVKMMDL-RKQQRRELL----FNEVVIMRDYQHFNVVEMYKS 110

Query: 126 FGYMSNVSLVFEFVD----TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
           +     + ++ EF+     TD   I+    +      I       L+ L YLH   ++HR
Sbjct: 111 YLVGEELWVLMEFLQGGALTD---IVS--QVRLNEEQIATVCEAVLQALAYLHAQGVIHR 165

Query: 182 DLKPNNLLINKQGVLKIGDFGLA 204
           D+K +++L+   G +K+ DFG  
Sbjct: 166 DIKSDSILLTLDGRVKLSDFGFC 188

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 99.3 bits (248), Expect = 2e-24
 Identities = 38/143 (26%), Positives = 71/143 (49%), Gaps = 14/143 (9%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G   TV+ A D+ T   VA++++ L      K+ I    + EI +++E  + N++   D 
Sbjct: 31  GASGTVYTAMDVATGQEVAIRQMNL-QQQPKKELI----INEILVMRENKNPNIVNYLDS 85

Query: 126 FGYMSNVSLVFEFVD----TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
           +     + +V E++     TD   ++ +         I A     L+ LE+LH + ++HR
Sbjct: 86  YLVGDELWVVMEYLAGGSLTD---VVTETC--MDEGQIAAVCRECLQALEFLHSNQVIHR 140

Query: 182 DLKPNNLLINKQGVLKIGDFGLA 204
           D+K +N+L+   G +K+ DFG  
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFC 163

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 99.7 bits (249), Expect = 2e-24
 Identities = 31/143 (21%), Positives = 64/143 (44%), Gaps = 10/143 (6%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIK-LLQELHHENVLGLTD 124
           G + +V K     +  I+AVK+I     +   +   +  L ++  +++      ++    
Sbjct: 33  GAYGSVNKMVHKPSGQIMAVKRI----RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88

Query: 125 VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFT---PSNIKAY-AIMTLRGLEYLHD-HWIL 179
                 +  +  E + T  +   K    V     P  I     + T++ L +L +   I+
Sbjct: 89  ALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKII 148

Query: 180 HRDLKPNNLLINKQGVLKIGDFG 202
           HRD+KP+N+L+++ G +K+ DFG
Sbjct: 149 HRDIKPSNILLDRSGNIKLCDFG 171

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 98.1 bits (245), Expect = 4e-24
 Identities = 46/184 (25%), Positives = 83/184 (45%), Gaps = 20/184 (10%)

Query: 47  DCEVKNDLLVYYQWRSVHVGRFATVFKAR---DIETDMIVAVKKIKLGTHADAKDGINRT 103
           D E+ +  +   Q   +  G F TV+K +   D      VAVK + +      +    + 
Sbjct: 18  DWEIPDGQITVGQR--IGSGSFGTVYKGKWHGD------VAVKMLNVTAPTPQQL---QA 66

Query: 104 ALREIKLLQELHHENVLGLTDVFGYMS--NVSLVFEFVDT-DLEVIIKDPTIVFTPSNIK 160
              E+ +L++  H N+L      GY +   +++V ++ +   L   +      F    + 
Sbjct: 67  FKNEVGVLRKTRHVNILLF---MGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLI 123

Query: 161 AYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVT 220
             A  T RG++YLH   I+HRDLK NN+ +++   +KIGDFGLA      +  +  + ++
Sbjct: 124 DIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS 183

Query: 221 RWYR 224
               
Sbjct: 184 GSIL 187

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  100 bits (251), Expect = 5e-24
 Identities = 50/166 (30%), Positives = 79/166 (47%), Gaps = 16/166 (9%)

Query: 66  GRFATVFKARDIETDMIVAVKKI---KLGTHADAKDGINRTALREIKLLQELHHENVLGL 122
           G F  V   +D  T    AVK I   ++    D +       LRE++LL++L H N++ L
Sbjct: 37  GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES-----LLREVQLLKQLDHPNIMKL 91

Query: 123 TDVFGYMSNVSLVFEFVD-TDL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
            + F       LV E     +L + II      F+  +        L G+ Y+H + I+H
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEIISRKR--FSEVDAARIIRQVLSGITYMHKNKIVH 149

Query: 181 RDLKPNNLLI---NKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWY 223
           RDLKP NLL+   +K   ++I DFGL+  F   ++    ++ T +Y
Sbjct: 150 RDLKPENLLLESKSKDANIRIIDFGLSTHF-EASKKMKDKIGTAYY 194

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 97.7 bits (244), Expect = 5e-24
 Identities = 33/158 (20%), Positives = 60/158 (37%), Gaps = 15/158 (9%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL--- 122
                ++K R    D  + VK +K+    D     +R    E   L+   H NVL +   
Sbjct: 21  NHSGELWKGRWQGND--IVVKVLKVR---DWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75

Query: 123 -TDVFGYMSNVSLVFEFVDT-DL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH--W 177
                    + +L+  ++    L  V+ +    V   S    +A+   RG+ +LH     
Sbjct: 76  CQS--PPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPL 133

Query: 178 ILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYT 215
           I    L   +++I++    +I    +   F SP R+Y 
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYA 171

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 97.7 bits (244), Expect = 5e-24
 Identities = 43/155 (27%), Positives = 65/155 (41%), Gaps = 12/155 (7%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A    T +  A KKI      D          +EI++++ L H N++ L + 
Sbjct: 20  GSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDR-----FKQEIEIMKSLDHPNIIRLYET 74

Query: 126 FGYMSNVSLVFEFVDT-DL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
           F   +++ LV E     +L E ++      F  S+        L  + Y H   + HRDL
Sbjct: 75  FEDNTDIYLVMELCTGGELFERVVHKRV--FRESDAARIMKDVLSAVAYCHKLNVAHRDL 132

Query: 184 KPNNLLI---NKQGVLKIGDFGLAKFFGSPTRLYT 215
           KP N L    +    LK+ DFGLA  F     + T
Sbjct: 133 KPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT 167

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 98.6 bits (246), Expect = 5e-24
 Identities = 49/176 (27%), Positives = 85/176 (48%), Gaps = 14/176 (7%)

Query: 33  IRVHSALKKQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGT 92
           +R     + + L  D   K    V+     +  G + +V+KA   ET  IVA+K++ +  
Sbjct: 7   LRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV-- 64

Query: 93  HADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVD----TDLEVIIK 148
            +D ++ I      EI ++Q+    +V+     +   +++ +V E+      +D   II+
Sbjct: 65  ESDLQEIIK-----EISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD---IIR 116

Query: 149 DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
                 T   I      TL+GLEYLH    +HRD+K  N+L+N +G  K+ DFG+A
Sbjct: 117 LRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVA 172

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 98.6 bits (246), Expect = 6e-24
 Identities = 41/156 (26%), Positives = 65/156 (41%), Gaps = 8/156 (5%)

Query: 66  GRFATVFKARDIETDMIVAVK---KIKLGTHADAKDGINRTALREIKLLQELHHENVLGL 122
           G F  V+ A D E +  V VK   K K+      +D        EI +L  + H N++ +
Sbjct: 35  GAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKV 94

Query: 123 TDVFGYMSNVSLVFEFVDTDLEV---IIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWIL 179
            D+F       LV E   + L++   I + P                +  + YL    I+
Sbjct: 95  LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR--LDEPLASYIFRQLVSAVGYLRLKDII 152

Query: 180 HRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYT 215
           HRD+K  N++I +   +K+ DFG A +       YT
Sbjct: 153 HRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT 188

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 99.7 bits (248), Expect = 6e-24
 Identities = 22/185 (11%), Positives = 57/185 (30%), Gaps = 31/185 (16%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKD--------------------GINRTAL 105
                  +A D ET     V          +                         +  L
Sbjct: 89  EDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHL 148

Query: 106 REIKLLQELHHENVLGLTDVFG-----YMSNVSLVFEFVDTDL----EVIIKDPTIVFTP 156
           R I     +       +  V       ++ +   ++  + ++L    EV++   +   + 
Sbjct: 149 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSL 208

Query: 157 SNIKAYAIM--TLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY 214
            +     +    +R L  LH + ++H  L+P +++++++G + +  F      G+     
Sbjct: 209 VHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSP 268

Query: 215 THQVV 219
             +  
Sbjct: 269 IGRGF 273

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 98.2 bits (245), Expect = 7e-24
 Identities = 39/173 (22%), Positives = 75/173 (43%), Gaps = 16/173 (9%)

Query: 40  KKQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKAR---DIETDMIVAVKKIKLGTHADA 96
           +    L + ++  + L   +   +  GRF  V+  R   +      VA++ I +    + 
Sbjct: 20  QTSIFLQEWDIPFEQLEIGEL--IGKGRFGQVYHGRWHGE------VAIRLIDIERDNED 71

Query: 97  KDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFT 155
           +    +   RE+   ++  HENV+          +++++        L  +++D  IV  
Sbjct: 72  Q---LKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLD 128

Query: 156 PSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG 208
            +  +  A   ++G+ YLH   ILH+DLK  N+  +  G + I DFGL    G
Sbjct: 129 VNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDN-GKVVITDFGLFSISG 180

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 99.2 bits (247), Expect = 7e-24
 Identities = 29/142 (20%), Positives = 55/142 (38%), Gaps = 11/142 (7%)

Query: 68  FATVFKARDIETDMIVAVKKIKLGTHADAK-DGINRTALREIKLLQELHHENVLGLTDVF 126
             TV  AR   T   V V++I L   ++     +      E+ + +  +H N++     F
Sbjct: 40  LMTVNLARYKPTGEYVTVRRINLEACSNEMVTFL----QGELHVSKLFNHPNIVPYRATF 95

Query: 127 GYMSNVSLVFEFVD----TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
              + + +V  F+      DL  I            I       L+ L+Y+H    +HR 
Sbjct: 96  IADNELWVVTSFMAYGSAKDL--ICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRS 153

Query: 183 LKPNNLLINKQGVLKIGDFGLA 204
           +K +++LI+  G + +      
Sbjct: 154 VKASHILISVDGKVYLSGLRSN 175

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 99.5 bits (248), Expect = 8e-24
 Identities = 38/176 (21%), Positives = 64/176 (36%), Gaps = 29/176 (16%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTD 124
           G   TV   +       VAVK++ +     A          EIKLL E   H NV+    
Sbjct: 26  GSSGTV-VFQGSFQGRPVAVKRMLIDFCDIAL--------MEIKLLTESDDHPNVIRYYC 76

Query: 125 VFGYMSNVSLVFEFVDTDLEVIIKDP----TIVFTPSNIKAYAIM--TLRGLEYLHDHWI 178
                  + +  E  + +L+ +++        +         +++     G+ +LH   I
Sbjct: 77  SETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKI 136

Query: 179 LHRDLKPNNLLINKQGV-------------LKIGDFGLAKFFGSPTRLYTHQVVTR 221
           +HRDLKP N+L++                 + I DFGL K   S    +   +   
Sbjct: 137 IHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 97.9 bits (244), Expect = 1e-23
 Identities = 33/171 (19%), Positives = 73/171 (42%), Gaps = 24/171 (14%)

Query: 66  GRFATVFKARDIETDMIVAVK--------KIKLGTHADAKDGINRTAL----REIKLLQE 113
           G+F  +      + +   A+K        K +  T ++      ++       E++++ +
Sbjct: 42  GKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITD 99

Query: 114 LHHENVLGLTDVFGYMSNVSLVFEFVD--------TDLEVIIKDPTIVFTPSNIKAYAIM 165
           + +E  L    +      V +++E+++            V+ K+ T       IK     
Sbjct: 100 IKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKS 159

Query: 166 TLRGLEYLHDH-WILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYT 215
            L    Y+H+   I HRD+KP+N+L++K G +K+ DFG +++     ++  
Sbjct: 160 VLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD-KKIKG 209

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 98.3 bits (245), Expect = 2e-23
 Identities = 43/162 (26%), Positives = 64/162 (39%), Gaps = 24/162 (14%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTD 124
           G    V +  +  T    A+K ++     D        A RE++L        +++ + D
Sbjct: 73  GINGKVLQIFNKRTQEKFALKMLQ-----DCPK-----ARREVELHWRASQCPHIVRIVD 122

Query: 125 VF----GYMSNVSLVFEFVD--TDLEVIIKDPTIVFTPSNIKAYAIMT--LRGLEYLHDH 176
           V+         + +V E +D       I       FT    +A  IM      ++YLH  
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER--EASEIMKSIGEAIQYLHSI 180

Query: 177 WILHRDLKPNNLLI---NKQGVLKIGDFGLAKFFGSPTRLYT 215
            I HRD+KP NLL        +LK+ DFG AK   S   L T
Sbjct: 181 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 222

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 99.0 bits (247), Expect = 2e-23
 Identities = 51/163 (31%), Positives = 71/163 (43%), Gaps = 15/163 (9%)

Query: 66  GRFATVFKARDIETDMIVAVKKI---KLGTHADAKDGINRTA-----LREIKLLQELHHE 117
           G +  V   ++       A+K I   +      + D  N          EI LL+ L H 
Sbjct: 47  GAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHP 106

Query: 118 NVLGLTDVFGYMSNVSLVFEFVD-TDL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
           N++ L DVF       LV EF +  +L E II      F   +        L G+ YLH 
Sbjct: 107 NIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK--FDECDAANIMKQILSGICYLHK 164

Query: 176 HWILHRDLKPNNLLI---NKQGVLKIGDFGLAKFFGSPTRLYT 215
           H I+HRD+KP N+L+   N    +KI DFGL+ FF    +L  
Sbjct: 165 HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD 207

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 96.2 bits (240), Expect = 2e-23
 Identities = 49/173 (28%), Positives = 75/173 (43%), Gaps = 28/173 (16%)

Query: 66  GRFATVFKARDIETDMIVAVK---KIKLGTHADAKDGINRTAL----------------- 105
           G +  V  A +   +   A+K   K KL   A                            
Sbjct: 24  GSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQV 83

Query: 106 -REIKLLQELHHENVLGLTDVFGYMSNVSL--VFEFVDTD--LEVIIKDPTIVFTPSNIK 160
            +EI +L++L H NV+ L +V    +   L  VFE V+    +EV    P    +    +
Sbjct: 84  YQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP---LSEDQAR 140

Query: 161 AYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL 213
            Y    ++G+EYLH   I+HRD+KP+NLL+ + G +KI DFG++  F     L
Sbjct: 141 FYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 96.8 bits (241), Expect = 3e-23
 Identities = 41/188 (21%), Positives = 63/188 (33%), Gaps = 42/188 (22%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A + +T  I A+K +                  E++L+++LHH N+  L +V
Sbjct: 37  GSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEV 96

Query: 126 FGYMSNVSLVFEFV----------------------------------------DTDLEV 145
           +     + LV E                                          +  +  
Sbjct: 97  YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHG 156

Query: 146 IIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLI--NKQGVLKIGDFGL 203
             +    V     I          L YLH+  I HRD+KP N L   NK   +K+ DFGL
Sbjct: 157 FRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGL 216

Query: 204 AKFFGSPT 211
           +K F    
Sbjct: 217 SKEFYKLN 224

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 98.2 bits (245), Expect = 3e-23
 Identities = 53/166 (31%), Positives = 78/166 (46%), Gaps = 17/166 (10%)

Query: 66  GRFATVFKARDIETDMIVAVKKI---KLGTHADAKDGINRTALREIKLLQELHHENVLGL 122
           G +  V   RD  T +  A+K I    + T +++K       L E+ +L+ L H N++ L
Sbjct: 48  GAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK------LLEEVAVLKLLDHPNIMKL 101

Query: 123 TDVFGYMSNVSLVFEFVD-TDL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
            D F    N  LV E     +L + II      F   +        L G+ YLH H I+H
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEIIHRMK--FNEVDAAVIIKQVLSGVTYLHKHNIVH 159

Query: 181 RDLKPNNLLI---NKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWY 223
           RDLKP NLL+    K  ++KI DFGL+  F    +    ++ T +Y
Sbjct: 160 RDLKPENLLLESKEKDALIKIVDFGLSAVF-ENQKKMKERLGTAYY 204

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 95.6 bits (238), Expect = 7e-23
 Identities = 47/175 (26%), Positives = 67/175 (38%), Gaps = 28/175 (16%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL--- 122
           GR+  V+  +       VAVK       A            EI     + HEN+LG    
Sbjct: 48  GRYGEVWMGKWRGEK--VAVKVFFTTEEAS------WFRETEIYQTVLMRHENILGFIAA 99

Query: 123 -TDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHW--- 177
                G  + + L+ ++ +   L   +K  T+        AY+   + GL +LH      
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSS--VSGLCHLHTEIFST 157

Query: 178 -----ILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY----THQVVT-RW 222
                I HRDLK  N+L+ K G   I D GLA  F S T         +V T R+
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 96.3 bits (240), Expect = 1e-22
 Identities = 50/168 (29%), Positives = 92/168 (54%), Gaps = 18/168 (10%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHE------NV 119
           G F  V KA D +    VA+K ++       +   +R A  EI++L+ L  +      NV
Sbjct: 108 GSFGQVVKAYDHKVHQHVALKMVR------NEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161

Query: 120 LGLTDVFGYMSNVSLVFEFVDTDL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
           + + + F + +++ + FE +  +L E+I K+    F+   ++ +A   L+ L+ LH + I
Sbjct: 162 IHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRI 221

Query: 179 LHRDLKPNNLLINKQG--VLKIGDFGLAKFFGSPTRLYTHQVVTRWYR 224
           +H DLKP N+L+ +QG   +K+ DFG + +     R+YT+ + +R+YR
Sbjct: 222 IHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ--RVYTY-IQSRFYR 266

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 96.3 bits (240), Expect = 1e-22
 Identities = 52/164 (31%), Positives = 77/164 (46%), Gaps = 13/164 (7%)

Query: 66  GRFATVFKARDIETDMIVAVKKI-KLGTHADAKDGINRTALREIKLLQELHHENVLGLTD 124
           G F  V K +D  T    AVK I K          I    LRE++LL++L H N++ L +
Sbjct: 33  GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTI----LREVELLKKLDHPNIMKLFE 88

Query: 125 VFGYMSNVSLVFEFVD-TDL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
           +    S+  +V E     +L + IIK     F+  +          G+ Y+H H I+HRD
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKHNIVHRD 146

Query: 183 LKPNNLLI---NKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWY 223
           LKP N+L+    K   +KI DFGL+  F         ++ T +Y
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKMKDRIGTAYY 189

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 94.8 bits (236), Expect = 1e-22
 Identities = 38/161 (23%), Positives = 69/161 (42%), Gaps = 18/161 (11%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTD 124
           G FA V++A+D+ +    A+K++            NR  ++E+  +++L  H N++    
Sbjct: 39  GGFAFVYEAQDVGSGREYALKRLLSNEEEK-----NRAIIQEVCFMKKLSGHPNIVQFCS 93

Query: 125 VFGYMSNVS--------LVFEFVD-TDLEVIIK-DPTIVFTPSNIKAYAIMTLRGLEYLH 174
                   S        L+ E      +E + K +     +   +      T R ++++H
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153

Query: 175 DH--WILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL 213
                I+HRDLK  NLL++ QG +K+ DFG A         
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDY 194

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 94.2 bits (235), Expect = 1e-22
 Identities = 44/152 (28%), Positives = 75/152 (49%), Gaps = 4/152 (2%)

Query: 69  ATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY 128
           +TV+ A D   ++ VA+K I +       + + R   RE+    +L H+N++ + DV   
Sbjct: 25  STVYLAEDTILNIKVAIKAIFIPPREKE-ETLKRFE-REVHNSSQLSHQNIVSMIDVDEE 82

Query: 129 MSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNN 187
                LV E+++   L   I+      +      +    L G+++ HD  I+HRD+KP N
Sbjct: 83  DDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQN 141

Query: 188 LLINKQGVLKIGDFGLAKFFGSPTRLYTHQVV 219
           +LI+    LKI DFG+AK     +   T+ V+
Sbjct: 142 ILIDSNKTLKIFDFGIAKALSETSLTQTNHVL 173

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 94.7 bits (236), Expect = 1e-22
 Identities = 41/165 (24%), Positives = 65/165 (39%), Gaps = 27/165 (16%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTD 124
           G    V +     T    A+K +      D+       A +E+    +     +++ + D
Sbjct: 40  GVNGKVLECFHRRTGQKCALKLLY-----DSPK-----ARQEVDHHWQASGGPHIVCILD 89

Query: 125 VF----GYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAIMT--LRGLEYLHDH 176
           V+         + ++ E ++       I +     FT    +A  IM      +++LH H
Sbjct: 90  VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTER--EAAEIMRDIGTAIQFLHSH 147

Query: 177 WILHRDLKPNNLLI---NKQGVLKIGDFGLAKFFGSP---TRLYT 215
            I HRD+KP NLL     K  VLK+ DFG AK        T  YT
Sbjct: 148 NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYT 192

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 92.3 bits (230), Expect = 4e-22
 Identities = 51/153 (33%), Positives = 72/153 (47%), Gaps = 17/153 (11%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V++A  I  +  VAVK  +     D    I     +E KL   L H N++ L  V
Sbjct: 18  GGFGKVYRAFWIGDE--VAVKAARHDPDEDISQTIENV-RQEAKLFAMLKHPNIIALRGV 74

Query: 126 FGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH---WILHR 181
                N+ LV EF     L  ++    I   P  +  +A+   RG+ YLHD     I+HR
Sbjct: 75  CLKEPNLCLVMEFARGGPLNRVLSGKRI--PPDILVNWAVQIARGMNYLHDEAIVPIIHR 132

Query: 182 DLKPNNLLINKQG--------VLKIGDFGLAKF 206
           DLK +N+LI ++         +LKI DFGLA+ 
Sbjct: 133 DLKSSNILILQKVENGDLSNKILKITDFGLARE 165

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 91.9 bits (229), Expect = 1e-21
 Identities = 48/145 (33%), Positives = 69/145 (47%), Gaps = 10/145 (6%)

Query: 66  GRFATVFKARDIETDMIVAVK---KIKLGTHADAKDGINRTALREIKLLQELHHENVLGL 122
           G +  V +  D ET    AVK   K KL    + +  + +    EI+LL+ L H+NV+ L
Sbjct: 16  GSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKK----EIQLLRRLRHKNVIQL 71

Query: 123 TDVFGYMS--NVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWIL 179
            DV        + +V E+      E++   P   F       Y    + GLEYLH   I+
Sbjct: 72  VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIV 131

Query: 180 HRDLKPNNLLINKQGVLKIGDFGLA 204
           H+D+KP NLL+   G LKI   G+A
Sbjct: 132 HKDIKPGNLLLTTGGTLKISALGVA 156

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 92.5 bits (230), Expect = 1e-21
 Identities = 49/175 (28%), Positives = 68/175 (38%), Gaps = 28/175 (16%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL--- 122
           GRF  V++ +    +  VAVK                    EI     L HEN+LG    
Sbjct: 53  GRFGEVWRGKWRGEE--VAVKIFSSREERSWF------REAEIYQTVMLRHENILGFIAA 104

Query: 123 -TDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHW--- 177
                G  + + LV ++ +   L   +   T+  T   +   A+ T  GL +LH      
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTV--TVEGMIKLALSTASGLAHLHMEIVGT 162

Query: 178 -----ILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY----THQVVT-RW 222
                I HRDLK  N+L+ K G   I D GLA    S T        H+V T R+
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 91.6 bits (228), Expect = 2e-21
 Identities = 44/150 (29%), Positives = 63/150 (42%), Gaps = 17/150 (11%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTD 124
           G  A V    ++ T    AVK I+                RE+++L +   H NVL L +
Sbjct: 24  GAHARVQTCINLITSQEYAVKIIEKQPGHIRSR-----VFREVEMLYQCQGHRNVLELIE 78

Query: 125 VFGYMSNVSLVFEFVD--TDLEVIIKDPTIVFTPSNIKAYAIMT--LRGLEYLHDHWILH 180
            F       LVFE +   + L  I K     F     +A  ++      L++LH+  I H
Sbjct: 79  FFEEEDRFYLVFEKMRGGSILSHIHKRRH--FNEL--EASVVVQDVASALDFLHNKGIAH 134

Query: 181 RDLKPNNLLI---NKQGVLKIGDFGLAKFF 207
           RDLKP N+L    N+   +KI DF L    
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGI 164

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 91.3 bits (227), Expect = 2e-21
 Identities = 41/175 (23%), Positives = 61/175 (34%), Gaps = 28/175 (16%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL--- 122
           GR+  V++      +  VAVK                    E+     L HEN+LG    
Sbjct: 19  GRYGEVWRGSWQGEN--VAVKIFSSRDEKSWF------RETELYNTVMLRHENILGFIAS 70

Query: 123 -TDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHW--- 177
                   + + L+  + +   L   ++  T+          +I    GL +LH      
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIA--SGLAHLHIEIFGT 128

Query: 178 -----ILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY----THQVVT-RW 222
                I HRDLK  N+L+ K G   I D GLA      T         +V T R+
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 90.8 bits (226), Expect = 2e-21
 Identities = 40/152 (26%), Positives = 61/152 (40%), Gaps = 24/152 (15%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTD 124
           G    V +  +  T    A+K ++     D        A RE++L        +++ + D
Sbjct: 29  GINGKVLQIFNKRTQEKFALKMLQ-----DCPK-----ARREVELHWRASQCPHIVRIVD 78

Query: 125 VF----GYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAIMT--LRGLEYLHDH 176
           V+         + +V E +D       I       FT    +A  IM      ++YLH  
Sbjct: 79  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER--EASEIMKSIGEAIQYLHSI 136

Query: 177 WILHRDLKPNNLLI---NKQGVLKIGDFGLAK 205
            I HRD+KP NLL        +LK+ DFG AK
Sbjct: 137 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 91.2 bits (227), Expect = 2e-21
 Identities = 35/163 (21%), Positives = 70/163 (42%), Gaps = 22/163 (13%)

Query: 66  GRFATVFKARDIETDMIVAVK---KIKLGTHADAKDGINRTALREIKLLQELHHE--NVL 120
           G F +V+    +  ++ VA+K   K ++    +  +G       E+ LL+++      V+
Sbjct: 54  GGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG--TRVPMEVVLLKKVSSGFSGVI 111

Query: 121 GLTDVFGYMSNVSLVFEFVDTDLEV---IIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHW 177
            L D F    +  L+ E  +   ++   I +   +       +++    L  + + H+  
Sbjct: 112 RLLDWFERPDSFVLILERPEPVQDLFDFITERGAL--QEELARSFFWQVLEAVRHCHNCG 169

Query: 178 ILHRDLKPNNLLIN-KQGVLKIGDFGLAKFF---------GSP 210
           +LHRD+K  N+LI+  +G LK+ DFG              G+ 
Sbjct: 170 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR 212

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 92.0 bits (228), Expect = 2e-21
 Identities = 20/177 (11%), Positives = 51/177 (28%), Gaps = 31/177 (17%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKD--------------------GINRTAL 105
                  +A D ET     V          +                         +  L
Sbjct: 84  EDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHL 143

Query: 106 REIKLLQELHHENVLGLTDVFG-----YMSNVSLVFEFVDTDLEVIIKD------PTIVF 154
           R I     +       +  V       ++ +   ++  + ++L+   +            
Sbjct: 144 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSL 203

Query: 155 TPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT 211
                    +  +R L  LH + ++H  L+P +++++++G + +  F      G+  
Sbjct: 204 VHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARV 260

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 91.2 bits (227), Expect = 2e-21
 Identities = 46/166 (27%), Positives = 72/166 (43%), Gaps = 20/166 (12%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTD 124
           G F+   K    +++   AVK I     A+ +        +EI  L+    H N++ L +
Sbjct: 22  GSFSICRKCVHKKSNQAFAVKIISKRMEANTQ--------KEITALKLCEGHPNIVKLHE 73

Query: 125 VFGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAIM--TLRGLEYLHDHWILH 180
           VF    +  LV E ++     E I K     F+ +  +A  IM   +  + ++HD  ++H
Sbjct: 74  VFHDQLHTFLVMELLNGGELFERIKKKKH--FSET--EASYIMRKLVSAVSHMHDVGVVH 129

Query: 181 RDLKPNNLLI---NKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWY 223
           RDLKP NLL    N    +KI DFG A+      +       T  Y
Sbjct: 130 RDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHY 175

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 91.7 bits (228), Expect = 3e-21
 Identities = 48/182 (26%), Positives = 76/182 (41%), Gaps = 32/182 (17%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH---------- 115
           G F+TV+ A+D+  +  VA+K ++              A  EIKLLQ ++          
Sbjct: 30  GHFSTVWLAKDMVNNTHVAMKIVR------GDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83

Query: 116 -HENVLGLTDVFGYMSNVS----LVFEFVDTDL-EVIIKDPTIVFTPSNIKAYAIMTLRG 169
              ++L L D F +         +VFE +  +L  +I K          +K  +   L G
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 143

Query: 170 LEYLHDHW-ILHRDLKPNNLLIN------KQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW 222
           L+Y+H    I+H D+KP N+L+           +KI D G A +           + TR 
Sbjct: 144 LDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW--YDEHYTNS-IQTRE 200

Query: 223 YR 224
           YR
Sbjct: 201 YR 202

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 90.9 bits (226), Expect = 4e-21
 Identities = 45/152 (29%), Positives = 72/152 (47%), Gaps = 23/152 (15%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTD 124
           G +  V+K R ++T  + A+K + + T  + ++        EI +L++  HH N+     
Sbjct: 35  GTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQ-----EINMLKKYSHHRNIATYYG 88

Query: 125 VFGYMSNVS------LVFEFVD----TDLEVIIKDPTIVFTPSNIKAYAIM--TLRGLEY 172
            F   +         LV EF      TDL    K  T       I AY I    LRGL +
Sbjct: 89  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT--LKEEWI-AY-ICREILRGLSH 144

Query: 173 LHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           LH H ++HRD+K  N+L+ +   +K+ DFG++
Sbjct: 145 LHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 92.6 bits (230), Expect = 4e-21
 Identities = 33/152 (21%), Positives = 63/152 (41%), Gaps = 25/152 (16%)

Query: 66  GRFATVFKARDIETDM-IVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTD 124
           G    ++ A D   +   V +K +     A+A+      A+ E + L E+ H +++ + +
Sbjct: 91  GGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQ----AMAMAERQFLAEVVHPSIVQIFN 146

Query: 125 V----------FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYL 173
                       GY     +V E+V    L+            +   AY +  L  L YL
Sbjct: 147 FVEHTDRHGDPVGY-----IVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYL 198

Query: 174 HDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           H   +++ DLKP N+++ ++ + K+ D G   
Sbjct: 199 HSIGLVYNDLKPENIMLTEEQL-KLIDLGAVS 229

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 89.4 bits (222), Expect = 6e-21
 Identities = 21/142 (14%), Positives = 43/142 (30%), Gaps = 10/142 (7%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
                 ++A D   D  VA+  +         D +    L     L  +    V  + DV
Sbjct: 42  VPPLQFWQALDTALDRQVALTFVDPQGVLPD-DVLQE-TLSRTLRLSRIDKPGVARVLDV 99

Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMT--LRGLEYLHDHWILHRD 182
               +   +V E++    L+ +         PS + A   M       +  H   +    
Sbjct: 100 VHTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAGVALSI 154

Query: 183 LKPNNLLINKQGVLKIGDFGLA 204
             P+ + ++  G + +      
Sbjct: 155 DHPSRVRVSIDGDVVLAYPATM 176

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 90.0 bits (224), Expect = 8e-21
 Identities = 46/159 (28%), Positives = 77/159 (48%), Gaps = 22/159 (13%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIK-LLQELHHENVLGLTD 124
           G ++   +     T+M  AVK I       +K    R    EI+ LL+   H N++ L D
Sbjct: 33  GSYSVCKRCIHKATNMEFAVKIID-----KSK----RDPTEEIEILLRYGQHPNIITLKD 83

Query: 125 VFGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAIMT--LRGLEYLHDHWILH 180
           V+     V +V E +     L+ I++     F+    +A A++    + +EYLH   ++H
Sbjct: 84  VYDDGKYVYVVTELMKGGELLDKILRQKF--FSER--EASAVLFTITKTVEYLHAQGVVH 139

Query: 181 RDLKPNNLL-INKQG---VLKIGDFGLAKFFGSPTRLYT 215
           RDLKP+N+L +++ G    ++I DFG AK   +   L  
Sbjct: 140 RDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM 178

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 89.8 bits (223), Expect = 1e-20
 Identities = 50/219 (22%), Positives = 94/219 (42%), Gaps = 31/219 (14%)

Query: 28  SSVWYIRVHSALKKQYLLPDCE---------VKNDLLV--YYQWRSVHVGRFATVFKARD 76
            ++++  + S  K++ +  D              +  +  Y     +  G F  V KA D
Sbjct: 16  ENLYFQSMSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYD 75

Query: 77  IETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHE------NVLGLTDVFGYMS 130
                 VA+K IK       K      A  E++LL+ ++         ++ L   F + +
Sbjct: 76  RVEQEWVAIKIIK------NKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129

Query: 131 NVSLVFEFVDTDL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHW--ILHRDLKPNN 187
           ++ LVFE +  +L +++        + +  + +A      L +L      I+H DLKP N
Sbjct: 130 HLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPEN 189

Query: 188 LLI--NKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYR 224
           +L+   K+  +KI DFG +   G   R+Y + + +R+YR
Sbjct: 190 ILLCNPKRSAIKIVDFGSSCQLGQ--RIYQY-IQSRFYR 225

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 88.5 bits (220), Expect = 2e-20
 Identities = 43/157 (27%), Positives = 75/157 (47%), Gaps = 15/157 (9%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL----REIKLLQELHHENVLG 121
           G FA V  AR I T   VA+K I        K  +N T+L    RE+++++ L+H N++ 
Sbjct: 26  GNFAKVKLARHILTGREVAIKIID-------KTQLNPTSLQKLFREVRIMKILNHPNIVK 78

Query: 122 LTDVFGYMSNVSLVFEFVDT-DL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWIL 179
           L +V      + L+ E+    ++ + ++    +       ++     +  ++Y H   I+
Sbjct: 79  LFEVIETEKTLYLIMEYASGGEVFDYLVAHGRM--KEKEARSKFRQIVSAVQYCHQKRIV 136

Query: 180 HRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTH 216
           HRDLK  NLL++    +KI DFG +  F    +L   
Sbjct: 137 HRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF 173

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 87.3 bits (217), Expect = 3e-20
 Identities = 45/144 (31%), Positives = 70/144 (48%), Gaps = 8/144 (5%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A +  T+  VAVK + +    D  + I +    EI + + L+HENV+     
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVKFYGH 73

Query: 126 FGYMSNVSLVFEFVDT-DL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
               +   L  E+    +L + I  D  I     + + +    + G+ YLH   I HRD+
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDI 131

Query: 184 KPNNLLINKQGVLKIGDFGLAKFF 207
           KP NLL++++  LKI DFGLA  F
Sbjct: 132 KPENLLLDERDNLKISDFGLATVF 155

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 87.3 bits (217), Expect = 5e-20
 Identities = 39/153 (25%), Positives = 63/153 (41%), Gaps = 8/153 (5%)

Query: 69  ATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV--- 125
           + V  ARD+     VAVK ++     D      R   RE +    L+H  ++ + D    
Sbjct: 26  SEVHLARDLRDHRDVAVKVLRADLARDP-SFYLRFR-REAQNAAALNHPAIVAVYDTGEA 83

Query: 126 -FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
                    +V E+VD   L  I+       TP           + L + H + I+HRD+
Sbjct: 84  ETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNGIIHRDV 142

Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTH 216
           KP N++I+    +K+ DFG+A+         T 
Sbjct: 143 KPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 87.6 bits (217), Expect = 6e-20
 Identities = 38/159 (23%), Positives = 55/159 (34%), Gaps = 25/159 (15%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL--- 122
           GR+  V+K    E    VAVK        +          + I  +  + H+N+      
Sbjct: 24  GRYGAVYKGSLDERP--VAVKVFSFANRQNFI------NEKNIYRVPLMEHDNIARFIVG 75

Query: 123 --TDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHW-- 177
                        LV E+     L   +   T  +  S   A+++   RGL YLH     
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVT--RGLAYLHTELPR 133

Query: 178 -------ILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS 209
                  I HRDL   N+L+   G   I DFGL+     
Sbjct: 134 GDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 86.9 bits (216), Expect = 8e-20
 Identities = 45/156 (28%), Positives = 75/156 (48%), Gaps = 15/156 (9%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL-----REIKLLQELHHENVL 120
           G F  V  A   +T   VA+K I        +  + ++ +     REI  L+ L H +++
Sbjct: 20  GSFGKVKLATHYKTQQKVALKFIS-------RQLLKKSDMHMRVEREISYLKLLRHPHII 72

Query: 121 GLTDVFGYMSNVSLVFEFVDTDL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWIL 179
            L DV    +++ +V E+   +L + I++   +  T    + +    +  +EY H H I+
Sbjct: 73  KLYDVITTPTDIVMVIEYAGGELFDYIVEKKRM--TEDEGRRFFQQIICAIEYCHRHKIV 130

Query: 180 HRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYT 215
           HRDLKP NLL++    +KI DFGL+        L T
Sbjct: 131 HRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT 166

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 86.6 bits (215), Expect = 9e-20
 Identities = 35/165 (21%), Positives = 66/165 (40%), Gaps = 24/165 (14%)

Query: 66  GRFATVFKARDIETDMIVAVK---KIKLGTHADAKDGINRTALREIKLLQELH----HEN 118
           G F TVF    +   + VA+K   + ++   +   D +      E+ LL ++     H  
Sbjct: 42  GGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCP--LEVALLWKVGAGGGHPG 99

Query: 119 VLGLTDVFGYMSNVSLVFEFVDTDLEV---IIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
           V+ L D F       LV E      ++   I +   +       + +    +  +++ H 
Sbjct: 100 VIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPL--GEGPSRCFFGQVVAAIQHCHS 157

Query: 176 HWILHRDLKPNNLLIN-KQGVLKIGDFGLAKFF---------GSP 210
             ++HRD+K  N+LI+ ++G  K+ DFG              G+ 
Sbjct: 158 RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTR 202

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 87.0 bits (216), Expect = 9e-20
 Identities = 45/144 (31%), Positives = 70/144 (48%), Gaps = 8/144 (5%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A +  T+  VAVK + +    D  + I +    EI + + L+HENV+     
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVKFYGH 73

Query: 126 FGYMSNVSLVFEFVDT-DL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
               +   L  E+    +L + I  D  I     + + +    + G+ YLH   I HRD+
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDI 131

Query: 184 KPNNLLINKQGVLKIGDFGLAKFF 207
           KP NLL++++  LKI DFGLA  F
Sbjct: 132 KPENLLLDERDNLKISDFGLATVF 155

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 86.7 bits (215), Expect = 1e-19
 Identities = 47/175 (26%), Positives = 70/175 (40%), Gaps = 27/175 (15%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL--- 122
           GRF  V+KA+ +     VAVK   +      +         E+  L  + HEN+L     
Sbjct: 35  GRFGCVWKAQLLNEY--VAVKIFPIQDKQSWQ------NEYEVYSLPGMKHENILQFIGA 86

Query: 123 -TDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHW--- 177
                    ++ L+  F +   L   +K   +  + + +   A    RGL YLH+     
Sbjct: 87  EKRGTSVDVDLWLITAFHEKGSLSDFLKANVV--SWNELCHIAETMARGLAYLHEDIPGL 144

Query: 178 -------ILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS-PTRLYTHQVV-TRWY 223
                  I HRD+K  N+L+       I DFGLA  F +  +   TH  V TR Y
Sbjct: 145 KDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRY 199

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 86.5 bits (214), Expect = 1e-19
 Identities = 38/230 (16%), Positives = 74/230 (32%), Gaps = 48/230 (20%)

Query: 107 EIKLLQELHHENVLGLTDVFGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIM 165
           +I+ +     +N +G          + +  +     +L+  +     +    +     I 
Sbjct: 111 KIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIF 170

Query: 166 T--LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT------------ 211
                 +E+LH   ++HRDLKP+N+      V+K+GDFGL                    
Sbjct: 171 IQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 230

Query: 212 RLYTHQVVTRWYR---LIK--------------CLLY--CVQFNVKNVQWCCFAKDPSSH 252
             +T QV T+ Y     I                +L+     F                 
Sbjct: 231 ATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSF-----------STQMER 279

Query: 253 GNLFPGI---PLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF 299
             +   +       +FT        ++  +L  +PT+R + T  ++   F
Sbjct: 280 VRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIF 329

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 52.6 bits (126), Expect = 4e-08
 Identities = 23/126 (18%), Positives = 43/126 (34%), Gaps = 5/126 (3%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  VF+A++   D   A+K+I+L     A+       +RE+K L +L H  ++   + 
Sbjct: 17  GGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR----EKVMREVKALAKLEHPGIVRYFNA 72

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT-LRGLEYLHDHWILHRDLK 184
           +          E  +  L+    D  +            +  +      +    L     
Sbjct: 73  WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132

Query: 185 PNNLLI 190
              L I
Sbjct: 133 KVYLYI 138

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 85.8 bits (213), Expect = 2e-19
 Identities = 34/155 (21%), Positives = 61/155 (39%), Gaps = 10/155 (6%)

Query: 69  ATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY 128
             V++A D   + IVA+K +     +D      R   RE +    L   +V+ + D  G 
Sbjct: 48  GDVYEAEDTVRERIVALKLMSETLSSDP-VFRTRM-QREARTAGRLQEPHVVPIHDF-GE 104

Query: 129 MSNVS-LVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMT--LRGLEYLHDHWILHRDLK 184
           +     +    ++  DL  +++        +  +A AI+      L+  H     HRD+K
Sbjct: 105 IDGQLYVDMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVK 161

Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVV 219
           P N+L++      + DFG+A              V
Sbjct: 162 PENILVSADDFAYLVDFGIASATTDEKLTQLGNTV 196

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 84.2 bits (209), Expect = 4e-19
 Identities = 41/159 (25%), Positives = 63/159 (39%), Gaps = 20/159 (12%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL-----REIKLLQELHHENVL 120
           G F  V       T   VAVK +        +  I    +     REI+ L+   H +++
Sbjct: 22  GTFGKVKIGEHQLTGHKVAVKILN-------RQKIRSLDVVGKIKREIQNLKLFRHPHII 74

Query: 121 GLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIV----FTPSNIKAYAIMTLRGLEYLHDH 176
            L  V    ++  +V E+V    E+      I           +      L  ++Y H H
Sbjct: 75  KLYQVISTPTDFFMVMEYVSGG-ELFDY---ICKHGRVEEMEARRLFQQILSAVDYCHRH 130

Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYT 215
            ++HRDLKP N+L++     KI DFGL+        L T
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT 169

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 85.0 bits (210), Expect = 7e-19
 Identities = 34/176 (19%), Positives = 58/176 (32%), Gaps = 33/176 (18%)

Query: 66  GRFATVFKAR-----DIETDMIVAVKKIKLGTHADAKDGIN--RTALREIKLLQELHHEN 118
           G FA V++A      D +      +K  K                  + ++ L+      
Sbjct: 76  GAFAQVYEATQGDLNDAKNKQKFVLKVQK-------PANPWEFYIGTQLMERLKPSMQHM 128

Query: 119 VLGLTDVFGYMSNVSLVFEFVD--TDLEVIIK---DPTIVFTPSNIKAYAIMTLRGLEYL 173
            +       + +   LV E     T L  I      P  V     + ++A+  L  +E +
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188

Query: 174 HDHWILHRDLKPNNLLINKQ-----------GVLKIGDFGLA---KFFGSPTRLYT 215
           HD  I+H D+KP+N ++                L + D G +   K F   T    
Sbjct: 189 HDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA 244

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 82.0 bits (203), Expect = 3e-18
 Identities = 42/164 (25%), Positives = 72/164 (43%), Gaps = 11/164 (6%)

Query: 66  GRFATVFKAR----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F  V   R       T   VAVK +K  +  +    +     +EI++L+ L+HEN++ 
Sbjct: 32  GHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADL----KKEIEILRNLYHENIVK 87

Query: 122 LTDV--FGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
              +      + + L+ EF+ +  L+  +              YA+   +G++YL     
Sbjct: 88  YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQY 147

Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW 222
           +HRDL   N+L+  +  +KIGDFGL K   +    YT +     
Sbjct: 148 VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDS 191

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 82.2 bits (204), Expect = 4e-18
 Identities = 51/170 (30%), Positives = 75/170 (44%), Gaps = 30/170 (17%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTD- 124
           G F  V+K R +    +VAVK++K         G       E++++    H N+L L   
Sbjct: 41  GGFGKVYKGR-LADGTLVAVKRLKEERTQ----GGELQFQTEVEMISMAVHRNLLRLRGF 95

Query: 125 ---------VFGYMSNVSLVFEFVDTDLEVIIKD-PTIVFTPSNIKAYAIMTLRGLEYLH 174
                    V+ YM+N S+     +        D P        I   A+ + RGL YLH
Sbjct: 96  CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ----RI---ALGSARGLAYLH 148

Query: 175 DHW---ILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTR 221
           DH    I+HRD+K  N+L++++    +GDFGLAK         TH V T 
Sbjct: 149 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK---DTH-VTTA 194

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 82.0 bits (203), Expect = 4e-18
 Identities = 44/164 (26%), Positives = 70/164 (42%), Gaps = 12/164 (7%)

Query: 66  GRFATVFKAR----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F +V   R       T  +VAVKK++  T    +D       REI++L+ L H+N++ 
Sbjct: 52  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----FEREIEILKSLQHDNIVK 106

Query: 122 LTDV--FGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
              V       N+ L+ E++    L   ++          +  Y     +G+EYL     
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 166

Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW 222
           +HRDL   N+L+  +  +KIGDFGL K        Y  +     
Sbjct: 167 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGES 210

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 80.4 bits (199), Expect = 1e-17
 Identities = 43/164 (26%), Positives = 70/164 (42%), Gaps = 12/164 (7%)

Query: 66  GRFATVFKAR----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F +V   R       T  +VAVKK++  T    +D       REI++L+ L H+N++ 
Sbjct: 21  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----FEREIEILKSLQHDNIVK 75

Query: 122 LTDV--FGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
              V       N+ L+ E++    L   ++          +  Y     +G+EYL     
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 135

Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW 222
           +HRDL   N+L+  +  +KIGDFGL K        +  +     
Sbjct: 136 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES 179

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 81.3 bits (201), Expect = 1e-17
 Identities = 42/154 (27%), Positives = 67/154 (43%), Gaps = 12/154 (7%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F      RD  T  +VAVK I      +    I+    REI   + L H N++   +V
Sbjct: 31  GNFGVARLMRDKLTKELVAVKYI------ERGAAIDENVQREIINHRSLRHPNIVRFKEV 84

Query: 126 FGYMSNVSLVFEFVDT-DL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
               ++++++ E+    +L E I       F+    + +    L G+ Y H   I HRDL
Sbjct: 85  ILTPTHLAIIMEYASGGELYERICNAGR--FSEDEARFFFQQLLSGVSYCHSMQICHRDL 142

Query: 184 KPNNLLI--NKQGVLKIGDFGLAKFFGSPTRLYT 215
           K  N L+  +    LKI DFG +K     ++  +
Sbjct: 143 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 176

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 81.8 bits (202), Expect = 2e-17
 Identities = 43/163 (26%), Positives = 65/163 (39%), Gaps = 28/163 (17%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL-----REIKLLQELHHENVL 120
           G F  V   +   T   VAVK +        +  I    +     REI+ L+   H +++
Sbjct: 27  GTFGKVKVGKHELTGHKVAVKILN-------RQKIRSLDVVGKIRREIQNLKLFRHPHII 79

Query: 121 GLTDVFGYMSNVSLVFEFVDT----DLEVIIKDPTIV----FTPSNIKAYAIMTLRGLEY 172
            L  V    S++ +V E+V      D         I           +      L G++Y
Sbjct: 80  KLYQVISTPSDIFMVMEYVSGGELFDY--------ICKNGRLDEKESRRLFQQILSGVDY 131

Query: 173 LHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYT 215
            H H ++HRDLKP N+L++     KI DFGL+        L T
Sbjct: 132 CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT 174

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 80.0 bits (198), Expect = 3e-17
 Identities = 42/152 (27%), Positives = 73/152 (48%), Gaps = 14/152 (9%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRT-----ALREIKLLQELHHENVL 120
           G F  V   +  E+    A+K +        K  + +       L E ++LQ ++   ++
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILD-------KQKVVKLKQIEHTLNEKRILQAVNFPFLV 104

Query: 121 GLTDVFGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWIL 179
            L   F   SN+ +V E+V   ++   ++     F+  + + YA   +   EYLH   ++
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLHSLDLI 163

Query: 180 HRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT 211
           +RDLKP NLLI++QG +++ DFG AK     T
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 80.6 bits (199), Expect = 4e-17
 Identities = 40/152 (26%), Positives = 66/152 (43%), Gaps = 4/152 (2%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V   +   T  + A KK++       + G     L E ++L++++   V+ L   
Sbjct: 195 GGFGEVCACQVRATGKMYACKKLEKK-RIKKRKGEAMA-LNEKQILEKVNSRFVVSLAYA 252

Query: 126 FGYMSNVSLVFEFVDT-DLEV-IIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
           +     + LV   ++  DL+  I       F  +    YA     GLE LH   I++RDL
Sbjct: 253 YETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDL 312

Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTRLYT 215
           KP N+L++  G ++I D GLA        +  
Sbjct: 313 KPENILLDDHGHIRISDLGLAVHVPEGQTIKG 344

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 79.3 bits (196), Expect = 5e-17
 Identities = 47/190 (24%), Positives = 77/190 (40%), Gaps = 40/190 (21%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-----HHENVL 120
           G F  V   + I+     AVK ++            R+A  E  +L+++     ++ N++
Sbjct: 46  GTFGRVLLCQHIDNKKYYAVKVVR------NIKKYTRSAKIEADILKKIQNDDINNNNIV 99

Query: 121 GLTDVFGYMSNVSLVFEFVDTDL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWIL 179
                F Y  ++ L+FE +   L E+I ++    F   +IK Y I  L+ L YL    + 
Sbjct: 100 KYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLT 159

Query: 180 HRDLKPNNLLIN-------------------------KQGVLKIGDFGLAKFFGSPTRLY 214
           H DLKP N+L++                         K   +K+ DFG A F        
Sbjct: 160 HTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHG 217

Query: 215 THQVVTRWYR 224
           +  + TR YR
Sbjct: 218 SI-INTRQYR 226

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 78.7 bits (195), Expect = 5e-17
 Identities = 41/165 (24%), Positives = 75/165 (45%), Gaps = 21/165 (12%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V+K   +  +  VAVKK+        ++   +   +EIK++ +  HEN++ L   
Sbjct: 42  GGFGVVYKGY-VN-NTTVAVKKLAAMVDITTEEL-KQQFDQEIKVMAKCQHENLVEL--- 95

Query: 126 FGY---MSNVSLVFEFV-DTDLEVIIKDPTIVFTPS-----NIKAYAIMTLRGLEYLHDH 176
            G+     ++ LV+ ++ +  L   +         S      I   A     G+ +LH++
Sbjct: 96  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKI---AQGAANGINFLHEN 152

Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTR 221
             +HRD+K  N+L+++    KI DFGLA+         T  + +R
Sbjct: 153 HHIHRDIKSANILLDEAFTAKISDFGLARAS--EKFAQTV-MTSR 194

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 76.8 bits (190), Expect = 3e-16
 Identities = 41/156 (26%), Positives = 66/156 (42%), Gaps = 22/156 (14%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRT-----ALREIKLLQELHHENVL 120
           G F  V   R        A+K +K       K+ + R         E  +L  + H  ++
Sbjct: 17  GSFGRVHLIRSRHNGRYYAMKVLK-------KEIVVRLKQVEHTNDERLMLSIVTHPFII 69

Query: 121 GLTDVFGYMSNVSLVFEFVD-----TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
            +   F     + ++ ++++     + L    +     F     K YA      LEYLH 
Sbjct: 70  RMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR-----FPNPVAKFYAAEVCLALEYLHS 124

Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT 211
             I++RDLKP N+L++K G +KI DFG AK+    T
Sbjct: 125 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 160

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 76.1 bits (188), Expect = 5e-16
 Identities = 42/146 (28%), Positives = 65/146 (44%), Gaps = 14/146 (9%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRT-----ALREIKLLQELHHENVL 120
           G F+TV  AR++ T    A+K ++       K  I +        RE  ++  L H   +
Sbjct: 41  GSFSTVVLARELATSREYAIKILE-------KRHIIKENKVPYVTRERDVMSRLDHPFFV 93

Query: 121 GLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWIL 179
            L   F     +     +    +L   I+     F  +  + Y    +  LEYLH   I+
Sbjct: 94  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYLHGKGII 152

Query: 180 HRDLKPNNLLINKQGVLKIGDFGLAK 205
           HRDLKP N+L+N+   ++I DFG AK
Sbjct: 153 HRDLKPENILLNEDMHIQITDFGTAK 178

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 76.5 bits (189), Expect = 5e-16
 Identities = 39/142 (27%), Positives = 62/142 (43%), Gaps = 5/142 (3%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  VF  R    + +VAVK  +     D K       L+E ++L++  H N++ L  V
Sbjct: 125 GNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKF----LQEARILKQYSHPNIVRLIGV 180

Query: 126 FGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
                 + +V E V   D    ++          +         G+EYL     +HRDL 
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLA 240

Query: 185 PNNLLINKQGVLKIGDFGLAKF 206
             N L+ ++ VLKI DFG+++ 
Sbjct: 241 ARNCLVTEKNVLKISDFGMSRE 262

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 75.7 bits (187), Expect = 6e-16
 Identities = 38/163 (23%), Positives = 66/163 (40%), Gaps = 28/163 (17%)

Query: 66  GRFATVFKAR-----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENV 119
           G F  V +A        +  M VAVK +K   H   ++ +    + E+K+L  L +H N+
Sbjct: 34  GAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREAL----MSELKVLSYLGNHMNI 89

Query: 120 LGL----TD------VFGYMSNVSL--------VFEFVDTDLEVIIKDPTIVFTPSNIKA 161
           + L    T       +  Y     L                   I++D  +     ++ +
Sbjct: 90  VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149

Query: 162 YAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
           ++    +G+ +L     +HRDL   N+L+    + KI DFGLA
Sbjct: 150 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 75.5 bits (186), Expect = 9e-16
 Identities = 43/164 (26%), Positives = 71/164 (43%), Gaps = 13/164 (7%)

Query: 66  GRFATVFKAR----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F  V        +  T  +VAVK +K       + G      +EI +L+ L+HE+++ 
Sbjct: 42  GHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGW----KQEIDILRTLYHEHIIK 97

Query: 122 LTDV--FGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
                     +++ LV E+V    L   +   +I    + +  +A     G+ YLH    
Sbjct: 98  YKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSI--GLAQLLLFAQQICEGMAYLHAQHY 155

Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW 222
           +HRDL   N+L++   ++KIGDFGLAK        Y  +     
Sbjct: 156 IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 199

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 75.4 bits (186), Expect = 9e-16
 Identities = 42/184 (22%), Positives = 74/184 (40%), Gaps = 32/184 (17%)

Query: 66  GRFATVFKARDIET-DMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHE------N 118
           G F  V +  D +     VAVK +K        D     A  EI++L+ L+         
Sbjct: 25  GAFGKVVECIDHKAGGRHVAVKIVK------NVDRYCEAARSEIQVLEHLNTTDPNSTFR 78

Query: 119 VLGLTDVFGYMSNVSLVFEFVDTDL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHW 177
            + + + F +  ++ +VFE +     + I ++  + F   +I+  A    + + +LH + 
Sbjct: 79  CVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK 138

Query: 178 ILHRDLKPNNLLINKQGVLKIGDFGLAKF-------------FGSPT----RLYTHQVVT 220
           + H DLKP N+L  +    +  +  + +              FGS T       T  V T
Sbjct: 139 LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTL-VST 197

Query: 221 RWYR 224
           R YR
Sbjct: 198 RHYR 201

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 76.4 bits (188), Expect = 1e-15
 Identities = 39/144 (27%), Positives = 66/144 (45%), Gaps = 6/144 (4%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  VF  +   T  + A KK+        + G     + E K+L ++H   ++ L   
Sbjct: 196 GGFGEVFACQMKATGKLYACKKLNKK-RLKKRKGYQGA-MVEKKILAKVHSRFIVSLAYA 253

Query: 126 FGYMSNVSLVFEFVDT-DLE---VIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
           F   +++ LV   ++  D+      + +    F       Y    + GLE+LH   I++R
Sbjct: 254 FETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYR 313

Query: 182 DLKPNNLLINKQGVLKIGDFGLAK 205
           DLKP N+L++  G ++I D GLA 
Sbjct: 314 DLKPENVLLDDDGNVRISDLGLAV 337

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 75.4 bits (186), Expect = 1e-15
 Identities = 40/186 (21%), Positives = 72/186 (38%), Gaps = 36/186 (19%)

Query: 66  GRFATVFKARD-IETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHE------N 118
           G F  V +  D       VA+K I+              A  EI +L+++  +       
Sbjct: 30  GTFGKVVECLDHARGKSQVALKIIR------NVGKYREAARLEINVLKKIKEKDKENKFL 83

Query: 119 VLGLTDVFGYMSNVSLVFEFVDTDL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHW 177
            + ++D F +  ++ + FE +  +  E + ++    +   +++  A      L +LH++ 
Sbjct: 84  CVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ 143

Query: 178 ILHRDLKPNNLLIN-------------------KQGVLKIGDFGLAKFFGSPTRLYTHQV 218
           + H DLKP N+L                     K   +++ DFG A F        T  V
Sbjct: 144 LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE--HHTTI-V 200

Query: 219 VTRWYR 224
            TR YR
Sbjct: 201 ATRHYR 206

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 75.1 bits (185), Expect = 1e-15
 Identities = 42/164 (25%), Positives = 72/164 (43%), Gaps = 12/164 (7%)

Query: 66  GRFATVFKAR----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F +V   R       T  +VAVK+++       +D       REI++L+ LH + ++ 
Sbjct: 34  GNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD-----FQREIQILKALHSDFIVK 88

Query: 122 LTDV--FGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
              V       ++ LV E++ +  L   ++        S +  Y+    +G+EYL     
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRC 148

Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW 222
           +HRDL   N+L+  +  +KI DFGLAK        Y  +   + 
Sbjct: 149 VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 192

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 74.6 bits (184), Expect = 1e-15
 Identities = 46/161 (28%), Positives = 66/161 (40%), Gaps = 28/161 (17%)

Query: 66  GRFATVFKAR-----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           G F  VF A        +  M+VAVK +K  T A  KD       RE +LL  L HE+++
Sbjct: 26  GAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD-----FQREAELLTNLQHEHIV 80

Query: 121 GL----TD------VFGYMSNVSLVFEF-------VDTDLEVIIKDPTIVFTPSNIKAYA 163
                  D      VF YM +  L  +F           ++   +        S +   A
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLN-KFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139

Query: 164 IMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
                G+ YL     +HRDL   N L+    ++KIGDFG++
Sbjct: 140 SQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 29/146 (19%), Positives = 59/146 (40%), Gaps = 13/146 (8%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGI---NRTA--LREIKLLQELHHENVL 120
           G F+ V   +  +T  + A+K +        K  +      +    E  +L       + 
Sbjct: 72  GAFSEVAVVKMKQTGQVYAMKIMN-------KWDMLKRGEVSCFREERDVLVNGDRRWIT 124

Query: 121 GLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWIL 179
            L   F   + + LV E+    DL  ++            + Y    +  ++ +H    +
Sbjct: 125 QLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYV 184

Query: 180 HRDLKPNNLLINKQGVLKIGDFGLAK 205
           HRD+KP+N+L+++ G +++ DFG   
Sbjct: 185 HRDIKPDNILLDRCGHIRLADFGSCL 210

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 74.5 bits (184), Expect = 2e-15
 Identities = 41/167 (24%), Positives = 74/167 (44%), Gaps = 25/167 (14%)

Query: 65  VGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTD 124
            G F  V+K   +     VA+K+       ++  G       EI+ L    H +++ L  
Sbjct: 49  HGVFGKVYKGV-LRDGAKVALKRRT----PESSQG-IEEFETEIETLSFCRHPHLVSL-- 100

Query: 125 VFGY---MSNVSLVFEFVDT-DLEVIIKDPTIVFTPSN------IKAYAIMTLRGLEYLH 174
             G+    + + L++++++  +L+  +    +     +      I    I   RGL YLH
Sbjct: 101 -IGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEI---CIGAARGLHYLH 156

Query: 175 DHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTR 221
              I+HRD+K  N+L+++  V KI DFG++K         TH + T 
Sbjct: 157 TRAIIHRDVKSINILLDENFVPKITDFGISKKG--TELDQTH-LSTV 200

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 75.4 bits (185), Expect = 2e-15
 Identities = 40/160 (25%), Positives = 71/160 (44%), Gaps = 8/160 (5%)

Query: 66  GRFATVFKA--RDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLT 123
           G F +V +   R  +  + VA+K +K GT     + +    +RE +++ +L +  ++ L 
Sbjct: 347 GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEM----MREAQIMHQLDNPYIVRLI 402

Query: 124 DVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
            V      + LV E      L   +         SN+         G++YL +   +HR+
Sbjct: 403 GVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRN 461

Query: 183 LKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW 222
           L   N+L+  +   KI DFGL+K  G+    YT +   +W
Sbjct: 462 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 501

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 73.4 bits (181), Expect = 3e-15
 Identities = 41/160 (25%), Positives = 72/160 (45%), Gaps = 8/160 (5%)

Query: 66  GRFATVFKA--RDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLT 123
           G F +V +   R  +  + VA+K +K GT     + +    +RE +++ +L +  ++ L 
Sbjct: 21  GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEM----MREAQIMHQLDNPYIVRLI 76

Query: 124 DVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
            V    + + LV E      L   +         SN+         G++YL +   +HRD
Sbjct: 77  GVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRD 135

Query: 183 LKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW 222
           L   N+L+  +   KI DFGL+K  G+    YT +   +W
Sbjct: 136 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 175

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 73.1 bits (180), Expect = 5e-15
 Identities = 36/161 (22%), Positives = 63/161 (39%), Gaps = 8/161 (4%)

Query: 66  GRFATVFKAR---DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL 122
           G    V   R     + D+ VA+K +K G     +       L E  ++ +  H N++ L
Sbjct: 60  GDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDF----LSEASIMGQFDHPNIIRL 115

Query: 123 TDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
             V        +V E+++   L+  ++     FT   +         G+ YL D   +HR
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHR 175

Query: 182 DLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW 222
           DL   N+L++   V K+ DFGL++               + 
Sbjct: 176 DLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI 216

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 73.6 bits (181), Expect = 6e-15
 Identities = 39/161 (24%), Positives = 66/161 (40%), Gaps = 8/161 (4%)

Query: 66  GRFATVFKAR---DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL 122
           G F  V   R     + ++ VA+K +K+G     +       L E  ++ +  H N++ L
Sbjct: 56  GEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF----LGEASIMGQFDHPNIIRL 111

Query: 123 TDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
             V      V +V E+++   L+  ++     FT   +         G++YL D   +HR
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 171

Query: 182 DLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW 222
           DL   N+LIN   V K+ DFGL +               + 
Sbjct: 172 DLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI 212

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 73.1 bits (180), Expect = 6e-15
 Identities = 44/160 (27%), Positives = 65/160 (40%), Gaps = 27/160 (16%)

Query: 66  GRFATVFKAR-----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           G F  VF A        +  M+VAVK +K  + +  +D       RE +LL  L H++++
Sbjct: 52  GAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD-----FQREAELLTMLQHQHIV 106

Query: 121 GL----TD------VFGYMSNVSLVFEF------VDTDLEVIIKDPTIVFTPSNIKAYAI 164
                 T+      VF YM +  L   F          L               + A A 
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLN-RFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165

Query: 165 MTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
               G+ YL     +HRDL   N L+ +  V+KIGDFG++
Sbjct: 166 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 73.8 bits (181), Expect = 8e-15
 Identities = 38/149 (25%), Positives = 75/149 (50%), Gaps = 17/149 (11%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINR-----TALREIKLLQELHHEN-- 118
           G F  V+  R  +T  + A+K +        K  I        AL E  +L  +   +  
Sbjct: 200 GGFGEVYGCRKADTGKMYAMKCLD-------KKRIKMKQGETLALNERIMLSLVSTGDCP 252

Query: 119 -VLGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH 176
            ++ ++  F     +S + + ++  DL   +     VF+ ++++ YA   + GLE++H+ 
Sbjct: 253 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNR 311

Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           ++++RDLKP N+L+++ G ++I D GLA 
Sbjct: 312 FVVYRDLKPANILLDEHGHVRISDLGLAC 340

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 73.1 bits (180), Expect = 9e-15
 Identities = 36/156 (23%), Positives = 71/156 (45%), Gaps = 14/156 (8%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRT-----ALREIKLLQELHHENVL 120
           G F  V   +  +T  + A+K +        K             +E++++Q L H  ++
Sbjct: 26  GSFGKVCIVQKNDTKKMYAMKYMN-------KQKCVERNEVRNVFKELQIMQGLEHPFLV 78

Query: 121 GLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWIL 179
            L   F    ++ +V + +   DL   ++     F    +K +    +  L+YL +  I+
Sbjct: 79  NLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVH-FKEETVKLFICELVMALDYLQNQRII 137

Query: 180 HRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYT 215
           HRD+KP+N+L+++ G + I DF +A      T++ T
Sbjct: 138 HRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT 173

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 73.3 bits (180), Expect = 9e-15
 Identities = 30/157 (19%), Positives = 61/157 (38%), Gaps = 13/157 (8%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTA-----LREIKLLQELHHENVL 120
           G F  V   +    D + A+K +        K  + + A       E  +L     + + 
Sbjct: 85  GAFGEVAVVKLKNADKVFAMKILN-------KWEMLKRAETACFREERDVLVNGDSKWIT 137

Query: 121 GLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWIL 179
            L   F   +N+ LV ++    DL  ++            + Y    +  ++ +H    +
Sbjct: 138 TLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYV 197

Query: 180 HRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTH 216
           HRD+KP+N+L++  G +++ DFG          + + 
Sbjct: 198 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSS 234

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 71.9 bits (177), Expect = 1e-14
 Identities = 39/169 (23%), Positives = 63/169 (37%), Gaps = 23/169 (13%)

Query: 66  GRFATVFKAR---DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL 122
           G F  V +          + VAVK +K    +  +       +RE+  +  L H N++ L
Sbjct: 29  GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEA--MDDFIREVNAMHSLDHRNLIRL 86

Query: 123 ----TD-----VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYL 173
                      V       SL+ + +        +     F    +  YA+    G+ YL
Sbjct: 87  YGVVLTPPMKMVTELAPLGSLL-DRL--------RKHQGHFLLGTLSRYAVQVAEGMGYL 137

Query: 174 HDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW 222
                +HRDL   NLL+  + ++KIGDFGL +        Y  Q   + 
Sbjct: 138 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 186

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 72.4 bits (178), Expect = 1e-14
 Identities = 34/146 (23%), Positives = 67/146 (45%), Gaps = 9/146 (6%)

Query: 66  GRFATVFKAR----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F  V+K        + ++ VA+K +K G     +       L E  ++ +  H N++ 
Sbjct: 55  GEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDF----LGEAGIMGQFSHHNIIR 110

Query: 122 LTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
           L  V      + ++ E+++   L+  +++    F+   +         G++YL +   +H
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVH 170

Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKF 206
           RDL   N+L+N   V K+ DFGL++ 
Sbjct: 171 RDLAARNILVNSNLVCKVSDFGLSRV 196

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 72.3 bits (178), Expect = 1e-14
 Identities = 45/196 (22%), Positives = 76/196 (38%), Gaps = 35/196 (17%)

Query: 39  LKKQYLLPDCEVKNDLLVY--YQWRSVHVGR------FATVFKAR--DIETDMIVAVKKI 88
           +KK +     +   D  +Y    W  +          F  V KAR       M  A+K++
Sbjct: 1   MKKHHHHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM 60

Query: 89  KLG-THADAKDGINRTALREIKLLQEL-HHENVLGL----TD------VFGYMSNVSLVF 136
           K   +  D +D        E+++L +L HH N++ L               Y  + +L+ 
Sbjct: 61  KEYASKDDHRD-----FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLL- 114

Query: 137 EF-------VDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLL 189
           +F              I        +   +  +A    RG++YL     +HRDL   N+L
Sbjct: 115 DFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL 174

Query: 190 INKQGVLKIGDFGLAK 205
           + +  V KI DFGL++
Sbjct: 175 VGENYVAKIADFGLSR 190

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 72.3 bits (178), Expect = 1e-14
 Identities = 40/160 (25%), Positives = 69/160 (43%), Gaps = 26/160 (16%)

Query: 66  GRFATVFKA-----RDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENV 119
           G F  V +A        +  + VAVK +K   HAD K+ +    + E+K++  L  HEN+
Sbjct: 57  GAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL----MSELKIMSHLGQHENI 112

Query: 120 LGL----TD------VFGYMSNVSLVFEFV-----DTDLEVIIKDPTIVFTPSNIKAYAI 164
           + L    T       +  Y     L+  F+       + +          +  ++  ++ 
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLL-NFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171

Query: 165 MTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
              +G+ +L     +HRD+   N+L+    V KIGDFGLA
Sbjct: 172 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 71.1 bits (175), Expect = 3e-14
 Identities = 36/169 (21%), Positives = 66/169 (39%), Gaps = 33/169 (19%)

Query: 66  GRFATVFKAR-----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           G F  V KA             VAVK +K          +    L E  +L++++H +V+
Sbjct: 34  GEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDL----LSEFNVLKQVNHPHVI 89

Query: 121 GL----TD------VFGYMSNVSL--------------VFEFVDTDLEVIIKDPTIVFTP 156
            L    +       +  Y    SL              +      +   +        T 
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149

Query: 157 SNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
            ++ ++A    +G++YL +  ++HRDL   N+L+ +   +KI DFGL++
Sbjct: 150 GDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 71.7 bits (176), Expect = 3e-14
 Identities = 32/151 (21%), Positives = 66/151 (43%), Gaps = 24/151 (15%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL--- 122
           G++  V++    +  + VAVK +K  T    +       L+E  +++E+ H N++ L   
Sbjct: 231 GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGV 284

Query: 123 -TD------VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
            T       +  +M+  +L        L+ + +      +   +   A      +EYL  
Sbjct: 285 CTREPPFYIITEFMTYGNL--------LDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336

Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFGLAKF 206
              +HR+L   N L+ +  ++K+ DFGL++ 
Sbjct: 337 KNFIHRNLAARNCLVGENHLVKVADFGLSRL 367

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 70.3 bits (173), Expect = 3e-14
 Identities = 34/142 (23%), Positives = 65/142 (45%), Gaps = 8/142 (5%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G+F  V           VA+K I+ G  ++         + E +++ +L H  ++ L  V
Sbjct: 19  GQFGLVHLGY-WLNKDKVAIKTIREGAMSEED------FIEEAEVMMKLSHPKLVQLYGV 71

Query: 126 FGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
               + + LV EF++   L   ++    +F    +    +    G+ YL +  ++HRDL 
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA 131

Query: 185 PNNLLINKQGVLKIGDFGLAKF 206
             N L+ +  V+K+ DFG+ +F
Sbjct: 132 ARNCLVGENQVIKVSDFGMTRF 153

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 70.7 bits (174), Expect = 3e-14
 Identities = 36/154 (23%), Positives = 64/154 (41%), Gaps = 26/154 (16%)

Query: 66  GRFATVFKAR----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F TV+K        +  + VA+K+++  T   A   I    L E  ++  + + +V  
Sbjct: 26  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI----LDEAYVMASVDNPHVCR 81

Query: 122 L----TD-----VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEY 172
           L           +   M    L+ ++V        ++         +  + +   +G+ Y
Sbjct: 82  LLGICLTSTVQLITQLMPFGCLL-DYV--------REHKDNIGSQYLLNWCVQIAKGMNY 132

Query: 173 LHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF 206
           L D  ++HRDL   N+L+     +KI DFGLAK 
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 70.3 bits (173), Expect = 3e-14
 Identities = 33/152 (21%), Positives = 68/152 (44%), Gaps = 24/152 (15%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL--- 122
           G++  V++    +  + VAVK +K  T  + ++      L+E  +++E+ H N++ L   
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEE-----FLKEAAVMKEIKHPNLVQLLGV 77

Query: 123 -TD------VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
            T       +  +M+  +L        L+ + +      +   +   A      +EYL  
Sbjct: 78  CTREPPFYIITEFMTYGNL--------LDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129

Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFGLAKFF 207
              +HRDL   N L+ +  ++K+ DFGL++  
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLM 161

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 70.3 bits (173), Expect = 4e-14
 Identities = 40/161 (24%), Positives = 58/161 (36%), Gaps = 27/161 (16%)

Query: 66  GRFATVFKAR-----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
            RF  V+K         E    VA+K +K       ++        E  L   L H NV+
Sbjct: 20  DRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEF----RHEAMLRARLQHPNVV 75

Query: 121 GL----TD------VFGYMSNVSLVFEF-------VDTDLEVIIKDPTIVFTPSNIKAYA 163
            L    T       +F Y S+  L  EF        D       +       P +     
Sbjct: 76  CLLGVVTKDQPLSMIFSYCSHGDLH-EFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 164 IMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
                G+EYL  H ++H+DL   N+L+  +  +KI D GL 
Sbjct: 135 AQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 70.3 bits (173), Expect = 4e-14
 Identities = 30/150 (20%), Positives = 62/150 (41%), Gaps = 19/150 (12%)

Query: 66  GRFATVFKAR---DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL 122
           G F  V++          + VAVK  K     D K+      + E  +++ L H +++ L
Sbjct: 23  GFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKF----MSEAVIMKNLDHPHIVKL 78

Query: 123 TDVFGYMSNVS-----LVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH 176
             +      +      ++ E     +L   ++          +  Y++   + + YL   
Sbjct: 79  IGI------IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI 132

Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAKF 206
             +HRD+   N+L+     +K+GDFGL+++
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRY 162

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 70.4 bits (173), Expect = 4e-14
 Identities = 40/169 (23%), Positives = 64/169 (37%), Gaps = 26/169 (15%)

Query: 66  GRFATVFKA--RDIETDMIVAVKKIKLGT-HADAKDGINRTALREIKLLQELHHENVLGL 122
           G F TV K   +  +    VAVK +K        KD +    L E  ++Q+L +  ++ +
Sbjct: 28  GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDEL----LAEANVMQQLDNPYIVRM 83

Query: 123 ----TD-----VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYL 173
                      V        L  +++  +               NI         G++YL
Sbjct: 84  IGICEAESWMLVMEMAELGPLN-KYLQQNRH---------VKDKNIIELVHQVSMGMKYL 133

Query: 174 HDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW 222
            +   +HRDL   N+L+  Q   KI DFGL+K   +    Y  Q   +W
Sbjct: 134 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 182

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 70.3 bits (173), Expect = 6e-14
 Identities = 42/147 (28%), Positives = 66/147 (44%), Gaps = 16/147 (10%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V   R+  T    A+K ++      AKD +  T + E ++LQ   H  +  L   
Sbjct: 16  GTFGKVILVREKATGRYYAMKILRKE-VIIAKDEVAHT-VTESRVLQNTRHPFLTALKYA 73

Query: 126 FGYMSNVSLVFEFVD-TDL------EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
           F     +  V E+ +  +L      E +  +    F       Y    +  LEYLH   +
Sbjct: 74  FQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-------YGAEIVSALEYLHSRDV 126

Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAK 205
           ++RD+K  NL+++K G +KI DFGL K
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCK 153

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 70.0 bits (172), Expect = 6e-14
 Identities = 34/145 (23%), Positives = 65/145 (44%), Gaps = 9/145 (6%)

Query: 66  GRFATVFKAR---DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL 122
           G F  V+      +    +  AVK +   T            L E  ++++  H NVL L
Sbjct: 36  GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF----LTEGIIMKDFSHPNVLSL 91

Query: 123 TDV-FGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
             +      +  +V  ++   DL   I++ T   T  ++  + +   +G++YL     +H
Sbjct: 92  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVH 151

Query: 181 RDLKPNNLLINKQGVLKIGDFGLAK 205
           RDL   N +++++  +K+ DFGLA+
Sbjct: 152 RDLAARNCMLDEKFTVKVADFGLAR 176

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 71.2 bits (174), Expect = 6e-14
 Identities = 39/141 (27%), Positives = 61/141 (43%), Gaps = 3/141 (2%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V  +    TD + AVK +K        D       + + L        +  L   
Sbjct: 352 GSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRV-LALPGKPPFLTQLHSC 410

Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           F  M  +  V E+V+  DL   I+     F   +   YA     GL +L    I++RDLK
Sbjct: 411 FQTMDRLYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLK 469

Query: 185 PNNLLINKQGVLKIGDFGLAK 205
            +N++++ +G +KI DFG+ K
Sbjct: 470 LDNVMLDSEGHIKIADFGMCK 490

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 69.2 bits (170), Expect = 8e-14
 Identities = 31/150 (20%), Positives = 64/150 (42%), Gaps = 19/150 (12%)

Query: 66  GRFATVFKAR---DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL 122
           G+F  V +          + VA+K  K  T    ++      L+E   +++  H +++ L
Sbjct: 26  GQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKF----LQEALTMRQFDHPHIVKL 81

Query: 123 TDVFGYMSNVS-----LVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH 176
             V      ++     ++ E     +L   ++        +++  YA      L YL   
Sbjct: 82  IGV------ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK 135

Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAKF 206
             +HRD+   N+L++    +K+GDFGL+++
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 70.1 bits (172), Expect = 9e-14
 Identities = 32/152 (21%), Positives = 59/152 (38%), Gaps = 5/152 (3%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V   R   T  + A+K +        +         E  ++   +   V+ L   
Sbjct: 80  GAFGEVQLVRHKSTRKVYAMKLLSK-FEMIKRSDSAFF-WEERDIMAFANSPWVVQLFYA 137

Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           F     + +V E++   DL  ++ +          + Y    +  L+ +H    +HRD+K
Sbjct: 138 FQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIHSMGFIHRDVK 195

Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTH 216
           P+N+L++K G LK+ DFG          +   
Sbjct: 196 PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD 227

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 69.6 bits (171), Expect = 9e-14
 Identities = 40/168 (23%), Positives = 68/168 (40%), Gaps = 33/168 (19%)

Query: 66  GRFATVFKAR-----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENV 119
           G F  V  A           + VAVK +K    +  ++ +    + E+K++ +L  HEN+
Sbjct: 56  GAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREAL----MSELKMMTQLGSHENI 111

Query: 120 LGL----TD------VFGYMSNVSL-------------VFEFVDTDLEVIIKDPTIVFTP 156
           + L    T       +F Y     L                  +    +  ++   V T 
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171

Query: 157 SNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA 204
            ++  +A    +G+E+L     +HRDL   N+L+    V+KI DFGLA
Sbjct: 172 EDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 219

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 69.3 bits (170), Expect = 1e-13
 Identities = 30/154 (19%), Positives = 60/154 (38%), Gaps = 26/154 (16%)

Query: 66  GRFATVFKAR----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F TV K           + V +K I+  +   +   +       +  +  L H +++ 
Sbjct: 24  GVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAV----TDHMLAIGSLDHAHIVR 79

Query: 122 L----TD-----VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEY 172
           L           V  Y+   SL+ + V        +       P  +  + +   +G+ Y
Sbjct: 80  LLGLCPGSSLQLVTQYLPLGSLL-DHV--------RQHRGALGPQLLLNWGVQIAKGMYY 130

Query: 173 LHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF 206
           L +H ++HR+L   N+L+     +++ DFG+A  
Sbjct: 131 LEEHGMVHRNLAARNVLLKSPSQVQVADFGVADL 164

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 68.8 bits (169), Expect = 1e-13
 Identities = 38/142 (26%), Positives = 66/142 (46%), Gaps = 8/142 (5%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G+F  V   +       VA+K IK G+ ++ +       + E K++  L HE ++ L  V
Sbjct: 35  GQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDE------FIEEAKVMMNLSHEKLVQLYGV 87

Query: 126 FGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
                 + ++ E++    L   +++    F    +          +EYL     LHRDL 
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 147

Query: 185 PNNLLINKQGVLKIGDFGLAKF 206
             N L+N QGV+K+ DFGL+++
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRY 169

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 69.7 bits (171), Expect = 1e-13
 Identities = 38/151 (25%), Positives = 61/151 (40%), Gaps = 28/151 (18%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL--- 122
           G F  V           VAVK IK    A       +  L E  ++ +L H N++ L   
Sbjct: 204 GEFGDVMLGDYRGNK--VAVKCIKNDATA-------QAFLAEASVMTQLRHSNLVQLLGV 254

Query: 123 -TD-------VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH 174
             +       V  YM+  SL        ++ +      V     +  +++     +EYL 
Sbjct: 255 IVEEKGGLYIVTEYMAKGSL--------VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 306

Query: 175 DHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
            +  +HRDL   N+L+++  V K+ DFGL K
Sbjct: 307 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 69.3 bits (170), Expect = 1e-13
 Identities = 41/169 (24%), Positives = 64/169 (37%), Gaps = 33/169 (19%)

Query: 66  GRFATVFKAR-----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           G F  VF+AR       E   +VAVK +K    AD +        RE  L+ E  + N++
Sbjct: 58  GAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF----QREAALMAEFDNPNIV 113

Query: 121 GL----TD------VFGYMSNVSL--------------VFEFVDTDLEVIIKDPTIVFTP 156
            L            +F YM+   L              +     +    +        + 
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173

Query: 157 SNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           +     A     G+ YL +   +HRDL   N L+ +  V+KI DFGL++
Sbjct: 174 AEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR 222

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 69.6 bits (170), Expect = 2e-13
 Identities = 47/208 (22%), Positives = 74/208 (35%), Gaps = 32/208 (15%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH--------HE 117
           G F+TV+ + DI+    VA+K +K   H         TAL EI+LL+ +          E
Sbjct: 48  GHFSTVWLSWDIQGKKFVAMKVVKSAEH------YTETALDEIRLLKSVRNSDPNDPNRE 101

Query: 118 NVLGLTDVFGYMSN----VSLVFEFVDTDLEVIIKD-PTIVFTPSNIKAYAIMTLRGLEY 172
            V+ L D F         + +VFE +   L   I            +K      L+GL+Y
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDY 161

Query: 173 LHDHW-ILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLY 231
           LH    I+H D+KP N+L      L + +  + +     T              +     
Sbjct: 162 LHTKCRIIHTDIKPENIL------LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215

Query: 232 CVQFNVKNVQWCCFAKDPSSHGNLFPGI 259
                     +     +P +   L   I
Sbjct: 216 TAG------NFLVNPLEPKNAEKLKVKI 237

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 69.2 bits (170), Expect = 2e-13
 Identities = 43/142 (30%), Positives = 68/142 (47%), Gaps = 5/142 (3%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRT-ALREIKLLQELHHENVLGLTD 124
           G F  VF A   +T+   A+K +K        D +  T   + + L     H  +  +  
Sbjct: 28  GSFGKVFLAEFKKTNQFFAIKALKKD-VVLMDDDVECTMVEKRV-LSLAWEHPFLTHMFC 85

Query: 125 VFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
            F    N+  V E+++  DL   I+     F  S    YA   + GL++LH   I++RDL
Sbjct: 86  TFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKGIVYRDL 144

Query: 184 KPNNLLINKQGVLKIGDFGLAK 205
           K +N+L++K G +KI DFG+ K
Sbjct: 145 KLDNILLDKDGHIKIADFGMCK 166

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 69.9 bits (171), Expect = 2e-13
 Identities = 33/144 (22%), Positives = 63/144 (43%), Gaps = 9/144 (6%)

Query: 66  GRFATVFKAR---DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL 122
           G+F  V +          M VA+K  K  T    ++      L+E   +++  H +++ L
Sbjct: 401 GQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKF----LQEALTMRQFDHPHIVKL 456

Query: 123 TDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
             V    + V ++ E     +L   ++        +++  YA      L YL     +HR
Sbjct: 457 IGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHR 515

Query: 182 DLKPNNLLINKQGVLKIGDFGLAK 205
           D+   N+L++    +K+GDFGL++
Sbjct: 516 DIAARNVLVSSNDCVKLGDFGLSR 539

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 69.0 bits (169), Expect = 2e-13
 Identities = 33/145 (22%), Positives = 65/145 (44%), Gaps = 9/145 (6%)

Query: 66  GRFATVFKAR---DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL 122
           G F  V+      +    +  AVK +   T            L E  ++++  H NVL L
Sbjct: 100 GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF----LTEGIIMKDFSHPNVLSL 155

Query: 123 TDV-FGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
             +      +  +V  ++   DL   I++ T   T  ++  + +   +G+++L     +H
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVH 215

Query: 181 RDLKPNNLLINKQGVLKIGDFGLAK 205
           RDL   N +++++  +K+ DFGLA+
Sbjct: 216 RDLAARNCMLDEKFTVKVADFGLAR 240

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 68.5 bits (168), Expect = 2e-13
 Identities = 37/150 (24%), Positives = 65/150 (43%), Gaps = 18/150 (12%)

Query: 66  GRFATVFKAR----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F TV+K        +  + VA+K+++  T   A   I    L E  ++  + + +V  
Sbjct: 26  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI----LDEAYVMASVDNPHVCR 81

Query: 122 L----TDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH 176
           L           S V L+ + +    L   +++         +  + +   +G+ YL D 
Sbjct: 82  LLGICLT-----STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136

Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAKF 206
            ++HRDL   N+L+     +KI DFGLAK 
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 68.5 bits (168), Expect = 2e-13
 Identities = 30/156 (19%), Positives = 60/156 (38%), Gaps = 21/156 (13%)

Query: 66  GRFATVFKAR-----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           G F  V++         E +  VA+K +        +       L E  +++E +  +V+
Sbjct: 36  GSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEF----LNEASVMKEFNCHHVV 91

Query: 121 GL----TD------VFGYMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRG 169
            L    +       +   M+   L   ++      +         + S +   A     G
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLK-SYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 170 LEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           + YL+ +  +HRDL   N ++ +   +KIGDFG+ +
Sbjct: 151 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 67.6 bits (166), Expect = 2e-13
 Identities = 32/142 (22%), Positives = 63/142 (44%), Gaps = 8/142 (5%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G+F  V   +  +    VAVK IK G+ ++ +        +E + + +L H  ++    V
Sbjct: 19  GQFGVVKLGK-WKGQYDVAVKMIKEGSMSEDE------FFQEAQTMMKLSHPKLVKFYGV 71

Query: 126 FGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
                 + +V E++    L   ++       PS +         G+ +L  H  +HRDL 
Sbjct: 72  CSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLA 131

Query: 185 PNNLLINKQGVLKIGDFGLAKF 206
             N L+++   +K+ DFG+ ++
Sbjct: 132 ARNCLVDRDLCVKVSDFGMTRY 153

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 68.1 bits (167), Expect = 3e-13
 Identities = 39/154 (25%), Positives = 68/154 (44%), Gaps = 27/154 (17%)

Query: 66  GRFATVFKAR---DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL 122
           G F  V+        +  +  A+K +   T     +      LRE  L++ L+H NVL L
Sbjct: 32  GHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAF----LREGLLMRGLNHPNVLAL 87

Query: 123 ----TD-------VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLE 171
                        +  YM +  L+ +F        I+ P    T  ++ ++ +   RG+E
Sbjct: 88  IGIMLPPEGLPHVLLPYMCHGDLL-QF--------IRSPQRNPTVKDLISFGLQVARGME 138

Query: 172 YLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           YL +   +HRDL   N ++++   +K+ DFGLA+
Sbjct: 139 YLAEQKFVHRDLAARNCMLDESFTVKVADFGLAR 172

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 68.1 bits (167), Expect = 3e-13
 Identities = 40/165 (24%), Positives = 68/165 (41%), Gaps = 30/165 (18%)

Query: 66  GRFATVFKAR-------DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHE 117
           G F  V  A          +  + VAVK +K          +    + E+++++ +  H+
Sbjct: 46  GAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL----VSEMEMMKMIGKHK 101

Query: 118 NVLGL----TD------VFGYMSNVSLVFEF-------VDTDLEVIIKDPTIVFTPSNIK 160
           N++ L    T       +  Y S  +L  E+              I + P    T  ++ 
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLR-EYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 161 AYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           +      RG+EYL     +HRDL   N+L+ +  V+KI DFGLA+
Sbjct: 161 SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 67.6 bits (166), Expect = 3e-13
 Identities = 39/151 (25%), Positives = 61/151 (40%), Gaps = 28/151 (18%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL--- 122
           G F  V           VAVK IK    A A        L E  ++ +L H N++ L   
Sbjct: 32  GEFGDVMLGDYRGNK--VAVKCIKNDATAQA-------FLAEASVMTQLRHSNLVQLLGV 82

Query: 123 -TD-------VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH 174
             +       V  YM+  SL        ++ +      V     +  +++     +EYL 
Sbjct: 83  IVEEKGGLYIVTEYMAKGSL--------VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 134

Query: 175 DHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
            +  +HRDL   N+L+++  V K+ DFGL K
Sbjct: 135 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 67.7 bits (166), Expect = 4e-13
 Identities = 37/157 (23%), Positives = 68/157 (43%), Gaps = 22/157 (14%)

Query: 66  GRFATVFKAR---DIETDMIVAVKKIKLG--THADAKDGINRTALREIKLLQELHHENVL 120
           G F +V +A+   +  + + VAVK +K      +D ++      LRE   ++E  H +V 
Sbjct: 34  GEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEE-----FLREAACMKEFDHPHVA 88

Query: 121 GL------TDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTL-----R 168
            L      +   G +    ++  F+   DL   +    I   P N+    ++        
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 169 GLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           G+EYL     +HRDL   N ++ +   + + DFGL++
Sbjct: 149 GMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 68.2 bits (167), Expect = 4e-13
 Identities = 40/165 (24%), Positives = 68/165 (41%), Gaps = 30/165 (18%)

Query: 66  GRFATVFKAR-------DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHE 117
           G F  V  A          +  + VAVK +K          +    + E+++++ +  H+
Sbjct: 92  GCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL----VSEMEMMKMIGKHK 147

Query: 118 NVLGL----TD------VFGYMSNVSLVFEF-------VDTDLEVIIKDPTIVFTPSNIK 160
           N++ L    T       +  Y S  +L  E+              I + P    T  ++ 
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLR-EYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206

Query: 161 AYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           +      RG+EYL     +HRDL   N+L+ +  V+KI DFGLA+
Sbjct: 207 SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 67.8 bits (166), Expect = 4e-13
 Identities = 34/163 (20%), Positives = 58/163 (35%), Gaps = 28/163 (17%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL----------- 114
           G F  ++ A         A   +K+          N     E+K  Q +           
Sbjct: 48  GGFGLIYLAFPTNKPEKDARHVVKVEYQE------NGPLFSELKFYQRVAKKDCIKKWIE 101

Query: 115 -HHENVLGLTDVFGYMSNVS-------LVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMT 166
               + LG+   +G             +V E +  DL+ I       F  S +    I  
Sbjct: 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQ-NGTFKKSTVLQLGIRM 160

Query: 167 LRGLEYLHDHWILHRDLKPNNLLI--NKQGVLKIGDFGLAKFF 207
           L  LEY+H++  +H D+K  NLL+       + + D+GL+  +
Sbjct: 161 LDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 68.1 bits (167), Expect = 4e-13
 Identities = 42/147 (28%), Positives = 68/147 (46%), Gaps = 15/147 (10%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V  AR    ++  AVK ++       K+  +  + R + LL+ + H  ++GL   
Sbjct: 49  GSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNV-LLKNVKHPFLVGLHFS 107

Query: 126 FGYMSNVSLVFEFVDT-DL------EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
           F     +  V ++++  +L      E    +P   F       YA      L YLH   I
Sbjct: 108 FQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-------YAAEIASALGYLHSLNI 160

Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAK 205
           ++RDLKP N+L++ QG + + DFGL K
Sbjct: 161 VYRDLKPENILLDSQGHIVLTDFGLCK 187

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 67.3 bits (165), Expect = 5e-13
 Identities = 40/164 (24%), Positives = 66/164 (40%), Gaps = 29/164 (17%)

Query: 66  GRFATVFKAR-----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENV 119
           G F  V +A         T   VAVK +K G        +    + E+K+L  + HH NV
Sbjct: 38  GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL----MSELKILIHIGHHLNV 93

Query: 120 LGL----TD-------VFGYMSNVSLVFEF-------VDTDLEVIIKDPTIVFTPSNIKA 161
           + L    T        +  +    +L   +                       T  ++  
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLS-TYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 162 YAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           Y+    +G+E+L     +HRDL   N+L++++ V+KI DFGLA+
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 67.8 bits (166), Expect = 5e-13
 Identities = 39/148 (26%), Positives = 71/148 (47%), Gaps = 17/148 (11%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRT-ALREIKLLQELHHENVLGLTD 124
           G +A V   R  +TD I A++ +K     +  + I+     + +   Q  +H  ++GL  
Sbjct: 63  GSYAKVLLVRLKKTDRIYAMRVVKKE-LVNDDEDIDWVQTEKHV-FEQASNHPFLVGLHS 120

Query: 125 VFGYMSNVSLVFEFVDT-DL------EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHW 177
            F   S +  V E+V+  DL      +  + +    F       Y+      L YLH+  
Sbjct: 121 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-------YSAEISLALNYLHERG 173

Query: 178 ILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           I++RDLK +N+L++ +G +K+ D+G+ K
Sbjct: 174 IIYRDLKLDNVLLDSEGHIKLTDYGMCK 201

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 67.8 bits (166), Expect = 6e-13
 Identities = 43/142 (30%), Positives = 68/142 (47%), Gaps = 5/142 (3%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V   ++  T    A+K +K      AKD +  T L E ++LQ   H  +  L   
Sbjct: 159 GTFGKVILVKEKATGRYYAMKILKKE-VIVAKDEVAHT-LTENRVLQNSRHPFLTALKYS 216

Query: 126 FGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH-DHWILHRDL 183
           F     +  V E+ +  +L   +     VF+    + Y    +  L+YLH +  +++RDL
Sbjct: 217 FQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 275

Query: 184 KPNNLLINKQGVLKIGDFGLAK 205
           K  NL+++K G +KI DFGL K
Sbjct: 276 KLENLMLDKDGHIKITDFGLCK 297

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 67.3 bits (165), Expect = 7e-13
 Identities = 45/142 (31%), Positives = 68/142 (47%), Gaps = 5/142 (3%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRT-ALREIKLLQELHHENVLGLTD 124
           G F  V  AR  ET  + AVK +K        D +  T   + I L    +H  +  L  
Sbjct: 34  GSFGKVMLARVKETGDLYAVKVLKKD-VILQDDDVECTMTEKRI-LSLARNHPFLTQLFC 91

Query: 125 VFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
            F     +  V EFV+  DL   I+  +  F  +  + YA   +  L +LHD  I++RDL
Sbjct: 92  CFQTPDRLFFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEIISALMFLHDKGIIYRDL 150

Query: 184 KPNNLLINKQGVLKIGDFGLAK 205
           K +N+L++ +G  K+ DFG+ K
Sbjct: 151 KLDNVLLDHEGHCKLADFGMCK 172

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 67.3 bits (165), Expect = 7e-13
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 17/148 (11%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRT-ALREIKLLQELHHENVLGLTD 124
           G +A V   R  +TD I A+K +K     +  + I+     + +   Q  +H  ++GL  
Sbjct: 20  GSYAKVLLVRLKKTDRIYAMKVVKKE-LVNDDEDIDWVQTEKHV-FEQASNHPFLVGLHS 77

Query: 125 VFGYMSNVSLVFEFVDT-DL------EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHW 177
            F   S +  V E+V+  DL      +  + +    F       Y+      L YLH+  
Sbjct: 78  CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-------YSAEISLALNYLHERG 130

Query: 178 ILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           I++RDLK +N+L++ +G +K+ D+G+ K
Sbjct: 131 IIYRDLKLDNVLLDSEGHIKLTDYGMCK 158

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 67.4 bits (165), Expect = 8e-13
 Identities = 39/165 (23%), Positives = 66/165 (40%), Gaps = 30/165 (18%)

Query: 66  GRFATVFKAR-------DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHE 117
           G F  V  A               VAVK +K          +    + E+++++ +  H+
Sbjct: 80  GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL----ISEMEMMKMIGKHK 135

Query: 118 NVLGL----TD------VFGYMSNVSLVFEF-------VDTDLEVIIKDPTIVFTPSNIK 160
           N++ L    T       +  Y S  +L  E+                 +P    +  ++ 
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLR-EYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194

Query: 161 AYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           + A    RG+EYL     +HRDL   N+L+ +  V+KI DFGLA+
Sbjct: 195 SCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 66.2 bits (162), Expect = 1e-12
 Identities = 35/155 (22%), Positives = 61/155 (39%), Gaps = 19/155 (12%)

Query: 66  GRFATVFKAR---DIETDMIVAVKKIKLGTHADAKDGINRTA-LREIKLLQELHHENVLG 121
           G F +V +     +  T + VAVK +KL   +           L E   +++  H NV+ 
Sbjct: 45  GEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQR----EIEEFLSEAACMKDFSHPNVIR 100

Query: 122 LTDV-----FGYMSNVSLVFEFVDT-DL-----EVIIKDPTIVFTPSNIKAYAIMTLRGL 170
           L  V        +    ++  F+   DL        ++          +  + +    G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160

Query: 171 EYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           EYL +   LHRDL   N ++     + + DFGL+K
Sbjct: 161 EYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 66.2 bits (162), Expect = 1e-12
 Identities = 36/151 (23%), Positives = 65/151 (43%), Gaps = 19/151 (12%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  +   +++ T+  VA+K         ++         E +  ++L   +  G+  V
Sbjct: 20  GNFGELRLGKNLYTNEYVAIKL----EPMKSR---APQLHLEYRFYKQLG--SGDGIPQV 70

Query: 126 FGY----MSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
           + +      N  +V E +   LE +       F+   +   AI  +  +EY+H   +++R
Sbjct: 71  YYFGPCGKYNA-MVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYR 129

Query: 182 DLKPNNLLI-----NKQGVLKIGDFGLAKFF 207
           D+KP N LI       Q V+ I DF LAK +
Sbjct: 130 DVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 66.8 bits (163), Expect = 1e-12
 Identities = 38/150 (25%), Positives = 65/150 (43%), Gaps = 24/150 (16%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL--- 122
           G F  V+          VA+K +K GT +          L+E +++++L HE ++ L   
Sbjct: 278 GCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQLYAV 330

Query: 123 -TD-----VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH 176
            ++     V  YMS  SL        L+ +  +         +   A     G+ Y+   
Sbjct: 331 VSEEPIYIVTEYMSKGSL--------LDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382

Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAKF 206
             +HRDL+  N+L+ +  V K+ DFGLA+ 
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARL 412

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 66.5 bits (163), Expect = 1e-12
 Identities = 40/142 (28%), Positives = 63/142 (44%), Gaps = 5/142 (3%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRT-ALREIKLLQELHHENVLGLTD 124
           G F  V  +    TD + AVK +K        D +  T   + + L        +  L  
Sbjct: 31  GSFGKVMLSERKGTDELYAVKILKKD-VVIQDDDVECTMVEKRV-LALPGKPPFLTQLHS 88

Query: 125 VFGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
            F  M  +  V E+V+  DL   I+     F   +   YA     GL +L    I++RDL
Sbjct: 89  CFQTMDRLYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 147

Query: 184 KPNNLLINKQGVLKIGDFGLAK 205
           K +N++++ +G +KI DFG+ K
Sbjct: 148 KLDNVMLDSEGHIKIADFGMCK 169

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 38/166 (22%), Positives = 69/166 (41%), Gaps = 26/166 (15%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL--- 122
           G+F  V+ A        VAVK +K G+ +          L E  +++ L H+ ++ L   
Sbjct: 199 GQFGEVWMATY-NKHTKVAVKTMKPGSMS------VEAFLAEANVMKTLQHDKLVKLHAV 251

Query: 123 -TD-----VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH 176
            T      +  +M+  SL        L+ +  D         +  ++     G+ ++   
Sbjct: 252 VTKEPIYIITEFMAKGSL--------LDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 303

Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW 222
             +HRDL+  N+L++   V KI DFGLA+        YT +   ++
Sbjct: 304 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE--YTAREGAKF 347

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 64.9 bits (159), Expect = 2e-12
 Identities = 40/166 (24%), Positives = 70/166 (42%), Gaps = 26/166 (15%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL--- 122
           G+F  V+          VAVK +K G+ +          L E  L+++L H+ ++ L   
Sbjct: 24  GQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDA------FLAEANLMKQLQHQRLVRLYAV 76

Query: 123 -TD-----VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH 176
            T      +  YM N SL        ++ +     I  T + +   A     G+ ++ + 
Sbjct: 77  VTQEPIYIITEYMENGSL--------VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128

Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW 222
             +HRDL+  N+L++     KI DFGLA+        YT +   ++
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE--YTAREGAKF 172

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 65.8 bits (160), Expect = 3e-12
 Identities = 37/152 (24%), Positives = 65/152 (42%), Gaps = 17/152 (11%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  ++   +I+T+  VA+K              +   L E K+ + L      G+ +V
Sbjct: 18  GSFGEIYLGTNIQTNEEVAIKLEN-------VKTKHPQLLYESKIYRILQ--GGTGIPNV 68

Query: 126 FGY----MSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
             +      NV LV + +   LE +    +   +   +   A   +  +E++H    LHR
Sbjct: 69  RWFGVEGDYNV-LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 127

Query: 182 DLKPNNLLI---NKQGVLKIGDFGLAKFFGSP 210
           D+KP+N L+    +   + I DFGLAK +   
Sbjct: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 65.5 bits (160), Expect = 3e-12
 Identities = 38/150 (25%), Positives = 65/150 (43%), Gaps = 24/150 (16%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL--- 122
           G F  V+          VA+K +K GT +          L+E +++++L HE ++ L   
Sbjct: 195 GCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQLYAV 247

Query: 123 -TD-----VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH 176
            ++     V  YMS  SL        L+ +  +         +   A     G+ Y+   
Sbjct: 248 VSEEPIYIVTEYMSKGSL--------LDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299

Query: 177 WILHRDLKPNNLLINKQGVLKIGDFGLAKF 206
             +HRDL+  N+L+ +  V K+ DFGLA+ 
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARL 329

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 64.7 bits (158), Expect = 4e-12
 Identities = 34/172 (19%), Positives = 72/172 (41%), Gaps = 22/172 (12%)

Query: 52  NDLLVYYQWRSVHV---GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREI 108
            + +V   ++       G F  +F+  ++  +  VA+K         +          E 
Sbjct: 4   QNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF----EPRRSD---APQLRDEY 56

Query: 109 KLLQELHHENVLGLTDVFGY----MSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAI 164
           +  + L      G+ +V+ +    + NV LV + +   LE ++      F+   +   A 
Sbjct: 57  RTYKLLA--GCTGIPNVYYFGQEGLHNV-LVIDLLGPSLEDLLDLCGRKFSVKTVAMAAK 113

Query: 165 MTLRGLEYLHDHWILHRDLKPNNLLI-----NKQGVLKIGDFGLAKFFGSPT 211
             L  ++ +H+  +++RD+KP+N LI         ++ + DFG+ KF+  P 
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 165

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 64.3 bits (157), Expect = 5e-12
 Identities = 37/149 (24%), Positives = 63/149 (42%), Gaps = 17/149 (11%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  ++   DI     VA+K          K   +     E K+ + +     +G+  +
Sbjct: 20  GSFGDIYLGTDIAAGEEVAIKL----ECVKTK---HPQLHIESKIYKMMQ--GGVGIPTI 70

Query: 126 FGY----MSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
                    NV +V E +   LE +    +  F+   +   A   +  +EY+H    +HR
Sbjct: 71  RWCGAEGDYNV-MVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHR 129

Query: 182 DLKPNNLLI---NKQGVLKIGDFGLAKFF 207
           D+KP+N L+    K  ++ I DFGLAK +
Sbjct: 130 DVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 64.6 bits (158), Expect = 5e-12
 Identities = 34/159 (21%), Positives = 65/159 (40%), Gaps = 27/159 (16%)

Query: 66  GRFATVFKAR-----DIETDMIVAVKKIKLG-THADAKDGINRTALREIKLLQELHHENV 119
           G F  V++ +     +  + + VAVK +    +  D  D      L E  ++ + +H+N+
Sbjct: 41  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-----FLMEALIISKFNHQNI 95

Query: 120 LGL----TD------VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRG 169
           +              +   M+   L   F+        +  ++     ++   A     G
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLK-SFLRETRPRPSQPSSL--AMLDLLHVARDIACG 152

Query: 170 LEYLHDHWILHRDLKPNNLLINKQG---VLKIGDFGLAK 205
            +YL ++  +HRD+   N L+   G   V KIGDFG+A+
Sbjct: 153 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 63.3 bits (155), Expect = 1e-11
 Identities = 43/150 (28%), Positives = 67/150 (44%), Gaps = 18/150 (12%)

Query: 66  GRFATVFKARDI---ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL 122
           G +  VF+ R +    T  I A+K +K             T   E  +L+E+ H  ++ L
Sbjct: 28  GGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT-KAERNILEEVKHPFIVDL 86

Query: 123 TDVFGYMSNVSLVFEFVDT-DL------EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
              F     + L+ E++   +L      E I  + T  F       Y       L +LH 
Sbjct: 87  IYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-------YLAEISMALGHLHQ 139

Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
             I++RDLKP N+++N QG +K+ DFGL K
Sbjct: 140 KGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 63.6 bits (155), Expect = 1e-11
 Identities = 34/159 (21%), Positives = 65/159 (40%), Gaps = 27/159 (16%)

Query: 66  GRFATVFKAR-----DIETDMIVAVKKIKLG-THADAKDGINRTALREIKLLQELHHENV 119
           G F  V++ +     +  + + VAVK +    +  D  D      L E  ++ + +H+N+
Sbjct: 82  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-----FLMEALIISKFNHQNI 136

Query: 120 LGL----TD------VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRG 169
           +              +   M+   L   F+        +  ++     ++   A     G
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLK-SFLRETRPRPSQPSSL--AMLDLLHVARDIACG 193

Query: 170 LEYLHDHWILHRDLKPNNLLINKQG---VLKIGDFGLAK 205
            +YL ++  +HRD+   N L+   G   V KIGDFG+A+
Sbjct: 194 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 61.9 bits (151), Expect = 3e-11
 Identities = 24/157 (15%), Positives = 55/157 (35%), Gaps = 21/157 (13%)

Query: 66  GRFATVFKAR-------DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHEN 118
           G F  +FK             +  V +K +       ++            ++ +L H++
Sbjct: 19  GTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSES-----FFEAASMMSKLSHKH 73

Query: 119 VLGLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHW 177
           ++    V        LV EFV    L+  +K              A      + +L ++ 
Sbjct: 74  LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT 133

Query: 178 ILHRDLKPNNLLINKQG--------VLKIGDFGLAKF 206
           ++H ++   N+L+ ++          +K+ D G++  
Sbjct: 134 LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT 170

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 61.4 bits (150), Expect = 6e-11
 Identities = 41/154 (26%), Positives = 71/154 (46%), Gaps = 28/154 (18%)

Query: 66  GRFATVFKARDI---ETDMIVAVKKIKLGTHADAKDGINRTALREIK----LLQELHHEN 118
           G F  VF  + I   +   + A+K +K       K  +        K    +L E++H  
Sbjct: 35  GSFGKVFLVKKISGSDARQLYAMKVLK-------KATLKVRDRVRTKMERDILVEVNHPF 87

Query: 119 VLGLTDVFGYMSNVSLVFEFVDT-DL------EVIIKDPTIVFTPSNIKAYAIMTLRGLE 171
           ++ L   F     + L+ +F+   DL      EV+  +  + F       Y       L+
Sbjct: 88  IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-------YLAELALALD 140

Query: 172 YLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
           +LH   I++RDLKP N+L++++G +K+ DFGL+K
Sbjct: 141 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK 174

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 61.3 bits (149), Expect = 7e-11
 Identities = 22/159 (13%), Positives = 55/159 (34%), Gaps = 17/159 (10%)

Query: 66  GRFATVFKARDIETDMI--------VAVK--KIKLGTHADAKDGINRTALREIKLLQELH 115
                +++A    T            ++K          +           ++   ++L+
Sbjct: 53  DNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLY 112

Query: 116 HENVLGLTDVFGYMSNVS----LVFEFVDTDLEVIIKD-PTIVFTPSNIKAYAIMTLRGL 170
              +L +    G+  +      LV   +   L+  +   P  V +  ++   A   L  L
Sbjct: 113 STPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDAL 172

Query: 171 EYLHDHWILHRDLKPNNLLI--NKQGVLKIGDFGLAKFF 207
           E+LH++  +H ++   N+ +    Q  + +  +G A  +
Sbjct: 173 EFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 61.2 bits (149), Expect = 8e-11
 Identities = 34/151 (22%), Positives = 64/151 (42%), Gaps = 19/151 (12%)

Query: 66  GRFATVFKARDI---ETDMIVAVKKIKLGTHADAKDGINRT-ALREIKLLQELHHENVLG 121
           G +  VF  R I   +T  + A+K +K  T          T   R++ L        ++ 
Sbjct: 65  GAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV-LEHIRQSPFLVT 123

Query: 122 LTDVFGYMSNVSLVFEFVDT-DL------EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH 174
           L   F   + + L+ ++++  +L           +  +         Y    +  LE+LH
Sbjct: 124 LHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQI-------YVGEIVLALEHLH 176

Query: 175 DHWILHRDLKPNNLLINKQGVLKIGDFGLAK 205
              I++RD+K  N+L++  G + + DFGL+K
Sbjct: 177 KLGIIYRDIKLENILLDSNGHVVLTDFGLSK 207

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 56.0 bits (134), Expect = 3e-09
 Identities = 46/238 (19%), Positives = 67/238 (28%), Gaps = 62/238 (26%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTA---LREIKLLQELH------- 115
           G F  VF+     T   VA+K I +           +T    L EI + +EL        
Sbjct: 31  GVFGEVFQTIADHTP--VAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVC 88

Query: 116 --HENVLGLTDVF------------------------------GYMSNVSLVFEFVD--T 141
              E  +GL  V                                    + +V EF     
Sbjct: 89  NRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGI 148

Query: 142 DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD-HWILHRDLKPNNLLINKQGVLKIGD 200
           DLE +      + + +  K+        L          HRDL   N+L+ K  + K+  
Sbjct: 149 DLEQMRTK---LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHY 205

Query: 201 FGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWCCFAKDPSSHGNLFPG 258
               K    P+     QV    Y L +                    D S   +LF G
Sbjct: 206 TLNGKSSTIPS--CGLQVSIIDYTLSRLERD----------GIVVFCDVSMDEDLFTG 251

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 55.2 bits (133), Expect = 7e-09
 Identities = 25/110 (22%), Positives = 50/110 (45%), Gaps = 9/110 (8%)

Query: 107 EIKLLQELHHENVLGLTDVFGYMSNVS-------LVFEFVDTDLEVIIKDPTIVFTPSNI 159
           +I+          LG+   +G   +         ++ +   +DL+ I +     F+   +
Sbjct: 95  QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTV 154

Query: 160 KAYAIMTLRGLEYLHDHWILHRDLKPNNLLIN--KQGVLKIGDFGLAKFF 207
              ++  L  LEY+H+H  +H D+K +NLL+N      + + D+GLA  +
Sbjct: 155 LQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 51.5 bits (123), Expect = 1e-07
 Identities = 20/62 (32%), Positives = 34/62 (54%)

Query: 144 EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGL 203
           E          T  ++  Y+    +G+E+L     +HRDL   N+L++++ V+KI DFGL
Sbjct: 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL 239

Query: 204 AK 205
           A+
Sbjct: 240 AR 241

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	307
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.95
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.91
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.83
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.53
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.42
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.33
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	99.01
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.84
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.83
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.83
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.75
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.63
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.61
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.43
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.38
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	98.1
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.05
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.04
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.88
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.86
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.78
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.76
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.64
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.64
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.63
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.61
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.48
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.25
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.91
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.09
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	95.12
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	89.5
1cja_A	342	Protein (actin-fragmin kinase); transferase; HET:	87.74
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	84.22
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	83.95

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=7.2e-62  Score=421.81  Aligned_cols=243  Identities=20%  Similarity=0.301  Sum_probs=210.7

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ....|+++++||+|+||+||+|++..+|+.||||++......     ..+.+.+|+++|+.++|||||++++++.+++.+
T Consensus        72 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-----~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  146 (346)
T 4fih_A           72 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-----RRELLFNEVVIMRDYQHENVVEMYNSYLVGDEL  146 (346)
T ss_dssp             GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS-----SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             hhHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh-----HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            456799999999999999999999999999999999753221     245578999999999999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT  211 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  211 (307)
                      ||||||+ +|+|.+++.+.  .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus       147 ~ivmEy~~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  224 (346)
T 4fih_A          147 WVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  224 (346)
T ss_dssp             EEEECCCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred             EEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence            9999999 57888888764  48999999999999999999999999999999999999999999999999999886655


Q ss_pred             cccccceeeceehhhhhhhccccccccccee---eeee----cCCCCCCCCCCC---------CChhhhccccCHHHHHH
Q psy9858         212 RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KDPSSHGNLFPG---------IPLNEIFTAAGDDLLAV  275 (307)
Q Consensus       212 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~~~~f~~~~~~~---------~~~~~~~~~~~~~l~~l  275 (307)
                      ....+.+||+.|||||++.+. .|+.++|||   |+++    |.+||.+.....         ......+..+|+++.+|
T Consensus       225 ~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dl  303 (346)
T 4fih_A          225 PRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGF  303 (346)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHH
T ss_pred             CcccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHH
Confidence            556677999999999999887 899999999   4443    999998732110         11112235689999999


Q ss_pred             HHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         276 ISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       276 i~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      |.+||+.||++|||++|+|+||||++..
T Consensus       304 i~~~L~~dP~~R~ta~e~l~Hp~~~~~~  331 (346)
T 4fih_A          304 LDRLLVRDPAQRATAAELLKHPFLAKAG  331 (346)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence            9999999999999999999999998653

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.8e-62  Score=412.87  Aligned_cols=246  Identities=22%  Similarity=0.320  Sum_probs=195.5

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|++++.||+|+||+||+|++..+|+.||||++.+.....  ......+.+|+++++.++||||+++++++++++.+
T Consensus        11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   88 (275)
T 3hyh_A           11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAK--SDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEI   88 (275)
T ss_dssp             ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCC--HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence            4578999999999999999999999999999999998654332  22356788999999999999999999999999999


Q ss_pred             EEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc
Q psy9858         133 SLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR  212 (307)
Q Consensus       133 ~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  212 (307)
                      |+||||++|+|.+++.+.. .+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..... .
T Consensus        89 ~ivmEy~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~  166 (275)
T 3hyh_A           89 IMVIEYAGNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-N  166 (275)
T ss_dssp             EEEEECCCEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred             EEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC-C
Confidence            9999999999999987654 5999999999999999999999999999999999999999999999999999876433 3


Q ss_pred             ccccceeeceehhhhhhhccccccccccee---ee----eecCCCCCCCCCCCC------ChhhhccccCHHHHHHHHHh
Q psy9858         213 LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FAKDPSSHGNLFPGI------PLNEIFTAAGDDLLAVISSL  279 (307)
Q Consensus       213 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~~~~~f~~~~~~~~------~~~~~~~~~~~~l~~li~~~  279 (307)
                      ...+.+||+.|||||++.+...++.++|||   |+    ++|.+||.+......      .....+..+|+++.+||.+|
T Consensus       167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  246 (275)
T 3hyh_A          167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRM  246 (275)
T ss_dssp             --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHH
T ss_pred             ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence            345678999999999999885567899999   33    349999987332110      00122356899999999999


Q ss_pred             hhcCCCCCCCHHHHhcCcccCCC
Q psy9858         280 LCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       280 l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                      |+.||++|||++|+|+||||+..
T Consensus       247 L~~dP~~R~s~~eil~hpw~k~~  269 (275)
T 3hyh_A          247 LIVNPLNRISIHEIMQDDWFKVD  269 (275)
T ss_dssp             SCSSGGGSCCHHHHHHCHHHHTT
T ss_pred             ccCChhHCcCHHHHHcCcccccC
Confidence            99999999999999999999754

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.5e-62  Score=426.80  Aligned_cols=249  Identities=21%  Similarity=0.368  Sum_probs=207.8

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN  131 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  131 (307)
                      ...++|++++.||+|+||+||+|++..+|+.||||++.+....   ......+.+|+++|++|+|||||++++++++++.
T Consensus        21 ~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~   97 (350)
T 4b9d_A           21 QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS---SKEREESRREVAVLANMKHPNIVQYRESFEENGS   97 (350)
T ss_dssp             SCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC---HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             CcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC---HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCE
Confidence            3467999999999999999999999999999999999875432   2235678999999999999999999999999999


Q ss_pred             EEEEEEcc-CCChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCC
Q psy9858         132 VSLVFEFV-DTDLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS  209 (307)
Q Consensus       132 ~~lv~e~~-~g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  209 (307)
                      +||||||+ +|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus        98 ~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  177 (350)
T 4b9d_A           98 LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS  177 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence            99999999 68999999754 44579999999999999999999999999999999999999999999999999998754


Q ss_pred             CCcccccceeeceehhhhhhhccccccccccee---eeee----cCCCCCCCCCCC-------CChhhhccccCHHHHHH
Q psy9858         210 PTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KDPSSHGNLFPG-------IPLNEIFTAAGDDLLAV  275 (307)
Q Consensus       210 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~~~~f~~~~~~~-------~~~~~~~~~~~~~l~~l  275 (307)
                      ........+||+.|||||++.+. .|+.++|||   |+++    |.+||.+.....       ......+..+|+++.+|
T Consensus       178 ~~~~~~~~~GT~~YmAPE~l~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~l  256 (350)
T 4b9d_A          178 TVELARACIGTPYYLSPEICENK-PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSL  256 (350)
T ss_dssp             HHHHHHHHHSCCTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHH
T ss_pred             CcccccccCCCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHH
Confidence            33344566899999999999987 899999999   4444    999998732211       11122345689999999


Q ss_pred             HHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         276 ISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       276 i~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                      |.+||+.||++|||++|+|+||||++.-+
T Consensus       257 i~~~L~~dP~~R~s~~e~l~hp~~~~~~~  285 (350)
T 4b9d_A          257 VSQLFKRNPRDRPSVNSILEKGFIAKRIE  285 (350)
T ss_dssp             HHHHTCSSGGGSCCHHHHHTSHHHHTTGG
T ss_pred             HHHHccCChhHCcCHHHHhcCHHhhcCCC
Confidence            99999999999999999999999976543

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4e-62  Score=417.49  Aligned_cols=247  Identities=23%  Similarity=0.262  Sum_probs=210.4

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|++++.||+|+||+||+|++..+|+.||||++.+....  .....+.+.+|+++|++++||||+++++++++++.+
T Consensus        30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  107 (311)
T 4aw0_A           30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII--KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL  107 (311)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH--HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            346799999999999999999999999999999999853221  122356788999999999999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC-
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP-  210 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-  210 (307)
                      ||||||+ +|+|.+++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+... 
T Consensus       108 yivmEy~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          108 YFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  186 (311)
T ss_dssp             EEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred             EEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence            9999999 679999987654 5999999999999999999999999999999999999999999999999999987532 


Q ss_pred             -Ccccccceeeceehhhhhhhccccccccccee---eee----ecCCCCCCCCCCCCC------hhhhccccCHHHHHHH
Q psy9858         211 -TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCF----AKDPSSHGNLFPGIP------LNEIFTAAGDDLLAVI  276 (307)
Q Consensus       211 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~----~~~~~f~~~~~~~~~------~~~~~~~~~~~l~~li  276 (307)
                       .....+.+||+.|||||++.+. .|+.++|||   |++    +|.+||.+.......      ....+..+++++++||
T Consensus       187 ~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli  265 (311)
T 4aw0_A          187 KQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLV  265 (311)
T ss_dssp             TCCCBCCCCSCGGGCCHHHHHHS-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHH
T ss_pred             CcccccCcccCcccCCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHH
Confidence             2234567899999999999987 899999999   443    399999873221100      0123456899999999


Q ss_pred             HHhhhcCCCCCCCHHH------HhcCcccCCCc
Q psy9858         277 SSLLCLNPTKRADCTA------TLKMDYFSLTK  303 (307)
Q Consensus       277 ~~~l~~dP~~Rpt~~~------il~hp~f~~~~  303 (307)
                      .+||+.||++|||++|      +++||||++++
T Consensus       266 ~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~id  298 (311)
T 4aw0_A          266 EKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT  298 (311)
T ss_dssp             HHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred             HHHccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence            9999999999999988      58999998864

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.3e-60  Score=423.70  Aligned_cols=244  Identities=20%  Similarity=0.303  Sum_probs=211.5

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN  131 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  131 (307)
                      ...+.|+++++||+|+||+||+|++..+|+.||||++......     ..+.+.+|+++|+.++|||||++++++.+++.
T Consensus       148 dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-----~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  222 (423)
T 4fie_A          148 DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-----RRELLFNEVVIMRDYQHENVVEMYNSYLVGDE  222 (423)
T ss_dssp             CGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS-----SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             ChhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh-----HHHHHHHHHHHHHhCCCCCCCceEEEEEECCE
Confidence            4557899999999999999999999999999999999864322     24568899999999999999999999999999


Q ss_pred             EEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         132 VSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       132 ~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      +||||||| +|+|.+++...  .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.+...
T Consensus       223 ~~iVmEy~~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~  300 (423)
T 4fie_A          223 LWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  300 (423)
T ss_dssp             EEEEEECCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred             EEEEEeCCCCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence            99999999 67898888754  4899999999999999999999999999999999999999999999999999988655


Q ss_pred             Ccccccceeeceehhhhhhhccccccccccee---eeee----cCCCCCCCCCCC---------CChhhhccccCHHHHH
Q psy9858         211 TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KDPSSHGNLFPG---------IPLNEIFTAAGDDLLA  274 (307)
Q Consensus       211 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~~~~f~~~~~~~---------~~~~~~~~~~~~~l~~  274 (307)
                      .....+.+||+.|||||++.+. .|+.++|||   |+++    |++||.+.....         ......+..+++++.+
T Consensus       301 ~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~d  379 (423)
T 4fie_A          301 VPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKG  379 (423)
T ss_dssp             CCCBCCCEECTTTCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHH
T ss_pred             CccccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHH
Confidence            5556677999999999999887 899999999   4333    999998732110         1111223468999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         275 VISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       275 li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      ||.+||+.||++|||++|+|+||||++..
T Consensus       380 li~~~L~~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          380 FLDRLLVRDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence            99999999999999999999999998753

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.9e-60  Score=406.91  Aligned_cols=246  Identities=21%  Similarity=0.264  Sum_probs=201.5

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEc---CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDI---ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM  129 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  129 (307)
                      ..++|++++.||+|+||+||+|++.   .+++.||||++.+.......   ...+.+|+++|++++||||++++++++++
T Consensus        22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~~~~~~~   98 (304)
T 3ubd_A           22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD---RVRTKMERDILVEVNHPFIVKLHYAFQTE   98 (304)
T ss_dssp             CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE---CC------CCCCCCCCTTEECEEEEEEET
T ss_pred             CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH---HHHHHHHHHHHHHCCCCCCCeEEEEEEEC
Confidence            3468999999999999999999874   46889999999864322221   34578899999999999999999999999


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                      +.+||||||+ +|+|.+++.+.. .+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus        99 ~~~~ivmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A           99 GKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             TEEEEEECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            9999999999 689999987654 59999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCC------ChhhhccccCHHHHHH
Q psy9858         209 SPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGI------PLNEIFTAAGDDLLAV  275 (307)
Q Consensus       209 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~------~~~~~~~~~~~~l~~l  275 (307)
                      .......+.+||+.|||||++.+. .|+.++|||   |    +++|.+||.+......      .....+..+|+++.+|
T Consensus       178 ~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  256 (304)
T 3ubd_A          178 DHEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSL  256 (304)
T ss_dssp             ---CCCCSCCCCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred             CCCccccccccCcccCCHHHhccC-CCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence            555555667999999999999887 899999999   3    3449999987322110      0112345689999999


Q ss_pred             HHHhhhcCCCCCCC-----HHHHhcCcccCCCc
Q psy9858         276 ISSLLCLNPTKRAD-----CTATLKMDYFSLTK  303 (307)
Q Consensus       276 i~~~l~~dP~~Rpt-----~~~il~hp~f~~~~  303 (307)
                      |.+||+.||++|||     ++|+++||||++.+
T Consensus       257 i~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~id  289 (304)
T 3ubd_A          257 LRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID  289 (304)
T ss_dssp             HHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             HHHHcccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence            99999999999998     58999999999864

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=5.2e-59  Score=396.18  Aligned_cols=237  Identities=22%  Similarity=0.293  Sum_probs=198.6

Q ss_pred             eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee----cCeE
Q psy9858          57 YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY----MSNV  132 (307)
Q Consensus        57 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----~~~~  132 (307)
                      |++.++||+|+||+||+|.+..++..||+|++.....   .....+.|.+|++++++++|||||++++++++    +..+
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~  104 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL---TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence            4778899999999999999999999999999975432   22235678999999999999999999999865    4568


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeecCCCCcEEEec-CCcEEEEeecCccccC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHW--ILHRDLKPNNLLINK-QGVLKIGDFGLAKFFG  208 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~-~~~~kl~Dfg~a~~~~  208 (307)
                      ||||||+ +|+|.+++.+.. .+++..++.++.||+.||.|||++|  |+||||||+|||++. ++.+||+|||+|+...
T Consensus       105 ~lvmEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          105 VLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            9999999 689999887643 5899999999999999999999998  999999999999984 7899999999998653


Q ss_pred             CCCcccccceeeceehhhhhhhccccccccccee---ee----eecCCCCCCCCC---------CCCChhhhccccCHHH
Q psy9858         209 SPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FAKDPSSHGNLF---------PGIPLNEIFTAAGDDL  272 (307)
Q Consensus       209 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~~~~~f~~~~~---------~~~~~~~~~~~~~~~l  272 (307)
                      .  ....+.+||+.|||||++.+  .|+.++|||   |+    ++|.+||.+...         ...........+++++
T Consensus       184 ~--~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  259 (290)
T 3fpq_A          184 A--SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV  259 (290)
T ss_dssp             T--TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHH
T ss_pred             C--CccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHH
Confidence            2  33456689999999998864  599999999   33    349999976221         1112223345678999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHhcCcccCC
Q psy9858         273 LAVISSLLCLNPTKRADCTATLKMDYFSL  301 (307)
Q Consensus       273 ~~li~~~l~~dP~~Rpt~~~il~hp~f~~  301 (307)
                      .+||.+||+.||++|||++|+|+||||++
T Consensus       260 ~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          260 KEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            99999999999999999999999999985

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.7e-58  Score=409.12  Aligned_cols=244  Identities=29%  Similarity=0.515  Sum_probs=207.5

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee------
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY------  128 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~------  128 (307)
                      ++|++++.||+|+||+||+|++..+|+.||||++.....   .....+.+.+|+++|+.++|||||++++++..      
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~  130 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD---VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE  130 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS---SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc---chHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccccc
Confidence            579999999999999999999999999999999975432   22234678899999999999999999998753      


Q ss_pred             cCeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         129 MSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       129 ~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                      .+.+||||||++|+|.+++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+.
T Consensus       131 ~~~~~ivmE~~~g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~  209 (398)
T 4b99_A          131 FKSVYVVLDLMESDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC  209 (398)
T ss_dssp             CCCEEEEEECCSEEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred             CCEEEEEEeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence            46899999999999999987654 69999999999999999999999999999999999999999999999999998764


Q ss_pred             CC----Ccccccceeeceehhhhhhhccccccccccee---eeee----cCCCCCCCC----------------------
Q psy9858         209 SP----TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KDPSSHGNL----------------------  255 (307)
Q Consensus       209 ~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~~~~f~~~~----------------------  255 (307)
                      ..    .....+.+||+.|+|||++.+...++.++|||   |+++    |.+||.+..                      
T Consensus       210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~  289 (398)
T 4b99_A          210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA  289 (398)
T ss_dssp             ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred             cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence            32    22345679999999999999876789999999   4444    999998721                      


Q ss_pred             ---------------CCCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         256 ---------------FPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       256 ---------------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                                     .........++.+++++.+||.+||+.||++|||++|+|+||||++.
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  351 (398)
T 4b99_A          290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY  351 (398)
T ss_dssp             ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred             hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence                           11122334455689999999999999999999999999999999875

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.6e-58  Score=399.66  Aligned_cols=243  Identities=23%  Similarity=0.255  Sum_probs=205.6

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY  128 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  128 (307)
                      ......+.|++.++||+|+||+||+|++..+|+.||||+++....          ..+|+.+++.++|||||++++++.+
T Consensus        52 ~~~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----------~~~E~~il~~l~HpnIV~l~~~~~~  121 (336)
T 4g3f_A           52 EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----------RVEELVACAGLSSPRIVPLYGAVRE  121 (336)
T ss_dssp             BCCBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----------CTHHHHTTTTCCCTTBCCEEEEEEE
T ss_pred             hhhcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----------HHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            344456789999999999999999999999999999999975321          2379999999999999999999999


Q ss_pred             cCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCC-cEEEEeecCccc
Q psy9858         129 MSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG-VLKIGDFGLAKF  206 (307)
Q Consensus       129 ~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a~~  206 (307)
                      ++.+||||||+ +|+|.+++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++.+| .+||+|||+|+.
T Consensus       122 ~~~~~ivmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~  200 (336)
T 4g3f_A          122 GPWVNIFMELLEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALC  200 (336)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEE
T ss_pred             CCEEEEEEeccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeE
Confidence            99999999999 689999987654 599999999999999999999999999999999999999988 699999999998


Q ss_pred             cCCCCc-----ccccceeeceehhhhhhhccccccccccee---ee----eecCCCCCCCCCCCC---------Chhhhc
Q psy9858         207 FGSPTR-----LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FAKDPSSHGNLFPGI---------PLNEIF  265 (307)
Q Consensus       207 ~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~~~~~f~~~~~~~~---------~~~~~~  265 (307)
                      ......     .....+||+.|||||++.+. .|+.++|||   |+    ++|.+||.+......         .....+
T Consensus       201 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~  279 (336)
T 4g3f_A          201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGK-PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIP  279 (336)
T ss_dssp             C------------CCCCCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSC
T ss_pred             ccCCCcccceecCCccccCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcC
Confidence            743221     12234799999999999987 899999999   43    349999988443321         223455


Q ss_pred             cccCHHHHHHHHHhhhcCCCCCCCHHHH-------------hcCcccCCCc
Q psy9858         266 TAAGDDLLAVISSLLCLNPTKRADCTAT-------------LKMDYFSLTK  303 (307)
Q Consensus       266 ~~~~~~l~~li~~~l~~dP~~Rpt~~~i-------------l~hp~f~~~~  303 (307)
                      +.+++++.+||.+||+.||++|||++|+             |+|||+...+
T Consensus       280 ~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~  330 (336)
T 4g3f_A          280 PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK  330 (336)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred             ccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence            6789999999999999999999999997             6899998754

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=5.8e-58  Score=392.76  Aligned_cols=246  Identities=20%  Similarity=0.277  Sum_probs=191.5

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC--
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS--  130 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--  130 (307)
                      ..++|++++.||+|+||+||+|++..+|+.||||++....    .+...+.+.+|+++|++++|||||++++++.+.+  
T Consensus         3 ~l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~   78 (299)
T 4g31_A            3 YLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN----RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTT   78 (299)
T ss_dssp             HHHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--
T ss_pred             cchhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcc
Confidence            4568999999999999999999999999999999997532    2333567889999999999999999999987544  


Q ss_pred             ----------eEEEEEEcc-CCChHHHHhCCCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEE
Q psy9858         131 ----------NVSLVFEFV-DTDLEVIIKDPTI--VFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLK  197 (307)
Q Consensus       131 ----------~~~lv~e~~-~g~l~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~k  197 (307)
                                ++|+||||+ +|+|.+++.....  ...+..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus        79 ~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vK  158 (299)
T 4g31_A           79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVK  158 (299)
T ss_dssp             --------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred             ccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEE
Confidence                      479999999 6889999976542  245567889999999999999999999999999999999999999


Q ss_pred             EEeecCccccCCCCc------------ccccceeeceehhhhhhhccccccccccee---eeee-cCCCCCCCC------
Q psy9858         198 IGDFGLAKFFGSPTR------------LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA-KDPSSHGNL------  255 (307)
Q Consensus       198 l~Dfg~a~~~~~~~~------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~-~~~~f~~~~------  255 (307)
                      |+|||+|+.......            .....+||+.|||||++.+. .|+.++|||   |+++ --.||.+..      
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyell~Pf~~~~~~~~~~  237 (299)
T 4g31_A          159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELLYPFSTQMERVRTL  237 (299)
T ss_dssp             ECCCCCC--------------------------CCCTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHH
T ss_pred             EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCC-CCCCHHHHHHHHHHHHHHccCCCCccHHHHHH
Confidence            999999987743221            12345799999999999987 899999999   4433 113665411      


Q ss_pred             --CCCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         256 --FPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       256 --~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                        .........+...++.+.+||.+||+.||++|||++|+|+||||++.+
T Consensus       238 ~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~  287 (299)
T 4g31_A          238 TDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD  287 (299)
T ss_dssp             HHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred             HHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence              011112233445678889999999999999999999999999998754

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.8e-55  Score=386.88  Aligned_cols=240  Identities=20%  Similarity=0.283  Sum_probs=196.9

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEc---CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeee
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDI---ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGY  128 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~  128 (307)
                      ..++|++++.||+|+||+||+|++.   .+++.||+|++....       ....+.+|+++|+.+ +||||+++++++.+
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-------~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~   91 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-------HPIRIAAELQCLTVAGGQDNVMGVKYCFRK   91 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-------CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-------CHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence            4568999999999999999999875   467899999986431       134578999999998 69999999999999


Q ss_pred             cCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecC-CcEEEEeecCccc
Q psy9858         129 MSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ-GVLKIGDFGLAKF  206 (307)
Q Consensus       129 ~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~a~~  206 (307)
                      .+++|+||||+ +|+|.+++.    .+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.
T Consensus        92 ~~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~  167 (361)
T 4f9c_A           92 NDHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG  167 (361)
T ss_dssp             TTEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             CCEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence            99999999999 578988884    38999999999999999999999999999999999999877 7999999999986


Q ss_pred             cCCCC----------------------------cccccceeeceehhhhhhhccccccccccee---eeee----cCCCC
Q psy9858         207 FGSPT----------------------------RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KDPSS  251 (307)
Q Consensus       207 ~~~~~----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~~~~f  251 (307)
                      .....                            ....+.+||+.|+|||++.+...|+.++|||   |+++    |+.||
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf  247 (361)
T 4f9c_A          168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF  247 (361)
T ss_dssp             CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred             cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence            53321                            1123457999999999999876799999999   4444    99998


Q ss_pred             CCCCC----------------------------------CCCC---------------------------hhhhccccCH
Q psy9858         252 HGNLF----------------------------------PGIP---------------------------LNEIFTAAGD  270 (307)
Q Consensus       252 ~~~~~----------------------------------~~~~---------------------------~~~~~~~~~~  270 (307)
                      .....                                  +...                           ..+.+..+|+
T Consensus       248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~  327 (361)
T 4f9c_A          248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD  327 (361)
T ss_dssp             SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred             CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence            54211                                  0000                           0112345789


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         271 DLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       271 ~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      ++.+||.+||+.||++|||++|+|+||||+++.
T Consensus       328 ~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          328 EAYDLLDKLLDLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             HHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            999999999999999999999999999999763

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.9e-55  Score=374.95  Aligned_cols=240  Identities=18%  Similarity=0.226  Sum_probs=195.4

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY  128 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  128 (307)
                      .|....+++.+.++||+|+||+||+|++..   .||||+++...   ......+.|.+|++++++++|||||++++++..
T Consensus        30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~---~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~  103 (307)
T 3omv_A           30 YWEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVD---PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK  103 (307)
T ss_dssp             CCBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSS---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             CcEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecC---CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC
Confidence            455677889999999999999999998542   59999987532   223335779999999999999999999998754


Q ss_pred             cCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         129 MSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       129 ~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                       +.++|||||+ +|+|.+++......+++.++..++.||+.||.|||+++||||||||+|||++.++.+||+|||+|+..
T Consensus       104 -~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  182 (307)
T 3omv_A          104 -DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVK  182 (307)
T ss_dssp             -SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred             -CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceec
Confidence             5689999999 68999999877777999999999999999999999999999999999999999999999999999876


Q ss_pred             CCC--Ccccccceeeceehhhhhhhcc--ccccccccee-------eeeecCCCCCCCC------------CCCCChhhh
Q psy9858         208 GSP--TRLYTHQVVTRWYRLIKCLLYC--VQFNVKNVQW-------CCFAKDPSSHGNL------------FPGIPLNEI  264 (307)
Q Consensus       208 ~~~--~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~Diw-------~i~~~~~~f~~~~------------~~~~~~~~~  264 (307)
                      ...  .......+||+.|||||++.+.  ..|+.++|||       .+++|+.||.+..            .........
T Consensus       183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~  262 (307)
T 3omv_A          183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKL  262 (307)
T ss_dssp             -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTS
T ss_pred             ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Confidence            432  2234456899999999999753  2589999999       3444999998722            122223345


Q ss_pred             ccccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         265 FTAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       265 ~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      +.++++++.+|+.+||+.||++|||+.|+++
T Consensus       263 ~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~  293 (307)
T 3omv_A          263 YKNCPKAMKRLVADCVKKVKEERPLFPQILS  293 (307)
T ss_dssp             CTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred             cccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            5678999999999999999999999998753

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=8.7e-55  Score=404.02  Aligned_cols=244  Identities=19%  Similarity=0.233  Sum_probs=211.8

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN  131 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  131 (307)
                      ...++|++++.||+|+||+||+|.++.+|+.||+|++.....     ...+.+.+|+++|+.++||||+++++++.+.+.
T Consensus       154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~-----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  228 (573)
T 3uto_A          154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-----SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE  228 (573)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-----HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSE
T ss_pred             cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch-----hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            345789999999999999999999999999999999976321     224567899999999999999999999999999


Q ss_pred             EEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecC--CcEEEEeecCccccC
Q psy9858         132 VSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ--GVLKIGDFGLAKFFG  208 (307)
Q Consensus       132 ~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~--~~~kl~Dfg~a~~~~  208 (307)
                      +||||||+ +|+|.+++....+.+++.+++.++.||+.||.|||++||+||||||+|||++.+  +.+||+|||+|+.+.
T Consensus       229 ~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~  308 (573)
T 3uto_A          229 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD  308 (573)
T ss_dssp             EEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred             EEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence            99999999 689999998777779999999999999999999999999999999999999854  899999999999885


Q ss_pred             CCCcccccceeeceehhhhhhhccccccccccee---eee----ecCCCCCCCCC----------CCCChhhhccccCHH
Q psy9858         209 SPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCF----AKDPSSHGNLF----------PGIPLNEIFTAAGDD  271 (307)
Q Consensus       209 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~----~~~~~f~~~~~----------~~~~~~~~~~~~~~~  271 (307)
                      .. ......+||+.|||||++.+. .|+.++|||   |++    +|.+||.+...          ........+..+|++
T Consensus       309 ~~-~~~~~~~GT~~y~APEv~~~~-~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  386 (573)
T 3uto_A          309 PK-QSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED  386 (573)
T ss_dssp             TT-SEEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHH
T ss_pred             CC-CceeeeEECccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence            43 344556899999999999987 899999999   433    39999987321          111223445678999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         272 LLAVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       272 l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                      +.+||.+||+.||.+|||++|+|+||||+..
T Consensus       387 ~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~  417 (573)
T 3uto_A          387 GKDFIRKLLLADPNTRMTIHQALEHPWLTPG  417 (573)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCcCcCCC
Confidence            9999999999999999999999999999864

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=8e-55  Score=403.36  Aligned_cols=247  Identities=20%  Similarity=0.294  Sum_probs=206.6

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHH---HHHHHHHhcCCCCccccceeeee
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL---REIKLLQELHHENVLGLTDVFGY  128 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~---~e~~~l~~l~h~ni~~~~~~~~~  128 (307)
                      ...++|++++.||+|+||+||+|++..+|+.||||++.+........  .....   +++.+++.++|||||+++++|++
T Consensus       186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~--~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~  263 (689)
T 3v5w_A          186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG--ETLALNERIMLSLVSTGDCPFIVCMSYAFHT  263 (689)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTC--HHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred             CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhh--HHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence            35688999999999999999999999999999999997643222111  22233   34667777899999999999999


Q ss_pred             cCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         129 MSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       129 ~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      .+.+||||||+ +|+|.+++.+.+ .+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+..
T Consensus       264 ~~~lylVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          264 PDKLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCEEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence            99999999999 689999997654 5999999999999999999999999999999999999999999999999999987


Q ss_pred             CCCCcccccceeeceehhhhhhhccccccccccee---eeee----cCCCCCCCCCCCC---------ChhhhccccCHH
Q psy9858         208 GSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KDPSSHGNLFPGI---------PLNEIFTAAGDD  271 (307)
Q Consensus       208 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~~~~f~~~~~~~~---------~~~~~~~~~~~~  271 (307)
                      ...  ...+.+||+.|||||++.+...|+.++|+|   |+++    |.+||.+......         .....+..+|++
T Consensus       343 ~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~  420 (689)
T 3v5w_A          343 SKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE  420 (689)
T ss_dssp             SSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred             CCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHH
Confidence            433  334569999999999997655899999999   4444    9999977433211         011234568999


Q ss_pred             HHHHHHHhhhcCCCCCCC-----HHHHhcCcccCCCc
Q psy9858         272 LLAVISSLLCLNPTKRAD-----CTATLKMDYFSLTK  303 (307)
Q Consensus       272 l~~li~~~l~~dP~~Rpt-----~~~il~hp~f~~~~  303 (307)
                      +.+||.+||+.||++|++     ++||++||||++.+
T Consensus       421 a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~id  457 (689)
T 3v5w_A          421 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD  457 (689)
T ss_dssp             HHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred             HHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCC
Confidence            999999999999999998     79999999999864

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.9e-55  Score=374.74  Aligned_cols=241  Identities=21%  Similarity=0.284  Sum_probs=198.5

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeee
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDI-----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG  127 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~  127 (307)
                      ..++|.+.+.||+|+||+||+|++.     .+++.||||++...     .....+.|.+|+++|++++|||||++++++.
T Consensus        11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~   85 (299)
T 4asz_A           11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-----SDNARKDFHREAELLTNLQHEHIVKFYGVCV   85 (299)
T ss_dssp             CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-----ChHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence            4568999999999999999999865     36889999999743     2233567999999999999999999999999


Q ss_pred             ecCeEEEEEEcc-CCChHHHHhCC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCC
Q psy9858         128 YMSNVSLVFEFV-DTDLEVIIKDP------------TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG  194 (307)
Q Consensus       128 ~~~~~~lv~e~~-~g~l~~~~~~~------------~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~  194 (307)
                      +++..+|||||+ +|+|.+++...            ...+++.++..++.||+.||.|||+++|+||||||+|||++.++
T Consensus        86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL  165 (299)
T ss_dssp             SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence            999999999999 78999999653            24589999999999999999999999999999999999999999


Q ss_pred             cEEEEeecCccccCCCCcc--cccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCC-------
Q psy9858         195 VLKIGDFGLAKFFGSPTRL--YTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFP-------  257 (307)
Q Consensus       195 ~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~-------  257 (307)
                      .+||+|||+|+........  .....||+.|||||.+.+. .|+.++|||       .+++ |+.||.+....       
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~  244 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT  244 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            9999999999876433222  2335789999999999988 899999999       3444 89999873211       


Q ss_pred             CCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCC
Q psy9858         258 GIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSL  301 (307)
Q Consensus       258 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~  301 (307)
                      .......+..+++++.+|+.+||+.||++|||+++++  +|+++
T Consensus       245 ~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~  286 (299)
T 4asz_A          245 QGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQN  286 (299)
T ss_dssp             HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHH
T ss_pred             cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHH
Confidence            1111233457899999999999999999999999994  45543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=9.6e-55  Score=373.83  Aligned_cols=239  Identities=20%  Similarity=0.275  Sum_probs=199.1

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeee
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDI-----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG  127 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~  127 (307)
                      ..+++++.++||+|+||+||+|.+.     .+++.||||++....    .....+.|.+|+.++++++|||||++++++.
T Consensus        24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~----~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~   99 (308)
T 4gt4_A           24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA----EGPLREEFRHEAMLRARLQHPNVVCLLGVVT   99 (308)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C----CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc----ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence            5567899999999999999999853     467899999997432    2223567999999999999999999999999


Q ss_pred             ecCeEEEEEEcc-CCChHHHHhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEe
Q psy9858         128 YMSNVSLVFEFV-DTDLEVIIKDPT---------------IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLIN  191 (307)
Q Consensus       128 ~~~~~~lv~e~~-~g~l~~~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~  191 (307)
                      +++..+|||||+ +|+|.+++....               ..+++..+..++.||+.||.|||+++||||||||+|||++
T Consensus       100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~  179 (308)
T 4gt4_A          100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY  179 (308)
T ss_dssp             SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence            999999999999 789999996432               3489999999999999999999999999999999999999


Q ss_pred             cCCcEEEEeecCccccCCCC--cccccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCC-----
Q psy9858         192 KQGVLKIGDFGLAKFFGSPT--RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLF-----  256 (307)
Q Consensus       192 ~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~-----  256 (307)
                      .++.+||+|||+|+......  .......||+.|||||++.+. .|+.++|||       .+++ |..||.+...     
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~  258 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE  258 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred             CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            99999999999998764322  223456899999999999988 899999999       3444 8899987321     


Q ss_pred             --CCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         257 --PGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       257 --~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                        ......+.+..+++++.+|+.+||+.||++|||++||+++
T Consensus       259 ~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          259 MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence              1111223456789999999999999999999999999875

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.2e-54  Score=374.87  Aligned_cols=239  Identities=22%  Similarity=0.251  Sum_probs=192.6

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceee
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDI-----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVF  126 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~  126 (307)
                      ...++|.+.++||+|+||+||+|++.     .+++.||||++...     .....+.|.+|+++|++++|||||++++++
T Consensus        38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~  112 (329)
T 4aoj_A           38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-----SESARQDFQREAELLTMLQHQHIVRFFGVC  112 (329)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            35578999999999999999999864     46889999999742     223356799999999999999999999999


Q ss_pred             eecCeEEEEEEcc-CCChHHHHhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEe
Q psy9858         127 GYMSNVSLVFEFV-DTDLEVIIKDPT--------------IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLIN  191 (307)
Q Consensus       127 ~~~~~~~lv~e~~-~g~l~~~~~~~~--------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~  191 (307)
                      .+....+|||||+ +|+|.+++....              ..+++.++..++.||+.||.|||+++|+||||||+|||++
T Consensus       113 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~  192 (329)
T 4aoj_A          113 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG  192 (329)
T ss_dssp             CSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred             EECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence            9999999999999 789999987532              3589999999999999999999999999999999999999


Q ss_pred             cCCcEEEEeecCccccCCCCc--ccccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCC----
Q psy9858         192 KQGVLKIGDFGLAKFFGSPTR--LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFP----  257 (307)
Q Consensus       192 ~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~----  257 (307)
                      .++.+||+|||+|+.......  ......||+.|||||++.+. .|+.++|||       .+++ |+.||.+....    
T Consensus       193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~  271 (329)
T 4aoj_A          193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID  271 (329)
T ss_dssp             TTTEEEECCCC----------------CCCCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred             CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCC-CCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            999999999999987643322  23345789999999999988 899999999       3444 89999872211    


Q ss_pred             ---CCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         258 ---GIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       258 ---~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                         .......+..+++++.+|+.+||+.||++|||++|++++
T Consensus       272 ~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          272 CITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence               011123345789999999999999999999999999875

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4.4e-53  Score=369.61  Aligned_cols=243  Identities=19%  Similarity=0.247  Sum_probs=201.3

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEEcCC-----CcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCC-CCcccc
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARDIET-----DMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH-ENVLGL  122 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~  122 (307)
                      .|....++|++++.||+|+||+||+|.+...     ++.||||++....    .....+.|.+|+++|.+++| ||||++
T Consensus        58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~----~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc----ChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            3556778999999999999999999987653     4689999997532    22235678999999999965 999999


Q ss_pred             ceeeee-cCeEEEEEEcc-CCChHHHHhCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCC
Q psy9858         123 TDVFGY-MSNVSLVFEFV-DTDLEVIIKDP---------------TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP  185 (307)
Q Consensus       123 ~~~~~~-~~~~~lv~e~~-~g~l~~~~~~~---------------~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp  185 (307)
                      +++|.. +..++|||||+ +|+|.+++...               ...+++..+..++.||+.||.|||+++||||||||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~  213 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA  213 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCc
Confidence            999865 46799999999 68999998643               23488999999999999999999999999999999


Q ss_pred             CcEEEecCCcEEEEeecCccccCCCCc--ccccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCC
Q psy9858         186 NNLLINKQGVLKIGDFGLAKFFGSPTR--LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNL  255 (307)
Q Consensus       186 ~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~  255 (307)
                      +|||++.++.+||+|||+|+.......  ......||+.|||||++.+. .|+.++|||       .+++ |..||.+..
T Consensus       214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~  292 (353)
T 4ase_A          214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVK  292 (353)
T ss_dssp             GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC-CCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence            999999999999999999997744322  23456789999999999988 899999999       3444 899998743


Q ss_pred             CCCC--------ChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         256 FPGI--------PLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       256 ~~~~--------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      ....        .....+..+++++.+|+.+||+.||++|||++|+++|
T Consensus       293 ~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          293 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             CSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            3211        1123345689999999999999999999999999998

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.4e-51  Score=356.90  Aligned_cols=253  Identities=38%  Similarity=0.638  Sum_probs=212.5

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY  128 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  128 (307)
                      ......++|++++.||+|+||+||+|++. +|+.||+|++....   ........+.+|+++++.++||||+++++++.+
T Consensus        15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   90 (311)
T 3niz_A           15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDA---EDEGIPSTAIREISLLKELHHPNIVSLIDVIHS   90 (311)
T ss_dssp             CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC---------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             eecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEeccc---ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc
Confidence            44557789999999999999999999974 68999999997532   222335678899999999999999999999999


Q ss_pred             cCeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         129 MSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       129 ~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                      ....++||||++|++.+.+......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus        91 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  170 (311)
T 3niz_A           91 ERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFG  170 (311)
T ss_dssp             SSCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred             CCEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence            99999999999999999998877779999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCC------------------------
Q psy9858         209 SPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFP------------------------  257 (307)
Q Consensus       209 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~------------------------  257 (307)
                      ..........+|+.|+|||.+.+...++.++|||   +    +++|..||.+....                        
T Consensus       171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  250 (311)
T 3niz_A          171 IPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL  250 (311)
T ss_dssp             SCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred             CCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence            5545555668899999999998865789999999   3    33499999762211                        


Q ss_pred             ------------CCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCccc
Q psy9858         258 ------------GIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKEM  305 (307)
Q Consensus       258 ------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~~  305 (307)
                                  ........+.+++++.+||.+||+.||++|||++|+|+||||++.+.+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  310 (311)
T 3niz_A          251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDPQ  310 (311)
T ss_dssp             HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCTT
T ss_pred             chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCcc
Confidence                        111222334578899999999999999999999999999999998754

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=4.7e-51  Score=350.42  Aligned_cols=247  Identities=36%  Similarity=0.601  Sum_probs=208.9

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEE
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVS  133 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  133 (307)
                      .++|++++.||+|+||+||+|++..+|+.||+|++.....   .......+.+|+++++.++||||+++++++.++...+
T Consensus         1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   77 (292)
T 3o0g_A            1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLT   77 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS---STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC---cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEE
Confidence            3689999999999999999999999999999999986432   2233467889999999999999999999999999999


Q ss_pred             EEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc
Q psy9858         134 LVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL  213 (307)
Q Consensus       134 lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  213 (307)
                      +||||++|++.+.+....+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.........
T Consensus        78 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  157 (292)
T 3o0g_A           78 LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             EEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence            99999999999988877677999999999999999999999999999999999999999999999999999987655555


Q ss_pred             cccceeeceehhhhhhhccccccccccee---eeee----cCCC-CCCCCC--------------C--------------
Q psy9858         214 YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KDPS-SHGNLF--------------P--------------  257 (307)
Q Consensus       214 ~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~~~~-f~~~~~--------------~--------------  257 (307)
                      .....+|+.|+|||.+.+...++.++|||   ++++    |..| |.+...              .              
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T 3o0g_A          158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK  237 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred             ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence            56668899999999998875689999999   3332    5555 433110              0              


Q ss_pred             -------CCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         258 -------GIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       258 -------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                             ..........+++++.+||.+||+.||++|||++|+|+||||++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence                   0111122345789999999999999999999999999999998753

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.2e-50  Score=347.14  Aligned_cols=244  Identities=34%  Similarity=0.600  Sum_probs=202.9

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ++|++++.||+|+||+||+|++ .+|+.||+|++.....   .......+.+|+++++.++||||+++++++.+.+..++
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE---DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVL   77 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG---GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc---ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEE
Confidence            6899999999999999999998 7789999999975432   22234668899999999999999999999999999999


Q ss_pred             EEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCccc
Q psy9858         135 VFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY  214 (307)
Q Consensus       135 v~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  214 (307)
                      ||||++++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..........
T Consensus        78 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  157 (288)
T 1ob3_A           78 VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY  157 (288)
T ss_dssp             EEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             EEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence            99999999999998776679999999999999999999999999999999999999999999999999998775444444


Q ss_pred             ccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCC-------------------------------
Q psy9858         215 THQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLF-------------------------------  256 (307)
Q Consensus       215 ~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~-------------------------------  256 (307)
                      ....+|+.|+|||.+.+...++.++|||   +    +++|..||.+...                               
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T 1ob3_A          158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN  237 (288)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence            5567899999999998765789999999   3    3349999876210                               


Q ss_pred             ----CCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         257 ----PGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       257 ----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                          ...........+++++.+||.+||+.||++|||++|+|+||||++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence                0011122234578999999999999999999999999999999874

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.2e-50  Score=353.25  Aligned_cols=247  Identities=21%  Similarity=0.250  Sum_probs=208.9

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN  131 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  131 (307)
                      ...++|++++.||+|+||.||+|.+..+|+.||||++.....   .....+.+.+|+++++.++||||+++++++...+.
T Consensus        12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~   88 (328)
T 3fe3_A           12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL---NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKT   88 (328)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE
Confidence            456789999999999999999999999999999999976322   22335668899999999999999999999999999


Q ss_pred             EEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         132 VSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       132 ~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      .++||||+ +|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           89 LYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             EEEEECCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             EEEEEECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            99999999 678988886553 4899999999999999999999999999999999999999999999999999877433


Q ss_pred             Ccccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCCC------hhhhccccCHHHHHHHH
Q psy9858         211 TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGIP------LNEIFTAAGDDLLAVIS  277 (307)
Q Consensus       211 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~------~~~~~~~~~~~l~~li~  277 (307)
                       .......||+.|+|||.+.+....+.++|||   +    +++|..||.+.......      ....+..+++++.+|+.
T Consensus       168 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  246 (328)
T 3fe3_A          168 -GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK  246 (328)
T ss_dssp             -CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred             -CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence             3345568999999999999884556899999   3    33499999874321110      01123357899999999


Q ss_pred             HhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         278 SLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       278 ~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      +||+.||.+|||++|+++||||+...
T Consensus       247 ~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          247 RFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             HHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             HHCCCChhHCcCHHHHhcCHhhcCCC
Confidence            99999999999999999999998653

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.7e-50  Score=347.76  Aligned_cols=247  Identities=19%  Similarity=0.316  Sum_probs=211.8

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM  129 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  129 (307)
                      .+...++|++++.||+|+||+||+|.+..+|+.||+|++.....     .....+.+|+.+++.++||||+++++++...
T Consensus        15 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   89 (297)
T 3fxz_A           15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-----PKKELIINEILVMRENKNPNIVNYLDSYLVG   89 (297)
T ss_dssp             SSCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC-----SCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             cCChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc-----cHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC
Confidence            44577899999999999999999999999999999999975321     1245678999999999999999999999999


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                      +..++||||+ +|+|.+++...  .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus        90 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (297)
T 3fxz_A           90 DELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (297)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CEEEEEEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence            9999999999 68899888765  38999999999999999999999999999999999999999999999999998876


Q ss_pred             CCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC---------CChhhhccccCHHH
Q psy9858         209 SPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG---------IPLNEIFTAAGDDL  272 (307)
Q Consensus       209 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~---------~~~~~~~~~~~~~l  272 (307)
                      ..........||+.|+|||.+.+. .++.++|||   +    +++|..||.+.....         ......+..+++.+
T Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (297)
T 3fxz_A          168 PEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF  246 (297)
T ss_dssp             STTCCBCCCCSCGGGCCHHHHHCS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHH
T ss_pred             CcccccCCccCCcCccChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHH
Confidence            555555566899999999999887 899999999   3    334999997632110         11112235688999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         273 LAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       273 ~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                      .+||.+||+.||++|||++|+|+||||+..+.
T Consensus       247 ~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  278 (297)
T 3fxz_A          247 RDFLNRCLEMDVEKRGSAKELLQHQFLKIAKP  278 (297)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHHHHHHccCChhHCcCHHHHhhChhhcccCc
Confidence            99999999999999999999999999987654

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.3e-49  Score=350.65  Aligned_cols=250  Identities=22%  Similarity=0.298  Sum_probs=211.0

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccc-hhhhHhHHHHHHHHHhcCCCCccccceeeeec
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAK-DGINRTALREIKLLQELHHENVLGLTDVFGYM  129 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  129 (307)
                      ....++|++++.||+|+||.||+|.+..+|+.||+|++.+....... ......+.+|+.+++.++||||+++++++.+.
T Consensus         8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~   87 (361)
T 2yab_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR   87 (361)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC
Confidence            34567899999999999999999999999999999999875433221 11245688999999999999999999999999


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCC----cEEEEeecCc
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG----VLKIGDFGLA  204 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~----~~kl~Dfg~a  204 (307)
                      ...++||||+ +|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++    .+||+|||++
T Consensus        88 ~~~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a  166 (361)
T 2yab_A           88 TDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (361)
T ss_dssp             SEEEEEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence            9999999999 688999887643 689999999999999999999999999999999999998877    7999999999


Q ss_pred             cccCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCC----------CCCChhhhccc
Q psy9858         205 KFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLF----------PGIPLNEIFTA  267 (307)
Q Consensus       205 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~----------~~~~~~~~~~~  267 (307)
                      ...... .......||+.|+|||++.+. .++.++|||   +    +++|..||.+...          ........+..
T Consensus       167 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (361)
T 2yab_A          167 HEIEDG-VEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQ  244 (361)
T ss_dssp             EECCTT-CCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred             eEcCCC-CccccCCCCccEECchHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccC
Confidence            887543 233456899999999999887 899999999   3    3339999977321          11112234467


Q ss_pred             cCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         268 AGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       268 ~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      +++++.+||.+||+.||.+|||++|+|+||||+...
T Consensus       245 ~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  280 (361)
T 2yab_A          245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (361)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence            899999999999999999999999999999998653

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.2e-50  Score=352.93  Aligned_cols=247  Identities=34%  Similarity=0.543  Sum_probs=201.7

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ++|++++.||+|+||+||+|++..+++.||+|++.......    ....+.+|+++++.++||||+++++++.+....++
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG----APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL   77 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC----------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccc----cchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEE
Confidence            68999999999999999999999999999999997533221    12234579999999999999999999999999999


Q ss_pred             EEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCccc
Q psy9858         135 VFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY  214 (307)
Q Consensus       135 v~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  214 (307)
                      ||||++|+|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..........
T Consensus        78 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~  157 (324)
T 3mtl_A           78 VFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY  157 (324)
T ss_dssp             EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             EecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence            99999999999998877779999999999999999999999999999999999999999999999999998765444445


Q ss_pred             ccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCC-------------------------------
Q psy9858         215 THQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLF-------------------------------  256 (307)
Q Consensus       215 ~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~-------------------------------  256 (307)
                      ....+|+.|+|||.+.+...++.++|||   +    +++|..||.+...                               
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
T 3mtl_A          158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY  237 (324)
T ss_dssp             -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred             ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence            5568899999999998865889999999   3    3449999977221                               


Q ss_pred             -----CCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCccc
Q psy9858         257 -----PGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKEM  305 (307)
Q Consensus       257 -----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~~  305 (307)
                           ...........+++++.+||.+||+.||.+|||++|+|+||||.+..+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  291 (324)
T 3mtl_A          238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER  291 (324)
T ss_dssp             CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred             ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence                 0011112234578999999999999999999999999999999887653

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.1e-49  Score=343.02  Aligned_cols=248  Identities=31%  Similarity=0.498  Sum_probs=200.2

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEE
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVS  133 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  133 (307)
                      .++|++++.||+|+||+||+|.+..+|+.||+|++....   ......+.+.+|++++++++||||+++++++.+.+..+
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE---DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLH   78 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC---C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc---cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEE
Confidence            468999999999999999999999999999999987532   22333566889999999999999999999999999999


Q ss_pred             EEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc
Q psy9858         134 LVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL  213 (307)
Q Consensus       134 lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  213 (307)
                      +||||++|+++..+......+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.........
T Consensus        79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  158 (311)
T 4agu_A           79 LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY  158 (311)
T ss_dssp             EEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             EEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence            99999976655444444456899999999999999999999999999999999999999999999999999987655445


Q ss_pred             cccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCC-----------------------------
Q psy9858         214 YTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFP-----------------------------  257 (307)
Q Consensus       214 ~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~-----------------------------  257 (307)
                      .....+|+.|+|||.+.+...++.++|||       .+++|..||.+....                             
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (311)
T 4agu_A          159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG  238 (311)
T ss_dssp             -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred             cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence            55668899999999998865889999999       334499998762110                             


Q ss_pred             --------CCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         258 --------GIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       258 --------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                              .........++++++.+||.+||+.||.+|||++|+|+||||++.++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  293 (311)
T 4agu_A          239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE  293 (311)
T ss_dssp             CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred             CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence                    01112223468899999999999999999999999999999998765

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.9e-50  Score=352.76  Aligned_cols=247  Identities=21%  Similarity=0.298  Sum_probs=210.1

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN  131 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  131 (307)
                      ...++|.+++.||+|+||.||+|.+..+|+.||+|++......  .......+.+|+++++.++||||+++++++.+...
T Consensus         6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~   83 (336)
T 3h4j_B            6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLK--KSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTD   83 (336)
T ss_dssp             SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH--HTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHcc--chhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence            4567899999999999999999999999999999999753211  12224568899999999999999999999999999


Q ss_pred             EEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC
Q psy9858         132 VSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT  211 (307)
Q Consensus       132 ~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  211 (307)
                      .++||||++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... 
T Consensus        84 ~~lv~E~~~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~-  161 (336)
T 3h4j_B           84 IVMVIEYAGGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-  161 (336)
T ss_dssp             EEEEECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-
T ss_pred             EEEEEECCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC-
Confidence            99999999999999887654 4899999999999999999999999999999999999999999999999999876443 


Q ss_pred             cccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCCC------hhhhccccCHHHHHHHHH
Q psy9858         212 RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGIP------LNEIFTAAGDDLLAVISS  278 (307)
Q Consensus       212 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~------~~~~~~~~~~~l~~li~~  278 (307)
                      ......+||+.|+|||.+.+....+.++|||   +    +++|..||.+.......      ....+..+++++.+||.+
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  241 (336)
T 3h4j_B          162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRR  241 (336)
T ss_dssp             BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHT
T ss_pred             cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence            3345568999999999999874558999999   3    33499999874333221      122345689999999999


Q ss_pred             hhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         279 LLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       279 ~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                      ||+.||.+|||++|+++||||+..
T Consensus       242 ~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          242 MIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             TSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             HcCCChhHCcCHHHHHhChhhccC
Confidence            999999999999999999999754

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.1e-50  Score=351.18  Aligned_cols=253  Identities=60%  Similarity=0.957  Sum_probs=205.6

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS  130 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  130 (307)
                      ....++|++++.||+|+||.||+|.+..+|+.||||++...............+.+|+++++.++||||+++++++.+..
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            34567899999999999999999999999999999999764433333333456889999999999999999999999999


Q ss_pred             eEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         131 NVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       131 ~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      ..++||||++++|.+.+......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        86 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  165 (346)
T 1ua2_A           86 NISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP  165 (346)
T ss_dssp             CCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred             ceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence            99999999999999999887777999999999999999999999999999999999999999999999999999987655


Q ss_pred             Ccccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCC---------------------------
Q psy9858         211 TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLF---------------------------  256 (307)
Q Consensus       211 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~---------------------------  256 (307)
                      ........+|+.|+|||.+.+...++.++|||   +    +++|.+||.+...                           
T Consensus       166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  245 (346)
T 1ua2_A          166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD  245 (346)
T ss_dssp             CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred             cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcc
Confidence            55555668899999999998765789999999   3    3338888876210                           


Q ss_pred             -------CCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         257 -------PGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       257 -------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                             +.......+..+++++.+||.+||+.||++|||++|+|+||||++..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~  299 (346)
T 1ua2_A          246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  299 (346)
T ss_dssp             CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             cccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence                   11112233456789999999999999999999999999999998754

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=7.5e-50  Score=363.74  Aligned_cols=247  Identities=32%  Similarity=0.488  Sum_probs=191.0

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeee-----
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG-----  127 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----  127 (307)
                      ..++|++++.||+|+||+||+|.+..+|+.||||++....   ......+.+.+|+++|+.++||||+++++++.     
T Consensus        51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  127 (458)
T 3rp9_A           51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF---EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVE  127 (458)
T ss_dssp             SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTT---SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTT
T ss_pred             cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh---cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcc
Confidence            4578999999999999999999999999999999997532   12223567889999999999999999999984     


Q ss_pred             ecCeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         128 YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       128 ~~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      ....+|+||||++|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus       128 ~~~~~~lv~e~~~~~L~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          128 KFDELYVVLEIADSDFKKLFRTPV-YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             TCCCEEEEECCCSEEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             cCceEEEEEeccccchhhhcccCC-CCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence            336799999999999999987654 5899999999999999999999999999999999999999999999999999876


Q ss_pred             CCCC---------------------------cccccceeeceehhhhhhhccccccccccee---eeee-----------
Q psy9858         208 GSPT---------------------------RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA-----------  246 (307)
Q Consensus       208 ~~~~---------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~-----------  246 (307)
                      ....                           ......+||++|+|||++.....++.++|||   |+++           
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~  286 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA  286 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence            4221                           1234457899999999886665899999999   3332           


Q ss_pred             ----cCCCCCCCCC---------------------------------------------------------CCCChhhhc
Q psy9858         247 ----KDPSSHGNLF---------------------------------------------------------PGIPLNEIF  265 (307)
Q Consensus       247 ----~~~~f~~~~~---------------------------------------------------------~~~~~~~~~  265 (307)
                          +.++|.+...                                                         ........+
T Consensus       287 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  366 (458)
T 3rp9_A          287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERF  366 (458)
T ss_dssp             SGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGS
T ss_pred             ccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHC
Confidence                5566655221                                                         011122234


Q ss_pred             cccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         266 TAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       266 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      +.+++++.+||.+||+.||++|||++|+|+||||++..
T Consensus       367 ~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~  404 (458)
T 3rp9_A          367 PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR  404 (458)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             CCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence            45689999999999999999999999999999998764

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.9e-49  Score=341.77  Aligned_cols=250  Identities=32%  Similarity=0.539  Sum_probs=202.1

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC---CCCccccceeeeec
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH---HENVLGLTDVFGYM  129 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~ni~~~~~~~~~~  129 (307)
                      ..++|++++.||+|+||+||+|++..+|+.||+|++...............+.+|+++++.++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            457899999999999999999999999999999999754333233333456778888877764   99999999998765


Q ss_pred             C-----eEEEEEEccCCChHHHHhCCCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecC
Q psy9858         130 S-----NVSLVFEFVDTDLEVIIKDPTI-VFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGL  203 (307)
Q Consensus       130 ~-----~~~lv~e~~~g~l~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  203 (307)
                      .     ..+++|||++|+|.+++..... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus        87 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  166 (308)
T 3g33_A           87 RTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL  166 (308)
T ss_dssp             CSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred             CCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCcc
Confidence            4     5899999999999999886543 389999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCC--------------------
Q psy9858         204 AKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLF--------------------  256 (307)
Q Consensus       204 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~--------------------  256 (307)
                      +...... .......+|+.|+|||.+.+. .++.++|||   +    +++|.+||.+...                    
T Consensus       167 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  244 (308)
T 3g33_A          167 ARIYSYQ-MALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  244 (308)
T ss_dssp             TTTSTTC-CCSGGGGCCCSSCCHHHHHTS-CCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSC
T ss_pred             ccccCCC-cccCCccccccccCchHHcCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence            9876433 333456889999999999887 799999999   3    3448999876211                    


Q ss_pred             -------------CCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         257 -------------PGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       257 -------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                                   .........+.+++++.+||.+||+.||++|||++|+|+||||++..+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~~  305 (308)
T 3g33_A          245 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG  305 (308)
T ss_dssp             SSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC-----
T ss_pred             chhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCCC
Confidence                         011122334568899999999999999999999999999999997654

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.5e-50  Score=345.83  Aligned_cols=232  Identities=24%  Similarity=0.204  Sum_probs=177.7

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC----
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS----  130 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----  130 (307)
                      ++|.+.++||+|+||+||+|++  +|+.||||++...   . .  ....+..|+..+.+++||||+++++++.+++    
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~---~-~--~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~   74 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---E-E--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT   74 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGG---G-H--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc---c-h--hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCce
Confidence            4689999999999999999986  6899999998642   1 1  1112234566667889999999999997653    


Q ss_pred             eEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeecCCCCcEEEecCCcEEEEee
Q psy9858         131 NVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH--------WILHRDLKPNNLLINKQGVLKIGDF  201 (307)
Q Consensus       131 ~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--------~ivH~dlkp~Nil~~~~~~~kl~Df  201 (307)
                      .+||||||+ +|+|.+++....  ++++.+..++.|++.||+|||++        +|+||||||+|||++.++.+||+||
T Consensus        75 ~~~lV~Ey~~~gsL~~~l~~~~--l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF  152 (303)
T 3hmm_A           75 QLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  152 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEecCCCCCcHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence            689999999 689999998654  89999999999999999999987        9999999999999999999999999


Q ss_pred             cCccccCCCCcc----cccceeeceehhhhhhhccc-----cccccccee---e----eeecCCCCCCCCCCCCC-----
Q psy9858         202 GLAKFFGSPTRL----YTHQVVTRWYRLIKCLLYCV-----QFNVKNVQW---C----CFAKDPSSHGNLFPGIP-----  260 (307)
Q Consensus       202 g~a~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~-----~~~~~~Diw---~----i~~~~~~f~~~~~~~~~-----  260 (307)
                      |+|+........    ....+||+.|||||++.+..     .++.++|||   +    +++|.+||........+     
T Consensus       153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~  232 (303)
T 3hmm_A          153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  232 (303)
T ss_dssp             TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred             CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc
Confidence            999876443221    23457999999999997642     478899999   3    33376665442111110     


Q ss_pred             -----hh-------------hhc-----cccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         261 -----LN-------------EIF-----TAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       261 -----~~-------------~~~-----~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                           ..             ..+     ...++.+.+|+.+||+.||++|||+.|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             cccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                 00             011     1233568899999999999999999999864

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.7e-49  Score=353.37  Aligned_cols=249  Identities=22%  Similarity=0.258  Sum_probs=207.7

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeeec
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGYM  129 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~  129 (307)
                      ....++|++++.||+|+||+||+|++..+++.||+|++.+......  .....+.+|..++.++ +||||+++++++.+.
T Consensus        48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~--~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~  125 (396)
T 4dc2_A           48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD--EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE  125 (396)
T ss_dssp             -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC------CCHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCH--HHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC
Confidence            4467899999999999999999999999999999999986432221  2234577899999887 899999999999999


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                      ...++||||+ +|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus       126 ~~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          126 SRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             CEEEEEEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            9999999999 578888887543 58999999999999999999999999999999999999999999999999998754


Q ss_pred             CCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCCC---------------hhhhcc
Q psy9858         209 SPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGIP---------------LNEIFT  266 (307)
Q Consensus       209 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~---------------~~~~~~  266 (307)
                      .........+||+.|+|||++.+. .++.++|+|   +    +++|..||.........               ....+.
T Consensus       205 ~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~  283 (396)
T 4dc2_A          205 RPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR  283 (396)
T ss_dssp             CTTCCBCCCCBCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT
T ss_pred             cCCCccccccCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC
Confidence            444455667899999999999987 899999999   3    34499999753211110               012234


Q ss_pred             ccCHHHHHHHHHhhhcCCCCCCCH------HHHhcCcccCCCc
Q psy9858         267 AAGDDLLAVISSLLCLNPTKRADC------TATLKMDYFSLTK  303 (307)
Q Consensus       267 ~~~~~l~~li~~~l~~dP~~Rpt~------~~il~hp~f~~~~  303 (307)
                      .+++++.+||.+||+.||++||++      +|+++||||++.+
T Consensus       284 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~  326 (396)
T 4dc2_A          284 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  326 (396)
T ss_dssp             TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCC
T ss_pred             cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCC
Confidence            678999999999999999999995      8999999998763

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1e-49  Score=348.37  Aligned_cols=247  Identities=20%  Similarity=0.245  Sum_probs=208.2

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|++++.||+|+||+||+|++..+|+.||+|++.+....  .......+.+|+++++.++||||+++++++.+....
T Consensus         3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~   80 (337)
T 1o6l_A            3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII--AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL   80 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred             ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhh--hhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEE
Confidence            467899999999999999999999999999999999753211  112245678999999999999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT  211 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  211 (307)
                      |+||||+ +|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||+++......
T Consensus        81 ~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  159 (337)
T 1o6l_A           81 CFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             EEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence            9999999 578888886543 58999999999999999999999999999999999999999999999999998754444


Q ss_pred             cccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCCC------hhhhccccCHHHHHHHHH
Q psy9858         212 RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGIP------LNEIFTAAGDDLLAVISS  278 (307)
Q Consensus       212 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~------~~~~~~~~~~~l~~li~~  278 (307)
                      ......+||+.|+|||++.+. .++.++|+|   +    +++|..||.+.......      ....+..+++++.+||.+
T Consensus       160 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  238 (337)
T 1o6l_A          160 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG  238 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred             CcccccccChhhCChhhhcCC-CCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            445567899999999999887 899999999   3    33499999763211100      011234679999999999


Q ss_pred             hhhcCCCCCC-----CHHHHhcCcccCCCc
Q psy9858         279 LLCLNPTKRA-----DCTATLKMDYFSLTK  303 (307)
Q Consensus       279 ~l~~dP~~Rp-----t~~~il~hp~f~~~~  303 (307)
                      ||+.||++||     +++++++||||++.+
T Consensus       239 lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~  268 (337)
T 1o6l_A          239 LLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  268 (337)
T ss_dssp             HTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             HhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence            9999999999     999999999998753

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-49  Score=345.97  Aligned_cols=243  Identities=18%  Similarity=0.246  Sum_probs=208.6

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|++++.||+|+||.||+|.+..+++.||+|++....      .....+.+|+++++.++||||+++++++.+....
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~   76 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG------TDQVLVKKEISILNIARHRNILHLHESFESMEEL   76 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT------HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEE
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc------ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEE
Confidence            4578999999999999999999999999999999987421      1235578999999999999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEec--CCcEEEEeecCccccCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK--QGVLKIGDFGLAKFFGS  209 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~a~~~~~  209 (307)
                      ++||||+ +|+|.+.+......+++..+..++.||+.||.|||++||+||||||+||+++.  ++.+||+|||++.....
T Consensus        77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~  156 (321)
T 1tki_A           77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence            9999999 57899999877667999999999999999999999999999999999999987  78999999999988754


Q ss_pred             CCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCC----------CCChhhhccccCHHH
Q psy9858         210 PTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFP----------GIPLNEIFTAAGDDL  272 (307)
Q Consensus       210 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~----------~~~~~~~~~~~~~~l  272 (307)
                      . .......+|+.|+|||.+.+. .++.++|||   +    +++|..||.+....          .......+..+++++
T Consensus       157 ~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  234 (321)
T 1tki_A          157 G-DNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA  234 (321)
T ss_dssp             T-CEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred             C-CccccccCChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHH
Confidence            3 333456789999999999887 789999999   3    33499999773211          111223345789999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         273 LAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       273 ~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      .+||.+||+.||.+|||++|+|+||||++..
T Consensus       235 ~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  265 (321)
T 1tki_A          235 MDFVDRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             HHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence            9999999999999999999999999997653

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.3e-49  Score=359.51  Aligned_cols=246  Identities=20%  Similarity=0.224  Sum_probs=207.6

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS  130 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  130 (307)
                      ....++|++++.||+|+||.||+|.+..+|+.||+|++......   ......+.+|+++++.++||||+++++++.+.+
T Consensus         7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~   83 (444)
T 3soa_A            7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS---ARDHQKLEREARICRLLKHPNIVRLHDSISEEG   83 (444)
T ss_dssp             CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH---HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSS
T ss_pred             ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECC
Confidence            34567899999999999999999999999999999999864322   222466889999999999999999999999999


Q ss_pred             eEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEe---cCCcEEEEeecCccc
Q psy9858         131 NVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLIN---KQGVLKIGDFGLAKF  206 (307)
Q Consensus       131 ~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~a~~  206 (307)
                      ..++||||+ +|+|.+.+.... .+++..+..++.||+.||.|||++||+||||||+||+++   .++.+||+|||++..
T Consensus        84 ~~~lv~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           84 HHYLIFDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             EEEEEECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EEEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            999999999 678988887654 589999999999999999999999999999999999998   467899999999988


Q ss_pred             cCCCCcccccceeeceehhhhhhhccccccccccee---ee----eecCCCCCCCCCC----------CCChhhhccccC
Q psy9858         207 FGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FAKDPSSHGNLFP----------GIPLNEIFTAAG  269 (307)
Q Consensus       207 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~~~~~f~~~~~~----------~~~~~~~~~~~~  269 (307)
                      ............||+.|+|||++.+. .++.++|||   ++    ++|.+||.+....          .......+..++
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  241 (444)
T 3soa_A          163 VEGEQQAWFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVT  241 (444)
T ss_dssp             CCTTCCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred             ecCCCceeecccCCcccCCHHHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCC
Confidence            76555555567899999999999887 899999999   33    3399999773210          011122235689


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHhcCcccCC
Q psy9858         270 DDLLAVISSLLCLNPTKRADCTATLKMDYFSL  301 (307)
Q Consensus       270 ~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~  301 (307)
                      +++.+||.+||+.||.+|||++|+|+||||+.
T Consensus       242 ~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~  273 (444)
T 3soa_A          242 PEAKDLINKMLTINPSKRITAAEALKHPWISH  273 (444)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred             HHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence            99999999999999999999999999999964

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=6.7e-50  Score=351.93  Aligned_cols=249  Identities=20%  Similarity=0.279  Sum_probs=206.8

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|++.+.||+|+||+||+|.+..+|+.||||++...............+.+|+++++.++||||+++++++.+.+..
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            45689999999999999999999999999999999975321111112246688999999999999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCc---EEEEeecCcc
Q psy9858         133 SLVFEFV-DTDLEVIIKD---PTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGV---LKIGDFGLAK  205 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~a~  205 (307)
                      |+||||+ +|+|.+.+..   ....+++..+..++.||+.||.|||++||+||||||+||+++.++.   +||+|||++.
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~  181 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI  181 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence            9999999 5788777753   2334899999999999999999999999999999999999987665   9999999999


Q ss_pred             ccCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCC---------CCCChhhhccccC
Q psy9858         206 FFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLF---------PGIPLNEIFTAAG  269 (307)
Q Consensus       206 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~---------~~~~~~~~~~~~~  269 (307)
                      .............||+.|+|||++.+. .++.++|||   +    +++|..||.+...         ........+..++
T Consensus       182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~~~~~~~~~~~s  260 (351)
T 3c0i_A          182 QLGESGLVAGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHIS  260 (351)
T ss_dssp             ECCTTSCBCCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred             EecCCCeeecCCcCCcCccCHHHHcCC-CCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCCCCCccccccCC
Confidence            876554445566899999999999887 789999999   3    3339999977311         0011122235689


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         270 DDLLAVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       270 ~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                      +++.+||.+||+.||++|||++++|+||||+..
T Consensus       261 ~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          261 ESAKDLVRRMLMLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred             HHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence            999999999999999999999999999999864

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=7.2e-50  Score=351.47  Aligned_cols=248  Identities=24%  Similarity=0.243  Sum_probs=201.8

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeeecC
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGYMS  130 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~  130 (307)
                      ...++|++++.||+|+||+||+|++..+|+.||||++.+....  .......+.+|.++++.+ +||||+++++++.+..
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~--~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~   97 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL--QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD   97 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH--HHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhc--chhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence            3567899999999999999999999999999999999753211  122245677899999988 6999999999999999


Q ss_pred             eEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCC
Q psy9858         131 NVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS  209 (307)
Q Consensus       131 ~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  209 (307)
                      ..|+||||+ +|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus        98 ~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~  176 (353)
T 3txo_A           98 RLFFVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC  176 (353)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence            999999999 578888887643 589999999999999999999999999999999999999999999999999987544


Q ss_pred             CCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCCC------hhhhccccCHHHHHHH
Q psy9858         210 PTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGIP------LNEIFTAAGDDLLAVI  276 (307)
Q Consensus       210 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~------~~~~~~~~~~~l~~li  276 (307)
                      ........+||+.|+|||++.+. .++.++|||   +    +++|..||.+.......      ....+..+++++.+||
T Consensus       177 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li  255 (353)
T 3txo_A          177 NGVTTATFCGTPDYIAPEILQEM-LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGIL  255 (353)
T ss_dssp             ---------CCGGGCCHHHHHHH-HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred             CCccccccCCCcCeEChhhcCCC-CcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            44455566899999999999887 899999999   3    33499999873221100      0112345789999999


Q ss_pred             HHhhhcCCCCCCCH------HHHhcCcccCCCc
Q psy9858         277 SSLLCLNPTKRADC------TATLKMDYFSLTK  303 (307)
Q Consensus       277 ~~~l~~dP~~Rpt~------~~il~hp~f~~~~  303 (307)
                      .+||+.||++||++      +++++||||++.+
T Consensus       256 ~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~  288 (353)
T 3txo_A          256 KSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID  288 (353)
T ss_dssp             HHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCC
T ss_pred             HHHhhhCHHHccCCcccCCHHHHhhCCcccCCC
Confidence            99999999999998      9999999998753

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.6e-49  Score=344.91  Aligned_cols=247  Identities=35%  Similarity=0.564  Sum_probs=193.0

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|++++.||+|+||.||+|.+..+|+.||+|++....    .......+.+|+++++.++||||+++++++.+++..
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   78 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS----EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKL   78 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCS----TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc----ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeE
Confidence            3568999999999999999999999999999999997543    122245688999999999999999999999999999


Q ss_pred             EEEEEccCCChHHHHhCC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         133 SLVFEFVDTDLEVIIKDP-----TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       133 ~lv~e~~~g~l~~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      ++||||++|+|.+++...     ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus        79 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           79 TLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             EEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             EEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence            999999999998888643     234899999999999999999999999999999999999999999999999999987


Q ss_pred             CCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCC--------------C--------
Q psy9858         208 GSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFP--------------G--------  258 (307)
Q Consensus       208 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~--------------~--------  258 (307)
                      ...........+|+.|+|||++.+...++.++|||   +    +++|..||.+....              .        
T Consensus       159 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  238 (317)
T 2pmi_A          159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK  238 (317)
T ss_dssp             TSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred             CCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence            55444455568899999999998765789999999   3    33499999762110              0        


Q ss_pred             -------------CC-----hhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         259 -------------IP-----LNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       259 -------------~~-----~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                                   ..     .......+++++.+||.+||+.||++|||++|+|+||||++..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  301 (317)
T 2pmi_A          239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY  301 (317)
T ss_dssp             CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence                         00     0011125788999999999999999999999999999998643

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.7e-49  Score=346.43  Aligned_cols=249  Identities=33%  Similarity=0.589  Sum_probs=197.9

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS  130 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  130 (307)
                      ....++|++++.||+|+||+||+|.+..+++.||||++.....   .......+.+|+++++.++||||+++++++.++.
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE---EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH  106 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC-----------CHHHHHHGGGCCCTTBCCEEEEEEETT
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc---ccccchhHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence            3467799999999999999999999999999999999975432   2223455779999999999999999999999999


Q ss_pred             eEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEe-----cCCcEEEEeecCcc
Q psy9858         131 NVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLIN-----KQGVLKIGDFGLAK  205 (307)
Q Consensus       131 ~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~-----~~~~~kl~Dfg~a~  205 (307)
                      ..++||||++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++     .++.+||+|||++.
T Consensus       107 ~~~lv~e~~~~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~  185 (329)
T 3gbz_A          107 RLHLIFEYAENDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR  185 (329)
T ss_dssp             EEEEEEECCSEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred             EEEEEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence            999999999999999987664 489999999999999999999999999999999999994     45569999999998


Q ss_pred             ccCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCC---------------------
Q psy9858         206 FFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFP---------------------  257 (307)
Q Consensus       206 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~---------------------  257 (307)
                      .............+|+.|+|||++.+...++.++|||   +    +++|..||.+....                     
T Consensus       186 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (329)
T 3gbz_A          186 AFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV  265 (329)
T ss_dssp             HHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             ccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhh
Confidence            8765544455667899999999998875789999999   3    33499998762110                     


Q ss_pred             --------------CCCh-hhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         258 --------------GIPL-NEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       258 --------------~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                                    .... ......+++++.+||.+||+.||++|||++|+|+||||++.+
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  326 (329)
T 3gbz_A          266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND  326 (329)
T ss_dssp             GGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred             hhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence                          0000 011123789999999999999999999999999999999865

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=9.2e-49  Score=353.82  Aligned_cols=249  Identities=30%  Similarity=0.444  Sum_probs=202.4

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec--
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM--  129 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--  129 (307)
                      ...++|++++.||+|+||.||+|.+..+|+.||||++....   ......+.+.+|+++++.++||||+++++++...  
T Consensus        23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~   99 (432)
T 3n9x_A           23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF---EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDL   99 (432)
T ss_dssp             CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT---TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred             eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh---cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCC
Confidence            34578999999999999999999999999999999997532   2222356788999999999999999999998766  


Q ss_pred             ---CeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         130 ---SNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       130 ---~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                         ...|+||||++|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus       100 ~~~~~~~lv~e~~~~~L~~~~~~~~-~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          100 LKFDELYIVLEIADSDLKKLFKTPI-FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             TTCCCEEEEEECCSEEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             CcCCeEEEEEecCCcCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence               6799999999999999998654 589999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCc----------------------ccccceeeceehhhhhhhccccccccccee---eeee----c----------
Q psy9858         207 FGSPTR----------------------LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----K----------  247 (307)
Q Consensus       207 ~~~~~~----------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~----------  247 (307)
                      ......                      .....++|++|+|||++.....++.++|||   |+++    |          
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~  258 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN  258 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence            743221                      235568899999999986665899999999   3332    3          


Q ss_pred             -CCCCCCCCC------------------------------------------------------CCCChhhhccccCHHH
Q psy9858         248 -DPSSHGNLF------------------------------------------------------PGIPLNEIFTAAGDDL  272 (307)
Q Consensus       248 -~~~f~~~~~------------------------------------------------------~~~~~~~~~~~~~~~l  272 (307)
                       .++|.+...                                                      ........++.+++++
T Consensus       259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  338 (432)
T 3n9x_A          259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDG  338 (432)
T ss_dssp             CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHH
T ss_pred             ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHH
Confidence             344433211                                                      0011112234679999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         273 LAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       273 ~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                      .+||.+||+.||++|||++|+|+||||++...
T Consensus       339 ~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  370 (432)
T 3n9x_A          339 INLLESMLKFNPNKRITIDQALDHPYLKDVRK  370 (432)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred             HHHHHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence            99999999999999999999999999998653

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=8.1e-49  Score=345.07  Aligned_cols=254  Identities=37%  Similarity=0.592  Sum_probs=209.2

Q ss_pred             CceeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceee
Q psy9858          47 DCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVF  126 (307)
Q Consensus        47 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~  126 (307)
                      .+......++|++++.||+|+||.||+|++..+|+.||+|++.....   .......+.+|+++++.++||||+++++++
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   85 (351)
T 3mi9_A            9 ECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE---KEGFPITALREIKILQLLKHENVVNLIEIC   85 (351)
T ss_dssp             CCTTSCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC---SSSSCHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccccccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc---cccchHHHHHHHHHHHhccCCCcccHhhee
Confidence            44555678999999999999999999999999999999999875432   222345678999999999999999999998


Q ss_pred             ee--------cCeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEE
Q psy9858         127 GY--------MSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKI  198 (307)
Q Consensus       127 ~~--------~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl  198 (307)
                      ..        .+..++||||++|++.+.+......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||
T Consensus        86 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl  165 (351)
T 3mi9_A           86 RTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKL  165 (351)
T ss_dssp             EEC--------CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEE
T ss_pred             eccccccccCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEE
Confidence            76        4579999999999999999887777999999999999999999999999999999999999999999999


Q ss_pred             EeecCccccCCC----Ccccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCC-----------
Q psy9858         199 GDFGLAKFFGSP----TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLF-----------  256 (307)
Q Consensus       199 ~Dfg~a~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~-----------  256 (307)
                      +|||++......    ........+|+.|+|||.+.+...++.++|||   +    +++|.+||.+...           
T Consensus       166 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~  245 (351)
T 3mi9_A          166 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC  245 (351)
T ss_dssp             CCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             ccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence            999999876422    12234457899999999998865789999999   3    3339999887211           


Q ss_pred             ---CCCChhh-----hc-------------------cccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         257 ---PGIPLNE-----IF-------------------TAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       257 ---~~~~~~~-----~~-------------------~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                         .......     ..                   ...++++.+||.+||+.||++|||++|+|+||||+...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  319 (351)
T 3mi9_A          246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP  319 (351)
T ss_dssp             CCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred             CCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence               0000000     00                   01377899999999999999999999999999997643

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.3e-48  Score=342.59  Aligned_cols=247  Identities=22%  Similarity=0.256  Sum_probs=207.5

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeeecCe
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGYMSN  131 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~  131 (307)
                      ..++|++++.||+|+||.||+|++..+|+.||+|++.+....  .......+.+|..++.++ +||||+++++++.+...
T Consensus         7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   84 (345)
T 3a8x_A            7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVN--DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR   84 (345)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSC--SHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhc--chHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence            467899999999999999999999999999999999864322  222345678999999988 89999999999999999


Q ss_pred             EEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         132 VSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       132 ~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      .|+||||+ +|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus        85 ~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           85 LFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred             EEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence            99999999 678888887543 5899999999999999999999999999999999999999999999999999875444


Q ss_pred             Ccccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCC----C-----------hhhhcccc
Q psy9858         211 TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGI----P-----------LNEIFTAA  268 (307)
Q Consensus       211 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~----~-----------~~~~~~~~  268 (307)
                      .......+||+.|+|||++.+. .++.++|+|   +    +++|..||........    .           ....+..+
T Consensus       164 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~  242 (345)
T 3a8x_A          164 GDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL  242 (345)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTS
T ss_pred             CCcccccCCCccccCccccCCC-CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCC
Confidence            4445566899999999999887 889999999   3    3349999975221110    0           01123467


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCH------HHHhcCcccCCCc
Q psy9858         269 GDDLLAVISSLLCLNPTKRADC------TATLKMDYFSLTK  303 (307)
Q Consensus       269 ~~~l~~li~~~l~~dP~~Rpt~------~~il~hp~f~~~~  303 (307)
                      +.++.+||.+||+.||++|||+      +++++||||++.+
T Consensus       243 s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~  283 (345)
T 3a8x_A          243 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  283 (345)
T ss_dssp             CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred             CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence            8999999999999999999995      8999999998754

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.1e-48  Score=355.82  Aligned_cols=242  Identities=28%  Similarity=0.454  Sum_probs=196.4

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec--
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM--  129 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--  129 (307)
                      ...++|++++.||+|+||+||+|.+..+|+.||||++....   ......+.+.+|+++++.++||||+++++++...  
T Consensus        59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  135 (464)
T 3ttj_A           59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF---QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT  135 (464)
T ss_dssp             EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG---GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred             eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc---cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCc
Confidence            34678999999999999999999999999999999997531   2233356788999999999999999999998654  


Q ss_pred             ----CeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcc
Q psy9858         130 ----SNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK  205 (307)
Q Consensus       130 ----~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  205 (307)
                          ...|+||||+++++.+.+...   +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus       136 ~~~~~~~~lv~E~~~~~l~~~~~~~---l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~  212 (464)
T 3ttj_A          136 LEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (464)
T ss_dssp             TTTCCEEEEEEECCSEEHHHHHTSC---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred             cccCCeEEEEEeCCCCCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence                468999999999988888653   8999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCcccccceeeceehhhhhhhccccccccccee---eee----ecCCCCCCCCC----------------------
Q psy9858         206 FFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCF----AKDPSSHGNLF----------------------  256 (307)
Q Consensus       206 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~----~~~~~f~~~~~----------------------  256 (307)
                      ..... ......++|+.|+|||++.+. .++.++|||   |++    +|++||.+...                      
T Consensus       213 ~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~  290 (464)
T 3ttj_A          213 TAGTS-FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  290 (464)
T ss_dssp             ----C-CCC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred             ecCCC-cccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence            77432 334556899999999999987 899999999   433    39999987321                      


Q ss_pred             --------------CCCChhhhcc------------ccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCC
Q psy9858         257 --------------PGIPLNEIFT------------AAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSL  301 (307)
Q Consensus       257 --------------~~~~~~~~~~------------~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~  301 (307)
                                    ........++            ..++++.+||.+||+.||++|||++|+|+||||+.
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~  361 (464)
T 3ttj_A          291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  361 (464)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence                          0111111111            12567999999999999999999999999999975

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=9.3e-49  Score=339.14  Aligned_cols=243  Identities=21%  Similarity=0.234  Sum_probs=198.6

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeeecCe
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGYMSN  131 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~  131 (307)
                      ..++|++++.||+|+||+||+|.+..+|+.||||++......   .........|+..+..+ +||||+++++++.+.+.
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~  131 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRG---PKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI  131 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCS---HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccC---hHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCE
Confidence            347899999999999999999999999999999998653222   12234455666666555 89999999999999999


Q ss_pred             EEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC
Q psy9858         132 VSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT  211 (307)
Q Consensus       132 ~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  211 (307)
                      .++||||++++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... 
T Consensus       132 ~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~-  210 (311)
T 3p1a_A          132 LYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-  210 (311)
T ss_dssp             EEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred             EEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC-
Confidence            9999999999999998877667999999999999999999999999999999999999999999999999999877433 


Q ss_pred             cccccceeeceehhhhhhhccccccccccee---ee----eecCCCCCC-C----CCCCCChhhhccccCHHHHHHHHHh
Q psy9858         212 RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FAKDPSSHG-N----LFPGIPLNEIFTAAGDDLLAVISSL  279 (307)
Q Consensus       212 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~~~~~f~~-~----~~~~~~~~~~~~~~~~~l~~li~~~  279 (307)
                      .......||+.|+|||++.+  .++.++|||   ++    ++|..++.+ .    .............+++++.+||.+|
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  288 (311)
T 3p1a_A          211 GAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMM  288 (311)
T ss_dssp             ----CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTTCCCHHHHTTSCHHHHHHHHHH
T ss_pred             CCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhccCCCcccccCCCHHHHHHHHHH
Confidence            23344578999999999876  589999999   33    336555444 1    1111222344567899999999999


Q ss_pred             hhcCCCCCCCHHHHhcCcccCC
Q psy9858         280 LCLNPTKRADCTATLKMDYFSL  301 (307)
Q Consensus       280 l~~dP~~Rpt~~~il~hp~f~~  301 (307)
                      |+.||++|||++|+|+||||++
T Consensus       289 L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          289 LEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             SCSSTTTSCCHHHHHTSGGGSC
T ss_pred             cCCChhhCcCHHHHHhCccccC
Confidence            9999999999999999999986

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-48  Score=340.29  Aligned_cols=249  Identities=24%  Similarity=0.311  Sum_probs=209.3

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccc-hhhhHhHHHHHHHHHhcCCCCccccceeeeecC
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAK-DGINRTALREIKLLQELHHENVLGLTDVFGYMS  130 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  130 (307)
                      ...++|++.+.||+|+||.||+|.+..+|+.||+|++......... ......+.+|+.+++.++||||+++++++.+..
T Consensus         8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   87 (326)
T 2y0a_A            8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT   87 (326)
T ss_dssp             CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            3457899999999999999999999999999999999865433221 112466889999999999999999999999999


Q ss_pred             eEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCC----cEEEEeecCcc
Q psy9858         131 NVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG----VLKIGDFGLAK  205 (307)
Q Consensus       131 ~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~----~~kl~Dfg~a~  205 (307)
                      ..++||||+ +|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++    .+||+|||++.
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  166 (326)
T 2y0a_A           88 DVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  166 (326)
T ss_dssp             EEEEEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence            999999999 67898888654 3589999999999999999999999999999999999999887    89999999998


Q ss_pred             ccCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCC----------CCChhhhcccc
Q psy9858         206 FFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFP----------GIPLNEIFTAA  268 (307)
Q Consensus       206 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~----------~~~~~~~~~~~  268 (307)
                      ...... ......+|+.|+|||++.+. .++.++|||   +    +++|..||.+....          .......+..+
T Consensus       167 ~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (326)
T 2y0a_A          167 KIDFGN-EFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT  244 (326)
T ss_dssp             ECCTTS-CCCCCCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTS
T ss_pred             ECCCCC-ccccccCCcCcCCceeecCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccC
Confidence            874332 33455799999999999877 899999999   3    33399999763211          11122334568


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         269 GDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       269 ~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      ++.+.+||.+||+.||++|||++|+|+||||+...
T Consensus       245 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  279 (326)
T 2y0a_A          245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  279 (326)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence            99999999999999999999999999999998754

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=9.4e-49  Score=344.31  Aligned_cols=249  Identities=22%  Similarity=0.282  Sum_probs=194.4

Q ss_pred             CCceeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCcccccee
Q psy9858          46 PDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV  125 (307)
Q Consensus        46 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~  125 (307)
                      .........++|++.+.||+|+||.||+|++..+++.||||++....       ..+.+.+|+++++.++||||++++++
T Consensus        44 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~  116 (349)
T 2w4o_A           44 DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-------DKKIVRTEIGVLLRLSHPNIIKLKEI  116 (349)
T ss_dssp             CSSBCSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------------CHHHHHCCCTTBCCEEEE
T ss_pred             cCcccccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-------hHHHHHHHHHHHHhCCCCCCcceeee
Confidence            33344556678999999999999999999999999999999997532       13457789999999999999999999


Q ss_pred             eeecCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEec---CCcEEEEee
Q psy9858         126 FGYMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK---QGVLKIGDF  201 (307)
Q Consensus       126 ~~~~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~---~~~~kl~Df  201 (307)
                      +.+....++||||+ +|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.   ++.+||+||
T Consensus       117 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Df  195 (349)
T 2w4o_A          117 FETPTEISLVLELVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADF  195 (349)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             EecCCeEEEEEEeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccC
Confidence            99999999999999 578988887654 5899999999999999999999999999999999999975   889999999


Q ss_pred             cCccccCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC-----------CChhh
Q psy9858         202 GLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG-----------IPLNE  263 (307)
Q Consensus       202 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~-----------~~~~~  263 (307)
                      |+++..... .......||+.|+|||.+.+. .++.++|||   +    +++|..||.......           .....
T Consensus       196 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~  273 (349)
T 2w4o_A          196 GLSKIVEHQ-VLMKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISP  273 (349)
T ss_dssp             C-----------------CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTT
T ss_pred             ccccccCcc-cccccccCCCCccCHHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCc
Confidence            999876432 233455789999999999887 899999999   3    333989987632211           11122


Q ss_pred             hccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         264 IFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       264 ~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                      .+..++.++.+||.+||+.||++|||++|+|+||||++...
T Consensus       274 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  314 (349)
T 2w4o_A          274 WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAA  314 (349)
T ss_dssp             TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred             hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCcc
Confidence            33568899999999999999999999999999999988764

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.7e-49  Score=352.70  Aligned_cols=247  Identities=30%  Similarity=0.499  Sum_probs=194.5

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-CCCccccceeeeecC-
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-HENVLGLTDVFGYMS-  130 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~-  130 (307)
                      ..++|++++.||+|+||.||+|.+..+|+.||||++....   ........+.+|+.+++.+. ||||+++++++...+ 
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~   83 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF---QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND   83 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC-----CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc---cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence            4578999999999999999999999999999999986532   12223566789999999997 999999999987544 


Q ss_pred             -eEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCC
Q psy9858         131 -NVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS  209 (307)
Q Consensus       131 -~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  209 (307)
                       ..|+||||++|+|.+++...  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus        84 ~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  161 (388)
T 3oz6_A           84 RDVYLVFDYMETDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVN  161 (388)
T ss_dssp             SCEEEEEECCSEEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred             CEEEEEecccCcCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence             79999999999999988764  489999999999999999999999999999999999999999999999999987532


Q ss_pred             C---------------------Ccccccceeeceehhhhhhhccccccccccee---eee----ecCCCCCCCCCC----
Q psy9858         210 P---------------------TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCF----AKDPSSHGNLFP----  257 (307)
Q Consensus       210 ~---------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~----~~~~~f~~~~~~----  257 (307)
                      .                     .......++|++|+|||++.+...++.++|||   |++    +|.+||.+....    
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~  241 (388)
T 3oz6_A          162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE  241 (388)
T ss_dssp             CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            1                     11234457999999999998865899999999   433    399999773210    


Q ss_pred             ------------------------------------CCChhhh-------------ccccCHHHHHHHHHhhhcCCCCCC
Q psy9858         258 ------------------------------------GIPLNEI-------------FTAAGDDLLAVISSLLCLNPTKRA  288 (307)
Q Consensus       258 ------------------------------------~~~~~~~-------------~~~~~~~l~~li~~~l~~dP~~Rp  288 (307)
                                                          .......             ...+++++.+||.+||+.||++||
T Consensus       242 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~  321 (388)
T 3oz6_A          242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRI  321 (388)
T ss_dssp             HHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSC
T ss_pred             HHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCC
Confidence                                                0000000             115688999999999999999999


Q ss_pred             CHHHHhcCcccCCCcc
Q psy9858         289 DCTATLKMDYFSLTKE  304 (307)
Q Consensus       289 t~~~il~hp~f~~~~~  304 (307)
                      |++|+|+||||+....
T Consensus       322 t~~e~l~Hp~~~~~~~  337 (388)
T 3oz6_A          322 SANDALKHPFVSIFHN  337 (388)
T ss_dssp             CHHHHTTSTTTTTTCC
T ss_pred             CHHHHhCCHHHHHhcC
Confidence            9999999999986543

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.3e-48  Score=338.42  Aligned_cols=245  Identities=23%  Similarity=0.234  Sum_probs=204.4

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|++++.||+|+||+||+|.+..+++.||+|++.......    ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~   80 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD----CPENIKKEICINKMLNHENVVKFYGHRREGNIQ   80 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc----hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence            5679999999999999999999999999999999997543221    235678999999999999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC-
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP-  210 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-  210 (307)
                      ++||||+ +|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... 
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           81 YLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             EEEEECCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             EEEEEcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence            9999999 568888776543 5899999999999999999999999999999999999999999999999999866322 


Q ss_pred             -Ccccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCC---------ChhhhccccCHHHH
Q psy9858         211 -TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGI---------PLNEIFTAAGDDLL  273 (307)
Q Consensus       211 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~---------~~~~~~~~~~~~l~  273 (307)
                       ........||+.|+|||.+.+...++.++|||   +    +++|..||........         .....+..+++++.
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (323)
T 3tki_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL  239 (323)
T ss_dssp             EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred             cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHH
Confidence             22234568899999999998875568899999   3    3349999987433211         11122356899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         274 AVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       274 ~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                      +||.+||+.||++|||++|+++||||++.
T Consensus       240 ~li~~~L~~dP~~R~t~~eil~h~~~~~~  268 (323)
T 3tki_A          240 ALLHKILVENPSARITIPDIKKDRWYNKP  268 (323)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             HHHHHHccCChhhCcCHHHHhhChhhccc
Confidence            99999999999999999999999999864

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.5e-49  Score=346.81  Aligned_cols=249  Identities=23%  Similarity=0.241  Sum_probs=207.0

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeeec
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGYM  129 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~  129 (307)
                      ....++|.+.+.||+|+||.||+|++..+|+.||||++.+....  .......+.+|..++..+ +||||+++++++.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~   90 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL--MDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK   90 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhh--hhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC
Confidence            34668899999999999999999999999999999999753211  112245577899999887 899999999999999


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                      ...|+||||+ +|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||+++...
T Consensus        91 ~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A           91 ENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM  169 (345)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence            9999999999 678988887543 58999999999999999999999999999999999999999999999999998754


Q ss_pred             CCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCC------ChhhhccccCHHHHHH
Q psy9858         209 SPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGI------PLNEIFTAAGDDLLAV  275 (307)
Q Consensus       209 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~------~~~~~~~~~~~~l~~l  275 (307)
                      .........+||+.|+|||++.+. .++.++|+|   +    +++|..||.+......      .....+..+++++.+|
T Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  248 (345)
T 1xjd_A          170 LGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDL  248 (345)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred             cCCCcccCCCCCcccCChhhhcCC-CCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHH
Confidence            444445566899999999999887 899999999   3    3349999977321110      0011234578999999


Q ss_pred             HHHhhhcCCCCCCCHH-HHhcCcccCCCc
Q psy9858         276 ISSLLCLNPTKRADCT-ATLKMDYFSLTK  303 (307)
Q Consensus       276 i~~~l~~dP~~Rpt~~-~il~hp~f~~~~  303 (307)
                      |.+||+.||++|||+. ++++||||++.+
T Consensus       249 i~~lL~~dp~~R~~~~~~i~~hp~f~~~~  277 (345)
T 1xjd_A          249 LVKLFVREPEKRLGVRGDIRQHPLFREIN  277 (345)
T ss_dssp             HHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             HHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence            9999999999999998 999999998764

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.7e-48  Score=344.22  Aligned_cols=243  Identities=22%  Similarity=0.247  Sum_probs=205.3

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++......   ......+.+|+++++.++||||+++++++.+.+..
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  103 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS---ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH  103 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            457899999999999999999999999999999999864322   22245688999999999999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCC---cEEEEeecCccccC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG---VLKIGDFGLAKFFG  208 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~a~~~~  208 (307)
                      ++||||+ +|+|.+.+.... .+++..+..++.||+.||.|||++||+||||||+||+++.++   .+||+|||++....
T Consensus       104 ~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~  182 (362)
T 2bdw_A          104 YLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  182 (362)
T ss_dssp             EEEECCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred             EEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence            9999999 578888887654 589999999999999999999999999999999999998654   59999999998775


Q ss_pred             CCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCC----------CCChhhhccccCHH
Q psy9858         209 SPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFP----------GIPLNEIFTAAGDD  271 (307)
Q Consensus       209 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~----------~~~~~~~~~~~~~~  271 (307)
                      .. .......||+.|+|||++.+. .++.++|||   +    +++|..||.+....          .......+..++++
T Consensus       183 ~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  260 (362)
T 2bdw_A          183 DS-EAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE  260 (362)
T ss_dssp             TC-CSCCCSCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHH
T ss_pred             CC-cccccCCCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence            33 233456899999999999887 899999999   3    33399999773210          01112234568999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhcCcccCC
Q psy9858         272 LLAVISSLLCLNPTKRADCTATLKMDYFSL  301 (307)
Q Consensus       272 l~~li~~~l~~dP~~Rpt~~~il~hp~f~~  301 (307)
                      +.+||.+||+.||++|||++++|+||||..
T Consensus       261 ~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          261 AKSLIDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence            999999999999999999999999999975

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.6e-49  Score=338.45  Aligned_cols=247  Identities=22%  Similarity=0.275  Sum_probs=197.8

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCcccc---------------------chhhhHhHHHHHHHH
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADA---------------------KDGINRTALREIKLL  111 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---------------------~~~~~~~~~~e~~~l  111 (307)
                      ..++|++.+.||+|+||.||+|++..+|+.||||++........                     .....+.+.+|++++
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   90 (298)
T 2zv2_A           11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL   90 (298)
T ss_dssp             EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred             eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence            46789999999999999999999999999999999986432111                     011235688999999


Q ss_pred             HhcCCCCccccceeeee--cCeEEEEEEccC-CChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcE
Q psy9858         112 QELHHENVLGLTDVFGY--MSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNL  188 (307)
Q Consensus       112 ~~l~h~ni~~~~~~~~~--~~~~~lv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Ni  188 (307)
                      +.++||||+++++++.+  ....++||||++ |+|.++...  ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus        91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni  168 (298)
T 2zv2_A           91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL  168 (298)
T ss_dssp             HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence            99999999999999976  678999999994 667665433  3589999999999999999999999999999999999


Q ss_pred             EEecCCcEEEEeecCccccCCCCcccccceeeceehhhhhhhcccc--ccccccee---e----eeecCCCCCCCCCCC-
Q psy9858         189 LINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQ--FNVKNVQW---C----CFAKDPSSHGNLFPG-  258 (307)
Q Consensus       189 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~--~~~~~Diw---~----i~~~~~~f~~~~~~~-  258 (307)
                      +++.++.+||+|||++..............+|+.|+|||.+.+...  ++.++|||   +    +++|..||.+..... 
T Consensus       169 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  248 (298)
T 2zv2_A          169 LVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL  248 (298)
T ss_dssp             EECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHH
Confidence            9999999999999999887554444455689999999999987632  57899999   3    334999997632110 


Q ss_pred             -------CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCC
Q psy9858         259 -------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSL  301 (307)
Q Consensus       259 -------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~  301 (307)
                             .........+++++.+||.+||+.||++|||++|+++||||++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          249 HSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             HHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             HHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence                   0000112357899999999999999999999999999999964

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-48  Score=345.48  Aligned_cols=247  Identities=20%  Similarity=0.253  Sum_probs=209.2

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM  129 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  129 (307)
                      .+...++|++++.||+|+||.||+|.+..+|+.||+|++.....     .....+.+|+++++.++||||+++++++.+.
T Consensus        46 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-----~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~  120 (387)
T 1kob_A           46 QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-----LDKYTVKNEISIMNQLHHPKLINLHDAFEDK  120 (387)
T ss_dssp             CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-----HHHHHHHHHHHHHTTCCSTTBCCEEEEEECS
T ss_pred             CCccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch-----hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC
Confidence            44567889999999999999999999999999999999975321     1234688999999999999999999999999


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEec--CCcEEEEeecCccc
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK--QGVLKIGDFGLAKF  206 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~a~~  206 (307)
                      ...++||||+ +|+|.+++......+++..+..++.||+.||.|||++||+||||||+||+++.  ++.+||+|||++..
T Consensus       121 ~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~  200 (387)
T 1kob_A          121 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATK  200 (387)
T ss_dssp             SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEeccccee
Confidence            9999999999 67899998877667999999999999999999999999999999999999974  46799999999998


Q ss_pred             cCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCC----------CCChhhhccccC
Q psy9858         207 FGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFP----------GIPLNEIFTAAG  269 (307)
Q Consensus       207 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~----------~~~~~~~~~~~~  269 (307)
                      .... .......+|+.|+|||++.+. .++.++|||   +    +++|..||.+....          .......+..++
T Consensus       201 ~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  278 (387)
T 1kob_A          201 LNPD-EIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS  278 (387)
T ss_dssp             CCTT-SCEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSC
T ss_pred             cCCC-cceeeeccCCCccCchhccCC-CCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCC
Confidence            7543 233445789999999999887 899999999   3    33499999873211          011122335689


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         270 DDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       270 ~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      +++.+||.+||+.||++|||++|+|+||||++..
T Consensus       279 ~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          279 PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence            9999999999999999999999999999998653

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=6.5e-49  Score=353.83  Aligned_cols=251  Identities=16%  Similarity=0.184  Sum_probs=209.5

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS  130 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  130 (307)
                      ....++|++++.||+|+||+||+|++..+++.||+|++.+....  .......+.+|..++..++||||+++++++.+..
T Consensus        70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~  147 (437)
T 4aw2_A           70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML--KRAETACFREERDVLVNGDSKWITTLHYAFQDDN  147 (437)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH--HTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred             cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhh--hHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence            44568999999999999999999999999999999999752111  1112344889999999999999999999999999


Q ss_pred             eEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCC
Q psy9858         131 NVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS  209 (307)
Q Consensus       131 ~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  209 (307)
                      ..|+||||+ +|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus       148 ~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~  227 (437)
T 4aw2_A          148 NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME  227 (437)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence            999999999 7899999988666799999999999999999999999999999999999999999999999999987654


Q ss_pred             CCc-ccccceeeceehhhhhhhc----cccccccccee-------eeeecCCCCCCCCCCC-----------CChhhhcc
Q psy9858         210 PTR-LYTHQVVTRWYRLIKCLLY----CVQFNVKNVQW-------CCFAKDPSSHGNLFPG-----------IPLNEIFT  266 (307)
Q Consensus       210 ~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~Diw-------~i~~~~~~f~~~~~~~-----------~~~~~~~~  266 (307)
                      ... .....+||+.|+|||++..    ...++.++|||       .+++|..||.+.....           ........
T Consensus       228 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  307 (437)
T 4aw2_A          228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVT  307 (437)
T ss_dssp             TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCC
T ss_pred             CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccc
Confidence            332 2334689999999999972    33789999999       3444999998733211           11111223


Q ss_pred             ccCHHHHHHHHHhhhcCCCC--CCCHHHHhcCcccCCCc
Q psy9858         267 AAGDDLLAVISSLLCLNPTK--RADCTATLKMDYFSLTK  303 (307)
Q Consensus       267 ~~~~~l~~li~~~l~~dP~~--Rpt~~~il~hp~f~~~~  303 (307)
                      .+++++.+||.+||..+|++  |++++|+++||||++.+
T Consensus       308 ~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~  346 (437)
T 4aw2_A          308 DVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGID  346 (437)
T ss_dssp             CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCC
T ss_pred             cCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCC
Confidence            58999999999999998888  99999999999998764

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.3e-48  Score=341.15  Aligned_cols=250  Identities=30%  Similarity=0.530  Sum_probs=203.4

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM  129 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  129 (307)
                      .....++|++++.||+|+||.||+|++..+|+.||+|++....   ......+.+.+|+++++.++||||+++++++.+.
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   96 (331)
T 4aaa_A           20 YFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD---DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK   96 (331)
T ss_dssp             CCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS---SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             hhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC---CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC
Confidence            4456789999999999999999999999999999999987532   2233355678999999999999999999999999


Q ss_pred             CeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCC
Q psy9858         130 SNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS  209 (307)
Q Consensus       130 ~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  209 (307)
                      ...++||||++|++++.+......+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus        97 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A           97 KRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  176 (331)
T ss_dssp             TEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             CEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence            99999999997766665554444699999999999999999999999999999999999999999999999999987755


Q ss_pred             CCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCC--------------------------
Q psy9858         210 PTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLF--------------------------  256 (307)
Q Consensus       210 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~--------------------------  256 (307)
                      .........+|+.|+|||.+.+...++.++|||   +    +++|..||.+...                          
T Consensus       177 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (331)
T 4aaa_A          177 PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP  256 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred             CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence            444455668899999999998866789999999   3    3349999976321                          


Q ss_pred             -----------CCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         257 -----------PGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       257 -----------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                                 .........+.+++++.+||.+||+.||++|||++|+|+||||+..
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence                       1111222334678999999999999999999999999999999764

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.9e-48  Score=330.57  Aligned_cols=251  Identities=24%  Similarity=0.331  Sum_probs=188.5

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS  130 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  130 (307)
                      +...++|++.+.||+|+||.||+|++..+|+.||+|++.....  ........+.+|+++++.++||||+++++++.+.+
T Consensus         7 g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   84 (278)
T 3cok_A            7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAM--YKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN   84 (278)
T ss_dssp             CSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS
T ss_pred             ccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhh--hhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC
Confidence            4566889999999999999999999999999999999974211  11223467889999999999999999999999999


Q ss_pred             eEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCC
Q psy9858         131 NVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS  209 (307)
Q Consensus       131 ~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  209 (307)
                      ..++||||+ +++|.+++......+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           85 YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             eEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            999999999 5789998887766799999999999999999999999999999999999999999999999999988754


Q ss_pred             CCcccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCCCC------hhhhccccCHHHHHHH
Q psy9858         210 PTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPGIP------LNEIFTAAGDDLLAVI  276 (307)
Q Consensus       210 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~~~------~~~~~~~~~~~l~~li  276 (307)
                      .........+|+.|+|||.+.+. .++.++|||       .+++|..||.........      ....+..++.++.++|
T Consensus       165 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  243 (278)
T 3cok_A          165 PHEKHYTLCGTPNYISPEIATRS-AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLI  243 (278)
T ss_dssp             ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHH
T ss_pred             CCCcceeccCCCCcCCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHH
Confidence            43333455789999999999887 789999999       234499999874332211      1123345789999999


Q ss_pred             HHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         277 SSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       277 ~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                      .+||+.||++|||++++++||||.+...
T Consensus       244 ~~~l~~dp~~Rps~~~~l~h~~~~~~~~  271 (278)
T 3cok_A          244 HQLLRRNPADRLSLSSVLDHPFMSRNSS  271 (278)
T ss_dssp             HHHSCSSGGGSCCHHHHTTSTTTC----
T ss_pred             HHHcccCHhhCCCHHHHhcCccccCCCC
Confidence            9999999999999999999999987653

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-48  Score=342.87  Aligned_cols=243  Identities=33%  Similarity=0.488  Sum_probs=200.7

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec---
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM---  129 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---  129 (307)
                      ..++|++++.||+|+||.||+|.+..+|+.||||++....   ......+.+.+|+++++.++||||+++++++...   
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~   99 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF---QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL   99 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT---SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc---cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcc
Confidence            4568999999999999999999999999999999986532   2233356788999999999999999999998765   


Q ss_pred             ---CeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         130 ---SNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       130 ---~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                         ...|+||||++++|.+++...  .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.
T Consensus       100 ~~~~~~~lv~e~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          100 DDFTDFYLVMPFMGTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             TTCCCCEEEEECCSEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             ccCceEEEEEecCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence               346999999988999988764  489999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCcccccceeeceehhhhhhhccccccccccee---eee----ecCCCCCCCCC-----------------------
Q psy9858         207 FGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCF----AKDPSSHGNLF-----------------------  256 (307)
Q Consensus       207 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~----~~~~~f~~~~~-----------------------  256 (307)
                      ....   .....+|+.|+|||++.+...++.++|||   |++    +|..||.+...                       
T Consensus       178 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~  254 (367)
T 1cm8_A          178 ADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ  254 (367)
T ss_dssp             CCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred             cccc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence            6432   34457899999999998855899999999   433    39999986321                       


Q ss_pred             --------------CCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         257 --------------PGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       257 --------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                                    ........+...++++.+||.+||+.||++|||++|+|+||||+...
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~  315 (367)
T 1cm8_A          255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  315 (367)
T ss_dssp             CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence                          11223344456789999999999999999999999999999998754

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=5e-48  Score=344.66  Aligned_cols=255  Identities=16%  Similarity=0.130  Sum_probs=206.9

Q ss_pred             CceeccccceeeEEeEEeec--CceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccce
Q psy9858          47 DCEVKNDLLVYYQWRSVHVG--RFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTD  124 (307)
Q Consensus        47 ~~~~~~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~  124 (307)
                      ...+....++|++++.||+|  +||+||+|++..+|+.||||++....   ........+.+|+++++.++||||+++++
T Consensus        17 ~s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~   93 (389)
T 3gni_B           17 MSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA---CSNEMVTFLQGELHVSKLFNHPNIVPYRA   93 (389)
T ss_dssp             -CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGG---SCHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hhcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccc---cChHHHHHHHHHHHHHHhCCCCCCCcEeE
Confidence            44555677899999999999  99999999999999999999998632   22334567889999999999999999999


Q ss_pred             eeeecCeEEEEEEcc-CCChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeec
Q psy9858         125 VFGYMSNVSLVFEFV-DTDLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG  202 (307)
Q Consensus       125 ~~~~~~~~~lv~e~~-~g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg  202 (307)
                      ++.+.+..++||||+ +|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg  173 (389)
T 3gni_B           94 TFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLR  173 (389)
T ss_dssp             EEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGG
T ss_pred             EEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccc
Confidence            999999999999999 57898888754 3458999999999999999999999999999999999999999999999999


Q ss_pred             CccccCCCC-------cccccceeeceehhhhhhhcc-ccccccccee---ee----eecCCCCCCCCCCCCC-------
Q psy9858         203 LAKFFGSPT-------RLYTHQVVTRWYRLIKCLLYC-VQFNVKNVQW---CC----FAKDPSSHGNLFPGIP-------  260 (307)
Q Consensus       203 ~a~~~~~~~-------~~~~~~~~t~~y~aPE~~~~~-~~~~~~~Diw---~i----~~~~~~f~~~~~~~~~-------  260 (307)
                      .+.......       .......+|+.|+|||++.+. ..++.++|||   |+    ++|..||.+.......       
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  253 (389)
T 3gni_B          174 SNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT  253 (389)
T ss_dssp             GCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----
T ss_pred             cceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC
Confidence            986542211       112234788999999999873 3789999999   33    3399999773221110       


Q ss_pred             ---------------------------------------------hhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         261 ---------------------------------------------LNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       261 ---------------------------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                                                                   ....+..+++++.+||.+||+.||++|||++|+|+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             ----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence                                                         01123457889999999999999999999999999


Q ss_pred             CcccCCCcc
Q psy9858         296 MDYFSLTKE  304 (307)
Q Consensus       296 hp~f~~~~~  304 (307)
                      ||||++.+.
T Consensus       334 hp~f~~~~~  342 (389)
T 3gni_B          334 HSFFKQIKR  342 (389)
T ss_dssp             SGGGGGC--
T ss_pred             CHHHHHHhh
Confidence            999987653

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.4e-47  Score=338.77  Aligned_cols=245  Identities=31%  Similarity=0.517  Sum_probs=206.6

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec--
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM--  129 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--  129 (307)
                      ...++|++++.||+|+||.||+|.+..+++.||||++...    ........+.+|+++++.++||||+++++++...  
T Consensus        24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   99 (364)
T 3qyz_A           24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF----EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI   99 (364)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT----TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc----cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence            3456899999999999999999999999999999999742    2233346788999999999999999999998654  


Q ss_pred             ---CeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         130 ---SNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       130 ---~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                         ...++||||++|+|.+++...  .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus       100 ~~~~~~~iv~e~~~~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          100 EQMKDVYIVQDLMETDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             TTCCCEEEEEECCSEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             cccceEEEEEcccCcCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence               479999999999999988765  389999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCc---ccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCC-------------------
Q psy9858         207 FGSPTR---LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFP-------------------  257 (307)
Q Consensus       207 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~-------------------  257 (307)
                      ......   ......+|+.|+|||.+.+...++.++|||   +    +++|..||.+....                   
T Consensus       178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  257 (364)
T 3qyz_A          178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN  257 (364)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred             cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            643221   124458899999999988775799999999   3    33499999773211                   


Q ss_pred             ------------------CCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         258 ------------------GIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       258 ------------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                                        ..........+++++.+||.+||+.||++|||++|+|+||||++.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  320 (364)
T 3qyz_A          258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  320 (364)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence                              112233345678999999999999999999999999999999875

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.5e-48  Score=343.71  Aligned_cols=248  Identities=19%  Similarity=0.306  Sum_probs=208.2

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN  131 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  131 (307)
                      ...++|++++.||+|+||.||+|.+..+++.||+|++.+....  .......+.+|+++++.++||||+++++++.+...
T Consensus        12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~--~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   89 (384)
T 4fr4_A           12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCV--ERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED   89 (384)
T ss_dssp             CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcc--cHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            4568999999999999999999999999999999999753211  12224668899999999999999999999999999


Q ss_pred             EEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         132 VSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       132 ~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      .|+||||+ +|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++......
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           90 MFMVVDLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             EEEEECCCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            99999999 678888887653 5899999999999999999999999999999999999999999999999999887433


Q ss_pred             Ccccccceeeceehhhhhhhcc--ccccccccee---e----eeecCCCCCCCCCCCCC---------hhhhccccCHHH
Q psy9858         211 TRLYTHQVVTRWYRLIKCLLYC--VQFNVKNVQW---C----CFAKDPSSHGNLFPGIP---------LNEIFTAAGDDL  272 (307)
Q Consensus       211 ~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~---------~~~~~~~~~~~l  272 (307)
                       .......||+.|+|||++.+.  ..++.++|||   +    +++|..||.........         ....+..+++++
T Consensus       169 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~  247 (384)
T 4fr4_A          169 -TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEM  247 (384)
T ss_dssp             -CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred             -CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHHH
Confidence             334556899999999999753  2589999999   3    33499999763322110         112234678999


Q ss_pred             HHHHHHhhhcCCCCCCC-HHHHhcCcccCCCc
Q psy9858         273 LAVISSLLCLNPTKRAD-CTATLKMDYFSLTK  303 (307)
Q Consensus       273 ~~li~~~l~~dP~~Rpt-~~~il~hp~f~~~~  303 (307)
                      .+||.+||+.||.+||+ ++++++||||++.+
T Consensus       248 ~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~  279 (384)
T 4fr4_A          248 VSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN  279 (384)
T ss_dssp             HHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred             HHHHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence            99999999999999998 99999999998764

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.2e-48  Score=341.75  Aligned_cols=249  Identities=20%  Similarity=0.198  Sum_probs=208.2

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCcccc---chhhhHhHHHHHHHHHhcCCCCccccceeeee
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADA---KDGINRTALREIKLLQELHHENVLGLTDVFGY  128 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  128 (307)
                      ...++|++++.||+|+||.||+|.+..+++.||||++........   .......+.+|+++++.++||||+++++++.+
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  100 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN  100 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            356789999999999999999999999999999999986543221   11123456789999999999999999999999


Q ss_pred             cCeEEEEEEcc-CC-ChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         129 MSNVSLVFEFV-DT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       129 ~~~~~lv~e~~-~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                      .+..++||||+ .| +|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus       101 ~~~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  179 (335)
T 3dls_A          101 QGFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY  179 (335)
T ss_dssp             SSEEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCEEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence            99999999998 55 7888877654 589999999999999999999999999999999999999999999999999988


Q ss_pred             cCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCCChhhhccccCHHHHHHHHHh
Q psy9858         207 FGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGIPLNEIFTAAGDDLLAVISSL  279 (307)
Q Consensus       207 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~~~~~~~~~~~~l~~li~~~  279 (307)
                      .... .......||+.|+|||.+.+...++.++|||   +    +++|..||.............+..+++++.+||.+|
T Consensus       180 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~l~~li~~~  258 (335)
T 3dls_A          180 LERG-KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMSLVSGL  258 (335)
T ss_dssp             CCTT-CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTTTCCCCSSCCCHHHHHHHHHH
T ss_pred             CCCC-CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHhhccCCCcccCHHHHHHHHHH
Confidence            7543 2334557899999999999884558999999   3    334999997632222222223345799999999999


Q ss_pred             hhcCCCCCCCHHHHhcCcccCCC
Q psy9858         280 LCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       280 l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                      |+.||++|||++++++||||++.
T Consensus       259 L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          259 LQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             TCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             ccCChhhCcCHHHHhcCccccCC
Confidence            99999999999999999999874

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-48  Score=337.85  Aligned_cols=244  Identities=20%  Similarity=0.243  Sum_probs=205.8

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|++++.||+|+||+||+|++..+|+.||+|++.+....  .......+.+|..+++.++||||+++++++.+....
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~   81 (318)
T 1fot_A            4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV--RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI   81 (318)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred             ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEE
Confidence            467899999999999999999999999999999999753211  112245677899999999999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT  211 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  211 (307)
                      |+||||+ +|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||+++..... 
T Consensus        82 ~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-  159 (318)
T 1fot_A           82 FMIMDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  159 (318)
T ss_dssp             EEEECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             EEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence            9999999 578998887654 5899999999999999999999999999999999999999999999999999876432 


Q ss_pred             cccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCCC------hhhhccccCHHHHHHHHH
Q psy9858         212 RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGIP------LNEIFTAAGDDLLAVISS  278 (307)
Q Consensus       212 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~------~~~~~~~~~~~l~~li~~  278 (307)
                        ....+||+.|+|||++.+. .++.++|+|   +    +++|..||.+.......      ....+..+++++.+||.+
T Consensus       160 --~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~  236 (318)
T 1fot_A          160 --TYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR  236 (318)
T ss_dssp             --BCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred             --cccccCCccccCHhHhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence              3345899999999999887 899999999   3    33499999763211100      011234678999999999


Q ss_pred             hhhcCCCCCC-----CHHHHhcCcccCCCc
Q psy9858         279 LLCLNPTKRA-----DCTATLKMDYFSLTK  303 (307)
Q Consensus       279 ~l~~dP~~Rp-----t~~~il~hp~f~~~~  303 (307)
                      ||+.||++||     +++++++||||++..
T Consensus       237 lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~  266 (318)
T 1fot_A          237 LITRDLSQRLGNLQNGTEDVKNHPWFKEVV  266 (318)
T ss_dssp             HTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred             HhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence            9999999999     999999999998753

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=5.8e-48  Score=345.06  Aligned_cols=240  Identities=23%  Similarity=0.275  Sum_probs=193.7

Q ss_pred             ccccceeeEE-eEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHh-cCCCCccccceeeee
Q psy9858          51 KNDLLVYYQW-RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQE-LHHENVLGLTDVFGY  128 (307)
Q Consensus        51 ~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~ni~~~~~~~~~  128 (307)
                      ....++|.+. +.||+|+||+||+|.+..+|+.||||++..          ...+.+|++++.+ .+||||+++++++..
T Consensus        57 ~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~  126 (400)
T 1nxk_A           57 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----------CPKARREVELHWRASQCPHIVRIVDVYEN  126 (400)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----------SHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             CcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc----------chhHHHHHHHHHHhcCCCCcceEeEEEee
Confidence            4566788887 789999999999999999999999999863          2346689988754 589999999999876


Q ss_pred             ----cCeEEEEEEcc-CCChHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEec---CCcEEEE
Q psy9858         129 ----MSNVSLVFEFV-DTDLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK---QGVLKIG  199 (307)
Q Consensus       129 ----~~~~~lv~e~~-~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~---~~~~kl~  199 (307)
                          ...+|+||||+ +|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+
T Consensus       127 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~  206 (400)
T 1nxk_A          127 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT  206 (400)
T ss_dssp             EETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEEC
T ss_pred             cccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEE
Confidence                67799999999 579999998653 35899999999999999999999999999999999999997   7899999


Q ss_pred             eecCccccCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCCC------------
Q psy9858         200 DFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGIP------------  260 (307)
Q Consensus       200 Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~------------  260 (307)
                      |||+++..... ......++|+.|+|||++.+. .++.++|||   +    +++|..||.+.......            
T Consensus       207 DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~  284 (400)
T 1nxk_A          207 DFGFAKETTSH-NSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY  284 (400)
T ss_dssp             CCTTCEECC------------CTTCCGGGSCCC-CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCC
T ss_pred             ecccccccCCC-CccccCCCCCCccCHhhcCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcc
Confidence            99999876432 233456889999999999877 899999999   3    33499999774332211            


Q ss_pred             --hhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         261 --LNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       261 --~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                        ....+..+++++.+||.+||+.||++|||++|+++||||.+.
T Consensus       285 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          285 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence              011224689999999999999999999999999999999754

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.6e-48  Score=342.76  Aligned_cols=248  Identities=21%  Similarity=0.229  Sum_probs=206.6

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeeecC
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGYMS  130 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~  130 (307)
                      ...++|++++.||+|+||+||+|++..+|+.||||++.+....  .......+.+|..++..+ +||||+++++++.+..
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~--~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~   94 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI--QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD   94 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHH--HTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh--cchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence            3567899999999999999999999999999999999753211  112245678899999988 7999999999999999


Q ss_pred             eEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCC
Q psy9858         131 NVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS  209 (307)
Q Consensus       131 ~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  209 (307)
                      ..|+||||+ +|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||+++....
T Consensus        95 ~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A           95 RLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            999999999 678988887543 489999999999999999999999999999999999999999999999999987544


Q ss_pred             CCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCCC------hhhhccccCHHHHHHH
Q psy9858         210 PTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGIP------LNEIFTAAGDDLLAVI  276 (307)
Q Consensus       210 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~------~~~~~~~~~~~l~~li  276 (307)
                      ........+||+.|+|||++.+. .++.++|+|   +    +++|..||.+.......      ....+..+++++.+||
T Consensus       174 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li  252 (353)
T 2i0e_A          174 DGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAIC  252 (353)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred             CCcccccccCCccccChhhhcCC-CcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            44445566899999999999887 889999999   3    33499999873221100      0112346899999999


Q ss_pred             HHhhhcCCCCCCC-----HHHHhcCcccCCCc
Q psy9858         277 SSLLCLNPTKRAD-----CTATLKMDYFSLTK  303 (307)
Q Consensus       277 ~~~l~~dP~~Rpt-----~~~il~hp~f~~~~  303 (307)
                      .+||+.||.+||+     ++++++||||+..+
T Consensus       253 ~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~  284 (353)
T 2i0e_A          253 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  284 (353)
T ss_dssp             HHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCC
T ss_pred             HHHhhcCHHHcCCCCCCCHHHHhcCccccCCC
Confidence            9999999999995     69999999998753

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.2e-48  Score=349.58  Aligned_cols=250  Identities=18%  Similarity=0.177  Sum_probs=207.6

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM  129 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  129 (307)
                      +....++|++++.||+|+||+||+|++..+++.||+|++.+.....  ......+.+|+.+++.++||||+++++++.+.
T Consensus        64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~--~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK--RSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH--TCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhh--hHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            4456789999999999999999999999999999999997522111  11234578999999999999999999999999


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                      ...|+||||+ +|+|.+++...  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~  219 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN  219 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeec
Confidence            9999999999 67899888764  48999999999999999999999999999999999999999999999999998775


Q ss_pred             CCCc-ccccceeeceehhhhhhhccc---cccccccee---e----eeecCCCCCCCCCCCCC----------hhhhccc
Q psy9858         209 SPTR-LYTHQVVTRWYRLIKCLLYCV---QFNVKNVQW---C----CFAKDPSSHGNLFPGIP----------LNEIFTA  267 (307)
Q Consensus       209 ~~~~-~~~~~~~t~~y~aPE~~~~~~---~~~~~~Diw---~----i~~~~~~f~~~~~~~~~----------~~~~~~~  267 (307)
                      .... .....+||+.|+|||++.+..   .++.++|||   +    +++|..||.+.......          .......
T Consensus       220 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  299 (410)
T 3v8s_A          220 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND  299 (410)
T ss_dssp             TTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCC
T ss_pred             cCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCccc
Confidence            4332 234568999999999998752   288999999   3    34499999873321100          0011135


Q ss_pred             cCHHHHHHHHHhhhcCCCC--CCCHHHHhcCcccCCCc
Q psy9858         268 AGDDLLAVISSLLCLNPTK--RADCTATLKMDYFSLTK  303 (307)
Q Consensus       268 ~~~~l~~li~~~l~~dP~~--Rpt~~~il~hp~f~~~~  303 (307)
                      +++++.+||.+||+.+|.+  |++++||++||||++.+
T Consensus       300 ~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~  337 (410)
T 3v8s_A          300 ISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  337 (410)
T ss_dssp             CCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred             ccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence            8999999999999999988  99999999999998863

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.6e-48  Score=340.38  Aligned_cols=246  Identities=24%  Similarity=0.269  Sum_probs=208.1

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS  130 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  130 (307)
                      ....++|++++.||+|+||.||+|++..+|+.||+|++.+....  .......+.+|+++++.++||||+++++++.+..
T Consensus        37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  114 (350)
T 1rdq_E           37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV--KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS  114 (350)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH--HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhc--cHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            35678999999999999999999999999999999999753211  1122456889999999999999999999999999


Q ss_pred             eEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCC
Q psy9858         131 NVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS  209 (307)
Q Consensus       131 ~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  209 (307)
                      ..|+||||+ +|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus       115 ~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          115 NLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC
Confidence            999999999 688988887643 489999999999999999999999999999999999999999999999999987643


Q ss_pred             CCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCCC------hhhhccccCHHHHHHH
Q psy9858         210 PTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGIP------LNEIFTAAGDDLLAVI  276 (307)
Q Consensus       210 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~------~~~~~~~~~~~l~~li  276 (307)
                      .   .....||+.|+|||++.+. .++.++|||   +    +++|..||.+.......      ....+..+++++.+||
T Consensus       194 ~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li  269 (350)
T 1rdq_E          194 R---TWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL  269 (350)
T ss_dssp             C---BCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHH
T ss_pred             C---cccccCCccccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            2   2345899999999999887 899999999   3    33399999773211100      0122346799999999


Q ss_pred             HHhhhcCCCCCCC-----HHHHhcCcccCCCc
Q psy9858         277 SSLLCLNPTKRAD-----CTATLKMDYFSLTK  303 (307)
Q Consensus       277 ~~~l~~dP~~Rpt-----~~~il~hp~f~~~~  303 (307)
                      .+||+.||.+||+     ++++++||||++.+
T Consensus       270 ~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~  301 (350)
T 1rdq_E          270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD  301 (350)
T ss_dssp             HHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred             HHHhhcCHHhccCCccCCHHHHHhCcCcCCCC
Confidence            9999999999998     99999999998754

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.3e-48  Score=339.05  Aligned_cols=245  Identities=20%  Similarity=0.284  Sum_probs=195.7

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC--
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS--  130 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--  130 (307)
                      ..++|++++.||+|+||.||+|++..+|+.||||++....    .....+.+.+|++++++++||||+++++++.+..  
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   79 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN----RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPE   79 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS----TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSC
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC----chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccc
Confidence            4678999999999999999999999999999999998542    2223567889999999999999999999885433  


Q ss_pred             -------------------------------------------------------eEEEEEEcc-CCChHHHHhCCCC--
Q psy9858         131 -------------------------------------------------------NVSLVFEFV-DTDLEVIIKDPTI--  152 (307)
Q Consensus       131 -------------------------------------------------------~~~lv~e~~-~g~l~~~~~~~~~--  152 (307)
                                                                             ..++||||+ +|+|.+++.....  
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~  159 (332)
T 3qd2_B           80 KWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE  159 (332)
T ss_dssp             HHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGG
T ss_pred             hhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCcc
Confidence                                                                   389999999 5789998876532  


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC------------cccccceee
Q psy9858         153 VFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT------------RLYTHQVVT  220 (307)
Q Consensus       153 ~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~------------~~~~~~~~t  220 (307)
                      ...+..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++......            .......+|
T Consensus       160 ~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt  239 (332)
T 3qd2_B          160 DREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT  239 (332)
T ss_dssp             GSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred             chhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence            25666789999999999999999999999999999999999999999999998875432            122345799


Q ss_pred             ceehhhhhhhccccccccccee--e-eee----cCCCCCC-----CCCCCCChhhhccccCHHHHHHHHHhhhcCCCCCC
Q psy9858         221 RWYRLIKCLLYCVQFNVKNVQW--C-CFA----KDPSSHG-----NLFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRA  288 (307)
Q Consensus       221 ~~y~aPE~~~~~~~~~~~~Diw--~-i~~----~~~~f~~-----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp  288 (307)
                      +.|+|||.+.+. .++.++|||  + +++    |..++..     ...........+...++++.+||.+||+.||++||
T Consensus       240 ~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  318 (332)
T 3qd2_B          240 KLYMSPEQIHGN-NYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERP  318 (332)
T ss_dssp             GGGSCHHHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSC
T ss_pred             cCccChHHhcCC-CCcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCC
Confidence            999999999887 899999999  2 222    4333221     00011122233345688899999999999999999


Q ss_pred             CHHHHhcCcccCCC
Q psy9858         289 DCTATLKMDYFSLT  302 (307)
Q Consensus       289 t~~~il~hp~f~~~  302 (307)
                      |++|+|+||||+++
T Consensus       319 s~~~~l~~~~f~~~  332 (332)
T 3qd2_B          319 EATDIIENAIFENL  332 (332)
T ss_dssp             CHHHHHHSTTCCCC
T ss_pred             CHHHHhhchhhhcC
Confidence            99999999999874

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2e-47  Score=332.14  Aligned_cols=243  Identities=19%  Similarity=0.281  Sum_probs=204.7

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ....|...+.||+|+||.||+|++..+|+.||||++.....     .....+.+|+.+++.++||||+++++++......
T Consensus        43 ~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  117 (321)
T 2c30_A           43 PRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ-----QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEEL  117 (321)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             chhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch-----hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEE
Confidence            34458888999999999999999988999999999975421     1245688999999999999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT  211 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  211 (307)
                      ++||||+ +|+|.+++...  .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus       118 ~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  195 (321)
T 2c30_A          118 WVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV  195 (321)
T ss_dssp             EEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred             EEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc
Confidence            9999999 57788877654  48999999999999999999999999999999999999999999999999998875544


Q ss_pred             cccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCC---------CChhhhccccCHHHHHH
Q psy9858         212 RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPG---------IPLNEIFTAAGDDLLAV  275 (307)
Q Consensus       212 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~---------~~~~~~~~~~~~~l~~l  275 (307)
                      .......||+.|+|||.+.+. .++.++|||       .+++|..||.......         .........+++.+.++
T Consensus       196 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  274 (321)
T 2c30_A          196 PKRKSLVGTPYWMAPEVISRS-LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDF  274 (321)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHH
T ss_pred             cccccccCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHH
Confidence            444556899999999999887 889999999       3344999987632100         00011123578999999


Q ss_pred             HHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         276 ISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       276 i~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      |.+||+.||++|||++++++||||.+..
T Consensus       275 i~~~l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          275 LERMLVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             HHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             HHHHccCChhhCcCHHHHhcChhhccCC
Confidence            9999999999999999999999997653

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=4.8e-48  Score=336.63  Aligned_cols=240  Identities=21%  Similarity=0.265  Sum_probs=183.3

Q ss_pred             cceeeEE---eEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-CCCccccceeeeec
Q psy9858          54 LLVYYQW---RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-HENVLGLTDVFGYM  129 (307)
Q Consensus        54 ~~~y~~~---~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~  129 (307)
                      .++|++.   +.||+|+||.||+|.+..+|+.||||++...        ....+.+|+.+++.+. ||||+++++++.+.
T Consensus         7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~   78 (325)
T 3kn6_A            7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--------MEANTQKEITALKLCEGHPNIVKLHEVFHDQ   78 (325)
T ss_dssp             HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence            4567775   7899999999999999999999999999742        1355778999999997 99999999999999


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCC---cEEEEeecCcc
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG---VLKIGDFGLAK  205 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~a~  205 (307)
                      ...++||||+ +|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++   .+||+|||++.
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~  157 (325)
T 3kn6_A           79 LHTFLVMELLNGGELFERIKKKK-HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR  157 (325)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred             CEEEEEEEccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence            9999999999 568988887653 589999999999999999999999999999999999998766   89999999998


Q ss_pred             ccCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC-----------------CCh
Q psy9858         206 FFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG-----------------IPL  261 (307)
Q Consensus       206 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~-----------------~~~  261 (307)
                      .............+|+.|+|||.+.+. .++.++|||   +    +++|..||.+.....                 ...
T Consensus       158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~  236 (325)
T 3kn6_A          158 LKPPDNQPLKTPCFTLHYAAPELLNQN-GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE  236 (325)
T ss_dssp             ECCC----------------------C-CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC
T ss_pred             ecCCCCCcccccCCCcCccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC
Confidence            776555555566889999999999887 899999999   3    334999998633211                 111


Q ss_pred             hhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         262 NEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       262 ~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      ...+..+++++.+||.+||+.||++|||++|+++||||++..
T Consensus       237 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~  278 (325)
T 3kn6_A          237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS  278 (325)
T ss_dssp             SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred             cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence            122346899999999999999999999999999999998764

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.9e-48  Score=341.85  Aligned_cols=244  Identities=23%  Similarity=0.238  Sum_probs=193.3

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM  129 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  129 (307)
                      .....++|++++.||+|+||+||+|++..+++.||+|++.....      ....+.+|+.+++.++||||+++++++.+.
T Consensus        15 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   88 (361)
T 3uc3_A           15 IMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA------IDENVQREIINHRSLRHPNIVRFKEVILTP   88 (361)
T ss_dssp             CCCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT------SCHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CCCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc------ccHHHHHHHHHHHhCCCCCCCcEEEEEeeC
Confidence            34566789999999999999999999999999999999975321      135578999999999999999999999999


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCc--EEEEeecCccc
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGV--LKIGDFGLAKF  206 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~a~~  206 (307)
                      ...++||||+ +|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||+++.
T Consensus        89 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~  167 (361)
T 3uc3_A           89 THLAIIMEYASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS  167 (361)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred             CEEEEEEEeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence            9999999999 678988886543 5899999999999999999999999999999999999987775  99999999985


Q ss_pred             cCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCCChh------------hhccc
Q psy9858         207 FGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGIPLN------------EIFTA  267 (307)
Q Consensus       207 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~~~------------~~~~~  267 (307)
                      .... .......||+.|+|||.+.+....+.++|||   +    +++|..||.+.........            .....
T Consensus       168 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (361)
T 3uc3_A          168 SVLH-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR  246 (361)
T ss_dssp             --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSC
T ss_pred             cccc-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCC
Confidence            4322 2234457999999999998884455669999   3    3349999987433221111            11124


Q ss_pred             cCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCC
Q psy9858         268 AGDDLLAVISSLLCLNPTKRADCTATLKMDYFSL  301 (307)
Q Consensus       268 ~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~  301 (307)
                      +++++.+||.+||+.||++|||++|+++||||.+
T Consensus       247 ~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~  280 (361)
T 3uc3_A          247 ISPECCHLISRIFVADPATRISIPEIKTHSWFLK  280 (361)
T ss_dssp             CCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence            7899999999999999999999999999999954

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-48  Score=347.83  Aligned_cols=251  Identities=18%  Similarity=0.191  Sum_probs=207.4

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM  129 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  129 (307)
                      .....++|++++.||+|+||+||+|++..+|+.||||++.+....  .......+.+|..++..++||||+++++++.+.
T Consensus        56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~--~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~  133 (412)
T 2vd5_A           56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML--KRGEVSCFREERDVLVNGDRRWITQLHFAFQDE  133 (412)
T ss_dssp             HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH--HHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred             ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhh--hHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            345678999999999999999999999999999999999752111  122244578999999999999999999999999


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                      +..|+||||+ +|+|.+++.+.+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       134 ~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~  213 (412)
T 2vd5_A          134 NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR  213 (412)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheecc
Confidence            9999999999 789999998755569999999999999999999999999999999999999999999999999998875


Q ss_pred             CCCc-ccccceeeceehhhhhhhc------cccccccccee---e----eeecCCCCCCCCCCC-----------CChhh
Q psy9858         209 SPTR-LYTHQVVTRWYRLIKCLLY------CVQFNVKNVQW---C----CFAKDPSSHGNLFPG-----------IPLNE  263 (307)
Q Consensus       209 ~~~~-~~~~~~~t~~y~aPE~~~~------~~~~~~~~Diw---~----i~~~~~~f~~~~~~~-----------~~~~~  263 (307)
                      .... .....+||+.|+|||++.+      ...++.++|+|   +    +++|..||.+.....           .....
T Consensus       214 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~  293 (412)
T 2vd5_A          214 ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPL  293 (412)
T ss_dssp             TTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC-
T ss_pred             CCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCc
Confidence            4332 2234589999999999984      23789999999   3    334999998733211           01111


Q ss_pred             hccccCHHHHHHHHHhhhcCCCCC---CCHHHHhcCcccCCCc
Q psy9858         264 IFTAAGDDLLAVISSLLCLNPTKR---ADCTATLKMDYFSLTK  303 (307)
Q Consensus       264 ~~~~~~~~l~~li~~~l~~dP~~R---pt~~~il~hp~f~~~~  303 (307)
                      ....+++++.+||++||. +|++|   ++++|+++||||++.+
T Consensus       294 ~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~  335 (412)
T 2vd5_A          294 VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLD  335 (412)
T ss_dssp             ---CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCC
T ss_pred             cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCC
Confidence            224689999999999999 99998   5999999999998763

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.7e-47  Score=331.33  Aligned_cols=250  Identities=22%  Similarity=0.301  Sum_probs=210.1

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccc-hhhhHhHHHHHHHHHhcCCCCccccceeeeec
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAK-DGINRTALREIKLLQELHHENVLGLTDVFGYM  129 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  129 (307)
                      ....++|++.+.||+|+||.||+|.+..+|+.||+|++......... ......+.+|+.+++.++||||+++++++.+.
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   87 (321)
T 2a2a_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR   87 (321)
T ss_dssp             SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            34567899999999999999999999999999999999865433221 11246688999999999999999999999999


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCC----cEEEEeecCc
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG----VLKIGDFGLA  204 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~----~~kl~Dfg~a  204 (307)
                      ...++||||+ +++|.+++.... .+++..+..++.||+.||.|||++|++||||||+||+++.++    .++|+|||++
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~  166 (321)
T 2a2a_A           88 TDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (321)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence            9999999999 678998887643 589999999999999999999999999999999999999888    7999999999


Q ss_pred             cccCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCC----------CCCChhhhccc
Q psy9858         205 KFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLF----------PGIPLNEIFTA  267 (307)
Q Consensus       205 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~----------~~~~~~~~~~~  267 (307)
                      ....... ......+|+.|+|||.+.+. .++.++|||   +    +++|..||.+...          ........+..
T Consensus       167 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (321)
T 2a2a_A          167 HEIEDGV-EFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSH  244 (321)
T ss_dssp             EECCTTC-CCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred             eecCccc-cccccCCCCCccCcccccCC-CCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcc
Confidence            8875432 23445789999999999887 889999999   3    3339999976321          11112233456


Q ss_pred             cCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         268 AGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       268 ~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      +++.+.+||.+||+.||++|||++|+++||||+..+
T Consensus       245 ~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~  280 (321)
T 2a2a_A          245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (321)
T ss_dssp             CCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred             cCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence            889999999999999999999999999999998765

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=7.9e-48  Score=337.27  Aligned_cols=240  Identities=22%  Similarity=0.283  Sum_probs=201.8

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeeecC
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGYMS  130 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~  130 (307)
                      ...++|++.+.||+|+||.||+|.+..+|+.||+|++.....         ...+|++++.++ +||||+++++++.+..
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~   89 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---------DPTEEIEILLRYGQHPNIITLKDVYDDGK   89 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---------CCHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---------ChHHHHHHHHHhcCCCCcCeEEEEEEcCC
Confidence            356789999999999999999999999999999999975321         234688888888 7999999999999999


Q ss_pred             eEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecC----CcEEEEeecCcc
Q psy9858         131 NVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ----GVLKIGDFGLAK  205 (307)
Q Consensus       131 ~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~----~~~kl~Dfg~a~  205 (307)
                      ..|+||||+ +|+|.+.+.... .+++..+..++.||+.||.|||++||+||||||+||++..+    +.+||+|||++.
T Consensus        90 ~~~lv~E~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~  168 (342)
T 2qr7_A           90 YVYVVTELMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK  168 (342)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred             EEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence            999999999 678998887654 58999999999999999999999999999999999998543    259999999999


Q ss_pred             ccCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCC-------------Chhhhc
Q psy9858         206 FFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGI-------------PLNEIF  265 (307)
Q Consensus       206 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~-------------~~~~~~  265 (307)
                      .............+|+.|+|||++.+. .++.++|||   +    +++|..||.+......             .....+
T Consensus       169 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  247 (342)
T 2qr7_A          169 QLRAENGLLMTPCYTANFVAPEVLERQ-GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYW  247 (342)
T ss_dssp             ECBCTTCCBCCSSCCSSCCCHHHHHHH-HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTT
T ss_pred             cCcCCCCceeccCCCccccCHHHhcCC-CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccc
Confidence            775544445566889999999999887 789999999   3    3339999976321110             011223


Q ss_pred             cccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         266 TAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       266 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                      ..+++++.+||.+||+.||++|||++++++||||.+.
T Consensus       248 ~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  284 (342)
T 2qr7_A          248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW  284 (342)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred             ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence            5689999999999999999999999999999999654

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=9.2e-48  Score=328.86  Aligned_cols=247  Identities=20%  Similarity=0.285  Sum_probs=198.9

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY  128 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  128 (307)
                      ..+...++|.+.+.||+|+||.||+|.+..++..||+|++....    .......+.+|+++++.++||||+++++++.+
T Consensus        16 ~~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   91 (285)
T 3is5_A           16 FQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR----SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED   91 (285)
T ss_dssp             ESSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG----CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             CCCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc----cchhHHHHHHHHHHHHhCCCchHHhHHHheec
Confidence            34556688999999999999999999999999999999997532    12224668899999999999999999999999


Q ss_pred             cCeEEEEEEcc-CCChHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEE---ecCCcEEEEee
Q psy9858         129 MSNVSLVFEFV-DTDLEVIIKDP---TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLI---NKQGVLKIGDF  201 (307)
Q Consensus       129 ~~~~~lv~e~~-~g~l~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Df  201 (307)
                      ....++||||+ +|+|.+.+...   ...+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+||
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Df  171 (285)
T 3is5_A           92 YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDF  171 (285)
T ss_dssp             SSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             CCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEee
Confidence            99999999999 56888887532   3458999999999999999999999999999999999999   45678999999


Q ss_pred             cCccccCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC---------CChhhhc
Q psy9858         202 GLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG---------IPLNEIF  265 (307)
Q Consensus       202 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~---------~~~~~~~  265 (307)
                      |++...... .......+|+.|+|||.+.+  .++.++|||   +    +++|..||.+.....         .......
T Consensus       172 g~a~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  248 (285)
T 3is5_A          172 GLAELFKSD-EHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVEC  248 (285)
T ss_dssp             CCCCC-----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--
T ss_pred             ecceecCCc-ccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccccc
Confidence            999876433 23345578999999999864  588999999   3    334999998732111         1111112


Q ss_pred             cccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         266 TAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       266 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                      ..+++++.+||.+||+.||++|||++|+|+||||+++
T Consensus       249 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~a  285 (285)
T 3is5_A          249 RPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA  285 (285)
T ss_dssp             CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC-
T ss_pred             CcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhcC
Confidence            3478999999999999999999999999999999864

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=6.9e-47  Score=329.87  Aligned_cols=240  Identities=25%  Similarity=0.416  Sum_probs=199.0

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-CCCccccceeeee--
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-HENVLGLTDVFGY--  128 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~--  128 (307)
                      ...++|++++.||+|+||+||+|.+..+++.||+|++....        .+.+.+|+++++.++ ||||+++++++.+  
T Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~  104 (330)
T 3nsz_A           33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--------KKKIKREIKILENLRGGPNIITLADIVKDPV  104 (330)
T ss_dssp             EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC--------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTT
T ss_pred             cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc--------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCC
Confidence            34578999999999999999999999999999999987421        356889999999997 9999999999987  


Q ss_pred             cCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCC-cEEEEeecCccc
Q psy9858         129 MSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG-VLKIGDFGLAKF  206 (307)
Q Consensus       129 ~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a~~  206 (307)
                      ....++||||+ +++|.+++..    +++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++..
T Consensus       105 ~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~  180 (330)
T 3nsz_A          105 SRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  180 (330)
T ss_dssp             TCCEEEEEECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             CCceEEEEeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence            67899999999 4677777643    78999999999999999999999999999999999999777 899999999987


Q ss_pred             cCCCCcccccceeeceehhhhhhhccccccccccee---ee----eecCCCCCCCCCC----------------------
Q psy9858         207 FGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FAKDPSSHGNLFP----------------------  257 (307)
Q Consensus       207 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~~~~~f~~~~~~----------------------  257 (307)
                      .... .......++..|+|||.+.+...++.++|||   ++    ++|..||......                      
T Consensus       181 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  259 (330)
T 3nsz_A          181 YHPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  259 (330)
T ss_dssp             CCTT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             cCCC-CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence            6433 2344558899999999998865899999999   33    3388888431100                      


Q ss_pred             -----------------CC-----ChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         258 -----------------GI-----PLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       258 -----------------~~-----~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                                       ..     ........+++++.+||.+||+.||++|||++|+|+||||+++.+
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  328 (330)
T 3nsz_A          260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  328 (330)
T ss_dssp             TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred             hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence                             00     001112237899999999999999999999999999999998764

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=8.2e-48  Score=340.31  Aligned_cols=243  Identities=33%  Similarity=0.495  Sum_probs=188.0

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec---
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM---  129 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---  129 (307)
                      ..++|++++.||+|+||.||+|.+..+|+.||||++....   ......+.+.+|+++++.++||||+++++++...   
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  103 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF---QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL  103 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT---SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSG
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc---cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcc
Confidence            4478999999999999999999999999999999987532   1222356788999999999999999999998653   


Q ss_pred             ---CeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         130 ---SNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       130 ---~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                         ...+++||+++++|.+++...  .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.
T Consensus       104 ~~~~~~~lv~e~~~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~  181 (367)
T 2fst_X          104 EEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH  181 (367)
T ss_dssp             GGCCCCEEEEECCCEECC-----C--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred             ccCCeEEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence               668999999999998888763  489999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCcccccceeeceehhhhhhhccccccccccee---eee----ecCCCCCCCCC-----------------------
Q psy9858         207 FGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCF----AKDPSSHGNLF-----------------------  256 (307)
Q Consensus       207 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~----~~~~~f~~~~~-----------------------  256 (307)
                      ....   .....+|+.|+|||++.+...++.++|||   |++    +|..||.+...                       
T Consensus       182 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~  258 (367)
T 2fst_X          182 TADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  258 (367)
T ss_dssp             ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred             cccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence            6432   34458899999999998855899999999   333    39999977321                       


Q ss_pred             --------------CCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         257 --------------PGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       257 --------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                                    +.......+...++++.+||.+||+.||.+|||++|+|+||||+...
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~  319 (367)
T 2fst_X          259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  319 (367)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence                          11222334456789999999999999999999999999999998753

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3e-47  Score=325.25  Aligned_cols=246  Identities=22%  Similarity=0.242  Sum_probs=205.8

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++.....   .......+.+|++++++++||||+++++++......
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL---SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH   80 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC---CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEE
Confidence            46789999999999999999999999999999999975322   222346688999999999999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCc---EEEEeecCccccC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGV---LKIGDFGLAKFFG  208 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~a~~~~  208 (307)
                      ++||||+ +|+|.+.+.... .+++..+..++.||+.||.|||++|++||||||+||+++.++.   +||+|||++....
T Consensus        81 ~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           81 YLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             EEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             EEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            9999999 568878776543 5899999999999999999999999999999999999987665   9999999998775


Q ss_pred             CCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCC----------CCChhhhccccCHH
Q psy9858         209 SPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFP----------GIPLNEIFTAAGDD  271 (307)
Q Consensus       209 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~----------~~~~~~~~~~~~~~  271 (307)
                      .. .......+|+.|+|||.+.+. .++.++|||   +    +++|..||.+....          .......+..++++
T Consensus       160 ~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T 3kk8_A          160 DS-EAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE  237 (284)
T ss_dssp             SS-CBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred             cC-ccccCCCCCcCCcCchhhcCC-CCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHH
Confidence            43 233445789999999999887 889999999   3    33499998762211          01111223467899


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         272 LLAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       272 l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                      +.+||.+||+.||++|||++|+|+||||++.++
T Consensus       238 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (284)
T 3kk8_A          238 AKSLIDSMLTVNPKKRITADQALKVPWICNRER  270 (284)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred             HHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence            999999999999999999999999999987654

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.8e-48  Score=339.87  Aligned_cols=261  Identities=21%  Similarity=0.216  Sum_probs=207.0

Q ss_pred             CCceeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCcccccee
Q psy9858          46 PDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV  125 (307)
Q Consensus        46 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~  125 (307)
                      +...+....++|++++.||+|+||.||+|.+..+++.||+|++...............+.+|+++++.++||||++++++
T Consensus        17 q~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~   96 (345)
T 3hko_A           17 QGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEV   96 (345)
T ss_dssp             CCBCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cCchhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehh
Confidence            33445566789999999999999999999999999999999997532222223335678899999999999999999999


Q ss_pred             eeecCeEEEEEEcc-CCChHHHHhCC---------------------------------------CCCCCHHHHHHHHHH
Q psy9858         126 FGYMSNVSLVFEFV-DTDLEVIIKDP---------------------------------------TIVFTPSNIKAYAIM  165 (307)
Q Consensus       126 ~~~~~~~~lv~e~~-~g~l~~~~~~~---------------------------------------~~~~~~~~~~~i~~~  165 (307)
                      +.+....++||||+ +|+|.+++...                                       ...+++..++.++.|
T Consensus        97 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~q  176 (345)
T 3hko_A           97 YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQ  176 (345)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHH
T ss_pred             hccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHH
Confidence            99999999999999 68888887420                                       112467788899999


Q ss_pred             HHHHHHHHHHCCceeecCCCCcEEEecCC--cEEEEeecCccccCCCC----cccccceeeceehhhhhhhcc-cccccc
Q psy9858         166 TLRGLEYLHDHWILHRDLKPNNLLINKQG--VLKIGDFGLAKFFGSPT----RLYTHQVVTRWYRLIKCLLYC-VQFNVK  238 (307)
Q Consensus       166 i~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~a~~~~~~~----~~~~~~~~t~~y~aPE~~~~~-~~~~~~  238 (307)
                      |+.||.|||++||+||||||+||+++.++  .+||+|||++.......    .......+|+.|+|||.+.+. ..++.+
T Consensus       177 i~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          177 IFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            99999999999999999999999998777  89999999998653211    123455789999999999752 378999


Q ss_pred             ccee---e----eeecCCCCCCCCCC----------CCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCC
Q psy9858         239 NVQW---C----CFAKDPSSHGNLFP----------GIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSL  301 (307)
Q Consensus       239 ~Diw---~----i~~~~~~f~~~~~~----------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~  301 (307)
                      +|||   +    +++|..||.+....          ..........+++++.+||.+||+.||.+|||+.++|+||||++
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~  336 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQ  336 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHT
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhcc
Confidence            9999   3    33499999772211          11111223457999999999999999999999999999999998


Q ss_pred             CcccC
Q psy9858         302 TKEMY  306 (307)
Q Consensus       302 ~~~~~  306 (307)
                      ..++.
T Consensus       337 ~~~~~  341 (345)
T 3hko_A          337 FSDKI  341 (345)
T ss_dssp             TSSCS
T ss_pred             ChHhh
Confidence            87654

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.9e-47  Score=334.47  Aligned_cols=249  Identities=30%  Similarity=0.481  Sum_probs=206.1

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY  128 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  128 (307)
                      ......++|++.+.||+|+||.||+|.+..+|+.||||++...    ........+.+|+++++.++||||+++++++..
T Consensus         5 ~~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   80 (353)
T 2b9h_A            5 IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF----DKPLFALRTLREIKILKHFKHENIITIFNIQRP   80 (353)
T ss_dssp             CCCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred             cccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc----ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecc
Confidence            3445668999999999999999999999999999999999642    223335567899999999999999999998765


Q ss_pred             c-----CeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecC
Q psy9858         129 M-----SNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGL  203 (307)
Q Consensus       129 ~-----~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  203 (307)
                      .     ...++||||++|+|.+++...  .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus        81 ~~~~~~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  158 (353)
T 2b9h_A           81 DSFENFNEVYIIQELMQTDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGL  158 (353)
T ss_dssp             SCSTTCCCEEEEECCCSEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             cccCccceEEEEEeccCccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccc
Confidence            4     779999999999999988764  489999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCc----------ccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCC----------
Q psy9858         204 AKFFGSPTR----------LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLF----------  256 (307)
Q Consensus       204 a~~~~~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~----------  256 (307)
                      +........          ......+|+.|+|||.+.+...++.++|||   +    +++|..||.+...          
T Consensus       159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  238 (353)
T 2b9h_A          159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI  238 (353)
T ss_dssp             CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Confidence            987643211          122346799999999987755899999999   3    3349999976321          


Q ss_pred             ----------------------------CCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         257 ----------------------------PGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       257 ----------------------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                                                  ........+..+++++.+||.+||+.||++|||++++|+||||+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (353)
T 2b9h_A          239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH  313 (353)
T ss_dssp             HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence                                        11122233457899999999999999999999999999999998754

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.5e-48  Score=353.89  Aligned_cols=248  Identities=21%  Similarity=0.247  Sum_probs=198.1

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN  131 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  131 (307)
                      ...++|++++.||+|+||.||+|.+..+|+.||||++......  .......+.+|+++++.++||||+++++++.+.+.
T Consensus       145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~  222 (446)
T 4ejn_A          145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV--AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR  222 (446)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC---------------CCCCCSCTTSCCEEEEEEETTE
T ss_pred             CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhh--hhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE
Confidence            3557899999999999999999999999999999999753211  11223557789999999999999999999999999


Q ss_pred             EEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCcEEEecCCcEEEEeecCccccCC
Q psy9858         132 VSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD-HWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS  209 (307)
Q Consensus       132 ~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  209 (307)
                      .++||||+ +|+|.+++.... .+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+|+....
T Consensus       223 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          223 LCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  301 (446)
T ss_dssp             EEEEECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred             EEEEEeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence            99999999 568888776543 58999999999999999999998 9999999999999999999999999999987544


Q ss_pred             CCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCCC------hhhhccccCHHHHHHH
Q psy9858         210 PTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGIP------LNEIFTAAGDDLLAVI  276 (307)
Q Consensus       210 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~------~~~~~~~~~~~l~~li  276 (307)
                      .........||+.|+|||++.+. .++.++|||   +    +++|..||.+.......      ....+..+++++.+||
T Consensus       302 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li  380 (446)
T 4ejn_A          302 DGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLL  380 (446)
T ss_dssp             -----CCSSSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred             CCcccccccCCccccCHhhcCCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence            44445567899999999999887 899999999   3    33499999773221100      0112346789999999


Q ss_pred             HHhhhcCCCCCC-----CHHHHhcCcccCCCc
Q psy9858         277 SSLLCLNPTKRA-----DCTATLKMDYFSLTK  303 (307)
Q Consensus       277 ~~~l~~dP~~Rp-----t~~~il~hp~f~~~~  303 (307)
                      .+||+.||.+||     |++|+++||||++..
T Consensus       381 ~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~  412 (446)
T 4ejn_A          381 SGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV  412 (446)
T ss_dssp             HHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             HHHcccCHHHhCCCCCCCHHHHHhCccccCCC
Confidence            999999999999     999999999998763

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.2e-47  Score=341.60  Aligned_cols=243  Identities=23%  Similarity=0.366  Sum_probs=198.4

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee---
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY---  128 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~---  128 (307)
                      ...++|++++.||+|+||.||+|++..+|+.||||++....         ....+|+++++.++||||+++++++..   
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   74 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP---------RYKNRELDIMKVLDHVNIIKLVDYFYTTGD   74 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT---------TSCCHHHHHHTTCCCTTBCCEEEEEEEC--
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc---------chHHHHHHHHHHcCCCCccchhheeeecCc
Confidence            45678999999999999999999999999999999987431         112379999999999999999999843   


Q ss_pred             -----------------------------------cCeEEEEEEccCCChHHHHh---CCCCCCCHHHHHHHHHHHHHHH
Q psy9858         129 -----------------------------------MSNVSLVFEFVDTDLEVIIK---DPTIVFTPSNIKAYAIMTLRGL  170 (307)
Q Consensus       129 -----------------------------------~~~~~lv~e~~~g~l~~~~~---~~~~~~~~~~~~~i~~~i~~~l  170 (307)
                                                         ....++||||++|+|.+.+.   .....+++..++.++.||+.||
T Consensus        75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL  154 (383)
T 3eb0_A           75 EEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV  154 (383)
T ss_dssp             -----------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence                                               34589999999988777665   3445699999999999999999


Q ss_pred             HHHHHCCceeecCCCCcEEEe-cCCcEEEEeecCccccCCCCcccccceeeceehhhhhhhccccccccccee---e---
Q psy9858         171 EYLHDHWILHRDLKPNNLLIN-KQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C---  243 (307)
Q Consensus       171 ~~lH~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~---  243 (307)
                      .|||++||+||||||+||+++ .++.+||+|||+++..... .......+|+.|+|||.+.+...++.++|||   |   
T Consensus       155 ~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~  233 (383)
T 3eb0_A          155 GFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG  233 (383)
T ss_dssp             HHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred             HHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence            999999999999999999998 6889999999999877433 2334557899999999998875799999999   3   


Q ss_pred             -eeecCCCCCCCCCC----------------------------------CCC-hhhhccccCHHHHHHHHHhhhcCCCCC
Q psy9858         244 -CFAKDPSSHGNLFP----------------------------------GIP-LNEIFTAAGDDLLAVISSLLCLNPTKR  287 (307)
Q Consensus       244 -i~~~~~~f~~~~~~----------------------------------~~~-~~~~~~~~~~~l~~li~~~l~~dP~~R  287 (307)
                       +++|..||.+....                                  ... ....+..+++++.+||.+||+.||++|
T Consensus       234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  313 (383)
T 3eb0_A          234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR  313 (383)
T ss_dssp             HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence             33499999872210                                  001 111234578999999999999999999


Q ss_pred             CCHHHHhcCcccCCCcc
Q psy9858         288 ADCTATLKMDYFSLTKE  304 (307)
Q Consensus       288 pt~~~il~hp~f~~~~~  304 (307)
                      ||++|+|+||||+..+.
T Consensus       314 ~t~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          314 INPYEAMAHPFFDHLRN  330 (383)
T ss_dssp             CCHHHHHTSGGGHHHHH
T ss_pred             CCHHHHhcCHHHHHHHh
Confidence            99999999999976543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1e-47  Score=337.42  Aligned_cols=245  Identities=22%  Similarity=0.330  Sum_probs=205.8

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..+.|++++.||+|+||+||+|++..+|+.||||++......  .....+.+.+|+++++.++||||+++++++..+...
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  129 (348)
T 1u5q_A           52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ--SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA  129 (348)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeE
Confidence            456799999999999999999999999999999999754322  222346788999999999999999999999999999


Q ss_pred             EEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc
Q psy9858         133 SLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR  212 (307)
Q Consensus       133 ~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  212 (307)
                      ++||||+.|++.+.+......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......  
T Consensus       130 ~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--  207 (348)
T 1u5q_A          130 WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  207 (348)
T ss_dssp             EEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred             EEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence            999999999999988765567999999999999999999999999999999999999999999999999999876432  


Q ss_pred             ccccceeeceehhhhhhhc--cccccccccee---e----eeecCCCCCCCCCCC--------CChhhhccccCHHHHHH
Q psy9858         213 LYTHQVVTRWYRLIKCLLY--CVQFNVKNVQW---C----CFAKDPSSHGNLFPG--------IPLNEIFTAAGDDLLAV  275 (307)
Q Consensus       213 ~~~~~~~t~~y~aPE~~~~--~~~~~~~~Diw---~----i~~~~~~f~~~~~~~--------~~~~~~~~~~~~~l~~l  275 (307)
                        ....+|+.|+|||.+.+  ...++.++|||   +    +++|..||.+.....        .........+++.+.+|
T Consensus       208 --~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  285 (348)
T 1u5q_A          208 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF  285 (348)
T ss_dssp             --CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHH
T ss_pred             --CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence              34578999999999863  33789999999   3    334999987632110        00011123578999999


Q ss_pred             HHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         276 ISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       276 i~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      |.+||+.||++|||++++++||||.+..
T Consensus       286 i~~~l~~dP~~Rps~~~ll~h~~~~~~~  313 (348)
T 1u5q_A          286 VDSCLQKIPQDRPTSEVLLKHRFVLRER  313 (348)
T ss_dssp             HHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             HHHHcccChhhCcCHHHHhhChhhhccC
Confidence            9999999999999999999999997654

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=9.3e-48  Score=335.12  Aligned_cols=248  Identities=21%  Similarity=0.255  Sum_probs=195.5

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEc---CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDI---ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY  128 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  128 (307)
                      ...++|++++.||+|+||.||+|++.   .+|+.||+|++.+..... .......+.+|+++++.++||||+++++++..
T Consensus        14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   92 (327)
T 3a62_A           14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR-NAKDTAHTKAERNILEEVKHPFIVDLIYAFQT   92 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC---------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhh-hhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence            35678999999999999999999975   689999999998643221 11123457789999999999999999999999


Q ss_pred             cCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         129 MSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       129 ~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      .+..|+||||+ +|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           93 GGKLYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             SSCEEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            99999999999 578888887543 5899999999999999999999999999999999999999999999999999865


Q ss_pred             CCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCCC------hhhhccccCHHHHH
Q psy9858         208 GSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGIP------LNEIFTAAGDDLLA  274 (307)
Q Consensus       208 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~------~~~~~~~~~~~l~~  274 (307)
                      ...........||+.|+|||.+.+. .++.++|||   +    +++|..||.+.......      ....+..+++++.+
T Consensus       172 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  250 (327)
T 3a62_A          172 IHDGTVTHTFCGTIEYMAPEILMRS-GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARD  250 (327)
T ss_dssp             -------CTTSSCCTTSCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHHH
T ss_pred             ccCCccccccCCCcCccCHhhCcCC-CCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            4443444556899999999999887 789999999   3    33499999873221100      01223467899999


Q ss_pred             HHHHhhhcCCCCCC-----CHHHHhcCcccCCC
Q psy9858         275 VISSLLCLNPTKRA-----DCTATLKMDYFSLT  302 (307)
Q Consensus       275 li~~~l~~dP~~Rp-----t~~~il~hp~f~~~  302 (307)
                      ||.+||+.||++||     +++++++||||++.
T Consensus       251 li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~  283 (327)
T 3a62_A          251 LLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI  283 (327)
T ss_dssp             HHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred             HHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence            99999999999999     89999999999875

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=7.5e-48  Score=350.27  Aligned_cols=246  Identities=21%  Similarity=0.279  Sum_probs=207.6

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|.+++.||+|+||.||+|++..+|+.||||++......  .......+.+|+++++.++||||+++++++...+..
T Consensus        14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~   91 (476)
T 2y94_A           14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR--SLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI   91 (476)
T ss_dssp             EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHH--HTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            467899999999999999999999999999999999753211  112245688999999999999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT  211 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  211 (307)
                      ++||||+ +|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... 
T Consensus        92 ~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~-  169 (476)
T 2y94_A           92 FMVMEYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-  169 (476)
T ss_dssp             EEEEECCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT-
T ss_pred             EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc-
Confidence            9999999 67898888754 35899999999999999999999999999999999999999999999999999987543 


Q ss_pred             cccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCCC------hhhhccccCHHHHHHHHH
Q psy9858         212 RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGIP------LNEIFTAAGDDLLAVISS  278 (307)
Q Consensus       212 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~------~~~~~~~~~~~l~~li~~  278 (307)
                      ......+||+.|+|||.+.+....+.++|||   +    +++|..||.+.......      ....+..+++++.+||.+
T Consensus       170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~  249 (476)
T 2y94_A          170 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKH  249 (476)
T ss_dssp             CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHHHH
T ss_pred             ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHHHH
Confidence            3344568999999999999875568999999   3    33499999874322110      011234578999999999


Q ss_pred             hhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         279 LLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       279 ~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                      ||+.||.+|||++++++||||++.
T Consensus       250 ~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          250 MLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             HTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             HcCCCchhCcCHHHHHhCHHhhhc
Confidence            999999999999999999999764

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.7e-47  Score=351.65  Aligned_cols=248  Identities=23%  Similarity=0.283  Sum_probs=209.2

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN  131 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  131 (307)
                      ...++|++.+.||+|+||.||+|++..+|+.||+|++.+....  .......+.+|+++++.++||||+++++++.+...
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~--~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  258 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA  258 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhh--hhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCE
Confidence            4567899999999999999999999999999999999753211  11224567899999999999999999999999999


Q ss_pred             EEEEEEcc-CCChHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCC
Q psy9858         132 VSLVFEFV-DTDLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS  209 (307)
Q Consensus       132 ~~lv~e~~-~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  209 (307)
                      .|+||||+ +|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus       259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            99999999 688988887643 3489999999999999999999999999999999999999999999999999988754


Q ss_pred             CCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCCC----------hhhhccccCHHH
Q psy9858         210 PTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGIP----------LNEIFTAAGDDL  272 (307)
Q Consensus       210 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~----------~~~~~~~~~~~l  272 (307)
                      .. .....+||+.|+|||++.+. .++.++|||   +    +++|..||.+.......          ....+..+++++
T Consensus       339 ~~-~~~~~~GT~~Y~APEvl~~~-~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~  416 (576)
T 2acx_A          339 GQ-TIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQA  416 (576)
T ss_dssp             TC-CEECCCSCGGGCCHHHHTTC-EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred             Cc-cccccCCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHH
Confidence            32 33445899999999999887 899999999   3    33499999875332211          012234678999


Q ss_pred             HHHHHHhhhcCCCCCC-----CHHHHhcCcccCCCc
Q psy9858         273 LAVISSLLCLNPTKRA-----DCTATLKMDYFSLTK  303 (307)
Q Consensus       273 ~~li~~~l~~dP~~Rp-----t~~~il~hp~f~~~~  303 (307)
                      .+||.+||+.||.+||     |++|+++||||++.+
T Consensus       417 ~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~  452 (576)
T 2acx_A          417 RSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN  452 (576)
T ss_dssp             HHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCC
T ss_pred             HHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCC
Confidence            9999999999999999     899999999999753

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=6.4e-47  Score=335.40  Aligned_cols=242  Identities=32%  Similarity=0.500  Sum_probs=201.1

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|.+.+.||+|+||.||+|.+..+|+.||||++....   ......+.+.+|+.+++.++||||+++++++......
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  116 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF---QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSL  116 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT---SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSS
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc---cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCc
Confidence            3468999999999999999999999999999999997532   2233356788999999999999999999999877654


Q ss_pred             ------EEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         133 ------SLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       133 ------~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                            ++||||++|+|.+.+...   +++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.
T Consensus       117 ~~~~~~~lv~e~~~~~l~~~~~~~---~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  193 (371)
T 4exu_A          117 RNFYDFYLVMPFMQTDLQKIMGME---FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH  193 (371)
T ss_dssp             TTCCCCEEEEECCCEEHHHHTTSC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred             ccceeEEEEEccccccHHHHhhcC---CCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence                  999999999988887543   89999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCC------------------------
Q psy9858         207 FGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNL------------------------  255 (307)
Q Consensus       207 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~------------------------  255 (307)
                      ....   .....+|+.|+|||.+.+...++.++|||   +    +++|..||.+..                        
T Consensus       194 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  270 (371)
T 4exu_A          194 ADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN  270 (371)
T ss_dssp             ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred             cccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhh
Confidence            6432   33457899999999998855899999999   3    334999998732                        


Q ss_pred             -------------CCCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         256 -------------FPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       256 -------------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                                   .........+..+++++.+||.+||+.||++|||++|+|+||||+...
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  331 (371)
T 4exu_A          271 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  331 (371)
T ss_dssp             CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence                         111122233456789999999999999999999999999999998654

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=7.7e-48  Score=340.72  Aligned_cols=248  Identities=21%  Similarity=0.255  Sum_probs=199.3

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHH-HHhcCCCCccccceeeeecC
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKL-LQELHHENVLGLTDVFGYMS  130 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~ni~~~~~~~~~~~  130 (307)
                      ...++|++++.||+|+||.||+|++..+++.||||++.+......  .....+.+|..+ ++.++||||+++++++.+.+
T Consensus        35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~--~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~  112 (373)
T 2r5t_A           35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKK--KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD  112 (373)
T ss_dssp             CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC---------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhh--HHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence            456789999999999999999999999999999999986432221  123445677776 56789999999999999999


Q ss_pred             eEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCC
Q psy9858         131 NVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS  209 (307)
Q Consensus       131 ~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  209 (307)
                      ..|+||||+ +|+|.+++.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus       113 ~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          113 KLYFVLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred             EEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence            999999999 578888887543 589999999999999999999999999999999999999999999999999987544


Q ss_pred             CCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCCC------hhhhccccCHHHHHHH
Q psy9858         210 PTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGIP------LNEIFTAAGDDLLAVI  276 (307)
Q Consensus       210 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~------~~~~~~~~~~~l~~li  276 (307)
                      ........+||+.|+|||++.+. .++.++|+|   +    +++|..||.+.......      ....+..++.++.+||
T Consensus       192 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li  270 (373)
T 2r5t_A          192 HNSTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLL  270 (373)
T ss_dssp             CCCCCCSBSCCCCCCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHH
T ss_pred             CCCccccccCCccccCHHHhCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Confidence            44445566899999999999887 899999999   3    33499999773211100      0112346889999999


Q ss_pred             HHhhhcCCCCCCCH----HHHhcCcccCCCc
Q psy9858         277 SSLLCLNPTKRADC----TATLKMDYFSLTK  303 (307)
Q Consensus       277 ~~~l~~dP~~Rpt~----~~il~hp~f~~~~  303 (307)
                      .+||+.||.+||++    +++++||||++.+
T Consensus       271 ~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~  301 (373)
T 2r5t_A          271 EGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN  301 (373)
T ss_dssp             HHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred             HHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence            99999999999996    6999999998753

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4.3e-47  Score=335.37  Aligned_cols=252  Identities=30%  Similarity=0.478  Sum_probs=200.7

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCcccc------chhhhHhHHHHHHHHHhcCCCCccccc
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADA------KDGINRTALREIKLLQELHHENVLGLT  123 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~ni~~~~  123 (307)
                      +....++|++++.||+|+||.||+|.+. +|+.||||++........      .....+.+.+|+++++.++||||++++
T Consensus        17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   95 (362)
T 3pg1_A           17 LHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLR   95 (362)
T ss_dssp             HHHTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred             HHHhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcccee
Confidence            3456678999999999999999999975 499999999865332211      122236788999999999999999999


Q ss_pred             eeeee-----cCeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEE
Q psy9858         124 DVFGY-----MSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKI  198 (307)
Q Consensus       124 ~~~~~-----~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl  198 (307)
                      +++..     ....++||||++|+|.+.+......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||
T Consensus        96 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl  175 (362)
T 3pg1_A           96 DIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI  175 (362)
T ss_dssp             EEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred             eeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEE
Confidence            99843     3478999999999999999987777999999999999999999999999999999999999999999999


Q ss_pred             EeecCccccCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCC----------------
Q psy9858         199 GDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNL----------------  255 (307)
Q Consensus       199 ~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~----------------  255 (307)
                      +|||++...... .......+|+.|+|||.+.+...++.++|||   +    +++|..||.+..                
T Consensus       176 ~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  254 (362)
T 3pg1_A          176 CDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK  254 (362)
T ss_dssp             CCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             EecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            999999865332 2334457899999999998855899999999   3    334999997732                


Q ss_pred             ----------------------CCCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         256 ----------------------FPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       256 ----------------------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                                            ............+++.+.+||.+||+.||++|||++|+|+||||+...
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  324 (362)
T 3pg1_A          255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF  324 (362)
T ss_dssp             HHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             hHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence                                  111222333456789999999999999999999999999999998763

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.3e-48  Score=345.44  Aligned_cols=248  Identities=11%  Similarity=0.083  Sum_probs=195.5

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHH---HHHHhcCCCCccccc----
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREI---KLLQELHHENVLGLT----  123 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~---~~l~~l~h~ni~~~~----  123 (307)
                      ....++|++.+.||+|+||+||+|++..+|+.||||++.......  ....+.+.+|+   ++++.++||||++++    
T Consensus        69 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~  146 (377)
T 3byv_A           69 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP--SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI  146 (377)
T ss_dssp             SCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CC--TTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBC
T ss_pred             CCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccc--hHHHHHHHHHHHHHHhccccCCHHHHHHHhhhh
Confidence            345689999999999999999999998999999999998543222  22356788999   455556899999998    


Q ss_pred             ---eeeeecC-----------------eEEEEEEccCCChHHHHhCCCC------CCCHHHHHHHHHHHHHHHHHHHHCC
Q psy9858         124 ---DVFGYMS-----------------NVSLVFEFVDTDLEVIIKDPTI------VFTPSNIKAYAIMTLRGLEYLHDHW  177 (307)
Q Consensus       124 ---~~~~~~~-----------------~~~lv~e~~~g~l~~~~~~~~~------~~~~~~~~~i~~~i~~~l~~lH~~~  177 (307)
                         +++...+                 ..|++|||++|+|.+++.....      .+++..+..++.||+.||.|||++|
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  226 (377)
T 3byv_A          147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG  226 (377)
T ss_dssp             CCSEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hhhhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence               5555443                 3899999999999999875421      1234788889999999999999999


Q ss_pred             ceeecCCCCcEEEecCCcEEEEeecCccccCCCCcccccceeeceehhhhhhhcc----------ccccccccee---e-
Q psy9858         178 ILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYC----------VQFNVKNVQW---C-  243 (307)
Q Consensus       178 ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~----------~~~~~~~Diw---~-  243 (307)
                      |+||||||+|||++.++.+||+|||+++....   ......| +.|+|||++.+.          ..++.++|||   + 
T Consensus       227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             eecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            99999999999999999999999999986532   3344567 999999999876          4789999999   3 


Q ss_pred             ---eeecCCCCCCCCCCCCChh--hhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         244 ---CFAKDPSSHGNLFPGIPLN--EIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       244 ---i~~~~~~f~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                         +++|..||.+.........  .....+++++.+||.+||+.||++|||+.|+++||||++.++
T Consensus       303 l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~  368 (377)
T 3byv_A          303 IYWIWCADLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT  368 (377)
T ss_dssp             HHHHHHSSCCC------CCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHH
T ss_pred             HHHHHHCCCCCcccccccchhhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHH
Confidence               3349999987544333222  223578999999999999999999999999999999987654

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=8.9e-48  Score=340.82  Aligned_cols=240  Identities=25%  Similarity=0.301  Sum_probs=197.3

Q ss_pred             eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEE
Q psy9858          57 YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVF  136 (307)
Q Consensus        57 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  136 (307)
                      +...+.||+|+||.||+|.+..+|+.||+|++.....     .....+.+|+++++.++||||+++++++.+.+..++||
T Consensus        91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  165 (373)
T 2x4f_A           91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-----KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVM  165 (373)
T ss_dssp             EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH-----HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            3446789999999999999999999999999985321     22456889999999999999999999999999999999


Q ss_pred             Ecc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEE--ecCCcEEEEeecCccccCCCCcc
Q psy9858         137 EFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLI--NKQGVLKIGDFGLAKFFGSPTRL  213 (307)
Q Consensus       137 e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~--~~~~~~kl~Dfg~a~~~~~~~~~  213 (307)
                      ||+ +|+|.+.+......+++..+..++.||+.||.|||++||+||||||+|||+  +.++.+||+|||+++...... .
T Consensus       166 E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-~  244 (373)
T 2x4f_A          166 EYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-K  244 (373)
T ss_dssp             ECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-B
T ss_pred             eCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-c
Confidence            999 578988887766678999999999999999999999999999999999999  456789999999999875432 3


Q ss_pred             cccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC----------CChhhhccccCHHHHHHH
Q psy9858         214 YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG----------IPLNEIFTAAGDDLLAVI  276 (307)
Q Consensus       214 ~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~----------~~~~~~~~~~~~~l~~li  276 (307)
                      .....+|+.|+|||++.+. .++.++|||   +    +++|..||.+.....          ......+..+++++.+||
T Consensus       245 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  323 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNYD-FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFI  323 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTTC-BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHH
T ss_pred             cccccCCCcEeChhhccCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHH
Confidence            3445799999999999877 899999999   3    334999997732110          111223456899999999


Q ss_pred             HHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         277 SSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       277 ~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      .+||+.||.+|||++|+|+||||++.+
T Consensus       324 ~~~L~~dp~~Rps~~e~l~hp~~~~~~  350 (373)
T 2x4f_A          324 SKLLIKEKSWRISASEALKHPWLSDHK  350 (373)
T ss_dssp             HTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred             HHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence            999999999999999999999998653

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=4.1e-47  Score=349.41  Aligned_cols=249  Identities=21%  Similarity=0.223  Sum_probs=209.9

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN  131 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  131 (307)
                      ...++|.+++.||+|+||.||+|++..+|+.||+|++.+.....  ......+.+|+++++.++||||+++++++.+...
T Consensus       182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~--~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  259 (543)
T 3c4z_A          182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKK--RKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD  259 (543)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhh--hHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE
Confidence            45688999999999999999999999999999999997532111  1224568899999999999999999999999999


Q ss_pred             EEEEEEcc-CCChHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         132 VSLVFEFV-DTDLEVIIKDP---TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       132 ~~lv~e~~-~g~l~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      .|+||||+ +|+|.+++...   ...+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||+++..
T Consensus       260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~  339 (543)
T 3c4z_A          260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL  339 (543)
T ss_dssp             EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence            99999999 57898888653   335899999999999999999999999999999999999999999999999999987


Q ss_pred             CCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCCC----------hhhhccccCH
Q psy9858         208 GSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGIP----------LNEIFTAAGD  270 (307)
Q Consensus       208 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~----------~~~~~~~~~~  270 (307)
                      ..........+||+.|+|||++.+. .++.++|+|   +    +++|..||.+.......          ....+..+++
T Consensus       340 ~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~  418 (543)
T 3c4z_A          340 KAGQTKTKGYAGTPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSP  418 (543)
T ss_dssp             CTTCCCBCCCCSCTTTSCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred             cCCCcccccccCCccccChhhhcCC-CCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCH
Confidence            5544444456899999999999987 899999999   3    33499999875322111          0122346799


Q ss_pred             HHHHHHHHhhhcCCCCCCC-----HHHHhcCcccCCCc
Q psy9858         271 DLLAVISSLLCLNPTKRAD-----CTATLKMDYFSLTK  303 (307)
Q Consensus       271 ~l~~li~~~l~~dP~~Rpt-----~~~il~hp~f~~~~  303 (307)
                      ++.+||.+||+.||++||+     ++++++||||++.+
T Consensus       419 ~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~  456 (543)
T 3c4z_A          419 ASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS  456 (543)
T ss_dssp             HHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCC
T ss_pred             HHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCC
Confidence            9999999999999999996     58999999999753

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=5.3e-47  Score=322.65  Aligned_cols=243  Identities=23%  Similarity=0.268  Sum_probs=203.9

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS  130 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  130 (307)
                      +...++|++.+.||+|+||.||+|.+..++..||+|++......     ....+.+|+++++.++||||+++++++.+..
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   79 (277)
T 3f3z_A            5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE-----DVDRFKQEIEIMKSLDHPNIIRLYETFEDNT   79 (277)
T ss_dssp             -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS-----CHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc-----hHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            34567899999999999999999999999999999999753221     2456889999999999999999999999999


Q ss_pred             eEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEE---ecCCcEEEEeecCccc
Q psy9858         131 NVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLI---NKQGVLKIGDFGLAKF  206 (307)
Q Consensus       131 ~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~a~~  206 (307)
                      ..++||||+ +++|.+.+.... .+++..+..++.|++.||.|||++|++|+||||+||++   +.++.++|+|||++..
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~  158 (277)
T 3f3z_A           80 DIYLVMELCTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR  158 (277)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             eEEEEEeccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence            999999999 568888776543 48999999999999999999999999999999999999   7888999999999987


Q ss_pred             cCCCCcccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCC----------CCChhhhccccC
Q psy9858         207 FGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFP----------GIPLNEIFTAAG  269 (307)
Q Consensus       207 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~----------~~~~~~~~~~~~  269 (307)
                      .... .......+|+.|+|||.+.+  .++.++|||       .+++|..||......          ..........++
T Consensus       159 ~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (277)
T 3f3z_A          159 FKPG-KMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVS  235 (277)
T ss_dssp             CCTT-SCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSC
T ss_pred             ccCc-cchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCC
Confidence            7533 33445578999999999865  489999999       334499999773211          111122223679


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         270 DDLLAVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       270 ~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                      +++.+||.+||+.||++|||+.++|+||||++.
T Consensus       236 ~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  268 (277)
T 3f3z_A          236 PQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ  268 (277)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence            999999999999999999999999999999754

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=8.6e-47  Score=333.22  Aligned_cols=241  Identities=25%  Similarity=0.349  Sum_probs=200.0

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-----CCCccccce
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-----HENVLGLTD  124 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~ni~~~~~  124 (307)
                      .....++|++++.||+|+||+||+|++..+++.||||++...      ......+..|+.+++.++     ||||+++++
T Consensus        30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~  103 (360)
T 3llt_A           30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI------KKYTRSAKIEADILKKIQNDDINNNNIVKYHG  103 (360)
T ss_dssp             TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred             ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc------hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence            334567899999999999999999999999999999998631      222455778999999996     999999999


Q ss_pred             eeeecCeEEEEEEccCCChHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEec-----------
Q psy9858         125 VFGYMSNVSLVFEFVDTDLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK-----------  192 (307)
Q Consensus       125 ~~~~~~~~~lv~e~~~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~-----------  192 (307)
                      ++...+..++||||++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.           
T Consensus       104 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~  183 (360)
T 3llt_A          104 KFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVR  183 (360)
T ss_dssp             EEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEE
T ss_pred             eeeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchh
Confidence            999999999999999999999987653 34899999999999999999999999999999999999975           


Q ss_pred             --------------CCcEEEEeecCccccCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCC
Q psy9858         193 --------------QGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSS  251 (307)
Q Consensus       193 --------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f  251 (307)
                                    ++.+||+|||++......   .....+|+.|+|||++.+. .++.++|||   +    +++|..||
T Consensus       184 ~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf  259 (360)
T 3llt_A          184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLF  259 (360)
T ss_dssp             CTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred             cccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCC-CCCCccchHHHHHHHHHHHHCCCCC
Confidence                          789999999999875432   2345789999999999987 899999999   3    33499999


Q ss_pred             CCCCCC-----------CCCh-----------------------------------------hhhccccCHHHHHHHHHh
Q psy9858         252 HGNLFP-----------GIPL-----------------------------------------NEIFTAAGDDLLAVISSL  279 (307)
Q Consensus       252 ~~~~~~-----------~~~~-----------------------------------------~~~~~~~~~~l~~li~~~  279 (307)
                      .+....           ....                                         .......++.+.+||.+|
T Consensus       260 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  339 (360)
T 3llt_A          260 RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSI  339 (360)
T ss_dssp             CCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHH
T ss_pred             CCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHH
Confidence            762210           0000                                         000012247788999999


Q ss_pred             hhcCCCCCCCHHHHhcCcccC
Q psy9858         280 LCLNPTKRADCTATLKMDYFS  300 (307)
Q Consensus       280 l~~dP~~Rpt~~~il~hp~f~  300 (307)
                      |+.||++|||++|+|+||||+
T Consensus       340 L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          340 LQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             CCSSGGGSCCHHHHTTSGGGC
T ss_pred             hcCChhhCCCHHHHhcCcccC
Confidence            999999999999999999996

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=6.1e-47  Score=335.54  Aligned_cols=242  Identities=27%  Similarity=0.428  Sum_probs=191.7

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC--
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS--  130 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--  130 (307)
                      ..++|++++.||+|+||.||+|.+..+|+.||||++.....   .......+.+|+.+++.++||||+++++++....  
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   99 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ---NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL   99 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS---SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCST
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC---ChHHHHHHHHHHHHHHhcCCCCccceEEeecccccc
Confidence            45789999999999999999999999999999999985321   2233566889999999999999999999987654  


Q ss_pred             ----eEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         131 ----NVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       131 ----~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                          ..++||||++|+|.+.+..   .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.
T Consensus       100 ~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  176 (371)
T 2xrw_A          100 EEFQDVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  176 (371)
T ss_dssp             TTCCEEEEEEECCSEEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred             ccccceEEEEEcCCCCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence                7899999999999988864   379999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCC----------------------
Q psy9858         207 FGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFP----------------------  257 (307)
Q Consensus       207 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~----------------------  257 (307)
                      .... .......+|+.|+|||++.+. .++.++|||   +    +++|..||.+....                      
T Consensus       177 ~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  254 (371)
T 2xrw_A          177 AGTS-FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  254 (371)
T ss_dssp             --------------CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred             cccc-cccCCceecCCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence            6432 233456889999999999987 899999999   3    33399999763210                      


Q ss_pred             --------------CCChhhhc------------cccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         258 --------------GIPLNEIF------------TAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       258 --------------~~~~~~~~------------~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                                    ........            ...++++.+||.+||+.||++|||++|+|+||||+..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  325 (371)
T 2xrw_A          255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  325 (371)
T ss_dssp             HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence                          00000000            1125689999999999999999999999999999753

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=4.2e-47  Score=348.62  Aligned_cols=245  Identities=25%  Similarity=0.353  Sum_probs=200.4

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS  130 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  130 (307)
                      +...++|++++.||+|+||+||+|++..++..||+|++........   ....+.+|+++++.++||||+++++++.+..
T Consensus        33 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  109 (494)
T 3lij_A           33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS---SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKR  109 (494)
T ss_dssp             CCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C---TTHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             CchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch---HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence            3456689999999999999999999999999999999986432222   2466889999999999999999999999999


Q ss_pred             eEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecC---CcEEEEeecCccc
Q psy9858         131 NVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ---GVLKIGDFGLAKF  206 (307)
Q Consensus       131 ~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~a~~  206 (307)
                      ..++||||+ +|+|.+.+.... .+++..+..++.||+.||.|||++||+||||||+||+++..   +.+||+|||++..
T Consensus       110 ~~~lv~e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          110 NYYLVMECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            999999999 678888876543 48999999999999999999999999999999999999764   4599999999988


Q ss_pred             cCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCC----------CCChhhhccccC
Q psy9858         207 FGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFP----------GIPLNEIFTAAG  269 (307)
Q Consensus       207 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~----------~~~~~~~~~~~~  269 (307)
                      .... .......||+.|+|||++.+  .++.++|||   +    +++|.+||.+....          .......+..++
T Consensus       189 ~~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  265 (494)
T 3lij_A          189 FENQ-KKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVS  265 (494)
T ss_dssp             CBTT-BCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSC
T ss_pred             CCCC-ccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCC
Confidence            7543 33445689999999999864  689999999   3    33399999873211          111122345689


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         270 DDLLAVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       270 ~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                      +++.+||.+||+.||.+|||++|+|+||||++.
T Consensus       266 ~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          266 EGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             HHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence            999999999999999999999999999999753

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.5e-47  Score=349.49  Aligned_cols=247  Identities=26%  Similarity=0.326  Sum_probs=204.6

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM  129 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  129 (307)
                      .+...++|++++.||+|+||+||+|.+..+|+.||||++.....   .......+.+|++++++++||||+++++++.+.
T Consensus        17 ~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   93 (486)
T 3mwu_A           17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA---KNKDTSTILREVELLKKLDHPNIMKLFEILEDS   93 (486)
T ss_dssp             CCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHH---BCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             cCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC
Confidence            34567899999999999999999999999999999999975321   112246688999999999999999999999999


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEe---cCCcEEEEeecCcc
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLIN---KQGVLKIGDFGLAK  205 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~a~  205 (307)
                      ...++||||+ +|+|.+.+.... .+++..+..++.||+.||.|||++||+||||||+||+++   .++.+||+|||++.
T Consensus        94 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  172 (486)
T 3mwu_A           94 SSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (486)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence            9999999999 678888886543 589999999999999999999999999999999999995   45679999999998


Q ss_pred             ccCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCC----------CCChhhhcccc
Q psy9858         206 FFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFP----------GIPLNEIFTAA  268 (307)
Q Consensus       206 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~----------~~~~~~~~~~~  268 (307)
                      ..... .......||+.|+|||++.+  .++.++|||   +    +++|.+||.+....          .......+..+
T Consensus       173 ~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  249 (486)
T 3mwu_A          173 CFQQN-TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTI  249 (486)
T ss_dssp             TBCCC-----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGS
T ss_pred             ECCCC-CccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCC
Confidence            77443 23345579999999999876  489999999   3    33399999773211          01112234568


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         269 GDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       269 ~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      ++++.+||.+||+.||.+|||+.|+|+||||++..
T Consensus       250 s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          250 SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence            99999999999999999999999999999997643

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=5e-47  Score=341.07  Aligned_cols=248  Identities=23%  Similarity=0.333  Sum_probs=194.1

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccc---cchhhhHhHHHHHHHHHhcCCCCccccceeeeec
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHAD---AKDGINRTALREIKLLQELHHENVLGLTDVFGYM  129 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  129 (307)
                      ..++|.+.+.||+|+||+||+|.+..+++.||||++.+.....   ........+.+|++++++++||||+++++++. .
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence            3578999999999999999999999999999999998642211   11112335789999999999999999999875 4


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCC---cEEEEeecCcc
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG---VLKIGDFGLAK  205 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~a~  205 (307)
                      ...++||||+ +|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~  290 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK  290 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred             CceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence            5689999999 678888776554 589999999999999999999999999999999999997654   59999999998


Q ss_pred             ccCCCCcccccceeeceehhhhhhhc--cccccccccee---e----eeecCCCCCCCCCCCC-----------Chhhhc
Q psy9858         206 FFGSPTRLYTHQVVTRWYRLIKCLLY--CVQFNVKNVQW---C----CFAKDPSSHGNLFPGI-----------PLNEIF  265 (307)
Q Consensus       206 ~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~-----------~~~~~~  265 (307)
                      ..... .......||+.|+|||++.+  ...++.++|||   +    +++|..||........           .....+
T Consensus       291 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~  369 (419)
T 3i6u_A          291 ILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW  369 (419)
T ss_dssp             SCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHH
T ss_pred             ecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhh
Confidence            87533 33345689999999999864  33788999999   3    3349999976432221           112334


Q ss_pred             cccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         266 TAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       266 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      ..+++++.+||.+||+.||++|||++|+|+||||++.+
T Consensus       370 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~  407 (419)
T 3i6u_A          370 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED  407 (419)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHH
T ss_pred             cccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChh
Confidence            56899999999999999999999999999999998653

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=9.1e-47  Score=347.20  Aligned_cols=249  Identities=25%  Similarity=0.347  Sum_probs=203.9

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCcccc--------chhhhHhHHHHHHHHHhcCCCCcccc
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADA--------KDGINRTALREIKLLQELHHENVLGL  122 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--------~~~~~~~~~~e~~~l~~l~h~ni~~~  122 (307)
                      +...++|++++.||+|+||+||+|++..+++.||+|++........        .......+.+|+++++.++||||+++
T Consensus        32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  111 (504)
T 3q5i_A           32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL  111 (504)
T ss_dssp             SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence            3456789999999999999999999999999999999986432211        01235678899999999999999999


Q ss_pred             ceeeeecCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCC---cEEE
Q psy9858         123 TDVFGYMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG---VLKI  198 (307)
Q Consensus       123 ~~~~~~~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~---~~kl  198 (307)
                      ++++.+....++||||+ +|+|.+.+.... .+++..+..++.||+.||.|||++||+||||||+||+++.++   .+||
T Consensus       112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl  190 (504)
T 3q5i_A          112 FDVFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI  190 (504)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred             EEEEEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence            99999999999999999 578888886543 589999999999999999999999999999999999998876   6999


Q ss_pred             EeecCccccCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC----------CCh
Q psy9858         199 GDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG----------IPL  261 (307)
Q Consensus       199 ~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~----------~~~  261 (307)
                      +|||++...... .......||+.|+|||++.+  .++.++|||   +    +++|.+||.+.....          ...
T Consensus       191 ~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  267 (504)
T 3q5i_A          191 VDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD  267 (504)
T ss_dssp             CCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             EECCCCEEcCCC-CccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            999999887543 23445689999999999874  589999999   3    333999998732211          111


Q ss_pred             hhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         262 NEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       262 ~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      ...+..+++++.+||.+||+.||.+|||++|+|+||||++..
T Consensus       268 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  309 (504)
T 3q5i_A          268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA  309 (504)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred             ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence            223457899999999999999999999999999999997643

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=5.4e-47  Score=323.91  Aligned_cols=245  Identities=20%  Similarity=0.268  Sum_probs=198.0

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeeecCe
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGYMSN  131 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~  131 (307)
                      ..++|++++.||+|+||+||+|.+..+++.||+|++.......   .....+.+|+..+..+ +||||+++++++.+.+.
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~   85 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS---VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDH   85 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS---HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc---HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe
Confidence            4578999999999999999999999999999999998643222   2256688999999999 89999999999999999


Q ss_pred             EEEEEEcc-CCChHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecC--------------
Q psy9858         132 VSLVFEFV-DTDLEVIIKDP---TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ--------------  193 (307)
Q Consensus       132 ~~lv~e~~-~g~l~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~--------------  193 (307)
                      .++||||+ +|+|.+++...   ...+++..++.++.||+.||.|||++||+||||||+||+++.+              
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------------
T ss_pred             EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            99999999 56999988753   2458999999999999999999999999999999999999844              


Q ss_pred             -----CcEEEEeecCccccCCCCcccccceeeceehhhhhhhccccccccccee---eeee----cCCCCCCCC----CC
Q psy9858         194 -----GVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KDPSSHGNL----FP  257 (307)
Q Consensus       194 -----~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~~~~f~~~~----~~  257 (307)
                           ..++|+|||++.......    ...+|+.|+|||.+.+...++.++|||   ++++    |.+++....    ..
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~  241 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIR  241 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHHHH
T ss_pred             ccCCceEEEEcccccccccCCcc----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHHHH
Confidence                 479999999998875432    336899999999998876778999999   3332    555544311    01


Q ss_pred             CCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         258 GIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       258 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                      .......+..+++++.++|.+||+.||++|||++++++||||++...
T Consensus       242 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  288 (289)
T 1x8b_A          242 QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR  288 (289)
T ss_dssp             TTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC-----
T ss_pred             cCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhcc
Confidence            11122334568999999999999999999999999999999998654

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.4e-46  Score=317.36  Aligned_cols=247  Identities=23%  Similarity=0.229  Sum_probs=206.6

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|++++.||+|+||.||+|.+..+++.||+|++....    .......+.+|+.+++.++||||+++++++.+.+..
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR----AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ   80 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG----CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc----chhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEE
Confidence            4578999999999999999999999999999999997432    122346688999999999999999999999999999


Q ss_pred             EEEEEccC-CChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC
Q psy9858         133 SLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT  211 (307)
Q Consensus       133 ~lv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  211 (307)
                      ++||||+. ++|.+++... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           81 YLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             EEEEECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             EEEEEecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            99999995 6888877654 358999999999999999999999999999999999999999999999999998663221


Q ss_pred             --cccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCC---------ChhhhccccCHHHH
Q psy9858         212 --RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGI---------PLNEIFTAAGDDLL  273 (307)
Q Consensus       212 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~---------~~~~~~~~~~~~l~  273 (307)
                        .......+++.|+|||.+.+...++.++|||   +    +++|..||........         ........+++.+.
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL  239 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred             chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHH
Confidence              2234457899999999998874568899999   3    3349999987433211         11112346899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         274 AVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       274 ~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                      +||.+||+.||++|||++|+++||||++..+
T Consensus       240 ~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  270 (276)
T 2yex_A          240 ALLHKILVENPSARITIPDIKKDRWYNKPLK  270 (276)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             HHHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence            9999999999999999999999999987654

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.7e-47  Score=327.66  Aligned_cols=247  Identities=19%  Similarity=0.220  Sum_probs=189.0

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN  131 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  131 (307)
                      ...++|++++.||+|+||+||+|++..+|+.||+|++.....   .......+..+...++.++||||+++++++.+.+.
T Consensus         4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~   80 (290)
T 3fme_A            4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN---SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD   80 (290)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C---HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSS
T ss_pred             ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC---cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCC
Confidence            456899999999999999999999999999999999975321   12223334455556788899999999999999999


Q ss_pred             EEEEEEccCCChHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         132 VSLVFEFVDTDLEVIIKD---PTIVFTPSNIKAYAIMTLRGLEYLHDH-WILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       132 ~~lv~e~~~g~l~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      .++||||++|+|.+++..   ....+++..++.++.||+.||.|||++ |++||||||+||+++.++.+||+|||++...
T Consensus        81 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           81 VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             EEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            999999999988777653   455699999999999999999999998 9999999999999999999999999999876


Q ss_pred             CCCCcccccceeeceehhhhhh---hccccccccccee---e----eeecCCCCCCCCCCCC---------Chhhhcccc
Q psy9858         208 GSPTRLYTHQVVTRWYRLIKCL---LYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGI---------PLNEIFTAA  268 (307)
Q Consensus       208 ~~~~~~~~~~~~t~~y~aPE~~---~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~---------~~~~~~~~~  268 (307)
                      ... .......+|+.|+|||.+   .....++.++|||   +    +++|..||........         ........+
T Consensus       161 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (290)
T 3fme_A          161 VDD-VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF  239 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTS
T ss_pred             ccc-ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccC
Confidence            433 223344789999999997   2334789999999   3    3349999875211100         001112357


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         269 GDDLLAVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       269 ~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                      ++++.+++.+||+.||++|||++|+++||||+..
T Consensus       240 ~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          240 SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             CHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence            8999999999999999999999999999999753

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.2e-47  Score=348.72  Aligned_cols=245  Identities=24%  Similarity=0.305  Sum_probs=206.9

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN  131 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  131 (307)
                      ...++|++.+.||+|+||.||+|++..+|+.||||++........  .....+.+|++++++++||||+++++++.+...
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  100 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQK--TDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY  100 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBS--SCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccc--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            456789999999999999999999999999999999986543222  224668899999999999999999999999999


Q ss_pred             EEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEE---ecCCcEEEEeecCcccc
Q psy9858         132 VSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLI---NKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       132 ~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~a~~~  207 (307)
                      .++||||+ +|+|.+.+.... .+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++...
T Consensus       101 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  179 (484)
T 3nyv_A          101 FYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF  179 (484)
T ss_dssp             EEEEECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred             EEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence            99999999 678988887654 58999999999999999999999999999999999999   56789999999999887


Q ss_pred             CCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCC----------CCChhhhccccCH
Q psy9858         208 GSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFP----------GIPLNEIFTAAGD  270 (307)
Q Consensus       208 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~----------~~~~~~~~~~~~~  270 (307)
                      .... ......||+.|+|||++.+  .++.++|||   +    +++|.+||.+....          .......+..+++
T Consensus       180 ~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  256 (484)
T 3nyv_A          180 EASK-KMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE  256 (484)
T ss_dssp             CCCC-SHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCH
T ss_pred             cccc-ccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCH
Confidence            5432 3345579999999999876  589999999   3    33499999873211          0111223456899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         271 DLLAVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       271 ~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                      ++.+||.+||+.||.+|||++|+|+||||+..
T Consensus       257 ~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~  288 (484)
T 3nyv_A          257 SAKDLIRKMLTYVPSMRISARDALDHEWIQTY  288 (484)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence            99999999999999999999999999999754

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.2e-47  Score=340.19  Aligned_cols=249  Identities=16%  Similarity=0.109  Sum_probs=187.6

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc--CCCCccccc-----
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL--HHENVLGLT-----  123 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~ni~~~~-----  123 (307)
                      +....+|++.+.||+|+||.||+|++..+|+.||||++.......  ......+.+|+.+++.+  +||||++++     
T Consensus        58 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~  135 (371)
T 3q60_A           58 SQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENS--RSELERLHEATFAAARLLGESPEEARDRRRLLL  135 (371)
T ss_dssp             TCCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTH--HHHHHHHHHHHHHHHHHHC----------CBCC
T ss_pred             CCCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccccc--ccHHHHHHHHHHHHHHhcccChhhhhhceeEEe
Confidence            345567999999999999999999999999999999998753222  22345677885544444  699988755     


Q ss_pred             --eeeeec-----------------CeEEEEEEccCCChHHHHhCCCCCCCHHHH------HHHHHHHHHHHHHHHHCCc
Q psy9858         124 --DVFGYM-----------------SNVSLVFEFVDTDLEVIIKDPTIVFTPSNI------KAYAIMTLRGLEYLHDHWI  178 (307)
Q Consensus       124 --~~~~~~-----------------~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~------~~i~~~i~~~l~~lH~~~i  178 (307)
                        +++...                 ...++||||++|+|.+++...+..+.+..+      ..++.||+.||.|||++||
T Consensus       136 p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~i  215 (371)
T 3q60_A          136 PSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGL  215 (371)
T ss_dssp             CCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             eehheecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCC
Confidence              333322                 448999999999999999865434555555      6777999999999999999


Q ss_pred             eeecCCCCcEEEecCCcEEEEeecCccccCCCCcccccceeeceehhhhhhhcc-ccccccccee---e----eeecCCC
Q psy9858         179 LHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYC-VQFNVKNVQW---C----CFAKDPS  250 (307)
Q Consensus       179 vH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~Diw---~----i~~~~~~  250 (307)
                      +||||||+|||++.++.+||+|||+++.....   .....+|+.|+|||.+.+. ..++.++|||   +    +++|..|
T Consensus       216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P  292 (371)
T 3q60_A          216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR---GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP  292 (371)
T ss_dssp             EETTCSGGGEEECTTSCEEECCGGGEEETTCE---EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccCcCCHHHEEECCCCCEEEEecceeeecCCC---ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999999976432   2244667999999999861 2789999999   3    3349999


Q ss_pred             CCCCCCCC---------------CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         251 SHGNLFPG---------------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       251 f~~~~~~~---------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                      |.+.....               .........+++.+.+||.+||+.||++|||++++|+||||++.++
T Consensus       293 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  361 (371)
T 3q60_A          293 FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQN  361 (371)
T ss_dssp             TTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHH
T ss_pred             CCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHH
Confidence            98752111               0011122468999999999999999999999999999999987653

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.3e-46  Score=324.94  Aligned_cols=251  Identities=31%  Similarity=0.515  Sum_probs=205.8

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEEc-CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc---CCCCccccce
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARDI-ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL---HHENVLGLTD  124 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~ni~~~~~  124 (307)
                      ......++|++++.||+|+||.||+|.+. .+|+.||+|++......   ......+.+|+.+++.+   +||||+++++
T Consensus         5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~   81 (326)
T 1blx_A            5 GLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE---EGMPLSTIREVAVLRHLETFEHPNVVRLFD   81 (326)
T ss_dssp             CCCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT---TSCBCTHHHHHHHHHHHHHTCCTTBCCEEE
T ss_pred             cccCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccc---ccCCchhhHHHHHHHhhhccCCCCeEeeee
Confidence            34456789999999999999999999985 67899999999753221   11233566788877776   8999999999


Q ss_pred             eee-----ecCeEEEEEEccCCChHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEE
Q psy9858         125 VFG-----YMSNVSLVFEFVDTDLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKI  198 (307)
Q Consensus       125 ~~~-----~~~~~~lv~e~~~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl  198 (307)
                      ++.     .....++||||++|+|.+++.... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl  161 (326)
T 1blx_A           82 VCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKL  161 (326)
T ss_dssp             EEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred             eeeecccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEE
Confidence            987     567899999999999999887543 34899999999999999999999999999999999999999999999


Q ss_pred             EeecCccccCCCCcccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCC---------------
Q psy9858         199 GDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLF---------------  256 (307)
Q Consensus       199 ~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~---------------  256 (307)
                      +|||++...... .......+|..|+|||.+.+. .++.++|||       .+++|..||.+...               
T Consensus       162 ~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  239 (326)
T 1blx_A          162 ADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG  239 (326)
T ss_dssp             CSCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             ecCcccccccCC-CCccccccccceeCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            999999876432 233445789999999999887 799999999       33349999976221               


Q ss_pred             ------------------CCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         257 ------------------PGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       257 ------------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                                        ...........++..+.+||.+||+.||.+|||++++|+||||++...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  305 (326)
T 1blx_A          240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  305 (326)
T ss_dssp             GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence                              011122334568899999999999999999999999999999988754

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.1e-47  Score=331.34  Aligned_cols=246  Identities=24%  Similarity=0.299  Sum_probs=197.8

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCC--CCccccceeeee
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH--ENVLGLTDVFGY  128 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~ni~~~~~~~~~  128 (307)
                      ....++|++++.||+|+||.||+|.+ .+++.||||++....   ........+.+|+++++.++|  +||+++++++.+
T Consensus         5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~   80 (343)
T 3dbq_A            5 SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE---ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT   80 (343)
T ss_dssp             ESSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             eeecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccc---cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee
Confidence            34567899999999999999999996 578999999998643   222335678899999999986  999999999999


Q ss_pred             cCeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         129 MSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       129 ~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                      ....++|||+.+|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++...
T Consensus        81 ~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~  158 (343)
T 3dbq_A           81 DQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  158 (343)
T ss_dssp             SSEEEEEECCCSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred             CCEEEEEEeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence            99999999987999999998754 589999999999999999999999999999999999996 6889999999998774


Q ss_pred             CCCc--ccccceeeceehhhhhhhc----------cccccccccee---e----eeecCCCCCCCCCC---------CCC
Q psy9858         209 SPTR--LYTHQVVTRWYRLIKCLLY----------CVQFNVKNVQW---C----CFAKDPSSHGNLFP---------GIP  260 (307)
Q Consensus       209 ~~~~--~~~~~~~t~~y~aPE~~~~----------~~~~~~~~Diw---~----i~~~~~~f~~~~~~---------~~~  260 (307)
                      ....  ......||+.|+|||.+.+          ...++.++|||   +    +++|..||......         ...
T Consensus       159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  238 (343)
T 3dbq_A          159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH  238 (343)
T ss_dssp             -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred             cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCc
Confidence            3322  2335579999999999975          13789999999   3    33499999762211         011


Q ss_pred             hhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         261 LNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       261 ~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                      ....+...+.++.+||.+||+.||.+|||++|+|+||||+..
T Consensus       239 ~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  280 (343)
T 3dbq_A          239 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  280 (343)
T ss_dssp             CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence            112234467889999999999999999999999999999753

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.7e-46  Score=337.18  Aligned_cols=241  Identities=24%  Similarity=0.375  Sum_probs=198.8

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc------CCCCccccceee
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL------HHENVLGLTDVF  126 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~ni~~~~~~~  126 (307)
                      ...+|++++.||+|+||+||+|.+..+++.||||++...      ......+.+|+++++.+      .|+||+++++++
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~------~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~  168 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE------KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF  168 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc------cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeec
Confidence            446799999999999999999999999999999999742      22345677888888877      577999999999


Q ss_pred             eecCeEEEEEEccCCChHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCc--EEEEeecC
Q psy9858         127 GYMSNVSLVFEFVDTDLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGV--LKIGDFGL  203 (307)
Q Consensus       127 ~~~~~~~lv~e~~~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~  203 (307)
                      ......++||||++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+
T Consensus       169 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~  248 (429)
T 3kvw_A          169 TFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS  248 (429)
T ss_dssp             EETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             ccCCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence            9999999999999999999887653 34899999999999999999999999999999999999999987  99999999


Q ss_pred             ccccCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC------------------
Q psy9858         204 AKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG------------------  258 (307)
Q Consensus       204 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~------------------  258 (307)
                      +......   .....+|+.|+|||++.+. .++.++|||   |    +++|.+||.+.....                  
T Consensus       249 a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~  324 (429)
T 3kvw_A          249 SCYEHQR---VYTYIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD  324 (429)
T ss_dssp             CEETTCC---CCSSCSCGGGCCHHHHHTB-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             ceecCCc---ccccCCCCCccChHHHhCC-CCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            9865432   3345889999999999988 899999999   3    334999987632100                  


Q ss_pred             ----------------------------------------------CC-hhhhccccCHHHHHHHHHhhhcCCCCCCCHH
Q psy9858         259 ----------------------------------------------IP-LNEIFTAAGDDLLAVISSLLCLNPTKRADCT  291 (307)
Q Consensus       259 ----------------------------------------------~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~  291 (307)
                                                                    .. ...+....++++.+||.+||+.||++|||++
T Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~  404 (429)
T 3kvw_A          325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG  404 (429)
T ss_dssp             TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence                                                          00 0001112378899999999999999999999


Q ss_pred             HHhcCcccCCCc
Q psy9858         292 ATLKMDYFSLTK  303 (307)
Q Consensus       292 ~il~hp~f~~~~  303 (307)
                      |+|+||||++..
T Consensus       405 e~L~Hpw~~~~~  416 (429)
T 3kvw_A          405 QALRHPWLRRRL  416 (429)
T ss_dssp             HHHTSTTTC---
T ss_pred             HHhCChhhccCC
Confidence            999999998754

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.5e-47  Score=326.35  Aligned_cols=246  Identities=24%  Similarity=0.318  Sum_probs=202.4

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN  131 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  131 (307)
                      -..++|++++.||+|+||.||+|.+..+++.||+|++.....  ........+.+|+++++.++||||+++++++.+...
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   83 (279)
T 3fdn_A            6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR   83 (279)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEecccc--chhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE
Confidence            356899999999999999999999999999999999875321  122234668899999999999999999999999999


Q ss_pred             EEEEEEccC-CChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         132 VSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       132 ~~lv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      .++||||+. |+|.+.+.... .+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus        84 ~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           84 VYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             EEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred             EEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence            999999995 67888876543 4899999999999999999999999999999999999999999999999998765332


Q ss_pred             Ccccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCCCC------hhhhccccCHHHHHHHH
Q psy9858         211 TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPGIP------LNEIFTAAGDDLLAVIS  277 (307)
Q Consensus       211 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~~~------~~~~~~~~~~~l~~li~  277 (307)
                        ......+++.|+|||.+.+. .++.++|||       .+++|..||.........      ....+..+++++.+||.
T Consensus       163 --~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  239 (279)
T 3fdn_A          163 --RRTDLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS  239 (279)
T ss_dssp             -------CCCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHH
T ss_pred             --cccccCCCCCccCHhHhccC-CCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHH
Confidence              23445789999999999887 889999999       334499998763321110      01123457899999999


Q ss_pred             HhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         278 SLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       278 ~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      +||+.||.+|||++|+++||||+...
T Consensus       240 ~~l~~~p~~Rps~~e~l~h~~~~~~~  265 (279)
T 3fdn_A          240 RLLKHNPSQRPMLREVLEHPWITANS  265 (279)
T ss_dssp             HHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred             HHhccChhhCCCHHHHhhCccccCCc
Confidence            99999999999999999999997654

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.8e-46  Score=334.89  Aligned_cols=241  Identities=27%  Similarity=0.421  Sum_probs=195.4

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC--
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS--  130 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--  130 (307)
                      ...+|++++.||+|+||+||+|++..+++ ||+|++.....         ...+|+++++.++||||+++++++....  
T Consensus        38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~---------~~~~E~~il~~l~h~niv~l~~~~~~~~~~  107 (394)
T 4e7w_A           38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR---------FKNRELQIMRIVKHPNVVDLKAFFYSNGDK  107 (394)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT---------SCCHHHHHHHTCCCTTBCCEEEEEEEESSS
T ss_pred             ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc---------hHHHHHHHHHhCCCCCcceEEEEEEecCCC
Confidence            45689999999999999999999876665 88888864211         1237999999999999999999985443  


Q ss_pred             ----eEEEEEEccCCChHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEe-cCCcEEEEeec
Q psy9858         131 ----NVSLVFEFVDTDLEVIIK---DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLIN-KQGVLKIGDFG  202 (307)
Q Consensus       131 ----~~~lv~e~~~g~l~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg  202 (307)
                          ..++||||+++++.+.+.   .....+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||
T Consensus       108 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG  187 (394)
T 4e7w_A          108 KDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFG  187 (394)
T ss_dssp             SSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             CCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence                388999999888766554   2344689999999999999999999999999999999999999 79999999999


Q ss_pred             CccccCCCCcccccceeeceehhhhhhhccccccccccee---ee----eecCCCCCCCCCC------------------
Q psy9858         203 LAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FAKDPSSHGNLFP------------------  257 (307)
Q Consensus       203 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~~~~~f~~~~~~------------------  257 (307)
                      +++...... ......+|+.|+|||.+.+...++.++|||   |+    ++|..||.+....                  
T Consensus       188 ~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~  266 (394)
T 4e7w_A          188 SAKILIAGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI  266 (394)
T ss_dssp             TCEECCTTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             CcccccCCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            998774332 334557899999999998876799999999   33    3399999873210                  


Q ss_pred             ----------------CCChh-hhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         258 ----------------GIPLN-EIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       258 ----------------~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                                      ..... .....+++++.+||.+||+.||.+|||+.|+++||||++.+.
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (394)
T 4e7w_A          267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT  330 (394)
T ss_dssp             HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred             HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence                            00111 122347899999999999999999999999999999987643

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.9e-46  Score=325.12  Aligned_cols=247  Identities=21%  Similarity=0.221  Sum_probs=196.8

Q ss_pred             ccccceeeEE-eEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeee
Q psy9858          51 KNDLLVYYQW-RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGY  128 (307)
Q Consensus        51 ~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~  128 (307)
                      +...+.|++. +.||+|+||.||+|.+..+++.||||++....     ......+.+|++++.++ +||||+++++++.+
T Consensus         8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~   82 (316)
T 2ac3_A            8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-----GHIRSRVFREVEMLYQCQGHRNVLELIEFFEE   82 (316)
T ss_dssp             CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-----SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-----chhHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            3456789996 78999999999999999999999999997542     12245688999999985 79999999999999


Q ss_pred             cCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCc---EEEEeecCc
Q psy9858         129 MSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGV---LKIGDFGLA  204 (307)
Q Consensus       129 ~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~a  204 (307)
                      .+..++||||+ +|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++.   +||+|||++
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~  161 (316)
T 2ac3_A           83 EDRFYLVFEKMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLG  161 (316)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred             CCEEEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence            99999999999 588988887643 5899999999999999999999999999999999999988776   999999999


Q ss_pred             cccCCCC-------cccccceeeceehhhhhhhc----cccccccccee---e----eeecCCCCCCCCCCCCC------
Q psy9858         205 KFFGSPT-------RLYTHQVVTRWYRLIKCLLY----CVQFNVKNVQW---C----CFAKDPSSHGNLFPGIP------  260 (307)
Q Consensus       205 ~~~~~~~-------~~~~~~~~t~~y~aPE~~~~----~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~------  260 (307)
                      .......       .......+|+.|+|||.+.+    ...++.++|||   +    +++|..||.+.......      
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~  241 (316)
T 2ac3_A          162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA  241 (316)
T ss_dssp             C-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----C
T ss_pred             cccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccccc
Confidence            8653211       11223468999999999975    23688999999   3    33399999874322100      


Q ss_pred             -------------------hhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         261 -------------------LNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       261 -------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                                         ....+..+++++.+||.+||+.||.+|||++|+|+||||++..
T Consensus       242 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~  303 (316)
T 2ac3_A          242 CPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA  303 (316)
T ss_dssp             CHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred             chhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence                               0111235788999999999999999999999999999998754

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.8e-46  Score=327.02  Aligned_cols=250  Identities=23%  Similarity=0.291  Sum_probs=203.8

Q ss_pred             eeccccceeeEE-eEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-CCCccccceee
Q psy9858          49 EVKNDLLVYYQW-RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-HENVLGLTDVF  126 (307)
Q Consensus        49 ~~~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~  126 (307)
                      ......++|.+. +.||+|+||.||+|.+..+|+.||+|++.....   .......+.+|+.+++.+. ||||+++++++
T Consensus        22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~   98 (327)
T 3lm5_A           22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR---GQDCRAEILHEIAVLELAKSCPRVINLHEVY   98 (327)
T ss_dssp             CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET---TEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc---chHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            334456778888 899999999999999999999999999985322   2223467889999999995 69999999999


Q ss_pred             eecCeEEEEEEcc-CCChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEec---CCcEEEEee
Q psy9858         127 GYMSNVSLVFEFV-DTDLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK---QGVLKIGDF  201 (307)
Q Consensus       127 ~~~~~~~lv~e~~-~g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~---~~~~kl~Df  201 (307)
                      .+....++||||+ +|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++.   ++.+||+||
T Consensus        99 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Df  178 (327)
T 3lm5_A           99 ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDF  178 (327)
T ss_dssp             ECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred             EeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeC
Confidence            9999999999999 56888887643 346899999999999999999999999999999999999987   789999999


Q ss_pred             cCccccCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCC----------CCCChhhh
Q psy9858         202 GLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLF----------PGIPLNEI  264 (307)
Q Consensus       202 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~----------~~~~~~~~  264 (307)
                      |++....... ......+|+.|+|||.+.+. .++.++|||   +    +++|..||.+...          ........
T Consensus       179 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  256 (327)
T 3lm5_A          179 GMSRKIGHAC-ELREIMGTPEYLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEET  256 (327)
T ss_dssp             GGCEEC----------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred             ccccccCCcc-ccccccCCcCccCCeeecCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchh
Confidence            9998874332 23445789999999999887 889999999   3    3349999977321          11112233


Q ss_pred             ccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         265 FTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       265 ~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      +..+++.+.+||.+||+.||++|||++++|+||||++..
T Consensus       257 ~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~  295 (327)
T 3lm5_A          257 FSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD  295 (327)
T ss_dssp             TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred             hcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence            456889999999999999999999999999999998764

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.2e-46  Score=336.97  Aligned_cols=241  Identities=24%  Similarity=0.403  Sum_probs=196.1

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee----
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY----  128 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----  128 (307)
                      ...+|++++.||+|+||.||+|++..+|+.||||++....         ....+|+++++.++||||+++++++..    
T Consensus        52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  122 (420)
T 1j1b_A           52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEK  122 (420)
T ss_dssp             EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT---------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETT
T ss_pred             ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc---------hhHHHHHHHHHHcCCCCccceeeEEeccCCC
Confidence            4457999999999999999999999999999999987421         112379999999999999999998843    


Q ss_pred             --cCeEEEEEEccCCChHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecC-CcEEEEeec
Q psy9858         129 --MSNVSLVFEFVDTDLEVIIK---DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ-GVLKIGDFG  202 (307)
Q Consensus       129 --~~~~~lv~e~~~g~l~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg  202 (307)
                        ...+++||||+++++.+.+.   .....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||
T Consensus       123 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG  202 (420)
T 1j1b_A          123 KDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG  202 (420)
T ss_dssp             TTEEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             CcceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccch
Confidence              23478999999988776664   334568999999999999999999999999999999999999965 578999999


Q ss_pred             CccccCCCCcccccceeeceehhhhhhhccccccccccee---eee----ecCCCCCCCCC-------------------
Q psy9858         203 LAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCF----AKDPSSHGNLF-------------------  256 (307)
Q Consensus       203 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~----~~~~~f~~~~~-------------------  256 (307)
                      +++...... ......+|+.|+|||++.+...++.++|||   |++    +|..||.+...                   
T Consensus       203 ~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~  281 (420)
T 1j1b_A          203 SAKQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI  281 (420)
T ss_dssp             TCEECCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             hhhhcccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            998764332 234457899999999998766799999999   433    39999977321                   


Q ss_pred             -------CCC--------Chh-hhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         257 -------PGI--------PLN-EIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       257 -------~~~--------~~~-~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                             ...        ... .....+++++.+||.+||+.||.+|||++|+|+||||+...
T Consensus       282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~  344 (420)
T 1j1b_A          282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  344 (420)
T ss_dssp             HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence                   000        000 11235689999999999999999999999999999997653

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=6.2e-47  Score=358.26  Aligned_cols=248  Identities=22%  Similarity=0.252  Sum_probs=208.6

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeeecC
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGYMS  130 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~  130 (307)
                      ...++|++++.||+|+||+||+|++..+++.||||++.+....  .......+.+|..++..+ +||||+++++++.+..
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~--~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~  415 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI--QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD  415 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHH--HTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence            3567899999999999999999999999999999999753211  122245678899999988 7999999999999999


Q ss_pred             eEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCC
Q psy9858         131 NVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS  209 (307)
Q Consensus       131 ~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  209 (307)
                      .+||||||+ +|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus       416 ~~~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          416 RLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             EEEEEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            999999999 678988887654 589999999999999999999999999999999999999999999999999987544


Q ss_pred             CCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCC------ChhhhccccCHHHHHHH
Q psy9858         210 PTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGI------PLNEIFTAAGDDLLAVI  276 (307)
Q Consensus       210 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~------~~~~~~~~~~~~l~~li  276 (307)
                      .........||+.|+|||++.+. .++.++|||   +    +++|..||.+......      .....+..+++++.+||
T Consensus       495 ~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li  573 (674)
T 3pfq_A          495 DGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAIC  573 (674)
T ss_dssp             TTCCBCCCCSCSSSCCHHHHTCC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHH
T ss_pred             CCcccccccCCCcccCHhhhcCC-CCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence            44455667899999999999887 899999999   3    3449999987321110      01122356899999999


Q ss_pred             HHhhhcCCCCCCCH-----HHHhcCcccCCCc
Q psy9858         277 SSLLCLNPTKRADC-----TATLKMDYFSLTK  303 (307)
Q Consensus       277 ~~~l~~dP~~Rpt~-----~~il~hp~f~~~~  303 (307)
                      .+||+.||++||++     +||++||||++.+
T Consensus       574 ~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~  605 (674)
T 3pfq_A          574 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  605 (674)
T ss_dssp             HHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCC
T ss_pred             HHHccCCHHHCCCCCCCcHHHHhcCccccCCC
Confidence            99999999999997     9999999998764

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.8e-46  Score=328.33  Aligned_cols=241  Identities=32%  Similarity=0.499  Sum_probs=199.7

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe--
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN--  131 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~--  131 (307)
                      .++|.+.+.||+|+||.||+|.+..+|+.||||++....   ........+.+|+.+++.++||||+++++++.....  
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   99 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF---QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR   99 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT---SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc---cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccc
Confidence            468999999999999999999999999999999997532   223335678899999999999999999999977654  


Q ss_pred             ----EEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         132 ----VSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       132 ----~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                          .++||||++|+|.+.+..   .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus       100 ~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  176 (353)
T 3coi_A          100 NFYDFYLVMPFMQTDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA  176 (353)
T ss_dssp             GCCCCEEEEECCSEEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred             cceeEEEEeccccCCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence                599999999988887754   3899999999999999999999999999999999999999999999999999875


Q ss_pred             CCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCC-----------------------
Q psy9858         208 GSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFP-----------------------  257 (307)
Q Consensus       208 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~-----------------------  257 (307)
                      ...   .....+|+.|+|||.+.+...++.++|||   +    +++|..||.+....                       
T Consensus       177 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  253 (353)
T 3coi_A          177 DAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND  253 (353)
T ss_dssp             ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred             CCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence            332   33457899999999998855899999999   3    33399999763210                       


Q ss_pred             --------------CCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         258 --------------GIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       258 --------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                                    .......+..+++++.+||.+||+.||++|||++|+|+||||+...
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  313 (353)
T 3coi_A          254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  313 (353)
T ss_dssp             HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence                          1112223346789999999999999999999999999999998654

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.4e-46  Score=320.90  Aligned_cols=248  Identities=23%  Similarity=0.319  Sum_probs=204.7

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccc-hhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAK-DGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      .++|++++.||+|+||.||+|++..+|+.||+|++......... ......+.+|+++++.++||||+++++++.+....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            36799999999999999999999999999999999865433221 12356788999999999999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCC----cEEEEeecCcccc
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG----VLKIGDFGLAKFF  207 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~----~~kl~Dfg~a~~~  207 (307)
                      ++||||+ +++|.+++.... .+++..+..++.||+.||.|||++|++|+||||+||+++.++    .++|+|||++...
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~  162 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI  162 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence            9999999 678988886543 589999999999999999999999999999999999998877    8999999999877


Q ss_pred             CCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCC----------CCCChhhhccccCH
Q psy9858         208 GSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLF----------PGIPLNEIFTAAGD  270 (307)
Q Consensus       208 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~----------~~~~~~~~~~~~~~  270 (307)
                      .... ......+++.|+|||.+.+. .++.++|||   +    +++|..||.+...          ........+..+++
T Consensus       163 ~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (283)
T 3bhy_A          163 EAGN-EFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE  240 (283)
T ss_dssp             C---------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred             cCCC-cccccCCCcCccCcceecCC-CCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCH
Confidence            4332 23445789999999999877 889999999   2    3339999877321          11112233456789


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         271 DLLAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       271 ~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                      .+.+++.+||+.||++|||++++++||||+....
T Consensus       241 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  274 (283)
T 3bhy_A          241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR  274 (283)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence            9999999999999999999999999999987543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.1e-46  Score=321.75  Aligned_cols=248  Identities=23%  Similarity=0.274  Sum_probs=208.2

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN  131 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  131 (307)
                      ...++|.+.+.||+|+||.||+|.+..+++.||+|++......  .......+.+|+.+++.++||||+++++++.+.+.
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   89 (294)
T 2rku_A           12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL--KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF   89 (294)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhcc--CHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCE
Confidence            4567899999999999999999999999999999999754222  22235668899999999999999999999999999


Q ss_pred             EEEEEEccC-CChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         132 VSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       132 ~~lv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      .++||||++ ++|.+++.... .+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++......
T Consensus        90 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  168 (294)
T 2rku_A           90 VFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  168 (294)
T ss_dssp             EEEEEECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence            999999995 77887776543 5899999999999999999999999999999999999999999999999999887544


Q ss_pred             Ccccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCCC------ChhhhccccCHHHHHHHH
Q psy9858         211 TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPGI------PLNEIFTAAGDDLLAVIS  277 (307)
Q Consensus       211 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~~------~~~~~~~~~~~~l~~li~  277 (307)
                      ........+|+.|+|||.+.+. .++.++|||       .+++|..||........      .....+..+++.+.+++.
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  247 (294)
T 2rku_A          169 GERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ  247 (294)
T ss_dssp             TCCBCCCCSCCSSCCHHHHTTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHH
T ss_pred             ccccccccCCCCcCCcchhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHH
Confidence            4444556789999999999887 789999999       23349999877322110      011223467899999999


Q ss_pred             HhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         278 SLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       278 ~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      +||+.||++|||++|+++||||+...
T Consensus       248 ~~l~~~p~~Rps~~~ll~~~~~~~~~  273 (294)
T 2rku_A          248 KMLQTDPTARPTINELLNDEFFTSGY  273 (294)
T ss_dssp             HHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             HHcccChhhCcCHHHHhhChheecCC
Confidence            99999999999999999999997653

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=4.5e-46  Score=329.16  Aligned_cols=247  Identities=19%  Similarity=0.262  Sum_probs=204.6

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccc---cchhhhHhHHHHHHHHHhc-CCCCccccceeeee
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHAD---AKDGINRTALREIKLLQEL-HHENVLGLTDVFGY  128 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~  128 (307)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++.......   ........+.+|+.+++.+ +||||+++++++..
T Consensus        92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  171 (365)
T 2y7j_A           92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES  171 (365)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred             hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence            4468999999999999999999998899999999998643221   1123345678999999999 79999999999999


Q ss_pred             cCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         129 MSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       129 ~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      ....++||||+ +|+|.+++.... .+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++...
T Consensus       172 ~~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~  250 (365)
T 2y7j_A          172 SSFMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL  250 (365)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence            99999999999 568888887543 5899999999999999999999999999999999999999999999999999887


Q ss_pred             CCCCcccccceeeceehhhhhhhcc-----ccccccccee---e----eeecCCCCCCCCCC----------CCChhhhc
Q psy9858         208 GSPTRLYTHQVVTRWYRLIKCLLYC-----VQFNVKNVQW---C----CFAKDPSSHGNLFP----------GIPLNEIF  265 (307)
Q Consensus       208 ~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~~Diw---~----i~~~~~~f~~~~~~----------~~~~~~~~  265 (307)
                      .... ......||+.|+|||++.+.     ..++.++|||   +    +++|..||......          .......+
T Consensus       251 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  329 (365)
T 2y7j_A          251 EPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEW  329 (365)
T ss_dssp             CTTC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred             CCCc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence            5432 33456889999999998743     2588999999   3    33499999763210          01111223


Q ss_pred             cccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCC
Q psy9858         266 TAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSL  301 (307)
Q Consensus       266 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~  301 (307)
                      ..++..+.+||.+||+.||++|||++++|+||||++
T Consensus       330 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          330 DDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            467889999999999999999999999999999974

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1e-46  Score=337.85  Aligned_cols=244  Identities=32%  Similarity=0.487  Sum_probs=183.9

Q ss_pred             ccceeeE-EeEEeecCceEEEEEEEc--CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeee--
Q psy9858          53 DLLVYYQ-WRSVHVGRFATVFKARDI--ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG--  127 (307)
Q Consensus        53 ~~~~y~~-~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~--  127 (307)
                      ..+.|++ .++||+|+||+||+|++.  .+++.||||++....       ....+.+|+++++.++||||+++++++.  
T Consensus        18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   90 (405)
T 3rgf_A           18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-------ISMSACREIALLRELKHPNVISLQKVFLSH   90 (405)
T ss_dssp             HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-------CCHHHHHHHHHHHHCCCTTBCCCCEEEEET
T ss_pred             hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-------CCHHHHHHHHHHHhcCCCCeeeEeeEEecC
Confidence            4456777 457999999999999965  578899999986421       1345789999999999999999999994  


Q ss_pred             ecCeEEEEEEccCCChHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEE----ecCCc
Q psy9858         128 YMSNVSLVFEFVDTDLEVIIKDP--------TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLI----NKQGV  195 (307)
Q Consensus       128 ~~~~~~lv~e~~~g~l~~~~~~~--------~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~----~~~~~  195 (307)
                      .....++||||++|+|.+++...        ...+++..++.++.||+.||.|||++||+||||||+|||+    +.++.
T Consensus        91 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~  170 (405)
T 3rgf_A           91 ADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR  170 (405)
T ss_dssp             TTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTC
T ss_pred             CCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCc
Confidence            47789999999999998887521        2248999999999999999999999999999999999999    67789


Q ss_pred             EEEEeecCccccCCCC---cccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCCC-----
Q psy9858         196 LKIGDFGLAKFFGSPT---RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGIP-----  260 (307)
Q Consensus       196 ~kl~Dfg~a~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~-----  260 (307)
                      +||+|||+++......   .......+|+.|+|||++.+...++.++|||   |    +++|.+||.+.......     
T Consensus       171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~  250 (405)
T 3rgf_A          171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH  250 (405)
T ss_dssp             EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred             EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence            9999999998774322   2234457899999999999865799999999   3    33499999763321000     


Q ss_pred             ------------------hhhh------------------------------ccccCHHHHHHHHHhhhcCCCCCCCHHH
Q psy9858         261 ------------------LNEI------------------------------FTAAGDDLLAVISSLLCLNPTKRADCTA  292 (307)
Q Consensus       261 ------------------~~~~------------------------------~~~~~~~l~~li~~~l~~dP~~Rpt~~~  292 (307)
                                        ....                              ....++++.+||.+||+.||.+|||++|
T Consensus       251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e  330 (405)
T 3rgf_A          251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ  330 (405)
T ss_dssp             HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence                              0000                              0012678999999999999999999999


Q ss_pred             HhcCcccCCCc
Q psy9858         293 TLKMDYFSLTK  303 (307)
Q Consensus       293 il~hp~f~~~~  303 (307)
                      +|+||||++..
T Consensus       331 ~L~hp~f~~~~  341 (405)
T 3rgf_A          331 AMQDPYFLEDP  341 (405)
T ss_dssp             HHTSGGGTSSS
T ss_pred             HhcChhhccCC
Confidence            99999998753

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.3e-46  Score=322.66  Aligned_cols=246  Identities=23%  Similarity=0.307  Sum_probs=201.7

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS  130 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  130 (307)
                      ....++|++++.||+|+||.||+|.+..+|+.||+|++....       ....+.+|+.+++.++||||+++++++...+
T Consensus        25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   97 (314)
T 3com_A           25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-------DLQEIIKEISIMQQCDSPHVVKYYGSYFKNT   97 (314)
T ss_dssp             -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-------CCHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-------HHHHHHHHHHHHHhCCCCCCccEEEEEEeCC
Confidence            345678999999999999999999999999999999997531       1356889999999999999999999999999


Q ss_pred             eEEEEEEccC-CChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCC
Q psy9858         131 NVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS  209 (307)
Q Consensus       131 ~~~lv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  209 (307)
                      ..++||||++ |+|.+++......+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus        98 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (314)
T 3com_A           98 DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD  177 (314)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred             EEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence            9999999995 689888875555689999999999999999999999999999999999999999999999999987754


Q ss_pred             CCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCC---------CCChhhhccccCHHHH
Q psy9858         210 PTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFP---------GIPLNEIFTAAGDDLL  273 (307)
Q Consensus       210 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~---------~~~~~~~~~~~~~~l~  273 (307)
                      .........+++.|+|||.+.+. .++.++|||   +    +++|..||......         .......+..+++.+.
T Consensus       178 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  256 (314)
T 3com_A          178 TMAKRNTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFT  256 (314)
T ss_dssp             TBSCBCCCCSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred             hccccCccCCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHH
Confidence            43344456789999999999887 789999999   3    33399998762210         0001112345789999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         274 AVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       274 ~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                      +||.+||+.||.+|||++++++||||++.+.
T Consensus       257 ~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~  287 (314)
T 3com_A          257 DFVKQCLVKSPEQRATATQLLQHPFVRSAKG  287 (314)
T ss_dssp             HHHHHHTCSCTTTSCCHHHHTTSHHHHTCCC
T ss_pred             HHHHHHccCChhhCcCHHHHHhCHHHhcCCc
Confidence            9999999999999999999999999987653

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=7.5e-46  Score=318.74  Aligned_cols=251  Identities=19%  Similarity=0.235  Sum_probs=206.3

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccc----cchhhhHhHHHHHHHHHhcC-CCCcccccee
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHAD----AKDGINRTALREIKLLQELH-HENVLGLTDV  125 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~  125 (307)
                      ....++|++.+.||+|+||.||+|.+..+|+.||||++.......    ........+.+|+++++++. ||||++++++
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (298)
T 1phk_A           13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT   92 (298)
T ss_dssp             --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence            346789999999999999999999999999999999998643211    11223456789999999995 9999999999


Q ss_pred             eeecCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCc
Q psy9858         126 FGYMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA  204 (307)
Q Consensus       126 ~~~~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  204 (307)
                      +......++||||+ +++|.+++... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  171 (298)
T 1phk_A           93 YETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS  171 (298)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             eccCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccch
Confidence            99999999999999 57898888754 35899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCcccccceeeceehhhhhhhc-----cccccccccee---e----eeecCCCCCCCCCC----------CCChh
Q psy9858         205 KFFGSPTRLYTHQVVTRWYRLIKCLLY-----CVQFNVKNVQW---C----CFAKDPSSHGNLFP----------GIPLN  262 (307)
Q Consensus       205 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~Diw---~----i~~~~~~f~~~~~~----------~~~~~  262 (307)
                      ...... .......+++.|+|||.+.+     ...++.++|||   +    +++|..||......          .....
T Consensus       172 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  250 (298)
T 1phk_A          172 CQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS  250 (298)
T ss_dssp             EECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred             hhcCCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc
Confidence            877433 23344578999999999863     33678999999   2    33499998762210          00111


Q ss_pred             hhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         263 EIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       263 ~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      ..+..+++.+.+||.+||+.||++|||++++|+||||++..
T Consensus       251 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (298)
T 1phk_A          251 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV  291 (298)
T ss_dssp             TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred             ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence            22346889999999999999999999999999999998764

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.6e-46  Score=324.43  Aligned_cols=244  Identities=31%  Similarity=0.531  Sum_probs=196.5

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeee-----
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG-----  127 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----  127 (307)
                      ..++|++++.||+|+||.||+|.+..+|+.||+|++...     .....+.+.+|+++++.++||||+++++++.     
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   83 (320)
T 2i6l_A            9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-----DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQ   83 (320)
T ss_dssp             ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-----SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCB
T ss_pred             cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-----ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccc
Confidence            346899999999999999999999999999999998753     2223567889999999999999999998873     


Q ss_pred             ---------ecCeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEe-cCCcEE
Q psy9858         128 ---------YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLIN-KQGVLK  197 (307)
Q Consensus       128 ---------~~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~-~~~~~k  197 (307)
                               .....++||||++|+|.+++...  .+++..++.++.||+.||.|||++|++||||||+||+++ .++.+|
T Consensus        84 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           84 LTDDVGSLTELNSVYIVQEYMETDLANVLEQG--PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             CCC----CCSCSEEEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEE
T ss_pred             cccccccccccCceeEEeeccCCCHHHHhhcC--CccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEE
Confidence                     44789999999999999988654  489999999999999999999999999999999999997 567999


Q ss_pred             EEeecCccccCCC---Ccccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCC-----------
Q psy9858         198 IGDFGLAKFFGSP---TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLF-----------  256 (307)
Q Consensus       198 l~Dfg~a~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~-----------  256 (307)
                      |+|||++......   ........++..|+|||.+.+...++.++|||   +    +++|..||.+...           
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  241 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI  241 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            9999999876432   11223446789999999998755899999999   3    3449999987321           


Q ss_pred             -------------------------CCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         257 -------------------------PGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       257 -------------------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                                               ...........+++++.+||.+||+.||++|||++|+|+||||+...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (320)
T 2i6l_A          242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS  313 (320)
T ss_dssp             CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred             CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence                                     11122233456899999999999999999999999999999998643

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.7e-46  Score=333.33  Aligned_cols=244  Identities=23%  Similarity=0.285  Sum_probs=197.1

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC--CCCccccceeeeecC
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH--HENVLGLTDVFGYMS  130 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~ni~~~~~~~~~~~  130 (307)
                      ...+|++++.||+|+||.||+|.+. +++.||||++.....   .......+.+|+++++.++  ||||+++++++....
T Consensus        54 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~  129 (390)
T 2zmd_A           54 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA---DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ  129 (390)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             cCCceEEEEEEccCCCeEEEEEEcC-CCCEEEEEEEecccc---cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC
Confidence            3457999999999999999999975 489999999986432   2233567889999999996  599999999999999


Q ss_pred             eEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         131 NVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       131 ~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      ..++|||+.+++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.....
T Consensus       130 ~~~lv~E~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          130 YIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             EEEEEEECCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             EEEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence            999999977899999988654 588999999999999999999999999999999999995 689999999999877433


Q ss_pred             Cc--ccccceeeceehhhhhhhcc----------ccccccccee---e----eeecCCCCCCCCCCC---------CChh
Q psy9858         211 TR--LYTHQVVTRWYRLIKCLLYC----------VQFNVKNVQW---C----CFAKDPSSHGNLFPG---------IPLN  262 (307)
Q Consensus       211 ~~--~~~~~~~t~~y~aPE~~~~~----------~~~~~~~Diw---~----i~~~~~~f~~~~~~~---------~~~~  262 (307)
                      ..  ......||+.|+|||++.+.          ..++.++|||   +    +++|..||.......         ....
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~  287 (390)
T 2zmd_A          208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI  287 (390)
T ss_dssp             ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCC
T ss_pred             CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccC
Confidence            21  23455799999999999752          2689999999   3    334999997632110         0111


Q ss_pred             hhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         263 EIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       263 ~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                      ..+...+.++.+||.+||+.||.+|||++|+|+||||+..
T Consensus       288 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~  327 (390)
T 2zmd_A          288 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  327 (390)
T ss_dssp             CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             CCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence            2233457899999999999999999999999999999754

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.6e-46  Score=335.42  Aligned_cols=239  Identities=28%  Similarity=0.389  Sum_probs=198.8

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC--------CCCccccce
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH--------HENVLGLTD  124 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~ni~~~~~  124 (307)
                      ..++|++++.||+|+||+||+|++..+++.||||++...      ......+.+|+++++.++        |+||+++++
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~  108 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA------EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD  108 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC------CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence            347899999999999999999999999999999999732      223466889999999985        788999999


Q ss_pred             eee----ecCeEEEEEEccCCChHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC-CceeecCCCCcEEEecCC----
Q psy9858         125 VFG----YMSNVSLVFEFVDTDLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDH-WILHRDLKPNNLLINKQG----  194 (307)
Q Consensus       125 ~~~----~~~~~~lv~e~~~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~----  194 (307)
                      ++.    .....++||||+++++.+.+.... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++    
T Consensus       109 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~  188 (397)
T 1wak_A          109 DFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIR  188 (397)
T ss_dssp             EEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHH
T ss_pred             ceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhh
Confidence            987    567899999999999888876543 5689999999999999999999998 999999999999998775    


Q ss_pred             ---------------------------------------------cEEEEeecCccccCCCCcccccceeeceehhhhhh
Q psy9858         195 ---------------------------------------------VLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCL  229 (307)
Q Consensus       195 ---------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~  229 (307)
                                                                   .+||+|||++......   .....+|+.|+|||++
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHH
T ss_pred             hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChhh
Confidence                                                         7999999999876432   3445789999999999


Q ss_pred             hccccccccccee---ee----eecCCCCCCCCCCCCChh----------------------------------------
Q psy9858         230 LYCVQFNVKNVQW---CC----FAKDPSSHGNLFPGIPLN----------------------------------------  262 (307)
Q Consensus       230 ~~~~~~~~~~Diw---~i----~~~~~~f~~~~~~~~~~~----------------------------------------  262 (307)
                      .+. .++.++|||   |+    ++|..||...........                                        
T Consensus       266 ~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  344 (397)
T 1wak_A          266 IGS-GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK  344 (397)
T ss_dssp             HTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred             cCC-CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence            987 799999999   33    339999976432221100                                        


Q ss_pred             --------------hhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCC
Q psy9858         263 --------------EIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSL  301 (307)
Q Consensus       263 --------------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~  301 (307)
                                    ......++.+.+||.+||+.||++|||++|+|+||||++
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence                          011234567899999999999999999999999999974

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2e-46  Score=327.74  Aligned_cols=248  Identities=24%  Similarity=0.289  Sum_probs=208.4

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS  130 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  130 (307)
                      ....++|.+.+.||+|+||.||+|.+..+++.||+|++......  .......+.+|+.+++.++||||+++++++.+.+
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  114 (335)
T 2owb_A           37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL--KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND  114 (335)
T ss_dssp             TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            34567899999999999999999999999999999999753221  2233566889999999999999999999999999


Q ss_pred             eEEEEEEccC-CChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCC
Q psy9858         131 NVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS  209 (307)
Q Consensus       131 ~~~lv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  209 (307)
                      ..++||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus       115 ~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          115 FVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             eEEEEEecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            9999999995 77888776543 589999999999999999999999999999999999999999999999999988754


Q ss_pred             CCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCCC------hhhhccccCHHHHHHH
Q psy9858         210 PTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGIP------LNEIFTAAGDDLLAVI  276 (307)
Q Consensus       210 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~------~~~~~~~~~~~l~~li  276 (307)
                      .........+|..|+|||.+.+. .++.++|||   +    +++|..||.........      ....+..+++++.+||
T Consensus       194 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  272 (335)
T 2owb_A          194 DGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLI  272 (335)
T ss_dssp             TTCCBCCCCSCCSSCCHHHHHTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHH
T ss_pred             CcccccccCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHH
Confidence            44444556789999999999887 789999999   3    33499998763211100      0112346789999999


Q ss_pred             HHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         277 SSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       277 ~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                      .+||+.||++|||++|+|+||||...
T Consensus       273 ~~~l~~dp~~Rps~~ell~~~~~~~~  298 (335)
T 2owb_A          273 QKMLQTDPTARPTINELLNDEFFTSG  298 (335)
T ss_dssp             HHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             HHHccCChhHCcCHHHHhcCccccCC
Confidence            99999999999999999999999764

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4.5e-47  Score=326.94  Aligned_cols=252  Identities=24%  Similarity=0.322  Sum_probs=183.2

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY  128 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  128 (307)
                      .+....++|++.+.||+|+||.||+|.+..+++.||||++.....    ......+.+|+++++.++||||+++++++..
T Consensus         9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   84 (303)
T 2vwi_A            9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC----QTSMDELLKEIQAMSQCHHPNIVSYYTSFVV   84 (303)
T ss_dssp             ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC--------------------CCCCCCCTTBCCEEEEEES
T ss_pred             ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc----chhHHHHHHHHHHHhhcCCCCEeeEEEEEee
Confidence            345567899999999999999999999888999999999875321    1224567899999999999999999999999


Q ss_pred             cCeEEEEEEcc-CCChHHHHhC-------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEe
Q psy9858         129 MSNVSLVFEFV-DTDLEVIIKD-------PTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGD  200 (307)
Q Consensus       129 ~~~~~lv~e~~-~g~l~~~~~~-------~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~D  200 (307)
                      .+..++||||+ +|+|.+++..       ....+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|
T Consensus        85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~d  164 (303)
T 2vwi_A           85 KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIAD  164 (303)
T ss_dssp             SSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECC
T ss_pred             cCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEe
Confidence            99999999999 6788888863       344589999999999999999999999999999999999999999999999


Q ss_pred             ecCccccCCCC-----cccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCC-----------
Q psy9858         201 FGLAKFFGSPT-----RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFP-----------  257 (307)
Q Consensus       201 fg~a~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~-----------  257 (307)
                      ||++.......     .......+|+.|+|||.+.+...++.++|||   +    +++|..||......           
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  244 (303)
T 2vwi_A          165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP  244 (303)
T ss_dssp             CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSC
T ss_pred             ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCC
Confidence            99998764321     1123457899999999998754789999999   3    33399998762211           


Q ss_pred             -----CCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         258 -----GIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       258 -----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                           ..........+++++.++|.+||+.||.+|||++++++||||++.+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  296 (303)
T 2vwi_A          245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN  296 (303)
T ss_dssp             CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred             CccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence                 01112233467899999999999999999999999999999998764

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.1e-46  Score=324.56  Aligned_cols=248  Identities=20%  Similarity=0.267  Sum_probs=199.9

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN  131 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  131 (307)
                      ...++|++++.||+|+||.||+|.+..+++.||+|++....     ......+.+|+++++.++||||+++++++...+.
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-----EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGK   90 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-C
T ss_pred             CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-----HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCe
Confidence            46678999999999999999999999999999999987532     1224668899999999999999999999999999


Q ss_pred             EEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         132 VSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       132 ~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      .++||||+ +++|.+++......+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++......
T Consensus        91 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (302)
T 2j7t_A           91 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT  170 (302)
T ss_dssp             EEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred             EEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence            99999999 56787777765556999999999999999999999999999999999999999999999999997643221


Q ss_pred             Ccccccceeeceehhhhhhh----ccccccccccee---e----eeecCCCCCCCCCC---------CCChhhhccccCH
Q psy9858         211 TRLYTHQVVTRWYRLIKCLL----YCVQFNVKNVQW---C----CFAKDPSSHGNLFP---------GIPLNEIFTAAGD  270 (307)
Q Consensus       211 ~~~~~~~~~t~~y~aPE~~~----~~~~~~~~~Diw---~----i~~~~~~f~~~~~~---------~~~~~~~~~~~~~  270 (307)
                      ........+++.|+|||.+.    ....++.++|||   +    +++|..||......         ..........++.
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (302)
T 2j7t_A          171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSV  250 (302)
T ss_dssp             HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCH
T ss_pred             ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCH
Confidence            12223457899999999985    233788999999   3    33388998763211         0011112346789


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         271 DLLAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       271 ~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                      ++.++|.+||+.||++|||++++++||||++...
T Consensus       251 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  284 (302)
T 2j7t_A          251 EFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS  284 (302)
T ss_dssp             HHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred             HHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence            9999999999999999999999999999998653

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.4e-45  Score=315.91  Aligned_cols=245  Identities=22%  Similarity=0.273  Sum_probs=201.0

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee-
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY-  128 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-  128 (307)
                      .......|++.+.||+|+||.||+|.+..++..||+|++.....   .....+.+.+|+.+++.++||||+++++++.. 
T Consensus        21 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   97 (290)
T 1t4h_A           21 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL---TKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST   97 (290)
T ss_dssp             ECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred             cccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh---CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccc
Confidence            34455679999999999999999999999999999999975322   22335678899999999999999999998865 


Q ss_pred             ---cCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeecCCCCcEEEe-cCCcEEEEee
Q psy9858         129 ---MSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHW--ILHRDLKPNNLLIN-KQGVLKIGDF  201 (307)
Q Consensus       129 ---~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Df  201 (307)
                         ....++||||+ +|+|.+++.... .+++..++.++.||+.||.|||++|  ++|+||||+||+++ .++.+||+||
T Consensus        98 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Df  176 (290)
T 1t4h_A           98 VKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL  176 (290)
T ss_dssp             SSSCEEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred             cCCCceEEEEEEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeC
Confidence               46699999999 578988887543 4899999999999999999999999  99999999999997 7889999999


Q ss_pred             cCccccCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCC---------CCCChhhhc
Q psy9858         202 GLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLF---------PGIPLNEIF  265 (307)
Q Consensus       202 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~---------~~~~~~~~~  265 (307)
                      |++......  ......+|+.|+|||.+.+  .++.++|||   +    +++|..||.....         .........
T Consensus       177 g~~~~~~~~--~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  252 (290)
T 1t4h_A          177 GLATLKRAS--FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD  252 (290)
T ss_dssp             TGGGGCCTT--SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG
T ss_pred             CCccccccc--ccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccC
Confidence            999765432  2334578999999998764  589999999   3    3339999876221         111222334


Q ss_pred             cccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         266 TAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       266 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                      ...++++.+||.+||+.||.+|||++++|+||||++.
T Consensus       253 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          253 KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             CCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence            4567899999999999999999999999999999864

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3e-46  Score=322.08  Aligned_cols=245  Identities=19%  Similarity=0.261  Sum_probs=206.4

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN  131 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  131 (307)
                      ...+.|++++.||+|+||.||+|.+..+++.||+|++......    .....+.+|+.+++.++||||+++++++.+...
T Consensus        19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   94 (303)
T 3a7i_A           19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE----DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK   94 (303)
T ss_dssp             CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS----TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH----HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence            3456799999999999999999999999999999999854321    224678899999999999999999999999999


Q ss_pred             EEEEEEccC-CChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         132 VSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       132 ~~lv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      .++||||++ ++|.+++...  .+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus        95 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  172 (303)
T 3a7i_A           95 LWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT  172 (303)
T ss_dssp             EEEEEECCTTEEHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred             EEEEEEeCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence            999999995 6788887653  5899999999999999999999999999999999999999999999999999887544


Q ss_pred             Ccccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC-------CChhhhccccCHHHHHHH
Q psy9858         211 TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG-------IPLNEIFTAAGDDLLAVI  276 (307)
Q Consensus       211 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~-------~~~~~~~~~~~~~l~~li  276 (307)
                      ........+++.|+|||.+.+. .++.++|||   +    +++|..||.......       .........++..+.+||
T Consensus       173 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  251 (303)
T 3a7i_A          173 QIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFV  251 (303)
T ss_dssp             BCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHH
T ss_pred             ccccCccCCCcCccCHHHHhcC-CCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHH
Confidence            4344556789999999999887 889999999   3    333999987622110       011122346789999999


Q ss_pred             HHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         277 SSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       277 ~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      .+||+.||.+|||++++++||||.+..
T Consensus       252 ~~~l~~dp~~Rps~~~ll~~~~~~~~~  278 (303)
T 3a7i_A          252 EACLNKEPSFRPTAKELLKHKFILRNA  278 (303)
T ss_dssp             HHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred             HHHcCCChhhCcCHHHHhhChhhhcCC
Confidence            999999999999999999999996543

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.3e-46  Score=321.53  Aligned_cols=247  Identities=22%  Similarity=0.287  Sum_probs=206.2

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN  131 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  131 (307)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++.....  ........+.+|+++++.++||||+++++++.+.+.
T Consensus        11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   88 (284)
T 2vgo_A           11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL--EKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKR   88 (284)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEccccc--chHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCE
Confidence            356789999999999999999999999999999999974211  112234668899999999999999999999999999


Q ss_pred             EEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         132 VSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       132 ~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      .++||||+ +|+|.+++.... .+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           89 IYLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             EEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred             EEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence            99999999 568988887543 5899999999999999999999999999999999999999999999999999776432


Q ss_pred             Ccccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCCC------ChhhhccccCHHHHHHHH
Q psy9858         211 TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPGI------PLNEIFTAAGDDLLAVIS  277 (307)
Q Consensus       211 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~~------~~~~~~~~~~~~l~~li~  277 (307)
                        ......+++.|+|||.+.+. .++.++|||       .+++|..||........      .....+..+++++.++|.
T Consensus       168 --~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  244 (284)
T 2vgo_A          168 --RRRTMCGTLDYLPPEMIEGK-THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLIS  244 (284)
T ss_dssp             --CBCCCCSCGGGCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHH
T ss_pred             --ccccccCCCCcCCHHHhccC-CCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHHH
Confidence              23345789999999999887 789999999       23449999876321110      001123457899999999


Q ss_pred             HhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         278 SLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       278 ~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                      +||+.||.+|||++++++||||+....
T Consensus       245 ~~l~~~p~~Rps~~~ll~h~~~~~~~~  271 (284)
T 2vgo_A          245 KLLRYHPPQRLPLKGVMEHPWVKANSR  271 (284)
T ss_dssp             HHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred             HHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence            999999999999999999999976543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=5.2e-46  Score=320.80  Aligned_cols=242  Identities=23%  Similarity=0.316  Sum_probs=202.2

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|.+.+.||+|+||.||+|++..+|+.||+|++......     ....+.+|+++++.++||||+++++++.+....
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF-----RDSSLENEIAVLKKIKHENIVTLEDIYESTTHY   81 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-----------HHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc-----chHHHHHHHHHHHhCCCCCeeehhhhcccCCEE
Confidence            456899999999999999999999999999999999853211     134578999999999999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEE---ecCCcEEEEeecCccccC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLI---NKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~a~~~~  208 (307)
                      ++||||+ +|+|.+.+.... .+++..+..++.||+.||.|||++|++|+||||+||++   +.++.++|+|||++....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           82 YLVMQLVSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             EEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             EEEEEcCCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            9999999 578888886543 58999999999999999999999999999999999999   788899999999997653


Q ss_pred             CCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC----------CChhhhccccCHH
Q psy9858         209 SPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG----------IPLNEIFTAAGDD  271 (307)
Q Consensus       209 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~----------~~~~~~~~~~~~~  271 (307)
                      ..  ......+++.|+|||.+.+. .++.++|||   +    +++|..||.......          ......+..++++
T Consensus       161 ~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  237 (304)
T 2jam_A          161 NG--IMSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISES  237 (304)
T ss_dssp             CB--TTHHHHSCCCBCCTTTBSSC-SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHH
T ss_pred             CC--ccccccCCCCccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHH
Confidence            32  23445789999999999887 899999999   3    333999987632110          0111233568899


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         272 LLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       272 l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      +.++|.+||+.||++|||++++|+||||++..
T Consensus       238 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          238 AKDFICHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             HHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence            99999999999999999999999999998654

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3e-46  Score=330.83  Aligned_cols=243  Identities=18%  Similarity=0.251  Sum_probs=200.0

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEEc-------CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCcc
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARDI-------ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVL  120 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~  120 (307)
                      .+....++|++++.||+|+||.||+|++.       .++..||||++...    ........+.+|+++++.+ +||||+
T Consensus        75 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hpnIv  150 (370)
T 2psq_A           75 KWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD----ATEKDLSDLVSEMEMMKMIGKHKNII  150 (370)
T ss_dssp             TTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT----CBHHHHHHHHHHHHHHHHSCCCTTBC
T ss_pred             cccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC----cCHHHHHHHHHHHHHHHHhcCCCCEe
Confidence            34556789999999999999999999864       35678999999753    2223356788999999999 899999


Q ss_pred             ccceeeeecCeEEEEEEcc-CCChHHHHhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCC
Q psy9858         121 GLTDVFGYMSNVSLVFEFV-DTDLEVIIKDPT---------------IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK  184 (307)
Q Consensus       121 ~~~~~~~~~~~~~lv~e~~-~g~l~~~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlk  184 (307)
                      ++++++.+.+..|+||||+ +|+|.+++....               ..+++..+..++.||+.||.|||++||+|||||
T Consensus       151 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlk  230 (370)
T 2psq_A          151 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA  230 (370)
T ss_dssp             CEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred             eEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence            9999999999999999999 679999987543               247899999999999999999999999999999


Q ss_pred             CCcEEEecCCcEEEEeecCccccCCCCc--ccccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCC
Q psy9858         185 PNNLLINKQGVLKIGDFGLAKFFGSPTR--LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGN  254 (307)
Q Consensus       185 p~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~  254 (307)
                      |+|||++.++.+||+|||+++.......  ......+|+.|+|||.+.+. .++.++|||       .+++ |..||.+.
T Consensus       231 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~p~~~~  309 (370)
T 2psq_A          231 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGI  309 (370)
T ss_dssp             GGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             hhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            9999999999999999999987654322  22334567899999999887 899999999       3444 88888774


Q ss_pred             CCCCC-------ChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         255 LFPGI-------PLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       255 ~~~~~-------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      .....       .....+..+++++.++|.+||+.||.+|||++|++++
T Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          310 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             CGGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            32211       1122334678999999999999999999999999874

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.7e-46  Score=329.08  Aligned_cols=248  Identities=26%  Similarity=0.434  Sum_probs=190.5

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM  129 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  129 (307)
                      .....++|++.+.||+|+||.||+|++..+|+.||||++.....      ......++++.++.++||||+++++++...
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~~l~~l~h~niv~~~~~~~~~   91 (360)
T 3e3p_A           18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR------FRNRELQIMQDLAVLHHPNIVQLQSYFYTL   91 (360)
T ss_dssp             HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT------CCCHHHHHHHHHHHHCCTTBCCEEEEEEEE
T ss_pred             chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc------ccHHHHHHHHHHHhcCCCCcccHHHhhhcc
Confidence            34567899999999999999999999999999999999864321      123466788888999999999999998654


Q ss_pred             Ce-------EEEEEEccCCChHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHH--HCCceeecCCCCcEEEec-CCcE
Q psy9858         130 SN-------VSLVFEFVDTDLEVIIK---DPTIVFTPSNIKAYAIMTLRGLEYLH--DHWILHRDLKPNNLLINK-QGVL  196 (307)
Q Consensus       130 ~~-------~~lv~e~~~g~l~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~ivH~dlkp~Nil~~~-~~~~  196 (307)
                      ..       .++||||++|++.+.+.   .....+++..+..++.||+.||.|||  ++||+||||||+||+++. ++.+
T Consensus        92 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~  171 (360)
T 3e3p_A           92 GERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTL  171 (360)
T ss_dssp             CSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEE
T ss_pred             ccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcE
Confidence            33       89999999988766554   34556899999999999999999999  999999999999999997 8999


Q ss_pred             EEEeecCccccCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCC------------
Q psy9858         197 KIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFP------------  257 (307)
Q Consensus       197 kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~------------  257 (307)
                      ||+|||++....... ......+|+.|+|||.+.+...++.++|||   +    +++|..||.+....            
T Consensus       172 kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  250 (360)
T 3e3p_A          172 KLCDFGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC  250 (360)
T ss_dssp             EECCCTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             EEeeCCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCC
Confidence            999999998775432 334457899999999998775689999999   3    33499999873210            


Q ss_pred             ----------------------CCChhhhc----cccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         258 ----------------------GIPLNEIF----TAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       258 ----------------------~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                                            .......+    ...++++.+||.+||+.||.+|||++|+|+||||++..+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  323 (360)
T 3e3p_A          251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD  323 (360)
T ss_dssp             CCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred             CCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence                                  00001111    124678999999999999999999999999999987643

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=6.2e-46  Score=322.92  Aligned_cols=248  Identities=23%  Similarity=0.323  Sum_probs=198.6

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccc---cchhhhHhHHHHHHHHHhcCCCCccccceeeeec
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHAD---AKDGINRTALREIKLLQELHHENVLGLTDVFGYM  129 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  129 (307)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++.......   ........+.+|+++++.++||||+++++++..+
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            3468999999999999999999999999999999997543211   1112234578999999999999999999998665


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCc---EEEEeecCcc
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGV---LKIGDFGLAK  205 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~a~  205 (307)
                      . .++||||+ +|+|.+.+.... .+++..++.++.||+.||.|||++|++||||||+||+++.++.   +||+|||++.
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~  165 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK  165 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred             c-eEEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence            5 89999999 568888876543 5899999999999999999999999999999999999987665   9999999998


Q ss_pred             ccCCCCcccccceeeceehhhhhhhc--cccccccccee---e----eeecCCCCCCCCCCCCC-----------hhhhc
Q psy9858         206 FFGSPTRLYTHQVVTRWYRLIKCLLY--CVQFNVKNVQW---C----CFAKDPSSHGNLFPGIP-----------LNEIF  265 (307)
Q Consensus       206 ~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~-----------~~~~~  265 (307)
                      ..... .......+|+.|+|||.+.+  ...++.++|||   +    +++|..||.........           ....+
T Consensus       166 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (322)
T 2ycf_A          166 ILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW  244 (322)
T ss_dssp             ECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHH
T ss_pred             ecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhh
Confidence            87433 22334578999999999853  34789999999   3    33399999764332211           12233


Q ss_pred             cccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         266 TAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       266 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      ..+++++.+||.+||+.||++|||++++|+||||++..
T Consensus       245 ~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~  282 (322)
T 2ycf_A          245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED  282 (322)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHH
T ss_pred             hhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHH
Confidence            56789999999999999999999999999999998653

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.8e-46  Score=331.24  Aligned_cols=244  Identities=22%  Similarity=0.315  Sum_probs=202.2

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN  131 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  131 (307)
                      ...++|++++.||+|+||.||+|.+..+|+.||+|++....    .......+.+|+++++.++||||+++++++.+.+.
T Consensus        30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  105 (360)
T 3eqc_A           30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE  105 (360)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC----CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTE
T ss_pred             cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc----CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCE
Confidence            34678999999999999999999999999999999998532    23345678899999999999999999999999999


Q ss_pred             EEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeecCCCCcEEEecCCcEEEEeecCccccCC
Q psy9858         132 VSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH-WILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS  209 (307)
Q Consensus       132 ~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  209 (307)
                      .++||||+ +|+|.+++.... .+++..+..++.|++.||.|||++ ||+||||||+||+++.++.++|+|||++.....
T Consensus       106 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          106 ISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  184 (360)
T ss_dssp             EEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             EEEEEECCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence            99999999 568988887643 489999999999999999999996 999999999999999999999999999976522


Q ss_pred             CCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC------------------------
Q psy9858         210 PTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG------------------------  258 (307)
Q Consensus       210 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~------------------------  258 (307)
                        .......+|+.|+|||.+.+. .++.++|||   +    +++|..||.......                        
T Consensus       185 --~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3eqc_A          185 --SMANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  261 (360)
T ss_dssp             --HC----CCCCTTCCHHHHTTC-CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred             --ccccCCCCCCCeECHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence              123345789999999999887 899999999   3    334999987521100                        


Q ss_pred             -------------C-------------ChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         259 -------------I-------------PLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       259 -------------~-------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                                   .             ........++.++.+||.+||+.||++|||++|+|+||||++..
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  332 (360)
T 3eqc_A          262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  332 (360)
T ss_dssp             ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence                         0             00000123688999999999999999999999999999998654

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.8e-46  Score=324.02  Aligned_cols=252  Identities=19%  Similarity=0.265  Sum_probs=198.5

Q ss_pred             CCceeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccce
Q psy9858          46 PDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTD  124 (307)
Q Consensus        46 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~  124 (307)
                      ....+....++|++++.||+|+||.||+|++..+|+.||+|++.....      ....+.+|+.+++++ +||||+++++
T Consensus        15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~e~~~l~~l~~h~~i~~~~~   88 (326)
T 2x7f_A           15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD------EEEEIKQEINMLKKYSHHRNIATYYG   88 (326)
T ss_dssp             -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------TTHHHHHHHHHHHHHCCSTTBCCEEE
T ss_pred             cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc------cHHHHHHHHHHHHhccCCCCeeeeee
Confidence            344556678899999999999999999999999999999999975321      135688999999999 7999999999


Q ss_pred             eeee------cCeEEEEEEccC-CChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcE
Q psy9858         125 VFGY------MSNVSLVFEFVD-TDLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVL  196 (307)
Q Consensus       125 ~~~~------~~~~~lv~e~~~-g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~  196 (307)
                      ++..      ....++||||++ |+|.+++... ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.+
T Consensus        89 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~  168 (326)
T 2x7f_A           89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEV  168 (326)
T ss_dssp             EEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCE
T ss_pred             EEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCE
Confidence            9976      568999999995 6899988754 2458999999999999999999999999999999999999999999


Q ss_pred             EEEeecCccccCCCCcccccceeeceehhhhhhhc----cccccccccee---e----eeecCCCCCCCCCCC-------
Q psy9858         197 KIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLY----CVQFNVKNVQW---C----CFAKDPSSHGNLFPG-------  258 (307)
Q Consensus       197 kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~Diw---~----i~~~~~~f~~~~~~~-------  258 (307)
                      ||+|||++..............+++.|+|||.+.+    ...++.++|||   +    +++|..||.......       
T Consensus       169 kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  248 (326)
T 2x7f_A          169 KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR  248 (326)
T ss_dssp             EECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred             EEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc
Confidence            99999999876543333445578999999999873    23688999999   3    333999987622110       


Q ss_pred             -CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         259 -IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       259 -~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                       .........+++.+.+||.+||+.||.+|||++++++||||++..
T Consensus       249 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  294 (326)
T 2x7f_A          249 NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP  294 (326)
T ss_dssp             SCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred             CccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence             000111245789999999999999999999999999999998754

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3e-45  Score=316.93  Aligned_cols=237  Identities=20%  Similarity=0.244  Sum_probs=199.1

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|.+.+.||+|+||+||+|.+..+++.||+|++...     .....+.+.+|+++++.++||||+++++++.+....
T Consensus         8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   82 (310)
T 3s95_A            8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-----DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRL   82 (310)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-----CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCee
Confidence            467899999999999999999999999999999998542     233356788999999999999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT  211 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  211 (307)
                      ++||||+ +|+|.+++......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  162 (310)
T 3s95_A           83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK  162 (310)
T ss_dssp             EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred             EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence            9999999 679999998766679999999999999999999999999999999999999999999999999998764322


Q ss_pred             cc--------------cccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCCCh---------
Q psy9858         212 RL--------------YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGIPL---------  261 (307)
Q Consensus       212 ~~--------------~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~~---------  261 (307)
                      ..              .....||+.|+|||.+.+. .++.++|||   +    +++|..|+..........         
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~  241 (310)
T 3s95_A          163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR-SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD  241 (310)
T ss_dssp             -----------------CCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred             ccccccccccccccccccccCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence            11              1145789999999999887 899999999   3    333777776532222111         


Q ss_pred             hhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         262 NEIFTAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       262 ~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      ...+..+++.+.+++.+||+.||++|||++++++
T Consensus       242 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          242 RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            1123567899999999999999999999999986

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-45  Score=319.18  Aligned_cols=241  Identities=18%  Similarity=0.198  Sum_probs=196.7

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC-
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS-  130 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-  130 (307)
                      ...++|++.+.||+|+||+||+|.+..+|+.||||++....    .......+.+|+++++.++||||+++++++.... 
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   81 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS----FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT   81 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG----GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred             CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccc----ccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCC
Confidence            34578999999999999999999999999999999997422    1222456789999999999999999999987655 


Q ss_pred             -eEEEEEEcc-CCChHHHHhCCCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEE----ecCCcEEEEeec
Q psy9858         131 -NVSLVFEFV-DTDLEVIIKDPTI--VFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLI----NKQGVLKIGDFG  202 (307)
Q Consensus       131 -~~~lv~e~~-~g~l~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~----~~~~~~kl~Dfg  202 (307)
                       ..++||||+ +|+|.+++.....  .+++..++.++.||+.||.|||++||+||||||+||++    +.++.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg  161 (319)
T 4euu_A           82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG  161 (319)
T ss_dssp             CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred             ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence             789999999 5789998876432  38999999999999999999999999999999999999    777789999999


Q ss_pred             CccccCCCCcccccceeeceehhhhhhhc-------cccccccccee---e----eeecCCCCCCCCCCCC---------
Q psy9858         203 LAKFFGSPTRLYTHQVVTRWYRLIKCLLY-------CVQFNVKNVQW---C----CFAKDPSSHGNLFPGI---------  259 (307)
Q Consensus       203 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~---------  259 (307)
                      +++...... ......+|+.|+|||++..       ...++.++|||   +    +++|..||........         
T Consensus       162 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  240 (319)
T 4euu_A          162 AARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (319)
T ss_dssp             TCEECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred             CceecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence            998875433 3344578999999999873       23789999999   3    3339999864211110         


Q ss_pred             --------------------------ChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCc
Q psy9858         260 --------------------------PLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMD  297 (307)
Q Consensus       260 --------------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp  297 (307)
                                                ........+++.+.++|.+||+.||++|||++|+|+||
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence                                      00112234567889999999999999999999999987

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.9e-46  Score=317.85  Aligned_cols=247  Identities=20%  Similarity=0.255  Sum_probs=197.1

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|.+++.||+|+||.||+|.+..+|+.||+|++.....  ........+.+|+++++.++||||+++++++......
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   86 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI--RSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF   86 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccc--cchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence            45789999999999999999999999999999999974211  1122345688999999999999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT  211 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  211 (307)
                      ++||||+ +++|.+++.... .+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++...... 
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~-  164 (276)
T 2h6d_A           87 FMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-  164 (276)
T ss_dssp             EEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             EEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC-
Confidence            9999999 578988887543 4899999999999999999999999999999999999999999999999999877443 


Q ss_pred             cccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCCC------hhhhccccCHHHHHHHHH
Q psy9858         212 RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGIP------LNEIFTAAGDDLLAVISS  278 (307)
Q Consensus       212 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~------~~~~~~~~~~~l~~li~~  278 (307)
                      .......+++.|+|||.+.+....+.++|||   +    +++|..||.........      ....+..++.++.++|.+
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  244 (276)
T 2h6d_A          165 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMH  244 (276)
T ss_dssp             ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred             cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHHHH
Confidence            2234457899999999998874557999999   2    33499998763211100      001234578999999999


Q ss_pred             hhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         279 LLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       279 ~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      ||+.||.+|||++++++||||++.-
T Consensus       245 ~l~~~p~~Rps~~~~l~h~~~~~~~  269 (276)
T 2h6d_A          245 MLQVDPLKRATIKDIREHEWFKQDL  269 (276)
T ss_dssp             HTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             HccCChhhCCCHHHHHhChhhccCc
Confidence            9999999999999999999997654

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.7e-45  Score=316.76  Aligned_cols=245  Identities=23%  Similarity=0.246  Sum_probs=194.6

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee----
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY----  128 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----  128 (307)
                      ..++|++++.||+|+||.||+|++..+|+.||||++..      .......+.+|+++++.++||||+++++++.+    
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   77 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH------TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNF   77 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE------EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCC
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec------cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcch
Confidence            45689999999999999999999999999999999863      12234678899999999999999999998754    


Q ss_pred             ---------cCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEE
Q psy9858         129 ---------MSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKI  198 (307)
Q Consensus       129 ---------~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl  198 (307)
                               ....++||||+ +|+|.+++......+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||
T Consensus        78 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl  157 (303)
T 1zy4_A           78 VKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKI  157 (303)
T ss_dssp             CC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEE
T ss_pred             hhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEE
Confidence                     46799999999 57999999876667889999999999999999999999999999999999999999999


Q ss_pred             EeecCccccCCC--------------Ccccccceeeceehhhhhhhccccccccccee---eeee-cCCCCCCC------
Q psy9858         199 GDFGLAKFFGSP--------------TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA-KDPSSHGN------  254 (307)
Q Consensus       199 ~Dfg~a~~~~~~--------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~-~~~~f~~~------  254 (307)
                      +|||++......              ........+++.|+|||.+.+...++.++|||   ++++ --.||...      
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~p~~~~~~~~~~  237 (303)
T 1zy4_A          158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNI  237 (303)
T ss_dssp             CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHH
T ss_pred             eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHhccCCchhHHHH
Confidence            999999876422              11223457899999999998765789999999   3333 11144320      


Q ss_pred             -----CCCCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         255 -----LFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       255 -----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                           ..............++.+.++|.+||+.||.+|||++++++||||+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (303)
T 1zy4_A          238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH  291 (303)
T ss_dssp             HHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCC
T ss_pred             HHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCC
Confidence                 0011111223345678899999999999999999999999999998654

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.4e-45  Score=318.86  Aligned_cols=251  Identities=20%  Similarity=0.195  Sum_probs=194.6

Q ss_pred             CCCceeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccce
Q psy9858          45 LPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTD  124 (307)
Q Consensus        45 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~  124 (307)
                      +....+....++|++.+.||+|+||+||+|++  +|+.||||++.....   .......+.+|++++++++||||+++++
T Consensus        27 ~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~  101 (309)
T 3p86_A           27 MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF---HAERVNEFLREVAIMKRLRHPNIVLFMG  101 (309)
T ss_dssp             -----CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC---SHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CCcccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            44455666788999999999999999999986  688999999975432   2223467889999999999999999999


Q ss_pred             eeeecCeEEEEEEcc-CCChHHHHhCCCC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceeecCCCCcEEEecCCcEEEE
Q psy9858         125 VFGYMSNVSLVFEFV-DTDLEVIIKDPTI--VFTPSNIKAYAIMTLRGLEYLHDHW--ILHRDLKPNNLLINKQGVLKIG  199 (307)
Q Consensus       125 ~~~~~~~~~lv~e~~-~g~l~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~  199 (307)
                      ++.+....++||||+ +|+|.+++.....  .+++..+..++.||+.||.|||++|  |+||||||+||+++.++.+||+
T Consensus       102 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~  181 (309)
T 3p86_A          102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVC  181 (309)
T ss_dssp             EECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEEC
T ss_pred             EEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEEC
Confidence            999999999999999 5789998876542  3899999999999999999999999  9999999999999999999999


Q ss_pred             eecCccccCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCC--------CCChhhh
Q psy9858         200 DFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFP--------GIPLNEI  264 (307)
Q Consensus       200 Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~--------~~~~~~~  264 (307)
                      |||+++.............||+.|+|||.+.+. .++.++|||   +    +++|..||.+....        .......
T Consensus       182 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  260 (309)
T 3p86_A          182 DFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEI  260 (309)
T ss_dssp             CCC-----------------CCTTSCHHHHTTC-CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCC
T ss_pred             CCCCCccccccccccccCCCCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC
Confidence            999998765443334556889999999999887 789999999   3    33499999873211        1111233


Q ss_pred             ccccCHHHHHHHHHhhhcCCCCCCCHHHHhc--CcccCC
Q psy9858         265 FTAAGDDLLAVISSLLCLNPTKRADCTATLK--MDYFSL  301 (307)
Q Consensus       265 ~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~--hp~f~~  301 (307)
                      +..+++++.+||.+||+.||.+|||++++++  .++++.
T Consensus       261 ~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          261 PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            4568999999999999999999999999988  455443

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2e-45  Score=315.55  Aligned_cols=247  Identities=23%  Similarity=0.294  Sum_probs=198.3

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|.....||+|+||.||+|.+..+++.||+|++....     ....+.+.+|+.+++.++||||+++++++...+..
T Consensus        20 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   94 (295)
T 2clq_A           20 EYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-----SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFI   94 (295)
T ss_dssp             CBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-----C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             cccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-----hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcE
Confidence            3444555569999999999999999999999999997532     22246688999999999999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEec-CCcEEEEeecCccccC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPT--IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK-QGVLKIGDFGLAKFFG  208 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~a~~~~  208 (307)
                      ++||||+ +++|.+++....  ..+++..+..++.||+.||.|||++|++|+||||+||+++. ++.++|+|||++....
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~  174 (295)
T 2clq_A           95 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA  174 (295)
T ss_dssp             EEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred             EEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence            9999999 578888887543  24678899999999999999999999999999999999997 8999999999998775


Q ss_pred             CCCcccccceeeceehhhhhhhcc-ccccccccee-------eeeecCCCCCCCCCCC---------CChhhhccccCHH
Q psy9858         209 SPTRLYTHQVVTRWYRLIKCLLYC-VQFNVKNVQW-------CCFAKDPSSHGNLFPG---------IPLNEIFTAAGDD  271 (307)
Q Consensus       209 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~Diw-------~i~~~~~~f~~~~~~~---------~~~~~~~~~~~~~  271 (307)
                      ..........+++.|+|||.+.+. ..++.++|||       .+++|..||.......         ......+..++++
T Consensus       175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (295)
T 2clq_A          175 GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAE  254 (295)
T ss_dssp             C-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHH
T ss_pred             CCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHH
Confidence            433334455789999999999775 2478999999       2334999986522111         0111234567899


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         272 LLAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       272 l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                      +.++|.+||+.||++|||++++|+||||+...+
T Consensus       255 ~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  287 (295)
T 2clq_A          255 AKAFILKCFEPDPDKRACANDLLVDEFLKVSSK  287 (295)
T ss_dssp             HHHHHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred             HHHHHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence            999999999999999999999999999987654

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.3e-46  Score=319.00  Aligned_cols=248  Identities=22%  Similarity=0.307  Sum_probs=203.8

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeee--ecC
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG--YMS  130 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~--~~~  130 (307)
                      ..++|++++.||+|+||.||+|.+..+|+.||+|++......   ....+.+.+|+++++.++||||+++++++.  ...
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT---EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT   80 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC---HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGT
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC---HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCc
Confidence            467999999999999999999999999999999999864322   223567889999999999999999999874  467


Q ss_pred             eEEEEEEccC-CChHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeecCCCCcEEEecCCcEEEEee
Q psy9858         131 NVSLVFEFVD-TDLEVIIKDP---TIVFTPSNIKAYAIMTLRGLEYLHDHW-----ILHRDLKPNNLLINKQGVLKIGDF  201 (307)
Q Consensus       131 ~~~lv~e~~~-g~l~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~-----ivH~dlkp~Nil~~~~~~~kl~Df  201 (307)
                      ..++||||+. |+|.+++...   ...+++..+..++.||+.||.|||++|     ++|+||||+||+++.++.+||+||
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df  160 (279)
T 2w5a_A           81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF  160 (279)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred             eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence            8999999994 6898888642   334899999999999999999999999     999999999999999999999999


Q ss_pred             cCccccCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC-------CChhhhccc
Q psy9858         202 GLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG-------IPLNEIFTA  267 (307)
Q Consensus       202 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~-------~~~~~~~~~  267 (307)
                      |++..............+++.|+|||.+.+. .++.++|||   +    +++|..||.......       ......+..
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~  239 (279)
T 2w5a_A          161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR  239 (279)
T ss_dssp             CHHHHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred             chheeeccccccccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcc
Confidence            9998775443334455789999999999887 889999999   3    334999987732110       111123346


Q ss_pred             cCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         268 AGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       268 ~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                      +++++.++|.+||+.||++|||++|+|+|+|+.+..+
T Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~  276 (279)
T 2w5a_A          240 YSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHH  276 (279)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGS
T ss_pred             cCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhcc
Confidence            7899999999999999999999999999999987654

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-45  Score=325.25  Aligned_cols=253  Identities=19%  Similarity=0.223  Sum_probs=204.2

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEEc---CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccce
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARDI---ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTD  124 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~  124 (307)
                      ......++|++++.||+|+||.||+|++.   .+|+.||||++....... .......+.+|+++++.+ +||||+++++
T Consensus        48 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~  126 (355)
T 1vzo_A           48 AEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ-KAKTTEHTRTERQVLEHIRQSPFLVTLHY  126 (355)
T ss_dssp             CCCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEE-EESSGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred             cccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhh-hhhHHHHHHHHHHHHHHccCCCceeEEEE
Confidence            33446689999999999999999999984   589999999987532111 112234566899999999 6999999999


Q ss_pred             eeeecCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecC
Q psy9858         125 VFGYMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGL  203 (307)
Q Consensus       125 ~~~~~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  203 (307)
                      ++......++||||+ +|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus       127 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~  205 (355)
T 1vzo_A          127 AFQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL  205 (355)
T ss_dssp             EEEETTEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             EEeeCceEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCC
Confidence            999999999999999 578988887543 589999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCC-cccccceeeceehhhhhhhcc-ccccccccee---e----eeecCCCCCCCCCCCCC----------hhhh
Q psy9858         204 AKFFGSPT-RLYTHQVVTRWYRLIKCLLYC-VQFNVKNVQW---C----CFAKDPSSHGNLFPGIP----------LNEI  264 (307)
Q Consensus       204 a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~-~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~----------~~~~  264 (307)
                      ++...... .......||+.|+|||.+.+. ..++.++|||   +    +++|..||.........          ....
T Consensus       206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  285 (355)
T 1vzo_A          206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY  285 (355)
T ss_dssp             EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCC
T ss_pred             CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCC
Confidence            98764322 223345789999999999863 3578999999   3    33499999764332211          1122


Q ss_pred             ccccCHHHHHHHHHhhhcCCCCCC-----CHHHHhcCcccCCCc
Q psy9858         265 FTAAGDDLLAVISSLLCLNPTKRA-----DCTATLKMDYFSLTK  303 (307)
Q Consensus       265 ~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~hp~f~~~~  303 (307)
                      +..++..+.+||.+||+.||++||     |++++++||||++..
T Consensus       286 ~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~  329 (355)
T 1vzo_A          286 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  329 (355)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence            346789999999999999999999     999999999998753

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3.2e-45  Score=314.52  Aligned_cols=244  Identities=23%  Similarity=0.236  Sum_probs=197.9

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|++++.||+|+||.||+|.+..+++.||+|++.....  ......+.+.+|+.+++.++||||+++++++.+.+..
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~   86 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR--EKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY   86 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSS--CCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcc--ccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence            34679999999999999999999999999999999975432  2233456788999999999999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT  211 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  211 (307)
                      ++||||+ +|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        87 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  165 (294)
T 4eqm_A           87 YLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS  165 (294)
T ss_dssp             EEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred             EEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence            9999999 568988887553 58999999999999999999999999999999999999999999999999998764332


Q ss_pred             -cccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCC-----------CCChhhhccccCHHH
Q psy9858         212 -RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFP-----------GIPLNEIFTAAGDDL  272 (307)
Q Consensus       212 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~-----------~~~~~~~~~~~~~~l  272 (307)
                       .......||+.|+|||.+.+. .++.++|||       .+++|..||.+....           ..........+++.+
T Consensus       166 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  244 (294)
T 4eqm_A          166 LTQTNHVLGTVQYFSPEQAKGE-ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSL  244 (294)
T ss_dssp             ---------CCSSCCHHHHHTC-CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHH
T ss_pred             ccccCccccCccccCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHH
Confidence             223345789999999999887 789999999       334499999873211           111223345689999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHhcCcccC
Q psy9858         273 LAVISSLLCLNPTKRADCTATLKMDYFS  300 (307)
Q Consensus       273 ~~li~~~l~~dP~~Rpt~~~il~hp~f~  300 (307)
                      .++|.+||+.||++||+..+.+.+.|..
T Consensus       245 ~~li~~~l~~dp~~R~~~~~~l~~~l~~  272 (294)
T 4eqm_A          245 SNVILRATEKDKANRYKTIQEMKDDLSS  272 (294)
T ss_dssp             HHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred             HHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence            9999999999999999766666665543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.5e-46  Score=323.87  Aligned_cols=246  Identities=22%  Similarity=0.276  Sum_probs=197.4

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC-
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS-  130 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-  130 (307)
                      ...++|++++.||+|+||.||+|++..+++.||||++......  .......+.+|+++++.++||||+++++++.... 
T Consensus         9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   86 (311)
T 3ork_A            9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLAR--DPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP   86 (311)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTT--SHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET
T ss_pred             eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccC--CHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC
Confidence            3567899999999999999999999999999999999864322  2333567889999999999999999999987654 


Q ss_pred             ---eEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         131 ---NVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       131 ---~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                         ..|+||||+ +|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus        87 ~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  165 (311)
T 3ork_A           87 AGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA  165 (311)
T ss_dssp             TEEEEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred             CCcccEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence               359999999 578888887543 589999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCc---ccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCC----------CCCChhhhcc
Q psy9858         207 FGSPTR---LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLF----------PGIPLNEIFT  266 (307)
Q Consensus       207 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~----------~~~~~~~~~~  266 (307)
                      ......   ......||+.|+|||.+.+. .++.++|||   +    +++|..||.+...          ..........
T Consensus       166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (311)
T 3ork_A          166 IADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE  244 (311)
T ss_dssp             ----------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHST
T ss_pred             ccccccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccC
Confidence            643221   22334689999999999887 899999999   3    3449999977321          1112223335


Q ss_pred             ccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCC
Q psy9858         267 AAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSL  301 (307)
Q Consensus       267 ~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~  301 (307)
                      .+++++.++|.+||+.||++||++.++|.|+|++.
T Consensus       245 ~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          245 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            68999999999999999999999999999999863

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.5e-45  Score=319.70  Aligned_cols=243  Identities=24%  Similarity=0.327  Sum_probs=199.3

Q ss_pred             ccceeeEEeEEeecCceEEEEEEE-cCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCC------Ccccccee
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARD-IETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHE------NVLGLTDV  125 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~------ni~~~~~~  125 (307)
                      ..++|++++.||+|+||+||+|.+ ..+++.||+|++...      ......+.+|+++++.++|+      ++++++++
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~   85 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV------DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEW   85 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS------HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEE
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC------CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecc
Confidence            346899999999999999999998 568899999998632      22345678999999988755      49999999


Q ss_pred             eeecCeEEEEEEccCCChHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEec------------
Q psy9858         126 FGYMSNVSLVFEFVDTDLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK------------  192 (307)
Q Consensus       126 ~~~~~~~~lv~e~~~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~------------  192 (307)
                      +...+..++||||++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.            
T Consensus        86 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           86 FEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             EEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred             cccCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccc
Confidence            99999999999999999999987654 35889999999999999999999999999999999999987            


Q ss_pred             -------CCcEEEEeecCccccCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC
Q psy9858         193 -------QGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG  258 (307)
Q Consensus       193 -------~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~  258 (307)
                             ++.+||+|||++......   .....+|+.|+|||.+.+. .++.++|||   +    +++|..||.......
T Consensus       166 ~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  241 (339)
T 1z57_A          166 RDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE  241 (339)
T ss_dssp             CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred             cccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence                   668999999999875432   2345789999999999887 889999999   3    334999987632110


Q ss_pred             C-----------Ch---------------------------------------hhhccccCHHHHHHHHHhhhcCCCCCC
Q psy9858         259 I-----------PL---------------------------------------NEIFTAAGDDLLAVISSLLCLNPTKRA  288 (307)
Q Consensus       259 ~-----------~~---------------------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rp  288 (307)
                      .           +.                                       .......++++.+||.+||+.||.+||
T Consensus       242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  321 (339)
T 1z57_A          242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI  321 (339)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence            0           00                                       000112357789999999999999999


Q ss_pred             CHHHHhcCcccCCCccc
Q psy9858         289 DCTATLKMDYFSLTKEM  305 (307)
Q Consensus       289 t~~~il~hp~f~~~~~~  305 (307)
                      |++|+++||||+..++.
T Consensus       322 t~~ell~hp~f~~~~~~  338 (339)
T 1z57_A          322 TLREALKHPFFDLLKKS  338 (339)
T ss_dssp             CHHHHTTSGGGGGGGC-
T ss_pred             CHHHHhcCHHHHHHhcc
Confidence            99999999999988753

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3e-46  Score=324.69  Aligned_cols=256  Identities=20%  Similarity=0.232  Sum_probs=205.4

Q ss_pred             CCCceeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccch-hhhHhHHHHHHHHHhcC--CCCccc
Q psy9858          45 LPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKD-GINRTALREIKLLQELH--HENVLG  121 (307)
Q Consensus        45 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~~~~e~~~l~~l~--h~ni~~  121 (307)
                      .+........++|++.+.||+|+||.||+|.+..+++.||||++.......... .....+.+|+.+++.++  |+||++
T Consensus        33 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~  112 (320)
T 3a99_A           33 APGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR  112 (320)
T ss_dssp             -------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCC
T ss_pred             CcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceE
Confidence            344455567788999999999999999999999999999999998643222111 12245668999999996  599999


Q ss_pred             cceeeeecCeEEEEEEccC--CChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEe-cCCcEEE
Q psy9858         122 LTDVFGYMSNVSLVFEFVD--TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLIN-KQGVLKI  198 (307)
Q Consensus       122 ~~~~~~~~~~~~lv~e~~~--g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~-~~~~~kl  198 (307)
                      +++++...+..+++||++.  ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||
T Consensus       113 ~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL  191 (320)
T 3a99_A          113 LLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKL  191 (320)
T ss_dssp             EEEEEECSSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEE
T ss_pred             EEEEEecCCcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEE
Confidence            9999999999999999995  78888887643 589999999999999999999999999999999999999 7889999


Q ss_pred             EeecCccccCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCCChhhhccccCHH
Q psy9858         199 GDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGIPLNEIFTAAGDD  271 (307)
Q Consensus       199 ~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~~~~~~~~~~~~  271 (307)
                      +|||++......  ......+|+.|+|||.+.+...++.++|||   +    +++|..||................++++
T Consensus       192 ~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  269 (320)
T 3a99_A          192 IDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSE  269 (320)
T ss_dssp             CCCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCCCCSSCCCHH
T ss_pred             eeCccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhcccccccccCCHH
Confidence            999999887432  234457899999999998875568999999   3    3349999876211000011123467899


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         272 LLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       272 l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      +.+||.+||+.||++|||++++++||||++..
T Consensus       270 ~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          270 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence            99999999999999999999999999998764

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=3.8e-45  Score=325.23  Aligned_cols=244  Identities=25%  Similarity=0.350  Sum_probs=197.1

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-CC-----Cccccce
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-HE-----NVLGLTD  124 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----ni~~~~~  124 (307)
                      ....++|++.+.||+|+||+||+|.+..+++.||||++...      ......+.+|+++++.++ |+     +|+++++
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~  123 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK------KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR  123 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS------HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc------HHHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence            34568999999999999999999999999999999999732      223456778999988885 55     4999999


Q ss_pred             eeeecCeEEEEEEccCCChHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHH--HCCceeecCCCCcEEEe--cCCcEEEE
Q psy9858         125 VFGYMSNVSLVFEFVDTDLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLH--DHWILHRDLKPNNLLIN--KQGVLKIG  199 (307)
Q Consensus       125 ~~~~~~~~~lv~e~~~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH--~~~ivH~dlkp~Nil~~--~~~~~kl~  199 (307)
                      ++...+..++||||++|+|.+++.... ..+++..++.++.||+.||.|||  +.||+||||||+|||++  .++.+||+
T Consensus       124 ~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~  203 (382)
T 2vx3_A          124 HFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIV  203 (382)
T ss_dssp             EEEETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred             eeccCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEE
Confidence            999999999999999999999987653 45899999999999999999999  57999999999999995  47789999


Q ss_pred             eecCccccCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC--------------
Q psy9858         200 DFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG--------------  258 (307)
Q Consensus       200 Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~--------------  258 (307)
                      |||++......   .....+|+.|+|||++.+. .++.++|||   +    +++|..||.+.....              
T Consensus       204 DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  279 (382)
T 2vx3_A          204 DFGSSCQLGQR---IYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPA  279 (382)
T ss_dssp             CCTTCEETTCC---CCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred             eccCceecccc---cccccCCccccChHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            99999877432   2345889999999999988 799999999   3    344999998721100              


Q ss_pred             ------CChhhhcc--------------------------------------------------ccCHHHHHHHHHhhhc
Q psy9858         259 ------IPLNEIFT--------------------------------------------------AAGDDLLAVISSLLCL  282 (307)
Q Consensus       259 ------~~~~~~~~--------------------------------------------------~~~~~l~~li~~~l~~  282 (307)
                            ......+.                                                  ..++++.+||.+||+.
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~  359 (382)
T 2vx3_A          280 HILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDY  359 (382)
T ss_dssp             HHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCS
T ss_pred             HHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCC
Confidence                  00000000                                                  0114789999999999


Q ss_pred             CCCCCCCHHHHhcCcccCCCcc
Q psy9858         283 NPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       283 dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                      ||++|||++|+|+||||++..+
T Consensus       360 dP~~Rpta~e~L~hp~f~~~~~  381 (382)
T 2vx3_A          360 DPKTRIQPYYALQHSFFKKTAD  381 (382)
T ss_dssp             CTTTSCCHHHHTTSGGGCC---
T ss_pred             ChhhCCCHHHHhcCcccccCCC
Confidence            9999999999999999987653

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.1e-45  Score=320.21  Aligned_cols=253  Identities=16%  Similarity=0.204  Sum_probs=185.8

Q ss_pred             CCceeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHH-HHHhcCCCCccccce
Q psy9858          46 PDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIK-LLQELHHENVLGLTD  124 (307)
Q Consensus        46 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~ni~~~~~  124 (307)
                      +...+....++|++++.||+|+||.||+|.+..+|+.||||++....    .......+.+|+. +++.++||||+++++
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~~~~h~niv~~~~   88 (327)
T 3aln_A           13 PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV----DEKEQKQLLMDLDVVMRSSDCPYIVQFYG   88 (327)
T ss_dssp             CCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC----CHHHHHHHHHHHHHHHSSCCCTTBCCEEE
T ss_pred             hHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc----CchHHHHHHHHHHHHHHcCCCCcEeeeee
Confidence            34456667789999999999999999999999999999999998542    1222345556665 677789999999999


Q ss_pred             eeeecCeEEEEEEccCCChHHHHhC----CCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeecCCCCcEEEecCCcEEEE
Q psy9858         125 VFGYMSNVSLVFEFVDTDLEVIIKD----PTIVFTPSNIKAYAIMTLRGLEYLHDH-WILHRDLKPNNLLINKQGVLKIG  199 (307)
Q Consensus       125 ~~~~~~~~~lv~e~~~g~l~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~  199 (307)
                      ++...+..++||||+.|+|.+++..    ....+++..+..++.|++.||.|||+. |++||||||+||+++.++.+||+
T Consensus        89 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~  168 (327)
T 3aln_A           89 ALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLC  168 (327)
T ss_dssp             EEECSSEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEEC
T ss_pred             EEEeCCceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEc
Confidence            9999999999999999888777752    244689999999999999999999999 99999999999999999999999


Q ss_pred             eecCccccCCCCcccccceeeceehhhhhhh---ccccccccccee---e----eeecCCCCCCCCCC--------CCC-
Q psy9858         200 DFGLAKFFGSPTRLYTHQVVTRWYRLIKCLL---YCVQFNVKNVQW---C----CFAKDPSSHGNLFP--------GIP-  260 (307)
Q Consensus       200 Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~~Diw---~----i~~~~~~f~~~~~~--------~~~-  260 (307)
                      |||++...... .......+|+.|+|||.+.   ....++.++|||   +    +++|..||.+....        ... 
T Consensus       169 Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  247 (327)
T 3aln_A          169 DFGISGQLVDS-IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDP  247 (327)
T ss_dssp             CCSSSCC-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCC
T ss_pred             cCCCceecccc-cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCC
Confidence            99999876433 2233447899999999984   223689999999   3    33499998762211        000 


Q ss_pred             ---hhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         261 ---LNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       261 ---~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                         .......+++++.+||.+||+.||++|||++++++||||....
T Consensus       248 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  293 (327)
T 3aln_A          248 PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE  293 (327)
T ss_dssp             CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence               0111235789999999999999999999999999999997644

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.7e-45  Score=319.27  Aligned_cols=240  Identities=18%  Similarity=0.200  Sum_probs=196.8

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCc---EEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDM---IVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY  128 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  128 (307)
                      ...++|++.+.||+|+||.||+|.+..+++   .||||++....    .....+.+.+|+++++.++||||+++++++.+
T Consensus        46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  121 (325)
T 3kul_A           46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY----TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR  121 (325)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred             cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            456789999999999999999999875554   59999997432    23335678899999999999999999999999


Q ss_pred             cCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         129 MSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       129 ~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      ....++||||+ +|+|.+++......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            99999999999 67999999877667999999999999999999999999999999999999999999999999999887


Q ss_pred             CCCCcc---cccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCCC-------CChhhhccccC
Q psy9858         208 GSPTRL---YTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFPG-------IPLNEIFTAAG  269 (307)
Q Consensus       208 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~~-------~~~~~~~~~~~  269 (307)
                      ......   .....+|+.|+|||.+.+. .++.++|||       .+++ |..||.+.....       ......+..++
T Consensus       202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (325)
T 3kul_A          202 EDDPDAAYTTTGGKIPIRWTAPEAIAFR-TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCP  280 (325)
T ss_dssp             C----CCEECC---CCGGGSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCC
T ss_pred             ccCccceeeccCCCCcccccCHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcC
Confidence            543221   2223457789999999887 899999999       2444 888887622110       11112234678


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         270 DDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       270 ~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      +++.+||.+||+.||++|||++++++.
T Consensus       281 ~~l~~li~~~l~~dp~~Rps~~eil~~  307 (325)
T 3kul_A          281 HALHQLMLDCWHKDRAQRPRFSQIVSV  307 (325)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            999999999999999999999999863

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.2e-46  Score=323.22  Aligned_cols=250  Identities=21%  Similarity=0.208  Sum_probs=194.0

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccc-hhhhHhHHHHHHHHHhc----CCCCccccceee
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAK-DGINRTALREIKLLQEL----HHENVLGLTDVF  126 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~~~e~~~l~~l----~h~ni~~~~~~~  126 (307)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++......... ......+.+|+.++.++    +|+||+++++++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~  107 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF  107 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence            3557899999999999999999999999999999999764322211 01123456799999998    899999999999


Q ss_pred             eecCeEEEEEEc-c-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEe-cCCcEEEEeecC
Q psy9858         127 GYMSNVSLVFEF-V-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLIN-KQGVLKIGDFGL  203 (307)
Q Consensus       127 ~~~~~~~lv~e~-~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~  203 (307)
                      ...+..++|||+ + +++|.+++.... .+++..++.++.||+.||.|||++|++||||||+||+++ .++.+||+|||+
T Consensus       108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~  186 (312)
T 2iwi_A          108 ETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS  186 (312)
T ss_dssp             -----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred             ecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence            999999999999 5 578988887643 589999999999999999999999999999999999999 889999999999


Q ss_pred             ccccCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCCChhhhccccCHHHHHHH
Q psy9858         204 AKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGIPLNEIFTAAGDDLLAVI  276 (307)
Q Consensus       204 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~~~~~~~~~~~~l~~li  276 (307)
                      +......  ......++..|+|||.+.+....+.++|||   +    +++|..||................+++++.++|
T Consensus       187 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~li  264 (312)
T 2iwi_A          187 GALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVSPDCCALI  264 (312)
T ss_dssp             CEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHTCCCCCTTSCHHHHHHH
T ss_pred             hhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhhhccCCcccCCHHHHHHH
Confidence            9887543  234457899999999998874557799999   3    334999987621111111122356789999999


Q ss_pred             HHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         277 SSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       277 ~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                      .+||+.||++|||++|+++||||+...+
T Consensus       265 ~~~l~~~p~~Rps~~e~l~~~~~~~~~~  292 (312)
T 2iwi_A          265 RRCLAPKPSSRPSLEEILLDPWMQTPAE  292 (312)
T ss_dssp             HHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred             HHHccCChhhCcCHHHHhcChhhcCchh
Confidence            9999999999999999999999998764

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=318.02  Aligned_cols=250  Identities=23%  Similarity=0.268  Sum_probs=200.3

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceee--eecC
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVF--GYMS  130 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~--~~~~  130 (307)
                      ..++|++++.||+|+||.||+|.+..+++.||+|++....... .......+.+|+++++.++||||+++++++  .+..
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRR-IPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ   81 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHH-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccc-cchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence            3578999999999999999999999999999999997532111 112346688999999999999999999998  4556


Q ss_pred             eEEEEEEccCCChHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCC
Q psy9858         131 NVSLVFEFVDTDLEVIIKD-PTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS  209 (307)
Q Consensus       131 ~~~lv~e~~~g~l~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  209 (307)
                      ..++||||+.+++.+++.. ....+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus        82 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~  161 (305)
T 2wtk_C           82 KMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP  161 (305)
T ss_dssp             CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             eEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence            8999999998778777764 344689999999999999999999999999999999999999999999999999987643


Q ss_pred             C--Ccccccceeeceehhhhhhhccc-cccccccee---e----eeecCCCCCCCCCCCCC------hhhhccccCHHHH
Q psy9858         210 P--TRLYTHQVVTRWYRLIKCLLYCV-QFNVKNVQW---C----CFAKDPSSHGNLFPGIP------LNEIFTAAGDDLL  273 (307)
Q Consensus       210 ~--~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~Diw---~----i~~~~~~f~~~~~~~~~------~~~~~~~~~~~l~  273 (307)
                      .  ........+|+.|+|||.+.+.. .++.++|||   +    +++|..||.+.......      ....+..+++.+.
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~  241 (305)
T 2wtk_C          162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLS  241 (305)
T ss_dssp             TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHH
T ss_pred             cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHHH
Confidence            2  22234457899999999998642 357899999   3    33499998873221100      0122346789999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         274 AVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       274 ~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      +||.+||+.||.+|||++|+++||||++..
T Consensus       242 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  271 (305)
T 2wtk_C          242 DLLKGMLEYEPAKRFSIRQIRQHSWFRKKH  271 (305)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred             HHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence            999999999999999999999999997654

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.4e-45  Score=322.38  Aligned_cols=247  Identities=19%  Similarity=0.285  Sum_probs=201.7

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccch------------hhhHhHHHHHHHHHhcCCCCcc
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKD------------GINRTALREIKLLQELHHENVL  120 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~ni~  120 (307)
                      ..++|++++.||+|+||.||+|.+  +|+.||+|++..........            .....+.+|+++++.++||||+
T Consensus        29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~  106 (348)
T 2pml_X           29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL  106 (348)
T ss_dssp             EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred             ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence            457899999999999999999997  89999999997532211110            0116788999999999999999


Q ss_pred             ccceeeeecCeEEEEEEccC-CChHHH------HhCC-CCCCCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCcEEEe
Q psy9858         121 GLTDVFGYMSNVSLVFEFVD-TDLEVI------IKDP-TIVFTPSNIKAYAIMTLRGLEYLHD-HWILHRDLKPNNLLIN  191 (307)
Q Consensus       121 ~~~~~~~~~~~~~lv~e~~~-g~l~~~------~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~  191 (307)
                      ++++++.+.+..++||||+. |+|.++      +... ...+++..++.++.||+.||.|||+ +|++|+||||+||+++
T Consensus       107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~  186 (348)
T 2pml_X          107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD  186 (348)
T ss_dssp             CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEEC
T ss_pred             eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEc
Confidence            99999999999999999995 588887      5442 4568999999999999999999999 9999999999999999


Q ss_pred             cCCcEEEEeecCccccCCCCcccccceeeceehhhhhhhccccccc-cccee---e----eeecCCCCCCCCCCC-----
Q psy9858         192 KQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNV-KNVQW---C----CFAKDPSSHGNLFPG-----  258 (307)
Q Consensus       192 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~Diw---~----i~~~~~~f~~~~~~~-----  258 (307)
                      .++.++|+|||++......  ......++..|+|||.+.+...++. ++|||   +    +++|..||.......     
T Consensus       187 ~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  264 (348)
T 2pml_X          187 KNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN  264 (348)
T ss_dssp             TTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHH
T ss_pred             CCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence            9999999999999876433  3345578999999999988745555 99999   3    334999997633200     


Q ss_pred             -----CCh----------------hhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         259 -----IPL----------------NEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       259 -----~~~----------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                           ...                ......+++++.+||.+||+.||.+|||++|+++||||++.+
T Consensus       265 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~  330 (348)
T 2pml_X          265 IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN  330 (348)
T ss_dssp             HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence                 000                001145789999999999999999999999999999999865

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=5.3e-45  Score=311.97  Aligned_cols=245  Identities=26%  Similarity=0.335  Sum_probs=202.4

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN  131 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  131 (307)
                      ...++|++++.||+|+||.||+|++..+++.||+|++......   ......+.+|++++++++||||+++++++.+...
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   95 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK---NKDTSTILREVELLKKLDHPNIMKLFEILEDSSS   95 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS---SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc---hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence            4557899999999999999999999999999999999753222   2224678899999999999999999999999999


Q ss_pred             EEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCC---cEEEEeecCcccc
Q psy9858         132 VSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG---VLKIGDFGLAKFF  207 (307)
Q Consensus       132 ~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~a~~~  207 (307)
                      .++||||+ +++|.+.+.... .+++..+..++.||+.||.|||++|++|+||||+||+++.++   .+||+|||++...
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~  174 (287)
T 2wei_A           96 FYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (287)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred             EEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence            99999999 678888776543 489999999999999999999999999999999999997644   6999999999877


Q ss_pred             CCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC----------CChhhhccccCH
Q psy9858         208 GSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG----------IPLNEIFTAAGD  270 (307)
Q Consensus       208 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~----------~~~~~~~~~~~~  270 (307)
                      .... ......+++.|+|||.+.+  .++.++|||   +    +++|..||.+.....          ......+..+++
T Consensus       175 ~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (287)
T 2wei_A          175 QQNT-KMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD  251 (287)
T ss_dssp             CCCS-SCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCH
T ss_pred             cCCC-ccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCH
Confidence            4432 2334568999999999876  488999999   2    334999987632110          001122346789


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         271 DLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       271 ~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      ++.++|.+||+.||++|||++++|+||||++..
T Consensus       252 ~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  284 (287)
T 2wei_A          252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (287)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred             HHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence            999999999999999999999999999998654

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=5.5e-45  Score=322.96  Aligned_cols=242  Identities=28%  Similarity=0.393  Sum_probs=196.5

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-----------CCCccc
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-----------HENVLG  121 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~ni~~  121 (307)
                      ..++|++++.||+|+||+||+|++..+++.||||++...      ......+.+|+++++.++           |+||++
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~   90 (373)
T 1q8y_A           17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD------KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK   90 (373)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred             cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC------ccchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence            456899999999999999999999999999999998742      222456788999999886           899999


Q ss_pred             cceeeeecC----eEEEEEEccCCChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC-CceeecCCCCcEEEecC--
Q psy9858         122 LTDVFGYMS----NVSLVFEFVDTDLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDH-WILHRDLKPNNLLINKQ--  193 (307)
Q Consensus       122 ~~~~~~~~~----~~~lv~e~~~g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~--  193 (307)
                      +++++...+    ..+++||+++++|.+++... ...+++..+..++.||+.||.|||++ ||+||||||+||+++.+  
T Consensus        91 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           91 LLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             CCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred             HHHHhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence            999987654    79999999999999998753 34589999999999999999999998 99999999999999543  


Q ss_pred             ----CcEEEEeecCccccCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCCC--
Q psy9858         194 ----GVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGIP--  260 (307)
Q Consensus       194 ----~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~--  260 (307)
                          +.+||+|||++......   .....+|+.|+|||.+.+. .++.++|||   +    +++|..||.+.......  
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             CcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence                37999999999876432   3345789999999999987 789999999   3    34499999863311100  


Q ss_pred             ---------------------------------------------hh-------hhccccCHHHHHHHHHhhhcCCCCCC
Q psy9858         261 ---------------------------------------------LN-------EIFTAAGDDLLAVISSLLCLNPTKRA  288 (307)
Q Consensus       261 ---------------------------------------------~~-------~~~~~~~~~l~~li~~~l~~dP~~Rp  288 (307)
                                                                   ..       .....+++++.+||.+||+.||++||
T Consensus       247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  326 (373)
T 1q8y_A          247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  326 (373)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence                                                         00       11234567899999999999999999


Q ss_pred             CHHHHhcCcccCCCcc
Q psy9858         289 DCTATLKMDYFSLTKE  304 (307)
Q Consensus       289 t~~~il~hp~f~~~~~  304 (307)
                      |++|+|+||||++...
T Consensus       327 t~~ell~hp~f~~~~~  342 (373)
T 1q8y_A          327 DAGGLVNHPWLKDTLG  342 (373)
T ss_dssp             CHHHHHTCGGGTTCTT
T ss_pred             CHHHHhhChhhhcccC
Confidence            9999999999998643

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.5e-44  Score=317.83  Aligned_cols=242  Identities=21%  Similarity=0.319  Sum_probs=198.3

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCC-cEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCC------cccccee
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETD-MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHEN------VLGLTDV  125 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n------i~~~~~~  125 (307)
                      ..++|++++.||+|+||+||+|.+..++ +.||+|++...      ......+.+|+++++.++|++      ++.++++
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~   90 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV------GKYREAARLEINVLKKIKEKDKENKFLCVLMSDW   90 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc------ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeee
Confidence            3478999999999999999999998776 78999998642      222456788999999987655      8999999


Q ss_pred             eeecCeEEEEEEccCCChHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEE--------------
Q psy9858         126 FGYMSNVSLVFEFVDTDLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLI--------------  190 (307)
Q Consensus       126 ~~~~~~~~lv~e~~~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~--------------  190 (307)
                      +...+..++||||+++++.+.+.... ..+++..++.++.||+.||.|||++||+||||||+||++              
T Consensus        91 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           91 FNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             EEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             eeeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccc
Confidence            99999999999999999888887543 458999999999999999999999999999999999999              


Q ss_pred             -----ecCCcEEEEeecCccccCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC
Q psy9858         191 -----NKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG  258 (307)
Q Consensus       191 -----~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~  258 (307)
                           +.++.+||+|||++......   .....+|+.|+|||++.+. .++.++|||   +    +++|..||.+.....
T Consensus       171 ~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  246 (355)
T 2eu9_A          171 CEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENRE  246 (355)
T ss_dssp             CCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                 67889999999999875432   2345789999999999887 899999999   3    334999997632110


Q ss_pred             -----------CChh---------------------------------------hhccccCHHHHHHHHHhhhcCCCCCC
Q psy9858         259 -----------IPLN---------------------------------------EIFTAAGDDLLAVISSLLCLNPTKRA  288 (307)
Q Consensus       259 -----------~~~~---------------------------------------~~~~~~~~~l~~li~~~l~~dP~~Rp  288 (307)
                                 .+..                                       ......+.++.+||.+||+.||++||
T Consensus       247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  326 (355)
T 2eu9_A          247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI  326 (355)
T ss_dssp             HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence                       0000                                       00011245789999999999999999


Q ss_pred             CHHHHhcCcccCCCcc
Q psy9858         289 DCTATLKMDYFSLTKE  304 (307)
Q Consensus       289 t~~~il~hp~f~~~~~  304 (307)
                      |++|+|+||||++...
T Consensus       327 t~~e~l~hp~f~~~~~  342 (355)
T 2eu9_A          327 TLAEALLHPFFAGLTP  342 (355)
T ss_dssp             CHHHHTTSGGGGGCCH
T ss_pred             CHHHHhcChhhcCCCh
Confidence            9999999999998653

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=9.9e-45  Score=317.17  Aligned_cols=243  Identities=21%  Similarity=0.239  Sum_probs=176.4

Q ss_pred             CceeccccceeeEEe-EEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHH-HHHHhcCCCCccccce
Q psy9858          47 DCEVKNDLLVYYQWR-SVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREI-KLLQELHHENVLGLTD  124 (307)
Q Consensus        47 ~~~~~~~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~ni~~~~~  124 (307)
                      ........++|.+.+ .||+|+||+||+|.+..+|+.||||++...          ....+|+ ..++.+.||||+++++
T Consensus        20 ~~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----------~~~~~e~~~~~~~~~h~~i~~~~~   89 (336)
T 3fhr_A           20 EPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----------PKARQEVDHHWQASGGPHIVCILD   89 (336)
T ss_dssp             CCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----------HHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred             CCCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----------HHHHHHHHHHHHhcCCCChHHHHH
Confidence            334445678899966 599999999999999999999999998642          1122333 3456679999999999


Q ss_pred             eeee----cCeEEEEEEcc-CCChHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEec---CCc
Q psy9858         125 VFGY----MSNVSLVFEFV-DTDLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK---QGV  195 (307)
Q Consensus       125 ~~~~----~~~~~lv~e~~-~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~---~~~  195 (307)
                      ++..    ....++||||+ +|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.   ++.
T Consensus        90 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~  169 (336)
T 3fhr_A           90 VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAV  169 (336)
T ss_dssp             EEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCC
T ss_pred             HHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCce
Confidence            9876    55689999999 569999998654 35899999999999999999999999999999999999976   445


Q ss_pred             EEEEeecCccccCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCC---------
Q psy9858         196 LKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGI---------  259 (307)
Q Consensus       196 ~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~---------  259 (307)
                      +||+|||++......  ......+|+.|+|||.+.+. .++.++|||   +    +++|..||........         
T Consensus       170 ~kl~Dfg~~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  246 (336)
T 3fhr_A          170 LKLTDFGFAKETTQN--ALQTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIR  246 (336)
T ss_dssp             EEECCCTTCEEC------------------------C-HHHHHHHHHHHHHHHHHHHHSSCCC-----------------
T ss_pred             EEEeccccceecccc--ccccCCCCcCccChhhhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhh
Confidence            999999999876432  23445789999999999777 889999999   3    3349999976332211         


Q ss_pred             -----ChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         260 -----PLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       260 -----~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                           .....+..+++++.+||.+||+.||++|||++|+|+||||++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          247 LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             ----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             ccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence                 0111224679999999999999999999999999999999764

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.8e-45  Score=325.48  Aligned_cols=242  Identities=19%  Similarity=0.245  Sum_probs=200.5

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY  128 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  128 (307)
                      .+....++|.+.+.||+|+||.||+|.+..+++.||||++....    .......+.+|+++++.++||||+++++++..
T Consensus       108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  183 (377)
T 3cbl_A          108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL----PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ  183 (377)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS----CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC----CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec
Confidence            44556789999999999999999999998899999999987432    22234567899999999999999999999999


Q ss_pred             cCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         129 MSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       129 ~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      ....++||||+ +|+|.+++......+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++..
T Consensus       184 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~  263 (377)
T 3cbl_A          184 KQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREE  263 (377)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence            99999999999 68999999876656899999999999999999999999999999999999999999999999999875


Q ss_pred             CCCCccc--ccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCC-------CCChhhhccccCH
Q psy9858         208 GSPTRLY--THQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFP-------GIPLNEIFTAAGD  270 (307)
Q Consensus       208 ~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~-------~~~~~~~~~~~~~  270 (307)
                      .......  ....++..|+|||.+.+. .++.++|||       .+++ |..||.+....       .......+..+++
T Consensus       264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (377)
T 3cbl_A          264 ADGVYAASGGLRQVPVKWTAPEALNYG-RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPD  342 (377)
T ss_dssp             TTSEEECCSSCCEEEGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred             CCCceeecCCCCCCCcCcCCHhHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence            4322111  123467889999999887 899999999       2343 88888762211       0111122345789


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         271 DLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       271 ~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      ++.+|+.+||+.||++|||++++++
T Consensus       343 ~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          343 AVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCCchhCcCHHHHHH
Confidence            9999999999999999999999986

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=5.1e-45  Score=316.27  Aligned_cols=254  Identities=16%  Similarity=0.203  Sum_probs=188.5

Q ss_pred             CCceeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCcccccee
Q psy9858          46 PDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV  125 (307)
Q Consensus        46 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~  125 (307)
                      ....+....++|++++.||+|+||.||+|.+..+|+.||||++.....   .....+.+..+..+++.++||||++++++
T Consensus        16 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   92 (318)
T 2dyl_A           16 GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN---KEENKRILMDLDVVLKSHDCPYIVQCFGT   92 (318)
T ss_dssp             SSSEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC---HHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             cchhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc---chHHHHHHHHHHHHHHhcCCCceeeEEEE
Confidence            344566678899999999999999999999999999999999986432   12223334455567888899999999999


Q ss_pred             eeecCeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeecCCCCcEEEecCCcEEEEeecCc
Q psy9858         126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH-WILHRDLKPNNLLINKQGVLKIGDFGLA  204 (307)
Q Consensus       126 ~~~~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  204 (307)
                      +.+....++||||+++.+..+.......+++..+..++.||+.||.|||++ |++|+||||+||+++.++.+||+|||++
T Consensus        93 ~~~~~~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  172 (318)
T 2dyl_A           93 FITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGIS  172 (318)
T ss_dssp             EECSSEEEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EecCCcEEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCc
Confidence            999999999999997666666655455689999999999999999999995 9999999999999999999999999999


Q ss_pred             cccCCCCcccccceeeceehhhhhhhc----cccccccccee---e----eeecCCCCCCCCCCCC----------Chhh
Q psy9858         205 KFFGSPTRLYTHQVVTRWYRLIKCLLY----CVQFNVKNVQW---C----CFAKDPSSHGNLFPGI----------PLNE  263 (307)
Q Consensus       205 ~~~~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~----------~~~~  263 (307)
                      ...... .......+++.|+|||.+.+    ...++.++|||   +    +++|..||........          ....
T Consensus       173 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  251 (318)
T 2dyl_A          173 GRLVDD-KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLP  251 (318)
T ss_dssp             ---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCC
T ss_pred             hhccCC-ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCC
Confidence            876432 22334578999999999952    33688999999   3    3349999876221100          0001


Q ss_pred             hccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         264 IFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       264 ~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      ....+++++.++|.+||+.||.+|||++++++||||++..
T Consensus       252 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (318)
T 2dyl_A          252 GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE  291 (318)
T ss_dssp             SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred             ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence            1134789999999999999999999999999999997643

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7.5e-45  Score=308.12  Aligned_cols=239  Identities=18%  Similarity=0.253  Sum_probs=198.8

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM  129 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  129 (307)
                      +....++|++++.||+|+||.||+|.+. +++.||+|++.....      ..+.+.+|++++++++||||+++++++.+.
T Consensus         5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   77 (269)
T 4hcu_A            5 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM------SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ   77 (269)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB------CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             EEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc------CHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            3445679999999999999999999975 577899999975321      135688999999999999999999999999


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                      ...++||||+ +|+|.+++......+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  157 (269)
T 4hcu_A           78 APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL  157 (269)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred             CceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccc
Confidence            9999999999 578999998777779999999999999999999999999999999999999999999999999998764


Q ss_pred             CCC-cccccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCCC-------CChhhhccccCHHH
Q psy9858         209 SPT-RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFPG-------IPLNEIFTAAGDDL  272 (307)
Q Consensus       209 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~~-------~~~~~~~~~~~~~l  272 (307)
                      ... .......++..|+|||.+.+. .++.++|||       .+++ |..||.......       ......+..+++++
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (269)
T 4hcu_A          158 DDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHV  236 (269)
T ss_dssp             CHHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHH
T ss_pred             ccccccccCcccccccCCHHHhcCC-CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHH
Confidence            321 122334567889999999887 899999999       2344 888887732111       01112233468999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         273 LAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       273 ~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      .+++.+||+.||++|||++++++|
T Consensus       237 ~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          237 YQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHccCCcccCcCHHHHHHH
Confidence            999999999999999999999976

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.3e-44  Score=318.98  Aligned_cols=243  Identities=19%  Similarity=0.257  Sum_probs=198.7

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEE-----EcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCcccc
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKAR-----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGL  122 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~  122 (307)
                      .+....++|++++.||+|+||.||+|+     +..+++.||||++....    .....+.+.+|++++.++ +||||+++
T Consensus        16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC----CHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            445567899999999999999999998     45677999999997532    222346688999999999 79999999


Q ss_pred             ceeeeecC-eEEEEEEcc-CCChHHHHhCCCC------------------------------------------------
Q psy9858         123 TDVFGYMS-NVSLVFEFV-DTDLEVIIKDPTI------------------------------------------------  152 (307)
Q Consensus       123 ~~~~~~~~-~~~lv~e~~-~g~l~~~~~~~~~------------------------------------------------  152 (307)
                      ++++...+ ..++||||+ +|+|.+++.....                                                
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            99987754 499999999 5789999876532                                                


Q ss_pred             -----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC--cc
Q psy9858         153 -----------------VFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT--RL  213 (307)
Q Consensus       153 -----------------~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--~~  213 (307)
                                       .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......  ..
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  251 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR  251 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEE
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchh
Confidence                             18899999999999999999999999999999999999999999999999998764322  22


Q ss_pred             cccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCCCCC--------hhhhccccCHHHHHHHH
Q psy9858         214 YTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFPGIP--------LNEIFTAAGDDLLAVIS  277 (307)
Q Consensus       214 ~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~~~~--------~~~~~~~~~~~l~~li~  277 (307)
                      .....+|+.|+|||.+.+. .++.++|||       .+++ |..||.+.......        ....+..+++++.+++.
T Consensus       252 ~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  330 (359)
T 3vhe_A          252 KGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML  330 (359)
T ss_dssp             C--CEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHH
T ss_pred             ccccCCCceeEChhhhcCC-CCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence            3445788999999999887 899999999       3444 88888774332211        11223457899999999


Q ss_pred             HhhhcCCCCCCCHHHHhcC
Q psy9858         278 SLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       278 ~~l~~dP~~Rpt~~~il~h  296 (307)
                      +||+.||.+|||++|+++|
T Consensus       331 ~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          331 DCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             HHTCSSGGGSCCHHHHHHH
T ss_pred             HHccCChhhCCCHHHHHHH
Confidence            9999999999999999986

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-44  Score=319.87  Aligned_cols=247  Identities=19%  Similarity=0.240  Sum_probs=202.2

Q ss_pred             CCCceeccccceeeEEeEEeecCceEEEEEEEcC-------CCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CC
Q psy9858          45 LPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIE-------TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HH  116 (307)
Q Consensus        45 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h  116 (307)
                      .....+....++|.+++.||+|+||.||+|++..       .+..||+|++...    ........+.+|+++++.+ +|
T Consensus        59 ~~~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~h  134 (382)
T 3tt0_A           59 PEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD----ATEKDLSDLISEMEMMKMIGKH  134 (382)
T ss_dssp             CCCTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCC
T ss_pred             ccCcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc----cCHHHHHHHHHHHHHHHHhcCC
Confidence            3344556677899999999999999999999753       3468999999753    2223346788999999999 89


Q ss_pred             CCccccceeeeecCeEEEEEEcc-CCChHHHHhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy9858         117 ENVLGLTDVFGYMSNVSLVFEFV-DTDLEVIIKDPT---------------IVFTPSNIKAYAIMTLRGLEYLHDHWILH  180 (307)
Q Consensus       117 ~ni~~~~~~~~~~~~~~lv~e~~-~g~l~~~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH  180 (307)
                      |||+++++++...+..++||||+ +|+|.+++....               ..+++..++.++.||+.||.|||++||+|
T Consensus       135 pnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH  214 (382)
T 3tt0_A          135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIH  214 (382)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             chhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEec
Confidence            99999999999999999999999 579999987543               34899999999999999999999999999


Q ss_pred             ecCCCCcEEEecCCcEEEEeecCccccCCCC--cccccceeeceehhhhhhhccccccccccee-------eeee-cCCC
Q psy9858         181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPT--RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPS  250 (307)
Q Consensus       181 ~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~  250 (307)
                      |||||+||+++.++.+||+|||+++......  .......+|+.|+|||.+.+. .++.++|||       .+++ |..|
T Consensus       215 ~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt~g~~p  293 (382)
T 3tt0_A          215 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSP  293 (382)
T ss_dssp             SCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             CCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC-CCCchhHHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999999998765432  223344678899999999887 899999999       2444 8888


Q ss_pred             CCCCCCCC-------CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         251 SHGNLFPG-------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       251 f~~~~~~~-------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      |.+.....       ......+..+++++.+||.+||+.||++|||++|++++
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          294 YPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             STTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            87632111       11112234678999999999999999999999999985

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=8.2e-45  Score=315.89  Aligned_cols=250  Identities=19%  Similarity=0.197  Sum_probs=180.3

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEcCCCc---EEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceee
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDIETDM---IVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVF  126 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~  126 (307)
                      .....++|++++.||+|+||.||+|++..++.   .||||++......   ....+.+.+|+++++.++||||+++++++
T Consensus        18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   94 (323)
T 3qup_A           18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA---SSDIEEFLREAACMKEFDHPHVAKLVGVS   94 (323)
T ss_dssp             TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC---------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred             cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC---HHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence            34456789999999999999999999877664   8999999753222   22256788999999999999999999999


Q ss_pred             eecCeE------EEEEEcc-CCChHHHHhCC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCC
Q psy9858         127 GYMSNV------SLVFEFV-DTDLEVIIKDP-----TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG  194 (307)
Q Consensus       127 ~~~~~~------~lv~e~~-~g~l~~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~  194 (307)
                      ......      +++|||+ +|+|.+++...     ...+++..+..++.||+.||.|||++||+||||||+||+++.++
T Consensus        95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~  174 (323)
T 3qup_A           95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM  174 (323)
T ss_dssp             ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS
T ss_pred             eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC
Confidence            776654      9999999 56888888532     22489999999999999999999999999999999999999999


Q ss_pred             cEEEEeecCccccCCCCc--ccccceeeceehhhhhhhccccccccccee---e----eee-cCCCCCCCCCCCC-----
Q psy9858         195 VLKIGDFGLAKFFGSPTR--LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPSSHGNLFPGI-----  259 (307)
Q Consensus       195 ~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~f~~~~~~~~-----  259 (307)
                      .+||+|||+++.......  ......+++.|+|||.+.+. .++.++|||   +    +++ |..||.+......     
T Consensus       175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~  253 (323)
T 3qup_A          175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI  253 (323)
T ss_dssp             CEEECCCCC-----------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred             CEEEeeccccccccccccccccccccCcccccCchhhcCC-CCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh
Confidence            999999999987643321  12233567789999999887 899999999   2    344 8888877332111     


Q ss_pred             --ChhhhccccCHHHHHHHHHhhhcCCCCCCC-------HHHHhcCcccCCCc
Q psy9858         260 --PLNEIFTAAGDDLLAVISSLLCLNPTKRAD-------CTATLKMDYFSLTK  303 (307)
Q Consensus       260 --~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-------~~~il~hp~f~~~~  303 (307)
                        .....+..+++++.+|+.+||+.||++|||       ++++++|||+....
T Consensus       254 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~  306 (323)
T 3qup_A          254 GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS  306 (323)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred             cCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence              112223467899999999999999999999       88999999997754

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3.3e-44  Score=310.81  Aligned_cols=249  Identities=24%  Similarity=0.294  Sum_probs=197.5

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC--CCCccccceee
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH--HENVLGLTDVF  126 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~ni~~~~~~~  126 (307)
                      .+....++|++++.||+|+||.||+|.+ .+++.||+|++.....   .......+.+|++++++++  |+||+++++++
T Consensus        22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~   97 (313)
T 3cek_A           22 SMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA---DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE   97 (313)
T ss_dssp             EEEETTEEEEEEEEEECCSSEEEEEEEC-TTCCEEEEEEEECSSC---CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred             eeeeccceEEEEEEecCCCCEEEEEEEc-CCCcEEEEEEeccccc---cccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence            3445667899999999999999999997 4588999999975432   2233567889999999997  59999999999


Q ss_pred             eecCeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         127 GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       127 ~~~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                      ......+++||+.+++|.+++.... .+++..+..++.||+.||.|||++|++||||||+||+++ ++.+||+|||++..
T Consensus        98 ~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~  175 (313)
T 3cek_A           98 ITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ  175 (313)
T ss_dssp             ECSSEEEEEECCCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred             ecCCEEEEEEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccccc
Confidence            9999999999977899999988654 589999999999999999999999999999999999996 58999999999987


Q ss_pred             cCCCCc--ccccceeeceehhhhhhhcc----------ccccccccee---e----eeecCCCCCCCCCC---------C
Q psy9858         207 FGSPTR--LYTHQVVTRWYRLIKCLLYC----------VQFNVKNVQW---C----CFAKDPSSHGNLFP---------G  258 (307)
Q Consensus       207 ~~~~~~--~~~~~~~t~~y~aPE~~~~~----------~~~~~~~Diw---~----i~~~~~~f~~~~~~---------~  258 (307)
                      ......  ......+++.|+|||.+.+.          ..++.++|||   +    +++|..||......         .
T Consensus       176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  255 (313)
T 3cek_A          176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP  255 (313)
T ss_dssp             --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT
T ss_pred             ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhc
Confidence            643221  22345789999999998752          3688999999   2    33499998763211         0


Q ss_pred             CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         259 IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       259 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      ......+...++++.++|.+||+.||.+|||++++|+||||+...
T Consensus       256 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  300 (313)
T 3cek_A          256 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  300 (313)
T ss_dssp             TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred             ccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence            111122344678999999999999999999999999999998654

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.4e-43  Score=304.40  Aligned_cols=236  Identities=17%  Similarity=0.177  Sum_probs=199.9

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeeecCe
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGYMSN  131 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~  131 (307)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++....       ....+.+|+++++.+ +|+|++++++++.....
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~   80 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-------DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH   80 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-------TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-------ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence            3467999999999999999999999999999999987432       123577899999999 79999999999999999


Q ss_pred             EEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCc-----EEEEeecCccc
Q psy9858         132 VSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGV-----LKIGDFGLAKF  206 (307)
Q Consensus       132 ~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~-----~kl~Dfg~a~~  206 (307)
                      .++||||++++|.+++......+++..+..++.||+.||.|||++||+||||||+||+++.++.     +||+|||++..
T Consensus        81 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           81 NVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             EEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             eEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            9999999999999999876667999999999999999999999999999999999999987776     99999999987


Q ss_pred             cCCCCc-------ccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC--------------
Q psy9858         207 FGSPTR-------LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG--------------  258 (307)
Q Consensus       207 ~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~--------------  258 (307)
                      ......       ......+|+.|+|||.+.+. .++.++|||   +    +++|..||.+.....              
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  239 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence            754321       23445789999999999887 789999999   3    334999998743221              


Q ss_pred             CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         259 IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       259 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      .........+++++.+++.+||+.||++|||++++++.
T Consensus       240 ~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          240 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            11222334678999999999999999999999998763

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.1e-44  Score=305.10  Aligned_cols=238  Identities=18%  Similarity=0.210  Sum_probs=197.4

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS  130 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  130 (307)
                      ....++|++++.||+|+||.||+|.+. ++..||+|++.....      ....+.+|+++++.++||||+++++++.+..
T Consensus         4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   76 (268)
T 3sxs_A            4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM------SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEY   76 (268)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC------cHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            345678999999999999999999864 677899999975321      1356889999999999999999999999999


Q ss_pred             eEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCC
Q psy9858         131 NVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS  209 (307)
Q Consensus       131 ~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  209 (307)
                      ..++||||+ +|+|.+++......+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  156 (268)
T 3sxs_A           77 PIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD  156 (268)
T ss_dssp             SEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred             ceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecch
Confidence            999999999 6789998887665689999999999999999999999999999999999999999999999999987654


Q ss_pred             CCc-ccccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCCC-------CChhhhccccCHHHH
Q psy9858         210 PTR-LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFPG-------IPLNEIFTAAGDDLL  273 (307)
Q Consensus       210 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~~-------~~~~~~~~~~~~~l~  273 (307)
                      ... ......+|+.|+|||.+.+. .++.++|||       .+++ |..||.......       ......+...++.+.
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  235 (268)
T 3sxs_A          157 DQYVSSVGTKFPVKWSAPEVFHYF-KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIY  235 (268)
T ss_dssp             TCEEECCSCCCCGGGCCHHHHHHS-EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHH
T ss_pred             hhhhcccCCCcCcccCCHHHHhcc-CCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHH
Confidence            322 22233556789999999887 789999999       3444 888887622111       011112234688999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         274 AVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       274 ~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      +++.+||+.||.+|||+++++++
T Consensus       236 ~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          236 QIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             HHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999999986

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.5e-45  Score=323.67  Aligned_cols=244  Identities=17%  Similarity=0.201  Sum_probs=196.8

Q ss_pred             cccceeeEEeEEeecCceEEEEEE-----EcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceee
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKAR-----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVF  126 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~  126 (307)
                      ...++|++++.||+|+||.||+|+     +..+++.||||++....    .......+.+|+.+++.++||||+++++++
T Consensus        68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  143 (367)
T 3l9p_A           68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC----SEQDELDFLMEALIISKFNHQNIVRCIGVS  143 (367)
T ss_dssp             CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC----CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc----ChhhHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            456789999999999999999999     45578899999986422    222345688999999999999999999999


Q ss_pred             eecCeEEEEEEcc-CCChHHHHhCCC------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCC---cE
Q psy9858         127 GYMSNVSLVFEFV-DTDLEVIIKDPT------IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG---VL  196 (307)
Q Consensus       127 ~~~~~~~lv~e~~-~g~l~~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~---~~  196 (307)
                      .+....++||||+ +|+|.+++....      ..+++..++.++.||+.||.|||++||+||||||+|||++.++   .+
T Consensus       144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~  223 (367)
T 3l9p_A          144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA  223 (367)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred             ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence            9999999999999 679999887532      3489999999999999999999999999999999999999555   59


Q ss_pred             EEEeecCccccCCC--Ccccccceeeceehhhhhhhccccccccccee---e----eee-cCCCCCCCCCCC-------C
Q psy9858         197 KIGDFGLAKFFGSP--TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPSSHGNLFPG-------I  259 (307)
Q Consensus       197 kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~f~~~~~~~-------~  259 (307)
                      ||+|||+++.....  ........+|+.|+|||.+.+. .++.++|||   +    +++ |..||.+.....       .
T Consensus       224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~  302 (367)
T 3l9p_A          224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG  302 (367)
T ss_dssp             EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred             EECCCccccccccccccccCCCcCCcccEECHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            99999999754221  1222344678999999999887 899999999   2    343 888887732111       1


Q ss_pred             ChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccC
Q psy9858         260 PLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS  300 (307)
Q Consensus       260 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~  300 (307)
                      .....+..+++.+.+|+.+||+.||++|||++++++|.++-
T Consensus       303 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          303 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            11122346789999999999999999999999999987763

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4.8e-44  Score=312.04  Aligned_cols=233  Identities=18%  Similarity=0.187  Sum_probs=195.7

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeeecCeE
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~  132 (307)
                      .++|++.+.||+|+||+||+|++..+|+.||||++.....       ...+.+|+++++.+ +||||+++++++......
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~   80 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-------APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYN   80 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-------SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-------hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCcc
Confidence            3689999999999999999999999999999999875321       23578999999999 899999999999999999


Q ss_pred             EEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCc-----EEEEeecCcccc
Q psy9858         133 SLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGV-----LKIGDFGLAKFF  207 (307)
Q Consensus       133 ~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~-----~kl~Dfg~a~~~  207 (307)
                      ++||||++++|.+++......+++..+..++.||+.||.|||++||+||||||+||+++.++.     +||+|||+++..
T Consensus        81 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           81 AMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             EEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             EEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            999999999999999876667999999999999999999999999999999999999998887     999999999876


Q ss_pred             CCCCc-------ccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCCC-------------
Q psy9858         208 GSPTR-------LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGIP-------------  260 (307)
Q Consensus       208 ~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~-------------  260 (307)
                      .....       ......||+.|+|||.+.+. .++.++|||   +    +++|..||.+.......             
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~  239 (330)
T 2izr_A          161 IDPETKKHIPYREHKSLTGTARYMSINTHLGK-EQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT  239 (330)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred             ecCCCCccccccccCCcCCCccccChHHHcCC-CCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence            43322       12456789999999999987 889999999   3    33499999875432211             


Q ss_pred             -hhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         261 -LNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       261 -~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                       ........+ ++.+++.+||+.||.+|||++++++
T Consensus       240 ~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          240 PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence             000111233 9999999999999999999988876

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.2e-44  Score=309.28  Aligned_cols=238  Identities=21%  Similarity=0.279  Sum_probs=191.7

Q ss_pred             cccceeeEEeEEeecCceEEEEEE----EcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeee
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKAR----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG  127 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~  127 (307)
                      -..++|++++.||+|+||+||+|+    +..+++.||||++...     .....+.+.+|+++++.++||||+++++++.
T Consensus         7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   81 (295)
T 3ugc_A            7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-----TEEHLRDFEREIEILKSLQHDNIVKYKGVCY   81 (295)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            356789999999999999999998    5678999999998743     2223467889999999999999999999885


Q ss_pred             e--cCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCc
Q psy9858         128 Y--MSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA  204 (307)
Q Consensus       128 ~--~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  204 (307)
                      .  ....++||||+ +|+|.+++......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~  161 (295)
T 3ugc_A           82 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT  161 (295)
T ss_dssp             HHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred             cCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence            4  45699999999 67999999877667999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCc---ccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCC---------CC--------
Q psy9858         205 KFFGSPTR---LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNL---------FP--------  257 (307)
Q Consensus       205 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~---------~~--------  257 (307)
                      ........   ......++..|+|||.+.+. .++.++|||       .+++|..|+....         ..        
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T 3ugc_A          162 KVLPQDKEFFKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  240 (295)
T ss_dssp             C-------------CTTCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             ccccCCcceeeeccCCCCccceeCcHHhcCC-CCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence            87743321   12233567789999999887 899999999       2333777776511         00        


Q ss_pred             ------CCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         258 ------GIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       258 ------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                            .......+..+++++.+++.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                  00111223467899999999999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3e-44  Score=323.78  Aligned_cols=243  Identities=21%  Similarity=0.167  Sum_probs=189.1

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeeecC
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGYMS  130 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~  130 (307)
                      ....+|.+.+.||+|+||+||.. ...+|+.||||++.....        ..+.+|+++++.+ +||||+++++++.+..
T Consensus        21 i~~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~--------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~   91 (432)
T 3p23_A           21 VGKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECF--------SFADREVQLLRESDEHPNVIRYFCTEKDRQ   91 (432)
T ss_dssp             ETTEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTE--------EECHHHHHHHHHSCCCTTBCCEEEEEEETT
T ss_pred             EccEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHH--------HHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence            34457999999999999997643 346889999999974321        2245899999999 7999999999999999


Q ss_pred             eEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecC-----CcEEEEeecCcc
Q psy9858         131 NVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ-----GVLKIGDFGLAK  205 (307)
Q Consensus       131 ~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~-----~~~kl~Dfg~a~  205 (307)
                      ..|+||||++|+|.+++........+..+..++.||+.||.|||++||+||||||+||+++.+     ..+||+|||+|+
T Consensus        92 ~~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~  171 (432)
T 3p23_A           92 FQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK  171 (432)
T ss_dssp             EEEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred             EEEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence            999999999999999998876666666778999999999999999999999999999999532     358899999998


Q ss_pred             ccCCCC---cccccceeeceehhhhhhhc--cccccccccee---e----eee-cCCCCCCCCCCC---------CChhh
Q psy9858         206 FFGSPT---RLYTHQVVTRWYRLIKCLLY--CVQFNVKNVQW---C----CFA-KDPSSHGNLFPG---------IPLNE  263 (307)
Q Consensus       206 ~~~~~~---~~~~~~~~t~~y~aPE~~~~--~~~~~~~~Diw---~----i~~-~~~~f~~~~~~~---------~~~~~  263 (307)
                      ......   .......||+.|+|||++.+  ...++.++|||   |    +++ |..||.......         .....
T Consensus       172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~  251 (432)
T 3p23_A          172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLH  251 (432)
T ss_dssp             CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSC
T ss_pred             eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccC
Confidence            774332   22344578999999999974  23678899999   3    333 888886521110         00001


Q ss_pred             hccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         264 IFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       264 ~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      .....+..+.+||.+||+.||.+|||++++++||||+...
T Consensus       252 ~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~  291 (432)
T 3p23_A          252 PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE  291 (432)
T ss_dssp             TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred             ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence            1123456689999999999999999999999999998653

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3.5e-44  Score=310.45  Aligned_cols=247  Identities=19%  Similarity=0.239  Sum_probs=202.2

Q ss_pred             CCCceeccccceeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCc
Q psy9858          45 LPDCEVKNDLLVYYQWRSVHVGRFATVFKARDI-----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENV  119 (307)
Q Consensus        45 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni  119 (307)
                      +....+....++|.+.+.||+|+||.||+|.+.     .++..||+|++....    .....+.+.+|+++++.++||||
T Consensus        13 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hp~i   88 (314)
T 2ivs_A           13 LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA----SPSELRDLLSEFNVLKQVNHPHV   88 (314)
T ss_dssp             -CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC----CHHHHHHHHHHHHHHTTCCCTTB
T ss_pred             cCCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC----CHHHHHHHHHHHHHHhhCCCCce
Confidence            344455667889999999999999999999873     456899999997432    22334678899999999999999


Q ss_pred             cccceeeeecCeEEEEEEcc-CCChHHHHhCCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHH
Q psy9858         120 LGLTDVFGYMSNVSLVFEFV-DTDLEVIIKDPT-----------------------IVFTPSNIKAYAIMTLRGLEYLHD  175 (307)
Q Consensus       120 ~~~~~~~~~~~~~~lv~e~~-~g~l~~~~~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~lH~  175 (307)
                      +++++++.+.+..++||||+ +|+|.+++....                       ..+++..++.++.||+.||.|||+
T Consensus        89 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~  168 (314)
T 2ivs_A           89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE  168 (314)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH
T ss_pred             eeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999999999999 588999887543                       237899999999999999999999


Q ss_pred             CCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc--cccceeeceehhhhhhhccccccccccee-------eeee
Q psy9858         176 HWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL--YTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA  246 (307)
Q Consensus       176 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~  246 (307)
                      +||+||||||+||+++.++.+||+|||++.........  .....+++.|+|||.+.+. .++.++|||       .+++
T Consensus       169 ~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t  247 (314)
T 2ivs_A          169 MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVT  247 (314)
T ss_dssp             TTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHT
T ss_pred             CCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC-CcCchhhHHHHHHHHHHHHh
Confidence            99999999999999999999999999999877543222  2234567889999999887 899999999       3444


Q ss_pred             -cCCCCCCCCCCC-------CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         247 -KDPSSHGNLFPG-------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       247 -~~~~f~~~~~~~-------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                       |..||.+.....       ......+..+++++.+++.+||+.||++|||+++++++
T Consensus       248 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          248 LGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             TSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence             888887633211       11112334678999999999999999999999999875

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.5e-44  Score=314.81  Aligned_cols=238  Identities=18%  Similarity=0.253  Sum_probs=189.3

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEE----EEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIV----AVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY  128 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----avK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  128 (307)
                      ..++|++++.||+|+||+||+|++..+++.+    |+|.+...    ......+.+.+|++++++++||||+++++++..
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   88 (327)
T 3poz_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----TSPKANKEILDEAYVMASVDNPHVCRLLGICLT   88 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-----------CHHHHHHHHHHHHHCCBTTBCCEEEEEES
T ss_pred             CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc----cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence            4568999999999999999999988777654    77776532    222335678899999999999999999999877


Q ss_pred             cCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         129 MSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       129 ~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      .. .+++++|+ +|+|.+++......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus        89 ~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           89 ST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             SS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             CC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            55 77888988 78999999887777999999999999999999999999999999999999999999999999999877


Q ss_pred             CCCCcc--cccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCCCC-------ChhhhccccCH
Q psy9858         208 GSPTRL--YTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFPGI-------PLNEIFTAAGD  270 (307)
Q Consensus       208 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~~~-------~~~~~~~~~~~  270 (307)
                      ......  .....+|..|+|||.+.+. .++.++|||       .+++ |..||.+......       .....+..++.
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTI  246 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCH
T ss_pred             cCCcccccccCCCccccccChHHhccC-CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCH
Confidence            543222  2233557899999999987 899999999       3444 8999877332111       11122345789


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         271 DLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       271 ~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      ++.+++.+||+.||.+|||+.+++++
T Consensus       247 ~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          247 DVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            99999999999999999999999975

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-43  Score=311.00  Aligned_cols=245  Identities=21%  Similarity=0.265  Sum_probs=200.2

Q ss_pred             ceeccccceeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccc
Q psy9858          48 CEVKNDLLVYYQWRSVHVGRFATVFKARDI-----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLG  121 (307)
Q Consensus        48 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~  121 (307)
                      ..+....++|++.+.||+|+||.||+|.+.     .++..||+|++....    .......+.+|+++++++ +||||++
T Consensus        38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~  113 (344)
T 1rjb_A           38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA----DSSEREALMSELKMMTQLGSHENIVN  113 (344)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc----CHHHHHHHHHHHHHHHhhcCCCCeee
Confidence            345567789999999999999999999973     467789999997432    222346788999999999 8999999


Q ss_pred             cceeeeecCeEEEEEEcc-CCChHHHHhCCCC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy9858         122 LTDVFGYMSNVSLVFEFV-DTDLEVIIKDPTI----------------------VFTPSNIKAYAIMTLRGLEYLHDHWI  178 (307)
Q Consensus       122 ~~~~~~~~~~~~lv~e~~-~g~l~~~~~~~~~----------------------~~~~~~~~~i~~~i~~~l~~lH~~~i  178 (307)
                      +++++...+..++||||+ +|+|.+++.....                      .+++..+..++.||+.||.|||++||
T Consensus       114 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i  193 (344)
T 1rjb_A          114 LLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC  193 (344)
T ss_dssp             EEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             EEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            999999999999999999 6799999976543                      37889999999999999999999999


Q ss_pred             eeecCCCCcEEEecCCcEEEEeecCccccCCCCc--ccccceeeceehhhhhhhccccccccccee-------eeee-cC
Q psy9858         179 LHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR--LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KD  248 (307)
Q Consensus       179 vH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~  248 (307)
                      +||||||+||+++.++.+||+|||++........  ......+|+.|+|||.+.+. .++.++|||       .+++ |.
T Consensus       194 vH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~  272 (344)
T 1rjb_A          194 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGV  272 (344)
T ss_dssp             EETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSC
T ss_pred             ccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC-CCChhHhHHHHHHHHHHHHcCCC
Confidence            9999999999999999999999999987643322  23345678899999999887 899999999       3444 88


Q ss_pred             CCCCCCCCCCC--------ChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCc
Q psy9858         249 PSSHGNLFPGI--------PLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMD  297 (307)
Q Consensus       249 ~~f~~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp  297 (307)
                      .||.+......        .....+..+++++.+||.+||+.||.+|||++++++|.
T Consensus       273 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          273 NPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL  329 (344)
T ss_dssp             CSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            88877433211        11122345789999999999999999999999999874

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-44  Score=316.13  Aligned_cols=242  Identities=21%  Similarity=0.278  Sum_probs=198.8

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccce
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDI-----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTD  124 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~  124 (307)
                      +....++|++++.||+|+||.||+|++.     .+++.||+|++....    .......+.+|+++++.++||||+++++
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~  117 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA----SADMQADFQREAALMAEFDNPNIVKLLG  117 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC----CHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc----CHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence            3456789999999999999999999986     456899999997532    2233567889999999999999999999


Q ss_pred             eeeecCeEEEEEEcc-CCChHHHHhCCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy9858         125 VFGYMSNVSLVFEFV-DTDLEVIIKDPT-----------------------IVFTPSNIKAYAIMTLRGLEYLHDHWILH  180 (307)
Q Consensus       125 ~~~~~~~~~lv~e~~-~g~l~~~~~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH  180 (307)
                      ++.+....++||||+ +|+|.+++....                       ..+++..++.++.||+.||.|||++||+|
T Consensus       118 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH  197 (343)
T 1luf_A          118 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH  197 (343)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            999999999999999 579999887532                       45899999999999999999999999999


Q ss_pred             ecCCCCcEEEecCCcEEEEeecCccccCCCC--cccccceeeceehhhhhhhccccccccccee-------eeee-cCCC
Q psy9858         181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPT--RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPS  250 (307)
Q Consensus       181 ~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~  250 (307)
                      |||||+||+++.++.+||+|||++.......  .......+|+.|+|||.+.+. .++.++|||       .+++ |..|
T Consensus       198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p  276 (343)
T 1luf_A          198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQP  276 (343)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC-CcCcccccHHHHHHHHHHHhcCCCc
Confidence            9999999999999999999999998764322  122344678899999999887 799999999       3444 8888


Q ss_pred             CCCCCCCC-------CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         251 SHGNLFPG-------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       251 f~~~~~~~-------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      |.+.....       ......+..+++++.+++.+||+.||.+|||+++++++
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          277 YYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             TTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            87632111       11112345678999999999999999999999999864

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=5.3e-45  Score=318.91  Aligned_cols=232  Identities=16%  Similarity=0.094  Sum_probs=185.3

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccc---cchhhhHhHHHHHHHHHhcC--------------
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHAD---AKDGINRTALREIKLLQELH--------------  115 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~e~~~l~~l~--------------  115 (307)
                      ..++|++++.||+|+||+||+|++  +|+.||||++.......   ......+.+.+|+++++.++              
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv   95 (336)
T 2vuw_A           18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI   95 (336)
T ss_dssp             CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred             ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence            457899999999999999999997  78999999998654321   12222467889999999886              


Q ss_pred             ------------CCCccccceeeee-------------cCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHH
Q psy9858         116 ------------HENVLGLTDVFGY-------------MSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRG  169 (307)
Q Consensus       116 ------------h~ni~~~~~~~~~-------------~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~  169 (307)
                                  ||||+++++++.+             ....|+||||+ +|++++.+.+  ..+++..++.++.||+.|
T Consensus        96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHH
T ss_pred             hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHH
Confidence                        5555555555554             78999999999 5667777654  348999999999999999


Q ss_pred             HHHHH-HCCceeecCCCCcEEEecCC--------------------cEEEEeecCccccCCCCcccccceeeceehhhhh
Q psy9858         170 LEYLH-DHWILHRDLKPNNLLINKQG--------------------VLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKC  228 (307)
Q Consensus       170 l~~lH-~~~ivH~dlkp~Nil~~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~  228 (307)
                      |.||| ++||+||||||+|||++.++                    .+||+|||+|+.....     ...||+.|+|||+
T Consensus       174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE~  248 (336)
T 2vuw_A          174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDEDL  248 (336)
T ss_dssp             HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSGG
T ss_pred             HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChhh
Confidence            99999 99999999999999999987                    8999999999876432     3489999999999


Q ss_pred             hhcccccccccceee--------eeecCCCCCC--------------CCCCCCChhhhccccCHHHHHHHHHhhhcCCCC
Q psy9858         229 LLYCVQFNVKNVQWC--------CFAKDPSSHG--------------NLFPGIPLNEIFTAAGDDLLAVISSLLCLNPTK  286 (307)
Q Consensus       229 ~~~~~~~~~~~Diw~--------i~~~~~~f~~--------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~  286 (307)
                      +.+. . +.++|||.        ++.|..||.+              ...........+..+++++.+||.+||+.|   
T Consensus       249 ~~g~-~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d---  323 (336)
T 2vuw_A          249 FTGD-G-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS---  323 (336)
T ss_dssp             GCCC-S-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS---
T ss_pred             hcCC-C-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC---
Confidence            9877 3 88999992        2227777753              122222333445678999999999999977   


Q ss_pred             CCCHHHHh-cCcccC
Q psy9858         287 RADCTATL-KMDYFS  300 (307)
Q Consensus       287 Rpt~~~il-~hp~f~  300 (307)
                        |++|+| +||||+
T Consensus       324 --sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          324 --SATDLLCQHSLFK  336 (336)
T ss_dssp             --SHHHHHHHCGGGC
T ss_pred             --CHHHHHhcCCCcC
Confidence              999999 999995

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.5e-44  Score=307.03  Aligned_cols=240  Identities=20%  Similarity=0.236  Sum_probs=196.0

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY  128 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  128 (307)
                      .+....++|++++.||+|+||.||+|.+. ++..||+|++.....      ..+.+.+|+++++.++||||+++++++.+
T Consensus        18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   90 (283)
T 3gen_A           18 SWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM------SEDEFIEEAKVMMNLSHEKLVQLYGVCTK   90 (283)
T ss_dssp             TTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB------CHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             CccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC------CHHHHHHHHHHHhcCCCCCEeeEEEEEec
Confidence            34456789999999999999999999864 677899999975321      13568899999999999999999999999


Q ss_pred             cCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         129 MSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       129 ~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      ....++||||+ +|+|.+++......+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++...
T Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  170 (283)
T 3gen_A           91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV  170 (283)
T ss_dssp             SSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred             CCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccc
Confidence            99999999999 68899999876667999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCc-ccccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCCC-------CChhhhccccCHH
Q psy9858         208 GSPTR-LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFPG-------IPLNEIFTAAGDD  271 (307)
Q Consensus       208 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~~-------~~~~~~~~~~~~~  271 (307)
                      ..... ......+|+.|+|||.+.+. .++.++|||       .+++ |..||.......       ......+...++.
T Consensus       171 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (283)
T 3gen_A          171 LDDEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK  249 (283)
T ss_dssp             CCHHHHSTTSTTSCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             cccccccccCCccCcccCCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHH
Confidence            43211 12233567889999999987 799999999       3444 888887622110       0111123456889


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         272 LLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       272 l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      +.+++.+||+.||.+|||++++++|
T Consensus       250 l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          250 VYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             HHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHccCChhHCcCHHHHHHH
Confidence            9999999999999999999999986

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.1e-43  Score=307.15  Aligned_cols=245  Identities=18%  Similarity=0.259  Sum_probs=202.2

Q ss_pred             CceeccccceeeEEeEEeecCceEEEEEEE-----cCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCcc
Q psy9858          47 DCEVKNDLLVYYQWRSVHVGRFATVFKARD-----IETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVL  120 (307)
Q Consensus        47 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~  120 (307)
                      ...+....++|++.+.||+|+||.||+|.+     ..+++.||+|++....    .......+.+|+++++++ +||||+
T Consensus        15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~i~   90 (313)
T 1t46_A           15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA----HLTEREALMSELKVLSYLGNHMNIV   90 (313)
T ss_dssp             CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             ccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch----hHHHHHHHHHHHHHHhhcccCCCee
Confidence            344556678999999999999999999985     4578899999997532    222346788999999999 899999


Q ss_pred             ccceeeeecCeEEEEEEcc-CCChHHHHhCCCC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeec
Q psy9858         121 GLTDVFGYMSNVSLVFEFV-DTDLEVIIKDPTI-----------------VFTPSNIKAYAIMTLRGLEYLHDHWILHRD  182 (307)
Q Consensus       121 ~~~~~~~~~~~~~lv~e~~-~g~l~~~~~~~~~-----------------~~~~~~~~~i~~~i~~~l~~lH~~~ivH~d  182 (307)
                      ++++++.+.+..++||||+ +|+|.+++.....                 .+++..+..++.||+.||.|||++|++|||
T Consensus        91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~d  170 (313)
T 1t46_A           91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRD  170 (313)
T ss_dssp             CEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             eEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence            9999999999999999999 5699998875432                 389999999999999999999999999999


Q ss_pred             CCCCcEEEecCCcEEEEeecCccccCCCCc--ccccceeeceehhhhhhhccccccccccee-------eeee-cCCCCC
Q psy9858         183 LKPNNLLINKQGVLKIGDFGLAKFFGSPTR--LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSH  252 (307)
Q Consensus       183 lkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~  252 (307)
                      |||+||+++.++.+||+|||++........  ......+|+.|+|||.+.+. .++.++|||       .+++ |..||.
T Consensus       171 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~  249 (313)
T 1t46_A          171 LAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYP  249 (313)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             CccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999999987754332  23344678899999999887 899999999       3444 888887


Q ss_pred             CCCCCCCC--------hhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         253 GNLFPGIP--------LNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       253 ~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      +.......        ....+..+++++.+++.+||+.||.+|||+++++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          250 GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             TCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            74432111        111234578999999999999999999999999875

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=7.6e-45  Score=316.49  Aligned_cols=238  Identities=16%  Similarity=0.241  Sum_probs=193.3

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcE----EEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMI----VAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY  128 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  128 (307)
                      ..++|++++.||+|+||+||+|.+..+++.    ||+|.+.....    ......+.+|+.+++.++||||+++++++. 
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-   85 (325)
T 3kex_A           11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG----RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-   85 (325)
T ss_dssp             CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS----CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred             CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc----HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence            456899999999999999999999888765    77777753321    112345678999999999999999999886 


Q ss_pred             cCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         129 MSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       129 ~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      ....++||||+ +|+|.+++......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus        86 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           86 GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLL  165 (325)
T ss_dssp             BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred             CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccccc
Confidence            56789999999 68999999887667999999999999999999999999999999999999999999999999999987


Q ss_pred             CCCCc--ccccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCCCC-------ChhhhccccCH
Q psy9858         208 GSPTR--LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFPGI-------PLNEIFTAAGD  270 (307)
Q Consensus       208 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~~~-------~~~~~~~~~~~  270 (307)
                      .....  ......++..|+|||.+.+. .++.++|||       .+++ |..||.+......       .....+..++.
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (325)
T 3kex_A          166 PPDDKQLLYSEAKTPIKWMALESIHFG-KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTI  244 (325)
T ss_dssp             CCCTTCCC-----CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCT
T ss_pred             CcccccccccCCCCcccccChHHhccC-CCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcH
Confidence            54322  23445677899999999887 799999999       3444 8999887432211       11122345788


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         271 DLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       271 ~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      ++.+++.+||+.||.+|||++++++|
T Consensus       245 ~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          245 DVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             TTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999999999886

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.5e-44  Score=305.95  Aligned_cols=241  Identities=17%  Similarity=0.261  Sum_probs=187.4

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEcCC---CcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceee
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDIET---DMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVF  126 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~  126 (307)
                      +....++|++.+.||+|+||.||+|.+..+   +..||+|++...    ........+.+|+.+++.++||||+++++++
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   85 (281)
T 1mp8_A           10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC----TSDSVREKFLQEALTMRQFDHPHIVKLIGVI   85 (281)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT----TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCccceEEEEE
Confidence            455678999999999999999999998653   567999998743    2233356788999999999999999999987


Q ss_pred             eecCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcc
Q psy9858         127 GYMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK  205 (307)
Q Consensus       127 ~~~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  205 (307)
                       .++..++||||+ +|+|.+++......+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.
T Consensus        86 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  164 (281)
T 1mp8_A           86 -TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR  164 (281)
T ss_dssp             -CSSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             -ccCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccc
Confidence             456789999999 468999998766679999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCc-ccccceeeceehhhhhhhccccccccccee---e----eee-cCCCCCCCCCCC-------CChhhhccccC
Q psy9858         206 FFGSPTR-LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPSSHGNLFPG-------IPLNEIFTAAG  269 (307)
Q Consensus       206 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~f~~~~~~~-------~~~~~~~~~~~  269 (307)
                      ....... ......+++.|+|||.+.+. .++.++|||   +    +++ |..||.+.....       ......+..++
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  243 (281)
T 1mp8_A          165 YMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP  243 (281)
T ss_dssp             --------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCC
T ss_pred             ccCcccccccccCCCcccccChhhcccC-CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCC
Confidence            7643322 12233567889999999877 889999999   2    333 888887633211       11122345689


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         270 DDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       270 ~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      +++.+++.+||+.||++|||+++++++
T Consensus       244 ~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          244 PTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            999999999999999999999999874

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=5.4e-44  Score=307.73  Aligned_cols=238  Identities=21%  Similarity=0.314  Sum_probs=192.6

Q ss_pred             ccceeeEEeEEeecCceEEEEEE----EcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKAR----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY  128 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  128 (307)
                      ..++|++++.||+|+||.||+|+    +..+++.||+|++....    .......+.+|+++++.++||||+++++++..
T Consensus        19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   94 (302)
T 4e5w_A           19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES----GGNHIADLKKEIEILRNLYHENIVKYKGICTE   94 (302)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC---------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc----cchhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence            34669999999999999999998    56789999999997532    22224668899999999999999999999977


Q ss_pred             c--CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcc
Q psy9858         129 M--SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK  205 (307)
Q Consensus       129 ~--~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  205 (307)
                      .  ...++||||+ +|+|.+++......+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.
T Consensus        95 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A           95 DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             CCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccc
Confidence            6  6799999999 579999997666679999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCc---ccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCC---------CCC---------
Q psy9858         206 FFGSPTR---LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGN---------LFP---------  257 (307)
Q Consensus       206 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~---------~~~---------  257 (307)
                      .......   ......+|..|+|||.+.+. .++.++|||   +    +++|..|+...         ...         
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  253 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQS-KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV  253 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCC-CCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence            8754332   23345678889999999887 889999999   3    33366654331         000         


Q ss_pred             ----CCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         258 ----GIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       258 ----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                          .......+..+++++.+||.+||+.||.+|||++++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          254 NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence                00111223467899999999999999999999999986

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.6e-44  Score=312.47  Aligned_cols=238  Identities=18%  Similarity=0.243  Sum_probs=188.6

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEE----EEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIV----AVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY  128 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----avK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  128 (307)
                      ..++|++++.||+|+||.||+|.+..+++.|    |+|.+...    ........+.+|+.+++.++||||+++++++..
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   88 (327)
T 3lzb_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----TSPKANKEILDEAYVMASVDNPHVCRLLGICLT   88 (327)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC----SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES
T ss_pred             CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc----cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec
Confidence            4568999999999999999999998887655    66666432    222235678899999999999999999999877


Q ss_pred             cCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         129 MSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       129 ~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      .. .+++++++ +|+|.+++......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus        89 ~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           89 ST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             SS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             CC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            65 77888888 78999999877777999999999999999999999999999999999999999999999999999877


Q ss_pred             CCCCc--ccccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCCC-------CChhhhccccCH
Q psy9858         208 GSPTR--LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFPG-------IPLNEIFTAAGD  270 (307)
Q Consensus       208 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~~-------~~~~~~~~~~~~  270 (307)
                      .....  ......+|+.|+|||.+.+. .++.++|||       .+++ |..||.+.....       ......+..++.
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTI  246 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCH
T ss_pred             cCccccccccCCCccccccCHHHHcCC-CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCH
Confidence            43322  22233567789999999987 899999999       3444 899988733221       111122345789


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         271 DLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       271 ~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      ++.++|.+||+.||.+|||++++++.
T Consensus       247 ~l~~li~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          247 DVYMIMRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            99999999999999999999999873

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.7e-44  Score=313.00  Aligned_cols=254  Identities=20%  Similarity=0.200  Sum_probs=203.7

Q ss_pred             CCCceeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccce
Q psy9858          45 LPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTD  124 (307)
Q Consensus        45 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~  124 (307)
                      ++..++....++|++.+.||+|+||.||+|.+ .+|+.||||++.......    ....+.+|+++++.++||||+++++
T Consensus        20 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQG----GELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             CCTHHHHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC---------CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             ecHHHHHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCch----HHHHHHHHHHHHHhccCCCccceEE
Confidence            44556667788999999999999999999984 578999999997543221    1235889999999999999999999


Q ss_pred             eeeecCeEEEEEEcc-CCChHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeecCCCCcEEEecCCcEE
Q psy9858         125 VFGYMSNVSLVFEFV-DTDLEVIIKDPT---IVFTPSNIKAYAIMTLRGLEYLHDH---WILHRDLKPNNLLINKQGVLK  197 (307)
Q Consensus       125 ~~~~~~~~~lv~e~~-~g~l~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~k  197 (307)
                      ++......++||||+ +|+|.+++....   ..+++..+..++.||+.||.|||++   ||+||||||+||+++.++.+|
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A           95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred             EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence            999999999999999 578999887643   2489999999999999999999999   999999999999999999999


Q ss_pred             EEeecCccccCCCC-cccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCC---------------
Q psy9858         198 IGDFGLAKFFGSPT-RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGN---------------  254 (307)
Q Consensus       198 l~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~---------------  254 (307)
                      |+|||++....... .......||+.|+|||.+.+. .++.++|||   +    +++|..||...               
T Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  253 (326)
T 3uim_A          175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK  253 (326)
T ss_dssp             ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHS-EECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred             eccCccccccCcccccccccccCCcCccCHHHhccC-CCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence            99999998775332 223344689999999999887 789999999   3    34499998520               


Q ss_pred             ------CCCC----CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         255 ------LFPG----IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       255 ------~~~~----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                            ....    ..........+..+.+++.+||+.||.+|||++++++|-.-....+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~  313 (326)
T 3uim_A          254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAE  313 (326)
T ss_dssp             TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSS
T ss_pred             HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhh
Confidence                  0000    0111222345578999999999999999999999999865444443

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=8.8e-44  Score=309.20  Aligned_cols=246  Identities=19%  Similarity=0.191  Sum_probs=201.7

Q ss_pred             CCCceeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccce
Q psy9858          45 LPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTD  124 (307)
Q Consensus        45 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~  124 (307)
                      ++...+....++|++.+.||+|+||.||+|.+ .+|+.||+|++....     ......+.+|+++++.++||||+++++
T Consensus        29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~  102 (321)
T 2qkw_B           29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES-----SQGIEEFETEIETLSFCRHPHLVSLIG  102 (321)
T ss_dssp             -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC-----SSHHHHHHHHHHGGGSCCCTTBCCEEE
T ss_pred             ecHHHHHHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC-----hHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            44556677889999999999999999999995 578999999887532     122456889999999999999999999


Q ss_pred             eeeecCeEEEEEEcc-CCChHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEe
Q psy9858         125 VFGYMSNVSLVFEFV-DTDLEVIIKDPT---IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGD  200 (307)
Q Consensus       125 ~~~~~~~~~lv~e~~-~g~l~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~D  200 (307)
                      ++.+.+..++||||+ +|+|.+++....   ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|
T Consensus       103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~D  182 (321)
T 2qkw_B          103 FCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITD  182 (321)
T ss_dssp             ECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECC
T ss_pred             EEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEee
Confidence            999999999999999 578988886543   2489999999999999999999999999999999999999999999999


Q ss_pred             ecCccccCCCC--cccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCC------------
Q psy9858         201 FGLAKFFGSPT--RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGI------------  259 (307)
Q Consensus       201 fg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~------------  259 (307)
                      ||++.......  .......+|+.|+|||.+.+. .++.++|||   +    +++|..||.+......            
T Consensus       183 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  261 (321)
T 2qkw_B          183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN  261 (321)
T ss_dssp             CTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHC-BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT
T ss_pred             cccccccccccccccccccCCCccccCHHHhcCC-CCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc
Confidence            99998754322  223345689999999999887 899999999   3    3448888876322111            


Q ss_pred             -----------ChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCc
Q psy9858         260 -----------PLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMD  297 (307)
Q Consensus       260 -----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp  297 (307)
                                 ........++..+.+++.+||+.||++|||++|++++.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence                       01112234567899999999999999999999999874

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.5e-43  Score=307.92  Aligned_cols=242  Identities=22%  Similarity=0.200  Sum_probs=192.9

Q ss_pred             CCCceeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccce
Q psy9858          45 LPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTD  124 (307)
Q Consensus        45 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~  124 (307)
                      .....+....++|++++.||+|+||+||+|++.  ++.||||++...      ........+|+.++++++||||+++++
T Consensus        14 ~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~   85 (322)
T 3soc_A           14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ------DKQSWQNEYEVYSLPGMKHENILQFIG   85 (322)
T ss_dssp             CCCCCEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG------GHHHHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred             cCccccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC------chHHHHHHHHHHHHhcCCCCCchhhcc
Confidence            444556667789999999999999999999864  789999998642      111334567899999999999999999


Q ss_pred             eeeecC----eEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC----------CceeecCCCCcEE
Q psy9858         125 VFGYMS----NVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH----------WILHRDLKPNNLL  189 (307)
Q Consensus       125 ~~~~~~----~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~----------~ivH~dlkp~Nil  189 (307)
                      ++....    ..++||||+ +|+|.+++....  +++..+..++.||+.||.|||+.          ||+||||||+||+
T Consensus        86 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nil  163 (322)
T 3soc_A           86 AEKRGTSVDVDLWLITAFHEKGSLSDFLKANV--VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVL  163 (322)
T ss_dssp             EEEEECSSSEEEEEEEECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEE
T ss_pred             eeccCCCCCceEEEEEecCCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEE
Confidence            997744    479999999 579999997654  89999999999999999999999          9999999999999


Q ss_pred             EecCCcEEEEeecCccccCCCCc--ccccceeeceehhhhhhhcc----ccccccccee---e----eeecCCCCCCCCC
Q psy9858         190 INKQGVLKIGDFGLAKFFGSPTR--LYTHQVVTRWYRLIKCLLYC----VQFNVKNVQW---C----CFAKDPSSHGNLF  256 (307)
Q Consensus       190 ~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~----~~~~~~~Diw---~----i~~~~~~f~~~~~  256 (307)
                      ++.++.+||+|||+++.......  ......+|+.|+|||.+.+.    ..++.++|||   +    +++|..||.+...
T Consensus       164 l~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~  243 (322)
T 3soc_A          164 LKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD  243 (322)
T ss_dssp             ECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCC
T ss_pred             ECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcc
Confidence            99999999999999987654322  23345789999999999873    3677899999   3    3449999876332


Q ss_pred             CCCCh-----------hhh------------------ccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         257 PGIPL-----------NEI------------------FTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       257 ~~~~~-----------~~~------------------~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      .....           ...                  ....++++.+||.+||+.||++|||++++++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  312 (322)
T 3soc_A          244 EYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER  312 (322)
T ss_dssp             CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            21110           000                  01223559999999999999999999999863

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.4e-43  Score=303.08  Aligned_cols=239  Identities=20%  Similarity=0.211  Sum_probs=197.3

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccch--hhhHhHHHHHHHHHhcCCCCccccceeeeec
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKD--GINRTALREIKLLQELHHENVLGLTDVFGYM  129 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  129 (307)
                      ...++|++.+.||+|+||+||+|++..+++.||+|++..........  ...+.+.+|+++++.++||||+++++++.+.
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP   95 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred             hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence            45578999999999999999999999999999999997643322211  1126788999999999999999999998766


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeecCCCCcEEEecCCc-----EEEEee
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHW--ILHRDLKPNNLLINKQGV-----LKIGDF  201 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~-----~kl~Df  201 (307)
                      .  ++||||+ +|+|.+.+......+++..+..++.|++.||.|||++|  ++||||||+||+++.++.     +||+||
T Consensus        96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df  173 (287)
T 4f0f_A           96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF  173 (287)
T ss_dssp             T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred             C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence            5  6999999 58999999887778999999999999999999999999  999999999999988876     999999


Q ss_pred             cCccccCCCCcccccceeeceehhhhhhhc-cccccccccee---e----eeecCCCCCCCCCCCC----------Chhh
Q psy9858         202 GLAKFFGSPTRLYTHQVVTRWYRLIKCLLY-CVQFNVKNVQW---C----CFAKDPSSHGNLFPGI----------PLNE  263 (307)
Q Consensus       202 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~----------~~~~  263 (307)
                      |++.....   ......+|+.|+|||.+.+ ...++.++|||   +    +++|..||........          ....
T Consensus       174 g~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  250 (287)
T 4f0f_A          174 GLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT  250 (287)
T ss_dssp             TTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCC
T ss_pred             Cccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCC
Confidence            99985532   2344578999999999843 23678999999   3    3349999977433221          1112


Q ss_pred             hccccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         264 IFTAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       264 ~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      .+..+++++.++|.+||+.||++|||++++++
T Consensus       251 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            34568899999999999999999999999986

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.2e-44  Score=318.06  Aligned_cols=241  Identities=20%  Similarity=0.254  Sum_probs=187.4

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEc---CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceee
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDI---ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVF  126 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~  126 (307)
                      .....++|++.+.||+|+||.||+|++.   .++..||||++....    .....+.+.+|++++++++||||+++++++
T Consensus        40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~  115 (373)
T 2qol_A           40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY----TEKQRRDFLGEASIMGQFDHPNIIRLEGVV  115 (373)
T ss_dssp             CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            3456678999999999999999999876   467789999997532    223356789999999999999999999999


Q ss_pred             eecCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcc
Q psy9858         127 GYMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK  205 (307)
Q Consensus       127 ~~~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  205 (307)
                      .+....++||||+ +|+|.+++......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++
T Consensus       116 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  195 (373)
T 2qol_A          116 TKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGR  195 (373)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred             eeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccc
Confidence            9999999999999 689999998877679999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCcc---cccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCCC-------CChhhhccc
Q psy9858         206 FFGSPTRL---YTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFPG-------IPLNEIFTA  267 (307)
Q Consensus       206 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~~-------~~~~~~~~~  267 (307)
                      ........   .....++..|+|||.+.+. .++.++|||       .+++ |..||.......       ......+..
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~  274 (373)
T 2qol_A          196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD  274 (373)
T ss_dssp             ------------------CTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTT
T ss_pred             ccccCCccceeccCCCcCCCccChhhhccC-CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence            77433211   1122346789999999887 899999999       2343 888887632111       001112235


Q ss_pred             cCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         268 AGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       268 ~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      ++.++.+++.+||+.||++|||++++++
T Consensus       275 ~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          275 CPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             CBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            7889999999999999999999999876

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=5.1e-43  Score=302.86  Aligned_cols=242  Identities=26%  Similarity=0.398  Sum_probs=186.7

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN  131 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  131 (307)
                      ...++|++.+.||+|+||.||+|.+..+|+.||+|++......  .......+.+|+++++.++||||+++++++...+.
T Consensus        29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~  106 (310)
T 2wqm_A           29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM--DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE  106 (310)
T ss_dssp             SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhcc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCc
Confidence            4567899999999999999999999999999999999753322  22335678899999999999999999999999999


Q ss_pred             EEEEEEcc-CCChHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         132 VSLVFEFV-DTDLEVIIKD---PTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       132 ~~lv~e~~-~g~l~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      .++||||+ +|+|.+++..   ....+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            99999999 4688887753   3445899999999999999999999999999999999999999999999999999877


Q ss_pred             CCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCC---------Chh-hhccccCH
Q psy9858         208 GSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGI---------PLN-EIFTAAGD  270 (307)
Q Consensus       208 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~---------~~~-~~~~~~~~  270 (307)
                      ...........+++.|+|||.+.+. .++.++|||   +    +++|..||.+......         ... .....+++
T Consensus       187 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (310)
T 2wqm_A          187 SSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE  265 (310)
T ss_dssp             ------------CCSSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCH
T ss_pred             cCCCccccccCCCeeEeChHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCH
Confidence            5444344455789999999999887 889999999   2    3348889876332110         000 11245789


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         271 DLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       271 ~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      ++.++|.+||+.||.+|||+++++++
T Consensus       266 ~l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          266 ELRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            99999999999999999999999864

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-43  Score=301.78  Aligned_cols=242  Identities=19%  Similarity=0.239  Sum_probs=198.9

Q ss_pred             eccccceeeEEe-EEeecCceEEEEEEEc--CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceee
Q psy9858          50 VKNDLLVYYQWR-SVHVGRFATVFKARDI--ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVF  126 (307)
Q Consensus        50 ~~~~~~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~  126 (307)
                      +....++|.+.+ .||+|+||.||+|.+.  .++..||+|++....    .....+.+.+|+++++.++||||+++++++
T Consensus         4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   79 (287)
T 1u59_A            4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT----EKADTEEMMREAQIMHQLDNPYIVRLIGVC   79 (287)
T ss_dssp             CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC----CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc----chhHHHHHHHHHHHHHhCCCCCEeEEEEEe
Confidence            445567888887 9999999999999854  468899999997532    233356788999999999999999999998


Q ss_pred             eecCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcc
Q psy9858         127 GYMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK  205 (307)
Q Consensus       127 ~~~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  205 (307)
                       ..+..++||||+ +++|.+++......+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.
T Consensus        80 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~  158 (287)
T 1u59_A           80 -QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSK  158 (287)
T ss_dssp             -ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             -cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECccccee
Confidence             556799999999 568999887776679999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCcc---cccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCCC-------CChhhhccc
Q psy9858         206 FFGSPTRL---YTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFPG-------IPLNEIFTA  267 (307)
Q Consensus       206 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~~-------~~~~~~~~~  267 (307)
                      ........   .....+|+.|+|||.+.+. .++.++|||       .+++ |..||.......       ......+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~  237 (287)
T 1u59_A          159 ALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPE  237 (287)
T ss_dssp             ECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTT
T ss_pred             eeccCcceeeccccccccccccCHHHhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCC
Confidence            87543221   2233567899999999877 789999999       3454 889987633211       111223457


Q ss_pred             cCHHHHHHHHHhhhcCCCCCCCHHHHhcCc
Q psy9858         268 AGDDLLAVISSLLCLNPTKRADCTATLKMD  297 (307)
Q Consensus       268 ~~~~l~~li~~~l~~dP~~Rpt~~~il~hp  297 (307)
                      +++++.++|.+||+.||++|||++++++|.
T Consensus       238 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l  267 (287)
T 1u59_A          238 CPPELYALMSDCWIYKWEDRPDFLTVEQRM  267 (287)
T ss_dssp             CCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             cCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            899999999999999999999999999874

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.1e-43  Score=313.77  Aligned_cols=243  Identities=15%  Similarity=0.094  Sum_probs=191.2

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCC-----CcEEEEEEeecCCccccc------hhhhHhHHHHHHHHHhcCCCCcc
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIET-----DMIVAVKKIKLGTHADAK------DGINRTALREIKLLQELHHENVL  120 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~------~~~~~~~~~e~~~l~~l~h~ni~  120 (307)
                      ...++|++++.||+|+||.||+|.+..+     ++.||||++.........      ......+..|+..+..++||||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            4556999999999999999999998664     588999998754211100      00112234566677788899999


Q ss_pred             ccceeeeec----CeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEe--cCC
Q psy9858         121 GLTDVFGYM----SNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLIN--KQG  194 (307)
Q Consensus       121 ~~~~~~~~~----~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~--~~~  194 (307)
                      ++++++...    ...++||||++++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++  .++
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~  191 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD  191 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred             eEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence            999998764    56899999998899999987766799999999999999999999999999999999999999  889


Q ss_pred             cEEEEeecCccccCCCCc-------ccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCCC
Q psy9858         195 VLKIGDFGLAKFFGSPTR-------LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGIP  260 (307)
Q Consensus       195 ~~kl~Dfg~a~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~  260 (307)
                      .+||+|||+++.......       ......||+.|+|||.+.+. .++.++|||   +    +++|..||.+.......
T Consensus       192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~  270 (364)
T 3op5_A          192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV-APSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY  270 (364)
T ss_dssp             CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred             eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence            999999999987643211       11234599999999999887 799999999   3    34499999863222110


Q ss_pred             -----------hhhhc------cccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         261 -----------LNEIF------TAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       261 -----------~~~~~------~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                                 .....      ..+++++.+++..||+.||++|||++++++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          271 VRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence                       11111      356899999999999999999999999876

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.4e-44  Score=311.76  Aligned_cols=243  Identities=18%  Similarity=0.194  Sum_probs=198.9

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccc
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARDI-----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLT  123 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~  123 (307)
                      .+....++|++.+.||+|+||.||+|.+.     .+++.||+|++....    .......+.+|+++++.++||||++++
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA----SMRERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS----CHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc----CHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            44556789999999999999999999876     467899999987432    222345688999999999999999999


Q ss_pred             eeeeecCeEEEEEEcc-CCChHHHHhCCC---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecC
Q psy9858         124 DVFGYMSNVSLVFEFV-DTDLEVIIKDPT---------IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ  193 (307)
Q Consensus       124 ~~~~~~~~~~lv~e~~-~g~l~~~~~~~~---------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~  193 (307)
                      +++.+....++||||+ +|+|.+++....         ..+++..+..++.||+.||.|||++||+||||||+||+++.+
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~  174 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED  174 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCC
Confidence            9999999999999999 579998886421         346899999999999999999999999999999999999999


Q ss_pred             CcEEEEeecCccccCCCCc--ccccceeeceehhhhhhhccccccccccee---e----eee-cCCCCCCCCCC------
Q psy9858         194 GVLKIGDFGLAKFFGSPTR--LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPSSHGNLFP------  257 (307)
Q Consensus       194 ~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~f~~~~~~------  257 (307)
                      +.+||+|||++........  ......+|+.|+|||.+.+. .++.++|||   +    +++ |..||.+....      
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  253 (322)
T 1p4o_A          175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV  253 (322)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred             CeEEECcCccccccccccccccccCCCCCCCccChhhhccC-CCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH
Confidence            9999999999986643221  22334678899999999887 789999999   2    333 78888763211      


Q ss_pred             -CCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         258 -GIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       258 -~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                       .......+..+++.+.++|.+||+.||.+|||++++++|
T Consensus       254 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          254 MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence             111122345688999999999999999999999999987

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.5e-43  Score=300.21  Aligned_cols=237  Identities=25%  Similarity=0.311  Sum_probs=183.2

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN  131 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  131 (307)
                      ...++|++.+.||+|+||.||+|.+.  |+.||+|++....... .....+.+.+|+++++.++||||+++++++.+.+.
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (271)
T 3dtc_A            4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDED-ISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN   80 (271)
T ss_dssp             CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC-----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred             cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCccc-HHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence            45679999999999999999999964  8899999987543222 12234668899999999999999999999999999


Q ss_pred             EEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeecCCCCcEEEec--------CCcEEEE
Q psy9858         132 VSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHW---ILHRDLKPNNLLINK--------QGVLKIG  199 (307)
Q Consensus       132 ~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~--------~~~~kl~  199 (307)
                      .++||||+ +++|.+++...  .+++..+..++.|++.||.|||++|   ++||||||+||+++.        ++.++|+
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~  158 (271)
T 3dtc_A           81 LCLVMEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT  158 (271)
T ss_dssp             CEEEEECCTTEEHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred             eEEEEEcCCCCCHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence            99999999 56777777543  5899999999999999999999999   899999999999986        7789999


Q ss_pred             eecCccccCCCCcccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCC--------CCChhhh
Q psy9858         200 DFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFP--------GIPLNEI  264 (307)
Q Consensus       200 Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~--------~~~~~~~  264 (307)
                      |||++.......  .....+|+.|+|||.+.+. .++.++|||       .+++|..||.+....        .......
T Consensus       159 Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  235 (271)
T 3dtc_A          159 DFGLAREWHRTT--KMSAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI  235 (271)
T ss_dssp             CCCC---------------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCC
T ss_pred             cCCccccccccc--ccCCCCccceeCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCC
Confidence            999998764332  2345789999999999887 899999999       334499999872211        1111223


Q ss_pred             ccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         265 FTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       265 ~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      +..+++.+.+++.+||+.||.+|||++|++++
T Consensus       236 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          236 PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            35678999999999999999999999999875

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=9.2e-44  Score=304.24  Aligned_cols=241  Identities=18%  Similarity=0.239  Sum_probs=201.8

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY  128 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  128 (307)
                      .+....++|++.+.||+|+||.||+|.+..++..||+|++....      ...+.+.+|+++++.++||||+++++++.+
T Consensus         7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   80 (288)
T 3kfa_A            7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT------MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR   80 (288)
T ss_dssp             TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS------THHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH------HHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence            45567789999999999999999999999999999999997421      124668899999999999999999999999


Q ss_pred             cCeEEEEEEccC-CChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         129 MSNVSLVFEFVD-TDLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       129 ~~~~~lv~e~~~-g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                      ....++||||+. |+|.+++... ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..
T Consensus        81 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~  160 (288)
T 3kfa_A           81 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL  160 (288)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred             CCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCcccee
Confidence            999999999995 7899988753 34589999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCC-cccccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCCCC-------ChhhhccccCH
Q psy9858         207 FGSPT-RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFPGI-------PLNEIFTAAGD  270 (307)
Q Consensus       207 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~~~-------~~~~~~~~~~~  270 (307)
                      ..... .......+++.|+|||.+.+. .++.++|||       .+++ |..||.+......       .....+..+++
T Consensus       161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T 3kfa_A          161 MTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE  239 (288)
T ss_dssp             SCSSSSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred             ccCCccccccCCccccCcCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCH
Confidence            75433 223344667899999999887 899999999       3444 8888876332111       11122346789


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         271 DLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       271 ~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      .+.+|+.+||+.||.+|||++++++.
T Consensus       240 ~l~~li~~~l~~dp~~Rps~~~~~~~  265 (288)
T 3kfa_A          240 KVYELMRACWQWNPSDRPSFAEIHQA  265 (288)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHhCCChhhCcCHHHHHHH
Confidence            99999999999999999999999863

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1e-42  Score=298.76  Aligned_cols=235  Identities=18%  Similarity=0.167  Sum_probs=192.7

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceee-eecCe
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVF-GYMSN  131 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-~~~~~  131 (307)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++.....       ...+.+|+++++.++|++++..+..+ .....
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-------HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY   79 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-------chHHHHHHHHHHHhcCCCCCCeeeeecCCCCc
Confidence            44789999999999999999999999999999998764321       23477899999999988877766655 67788


Q ss_pred             EEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEE---ecCCcEEEEeecCccccC
Q psy9858         132 VSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLI---NKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       132 ~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~a~~~~  208 (307)
                      .++||||++++|.+++......+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++....
T Consensus        80 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           80 NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             EEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             eEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            99999999999999998666679999999999999999999999999999999999999   789999999999998764


Q ss_pred             CCCc-------ccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCCC--------------
Q psy9858         209 SPTR-------LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGIP--------------  260 (307)
Q Consensus       209 ~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~--------------  260 (307)
                      ....       ......+|+.|+|||.+.+. .++.++|||   +    +++|..||.+.......              
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCC-CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence            4322       22345789999999999988 799999999   3    33499999874333221              


Q ss_pred             hhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         261 LNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       261 ~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      .......+++++.+++.+||+.||++|||++++++
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            11122456899999999999999999999999986

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=4.7e-44  Score=306.20  Aligned_cols=235  Identities=15%  Similarity=0.154  Sum_probs=193.5

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCC-------cEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCcccccee
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETD-------MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV  125 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~  125 (307)
                      ..++|.+.+.||+|+||+||+|.+..++       ..||+|++...     .....+.+.+|+++++.++||||++++++
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   80 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-----HRNYSESFFEAASMMSKLSHKHLVLNYGV   80 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG-----GGGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc-----cHHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence            4578999999999999999999988776       57999998642     22235678899999999999999999999


Q ss_pred             eeecCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCc--------E
Q psy9858         126 FGYMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGV--------L  196 (307)
Q Consensus       126 ~~~~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--------~  196 (307)
                      +.+.+..++||||+ +|+|.+++......+++..+..++.||+.||.|||++||+||||||+||+++.++.        +
T Consensus        81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence            99999999999999 57999999877666899999999999999999999999999999999999999887        9


Q ss_pred             EEEeecCccccCCCCcccccceeeceehhhhhhhccccccccccee---e----eee-cCCCCCCCCCCCC-----Chhh
Q psy9858         197 KIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPSSHGNLFPGI-----PLNE  263 (307)
Q Consensus       197 kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~f~~~~~~~~-----~~~~  263 (307)
                      ||+|||++......    ....+|..|+|||.+.+...++.++|||   +    +++ +.+|+........     ....
T Consensus       161 kl~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~  236 (289)
T 4fvq_A          161 KLSDPGISITVLPK----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQ  236 (289)
T ss_dssp             EECCCCSCTTTSCH----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC
T ss_pred             eeccCcccccccCc----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCC
Confidence            99999999765322    2346788999999999855899999999   2    333 4444444111000     0111


Q ss_pred             hccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         264 IFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       264 ~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      .+...++++.+|+.+||+.||++|||++++++|
T Consensus       237 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          237 LPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            233467889999999999999999999999986

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.2e-43  Score=302.78  Aligned_cols=242  Identities=19%  Similarity=0.254  Sum_probs=188.1

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM  129 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  129 (307)
                      .+...++|++.+.||+|+||.||+|.+..+++.||+|++.....  ........+.+|+.+++.++||||+++++++..+
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~  106 (309)
T 2h34_A           29 EGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLS--SDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID  106 (309)
T ss_dssp             -----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGG--GSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred             CCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccc--cCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC
Confidence            45567899999999999999999999999999999999875321  2233356788999999999999999999999999


Q ss_pred             CeEEEEEEccC-CChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         130 SNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       130 ~~~~lv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                      +..+++|||+. ++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++....
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          107 GQLYVDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATT  185 (309)
T ss_dssp             TEEEEEEECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred             CeEEEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence            99999999995 68888887543 58999999999999999999999999999999999999999999999999998764


Q ss_pred             CCC-cccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCC---------CCCChhhhccccCHH
Q psy9858         209 SPT-RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLF---------PGIPLNEIFTAAGDD  271 (307)
Q Consensus       209 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~---------~~~~~~~~~~~~~~~  271 (307)
                      ... .......+++.|+|||.+.+. .++.++|||   +    +++|..||.+...         ...........++++
T Consensus       186 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (309)
T 2h34_A          186 DEKLTQLGNTVGTLYYMAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVA  264 (309)
T ss_dssp             -----------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTH
T ss_pred             ccccccccccCCCcCccCHHHHcCC-CCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHH
Confidence            332 223345789999999999887 889999999   2    3349999987321         111222344578999


Q ss_pred             HHHHHHHhhhcCCCCCC-CHHHHhc
Q psy9858         272 LLAVISSLLCLNPTKRA-DCTATLK  295 (307)
Q Consensus       272 l~~li~~~l~~dP~~Rp-t~~~il~  295 (307)
                      +.++|.+||+.||++|| |++++++
T Consensus       265 l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          265 FDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             HHHHHHHhccCCHHHHHHhHHHHHH
Confidence            99999999999999999 7877765

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.8e-43  Score=307.76  Aligned_cols=246  Identities=18%  Similarity=0.242  Sum_probs=199.1

Q ss_pred             CCceeccccceeeEEeEEeecCceEEEEEEEc-------CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCC
Q psy9858          46 PDCEVKNDLLVYYQWRSVHVGRFATVFKARDI-------ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHE  117 (307)
Q Consensus        46 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~  117 (307)
                      ....+....++|++.+.||+|+||.||+|.+.       .++..||+|++....    .......+.+|+++++.+ +||
T Consensus        26 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hp  101 (334)
T 2pvf_A           26 EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA----TEKDLSDLVSEMEMMKMIGKHK  101 (334)
T ss_dssp             CCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC----CHHHHHHHHHHHHHHHHHCCCT
T ss_pred             CCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC----cHHHHHHHHHHHHHHHHhhcCC
Confidence            34445566789999999999999999999975       467889999997532    223356788999999999 899


Q ss_pred             CccccceeeeecCeEEEEEEcc-CCChHHHHhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceee
Q psy9858         118 NVLGLTDVFGYMSNVSLVFEFV-DTDLEVIIKDPT---------------IVFTPSNIKAYAIMTLRGLEYLHDHWILHR  181 (307)
Q Consensus       118 ni~~~~~~~~~~~~~~lv~e~~-~g~l~~~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~  181 (307)
                      ||+++++++.+.+..++||||+ +|+|.+++....               ..+++..+..++.||+.||.|||++||+||
T Consensus       102 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~  181 (334)
T 2pvf_A          102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR  181 (334)
T ss_dssp             TBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             CEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence            9999999999999999999999 579999987643               237899999999999999999999999999


Q ss_pred             cCCCCcEEEecCCcEEEEeecCccccCCCCcc--cccceeeceehhhhhhhccccccccccee-------eeee-cCCCC
Q psy9858         182 DLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL--YTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSS  251 (307)
Q Consensus       182 dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f  251 (307)
                      ||||+||+++.++.+||+|||++.........  .....+++.|+|||.+.+. .++.++|||       .+++ |..||
T Consensus       182 Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~  260 (334)
T 2pvf_A          182 DLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPY  260 (334)
T ss_dssp             CCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             CCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCC-CcChHHHHHHHHHHHHHHHhCCCCCc
Confidence            99999999999999999999999877543221  2233567889999999887 789999999       2344 88888


Q ss_pred             CCCCCCC-------CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         252 HGNLFPG-------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       252 ~~~~~~~-------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      .+.....       ......+..++.++.+++.+||+.||.+|||+++++++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          261 PGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             TTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CcCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            7632111       00112234678999999999999999999999999875

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.8e-43  Score=307.96  Aligned_cols=238  Identities=21%  Similarity=0.252  Sum_probs=195.5

Q ss_pred             ccceeeEEeEEeecCceEEEEEE----EcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeee-
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKAR----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG-  127 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-  127 (307)
                      ..++|++++.||+|+||.||+|+    +..+++.||+|++...     .....+.+.+|+++++.++||||+++++++. 
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   95 (327)
T 3lxl_A           21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-----GPDQQRDFQREIQILKALHSDFIVKYRGVSYG   95 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-----CHHHHHHHHHHHHHHHhcCCCceeEEEEEEec
Confidence            44689999999999999999998    5678999999999753     2222456889999999999999999999876 


Q ss_pred             -ecCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcc
Q psy9858         128 -YMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK  205 (307)
Q Consensus       128 -~~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  205 (307)
                       +....++||||+ +|+|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  175 (327)
T 3lxl_A           96 PGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK  175 (327)
T ss_dssp             SSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred             CCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccce
Confidence             556799999999 688999987755568999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCc---ccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCC----------C--------
Q psy9858         206 FFGSPTR---LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLF----------P--------  257 (307)
Q Consensus       206 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~----------~--------  257 (307)
                      .......   ......+|..|+|||.+.+. .++.++|||   +    +++|..||.....          .        
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  254 (327)
T 3lxl_A          176 LLPLDKDYYVVREPGQSPIFWYAPESLSDN-IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL  254 (327)
T ss_dssp             ECCTTCSEEECSSCCCSCGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred             ecccCCccceeeccCCccccccCHHHhccC-CCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence            8754322   22334678889999999887 889999999   3    3337777755110          0        


Q ss_pred             ----CCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         258 ----GIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       258 ----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                          .......+..+++++.+||.+||+.||++|||+++++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                000112234678999999999999999999999999764

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.2e-42  Score=296.78  Aligned_cols=236  Identities=18%  Similarity=0.171  Sum_probs=195.8

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceee-eecCe
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVF-GYMSN  131 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-~~~~~  131 (307)
                      ..++|++.+.||+|+||.||+|++..+|+.||+|++.....       ...+.+|+++++.++|++++..+..+ .....
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-------HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY   79 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-------CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-------hhHHHHHHHHHHHhhcCCCCCccccccCCCCc
Confidence            35689999999999999999999999999999999875321       23578999999999988876666555 56778


Q ss_pred             EEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEE---ecCCcEEEEeecCccccC
Q psy9858         132 VSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLI---NKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       132 ~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~a~~~~  208 (307)
                      .++||||++++|.+++......+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++....
T Consensus        80 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           80 NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             EEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             eEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            89999999999999998666679999999999999999999999999999999999999   488899999999998775


Q ss_pred             CCCc-------ccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCCC--------------
Q psy9858         209 SPTR-------LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGIP--------------  260 (307)
Q Consensus       209 ~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~--------------  260 (307)
                      ....       ......+|+.|+|||.+.+. .++.++|||   +    +++|..||.+.......              
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             ccccccccccccccccccccccCChhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence            4322       12445789999999999987 799999999   3    33499999874332211              


Q ss_pred             hhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         261 LNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       261 ~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      .......+++++.+++.+||+.||.+|||++++++.
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  274 (296)
T 3uzp_A          239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL  274 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred             hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH
Confidence            111224678999999999999999999999998763

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=4.2e-43  Score=316.92  Aligned_cols=239  Identities=21%  Similarity=0.177  Sum_probs=183.1

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeeecCeEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGYMSNVS  133 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~  133 (307)
                      +.|.+.+.||+|+||+||.+. ..+|+.||||++...        ....+.+|+++++.+ +||||+++++++.+....+
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~--------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~   85 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID--------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLY   85 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG--------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred             heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH--------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEE
Confidence            345667889999999998754 568999999998641        134567899999886 8999999999999999999


Q ss_pred             EEEEccCCChHHHHhCCCCC------CCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecC-------------C
Q psy9858         134 LVFEFVDTDLEVIIKDPTIV------FTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ-------------G  194 (307)
Q Consensus       134 lv~e~~~g~l~~~~~~~~~~------~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~-------------~  194 (307)
                      +||||++|+|.+++......      ..+..+..++.||+.||.|||++||+||||||+||+++.+             +
T Consensus        86 lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~  165 (434)
T 2rio_A           86 IALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENL  165 (434)
T ss_dssp             EEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred             EEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCce
Confidence            99999999999999765421      1223456799999999999999999999999999999754             4


Q ss_pred             cEEEEeecCccccCCCCc----ccccceeeceehhhhhhhc------cccccccccee-------eeee-cCCCCCCCCC
Q psy9858         195 VLKIGDFGLAKFFGSPTR----LYTHQVVTRWYRLIKCLLY------CVQFNVKNVQW-------CCFA-KDPSSHGNLF  256 (307)
Q Consensus       195 ~~kl~Dfg~a~~~~~~~~----~~~~~~~t~~y~aPE~~~~------~~~~~~~~Diw-------~i~~-~~~~f~~~~~  256 (307)
                      .+||+|||++........    ......||+.|+|||++.+      ...++.++|||       .+++ |..||.....
T Consensus       166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~  245 (434)
T 2rio_A          166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS  245 (434)
T ss_dssp             EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred             EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence            899999999998754322    1234579999999999976      23689999999       3444 8899876321


Q ss_pred             CC----------CChh-hhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         257 PG----------IPLN-EIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       257 ~~----------~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                      ..          .... .....+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus       246 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~  302 (434)
T 2rio_A          246 RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK  302 (434)
T ss_dssp             HHHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred             hHHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence            10          0000 1112456889999999999999999999999999999764

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=5.1e-43  Score=305.87  Aligned_cols=246  Identities=21%  Similarity=0.267  Sum_probs=182.9

Q ss_pred             CceeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-CCCcccccee
Q psy9858          47 DCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-HENVLGLTDV  125 (307)
Q Consensus        47 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~  125 (307)
                      ...+.....+|++.+.||+|+||.||+|++..+|+.||+|++...     .......+.+|+.+++++. ||||++++++
T Consensus        20 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~   94 (337)
T 3ll6_A           20 GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-----EEEKNRAIIQEVCFMKKLSGHPNIVQFCSA   94 (337)
T ss_dssp             TCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-----SHHHHHHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred             cceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-----chHHHHHHHHHHHHHHHhccCCChhhcccc
Confidence            344555667999999999999999999999999999999998643     2223466889999999996 9999999998


Q ss_pred             e--------eecCeEEEEEEccCCChHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeecCCCCcEEEecC
Q psy9858         126 F--------GYMSNVSLVFEFVDTDLEVIIKD--PTIVFTPSNIKAYAIMTLRGLEYLHDHW--ILHRDLKPNNLLINKQ  193 (307)
Q Consensus       126 ~--------~~~~~~~lv~e~~~g~l~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~  193 (307)
                      +        ......+++|||++|+|.+++..  ....+++..+..++.||+.||.|||++|  |+||||||+||+++.+
T Consensus        95 ~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~  174 (337)
T 3ll6_A           95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ  174 (337)
T ss_dssp             EEECTTTSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTT
T ss_pred             ccccccccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCC
Confidence            8        34456899999999999988864  4446899999999999999999999999  9999999999999999


Q ss_pred             CcEEEEeecCccccCCCCcc------------cccceeeceehhhhhhh--ccccccccccee---e----eeecCCCCC
Q psy9858         194 GVLKIGDFGLAKFFGSPTRL------------YTHQVVTRWYRLIKCLL--YCVQFNVKNVQW---C----CFAKDPSSH  252 (307)
Q Consensus       194 ~~~kl~Dfg~a~~~~~~~~~------------~~~~~~t~~y~aPE~~~--~~~~~~~~~Diw---~----i~~~~~~f~  252 (307)
                      +.+||+|||++.........            .....+|+.|+|||.+.  ....++.++|||   +    +++|..||.
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~  254 (337)
T 3ll6_A          175 GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE  254 (337)
T ss_dssp             SCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred             CCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence            99999999999876432211            11346899999999984  223789999999   3    344999997


Q ss_pred             CCCCCCCC----hhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCc
Q psy9858         253 GNLFPGIP----LNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMD  297 (307)
Q Consensus       253 ~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp  297 (307)
                      ........    ........+..+.+||.+||+.||.+|||++|+++|-
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l  303 (337)
T 3ll6_A          255 DGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL  303 (337)
T ss_dssp             -----------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             chhHHHhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            73322211    1112235678899999999999999999999999874

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.9e-43  Score=314.52  Aligned_cols=240  Identities=18%  Similarity=0.204  Sum_probs=194.0

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC-
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS-  130 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-  130 (307)
                      ...++|.+.+.||+|+||+||+|.+..+|+.||||++....    .......+.+|++++++++||||+++++++.... 
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~   81 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS----FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT   81 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG----GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccc----ccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCC
Confidence            34578999999999999999999999999999999997422    1222456789999999999999999999987655 


Q ss_pred             -eEEEEEEcc-CCChHHHHhCCCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEE----ecCCcEEEEeec
Q psy9858         131 -NVSLVFEFV-DTDLEVIIKDPTI--VFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLI----NKQGVLKIGDFG  202 (307)
Q Consensus       131 -~~~lv~e~~-~g~l~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~----~~~~~~kl~Dfg  202 (307)
                       ..++||||+ +|+|.+++.....  .+++..++.++.||+.||.|||++||+||||||+||++    +.++.+||+|||
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG  161 (396)
T 4eut_A           82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG  161 (396)
T ss_dssp             CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred             CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence             789999999 5789888876432  38999999999999999999999999999999999999    777789999999


Q ss_pred             CccccCCCCcccccceeeceehhhhhhhcc-------ccccccccee---e----eeecCCCCCCCCCCCCC--------
Q psy9858         203 LAKFFGSPTRLYTHQVVTRWYRLIKCLLYC-------VQFNVKNVQW---C----CFAKDPSSHGNLFPGIP--------  260 (307)
Q Consensus       203 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~--------  260 (307)
                      +++..... .......+|+.|+|||.+.+.       ..++.++|||   +    +++|..||.........        
T Consensus       162 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  240 (396)
T 4eut_A          162 AARELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (396)
T ss_dssp             GCEECCCG-GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred             CceEccCC-CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence            99887443 233455789999999998762       3788999999   3    33399998652211110        


Q ss_pred             ---------------------------hhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         261 ---------------------------LNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       261 ---------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                                                 ...+...++..+.+++.+||+.||++|||++|++++
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence                                       011123456788999999999999999999998653

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.3e-43  Score=307.29  Aligned_cols=239  Identities=21%  Similarity=0.264  Sum_probs=193.8

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEE--EEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeee
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIV--AVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGY  128 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v--avK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~  128 (307)
                      ...++|++.+.||+|+||.||+|++..+|..+  |+|.+....    .......+.+|+++++++ +||||+++++++.+
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~   97 (327)
T 1fvr_A           22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH   97 (327)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred             ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc----chHHHHHHHHHHHHHHhccCCCchhhhceeeee
Confidence            35578999999999999999999998888865  999987432    122245688999999999 89999999999999


Q ss_pred             cCeEEEEEEcc-CCChHHHHhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEec
Q psy9858         129 MSNVSLVFEFV-DTDLEVIIKDPT---------------IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK  192 (307)
Q Consensus       129 ~~~~~lv~e~~-~g~l~~~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~  192 (307)
                      .+..++||||+ +|+|.+++....               ..+++..++.++.||+.||.|||++||+||||||+||+++.
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~  177 (327)
T 1fvr_A           98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE  177 (327)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred             CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcC
Confidence            99999999999 679999987653               35899999999999999999999999999999999999999


Q ss_pred             CCcEEEEeecCccccCCCCcccccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCCC------
Q psy9858         193 QGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFPG------  258 (307)
Q Consensus       193 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~~------  258 (307)
                      ++.+||+|||++...... .......+++.|+|||.+.+. .++.++|||       .+++ |..||.+.....      
T Consensus       178 ~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~  255 (327)
T 1fvr_A          178 NYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP  255 (327)
T ss_dssp             GGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred             CCeEEEcccCcCcccccc-ccccCCCCCccccChhhhccc-cCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence            999999999999754221 122334567899999999877 889999999       3443 888887632111      


Q ss_pred             -CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         259 -IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       259 -~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                       ......+..+++++.+||.+||+.||.+|||+++++++
T Consensus       256 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          256 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence             11112234678999999999999999999999999986

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.1e-43  Score=299.73  Aligned_cols=244  Identities=20%  Similarity=0.270  Sum_probs=195.3

Q ss_pred             ceeccccceeeEEeEEeecCceEEEEEEEcCCCc---EEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccce
Q psy9858          48 CEVKNDLLVYYQWRSVHVGRFATVFKARDIETDM---IVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTD  124 (307)
Q Consensus        48 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~  124 (307)
                      ..+......|.+.+.||+|+||+||+|.+..++.   .||+|++...    ......+.+.+|+++++.++||||+++++
T Consensus        14 ~~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   89 (298)
T 3pls_A           14 VLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI----TEMQQVEAFLREGLLMRGLNHPNVLALIG   89 (298)
T ss_dssp             GBCCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC----CSHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred             eEccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc----ccHHHHHHHHHHHHHHHhCCCCCeeeEEE
Confidence            3444556688999999999999999999765544   7999998742    22223567889999999999999999999


Q ss_pred             eeeecCeE-EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeec
Q psy9858         125 VFGYMSNV-SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFG  202 (307)
Q Consensus       125 ~~~~~~~~-~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg  202 (307)
                      ++.+.+.. +++|||+ +|+|.+++......+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||
T Consensus        90 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg  169 (298)
T 3pls_A           90 IMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFG  169 (298)
T ss_dssp             EECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTT
T ss_pred             EEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCC
Confidence            99766554 9999999 789999998877778999999999999999999999999999999999999999999999999


Q ss_pred             CccccCCCC----cccccceeeceehhhhhhhccccccccccee---e----eee-cCCCCCCCCCCC-------CChhh
Q psy9858         203 LAKFFGSPT----RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPSSHGNLFPG-------IPLNE  263 (307)
Q Consensus       203 ~a~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~f~~~~~~~-------~~~~~  263 (307)
                      ++.......    .......+++.|+|||.+.+. .++.++|||   +    +++ +.+||.......       .....
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~  248 (298)
T 3pls_A          170 LARDILDREYYSVQQHRHARLPVKWTALESLQTY-RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLP  248 (298)
T ss_dssp             SSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCC
T ss_pred             CcccccCCcccccccCcCCCCCccccChhhhccC-CCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCC
Confidence            998664321    122344678899999999887 889999999   2    333 444454421111       01112


Q ss_pred             hccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         264 IFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       264 ~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      .+..+++.+.+++.+||+.||.+|||++++++.
T Consensus       249 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  281 (298)
T 3pls_A          249 QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE  281 (298)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCccchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            234578999999999999999999999998863

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=5.8e-43  Score=299.62  Aligned_cols=239  Identities=18%  Similarity=0.216  Sum_probs=183.7

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM  129 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  129 (307)
                      .....++|++.+.||+|+||+||+|++.   ..||+|++.....   .....+.+.+|+++++.++||||++++++. ..
T Consensus        19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~   91 (289)
T 3og7_A           19 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP---TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TA   91 (289)
T ss_dssp             CBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CS
T ss_pred             CccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCC---CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cC
Confidence            3456678999999999999999999853   3599999975432   223356788999999999999999999954 56


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                      ...++||||+ +++|.+++......+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  171 (289)
T 3og7_A           92 PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS  171 (289)
T ss_dssp             SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred             CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccc
Confidence            6789999999 578989887777779999999999999999999999999999999999999999999999999998654


Q ss_pred             CC--Ccccccceeeceehhhhhhhc--cccccccccee---e----eeecCCCCCCCCC------------CCCChhhhc
Q psy9858         209 SP--TRLYTHQVVTRWYRLIKCLLY--CVQFNVKNVQW---C----CFAKDPSSHGNLF------------PGIPLNEIF  265 (307)
Q Consensus       209 ~~--~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~Diw---~----i~~~~~~f~~~~~------------~~~~~~~~~  265 (307)
                      ..  ........+|+.|+|||.+..  ...++.++|||   +    +++|..||.+...            .........
T Consensus       172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (289)
T 3og7_A          172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR  251 (289)
T ss_dssp             ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSC
T ss_pred             cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhcc
Confidence            21  222334578999999999862  33688999999   3    3349999976321            112222334


Q ss_pred             cccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         266 TAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       266 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      ..+++++.+|+.+||+.||.+|||++++++
T Consensus       252 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          252 SNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            568899999999999999999999999986

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.2e-43  Score=298.49  Aligned_cols=238  Identities=18%  Similarity=0.245  Sum_probs=197.5

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS  130 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  130 (307)
                      ....++|++.+.||+|+||.||+|.+. ++..||+|++.....      ..+.+.+|+++++.++||||+++++++.+.+
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   76 (267)
T 3t9t_A            4 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM------SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA   76 (267)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB------CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             EEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC------CHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            345679999999999999999999975 678899999975321      1356889999999999999999999999999


Q ss_pred             eEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCC
Q psy9858         131 NVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS  209 (307)
Q Consensus       131 ~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  209 (307)
                      ..+++|||+ +++|.+++......+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus        77 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  156 (267)
T 3t9t_A           77 PICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  156 (267)
T ss_dssp             SCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             CeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccc
Confidence            999999999 5789999987766789999999999999999999999999999999999999999999999999987643


Q ss_pred             CC-cccccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCCC-------CChhhhccccCHHHH
Q psy9858         210 PT-RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFPG-------IPLNEIFTAAGDDLL  273 (307)
Q Consensus       210 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~~-------~~~~~~~~~~~~~l~  273 (307)
                      .. .......++..|+|||.+.+. .++.++|||       .+++ |..||.......       ......+..+++.+.
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~  235 (267)
T 3t9t_A          157 DQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVY  235 (267)
T ss_dssp             HHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHH
T ss_pred             ccccccccccccccccChhhhcCC-CccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHH
Confidence            21 112234567889999999877 789999999       3344 788887632111       001112345689999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         274 AVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       274 ~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      +++.+||+.||++|||+++++++
T Consensus       236 ~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          236 QIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHccCChhhCcCHHHHHHH
Confidence            99999999999999999999875

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=5.2e-43  Score=305.76  Aligned_cols=244  Identities=19%  Similarity=0.272  Sum_probs=198.9

Q ss_pred             ceeccccceeeEEeEEeecCceEEEEEEEcCCCc-----EEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccc
Q psy9858          48 CEVKNDLLVYYQWRSVHVGRFATVFKARDIETDM-----IVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLG  121 (307)
Q Consensus        48 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~  121 (307)
                      ..+....++|++.+.||+|+||.||+|.+..++.     .||+|++....    .......+.+|+++++.+ +||||++
T Consensus        39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~iv~  114 (333)
T 2i1m_A           39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA----HADEKEALMSELKIMSHLGQHENIVN  114 (333)
T ss_dssp             GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc----ChHHHHHHHHHHHHHHhhcCCCCeee
Confidence            3455667899999999999999999999876654     89999997532    222346688999999999 8999999


Q ss_pred             cceeeeecCeEEEEEEcc-CCChHHHHhCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCc
Q psy9858         122 LTDVFGYMSNVSLVFEFV-DTDLEVIIKDP-------------TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNN  187 (307)
Q Consensus       122 ~~~~~~~~~~~~lv~e~~-~g~l~~~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~N  187 (307)
                      +++++.+.+..++||||+ +|+|.+++...             ...+++..+..++.||+.||.|||++||+||||||+|
T Consensus       115 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N  194 (333)
T 2i1m_A          115 LLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARN  194 (333)
T ss_dssp             EEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccce
Confidence            999999999999999999 56899888642             2347999999999999999999999999999999999


Q ss_pred             EEEecCCcEEEEeecCccccCCCCc--ccccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCC
Q psy9858         188 LLINKQGVLKIGDFGLAKFFGSPTR--LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFP  257 (307)
Q Consensus       188 il~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~  257 (307)
                      |+++.++.+||+|||++........  ......+|+.|+|||.+.+. .++.++|||       .+++ |..||.+....
T Consensus       195 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~  273 (333)
T 2i1m_A          195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNPYPGILVN  273 (333)
T ss_dssp             CEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS
T ss_pred             EEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccC-CCChHHHHHHHHHHHHHHHcCCCCCCcccchh
Confidence            9999999999999999986643222  23345678899999999887 899999999       2343 78888764322


Q ss_pred             CCC--------hhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         258 GIP--------LNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       258 ~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      ...        ....+..+++.+.+++.+||+.||.+|||+++++++
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          274 SKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            111        011233468899999999999999999999999874

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.2e-43  Score=323.70  Aligned_cols=240  Identities=18%  Similarity=0.231  Sum_probs=200.4

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY  128 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  128 (307)
                      .+.....+|++.+.||+|+||.||+|.+..++..||||++....      ...+.+.+|++++++++||||+++++++..
T Consensus       214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  287 (495)
T 1opk_A          214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT------MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR  287 (495)
T ss_dssp             CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS------SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc------cchHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence            34556788999999999999999999999889999999987432      124668999999999999999999999999


Q ss_pred             cCeEEEEEEcc-CCChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         129 MSNVSLVFEFV-DTDLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       129 ~~~~~lv~e~~-~g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                      ....++||||+ +|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       288 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  367 (495)
T 1opk_A          288 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRL  367 (495)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEEC
T ss_pred             CCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeeccccee
Confidence            99999999999 58999998753 34589999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCc-ccccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCCCC-------ChhhhccccCH
Q psy9858         207 FGSPTR-LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFPGI-------PLNEIFTAAGD  270 (307)
Q Consensus       207 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~~~-------~~~~~~~~~~~  270 (307)
                      ...... ......++..|+|||.+.+. .++.++|||       .+++ |..||.+......       .....+..+++
T Consensus       368 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  446 (495)
T 1opk_A          368 MTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE  446 (495)
T ss_dssp             CTTCCEECCTTCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred             ccCCceeecCCCcCCcceeCHhHHhcC-CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence            743322 12233557889999999887 899999999       2343 8888877332110       11122456889


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         271 DLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       271 ~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      ++.+||.+||+.||++|||++++++
T Consensus       447 ~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          447 KVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCcChhHCcCHHHHHH
Confidence            9999999999999999999999986

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3e-43  Score=300.16  Aligned_cols=243  Identities=14%  Similarity=0.177  Sum_probs=194.4

Q ss_pred             ceeccccceeeEEeEEeecCceEEEEEEEcC---CCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccce
Q psy9858          48 CEVKNDLLVYYQWRSVHVGRFATVFKARDIE---TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTD  124 (307)
Q Consensus        48 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~  124 (307)
                      ..+....++|.+.+.||+|+||.||+|.+..   ++..||+|++....    .....+.+.+|+++++.++||||+++++
T Consensus         5 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~   80 (281)
T 3cc6_A            5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC----TLDNKEKFMSEAVIMKNLDHPHIVKLIG   80 (281)
T ss_dssp             CCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS----CHHHHHHHHHHHHHHHHHCCTTBCCEEE
T ss_pred             ccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc----CchHHHHHHHHHHHHHhCCCCCcceEEE
Confidence            3456677899999999999999999998653   34569999987532    2223567889999999999999999999


Q ss_pred             eeeecCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecC
Q psy9858         125 VFGYMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGL  203 (307)
Q Consensus       125 ~~~~~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  203 (307)
                      ++.+ ...++||||+ +++|.+++......+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||+
T Consensus        81 ~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  159 (281)
T 3cc6_A           81 IIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGL  159 (281)
T ss_dssp             EECS-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCG
T ss_pred             EEcC-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCC
Confidence            8865 4568999999 5789999877666689999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCc-ccccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCCCC-------Chhhhccc
Q psy9858         204 AKFFGSPTR-LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFPGI-------PLNEIFTA  267 (307)
Q Consensus       204 a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~~~-------~~~~~~~~  267 (307)
                      +........ ......+++.|+|||.+.+. .++.++|||       .+++ |..||........       .....+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  238 (281)
T 3cc6_A          160 SRYIEDEDYYKASVTRLPIKWMSPESINFR-RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDL  238 (281)
T ss_dssp             GGCC---------CCCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTT
T ss_pred             CcccccccccccccCCCCcceeCchhhccC-CCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCC
Confidence            987643321 22334567899999999877 889999999       3444 8888865222110       01112345


Q ss_pred             cCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         268 AGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       268 ~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      +++.+.+++.+||+.||.+|||+++++++
T Consensus       239 ~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          239 CPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            78999999999999999999999999875

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.6e-43  Score=305.25  Aligned_cols=241  Identities=16%  Similarity=0.239  Sum_probs=190.5

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCCC----cEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceee
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIETD----MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVF  126 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~  126 (307)
                      ....++|.+.+.||+|+||.||+|.+..++    ..||+|++....    .......+.+|+++++.++||||+++++++
T Consensus        40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  115 (333)
T 1mqb_A           40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY----TEKQRVDFLGEAGIMGQFSHHNIIRLEGVI  115 (333)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            445678999999999999999999876543    469999997532    222345688999999999999999999999


Q ss_pred             eecCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcc
Q psy9858         127 GYMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK  205 (307)
Q Consensus       127 ~~~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  205 (307)
                      .+.+..++||||+ +|+|.+++......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus       116 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  195 (333)
T 1mqb_A          116 SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR  195 (333)
T ss_dssp             CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             ecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcch
Confidence            9999999999999 568999988776679999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCcc---cccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCCC-------CChhhhccc
Q psy9858         206 FFGSPTRL---YTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFPG-------IPLNEIFTA  267 (307)
Q Consensus       206 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~~-------~~~~~~~~~  267 (307)
                      ........   .....++..|+|||.+.+. .++.++|||       .+++ |..||.+.....       ......+..
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  274 (333)
T 1mqb_A          196 VLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMD  274 (333)
T ss_dssp             ---------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred             hhccccccccccCCCCccccccCchhcccC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCccc
Confidence            76432211   1223457789999999877 899999999       3444 888886622110       001112345


Q ss_pred             cCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         268 AGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       268 ~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      +++.+.+++.+||+.||++|||+.+++++
T Consensus       275 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          275 CPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             CBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            78999999999999999999999999875

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.1e-42  Score=298.94  Aligned_cols=243  Identities=19%  Similarity=0.239  Sum_probs=194.2

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEEcCC---CcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCcccccee
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARDIET---DMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV  125 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~  125 (307)
                      .+.....+|++.+.||+|+||.||+|.+..+   +..||+|.+...    ......+.+.+|++++++++||||++++++
T Consensus        19 ~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   94 (298)
T 3f66_A           19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----TDIGEVSQFLTEGIIMKDFSHPNVLSLLGI   94 (298)
T ss_dssp             BCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC----CSHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred             ecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC----CCHHHHHHHHHHHHHHHhCCCCCEeeeeeE
Confidence            4455677899999999999999999986543   346899998742    222335678899999999999999999998


Q ss_pred             e-eecCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecC
Q psy9858         126 F-GYMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGL  203 (307)
Q Consensus       126 ~-~~~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  203 (307)
                      + ..++..+++|||+ +|+|.+++......+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||+
T Consensus        95 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~  174 (298)
T 3f66_A           95 CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGL  174 (298)
T ss_dssp             ECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGG
T ss_pred             EEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccc
Confidence            5 5567899999999 5699999987777789999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCC----cccccceeeceehhhhhhhccccccccccee---e----eee-cCCCCCCCCCCCCC-------hhhh
Q psy9858         204 AKFFGSPT----RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPSSHGNLFPGIP-------LNEI  264 (307)
Q Consensus       204 a~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~f~~~~~~~~~-------~~~~  264 (307)
                      +.......    .......+|+.|+|||.+.+. .++.++|||   +    +++ +.+||.........       ....
T Consensus       175 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (298)
T 3f66_A          175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ  253 (298)
T ss_dssp             GCCCSCGGGCBC-----CCBCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCC
T ss_pred             cccccccchhccccccCCCCCccccChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCC
Confidence            98764322    112334567889999999887 899999999   2    333 66676663322211       1122


Q ss_pred             ccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         265 FTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       265 ~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      +..+++.+.+++.+||+.||++|||++++++.
T Consensus       254 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  285 (298)
T 3f66_A          254 PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  285 (298)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            34578999999999999999999999999873

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.1e-43  Score=316.98  Aligned_cols=248  Identities=11%  Similarity=0.055  Sum_probs=192.6

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCC-CCcccccee---
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH-ENVLGLTDV---  125 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~---  125 (307)
                      .+....+|...+.||+|+||+||+|++..+|+.||||++.......  ....+.+.+|+.+++.++| .|...+...   
T Consensus        73 ~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~--~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~  150 (413)
T 3dzo_A           73 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP--SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF  150 (413)
T ss_dssp             SSSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC------CCHHHHHHHHGGGGSTTCCSHHHHHHHTCB
T ss_pred             CCCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCcc--HHHHHHHHHHHHHHHhhccCCCHHHHHHhccc
Confidence            4456677999999999999999999999999999999987433222  2235678899999999987 332221111   


Q ss_pred             ------------------eee-----cCeEEEEEEccCCChHHHHh------CCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy9858         126 ------------------FGY-----MSNVSLVFEFVDTDLEVIIK------DPTIVFTPSNIKAYAIMTLRGLEYLHDH  176 (307)
Q Consensus       126 ------------------~~~-----~~~~~lv~e~~~g~l~~~~~------~~~~~~~~~~~~~i~~~i~~~l~~lH~~  176 (307)
                                        +..     ....+++|+++.++|.+++.      .....+++..+..++.||+.||.|||++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~  230 (413)
T 3dzo_A          151 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY  230 (413)
T ss_dssp             CCCCEEEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             ccchhhcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence                              111     23478899999999998884      3344578888999999999999999999


Q ss_pred             CceeecCCCCcEEEecCCcEEEEeecCccccCCCCcccccceeeceehhhhhhh---------ccccccccccee---e-
Q psy9858         177 WILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLL---------YCVQFNVKNVQW---C-  243 (307)
Q Consensus       177 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~---------~~~~~~~~~Diw---~-  243 (307)
                      ||+||||||+|||++.++.+||+|||+++.....   .....| +.|+|||++.         ....++.++|||   + 
T Consensus       231 ~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi  306 (413)
T 3dzo_A          231 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA  306 (413)
T ss_dssp             TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred             CcccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence            9999999999999999999999999999876432   344567 9999999994         333688999999   3 


Q ss_pred             ---eeecCCCCCCCCCCCCChhhh--ccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         244 ---CFAKDPSSHGNLFPGIPLNEI--FTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       244 ---i~~~~~~f~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                         +++|+.||.............  ...+++++.+||.+||+.||++|||+.++++||||+...
T Consensus       307 l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~  371 (413)
T 3dzo_A          307 IYWIWCADLPNTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR  371 (413)
T ss_dssp             HHHHHHSSCCCCTTGGGSCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             HHHHHHCCCCCCCcchhhhHHHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHH
Confidence               334999998754333222221  246899999999999999999999999999999998654

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.4e-42  Score=297.55  Aligned_cols=241  Identities=21%  Similarity=0.239  Sum_probs=193.4

Q ss_pred             eeccccceeeEEe-EEeecCceEEEEEE--EcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCcccccee
Q psy9858          49 EVKNDLLVYYQWR-SVHVGRFATVFKAR--DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV  125 (307)
Q Consensus        49 ~~~~~~~~y~~~~-~lg~G~~g~V~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~  125 (307)
                      ++....++|.+.+ .||+|+||.||+|.  +..+++.||||++....   ......+.+.+|+++++.++||||++++++
T Consensus        10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   86 (291)
T 1xbb_A           10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA---NDPALKDELLAEANVMQQLDNPYIVRMIGI   86 (291)
T ss_dssp             -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------CHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc---cCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            4455678999999 99999999999995  45678999999997532   222335678899999999999999999999


Q ss_pred             eeecCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCc
Q psy9858         126 FGYMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA  204 (307)
Q Consensus       126 ~~~~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  204 (307)
                      + .....++||||+ +++|.+++.... .+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++
T Consensus        87 ~-~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~  164 (291)
T 1xbb_A           87 C-EAESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS  164 (291)
T ss_dssp             E-ESSSEEEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             E-CCCCcEEEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcc
Confidence            8 667889999999 578888887653 5899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCcc---cccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCC-------CCChhhhcc
Q psy9858         205 KFFGSPTRL---YTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFP-------GIPLNEIFT  266 (307)
Q Consensus       205 ~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~-------~~~~~~~~~  266 (307)
                      .........   .....++..|+|||.+.+. .++.++|||       .+++ |..||.+....       .......+.
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  243 (291)
T 1xbb_A          165 KALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA  243 (291)
T ss_dssp             EECCTTCSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT
T ss_pred             eeeccCCCcccccccCCCCceeeChHHhccC-CCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            877543322   1223456889999999887 789999999       3444 88888762211       011122335


Q ss_pred             ccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         267 AAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       267 ~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      .+++++.++|.+||+.||.+|||+.++++
T Consensus       244 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          244 GCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             TCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            67899999999999999999999999986

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.8e-43  Score=304.20  Aligned_cols=243  Identities=19%  Similarity=0.255  Sum_probs=198.4

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEE-----cCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCcccc
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARD-----IETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGL  122 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~  122 (307)
                      .+....++|++.+.||+|+||.||+|.+     ..+++.||+|++....    .......+.+|++++.++ +||||+++
T Consensus        21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC----CcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            3445668999999999999999999985     3577899999997532    222345688999999999 79999999


Q ss_pred             ceeeeec-CeEEEEEEcc-CCChHHHHhCCCCC---------------CCHHHHHHHHHHHHHHHHHHHHCCceeecCCC
Q psy9858         123 TDVFGYM-SNVSLVFEFV-DTDLEVIIKDPTIV---------------FTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP  185 (307)
Q Consensus       123 ~~~~~~~-~~~~lv~e~~-~g~l~~~~~~~~~~---------------~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp  185 (307)
                      ++++... ...++||||+ +|+|.+++......               +++..+..++.||+.||.|||++||+||||||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp  176 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA  176 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCcc
Confidence            9998765 4599999999 57899998765432               78999999999999999999999999999999


Q ss_pred             CcEEEecCCcEEEEeecCccccCCCCc--ccccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCC
Q psy9858         186 NNLLINKQGVLKIGDFGLAKFFGSPTR--LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNL  255 (307)
Q Consensus       186 ~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~  255 (307)
                      +||+++.++.+||+|||++........  ......+|+.|+|||.+.+. .++.++|||       .+++ |..||.+..
T Consensus       177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~  255 (316)
T 2xir_A          177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVK  255 (316)
T ss_dssp             GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccc-cccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence            999999999999999999987643322  23345678899999999887 899999999       3444 888887743


Q ss_pred             CCCCC--------hhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         256 FPGIP--------LNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       256 ~~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      .....        ....+..+++++.+++.+||+.||.+|||++++++|
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          256 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             CSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            32211        112234578999999999999999999999999986

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.4e-43  Score=302.25  Aligned_cols=239  Identities=20%  Similarity=0.238  Sum_probs=195.1

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee----
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY----  128 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----  128 (307)
                      ...+|++++.||+|+||.||+|.+..+|+.||+|++....         ..+.+|+++++.++||||+++++++..    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   79 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---------EKAEREVKALAKLDHVNIVHYNGCWDGFDYD   79 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---------HHHHHHHHHHHhCCCCCEEEEeeeEeccccC
Confidence            4578999999999999999999999899999999997531         246689999999999999999998854    


Q ss_pred             ------------cCeEEEEEEccC-CChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCC
Q psy9858         129 ------------MSNVSLVFEFVD-TDLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG  194 (307)
Q Consensus       129 ------------~~~~~lv~e~~~-g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~  194 (307)
                                  ....++||||+. |+|.+++... ...+++..+..++.||+.||.|||++||+|+||||+||+++.++
T Consensus        80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~  159 (284)
T 2a19_B           80 PETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK  159 (284)
T ss_dssp             ---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT
T ss_pred             cccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCC
Confidence                        456899999995 6999988643 34589999999999999999999999999999999999999999


Q ss_pred             cEEEEeecCccccCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCC--CCCChhhhc
Q psy9858         195 VLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLF--PGIPLNEIF  265 (307)
Q Consensus       195 ~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~--~~~~~~~~~  265 (307)
                      .++|+|||++....... ......+++.|+|||.+.+. .++.++|||   +    +++|..|+.....  .........
T Consensus       160 ~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T 2a19_B          160 QVKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIIS  237 (284)
T ss_dssp             EEEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCS-CCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHHHHTTCCC
T ss_pred             CEEECcchhheeccccc-cccccCCcccccChhhhccC-CCcchhhhHHHHHHHHHHHhcCCcchhHHHHHHHhhccccc
Confidence            99999999998875432 23445789999999999887 889999999   2    2235555432100  000001122


Q ss_pred             cccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         266 TAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       266 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                      ..++.++.++|.+||+.||.+|||+.++++|.+.-..
T Consensus       238 ~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          238 DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence            4578899999999999999999999999999876443

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.8e-43  Score=307.98  Aligned_cols=244  Identities=17%  Similarity=0.190  Sum_probs=193.4

Q ss_pred             cccceeeEEeEEeecCceEEEEEE-----EcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceee
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKAR-----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVF  126 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~  126 (307)
                      ...++|++++.||+|+||.||+|+     +..++..||||++....    .......+.+|+.+++.++||||+++++++
T Consensus        27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  102 (327)
T 2yfx_A           27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC----SEQDELDFLMEALIISKFNHQNIVRCIGVS  102 (327)
T ss_dssp             CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC----CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc----chhhHHHHHHHHHHHhhCCCCCCCeEEEEE
Confidence            356789999999999999999998     55678899999997432    222345688999999999999999999999


Q ss_pred             eecCeEEEEEEcc-CCChHHHHhCCC------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEec---CCcE
Q psy9858         127 GYMSNVSLVFEFV-DTDLEVIIKDPT------IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK---QGVL  196 (307)
Q Consensus       127 ~~~~~~~lv~e~~-~g~l~~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~---~~~~  196 (307)
                      .+....++||||+ +|+|.+++....      ..+++..+..++.||+.||.|||++|++||||||+||+++.   +..+
T Consensus       103 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~  182 (327)
T 2yfx_A          103 LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA  182 (327)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred             cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceE
Confidence            9999999999999 678999987543      34889999999999999999999999999999999999984   4469


Q ss_pred             EEEeecCccccCCCC--cccccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCCC-------C
Q psy9858         197 KIGDFGLAKFFGSPT--RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFPG-------I  259 (307)
Q Consensus       197 kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~~-------~  259 (307)
                      +|+|||++.......  .......+++.|+|||.+.+. .++.++|||       .+++ |..||.......       .
T Consensus       183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~  261 (327)
T 2yfx_A          183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG  261 (327)
T ss_dssp             EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred             EECccccccccccccccccCCCcCCCcceeCHhHhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcC
Confidence            999999997653222  122334678899999999887 899999999       3343 888887632110       0


Q ss_pred             ChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccC
Q psy9858         260 PLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS  300 (307)
Q Consensus       260 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~  300 (307)
                      ........+++.+.++|.+||+.||.+|||++++++|.|+-
T Consensus       262 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          262 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            11122346789999999999999999999999999998764

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.3e-42  Score=315.10  Aligned_cols=233  Identities=19%  Similarity=0.233  Sum_probs=192.9

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM  129 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  129 (307)
                      +....++|++.+.||+|+||.||+|.+.  |+.||||++....       ..+.+.+|++++++++||||+++++++...
T Consensus       188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  258 (450)
T 1k9a_A          188 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-------TAQAFLAEASVMTQLRHSNLVQLLGVIVEE  258 (450)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-------TSHHHHHHHHHHHTCCCTTBCCEEEEEECT
T ss_pred             cccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-------HHHHHHHHHHHHHhccCCCEEEEEEEEEcC
Confidence            4456789999999999999999999864  7799999997421       246788999999999999999999997665


Q ss_pred             C-eEEEEEEcc-CCChHHHHhCCCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         130 S-NVSLVFEFV-DTDLEVIIKDPTI-VFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       130 ~-~~~lv~e~~-~g~l~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                      . ..++||||+ +|+|.+++..... .+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++.
T Consensus       259 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  338 (450)
T 1k9a_A          259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE  338 (450)
T ss_dssp             TSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence            4 799999999 6799999976543 368999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCCcccccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCCCC-------ChhhhccccCHH
Q psy9858         207 FGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFPGI-------PLNEIFTAAGDD  271 (307)
Q Consensus       207 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~~~-------~~~~~~~~~~~~  271 (307)
                      ....   .....++..|+|||.+.+. .++.++|||       .+++ |..||.+......       .....+..++++
T Consensus       339 ~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~  414 (450)
T 1k9a_A          339 ASST---QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA  414 (450)
T ss_dssp             CC---------CCCTTTSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHH
T ss_pred             cccc---ccCCCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHH
Confidence            5322   1223668899999999887 899999999       3444 8999987433221       111234568899


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         272 LLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       272 l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      +.+||.+||+.||++|||+.++++
T Consensus       415 l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          415 VYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999999875

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.8e-42  Score=298.03  Aligned_cols=231  Identities=22%  Similarity=0.217  Sum_probs=183.5

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHh--cCCCCccccceeeee--
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQE--LHHENVLGLTDVFGY--  128 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~ni~~~~~~~~~--  128 (307)
                      ..++|++++.||+|+||+||+|++  +|+.||||++...        ....+.+|.+++..  ++||||+++++++..  
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~   75 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR--------DEKSWFRETELYNTVMLRHENILGFIASDMTSR   75 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG--------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc--------cchhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence            567899999999999999999986  6899999998642        13445667777776  789999999998644  


Q ss_pred             --cCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCceeecCCCCcEEEecCCcEE
Q psy9858         129 --MSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH--------DHWILHRDLKPNNLLINKQGVLK  197 (307)
Q Consensus       129 --~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--------~~~ivH~dlkp~Nil~~~~~~~k  197 (307)
                        ....++||||+ +|+|.+++...  .+++..+..++.||+.||.|||        ++||+||||||+||+++.++.+|
T Consensus        76 ~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~k  153 (301)
T 3q4u_A           76 HSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCC  153 (301)
T ss_dssp             TTEEEEEEEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred             CCCceeEEehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEE
Confidence              35689999999 57999998654  4899999999999999999999        99999999999999999999999


Q ss_pred             EEeecCccccCCCCcc----cccceeeceehhhhhhhccc-----cccccccee---eee----ec----------CCCC
Q psy9858         198 IGDFGLAKFFGSPTRL----YTHQVVTRWYRLIKCLLYCV-----QFNVKNVQW---CCF----AK----------DPSS  251 (307)
Q Consensus       198 l~Dfg~a~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~-----~~~~~~Diw---~i~----~~----------~~~f  251 (307)
                      |+|||+++........    .....+|+.|+|||.+.+..     .++.++|||   +++    +|          ..||
T Consensus       154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf  233 (301)
T 3q4u_A          154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF  233 (301)
T ss_dssp             ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence            9999999876433222    23347899999999998753     345799999   333    36          6777


Q ss_pred             CCCCCCCCC------------------hhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         252 HGNLFPGIP------------------LNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       252 ~~~~~~~~~------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      .........                  .......+++++.+|+.+||+.||++|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          234 YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             cccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            552221111                  11112235678999999999999999999999986

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.4e-43  Score=309.16  Aligned_cols=243  Identities=19%  Similarity=0.225  Sum_probs=187.5

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEEcCC---CcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCcccccee
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARDIET---DMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV  125 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~  125 (307)
                      .+......|.+.+.||+|+||+||+|++..+   +..||+|.+...    ........+.+|+.++++++||||++++++
T Consensus        83 ~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~il~~l~hpnIv~~~~~  158 (373)
T 3c1x_A           83 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----TDIGEVSQFLTEGIIMKDFSHPNVLSLLGI  158 (373)
T ss_dssp             BCCSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC----SCSHHHHHHHHHHTTSTTCCCTTBCCCCEE
T ss_pred             ccChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC----CCHHHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            3445566799999999999999999987543   246899988642    122235678899999999999999999998


Q ss_pred             ee-ecCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecC
Q psy9858         126 FG-YMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGL  203 (307)
Q Consensus       126 ~~-~~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  203 (307)
                      +. .++..++||||+ +|+|.+++......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus       159 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~  238 (373)
T 3c1x_A          159 CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGL  238 (373)
T ss_dssp             ECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred             EEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccc
Confidence            64 556889999999 5799999988776789999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCc----ccccceeeceehhhhhhhccccccccccee---e----eee-cCCCCCCCCCCCC-------Chhhh
Q psy9858         204 AKFFGSPTR----LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPSSHGNLFPGI-------PLNEI  264 (307)
Q Consensus       204 a~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~f~~~~~~~~-------~~~~~  264 (307)
                      ++.......    ......+++.|+|||.+.+. .++.++|||   +    +++ |.+||........       .....
T Consensus       239 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
T 3c1x_A          239 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ  317 (373)
T ss_dssp             -------------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCC
T ss_pred             cccccccccccccccCCCCCcccccChHHhcCC-CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            987643221    12234567889999999887 899999999   2    333 7778776432221       11122


Q ss_pred             ccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         265 FTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       265 ~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      +..+++.+.+++.+||+.||++|||+++++++
T Consensus       318 p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          318 PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            34578999999999999999999999999875

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=9.1e-42  Score=293.64  Aligned_cols=221  Identities=23%  Similarity=0.289  Sum_probs=182.3

Q ss_pred             eccccceeeEE-eEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHH-HhcCCCCccccceeee
Q psy9858          50 VKNDLLVYYQW-RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLL-QELHHENVLGLTDVFG  127 (307)
Q Consensus        50 ~~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~ni~~~~~~~~  127 (307)
                      .+...++|.++ +.||+|+||.||+|.+..+++.||+|++..          ...+.+|++++ +.++||||+++++++.
T Consensus        12 ~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----------~~~~~~e~~~~~~~~~h~~i~~~~~~~~   81 (299)
T 3m2w_A           12 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----------CPKARREVELHWRASQCPHIVRIVDVYE   81 (299)
T ss_dssp             CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----------SHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             ccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc----------cHHHHHHHHHHHHhccCCCchhHHhhhh
Confidence            34566789888 779999999999999999999999999863          23466899888 5568999999999987


Q ss_pred             e----cCeEEEEEEcc-CCChHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEec---CCcEEE
Q psy9858         128 Y----MSNVSLVFEFV-DTDLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK---QGVLKI  198 (307)
Q Consensus       128 ~----~~~~~lv~e~~-~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~---~~~~kl  198 (307)
                      .    ....++||||+ +|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.   ++.++|
T Consensus        82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl  161 (299)
T 3m2w_A           82 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKL  161 (299)
T ss_dssp             EEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEE
T ss_pred             hhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEE
Confidence            7    77899999999 569999987653 35899999999999999999999999999999999999998   788999


Q ss_pred             EeecCccccCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC--------C----
Q psy9858         199 GDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG--------I----  259 (307)
Q Consensus       199 ~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~--------~----  259 (307)
                      +|||++.....                       ..++.++|||   +    +++|..||.+.....        .    
T Consensus       162 ~Dfg~a~~~~~-----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  218 (299)
T 3m2w_A          162 TDFGFAKETTG-----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ  218 (299)
T ss_dssp             CCCTTCEECTT-----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTC
T ss_pred             ecccccccccc-----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhcc
Confidence            99999975421                       2578899999   3    334999997632111        0    


Q ss_pred             --ChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         260 --PLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       260 --~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                        .....+..+++++.+||.+||+.||++|||++|+|+||||++..
T Consensus       219 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          219 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence              01111246899999999999999999999999999999997764

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=5.7e-44  Score=332.90  Aligned_cols=247  Identities=21%  Similarity=0.220  Sum_probs=196.4

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee---
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY---  128 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~---  128 (307)
                      ...++|++.+.||+|+||.||+|.+..+|+.||||++....    .......+.+|+++++.++||||+++++++..   
T Consensus        11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~----~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~   86 (676)
T 3qa8_A           11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL----SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQK   86 (676)
T ss_dssp             ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC----CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCC
T ss_pred             CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC----CHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccc
Confidence            34578999999999999999999999999999999987532    23335678899999999999999999998765   


Q ss_pred             ---cCeEEEEEEcc-CCChHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCc---EEEE
Q psy9858         129 ---MSNVSLVFEFV-DTDLEVIIKDPT--IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGV---LKIG  199 (307)
Q Consensus       129 ---~~~~~lv~e~~-~g~l~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~---~kl~  199 (307)
                         .+..++||||+ +|+|.+++....  ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.   ++|+
T Consensus        87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~  166 (676)
T 3qa8_A           87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKII  166 (676)
T ss_dssp             CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred             ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEc
Confidence               67889999999 679999887643  25889999999999999999999999999999999999997775   9999


Q ss_pred             eecCccccCCCCcccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCC-----------------
Q psy9858         200 DFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNL-----------------  255 (307)
Q Consensus       200 Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~-----------------  255 (307)
                      |||++...... .......+|+.|+|||.+.+. .++.++|||       .+++|..||....                 
T Consensus       167 DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~  244 (676)
T 3qa8_A          167 DLGYAKELDQG-ELCTEFVGTLQYLAPELLEQK-KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI  244 (676)
T ss_dssp             SCCCCCBTTSC-CCCCCCCSCCTTCSSCSSCCS-CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------C
T ss_pred             ccccccccccc-cccccccCCcccCChHHhccC-CCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhh
Confidence            99999887443 233456889999999999887 899999999       3344999985410                 


Q ss_pred             -CC----------C--CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         256 -FP----------G--IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       256 -~~----------~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                       ..          .  .........+++.+.++|.+||+.||++|||++++++||||+..++
T Consensus       245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~  306 (676)
T 3qa8_A          245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS  306 (676)
T ss_dssp             CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHH
T ss_pred             hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHH
Confidence             00          0  0011223346788999999999999999999999999999976543

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.7e-42  Score=299.90  Aligned_cols=244  Identities=20%  Similarity=0.199  Sum_probs=186.9

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEEcC---CCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCcccccee
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARDIE---TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV  125 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~  125 (307)
                      .+....++|.+.+.||+|+||.||+|.+..   ++..||+|++.....   .......+.+|+++++.++||||++++++
T Consensus        28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~  104 (313)
T 3brb_A           28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS---SQREIEEFLSEAACMKDFSHPNVIRLLGV  104 (313)
T ss_dssp             TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC---CHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred             hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc---chhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence            344566899999999999999999998765   566899999975422   22234668899999999999999999999


Q ss_pred             eeecC-----eEEEEEEcc-CCChHHHHhC-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCC
Q psy9858         126 FGYMS-----NVSLVFEFV-DTDLEVIIKD-----PTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG  194 (307)
Q Consensus       126 ~~~~~-----~~~lv~e~~-~g~l~~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~  194 (307)
                      +....     ..++||||+ +|+|.+++..     ....+++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus       105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~  184 (313)
T 3brb_A          105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM  184 (313)
T ss_dssp             EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS
T ss_pred             EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC
Confidence            87654     459999999 5788888742     334589999999999999999999999999999999999999999


Q ss_pred             cEEEEeecCccccCCCCc--ccccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCCC------
Q psy9858         195 VLKIGDFGLAKFFGSPTR--LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFPG------  258 (307)
Q Consensus       195 ~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~~------  258 (307)
                      .+||+|||++........  ......+++.|+|||.+.+. .++.++|||       .+++ |..||.+.....      
T Consensus       185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  263 (313)
T 3brb_A          185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL  263 (313)
T ss_dssp             CEEECSCSCC----------------CCGGGSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH
T ss_pred             cEEEeecCcceecccccccCcccccCCCccccCchhhcCC-CccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH
Confidence            999999999987643321  12234567899999999887 899999999       2344 788887633221      


Q ss_pred             -CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         259 -IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       259 -~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                       ......+..+++++.++|.+||+.||.+|||+++++++
T Consensus       264 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          264 HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             11122345678999999999999999999999999875

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.4e-42  Score=294.11  Aligned_cols=235  Identities=15%  Similarity=0.120  Sum_probs=193.7

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec-
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM-  129 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-  129 (307)
                      ....++|++.+.||+|+||.||+|++.  ++.||+|++.....   .....+.+.+|+.++++++||||+++++++.+. 
T Consensus         6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   80 (271)
T 3kmu_A            6 GIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW---STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP   80 (271)
T ss_dssp             CCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC---CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT
T ss_pred             CCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc---CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC
Confidence            446789999999999999999999974  88999999986432   222346788999999999999999999999877 


Q ss_pred             -CeEEEEEEcc-CCChHHHHhCCCC-CCCHHHHHHHHHHHHHHHHHHHHCC--ceeecCCCCcEEEecCCcEEEEeecCc
Q psy9858         130 -SNVSLVFEFV-DTDLEVIIKDPTI-VFTPSNIKAYAIMTLRGLEYLHDHW--ILHRDLKPNNLLINKQGVLKIGDFGLA  204 (307)
Q Consensus       130 -~~~~lv~e~~-~g~l~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~a  204 (307)
                       ...++||||+ +|+|.+++..... .+++..+..++.||+.||.|||++|  ++||||||+||+++.++.++|+|||++
T Consensus        81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~  160 (271)
T 3kmu_A           81 APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK  160 (271)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred             CCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccce
Confidence             7899999999 5799999987643 4899999999999999999999999  999999999999999999999999987


Q ss_pred             cccCCCCcccccceeeceehhhhhhhccc--cccccccee---e----eeecCCCCCCCCCC--------CCChhhhccc
Q psy9858         205 KFFGSPTRLYTHQVVTRWYRLIKCLLYCV--QFNVKNVQW---C----CFAKDPSSHGNLFP--------GIPLNEIFTA  267 (307)
Q Consensus       205 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~~Diw---~----i~~~~~~f~~~~~~--------~~~~~~~~~~  267 (307)
                      .....     ....+|+.|+|||.+.+..  .++.++|||   +    +++|..||.+....        .......+..
T Consensus       161 ~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  235 (271)
T 3kmu_A          161 FSFQS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPG  235 (271)
T ss_dssp             CTTSC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTT
T ss_pred             eeecc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCC
Confidence            65422     2347899999999998752  234489999   3    33499999762211        1111223456


Q ss_pred             cCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         268 AGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       268 ~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      +++++.+++.+||+.||++|||++++++
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          236 ISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            8999999999999999999999999986

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=305.35  Aligned_cols=242  Identities=15%  Similarity=0.119  Sum_probs=189.0

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcC---CCcEEEEEEeecCCccccc------hhhhHhHHHHHHHHHhcCCCCccccc
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIE---TDMIVAVKKIKLGTHADAK------DGINRTALREIKLLQELHHENVLGLT  123 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~------~~~~~~~~~e~~~l~~l~h~ni~~~~  123 (307)
                      ..++|++.+.||+|+||.||+|.+..   ++..||+|++.........      ......+.+|+.+++.++||||++++
T Consensus        35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~  114 (345)
T 2v62_A           35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY  114 (345)
T ss_dssp             TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred             cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence            45789999999999999999999887   7889999999864321111      11123466888999999999999999


Q ss_pred             eeeee----cCeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCC--cEE
Q psy9858         124 DVFGY----MSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG--VLK  197 (307)
Q Consensus       124 ~~~~~----~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~k  197 (307)
                      +++..    ....++||||++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++  .+|
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k  193 (345)
T 2v62_A          115 GSGLTEFKGRSYRFMVMERLGIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY  193 (345)
T ss_dssp             EEEEEESSSCEEEEEEEECEEEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred             cccccccCCCcEEEEEEeccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence            99987    78899999999888988887654 689999999999999999999999999999999999999888  999


Q ss_pred             EEeecCccccCCCC-------cccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCCCh--
Q psy9858         198 IGDFGLAKFFGSPT-------RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGIPL--  261 (307)
Q Consensus       198 l~Dfg~a~~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~~--  261 (307)
                      |+|||+++......       .......+|+.|+|||.+.+. .++.++|||   +    +++|..||.+........  
T Consensus       194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~  272 (345)
T 2v62_A          194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT  272 (345)
T ss_dssp             ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred             EEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence            99999998763221       112445789999999999987 899999999   3    344999996522111100  


Q ss_pred             ------hhhc-------c--ccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         262 ------NEIF-------T--AAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       262 ------~~~~-------~--~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                            ...+       .  .+++++.++|.+||+.||++|||++++++.
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          273 AKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             HHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence                  0001       1  678899999999999999999999998864

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=301.63  Aligned_cols=242  Identities=21%  Similarity=0.211  Sum_probs=192.8

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeee--
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG--  127 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~--  127 (307)
                      +....++|++++.||+|+||.||+|.+..+|+.||+|++...     .......+.+|+++++.++||||+++++++.  
T Consensus        24 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   98 (317)
T 2buj_A           24 VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-----EQQDREEAQREADMHRLFNHPNILRLVAYCLRE   98 (317)
T ss_dssp             EEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES-----SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE
T ss_pred             EEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC-----CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec
Confidence            344567999999999999999999999999999999998652     2223567889999999999999999999986  


Q ss_pred             --ecCeEEEEEEcc-CCChHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEee
Q psy9858         128 --YMSNVSLVFEFV-DTDLEVIIKD---PTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDF  201 (307)
Q Consensus       128 --~~~~~~lv~e~~-~g~l~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Df  201 (307)
                        .....++||||+ +|+|.+++..   ....+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+||
T Consensus        99 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~df  178 (317)
T 2buj_A           99 RGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDL  178 (317)
T ss_dssp             ETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred             cCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEec
Confidence              345799999999 5689888865   4556899999999999999999999999999999999999999999999999


Q ss_pred             cCccccCCCCc---------ccccceeeceehhhhhhhccc--cccccccee---e----eeecCCCCCCCCCCCC----
Q psy9858         202 GLAKFFGSPTR---------LYTHQVVTRWYRLIKCLLYCV--QFNVKNVQW---C----CFAKDPSSHGNLFPGI----  259 (307)
Q Consensus       202 g~a~~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~--~~~~~~Diw---~----i~~~~~~f~~~~~~~~----  259 (307)
                      |++........         ......+|+.|+|||.+.+..  .++.++|||   +    +++|..||........    
T Consensus       179 g~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~  258 (317)
T 2buj_A          179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL  258 (317)
T ss_dssp             SSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH
T ss_pred             CcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH
Confidence            99886532110         012335689999999987642  478999999   2    3348889854111000    


Q ss_pred             -----ChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         260 -----PLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       260 -----~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                           ........+++++.++|.+||+.||.+|||+++++++
T Consensus       259 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          259 AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             HHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence                 0111124578999999999999999999999999986

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.6e-42  Score=300.96  Aligned_cols=234  Identities=21%  Similarity=0.252  Sum_probs=189.5

Q ss_pred             ceeeEEeEEeecCceEEEEEEE----cCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee--
Q psy9858          55 LVYYQWRSVHVGRFATVFKARD----IETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY--  128 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--  128 (307)
                      +.|++++.||+|+||+||++..    ..+++.||||++...    ........+.+|+++++.++||||+++++++.+  
T Consensus        31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (318)
T 3lxp_A           31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD----AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG  106 (318)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc----cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence            3459999999999999988753    457899999999753    222335668899999999999999999999987  


Q ss_pred             cCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         129 MSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       129 ~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      ....++||||+ +|+|.+++....  +++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++...
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  184 (318)
T 3lxp_A          107 AASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  184 (318)
T ss_dssp             TTEEEEEECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             CceEEEEEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence            46899999999 578999887664  899999999999999999999999999999999999999999999999999987


Q ss_pred             CCCCc---ccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCC---------------------
Q psy9858         208 GSPTR---LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLF---------------------  256 (307)
Q Consensus       208 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~---------------------  256 (307)
                      .....   ......++..|+|||.+.+. .++.++|||       .+++|..||.....                     
T Consensus       185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (318)
T 3lxp_A          185 PEGHEYYRVREDGDSPVFWYAPECLKEY-KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL  263 (318)
T ss_dssp             CTTCSEEEC---CCCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred             cccccccccccCCCCCceeeChHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence            54332   22334678889999999887 889999999       23338777765110                     


Q ss_pred             -CCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         257 -PGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       257 -~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                       ........+..+++++.+||.+||+.||++|||++++++
T Consensus       264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence             001111223467899999999999999999999999985

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-42  Score=304.35  Aligned_cols=233  Identities=9%  Similarity=0.044  Sum_probs=189.6

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcC--------CCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccc---
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIE--------TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG---  121 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~---  121 (307)
                      ..++|++.+.||+|+||.||+|++..        .++.||+|++...          ..+.+|+++++.++||||++   
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----------~~~~~E~~~l~~l~h~niv~~~~  109 (352)
T 2jii_A           40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----------GRLFNEQNFFQRAAKPLQVNKWK  109 (352)
T ss_dssp             TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----------STHHHHHHHHHHHCCHHHHHHHH
T ss_pred             cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----------chHHHHHHHHHHhcccchhhhhh
Confidence            35799999999999999999999887        4889999998742          34779999999999999988   


Q ss_pred             ------------cceeeee-cCeEEEEEEccCCChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCc
Q psy9858         122 ------------LTDVFGY-MSNVSLVFEFVDTDLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNN  187 (307)
Q Consensus       122 ------------~~~~~~~-~~~~~lv~e~~~g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~N  187 (307)
                                  +++++.. ....++||||++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|
T Consensus       110 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~N  189 (352)
T 2jii_A          110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAEN  189 (352)
T ss_dssp             HHTTCTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGG
T ss_pred             hhccCCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHH
Confidence                        4555555 6889999999988999999865 3469999999999999999999999999999999999


Q ss_pred             EEEecCC--cEEEEeecCccccCCCCc-------ccccceeeceehhhhhhhccccccccccee---e----eeecCCCC
Q psy9858         188 LLINKQG--VLKIGDFGLAKFFGSPTR-------LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSS  251 (307)
Q Consensus       188 il~~~~~--~~kl~Dfg~a~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f  251 (307)
                      |+++.++  .+||+|||+++.......       ......+|+.|+|||.+.+. .++.++|||   +    +++|..||
T Consensus       190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf  268 (352)
T 2jii_A          190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYCMLKWLYGFLPW  268 (352)
T ss_dssp             EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred             EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCc
Confidence            9999998  899999999987643211       12344789999999999887 899999999   3    33499998


Q ss_pred             CCCCCCCCChh-----------------hhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         252 HGNLFPGIPLN-----------------EIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       252 ~~~~~~~~~~~-----------------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      ...........                 .....+++++.+||.+||+.||++|||++++++.
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  330 (352)
T 2jii_A          269 TNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN  330 (352)
T ss_dssp             GGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             ccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence            77431111000                 0012468999999999999999999999998763

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1e-42  Score=316.25  Aligned_cols=239  Identities=18%  Similarity=0.219  Sum_probs=195.3

Q ss_pred             ceeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeee
Q psy9858          48 CEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG  127 (307)
Q Consensus        48 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~  127 (307)
                      ..+....++|++.+.||+|+||+||+|.+. ++..||||++....      ...+.+.+|+++++.++||||+++++++.
T Consensus       181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~l~~~~~  253 (454)
T 1qcf_A          181 DAWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS------MSVEAFLAEANVMKTLQHDKLVKLHAVVT  253 (454)
T ss_dssp             TCSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS------BCHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             cceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC------ccHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence            345567789999999999999999999974 57789999997532      12467899999999999999999999886


Q ss_pred             ecCeEEEEEEcc-CCChHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcc
Q psy9858         128 YMSNVSLVFEFV-DTDLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK  205 (307)
Q Consensus       128 ~~~~~~lv~e~~-~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  205 (307)
                       ....++||||+ +|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus       254 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~  332 (454)
T 1qcf_A          254 -KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR  332 (454)
T ss_dssp             -SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGG
T ss_pred             -CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCce
Confidence             66789999999 689999997542 247889999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCc-ccccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCCC-------CChhhhccccC
Q psy9858         206 FFGSPTR-LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFPG-------IPLNEIFTAAG  269 (307)
Q Consensus       206 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~~-------~~~~~~~~~~~  269 (307)
                      ....... ......++..|+|||.+.+. .++.++|||       .+++ |..||.+.....       ......+..++
T Consensus       333 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~  411 (454)
T 1qcf_A          333 VIEDNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCP  411 (454)
T ss_dssp             GBCCHHHHTTCSSSSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSC
T ss_pred             EcCCCceeccCCCcccccccCHHHhccC-CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence            7643211 12233457789999999887 899999999       3444 889987632111       00111234678


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         270 DDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       270 ~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      +++.+||.+||+.||++|||++++++
T Consensus       412 ~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          412 EELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHH
Confidence            99999999999999999999999976

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3.5e-42  Score=293.19  Aligned_cols=238  Identities=20%  Similarity=0.261  Sum_probs=194.0

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY  128 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  128 (307)
                      ++....++|++++.||+|+||.||+|.+ .++..||+|++.....      ....+.+|+++++.++||||+++++++. 
T Consensus         7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~-   78 (279)
T 1qpc_A            7 EWEVPRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSM------SPDAFLAEANLMKQLQHQRLVRLYAVVT-   78 (279)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred             hcccCHHhhhheeeecCCCCeEEEEEEE-cCCcEEEEEEecCCcc------cHHHHHHHHHHHHhCCCcCcceEEEEEc-
Confidence            4566778999999999999999999996 4677899999875321      1456889999999999999999999876 


Q ss_pred             cCeEEEEEEcc-CCChHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         129 MSNVSLVFEFV-DTDLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       129 ~~~~~lv~e~~-~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                      .+..++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++..
T Consensus        79 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  158 (279)
T 1qpc_A           79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL  158 (279)
T ss_dssp             SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccc
Confidence            45689999999 678998887542 2489999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCc-ccccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCCC-------CChhhhccccCH
Q psy9858         207 FGSPTR-LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFPG-------IPLNEIFTAAGD  270 (307)
Q Consensus       207 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~~-------~~~~~~~~~~~~  270 (307)
                      ...... ......++..|+|||.+.+. .++.++|||       .+++ |..||.+.....       ......+..+++
T Consensus       159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (279)
T 1qpc_A          159 IEDNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE  237 (279)
T ss_dssp             CSSSCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred             ccCcccccccCCCCccCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccH
Confidence            754322 12234567889999999877 789999999       2444 788887632110       001122346789


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         271 DLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       271 ~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      ++.+++.+||+.||++|||++++++
T Consensus       238 ~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          238 ELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHhccChhhCCCHHHHHH
Confidence            9999999999999999999999986

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.4e-41  Score=309.56  Aligned_cols=235  Identities=17%  Similarity=0.181  Sum_probs=195.7

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCC-CCccccceeeeecCe
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH-ENVLGLTDVFGYMSN  131 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~  131 (307)
                      ..++|++++.||+|+||.||+|++..+++.||||++.....       ...+.+|+++++.++| +++..+..++.....
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-------~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~   77 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-------HPQLLYESKIYRILQGGTGIPNVRWFGVEGDY   77 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-------SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-------cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCE
Confidence            34689999999999999999999999999999998875321       2347799999999986 556666666677889


Q ss_pred             EEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEE---ecCCcEEEEeecCccccC
Q psy9858         132 VSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLI---NKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       132 ~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~a~~~~  208 (307)
                      .+|||||++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++...
T Consensus        78 ~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           78 NVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             EEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            99999999999999998666679999999999999999999999999999999999999   688999999999998775


Q ss_pred             CCCc-------ccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC--------------CC
Q psy9858         209 SPTR-------LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG--------------IP  260 (307)
Q Consensus       209 ~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~--------------~~  260 (307)
                      ....       ......||..|+|||.+.+. .++.++|||   +    +++|..||.+.....              ..
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS  236 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred             CCccccccccccccccCCCccccCHHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence            4322       12255789999999999988 899999999   3    334999998743321              11


Q ss_pred             hhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         261 LNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       261 ~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      ...+...+++++.+||.+||+.||++||+++++++
T Consensus       237 ~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            22333567899999999999999999999988776

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.5e-42  Score=313.43  Aligned_cols=249  Identities=20%  Similarity=0.227  Sum_probs=195.5

Q ss_pred             ceeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeee
Q psy9858          48 CEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG  127 (307)
Q Consensus        48 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~  127 (307)
                      ..+....++|++.+.||+|+||.||+|.+.. +..||||++.....      ..+.+.+|++++++++||||+++++++.
T Consensus       177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~hp~iv~~~~~~~  249 (452)
T 1fmk_A          177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM------SPEAFLQEAQVMKKLRHEKLVQLYAVVS  249 (452)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC------CHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            3455667889999999999999999999754 56799999975321      1356889999999999999999999886


Q ss_pred             ecCeEEEEEEcc-CCChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcc
Q psy9858         128 YMSNVSLVFEFV-DTDLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK  205 (307)
Q Consensus       128 ~~~~~~lv~e~~-~g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  205 (307)
                      + ...++||||+ +|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus       250 ~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~  328 (452)
T 1fmk_A          250 E-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR  328 (452)
T ss_dssp             S-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred             C-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccce
Confidence            6 6789999999 67999998743 2348999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCc-ccccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCC-------CCChhhhccccC
Q psy9858         206 FFGSPTR-LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFP-------GIPLNEIFTAAG  269 (307)
Q Consensus       206 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~-------~~~~~~~~~~~~  269 (307)
                      ....... ......++..|+|||.+.+. .++.++|||       .+++ |..||.+....       .......+..++
T Consensus       329 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~  407 (452)
T 1fmk_A          329 LIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP  407 (452)
T ss_dssp             --------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSC
T ss_pred             ecCCCceecccCCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence            7643221 12233567889999999887 899999999       3444 88898763211       011112235688


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHhcC--cccCCCccc
Q psy9858         270 DDLLAVISSLLCLNPTKRADCTATLKM--DYFSLTKEM  305 (307)
Q Consensus       270 ~~l~~li~~~l~~dP~~Rpt~~~il~h--p~f~~~~~~  305 (307)
                      +.+.+||.+||+.||++|||++++++.  .+|......
T Consensus       408 ~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~  445 (452)
T 1fmk_A          408 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ  445 (452)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcc
Confidence            999999999999999999999999874  666555443

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.3e-42  Score=319.98  Aligned_cols=239  Identities=20%  Similarity=0.255  Sum_probs=191.0

Q ss_pred             ccccceeeEEe-EEeecCceEEEEEEEc--CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeee
Q psy9858          51 KNDLLVYYQWR-SVHVGRFATVFKARDI--ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG  127 (307)
Q Consensus        51 ~~~~~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~  127 (307)
                      ....+++.+.+ .||+|+||.||+|.+.  .++..||||++....    .....+.+.+|+++++.++||||+++++++.
T Consensus       331 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~~~E~~il~~l~hpniv~l~~~~~  406 (613)
T 2ozo_A          331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT----EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ  406 (613)
T ss_dssp             BCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC----SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             eccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC----ChHHHHHHHHHHHHHHhCCCCCEeeEEEEec
Confidence            33445666666 8999999999999865  456789999997542    2223567899999999999999999999987


Q ss_pred             ecCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         128 YMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       128 ~~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                      . +..++||||+ +|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       407 ~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~  485 (613)
T 2ozo_A          407 A-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKA  485 (613)
T ss_dssp             S-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred             c-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence            6 5699999999 6789999987777799999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCccc---ccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCCC-------CChhhhcccc
Q psy9858         207 FGSPTRLY---THQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFPG-------IPLNEIFTAA  268 (307)
Q Consensus       207 ~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~~-------~~~~~~~~~~  268 (307)
                      ........   ....+++.|+|||++.+. .++.++|||       .+++ |..||.+.....       ......+..+
T Consensus       486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~  564 (613)
T 2ozo_A          486 LGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC  564 (613)
T ss_dssp             CC--------------CCTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTC
T ss_pred             ccCCCceeeeccCCCCccceeCHhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcC
Confidence            74332211   122346789999999887 899999999       3444 899998733211       1112234568


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         269 GDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       269 ~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      ++++.+||.+||+.||++|||++++++
T Consensus       565 ~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          565 PPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             CHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999999999854

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.3e-42  Score=295.92  Aligned_cols=242  Identities=21%  Similarity=0.231  Sum_probs=186.5

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcC-CC--cEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeee
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIE-TD--MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG  127 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~--~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~  127 (307)
                      ....++|++++.||+|+||+||+|.+.. ++  ..||+|++......  .....+.+.+|+++++.++||||+++++++.
T Consensus        14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   91 (291)
T 1u46_A           14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS--QPEAMDDFIREVNAMHSLDHRNLIRLYGVVL   91 (291)
T ss_dssp             ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence            3456789999999999999999998643 33  36999998754322  2233567889999999999999999999987


Q ss_pred             ecCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         128 YMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       128 ~~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                      ... .++||||+ +|+|.+++......+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++..
T Consensus        92 ~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           92 TPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             SSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             cCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccc
Confidence            665 88999999 5899999887656689999999999999999999999999999999999999999999999999988


Q ss_pred             cCCCCc---ccccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCC--------CCChhhhccc
Q psy9858         207 FGSPTR---LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFP--------GIPLNEIFTA  267 (307)
Q Consensus       207 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~--------~~~~~~~~~~  267 (307)
                      ......   ......++..|+|||.+.+. .++.++|||       .+++ |..||.+....        ..........
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  249 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED  249 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTT
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcC
Confidence            754322   12234567789999999887 789999999       3444 88888763211        0111122346


Q ss_pred             cCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         268 AGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       268 ~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      +++++.+++.+||+.||++|||+++++++
T Consensus       250 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~  278 (291)
T 1u46_A          250 CPQDIYNVMVQCWAHKPEDRPTFVALRDF  278 (291)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            78999999999999999999999999874

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=5.3e-42  Score=303.19  Aligned_cols=240  Identities=18%  Similarity=0.199  Sum_probs=191.3

Q ss_pred             CceeccccceeeEEeEEeecCceEEEEE-----EEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC---CCC
Q psy9858          47 DCEVKNDLLVYYQWRSVHVGRFATVFKA-----RDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH---HEN  118 (307)
Q Consensus        47 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~n  118 (307)
                      ...+....++|.+.+.||+|+||+||+|     .+..+++.||+|++....        ...+.+|+++++.++   |+|
T Consensus        57 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~e~~~~~~l~~~~~~~  128 (365)
T 3e7e_A           57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--------PWEFYIGTQLMERLKPSMQHM  128 (365)
T ss_dssp             SCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC--------HHHHHHHHHHHHHSCGGGGGG
T ss_pred             ceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC--------hhHHHHHHHHHHHhhhhhhhh
Confidence            3455666789999999999999999999     467789999999987421        345778888888887   999


Q ss_pred             ccccceeeeecCeEEEEEEcc-CCChHHHHhC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEec-
Q psy9858         119 VLGLTDVFGYMSNVSLVFEFV-DTDLEVIIKD----PTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK-  192 (307)
Q Consensus       119 i~~~~~~~~~~~~~~lv~e~~-~g~l~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~-  192 (307)
                      |+++++++...+..++||||+ +|+|.+++..    ....+++..++.++.||+.||.|||++||+||||||+|||++. 
T Consensus       129 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~  208 (365)
T 3e7e_A          129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNG  208 (365)
T ss_dssp             BCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGG
T ss_pred             hhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEeccc
Confidence            999999999999999999999 6899998864    3456999999999999999999999999999999999999998 


Q ss_pred             ----------CCcEEEEeecCccccC--CCCcccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCC
Q psy9858         193 ----------QGVLKIGDFGLAKFFG--SPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHG  253 (307)
Q Consensus       193 ----------~~~~kl~Dfg~a~~~~--~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~  253 (307)
                                ++.+||+|||+|+...  ..........||+.|+|||++.+. .++.++|||       .+++|..||..
T Consensus       209 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~  287 (365)
T 3e7e_A          209 FLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK-PWNYQIDYFGVAATVYCMLFGTYMKVK  287 (365)
T ss_dssp             GTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred             ccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC-CCCccccHHHHHHHHHHHHhCCCcccc
Confidence                      8999999999997543  223344556899999999999988 799999999       34449988865


Q ss_pred             CCCCCCChhhhcc--ccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         254 NLFPGIPLNEIFT--AAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       254 ~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      .............  ..++.+.+++.+||+.+|.+|++..+.+.
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~  331 (365)
T 3e7e_A          288 NEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLR  331 (365)
T ss_dssp             EETTEEEECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred             CCCCceeechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence            3221111111111  23567899999999999999976544444

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-41  Score=293.13  Aligned_cols=230  Identities=21%  Similarity=0.270  Sum_probs=184.1

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN  131 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  131 (307)
                      ...++|++.+.||+|+||.||+|++  .++.||+|++...       ...+.+.+|++++++++||||+++++++.+  .
T Consensus         5 i~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~   73 (307)
T 2eva_A            5 IDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE-------SERKAFIVELRQLSRVNHPNIVKLYGACLN--P   73 (307)
T ss_dssp             CCGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST-------THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--T
T ss_pred             CCHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh-------hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--C
Confidence            3567899999999999999999986  4788999998632       124668899999999999999999998763  4


Q ss_pred             EEEEEEcc-CCChHHHHhCCCC--CCCHHHHHHHHHHHHHHHHHHHH---CCceeecCCCCcEEEecCCc-EEEEeecCc
Q psy9858         132 VSLVFEFV-DTDLEVIIKDPTI--VFTPSNIKAYAIMTLRGLEYLHD---HWILHRDLKPNNLLINKQGV-LKIGDFGLA  204 (307)
Q Consensus       132 ~~lv~e~~-~g~l~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~-~kl~Dfg~a  204 (307)
                      .++||||+ +|+|.+++.....  .++...+..++.||+.||.|||+   +||+||||||+||+++.++. +||+|||++
T Consensus        74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~  153 (307)
T 2eva_A           74 VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA  153 (307)
T ss_dssp             TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-
T ss_pred             cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccc
Confidence            78999999 6799999876542  36889999999999999999999   89999999999999998886 799999999


Q ss_pred             cccCCCCcccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCC---------CChhhhcccc
Q psy9858         205 KFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPG---------IPLNEIFTAA  268 (307)
Q Consensus       205 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~---------~~~~~~~~~~  268 (307)
                      ......   .....+|+.|+|||.+.+. .++.++|||       .+++|..||.......         .........+
T Consensus       154 ~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (307)
T 2eva_A          154 CDIQTH---MTNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNL  229 (307)
T ss_dssp             --------------CCTTSSCHHHHTCC-CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTC
T ss_pred             cccccc---cccCCCCCceEChhhhCCC-CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCccccc
Confidence            865322   2334689999999999887 899999999       3344999987532211         1112234568


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         269 GDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       269 ~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      ++.+.+++.+||+.||++|||+++++++
T Consensus       230 ~~~l~~li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          230 PKPIESLMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            8999999999999999999999999983

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.6e-42  Score=293.84  Aligned_cols=234  Identities=19%  Similarity=0.223  Sum_probs=185.4

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY  128 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  128 (307)
                      .+....++|++.+.||+|+||.||+|.+  .|+.||+|++....       ..+.+.+|+++++.++||||+++++++..
T Consensus        15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   85 (278)
T 1byg_A           15 GWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-------TAQAFLAEASVMTQLRHSNLVQLLGVIVE   85 (278)
T ss_dssp             CCBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC---------HHHHHTHHHHTTCCCTTBCCEEEEECC
T ss_pred             cccCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-------HHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence            4456778999999999999999999986  48899999987421       24568899999999999999999998654


Q ss_pred             -cCeEEEEEEccC-CChHHHHhCCCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcc
Q psy9858         129 -MSNVSLVFEFVD-TDLEVIIKDPTI-VFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK  205 (307)
Q Consensus       129 -~~~~~lv~e~~~-g~l~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  205 (307)
                       .+..++||||+. |+|.+++..... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~  165 (278)
T 1byg_A           86 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK  165 (278)
T ss_dssp             C--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred             CCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccc
Confidence             457999999995 689998875432 27899999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCcccccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCCC-------CChhhhccccCH
Q psy9858         206 FFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFPG-------IPLNEIFTAAGD  270 (307)
Q Consensus       206 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~~-------~~~~~~~~~~~~  270 (307)
                      .....   .....+++.|+|||.+.+. .++.++|||       .+++ |..||.......       ......+..+++
T Consensus       166 ~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (278)
T 1byg_A          166 EASST---QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP  241 (278)
T ss_dssp             -------------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCH
T ss_pred             ccccc---ccCCCccccccCHHHhCCC-CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCH
Confidence            65432   2233668899999999887 889999999       3444 888887633211       111223356789


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         271 DLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       271 ~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      .+.++|.+||+.||++|||++++++
T Consensus       242 ~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          242 AVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHhcCChhhCCCHHHHHH
Confidence            9999999999999999999999986

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=7e-42  Score=321.68  Aligned_cols=237  Identities=21%  Similarity=0.244  Sum_probs=187.5

Q ss_pred             ccceeeEE-eEEeecCceEEEEEEE--cCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec
Q psy9858          53 DLLVYYQW-RSVHVGRFATVFKARD--IETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM  129 (307)
Q Consensus        53 ~~~~y~~~-~~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  129 (307)
                      ....+.+. +.||+|+||.||+|.+  ..+++.||||++....   ......+.+.+|++++++++||||+++++++.. 
T Consensus       366 ~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-  441 (635)
T 4fl3_A          366 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA---NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-  441 (635)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG---GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred             cchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence            34445554 4899999999999954  4567899999997532   222335678999999999999999999998864 


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                      ...++||||+ +|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       442 ~~~~lv~E~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~  520 (635)
T 4fl3_A          442 ESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  520 (635)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTT
T ss_pred             CCEEEEEEccCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccc
Confidence            5688999999 678988887543 58999999999999999999999999999999999999999999999999998775


Q ss_pred             CCCc---ccccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCC-------CCChhhhccccCH
Q psy9858         209 SPTR---LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFP-------GIPLNEIFTAAGD  270 (307)
Q Consensus       209 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~-------~~~~~~~~~~~~~  270 (307)
                      ....   ......+|..|+|||++.+. .++.++|||       .+++ |..||.+....       .......+..+++
T Consensus       521 ~~~~~~~~~~~~~~t~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~  599 (635)
T 4fl3_A          521 ADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR  599 (635)
T ss_dssp             C-------------CGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred             cCccccccccCCCCceeeeChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence            4322   12233567889999999887 899999999       3444 89999773211       1111223456899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         271 DLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       271 ~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      ++.+||.+||+.||++|||++++++
T Consensus       600 ~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          600 EMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            9999999999999999999999975

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.9e-42  Score=297.54  Aligned_cols=238  Identities=21%  Similarity=0.280  Sum_probs=193.8

Q ss_pred             cccceeeEEeEEeecCceEEEEEE----EcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeee
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKAR----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG  127 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~  127 (307)
                      ...++|++++.||+|+||.||+|+    +..+|+.||+|++...     .....+.+.+|+++++.++||||+++++++.
T Consensus        38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  112 (326)
T 2w1i_A           38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-----TEEHLRDFEREIEILKSLQHDNIVKYKGVCY  112 (326)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC-----CSHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC-----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence            355789999999999999999998    4668999999999753     2223467889999999999999999999886


Q ss_pred             ecC--eEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCc
Q psy9858         128 YMS--NVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA  204 (307)
Q Consensus       128 ~~~--~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  204 (307)
                      ...  ..++||||+ +|+|.+++......+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++
T Consensus       113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~  192 (326)
T 2w1i_A          113 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT  192 (326)
T ss_dssp             C----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             ecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence            544  789999999 57999999877667999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCcc---cccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCC---------CCCC-------
Q psy9858         205 KFFGSPTRL---YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGN---------LFPG-------  258 (307)
Q Consensus       205 ~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~---------~~~~-------  258 (307)
                      .........   .....++..|+|||.+.+. .++.++|||   +    +++|..|+...         ....       
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (326)
T 2w1i_A          193 KVLPQDKEYYKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  271 (326)
T ss_dssp             EECCSSCSEEECSSCCSCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             hhccccccccccccCCCCceeEECchhhcCC-CCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence            887543221   2234567789999999887 789999999   2    33377776541         0000       


Q ss_pred             -------CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         259 -------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       259 -------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                             ......+..+++++.++|.+||+.||++|||++++++
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          272 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                   0011223467899999999999999999999999985

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-41  Score=295.61  Aligned_cols=234  Identities=21%  Similarity=0.207  Sum_probs=183.0

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc--CCCCccccceeee
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL--HHENVLGLTDVFG  127 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~ni~~~~~~~~  127 (307)
                      .....++|++++.||+|+||.||+|++.  |+.||||++...    .    ...+.+|.+++..+  +||||+++++++.
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~  101 (337)
T 3mdy_A           32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT----E----EASWFRETEIYQTVLMRHENILGFIAADI  101 (337)
T ss_dssp             HTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG----G----HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred             ccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc----c----cchhhhHHHHHHHHhhcCCCeeeEEEEEc
Confidence            3445678999999999999999999864  899999998632    1    23355666666665  8999999999988


Q ss_pred             ec----CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeecCCCCcEEEecCC
Q psy9858         128 YM----SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH--------WILHRDLKPNNLLINKQG  194 (307)
Q Consensus       128 ~~----~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--------~ivH~dlkp~Nil~~~~~  194 (307)
                      ..    ...++||||+ +|+|.+++...  .+++..+..++.|++.||.|||++        ||+||||||+||+++.++
T Consensus       102 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~  179 (337)
T 3mdy_A          102 KGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG  179 (337)
T ss_dssp             ESCGGGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred             cCCCCCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC
Confidence            77    7899999999 57999999765  489999999999999999999998        999999999999999999


Q ss_pred             cEEEEeecCccccCCCCcc----cccceeeceehhhhhhhccccccc------cccee---eee----ec----------
Q psy9858         195 VLKIGDFGLAKFFGSPTRL----YTHQVVTRWYRLIKCLLYCVQFNV------KNVQW---CCF----AK----------  247 (307)
Q Consensus       195 ~~kl~Dfg~a~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~------~~Diw---~i~----~~----------  247 (307)
                      .+||+|||++.........    .....||+.|+|||.+.+. .+..      ++|||   +++    +|          
T Consensus       180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~  258 (337)
T 3mdy_A          180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES-LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY  258 (337)
T ss_dssp             CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTC-CCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccc-cCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence            9999999999876433221    2245789999999999876 4443      49999   333    36          


Q ss_pred             CCCCCCCCCCCCCh------------------hhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         248 DPSSHGNLFPGIPL------------------NEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       248 ~~~f~~~~~~~~~~------------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      ..||..........                  ......+++++.+||.+||+.||++|||++++++|
T Consensus       259 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          259 QLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             cccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            55555422111111                  11112466789999999999999999999999986

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.4e-41  Score=291.92  Aligned_cols=235  Identities=22%  Similarity=0.265  Sum_probs=189.9

Q ss_pred             eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEE
Q psy9858          57 YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVF  136 (307)
Q Consensus        57 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  136 (307)
                      |...+.||+|+||.||+|.+  +++.||+|++...... ......+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  109 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDI-TTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVY  109 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTS-CTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCc-chHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEE
Confidence            44558999999999999985  6889999998754321 22333567889999999999999999999999999999999


Q ss_pred             Ecc-CCChHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc-
Q psy9858         137 EFV-DTDLEVIIKDP--TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR-  212 (307)
Q Consensus       137 e~~-~g~l~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-  212 (307)
                      ||+ +|+|.+++...  ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++........ 
T Consensus       110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  189 (307)
T 2nru_A          110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT  189 (307)
T ss_dssp             ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC
T ss_pred             EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccc
Confidence            999 68898888643  33589999999999999999999999999999999999999999999999999987643222 


Q ss_pred             -ccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCCCh---------------------hh
Q psy9858         213 -LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGIPL---------------------NE  263 (307)
Q Consensus       213 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~~---------------------~~  263 (307)
                       ......+|+.|+|||.+.+  .++.++|||   +    +++|..||..........                     ..
T Consensus       190 ~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (307)
T 2nru_A          190 VMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND  267 (307)
T ss_dssp             EECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSC
T ss_pred             ccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccc
Confidence             2234578999999998875  478999999   2    334999998743322110                     11


Q ss_pred             hccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         264 IFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       264 ~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      .....++.+.+++.+||+.||.+|||+++++++
T Consensus       268 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          268 ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            122345778999999999999999999999874

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=6.4e-42  Score=316.65  Aligned_cols=248  Identities=20%  Similarity=0.229  Sum_probs=199.0

Q ss_pred             ceeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeee
Q psy9858          48 CEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG  127 (307)
Q Consensus        48 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~  127 (307)
                      ..+....++|++.+.||+|+||.||+|.+.. +..||||++.....      ..+.|.+|+++|++++|+||+++++++.
T Consensus       260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~  332 (535)
T 2h8h_A          260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM------SPEAFLQEAQVMKKLRHEKLVQLYAVVS  332 (535)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC------CHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            3455667889999999999999999999754 56799999975321      1356889999999999999999999886


Q ss_pred             ecCeEEEEEEcc-CCChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcc
Q psy9858         128 YMSNVSLVFEFV-DTDLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK  205 (307)
Q Consensus       128 ~~~~~~lv~e~~-~g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  205 (307)
                      + ...++||||+ +|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus       333 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~  411 (535)
T 2h8h_A          333 E-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR  411 (535)
T ss_dssp             S-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTT
T ss_pred             e-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccce
Confidence            6 6789999999 57899998743 2348999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCc-ccccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCCC-------CChhhhccccC
Q psy9858         206 FFGSPTR-LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFPG-------IPLNEIFTAAG  269 (307)
Q Consensus       206 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~~-------~~~~~~~~~~~  269 (307)
                      ....... ......++..|+|||.+.+. .++.++|||       .+++ |..||.+.....       ......+..++
T Consensus       412 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~  490 (535)
T 2h8h_A          412 LIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP  490 (535)
T ss_dssp             TCCCHHHHTTCSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred             ecCCCceecccCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence            7643211 12233467889999999887 899999999       3444 788887632110       01112234678


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHhcC--cccCCCcc
Q psy9858         270 DDLLAVISSLLCLNPTKRADCTATLKM--DYFSLTKE  304 (307)
Q Consensus       270 ~~l~~li~~~l~~dP~~Rpt~~~il~h--p~f~~~~~  304 (307)
                      +++.+||.+||+.||++|||++++++.  .+|.....
T Consensus       491 ~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~  527 (535)
T 2h8h_A          491 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP  527 (535)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence            999999999999999999999999875  56655443

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.8e-41  Score=319.91  Aligned_cols=242  Identities=17%  Similarity=0.268  Sum_probs=194.5

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEEcC---CCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCcccccee
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARDIE---TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV  125 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~  125 (307)
                      ......++|++.+.||+|+||.||+|.+..   .+..||+|++...    ........+.+|+.+++.++||||++++++
T Consensus       384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~  459 (656)
T 2j0j_A          384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC----TSDSVREKFLQEALTMRQFDHPHIVKLIGV  459 (656)
T ss_dssp             GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST----TCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            344556889999999999999999999764   3567999998742    223335678899999999999999999998


Q ss_pred             eeecCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCc
Q psy9858         126 FGYMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA  204 (307)
Q Consensus       126 ~~~~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  204 (307)
                      +. ++..++||||+ +|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus       460 ~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a  538 (656)
T 2j0j_A          460 IT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS  538 (656)
T ss_dssp             EC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred             Ee-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCC
Confidence            84 56689999999 58999999876667899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCcc-cccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCCC-------CChhhhcccc
Q psy9858         205 KFFGSPTRL-YTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFPG-------IPLNEIFTAA  268 (307)
Q Consensus       205 ~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~~-------~~~~~~~~~~  268 (307)
                      +........ .....+++.|+|||.+.+. .++.++|||       .+++ |..||.+.....       ......+..+
T Consensus       539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  617 (656)
T 2j0j_A          539 RYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC  617 (656)
T ss_dssp             CSCCC----------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTC
T ss_pred             eecCCCcceeccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence            877443221 2234567899999999887 899999999       2333 888887632110       0111234568


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         269 GDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       269 ~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      ++.+.+||.+||+.||.+|||+.++++.
T Consensus       618 ~~~l~~li~~~l~~dP~~RPs~~el~~~  645 (656)
T 2j0j_A          618 PPTLYSLMTKCWAYDPSRRPRFTELKAQ  645 (656)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            8999999999999999999999999863

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.5e-41  Score=320.29  Aligned_cols=233  Identities=18%  Similarity=0.210  Sum_probs=189.9

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcC-CCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe-
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIE-TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN-  131 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~-  131 (307)
                      .++|++++.||+|+||.||+|.+.. +|+.||||++....    .......+.+|+++++.++||||+++++++...+. 
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  154 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG----DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH  154 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC----CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC----CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence            3789999999999999999999876 78999999987432    22334568899999999999999999999987665 


Q ss_pred             ----EEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         132 ----VSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       132 ----~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                          .||||||+ +++|.+.+..   .+++..++.++.||+.||.|||++||+||||||+||+++.+ .+||+|||+++.
T Consensus       155 ~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~  230 (681)
T 2pzi_A          155 GDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR  230 (681)
T ss_dssp             SCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             CCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence                79999999 5677766554   48999999999999999999999999999999999999875 899999999987


Q ss_pred             cCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCCChhhhccccCHHHHHHHHHh
Q psy9858         207 FGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGIPLNEIFTAAGDDLLAVISSL  279 (307)
Q Consensus       207 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~~~~~~~~~~~~l~~li~~~  279 (307)
                      ....    ....||+.|+|||++.+.  ++.++|||   +    +++|..||.+...............++.+.+||.+|
T Consensus       231 ~~~~----~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  304 (681)
T 2pzi_A          231 INSF----GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLLRRA  304 (681)
T ss_dssp             TTCC----SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCCTTCHHHHHCHHHHHHHHHH
T ss_pred             cccC----CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccccccccccccccCHHHHHHHhhh
Confidence            7443    345789999999998775  48999999   3    333777776643332222222234678999999999


Q ss_pred             hhcCCCCCCCHHHHhcCcccC
Q psy9858         280 LCLNPTKRADCTATLKMDYFS  300 (307)
Q Consensus       280 l~~dP~~Rpt~~~il~hp~f~  300 (307)
                      |+.||.+||+..+++.|+|+.
T Consensus       305 l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          305 IDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             TCSSGGGSCSSHHHHHHHHHH
T ss_pred             ccCChhhCCCHHHHHHHHHHH
Confidence            999999999999999998874

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=4.7e-41  Score=293.70  Aligned_cols=240  Identities=20%  Similarity=0.189  Sum_probs=180.7

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHH--HHhcCCCCccccceeee-
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKL--LQELHHENVLGLTDVFG-  127 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~--l~~l~h~ni~~~~~~~~-  127 (307)
                      ....++|++++.||+|+||.||+|++  +++.||||++....        ...+..|.++  +..++||||+++++.+. 
T Consensus         9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~   78 (336)
T 3g2f_A            9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN--------RQNFINEKNIYRVPLMEHDNIARFIVGDER   78 (336)
T ss_dssp             CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG--------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred             CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc--------hhhHHHHHHHHHHHhccCcchhhheecccc
Confidence            44678999999999999999999975  68999999997421        2334445554  44589999999997543 


Q ss_pred             ----ecCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---------CceeecCCCCcEEEecC
Q psy9858         128 ----YMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH---------WILHRDLKPNNLLINKQ  193 (307)
Q Consensus       128 ----~~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---------~ivH~dlkp~Nil~~~~  193 (307)
                          .....++||||+ +|+|.+++....  .++..+..++.||+.||.|||+.         ||+||||||+|||++.+
T Consensus        79 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~  156 (336)
T 3g2f_A           79 VTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND  156 (336)
T ss_dssp             ECTTSCEEEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTT
T ss_pred             cccCCCceEEEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCC
Confidence                334689999999 679999997664  58899999999999999999999         99999999999999999


Q ss_pred             CcEEEEeecCccccCCCC--------cccccceeeceehhhhhhhcc------ccccccccee---eee----ec-CCCC
Q psy9858         194 GVLKIGDFGLAKFFGSPT--------RLYTHQVVTRWYRLIKCLLYC------VQFNVKNVQW---CCF----AK-DPSS  251 (307)
Q Consensus       194 ~~~kl~Dfg~a~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~------~~~~~~~Diw---~i~----~~-~~~f  251 (307)
                      +.+||+|||++.......        .......||+.|+|||++.+.      ..++.++|||   +++    +| .++|
T Consensus       157 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~  236 (336)
T 3g2f_A          157 GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF  236 (336)
T ss_dssp             SCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred             CcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence            999999999998764321        122344689999999999872      2677899999   333    35 4444


Q ss_pred             CCCCCCCCCh-------------------------hhhc------cccCHHHHHHHHHhhhcCCCCCCCHHHHhc-----
Q psy9858         252 HGNLFPGIPL-------------------------NEIF------TAAGDDLLAVISSLLCLNPTKRADCTATLK-----  295 (307)
Q Consensus       252 ~~~~~~~~~~-------------------------~~~~------~~~~~~l~~li~~~l~~dP~~Rpt~~~il~-----  295 (307)
                      .+........                         ...+      ..+++++.+||.+||+.||++|||++|+++     
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l  316 (336)
T 3g2f_A          237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL  316 (336)
T ss_dssp             TTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             CccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence            4322211100                         0000      113457999999999999999999999954     


Q ss_pred             -CcccCCC
Q psy9858         296 -MDYFSLT  302 (307)
Q Consensus       296 -hp~f~~~  302 (307)
                       ++|-++.
T Consensus       317 l~~~~~~~  324 (336)
T 3g2f_A          317 MMIWERNK  324 (336)
T ss_dssp             HHCCCC--
T ss_pred             HHHHHhcc
Confidence             6776654

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.8e-41  Score=294.16  Aligned_cols=242  Identities=19%  Similarity=0.225  Sum_probs=191.0

Q ss_pred             ceeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeee
Q psy9858          48 CEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG  127 (307)
Q Consensus        48 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~  127 (307)
                      ..+....++|++.+.||+|+||.||+|.+..   .||+|++.......   ...+.+.+|+.+++.++||||+++++++.
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   99 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNE---DQLKAFKREVMAYRQTRHENVVLFMGACM   99 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCC---CCCCCCCTTGGGGTTCCCTTBCCCCEEEE
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCH---HHHHHHHHHHHHHhcCCCCCEeEEEEEEe
Confidence            3455567899999999999999999999754   39999997643222   12345678999999999999999999999


Q ss_pred             ecCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         128 YMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       128 ~~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                      +....+++|||+ +++|.+++......+++..+..++.||+.||.|||++|++||||||+||+++ ++.++|+|||++..
T Consensus       100 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~  178 (319)
T 2y4i_B          100 SPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSI  178 (319)
T ss_dssp             CSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred             cCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccc
Confidence            999999999999 5789999887766799999999999999999999999999999999999997 78999999999876


Q ss_pred             cCCC-----Ccccccceeeceehhhhhhhcc--------ccccccccee-------eeeecCCCCCCCCCCC--------
Q psy9858         207 FGSP-----TRLYTHQVVTRWYRLIKCLLYC--------VQFNVKNVQW-------CCFAKDPSSHGNLFPG--------  258 (307)
Q Consensus       207 ~~~~-----~~~~~~~~~t~~y~aPE~~~~~--------~~~~~~~Diw-------~i~~~~~~f~~~~~~~--------  258 (307)
                      ....     ........+++.|+|||.+.+.        ..++.++|||       .+++|..||.......        
T Consensus       179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~  258 (319)
T 2y4i_B          179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG  258 (319)
T ss_dssp             ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTT
T ss_pred             cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccC
Confidence            5321     1223344689999999999752        2578999999       3334999987632110        


Q ss_pred             CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         259 IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       259 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      .........++.++.+++.+||+.||++|||++++++.
T Consensus       259 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~  296 (319)
T 2y4i_B          259 MKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM  296 (319)
T ss_dssp             CCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred             CCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            01111122578899999999999999999999999873

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.7e-40  Score=289.48  Aligned_cols=232  Identities=25%  Similarity=0.234  Sum_probs=186.4

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHh--cCCCCccccceeeeecC
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQE--LHHENVLGLTDVFGYMS  130 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~ni~~~~~~~~~~~  130 (307)
                      ..++|++.+.||+|+||.||+|++  +|+.||||++...        ....+.+|.+++..  ++||||+++++++....
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~  109 (342)
T 1b6c_B           40 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR--------EERSWFREAEIYQTVMLRHENILGFIAADNKDN  109 (342)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG--------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred             ccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch--------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence            447899999999999999999996  5899999998631        13457789999887  78999999999998775


Q ss_pred             ----eEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCceeecCCCCcEEEecCCcEE
Q psy9858         131 ----NVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH--------DHWILHRDLKPNNLLINKQGVLK  197 (307)
Q Consensus       131 ----~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--------~~~ivH~dlkp~Nil~~~~~~~k  197 (307)
                          ..++||||+ +|+|.+++...  .+++..+..++.||+.||.|||        +.||+||||||+||+++.++.+|
T Consensus       110 ~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~k  187 (342)
T 1b6c_B          110 GTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  187 (342)
T ss_dssp             SSCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEE
T ss_pred             CccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEE
Confidence                899999999 56999999765  4899999999999999999999        89999999999999999999999


Q ss_pred             EEeecCccccCCCCc----ccccceeeceehhhhhhhccc-----cccccccee---ee----eec----------CCCC
Q psy9858         198 IGDFGLAKFFGSPTR----LYTHQVVTRWYRLIKCLLYCV-----QFNVKNVQW---CC----FAK----------DPSS  251 (307)
Q Consensus       198 l~Dfg~a~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~-----~~~~~~Diw---~i----~~~----------~~~f  251 (307)
                      |+|||++........    ......+|+.|+|||.+.+..     .++.++|||   ++    ++|          ..||
T Consensus       188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~  267 (342)
T 1b6c_B          188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  267 (342)
T ss_dssp             ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence            999999987644322    123457899999999997752     234789999   33    336          6677


Q ss_pred             CCCCCCCCChhh-------------h-----ccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         252 HGNLFPGIPLNE-------------I-----FTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       252 ~~~~~~~~~~~~-------------~-----~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      ............             .     ...+++.+.+|+.+||+.||++|||++++++|
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          268 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            653222111110             0     11344678999999999999999999999986

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.8e-38  Score=271.29  Aligned_cols=209  Identities=12%  Similarity=-0.008  Sum_probs=174.1

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEE
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVS  133 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  133 (307)
                      .++|++.+.||+|+||.||+|++..+|+.||||++......  .......+.+|++++..++||||+++++++.+.+..|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  107 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVL--PDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL  107 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCS--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECccccc--CHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence            36799999999999999999999999999999999864322  2233567889999999999999999999999999999


Q ss_pred             EEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc
Q psy9858         134 LVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR  212 (307)
Q Consensus       134 lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  212 (307)
                      +||||+ +++|.+++...   ....++..++.||+.||.|||++||+||||||+||+++.+|.+||++++.         
T Consensus       108 lv~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~---------  175 (286)
T 3uqc_A          108 VVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT---------  175 (286)
T ss_dssp             EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC---------
T ss_pred             EEEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc---------
Confidence            999999 57888888543   36667889999999999999999999999999999999999999985433         


Q ss_pred             ccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCC-------------ChhhhccccCHHH
Q psy9858         213 LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGI-------------PLNEIFTAAGDDL  272 (307)
Q Consensus       213 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~-------------~~~~~~~~~~~~l  272 (307)
                                 ++        .++.++|||   +    +++|+.||.+......             ........+++++
T Consensus       176 -----------~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (286)
T 3uqc_A          176 -----------MP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI  236 (286)
T ss_dssp             -----------CT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHH
T ss_pred             -----------cC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHH
Confidence                       22        378899999   3    3449999987433221             1123345789999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         273 LAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       273 ~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      .++|.+||+.||++| |++++++.
T Consensus       237 ~~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          237 SAVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             HHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             HHHHHHHcccCCccC-CHHHHHHH
Confidence            999999999999999 99999873

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=1.6e-35  Score=274.75  Aligned_cols=231  Identities=11%  Similarity=-0.019  Sum_probs=150.6

Q ss_pred             eEEeecCceEEEEEEEcCCCcEEEEEEeecCCccc-----cchhhhHhHHHHHHHHHhc-CCCCccccceeeeecCeEEE
Q psy9858          61 RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHAD-----AKDGINRTALREIKLLQEL-HHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ...+.|++|.+..++....|+.|++|++.+.....     ..+...++|.+|+++|+++ .|+||++++++++++...||
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL  319 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL  319 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence            35667777777777777789999999998653222     2223346689999999999 69999999999999999999


Q ss_pred             EEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc
Q psy9858         135 VFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL  213 (307)
Q Consensus       135 v~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  213 (307)
                      ||||+ +|+|.+++...+ .+++.   .|+.||+.||+|+|++|||||||||+|||++.+|.+||+|||+|+........
T Consensus       320 VMEyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~  395 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSW  395 (569)
T ss_dssp             EEECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CC
T ss_pred             EEecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcc
Confidence            99999 578999887654 46654   48899999999999999999999999999999999999999999987655555


Q ss_pred             cccceeeceehhhhhhhccccccccccee--eeeecCCCCCCCCCCCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHH
Q psy9858         214 YTHQVVTRWYRLIKCLLYCVQFNVKNVQW--CCFAKDPSSHGNLFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCT  291 (307)
Q Consensus       214 ~~~~~~t~~y~aPE~~~~~~~~~~~~Diw--~i~~~~~~f~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~  291 (307)
                      ..+.+||+.|+|||++.+.  +..++|+|  ++.....+.....+... .... ......+..+...+...+|..|+...
T Consensus       396 ~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~~~~~~~-l~~~-~~~~~~~~~l~~~l~~~~~~~~~~~~  471 (569)
T 4azs_A          396 PTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPWSNWLYA-VWQE-PVERWNFVLLLALFEKKAKLPSAEQQ  471 (569)
T ss_dssp             SHHHHHHHHHHHHHHC-------------------CCCCTTHHHHHHH-HHTS-CGGGCSHHHHHHHHHTGGGSCCGGGS
T ss_pred             ccCceechhhccHHHhCCC--CCCcccccccccchhhhccccchhHHH-hhcC-CCCCCcHHHHHHHHhCCCCCCCCChh
Confidence            5667899999999999874  66789999  33333333221000000 0000 00111244555666666776676665


Q ss_pred             HHhcCccc
Q psy9858         292 ATLKMDYF  299 (307)
Q Consensus       292 ~il~hp~f  299 (307)
                      ....++|.
T Consensus       472 ~~~~~~~~  479 (569)
T 4azs_A          472 RGATEQWI  479 (569)
T ss_dssp             SCCHHHHH
T ss_pred             hhccchhH
Confidence            55555553

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=5.8e-30  Score=236.26  Aligned_cols=172  Identities=17%  Similarity=0.129  Sum_probs=131.7

Q ss_pred             eEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccc---cchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          58 YQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHAD---AKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        58 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ...+.||+|+||.||+|.  ..+..+++|+........   ......+.+.+|++++++++||||+++..++......+|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            445789999999999995  467889999876533221   111124558899999999999999966666667778899


Q ss_pred             EEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc
Q psy9858         135 VFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL  213 (307)
Q Consensus       135 v~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  213 (307)
                      ||||+ +|+|.+++..         +..++.||+.||.|||++||+||||||+|||++.  .+||+|||+++........
T Consensus       417 VmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~  485 (540)
T 3en9_A          417 MMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK  485 (540)
T ss_dssp             EEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred             EEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence            99999 5889888876         4689999999999999999999999999999988  9999999999987543221


Q ss_pred             -------cccceeeceehhhhhhhcc-ccccccccee
Q psy9858         214 -------YTHQVVTRWYRLIKCLLYC-VQFNVKNVQW  242 (307)
Q Consensus       214 -------~~~~~~t~~y~aPE~~~~~-~~~~~~~Diw  242 (307)
                             .....||+.|+|||++... ..|+..+|+|
T Consensus       486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~w  522 (540)
T 3en9_A          486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRW  522 (540)
T ss_dssp             HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTH
T ss_pred             ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHH
Confidence                   2356899999999999872 2577788888

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.95  E-value=2.3e-27  Score=201.72  Aligned_cols=146  Identities=23%  Similarity=0.219  Sum_probs=114.1

Q ss_pred             EEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccc-----h--------hhhHhHHHHHHHHHhcCCCCcccccee
Q psy9858          59 QWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAK-----D--------GINRTALREIKLLQELHHENVLGLTDV  125 (307)
Q Consensus        59 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-----~--------~~~~~~~~e~~~l~~l~h~ni~~~~~~  125 (307)
                      +.+.||+|+||.||+|.+ .+|+.||+|++.........     +        .....+.+|+++++.++  | +++.++
T Consensus        94 ~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~  169 (282)
T 1zar_A           94 IGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKV  169 (282)
T ss_dssp             EEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCE
T ss_pred             ecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeE
Confidence            339999999999999998 88999999999753221110     0        12456889999999999  5 677776


Q ss_pred             eeecCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCc
Q psy9858         126 FGYMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLA  204 (307)
Q Consensus       126 ~~~~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  204 (307)
                      +.. +..++||||+ +|+|.+ +..       .....++.||+.||.|||++||+||||||+||+++ ++.+||+|||+|
T Consensus       170 ~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a  239 (282)
T 1zar_A          170 YAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQS  239 (282)
T ss_dssp             EEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTC
T ss_pred             Eec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCC
Confidence            544 5569999999 457877 422       22456999999999999999999999999999999 999999999999


Q ss_pred             cccCCCCcccccceeeceehhhhhhhc
Q psy9858         205 KFFGSPTRLYTHQVVTRWYRLIKCLLY  231 (307)
Q Consensus       205 ~~~~~~~~~~~~~~~t~~y~aPE~~~~  231 (307)
                      +..             ..++|||.+.+
T Consensus       240 ~~~-------------~~~~a~e~l~r  253 (282)
T 1zar_A          240 VEV-------------GEEGWREILER  253 (282)
T ss_dssp             EET-------------TSTTHHHHHHH
T ss_pred             eEC-------------CCCCHHHHHHH
Confidence            743             34578888754

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.91  E-value=6.1e-24  Score=178.44  Aligned_cols=143  Identities=17%  Similarity=0.178  Sum_probs=109.6

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcE--EEEEEeecCCcccc-------------------chhhhHhHHHHHHHHHhc
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMI--VAVKKIKLGTHADA-------------------KDGINRTALREIKLLQEL  114 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~~~-------------------~~~~~~~~~~e~~~l~~l  114 (307)
                      -|.+.+.||+|+||.||+|.+..+|+.  ||||++........                   .......+.+|++++..+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            488999999999999999998778999  99999765321110                   001123578999999999


Q ss_pred             CCCCc--cccceeeeecCeEEEEEEccC--C----ChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCceeecCCC
Q psy9858         115 HHENV--LGLTDVFGYMSNVSLVFEFVD--T----DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLH-DHWILHRDLKP  185 (307)
Q Consensus       115 ~h~ni--~~~~~~~~~~~~~~lv~e~~~--g----~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~ivH~dlkp  185 (307)
                      .|+++  +.+++    ....+|||||++  |    .|.+....    .++..+..++.||+.+|.||| +.||+||||||
T Consensus       128 ~~~~i~~p~~~~----~~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp  199 (258)
T 1zth_A          128 KEAGVSVPQPYT----YMKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE  199 (258)
T ss_dssp             HHTTCCCCCEEE----EETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred             HhCCCCCCeEEE----cCCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence            88764  33332    135689999994  3    45554332    235567889999999999999 99999999999


Q ss_pred             CcEEEecCCcEEEEeecCccccC
Q psy9858         186 NNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       186 ~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                      +|||++.  .++|+|||+|....
T Consensus       200 ~NILl~~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          200 YNIMYID--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             TSEEESS--SEEECCCTTCEETT
T ss_pred             HHEEEcC--cEEEEECcccccCC
Confidence            9999988  89999999998763

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.83  E-value=1.3e-20  Score=164.77  Aligned_cols=143  Identities=17%  Similarity=0.163  Sum_probs=96.8

Q ss_pred             eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCcccc-----c----hhhhHhH--------HHHHHHHHhcCCCCc
Q psy9858          57 YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADA-----K----DGINRTA--------LREIKLLQELHHENV  119 (307)
Q Consensus        57 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~----~~~~~~~--------~~e~~~l~~l~h~ni  119 (307)
                      |++.++||+|++|.||+|.+ .+|+.||||+++.......     .    .......        .+|...|.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            89999999999999999996 5799999999864321100     0    0001111        235555555543333


Q ss_pred             cccceeeeecCeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCC-----
Q psy9858         120 LGLTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG-----  194 (307)
Q Consensus       120 ~~~~~~~~~~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-----  194 (307)
                      .... .+.. ...+|||||++|..+..+..      ......++.||+.+|.+||++|||||||||.|||++.++     
T Consensus       176 ~vp~-p~~~-~~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~  247 (397)
T 4gyi_A          176 PVPE-PIAQ-SRHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDP  247 (397)
T ss_dssp             SCCC-EEEE-ETTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCT
T ss_pred             CCCe-eeec-cCceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccc
Confidence            2111 1111 22369999996643322221      123456789999999999999999999999999998877     


Q ss_pred             -----cEEEEeecCccccC
Q psy9858         195 -----VLKIGDFGLAKFFG  208 (307)
Q Consensus       195 -----~~kl~Dfg~a~~~~  208 (307)
                           .+.|+||+-+....
T Consensus       248 ~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          248 SSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             TSEEEEEEECCCTTCEETT
T ss_pred             cccccceEEEEeCCcccCC
Confidence                 38999999887653

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.53  E-value=5.5e-14  Score=117.84  Aligned_cols=141  Identities=13%  Similarity=0.034  Sum_probs=109.4

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-CCCccccceeeeecCe
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-HENVLGLTDVFGYMSN  131 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~  131 (307)
                      .+..|++...++.|+.+.||++..  .+..+++|+........     ...+.+|+++++.+. +..+.+++++..+.+.
T Consensus        12 ~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~   84 (263)
T 3tm0_A           12 LIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT-----TYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             HHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTS-----TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             HhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCC-----HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCc
Confidence            445688999999999999999973  36789999987421111     234779999999984 7788899999988899


Q ss_pred             EEEEEEccCCC-hHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------
Q psy9858         132 VSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD-----------------------------------  175 (307)
Q Consensus       132 ~~lv~e~~~g~-l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-----------------------------------  175 (307)
                      .|+|||+++|. +.+.+.      +......++.+++.+|..||+                                   
T Consensus        85 ~~lv~e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T 3tm0_A           85 SNLLMSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEEEEECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred             eEEEEEecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence            99999999765 444321      112234678899999999998                                   


Q ss_pred             ------------------------CCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         176 ------------------------HWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       176 ------------------------~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                                              .+++|+|++|.||+++.++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                    4489999999999998765567999998864

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.42  E-value=8.2e-13  Score=110.29  Aligned_cols=139  Identities=17%  Similarity=0.078  Sum_probs=100.4

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCC--ccccceeeeec
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHEN--VLGLTDVFGYM  129 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--i~~~~~~~~~~  129 (307)
                      .....|.+....+.|..+.||++. ..+|..+++|+.....        ...+.+|+++++.+.+.+  +.+++++....
T Consensus        17 ~~~~~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~~--------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~   87 (264)
T 1nd4_A           17 ERLFGYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGA--------LNELQDEAARLSWLATTGVPCAAVLDVVTEA   87 (264)
T ss_dssp             TTTTTCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSCT--------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS
T ss_pred             HhcCCCceEecccCCCCceEEEEe-cCCCCeEEEEeCCccc--------chhhhHHHHHHHHHHhCCCCCCeEEEeccCC
Confidence            344456655444566679999996 4567789999976421        234678999999885444  56688888877


Q ss_pred             CeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--------------------------------
Q psy9858         130 SNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHW--------------------------------  177 (307)
Q Consensus       130 ~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--------------------------------  177 (307)
                      +..++||||++|...+ ...    ...   ..++.+++..|..||+..                                
T Consensus        88 ~~~~~v~e~i~G~~l~-~~~----~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (264)
T 1nd4_A           88 GRDWLLLGEVPGQDLL-SSH----LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLD  159 (264)
T ss_dssp             SCEEEEEECCSSEETT-TSC----CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCC
T ss_pred             CCCEEEEEecCCcccC-cCc----CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhh
Confidence            8899999999765434 211    121   256677778888888643                                


Q ss_pred             --------------------------ceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         178 --------------------------ILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       178 --------------------------ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                                                ++|+|++|.||+++.++.+.|+||+.+...
T Consensus       160 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g  215 (264)
T 1nd4_A          160 EEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA  215 (264)
T ss_dssp             GGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             hhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence                                      999999999999987766679999998754

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.33  E-value=5.8e-12  Score=110.40  Aligned_cols=141  Identities=16%  Similarity=0.138  Sum_probs=103.8

Q ss_pred             eEEeEEeecCceEEEEEEEcCCCcEEEEEEee--cCCccccchhhhHhHHHHHHHHHhcC--CCCccccceeeeec---C
Q psy9858          58 YQWRSVHVGRFATVFKARDIETDMIVAVKKIK--LGTHADAKDGINRTALREIKLLQELH--HENVLGLTDVFGYM---S  130 (307)
Q Consensus        58 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~~~e~~~l~~l~--h~ni~~~~~~~~~~---~  130 (307)
                      ..++.|+.|.++.||+...  .+..+++|+..  ......    ....+.+|.++++.+.  +..+++++.++.+.   +
T Consensus        41 ~~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~----~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g  114 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLP----SAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIG  114 (359)
T ss_dssp             CEEEECCC-CCSCEEEEEC--SSCEEEEECCCC--------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTS
T ss_pred             ceEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCC----cHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccC
Confidence            3467889999999999874  34678899875  322111    1245778999999997  45678888887766   4


Q ss_pred             eEEEEEEccCCChH-HHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------
Q psy9858         131 NVSLVFEFVDTDLE-VIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD----------------------------------  175 (307)
Q Consensus       131 ~~~lv~e~~~g~l~-~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~----------------------------------  175 (307)
                      ..|+||||++|... +...   ..+++.....++.+++..|..||+                                  
T Consensus       115 ~~~~vme~v~G~~l~~~~~---~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (359)
T 3dxp_A          115 RAFYIMEFVSGRVLWDQSL---PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET  191 (359)
T ss_dssp             SCEEEEECCCCBCCCCTTC---TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred             CeEEEEEecCCeecCCCcc---ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence            58999999976533 2111   126788888999999999999997                                  


Q ss_pred             ------------------------CCceeecCCCCcEEEecCCc--EEEEeecCcccc
Q psy9858         176 ------------------------HWILHRDLKPNNLLINKQGV--LKIGDFGLAKFF  207 (307)
Q Consensus       176 ------------------------~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~a~~~  207 (307)
                                              .+++|+|+++.||+++.++.  +.|+||+.+..-
T Consensus       192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                    35899999999999987753  689999998753

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.84  E-value=8.1e-09  Score=88.16  Aligned_cols=133  Identities=16%  Similarity=0.115  Sum_probs=94.2

Q ss_pred             EeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-CCC--ccccceeeeecC---eEE
Q psy9858          60 WRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-HEN--VLGLTDVFGYMS---NVS  133 (307)
Q Consensus        60 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~n--i~~~~~~~~~~~---~~~  133 (307)
                      ++.++.|....||+..     ..+++|+....       .....+.+|.++++.+. +..  +.+++.......   ..|
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~   92 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSF   92 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH-------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSC
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc-------chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcce
Confidence            3568999999999863     35889986421       22456789999998883 333  344544433332   458


Q ss_pred             EEEEccCCC-hHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q psy9858         134 LVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD-------------------------------------  175 (307)
Q Consensus       134 lv~e~~~g~-l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-------------------------------------  175 (307)
                      +||++++|. +.+....   .++.++...++.+++..|..||+                                     
T Consensus        93 ~vm~~i~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (304)
T 3sg8_A           93 AGFTKIKGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQ  169 (304)
T ss_dssp             EEEECCCCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHH
T ss_pred             EEEcccCCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCccc
Confidence            999999765 3332221   25777778888888888888885                                     


Q ss_pred             ---------------------CCceeecCCCCcEEEec--CCcEEEEeecCcccc
Q psy9858         176 ---------------------HWILHRDLKPNNLLINK--QGVLKIGDFGLAKFF  207 (307)
Q Consensus       176 ---------------------~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~a~~~  207 (307)
                                           ..++|+|++|.||+++.  .+.+.|+||+.+...
T Consensus       170 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~  224 (304)
T 3sg8_A          170 MKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS  224 (304)
T ss_dssp             HHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred             HHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence                                 13799999999999998  456789999998764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.83  E-value=5.9e-08  Score=82.91  Aligned_cols=133  Identities=20%  Similarity=0.079  Sum_probs=89.2

Q ss_pred             EeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCC---Cccccceeee-ecCeEEEE
Q psy9858          60 WRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHE---NVLGLTDVFG-YMSNVSLV  135 (307)
Q Consensus        60 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~---ni~~~~~~~~-~~~~~~lv  135 (307)
                      ++.++.|....||+.     |..+++|+...       ......+.+|.++|+.+.+.   .+.+.+.+.. ..+..+++
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-------~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v   91 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKS-------QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVG   91 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESS-------HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCC-------chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEE
Confidence            456788988899987     45688898431       12245678999999999642   3556665553 45668899


Q ss_pred             EEccCCC-hHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC--------------------------------------
Q psy9858         136 FEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH--------------------------------------  176 (307)
Q Consensus       136 ~e~~~g~-l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--------------------------------------  176 (307)
                      |++++|. +.+....   .++......++.++...|..||+.                                      
T Consensus        92 ~e~i~G~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~  168 (306)
T 3tdw_A           92 YRKVQGQILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL  168 (306)
T ss_dssp             EECCCSEECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred             EeccCCeECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence            9999775 3332111   134444455555555555555532                                      


Q ss_pred             ----------------------CceeecCCCCcEEEec---CCc-EEEEeecCcccc
Q psy9858         177 ----------------------WILHRDLKPNNLLINK---QGV-LKIGDFGLAKFF  207 (307)
Q Consensus       177 ----------------------~ivH~dlkp~Nil~~~---~~~-~kl~Dfg~a~~~  207 (307)
                                            .++|+|+++.||+++.   ++. +.|+||+.+...
T Consensus       169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                                  3599999999999987   455 489999998754

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.83  E-value=6e-08  Score=81.18  Aligned_cols=133  Identities=14%  Similarity=0.115  Sum_probs=92.7

Q ss_pred             EEeecCce-EEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-CCCccccceeeeecCeEEEEEEcc
Q psy9858          62 SVHVGRFA-TVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-HENVLGLTDVFGYMSNVSLVFEFV  139 (307)
Q Consensus        62 ~lg~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~  139 (307)
                      .+..|..+ .||+......+..+++|+-...        ....+.+|..+|+.+. +-.+.+++.++.+.+..++|||++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l  102 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAI  102 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH--------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC--------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEee
Confidence            44445444 6999876667778999986531        1345778999998884 445788888888999999999999


Q ss_pred             CCC-hHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC------------------------------------------
Q psy9858         140 DTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH------------------------------------------  176 (307)
Q Consensus       140 ~g~-l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~------------------------------------------  176 (307)
                      +|. +.+.....     ......+..++...|..||+.                                          
T Consensus       103 ~G~~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (272)
T 4gkh_A          103 PGKTAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE  177 (272)
T ss_dssp             CSEEHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred             CCccccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence            765 33332211     112233455555555555521                                          


Q ss_pred             ----------------CceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         177 ----------------WILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       177 ----------------~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                                      .++|+|+.+.||+++.++.+-|+||+.+..-
T Consensus       178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g  224 (272)
T 4gkh_A          178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA  224 (272)
T ss_dssp             HHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             HHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence                            2789999999999998777789999998753

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.61  E-value=1.8e-07  Score=82.80  Aligned_cols=81  Identities=16%  Similarity=0.024  Sum_probs=50.0

Q ss_pred             EEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCc--cccchhhhHhHHHHHHHHHhcCC--C-CccccceeeeecCeEE
Q psy9858          59 QWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTH--ADAKDGINRTALREIKLLQELHH--E-NVLGLTDVFGYMSNVS  133 (307)
Q Consensus        59 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~e~~~l~~l~h--~-ni~~~~~~~~~~~~~~  133 (307)
                      .++.||.|..+.||++....++..+++|.......  ..........+..|.++++.+..  + .+.+++.+  +....+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~  111 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  111 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence            35789999999999997655678899998753211  00001123446789998887742  3 34455543  445568


Q ss_pred             EEEEccCC
Q psy9858         134 LVFEFVDT  141 (307)
Q Consensus       134 lv~e~~~g  141 (307)
                      +|||+++|
T Consensus       112 lvmE~l~g  119 (397)
T 2olc_A          112 TVMEDLSH  119 (397)
T ss_dssp             EEECCCTT
T ss_pred             EEEEeCCC
Confidence            99999965

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.43  E-value=2e-06  Score=74.31  Aligned_cols=32  Identities=19%  Similarity=0.248  Sum_probs=28.7

Q ss_pred             CCceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         176 HWILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       176 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      .+++|+|+++.||+++.++.+.|+||+.+..-
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~g  253 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSFD  253 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCEEC
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcccC
Confidence            57999999999999988889999999998653

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.38  E-value=9.1e-07  Score=77.06  Aligned_cols=83  Identities=5%  Similarity=-0.058  Sum_probs=53.5

Q ss_pred             eEEeEE-eecCceEEEEEEEc--C----CCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-C--CCccccceeee
Q psy9858          58 YQWRSV-HVGRFATVFKARDI--E----TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-H--ENVLGLTDVFG  127 (307)
Q Consensus        58 ~~~~~l-g~G~~g~V~~~~~~--~----~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h--~ni~~~~~~~~  127 (307)
                      ...+.| +.|....+|+....  .    ++..+++|+..........  ....+.+|+.+++.+. +  ..+.+++.+..
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~--~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~  100 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVF--PTYRLDHQFEVIRLVGELTDVPVPRVRWIET  100 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSS--SCCCHHHHHHHHHHHHHHCCSCCCCEEEEEC
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccC--chhHHHHHHHHHHHHhhcCCCCCCcEEEEcc
Confidence            445677 88888999988642  1    2667899976532100000  0134678998888884 2  45777887765


Q ss_pred             ec---CeEEEEEEccCCC
Q psy9858         128 YM---SNVSLVFEFVDTD  142 (307)
Q Consensus       128 ~~---~~~~lv~e~~~g~  142 (307)
                      +.   +..++|||+++|.
T Consensus       101 ~~~~~g~~~~v~e~l~G~  118 (357)
T 3ats_A          101 TGDVLGTPFFLMDYVEGV  118 (357)
T ss_dssp             SSTTTSSCEEEEECCCCB
T ss_pred             CCCccCCceEEEEecCCC
Confidence            54   4578999999763

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=98.10  E-value=1.8e-05  Score=67.19  Aligned_cols=69  Identities=16%  Similarity=0.060  Sum_probs=43.9

Q ss_pred             EeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCc-cccceeeeecCeEEEEEEc
Q psy9858          60 WRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENV-LGLTDVFGYMSNVSLVFEF  138 (307)
Q Consensus        60 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-~~~~~~~~~~~~~~lv~e~  138 (307)
                      ++.|+.|....+|+.      ..+++|+.......      .....+|..+++.+...++ .+++..  +...-++++||
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~------~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~   88 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE------YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRY   88 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEEC
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccc------eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEee
Confidence            688999999999998      45889987642111      1113468888877743233 455543  34445789999


Q ss_pred             c-CCC
Q psy9858         139 V-DTD  142 (307)
Q Consensus       139 ~-~g~  142 (307)
                      + +|.
T Consensus        89 i~~g~   93 (301)
T 3dxq_A           89 IAGAQ   93 (301)
T ss_dssp             CTTCE
T ss_pred             cCCCc
Confidence            9 764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.05  E-value=1.3e-05  Score=71.32  Aligned_cols=32  Identities=13%  Similarity=0.295  Sum_probs=28.4

Q ss_pred             HCCceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         175 DHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       175 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      ...++|+|+++.||+++.++ +.|+||+.+..-
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            45799999999999998776 999999998764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.04  E-value=6.2e-05  Score=64.15  Aligned_cols=74  Identities=16%  Similarity=0.072  Sum_probs=57.6

Q ss_pred             EEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC---CCCccccceeeeecCeEEEE
Q psy9858          59 QWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH---HENVLGLTDVFGYMSNVSLV  135 (307)
Q Consensus        59 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~ni~~~~~~~~~~~~~~lv  135 (307)
                      -.+.|+.|....+|+...  ++..+++|+....        ....+..|.+.|+.|.   ...+++++.+....+..++|
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~--------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lv  109 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS--------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLL  109 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG--------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEE
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc--------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEE
Confidence            457789999999999873  5678899987631        1345778999888884   36788888888778899999


Q ss_pred             EEccCCC
Q psy9858         136 FEFVDTD  142 (307)
Q Consensus       136 ~e~~~g~  142 (307)
                      ||+++|.
T Consensus       110 me~l~G~  116 (312)
T 3jr1_A          110 LEALNKS  116 (312)
T ss_dssp             EECCCCC
T ss_pred             EEeccCC
Confidence            9999653

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.88  E-value=0.0003  Score=59.09  Aligned_cols=75  Identities=15%  Similarity=0.059  Sum_probs=52.1

Q ss_pred             eeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCC---CCccccceeeeecCeE
Q psy9858          56 VYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH---ENVLGLTDVFGYMSNV  132 (307)
Q Consensus        56 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h---~ni~~~~~~~~~~~~~  132 (307)
                      +..-++.+|.|..+.||+.. ..+|+.|++|+.......     ....|..|.+.|+.|.-   ..+++++.+  +  ..
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~~~-----~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~   85 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVE-LADGTPLFVKALPDDAPA-----LDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DR   85 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEE-ETTSCEEEEEECCTTCCC-----CTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TT
T ss_pred             CeEEEEecCCCCCeEEEEEE-ECCCCEEEEEEeCCCCcc-----hhhHHHHHHHHHHHHHhhCCCCcceEEec--c--Cc
Confidence            34567889999999999998 578999999986543211     12346789999998842   234455543  2  23


Q ss_pred             EEEEEccC
Q psy9858         133 SLVFEFVD  140 (307)
Q Consensus       133 ~lv~e~~~  140 (307)
                      ++|||++.
T Consensus        86 ~lv~e~l~   93 (288)
T 3f7w_A           86 TLAMEWVD   93 (288)
T ss_dssp             EEEEECCC
T ss_pred             eEEEEeec
Confidence            78999984

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.86  E-value=7e-05  Score=63.98  Aligned_cols=140  Identities=13%  Similarity=0.080  Sum_probs=78.1

Q ss_pred             eEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCC--cccccee------eeec
Q psy9858          58 YQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHEN--VLGLTDV------FGYM  129 (307)
Q Consensus        58 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--i~~~~~~------~~~~  129 (307)
                      .-++.|+.|....+|+... .+| .+++|+.....   .    ...+..|+.+++.+...+  +.+++..      ....
T Consensus        25 ~~~~~i~~G~~n~~~~v~~-~~g-~~vlk~~~~~~---~----~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~   95 (322)
T 2ppq_A           25 TSYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRV---E----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELS   95 (322)
T ss_dssp             EEEEEECC---EEEEEEEE-SSC-CEEEEEECC----------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEET
T ss_pred             eEeeccCCCcccceEEEEe-CCc-cEEEEEeCCCC---C----HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEEC
Confidence            3456778888899999874 344 58899886421   1    123556888777774212  3444422      1234


Q ss_pred             CeEEEEEEccCCChH---------------HHHhC--CC--CC----CCHHHHHH---------------HHHHHHHHHH
Q psy9858         130 SNVSLVFEFVDTDLE---------------VIIKD--PT--IV----FTPSNIKA---------------YAIMTLRGLE  171 (307)
Q Consensus       130 ~~~~lv~e~~~g~l~---------------~~~~~--~~--~~----~~~~~~~~---------------i~~~i~~~l~  171 (307)
                      +..+++|++++|...               ..++.  ..  ..    ........               +...+...+.
T Consensus        96 g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~  175 (322)
T 2ppq_A           96 GRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEID  175 (322)
T ss_dssp             TEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHH
T ss_pred             CEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHH
Confidence            678999999976311               00111  00  00    01000000               0011334455


Q ss_pred             HHHH-------CCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         172 YLHD-------HWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       172 ~lH~-------~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                      ++.+       .+++|+|+++.||+++.++.+.|+||+.+..
T Consensus       176 ~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          176 YLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             HHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            5552       3699999999999998776668999998864

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.78  E-value=8.8e-05  Score=66.19  Aligned_cols=72  Identities=14%  Similarity=0.114  Sum_probs=48.0

Q ss_pred             EEeEEeecCceEEEEEEEcC-------CCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCC-ccccceeeeecC
Q psy9858          59 QWRSVHVGRFATVFKARDIE-------TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHEN-VLGLTDVFGYMS  130 (307)
Q Consensus        59 ~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-i~~~~~~~~~~~  130 (307)
                      .++.|+.|....||++....       ++..+++|+....   ..    ...+.+|..+++.+...+ .+++++.+.+  
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~----~~~li~E~~~l~~L~~~g~~P~l~~~~~~--  147 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ET----ESHLVAESVIFTLLSERHLGPKLYGIFSG--  147 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CC----HHHHHHHHHHHHHHHHTTSSSCEEEEETT--
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---Cc----HHHHHHHHHHHHHHHhCCCCCcEEEEeCC--
Confidence            45678888889999998542       2578999987421   11    134557999888885333 3566665542  


Q ss_pred             eEEEEEEccCC
Q psy9858         131 NVSLVFEFVDT  141 (307)
Q Consensus       131 ~~~lv~e~~~g  141 (307)
                        .+|+||++|
T Consensus       148 --g~v~e~l~G  156 (429)
T 1nw1_A          148 --GRLEEYIPS  156 (429)
T ss_dssp             --EEEECCCCE
T ss_pred             --CEEEEEeCC
Confidence              289999965

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.76  E-value=9.7e-05  Score=64.67  Aligned_cols=137  Identities=13%  Similarity=0.060  Sum_probs=79.6

Q ss_pred             EeEEeecCceEEEEEEEcC-------CCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-CCCccccceeeeecCe
Q psy9858          60 WRSVHVGRFATVFKARDIE-------TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-HENVLGLTDVFGYMSN  131 (307)
Q Consensus        60 ~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~  131 (307)
                      ++.|..|-...+|++....       ++..+++|+.-..    .  .......+|.++++.+. +.-..++++.+.+.  
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~----~--~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g--  126 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI----L--QGVDSLVLESVMFAILAERSLGPQLYGVFPEG--  126 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE--
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc----c--chHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc--
Confidence            4567778888899988532       3578999985321    1  11334568999998884 32336666665432  


Q ss_pred             EEEEEEccCCChHH------------------HHhCCC----CCC--CHHHHHHHHHHHHH-------------------
Q psy9858         132 VSLVFEFVDTDLEV------------------IIKDPT----IVF--TPSNIKAYAIMTLR-------------------  168 (307)
Q Consensus       132 ~~lv~e~~~g~l~~------------------~~~~~~----~~~--~~~~~~~i~~~i~~-------------------  168 (307)
                        +||||++|....                  .++...    ...  .+.++..+..++..                   
T Consensus       127 --~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~  204 (379)
T 3feg_A          127 --RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKD  204 (379)
T ss_dssp             --EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHH
T ss_pred             --cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHH
Confidence              999999753111                  011111    111  13445555544322                   


Q ss_pred             HHHHHH----HC----CceeecCCCCcEEEecC----CcEEEEeecCccc
Q psy9858         169 GLEYLH----DH----WILHRDLKPNNLLINKQ----GVLKIGDFGLAKF  206 (307)
Q Consensus       169 ~l~~lH----~~----~ivH~dlkp~Nil~~~~----~~~kl~Dfg~a~~  206 (307)
                      .+..|.    ..    .++|+|+.+.||+++.+    +.+.++||..|..
T Consensus       205 ~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          205 EMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            233332    22    48999999999999876    7899999999864

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.64  E-value=0.00057  Score=58.43  Aligned_cols=137  Identities=13%  Similarity=-0.002  Sum_probs=77.8

Q ss_pred             eEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCC--CCcccccee-----eeecCeEE
Q psy9858          61 RSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH--ENVLGLTDV-----FGYMSNVS  133 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~ni~~~~~~-----~~~~~~~~  133 (307)
                      ..++ |....||+.. ..+|+.+++|+......   .   ...+..|..+++.+..  -.+++++..     ...++..+
T Consensus        32 ~~l~-g~~n~~y~v~-~~~g~~~vlK~~~~~~~---~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~  103 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQ-DEDRRRFVVKFYRPERW---T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYF  103 (328)
T ss_dssp             EEEC-CSSSEEEEEC-CTTCCCEEEEEECTTTS---C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEE
T ss_pred             Eeec-CcccceEEEE-cCCCCEEEEEEcCCCCC---C---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEE
Confidence            4456 7778899876 34566799999864211   1   2345678888877742  224444443     22356678


Q ss_pred             EEEEccCCChHH-----H----------HhC---C-C----CCCCHHHH----------------------HHHHHHHHH
Q psy9858         134 LVFEFVDTDLEV-----I----------IKD---P-T----IVFTPSNI----------------------KAYAIMTLR  168 (307)
Q Consensus       134 lv~e~~~g~l~~-----~----------~~~---~-~----~~~~~~~~----------------------~~i~~~i~~  168 (307)
                      ++|++++|...+     .          ++.   . .    ........                      ...+..++.
T Consensus       104 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  183 (328)
T 1zyl_A          104 AVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIA  183 (328)
T ss_dssp             EEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHH
T ss_pred             EEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHH
Confidence            999999763110     0          110   0 0    01111110                      011111222


Q ss_pred             HHHHH----HHCCceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         169 GLEYL----HDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       169 ~l~~l----H~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      .+..+    ....++|+|+++.||+++ + .+.|+||+.+..-
T Consensus       184 ~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          184 AVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             HHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred             HHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence            22221    123589999999999998 4 8999999988654

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.64  E-value=0.00034  Score=60.00  Aligned_cols=32  Identities=31%  Similarity=0.344  Sum_probs=28.0

Q ss_pred             CCceeecCCCCcEEEecC----CcEEEEeecCcccc
Q psy9858         176 HWILHRDLKPNNLLINKQ----GVLKIGDFGLAKFF  207 (307)
Q Consensus       176 ~~ivH~dlkp~Nil~~~~----~~~kl~Dfg~a~~~  207 (307)
                      ..++|+|+.+.||+++.+    +.+.|+||+.+..-
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            469999999999999874    68999999998764

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.63  E-value=0.00017  Score=62.91  Aligned_cols=73  Identities=11%  Similarity=0.104  Sum_probs=42.5

Q ss_pred             EEeEEeecCceEEEEEEEcC--------CCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCC-ccccceeeeec
Q psy9858          59 QWRSVHVGRFATVFKARDIE--------TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHEN-VLGLTDVFGYM  129 (307)
Q Consensus        59 ~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-i~~~~~~~~~~  129 (307)
                      .++.|+.|....+|+.....        .+..+++|+.....    ..  ......|.++++.+...+ +.++++..  .
T Consensus        37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~----~~--~~~~~~E~~~l~~L~~~g~~P~~~~~~--~  108 (369)
T 3c5i_A           37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV----DE--LYNTISEFEVYKTMSKYKIAPQLLNTF--N  108 (369)
T ss_dssp             EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG----GG--TSCHHHHHHHHHHHHHTTSSCCEEEEE--T
T ss_pred             EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc----cc--eecHHHHHHHHHHHHhcCCCCceEEec--C
Confidence            34667788888999987532        13678899865321    11  112357888888875333 44666543  2


Q ss_pred             CeEEEEEEccCC
Q psy9858         130 SNVSLVFEFVDT  141 (307)
Q Consensus       130 ~~~~lv~e~~~g  141 (307)
                        -++||+|++|
T Consensus       109 --~~~v~e~i~G  118 (369)
T 3c5i_A          109 --GGRIEEWLYG  118 (369)
T ss_dssp             --TEEEEECCCS
T ss_pred             --CcEEEEEecC
Confidence              2689999976

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.61  E-value=0.00081  Score=60.38  Aligned_cols=73  Identities=18%  Similarity=0.213  Sum_probs=46.5

Q ss_pred             EEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCc-cccceeeeecCeEEEEEE
Q psy9858          59 QWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENV-LGLTDVFGYMSNVSLVFE  137 (307)
Q Consensus        59 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-~~~~~~~~~~~~~~lv~e  137 (307)
                      .++.|+.|-...+|++.....+..+++|+.....    ..  .-...+|..+++.+...++ .++++.+.  +  .+|||
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~----~~--~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e  181 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT----DE--IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEE  181 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C----CS--CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEE
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh----hh--hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEE
Confidence            4567888888999999864445789999875321    11  0112479999998864444 56666653  2  25999


Q ss_pred             ccCC
Q psy9858         138 FVDT  141 (307)
Q Consensus       138 ~~~g  141 (307)
                      |++|
T Consensus       182 ~I~G  185 (458)
T 2qg7_A          182 FMDG  185 (458)
T ss_dssp             CCCS
T ss_pred             eeCC
Confidence            9965

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.48  E-value=0.002  Score=55.42  Aligned_cols=32  Identities=19%  Similarity=0.307  Sum_probs=28.3

Q ss_pred             CCceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         176 HWILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       176 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      .+++|+|+.+.||+++.++.+.|+||+.+...
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            36999999999999998888999999888754

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.91  E-value=0.0062  Score=53.99  Aligned_cols=74  Identities=11%  Similarity=0.110  Sum_probs=46.1

Q ss_pred             EEeEEeecCceEEEEEEEcCC-------CcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-CCCccccceeeeecC
Q psy9858          59 QWRSVHVGRFATVFKARDIET-------DMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-HENVLGLTDVFGYMS  130 (307)
Q Consensus        59 ~~~~lg~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~  130 (307)
                      -++.+..|-...+|+......       +..+++++.....    ..  .-...+|.++++.+. +.-..++++.+  . 
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t----~~--~idR~~E~~~l~~L~~~gi~P~l~~~~--~-  144 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV----GK--FYDSKVELDVFRYLSNINIAPNIIADF--P-  144 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----C--CCCHHHHHHHHHHHHHTTSSCCEEEEE--T-
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc----ch--hcCHHHHHHHHHHHHhcCCCCCEEEEc--C-
Confidence            456677788889999885421       5789999864321    10  112347888888874 32245555433  2 


Q ss_pred             eEEEEEEccCCC
Q psy9858         131 NVSLVFEFVDTD  142 (307)
Q Consensus       131 ~~~lv~e~~~g~  142 (307)
                       -++||+|++|.
T Consensus       145 -~~~I~efI~G~  155 (424)
T 3mes_A          145 -EGRIEEFIDGE  155 (424)
T ss_dssp             -TEEEEECCCSE
T ss_pred             -CCEEEEEeCCc
Confidence             26899999763

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=96.09  E-value=0.03  Score=49.24  Aligned_cols=29  Identities=24%  Similarity=0.448  Sum_probs=25.0

Q ss_pred             ceeecCCCCcEEEe------cCCcEEEEeecCccc
Q psy9858         178 ILHRDLKPNNLLIN------KQGVLKIGDFGLAKF  206 (307)
Q Consensus       178 ivH~dlkp~Nil~~------~~~~~kl~Dfg~a~~  206 (307)
                      ++|+|+.+.||++.      .++.+.++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            67999999999993      456799999999864

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=95.12  E-value=0.035  Score=44.10  Aligned_cols=135  Identities=10%  Similarity=-0.092  Sum_probs=78.7

Q ss_pred             ChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcccccceee
Q psy9858         142 DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD-HWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVT  220 (307)
Q Consensus       142 ~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t  220 (307)
                      +|.+.+...+.++++++++.++.|.+.+|.-+-. +.-..+=+.|..|++..+|.|.+.+ ..+.            ...
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~~~  100 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------AGE  100 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc------------ccc
Confidence            5888888888889999999999999999887632 2222344457889999999888765 1111            112


Q ss_pred             ceehhhhhhhcccccccccceeeeeecCCCCCCCCCCCCChhhhccccCHHHHHHHHHhhhcC-----------------
Q psy9858         221 RWYRLIKCLLYCVQFNVKNVQWCCFAKDPSSHGNLFPGIPLNEIFTAAGDDLLAVISSLLCLN-----------------  283 (307)
Q Consensus       221 ~~y~aPE~~~~~~~~~~~~Diw~i~~~~~~f~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d-----------------  283 (307)
                      ..+.+||....  ..+.+.-|+.+  |..+|..-.+.-  .......+|+.|.+||..|....                 
T Consensus       101 ~~~~~pe~~~~--~~te~~~IysL--G~tLY~ALDygL--~e~eE~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~  174 (229)
T 2yle_A          101 PPPVAGKLGYS--QCMETEVIESL--GIIIYKALDYGL--KENEERELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGL  174 (229)
T ss_dssp             ------CCSSS--SSCHHHHHHHH--HHHHHHHHTTTC--CTTEEECCCHHHHHHHHHHTTCCC----------------
T ss_pred             cCCCChhhccc--cchHHHHHHHH--HHHHHHHhhcCC--CcccchhhCHHHHHHHHHHHhccccccccccccccccccc
Confidence            34557776421  22223333300  111111111111  11223468999999999998662                 


Q ss_pred             --------CCCCCCHHHHhc
Q psy9858         284 --------PTKRADCTATLK  295 (307)
Q Consensus       284 --------P~~Rpt~~~il~  295 (307)
                              +..|.|.++|++
T Consensus       175 ~d~~~~~~~~~~~sl~~Vi~  194 (229)
T 2yle_A          175 GDEDEKRKISAIRSYRDVMK  194 (229)
T ss_dssp             ----CCSCCCCCCSHHHHHH
T ss_pred             ccccccccccCcCCHHHHHH
Confidence                    457889998886

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=89.50  E-value=0.018  Score=51.76  Aligned_cols=62  Identities=10%  Similarity=0.070  Sum_probs=16.7

Q ss_pred             EEeEEeecCceEEEEEEEcCCCcEEEE------EEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceee
Q psy9858          59 QWRSVHVGRFATVFKARDIETDMIVAV------KKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVF  126 (307)
Q Consensus        59 ~~~~lg~G~~g~V~~~~~~~~~~~vav------K~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~  126 (307)
                      +.+.||   ||.||+|.......+||+      |......   ........+.+|..+++.++|||+++.+++.
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~---~~~e~~~~~~rea~l~~~~~H~niv~~h~f~  213 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDG---VSEKRLTSLVRRATLKENEQIPKYEKIHNFK  213 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC--------------------------------------CBCCCEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCcccccccc---ccccccccccccccccccccccccCCCcceE
Confidence            345555   999999987655567888      6554321   1112234577899999999999999998865

>1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3

Probab=87.74  E-value=11  Score=31.83  Aligned_cols=140  Identities=14%  Similarity=0.088  Sum_probs=73.3

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCcccccee---------
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV---------  125 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~---------  125 (307)
                      .+.+.++....|..| ||.+..  ++..|+||...        ....+.+-.++...-.+.-|+..-+...         
T Consensus        69 ~~v~~I~~s~~Gstg-vff~~t--d~~~~VVK~s~--------~l~~E~l~s~LA~~LGlpiP~~Riv~~~~~E~~e~~~  137 (342)
T 1cja_A           69 QQFKGIERSEKGTEG-LFFVET--ESGVFIVKRST--------NIESETFCSLLCMRLGLHAPKVRVVSSNSEEGTNMLE  137 (342)
T ss_dssp             GGEEEEEECCSTTSC-EEEEEE--SSCEEEEECCT--------THHHHHHHHHHHHHHTCCCCCEEEEESSSHHHHHHHH
T ss_pred             cCeeEEEeccCCCCC-eEEEEe--CCCEEEEeCcH--------HHHHHHHHHHHHHHhCCCCCCeeEEeeCcHHHHHHHH
Confidence            457788888888766 554443  46789999431        1112223344444444455553221110         


Q ss_pred             -------------eeecCeEEEEEEccCCChHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeecCCC
Q psy9858         126 -------------FGYMSNVSLVFEFVDTDLEVIIKDP--TIVFTPSNIKAYAIMTLRGLEYLHDHW-----ILHRDLKP  185 (307)
Q Consensus       126 -------------~~~~~~~~lv~e~~~g~l~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~-----ivH~dlkp  185 (307)
                                   ....+...++|+|..|..+..+...  ...+.++....+.  -+-+++.+..++     +.+.--.+
T Consensus       138 ~L~~~~~~~~~l~~l~~~~~~l~meyv~G~~L~e~~~~~~~~~f~~~~~k~LG--~Ii~FDi~InN~DR~Pl~W~n~GN~  215 (342)
T 1cja_A          138 CLAAIDKSFRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTKSTMQQLG--SLMALDVIVNNSDRLPIAWTNEGNL  215 (342)
T ss_dssp             HHHHHCSSSCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHHHHHHHH--HHHHHHHHHTCCSSSCSSSCSCCCG
T ss_pred             HHHHhhhhhHHHHHhhcccceehhhhcCCCccccchhhhhhhhcCHHHHHhhc--hhheehhhhcCCccCcccccCCCCh
Confidence                         0112357799999976432222111  0012333322211  123455555442     23334689


Q ss_pred             CcEEEecCCc-EEEEeecCcccc
Q psy9858         186 NNLLINKQGV-LKIGDFGLAKFF  207 (307)
Q Consensus       186 ~Nil~~~~~~-~kl~Dfg~a~~~  207 (307)
                      +||+++.++. +.++|-+.+..-
T Consensus       216 ~NIL~~~~n~~~~~IDhn~af~~  238 (342)
T 1cja_A          216 DNIMLSERGATVVPIDSKIIPLD  238 (342)
T ss_dssp             GGEEEESBTTCEEECSCCCCCCC
T ss_pred             hheEEeCCCCeEEEEcCCccccC
Confidence            9999987555 899999998654

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=84.22  E-value=1.8  Score=34.15  Aligned_cols=86  Identities=16%  Similarity=0.184  Sum_probs=61.4

Q ss_pred             CCCCccccceeeeecCeEEEEEEccC-CChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecC
Q psy9858         115 HHENVLGLTDVFGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ  193 (307)
Q Consensus       115 ~h~ni~~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~  193 (307)
                      .||+.+.. .+-+.++.+.+.++.-. +.-...+..    ++....+.++.+|+....+  ...-+|--|+|+|++++.+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik~----~~~~eKlr~l~ni~~l~~~--~~~r~tf~L~P~NL~f~~~  115 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIKS----FTKNEKLRYLLNIKNLEEV--NRTRYTFVLAPDELFFTRD  115 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGGG----SCHHHHHHHHHHGGGGGGG--GGSSEECCCSGGGEEECTT
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHHh----cCHHHHHHHHHHHHHHHHH--hcCceEEEEecceEEEcCC
Confidence            57888866 45566676666666553 333343443    5677888888888776633  3446788899999999999


Q ss_pred             CcEEEEeecCcccc
Q psy9858         194 GVLKIGDFGLAKFF  207 (307)
Q Consensus       194 ~~~kl~Dfg~a~~~  207 (307)
                      +.+++.-.|+-...
T Consensus       116 ~~p~i~~RGik~~l  129 (215)
T 4ann_A          116 GLPIAKTRGLQNVV  129 (215)
T ss_dssp             SCEEESCCEETTTB
T ss_pred             CCEEEEEccCccCC
Confidence            99999999886544

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=83.95  E-value=3.1  Score=32.93  Aligned_cols=86  Identities=16%  Similarity=0.040  Sum_probs=60.1

Q ss_pred             CCCCccccceeeeecCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecC
Q psy9858         115 HHENVLGLTDVFGYMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ  193 (307)
Q Consensus       115 ~h~ni~~~~~~~~~~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~  193 (307)
                      .||++  -..+-.+++.+.+.++.- .+.-...+..    ++..+.+.++.+|+.... -|...-+|--|.|+|++++.+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~----~~~~eKlrll~nl~~L~~-~~~~~r~tf~l~P~NL~f~~~  120 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK----TTLLSRIRAAIHLVSKVK-HHSARRLIFIVCPENLMFNRA  120 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT----SCHHHHHHHHHHHHHHHS-SCCSSSEECCCCGGGEEECTT
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh----cCHHHHHHHHHHHHHHHH-HhhhCceeEEEeCceEEEeCC
Confidence            57777  333446777777777766 3444444543    567777777777765444 122567888899999999999


Q ss_pred             CcEEEEeecCcccc
Q psy9858         194 GVLKIGDFGLAKFF  207 (307)
Q Consensus       194 ~~~kl~Dfg~a~~~  207 (307)
                      +.+++.-.|+-...
T Consensus       121 ~~p~i~hRGi~~~l  134 (219)
T 4ano_A          121 LEPFFLHVGVKESL  134 (219)
T ss_dssp             CCEEESCCEETTTB
T ss_pred             CcEEEEEcCCcccC
Confidence            99999999986544

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	307
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-52
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-44
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-41
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-40
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-40
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-39
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	5e-39
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-38
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-38
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-38
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-37
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-37
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	5e-37
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-36
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-36
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-35
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-35
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	6e-35
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-34
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-34
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	7e-34
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-33
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-33
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-33
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	9e-33
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-32
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-32
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-32
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	6e-32
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	9e-32
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-31
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-31
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-31
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-31
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-31
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-31
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-30
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-30
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-30
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-30
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-30
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-30
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-29
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-29
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-29
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	8e-29
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-28
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-28
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-28
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-27
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	8e-27
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-26
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-26
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-25
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	7e-25
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-24
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-24
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-24
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-24
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	5e-24
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	5e-23
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-19
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-17

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 2e-52
 Identities = 150/276 (54%), Positives = 179/276 (64%), Gaps = 41/276 (14%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G+FATV+KARD  T+ IVA+KKIKLG  ++AKDGINRTALREIKLLQEL H N++GL D 
Sbjct: 9   GQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDA 68

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
           FG+ SN+SLVF+F++TDLEVIIKD ++V TPS+IKAY +MTL+GLEYLH HWILHRDLKP
Sbjct: 69  FGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKP 128

Query: 186 NNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWC-- 243
           NNLL+++ GVLK+ DFGLAK FGSP R YTHQVVTRWYR  + L     + V    W   
Sbjct: 129 NNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVG 188

Query: 244 -----CFAKDPSSHGN----------------------------------LFPGIPLNEI 264
                   + P   G+                                   FPGIPL+ I
Sbjct: 189 CILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHI 248

Query: 265 FTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
           F+AAGDDLL +I  L   NP  R   T  LKM YFS
Sbjct: 249 FSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 284

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 1e-44
 Identities = 56/256 (21%), Positives = 102/256 (39%), Gaps = 26/256 (10%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V+KA++ ET ++ A K I   +  + +D      + EI +L    H N++ L D 
Sbjct: 23  GAFGKVYKAQNKETSVLAAAKVIDTKSEEELED-----YMVEIDILASCDHPNIVKLLDA 77

Query: 126 FGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           F Y +N+ ++ EF     ++ ++ +     T S I+     TL  L YLHD+ I+HRDLK
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLK 137

Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQ----FNVKNV 240
             N+L    G +K+ DFG++       +     + T ++   + ++        ++ K  
Sbjct: 138 AGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKAD 197

Query: 241 QW--------CCFAKDPSSHGN--------LFPGIPLNEIFTAAGDDLLAVISSLLCLNP 284
            W            + P    N             P     +    +    +   L  N 
Sbjct: 198 VWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNV 257

Query: 285 TKRADCTATLKMDYFS 300
             R   +  L+  + +
Sbjct: 258 DARWTTSQLLQHPFVT 273

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 3e-41
 Identities = 56/253 (22%), Positives = 91/253 (35%), Gaps = 22/253 (8%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A +  T+  VAVK + +    D          +EI + + L+HENV+     
Sbjct: 16  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP----ENIKKEICINKMLNHENVVKFYGH 71

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
               +   L  E+          +P I     + + +    + G+ YLH   I HRD+KP
Sbjct: 72  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 131

Query: 186 NNLLINKQGVLKIGDFGLAKFF--GSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKN---- 239
            NLL++++  LKI DFGLA  F   +  RL      T  Y   + L              
Sbjct: 132 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 191

Query: 240 ---VQWCCFAKDPSSHG---------NLFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKR 287
              V     A +              +          +       LA++  +L  NP+ R
Sbjct: 192 CGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSAR 251

Query: 288 ADCTATLKMDYFS 300
                  K  +++
Sbjct: 252 ITIPDIKKDRWYN 264

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 2e-40
 Identities = 55/249 (22%), Positives = 94/249 (37%), Gaps = 20/249 (8%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G+F  V+ AR+ ++  I+A+K +          G+     RE+++   L H N+L L   
Sbjct: 17  GKFGNVYLAREKQSKFILALKVLFKAQLEK--AGVEHQLRREVEIQSHLRHPNILRLYGY 74

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
           F   + V L+ E+               F       Y       L Y H   ++HRD+KP
Sbjct: 75  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 134

Query: 186 NNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYR---LIKCLLYCVQFNVKNVQW 242
            NLL+   G LKI DFG +    +P+   T    T  Y    +I+  ++  + ++     
Sbjct: 135 ENLLLGSAGELKIADFGWSVH--APSSRRTTLCGTLDYLPPEMIEGRMHDEKVDL--WSL 190

Query: 243 CCFAKDPSSHGNLFPGIPLNEIFTAAG-----------DDLLAVISSLLCLNPTKRADCT 291
                +       F      E +               +    +IS LL  NP++R    
Sbjct: 191 GVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLR 250

Query: 292 ATLKMDYFS 300
             L+  + +
Sbjct: 251 EVLEHPWIT 259

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  140 bits (353), Expect = 4e-40
 Identities = 53/251 (21%), Positives = 94/251 (37%), Gaps = 23/251 (9%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V+ ARD+    +VA+KK+        +    +  ++E++ LQ+L H N +     
Sbjct: 26  GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK--WQDIIKEVRFLQKLRHPNTIQYRGC 83

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
           +       LV E+       +++          I A     L+GL YLH H ++HRD+K 
Sbjct: 84  YLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKA 143

Query: 186 NNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCV--QFNVKNVQWC 243
            N+L+++ G++K+GDFG A             V T ++   + +L     Q++ K   W 
Sbjct: 144 GNILLSEPGLVKLGDFGSASIMAPANSF----VGTPYWMAPEVILAMDEGQYDGKVDVWS 199

Query: 244 --CFAKDPSSHGNLFPGIPLNEIFTAAG-------------DDLLAVISSLLCLNPTKRA 288
                 + +        +                       +     + S L   P  R 
Sbjct: 200 LGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRP 259

Query: 289 DCTATLKMDYF 299
                LK  + 
Sbjct: 260 TSEVLLKHRFV 270

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 5e-39
 Identities = 48/257 (18%), Positives = 98/257 (38%), Gaps = 25/257 (9%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G   TV+ A D+ T   VA++++ L      +       + EI +++E  + N++   D 
Sbjct: 31  GASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-----IINEILVMRENKNPNIVNYLDS 85

Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           +     + +V E++    L  ++ +         I A     L+ LE+LH + ++HRD+K
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143

Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-- 242
            +N+L+   G +K+ DFG            +  V T ++   + +     +  K   W  
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSL 202

Query: 243 ------CCFAKDPSSHGN--------LFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRA 288
                     + P  + N           G P  +            ++  L ++  KR 
Sbjct: 203 GIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRG 262

Query: 289 DCTATLKMDYFSLTKEM 305
                L+  +  + K +
Sbjct: 263 SAKELLQHQFLKIAKPL 279

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  138 bits (348), Expect = 5e-39
 Identities = 46/253 (18%), Positives = 90/253 (35%), Gaps = 23/253 (9%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V +  +  T    A K +     +D +     T  +EI+ +  L H  ++ L D 
Sbjct: 37  GAFGVVHRVTERATGNNFAAKFVMTPHESDKE-----TVRKEIQTMSVLRHPTLVNLHDA 91

Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           F   + + +++EF+   +L   + D     +      Y     +GL ++H++  +H DLK
Sbjct: 92  FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLK 151

Query: 185 PNNLLINKQ--GVLKIGDFGLAKFFGSPTRLYTHQVVTRWYR--LIKCLLYCVQFNVKNV 240
           P N++   +    LK+ DFGL         +        +    + +        ++ +V
Sbjct: 152 PENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSV 211

Query: 241 QWCCFA----KDPSSHGNLF---------PGIPLNEIFTAAGDDLLAVISSLLCLNPTKR 287
               +       P    N                +  F+   +D    I  LL  +P  R
Sbjct: 212 GVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTR 271

Query: 288 ADCTATLKMDYFS 300
                 L+  + +
Sbjct: 272 MTIHQALEHPWLT 284

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  137 bits (347), Expect = 1e-38
 Identities = 51/253 (20%), Positives = 92/253 (36%), Gaps = 25/253 (9%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V +  +  T  +   K I      D       T   EI ++ +LHH  ++ L D 
Sbjct: 40  GAFGVVHRCVEKATGRVFVAKFINTPYPLDKY-----TVKNEISIMNQLHHPKLINLHDA 94

Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           F     + L+ EF+   +L   I       + + +  Y      GL+++H+H I+H D+K
Sbjct: 95  FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIK 154

Query: 185 PNNLLI--NKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYR---LIKCLLYCVQFNVKN 239
           P N++    K   +KI DFGLA    +P  +      T  +    ++         ++  
Sbjct: 155 PENIMCETKKASSVKIIDFGLATKL-NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWA 213

Query: 240 VQ----WCCFAKDPSSHGNLF---------PGIPLNEIFTAAGDDLLAVISSLLCLNPTK 286
           +            P +  +                 + F++   +    I +LL   P K
Sbjct: 214 IGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRK 273

Query: 287 RADCTATLKMDYF 299
           R      L+  + 
Sbjct: 274 RLTVHDALEHPWL 286

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 3e-38
 Identities = 91/278 (32%), Positives = 133/278 (47%), Gaps = 46/278 (16%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KAR+  T  +VA+KKI+L T     +G+  TA+REI LL+EL+H N++ L DV
Sbjct: 13  GTYGVVYKARNKLTGEVVALKKIRLDTE---TEGVPSTAIREISLLKELNHPNIVKLLDV 69

Query: 126 FGYMSNVSLVFEFVDTDL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
               + + LVFEF+  DL + +            IK+Y    L+GL + H H +LHRDLK
Sbjct: 70  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 129

Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWCC 244
           P NLLIN +G +K+ DFGLA+ FG P R YTH+VVT WYR  + LL C  ++     W  
Sbjct: 130 PQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSL 189

Query: 245 FA------------------------------------KDPSSHGNLFPGIP------LN 262
                                                    +S  +  P  P       +
Sbjct: 190 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFS 249

Query: 263 EIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
           ++     +D  +++S +L  +P KR    A L   +F 
Sbjct: 250 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 4e-38
 Identities = 45/161 (27%), Positives = 79/161 (49%), Gaps = 9/161 (5%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G    VFK     + +++A K I L    + K  I    +RE+++L E +   ++G    
Sbjct: 17  GNGGVVFKVSHKPSGLVMARKLIHL----EIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72

Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD-HWILHRDL 183
           F     +S+  E +D   L+ ++K          +   +I  ++GL YL + H I+HRD+
Sbjct: 73  FYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREKHKIMHRDV 131

Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYR 224
           KP+N+L+N +G +K+ DFG++        +    V TR Y 
Sbjct: 132 KPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFVGTRSYM 170

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 3e-37
 Identities = 76/286 (26%), Positives = 110/286 (38%), Gaps = 58/286 (20%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A D    + VA+KKI             +  LREIK+L    HEN++G+ D+
Sbjct: 19  GAYGMVCSAYDNVNKVRVAIKKISP----FEHQTYCQRTLREIKILLRFRHENIIGINDI 74

Query: 126 F-----GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
                   M +V LV   +  DL  ++K      +  +I  +    LRGL+Y+H   +LH
Sbjct: 75  IRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSANVLH 132

Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPT---RLYTHQVVTRWYR------------- 224
           RDLKP+NLL+N    LKI DFGLA+            T  V TRWYR             
Sbjct: 133 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 192

Query: 225 -----LIKCLLYC----------------------VQFNVKNVQWCCFAKDPSSHGNL-- 255
                 + C+L                        +  +       C     + +  L  
Sbjct: 193 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL 252

Query: 256 --FPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF 299
                +P N +F  A    L ++  +L  NP KR +    L   Y 
Sbjct: 253 PHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 298

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 4e-37
 Identities = 45/261 (17%), Positives = 83/261 (31%), Gaps = 42/261 (16%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V +  +  +      K +K+      K        +EI +L    H N+L L + 
Sbjct: 16  GEFGIVHRCVETSSKKTYMAKFVKV------KGTDQVLVKKEISILNIARHRNILHLHES 69

Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           F  M  + ++FEF+   D+   I           I +Y       L++LH H I H D++
Sbjct: 70  FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIR 129

Query: 185 PNNLLI--NKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIK--------------- 227
           P N++    +   +KI +FG A+                +Y                   
Sbjct: 130 PENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSL 189

Query: 228 -CLLYCVQF--------NVKNVQWCCFAKDPSSHGNLFPGIPLNEIFTAAGDDLLAVISS 278
             L+Y +            + +       + +     F  I           + +  +  
Sbjct: 190 GTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS---------IEAMDFVDR 240

Query: 279 LLCLNPTKRADCTATLKMDYF 299
           LL      R   +  L+  + 
Sbjct: 241 LLVKERKSRMTASEALQHPWL 261

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 5e-37
 Identities = 86/278 (30%), Positives = 124/278 (44%), Gaps = 46/278 (16%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G + TVFKA++ ET  IVA+K+++L    D  +G+  +ALREI LL+EL H+N++ L DV
Sbjct: 13  GTYGTVFKAKNRETHEIVALKRVRL---DDDDEGVPSSALREICLLKELKHKNIVRLHDV 69

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
                 ++LVFEF D DL+           P  +K++    L+GL + H   +LHRDLKP
Sbjct: 70  LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKP 129

Query: 186 NNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWCCF 245
            NLLIN+ G LK+ +FGLA+ FG P R Y+ +VVT WYR    L     ++     W   
Sbjct: 130 QNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAG 189

Query: 246 A-------------------------------------------KDPSSHGNLFPGIPLN 262
                                                        D   +        L 
Sbjct: 190 CIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLV 249

Query: 263 EIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
            +          ++ +LL  NP +R      L+  YFS
Sbjct: 250 NVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (324), Expect = 4e-36
 Identities = 52/254 (20%), Positives = 92/254 (36%), Gaps = 27/254 (10%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +    K R      I+  K++    +    +   +  + E+ LL+EL H N++   D 
Sbjct: 15  GSYGRCQKIRRKSDGKILVWKELD---YGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 71

Query: 126 FGYMSN--VSLVFEFVD-TDLEVIIKDPTI---VFTPSNIKAYAIMTLRGLEYLHD---- 175
               +N  + +V E+ +  DL  +I   T          +          L+  H     
Sbjct: 72  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 131

Query: 176 -HWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLY--- 231
            H +LHRDLKP N+ ++ +  +K+GDFGLA+     T      V T +Y   + +     
Sbjct: 132 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSY 191

Query: 232 ----------CVQFNVKNVQWCCFAKDPSSHGNLFPGIPLNEIFTAAGDDLLAVISSLLC 281
                     C+ + +  +     A                 I     D+L  +I+ +L 
Sbjct: 192 NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLN 251

Query: 282 LNPTKRADCTATLK 295
           L    R      L+
Sbjct: 252 LKDYHRPSVEEILE 265

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (326), Expect = 4e-36
 Identities = 93/292 (31%), Positives = 133/292 (45%), Gaps = 60/292 (20%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  VFKAR  +T   VA+KK+ +    + K+G   TALREIK+LQ L HENV+ L ++
Sbjct: 21  GTFGEVFKARHRKTGQKVALKKVLM---ENEKEGFPITALREIKILQLLKHENVVNLIEI 77

Query: 126 F--------GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHW 177
                        ++ LVF+F + DL  ++ +  + FT S IK    M L GL Y+H + 
Sbjct: 78  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK 137

Query: 178 ILHRDLKPNNLLINKQGVLKIGDFGLAKFFG----SPTRLYTHQVVTRWYRLIKCLLYCV 233
           ILHRD+K  N+LI + GVLK+ DFGLA+ F     S    YT++VVT WYR  + LL   
Sbjct: 138 ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGER 197

Query: 234 QFNVKNVQWC-------CFAKDPSSHGN-------------------LFPGIPLNEIFT- 266
            +      W         + + P   GN                   ++P +   E++  
Sbjct: 198 DYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEK 257

Query: 267 ------------------AAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                                   L +I  LL L+P +R D    L  D+F 
Sbjct: 258 LELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 309

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  129 bits (326), Expect = 1e-35
 Identities = 46/243 (18%), Positives = 102/243 (41%), Gaps = 21/243 (8%)

Query: 66  GRFATVFKARDIETDMIVAVKKI-KLGTHADAKDGINRTALREIKLLQELHHENVLGLTD 124
           G F  V+  R  +T  + A+K + K        + +       + L+       ++ ++ 
Sbjct: 15  GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY 74

Query: 125 VFGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
            F     +S + + ++  DL   +    + F+ ++++ YA   + GLE++H+ ++++RDL
Sbjct: 75  AFHTPDKLSFILDLMNGGDLHYHLSQHGV-FSEADMRFYAAEIILGLEHMHNRFVVYRDL 133

Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW- 242
           KP N+L+++ G ++I D GLA  F       +    T  Y   + L   V ++     + 
Sbjct: 134 KPANILLDEHGHVRISDLGLACDFSKKKPHASVG--THGYMAPEVLQKGVAYDSSADWFS 191

Query: 243 ------------CCFAKDPSSHGNLFPGIPLN---EIFTAAGDDLLAVISSLLCLNPTKR 287
                         F +  +   +    + L    E+  +   +L +++  LL  +  +R
Sbjct: 192 LGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRR 251

Query: 288 ADC 290
             C
Sbjct: 252 LGC 254

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  127 bits (320), Expect = 1e-35
 Identities = 80/276 (28%), Positives = 123/276 (44%), Gaps = 46/276 (16%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V+KA++       A+KKI+L       +GI  T +REI +L+EL H N++ L DV
Sbjct: 13  GTYGVVYKAQN-NYGETFALKKIRL---EKEDEGIPSTTIREISILKELKHSNIVKLYDV 68

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
                 + LVFE +D DL+ ++            K++ +  L G+ Y HD  +LHRDLKP
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKP 128

Query: 186 NNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWCC- 244
            NLLIN++G LKI DFGLA+ FG P R YTH++VT WYR    L+   +++     W   
Sbjct: 129 QNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVG 188

Query: 245 -----------------------------------------FAKDPSSHGNLFPGIPLNE 263
                                                           +  ++  +P   
Sbjct: 189 CIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWES 248

Query: 264 IFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF 299
                 +  + ++S +L L+P +R      L+  YF
Sbjct: 249 FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  126 bits (318), Expect = 6e-35
 Identities = 60/264 (22%), Positives = 97/264 (36%), Gaps = 44/264 (16%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F+ V  A D  T  +VA+K I       A +G   +   EI +L ++ H N++ L D+
Sbjct: 20  GAFSEVILAEDKRTQKLVAIKCIAK----KALEGKEGSMENEIAVLHKIKHPNIVALDDI 75

Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           +    ++ L+ + V   +L   I +    +T  +        L  ++YLHD  I+HRDLK
Sbjct: 76  YESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDLGIVHRDLK 134

Query: 185 PNNLLI---NKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYR----------------- 224
           P NLL    ++   + I DFGL+K    P  + +    T  Y                  
Sbjct: 135 PENLLYYSLDEDSKIMISDFGLSKME-DPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCW 193

Query: 225 -----LIKCLLYCVQF---NVKNVQWCCFAKDPSSHGNLFPGIPLNEIFTAAGDDLLAVI 276
                    L     F   N   +       +       +  I          D     I
Sbjct: 194 SIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDIS---------DSAKDFI 244

Query: 277 SSLLCLNPTKRADCTATLKMDYFS 300
             L+  +P KR  C   L+  + +
Sbjct: 245 RHLMEKDPEKRFTCEQALQHPWIA 268

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 4e-34
 Identities = 58/255 (22%), Positives = 98/255 (38%), Gaps = 22/255 (8%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL-REIKLLQELHHENVLGLTD 124
           G+FA V K R+  T +  A K IK      ++ G++R  + RE+ +L+E+ H NV+ L +
Sbjct: 21  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 80

Query: 125 VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           V+   ++V L+ E V               T      +    L G+ YLH   I H DLK
Sbjct: 81  VYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLK 140

Query: 185 PNNLLINKQGV----LKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLY--------- 231
           P N+++  + V    +KI DFGLA         + +   T  +   + + Y         
Sbjct: 141 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNYEPLGLEADM 199

Query: 232 ----CVQFNVKNVQWCCFAKDPSSHGNLF---PGIPLNEIFTAAGDDLLAVISSLLCLNP 284
                + + + +                         +E F+         I  LL  +P
Sbjct: 200 WSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDP 259

Query: 285 TKRADCTATLKMDYF 299
            KR     +L+  + 
Sbjct: 260 KKRMTIQDSLQHPWI 274

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  123 bits (310), Expect = 5e-34
 Identities = 45/248 (18%), Positives = 95/248 (38%), Gaps = 23/248 (9%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G++  V++    +  + VAVK +K  T            L+E  +++E+ H N++ L  V
Sbjct: 28  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEV------EEFLKEAAVMKEIKHPNLVQLLGV 81

Query: 126 FGYMSNVSLVFEFVD--TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
                   ++ EF+     L+ + +      +   +   A      +EYL     +HRDL
Sbjct: 82  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 141

Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW- 242
              N L+ +  ++K+ DFGL++     T                  L   +F++K+  W 
Sbjct: 142 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 201

Query: 243 --CCFAKDPSSHGNLFPGIPLNEIFTAAG------------DDLLAVISSLLCLNPTKRA 288
                 +  +   + +PGI L++++                + +  ++ +    NP+ R 
Sbjct: 202 FGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 261

Query: 289 DCTATLKM 296
                 + 
Sbjct: 262 SFAEIHQA 269

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 7e-34
 Identities = 54/239 (22%), Positives = 85/239 (35%), Gaps = 16/239 (6%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F+TV  AR++ T    A+K ++       K+       RE  ++  L H   + L   
Sbjct: 19  GSFSTVVLARELATSREYAIKILEK--RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT 76

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
           F     +     +      +        F  +  + Y    +  LEYLH   I+HRDLKP
Sbjct: 77  FQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKP 136

Query: 186 NNLLINKQGVLKIGDFGLAKFFGSPTRLY-THQVVTRWYRLIKCLLYCVQFNVKNVQW-- 242
            N+L+N+   ++I DFG AK     ++    +  V     +   LL        +  W  
Sbjct: 137 ENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWAL 196

Query: 243 CCFAKDPSSHGNLFPGIPLNEIFTA-----------AGDDLLAVISSLLCLNPTKRADC 290
            C      +    F       IF                    ++  LL L+ TKR  C
Sbjct: 197 GCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGC 255

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 1e-33
 Identities = 75/285 (26%), Positives = 109/285 (38%), Gaps = 58/285 (20%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G +  V  A D  T   VA+KK+         +   + A RE++LL+ + HENV+GL DV
Sbjct: 29  GAYGAVCSAVDGRTGAKVAIKKLYR---PFQSELFAKRAYRELRLLKHMRHENVIGLLDV 85

Query: 126 F------GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWIL 179
           F         ++  LV  F+ TDL  ++K          I+      L+GL Y+H   I+
Sbjct: 86  FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK--LGEDRIQFLVYQMLKGLRYIHAAGII 143

Query: 180 HRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRL-------------- 225
           HRDLKP NL +N+   LKI DFGLA+   S     T  VVTRWYR               
Sbjct: 144 HRDLKPGNLAVNEDCELKILDFGLARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTV 200

Query: 226 ----IKCLLYC---------------VQFNVKNVQWCCFAKDPSSHGNL----------- 255
               + C++                     +  V     A+      +            
Sbjct: 201 DIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPE 260

Query: 256 FPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
                   I T A    + ++  +L L+  +R      L   YF 
Sbjct: 261 LEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 305

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 1e-33
 Identities = 48/257 (18%), Positives = 96/257 (37%), Gaps = 27/257 (10%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G+F  V+          VAVK +K G+ +          L E  L+++L H+ ++ L  V
Sbjct: 24  GQFGEVWMGYY-NGHTKVAVKSLKQGSMSP------DAFLAEANLMKQLQHQRLVRLYAV 76

Query: 126 FGYMSNVSLVFEFVDTDL--EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
                 + ++ E+++     + +     I  T + +   A     G+ ++ +   +HRDL
Sbjct: 77  V-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 135

Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW- 242
           +  N+L++     KI DFGLA+                        +    F +K+  W 
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195

Query: 243 -CCFAKDPSSHGNL-FPGIPLNEIFTAAG------------DDLLAVISSLLCLNPTKRA 288
                 +  +HG + +PG+   E+                 ++L  ++       P  R 
Sbjct: 196 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRP 255

Query: 289 DCTATLKM--DYFSLTK 303
                  +  D+F+ T+
Sbjct: 256 TFDYLRSVLEDFFTATE 272

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  121 bits (305), Expect = 2e-33
 Identities = 54/265 (20%), Positives = 95/265 (35%), Gaps = 36/265 (13%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKL----GTHADAKDGINRTALREIKLLQELH-HENVL 120
           G  + V +     T    AVK I +       A+    +    L+E+ +L+++  H N++
Sbjct: 14  GVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII 73

Query: 121 GLTDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWIL 179
            L D +   +   LVF+ +   +L   + +     +    +      L  +  LH   I+
Sbjct: 74  QLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLEVICALHKLNIV 132

Query: 180 HRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKN 239
           HRDLKP N+L++    +K+ DFG +     P         T  Y   + +   +  N   
Sbjct: 133 HRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLREVCGTPSYLAPEIIECSMNDNHPG 191

Query: 240 ------------VQWCCFAKDPS-------------SHGNLFPGIPLNEIFTAAGDDLLA 274
                       + +   A  P                GN   G P  + ++    DL  
Sbjct: 192 YGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDL-- 249

Query: 275 VISSLLCLNPTKRADCTATLKMDYF 299
            +S  L + P KR      L   +F
Sbjct: 250 -VSRFLVVQPQKRYTAEEALAHPFF 273

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 9e-33
 Identities = 52/263 (19%), Positives = 97/263 (36%), Gaps = 28/263 (10%)

Query: 66  GRFATVFKARDIETD--MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLT 123
           G F +V +         + VA+K +K GT            +RE +++ +L +  ++ L 
Sbjct: 20  GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT----EEMMREAQIMHQLDNPYIVRLI 75

Query: 124 DVFGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
            V      + LV E      L   +         SN+         G++YL +   +HRD
Sbjct: 76  GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRD 134

Query: 183 LKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRW--YRLIKCLLYCVQFNVKNV 240
           L   N+L+  +   KI DFGL+K  G+    YT +   +W         +   +F+ ++ 
Sbjct: 135 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSD 194

Query: 241 QWCCFA--KDPSSHGNL-FPGIPLNEIFTA------------AGDDLLAVISSLLCLNPT 285
            W       +  S+G   +  +   E+                  +L A++S        
Sbjct: 195 VWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWE 254

Query: 286 KR---ADCTATLKMDYFSLTKEM 305
            R         ++  Y+SL  ++
Sbjct: 255 DRPDFLTVEQRMRACYYSLASKV 277

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (298), Expect = 3e-32
 Identities = 49/255 (19%), Positives = 100/255 (39%), Gaps = 31/255 (12%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F TV+K +       VAVK + +   A     +      E+ +L++  H N+L     
Sbjct: 19  GSFGTVYKGKWHGD---VAVKMLNV--TAPTPQQLQAF-KNEVGVLRKTRHVNILLFMG- 71

Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           +     +++V ++ + + L   +      F    +   A  T +G++YLH   I+HRDLK
Sbjct: 72  YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 131

Query: 185 PNNLLINKQGVLKIGDFGLAKFF--GSPTRLYTHQVVTRWYRLIKCLLY--CVQFNVKNV 240
            NN+ +++   +KIGDFGLA      S +  +     +  +   + +       ++ ++ 
Sbjct: 132 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 191

Query: 241 QW--------CCFAKDPSSHGNLFPGI-----------PLNEIFTAAGDDLLAVISSLLC 281
            +            + P S+ N    I            L+++ +     +  +++  L 
Sbjct: 192 VYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLK 251

Query: 282 LNPTKRADCTATLKM 296
               +R      L  
Sbjct: 252 KKRDERPLFPQILAS 266

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 4e-32
 Identities = 57/244 (23%), Positives = 94/244 (38%), Gaps = 17/244 (6%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  VF A   +T+   A+K +K        D +  T + +  L     H  +  +   
Sbjct: 13  GSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCT 71

Query: 126 FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
           F    N+  V E+++  DL   I+     F  S    YA   + GL++LH   I++RDLK
Sbjct: 72  FQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKGIVYRDLK 130

Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-- 242
            +N+L++K G +KI DFG+ K              T  Y   + LL   ++N     W  
Sbjct: 131 LDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSF 189

Query: 243 CCFAKDPSSHGNLFPGIPLNEIFTAAG-----------DDLLAVISSLLCLNPTKRADCT 291
                +     + F G    E+F +              +   ++  L    P KR    
Sbjct: 190 GVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVR 249

Query: 292 ATLK 295
             ++
Sbjct: 250 GDIR 253

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  119 bits (298), Expect = 4e-32
 Identities = 51/258 (19%), Positives = 89/258 (34%), Gaps = 35/258 (13%)

Query: 66  GRFATVFKARDIETD---MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL 122
           G F  V            + VA+K +K G     +    R  L E  ++ +  H NV+ L
Sbjct: 37  GEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR----RDFLSEASIMGQFDHPNVIHL 92

Query: 123 TDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
             V    + V ++ EF++   L+  ++     FT   +         G++YL D   +HR
Sbjct: 93  EGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHR 152

Query: 182 DLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQ 241
           DL   N+L+N   V K+ DFGL++F    T   T+         I+             +
Sbjct: 153 DLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY----R 208

Query: 242 WCCFAKDPSSHGNL-----------FPGIPLNEIFTAAGDD------------LLAVISS 278
               A D  S+G +           +  +   ++  A   D            L  ++  
Sbjct: 209 KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLD 268

Query: 279 LLCLNPTKRADCTATLKM 296
               +   R      +  
Sbjct: 269 CWQKDRNHRPKFGQIVNT 286

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 6e-32
 Identities = 75/283 (26%), Positives = 115/283 (40%), Gaps = 53/283 (18%)

Query: 66  GRFATVFKARDIETD-MIVAVKKIKLGTHADAKDGINRTALREIKLLQEL---HHENVLG 121
           G +  VFKARD++     VA+K++++      ++G+  + +RE+ +L+ L    H NV+ 
Sbjct: 18  GAYGKVFKARDLKNGGRFVALKRVRV---QTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74

Query: 122 LTDVF-----GYMSNVSLVFEFVDTD-LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD 175
           L DV         + ++LVFE VD D    + K P        IK      LRGL++LH 
Sbjct: 75  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 134

Query: 176 HWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIK-------- 227
           H ++HRDLKP N+L+   G +K+ DFGLA+ +       T  VVT WYR  +        
Sbjct: 135 HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSVVVTLWYRAPEVLLQSSYA 193

Query: 228 ---------CLLYC----------------------VQFNVKNVQWCCFAKDPSSHGNLF 256
                    C+                         V        W      P    +  
Sbjct: 194 TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSK 253

Query: 257 PGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF 299
              P+ +  T   +    ++   L  NP KR    + L   YF
Sbjct: 254 SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 9e-32
 Identities = 54/236 (22%), Positives = 87/236 (36%), Gaps = 18/236 (7%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V   R+  T    A+K ++      AKD +  T + E ++LQ   H  +  L   
Sbjct: 16  GTFGKVILVREKATGRYYAMKILRKE-VIIAKDEVAHT-VTESRVLQNTRHPFLTALKYA 73

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
           F     +  V E+ +            VFT    + Y    +  LEYLH   +++RD+K 
Sbjct: 74  FQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKL 133

Query: 186 NNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW--- 242
            NL+++K G +KI DFGL K   S          T  Y L   +L    +      W   
Sbjct: 134 ENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEY-LAPEVLEDNDYGRAVDWWGLG 192

Query: 243 CCFAKDPSSHGNLFPGIPLNEIFTAA-----------GDDLLAVISSLLCLNPTKR 287
               +        F       +F                +  ++++ LL  +P +R
Sbjct: 193 VVMYEMMCGR-LPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 247

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 2e-31
 Identities = 52/247 (21%), Positives = 90/247 (36%), Gaps = 16/247 (6%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRT-ALREIKLLQELH--HENVLGL 122
           G F +V+    +  ++ VA+K ++    +D  +  N T    E+ LL+++      V+ L
Sbjct: 15  GGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 74

Query: 123 TDVFGYMSNVSLVFEFVD--TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
            D F    +  L+ E  +   DL   I +          +++    L  + + H+  +LH
Sbjct: 75  LDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNCGVLH 133

Query: 181 RDLKPNNLLIN-KQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKN 239
           RD+K  N+LI+  +G LK+ DFG          +YT    TR Y   + + Y        
Sbjct: 134 RDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIRYHRYHGRSA 191

Query: 240 VQWCCFAKDPSSHGNLFPGIPLNEIFTA-------AGDDLLAVISSLLCLNPTKRADCTA 292
             W              P     EI             +   +I   L L P+ R     
Sbjct: 192 AVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEE 251

Query: 293 TLKMDYF 299
                + 
Sbjct: 252 IQNHPWM 258

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 2e-31
 Identities = 58/286 (20%), Positives = 102/286 (35%), Gaps = 60/286 (20%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V++A+  ++  +VA+KK+             R   RE++++++L H N++ L   
Sbjct: 31  GSFGVVYQAKLCDSGELVAIKKVLQD---------KRFKNRELQIMRKLDHCNIVRLRYF 81

Query: 126 F------GYMSNVSLVFEFVDTDLEVIIKD---PTIVFTPSNIKAYAIMTLRGLEYLHDH 176
           F           ++LV ++V   +  + +             +K Y     R L Y+H  
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141

Query: 177 WILHRDLKPNNLLINKQG-VLKIGDFGLAKFFGSPTRLYTHQVVTRWYR----------- 224
            I HRD+KP NLL++    VLK+ DFG AK         ++     +             
Sbjct: 142 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYT 201

Query: 225 ------LIKCLLYC--------------------VQFNVKNVQWCCFAKDPSSHGNLFPG 258
                    C+L                      ++      +      +P+     FP 
Sbjct: 202 SSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 261

Query: 259 I---PLNEIFTA-AGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
           I   P  ++F      + +A+ S LL   PT R          +F 
Sbjct: 262 IKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 307

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 2e-31
 Identities = 51/257 (19%), Positives = 93/257 (36%), Gaps = 30/257 (11%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F TV+K  D ET + VA  +++            +    E ++L+ L H N++   D 
Sbjct: 20  GSFKTVYKGLDTETTVEVAWCELQ---DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76

Query: 126 FGYMS----NVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDH--WIL 179
           +         + LV E + +           V     ++++    L+GL++LH     I+
Sbjct: 77  WESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPII 136

Query: 180 HRDLKPNNLLIN-KQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYR---LIK-------- 227
           HRDLK +N+ I    G +KIGD GLA             + T  +    + +        
Sbjct: 137 HRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKAVIGTPEFMAPEMYEEKYDESVD 194

Query: 228 -----CLLYCVQFNVKNVQWCCFAKDPSSHGNLFPGIPLNEIFTAAGDDLLAVISSLLCL 282
                  +  +  +      C  A     +  +  G+        A  ++  +I   +  
Sbjct: 195 VYAFGMCMLEMATSEYPYSECQNAAQ--IYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQ 252

Query: 283 NPTKRADCTATLKMDYF 299
           N  +R      L   +F
Sbjct: 253 NKDERYSIKDLLNHAFF 269

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (290), Expect = 2e-31
 Identities = 46/247 (18%), Positives = 95/247 (38%), Gaps = 23/247 (9%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G+F  V     +  D  VA+K I+ G  ++         + E +++ +L H  ++ L  V
Sbjct: 16  GQFGLVHLGYWLNKD-KVAIKTIREGAMSE------EDFIEEAEVMMKLSHPKLVQLYGV 68

Query: 126 FGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
               + + LVFEF++   L   ++    +F    +    +    G+ YL +  ++HRDL 
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA 128

Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWC- 243
             N L+ +  V+K+ DFG+ +F        +             +    +++ K+  W  
Sbjct: 129 ARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSF 188

Query: 244 ------CFAKDPSSHGNLFPGIPLNEIFTA--------AGDDLLAVISSLLCLNPTKRAD 289
                  F++    + N      + +I T         A   +  +++      P  R  
Sbjct: 189 GVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPA 248

Query: 290 CTATLKM 296
            +  L+ 
Sbjct: 249 FSRLLRQ 255

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  116 bits (292), Expect = 4e-31
 Identities = 46/235 (19%), Positives = 85/235 (36%), Gaps = 19/235 (8%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V   R        A+K +K       K         E  +L  + H  ++ +   
Sbjct: 15  GSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ--VEHTNDERLMLSIVTHPFIIRMWGT 72

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
           F     + ++ ++++      +   +  F     K YA      LEYLH   I++RDLKP
Sbjct: 73  FQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKP 132

Query: 186 NNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWC-- 243
            N+L++K G +KI DFG AK+    T             +   ++    +N     W   
Sbjct: 133 ENILLDKNGHIKITDFGFAKYVPDVTYTLCGTP----DYIAPEVVSTKPYNKSIDWWSFG 188

Query: 244 CFAKDPSSHGNLFPGIPLNEIFTA-----------AGDDLLAVISSLLCLNPTKR 287
               +  +    F      + +               +D+  ++S L+  + ++R
Sbjct: 189 ILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQR 243

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 4e-31
 Identities = 50/260 (19%), Positives = 93/260 (35%), Gaps = 27/260 (10%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V+      T   VA+K +K GT +          L+E +++++L HE ++ L  V
Sbjct: 28  GCFGEVWMGTWNGTT-RVAIKTLKPGTMSP------EAFLQEAQVMKKLRHEKLVQLYAV 80

Query: 126 FGYMSNVSLVFEFVDTD--LEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
                 + +V E++     L+ +  +         +   A     G+ Y+     +HRDL
Sbjct: 81  V-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 139

Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW- 242
           +  N+L+ +  V K+ DFGLA+                            +F +K+  W 
Sbjct: 140 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 199

Query: 243 --CCFAKDPSSHGNLFPGIPLNEIFTAAG------------DDLLAVISSLLCLNPTKRA 288
                 +  +     +PG+   E+                 + L  ++       P +R 
Sbjct: 200 FGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERP 259

Query: 289 DCTATLKM--DYFSLTKEMY 306
                     DYF+ T+  Y
Sbjct: 260 TFEYLQAFLEDYFTSTEPQY 279

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 1e-30
 Identities = 43/250 (17%), Positives = 92/250 (36%), Gaps = 24/250 (9%)

Query: 66  GRFATVFKARDIETD---MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL 122
           G+F  V +   +  +   + VA+K  K  T     D +    L+E   +++  H +++ L
Sbjct: 18  GQFGDVHQGIYMSPENPALAVAIKTCKNCT----SDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 123 TDVFGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
             V    + V ++ E     +L   ++        +++  YA      L YL     +HR
Sbjct: 74  IGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHR 132

Query: 182 DLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVK--- 238
           D+   N+L++    +K+GDFGL+++    T     +       +    +   +F      
Sbjct: 133 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDV 192

Query: 239 NVQWCCFAKDPSSHGNLFPGIPLNEIFTA------------AGDDLLAVISSLLCLNPTK 286
            +   C  +        F G+  N++                   L ++++     +P++
Sbjct: 193 WMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSR 252

Query: 287 RADCTATLKM 296
           R   T     
Sbjct: 253 RPRFTELKAQ 262

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 2e-30
 Identities = 50/253 (19%), Positives = 85/253 (33%), Gaps = 25/253 (9%)

Query: 66  GRFATVFKARDIETD---MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL 122
           G F  V +          + VAVK +K    +  +       +RE+  +  L H N++ L
Sbjct: 19  GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEA--MDDFIREVNAMHSLDHRNLIRL 76

Query: 123 TDVFGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
             V      + +V E      L   ++     F    +  YA+    G+ YL     +HR
Sbjct: 77  YGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHR 135

Query: 182 DLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY--THQVVTRWYRLIKCLLYCVQFNVKN 239
           DL   NLL+  + ++KIGDFGL +        Y         +       L    F+  +
Sbjct: 136 DLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHAS 195

Query: 240 VQWC--CFAKDPSSHGNL-FPGIPLNEIFTAAG-------------DDLLAVISSLLCLN 283
             W       +  ++G   + G+  ++I                   D+  V+       
Sbjct: 196 DTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHK 255

Query: 284 PTKRADCTATLKM 296
           P  R    A    
Sbjct: 256 PEDRPTFVALRDF 268

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 2e-30
 Identities = 57/291 (19%), Positives = 107/291 (36%), Gaps = 49/291 (16%)

Query: 39  LKKQYLLPDCEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKD 98
           +KK  ++ D +V + +L         +G    V +  +  T    A+K ++         
Sbjct: 4   IKKNAIIDDYKVTSQVL--------GLGINGKVLQIFNKRTQEKFALKMLQ--------- 46

Query: 99  GINRTALREIK-LLQELHHENVLGLTDVFGYMS----NVSLVFEFVD-TDL-EVIIKDPT 151
                A RE++   +     +++ + DV+  +      + +V E +D  +L   I     
Sbjct: 47  -DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD 105

Query: 152 IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ---GVLKIGDFGLAKFFG 208
             FT              ++YLH   I HRD+KP NLL   +    +LK+ DFG AK   
Sbjct: 106 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165

Query: 209 SPTRLYTHQVVTRWYRL----------IKCLLYCVQFNVKNVQWCCFAKDPSSHGNLFPG 258
           S   L T    T +Y              C ++ +   +  +         +    + PG
Sbjct: 166 SHNSLTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 224

Query: 259 I----------PLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF 299
           +            N  ++   +++  +I +LL   PT+R   T  +   + 
Sbjct: 225 MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 275

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 2e-30
 Identities = 49/247 (19%), Positives = 90/247 (36%), Gaps = 23/247 (9%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G+F  V   +       VA+K IK G+ ++         + E K++  L HE ++ L  V
Sbjct: 15  GQFGVVKYGKW-RGQYDVAIKMIKEGSMSE------DEFIEEAKVMMNLSHEKLVQLYGV 67

Query: 126 FGYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
                 + ++ E++    L   +++    F    +          +EYL     LHRDL 
Sbjct: 68  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 127

Query: 185 PNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWC- 243
             N L+N QGV+K+ DFGL+++        +             +L   +F+ K+  W  
Sbjct: 128 ARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAF 187

Query: 244 -CFAKDPSSHGNL-FPGIPLNEIFTA------------AGDDLLAVISSLLCLNPTKRAD 289
                +  S G + +     +E                A + +  ++ S       +R  
Sbjct: 188 GVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPT 247

Query: 290 CTATLKM 296
               L  
Sbjct: 248 FKILLSN 254

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 4e-30
 Identities = 57/278 (20%), Positives = 101/278 (36%), Gaps = 52/278 (18%)

Query: 66  GRFATVFKARDIETD-----MIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENV 119
           G F  V  A           + VAVK +K      A        + E+K++ +L  HEN+
Sbjct: 48  GAFGKVMNATAYGISKTGVSIQVAVKMLKE----KADSSEREALMSELKMMTQLGSHENI 103

Query: 120 LGLTDVFGYMSNVSLVFEFVD-TDLEVIIK----------------------DPTIVFTP 156
           + L         + L+FE+    DL   ++                      +   V T 
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163

Query: 157 SNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF--GSPTRLY 214
            ++  +A    +G+E+L     +HRDL   N+L+    V+KI DFGLA+     S   + 
Sbjct: 164 EDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVR 223

Query: 215 THQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFAKDPSSHGNLFPGIPLNEIFTA---- 267
            +  +   +   + L     + +K+  W       +  S   N +PGIP++  F      
Sbjct: 224 GNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQN 282

Query: 268 ---------AGDDLLAVISSLLCLNPTKRADCTATLKM 296
                    A +++  ++ S    +  KR         
Sbjct: 283 GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 5e-30
 Identities = 50/249 (20%), Positives = 92/249 (36%), Gaps = 31/249 (12%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V           VAVK IK        D   +  L E  ++ +L H N++ L  V
Sbjct: 18  GEFGDVMLGDY--RGNKVAVKCIK-------NDATAQAFLAEASVMTQLRHSNLVQLLGV 68

Query: 126 FG-YMSNVSLVFEFVD--TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRD 182
                  + +V E++   + ++ +      V     +  +++     +EYL  +  +HRD
Sbjct: 69  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 128

Query: 183 LKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW 242
           L   N+L+++  V K+ DFGL K   S         +   +   + L    +F+ K+  W
Sbjct: 129 LAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKLPVKWTAPEALREK-KFSTKSDVW 184

Query: 243 --CCFAKDPSSHGNL-FPGIPLNEIFTAAG------------DDLLAVISSLLCLNPTKR 287
                  +  S G + +P IPL ++                   +  V+ +   L+   R
Sbjct: 185 SFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMR 244

Query: 288 ADCTATLKM 296
                  + 
Sbjct: 245 PSFLQLREQ 253

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 1e-29
 Identities = 48/252 (19%), Positives = 98/252 (38%), Gaps = 26/252 (10%)

Query: 66  GRFATVFKARDIETD----MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F TV+K   I       + VA+K+++  T   A    N+  L E  ++  + + +V  
Sbjct: 20  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA----NKEILDEAYVMASVDNPHVCR 75

Query: 122 LTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
           L  +    +   +        L   +++         +  + +   +G+ YL D  ++HR
Sbjct: 76  LLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHR 135

Query: 182 DLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY--THQVVTRWYRLIKCLLYCVQFNVKN 239
           DL   N+L+     +KI DFGLAK  G+  + Y      V   +  ++ +L+   +  ++
Sbjct: 136 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQS 194

Query: 240 VQW--CCFAKDPSSHGNL-FPGIPLNEIFTA------------AGDDLLAVISSLLCLNP 284
             W       +  + G+  + GIP +EI +                D+  ++     ++ 
Sbjct: 195 DVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDA 254

Query: 285 TKRADCTATLKM 296
             R      +  
Sbjct: 255 DSRPKFRELIIE 266

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 2e-29
 Identities = 76/285 (26%), Positives = 115/285 (40%), Gaps = 58/285 (20%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G + +V  A D +T + VAVKK+             +   RE++LL+ + HENV+GL DV
Sbjct: 29  GAYGSVCAAFDTKTGLRVAVKKLSR---PFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85

Query: 126 F------GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWIL 179
           F         ++V LV   +  DL  I+K      T  +++      LRGL+Y+H   I+
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSADII 143

Query: 180 HRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKN 239
           HRDLKP+NL +N+   LKI DFGLA+         T  V TRWYR  + +L  + +N   
Sbjct: 144 HRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTV 200

Query: 240 VQWCC--------------------------------------------FAKDPSSHGNL 255
             W                                               A++       
Sbjct: 201 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 260

Query: 256 FPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFS 300
            P +    +F  A    + ++  +L L+  KR      L   YF+
Sbjct: 261 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 305

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 5e-29
 Identities = 50/264 (18%), Positives = 94/264 (35%), Gaps = 28/264 (10%)

Query: 66  GRFATVFKA--RDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLT 123
           G F TV K   +  +    VAVK +K   +      +    L E  ++Q+L +  ++ + 
Sbjct: 18  GNFGTVKKGYYQMKKVVKTVAVKILKNEAN---DPALKDELLAEANVMQQLDNPYIVRMI 74

Query: 124 DVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDL 183
            +     +  LV E  +                 NI         G++YL +   +HRDL
Sbjct: 75  GIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 133

Query: 184 KPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQ---VVTRWYRLIKCLLYCVQFNVKNV 240
              N+L+  Q   KI DFGL+K   +    Y  Q        +      +   +F+ K+ 
Sbjct: 134 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW-YAPECINYYKFSSKSD 192

Query: 241 QW--CCFAKDPSSHGNL-FPGIPLNEIFTA------------AGDDLLAVISSLLCLNPT 285
            W       +  S+G   + G+  +E+                  ++  +++     +  
Sbjct: 193 VWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVE 252

Query: 286 KR---ADCTATLKMDYFSLTKEMY 306
            R   A     L+  Y+ +  E +
Sbjct: 253 NRPGFAAVELRLRNYYYDVVNEGH 276

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  111 bits (277), Expect = 8e-29
 Identities = 54/233 (23%), Positives = 90/233 (38%), Gaps = 15/233 (6%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G F  V   +  E+    A+K +        K       L E ++LQ ++   ++ L   
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ--IEHTLNEKRILQAVNFPFLVKLEFS 109

Query: 126 FGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKP 185
           F   SN+ +V E+V              F+  + + YA   +   EYLH   +++RDLKP
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 169

Query: 186 NNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQWCCF 245
            NLLI++QG +++ DFG AK     T             +I    Y     V        
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYN--KAVDWWALGVL 227

Query: 246 AKDPSSHGNLFPGIPLNEIFTAAG-----------DDLLAVISSLLCLNPTKR 287
             + ++    F      +I+                DL  ++ +LL ++ TKR
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKR 280

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (274), Expect = 1e-28
 Identities = 52/272 (19%), Positives = 105/272 (38%), Gaps = 45/272 (16%)

Query: 66  GRFATVFKARDI-----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENV 119
           G F  V +A        +  M VAVK +K   H   ++ +    + E+K+L  L +H N+
Sbjct: 34  GAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREAL----MSELKVLSYLGNHMNI 89

Query: 120 LGLTDVFGYMSNVSLVFEFVD-TDLEVIIK-----------------DPTIVFTPSNIKA 161
           + L           ++ E+    DL   ++                 D  +     ++ +
Sbjct: 90  VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149

Query: 162 YAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF--GSPTRLYTHQVV 219
           ++    +G+ +L     +HRDL   N+L+    + KI DFGLA+     S   +  +  +
Sbjct: 150 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 209

Query: 220 TRWYRLIKCLLYCVQ-FNVKNVQWCCFAKDPSSHGNL-FPGIPLNEIFTA---------- 267
              +   + +  CV  F      +  F  +  S G+  +PG+P++  F            
Sbjct: 210 PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLS 269

Query: 268 ---AGDDLLAVISSLLCLNPTKRADCTATLKM 296
              A  ++  ++ +    +P KR      +++
Sbjct: 270 PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  109 bits (273), Expect = 2e-28
 Identities = 66/296 (22%), Positives = 121/296 (40%), Gaps = 70/296 (23%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTD 124
           G+++ VF+A +I  +  V VK +K       K        REIK+L+ L    N++ L D
Sbjct: 46  GKYSEVFEAINITNNEKVVVKILKPVKKKKIK--------REIKILENLRGGPNIITLAD 97

Query: 125 VF--GYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
           +         +LVFE V+ TD + + +      T  +I+ Y    L+ L+Y H   I+HR
Sbjct: 98  IVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHR 153

Query: 182 DLKPNNLLINKQG-VLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNV 240
           D+KP+N++I+ +   L++ D+GLA+F+  P + Y  +V +R+++  + L+    ++    
Sbjct: 154 DVKPHNVMIDHEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLVDYQMYDYSLD 212

Query: 241 QWC--------CFAKDPSSHGN-------------------------------------- 254
            W          F K+P  HG+                                      
Sbjct: 213 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILG 272

Query: 255 -----LFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYF-SLTKE 304
                 +     +E       + L  +  LL  +   R      ++  YF ++ K+
Sbjct: 273 RHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD 328

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  108 bits (270), Expect = 4e-28
 Identities = 51/276 (18%), Positives = 93/276 (33%), Gaps = 49/276 (17%)

Query: 66  GRFATVFKAR-----DIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           G F  VF+AR       E   +VAVK +K     +A   +     RE  L+ E  + N++
Sbjct: 24  GAFGRVFQARAPGLLPYEPFTMVAVKMLKE----EASADMQADFQREAALMAEFDNPNIV 79

Query: 121 GLTDVFGYMSNVSLVFEFVD-TDLEVIIKD-----------------------PTIVFTP 156
            L  V      + L+FE++   DL   ++                             + 
Sbjct: 80  KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 139

Query: 157 SNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY-T 215
           +     A     G+ YL +   +HRDL   N L+ +  V+KI DFGL++   S       
Sbjct: 140 AEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAD 199

Query: 216 HQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFAKDPSSHGNLFPGIPLNEIFTAAGD-- 270
                    +    ++  ++  ++  W       +  S     + G+   E+     D  
Sbjct: 200 GNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN 259

Query: 271 ----------DLLAVISSLLCLNPTKRADCTATLKM 296
                     +L  ++       P  R    +  ++
Sbjct: 260 ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 295

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  106 bits (265), Expect = 1e-27
 Identities = 58/264 (21%), Positives = 94/264 (35%), Gaps = 43/264 (16%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G  + V  ARD+     VAVK ++     D          RE +    L+H  ++ + D 
Sbjct: 18  GGMSEVHLARDLRLHRDVAVKVLRADLARDPSF--YLRFRREAQNAAALNHPAIVAVYDT 75

Query: 126 FGYMSNVS----LVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
               +       +V E+VD      I       TP           + L + H + I+HR
Sbjct: 76  GEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHR 135

Query: 182 DLKPNNLLINKQGVLKIGDFGLAKFF---GSPTRLYTHQVVTRWYRLIK----------- 227
           D+KP N++I+    +K+ DFG+A+     G+        + T  Y   +           
Sbjct: 136 DVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARS 195

Query: 228 ------CLLYCV--------QFNVKNVQWCCFAKDPSSHGNLFPGIPLNEIFTAAGDDLL 273
                 C+LY V          +  +V +    +DP        G+           DL 
Sbjct: 196 DVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS---------ADLD 246

Query: 274 AVISSLLCLNPTKRADCTATLKMD 297
           AV+   L  NP  R    A ++ D
Sbjct: 247 AVVLKALAKNPENRYQTAAEMRAD 270

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 8e-27
 Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 14/207 (6%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           G    V  A D   D  VA+KK+             + A RE+ L++ ++H+N++ L +V
Sbjct: 28  GAQGIVCAAYDAVLDRNVAIKKLSR---PFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84

Query: 126 F------GYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWIL 179
           F          +V LV E +D +L  +I+          +       L G+++LH   I+
Sbjct: 85  FTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLHSAGII 141

Query: 180 HRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYC-VQFNVK 238
           HRDLKP+N+++     LKI DFGLA+  G+     T  VVTR+YR  + +L    + NV 
Sbjct: 142 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYRAPEVILGMGYKENVD 200

Query: 239 NVQWCCFAKDPSSHGNLFPGIPLNEIF 265
                C   +   H  LFPG    + +
Sbjct: 201 IWSVGCIMGEMVRHKILFPGRDYIDQW 227

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (260), Expect = 1e-26
 Identities = 53/273 (19%), Positives = 96/273 (35%), Gaps = 56/273 (20%)

Query: 66  GRFATVFKARDIETD--MIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGL 122
           G F  V KAR  +    M  A+K++K     D      R    E+++L +L HH N++ L
Sbjct: 21  GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH----RDFAGELEVLCKLGHHPNIINL 76

Query: 123 TDVFGYMSNVSLVFEFVD-TDLEVIIKDPTIV---------------FTPSNIKAYAIMT 166
                +   + L  E+    +L   ++   ++                +   +  +A   
Sbjct: 77  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 136

Query: 167 LRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLI 226
            RG++YL     +HRDL   N+L+ +  V KI DFGL++      +      +   +  I
Sbjct: 137 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG-RLPVRWMAI 195

Query: 227 KCLLYCVQFNVKNVQWCCFAKDPSSHGNL-----------FPGIPLNEIFTAAG------ 269
           + L Y                D  S+G L           + G+   E++          
Sbjct: 196 ESLNY---------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 246

Query: 270 ------DDLLAVISSLLCLNPTKRADCTATLKM 296
                 D++  ++       P +R      L  
Sbjct: 247 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  102 bits (256), Expect = 3e-26
 Identities = 42/262 (16%), Positives = 78/262 (29%), Gaps = 38/262 (14%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTD 124
           G F  ++   DI     VA+K              +     E K+ + +     +  +  
Sbjct: 18  GSFGDIYLGTDIAAGEEVAIKLEC-------VKTKHPQLHIESKIYKMMQGGVGIPTIRW 70

Query: 125 VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
                    +V E +   LE +    +  F+   +   A   +  +EY+H    +HRD+K
Sbjct: 71  CGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVK 130

Query: 185 PNNLLINKQG---VLKIGDFGLAKFFGSP-------TRLYTHQVVTRWYRLIK------- 227
           P+N L+       ++ I DFGLAK +           R   +   T  Y  I        
Sbjct: 131 PDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQ 190

Query: 228 ----------CLLYCVQFNVKNVQWCCFAKDPS---SHGNLFPGIPLNEIFTAAGDDLLA 274
                      +L          Q    A                P+  +      +   
Sbjct: 191 SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFAT 250

Query: 275 VISSLLCLNPTKRADCTATLKM 296
            ++    L    + D +   ++
Sbjct: 251 YLNFCRSLRFDDKPDYSYLRQL 272

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  101 bits (252), Expect = 1e-25
 Identities = 41/257 (15%), Positives = 82/257 (31%), Gaps = 40/257 (15%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTD 124
           G F  +F+  ++  +  VA+K          +         E +  + L     +  +  
Sbjct: 16  GSFGVIFEGTNLLNNQQVAIKFEP-------RRSDAPQLRDEYRTYKLLAGCTGIPNVYY 68

Query: 125 VFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLK 184
                 +  LV + +   LE ++      F+   +   A   L  ++ +H+  +++RD+K
Sbjct: 69  FGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIK 128

Query: 185 PNNLLINKQ-----GVLKIGDFGLAKFFGSP-------TRLYTHQVVTRWYRLIKCL--- 229
           P+N LI +       ++ + DFG+ KF+  P        R   +   T  Y  I      
Sbjct: 129 PDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR 188

Query: 230 ----------LYCVQFNVKNVQWCCFAKDPSSH-------GNLFPGIPLNEIFTAAGDDL 272
                     L  V                +++       G      PL E+     ++ 
Sbjct: 189 EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEF 248

Query: 273 LAVISSLLCLNPTKRAD 289
              +     L      D
Sbjct: 249 YKYMHYARNLAFDATPD 265

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.1 bits (246), Expect = 7e-25
 Identities = 40/253 (15%), Positives = 86/253 (33%), Gaps = 26/253 (10%)

Query: 66  GRFATVFKARDIETD----MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLG 121
           G F  V+K     +     + VA+K +K G     +       L E  ++ +  H N++ 
Sbjct: 18  GEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDF----LGEAGIMGQFSHHNIIR 73

Query: 122 LTDVFGYMSNVSLVFEFVDTDLEV-IIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
           L  V      + ++ E+++       +++    F+   +         G++YL +   +H
Sbjct: 74  LEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVH 133

Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFF---GSPTRLYTHQVVTRWYRLIKCLLYCVQFNV 237
           RDL   N+L+N   V K+ DFGL++        T   +   +   +   + + Y    + 
Sbjct: 134 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSA 193

Query: 238 KNVQ------WCCFAKDPSSHGNLFPGIPLNEIFTA--------AGDDLLAVISSLLCLN 283
            +V       W         +  L     +  I               +  ++       
Sbjct: 194 SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQE 253

Query: 284 PTKRADCTATLKM 296
             +R      + +
Sbjct: 254 RARRPKFADIVSI 266

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.4 bits (244), Expect = 1e-24
 Identities = 52/271 (19%), Positives = 103/271 (38%), Gaps = 44/271 (16%)

Query: 66  GRFATVFKARDIETD-------MIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHE 117
           G F  V  A  I  D         VAVK +K     DA +      + E+++++ +  H+
Sbjct: 24  GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS----DATEKDLSDLISEMEMMKMIGKHK 79

Query: 118 NVLGLTDVFGYMSNVSLVFEFVD-TDLEVIIK---------------DPTIVFTPSNIKA 161
           N++ L         + ++ E+    +L   ++               +P    +  ++ +
Sbjct: 80  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139

Query: 162 YAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS-PTRLYTHQVVT 220
            A    RG+EYL     +HRDL   N+L+ +  V+KI DFGLA+          T     
Sbjct: 140 CAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 199

Query: 221 RWYRLIKCLLYCVQFNVKNVQW---CCFAKDPSSHGNLFPGIPLNEIFTAAG-------- 269
               +    L+   +  ++  W       +  +  G+ +PG+P+ E+F            
Sbjct: 200 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKP 259

Query: 270 ----DDLLAVISSLLCLNPTKRADCTATLKM 296
               ++L  ++       P++R      ++ 
Sbjct: 260 SNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.0 bits (243), Expect = 3e-24
 Identities = 43/263 (16%), Positives = 86/263 (32%), Gaps = 37/263 (14%)

Query: 66  GRFATVFKARD-----IETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           G F  V++         E +  VA+K +       A        L E  +++E +  +V+
Sbjct: 31  GSFGMVYEGVAKGVVKDEPETRVAIKTVNE----AASMRERIEFLNEASVMKEFNCHHVV 86

Query: 121 GLTDVFGYMSNVSLVFEFVD-TDLEVIIK---------DPTIVFTPSNIKAYAIMTLRGL 170
            L  V        ++ E +   DL+  ++               + S +   A     G+
Sbjct: 87  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 146

Query: 171 EYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP--TRLYTHQVVTRWYRLIKC 228
            YL+ +  +HRDL   N ++ +   +KIGDFG+ +        R     ++   +   + 
Sbjct: 147 AYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES 206

Query: 229 LLYCVQFNVKNVQW---CCFAKDPSSHGNLFPGIPLNEIFTA------------AGDDLL 273
           L     F   +  W       +  +     + G+   ++                 D L 
Sbjct: 207 LKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLF 265

Query: 274 AVISSLLCLNPTKRADCTATLKM 296
            ++      NP  R      +  
Sbjct: 266 ELMRMCWQYNPKMRPSFLEIISS 288

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.0 bits (243), Expect = 3e-24
 Identities = 58/288 (20%), Positives = 85/288 (29%), Gaps = 67/288 (23%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV 125
           GRF  V++ +       VAVK          ++  +     EI     L HEN+LG    
Sbjct: 14  GRFGEVWRGKW--RGEEVAVKIFSS------REERSWFREAEIYQTVMLRHENILGFIAA 65

Query: 126 F----GYMSNVSLVFEFVDT-DLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHW--- 177
                G  + + LV ++ +   L   +   T   T   +   A+ T  GL +LH      
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGT 123

Query: 178 -----ILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY----THQVVTRWYR---- 224
                I HRDLK  N+L+ K G   I D GLA    S T        H+V T+ Y     
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183

Query: 225 ------------------------LIKCLLYCVQFNVKNVQWCCFA------------KD 248
                                     +    C    +       +             + 
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243

Query: 249 PSSHGNLFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM 296
                 L P IP       A   +  ++      N   R       K 
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.9 bits (243), Expect = 3e-24
 Identities = 47/259 (18%), Positives = 88/259 (33%), Gaps = 37/259 (14%)

Query: 66  GRFATVFKARDIETD---MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGL 122
           G F  V+    ++ D   +  AVK +          G     L E  ++++  H NVL L
Sbjct: 38  GHFGCVYHGTLLDNDGKKIHCAVKSLNR----ITDIGEVSQFLTEGIIMKDFSHPNVLSL 93

Query: 123 TDV-FGYMSNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILH 180
             +      +  +V  ++   DL   I++ T   T  ++  + +   +G+++L     +H
Sbjct: 94  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVH 153

Query: 181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNV 240
           RDL   N +++++  +K+ DFGLA+          H          K  +  +       
Sbjct: 154 RDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG-----AKLPVKWMALESLQT 208

Query: 241 QWCCFAKDPSSHGNL-----------FPGIPLNEIFTA------------AGDDLLAVIS 277
           Q      D  S G L           +P +   +I                 D L  V+ 
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML 268

Query: 278 SLLCLNPTKRADCTATLKM 296
                    R   +  +  
Sbjct: 269 KCWHPKAEMRPSFSELVSR 287

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.9 bits (240), Expect = 5e-24
 Identities = 48/270 (17%), Positives = 92/270 (34%), Gaps = 42/270 (15%)

Query: 66  GRFATVFKARDIETDM-----IVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL 120
           G F  V +A     D       VAVK +K G        +         L+   HH NV+
Sbjct: 24  GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS---ELKILIHIGHHLNVV 80

Query: 121 GLTDVFGYMSN-VSLVFEFVD-TDLEVIIKD---------------PTIVFTPSNIKAYA 163
            L          + ++ EF    +L   ++                     T  ++  Y+
Sbjct: 81  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 140

Query: 164 IMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY--THQVVTR 221
               +G+E+L     +HRDL   N+L++++ V+KI DFGLA+               +  
Sbjct: 141 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 200

Query: 222 WYRLIKCLLYCVQFNVKNVQ--WCCFAKDPSSHGNLFPGIPLNEIFTAA----------- 268
            +   + +   V     +V        +  S   + +PG+ ++E F              
Sbjct: 201 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD 260

Query: 269 --GDDLLAVISSLLCLNPTKRADCTATLKM 296
               ++   +       P++R   +  ++ 
Sbjct: 261 YTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.9 bits (235), Expect = 5e-23
 Identities = 50/245 (20%), Positives = 89/245 (36%), Gaps = 24/245 (9%)

Query: 66  GRFATVFKARDI---ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLG 121
           G +  VF  R I   +T  + A+K +K  T          T   E ++L+ +     ++ 
Sbjct: 35  GAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT-RTERQVLEHIRQSPFLVT 93

Query: 122 LTDVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHR 181
           L   F   + + L+ ++++             FT   ++ Y    +  LE+LH   I++R
Sbjct: 94  LHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYR 153

Query: 182 DLKPNNLLINKQGVLKIGDFGLAKFFGS-PTRLYTHQVVTRWYRLIKCLLYCVQFNVKNV 240
           D+K  N+L++  G + + DFGL+K F +  T        T  Y     +      + K V
Sbjct: 154 DIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAV 213

Query: 241 QWCCFA----------------KDPSSHGNLFPGI--PLNEIFTAAGDDLLAVISSLLCL 282
            W                     + +S   +   I                 +I  LL  
Sbjct: 214 DWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMK 273

Query: 283 NPTKR 287
           +P KR
Sbjct: 274 DPKKR 278

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 82.1 bits (202), Expect = 2e-19
 Identities = 29/170 (17%), Positives = 53/170 (31%), Gaps = 18/170 (10%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTAL-----REIKLLQELHHENVL 120
           G+ + VF     E      VK  K+G  +  K    R                     + 
Sbjct: 11  GKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQ 69

Query: 121 GLTDVFGYMSNVSLVFEFVDTDL--EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWI 178
            L  +      V  V+ +    +  E+I           N      M L  +   +   I
Sbjct: 70  KLQGL-----AVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGI 124

Query: 179 LHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY----THQVVTRWYR 224
           +H DL   N+L++++G+  I DF  +   G            + +  ++ 
Sbjct: 125 VHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWREILERDVRNIITYFS 173

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 78.5 bits (192), Expect = 4e-17
 Identities = 60/245 (24%), Positives = 94/245 (38%), Gaps = 35/245 (14%)

Query: 66  GRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHEN------- 118
           G F+TV+ A+D+  +  VA+K ++              A  EIKLLQ ++  +       
Sbjct: 24  GHFSTVWLAKDMVNNTHVAMKIVR------GDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77

Query: 119 ----VLGLTDVFGYMSNVSLVFEFVD-----TDLEVIIKDPTIVFTPSNIKAYAIMTLRG 169
               +L L D F +     +    V        L +I K          +K  +   L G
Sbjct: 78  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137

Query: 170 LEYLHDHW-ILHRDLKPNNLLINKQGV------LKIGDFGLAKFFGSPTRLYTHQVVTRW 222
           L+Y+H    I+H D+KP N+L+           +KI D G A ++      YT+ + TR 
Sbjct: 138 LDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH---YTNSIQTRE 194

Query: 223 YRLIKCLLYC-VQFNVKNVQWCCFAKDPSSHGNLFPGIPLNEIFTAAGDDLLAVISSLLC 281
           YR  + LL              C   +  +   LF     +       DD +A I  LL 
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK--DDDHIAQIIELLG 252

Query: 282 LNPTK 286
             P+ 
Sbjct: 253 ELPSY 257

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	307
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.94
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.84
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.44
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.34
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.65
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.48
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.12

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-60  Score=398.98  Aligned_cols=246  Identities=23%  Similarity=0.237  Sum_probs=206.8

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|++++.||+|+||+||+|++..+|+.||||++......+    ..+.+.+|++++++++||||+++++++.+++..
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~----~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~   78 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD----CPENIKKEICINKMLNHENVVKFYGHRREGNIQ   78 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch----HHHHHHHHHHHHHhCCCCCEeeEeeeeccCcee
Confidence            4578999999999999999999999999999999998643222    235688999999999999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT  211 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  211 (307)
                      ||||||+ +|+|.+++... +.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus        79 ~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~  157 (271)
T d1nvra_          79 YLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  157 (271)
T ss_dssp             EEEEECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             EEEEeccCCCcHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence            9999999 57898888654 369999999999999999999999999999999999999999999999999998764322


Q ss_pred             --cccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCC---------ChhhhccccCHHHH
Q psy9858         212 --RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGI---------PLNEIFTAAGDDLL  273 (307)
Q Consensus       212 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~---------~~~~~~~~~~~~l~  273 (307)
                        ......+||+.|+|||++.+...++.++|||   +    +++|.+||........         .....+..+++++.
T Consensus       158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  237 (271)
T d1nvra_         158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL  237 (271)
T ss_dssp             EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred             ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHH
Confidence              2345568999999999998885568899999   3    3449999977432211         11122356899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         274 AVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       274 ~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      +||.+||+.||++|||++|+|+||||++.-
T Consensus       238 ~li~~~L~~dP~~R~t~~eil~hpwf~~~l  267 (271)
T d1nvra_         238 ALLHKILVENPSARITIPDIKKDRWYNKPL  267 (271)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHHHHHcCCChhHCcCHHHHhcCHhhCcCC
Confidence            999999999999999999999999998643

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-60  Score=401.15  Aligned_cols=245  Identities=19%  Similarity=0.317  Sum_probs=210.5

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS  130 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  130 (307)
                      +...++|++++.||+|+||+||+|++..+|+.||||++......     ..+.+.+|++++++++||||+++++++.+++
T Consensus        16 ~dp~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   90 (293)
T d1yhwa1          16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-----KKELIINEILVMRENKNPNIVNYLDSYLVGD   90 (293)
T ss_dssp             SCTTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS-----CHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             CCcccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh-----HHHHHHHHHHHHHhCCCCCEeeEeEEEEECC
Confidence            33456899999999999999999999999999999999753211     2456889999999999999999999999999


Q ss_pred             eEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCC
Q psy9858         131 NVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS  209 (307)
Q Consensus       131 ~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  209 (307)
                      ..|+||||+ +|+|.+++.+.  .+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus        91 ~~~ivmEy~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~  168 (293)
T d1yhwa1          91 ELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (293)
T ss_dssp             EEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEEEEEecCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence            999999999 67888877654  489999999999999999999999999999999999999999999999999998865


Q ss_pred             CCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCC---------CChhhhccccCHHHH
Q psy9858         210 PTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPG---------IPLNEIFTAAGDDLL  273 (307)
Q Consensus       210 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~---------~~~~~~~~~~~~~l~  273 (307)
                      ........+||+.|+|||++.+. .++.++|||   +    +++|..||.+.....         ......+..+++++.
T Consensus       169 ~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  247 (293)
T d1yhwa1         169 EQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR  247 (293)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHSSS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHH
T ss_pred             ccccccccccCCCccChhhhcCC-CCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHH
Confidence            55556667899999999999987 889999999   3    334999998732110         011123456899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         274 AVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       274 ~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      +||.+||+.||++|||++|+|+||||+..+
T Consensus       248 ~li~~~L~~dP~~R~s~~eil~Hp~~~~~~  277 (293)
T d1yhwa1         248 DFLNRCLDMDVEKRGSAKELLQHQFLKIAK  277 (293)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHHHccCChhHCcCHHHHhcCHhhCCCC
Confidence            999999999999999999999999997654

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-59  Score=391.73  Aligned_cols=242  Identities=24%  Similarity=0.328  Sum_probs=207.0

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEE
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVS  133 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  133 (307)
                      .++|++++.||+|+||+||+|++..+|+.||+|++.+...  .+......+.+|+++++.++||||+++++++.+++..|
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~   82 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY   82 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHc--cChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE
Confidence            5689999999999999999999999999999999975321  12233567889999999999999999999999999999


Q ss_pred             EEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc
Q psy9858         134 LVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR  212 (307)
Q Consensus       134 lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  212 (307)
                      +||||+ +|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|......  
T Consensus        83 ivmEy~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--  159 (263)
T d2j4za1          83 LILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--  159 (263)
T ss_dssp             EEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--
T ss_pred             EEEeecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC--
Confidence            999999 578988887544 5899999999999999999999999999999999999999999999999999876433  


Q ss_pred             ccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCC------ChhhhccccCHHHHHHHHHh
Q psy9858         213 LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGI------PLNEIFTAAGDDLLAVISSL  279 (307)
Q Consensus       213 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~------~~~~~~~~~~~~l~~li~~~  279 (307)
                      ......||+.|+|||++.+. .++.++|||   |    +++|..||.+......      .....+..+++++.+||.+|
T Consensus       160 ~~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  238 (263)
T d2j4za1         160 RRTTLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL  238 (263)
T ss_dssp             CCEETTEEGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHH
T ss_pred             cccccCCCCcccCHHHHcCC-CCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHH
Confidence            33456899999999999987 889999999   3    3349999987322110      01123356899999999999


Q ss_pred             hhcCCCCCCCHHHHhcCcccCC
Q psy9858         280 LCLNPTKRADCTATLKMDYFSL  301 (307)
Q Consensus       280 l~~dP~~Rpt~~~il~hp~f~~  301 (307)
                      |+.||++|||++|+|+||||++
T Consensus       239 L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         239 LKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             TCSSGGGSCCHHHHHTCHHHHH
T ss_pred             ccCCHhHCcCHHHHHcCcCcCC
Confidence            9999999999999999999974

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-59  Score=395.49  Aligned_cols=244  Identities=23%  Similarity=0.308  Sum_probs=206.8

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEE
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVS  133 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  133 (307)
                      .+.|++++.||+|+||+||+|++..+|+.||||++.....     ...+.+.+|++++++++||||+++++++.+++..+
T Consensus        11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-----~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~   85 (288)
T d2jfla1          11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE-----EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLW   85 (288)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS-----GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH-----HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEE
Confidence            4579999999999999999999999999999999986422     22456889999999999999999999999999999


Q ss_pred             EEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc
Q psy9858         134 LVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR  212 (307)
Q Consensus       134 lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  212 (307)
                      +||||+ +|+|.+++.+..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus        86 lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~  165 (288)
T d2jfla1          86 ILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ  165 (288)
T ss_dssp             EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH
T ss_pred             EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcc
Confidence            999999 5788888776666799999999999999999999999999999999999999999999999999987643333


Q ss_pred             ccccceeeceehhhhhhhc----cccccccccee---e----eeecCCCCCCCCCCC---------CChhhhccccCHHH
Q psy9858         213 LYTHQVVTRWYRLIKCLLY----CVQFNVKNVQW---C----CFAKDPSSHGNLFPG---------IPLNEIFTAAGDDL  272 (307)
Q Consensus       213 ~~~~~~~t~~y~aPE~~~~----~~~~~~~~Diw---~----i~~~~~~f~~~~~~~---------~~~~~~~~~~~~~l  272 (307)
                      ......||+.|+|||++..    ...|+.++|||   +    +++|.+||.+.....         ......+..+++++
T Consensus       166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~  245 (288)
T d2jfla1         166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNF  245 (288)
T ss_dssp             HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred             cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHH
Confidence            3445689999999999853    23689999999   3    334999998732211         11112235689999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         273 LAVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       273 ~~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                      .+||.+||+.||++|||++|+|+||||+..
T Consensus       246 ~~li~~~L~~dp~~R~t~~ell~hp~~~~~  275 (288)
T d2jfla1         246 KDFLKKCLEKNVDARWTTSQLLQHPFVTVD  275 (288)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            999999999999999999999999999754

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-58  Score=392.84  Aligned_cols=246  Identities=61%  Similarity=0.991  Sum_probs=205.1

Q ss_pred             eEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEEE
Q psy9858          58 YQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFE  137 (307)
Q Consensus        58 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  137 (307)
                      +.++.||+|+||+||+|++..+|+.||||++.........+...+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus         1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE   80 (299)
T d1ua2a_           1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD   80 (299)
T ss_dssp             CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred             CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence            35789999999999999999999999999998655444444455678999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcccccc
Q psy9858         138 FVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLYTHQ  217 (307)
Q Consensus       138 ~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  217 (307)
                      |+.|++...+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+............
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~  160 (299)
T d1ua2a_          81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ  160 (299)
T ss_dssp             CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCS
T ss_pred             hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccce
Confidence            99887777777767779999999999999999999999999999999999999999999999999998876655555566


Q ss_pred             eeeceehhhhhhhccccccccccee---e----eeecCCCCCCCC----------------------------------C
Q psy9858         218 VVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNL----------------------------------F  256 (307)
Q Consensus       218 ~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~----------------------------------~  256 (307)
                      ++|+.|+|||++.+...|+.++|||   |    +++|.+||.+..                                  .
T Consensus       161 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (299)
T d1ua2a_         161 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF  240 (299)
T ss_dssp             CCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCC
T ss_pred             ecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccC
Confidence            8999999999998776889999999   3    333999987521                                  1


Q ss_pred             CCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         257 PGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       257 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      +..........+++++.+||.+||+.||++|||++|+|+||||++.+
T Consensus       241 ~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p  287 (299)
T d1ua2a_         241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  287 (299)
T ss_dssp             CCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             CCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence            11222334456789999999999999999999999999999998754

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.7e-57  Score=396.07  Aligned_cols=245  Identities=19%  Similarity=0.241  Sum_probs=210.6

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCe
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSN  131 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  131 (307)
                      ...++|++++.||+|+||+||+|++..+|+.||||++....     ....+.+.+|+++|++++||||+++++++.+++.
T Consensus        23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   97 (350)
T d1koaa2          23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-----ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE   97 (350)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-----HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTE
T ss_pred             CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-----hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            45678999999999999999999999999999999997532     1224568899999999999999999999999999


Q ss_pred             EEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEec--CCcEEEEeecCccccC
Q psy9858         132 VSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK--QGVLKIGDFGLAKFFG  208 (307)
Q Consensus       132 ~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~a~~~~  208 (307)
                      +||||||+ +|+|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||+|+...
T Consensus        98 ~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~  177 (350)
T d1koaa2          98 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD  177 (350)
T ss_dssp             EEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred             EEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence            99999999 68999999877777999999999999999999999999999999999999964  6789999999999875


Q ss_pred             CCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCC----------CCChhhhccccCHH
Q psy9858         209 SPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFP----------GIPLNEIFTAAGDD  271 (307)
Q Consensus       209 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~----------~~~~~~~~~~~~~~  271 (307)
                      .. .......||+.|+|||++.+. .++.++|||   |    +++|..||.+....          .......+..++++
T Consensus       178 ~~-~~~~~~~gT~~Y~aPEv~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  255 (350)
T d1koaa2         178 PK-QSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED  255 (350)
T ss_dssp             TT-SCEEEECSCTTTCCHHHHHTC-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHH
T ss_pred             cc-cccceecCcccccCHHHHcCC-CCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence            43 344556899999999999887 889999999   3    33399999873211          11122334578999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         272 LLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       272 l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      +.+||.+||+.||++|||++|+|+||||+...
T Consensus       256 ~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~  287 (350)
T d1koaa2         256 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGN  287 (350)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            99999999999999999999999999998653

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.3e-57  Score=395.57  Aligned_cols=245  Identities=21%  Similarity=0.251  Sum_probs=211.1

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS  130 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  130 (307)
                      +...++|++++.||+|+||+||+|++..+|+.||||++.....     .....+.+|+++|++++||||+++++++.+++
T Consensus        25 ~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   99 (352)
T d1koba_          25 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-----LDKYTVKNEISIMNQLHHPKLINLHDAFEDKY   99 (352)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-----HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred             CCcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch-----hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            3456789999999999999999999999999999999986421     12456789999999999999999999999999


Q ss_pred             eEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEe--cCCcEEEEeecCcccc
Q psy9858         131 NVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLIN--KQGVLKIGDFGLAKFF  207 (307)
Q Consensus       131 ~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~--~~~~~kl~Dfg~a~~~  207 (307)
                      .+||||||+ +|+|.+.+......+++.+++.++.||+.||+|||++||+||||||+|||++  .++.+||+|||+|...
T Consensus       100 ~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~  179 (352)
T d1koba_         100 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL  179 (352)
T ss_dssp             EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             EEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceec
Confidence            999999999 6889888887776799999999999999999999999999999999999998  5789999999999987


Q ss_pred             CCCCcccccceeeceehhhhhhhccccccccccee---eee----ecCCCCCCCCCC----------CCChhhhccccCH
Q psy9858         208 GSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCF----AKDPSSHGNLFP----------GIPLNEIFTAAGD  270 (307)
Q Consensus       208 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~----~~~~~f~~~~~~----------~~~~~~~~~~~~~  270 (307)
                      ... .......+|+.|+|||++.+. .++.++|||   |++    +|.+||.+....          .......+..+++
T Consensus       180 ~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  257 (352)
T d1koba_         180 NPD-EIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP  257 (352)
T ss_dssp             CTT-SCEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCH
T ss_pred             CCC-CceeeccCcccccCHHHHcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence            543 344556899999999999887 899999999   433    399999872211          1112233457899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         271 DLLAVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       271 ~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                      ++.+||.+||+.||.+|||++|+|+||||++.
T Consensus       258 ~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         258 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            99999999999999999999999999999864

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-58  Score=389.09  Aligned_cols=242  Identities=23%  Similarity=0.317  Sum_probs=193.2

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee--cCe
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY--MSN  131 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~  131 (307)
                      .++|++++.||+|+||+||+|++..+|+.||+|++......   +...+.+.+|++++++++||||+++++++.+  .+.
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   79 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT---EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT   79 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC---HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----C
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC---HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCE
Confidence            36799999999999999999999999999999999865432   2235668899999999999999999998854  567


Q ss_pred             EEEEEEcc-CCChHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeecCCCCcEEEecCCcEEEEeec
Q psy9858         132 VSLVFEFV-DTDLEVIIKD---PTIVFTPSNIKAYAIMTLRGLEYLHDHW-----ILHRDLKPNNLLINKQGVLKIGDFG  202 (307)
Q Consensus       132 ~~lv~e~~-~g~l~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~-----ivH~dlkp~Nil~~~~~~~kl~Dfg  202 (307)
                      +|+||||+ +|+|.+++.+   ....+++..++.++.||+.||.|||++|     |+||||||+|||++.++.+||+|||
T Consensus        80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG  159 (269)
T d2java1          80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  159 (269)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHH
T ss_pred             EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecc
Confidence            89999999 6789988753   3446999999999999999999999876     9999999999999999999999999


Q ss_pred             CccccCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCC-------CCChhhhcccc
Q psy9858         203 LAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFP-------GIPLNEIFTAA  268 (307)
Q Consensus       203 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~-------~~~~~~~~~~~  268 (307)
                      +|+.............||+.|+|||++.+. .|+.++|||   +    +++|..||.+....       .......+..+
T Consensus       160 ~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  238 (269)
T d2java1         160 LARILNHDTSFAKAFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY  238 (269)
T ss_dssp             HHHHC-----------CCCSCCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTS
T ss_pred             ceeecccCCCccccCCCCcccCCHHHHcCC-CCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence            999876555555667899999999999887 899999999   3    33499999873221       11122334568


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         269 GDDLLAVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       269 ~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                      |+++.+||.+||+.||++|||++|+|+|||+
T Consensus       239 s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         239 SDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            9999999999999999999999999999996

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-57  Score=390.25  Aligned_cols=243  Identities=23%  Similarity=0.307  Sum_probs=191.3

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..+.|++++.||+|+||+||+|++..+|+.||||++.+.....    ....+.+|++++++++||||+++++++.+++.+
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   82 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG----KEGSMENEIAVLHKIKHPNIVALDDIYESGGHL   82 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC--------------CHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh----HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            3456999999999999999999999999999999998654322    234577999999999999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEe---cCCcEEEEeecCccccC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLIN---KQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~a~~~~  208 (307)
                      ||||||+ +|+|.+++...+ .+++.++..++.||+.||.|||++||+||||||+||++.   .++.+||+|||+|+...
T Consensus        83 ~lvmE~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          83 YLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             EEEECCCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             EEEEeccCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            9999999 589999987654 599999999999999999999999999999999999995   57899999999998764


Q ss_pred             CCCcccccceeeceehhhhhhhccccccccccee---ee----eecCCCCCCCCC----------CCCChhhhccccCHH
Q psy9858         209 SPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FAKDPSSHGNLF----------PGIPLNEIFTAAGDD  271 (307)
Q Consensus       209 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~~~~~f~~~~~----------~~~~~~~~~~~~~~~  271 (307)
                      .. ......+||+.|+|||++.+. .|+.++|||   |+    ++|.+||.+...          ........+..+|++
T Consensus       162 ~~-~~~~~~~GT~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  239 (307)
T d1a06a_         162 PG-SVLSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS  239 (307)
T ss_dssp             ------------CTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred             CC-CeeeeeeeCccccCcHHHcCC-CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHH
Confidence            33 334456899999999999887 899999999   33    339999987221          111122334578999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         272 LLAVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       272 l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                      +.+||.+||+.||++|||++|+|+||||++.
T Consensus       240 ~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         240 AKDFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             HHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            9999999999999999999999999999864

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-58  Score=396.82  Aligned_cols=243  Identities=22%  Similarity=0.340  Sum_probs=203.2

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|++++.||+|+||+||+|++..+|+.||+|++....    .......+.+|+.+|++++||||+++++++.++++.
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~----~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   79 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI   79 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC----CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            4578999999999999999999999999999999998542    223356788999999999999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCcEEEecCCcEEEEeecCccccCCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD-HWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  210 (307)
                      |+||||+ +|+|.+++.+.. .+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+|+.... 
T Consensus        80 ~iVmEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-  157 (322)
T d1s9ja_          80 SICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-  157 (322)
T ss_dssp             EEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred             EEEEEcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC-
Confidence            9999999 568888887554 58999999999999999999997 5999999999999999999999999999987632 


Q ss_pred             Ccccccceeeceehhhhhhhccccccccccee---eee----ecCCCCCCCCCCCC------------------------
Q psy9858         211 TRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCF----AKDPSSHGNLFPGI------------------------  259 (307)
Q Consensus       211 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~----~~~~~f~~~~~~~~------------------------  259 (307)
                       ....+.+||+.|+|||++.+. .|+.++|||   |++    +|+.||.+......                        
T Consensus       158 -~~~~~~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (322)
T d1s9ja_         158 -SMANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  235 (322)
T ss_dssp             -HTC---CCSSCCCCHHHHHCS-CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred             -CccccccCCccccCchHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence             223456899999999999998 899999999   443    39999976321100                        


Q ss_pred             -------------Chh------------hh-ccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         260 -------------PLN------------EI-FTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       260 -------------~~~------------~~-~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                                   ...            .. ...+|.++.+||.+||+.||++|||++|+|+||||++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~  305 (322)
T d1s9ja_         236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  305 (322)
T ss_dssp             ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence                         000            00 013578999999999999999999999999999997643

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-57  Score=390.93  Aligned_cols=243  Identities=23%  Similarity=0.330  Sum_probs=202.8

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEE
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVS  133 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  133 (307)
                      ...|+.++.||+|+||+||+|++..+|+.||||++.......  ....+.+.+|++++++++||||+++++++.+++..|
T Consensus        14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   91 (309)
T d1u5ra_          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS--NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW   91 (309)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCH--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccC--HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEE
Confidence            456999999999999999999999999999999998653322  233567889999999999999999999999999999


Q ss_pred             EEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc
Q psy9858         134 LVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL  213 (307)
Q Consensus       134 lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  213 (307)
                      +||||+.|++++.+....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|.....    
T Consensus        92 iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----  167 (309)
T d1u5ra_          92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----  167 (309)
T ss_dssp             EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred             EEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC----
Confidence            9999996655555444445699999999999999999999999999999999999999999999999999987643    


Q ss_pred             cccceeeceehhhhhhhcc--ccccccccee---e----eeecCCCCCCCCCCC--------CChhhhccccCHHHHHHH
Q psy9858         214 YTHQVVTRWYRLIKCLLYC--VQFNVKNVQW---C----CFAKDPSSHGNLFPG--------IPLNEIFTAAGDDLLAVI  276 (307)
Q Consensus       214 ~~~~~~t~~y~aPE~~~~~--~~~~~~~Diw---~----i~~~~~~f~~~~~~~--------~~~~~~~~~~~~~l~~li  276 (307)
                      .....||+.|+|||++.+.  ..|+.++|||   +    +++|..||.+.....        .........+|+++.+||
T Consensus       168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li  247 (309)
T d1u5ra_         168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV  247 (309)
T ss_dssp             BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHH
T ss_pred             CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHH
Confidence            2345899999999999753  3689999999   3    334999997732110        011111245789999999


Q ss_pred             HHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         277 SSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       277 ~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                      .+||+.||++|||++|+|+||||.+.
T Consensus       248 ~~~L~~dP~~Rpt~~ell~Hp~~~~~  273 (309)
T d1u5ra_         248 DSCLQKIPQDRPTSEVLLKHRFVLRE  273 (309)
T ss_dssp             HHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             HHHCcCChhHCcCHHHHHhCHHhcCC
Confidence            99999999999999999999999754

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-57  Score=392.44  Aligned_cols=246  Identities=20%  Similarity=0.240  Sum_probs=211.2

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|++++.||+|+||.||+|++..+|+.||||++.+.....  ....+.+.+|+.+|+.++||||+++++++.+.+.+
T Consensus         3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~--~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   80 (337)
T d1o6la_           3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA--KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL   80 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred             chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccC--HHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccc
Confidence            4678999999999999999999999999999999998532211  22246688999999999999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT  211 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  211 (307)
                      |+||||+ +|+|.+++.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus        81 ~iv~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~  159 (337)
T d1o6la_          81 CFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             ccceeccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence            9999999 678888877654 58999999999999999999999999999999999999999999999999999876555


Q ss_pred             cccccceeeceehhhhhhhccccccccccee---ee----eecCCCCCCCCCCCCC------hhhhccccCHHHHHHHHH
Q psy9858         212 RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FAKDPSSHGNLFPGIP------LNEIFTAAGDDLLAVISS  278 (307)
Q Consensus       212 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~~~~~f~~~~~~~~~------~~~~~~~~~~~l~~li~~  278 (307)
                      ......+||+.|+|||++.+. .|+.++|||   |+    ++|.+||.+.......      ....+..+|+++.+||.+
T Consensus       160 ~~~~~~~GT~~Y~aPE~~~~~-~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~  238 (337)
T d1o6la_         160 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG  238 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred             cccccceeCHHHhhhhhccCC-CCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHh
Confidence            556677999999999999988 889999999   33    3399999884321100      012345689999999999


Q ss_pred             hhhcCCCCCCC-----HHHHhcCcccCCC
Q psy9858         279 LLCLNPTKRAD-----CTATLKMDYFSLT  302 (307)
Q Consensus       279 ~l~~dP~~Rpt-----~~~il~hp~f~~~  302 (307)
                      ||+.||++|++     ++|+++||||++.
T Consensus       239 ~L~~dP~~R~~~~~~~~~eil~Hp~f~~i  267 (337)
T d1o6la_         239 LLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             HTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             hccCCchhhcccccccHHHHHcCcccccC
Confidence            99999999994     9999999999875

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-56  Score=383.23  Aligned_cols=247  Identities=24%  Similarity=0.314  Sum_probs=209.7

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccc-hhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAK-DGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      .++|++++.||+|+||+||+|++..+|+.||||++.+....... ....+.+.+|+++|++++||||+++++++.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            45799999999999999999999999999999999875543322 22356788999999999999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCC----cEEEEeecCcccc
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG----VLKIGDFGLAKFF  207 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~----~~kl~Dfg~a~~~  207 (307)
                      ||||||+ +|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+||+++.++    .+||+|||+|...
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~  167 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI  167 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence            9999999 578988887654 599999999999999999999999999999999999998777    4999999999887


Q ss_pred             CCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCC----------CCCChhhhccccCH
Q psy9858         208 GSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLF----------PGIPLNEIFTAAGD  270 (307)
Q Consensus       208 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~----------~~~~~~~~~~~~~~  270 (307)
                      ... .......+|+.|+|||++.+. .++.++|||   +    +++|..||.+...          ........+.++|+
T Consensus       168 ~~~-~~~~~~~~t~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  245 (293)
T d1jksa_         168 DFG-NEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA  245 (293)
T ss_dssp             TTS-CBCSCCCCCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred             CCC-ccccccCCCCcccCHHHHcCC-CCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCH
Confidence            443 334456889999999999887 899999999   3    3349999987321          11222344467899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         271 DLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       271 ~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                      ++.+||.+||+.||++|||++|+|+||||+..+
T Consensus       246 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  278 (293)
T d1jksa_         246 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  278 (293)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            999999999999999999999999999998643

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-56  Score=383.59  Aligned_cols=247  Identities=36%  Similarity=0.634  Sum_probs=209.3

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ++|++++.||+|+||+||+|++..+|+.||||++.....   .+.....+.+|++++++++||||+++++++.+.+..|+
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~i   78 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE---TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYL   78 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC----------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc---ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeE
Confidence            689999999999999999999999999999999975422   22235678899999999999999999999999999999


Q ss_pred             EEEccCCChHHHHh-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc
Q psy9858         135 VFEFVDTDLEVIIK-DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL  213 (307)
Q Consensus       135 v~e~~~g~l~~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  213 (307)
                      ||||++|++.+++. .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+........
T Consensus        79 v~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~  158 (298)
T d1gz8a_          79 VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT  158 (298)
T ss_dssp             EEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred             EEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCccc
Confidence            99999888776664 44556999999999999999999999999999999999999999999999999999988666666


Q ss_pred             cccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCC-------------------------------
Q psy9858         214 YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNL-------------------------------  255 (307)
Q Consensus       214 ~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~-------------------------------  255 (307)
                      .....+|+.|+|||.+.....++.++|||   +    +++|..||.+..                               
T Consensus       159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  238 (298)
T d1gz8a_         159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP  238 (298)
T ss_dssp             TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccc
Confidence            66778999999999998886779999999   3    334999997621                               


Q ss_pred             ----CCCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         256 ----FPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       256 ----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                          ............+++++.+||.+||+.||++|||++|+|+||||++..+
T Consensus       239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~  291 (298)
T d1gz8a_         239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK  291 (298)
T ss_dssp             TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence                0111112223467899999999999999999999999999999987654

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-57  Score=386.22  Aligned_cols=246  Identities=24%  Similarity=0.264  Sum_probs=204.7

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEE
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVS  133 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  133 (307)
                      .++|++++.||+|+||+||+|++..+|+.||||++.+....  .+...+.+.+|++++++++||||+++++++.+++..|
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~   84 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII--KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY   84 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEE
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHcc--CHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEE
Confidence            35799999999999999999999999999999999753211  2223466889999999999999999999999999999


Q ss_pred             EEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC-
Q psy9858         134 LVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT-  211 (307)
Q Consensus       134 lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-  211 (307)
                      +||||+ +|+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+|+...... 
T Consensus        85 ivmEy~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          85 FGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             EEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EEEEccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence            999999 578888877554 58999999999999999999999999999999999999999999999999999875322 


Q ss_pred             -cccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCC------ChhhhccccCHHHHHHHH
Q psy9858         212 -RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGI------PLNEIFTAAGDDLLAVIS  277 (307)
Q Consensus       212 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~------~~~~~~~~~~~~l~~li~  277 (307)
                       ......+||+.|+|||++.+. .|+.++|||   |    +++|..||.+......      .....+..+++++.+||.
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  242 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVE  242 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHH
T ss_pred             ccccccccCCccccCceeeccC-CCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence             233456899999999999888 899999999   3    3449999987321110      001234568999999999


Q ss_pred             HhhhcCCCCCCCHHH------HhcCcccCCCc
Q psy9858         278 SLLCLNPTKRADCTA------TLKMDYFSLTK  303 (307)
Q Consensus       278 ~~l~~dP~~Rpt~~~------il~hp~f~~~~  303 (307)
                      +||+.||++|||++|      +++||||++.+
T Consensus       243 ~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~  274 (288)
T d1uu3a_         243 KLLVLDATKRLGCEEMEGYGPLKAHPFFESVT  274 (288)
T ss_dssp             TTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred             HHccCCHhHCcCHHHHcCCHHHHcCCccCCCC
Confidence            999999999999988      58899998864

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-56  Score=376.10  Aligned_cols=236  Identities=22%  Similarity=0.299  Sum_probs=196.8

Q ss_pred             eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee----cCeE
Q psy9858          57 YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY----MSNV  132 (307)
Q Consensus        57 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----~~~~  132 (307)
                      |++.+.||+|+||+||+|++..+++.||+|++.....   .....+.+.+|+++|++++||||+++++++.+    ...+
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~   87 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL---TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI   87 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEE
Confidence            4778899999999999999999999999999975322   22235678899999999999999999999865    4568


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeecCCCCcEEEe-cCCcEEEEeecCccccC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHW--ILHRDLKPNNLLIN-KQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~a~~~~  208 (307)
                      |+||||+ +|+|.+++.+.. .+++..++.++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+|+...
T Consensus        88 ~ivmE~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          88 VLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEEeCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            9999999 678888887543 5899999999999999999999998  99999999999996 57899999999998653


Q ss_pred             CCCcccccceeeceehhhhhhhccccccccccee---ee----eecCCCCCCCCC---------CCCChhhhccccCHHH
Q psy9858         209 SPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FAKDPSSHGNLF---------PGIPLNEIFTAAGDDL  272 (307)
Q Consensus       209 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~~~~~f~~~~~---------~~~~~~~~~~~~~~~l  272 (307)
                      .  ......+||+.|+|||++.+  .++.++|||   ++    ++|+.||.+...         ............++++
T Consensus       167 ~--~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  242 (270)
T d1t4ha_         167 A--SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV  242 (270)
T ss_dssp             T--TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHH
T ss_pred             C--CccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHH
Confidence            3  23345689999999999865  589999999   33    339999976221         1112223345678999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHhcCcccC
Q psy9858         273 LAVISSLLCLNPTKRADCTATLKMDYFS  300 (307)
Q Consensus       273 ~~li~~~l~~dP~~Rpt~~~il~hp~f~  300 (307)
                      .+||.+||+.||++|||++|+|+||||+
T Consensus       243 ~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         243 KEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            9999999999999999999999999996

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.1e-55  Score=373.11  Aligned_cols=246  Identities=20%  Similarity=0.245  Sum_probs=208.8

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccc----hhhhHhHHHHHHHHHhcC-CCCccccceeeee
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAK----DGINRTALREIKLLQELH-HENVLGLTDVFGY  128 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~  128 (307)
                      .++|++.+.||+|+||+||+|++..+|+.||||++.+.......    ......+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            57899999999999999999999999999999999876543322    223456889999999997 9999999999999


Q ss_pred             cCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         129 MSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       129 ~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      ++..||||||+ +|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++..
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  160 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL  160 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CcceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence            99999999999 679999997654 6999999999999999999999999999999999999999999999999999987


Q ss_pred             CCCCcccccceeeceehhhhhhhcc-----ccccccccee-------eeeecCCCCCCCCCC----------CCChhhhc
Q psy9858         208 GSPTRLYTHQVVTRWYRLIKCLLYC-----VQFNVKNVQW-------CCFAKDPSSHGNLFP----------GIPLNEIF  265 (307)
Q Consensus       208 ~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~~Diw-------~i~~~~~~f~~~~~~----------~~~~~~~~  265 (307)
                      .... ......||+.|+|||.+.+.     ..++.++|||       ++++|..||.+....          ........
T Consensus       161 ~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  239 (277)
T d1phka_         161 DPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW  239 (277)
T ss_dssp             CTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTG
T ss_pred             cCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence            5433 34456899999999999743     2468899999       344499999883211          01112234


Q ss_pred             cccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCC
Q psy9858         266 TAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSL  301 (307)
Q Consensus       266 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~  301 (307)
                      .++|+++.+||.+||+.||++|||++|+|+||||++
T Consensus       240 ~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         240 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             ccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence            578999999999999999999999999999999975

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3e-56  Score=383.40  Aligned_cols=243  Identities=21%  Similarity=0.243  Sum_probs=205.4

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEE
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVS  133 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  133 (307)
                      .++|++++.||+|+||+||+|++..+|+.||||++.+....  .....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   80 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV--RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF   80 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHcc--CHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeee
Confidence            56899999999999999999999999999999999753211  2223567889999999999999999999999999999


Q ss_pred             EEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc
Q psy9858         134 LVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR  212 (307)
Q Consensus       134 lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  212 (307)
                      +||||+ +|++..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....  
T Consensus        81 ivmE~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--  157 (316)
T d1fota_          81 MIMDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  157 (316)
T ss_dssp             EEECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             eEeeecCCccccccccccc-cccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence            999999 466666666544 5889999999999999999999999999999999999999999999999999987432  


Q ss_pred             ccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCCC------hhhhccccCHHHHHHHHHh
Q psy9858         213 LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGIP------LNEIFTAAGDDLLAVISSL  279 (307)
Q Consensus       213 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~------~~~~~~~~~~~l~~li~~~  279 (307)
                       ....+||+.|+|||++.+. .|+.++|||   +    +++|..||.+.......      ....+..+++++.++|.+|
T Consensus       158 -~~~~~Gt~~Y~APE~l~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  235 (316)
T d1fota_         158 -TYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRL  235 (316)
T ss_dssp             -BCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred             -cccccCcccccCHHHHcCC-CCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence             3456899999999999887 899999999   3    34499999873221100      1122356899999999999


Q ss_pred             hhcCCCCCC-----CHHHHhcCcccCCCc
Q psy9858         280 LCLNPTKRA-----DCTATLKMDYFSLTK  303 (307)
Q Consensus       280 l~~dP~~Rp-----t~~~il~hp~f~~~~  303 (307)
                      |+.||.+|+     |++++++||||++..
T Consensus       236 L~~dp~~R~~~~r~t~~~il~Hp~f~~i~  264 (316)
T d1fota_         236 ITRDLSQRLGNLQNGTEDVKNHPWFKEVV  264 (316)
T ss_dssp             TCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred             hhhCHHhccccchhhHHHHHcCcccccCC
Confidence            999999996     999999999998753

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.5e-55  Score=375.18  Aligned_cols=244  Identities=34%  Similarity=0.591  Sum_probs=205.1

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEE
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVS  133 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  133 (307)
                      .++|++++.||+|+||+||+|++. +|+.||||++.....   .+...+.+.+|+.+|++++||||+++++++.+++..+
T Consensus         1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~   76 (286)
T d1ob3a_           1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE---DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLV   76 (286)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG---GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEE
T ss_pred             CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc---ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCcee
Confidence            368999999999999999999974 889999999976432   2333577899999999999999999999999999999


Q ss_pred             EEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc
Q psy9858         134 LVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL  213 (307)
Q Consensus       134 lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  213 (307)
                      ++||++.|++...+....+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.|.....+...
T Consensus        77 i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~  156 (286)
T d1ob3a_          77 LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK  156 (286)
T ss_dssp             EEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             EEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccc
Confidence            99999988888888777778999999999999999999999999999999999999999999999999999987655555


Q ss_pred             cccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCC-------------------------------
Q psy9858         214 YTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNL-------------------------------  255 (307)
Q Consensus       214 ~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~-------------------------------  255 (307)
                      .....+++.|+|||.+.+...++.++|||       .+++|..||.+..                               
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T d1ob3a_         157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP  236 (286)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence            55667899999999998876889999999       3444999997521                               


Q ss_pred             ----CCCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCC
Q psy9858         256 ----FPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSL  301 (307)
Q Consensus       256 ----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~  301 (307)
                          ............+++++.+||.+||+.||++|||++|+|+||||++
T Consensus       237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                1111122334567899999999999999999999999999999974

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-56  Score=381.41  Aligned_cols=242  Identities=18%  Similarity=0.244  Sum_probs=208.2

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|++++.||+|+||+||+|.+..+|+.||||++....      .....+.+|+++|+.++||||+++++++++++.+
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~------~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   76 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG------TDQVLVKKEISILNIARHRNILHLHESFESMEEL   76 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT------HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEE
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc------ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            4678999999999999999999999999999999997532      1134577999999999999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecC--CcEEEEeecCccccCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ--GVLKIGDFGLAKFFGS  209 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~--~~~kl~Dfg~a~~~~~  209 (307)
                      |+||||+ +|+|.+++......+++.+++.++.||+.||.|||++||+||||||+|||++.+  ..+||+|||+++....
T Consensus        77 ~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~  156 (321)
T d1tkia_          77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence            9999999 578999998776679999999999999999999999999999999999999854  4899999999998743


Q ss_pred             CCcccccceeeceehhhhhhhccccccccccee---eeee----cCCCCCCCCCC----------CCChhhhccccCHHH
Q psy9858         210 PTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KDPSSHGNLFP----------GIPLNEIFTAAGDDL  272 (307)
Q Consensus       210 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~~~~f~~~~~~----------~~~~~~~~~~~~~~l  272 (307)
                      . .......+|+.|+|||.+.+. .|+.++|||   |+++    |..||.+....          .......+..+|+++
T Consensus       157 ~-~~~~~~~~t~~y~ape~~~~~-~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  234 (321)
T d1tkia_         157 G-DNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA  234 (321)
T ss_dssp             T-CEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred             C-CcccccccccccccchhccCC-CCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHH
Confidence            3 334556889999999999888 899999999   4444    99999873321          111233345689999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         273 LAVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       273 ~~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                      .+||.+||+.||++|||++|+|+||||++.
T Consensus       235 ~~li~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         235 MDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence            999999999999999999999999999754

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.5e-55  Score=385.96  Aligned_cols=246  Identities=20%  Similarity=0.295  Sum_probs=204.3

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHH---HHHHHHhcCCCCccccceeeeec
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALR---EIKLLQELHHENVLGLTDVFGYM  129 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~---e~~~l~~l~h~ni~~~~~~~~~~  129 (307)
                      ..++|++++.||+|+||+||+|++..+|+.||||++.+......  .....+.+   ++++++.++||||+++++++.+.
T Consensus         2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~--~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~   79 (364)
T d1omwa3           2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK--QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP   79 (364)
T ss_dssp             CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHH--TCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred             CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchh--hHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC
Confidence            35789999999999999999999999999999999975322111  11223334   46777788899999999999999


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                      +..|+||||+ +|+|.+++.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus        80 ~~~~ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          80 DKLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  158 (364)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred             CEEEEEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence            9999999999 688988887654 58999999999999999999999999999999999999999999999999999774


Q ss_pred             CCCcccccceeeceehhhhhhhccccccccccee---eee----ecCCCCCCCCCCCC---------ChhhhccccCHHH
Q psy9858         209 SPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCF----AKDPSSHGNLFPGI---------PLNEIFTAAGDDL  272 (307)
Q Consensus       209 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~----~~~~~f~~~~~~~~---------~~~~~~~~~~~~l  272 (307)
                      ..  ......||+.|+|||++.+...|+.++|||   |++    +|..||.+......         .....+..+++++
T Consensus       159 ~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  236 (364)
T d1omwa3         159 KK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL  236 (364)
T ss_dssp             SS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHH
T ss_pred             CC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHH
Confidence            43  234558999999999998665799999999   433    39999987433211         1122345689999


Q ss_pred             HHHHHHhhhcCCCCCCC-----HHHHhcCcccCCCc
Q psy9858         273 LAVISSLLCLNPTKRAD-----CTATLKMDYFSLTK  303 (307)
Q Consensus       273 ~~li~~~l~~dP~~Rpt-----~~~il~hp~f~~~~  303 (307)
                      .+||.+||+.||++|||     ++|+++||||++.+
T Consensus       237 ~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~  272 (364)
T d1omwa3         237 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD  272 (364)
T ss_dssp             HHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCC
T ss_pred             HHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCC
Confidence            99999999999999999     79999999998764

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-56  Score=376.88  Aligned_cols=246  Identities=20%  Similarity=0.235  Sum_probs=202.5

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccch-hhhHhHHHHHHHHHhcC--CCCccccceeeeecC
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKD-GINRTALREIKLLQELH--HENVLGLTDVFGYMS  130 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~~~~e~~~l~~l~--h~ni~~~~~~~~~~~  130 (307)
                      .++|++.+.||+|+||+||+|++..+|+.||||++.+....+... .....+.+|+.++++++  ||||+++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            458999999999999999999999999999999998643332211 11234668999999996  899999999999999


Q ss_pred             eEEEEEEccC--CChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecC-CcEEEEeecCcccc
Q psy9858         131 NVSLVFEFVD--TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ-GVLKIGDFGLAKFF  207 (307)
Q Consensus       131 ~~~lv~e~~~--g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~a~~~  207 (307)
                      ..++||||+.  +++.+++.... .+++.+++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+..
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~  161 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL  161 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             eEEEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence            9999999995  35666665443 58999999999999999999999999999999999999854 79999999999876


Q ss_pred             CCCCcccccceeeceehhhhhhhccccccccccee---ee----eecCCCCCCCCCCCCChhhhccccCHHHHHHHHHhh
Q psy9858         208 GSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FAKDPSSHGNLFPGIPLNEIFTAAGDDLLAVISSLL  280 (307)
Q Consensus       208 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~~~~~f~~~~~~~~~~~~~~~~~~~~l~~li~~~l  280 (307)
                      ..  .......||+.|+|||++.+...++.++|||   |+    ++|+.||.+..............+|+++.+||.+||
T Consensus       162 ~~--~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~~~~~~~~~~~s~~~~~li~~~L  239 (273)
T d1xwsa_         162 KD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCL  239 (273)
T ss_dssp             CS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCCCCSSCCCHHHHHHHHHHT
T ss_pred             cc--ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHhhcccCCCCCCCHHHHHHHHHHc
Confidence            43  2345568999999999998875678899999   33    349999987211000111233568999999999999


Q ss_pred             hcCCCCCCCHHHHhcCcccCCC
Q psy9858         281 CLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       281 ~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                      +.||++|||++|+|+||||++.
T Consensus       240 ~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         240 ALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             CSSGGGSCCHHHHHTSGGGSSC
T ss_pred             cCCHhHCcCHHHHhcCHhhCCC
Confidence            9999999999999999999875

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.8e-55  Score=383.45  Aligned_cols=244  Identities=24%  Similarity=0.276  Sum_probs=207.5

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeE
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  132 (307)
                      ..++|++++.||+|+||+||+|++..+|+.||||++.+....  .....+.+.+|+++|+.++||||+++++++.+....
T Consensus        39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  116 (350)
T d1rdqe_          39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV--KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL  116 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH--HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHcc--CHHHHHHHHHHHHHHHHcCCCcEeeccccccccccc
Confidence            468999999999999999999999999999999999753211  122346688999999999999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT  211 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  211 (307)
                      ++||||+ +|++.+++.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..... 
T Consensus       117 ~~v~e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-  194 (350)
T d1rdqe_         117 YMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             ccccccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence            9999999 678888876554 5899999999999999999999999999999999999999999999999999987432 


Q ss_pred             cccccceeeceehhhhhhhccccccccccee---eee----ecCCCCCCCCCCCCC------hhhhccccCHHHHHHHHH
Q psy9858         212 RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCF----AKDPSSHGNLFPGIP------LNEIFTAAGDDLLAVISS  278 (307)
Q Consensus       212 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~----~~~~~f~~~~~~~~~------~~~~~~~~~~~l~~li~~  278 (307)
                        .....||+.|+|||++.+. .++.++|||   |++    +|..||.+.......      ....+..+++++.+||.+
T Consensus       195 --~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  271 (350)
T d1rdqe_         195 --TWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN  271 (350)
T ss_dssp             --BCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHH
T ss_pred             --cccccCccccCCHHHHcCC-CCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHH
Confidence              3456899999999999987 899999999   333    399999873211100      012234689999999999


Q ss_pred             hhhcCCCCCC-----CHHHHhcCcccCCCc
Q psy9858         279 LLCLNPTKRA-----DCTATLKMDYFSLTK  303 (307)
Q Consensus       279 ~l~~dP~~Rp-----t~~~il~hp~f~~~~  303 (307)
                      ||+.||.+|+     |++++++||||++.+
T Consensus       272 ~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~  301 (350)
T d1rdqe_         272 LLQVDLTKRFGNLKNGVNDIKNHKWFATTD  301 (350)
T ss_dssp             HSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred             HhhhCHHhccccccccHHHHHcCccccCCC
Confidence            9999999995     999999999998764

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-54  Score=370.58  Aligned_cols=249  Identities=33%  Similarity=0.549  Sum_probs=202.5

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCC-CcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc---CCCCccccceee
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIET-DMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL---HHENVLGLTDVF  126 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~ni~~~~~~~  126 (307)
                      +...++|++++.||+|+||+||+|++..+ ++.||||++......   +.....+.+|+.+++.+   +||||+++++++
T Consensus         3 c~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~---~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~   79 (305)
T d1blxa_           3 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE---EGMPLSTIREVAVLRHLETFEHPNVVRLFDVC   79 (305)
T ss_dssp             CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT---TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred             CCCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhcc---chHHHHHHHHHHHHHHHhhcCCCCcceeeeee
Confidence            34568999999999999999999999765 677999999753222   22234566788877766   799999999988


Q ss_pred             e-----ecCeEEEEEEccCCChHH-HHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEe
Q psy9858         127 G-----YMSNVSLVFEFVDTDLEV-IIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGD  200 (307)
Q Consensus       127 ~-----~~~~~~lv~e~~~g~l~~-~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~D  200 (307)
                      .     .....+++|||++|++.. ........+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus        80 ~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~d  159 (305)
T d1blxa_          80 TVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD  159 (305)
T ss_dssp             EEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred             cccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecc
Confidence            5     346799999999776554 4445555689999999999999999999999999999999999999999999999


Q ss_pred             ecCccccCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCC------------------
Q psy9858         201 FGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNL------------------  255 (307)
Q Consensus       201 fg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~------------------  255 (307)
                      ||+++.... ........||+.|+|||++.+. .|+.++|||   |    +++|.+||.+..                  
T Consensus       160 fg~~~~~~~-~~~~~~~~gT~~Y~APE~~~~~-~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  237 (305)
T d1blxa_         160 FGLARIYSF-QMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  237 (305)
T ss_dssp             CCSCCCCCG-GGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             hhhhhhhcc-cccCCCcccChhhcCcchhcCC-CCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence            999987633 3344567899999999999887 899999999   3    334999997621                  


Q ss_pred             ---------------CCCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         256 ---------------FPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       256 ---------------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                                     ............+++.+.+||.+||+.||++|||++|+|+||||++.++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~  301 (305)
T d1blxa_         238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  301 (305)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence                           1111222334567899999999999999999999999999999998754

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-55  Score=377.55  Aligned_cols=245  Identities=23%  Similarity=0.247  Sum_probs=206.0

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHH-hcCCCCccccceeeeecCeE
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQ-ELHHENVLGLTDVFGYMSNV  132 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~ni~~~~~~~~~~~~~  132 (307)
                      .++|++++.||+|+||+||+|++..+|+.||||++.+....  .+.....+.+|..++. .++||||+++++++.+.+..
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~--~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~   78 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL--MDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   78 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhcc--ChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCce
Confidence            36799999999999999999999999999999999753211  1122345667777665 68999999999999999999


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT  211 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  211 (307)
                      |+||||+ +|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus        79 yivmEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~  157 (320)
T d1xjda_          79 FFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  157 (320)
T ss_dssp             EEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             eEEEeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence            9999999 678998887554 58999999999999999999999999999999999999999999999999999876555


Q ss_pred             cccccceeeceehhhhhhhccccccccccee---eee----ecCCCCCCCCCCCC------ChhhhccccCHHHHHHHHH
Q psy9858         212 RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCF----AKDPSSHGNLFPGI------PLNEIFTAAGDDLLAVISS  278 (307)
Q Consensus       212 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~----~~~~~f~~~~~~~~------~~~~~~~~~~~~l~~li~~  278 (307)
                      .......||+.|+|||++.+. .++.++|||   |++    +|..||.+......      .....+..+|+++.+||.+
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~  236 (320)
T d1xjda_         158 AKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVK  236 (320)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred             ccccccCCCCCcCCHHHHcCC-CCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence            556667899999999999988 899999999   333    39999987322110      0112234689999999999


Q ss_pred             hhhcCCCCCCCHH-HHhcCcccCCC
Q psy9858         279 LLCLNPTKRADCT-ATLKMDYFSLT  302 (307)
Q Consensus       279 ~l~~dP~~Rpt~~-~il~hp~f~~~  302 (307)
                      ||+.||++|||++ ++++||||++.
T Consensus       237 ~L~~dP~~R~s~~~~l~~hpff~~~  261 (320)
T d1xjda_         237 LFVREPEKRLGVRGDIRQHPLFREI  261 (320)
T ss_dssp             HSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             hcccCCCCCcCHHHHHHhCchhccC
Confidence            9999999999996 89999999875

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-54  Score=374.53  Aligned_cols=238  Identities=23%  Similarity=0.269  Sum_probs=199.2

Q ss_pred             ccceeeEEe-EEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeee--
Q psy9858          53 DLLVYYQWR-SVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGY--  128 (307)
Q Consensus        53 ~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~--  128 (307)
                      ..++|++++ .||+|+||+||+|++..+|+.||||++..          ...+.+|++++.++ +||||+++++++++  
T Consensus         9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~   78 (335)
T d2ozaa1           9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----------CPKARREVELHWRASQCPHIVRIVDVYENLY   78 (335)
T ss_dssp             GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC----------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC----------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecc
Confidence            467899886 59999999999999999999999999863          23467899987655 89999999999876  


Q ss_pred             --cCeEEEEEEcc-CCChHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEec---CCcEEEEee
Q psy9858         129 --MSNVSLVFEFV-DTDLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK---QGVLKIGDF  201 (307)
Q Consensus       129 --~~~~~lv~e~~-~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~---~~~~kl~Df  201 (307)
                        ...+|+||||+ +|+|.+++.+.. ..+++.+++.++.||+.||+|||++||+||||||+|||++.   ++.+||+||
T Consensus        79 ~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DF  158 (335)
T d2ozaa1          79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF  158 (335)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             cCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccc
Confidence              46799999999 579999998653 46999999999999999999999999999999999999985   557999999


Q ss_pred             cCccccCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCC--------------C
Q psy9858         202 GLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGI--------------P  260 (307)
Q Consensus       202 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~--------------~  260 (307)
                      |+|+..... .......||+.|+|||++.+. .|+.++|||   |    +++|.+||.+......              .
T Consensus       159 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~  236 (335)
T d2ozaa1         159 GFAKETTSH-NSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF  236 (335)
T ss_dssp             TTCEECCCC-CCCCCCSCCCSSCCCCCCCGG-GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSC
T ss_pred             ceeeeccCC-CccccccCCcccCCcHHHcCC-CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCC
Confidence            999987543 334556899999999999887 899999999   3    3449999976332111              0


Q ss_pred             hhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         261 LNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       261 ~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                      ....+..+|+++.+||.+||+.||++|||++|+|+||||.+.
T Consensus       237 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence            112234689999999999999999999999999999999654

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=373.16  Aligned_cols=243  Identities=33%  Similarity=0.488  Sum_probs=201.9

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC--
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS--  130 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--  130 (307)
                      ..++|++++.||+|+||+||+|++..+|+.||||++.+..   ..+...+.+.+|+++|+.++||||+++++++...+  
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~   92 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF---QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL   92 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT---SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh---cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccc
Confidence            4578999999999999999999999999999999997532   23334567889999999999999999999997654  


Q ss_pred             ----eEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         131 ----NVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       131 ----~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                          .+|+||||+++++..+....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus        93 ~~~~~~~lv~e~~~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          93 DDFTDFYLVMPFMGTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  170 (346)
T ss_dssp             TTCCCCEEEEECCSEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             cccceEEEEEecccccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceec
Confidence                57999999987787777654  489999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCcccccceeeceehhhhhhhccccccccccee---eee----ecCCCCCCC-------------------------
Q psy9858         207 FGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCF----AKDPSSHGN-------------------------  254 (307)
Q Consensus       207 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~----~~~~~f~~~-------------------------  254 (307)
                      ...   ..+...+|+.|+|||.+.+...++.++|||   |++    +|.+||.+.                         
T Consensus       171 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (346)
T d1cm8a_         171 ADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ  247 (346)
T ss_dssp             CCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred             cCC---ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence            643   234568999999999998876789999999   333    399999762                         


Q ss_pred             ------------CCCCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         255 ------------LFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       255 ------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                                  ............++++++.+||.+||+.||.+|||++|+|+||||++..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             chhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence                        1223333444567899999999999999999999999999999998753

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-53  Score=366.82  Aligned_cols=252  Identities=37%  Similarity=0.599  Sum_probs=204.0

Q ss_pred             ceeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeee
Q psy9858          48 CEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG  127 (307)
Q Consensus        48 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~  127 (307)
                      |..+...++|++++.||+|+||+||+|++..+|+.||||++.....   .+.....+.+|+++|++++||||+++++++.
T Consensus         3 ~~~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~E~~il~~l~h~nii~~~~~~~   79 (318)
T d3blha1           3 CPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE---KEGFPITALREIKILQLLKHENVVNLIEICR   79 (318)
T ss_dssp             CTTSCBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C---TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCCCCccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc---chHHHHHHHHHHHHHHHhcCCCccceEeeee
Confidence            4456678999999999999999999999999999999999876432   2334567889999999999999999999875


Q ss_pred             e--------cCeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEE
Q psy9858         128 Y--------MSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIG  199 (307)
Q Consensus       128 ~--------~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~  199 (307)
                      .        +...+++|||+.+++..........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus        80 ~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~  159 (318)
T d3blha1          80 TKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLA  159 (318)
T ss_dssp             C----------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEEC
T ss_pred             cccccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEee
Confidence            4        45689999999888888777777779999999999999999999999999999999999999999999999


Q ss_pred             eecCccccCCCC----cccccceeeceehhhhhhhccccccccccee---ee----eecCCCCCCCC-------------
Q psy9858         200 DFGLAKFFGSPT----RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FAKDPSSHGNL-------------  255 (307)
Q Consensus       200 Dfg~a~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~~~~~f~~~~-------------  255 (307)
                      |||+++......    ......+||+.|+|||.+.+...++.++|||   |+    +.|..||.+..             
T Consensus       160 dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~  239 (318)
T d3blha1         160 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG  239 (318)
T ss_dssp             CCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcC
Confidence            999998764321    2233457999999999998876899999999   33    33999997611             


Q ss_pred             -CCCC--------C--------------hhhhc--cccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         256 -FPGI--------P--------------LNEIF--TAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       256 -~~~~--------~--------------~~~~~--~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                       ....        .              ....+  ...++++.+||.+||+.||++|||++|+|+||||+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence             0000        0              00000  1236788999999999999999999999999999863

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-53  Score=359.20  Aligned_cols=245  Identities=36%  Similarity=0.586  Sum_probs=206.9

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  134 (307)
                      ++|++++.||+|+||+||+|++..+|+.||||++....   ..+.....+.+|+.+++.++||||+++++++.+....++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~i   78 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD---DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL   78 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC---SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh---CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeE
Confidence            68999999999999999999999999999999997643   223346778999999999999999999999999999999


Q ss_pred             EEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCccc
Q psy9858         135 VFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRLY  214 (307)
Q Consensus       135 v~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  214 (307)
                      +++++.|..+..+....+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|+.........
T Consensus        79 v~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~  158 (292)
T d1unla_          79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY  158 (292)
T ss_dssp             EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC
T ss_pred             EeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccc
Confidence            99999766555555556678999999999999999999999999999999999999999999999999999886665566


Q ss_pred             ccceeeceehhhhhhhccccccccccee---e----eeecCCCCC-CCC-------------------------------
Q psy9858         215 THQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSH-GNL-------------------------------  255 (307)
Q Consensus       215 ~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~-~~~-------------------------------  255 (307)
                      ....+++.|+|||.+.+...++.++|||   |    +++|..||. +..                               
T Consensus       159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (292)
T d1unla_         159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP  238 (292)
T ss_dssp             CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred             eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccc
Confidence            6667889999999998876789999999   3    333777653 200                               


Q ss_pred             ----CCCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCC
Q psy9858         256 ----FPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLT  302 (307)
Q Consensus       256 ----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~  302 (307)
                          ............+++.+.+||.+||+.||++|||++|+|+||||++.
T Consensus       239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~  289 (292)
T d1unla_         239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred             cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence                00111222334578899999999999999999999999999999864

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-53  Score=359.48  Aligned_cols=240  Identities=18%  Similarity=0.197  Sum_probs=195.4

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM  129 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  129 (307)
                      |....++|++.+.||+|+||+||+|++.   ..||||++......   ....+.|.+|++++++++||||+++++++. +
T Consensus         3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~   75 (276)
T d1uwha_           3 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPT---PQQLQAFKNEVGVLRKTRHVNILLFMGYST-A   75 (276)
T ss_dssp             CBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCC---TTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred             cccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-c
Confidence            4456788999999999999999999843   35999999754322   223567899999999999999999999764 5


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                      +..++||||+ +|+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus        76 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~  155 (276)
T d1uwha_          76 PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS  155 (276)
T ss_dssp             SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred             cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence            6789999999 589999998776679999999999999999999999999999999999999999999999999998764


Q ss_pred             CCC--cccccceeeceehhhhhhhcc--ccccccccee-------eeeecCCCCCCCC------------CCCCChhhhc
Q psy9858         209 SPT--RLYTHQVVTRWYRLIKCLLYC--VQFNVKNVQW-------CCFAKDPSSHGNL------------FPGIPLNEIF  265 (307)
Q Consensus       209 ~~~--~~~~~~~~t~~y~aPE~~~~~--~~~~~~~Diw-------~i~~~~~~f~~~~------------~~~~~~~~~~  265 (307)
                      ...  .......||+.|+|||++.+.  ..|+.++|||       .+++|+.||.+..            ..........
T Consensus       156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~  235 (276)
T d1uwha_         156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR  235 (276)
T ss_dssp             ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSC
T ss_pred             ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcc
Confidence            322  233455789999999999753  2589999999       3444999998722            1222333445


Q ss_pred             cccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         266 TAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       266 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      .++++++.+|+.+||+.||++|||++|++++
T Consensus       236 ~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         236 SNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            6789999999999999999999999999987

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.1e-52  Score=364.20  Aligned_cols=239  Identities=26%  Similarity=0.424  Sum_probs=197.2

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-CCCccccceeeee--c
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-HENVLGLTDVFGY--M  129 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~--~  129 (307)
                      ..++|+++++||+|+||+||+|++..+|+.||||++....        .+.+.+|+++|+.+. ||||+++++++..  .
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~  104 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--------KKKIKREIKILENLRGGPNIITLADIVKDPVS  104 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCC
Confidence            4578999999999999999999999999999999987421        356789999999995 9999999999874  4


Q ss_pred             CeEEEEEEccC-CChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCC-cEEEEeecCcccc
Q psy9858         130 SNVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG-VLKIGDFGLAKFF  207 (307)
Q Consensus       130 ~~~~lv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a~~~  207 (307)
                      ...++||||+. |+|....    +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|...
T Consensus       105 ~~~~~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~  180 (328)
T d3bqca1         105 RTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  180 (328)
T ss_dssp             CSEEEEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred             CceeEEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceec
Confidence            57999999995 5565442    2489999999999999999999999999999999999999755 6899999999887


Q ss_pred             CCCCcccccceeeceehhhhhhhccccccccccee---eeee----cCCCCCCCCC------------------------
Q psy9858         208 GSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KDPSSHGNLF------------------------  256 (307)
Q Consensus       208 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~~~~f~~~~~------------------------  256 (307)
                      ... .......+|+.|+|||.+.+...++.++|||   |+++    |..||.....                        
T Consensus       181 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  259 (328)
T d3bqca1         181 HPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  259 (328)
T ss_dssp             CTT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             cCC-CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence            443 3345568899999999999876789999999   4333    8888865210                        


Q ss_pred             ---------------CCCC-----hhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCcc
Q psy9858         257 ---------------PGIP-----LNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTKE  304 (307)
Q Consensus       257 ---------------~~~~-----~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~~  304 (307)
                                     ....     .......+++++.+||.+||+.||++|||++|+|+||||+++..
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~  327 (328)
T d3bqca1         260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  327 (328)
T ss_dssp             TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred             ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence                           0000     01112347889999999999999999999999999999998753

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.8e-53  Score=361.50  Aligned_cols=240  Identities=18%  Similarity=0.238  Sum_probs=199.7

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY  128 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  128 (307)
                      .+....++|++.+.||+|+||+||+|.+..+|+.||||++.....      ..+.|.+|+++|++++||||+++++++.+
T Consensus        11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~------~~~~~~~E~~il~~l~HpnIv~~~~~~~~   84 (287)
T d1opja_          11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM------EVEEFLKEAAVMKEIKHPNLVQLLGVCTR   84 (287)
T ss_dssp             TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc------hHHHHHHHHHHHHhCCCCCEecCCccEee
Confidence            345567899999999999999999999999999999999874321      14568999999999999999999999999


Q ss_pred             cCeEEEEEEcc-CCChHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         129 MSNVSLVFEFV-DTDLEVIIKD-PTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       129 ~~~~~lv~e~~-~g~l~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                      ++..++||||+ +|+|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus        85 ~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~  164 (287)
T d1opja_          85 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL  164 (287)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred             CCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceee
Confidence            99999999999 6888888864 445689999999999999999999999999999999999999999999999999998


Q ss_pred             cCCCCc-ccccceeeceehhhhhhhccccccccccee---e----eeecC-CCCCCCCCC-------CCChhhhccccCH
Q psy9858         207 FGSPTR-LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKD-PSSHGNLFP-------GIPLNEIFTAAGD  270 (307)
Q Consensus       207 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~-~~f~~~~~~-------~~~~~~~~~~~~~  270 (307)
                      ...... ......+++.|+|||.+.+. .|+.++|||   +    ++++. ++|.+....       .......+..+++
T Consensus       165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~  243 (287)
T d1opja_         165 MTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE  243 (287)
T ss_dssp             CCSSSSEEETTEEECGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred             cCCCCceeeccccccccccChHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchH
Confidence            754322 23344688999999999987 899999999   3    33344 444442111       1111233456899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         271 DLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       271 ~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      ++.+||.+||+.||++|||++|+++
T Consensus       244 ~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         244 KVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            9999999999999999999999976

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-52  Score=365.18  Aligned_cols=244  Identities=31%  Similarity=0.481  Sum_probs=201.2

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec----
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM----  129 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~----  129 (307)
                      ..+|++++.||+|+||+||+|++..+|+.||||++.+..    .....+.+.+|+++|++++||||+++++++...    
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~   82 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE----HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ   82 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT----CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc----ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccc
Confidence            357999999999999999999999999999999997532    233456788999999999999999999998654    


Q ss_pred             -CeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         130 -SNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       130 -~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                       ...++++++.+|+|.+++...  .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....
T Consensus        83 ~~~~~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~  160 (345)
T d1pmea_          83 MKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  160 (345)
T ss_dssp             CCCEEEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             cceEEEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence             346777776689999998765  48999999999999999999999999999999999999999999999999998764


Q ss_pred             CCC---cccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCC-----------------------
Q psy9858         209 SPT---RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNL-----------------------  255 (307)
Q Consensus       209 ~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~-----------------------  255 (307)
                      ...   ......++|+.|+|||++.....++.++|||       .+++|..||.+..                       
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (345)
T d1pmea_         161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI  240 (345)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred             CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence            321   1234567899999999997776889999999       3344999997621                       


Q ss_pred             --------------CCCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         256 --------------FPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       256 --------------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                                    ............+++++.+||.+||+.||.+|||++|+|+||||+...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~  302 (345)
T d1pmea_         241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY  302 (345)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred             hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence                          112223344567889999999999999999999999999999998543

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-52  Score=365.45  Aligned_cols=240  Identities=25%  Similarity=0.403  Sum_probs=197.3

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee-----
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY-----  128 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-----  128 (307)
                      ..+|+.+++||+|+||+||+|++..+|+.||||++....         ....+|+++|++++||||+++++++..     
T Consensus        19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~---------~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~   89 (350)
T d1q5ka_          19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKK   89 (350)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---------SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CC
T ss_pred             cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc---------hHHHHHHHHHHhcCCCCCCcEEEEEEecCccC
Confidence            447999999999999999999999999999999997532         112379999999999999999999843     


Q ss_pred             -cCeEEEEEEccCCChHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCC-cEEEEeecC
Q psy9858         129 -MSNVSLVFEFVDTDLEVIIK---DPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQG-VLKIGDFGL  203 (307)
Q Consensus       129 -~~~~~lv~e~~~g~l~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~  203 (307)
                       ..+++|||||+++++.+.+.   .....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus        90 ~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~  169 (350)
T d1q5ka_          90 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS  169 (350)
T ss_dssp             SCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred             CceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccc
Confidence             34689999999877655543   3444699999999999999999999999999999999999999775 899999999


Q ss_pred             ccccCCCCcccccceeeceehhhhhhhccccccccccee---eeee----cCCCCCCCCC--------------------
Q psy9858         204 AKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCFA----KDPSSHGNLF--------------------  256 (307)
Q Consensus       204 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~~----~~~~f~~~~~--------------------  256 (307)
                      +...... .......||+.|+|||.+.+...++.++|||   |+++    |..||.....                    
T Consensus       170 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~  248 (350)
T d1q5ka_         170 AKQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR  248 (350)
T ss_dssp             CEECCTT-SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             hhhccCC-cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence            9887443 3344568999999999998876899999999   4333    9999975210                    


Q ss_pred             -----------CCC----ChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         257 -----------PGI----PLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       257 -----------~~~----~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                                 +..    .........++++.+||.+||+.||++|||++|+|+||||+...
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence                       000    01112235789999999999999999999999999999998754

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1e-52  Score=358.96  Aligned_cols=240  Identities=20%  Similarity=0.245  Sum_probs=188.2

Q ss_pred             cccceeeEEeEEeecCceEEEEEEEcCCCc---EEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee
Q psy9858          52 NDLLVYYQWRSVHVGRFATVFKARDIETDM---IVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY  128 (307)
Q Consensus        52 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  128 (307)
                      ...++|++.+.||+|+||+||+|++..+|+   .||||++....    .....+.|.+|+++|++++||||+++++++.+
T Consensus        23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~   98 (299)
T d1jpaa_          23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY----TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK   98 (299)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc----CHHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence            345789999999999999999999876664   68899886432    22335678999999999999999999999999


Q ss_pred             cCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         129 MSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       129 ~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      .+..++||||+ +|+|.+++....+.+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus        99 ~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  178 (299)
T d1jpaa_          99 STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL  178 (299)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             CCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEc
Confidence            99999999999 67888888887777999999999999999999999999999999999999999999999999999877


Q ss_pred             CCCCcc-----cccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCC-------CCChhhhccc
Q psy9858         208 GSPTRL-----YTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFP-------GIPLNEIFTA  267 (307)
Q Consensus       208 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~-------~~~~~~~~~~  267 (307)
                      ......     .....+|+.|+|||.+.+. .++.++|||       .+++ |++||.+....       .......+..
T Consensus       179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  257 (299)
T d1jpaa_         179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMD  257 (299)
T ss_dssp             -----------------CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred             cCCCCcceeeecccccCCccccCHHHHhcC-CCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence            533221     1123568899999999887 899999999       3443 89999873211       1111223456


Q ss_pred             cCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         268 AGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       268 ~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      +++++.+|+.+||+.||++|||++|++++
T Consensus       258 ~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         258 CPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             chHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            89999999999999999999999988765

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-53  Score=355.55  Aligned_cols=235  Identities=18%  Similarity=0.262  Sum_probs=187.5

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEE
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVS  133 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  133 (307)
                      .++|++++.||+|+||+||+|.+. +++.||||++.....      ..+.|.+|++++++++||||+++++++.+++..+
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM------SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   76 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC------cHHHHHHHHHHHHhcCCCCcccccceeccCCceE
Confidence            468999999999999999999964 678899999875321      1356899999999999999999999999999999


Q ss_pred             EEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc
Q psy9858         134 LVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR  212 (307)
Q Consensus       134 lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  212 (307)
                      +||||+ +|+|.+++......+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.......
T Consensus        77 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~  156 (263)
T d1sm2a_          77 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  156 (263)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred             EEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence            999999 6889999887777789999999999999999999999999999999999999999999999999987754322


Q ss_pred             -ccccceeeceehhhhhhhccccccccccee---e----eee-cCCCCCCCCCCC-------CChhhhccccCHHHHHHH
Q psy9858         213 -LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPSSHGNLFPG-------IPLNEIFTAAGDDLLAVI  276 (307)
Q Consensus       213 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~f~~~~~~~-------~~~~~~~~~~~~~l~~li  276 (307)
                       ......||+.|+|||++.+. .++.++|||   +    +++ |.+||.......       ......+..+++++.+|+
T Consensus       157 ~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li  235 (263)
T d1sm2a_         157 TSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIM  235 (263)
T ss_dssp             --------CTTSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHH
T ss_pred             eeecceecCcccCChHHhcCC-CCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHH
Confidence             22345789999999999887 899999999   2    333 566666522110       011122345789999999


Q ss_pred             HHhhhcCCCCCCCHHHHhcC
Q psy9858         277 SSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       277 ~~~l~~dP~~Rpt~~~il~h  296 (307)
                      .+||+.||++|||++|+++|
T Consensus       236 ~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         236 NHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCCHhHCcCHHHHHHH
Confidence            99999999999999999986

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=362.48  Aligned_cols=242  Identities=21%  Similarity=0.273  Sum_probs=199.7

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEcCCC-----cEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccc
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDIETD-----MIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLT  123 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~  123 (307)
                      +....++|++++.||+|+||+||+|++..++     ..||+|++....    .......+.+|+.++.++ +||||++++
T Consensus        32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~HpnIv~l~  107 (325)
T d1rjba_          32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA----DSSEREALMSELKMMTQLGSHENIVNLL  107 (325)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc----CHHHHHHHHHHHHHHHHhcCCCcEeEEE
Confidence            4456689999999999999999999986554     379999987432    222346788999999998 899999999


Q ss_pred             eeeeecCeEEEEEEcc-CCChHHHHhCCCC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy9858         124 DVFGYMSNVSLVFEFV-DTDLEVIIKDPTI----------------------VFTPSNIKAYAIMTLRGLEYLHDHWILH  180 (307)
Q Consensus       124 ~~~~~~~~~~lv~e~~-~g~l~~~~~~~~~----------------------~~~~~~~~~i~~~i~~~l~~lH~~~ivH  180 (307)
                      +++.+.+..++||||+ +|+|.+++.....                      .+++..++.++.||+.||+|||++||+|
T Consensus       108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiH  187 (325)
T d1rjba_         108 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH  187 (325)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred             EEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence            9999999999999999 6899999976532                      3788999999999999999999999999


Q ss_pred             ecCCCCcEEEecCCcEEEEeecCccccCCCCc--ccccceeeceehhhhhhhccccccccccee-------eeee-cCCC
Q psy9858         181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR--LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPS  250 (307)
Q Consensus       181 ~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~  250 (307)
                      |||||+||+++.++.+||+|||+|+.......  ......+|+.|+|||++.+. .++.++|||       .+++ |.+|
T Consensus       188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwS~Gvil~emlt~g~~P  266 (325)
T d1rjba_         188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNP  266 (325)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             ccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC-CCCcceeccchhHHHHHHHhCCCCC
Confidence            99999999999999999999999987644332  23355789999999999887 899999999       3444 8999


Q ss_pred             CCCCCCCCC--------ChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         251 SHGNLFPGI--------PLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       251 f~~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      |.+......        .....+..+++++.+||.+||+.||++|||++|+++|
T Consensus       267 f~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         267 YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             STTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            987433211        1123345789999999999999999999999999986

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-52  Score=354.38  Aligned_cols=242  Identities=20%  Similarity=0.268  Sum_probs=199.8

Q ss_pred             ccceeeEEeE-EeecCceEEEEEEEcC--CCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec
Q psy9858          53 DLLVYYQWRS-VHVGRFATVFKARDIE--TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM  129 (307)
Q Consensus        53 ~~~~y~~~~~-lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  129 (307)
                      ..++|.+.+. ||+|+||+||+|.+..  ++..||||++....    .....+.|.+|+++|++++||||+++++++.+ 
T Consensus         6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~----~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-   80 (285)
T d1u59a_           6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT----EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-   80 (285)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC----CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred             cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc----CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-
Confidence            4467888885 9999999999998653  45689999997532    22335678999999999999999999999865 


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                      +..|+||||+ +|+|.+++......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+|+...
T Consensus        81 ~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          81 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG  160 (285)
T ss_dssp             SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence            4689999999 578988887776679999999999999999999999999999999999999999999999999999875


Q ss_pred             CCCcc---cccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCC-------CCChhhhccccCH
Q psy9858         209 SPTRL---YTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFP-------GIPLNEIFTAAGD  270 (307)
Q Consensus       209 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~-------~~~~~~~~~~~~~  270 (307)
                      .....   .....+|+.|+|||.+.+. .++.++|||       .+++ |..||.+....       .....+.+..+++
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~  239 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP  239 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCH
T ss_pred             ccccccccccccccCccccChHHHhCC-CCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCH
Confidence            43322   2344688999999999887 899999999       2454 89999874321       1122234567899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHH---hcCcccC
Q psy9858         271 DLLAVISSLLCLNPTKRADCTAT---LKMDYFS  300 (307)
Q Consensus       271 ~l~~li~~~l~~dP~~Rpt~~~i---l~hp~f~  300 (307)
                      ++.+||.+||+.||++|||+.++   |+|+|+.
T Consensus       240 ~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         240 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            99999999999999999999888   6778873

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-53  Score=355.50  Aligned_cols=245  Identities=20%  Similarity=0.265  Sum_probs=199.1

Q ss_pred             ceeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeee
Q psy9858          48 CEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG  127 (307)
Q Consensus        48 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~  127 (307)
                      ..+....++|++++.||+|+||+||+|.+. +++.||||++....      ...+.|.+|++++++++||||+++++++.
T Consensus         6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~   78 (272)
T d1qpca_           6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS------MSPDAFLAEANLMKQLQHQRLVRLYAVVT   78 (272)
T ss_dssp             CTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS------SCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc------CCHHHHHHHHHHHHhCCCCCEeEEEeeec
Confidence            345556789999999999999999999964 67889999997432      11356899999999999999999999875


Q ss_pred             ecCeEEEEEEcc-CCChHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcc
Q psy9858         128 YMSNVSLVFEFV-DTDLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK  205 (307)
Q Consensus       128 ~~~~~~lv~e~~-~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  205 (307)
                      + +..++||||+ +|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+
T Consensus        79 ~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~  157 (272)
T d1qpca_          79 Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR  157 (272)
T ss_dssp             S-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             c-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceE
Confidence            4 5679999999 678888775443 248999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCC-cccccceeeceehhhhhhhccccccccccee---e----eee-cCCCCCCCCCC-------CCChhhhccccC
Q psy9858         206 FFGSPT-RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPSSHGNLFP-------GIPLNEIFTAAG  269 (307)
Q Consensus       206 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~f~~~~~~-------~~~~~~~~~~~~  269 (307)
                      ...... .......+|+.|+|||++.+. .++.++|||   +    +++ |.+|+......       .......+..++
T Consensus       158 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~  236 (272)
T d1qpca_         158 LIEDNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCP  236 (272)
T ss_dssp             ECSSSCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred             EccCCccccccccCCcccccChHHHhCC-CCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccCh
Confidence            875433 223445789999999999887 899999999   2    333 45555542110       111122345689


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHhc--CcccCC
Q psy9858         270 DDLLAVISSLLCLNPTKRADCTATLK--MDYFSL  301 (307)
Q Consensus       270 ~~l~~li~~~l~~dP~~Rpt~~~il~--hp~f~~  301 (307)
                      +++.+|+.+||+.||++|||++++++  |+||..
T Consensus       237 ~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         237 EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            99999999999999999999999998  788864

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-52  Score=349.74  Aligned_cols=235  Identities=20%  Similarity=0.244  Sum_probs=199.8

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEE
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVS  133 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  133 (307)
                      .++|++++.||+|+||+||+|++ .+++.||||++.....      ..+.|.+|++++++++||||+++++++.+++.++
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~------~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~   75 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSM------SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF   75 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSS------CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEE
T ss_pred             hHHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcC------CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceE
Confidence            46899999999999999999997 5788999999986422      1356899999999999999999999999999999


Q ss_pred             EEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCc
Q psy9858         134 LVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR  212 (307)
Q Consensus       134 lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  212 (307)
                      +||||+ +|++.+++......+++..+..++.||++||.|||++||+||||||+||+++.++.+||+|||+++.......
T Consensus        76 iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~  155 (258)
T d1k2pa_          76 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  155 (258)
T ss_dssp             EEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred             EEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence            999999 5788888887777799999999999999999999999999999999999999999999999999987654322


Q ss_pred             -ccccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCC-------CCChhhhccccCHHHHHHH
Q psy9858         213 -LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFP-------GIPLNEIFTAAGDDLLAVI  276 (307)
Q Consensus       213 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~-------~~~~~~~~~~~~~~l~~li  276 (307)
                       ......+|..|+|||.+.+. .++.++|||       .+++ |+.||.+....       .......+..+++++.+||
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~-~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li  234 (258)
T d1k2pa_         156 TSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIM  234 (258)
T ss_dssp             CCCCCSCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             eeecccCCCCCcCCcHHhcCC-CCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHH
Confidence             23345789999999999988 899999999       3444 78899872211       1111223456789999999


Q ss_pred             HHhhhcCCCCCCCHHHHhcC
Q psy9858         277 SSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       277 ~~~l~~dP~~Rpt~~~il~h  296 (307)
                      .+||+.||++|||++++++|
T Consensus       235 ~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         235 YSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCCHhHCcCHHHHHHH
Confidence            99999999999999999987

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-51  Score=361.53  Aligned_cols=240  Identities=28%  Similarity=0.442  Sum_probs=190.3

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeee------
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG------  127 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~------  127 (307)
                      .++|++++.||+|+||+||+|++..+|+.||||++.....   .....+.+.+|+.+++.++||||+++++++.      
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~---~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~   92 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ---NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE   92 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS---SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc---CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccc
Confidence            4789999999999999999999999999999999986432   2223456889999999999999999999985      


Q ss_pred             ecCeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         128 YMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       128 ~~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      ...++|+||||+.|++.+.+..   .+++..++.++.||+.||.|||++||+||||||+|||++.++.++++|||+++..
T Consensus        93 ~~~~~~iv~Ey~~~~l~~~~~~---~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~  169 (355)
T d2b1pa1          93 EFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_dssp             TCCEEEEEEECCSEEHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             cCceeEEEEeccchHHHHhhhc---CCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcc
Confidence            3478999999999888887754   3899999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCcccccceeeceehhhhhhhccccccccccee---ee----eecCCCCCCCC-------------------------
Q psy9858         208 GSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FAKDPSSHGNL-------------------------  255 (307)
Q Consensus       208 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~~~~~f~~~~-------------------------  255 (307)
                      ... .......+|+.|+|||.+.+. .++.++|||   |+    ++|.+||.+..                         
T Consensus       170 ~~~-~~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  247 (355)
T d2b1pa1         170 GTS-FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_dssp             ------------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred             ccc-cccccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence            433 334455789999999999887 899999999   33    33999996521                         


Q ss_pred             -----------CCCCChhh------------hccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCC
Q psy9858         256 -----------FPGIPLNE------------IFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSL  301 (307)
Q Consensus       256 -----------~~~~~~~~------------~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~  301 (307)
                                 ........            .....++++.+||.+||+.||++|||++|+|+||||+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~  316 (355)
T d2b1pa1         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  316 (355)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence                       00011010            11234678999999999999999999999999999986

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-51  Score=359.97  Aligned_cols=242  Identities=33%  Similarity=0.504  Sum_probs=198.0

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec----
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM----  129 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~----  129 (307)
                      .++|++++.||+|+||+||+|++..+|+.||||++.+...   .....+.+.+|+++|++++||||+++++++...    
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~   93 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ---SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE   93 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS---SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTT
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc---ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccc
Confidence            4689999999999999999999999999999999986432   222345688999999999999999999998532    


Q ss_pred             --CeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         130 --SNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       130 --~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                        ...++++++.+|+|.+++...  .+++.+++.++.||+.||+|||++||+||||||+|||++.++.+|++|||++...
T Consensus        94 ~~~~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~  171 (348)
T d2gfsa1          94 EFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT  171 (348)
T ss_dssp             TCCCCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred             cCceEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhccc
Confidence              335555555588999988654  4999999999999999999999999999999999999999999999999999765


Q ss_pred             CCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCC--------------------------
Q psy9858         208 GSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGN--------------------------  254 (307)
Q Consensus       208 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~--------------------------  254 (307)
                      .   .......|++.|+|||.+.+...++.++|||   |    +++|.+||.+.                          
T Consensus       172 ~---~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  248 (348)
T d2gfsa1         172 D---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  248 (348)
T ss_dssp             T---GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred             C---cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccc
Confidence            3   2344568999999999988876789999999   3    33399999762                          


Q ss_pred             -----------CCCCCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccCCCc
Q psy9858         255 -----------LFPGIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKMDYFSLTK  303 (307)
Q Consensus       255 -----------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f~~~~  303 (307)
                                 .............+++++.+||.+||+.||++|||++|+|+||||++..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~  308 (348)
T d2gfsa1         249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  308 (348)
T ss_dssp             HHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             hhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence                       1122233334457899999999999999999999999999999998653

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-52  Score=352.28  Aligned_cols=236  Identities=21%  Similarity=0.286  Sum_probs=189.5

Q ss_pred             eEEeecCceEEEEEEEc--CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecCeEEEEEEc
Q psy9858          61 RSVHVGRFATVFKARDI--ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMSNVSLVFEF  138 (307)
Q Consensus        61 ~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  138 (307)
                      ++||+|+||+||+|.+.  .+++.||||++....   ......+.|.+|++++++++||||+++++++.. +..+|||||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~   88 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA---NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEM   88 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEEC
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh---CCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEc
Confidence            47999999999999754  456789999997532   223335679999999999999999999999865 457899999


Q ss_pred             c-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCCcc---c
Q psy9858         139 V-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPTRL---Y  214 (307)
Q Consensus       139 ~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~---~  214 (307)
                      + +|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+........   .
T Consensus        89 ~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          89 AELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             CTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred             CCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence            9 578888887654 5899999999999999999999999999999999999999999999999999877543222   2


Q ss_pred             ccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCC-------CCChhhhccccCHHHHHHHHHh
Q psy9858         215 THQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFP-------GIPLNEIFTAAGDDLLAVISSL  279 (307)
Q Consensus       215 ~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~-------~~~~~~~~~~~~~~l~~li~~~  279 (307)
                      ....||+.|+|||.+.+. .++.++|||       .+++ |.+||.+....       .......+..+++++.+||.+|
T Consensus       168 ~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~c  246 (277)
T d1xbba_         168 THGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLC  246 (277)
T ss_dssp             ---CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred             cccCCCceecCchhhcCC-CCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHH
Confidence            234688999999999887 899999999       3454 89999873211       1122234457899999999999


Q ss_pred             hhcCCCCCCCHHHH---hcCcccCCC
Q psy9858         280 LCLNPTKRADCTAT---LKMDYFSLT  302 (307)
Q Consensus       280 l~~dP~~Rpt~~~i---l~hp~f~~~  302 (307)
                      |+.||++|||++++   |+|+|+.-.
T Consensus       247 l~~dp~~RPs~~~i~~~L~~~~~~~~  272 (277)
T d1xbba_         247 WTYDVENRPGFAAVELRLRNYYYDVV  272 (277)
T ss_dssp             TCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred             cCCCHhHCcCHHHHHHHhhCHHhhcC
Confidence            99999999999998   567776543

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-52  Score=350.50  Aligned_cols=250  Identities=20%  Similarity=0.242  Sum_probs=196.0

Q ss_pred             ceeccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeee
Q psy9858          48 CEVKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG  127 (307)
Q Consensus        48 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~  127 (307)
                      ..+....++|++.+.||+|+||+||+|++.. ++.||||++.....      ..+.|.+|+.++++++||||+++++++.
T Consensus        10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~~------~~~~~~~E~~~l~~l~h~nIv~~~g~~~   82 (285)
T d1fmka3          10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM------SPEAFLQEAQVMKKLRHEKLVQLYAVVS   82 (285)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cceEcCHHHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECcccC------CHHHHHHHHHHHHhcccCCEeEEEEEEe
Confidence            3445567899999999999999999999754 46799999974321      1356899999999999999999999985


Q ss_pred             ecCeEEEEEEcc-CCChHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcc
Q psy9858         128 YMSNVSLVFEFV-DTDLEVIIKDP-TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAK  205 (307)
Q Consensus       128 ~~~~~~lv~e~~-~g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  205 (307)
                      + +..++||||+ +|++..++... ...+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus        83 ~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~  161 (285)
T d1fmka3          83 E-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR  161 (285)
T ss_dssp             S-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred             c-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhh
Confidence            4 5678999999 57777777643 3358999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCC-cccccceeeceehhhhhhhccccccccccee---eee----e-cCCCCCCCCC-------CCCChhhhccccC
Q psy9858         206 FFGSPT-RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CCF----A-KDPSSHGNLF-------PGIPLNEIFTAAG  269 (307)
Q Consensus       206 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i~----~-~~~~f~~~~~-------~~~~~~~~~~~~~  269 (307)
                      ...... .......+|+.|+|||.+.+. .++.++|||   +++    + |.+++.....       ........+..++
T Consensus       162 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~  240 (285)
T d1fmka3         162 LIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP  240 (285)
T ss_dssp             --------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSC
T ss_pred             hccCCCceeeccccccccccChHHHhCC-CCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccC
Confidence            764332 223345789999999999887 899999999   333    3 4555555211       1111223456789


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHhc--CcccCCCcccC
Q psy9858         270 DDLLAVISSLLCLNPTKRADCTATLK--MDYFSLTKEMY  306 (307)
Q Consensus       270 ~~l~~li~~~l~~dP~~Rpt~~~il~--hp~f~~~~~~~  306 (307)
                      +++.+||.+||+.||++|||++++++  ++||......|
T Consensus       241 ~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~  279 (285)
T d1fmka3         241 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY  279 (285)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCC
T ss_pred             HHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCC
Confidence            99999999999999999999999998  89998766543

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.7e-51  Score=348.32  Aligned_cols=242  Identities=23%  Similarity=0.291  Sum_probs=192.1

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC---
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS---  130 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---  130 (307)
                      .++|++.+.||+|+||+||+|++..+|+.||||++.+....+  ......+.+|+++++.++||||+++++++...+   
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~   83 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARD--PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG   83 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccC--HHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence            357999999999999999999999999999999998654322  334567899999999999999999999987654   


Q ss_pred             -eEEEEEEccC-CChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         131 -NVSLVFEFVD-TDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       131 -~~~lv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                       ..|+||||+. |+|.+++...+ .+++.+++.++.||+.||.|||++||+||||||+||+++.++.++|+|||.+....
T Consensus        84 ~~~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~  162 (277)
T d1o6ya_          84 PLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA  162 (277)
T ss_dssp             EEEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred             ceEEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhc
Confidence             4899999995 67777766543 58999999999999999999999999999999999999999999999999987664


Q ss_pred             CCC---cccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCC----------CCCChhhhcccc
Q psy9858         209 SPT---RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLF----------PGIPLNEIFTAA  268 (307)
Q Consensus       209 ~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~----------~~~~~~~~~~~~  268 (307)
                      ...   .......||+.|+|||++.+. .++.++|||   +    +++|.+||.+...          ...........+
T Consensus       163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (277)
T d1o6ya_         163 DSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL  241 (277)
T ss_dssp             ----------------TTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSC
T ss_pred             cccccccccccccCcccccCHHHHcCC-CCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCC
Confidence            322   234456899999999999887 899999999   3    4449999987321          111222334578


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy9858         269 GDDLLAVISSLLCLNPTKRADCTATLKMDYF  299 (307)
Q Consensus       269 ~~~l~~li~~~l~~dP~~Rpt~~~il~hp~f  299 (307)
                      |+++.+||.+||+.||.+||+..+.|.|+|.
T Consensus       242 s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~  272 (277)
T d1o6ya_         242 SADLDAVVLKALAKNPENRYQTAAEMRADLV  272 (277)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             CHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence            9999999999999999999955555556665

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-51  Score=347.54  Aligned_cols=240  Identities=17%  Similarity=0.260  Sum_probs=189.1

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEcCC---CcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeee
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDIET---DMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG  127 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~  127 (307)
                      ....++|++++.||+|+||.||+|.+..+   +..||||.+...    ..+.....+.+|++++++++||||+++++++.
T Consensus         3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~   78 (273)
T d1mp8a_           3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC----TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT   78 (273)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT----TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc----cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            34567999999999999999999998654   457889988643    22333567899999999999999999999985


Q ss_pred             ecCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         128 YMSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       128 ~~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                       ++..++||||+ +|++.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+|+.
T Consensus        79 -~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~  157 (273)
T d1mp8a_          79 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  157 (273)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             -cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhhee
Confidence             56789999999 5788888777777799999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCc-ccccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCCC-------CChhhhccccCH
Q psy9858         207 FGSPTR-LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFPG-------IPLNEIFTAAGD  270 (307)
Q Consensus       207 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~~-------~~~~~~~~~~~~  270 (307)
                      ...... ......+|+.|+|||.+.+. .++.++|||       .+++ |.+||.+.....       ......++++++
T Consensus       158 ~~~~~~~~~~~~~gt~~y~apE~l~~~-~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~  236 (273)
T d1mp8a_         158 MEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP  236 (273)
T ss_dssp             -------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred             ccCCcceeccceecCcccchhhHhccC-CCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence            643322 23345678999999999887 899999999       2343 888988733221       112234567899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         271 DLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       271 ~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      ++.+||.+||+.||++|||++|+++|
T Consensus       237 ~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         237 TLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999999999986

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-51  Score=345.34  Aligned_cols=237  Identities=16%  Similarity=0.245  Sum_probs=186.1

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCCC----cEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeec
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIETD----MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYM  129 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  129 (307)
                      .+.|++.+.||+|+||+||+|.+..++    ..||||++....    .+.....|.+|++++++++||||+++++++.+.
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~   81 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY----TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY   81 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc----ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence            457999999999999999999877654    479999997532    222345688999999999999999999999999


Q ss_pred             CeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccC
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFG  208 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  208 (307)
                      ...++||||+ +|++.+.+......+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+...
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence            9999999999 567777777776679999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCc---ccccceeeceehhhhhhhccccccccccee---e----eee-cCCCCCCCCC-------CCCChhhhccccCH
Q psy9858         209 SPTR---LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPSSHGNLF-------PGIPLNEIFTAAGD  270 (307)
Q Consensus       209 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~f~~~~~-------~~~~~~~~~~~~~~  270 (307)
                      ....   ......||+.|+|||.+.+. .++.++|||   +    +++ +.+++.....       ........+..+++
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  240 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS  240 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBH
T ss_pred             CCCccceEeccCCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHH
Confidence            3322   12234678999999999887 899999999   3    333 4444544111       11111223456789


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         271 DLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       271 ~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      ++.+||.+||+.||++|||+.|+++
T Consensus       241 ~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         241 AIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            9999999999999999999999976

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-51  Score=351.73  Aligned_cols=236  Identities=18%  Similarity=0.248  Sum_probs=191.1

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCc----EEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDM----IVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS  130 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  130 (307)
                      .+|++++.||+|+||+||+|.+..+|+    +||+|.+...    ......+.+.+|++++++++||||+++++++.++ 
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-   83 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   83 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC--------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc----cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence            469999999999999999999888776    5888887642    2223356799999999999999999999999765 


Q ss_pred             eEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCC
Q psy9858         131 NVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS  209 (307)
Q Consensus       131 ~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  209 (307)
                      ..+++++++ +|+|.+.+......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+|+....
T Consensus        84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            456677777 7899998888777899999999999999999999999999999999999999999999999999998754


Q ss_pred             CCcc--cccceeeceehhhhhhhccccccccccee---e----eee-cCCCCCCCCCCC-------CChhhhccccCHHH
Q psy9858         210 PTRL--YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPSSHGNLFPG-------IPLNEIFTAAGDDL  272 (307)
Q Consensus       210 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~f~~~~~~~-------~~~~~~~~~~~~~l  272 (307)
                      ....  .....||+.|+|||.+.+. .++.++|||   +    +++ |.+||.+.....       ......+..+++++
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~  242 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV  242 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHH
T ss_pred             ccccccccccccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHH
Confidence            3322  2334679999999999988 899999999   3    333 888988743221       11122345689999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         273 LAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       273 ~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      .+|+.+||+.||++|||+.|+++|
T Consensus       243 ~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         243 YMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhCCCChhhCcCHHHHHHH
Confidence            999999999999999999999987

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-50  Score=347.46  Aligned_cols=249  Identities=20%  Similarity=0.234  Sum_probs=204.5

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEc---CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCC-CCccccceeeee
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDI---ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH-ENVLGLTDVFGY  128 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~  128 (307)
                      ..++|++++.||+|+||+||+|++.   .+|+.||||++.+..... +....+.+.+|++++++++| |||+++++++.+
T Consensus        22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~  100 (322)
T d1vzoa_          22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ-KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  100 (322)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEE-EESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhcc-chHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence            5688999999999999999999874   468999999987543221 12224567799999999976 899999999999


Q ss_pred             cCeEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCcccc
Q psy9858         129 MSNVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFF  207 (307)
Q Consensus       129 ~~~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  207 (307)
                      ....+++|||+ +|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+|+..
T Consensus       101 ~~~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         101 ETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             CCceeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            99999999999 678888887554 4789999999999999999999999999999999999999999999999999876


Q ss_pred             CCC-Ccccccceeeceehhhhhhhccc-cccccccee---e----eeecCCCCCCCCCCCCChh----------hhcccc
Q psy9858         208 GSP-TRLYTHQVVTRWYRLIKCLLYCV-QFNVKNVQW---C----CFAKDPSSHGNLFPGIPLN----------EIFTAA  268 (307)
Q Consensus       208 ~~~-~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~Diw---~----i~~~~~~f~~~~~~~~~~~----------~~~~~~  268 (307)
                      ... ........+++.|+|||.+.+.. .++.++|||   |    +++|..||.+.........          ..+..+
T Consensus       180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~  259 (322)
T d1vzoa_         180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM  259 (322)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred             cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccC
Confidence            432 23345568899999999997653 478899999   3    3349999988544332111          123468


Q ss_pred             CHHHHHHHHHhhhcCCCCCC-----CHHHHhcCcccCCCc
Q psy9858         269 GDDLLAVISSLLCLNPTKRA-----DCTATLKMDYFSLTK  303 (307)
Q Consensus       269 ~~~l~~li~~~l~~dP~~Rp-----t~~~il~hp~f~~~~  303 (307)
                      ++++.+||.+||+.||++||     |++|+++||||++..
T Consensus       260 s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~  299 (322)
T d1vzoa_         260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  299 (322)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             CHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence            99999999999999999999     589999999998754

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.9e-50  Score=341.49  Aligned_cols=240  Identities=21%  Similarity=0.279  Sum_probs=196.5

Q ss_pred             ccccceeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCcccccee
Q psy9858          51 KNDLLVYYQWRSVHVGRFATVFKARDI-----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDV  125 (307)
Q Consensus        51 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~  125 (307)
                      ....++|++++.||+|+||+||+|++.     .+++.||||++....    .....+.|.+|++++++++||||++++++
T Consensus         9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~~E~~il~~l~h~niv~~~~~   84 (301)
T d1lufa_           9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA----SADMQADFQREAALMAEFDNPNIVKLLGV   84 (301)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             cCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc----ChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence            346778999999999999999999865     356899999987432    23345679999999999999999999999


Q ss_pred             eeecCeEEEEEEcc-CCChHHHHhCCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceee
Q psy9858         126 FGYMSNVSLVFEFV-DTDLEVIIKDPT-----------------------IVFTPSNIKAYAIMTLRGLEYLHDHWILHR  181 (307)
Q Consensus       126 ~~~~~~~~lv~e~~-~g~l~~~~~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~  181 (307)
                      +......+++|||+ +|+|.+++....                       ..+++..+..++.||+.||+|||++|++||
T Consensus        85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHr  164 (301)
T d1lufa_          85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR  164 (301)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEee
Confidence            99999999999999 688999886432                       137888999999999999999999999999


Q ss_pred             cCCCCcEEEecCCcEEEEeecCccccCCCC--cccccceeeceehhhhhhhccccccccccee---e----eeec-CCCC
Q psy9858         182 DLKPNNLLINKQGVLKIGDFGLAKFFGSPT--RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAK-DPSS  251 (307)
Q Consensus       182 dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~-~~~f  251 (307)
                      ||||+|||++.++.+||+|||+|+...+..  .......+++.|+|||.+.+. .++.++|||   +    ++++ .+||
T Consensus       165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC-CCChhhhhccchhhHHHHHccCCCCC
Confidence            999999999999999999999998764322  223345788999999999988 899999999   3    3335 5677


Q ss_pred             CCCCCC-------CCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         252 HGNLFP-------GIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       252 ~~~~~~-------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      .+....       .......+..+++++.+|+.+||+.||++|||+.|+++
T Consensus       244 ~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         244 YGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             TTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            762211       11122345578999999999999999999999999964

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-50  Score=336.34  Aligned_cols=238  Identities=21%  Similarity=0.238  Sum_probs=185.8

Q ss_pred             cceeeEEeEEeecCceEEEEEEEcCC-C--cEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeeecC
Q psy9858          54 LLVYYQWRSVHVGRFATVFKARDIET-D--MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGYMS  130 (307)
Q Consensus        54 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~--~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  130 (307)
                      .++|++.+.||+|+||+||+|++..+ +  ..||||++.+.....  ....+.|.+|++++++++||||+++++++.+ .
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~   83 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ--PEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P   83 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCC--HHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence            46799999999999999999986533 2  478999987643322  2335679999999999999999999999965 4


Q ss_pred             eEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCC
Q psy9858         131 NVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGS  209 (307)
Q Consensus       131 ~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  209 (307)
                      ..++||||+ .|++.+.+......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus        84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            678999999 6888888877666799999999999999999999999999999999999999999999999999998754


Q ss_pred             CCc---ccccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCC--------CCChhhhccccCH
Q psy9858         210 PTR---LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFP--------GIPLNEIFTAAGD  270 (307)
Q Consensus       210 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~--------~~~~~~~~~~~~~  270 (307)
                      ...   ......++..|+|||.+.+. .++.++|||       .+++ |.+||.+....        .....+.+..+++
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  242 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ  242 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred             CCCcceecCccccCcccCCHHHHhCC-CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccH
Confidence            322   12234578899999999987 899999999       2454 89999872111        1112233457899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         271 DLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       271 ~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      ++.+||.+||+.||++|||++++++
T Consensus       243 ~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         243 DIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999999999999999863

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-49  Score=340.68  Aligned_cols=242  Identities=19%  Similarity=0.262  Sum_probs=187.2

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEcC-----CCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccc
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDIE-----TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLT  123 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~  123 (307)
                      +....++|++++.||+|+||+||+|.+..     +++.||||++....    .....+.+.+|..++.++ +|+||+.++
T Consensus         8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~----~~~~~~~~~~e~~~l~~~~~h~~iv~~~   83 (299)
T d1ywna1           8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVNLL   83 (299)
T ss_dssp             HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC--------CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc----CcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence            33455789999999999999999998754     45789999987432    222345677888888877 689999999


Q ss_pred             eeeee-cCeEEEEEEcc-CCChHHHHhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCC
Q psy9858         124 DVFGY-MSNVSLVFEFV-DTDLEVIIKDPT---------------IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPN  186 (307)
Q Consensus       124 ~~~~~-~~~~~lv~e~~-~g~l~~~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~  186 (307)
                      +++.. +..+++||||+ +|+|.+++....               ..+++..+..++.||+.||.|||++||+||||||+
T Consensus        84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~  163 (299)
T d1ywna1          84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR  163 (299)
T ss_dssp             EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcc
Confidence            98755 45789999999 688999886432               24789999999999999999999999999999999


Q ss_pred             cEEEecCCcEEEEeecCccccCCCCc--ccccceeeceehhhhhhhccccccccccee---e----eee-cCCCCCCCCC
Q psy9858         187 NLLINKQGVLKIGDFGLAKFFGSPTR--LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPSSHGNLF  256 (307)
Q Consensus       187 Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~f~~~~~  256 (307)
                      |||++.++.+||+|||+|+.......  ......||+.|+|||.+.+. .++.++|||   +    +++ +.+||.+...
T Consensus       164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~  242 (299)
T d1ywna1         164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  242 (299)
T ss_dssp             GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred             ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999987643322  23445789999999999987 899999999   3    333 4667776432


Q ss_pred             CC--------CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         257 PG--------IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       257 ~~--------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      ..        ......+..+++++.+|+.+||+.||++|||++|+++|
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         243 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            21        11123345688999999999999999999999999987

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-49  Score=340.84  Aligned_cols=238  Identities=21%  Similarity=0.276  Sum_probs=193.4

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcE--EEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCCccccceeeeec
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMI--VAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHENVLGLTDVFGYM  129 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~  129 (307)
                      +.++|++.+.||+|+||+||+|++..+|..  ||||.+......    ...+.+.+|+++|.++ +||||+++++++.++
T Consensus         8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~   83 (309)
T d1fvra_           8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK----DDHRDFAGELEVLCKLGHHPNIINLLGACEHR   83 (309)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred             CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccCh----HHHHHHHHHHHHHHhccCCCCEeeEEEEEecC
Confidence            568999999999999999999999888764  677777643211    1245689999999999 799999999999999


Q ss_pred             CeEEEEEEcc-CCChHHHHhCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecC
Q psy9858         130 SNVSLVFEFV-DTDLEVIIKDP---------------TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ  193 (307)
Q Consensus       130 ~~~~lv~e~~-~g~l~~~~~~~---------------~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~  193 (307)
                      +..++||||+ +|+|.+++...               ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus        84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~  163 (309)
T d1fvra_          84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN  163 (309)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred             CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC
Confidence            9999999999 68999998654               3458999999999999999999999999999999999999999


Q ss_pred             CcEEEEeecCccccCCCCcccccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCC-------CC
Q psy9858         194 GVLKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLF-------PG  258 (307)
Q Consensus       194 ~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~-------~~  258 (307)
                      +.+||+|||+|+..... .......+|..|+|||.+.+. .++.++|||       .+++ +.+||.+...       ..
T Consensus       164 ~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~  241 (309)
T d1fvra_         164 YVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  241 (309)
T ss_dssp             GCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred             CceEEcccccccccccc-ccccceecCCcccchHHhccC-CCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence            99999999999876432 222344689999999999887 899999999       2344 4567766221       11


Q ss_pred             CChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         259 IPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       259 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      ......+..+++++.+||.+||+.||++|||++++++|
T Consensus       242 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         242 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            11223345689999999999999999999999999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=333.39  Aligned_cols=234  Identities=19%  Similarity=0.220  Sum_probs=187.5

Q ss_pred             eccccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeee-e
Q psy9858          50 VKNDLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFG-Y  128 (307)
Q Consensus        50 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-~  128 (307)
                      |....++|++++.||+|+||.||+|.+  .|..||||+++..       ...+.+.+|++++++++||||+++++++. .
T Consensus         2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~-------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~   72 (262)
T d1byga_           2 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE   72 (262)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC-------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred             CccCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH-------HHHHHHHHHHHHHHhCCCCCEeeEEEEEEec
Confidence            345677899999999999999999996  4788999999642       12456889999999999999999999885 4


Q ss_pred             cCeEEEEEEcc-CCChHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         129 MSNVSLVFEFV-DTDLEVIIKDPT-IVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       129 ~~~~~lv~e~~-~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                      .+.+++||||+ +|+|.+++.... ..+++..++.++.||+.||.|||+.+|+||||||+||+++.++.+||+|||+++.
T Consensus        73 ~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~  152 (262)
T d1byga_          73 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE  152 (262)
T ss_dssp             --CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred             CCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeeccccccee
Confidence            56789999999 688999886543 2489999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCcccccceeeceehhhhhhhccccccccccee-------eeee-cCCCCCCCCCC-------CCChhhhccccCHH
Q psy9858         207 FGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFA-KDPSSHGNLFP-------GIPLNEIFTAAGDD  271 (307)
Q Consensus       207 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~-~~~~f~~~~~~-------~~~~~~~~~~~~~~  271 (307)
                      ...   ......++..|+|||.+.+. .++.++|||       .+++ |.+||......       .....+.+..++++
T Consensus       153 ~~~---~~~~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~  228 (262)
T d1byga_         153 ASS---TQDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA  228 (262)
T ss_dssp             ------------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHH
T ss_pred             cCC---CCccccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence            633   23344678899999999887 899999999       3443 78888773222       12223445578899


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         272 LLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       272 l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      +.+||.+||+.||++|||+.+++++
T Consensus       229 ~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         229 VYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcccCHhHCcCHHHHHHH
Confidence            9999999999999999999999874

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-49  Score=340.31  Aligned_cols=250  Identities=18%  Similarity=0.182  Sum_probs=203.9

Q ss_pred             eeccccceeeEEeEEeecCceEEEEEEEcC-----CCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccc
Q psy9858          49 EVKNDLLVYYQWRSVHVGRFATVFKARDIE-----TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLT  123 (307)
Q Consensus        49 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~  123 (307)
                      .+..+.++|++++.||+|+||+||+|.+..     +++.||||++....    .......+.+|++++++++||||++++
T Consensus        14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~----~~~~~~~~~~E~~il~~l~h~nIv~~~   89 (308)
T d1p4oa_          14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA----SMRERIEFLNEASVMKEFNCHHVVRLL   89 (308)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS----CHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc----ChHHHHHHHHHHHHHHHcCCCCEeeee
Confidence            355667899999999999999999998752     46789999997432    222345688999999999999999999


Q ss_pred             eeeeecCeEEEEEEcc-CCChHHHHhCC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecC
Q psy9858         124 DVFGYMSNVSLVFEFV-DTDLEVIIKDP---------TIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQ  193 (307)
Q Consensus       124 ~~~~~~~~~~lv~e~~-~g~l~~~~~~~---------~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~  193 (307)
                      +++..+...++||||+ +|+|.+++...         ...+++..+..++.|++.||.|||+++|+||||||+|||++.+
T Consensus        90 ~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~  169 (308)
T d1p4oa_          90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED  169 (308)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT
T ss_pred             eEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCC
Confidence            9999999999999999 68888887532         1236888999999999999999999999999999999999999


Q ss_pred             CcEEEEeecCccccCCCCcc--cccceeeceehhhhhhhccccccccccee---ee----eec-CCCCCCCCCC------
Q psy9858         194 GVLKIGDFGLAKFFGSPTRL--YTHQVVTRWYRLIKCLLYCVQFNVKNVQW---CC----FAK-DPSSHGNLFP------  257 (307)
Q Consensus       194 ~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~i----~~~-~~~f~~~~~~------  257 (307)
                      +++||+|||+|+........  .....+|+.|+|||.+.+. .++.++|||   ++    +++ .+||.+....      
T Consensus       170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~-~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i  248 (308)
T d1p4oa_         170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV  248 (308)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred             ceEEEeecccceeccCCcceeeccceecccccCCHHHHccC-CCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            99999999999876433222  2344789999999999988 889999999   33    334 6777762211      


Q ss_pred             -CCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhc------CcccCCCc
Q psy9858         258 -GIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLK------MDYFSLTK  303 (307)
Q Consensus       258 -~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~------hp~f~~~~  303 (307)
                       .......+..+++.+.+||.+||+.||.+|||++++++      +|+|++..
T Consensus       249 ~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~~  301 (308)
T d1p4oa_         249 MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS  301 (308)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHC
T ss_pred             HhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCCC
Confidence             11122334568899999999999999999999999998      78887654

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-49  Score=335.78  Aligned_cols=244  Identities=19%  Similarity=0.262  Sum_probs=196.1

Q ss_pred             CceeccccceeeEEeEEeecCceEEEEEEEcCCC-------cEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCC
Q psy9858          47 DCEVKNDLLVYYQWRSVHVGRFATVFKARDIETD-------MIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHEN  118 (307)
Q Consensus        47 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~n  118 (307)
                      +..+....++|++++.||+|+||.||+|++..++       ..||||++....    .+.....+.+|...+.++ +|||
T Consensus         5 ~~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~~~e~~~l~~~~~Hpn   80 (299)
T d1fgka_           5 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA----TEKDLSDLISEMEMMKMIGKHKN   80 (299)
T ss_dssp             CTTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC----CHHHHHHHHHHHHHHHHHCCCTT
T ss_pred             CCcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc----ChHHHHHHHHHHHHHHHhcCCCe
Confidence            4446667789999999999999999999876543       479999997532    223356788999999888 7999


Q ss_pred             ccccceeeeecCeEEEEEEcc-CCChHHHHhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeec
Q psy9858         119 VLGLTDVFGYMSNVSLVFEFV-DTDLEVIIKDPT---------------IVFTPSNIKAYAIMTLRGLEYLHDHWILHRD  182 (307)
Q Consensus       119 i~~~~~~~~~~~~~~lv~e~~-~g~l~~~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~d  182 (307)
                      |+++++++.++...++||||+ +|+|.+++....               ..+++..++.++.||+.||+|||++||+|||
T Consensus        81 Iv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrD  160 (299)
T d1fgka_          81 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRD  160 (299)
T ss_dssp             BCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             EEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeee
Confidence            999999999999999999999 688999987543               3489999999999999999999999999999


Q ss_pred             CCCCcEEEecCCcEEEEeecCccccCCCC--cccccceeeceehhhhhhhccccccccccee---e----eee-cCCCCC
Q psy9858         183 LKPNNLLINKQGVLKIGDFGLAKFFGSPT--RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPSSH  252 (307)
Q Consensus       183 lkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~f~  252 (307)
                      |||+|||++.++.+||+|||+++......  .......+++.|+|||.+.+. .|+.++|||   +    +++ |.+||.
T Consensus       161 iKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~y~~k~DiwS~Gvvl~ell~~g~~p~~  239 (299)
T d1fgka_         161 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYP  239 (299)
T ss_dssp             CSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC-CCCchhhhHHhHHHHHHhccCCCCCCC
Confidence            99999999999999999999998774322  223345789999999999887 899999999   2    343 788887


Q ss_pred             CCCCC-------CCChhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         253 GNLFP-------GIPLNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       253 ~~~~~-------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      +....       .......+..+++++.+||.+||+.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         240 GVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             TCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            63211       11122334568999999999999999999999999986

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-48  Score=333.57  Aligned_cols=246  Identities=18%  Similarity=0.260  Sum_probs=201.5

Q ss_pred             CCCceeccccceeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhc-CCCC
Q psy9858          45 LPDCEVKNDLLVYYQWRSVHVGRFATVFKARDI-----ETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQEL-HHEN  118 (307)
Q Consensus        45 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~n  118 (307)
                      ..+..+....++|++++.||+|+||.||+|++.     .+++.||||++....    .......+.+|+.+++++ +|||
T Consensus        13 ~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~~E~~~~~~l~~Hpn   88 (311)
T d1t46a_          13 PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA----HLTEREALMSELKVLSYLGNHMN   88 (311)
T ss_dssp             CCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTT
T ss_pred             CCcccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc----CHHHHHHHHHHHHHHHhccCCCC
Confidence            334556667789999999999999999999853     467899999997532    223356788999999999 6999


Q ss_pred             ccccceeeeecCeEEEEEEcc-CCChHHHHhCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy9858         119 VLGLTDVFGYMSNVSLVFEFV-DTDLEVIIKDPT-----------------IVFTPSNIKAYAIMTLRGLEYLHDHWILH  180 (307)
Q Consensus       119 i~~~~~~~~~~~~~~lv~e~~-~g~l~~~~~~~~-----------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH  180 (307)
                      |+++++++.+....+++|||+ +|+|.+++....                 ..+++..+..++.||+.||+|||++|++|
T Consensus        89 Iv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivH  168 (311)
T d1t46a_          89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIH  168 (311)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             EEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence            999999999999999999999 678888886432                 24889999999999999999999999999


Q ss_pred             ecCCCCcEEEecCCcEEEEeecCccccCCCCc--ccccceeeceehhhhhhhccccccccccee---e----eee-cCCC
Q psy9858         181 RDLKPNNLLINKQGVLKIGDFGLAKFFGSPTR--LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFA-KDPS  250 (307)
Q Consensus       181 ~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~-~~~~  250 (307)
                      |||||+||+++.++.++|+|||.++.......  ......+|+.|+|||.+.+. .++.++|||   +    +++ |.++
T Consensus       169 rDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwS~G~~l~ellt~g~p~  247 (311)
T d1t46a_         169 RDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSP  247 (311)
T ss_dssp             SCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             cccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC-CCCCcccccchHHHHHHHHhCCCCC
Confidence            99999999999999999999999998754332  23346889999999999887 899999999   2    334 6666


Q ss_pred             CCCCCCCCCC--------hhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         251 SHGNLFPGIP--------LNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       251 f~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      |.+.......        ....+..+++++.+||.+||+.||++|||++|+++
T Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         248 YPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             STTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            6663332111        11223457899999999999999999999999986

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-47  Score=329.11  Aligned_cols=235  Identities=18%  Similarity=0.221  Sum_probs=189.0

Q ss_pred             eeEEeEEeecCceEEEEEEEcCCC---cEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCccccceeeee-cCeE
Q psy9858          57 YYQWRSVHVGRFATVFKARDIETD---MIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVLGLTDVFGY-MSNV  132 (307)
Q Consensus        57 y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~  132 (307)
                      +...++||+|+||+||+|.+..++   ..||||+++..    ......+.|.+|++++++++||||+++++++.. ++..
T Consensus        29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~  104 (311)
T d1r0pa_          29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  104 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC----CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEE
T ss_pred             eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc----cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCce
Confidence            344688999999999999976543   46999998742    223335779999999999999999999999765 5689


Q ss_pred             EEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecCccccCCCC
Q psy9858         133 SLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGLAKFFGSPT  211 (307)
Q Consensus       133 ~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  211 (307)
                      ++||||+ +|+|.+++......+++..+..++.|++.||.|+|+.+|+||||||+|||++.++.+||+|||+++......
T Consensus       105 ~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         105 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred             EEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence            9999999 578888888777778889999999999999999999999999999999999999999999999998764332


Q ss_pred             c----ccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCCC--------ChhhhccccCHHH
Q psy9858         212 R----LYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPGI--------PLNEIFTAAGDDL  272 (307)
Q Consensus       212 ~----~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~~--------~~~~~~~~~~~~l  272 (307)
                      .    ......+|..|+|||.+.+. .++.++|||       .++++..||........        .....+..+++++
T Consensus       185 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l  263 (311)
T d1r0pa_         185 FDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL  263 (311)
T ss_dssp             CCCTTCTTCSSCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHH
T ss_pred             cccceecccccccccccChHHHhcC-CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHH
Confidence            1    12234689999999999887 899999999       23445555554221111        1112335678999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         273 LAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       273 ~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                      .+||.+||+.||++|||+.|+++|
T Consensus       264 ~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         264 YEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999999998

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.7e-47  Score=327.28  Aligned_cols=238  Identities=18%  Similarity=0.180  Sum_probs=194.1

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCcc-ccceeeeecCeEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENVL-GLTDVFGYMSNVS  133 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~-~~~~~~~~~~~~~  133 (307)
                      ++|++++.||+|+||+||+|++..+|+.||||++.....       ...+.+|+++++.++|+|++ .+..++.+....+
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-------~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~   79 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-------HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   79 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-------SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-------CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence            479999999999999999999999999999999875321       23477899999999876655 4555667788999


Q ss_pred             EEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEec---CCcEEEEeecCccccCCC
Q psy9858         134 LVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK---QGVLKIGDFGLAKFFGSP  210 (307)
Q Consensus       134 lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~---~~~~kl~Dfg~a~~~~~~  210 (307)
                      +||||++|++.+.+......+++..+..++.|++.||+|||++||+||||||+||+++.   +..++|+|||+|+.....
T Consensus        80 ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          80 MVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             EEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            99999999998888877777999999999999999999999999999999999999863   557999999999987432


Q ss_pred             C-------cccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCCC--------------hh
Q psy9858         211 T-------RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGIP--------------LN  262 (307)
Q Consensus       211 ~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~~--------------~~  262 (307)
                      .       .......||+.|+|||.+.+. .++.++|||   +    +++|..||.........              ..
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE  238 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTB-CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred             ccccceeccccCCcCCCccccCHHHHhCC-CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence            2       122345799999999999987 899999999   3    33499999874332211              12


Q ss_pred             hhccccCHHHHHHHHHhhhcCCCCCCCHH---HHhcCcccC
Q psy9858         263 EIFTAAGDDLLAVISSLLCLNPTKRADCT---ATLKMDYFS  300 (307)
Q Consensus       263 ~~~~~~~~~l~~li~~~l~~dP~~Rpt~~---~il~hp~f~  300 (307)
                      ....++|+++.+++.+||+.||++||+++   ++|+|+|.+
T Consensus       239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence            23356899999999999999999999986   557787754

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.7e-46  Score=318.48  Aligned_cols=233  Identities=18%  Similarity=0.201  Sum_probs=196.8

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCC-CCccccceeeeecCeEE
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHH-ENVLGLTDVFGYMSNVS  133 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~~~  133 (307)
                      ++|++++.||+|+||+||+|++..+|+.||||++.....       ...+.+|+++++.++| +|++.+++++......+
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   77 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-------APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV   77 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-------SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-------cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence            589999999999999999999999999999999865321       2346789999999975 89999999999999999


Q ss_pred             EEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEec-----CCcEEEEeecCccccC
Q psy9858         134 LVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINK-----QGVLKIGDFGLAKFFG  208 (307)
Q Consensus       134 lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~-----~~~~kl~Dfg~a~~~~  208 (307)
                      +||||++|+|.+++......++...+..++.|++.||.|||++||+||||||+||+++.     ++.+||+|||+|+...
T Consensus        78 ~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          78 LVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             EEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence            99999999999999877777999999999999999999999999999999999999974     5689999999998764


Q ss_pred             CCC-------cccccceeeceehhhhhhhccccccccccee-------eeeecCCCCCCCCCCCC--------------C
Q psy9858         209 SPT-------RLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW-------CCFAKDPSSHGNLFPGI--------------P  260 (307)
Q Consensus       209 ~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw-------~i~~~~~~f~~~~~~~~--------------~  260 (307)
                      ...       .......||+.|+|||.+.+. .++.++|||       .+++|..||.+......              .
T Consensus       158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (293)
T d1csna_         158 DPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP  236 (293)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred             cCccccceeecccCceEEchhhcCHHHhcCC-CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence            321       123345799999999999987 899999999       23449999987443321              1


Q ss_pred             hhhhccccCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy9858         261 LNEIFTAAGDDLLAVISSLLCLNPTKRADCTATLK  295 (307)
Q Consensus       261 ~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  295 (307)
                      ..+...++++++.+++..|++.+|++||+.+.+.+
T Consensus       237 ~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            23334568899999999999999999998766544

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-46  Score=317.62  Aligned_cols=230  Identities=24%  Similarity=0.202  Sum_probs=177.4

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHH--HHHHHHhcCCCCccccceeeeecC--
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALR--EIKLLQELHHENVLGLTDVFGYMS--  130 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~--e~~~l~~l~h~ni~~~~~~~~~~~--  130 (307)
                      ..|.+.++||+|+||.||+|++  +|+.||||++...    .    .+.+.+  |+..+..++||||+++++++.++.  
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~----~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~   72 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR----E----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGT   72 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG----G----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc----c----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCc
Confidence            4789999999999999999985  6889999998632    1    223334  455556789999999999987653  


Q ss_pred             --eEEEEEEcc-CCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCceeecCCCCcEEEecCCcEEEE
Q psy9858         131 --NVSLVFEFV-DTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD--------HWILHRDLKPNNLLINKQGVLKIG  199 (307)
Q Consensus       131 --~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--------~~ivH~dlkp~Nil~~~~~~~kl~  199 (307)
                        .+++||||+ .|+|.+++.+.  .+++..+..++.|++.||.|+|+        +||+||||||+|||++.++.+||+
T Consensus        73 ~~~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~  150 (303)
T d1vjya_          73 WTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  150 (303)
T ss_dssp             SEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred             ceEEEEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEE
Confidence              689999999 68999999875  38999999999999999999996        599999999999999999999999


Q ss_pred             eecCccccCCCCc----ccccceeeceehhhhhhhccc-----cccccccee---e----eeecCCCCCCCCCCCCChh-
Q psy9858         200 DFGLAKFFGSPTR----LYTHQVVTRWYRLIKCLLYCV-----QFNVKNVQW---C----CFAKDPSSHGNLFPGIPLN-  262 (307)
Q Consensus       200 Dfg~a~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~-----~~~~~~Diw---~----i~~~~~~f~~~~~~~~~~~-  262 (307)
                      |||+++.......    ......||+.|+|||++.+..     .++.++|||   +    +++|..||........... 
T Consensus       151 DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~  230 (303)
T d1vjya_         151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD  230 (303)
T ss_dssp             CCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred             ecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh
Confidence            9999988744322    233467899999999987642     367899999   3    3347766644221111100 


Q ss_pred             ---------------------------hhccccCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy9858         263 ---------------------------EIFTAAGDDLLAVISSLLCLNPTKRADCTATLKM  296 (307)
Q Consensus       263 ---------------------------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h  296 (307)
                                                 .........+.+|+.+||+.||++|||+.|++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             cccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                                       0011223458999999999999999999999864

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.6e-44  Score=316.84  Aligned_cols=239  Identities=28%  Similarity=0.392  Sum_probs=185.2

Q ss_pred             ceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-----------CCCccccc
Q psy9858          55 LVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-----------HENVLGLT  123 (307)
Q Consensus        55 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~ni~~~~  123 (307)
                      ++|++++.||+|+||+||+|++..+|+.||||++.+.      ....+.+.+|+++++.++           |+||++++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~------~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~   86 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD------KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL   86 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc------ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence            3699999999999999999999999999999999742      222456778999888875           57899999


Q ss_pred             eeeee--cCeEEEEEEcc--CCCh-HHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCcEEEecCCc--
Q psy9858         124 DVFGY--MSNVSLVFEFV--DTDL-EVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD-HWILHRDLKPNNLLINKQGV--  195 (307)
Q Consensus       124 ~~~~~--~~~~~lv~e~~--~g~l-~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~--  195 (307)
                      +++..  ....+++|++.  .++. ..........+++..++.++.||+.||.|||+ .||+||||||+|||++.++.  
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~  166 (362)
T d1q8ya_          87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE  166 (362)
T ss_dssp             EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred             EEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence            88754  35666777766  3333 33334455568999999999999999999998 89999999999999987663  


Q ss_pred             ----EEEEeecCccccCCCCcccccceeeceehhhhhhhccccccccccee---e----eeecCCCCCCCCCCCC-----
Q psy9858         196 ----LKIGDFGLAKFFGSPTRLYTHQVVTRWYRLIKCLLYCVQFNVKNVQW---C----CFAKDPSSHGNLFPGI-----  259 (307)
Q Consensus       196 ----~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw---~----i~~~~~~f~~~~~~~~-----  259 (307)
                          ++++|||.+.....   ......+|+.|+|||.+.+. .++.++|+|   +    +++|+.||........     
T Consensus       167 ~~~~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~  242 (362)
T d1q8ya_         167 NLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  242 (362)
T ss_dssp             TEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             ccceeeEeeccccccccc---ccccccccccccChhhcccc-CCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence                99999999987643   23455899999999999987 889999999   3    3339999875211100     


Q ss_pred             ---------------------------------------C---hh-------hhccccCHHHHHHHHHhhhcCCCCCCCH
Q psy9858         260 ---------------------------------------P---LN-------EIFTAAGDDLLAVISSLLCLNPTKRADC  290 (307)
Q Consensus       260 ---------------------------------------~---~~-------~~~~~~~~~l~~li~~~l~~dP~~Rpt~  290 (307)
                                                             .   ..       ......++++.+||.+||..||++|||+
T Consensus       243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta  322 (362)
T d1q8ya_         243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  322 (362)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence                                                   0   00       0112346789999999999999999999


Q ss_pred             HHHhcCcccCCCc
Q psy9858         291 TATLKMDYFSLTK  303 (307)
Q Consensus       291 ~~il~hp~f~~~~  303 (307)
                      +|+|+||||++..
T Consensus       323 ~e~L~Hp~f~~~~  335 (362)
T d1q8ya_         323 GGLVNHPWLKDTL  335 (362)
T ss_dssp             HHHHTCGGGTTCT
T ss_pred             HHHhcCcccCCCC
Confidence            9999999998653

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.94  E-value=2.4e-26  Score=182.49  Aligned_cols=139  Identities=22%  Similarity=0.158  Sum_probs=106.5

Q ss_pred             eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCcccc-------------chhhhHhHHHHHHHHHhcCCCCccccc
Q psy9858          57 YYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADA-------------KDGINRTALREIKLLQELHHENVLGLT  123 (307)
Q Consensus        57 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------------~~~~~~~~~~e~~~l~~l~h~ni~~~~  123 (307)
                      +.+.++||+|+||+||+|.+ .+|+.||||+++.......             .........+|...+.++.|.+++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            46789999999999999997 5789999998764321100             011123345688899999999999887


Q ss_pred             eeeeecCeEEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCcEEEecCCcEEEEeecC
Q psy9858         124 DVFGYMSNVSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHDHWILHRDLKPNNLLINKQGVLKIGDFGL  203 (307)
Q Consensus       124 ~~~~~~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  203 (307)
                      ++..    .+++|||+++.....       ++...+..++.|++.+|.|||++||+||||||+|||++++ .++|+|||.
T Consensus        81 ~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~  148 (191)
T d1zara2          81 AWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ  148 (191)
T ss_dssp             EEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred             EecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence            6532    379999997654322       3444567899999999999999999999999999999865 589999999


Q ss_pred             ccccC
Q psy9858         204 AKFFG  208 (307)
Q Consensus       204 a~~~~  208 (307)
                      |....
T Consensus       149 a~~~~  153 (191)
T d1zara2         149 SVEVG  153 (191)
T ss_dssp             CEETT
T ss_pred             cccCC
Confidence            98764

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.84  E-value=1.6e-08  Score=82.23  Aligned_cols=142  Identities=14%  Similarity=0.032  Sum_probs=93.6

Q ss_pred             ccceeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-CCCccccceeeeecCe
Q psy9858          53 DLLVYYQWRSVHVGRFATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-HENVLGLTDVFGYMSN  131 (307)
Q Consensus        53 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~  131 (307)
                      ...+|++++..+.++.+.||+..  .++..+++|+........     ...+.+|...++.+. +--+.+++.+..+++.
T Consensus        12 ~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~-----~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~   84 (263)
T d1j7la_          12 LIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT-----TYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             HHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS-----TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             hhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc-----hhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence            44577777776666667899886  456678889876432111     234668888888774 5557788888888899


Q ss_pred             EEEEEEccCCChHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q psy9858         132 VSLVFEFVDTDLEVIIKDPTIVFTPSNIKAYAIMTLRGLEYLHD------------------------------------  175 (307)
Q Consensus       132 ~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~------------------------------------  175 (307)
                      .++||++++|..........  ..   ...++.++...+..||+                                    
T Consensus        85 ~~lv~~~l~G~~~~~~~~~~--~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T d1j7la_          85 SNLLMSEADGVLCSEEYEDE--QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEEEEECCSSEEHHHHTTTC--SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred             eEEEEEeccccccccccccc--cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence            99999999775332221111  01   11223333333333332                                    


Q ss_pred             -----------------C------CceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         176 -----------------H------WILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       176 -----------------~------~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                                       .      .++|+|+.|.||+++.++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                             1      278999999999998776667999999875

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.44  E-value=4.9e-07  Score=72.79  Aligned_cols=72  Identities=19%  Similarity=0.088  Sum_probs=50.0

Q ss_pred             EEeecC-ceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC--CCCccccceeeeecCeEEEEEEc
Q psy9858          62 SVHVGR-FATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH--HENVLGLTDVFGYMSNVSLVFEF  138 (307)
Q Consensus        62 ~lg~G~-~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~ni~~~~~~~~~~~~~~lv~e~  138 (307)
                      .+..|. .+.||+.. ..++..+++|......        ...+..|...++.+.  .-.+.+++.+..+.+..++||++
T Consensus        17 ~~~~G~s~~~v~r~~-~~~~~~~vlK~~~~~~--------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~   87 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGA--------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   87 (255)
T ss_dssp             ECSCTTSSCEEEEEE-CTTSCCEEEEEECSCT--------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             EcCCcccCCeEEEEE-eCCCCEEEEEeCCccC--------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEe
Confidence            344444 46789987 4567678899865432        123567888887774  34467788887888899999999


Q ss_pred             cCCC
Q psy9858         139 VDTD  142 (307)
Q Consensus       139 ~~g~  142 (307)
                      ++|.
T Consensus        88 i~G~   91 (255)
T d1nd4a_          88 VPGQ   91 (255)
T ss_dssp             CSSE
T ss_pred             eecc
Confidence            9763

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.34  E-value=7.2e-07  Score=76.71  Aligned_cols=80  Identities=18%  Similarity=0.051  Sum_probs=48.4

Q ss_pred             EeEEeecCceEEEEEEEcCCCcEEEEEEeecCCc--cccchhhhHhHHHHHHHHHhcC-C--CCccccceeeeecCeEEE
Q psy9858          60 WRSVHVGRFATVFKARDIETDMIVAVKKIKLGTH--ADAKDGINRTALREIKLLQELH-H--ENVLGLTDVFGYMSNVSL  134 (307)
Q Consensus        60 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~e~~~l~~l~-h--~ni~~~~~~~~~~~~~~l  134 (307)
                      .+.||.|....||+..+..+++.|++|.-.....  .+.-.....+...|.+.|+.+. +  ..+++++.+  +....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            4578999999999998777788999997543110  0100111234557888887663 2  345556543  5556689


Q ss_pred             EEEccCC
Q psy9858         135 VFEFVDT  141 (307)
Q Consensus       135 v~e~~~g  141 (307)
                      +||++++
T Consensus       109 vmE~L~~  115 (392)
T d2pula1         109 VMEDLSH  115 (392)
T ss_dssp             EECCCTT
T ss_pred             EEeccCC
Confidence            9999954

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.65  E-value=7.9e-05  Score=61.86  Aligned_cols=67  Identities=16%  Similarity=0.096  Sum_probs=43.5

Q ss_pred             ceEEEEEEEcCCCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcCCCCc--cccc-----eeeeecCeEEEEEEccC
Q psy9858          68 FATVFKARDIETDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELHHENV--LGLT-----DVFGYMSNVSLVFEFVD  140 (307)
Q Consensus        68 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni--~~~~-----~~~~~~~~~~lv~e~~~  140 (307)
                      --.||++. .++|..|++|+.+.+...      ..++..|...+..|...++  +..+     ..+..+...+.++++++
T Consensus        35 EN~vy~v~-~~dg~~~VlK~~rp~~~s------~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~  107 (325)
T d1zyla1          35 ENRVYQFQ-DEDRRRFVVKFYRPERWT------ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG  107 (325)
T ss_dssp             SSEEEEEC-CTTCCCEEEEEECTTTSC------HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred             cceeEEEE-cCCCCEEEEEEeCCCCCC------HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence            36799998 478899999998754221      3446678888877742222  1111     12345677889999986


Q ss_pred             C
Q psy9858         141 T  141 (307)
Q Consensus       141 g  141 (307)
                      |
T Consensus       108 G  108 (325)
T d1zyla1         108 G  108 (325)
T ss_dssp             C
T ss_pred             C
Confidence            5

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.48  E-value=0.00022  Score=60.71  Aligned_cols=72  Identities=14%  Similarity=0.086  Sum_probs=46.9

Q ss_pred             EEeEEeecCceEEEEEEEcC-------CCcEEEEEEeecCCccccchhhhHhHHHHHHHHHhcC-CCCccccceeeeecC
Q psy9858          59 QWRSVHVGRFATVFKARDIE-------TDMIVAVKKIKLGTHADAKDGINRTALREIKLLQELH-HENVLGLTDVFGYMS  130 (307)
Q Consensus        59 ~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~  130 (307)
                      .++.|+.|-.-.+|++....       .+..|++++.-..     ..  .....+|..+++.+. +.-..++++++.+  
T Consensus        46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-----~~--~idr~~E~~i~~~ls~~gl~Pkll~~~~~--  116 (395)
T d1nw1a_          46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-----ET--ESHLVAESVIFTLLSERHLGPKLYGIFSG--  116 (395)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-----CC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT--
T ss_pred             EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-----ch--hhHHHHHHHHHHHHHhCCCCCeEEEEcCC--
Confidence            34678888889999987542       2456777765421     11  123457888888884 4334577776643  


Q ss_pred             eEEEEEEccCC
Q psy9858         131 NVSLVFEFVDT  141 (307)
Q Consensus       131 ~~~lv~e~~~g  141 (307)
                        .+|+||+.|
T Consensus       117 --g~I~efi~g  125 (395)
T d1nw1a_         117 --GRLEEYIPS  125 (395)
T ss_dssp             --EEEECCCCE
T ss_pred             --ceEEEEecc
Confidence              588999966

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.12  E-value=0.00028  Score=58.02  Aligned_cols=31  Identities=23%  Similarity=0.234  Sum_probs=27.7

Q ss_pred             CCceeecCCCCcEEEecCCcEEEEeecCccc
Q psy9858         176 HWILHRDLKPNNLLINKQGVLKIGDFGLAKF  206 (307)
Q Consensus       176 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  206 (307)
                      .|+||+|+.+.||+++.+...-|+||+.|..
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccccCCcchhhhhcccccceeEeccccccc
Confidence            3799999999999999887779999999864